<SEC-DOCUMENT>0001193125-12-097283.txt : 20120306
<SEC-HEADER>0001193125-12-097283.hdr.sgml : 20120306
<ACCEPTANCE-DATETIME>20120305201601
ACCESSION NUMBER:		0001193125-12-097283
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20120306
DATE AS OF CHANGE:		20120305

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GALECTIN THERAPEUTICS INC
		CENTRAL INDEX KEY:			0001133416
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				043562325
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-172849
		FILM NUMBER:		12668488

	BUSINESS ADDRESS:	
		STREET 1:		7 WELLS AVENUE
		STREET 2:		STE 34
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02459
		BUSINESS PHONE:		617-559-0033

	MAIL ADDRESS:	
		STREET 1:		7 WELLS AVENUE
		STREET 2:		STE 34
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02459

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRO PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20010612
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d309840d424b5.htm
<DESCRIPTION>FORM 424(B)(5)
<TEXT>
<HTML><HEAD>
<TITLE>Form 424(b)(5)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Filed Pursuant to Rule 424(b)(5)<BR>Registration No. 333-172849 </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#873940">The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these
securities became effective under the Securities Act of 1933, as amended. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities, and we are not soliciting an offer to buy these securities,
in any jurisdiction where the offer or sale is not permitted. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:4px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#873940">PRELIMINARY PROSPECTUS SUPPLEMENT SUBJECT TO COMPLETION&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DATED MARCH 5, 2012
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">(To the Prospectus dated May&nbsp;2, 2011) </FONT></P> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>$15,000,000 of Units
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g95a35.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Units Consisting of Two Shares of Common Stock and One Warrant to Purchase One Share of Common Stock
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We are offering $15,000,000 of units, with each unit consisting of two common voting shares, par value $0.001 per share (which we refer to as our common stock), and one warrant to purchase one share of
common stock (and the shares of common stock issuable from time to time upon exercise of the offered warrants) pursuant to this prospectus supplement and the accompanying prospectus. We expect to effect a 1-for-6 reverse stock split of our
outstanding common stock just prior to the date of this prospectus supplement. The units may not be separated into the underlying shares of common stock and warrants until the earlier of (1) the exercise in full of the underwriters&#146;
over-allotment option and (2) forty-five (45) days from the date of this prospectus supplement; and thereafter, the units may be separable only upon the request of a holder. Each warrant will have an exercise price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, will be exercisable upon separation of the units and will expire five years from the closing of this offering. </FONT></P> <P STYLE="margin-top:4px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our common stock is presently quoted on the OTC Bulletin Board under the symbol &#147;GALT.&#148; We have applied to have the units, common stock and warrants listed on The NASDAQ Capital Market. On March
2, 2012, the last reported sale price of our common stock on the OTC Bulletin Board was $0.85 per share. There is presently no public market for our units or warrants. </FONT></P> <P STYLE="margin-top:4px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Our business and an investment in our securities involve a high degree of risk. See &#147;Risk Factors&#148; beginning on page S-19 of this prospectus supplement and on page 4 of the accompanying
prospectus.</B> </FONT></P> <P STYLE="margin-top:4px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these
securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B> </FONT></P>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Per&nbsp;Unit</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Public offering price</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Underwriting discount</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proceeds, before expenses, to us</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The underwriters will receive compensation in addition to the underwriting discount. See &#147;Underwriting&#148; beginning on page S-47 of this prospectus supplement
for a description of compensation payable to the underwriters. </FONT></TD></TR></TABLE> <P STYLE="margin-top:4px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The underwriters may also purchase up to an
additional&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; units from us at the public offering price, less the underwriting discount, within 45 days from the date of this prospectus supplement to cover over-allotments, if any. </FONT></P>
<P STYLE="margin-top:4px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The underwriters expect to deliver the units against payment therefor on or about March &nbsp;&nbsp;&nbsp;&nbsp;, 2012. </FONT></P>
<P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>Aegis Capital Corp </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">, 2012 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top">


<IMG SRC="g309840g10d26.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>Drugs that Inhibit Disease-Causing Galectin Proteins</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>1. Normal cells secrete small quantities of galectins </B></FONT></P>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g08f20.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>2. Increased levels of galectins are associated with diseases including cancer and fibrosis </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g23k41.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>3. Inhibition of galectins is associated with reduced disease pathology </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g91d00.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Prospectus Supplement </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="93%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Page</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_1">About This Prospectus Supplement</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_2">Cautionary Statement Regarding Forward-Looking Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_3">Prospectus Supplement Summary</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_4">Risk Factors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_5">Use of Proceeds</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-39</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_6">Market For Common Stock</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_7">Dividend Policy</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_8">Dilution</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_9">Description of the Securities We Are Offering</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_10">Underwriting</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_11">Legal Matters</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_12">Experts</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_13">Where You Can Find More Information</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_14">Incorporation of Documents by Reference</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">S-58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Prospectus </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="93%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Page</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>&nbsp;&nbsp;</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_15">About This Prospectus</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_16">Special Note Regarding Forward-Looking Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_17">About Pro-Pharmaceuticals, Inc.</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_18">Recent Developments</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_19">Risk Factors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_20">Use of Proceeds</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_21">Description of Securities</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_22">Description of Warrants</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_23">Description of Units</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_24">Plan of Distribution</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_25">Legal Matters</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_26">Experts</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_27">Where You Can Find More Information</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><A HREF="#suptoc309840_28">Incorporation of Documents By Reference</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-i
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of this offering and also
adds to and updates information contained in the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus. The second part is the accompanying prospectus, which is part of a
shelf registration statement on Form S-3 (File No.&nbsp;333-172849) that we filed with the Securities and Exchange Commission, or SEC, under the Securities Act of 1933, as amended, or the Securities Act. The accompanying prospectus gives more
general information about securities we may offer from time to time, including the units, common stock and warrants in this offering. Generally, when we refer to this prospectus, we are referring to both parts of this document combined together with
all documents incorporated by reference. If the description of the offering varies between this prospectus supplement and the accompanying prospectus, you should rely on the information contained in this prospectus supplement. However, if any
statement in one of these documents is inconsistent with a statement in another document having a later date&#151;for example, a document incorporated by reference into this prospectus supplement or the accompanying prospectus&#151;the statement in
the document having the later date modifies or supersedes the earlier statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">You should rely only on the information
contained in or incorporated by reference into this prospectus supplement, the accompanying prospectus and any free writing prospectus we file with the SEC to which we have referred you. We have not authorized anyone to provide you with information
that is different. If anyone provides you with different or inconsistent information, you should not rely on it. The information contained in, or incorporated by reference into, this prospectus supplement, the accompanying prospectus and any free
writing prospectus is accurate only as of the respective dates thereof, regardless of the time of delivery of this prospectus supplement, the accompanying prospectus and any free writing prospectus or of any sale of securities offered hereby. It is
important for you to read and consider all information contained in this prospectus supplement, the accompanying prospectus and any free writing prospectus, including the documents incorporated by reference herein and therein, in making your
investment decision. You should also read and consider the information in the documents to which we have referred you under the captions &#147;Where You Can Find More Information&#148; and &#147;Incorporation of Documents by Reference&#148; in this
prospectus supplement and in the accompanying prospectus. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are offering to sell, and are seeking offers to buy, the units
only in jurisdictions where such offers and sales are permitted. The distribution of this prospectus supplement and the accompanying prospectus and the offering of the units in certain jurisdictions or to certain persons within such jurisdictions
may be restricted by law. Persons outside of the United States who come into possession of this prospectus supplement and the accompanying prospectus must inform themselves about and observe any restrictions relating to the offering of the units and
the distribution of this prospectus supplement and the accompanying prospectus outside the United States. This prospectus supplement and the accompanying prospectus do not constitute, and may not be used in connection with, an offer to sell, or a
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-1
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
solicitation of an offer to buy, any securities offered by this prospectus supplement and the accompanying prospectus by any person in any jurisdiction in which it is unlawful for such person to
make such an offer or solicitation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Unless we have indicated otherwise or the context otherwise requires, references in this
prospectus supplement, the accompanying prospectus and the documents incorporated by reference herein and therein to the &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148; refer to Galectin Therapeutics Inc. and its
subsidiaries. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_2"></A>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">This prospectus supplement and accompanying prospectus, including the documents that we incorporate by reference, contain forward-looking
statements within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These statements relate to future events or our future financial performance and
can be identified by the use of forward-looking terminology such as &#147;project,&#148; &#147;may,&#148; &#147;could,&#148; &#147;expect,&#148; &#147;anticipate,&#148; &#147;estimate,&#148; &#147;continue&#148; or other similar words. These
forward-looking statements are based on management&#146;s current expectations and are subject to a number of factors and uncertainties which could cause actual results to differ materially from those described in these statements. The following are
some of the important factors that could cause our actual performance to differ materially from those discussed in the forward-looking statements: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have incurred significant operating losses since our inception and cannot assure you that we will generate revenue or profit;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Although we believe that we have sufficient cash on hand to meet our financial and operating obligations through the first quarter of 2013, if we
cannot obtain additional financing by the end of the first quarter of 2013, our operations may be restricted and we may ultimately be unable to continue to develop and potentially commercialize our product candidates; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are subject to extensive and costly regulation by the U.S. Food and Drug Administration, or FDA, which must approve our product candidates in
development and could restrict the sales and marketing of such products in development; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We may be unable to achieve commercial viability and acceptance of our proposed products; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We may be unable to improve upon, protect and/or enforce our intellectual property; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We may be unable to enter into strategic partnerships for the development, commercialization, manufacturing and distribution of our proposed product
candidates; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are subject to significant competition; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-2
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">As a publicly traded company, we may be required to implement additional and expensive finance and accounting systems, procedures and controls as we
grow our business and organization to satisfy new reporting requirements, which will increase our costs and require additional management resources; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">The net proceeds from this offering may be invested in a way that does not yield a return, if any, that is favorable to us.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We caution investors that actual results or business conditions may differ materially from those projected
or suggested in forward-looking statements as a result of various factors including, but not limited to, those described above, those described in the &#147;Risk Factors&#148; section of this prospectus supplement and the other information in this
prospectus supplement, the accompanying prospectus and our Annual Report on Form 10-K for the year ended December&nbsp;31, 2010. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">We cannot assure you that we have identified all of the factors that create uncertainties. Moreover, new risks emerge from time to time and it is not possible for our management to predict all risks, nor
can we assess the impact of all risks on our business or the extent to which any risk, or combination of risks, may cause actual results to differ from those contained in any forward-looking statements. You should not place undue reliance on
forward-looking statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">You should read this prospectus supplement, the accompanying prospectus and the documents that we
incorporate by reference herein and therein completely and with the understanding that our actual future results may be materially different from what we expect. You should assume that the information appearing in this prospectus supplement, the
accompanying prospectus and the information incorporated by reference is accurate only as of their respective dates. Our business, financial condition, results of operations and prospects may change. We undertake no obligation to publicly release
the result of any revision of these forward-looking statements to reflect events or circumstances after the date they are made or to reflect the occurrence of unanticipated events. We qualify all of the information included or incorporated by
reference in this prospectus supplement and the accompanying prospectus and particularly our forward-looking statements, by these cautionary statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-3
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_3"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>This summary highlights information contained elsewhere or incorporated by reference into this prospectus supplement and the
accompanying prospectus. This summary does not contain all of the information that you should consider before deciding to invest in our securities. You should read this entire prospectus supplement and the accompanying prospectus carefully,
including the &#147;Risk Factors&#148; section contained in this prospectus supplement and our consolidated financial statements and the related notes and the other documents incorporated by reference into this prospectus supplement and the
accompanying prospectus. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Business Overview </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are a development-stage company engaged in drug development to create new therapies for cancer and fibrotic disease. Our drug
candidates are based on our method of targeting galectin proteins, which are key mediators of biologic and pathologic function. We use naturally occurring plant materials to create complex carbohydrates with specific molecular weights and
pharmaceutical properties. Using these unique carbohydrate-based candidate compounds that bind and inhibit galectin proteins, we are undertaking the pursuit of therapies for indications where galectins have a demonstrated role in the pathogenesis of
a given disease. We focus on diseases with serious, life-threatening consequences to patients and those where current treatment options are limited. Our strategy is to establish clinical development programs that add value to our business in the
shortest period of time possible and to seek strategic partners when a program becomes advanced and requires additional resources. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">We attempt to leverage our scientific and development expertise as well as established relationships with outside sources to achieve cost-effective and efficient development. We are pursuing a development
pathway to clinical enhancement and commercialization for our lead compounds in immune enhancement for cancer therapy as well as in both liver fibrosis and fatty liver disease. All of our proposed products are presently in development, including
pre-clinical and clinical trials. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Drug Compounds </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have two compounds in development, one intended to be used in cancer therapy and the other intended to be used in the treatment of
liver fibrosis and fatty liver disease. These two compounds are produced from completely different natural starting materials, both possessing the property which lends itself to binding to and inhibiting galectin proteins. GM-CT-01, our lead product
candidate for cancer therapy, is a proprietary linear polysaccharide polymer comprised of mannose and galactose that has a precisely defined chemical structure and is derived from a plant source. GR-MD-02, our lead product for treatment of liver
fibrosis and fatty liver disease with inflammation and fibrosis, is a proprietary complex polysaccharide polymer possessing both linear and globular structures, which also is derived from a plant source. </FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-4
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We believe the mechanism of action for GM-CT-01 and GR-MD-02 is based upon interaction
with, and inhibition of, galectin proteins, which are expressed at high levels in certain pathological states including inflammation, fibrosis and cancer. While GM-CT-01 and GR-MD-02 are capable of binding to multiple galectin proteins, we believe
that they have the greatest affinity for galectin-3, the most prominent galectin implicated in pathological processes. Blocking galectin in cancer and liver fibrosis has specific salutary effects on the disease process, as discussed below.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Galectin Inhibition in Cancer Therapy </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">We believe the potential exists for galectin inhibition to play an important role in cancer therapy. Galectin proteins, particularly galectin-1 and galectin-3, have been shown to be highly expressed in
the majority of cancers and have multiple roles in promoting cancer progression, including tumor cell invasion, metastasis, angiogenesis, and tumor evasion of the immune system. GM-CT-01 has progressed in development for the therapy of colorectal
cancer and is currently in a Phase I/II clinical trial as a combination therapy with a tumor vaccine in patients with advanced melanoma. The current developmental approach for GM-CT-01 is to enhance the activity of the immune system against the
cancer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We believe the potential exists for galectin inhibition to play a key role in the burgeoning area of cancer
immunotherapy. For example, there have been two recent approvals of drugs for using the patient&#146;s immune system to fight cancer, Provenge (Dendreon; a dendritic cell tumor vaccine) and Yervoy (BMC; a monoclonal inhibitor of CTLA4, which
activates cytotoxic T-cells). With many additional vaccines and immune stimulatory agents in development, industry analysts forecast that this market could grow to over $7 billion by 2015. It is our goal to produce an effective galectin inhibitor
that enhances the immune system&#146;s ability to fight cancer and, most important, that complements other approaches to this type of therapy. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">The role of galectins in cancer immunotherapy can be understood through the &#147;Galectin Effect&#148;, a recent discovery of how tumors avoid the body&#146;s own immune system. Our current program to
block the &#147;Galectin Effect&#148; is based on the research of Dr.&nbsp;Pierre van der Bruggen (of the Ludwig Institute of Cancer Research in Brussels, Belgium), demonstrating that galectin-3, which is produced by the vast majority of human
cancers, binds to and blocks the actions of tumor-infiltrating T-lymphocytes, the major immune cell in the body&#146;s defense against cancers (see figure of &#147;Galectin Effect&#148; below). Based on these results, we believe that the body&#146;s
immune cells are unable to attack and kill tumor cells in the presence of galectins. Using this approach, the mechanism of action for GM-CT-01 seeks to block galectins and, in turn, restore the ability of the T-lymphocytes to kill tumor cells.
</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-5
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P>&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g56y77.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We recently initiated a Phase I/II clinical trial of GM-CT-01 in Belgium in combination with a tumor
vaccine in patients with advanced melanoma, a deadly skin cancer. The Belgian Federal Agency of Medicine and Health Products, or FAMHP, granted approval for this clinical trial, which is being conducted at three centers in Belgium and one in
Luxembourg. The operational conduct of the trial is under the control of the Cancer Centre at the Cliniques Universitaires Saint-Luc and the Ludwig Institute for Cancer Research. The study has been initiated and patients are beginning to be
enrolled. We expect the first patient to be enrolled in March or April of 2012. We expect the first stage of this trial (involving 12 evaluable patients) to be completed within a year of enrollment of the first patient and that it will provide data
that could deliver an indication of efficacy. Depending on the results of Stage 1, the study could continue enrollment to complete Stage 2 (46 total patients), initiate a new Phase II trial based on positive results or be halted because of lack of
efficacy. Stage 1 of the trial is being funded by the Cancer Centre at the Cliniques Universitaires Saint-Luc and Stage 2 will require funding from the Company, currently estimated at approximately $1 million. Positive results from this study could
indicate that this approach of inhibiting the &#147;Galectin Effect&#148; would be an enabling technology for therapy in other tumor types. The Phase I/II clinical trial in Belgium is not being conducted under an FDA-approved IND, but there is an
open IND under the FDA for GM-CT-01. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">There are two additional pathways for the development of GM-CT-01 for use in treatment
of cancer. GM-CT-01 was found to be generally safe when studied in a Phase I clinical trial in end-stage cancer patients with multiple tumor types alone and in combination with 5-Fluorouracil (5-FU), which is an FDA-approved chemotherapy used for
treatment of various types of cancer. Three Phase II studies were conducted, but were only partially completed due to financing issues. DAVFU-003 was a Phase II, multi-center, open-label trial in end-stage, line 3/4&nbsp;metastatic colorectal cancer
patients, who were treated with a combination of GM-CT-01 and 5-FU. In the 20 enrolled patients, the median survival was 6.7 months and there was a notable reduction in the expected adverse events related to 5-FU therapy.
</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-6
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
DAVFU-003 was terminated in 2007. Although only partially completed, when compared to historical controls, the data collected for DAVFU-003 suggested a favorable effect of the therapy, since the
controls had an overall survival of 4.6 months. DAVFU-006 was a Phase II, open-label clinical trial in line 1 patients with locally advanced and unresectable or metastatic colorectal cancer (who were unable to tolerate intensive chemotherapy), who
were treated with a regimen of GM-CT-01, 5-FU, leucovorin and Avastin<FONT STYLE="font-family:Times New Roman" SIZE="2"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>. Ten patients were enrolled in this
study. DAVFU-006 was terminated in March 2010. Finally, DAVFU-007 was a Phase II, multi-center, open-label clinical trial to evaluate the efficacy and safety of GM-CT-01 in combination with 5-FU when administered as first line chemotherapy in
patients with advanced biliary cancer. Seventeen patients were enrolled in this study. This study was stopped in March 2010. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">It was notable in these four studies that, when the results of adverse events were pooled, there appeared to be a marked reduction in the
severity of 5-FU related adverse events when compared to historical controls. To examine 5-FU related side effects in patients receiving GM-CT-01 in all of the clinical trials, a post-hoc analysis was conducted of adverse events typically related to
5-FU including, diarrhea, nausea and vomiting, mucositis and neutropenia/leukopenia. Studies for comparison to our data were culled from the literature, providing a broad spectrum of 1128 patients treated with 5-FU (see table below). Comparison of
adverse events between the literature-derived patients and the 57 patients in our clinical trials that received 5-FU with full dose GM-CT-01 demonstrates that patients in our trials had a markedly lower grade: 3/4 adverse events for all of the 5-FU
related toxicities. These data suggest that GM-CT-01 may ameliorate toxicities related to 5-FU, which are important limiting events in cancer chemotherapy. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>
<TR>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Event in percent</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:56pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of patients (%)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Kabbinavar&nbsp;5-FU/LV</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Cunningham&nbsp;5-FU/LV</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bolus&nbsp;5-FU/LV</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>5-FU/LV (Mayo)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>5-FU+GM-CT-01</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N=104</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N=212</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N=219</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N=593</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>N=57</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Adverse Events</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Grade 3-4 (%)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Grade 3-4 (%)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Grade&nbsp;3-4&nbsp;(%)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Grade&nbsp;3-4&nbsp;(%)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Grade 3-4 (%)</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Diarrhea</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Nausea/Vomiting</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NR</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;2</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mucositis</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NR</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">NR</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;2</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Neutropenia/ Leukopenia</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;2</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Data on 5-FU adverse events in the above table were compiled from the following references: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rothenberg ML, et al. J Clin Oncol 19(18):3801-7, 2001. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chiara S, et al. Cancer Chemother Pharmacol 42 (4): 336-40, 1998. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Goldberg RM, et al. J Clin Oncol 15 (11): 3320-9, 1997. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sloan JA, et al. J Clin Oncol 20(6):1491-8, 2002. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tsalic M, et al. Am J Clin Oncol 26(1): 103-6, 2003. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kabbinavar, FF, et al J Clin Oncol 23:3697-370, 2005. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cunningham, D, et. al. Ann Oncol 7:961-965, 1996. </FONT></TD></TR></TABLE>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-7
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Based on these completed Phase I and partially completed Phase II clinical trials, we
are exploring two additional potential indicia for the use of GM-CT-01 in combination with cancer chemotherapy: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are seeking potential strategic partners to assist in researching the use of GM-CT-01 in the amelioration of 5-FU related side effects. Such a
partnership would permit additional clinical trials in the U.S., which would not be started until a partnership was consummated; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are attempting to gain regulatory approval of GM-CT-01 for use in combination with 5-FU for metastatic colorectal cancer in Colombia. This approach
was recommended to the Company by key oncology opinion leaders in Colombia and by PROCAPS S.A., a Colombia-based pharmaceutical company. While Colombian marketing is not a central component of our overall corporate strategy, it could potentially
help us to generate revenue in 2012 to support development programs, reduce the amount of capital we would need to raise in future equity offerings and gain additional clinical experience with GM-CT-01. There can be no assurance that we will receive
regulatory approval of GM-CT-01 in Colombia, particularly since there has been no approval of GM-CT-01 in a major region such as the U.S. or Europe. Moreover, even if we receive approval in Colombia, we cannot assure you that our approach will yield
successful results or that we will generate any revenue or lead to approval in any other countries, including the United States. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Liver Fibrosis: New Approach for an Unmet Medical Need </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The second main
initiative in our development strategy is the application of galectin inhibition in connection with liver fibrosis, a condition that leads to cirrhosis. Currently, nearly 500,000 patients have cirrhosis with nearly 50,000 losing their lives yearly
in the United States, while only 6,200 were saved by liver transplantation at a cost of $350,000 per transplantation. In addition, the National Institute of Health estimates that 9&nbsp;million to 15&nbsp;million Americans are affected by a form of
liver fibrosis known as non-alcoholic steatohepatitis, or NASH. NASH (also known as fatty liver disease) is a liver disease characterized by the accumulation of fat in the liver with associated inflammation and fibrosis that can lead to end-stage
cirrhosis requiring a liver transplantation. The NIH forecasts that the number of Americans affected by NASH is growing due to obesity and diabetes, and that NASH is an epidemic which has the potential to become the leading cause of liver cirrhosis
and liver transplantation in the future. To the best of our knowledge, there are currently no therapies on the market for NASH or other forms of liver fibrosis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">We believe that GR-MD-02 has the potential to treat NASH and other forms of liver fibrosis. The driving factor for our commitment to galectin inhibition for fibrosis is scientific evidence that strongly
suggests that galectin-3 is essential for the development of liver fibrosis in animals. Published data show that mice lacking the galectin-3 gene are incapable of developing liver fibrosis in response to toxin insult to the liver and in fatty liver
disease. Moreover, mice that do not have the galectin-3 gene are resistant to lung and kidney fibrosis. </FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-8
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have evaluated the ability of GR-MD-02 to block galectin-3 in animal models of liver
fibrosis, the conclusions of which yielded positive results. In the figure below, the microscopic section on the left shows a rat liver that was treated with a chemical toxin for eight weeks, which induced liver fibrosis and then was given a placebo
for four weeks. The reddish scars that marble the tissue in this rat liver are indicative of severe fibrosis. In contrast, the figure on the right shows a microscopic section of a rat liver that was treated with the same chemical toxin for eight
weeks and then given GR-MD-02 for four weeks. We believe that the lack of scar tissue seen in the figure on the right indicates that treatment with GR-MD-02 is able to reverse and prevent the development of scar tissue in the liver. These
experiments, along with several others that include human liver cells, have identified what we believe to be the mechanism of action for the creation of fibrotic scar tissue in the liver. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g48r20.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Recently, we presented pre-clinical data at the European Society for the Study of the Liver in Lisbon,
Portugal, which data demonstrated that GR-MD-02 reversed NASH-induced fibrosis in the liver of mice. The animal model used was analogous to that of humans, in that the mice were given diabetes and then subsequently fed a high-fat diet, both
conditions associated with the human disease. The figure below shows that there is a reduction in fat accumulation, hepatocyte degeneration and inflammation in the liver histology on the left after 4 weeks of treatment with GR-MD-02, which was
administered twice a week. The significant improvement is confirmed using a standard NASH grading system as shown in the graph on the right of the figure. </FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-9
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P>&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g86k91.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">In the next figure, the percent of collagen in the livers (fibrotic tissue as demonstrated by percent
Sirius red staining) was reduced by treatment with GR-MD-02 to levels equivalent to normal levels irrespective of whether treatment was started early (before fibrosis developed) or late (after the development of fibrosis). These effects in the NASH
mice were independent of serum glucose and lipid levels, which were elevated in all animals. In addition, the galectin-3 levels in the liver tissue were markedly reduced by the therapy, indicating the proposed mechanism of inhibiting galectin-3 is
likely operative. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g12d74.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">In summary, our pre-clinical data show that GR-MD-02 may have a therapeutic effect on liver fibrosis
as shown in several relevant animal models. Therefore, we chose GR-MD-02 as </FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-10
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
the lead candidate in a development program targeted initially at fibrotic liver disease associated with NASH. GR-MD-02 is currently being evaluated in pre-clinical toxicology and pharmacology
studies with the aim of obtaining an IND from the FDA by the end of 2012 for initiating human studies in patients with NASH. We will seek to gain FDA approval for Phase I and Phase II studies of GR-MD-02 in NASH as well as other indications in
diseases with liver fibrosis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Certain Contractual Arrangements </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The 10X Fund, L.P. owns all of our issued and outstanding Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred
Stock (together, the Series B Preferred Stock). As a holder of Series B Preferred Stock, the 10X Fund is entitled to various rights with respect to our corporate governance. See &#147;Risk Factors&#151;Risks Related to Our Common Stock and this
Offering&#151;One investor and certain of our directors, by virtue of ownership of our securities and related rights, may be able to control the Company&#148; in this prospectus supplement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">In February 2009, we entered into a separation agreement in connection with the resignation of David Platt, Ph.D., our former Chief
Executive Officer and Chairman of the Board of Directors. This separation agreement provides, among other things, for the deferral of a $1.0 million severance payment, due to Dr.&nbsp;Platt under his employment agreement, for six (6)&nbsp;months
following (1)&nbsp;the renewed listing of our securities on a national securities exchange and (2)&nbsp;our achieving a market capitalization of $100 million. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>Recent Developments </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Reverse Stock Split </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We expect to effect a 1-for-6 reverse stock split of our outstanding common stock just prior to the date of this prospectus supplement.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Changes to Management </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">On March 2, 2012, we entered into a consulting agreement with Thomas A. McGauley, pursuant to which Mr. McGauley will serve as our Acting Chief Financial Officer, effective March 6, 2012. Mr. McGauley
will serve as Acting Chief Financial Officer until the earlier of September 30, 2012 and the time upon which a permanent Chief Financial Officer can be found. Mr. McGauley replaces Anthony D. Squeglia, who will step down from his current role as our
Chief Financial Officer and leave the Company upon the expiration of his executive employment agreement on March 6, 2012. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">In
addition, on March 1, 2012, we extended the term of our employment agreement with Maureen E. Foley, our Chief Operating Officer, until June 30, 2012. </FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-11
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Cancer Program </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">On December&nbsp;8, 2011, we, the Cancer Centre at the Cliniques Universitaires Saint-Luc and the Ludwig Institute for Cancer Research, or LICR,
announced the initiation of a Phase 1/2 safety and efficacy trial testing a novel treatment combination in patients with advanced metastatic melanoma. The Belgian Federal Agency of Medicine and Health Products, or FAMHP, granted approval to evaluate
GM-CT-01 together with an LICR peptide vaccine. The trial will enroll up to 46 patients from four clinical centers in Belgium and Luxembourg. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">On October&nbsp;18, 2011, we entered into a Collaboration, Supply, Marketing and Distribution Agreement (which supersedes a March 2010 definitive term
sheet) which grants PROCAPS exclusive rights to market and sell GM-CT-01 in Colombia. PROCAPS is a large, international, privately-held pharmaceutical company based in Barranquilla, Colombia. Under terms of the agreement, PROCAPS is responsible for
obtaining regulatory and pricing approval in Colombia. PROCAPS also will be responsible for the vial filling, packaging, marketing and distribution of GM-CT-01 in the region. In October 2010, we received a payment of $200,000 and shipped GM-CT-01 to
PROCAPS to be used by PROCAPS to qualify its vial filling process and to replicate our stability study. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Liver Fibrosis Program </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Between June 2011 and February 2012, we conducted pre-clinical experiments to directly compare the utility of GM-CT-01 and GR-MD-02 in the treatment of
experimental fibrosis. The pre-clinical results showed that GR-MD-02 was the superior drug and, therefore, has been named the lead product candidate for the treatment of liver fibrosis and fatty liver disease, while GM-CT-01 remains the lead product
candidate for cancer therapy. Pre-clinical toxicology studies of GR-MD-02 are currently in progress and we plan to file an IND for GR-MD-02 in NASH and liver fibrosis by the end of 2012. In addition, a Phase I clinical trial in NASH is planned to
begin in the first quarter of 2013 with top line results expected in the third quarter of 2013 and Phase II studies in NASH and post-transplantation fibrosis to follow. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">In December 2011, we presented our preclinical and animal experimental results at the European Association for the Study of the Liver demonstrating
that GR-MD-02 was effective in reducing pathology in a mouse model of NASH, including a reduction in liver cell fat, necrosis, inflammation and collagen deposition. We believe these results establish GR-MD-02 as a candidate for NASH therapy, a large
unmet medical need. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">In October 2011, we announced the formation of a clinical trial advisory group composed of representatives from liver centers of Massachusetts General
Hospital (Harvard), Mount Sinai School of Medicine, University of Pennsylvania, Emory University, the University of Michigan and University of Wisconsin. </FONT></P></TD></TR></TABLE>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-12
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">In December 2010, we announced an extension of our research collaboration with Mount Sinai School of Medicine which began in 2006 to evaluate, in
pre-clinical models, the anti-fibrotic effects of several of our novel, galectin-targeting compounds. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Risks </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are a development-stage company and have not generated any revenues to date. Since our inception, we have incurred net losses in each
year of operation. Our business and our ability to execute our business strategy are subject to a number of risks of which you should be aware before you decide to invest in the units, including our common stock and the warrants, offered hereby. In
particular, you should carefully consider the following risks, which are discussed more fully under &#147;Risk Factors&#148; beginning on page S-19 of this prospectus supplement. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have incurred net losses to date, and if we do not raise additional capital by the end of the first quarter of 2013, we may not be able to develop
our product candidates. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are a development-stage company and have not yet generated any revenue. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are largely dependent on the success of our two lead product candidates, GM-CT-01 and GR-MD-02 and we cannot be certain that these product
candidates will receive regulatory approval or be successfully commercialized. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Even if we receive regulatory approval, we may be unable to commercialize our product candidates. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Performance milestones may not occur as contemplated by the agreement with PROCAPS. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">There are risks associated with our reliance on third parties to conduct trial protocols, including arranging for and monitoring the clinical trials
and collecting and analyzing data. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">There are risks associated with our reliance on third parties for manufacturing, marketing, sales, managed care and distribution infrastructure and
channels. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are exposed to product liability, pre-clinical and clinical liability risks, which could place a financial burden upon us, should we be sued,
because we do not currently have product liability insurance beyond our general insurance coverage. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We face intense competition in the biotechnology and pharmaceutical industries. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">The market for our proposed products is rapidly changing and competitive, and new drugs and new treatments which may be developed by others could
impair our ability to maintain and grow our business and remain competitive. </FONT></P></TD></TR></TABLE>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-13
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our lack of operating experience may cause us difficulty in managing our growth. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We depend on key individuals to develop our products and core technologies and pursue collaborative relationships. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We may be unable to comply with our reporting and other requirements under federal securities laws. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We will need regulatory approvals to commercialize our products. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Even if we obtain regulatory approvals, our marketed drugs will be subject to ongoing regulatory review. If we fail to comply with ongoing regulatory
requirements, we could lose our approvals to market drugs, in which case our business would be materially adversely affected. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">The drug development process to obtain FDA approval is very costly and time consuming and if we cannot complete our clinical trials in a cost-effective
manner, our results of operations may be adversely affected. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">If users of our proposed products are unable to obtain adequate reimbursement from third-party payers, market acceptance of our proposed products may
be limited and we may not achieve revenues or profits. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Data obtained from clinical trials may be negative or inconclusive, and are susceptible to varying interpretations, which could delay, limit or prevent
regulatory clearances. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We will need to obtain FDA approval of any proposed product brand names, and any failure or delay associated with such approval may adversely impact
our business. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our competitive position is contingent upon the protection of our intellectual property. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual property rights and we may be
unable to protect our rights to, or use of, our technology. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Obtaining and maintaining our patent protection depends upon compliance with various procedural, document submission, fee payment and other
requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our failure to secure trademark registration could adversely affect our ability to market our product candidates and our business.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Confidentiality agreements with employees and others may not adequately prevent disclosure of our trade secrets and other proprietary information and
may not adequately protect our intellectual property, which could impede our ability to compete. </FONT></P></TD></TR></TABLE>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-14
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We may be subject to claims that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">The market price of our common stock may be volatile and adversely affected by several factors. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our board of directors has the power to designate, without stockholder approval, additional series of preferred stock, the shares of which could be
senior to our common stock and be entitled to conversion or voting rights that adversely affect the holders of our common stock. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Nevada law and our charter documents could make it more difficult for a third party to acquire us and discourage a takeover, which could depress the
trading price of our common stock. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">One investor and certain directors, by virtue of ownership of our securities and related rights, may be able to control the Company.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">You will experience immediate dilution in the net tangible book value per share of the common stock included in the units you purchase.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We may issue additional common stock, which might dilute the net tangible book value per share of our common stock. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">A sale of a substantial number of shares of the common stock may cause the price of our common stock to decline. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Because we will have broad discretion and flexibility in how the net proceeds from this offering are used, we may use the net proceeds in ways in which
you disagree. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have not paid cash dividends in the past and do not expect to pay cash dividends in the foreseeable future. Any return on your investment in the
units may be limited to the market price of our common stock. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our shares of common stock and warrants may be thinly traded, so you may be unable to sell at or near ask prices or even at all if you need to sell
your shares or warrants to raise money or otherwise desire to liquidate your shares or warrants. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">There is presently no public market for the units and the warrants to purchase common stock being sold in this offering. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">We intend to effect a 1-for-6 reverse stock split of our outstanding common stock immediately prior to this offering. However, the reverse stock split
may not increase our stock price sufficiently and we may not be able to list our common stock on The NASDAQ Capital Market, in which case this offering will not be completed. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Even if the reverse stock split achieves the requisite increase in the market price of our common stock, we cannot assure you that we will be able to
continue to comply with the minimum bid price requirement of The NASDAQ Capital Market. </FONT></P></TD></TR></TABLE>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-15
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Even if the reverse stock split increases the market price of our common stock, there can be no assurance that we will be able to comply with other
continued listing standards of The NASDAQ Capital Market. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">The reverse stock split may decrease the liquidity of the shares of our common stock. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Following the reverse stock split, the resulting market price of our common stock may not attract new investors, including institutional investors, and
may not satisfy the investing requirements of those investors. Consequently, the trading liquidity of our common stock may not improve. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Corporate Information </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">DTR-Med Pharma Corp., or DTR, was incorporated in
Nevada on January&nbsp;26, 2001. On April&nbsp;25, 2001, DTR entered into a stock exchange agreement with Pro-Pharmaceuticals, Inc., a Massachusetts corporation, whereby DTR acquired all of the outstanding shares of common stock of
Pro-Pharmaceuticals, Inc. On May&nbsp;10, 2001, DTR changed its name to &#147;Pro-Pharmaceuticals, Inc.&#148; and on June&nbsp;7, 2001, the Massachusetts corporation was merged into the Nevada corporation. On May&nbsp;26, 2011, Pro-Pharmaceuticals,
Inc. changed its name to &#147;Galectin Therapeutics Inc.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our principal executive office is located at 7 Wells Avenue,
Newton, Massachusetts 02459. Our telephone number is (617)&nbsp;559-0033 and our website address is www.galectintherapeutics.com. The information on our website is not a part of, and should not be construed as being incorporated by reference into,
this prospectus supplement or the accompanying prospectus. </FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-16
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>The Offering </B></FONT></P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-top:3px;margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Securities offered by us </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; units, each unit consisting of two shares of common stock and a warrant to purchase one share of common stock. The units may not be separated
into the underlying shares of common stock and warrants until the earlier of (1) the exercise in full of the underwriters&#146; over-allotment option and (2) forty-five (45) days from the date of this prospectus supplement; and thereafter, the units
may be separable only upon the request of a holder. Each warrant will have an exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, will be exercisable upon separation of the units and will expire five years from the closing
of this offering. </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-top:3px;margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Common stock to be outstanding after this offering </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares if the warrants sold in this offering are exercised in full.
</FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-top:3px;margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Warrants </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="3">Warrants to purchase an aggregate of shares of common stock will be offered as part of the units being sold in this offering. </FONT></TD></TR></TABLE>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-top:3px;margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Warrant exercise price </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="3">The exercise price of the warrants is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-top:3px;margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Anti-dilution </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="3">The exercise price and the number of shares of common stock purchasable upon the exercise of the warrants are subject to adjustment upon the occurrence of specific events, including stock
dividends, stock splits, combinations and reclassifications of our common stock. </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-top:3px;margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Use of proceeds </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="3">We intend to use the net proceeds from this offering to fund our research and development activities and for working capital and other general corporate purposes and possibly acquisitions of
other companies, products or technologies, though no such acquisitions are currently contemplated. See &#147;Use of Proceeds&#148; on page S-39. </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-top:3px;margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Purposes of this Offering </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="3">We believe that being listed on The NASDAQ Capital Market and having additional cash on-hand to fund our research and development activities will broaden our shareholder base and provide
increased liquidity for our shareholders. </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-top:3px;margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Risk factors </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="3">See &#147;Risk Factors&#148; beginning on page S-19 of this prospectus supplement and the other information included or incorporated by reference into this prospectus supplement and the
accompanying prospectus for a discussion of factors you should carefully consider before investing in our securities. </FONT></TD></TR></TABLE>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-17
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1pt solid #000000;BORDER-LEFT:1pt solid #000000;BORDER-RIGHT:1pt solid #000000;BORDER-TOP:1pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-top:3px;margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">OTC Bulletin Board trading symbol </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="3">&#147;GALT&#148; </FONT></TD></TR></TABLE> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-top:3px;margin-bottom:1px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Listing </FONT></P></TD>
<TD><FONT STYLE="font-family:Times New Roman" SIZE="3">We have applied to have the units, common stock and warrants listed on The NASDAQ Capital Market. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Unless we indicate otherwise, all information in this prospectus supplement: (1)&nbsp;reflects a 1-for-6 reverse stock split of our authorized and issued and outstanding shares of common stock, options
and warrants to be effected just prior to the date of this prospectus supplement and the corresponding adjustment of all common stock price per share and stock option and warrant exercise price data; (2)&nbsp;is based on 12,921,093 shares of common
stock issued and outstanding as of February&nbsp;29, 2012; (3)&nbsp;assumes no exercise by the underwriters of their option to purchase up to an additional &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;units to cover over-allotments, if any;
(4)&nbsp;excludes 2,627,110 shares of common stock issuable upon conversion of outstanding convertible preferred stock; (5)&nbsp;excludes 3,089,557 shares of our common stock issuable upon exercise of outstanding stock options under our stock
incentive plans at a weighted average exercise price of $6.83 per share as of February 29, 2012, with 1,922,125 options remaining available for future grant under such plans; and (6)&nbsp;excludes 6,072,843 shares of our common stock issuable upon
exercise of outstanding warrants at a weighted average exercise price of $3.27 per share as of February&nbsp;29, 2012. </FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P></div></div>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-18
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_4"></A>RISK FACTORS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>An investment in the units, including our common stock and the warrants, offered hereby involves a high degree of risk. You should
carefully consider the risks described below and the other information included or incorporated by reference in this prospectus supplement and the accompanying prospectus before making an investment decision. The risks described below are not the
only ones we face. Additional risks not presently known to us or that we currently consider immaterial may also adversely affect our business. We have attempted to identify below the major factors that could cause differences between actual and
planned or expected results, but we cannot assure you that we have identified all such factors. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>If any of the
following risks actually happen, our business, financial condition and operating results could be materially adversely affected. In this case, the trading price of our common stock could decline, and you could lose all or part of your investment.
</I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>In assessing these risks, you should also refer to the other information contained or incorporated by reference into
this prospectus supplement and the accompanying prospectus, including our financial statements and related notes. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Risks Related to Our
Business </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>We have incurred net losses to date, and if we do not raise additional capital by the end of the first quarter of 2013, we
may not be able to develop our product candidates. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have incurred net losses in each year of operation since our
inception in July 2000. Our accumulated deficit as of September&nbsp;30, 2011 was approximately $65.4 million and our cumulative net loss applicable to common stockholders as of September&nbsp;30, 2011 was approximately $65.7 million. Based on
approximately $7.9 million of unrestricted cash as of September&nbsp;30, 2011, we believe that we have sufficient cash to meet our financial and operating obligations through the first quarter of 2013. We will require additional financing by the end
of the first quarter of 2013 to fund our operations and believe that we will be able to obtain such financing. We may raise capital through public or private equity financings, partnerships, debt financings, bank borrowings or other sources.
However, there can be no assurance that additional funding will be available on favorable terms or even at all. To obtain additional funding, we may need to enter into arrangements that require us to relinquish rights to certain technologies,
products and/or potential markets. To the extent that additional capital is raised through the sale of equity, or securities convertible into equity, our equity holders may experience dilution of their proportionate ownership of the company. If we
cannot obtain additional financing by the end of the first quarter of 2013, our operations may be restricted and we may ultimately be unable to continue to develop and potentially commercialize our product candidates. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>We are a development-stage company and have not yet generated any revenue. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are a development-stage company and have not generated any revenues to date. We granted PROCAPS exclusive rights to market and sell
GM-CT-01 to treat cancer patients in </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-19
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
Colombia, South America, which we refer to as the PROCAPS Channel. In addition, there is no assurance that we will obtain FDA approval of GM-CT-01, GR-MD-02 or any other of our products in
development to market products in the United States and, even if we do so, that we will generate revenue sufficient to become profitable. Our failure to generate revenue and profit would lead to a loss of your investment. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>We are largely dependent on the success of our two lead product candidates, GM-CT-01 and GR-MD-02 and we cannot be certain that these product
candidates will receive regulatory approval or be successfully commercialized. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We currently have no products for sale
and we cannot guarantee that we will ever have any drug products approved for sale. We and our product candidates are subject to extensive regulation by the FDA and comparable regulatory authorities in other countries governing, among other things,
research, testing, clinical trials, manufacturing, labeling, promotion, selling, adverse event reporting and recordkeeping. We are not permitted to market any of our product candidates in or outside the United States until we receive approval of a
new drug application for a product candidate from the FDA or the equivalent approval from a foreign regulatory authority. Obtaining FDA approval is a lengthy, expensive and uncertain process. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Before obtaining regulatory approval for the sale of any drug candidate, we must conduct extensive pre-clinical studies and clinical
trials to demonstrate the safety and efficacy of our product candidates in humans. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">GM-CT-01, our lead product candidate, is
currently in human clinical trials in Belgium for use in combination with peptide vaccine for therapy of metastatic melanoma. We are attempting to gain regulatory approval in Colombia of GM-CT-01 for use in combination with 5-FU for metastatic
colorectal cancer. While Colombian marketing is not a central component of our overall corporate strategy, it could help us to obtain revenue in 2012 to support development programs, reduce the amount of capital we would need to raise in future
equity offerings and gain additional clinical experience with GM-CT-01. There can be no assurance that we will receive regulatory approval of GM-CT-01 in Colombia, particularly since there has been no approval of GM-CT-01 in a major region such as
the U.S. or Europe. Moreover, even if we receive approval in Colombia, we cannot assure you that our approach will yield successful results or that we will generate any revenue, or that we will obtain approval in other countries. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">There are currently no FDA clinical trials underway for GM-CT-01. We are seeking strategic partners to explore possible FDA clinical
trials to study the use of GM-CT-01 in the amelioration of 5-FU related side effects. The Phase I/II clinical trial in Belgium is being conducted under an IMPD from the EMA, under an FDA-approved IND, </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">GR-MD-02 is currently being evaluated in pre-clinical toxicology and pharmacology studies with the aim of obtaining an IND from the FDA
by the end of 2012 for initiating human clinical trials in patients with NASH. Pre-clinical studies and clinical trials are expensive, time-consuming and ultimately may not be successful. The results of pre-clinical and initial clinical testing of
these products may not necessarily indicate the results that will be obtained from later or more extensive testing. Also, it is possible to suffer significant setbacks </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-20
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
in advanced clinical trials, even after obtaining promising results in earlier trials. For example, even though GM-CT-01 progressed successfully through Phase I and was progressing successfully
through Phase II human trials (which were only partially completed due to financing issues), it may fail in Phase III trials or in later stages of development. We will engage others to conduct our clinical trials, including clinical research
organizations and, possibly, government-sponsored agencies. Pre-clinical studies and clinical trials may not start or be completed as we forecast and may not achieve the desired results. The time required to obtain FDA and other approvals is
unpredictable but often can take years following the commencement of clinical trials, depending upon the complexity of the drug candidate. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Even if we receive regulatory approval, we may be unable to commercialize our product candidates. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Even if GM-CT-01, GR-MD-02 and other anticipated product candidates achieve positive results in clinical trials, we may be unable to
commercialize them. Although we anticipate receipt of regulatory approvals in connection with the PROCAPS Channel, there is no assurance that such approvals will be obtained. The availability of government and third party payor reimbursement, and
pricing, especially compared to competitor products, could affect our ability to commercialize our product candidates. Our general inability to obtain necessary regulatory approvals and, if obtained, to commercialize our products would substantially
impair our viability. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Performance milestones may not occur as contemplated by the agreement with PROCAPS. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">As our arrangement with PROCAPS is a collaboration and because collaborations take place over time, milestone and performance risks are
inherent and performance milestones may not occur as contemplated in our agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>There are risks associated with our reliance on
third parties to conduct trial protocols, including arranging for and monitoring the clinical trials and collecting and analyzing data. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">As we develop products eligible for clinical trials, including GM-CT-01 and GR-MD-02, we will contract with independent parties to assist us in the design of the trial protocols, arrange for and monitor
the clinical trials, collect data and analyze data. In addition, certain clinical trials for our products may be conducted by government-sponsored agencies and will be dependent on governmental participation and funding. Our dependence on
independent parties and clinical sites involves risks including reduced control over the timing in addition to other aspects of our clinical trials. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>There are risks associated with our reliance on third parties for manufacturing, marketing, sales, managed care and distribution infrastructure and channels. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We do not have, and do not now intend to develop, facilities for the manufacture of any of our products for clinical or commercial
production. At this time, we are not a party to any long-term agreement with any of our suppliers, and accordingly, our products are manufactured on a purchase-order basis from one of two primary suppliers. We are developing relationships with
manufacturers and will enter into collaborative arrangements </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-21
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
with licensees or, conversely, will have other vendors manufacture our products on a contract basis. We expect to depend on such collaborators to supply us with products that are manufactured in
compliance with standards imposed by the FDA and foreign regulators. Our failure to secure these arrangements as needed could have a materially adverse effect on our ability to complete the development of our product candidates or, if we obtain
regulatory approval for our product candidates, to commercialize them. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have limited experience in marketing, sales or
distribution and we do not intend to develop a sales and marketing infrastructure to commercialize our pharmaceutical products. If we develop commercial products, we will need to rely on licensees, collaborators, joint venture partners or
independent distributors to market and sell such products. Thus, we expect that we will be required to enter into agreements with commercial partners to engage in sales, marketing and distribution efforts around our products in development. We may
be unable to establish or maintain third-party relationships on a commercially reasonable basis, if at all. In addition, such third parties may have similar or more established relationships with our competitors. If we do not enter into
relationships with third parties for the sales and marketing of our proposed products, we will need to develop our own sales and marketing capabilities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Even if engaged, these distributors may: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">fail to satisfy financial or contractual obligations to us; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">fail to adequately market our products; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">cease operations with little or no notice to us; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">offer, design, manufacture or promote competing formulations or products. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">If we fail to develop sales, managed care, marketing and distribution channels, we would experience delays in generating sales and incur
increased costs, which would harm our financial results. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>We are exposed to product liability, pre-clinical and clinical liability
risks, which could place a financial burden upon us, should we be sued, because we do not currently have product liability insurance beyond our general insurance coverage. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our business exposes us to potential product liability and other liability risks that are inherent in the testing, manufacturing and
marketing of pharmaceutical formulations and products; accordingly, claims may be asserted against us. In addition, the use in our clinical trials of pharmaceutical formulations and products that our potential collaborators may develop and the
subsequent sale of such formulations or products by us or our potential collaborators may cause us to assume a portion of or all of the product liability risks. A successful liability claim or series of claims brought against us could have a
material adverse effect on our business, financial condition and results of operations. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-22
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Because we do not currently have any FDA-approved products or formulations, we do not
currently have any product liability insurance covering commercialized products. We may not be able to obtain or maintain adequate product liability insurance on acceptable terms, if at all, or such insurance may not provide adequate coverage
against our potential liabilities. Furthermore, our current and potential partners with whom we have collaborative agreements or our future licensees may not be willing to indemnify us against these types of liabilities and may not, themselves, be
sufficiently insured or have sufficient liquidity to satisfy any product liability claims. Claims or losses in excess of any product liability insurance coverage that may be obtained by us could have a material adverse effect on our business,
financial condition and results of operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>We face intense competition in the biotechnology and pharmaceutical industries.
</I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The biotechnology and pharmaceutical industries are intensely competitive. We face direct competition from U.S. and
foreign companies focusing on pharmaceutical products, which are rapidly evolving. Our competitors include major multinational pharmaceutical and chemical companies, specialized biotechnology firms and universities and other research institutions.
Many of these competitors possess greater financial and other resources, larger research and development staffs and more effective marketing and manufacturing organizations than we possess. In addition, academic and government institutions are
increasingly likely to enter into exclusive licensing agreements with commercial enterprises, including our competitors, to market commercial products based on technology developed at such institutions. Our competitors may succeed in developing or
licensing technologies and products that are more effective, or succeed in obtaining FDA or other regulatory approvals for product candidates before we do. Acquisitions of, or investments in, competing pharmaceutical or biotechnology companies by
large corporations could increase such competitors&#146; financial, marketing, manufacturing and other resources. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>The market for our
proposed products is rapidly changing and competitive, and new drugs and new treatments which may be developed by others could impair our ability to maintain and grow our business and remain competitive. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The pharmaceutical and biotechnology industries are subject to rapid and substantial technological change. Developments by others may
render our proposed products noncompetitive or obsolete, or we may be unable to keep pace with technological developments or other market factors. Technological competition from pharmaceutical and biotechnology companies, universities, governmental
entities and others diversifying into the field is intense and is expected to increase. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">As a pre-revenue company engaged in
the development of drug technologies, our resources are limited and we may experience technical challenges inherent in such technologies. Competitors have developed or are in the process of developing technologies that are, or in the future may be,
the basis for competition. Some of these technologies may have an entirely different approach or means of accomplishing similar therapeutic effects </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-23
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
compared to our proposed products. Our competitors may develop drugs that are safer, more effective and less costly than our proposed products and, therefore, present a serious competitive threat
to us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The potential widespread acceptance of therapies that are alternatives to ours may limit market acceptance of our
proposed products, even if commercialized. Many of our targeted diseases and conditions can also be treated by other medications. These treatments may be widely accepted in medical communities and have a longer history of use. The established use of
these competitive drugs may limit the potential for our technologies, formulations and products to receive widespread acceptance even if commercialized. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>Our lack of operating experience may cause us difficulty in managing our growth. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">We have limited experience in manufacturing or procuring products in commercial quantities, conducting other later-stage phases of the regulatory approval process, selling pharmaceutical products, or
negotiating, establishing and maintaining strategic relationships. Although we have engaged a number of consultants to assist us, any additional growth may require us to expand our management, operational and financial systems and controls. If we
are unable to do so, our business and financial condition would be materially harmed. If rapid growth occurs, it may strain our managerial, operational and financial resources. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>We depend on key individuals to develop our products and core technologies and pursue collaborative relationships. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">We are highly dependent on Peter G. Traber, M.D. Dr.&nbsp;Traber is our Chief Executive Officer and our Chief Medical Officer who, among other things, designs and leads our pre-clinical and clinical
studies, as well as our U.S. and European regulatory processes. The loss of Dr.&nbsp;Traber or failure to attract or retain other key personnel could prevent us from developing our products and core technologies and pursuing collaborative
relationships. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>We may be unable to comply with our reporting and other requirements under federal securities laws. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">As a publicly traded company, we are subject to the reporting requirements of the Exchange Act. The Exchange Act requires that we file
annual, quarterly and current reports. Our failure to prepare and disclose this information in a timely manner could subject us to penalties under federal securities laws, expose us to lawsuits and restrict our ability to access financing. We may be
required to implement additional and expensive finance and accounting systems, procedures and controls as we grow our business and organization to satisfy new reporting requirements, which will increase our costs and require additional management
resources. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-24
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Risks Related to Regulation of our Products </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>We will need regulatory approvals to commercialize our products. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We are required to obtain approval (i)&nbsp;from the FDA in order to sell our products in the U.S. and (ii)&nbsp;from foreign regulatory
authorities in order to sell our products in other countries. The FDA&#146;s review and approval process is lengthy, expensive and uncertain. Extensive pre-clinical and clinical data and supporting information must be submitted to the FDA for each
indication for each product candidate in order to secure FDA approval. Before receiving FDA clearance to market our proposed products, we will have to demonstrate that our products are safe on the patient population and effective for the diseases
that are to be treated. Clinical trials, manufacturing and marketing of drugs are subject to the rigorous testing and approval process of the FDA and equivalent foreign regulatory authorities. The Federal Food, Drug and Cosmetic Act and other
federal, state and foreign statutes and regulations govern and influence the testing, manufacture, labeling, advertising, distribution and promotion of drugs and medical devices. As a result, regulatory approvals can take several years to acquire
and may further require the expenditure of substantial financial, managerial and other resources. The FDA could reject an application or, in the alternative, require us to conduct additional clinical or other studies as part of the regulatory review
process. Delays in obtaining or failure to obtain FDA approvals would delay or prevent the commercialization of our product candidates, which would prevent, defer or decrease our receipt of revenues. In addition, should we receive initial regulatory
approval, our product candidates will be subject to extensive and rigorous ongoing domestic and foreign government regulation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Even if
we obtain regulatory approvals, our marketed drugs will be subject to ongoing regulatory review. If we fail to comply with ongoing regulatory requirements, we could lose our approvals to market drugs, in which case our business would be materially
adversely affected. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Following regulatory approval in the United States of any drugs we may develop, we will remain
subject to continuing regulatory review, including the review of adverse drug experiences and clinical results that are reported after our drug products are made available to patients. This would include results from any post marketing tests or
vigilance required as a condition of approval. The manufacturer and manufacturing facilities we use to make any of our drug products will also be subject to periodic review and inspection by the FDA. The discovery of any new or previously unknown
problems with the product, manufacturer or facility may result in restrictions on the drug or manufacturer or facility, including withdrawal of the drug from the market. We would continue to be subject to the FDA requirements governing the labeling,
packaging, storage, advertising, promotion, recordkeeping, and submission of safety and other post-market information for all of our product candidates, even those that the FDA had approved. If we fail to comply with applicable continuing regulatory
requirements, we may be subject to fines, suspension or withdrawal of regulatory approval, product recalls and seizures, operating restrictions and other adverse consequences. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-25
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>The drug development process to obtain FDA approval is very costly and time consuming and if we cannot
complete our clinical trials in a cost-effective manner, our results of operations may be adversely affected. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Costs
and timing of clinical trials may vary significantly over the life of a project owing to the following non-exclusive reasons: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the duration of the clinical trial; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the number of sites included in the trials; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the countries in which the trial is conducted; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the length of time required and ability to enroll eligible patients; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the number of patients that participate in the trials; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the number of doses that patients receive; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the drop-out or discontinuation rates of patients; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">per patient trial costs; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">third party contractors failing to comply with regulatory requirements or meet their contractual obligations to us in a timely manner;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">our drug product candidates having different chemical and pharmacological properties in humans than in lab testing; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the need to suspend or terminate our clinical trials; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">insufficient or inadequate supply or quality of drug product candidates or other necessary materials to conduct our trials;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">potential additional safety monitoring, or other conditions required by FDA or comparable foreign regulatory authorities regarding the scope or design
of our clinical trials, or other studies requested by regulatory agencies; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">problems engaging IRBs to oversee trials or in obtaining and maintaining IRB approval of studies; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the duration of patient follow-up; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the efficacy and safety profile of the product candidate; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the costs and timing of obtaining regulatory approvals; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the costs involved in enforcing or defending patent claims or other intellectual property rights. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-26
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>If users of our proposed products are unable to obtain adequate reimbursement from third-party
payers, market acceptance of our proposed products may be limited and we may not achieve revenues or profits. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The
continuing efforts of governments, insurance companies, health maintenance organizations and other payers of healthcare costs to contain or reduce costs of health care may affect our future revenues and profitability as well as the future revenues
and profitability of our potential customers, suppliers and collaborative partners in addition to the availability of capital. In other words, our ability to commercialize our proposed products will depend in large part on the extent to which
appropriate reimbursement levels for the cost of our proposed formulations, products and related treatments are obtained by the health care providers of these products and treatments. At this time we cannot predict the precise impact of the Patient
Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Affordability Act of 2010, the comprehensive health care reform legislation passed by Congress in March 2010. It is possible that the adoption of this
legislation could harm our business, financial condition and results of operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Data obtained from clinical trials may be negative
or inconclusive, and are susceptible to varying interpretations, which could delay, limit or prevent regulatory clearances. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Data already obtained, or in the future obtained, from pre-clinical studies and clinical trials do not necessarily predict the results that will be obtained from later pre-clinical studies and clinical
trials. Moreover, pre-clinical and clinical data may be negative or inconclusive. In addition, data is susceptible to varying interpretations. Negative or inconclusive data, or data interpreted in various ways, could delay, limit or prevent
regulatory approval. A number of companies in the pharmaceutical industry have suffered significant setbacks in advanced clinical trials, even after having obtained promising results in earlier trials. The failure to adequately demonstrate the
safety and effectiveness of a proposed formulation or product under development could delay or prevent regulatory clearance of the potential drug. The resulting delays in commercialization could materially harm our business. Our clinical trials may
not demonstrate sufficient levels of safety and efficacy necessary to obtain the requisite regulatory approvals for our drugs, and thus, our proposed drugs may not be approved for marketing. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>We will need to obtain FDA approval of any proposed product brand names, and any failure or delay associated with such approval may adversely impact our business. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">A pharmaceutical product cannot be marketed in the U.S. or other countries until it has completed rigorous and extensive regulatory
review processes, including approval of a brand name. Any brand names we intend to use for our product candidates will require approval from the FDA regardless of whether we have secured a formal trademark registration from the U.S. Patent and
Trademark Office, or the PTO. The FDA typically conducts a review of proposed product brand names, including an evaluation of potential for confusion with other product names. The FDA may also object to a product brand name if it believes the name
inappropriately implies medical claims. If the FDA objects to any of our proposed product brand names, we may be required to adopt an alternative brand name for our product </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-27
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
candidates. If we adopt an alternative brand name, we would lose the benefit of our existing trademark applications for such product candidate and may be required to expend significant additional
resources in an effort to identify a suitable product brand name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA. We may be unable to build a successful brand
identity for a new trademark in a timely manner or at all, which would limit our ability to commercialize our product candidates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Risks
Related to Our Intellectual Property </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Our competitive position is contingent upon the protection of our intellectual property.
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Development and protection of our intellectual property are critical to our business. All of our intellectual property,
patented or otherwise, has been invented and/or developed by employees or former employees of the Company. Our success depends, in part, on our ability to obtain patent protection for our products or processes in the U.S. and other countries,
protect trade secrets and prevent others from infringing on our proprietary rights. We will only be able to protect our product candidates from unauthorized making, using, selling, offering to sell or importation by third parties to the extent that
we have rights under valid and enforceable patents or trade secrets that cover these activities. If we do not adequately protect our intellectual property, competitors may be able to practice our technologies. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The patent positions of pharmaceutical and biotechnology companies can be highly uncertain and involve complex legal and factual
questions for which important legal principles remain unresolved. No consistent policy regarding the breadth of claims allowed in biotechnology patents has emerged to date in the United States. The biotechnology patent situation outside the United
States is even more uncertain. Changes in either the patent laws or in interpretations of patent laws in the United States and other countries may diminish the value of our intellectual property. Accordingly, we cannot predict the breadth of claims
that may be allowed in our pending patent applications or enforced in our issued patents or in third-party patents. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The
degree of future protection for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage. For example: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">others may be able to make compounds that are competitive with our product candidates but are not covered by the claims of our patents;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">we might not have been the first to make the inventions covered by our pending patent applications; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">we might not have been the first to file patent applications for these inventions; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">others may independently develop similar or alternative technologies or duplicate any of our technologies; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-28
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">it is possible that our pending patent applications will not result in issued patents; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">we may not develop additional proprietary technologies that are patentable; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the patents of others may have an adverse effect on our business. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We also may rely on trade secrets to protect our technology, especially where we do not believe patent protection is appropriate or
obtainable. However, trade secrets are difficult to protect. Although we require our scientific and technical employees and consultants to enter into broad assignment of inventions agreements, and all of our employees, consultants and corporate
partners with access to proprietary information to enter into confidentiality agreements, these agreements may not be honored. Enforcing a claim that a third party illegally obtained, and is using, our trade secrets is expensive and time consuming,
and the outcome is unpredictable. In addition, courts outside the United States are sometimes less willing to protect trade secrets. Moreover, our competitors may independently develop equivalent knowledge, methods and know-how. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>We may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual property rights and we may
be unable to protect our rights to, or use of, our technology. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Some or all of our patent applications may not issue
as patents, or the claims of any issued patents may not afford meaningful protection for our technologies or products. In addition, patents issued to us or our licensors, if any, may be challenged and subsequently narrowed, invalidated or
circumvented. Patent litigation is widespread in the biotechnology industry and could harm our business. Litigation might be necessary to protect our patent position or to determine the scope and validity of third-party proprietary rights.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">If we choose to go to court to stop someone else from using the inventions claimed in our patents, that individual or company
would have the right to ask the court to rule that such patents are invalid and/or should not be enforced against that third party. These lawsuits are expensive and we may not have the required resources to pursue such litigation or to protect our
patent rights. In addition, there is a risk that the court will decide that these patents are not valid and that we do not have the right to stop the other party from using the inventions. There is also the risk that, even if the validity of these
patents is upheld, the court will refuse to stop the other party on the ground that such other party&#146;s activities do not infringe our rights in these patents. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Furthermore, a third party may claim that we are using inventions covered by the third party&#146;s patent rights and may go to court to stop us from engaging in our normal operations and activities,
including making or selling our product candidates. These lawsuits are costly and could affect our results of operations and divert the attention of managerial and technical personnel. There is a risk that a court would decide that we are infringing
the third party&#146;s patents and would order us to stop the activities covered by the patents. In addition, there is a risk that a court will order us to pay the other party treble damages for having violated the other party&#146;s patents. The
biotechnology industry has produced a proliferation of patents, and it is not </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-29
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
always clear to industry participants, including us, which patents cover various types of products or methods of use. The coverage of patents is subject to interpretation by the courts, and the
interpretation is not always uniform. If we are sued for patent infringement, we would need to demonstrate that our products or methods of use either do not infringe the claims of the relevant patent and/or that the patent claims are invalid, and we
may not be able to do this. Proving invalidity in the U.S., in particular, is difficult since it requires a showing of clear and convincing evidence to overcome the presumption of validity enjoyed by issued patents. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Because some patent applications in the United States may be maintained in secrecy until the patents are issued, patent applications in
the United States and many foreign jurisdictions are typically not published until eighteen months after filing, and publications in the scientific literature often lag behind actual discoveries, we cannot be certain that others have not filed
patent applications for technology covered by our issued patents or our pending applications or that we were the first to invent the technology. Our competitors may have filed, and may in the future file, patent applications covering technology
similar to ours. Any such patent application may have priority over our patent applications and could further require us to obtain rights to issued patents covering such technologies. If another party has filed a United States patent application on
inventions similar to ours, we may have to participate in an interference or other proceeding in the PTO or a court to determine priority of invention in the United States. The costs of these proceedings could be substantial, and it is possible that
such efforts would be unsuccessful, resulting in a loss of our United States patent position with respect to such inventions. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have
substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Obtaining and maintaining our patent protection depends upon compliance with various procedural, document submission, fee payment and other
requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">The PTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the patent process. There are situations in
which noncompliance can result in abandonment or lapse of a patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, competitors might be able to enter the market earlier
than would otherwise have been the case. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Our failure to secure trademark registration could adversely affect our ability to market our
product candidates and our business. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our trademark applications in the United States, when filed, and any other
jurisdictions where we may file may not be allowed for registration, and our registered trademarks may not </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-30
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
be maintained or enforced. During trademark registration proceedings, we may receive rejections. Although we are given an opportunity to respond to those rejections, we may be unable to overcome
such rejections. In addition, in the PTO and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or
cancellation proceedings may be filed against our applications and/or registrations, and our applications and/or registrations may not survive such proceedings. Failure to secure such trademark registrations in the United States and in foreign
jurisdictions could adversely affect our ability to market our product candidates and our business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Confidentiality agreements with
employees and others may not adequately prevent disclosure of our trade secrets and other proprietary information and may not adequately protect our intellectual property, which could impede our ability to compete. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Because we operate in the highly technical field of biotechnology and pharmaceutical development, we rely in part on trade secret
protection in order to protect our proprietary trade secrets and unpatented know-how. However, trade secrets are difficult to protect, and we cannot be certain that others will not develop the same or similar technologies on their own. We have taken
steps, including entering into confidentiality agreements with all of our employees, consultants and corporate partners to protect our trade secrets and unpatented know-how. These agreements generally require that the other party keep confidential
and not disclose to third parties all confidential information developed by the party or made known to the party by us during the course of the party&#146;s relationship with us. We also typically obtain agreements from these parties which provide
that inventions conceived by the party in the course of rendering services to us will be our exclusive property. However, these agreements may not be honored and may not effectively assign intellectual property rights to us. Enforcing a claim that a
party illegally obtained and is using our trade secrets or know-how is difficult, expensive and time consuming, and the outcome is unpredictable. In addition, courts outside the United States may be less willing to protect trade secrets or know-how.
The failure to obtain or maintain trade secret protection could adversely affect our competitive position. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>We may be subject to claims
that our employees have wrongfully used or disclosed alleged trade secrets of their former employers. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">As is common in
the biotechnology and pharmaceutical industry, we employ individuals who were previously employed at other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although no claims against us are currently
pending, we may be subject to claims that these employees or we have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers. Litigation may be necessary to defend against these claims.
Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-31
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Risks Related to Our Common Stock and this Offering </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>The market price of our common stock may be volatile and adversely affected by several factors. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The market price of our common stock could fluctuate significantly in response to various factors and events, including but not limited
to: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">our ability to integrate operations, technology, products and services; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">our ability to execute our business plan; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">operating results below expectations; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">our issuance of additional securities, including debt or equity or a combination thereof, which will be necessary to fund our operating expenses;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">announcements of technological innovations or new products by us or our competitors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">loss of any strategic relationship; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">industry developments, including, without limitation, changes in healthcare policies or practices or third-party reimbursement policies;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">economic and other external factors; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">period-to-period fluctuations in our financial results; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">whether an active trading market in our common stock develops and is maintained. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">In addition, the market price for securities of pharmaceutical and biotechnology companies historically has been highly volatile, and the
securities markets have from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. These broad market fluctuations may cause the market price of our common stock
to decline substantially. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">In the past, securities class action litigation has often been brought against a company following
a decline in the market price of its securities. This risk is especially relevant for us because biotechnology and biopharmaceutical companies have experienced significant stock price volatility in recent years. We may become involved in this type
of litigation in the future. Litigation often is expensive and diverts management&#146;s attention and resources, which could materially and adversely affect our business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Additionally, fluctuations in the trading price or liquidity of our common stock may materially and adversely affect, among other things, the interest of investors to purchase our common stock on the open
market and, generally, our ability to raise capital. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Our board of directors has the power to designate, without stockholder approval,
additional series of preferred stock, the shares of which could be senior to our common stock and be entitled to conversion or voting rights that adversely affect the holders of our common stock. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our articles of incorporation authorize the issuance of capital stock including 3,333,334 authorized undesignated shares (1,333,501
designated as of February 29, 2012), and empowers our board of directors to prescribe, by resolution and without stockholder approval, a class or series of undesignated shares, including the number of shares in the class or series
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-32
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
and the voting powers, designations, rights, preferences, restrictions and the relative rights in each such class or series. Accordingly, we may designate and issue additional shares or series of
preferred stock that would rank senior to the shares of common stock as to dividend rights or rights upon our liquidation, winding-up, or dissolution. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>Nevada law and our charter documents could make it more difficult for a third party to acquire us and discourage a takeover, which could depress the trading price of our common stock.
</I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Nevada corporate law and our articles of incorporation and bylaws contain provisions that could discourage, delay, or
prevent a change in control of our Company or changes in our management that our stockholders may deem advantageous. For example, holders of our common stock do not have cumulative voting rights in the election of directors, meaning that
stockholders owning a majority of our outstanding shares of common stock will be able to elect all of our directors. In addition, because we have more than 200 stockholders of record, we are subject to the &#147;business combinations&#148;
provisions of the Nevada Revised Statutes, or NRS. These provisions could prohibit or delay a merger or other takeover or change in control attempt and, accordingly, may discourage attempts to acquire our company even though such a transaction may
be in our stockholders&#146; best interest and offer our stockholders the opportunity to sell their stock at a price above the prevailing market price. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>One investor and certain directors, by virtue of ownership of our securities and related rights, may be able to control the Company.</I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The 10X Fund owns all of our issued and outstanding Series B Preferred Stock, which are convertible into 2,000,000 shares of our common
stock.&nbsp;The 10X Fund owns related warrants exercisable to purchase an aggregate of 5,000,000 shares of our common stock. We have issued approximately 549,000 shares of our common stock as dividends on the Series B Preferred Stock and 1,000,000
shares of our common stock on the exercise of warrants. In addition, (i)&nbsp;James C. Czirr, a general partner of the 10X Fund and Executive Chairman of our board of directors, owns or controls approximately 832,000 shares of our common stock and
has the right to acquire approximately 667,000 additional shares (approximately 217,000 of which are exercisable as of February&nbsp;29, 2012) of our common stock upon the exercise of outstanding stock options; and (ii)&nbsp;Rod D. Martin, a general
partner of the 10X Fund and Vice Chairman of our board of directors, owns or controls approximately 87,000 shares of our common stock and has the right to acquire approximately 98,000 additional shares of our common stock upon the exercise of
outstanding stock options (approximately 90,000 of which are exercisable as of February&nbsp;29, 2012). As of February&nbsp;29, 2012, on a fully diluted basis, assuming conversion of all Series B Preferred Stock and exercise of all outstanding
warrants, the 10X Fund would own approximately 43% of our then outstanding shares of common stock, which, together with the shares of our common stock that would be owned by Mr.&nbsp;Czirr and Mr.&nbsp;Martin (assuming exercise of all vested options
at that date), would constitute approximately 48% of the then outstanding shares.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">As holder of Series B Preferred Stock, the
10X Fund is entitled to elect three directors in a separate class vote, nominate three directors for election by all shares entitled to vote, and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-33
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
provide or withhold consent to a range of fundamental corporate action we may wish to undertake, such as recapitalization, sale of our company, and other matters. Such concentration of stock
ownership and related rights could have the effect of delaying, deterring or preventing corporate events that our other security holders may desire or consider beneficial to the company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>You will experience immediate dilution in the net tangible book value per share of the common stock included in the units you purchase. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The public offering price of our common stock is substantially higher than our net tangible book value per share of common stock. Based
on the public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per unit, investors purchasing shares of common stock in this offering will, therefore, incur immediate dilution of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
in net tangible book value per share. This dilution figure deducts the underwriting discount and estimated offering expenses payable by us from the public offering price. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>We may issue additional common stock, which might dilute the net tangible book value per share of our common stock. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Our board of directors has the authority, without action or vote of our stockholders, to issue all or a part of our authorized but unissued shares. Such stock issuances could be made at a price that
reflects a discount to, or a premium from, the then-current market price of our common stock. In addition, in order to raise capital, we may need to issue securities that are convertible into or exchangeable for a significant amount of our common
stock. These issuances would dilute the percentage ownership interest, which would have the effect of reducing your influence on matters on which our stockholders vote, and might dilute the net tangible book value per share of our common stock. You
may incur additional dilution if holders of stock options, whether currently outstanding or subsequently granted, exercise their options, or if warrant holders exercise their warrants to purchase shares of our common stock. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>A sale of a substantial number of shares of the common stock may cause the price of our common stock to decline. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our common stock is currently traded on the OTC Bulletin Board and, despite certain increases of trading volume from time to time, there
have been periods when it could be considered &#147;thinly-traded,&#148; meaning that the number of persons interested in purchasing our common stock at or near bid prices at any given time may be relatively small or non-existent. Finance
transactions resulting in a large amount of newly issued shares that become readily tradable, or other events that cause current stockholders to sell shares, could place downward pressure on the trading price of our stock. In addition, the lack of a
robust resale market may require a stockholder who desires to sell a large number of shares of common stock to sell the shares in increments over time to mitigate any adverse impact of the sales on the market price of our stock. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">If our stockholders sell, or the market perceives that our stockholders intend to sell for various reasons, including the ending of
restriction on resale or the expiration of lock-up </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-34
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
agreements such as those entered into in connection with this offering, substantial amounts of our common stock in the public market, including shares issued upon the exercise of outstanding
options or warrants, the market price of our common stock could fall. Sales of a substantial number of shares of our common stock may make it more difficult for us to sell equity or equity-related securities in the future at a time and price that we
deem reasonable or appropriate. We may become involved in securities class action litigation that could divert management&#146;s attention and harm our business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">As of February&nbsp;29, 2012, we had 12,921,093 shares of common stock issued and outstanding. Substantially all of these shares are available for public sale, subject in some cases to volume and other
limitations or delivery of a prospectus. As of February&nbsp;29, 2012, we had reserved for issuance (i)&nbsp;2,627,110 shares of our common stock issuable upon the conversion of outstanding convertible preferred stock; (ii)&nbsp;6,072,843 shares of
our common stock issuable upon exercise of outstanding warrants at a weighted average exercise price of $3.27 per share as of February&nbsp;29, 2012; and (iii)&nbsp;3,089,557 shares of our common stock issuable upon exercise of outstanding stock
options under our stock incentive plans at a weighted average exercise price of $6.83 per share as of February 29, 2012. Subject to applicable vesting requirements, upon conversion or exercise of the outstanding preferred stock, warrants and
options, the underlying shares may be resold into the public market. In the case of outstanding preferred stock, warrants and options that have conversion or exercise prices, as the case may be, that are below the market price of our common stock
from time to time, investors would experience dilution. We cannot predict if future issuances or sales of our common stock, or the availability of our common stock for issuance or sale, will harm the market price of our common stock or our ability
to raise capital. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Because we will have broad discretion and flexibility in how the net proceeds from this offering are used, we may use
the net proceeds in ways in which you disagree. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We currently intend to use the net proceeds from this offering to
fund our research and development activities and for working capital and other general corporate purposes and possibly acquisitions of other companies, products or technologies, though no such acquisitions are currently contemplated. See &#147;Use
of Proceeds&#148; on page S-39 of this prospectus supplement. We have not allocated specific amounts of the net proceeds from this offering for any of the foregoing purposes. Accordingly, our management will have significant discretion and
flexibility in applying the net proceeds of this offering. You will be relying on the judgment of our management with regard to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess
whether the net proceeds are being used appropriately. It is possible that the net proceeds will be invested in a way that does not yield a favorable, or any, return for us. The failure of our management to use such funds effectively could have a
material adverse effect on our business, financial condition, operating results and cash flow. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-35
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>We have not paid cash dividends in the past and do not expect to pay cash dividends in the foreseeable
future. Any return on your investment in the units may be limited to the market price of our common stock. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have
never paid cash dividends on our capital stock and do not anticipate paying cash dividends on our capital stock in the foreseeable future. The payment of dividends on our capital stock will depend on our earnings, financial condition and other
business and economic factors affecting us at such time as the board of directors may consider relevant. If we do not pay dividends, our common stock may be less valuable because a return on your investment will only occur if the market price of our
common stock price appreciates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Our shares of common stock and warrants may be thinly traded, so you may be unable to sell at or near
ask prices or even at all if you need to sell your shares or warrants to raise money or otherwise desire to liquidate your shares or warrants. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">We cannot predict the extent to which an active public market for our common stock and warrants will develop or be sustained. We have applied for listing of our units, common stock and warrants on The
NASDAQ Capital Market, but cannot assure you that this listing or listing on any other exchange will ever occur. Even if our shares and warrants are listed on such exchange, we cannot assure you that a market will develop for our common stock or the
warrants or that you will obtain sufficient liquidity in your holdings of our common stock and warrants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our common stock is
currently traded on the OTC Bulletin Board and experiences periods when it could be considered &#147;thinly-traded.&#148; This situation may be attributable to a number of factors, including the fact that we are a small company which is relatively
unknown to stock analysts, stock brokers, institutional investors and others in the investment community that generate or influence sales volume, and that even if we came to the attention of such persons, they tend to be risk averse and would be
reluctant to follow an unproven company such as ours or purchase or recommend the purchase of our shares until such time as we became more seasoned and viable. As a consequence, there may be periods of several days, weeks or months when trading
activity in our shares is minimal or non-existent, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on share price. We cannot give you any
assurance that a broader or more active public trading market for our common stock will develop or be sustained, or that current trading levels will be sustained or not diminish. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>There is presently no public market for the units and the warrants to purchase common stock being sold in this offering. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">There is presently no established public trading market for the units and warrants being offered in this offering and we do not expect a
market to develop. Without an active market, the liquidity of the units and warrants will be limited. Further, the existence of the units and </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">warrants may act to reduce both the trading volume and the trading price of our common stock. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-36
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Risks Related to Our Reverse Stock Split </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>We intend to effect a 1-for-6 reverse stock split of our outstanding common stock immediately prior to this offering. However, the reverse stock split may not increase our stock price sufficiently
and we may not be able to list our common stock on The NASDAQ Capital Market, in which case this offering will not be completed. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">We expect that the 1-for-6 reverse stock split of our outstanding common stock will increase the market price of our common stock so that we will be able to meet the minimum bid price requirement of the
Listing Rules of The NASDAQ Capital Market. However, the effect of a reverse stock split upon the market price of our common stock cannot be predicted with certainty, and the results of reverse stock splits by companies in similar circumstances have
been varied. It is possible that the market price of our common stock following the reverse stock split will not increase sufficiently for us to be in compliance with the minimum bid price requirement. If we are unable meet the minimum bid price
requirement, we may be unable to list our shares on The NASDAQ Capital Market, in which case this offering will not be completed. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Even
if the reverse stock split achieves the requisite increase in the market price of our common stock, we cannot assure you that we will be able to continue to comply with the minimum bid price requirement of The NASDAQ Capital Market.
</I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Even if the reverse stock split achieves the requisite increase in the market price of our common stock to be in
compliance with the minimum bid price of The NASDAQ Capital Market, there can be no assurance that the market price of our common stock following the reverse stock split will remain at the level required for continuing compliance with that
requirement. It is not uncommon for the market price of a company&#146;s common stock to decline in the period following a reverse stock split. If the market price of our common stock declines following the effectuation of a reverse stock split, the
percentage decline may be greater than would occur in the absence of a reverse stock split. In any event, other factors unrelated to the number of shares of our common stock outstanding, such as negative financial or operational results, could
adversely affect the market price of our common stock and jeopardize our ability to meet or maintain The NASDAQ Capital Market&#146;s minimum bid price requirement. In addition to specific listing and maintenance standards, The NASDAQ Capital Market
has broad discretionary authority over the initial and continued listing of securities, which it could exercise with respect to the listing of our common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>Even if the reverse stock split increases the market price of our common stock, there can be no assurance that we will be able to comply with other continued listing standards of The NASDAQ Capital
Market. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Even if the market price of our common stock increases sufficiently so that we comply with the minimum bid
price requirement, we cannot assure you that we will be able to comply with the other standards that we are required to meet in order to maintain a listing of our common stock on The NASDAQ Capital Market. Our failure to meet these requirements may
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-37
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
result in our common stock being delisted from The NASDAQ Capital Market, irrespective of our compliance with the minimum bid price requirement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>The reverse stock split may decrease the liquidity of the shares of our common stock. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The liquidity of the shares of our common stock may be affected adversely by the reverse stock split given the reduced number of shares
that will be outstanding following the reverse stock split, especially if the market price of our common stock does not increase as a result of the reverse stock split. In addition, the reverse stock split may increase the number of stockholders who
own odd lots (less than 100 shares) of our common stock, creating the potential for such stockholders to experience an increase in the cost of selling their shares and greater difficulty effecting such sales. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Following the reverse stock split, the resulting market price of our common stock may not attract new investors, including institutional investors,
and may not satisfy the investing requirements of those investors. Consequently, the trading liquidity of our common stock may not improve. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Although we believe that a higher market price of our common stock may help generate greater or broader investor interest, there can be no assurance that the reverse stock split will result in a share
price that will attract new investors, including institutional investors. In addition, there can be no assurance that the market price of our common stock will satisfy the investing requirements of those investors. As a result, the trading liquidity
of our common stock may not necessarily improve. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-38
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_5"></A>USE OF PROCEEDS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We estimate that our net proceeds from the sale of the units offered pursuant to this prospectus supplement will be approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million if the underwriters exercise in full their option to purchase
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional units, based upon the public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per unit and after deducting the underwriting discount and the
estimated offering expenses that are payable by us. These amounts do not include the proceeds which we may receive in connection with the exercise of the warrants offered hereby. We cannot predict when or if these warrants will be exercised, and it
is possible that these warrants may expire and never be exercised. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We currently intend to use the net proceeds from this
offering to fund our research and development activities and for working capital and other general corporate purposes and possibly acquisitions of other companies, products or technologies, though no such acquisitions are currently contemplated.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have not yet determined the amount of net proceeds to be used specifically for any of the foregoing purposes. Accordingly,
our management will have significant discretion and flexibility in applying the net proceeds from this offering. Pending any use as described above, we intend to invest the net proceeds in high-quality, short-term, interest-bearing securities.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-39
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_6"></A>MARKET FOR COMMON STOCK </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Following the delisting of our common stock from the NYSE Amex as of the close of trading on January&nbsp;9, 2009, our common stock has
been quoted on the OTC Bulletin Board since January&nbsp;21, 2009 under the symbol &#147;PRWP.&#148; Our symbol changed to &#147;GALT&#148; in connection with our name change on May&nbsp;26, 2011. The high and low bid prices for our common stock as
reported on the OTC Bulletin Board, for the periods indicated below were as follows. These over-the-counter market quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent actual
transactions. The closing sale price of our common stock on March 2, 2012, as reported on the OTC Bulletin Board, was $0.85 per share. These prices do not reflect the expected 1-for-6 reverse stock split that we intend to effect in connection with
this offering. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>High</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Low</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Fiscal Year Ended December&nbsp;31, 2010</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">First Quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">0.50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">0.26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Second Quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">0.89</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">0.41</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Third Quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">0.82</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">0.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Fourth Quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">1.04</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">0.62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Fiscal Year Ended December 31, 2011</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">First Quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">1.44</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">0.87</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Second Quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">1.57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">0.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Third Quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">1.30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">0.76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Fourth Quarter</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">1.13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">0.64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_7"></A>DIVIDEND POLICY </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have never declared or paid cash dividends on our capital stock. We currently intend to retain our future earnings, if any, for use in
our business and therefore do not anticipate paying cash dividends in the foreseeable future. Payment of future dividends, if any, will be at the discretion of our board of directors after taking into account various factors, including our financial
condition, operating results, current and anticipated cash needs and plans for expansion. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_8"></A>DILUTION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">If you purchase units in this offering, your interest in our common stock will be diluted to the extent of the difference between the public offering price per unit and the net tangible book value per
share of our common stock after this offering. We calculate net tangible book value per share by dividing our net tangible assets (tangible assets less total liabilities) by the number of shares of our common stock issued and outstanding as of
September&nbsp;30, 2011. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-40
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our pro forma net tangible book value at September&nbsp;30, 2011 was approximately $7.3
million, or approximately $0.56 per share, based on 12,921,093 shares of our common stock outstanding, after giving effect to issuances of common stock from October&nbsp;1, 2011 through and immediately prior to the date of this offering. After
giving effect to the issuance and sale of all the units in this offering at the public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per unit, less the estimated offering expenses, our adjusted pro forma net tangible book value
at September&nbsp;30, 2011 would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. This represents an immediate increase in net tangible book value of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share to existing stockholders and an immediate dilution of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share to investors in this offering. The following table illustrates this per
share dilution: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Public offering price per unit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="3">Pro forma net tangible book value per share as of September&nbsp;30, 2011</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Increase per share attributable to investors in this offering</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="3">Adjusted pro forma net tangible book value per share as of September&nbsp;30, 2011</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Dilution per share to investors in this offering</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">If the underwriters exercise in full their option to
purchase&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional units at the public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per unit, the adjusted pro forma net tangible book value of the
common stock after this offering would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, representing an increase in pro forma net tangible book value of the common stock of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share to existing stockholders and immediate dilution in pro forma net tangible book value of the common stock of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share to new investors purchasing shares in this offering at the public offering price. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">The foregoing illustration does not reflect potential dilution from the exercise of outstanding options or warrants to purchase shares of our common stock. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-41
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_9"></A>DESCRIPTION OF THE SECURITIES WE ARE OFFERING </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">In this offering, we are offering units, consisting of shares of common stock and warrants to purchase shares of common stock. The common
stock and warrants will be sold in units, with each unit consisting of two shares of common stock and one warrant to purchase one share of common stock. The units may not be separated into the underlying shares of common stock and warrants until the
earlier of (1) the exercise in full of the underwriters&#146; over-allotment option and (2) forty-five (45) days from the date of this prospectus supplement; and thereafter, the units may be separable only upon the request of a holder. Each warrant
will have an exercise price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, will be exercisable upon separation of the units and will expire five years from the closing of this offering. The shares of common stock issuable from time
to time upon exercise of the warrants, if any, are also being offered pursuant to this prospectus supplement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Units </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Each unit consists of two shares of common stock and one warrant to purchase one share of common stock. The units may not be separated
into the underlying shares of common stock and warrants until the earlier of (1) the exercise in full of the underwriters&#146; over-allotment option and (2) forty-five (45) days from the date of this prospectus supplement; and thereafter, the units
may be separable only upon the request of a holder. The units will be issued in registered form under a unit agency agreement between us and Continental Stock Transfer&nbsp;&amp; Trust Co., as unit agent. We have applied for listing of the units on
The NASDAQ Capital Market. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Common Stock </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">A description of our common stock that we are offering pursuant to this prospectus supplement is set forth under the heading &#147;Description of Securities&#151;Common Stock&#148; beginning on page 40 of
the accompanying prospectus, as supplemented by the additional information set forth below. We have applied for listing of our common stock on The NASDAQ Capital Market. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">We have authorized 50,000,000 shares of common stock. As of February&nbsp;29, 2012, we had 12,921,093 shares of common stock outstanding. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B><I>Anti-takeover Effects of Our Articles of Incorporation and Bylaws </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Our articles of incorporation and bylaws contain certain provisions that may have anti-takeover effects, making it more difficult for or
preventing a third party from acquiring control of us or changing our board of directors and management. The holders of our common stock do not have cumulative voting rights in the election of our directors, meaning that stockholders owning a
majority of our outstanding shares of common stock will be able to elect all of our directors. The combination of the concentration of voting power for election of directors in a few stockholders and lack of cumulative voting makes it more difficult
for other stockholders to replace our board of directors or for a third party to obtain control of our company by replacing our board of directors. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-42
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><I>Anti-takeover Effects of Nevada Law </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Business Combinations </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">The &#147;business combination&#148; provisions of Sections 78.411 to 78.444, inclusive, of the NRS generally prohibit a Nevada corporation with at least 200 stockholders of record, a &#147;resident
domestic corporation,&#148; from engaging in various &#147;combination&#148; transactions with any &#147;interested stockholder&#148; unless certain conditions are met or the corporation has elected in its articles of incorporation to not be subject
to these provisions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">A &#147;combination&#148; is generally defined to include (a)&nbsp;a merger or consolidation of the
resident domestic corporation or any subsidiary of the resident domestic corporation with the interested stockholder or affiliate or associate of the interested stockholder; (b)&nbsp;any sale, lease, exchange, mortgage, pledge, transfer, or other
disposition, in one transaction or a series of transactions, by the resident domestic corporation or any subsidiary of the resident domestic corporation to or with the interested stockholder or affiliate or associate of the interested stockholder
having: (i)&nbsp;an aggregate market value equal to 5% or more of the aggregate market value of the assets of the resident domestic corporation, (ii)&nbsp;an aggregate market value equal to 5% or more of the aggregate market value of all outstanding
shares of the resident domestic corporation, or (iii)&nbsp;10% or more of the earning power or net income of the resident domestic corporation; (c)&nbsp;the issuance or transfer in one transaction or series of transactions of shares of the resident
domestic corporation or any subsidiary of the resident domestic corporation having an aggregate market value equal to 5% or more of the resident domestic corporation to the interested stockholder or affiliate or associate of the interested
stockholder; and (d)&nbsp;certain other transactions with an interested stockholder or affiliate or associate of the interested stockholder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">An &#147;interested stockholder&#148; is generally defined as a person who, together with affiliates and associates, owns (or within three years, did own) 10% or more of a corporation&#146;s voting stock.
An &#147;affiliate&#148; of the interested stockholder is any person that directly or indirectly through one or more intermediaries is controlled by or is under common control with the interested stockholder. An &#147;associate&#148; of an
interested stockholder is any (a)&nbsp;corporation or organization of which the interested stockholder is an officer or partner or is directly or indirectly the beneficial owner of 10% or more of any class of voting shares of such corporation or
organization; (b)&nbsp;trust or other estate in which the interested stockholder has a substantial beneficial interest or as to which the interested stockholder serves as trustee or in a similar fiduciary capacity; or (c)&nbsp;relative or spouse of
the interested stockholder, or any relative of the spouse of the interested stockholder, who has the same home as the interested stockholder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">If applicable, the prohibition is for a period of three years after the date of the transaction in which the person became an interested stockholder, unless such transaction is approved by our board of
directors prior to the date the interested stockholder obtained such status; and extends beyond the expiration of the three-year period, unless (a)&nbsp;the transaction was approved by our board of directors prior to the person becoming an
interested stockholder; (b)&nbsp;the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-43
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
transaction is approved by the affirmative vote of a majority of the voting power held by our disinterested stockholders at a meeting called for that purpose no earlier than three years after the
date the person first became an interested stockholder; or (c)&nbsp;if the consideration to be paid to all of our stockholders other than the interested stockholder is, generally, at least equal to the highest of: (i)&nbsp;the highest price per
share of our common stock paid by the interested stockholder within the three years immediately preceding the date of the announcement of the combination or in the transaction in which it became an interested stockholder, whichever is higher, plus
compounded interest and less dividends paid, (ii)&nbsp;the market value per share of our common stock on the date of announcement of the combination and the date the interested stockholder acquired the shares of our common stock, whichever is
higher, plus compounded interest and less dividends paid, or (iii)&nbsp;for holders of preferred stock, the highest liquidation value of the preferred stock, plus accrued dividends, if not included in the liquidation value. With respect to
(i)&nbsp;and (ii)&nbsp;above, the interest is compounded at the rate for one-year United States Treasury obligations from time to time in effect. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">We will be subject to the Nevada business combination provisions described above because we have more than 200 stockholders of record, unless our articles of incorporation are amended before such time to
elect to not be governed by these provisions. Applicability of these business combination provisions would discourage parties interested in taking control of our company if they cannot obtain the approval of our board of directors. These provisions
could prohibit or delay a merger or other takeover or change in control attempt and, accordingly, may discourage attempts to acquire our company even though such a transaction may offer our stockholders the opportunity to sell their stock at a price
above the prevailing market price. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Control Share Acquisitions </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The &#147;control share&#148; provisions of Sections 78.378 to 78.3793, inclusive, of the NRS, apply to &#147;issuing corporations,&#148;
which are Nevada corporations with at least 200 stockholders of record, including at least 100 stockholders of record who are Nevada residents, and which conduct business directly or indirectly in Nevada, unless the corporation has elected to not be
subject to these provisions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The control share statute prohibits an acquirer of shares of an issuing corporation, under
certain circumstances, from voting its shares of a corporation&#146;s stock after crossing certain ownership threshold percentages, unless the acquirer obtains approval of the target corporation&#146;s disinterested stockholders. The statute
specifies three thresholds: (a)&nbsp;one-fifth or more but less than one-third, (b)&nbsp;one-third but less than a majority, and (c)&nbsp;a majority or more, of the outstanding voting power. Generally, once a person acquires shares in excess of any
of the thresholds, those shares and any additional shares acquired within 90 days thereof become &#147;control shares&#148; and such control shares are deprived of the right to vote until disinterested stockholders restore the right. These
provisions also provide that if control shares are accorded full voting rights and the acquiring person has acquired a majority or more of all voting power, all other stockholders who do not vote in favor of authorizing voting rights to the control
shares are entitled to demand payment for the fair value of their shares in accordance with statutory procedures established for dissenters&#146; rights. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-44
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The effect of the Nevada control share provisions is that the acquiring person, and those
acting in association with the acquiring person, will obtain only such voting rights in the control shares as are conferred by a resolution of the stockholders at an annual or special meeting. The Nevada control share provisions, if applicable,
could have the effect of discouraging takeovers of our company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">A corporation may elect to not be governed by, or &#147;opt
out&#148; of, the control share provisions by making an election in its articles of incorporation or bylaws, provided that the opt-out election must be in place on the 10</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="3"> day following the date an acquiring person has acquired a controlling interest, that is, crossing any of the three
thresholds described above. We have opted out of the control share statutes in our bylaws, and will not be subject to this statute unless our bylaws are amended on or prior to the 10</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="3"> day following the date an acquiring person acquires a controlling interest. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Warrants </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>The
following summary of certain terms and provisions of the warrants offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions of the form of the warrant, which will be filed as an exhibit to a current report on
Form 8-K that will be incorporated by reference herein. Prospective investors should carefully review the terms and provisions set forth in the form of warrant. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><I>Exercisability</I>. The warrants are exercisable upon separation of the units as set forth above and at any time up to the date that is five years from the closing of this offering. The warrants will
be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice accompanied by payment in full for the number of shares of our common stock purchased upon such exercise (except in the case of a
cashless exercise as discussed below). Unless otherwise specified in the warrant, the holder will not have the right to exercise any portion of the warrant if the holder (together with its affiliates) would beneficially own in excess of 4.99% of the
number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the warrants. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Cashless Exercise</I>. In the event that a registration statement covering shares of common stock underlying the warrants, or an
exemption from registration, is not available for the resale of such shares of common stock underlying the warrants, the holder may, in its sole discretion, exercise the warrant in whole or in part and, in lieu of making the cash payment otherwise
contemplated to be made to us upon such exercise in payment of the aggregate exercise price, elect instead to receive upon such exercise the net number of shares of common stock determined according to the formula set forth in the warrant. In no
event shall we be required to make any cash payments or net cash settlement to the registered holder in lieu of issuance of common stock underlying the warrants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><I>Exercise Price and Certain Adjustments</I>. The initial exercise price per share of common stock purchasable upon exercise of the warrants is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per
share. The exercise price and the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-45
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
number of shares of common stock purchasable upon the exercise of the warrants are subject to adjustment upon the occurrence of certain events, including stock dividends and distributions, stock
splits, stock combinations, reclassifications or similar events affecting our common stock and also upon any distributions of assets, including cash, stock or other property to our stockholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Transferability</I>. Subject to applicable laws, the warrants may be transferred at the option of the holders upon surrender of the
warrants to us together with the appropriate instruments of transfer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Warrant Agent and Exchange Listing</I>. The warrants
will be issued in registered form under a warrant agreement between us and Continental Stock Transfer&nbsp;&amp; Trust Co., as warrant agent. We have applied for listing of the warrants on The NASDAQ Capital Market. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Fundamental Transaction</I>. If, at any time while the warrants are outstanding, (1)&nbsp;we consolidate or merge with or into another
corporation and we are not the surviving corporation, (2)&nbsp;we sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of our assets, (3)&nbsp;any purchase offer, tender offer or exchange offer (whether by
us or another individual or entity) is completed pursuant to which holders of our shares of common stock are permitted to sell, tender or exchange their shares of common stock for other securities, cash or property and has been accepted by the
holders of 50% or more of our outstanding shares of common stock, (4)&nbsp;we effect any reclassification or recapitalization of our shares of common stock or any compulsory share exchange pursuant to which our shares of common stock are converted
into or exchanged for other securities, cash or property, or (5)&nbsp;we consummate a stock or share purchase agreement or other business combination with another person or entity whereby such other person or entity acquires more than 50% of our
outstanding shares of common stock, each, a &#147;Fundamental Transaction,&#148; then upon any subsequent exercise of the warrants, the holders thereof will have the right to receive the same amount and kind of securities, cash or property as it
would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental Transaction, the holder of the number of warrant shares then issuable upon exercise of the warrant, and any
additional consideration payable as part of the Fundamental Transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Rights as a Stockholder</I>. Except as otherwise
provided in the warrants or by virtue of such holder&#146;s ownership of shares of our common stock, the holder of a warrant does not have the rights or privileges of a holder of our common stock, including any voting rights, until the holder
exercises the warrant. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-46
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_10"></A>UNDERWRITING </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We and the underwriters for the offering named below have entered into an underwriting agreement with respect to the units being offered.
Subject to the terms and conditions of the underwriting agreement, each underwriter has severally agreed to purchase from us the number of units set forth opposite its name below. Aegis Capital Corp. is the representative of the underwriters.
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Underwriter</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Number&nbsp;of<BR>Units</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Aegis Capital Corp.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The underwriting agreement provides that the obligations of the underwriters are subject to certain
conditions precedent and that the underwriters have agreed, severally and not jointly, to purchase all of the units sold under the underwriting agreement if any of these units are purchased. If an underwriter defaults, the underwriting agreement
provides that the purchase commitments of the non-defaulting underwriters may be increased or the underwriting agreement may be terminated. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">We have agreed to indemnify the underwriters against specified liabilities, including liabilities under the Securities Act, and to contribute to payments the underwriters may be required to make in
respect thereof. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The underwriters are offering the units, subject to prior sale, when, as and if issued to and accepted by
them, subject to approval of legal matters by their counsel and other conditions specified in the underwriting agreement. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have granted the underwriters an over-allotment option. This option, which is exercisable for up to 45 days after the date
of this prospectus, permits the underwriters to purchase a maximum of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional units (15% of the units sold in this offering) from us to cover over-allotments, if any. If the
underwriters exercise all or part of this option, they will purchase units covered by the option at the public offering price that appears on the cover page of this prospectus supplement, less the underwriting discount. If this option is exercised
in full, the total price to the public will be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million and the total proceeds to us will be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Discounts and Commissions</I>. The following table shows the public offering price, underwriting discount and proceeds,
before expenses, to us. The information assumes either no exercise or full exercise by the underwriters of their over-allotment option. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-47
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="3">Per&nbsp;Unit</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="3">Total&nbsp;Without</FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="3">Over-Allotment&nbsp;
Option</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="3">Total<BR>Over-Allotment&nbsp;Option</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Public offering price</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="3">Underwriting discount (7%)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="3">Non-accountable expense allowance (1%)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="3">Proceeds, before expense, to&nbsp;us</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="3">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The underwriters propose to offer the units offered by us to the public at the public offering price set
forth on the cover of this prospectus supplement. In addition, the underwriters may offer some of the units to other securities dealers at such price less a concession of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per unit. The underwriters
may also allow, and such dealers may re-allow, a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per unit to other dealers. If all of the units offered by us are not sold at the public offering price, the underwriters
may change the offering price and other selling terms by means of a further supplement to this prospectus supplement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have
paid a non-refundable expense deposit of $50,000 to the representative, which will be applied against the non-accountable expenses that will be paid by us to the underwriters in connection with this offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We have also agreed to pay the underwriters&#146; expenses relating to the offering, including (a)&nbsp;all fees, expenses and
disbursements relating to background checks of our officers and directors in an amount not to exceed $5,000 per individual and $10,000 in total; (b)&nbsp;all fees incurred in clearing this offering with FINRA; (c)&nbsp;all fees, expenses and
disbursements relating to the registration, qualification or exemption of securities offered under the securities laws of foreign jurisdictions designated by the underwriters; and (d)&nbsp;upon successfully completing this offering, $20,000 for the
underwriters&#146; use of Ipreo&#146;s book-building, prospectus tracking and compliance software for this offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We
estimate that the total expenses of the offering payable by us, excluding the total underwriting discount, will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Discretionary Accounts</I>. The underwriters do not intend to confirm sales of the securities offered hereby to any accounts over
which they have discretionary authority. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Lock-Up Agreements</I>. Pursuant to certain &#147;lock-up&#148; agreements, we,
our executive officers and directors, and certain of our stockholders have agreed, subject to certain exceptions, not to offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose of or announce the intention to otherwise dispose
of, or enter into any swap, hedge or similar agreement or arrangement that transfers, in whole or in part, the economic risk of ownership of, directly or indirectly, engage in any short selling of any common stock or securities convertible into or
exchangeable or exercisable for any common stock, whether currently owned or subsequently acquired, without the prior written consent of the representative, for a period of one-hundred and eighty (180) days after the date of this prospectus
supplement and subject to an 18-day extension. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-48
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Underwriter&#146;s Warrants</I>. We have agreed to issue to the underwriters warrants to
purchase up to a total of shares of common stock (2% of the shares of common stock sold in this offering). The warrants are exercisable at $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share (125% of the price of the shares of common stock
sold in this offering), commencing on a date which is one year from the date of the closing of the offering under this prospectus supplement and expiring five years after the effective date of our registration statement, or May&nbsp;2, 2016. The
warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(g)(1) of FINRA. The underwriters (or permitted assignees under Rule 5110(g)(1)) will not sell, transfer, assign, pledge, or
hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying
securities for a period of 180 days from the date of this prospectus supplement. In addition, the warrants provide for registration rights upon request, in certain cases. We will bear all fees and expenses attendant to registering the securities
issuable on exercise of the warrants other than underwriting commissions incurred and payable by the holders. The exercise price and number of shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the
event of a stock dividend, extraordinary cash dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price
below the warrant exercise price. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Right of First Refusal. </I>If at least $10 million in gross proceeds are raised in this
offering, for a period of twelve (12)&nbsp;months after the closing of this offering, the representative shall have a right of first refusal to purchase for its account or to sell for our account, or any subsidiary or successor, any securities of
our company or any such subsidiary or successor which we or any subsidiary or successor may seek to sell in public or private equity and public debt offerings during such twelve (12)-month period. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We may, however, in lieu of granting a right of first refusal, designate the representative as lead underwriter or co-manager of any
underwriting group or co-placement agent of any proposed financing, and the representative shall be entitled to receive as its compensation 50% of the compensation payable to the underwriting or placement agent group when serving as co-manager or
co-placement agent, and 33% of the compensation payable to the underwriting or placement agent group when serving as co-manager or co-placement agent with respect to a proposed financing in which there are three co-managing or lead underwriters or
co-placement agents. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Electronic Offer, Sale and Distribution of Shares</I>. A prospectus supplement in electronic format
may be made available on the websites maintained by one or more of the underwriters or selling group members, if any, participating in this offering and one or more of the underwriters participating in this offering may distribute prospectus
supplements electronically. The representative may agree to allocate a number of shares to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the underwriters and
selling group members that will make internet distributions on the same basis as other allocations. Other than the prospectus </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-49
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
supplement in electronic format, the information on these websites is not part of, nor incorporated by reference into, this prospectus supplement, the accompanying prospectus or the registration
statement of which this prospectus supplement and the accompanying prospectus form a part, has not been approved or endorsed by us or any underwriter in its capacity as underwriter, and should not be relied upon by investors. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Stabilization</I>. In connection with this offering, the underwriters may engage in stabilizing transactions, over-allotment
transactions, syndicate-covering transactions, penalty bids and purchases to cover positions created by short sales. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Stabilizing transactions permit bids to purchase shares so long as the stabilizing bids do not exceed a specified maximum, and are engaged in for the
purpose of preventing or retarding a decline in the market price of the shares while the offering is in progress. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Over-allotment transactions involve sales by the underwriters of shares in excess of the number of shares the underwriters are obligated to purchase.
This creates a syndicate short position which may be either a covered short position or a naked short position. In a covered short position, the number of shares over-allotted by the underwriters is not greater than the number of shares that they
may purchase in the over-allotment option. In a naked short position, the number of shares involved is greater than the number of shares in the over-allotment option. The underwriters may close out any short position by exercising their
over-allotment option and/or purchasing shares in the open market. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Syndicate covering transactions involve purchases of shares in the open market after the distribution has been completed in order to cover syndicate
short positions. In determining the source of shares to close out the short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared with the price at which they may
purchase shares through exercise of the over-allotment option. If the underwriters sell more shares than could be covered by exercise of the over-allotment option and, therefore, have a naked short position, the position can be closed out only by
buying shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that after pricing there could be downward pressure on the price of the shares in the open market that could adversely affect
investors who purchase in the offering. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">Penalty bids permit the representative to reclaim a selling concession from a syndicate member when the shares originally sold by that syndicate member
are purchased in stabilizing or syndicate covering transactions to cover syndicate short positions. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">These
stabilizing transactions, syndicate covering transactions and penalty bids may have the effect of raising or maintaining the market price of our shares or common stock or preventing or retarding a decline in the market price of our shares or common
stock. As a result, the price of our common stock in the open market may be higher than it would otherwise be in the absence of these transactions. Neither we nor the underwriters make any representation or prediction as to the effect that the
transactions described above may have on </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-50
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
the price of our common stock. These transactions may be effected on The NASDAQ Capital Market, in the over-the-counter market or otherwise and, if commenced, may be discontinued at any time.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Passive market making</I>. In connection with this offering, underwriters and selling group members may engage in passive
market making transactions in our common stock on The NASDAQ Capital Market or on the OTC Bulletin Board in accordance with Rule 103 of Regulation M under the Exchange Act, during a period before the commencement of offers or sales of the shares and
extending through the completion of the distribution. A passive market maker must display its bid at a price not in excess of the highest independent bid of that security. However, if all independent bids are lowered below the passive market
maker&#146;s bid, then that bid must then be lowered when specified purchase limits are exceeded. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3"><I>Other Relationships</I>.
Certain of the underwriters and their affiliates have provided, and may in the future provide, various investment banking, commercial banking and other financial services for us and our affiliates for which they have received, and may in the future
receive, customary fees; however, except as disclosed in this prospectus supplement, we have no present arrangements with any of the underwriters for any further services. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Offer restrictions outside the United States </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Other than in the United
States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus supplement and the accompanying prospectus in any jurisdiction where action for that purpose is required. The
securities offered by this prospectus supplement and the accompanying prospectus may not be offered or sold, directly or indirectly, nor may this prospectus supplement and the accompanying prospectus or any other offering material or advertisements
in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into
whose possession this prospectus supplement and the accompanying prospectus come are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus supplement and the accompanying
prospectus. This prospectus supplement and the accompanying prospectus do not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus supplement and the accompanying prospectus in any jurisdiction
in which such an offer or a solicitation is unlawful. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Australia </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">This prospectus is not a disclosure document under Chapter 6D of the Australian Corporations Act, has not been lodged with the Australian
Securities and Investments Commission and does not purport to include the information required of a disclosure document under Chapter 6D of the Australian Corporations Act. Accordingly, (i)&nbsp;the offer of the securities under this prospectus is
only made to persons to whom it is lawful to offer the securities without disclosure under Chapter 6D of the Australian Corporations Act under one </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-51
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3">
or more exemptions set out in section 708 of the Australian Corporations Act, (ii)&nbsp;this prospectus is made available in Australia only to those persons as set forth in clause (i)&nbsp;above,
and (iii)&nbsp;the offeree must be sent a notice stating in substance that by accepting this offer, the offeree represents that the offeree is such a person as set forth in clause (i)&nbsp;above, and, unless permitted under the Australian
Corporations Act, agrees not to sell or offer for sale within Australia any of the securities sold to the offeree within 12 months after its transfer to the offeree under this prospectus. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>China </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The information in this document does not constitute a public offer
of the securities, whether by way of sale or subscription, in the People&#146;s Republic of China (excluding, for purposes of this paragraph, Hong Kong Special Administrative Region, Macau Special Administrative Region and Taiwan). The securities
may not be offered or sold directly or indirectly in the PRC to legal or natural persons other than directly to &#147;qualified domestic institutional investors.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>European Economic Area&#151;Belgium, Germany, Luxembourg and Netherlands </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The information in this document has been prepared on the basis that all offers of securities will be made pursuant to an exemption under
the Directive 2003/71/EC (&#147;Prospectus Directive&#148;), as implemented in Member States of the European Economic Area (each, a &#147;Relevant Member State&#148;), from the requirement to produce a prospectus for offers of securities.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">An offer to the public of securities has not been made, and may not be made, in a Relevant Member State except pursuant to
one of the following exemptions under the Prospectus Directive as implemented in that Relevant Member State: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:5%; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">(a) to legal entities that are authorized or regulated to operate in the financial markets or, if not so authorized or
regulated, whose corporate purpose is solely to invest in securities; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:5%; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">(b) to any legal entity that has two or
more of (i)&nbsp;an average of at least 250 employees during its last fiscal year; (ii)&nbsp;a total balance sheet of more than &#128;43,000,000 (as shown on its last annual unconsolidated or consolidated financial statements) and (iii)&nbsp;an
annual net turnover of more than &#128;50,000,000 (as shown on its last annual unconsolidated or consolidated financial statements); </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:5%; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">(c) to fewer than 100 natural or legal persons (other than qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive) subject to obtaining the prior consent of the Company or
any underwriter for any such offer; or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:5%; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">(d) in any other circumstances falling within Article 3(2) of the
Prospectus Directive, provided that no such offer of securities shall result in a requirement for the publication by the Company of a prospectus pursuant to Article 3 of the Prospectus Directive. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-52
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>France </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">This document is not being distributed in the context of a public offering of financial securities (offre au public de titres financiers) in France within the meaning of Article L.411-1 of the French
Monetary and Financial Code (Code mon&eacute;taire et financier) and Articles 211-1 et seq. of the General Regulation of the French Autorit&eacute; des march&eacute;s financiers (&#147;AMF&#148;). The securities have not been offered or sold and
will not be offered or sold, directly or indirectly, to the public in France. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">This document and any other offering material
relating to the securities have not been, and will not be, submitted to the AMF for approval in France and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in France. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Such offers, sales and distributions have been and shall only be made in France to (i)&nbsp;qualified investors (investisseurs
qualifi&eacute;s) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2&deg; and D.411-1 to D.411-3, D. 744-1, D.754-1 and D.764-1 of the French Monetary and Financial Code and any implementing regulation and/or
(ii)&nbsp;a restricted number of non-qualified investors (cercle restreint d&#146;investisseurs) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2&deg; and D.411-4, D.744-1, D.754-1 and D.764-1 of the French
Monetary and Financial Code and any implementing regulation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Pursuant to Article 211-3 of the General Regulation of the AMF,
investors in France are informed that the securities cannot be distributed (directly or indirectly) to the public by the investors otherwise than in accordance with Articles L.411-1, L.411-2, L.412-1 and L.621-8 to L.621-8-3 of the French Monetary
and Financial Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Ireland </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">The information in this document does not constitute a prospectus under any Irish laws or regulations and this document has not been filed with or approved by any Irish regulatory authority as the
information has not been prepared in the context of a public offering of securities in Ireland within the meaning of the Irish Prospectus (Directive 2003/71/EC) Regulations 2005 (the &#147;Prospectus Regulations&#148;). The securities have not been
offered or sold, and will not be offered, sold or delivered directly or indirectly in Ireland by way of a public offering, except to (i)&nbsp;qualified investors as defined in Regulation 2(l) of the Prospectus Regulations and (ii)&nbsp;fewer than
100 natural or legal persons who are not qualified investors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Israel </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The securities offered by this prospectus have not been approved or disapproved by the Israeli Securities Authority (the ISA), or ISA,
nor have such securities been registered for sale in Israel. The shares may not be offered or sold, directly or indirectly, to the public in Israel, absent the publication of a prospectus. The ISA has not issued permits, approvals or licenses in
connection with the offering or publishing the prospectus; nor has it authenticated the details included herein, confirmed their reliability or completeness, or rendered an opinion as to the quality of the securities being offered. Any resale in
Israel, directly or indirectly, to the public of the securities offered by this prospectus is subject to restrictions on transferability and must be effected only in compliance with the Israeli securities laws and regulations. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-53
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Italy </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">The offering of the securities in the Republic of Italy has not been authorized by the Italian Securities and Exchange Commission (Commissione Nazionale per le Societ&#151;$$&#151;Aga e la Borsa,
&#147;CONSOB&#148; pursuant to the Italian securities legislation and, accordingly, no offering material relating to the securities may be distributed in Italy and such securities may not be offered or sold in Italy in a public offer within the
meaning of Article 1.1(t) of Legislative Decree No.&nbsp;58 of 24&nbsp;February 1998 (&#147;Decree No.&nbsp;58&#148;), other than: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">to Italian qualified investors, as defined in Article 100 of Decree no.58 by reference to Article 34-ter of CONSOB Regulation no. 11971 of 14&nbsp;May
1999 (&#147;Regulation no. 1197l&#148;) as amended (&#147;Qualified Investors&#148;); and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">in other circumstances that are exempt from the rules on public offer pursuant to Article 100 of Decree No.&nbsp;58 and Article 34-ter of Regulation
No.&nbsp;11971 as amended. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Any offer, sale or delivery of the securities or distribution of any offer
document relating to the securities in Italy (excluding placements where a Qualified Investor solicits an offer from the issuer) under the paragraphs above must be: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">made by investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with Legislative Decree
No.&nbsp;385 of 1&nbsp;September 1993 (as amended), Decree No.&nbsp;58, CONSOB Regulation No.&nbsp;16190 of 29&nbsp;October 2007 and any other applicable laws; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">in compliance with all relevant Italian securities, tax and exchange controls and any other applicable laws. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Any subsequent distribution of the securities in Italy must be made in compliance with the public offer and prospectus requirement rules
provided under Decree No.&nbsp;58 and the Regulation No.&nbsp;11971 as amended, unless an exception from those rules applies. Failure to comply with such rules may result in the sale of such securities being declared null and void and in the
liability of the entity transferring the securities for any damages suffered by the investors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Japan </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The securities have not been and will not be registered under Article 4, paragraph 1 of the Financial Instruments and Exchange Law of
Japan (Law No. 25 of 1948), as amended (the &#147;FIEL&#148;) pursuant to an exemption from the registration requirements applicable to a private placement of securities to Qualified Institutional Investors (as defined in and in accordance with
Article 2, paragraph 3 of the FIEL and the regulations promulgated thereunder). Accordingly, the securities may not be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan other than Qualified
Institutional Investors. Any Qualified Institutional Investor who acquires securities may not resell them to any person in Japan that is not a Qualified Institutional Investor, and acquisition by any such person of securities is conditional upon the
execution of an agreement to that effect. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-54
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Portugal </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">This document is not being distributed in the context of a public offer of financial securities (oferta p&uacute;blica de valores mobili&aacute;rios) in Portugal, within the meaning of Article 109 of the
Portuguese Securities Code (C&oacute;digo dos Valores Mobili&aacute;rios). The securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in Portugal. This document and any other offering material
relating to the securities have not been, and will not be, submitted to the Portuguese Securities Market Commission (Comiss&atilde;o do Mercado de Valores Mobili&aacute;rios) for approval in Portugal and, accordingly, may not be distributed or
caused to distributed, directly or indirectly, to the public in Portugal, other than under circumstances that are deemed not to qualify as a public offer under the Portuguese Securities Code. Such offers, sales and distributions of securities in
Portugal are limited to persons who are &#147;qualified investors&#148; (as defined in the Portuguese Securities Code). Only such investors may receive this document and they may not distribute it or the information contained in it to any other
person. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Sweden </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">This document has not been, and will not be, registered with or approved by Finansinspektionen (the Swedish Financial Supervisory Authority). Accordingly, this document may not be made available, nor may
the securities be offered for sale in Sweden, other than under circumstances that are deemed not to require a prospectus under the Swedish Financial Instruments Trading Act (1991:980)&nbsp;(Sw. lag (1991:980)&nbsp;om handel med finansiella
instrument). Any offering of securities in Sweden is limited to persons who are &#147;qualified investors&#148; (as defined in the Financial Instruments Trading Act). Only such investors may receive this document and they may not distribute it or
the information contained in it to any other person. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Switzerland </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&#147;SIX&#148;) or on any
other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure
standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering material relating to the
securities may be publicly distributed or otherwise made publicly available in Switzerland. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Neither this document nor any
other offering material relating to the securities have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of securities will not be supervised by, the Swiss
Financial Market Supervisory Authority (FINMA). </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-55
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">This document is personal to the recipient only and not for general circulation in
Switzerland. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>United Arab Emirates </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Neither this document nor the securities have been approved, disapproved or passed on in any way by the Central Bank of the United Arab Emirates or any other governmental authority in the United Arab
Emirates, nor has the Company received authorization or licensing from the Central Bank of the United Arab Emirates or any other governmental authority in the United Arab Emirates to market or sell the securities within the United Arab Emirates.
This document does not constitute and may not be used for the purpose of an offer or invitation. No services relating to the securities, including the receipt of applications and/or the allotment or redemption of such shares, may be rendered within
the United Arab Emirates by the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">No offer or invitation to subscribe for securities is valid or permitted in the
Dubai International Financial Centre. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>United Kingdom </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Neither the information in this document nor any other document relating to the offer has been delivered for approval to the Financial Services Authority in the United Kingdom and no prospectus (within
the meaning of section 85 of the Financial Services and Markets Act 2000, as amended (&#147;FSMA&#148;)) has been published or is intended to be published in respect of the securities. This document is issued on a confidential basis to
&#147;qualified investors&#148; (within the meaning of section 86(7) of FSMA) in the United Kingdom, and the securities may not be offered or sold in the United Kingdom by means of this document, any accompanying letter or any other document, except
in circumstances which do not require the publication of a prospectus pursuant to section 86(1) FSMA. This document should not be distributed, published or reproduced, in whole or in part, nor may its contents be disclosed by recipients to any other
person in the United Kingdom. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Any invitation or inducement to engage in investment activity (within the meaning of section 21
of FSMA) received in connection with the issue or sale of the securities has only been communicated or caused to be communicated and will only be communicated or caused to be communicated in the United Kingdom in circumstances in which section 21(1)
of FSMA does not apply to Tops Ships. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">In the United Kingdom, this document is being distributed only to, and is directed at,
persons (i)&nbsp;who have professional experience in matters relating to investments falling within Article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005 (&#147;FPO&#148;),
(ii)&nbsp;who fall within the categories of persons referred to in Article 49(2)(a) to (d)&nbsp;(high net worth companies, unincorporated associations, etc.) of the FPO or (iii)&nbsp;to whom it may otherwise be lawfully communicated (together
&#147;relevant persons&#148;). The investments to which this document relates are available only to, and any invitation, offer or agreement to purchase will be engaged in only with, relevant persons. Any person who is not a relevant person should
not act or rely on this document or any of its contents. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-56
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_11"></A>LEGAL MATTERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Certain legal matters related to the offering will be passed upon for us by Reed Smith LLP, New York, New York. The validity of the
securities offered hereby will be passed upon for us by Lewis and Roca LLP, Las Vegas, Nevada. Certain legal matters related to the offering will be passed upon for the underwriters by Sichenzia Ross Friedman Ference LLP, New York, New York.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_12"></A>EXPERTS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">The consolidated financial statements as of and for the year ended December&nbsp;31, 2010 and for the period from inception (July 10, 2000) to December&nbsp;31, 2010, incorporated by reference in this
prospectus supplement and the accompanying prospectus, have been audited by McGladrey&nbsp;&amp; Pullen, LLP, an independent registered public accounting firm, as stated in their report, and are so incorporated in reliance upon such report and upon
the authority of such firm as experts in accounting and auditing. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">The consolidated financial statements as of and for the
year ended December&nbsp;31, 2009, incorporated by reference in this prospectus supplement and the accompanying prospectus, have been audited by Caturano and Company, P.C. (whose name has been changed to Caturano and Company, Inc.), an independent
registered public accounting firm, as stated in their report (which report expresses an unqualified opinion and includes an explanatory paragraph relating to the Company&#146;s ability to continue as a going concern), and are so incorporated in
reliance upon such report and upon the authority of such firm as experts in accounting and auditing. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_13">
</A>WHERE YOU CAN FIND MORE INFORMATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">This prospectus supplement and the accompanying prospectus are part of the
registration statement on Form S-3 (File No.&nbsp;333-172849) we filed with the SEC under the Securities Act and do not contain all the information set forth in the registration statement. Whenever a reference is made in this prospectus supplement
or the accompanying prospectus to any of our contracts, agreements or other documents, the reference may not be complete, and you should refer to the exhibits that are a part of the registration statement or the exhibits to the reports or other
documents incorporated by reference into this prospectus supplement and the accompanying prospectus for a copy of such contract, agreement or other document. You may inspect a copy of the registration statement, including the exhibits and schedules,
without charge, at the SEC&#146;s public reference room mentioned below, or obtain a copy from the SEC upon payment of the fees prescribed by the SEC. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Because we are subject to the information and reporting requirements of the Exchange Act, we file annual, quarterly and special reports, proxy statements and other information with the SEC. Our SEC
filings are available to the public over the Internet at the SEC&#146;s website at www.sec.gov. You may also read and copy any document we file at the SEC&#146;s Public Reference Room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Please
call the SEC at 1-800-SEC-0330 for further information on the operation of the Public Reference Room. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-57
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We also maintain a web site at www.galectintherapeutics.com, through which you can access
our SEC filings. The information on our web site is not part of, and should not be construed as being incorporated by reference into, this prospectus supplement or the accompanying prospectus. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B><A NAME="suptoc309840_14"></A>INCORPORATION OF DOCUMENTS BY REFERENCE </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">We incorporate by reference the filed documents listed below, except as superseded, supplemented or modified by this prospectus, and any
future filings we will make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (unless otherwise noted, the SEC file number for each of the documents listed below is 001-31791): </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">our Annual Report on Form 10-K for the year ended December 31, 2010, filed with the SEC on March 15, 2011 (including the portions of our Proxy
Statement on Schedule 14A, filed with the SEC on April 12, 2011, incorporated by reference therein); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">our Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, filed with the SEC on May 13, 2011; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">our Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, filed with the SEC on August 12, 2011; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">our Quarterly Report on Form 10-Q for the quarter ended September 30, 2011, filed with the SEC on November 10, 2011; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">our Current Reports on Form 8-K, filed with the SEC on January 6, 2011, January 14, 2011, January 27, 2011, March 9, 2011, March 14, 2011, April 6,
2011, April 28, 2011, June 2, 2011, June 15, 2011, July 5, 2011, October 12, 2011, October 24, 2011, November 22, 2011, December 19, 2011, December 20, 2011, February 27, 2012 and March 5, 2012 (not including any information furnished under Items
2.02 or 7.01 of Form 8-K, including the related exhibits, which information is not incorporated by reference herein); and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="3">the description of our common stock contained in our registration statement on Form 8-A, filed with the SEC on September 9, 2003, including any
amendment thereto or report filed for the purpose of updating such description. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">In addition, all documents
filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act on or after the date of this prospectus supplement and before the termination of the offering under this prospectus supplement are deemed to be incorporated by reference
into, and to be a part of, this prospectus supplement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">Nothing in this prospectus supplement or the accompanying prospectus
shall be deemed to incorporate information furnished but not filed with the SEC pursuant to Item 2.02 or 7.01 of Form 8-K. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-58
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:5%"><FONT STYLE="font-family:Times New Roman" SIZE="3">You may request and obtain a copy of any of the filings incorporated herein by reference,
at no cost, by writing or telephoning us at the following address or phone number: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3">Galectin Therapeutics Inc. </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3">7 Wells Avenue </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3">Newton, Massachusetts 02459 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3">Attn: Investor Relations </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3">Tel: (617) 559-0033 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3">E-mail: ir@galectintherapeutics.com </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">S-59
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROSPECTUS </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g74a77.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>PRO-PHARMACEUTICALS,&nbsp;INC. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>$50,000,000 </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>Preferred Stock </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="4"><B>Common Stock </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>Warrants </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>Units </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">From time to
time, we may offer and sell shares of preferred stock, common stock, warrants, or units to purchase preferred stock, common stock, warrants or any combination of these securities, either separately or in units, in one or more offerings in amounts,
at prices and on terms that we will determine at the time of the offering. The aggregate initial offering price of all securities sold by us under this prospectus will not exceed $50,000,000. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each time we offer securities, we will provide you with specific terms of the securities offered in supplements to this prospectus. The
prospectus supplement may also add, update or change information contained in this prospectus. You should read this prospectus, the information incorporated by reference in this prospectus, any applicable prospectus supplement and the additional
information described below under the heading &#147;Where You Can Find More Information&#148; carefully before you invest in any securities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The securities offered by this prospectus may be sold directly by us to investors, through agents designated from time to time or to or through underwriters or dealers. We will set forth the names of any
underwriters or agents in an accompanying prospectus supplement. For additional information on the methods of sale, you should refer to the section entitled &#147;Plan of Distribution.&#148; The price to the public of such securities and the net
proceeds we expect to receive from such sale will also be set forth in a prospectus supplement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our common stock is listed on
The OTC Bulletin Board under the symbol &#147;PRWP&#148;. The last reported sale price of our common stock on March&nbsp;15, 2011 was $1.05 per share. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>INVESTING IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISKS. SEE &#147;<A HREF="#toc202300_5a">RISK FACTORS</A>&#148; ON PAGE 4 OF THIS PROSPECTUS AND IN THE OTHER DOCUMENTS INCORPORATED BY
REFERENCE IN THIS PROSPECTUS AND THE APPLICABLE PROSPECTUS SUPPLEMENT TO READ ABOUT FACTORS YOU SHOULD CONSIDER BEFORE BUYING OUR SECURITIES. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus or the accompanying prospectus
supplement is truthful or complete. Any representation to the contrary is a criminal offense. </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">The date of this
prospectus is May 2, 2011. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>Table of Contents </U></B></FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Page</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_15">About This Prospectus</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_16">Special Note Regarding Forward-looking Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_17">About Pro-Pharmaceuticals, Inc.</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_18">Recent Developments</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_19">Risk Factors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_20">Use of Proceeds</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_21">Description of Securities</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_22">Description of Warrants</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_23">Description of Units</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_24">Plan of Distribution</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_25">Legal Matters</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_26">Experts</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_27">Where You Can Find More Information</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#suptoc309840_28">Incorporation of Certain Documents by Reference</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our executive offices are located at 7 Wells Avenue, Newton, Massachusetts 02459. Our
telephone number is (617)&nbsp;559-0033, our facsimile number is (617)&nbsp;928-3450 and our website address is www.pro-phramaceuticals.com. The information on our website is not incorporated by reference into this prospectus. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Important Notice about the Information Presented in this Prospectus </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You should rely only on the information contained or incorporated by reference in this prospectus or any applicable prospectus
supplement. We have not authorized anyone to provide you with information in addition to or different from that contained in this prospectus or any applicable prospectus supplement. We will be offering to sell, and seeking offers to buy, the shares
only in jurisdictions whether offers and sales are permitted. You should not assume that the information in this prospectus or any applicable prospectus supplement is accurate as of any date other than the date on the front of those documents.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless the context otherwise requires, throughout this prospectus and any applicable prospectus supplement, the words
&#147;Pro-Pharmaceuticals&#148; &#147;we,&#148; &#147;us,&#148; the &#147;registrant&#148;, &#147;our Company&#148; or the &#147;Company&#148; refer to Pro- Pharmaceuticals, Inc., a Nevada corporation, , and its subsidiaries, and their respective
predecessor entities for the applicable periods, considered as a single enterprise; the term &#147;securities&#148; refers collectively to our preferred stock, common stock, warrants, units or debt securities to purchase preferred stock, common
stock or debt securities, or any combination of the foregoing securities. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_15"></A>ABOUT THIS
PROSPECTUS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission,
or the SEC, using a &#147;shelf&#148; registration process. Using this process, we may, from time to time, sell any combination of the securities described in this prospectus in one or more offering transactions up to a total dollar amount of
$50,000,000. This prospectus provides you with a general description of the securities we may offer. Each time we sell any securities under this prospectus, we will provide a prospectus supplement that will contain more specific information about
the specific terms of that particular offering. Each such prospectus supplement may also add, update or change information contained in this prospectus or in documents we have incorporated by reference into this prospectus. To the extent that any
statements that we make in a prospectus supplement are inconsistent with statements made in this prospectus, the statements made in this prospectus will be deemed modified or superseded by those made in the prospectus supplement. This prospectus,
together with the applicable prospectus supplements and the documents incorporated by reference into this prospectus, includes all material information relating to the offering of the securities described in this prospectus. The information
contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sales of securities. To obtain additional information that may be important to you, you should read the
exhibits filed by us with the registration statement of which this prospectus is a part or our other filings with the SEC. You should read this prospectus, any applicable prospectus supplement and the additional information described below under
&#147;Where You Can Find More Information&#148; before making any investment decision with respect to the securities offered hereby. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_16"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">This prospectus, any applicable prospectus supplement and the documents incorporated by reference contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of
1995. Various statements in this prospectus, and any prospectus supplement, may be &#147;forward-looking statements,&#148; under the securities laws. Words such as, but not limited to, &#147;believe,&#148; &#147;expect,&#148; &#147;anticipate,&#148;
&#147;estimate,&#148; &#147;intend,&#148; &#147;plan,&#148; &#147;may,&#148; &#147;targets,&#148; &#147;likely,&#148; &#147;will,&#148; &#147;would,&#148; and &#147;could,&#148; and similar expressions or words, identify forward-looking statements.
Forward-looking statements are based upon current expectations that involve risks, changes </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
in circumstances, assumptions and uncertainties. Important factors that could cause actual results to differ materially from those reflected in our forward-looking statements include, among
others: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>the extent and effectiveness of the development, sales and marketing and distribution support DAVANAT<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> receives; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>our ability to successfully commercialize DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>delays in the completion of our clinical trials; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>a failure of our products, product candidates or partnered products to be demonstrably safe and effective; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>our failure to obtain regulatory approval for our products or product candidates or to comply with ongoing regulatory requirements;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>a lack of acceptance of our products, product candidates or partnered products in the marketplace, or a failure to become or remain profitable;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>our expectations regarding trends with respect to our costs and expenses; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>our inability to obtain the capital necessary to fund additional research and development activities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>our failure to identify or obtain rights to new products or product candidates; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>our failure to develop or obtain sales, marketing and distribution resources and expertise or to otherwise manage our growth;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>a loss of any of our key scientists or management personnel; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>losses incurred from product liability claims made against us; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>a loss of rights to develop and commercialize our products or product candidates under our license and sublicense agreements.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All written and verbal forward-looking statements attributable to us or any person acting on our behalf are
expressly qualified in their entirety by the cautionary statements contained or referred to in this section. We caution investors not to rely too heavily on the forward-looking statements we make or that are made on our behalf. We undertake no
obligation, and specifically decline any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We encourage you to read the discussion and analysis of our financial condition and our consolidated financial statements contained in or
incorporated by reference in this prospectus, and any prospectus supplement. We also encourage you to read the statements under &#147;Risk Factors&#148; and other sections of this prospectus, which contains a more complete discussion of the risks
and uncertainties associated with our business. In addition to the risks described above and in the section entitled &#147;Risk Factors&#148; of this prospectus, other unknown or unpredictable factors also could affect our results. There can be no
assurance that the actual results or developments anticipated by us will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, us. Therefore, no assurance can be given that the outcomes
stated in such forward-looking statements and estimates will be achieved. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_17"></A>ABOUT
PRO-PHARMACEUTICALS, INC. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are a development-stage company engaged in the discovery and development of therapeutics
that target Galectin receptors that we believe enhance existing cancer treatments and could also be used in the treatment of tissue fibrosis, particularly liver fibrosis, inflammatory diseases, and enhancement of tumor vaccines. All of our products
are presently in development, including pre-clinical and clinical trials. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">Since our inception on July&nbsp;10, 2000, our primary focus has been
the development of a new generation of anti-cancer treatments using polysaccharide polymers that are aimed at increasing survival and improving the quality of life for cancer patients. Our lead product candidate, DAVANAT<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, is a patented new chemical entity that we believe, when administered in combination with chemotherapy, biologics
and vaccines, increases efficacy while reducing adverse side effects of the chemotherapy. The Company holds the patents on
DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, which were invented by the founders, without any license or royalty encumbrances. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2002, the Food and Drug Administration, or FDA, granted us an Investigational New Drug application, or IND, for
use of DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> in combination with 5-fluorouracil, or 5-FU, to treat late-stage cancer patients with solid
tumors. 5-FU is one of the most widely used chemotherapies for treatment of various types of cancer, including colorectal, breast and gastrointestinal. In September 2008, we submitted a clinical and pre-clinical package to the FDA in support of our
DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> New Drug Application, NDA. Following a meeting in December 2008, the FDA advised us that that we would
be required to conduct a Phase III trial to demonstrate superiority to the best standard of care for late stage colorectal cancer patients. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On December&nbsp;17, 2010, we met with the FDA to present our Phase III clinical development program for DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>. Agreement was reached on the design of pivotal, randomized, controlled and blinded Phase III clinical trials of DAVANAT<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> co-administered with standard chemotherapy for second line treatment of patients with metastatic colorectal
cancer.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We were incorporated under Nevada law on January&nbsp;26, 2001 and in May of that year acquired a Massachusetts
corporation (organized on July&nbsp;10, 2000) engaged in the business we now undertake. We have a wholly-owned Delaware subsidiary that we formed in 2003 to hold our cash and cash equivalents. We also have a wholly-owned Nevada subsidiary that we
formed in August 2010 for the development of our technology in cardiovascular treatments. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our common stock is quoted on The
OTC Bulletin Board under the symbol &#147;PRWP&#148;. Our executive offices are located at 7 Wells Avenue, Newton, Massachusetts 02459. Our telephone number is (617)&nbsp;559-0033, fax number is (617)&nbsp;928-3450 and our website address is
www.pro-phramaceuticals.com. The information on our website is not incorporated by reference into this prospectus. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_18">
</A>RECENT DEVELOPMENTS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">On March&nbsp;9</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">, 2011, we announced that our Board of Directors named Peter G. Traber, M.D., President and Chief Executive Officer,
effective March&nbsp;17, 2011.&nbsp;Dr.&nbsp;Traber was named Interim Chief Medical Officer in June 2010 and appointed to the Board of Directors in February 2009.&nbsp;Dr.&nbsp;Traber succeeds Theodore D. Zucconi, Ph.D., who continues as a member of
the Board of Directors. Dr.&nbsp;Zucconi also will direct Company operations with a focus on approvals and expansion of the Latin American business and manufacturing. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Federal research grant </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On February&nbsp;8, 2011, we received the final payment of $234,000
of our $489,000 federal grant under the Qualifying Therapeutic Discovery Project Program. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Warrant and option exercises </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subsequent to December&nbsp;31, 2010, we issued and sold 3,757,472 shares of common stock upon exercise of common stock warrants and options, resulting in
aggregate cash proceeds of $2,209,000. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Amendment of Series B Preferred Stock and related warrants </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">On January&nbsp;21, 2011, we entered into an agreement, or 10X Agreement, with 10X Fund, L.P., or 10X Fund, the holder of all of our issued and
outstanding shares of Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred, or Series B Preferred Stock, to amend the terms of the Series B Preferred Stock and related warrants. As provided for in the 10X Agreement, we amended
and restated the Certificate of Designation for the Series B Preferred Stock to delete the Company&#146;s right to trigger a mandatory conversion, to extend the redemption date for the Series B Preferred Stock, to permit dividends paid in shares in
common stock calculated at prevailing trading prices for the common stock, and to require that any request for transfer of shares of Series B Preferred Stock be deemed an automatic conversion to shares of our common stock. Also, as provided for in
the 10X Agreement, we amended the related warrants held by 10X Fund to extend the period for required exercise or termination when the mandatory exercise condition is triggered, and to reclassify one-half, of the Series B warrants (warrants for
12,000,000 shares of common stock) to allow for cashless exercise. Please see &#147;Description of Capital Stock - Preferred Stock&#148; in this prospectus for a more complete summary of the terms of the Series B Preferred Stock. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The requirement to amend the Certificate of Designation for the Series B Preferred Stock was based on a representation in the 10X Agreement that the 10X
Fund partnership agreement had been amended to bar its limited partners from withdrawals of their Series B Preferred Stock provided the 10X Fund had implemented a quarterly liquidation program entitling its partner to participate in sales of our
common stock owned by the 10X Fund. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Series C Super Dividend Convertible Preferred Stock </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of January&nbsp;10, 2011, we completed our private placement of 225 shares of our Series C Super Dividend Convertible Preferred Stock, or Series C
Preferred Stock, for aggregate gross proceeds of $2,250,000. Please see &#147;Description of Capital Stock - Preferred Stock&#148; in this prospectus for a more complete summary of the terms of the Series C Preferred Stock. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_19"></A>RISK FACTORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>An investment in our securities involves a high degree of risk. You should carefully consider the risks described below and the other information before deciding to invest in our securities. The risks
described below are not the only ones facing our company. Additional risks not presently known to us or that we currently consider immaterial may also adversely affect our business. We have attempted to identify below the major factors that could
cause differences between actual and planned or expected results, but we cannot assure you that we have identified all of those factors. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>If any of the following risks actually happen, our business, financial condition and operating results could be materially adversely affected. In this case, the trading price of our common stock could
decline, and you could lose all or part of your investment. </I></FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Risks Related to Our Company </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We have incurred net losses to date and must raise additional capital by the end of the second quarter of 2012 in order to continue to operate.
</I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have incurred net losses in each year of operation since our inception in July 2000. Our accumulated deficit as of
December&nbsp;31, 2010 was $56.4 million and our cumulative net loss applicable to common stockholders from inception to December&nbsp;31, 2010 was $56.7 million. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on approximately $8.1 million of cash as of February&nbsp;10, 2011, we believe that we
have sufficient cash to meet our financial and operating obligations into the second half of 2012. We will require more cash to fund our operations and believe that we will be able to obtain additional financing. However, there can be no assurance
that we will be successful in obtaining such new financing or, if available, that such financing will be obtainable on terms favorable to us. We must raise additional cash by the end of the second quarter of 2012, or we may not be able to continue
operations and may be forced to seek bankruptcy protection. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may raise capital through public or private equity financings,
partnerships, debt financings, bank borrowings, or other sources. Additional funding may not be available on favorable terms or at all. If adequate funds are not otherwise available, we may need to significantly curtail operations. To obtain
additional funding, we may need to enter into arrangements that require us to relinquish rights to certain technologies, products and/or potential markets. To the extent that additional capital is raised through the sale of equity, or securities
convertible into equity, our equity holders may experience dilution of their proportionate ownership of the company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We are a
development stage company and have not yet generated any revenue. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are a development stage
company and have not generated any revenues to date. We granted PROCAPS, S.A. exclusive rights to market and sell
DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> to treat cancer patients in Colombia, South America, which we refer to as the PROCAPS Channel. In
addition, there is no assurance that we will obtain FDA approval of DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> or any other of our products in
development and, even if we do so, that we will generate revenue sufficient to become profitable. Our failure to generate revenue and profit would likely lead to loss of your investment. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>We have one drug candidate in clinical trials and results are uncertain. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT
STYLE="font-family:Times New Roman" SIZE="2">DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, our lead product candidate, is in human clinical trials.
Clinical trials are expensive, time-consuming and may not be successful. They involve the testing of potential therapeutic agents, or effective treatments, in humans, typically in three phases, to determine the safety and efficacy of the product
candidates necessary for an approved drug. Many products in human clinical trials fail to demonstrate the desired safety and efficacy characteristics. Even though DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> progressed successfully through Phase I and Phase II human trials, it may fail in Phase III trials or in later stages of development. We will engage others to conduct
our clinical trials, including clinical research organizations and, possibly, government-sponsored agencies. These trials may not start or be completed as we forecast, or may not achieve desired results. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We may be unable to commercialize our product candidates. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">Even if DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> and other anticipated product candidates achieve positive results in clinical trials, we may be unable to commercialize them. Although we anticipate receipt of
regulatory approvals in connection with the PROCAPS Channel, there is no assurance that such approvals will be obtained. We granted PROCAPS exclusive rights to market and sell DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> to treat cancer in Colombia, South America. Our general inability to commercialize our products would substantially impair the viability of the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Performance milestones may not occur as contemplated by the agreement with PROCAPS S.A. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As our arrangement with PROCAPS is a collaboration, and because collaborations take place over time, milestone and performance risks are
inherent and so performance milestones may not occur as contemplated by our agreement. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>There are risks associated with our reliance on third parties to design trial protocols, arrange for
and monitor the clinical trials, and collect and analyze data. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">As we develop products eligible
for clinical trials, including DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, we will contract with independent parties to assist us in the design of
the trial protocols, arrange for and monitor the clinical trials, collect data and analyze data. In addition, certain clinical trials for our products may be conducted by government-sponsored agencies and will be dependent on governmental
participation and funding. Our dependence on independent parties and clinical sites involves risks including reduced control over the timing and other aspects of our clinical trials. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>There are risks associated with our reliance on third parties for manufacturing, marketing, sales, managed care and distribution infrastructure and channels. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We do not have, and do not now intend to develop, facilities for the manufacture of any of our products for clinical or commercial
production. At this time, we are not a party to any long-term agreement with any of our suppliers, and accordingly, we have our products manufactured on a purchase-order basis from one of two primary suppliers. We are developing relationships with
manufacturers and will enter into collaborative arrangements with licensees or have others manufacture our products on a contract basis. We expect to depend on such collaborators to supply us with products manufactured in compliance with standards
imposed by the FDA and foreign regulators. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have limited experience in marketing, sales or distribution, and we do not
intend to develop a sales and marketing infrastructure to commercialize our pharmaceutical products. If we develop commercial products, we will need to rely on licensees, collaborators, joint venture partners or independent distributors to market
and sell those products. Thus, we expect that we will be required to enter into agreements with commercial partners to engage in sales, marketing and distribution efforts around our products in development. We may be unable to establish or maintain
third-party relationships on a commercially reasonable basis, if at all. In addition, these third parties may have similar or more established relationships with our competitors. If we do not enter into relationships with third parties for the sales
and marketing of our proposed products, we will need to develop our own sales and marketing capabilities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Even if engaged,
these distributors may: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">fail to satisfy financial or contractual obligations to us; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">fail to adequately market our products; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">cease operations with little or no notice to us; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">offer, design, manufacture or promote competing formulations or products. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we fail to develop sales, managed care, marketing and distribution channels, we would experience delays in generating sales and incur
increased costs, which would harm our financial results. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Our lack of operating experience may cause us difficulty in managing our
growth. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have limited experience in manufacturing or procuring products in commercial quantities, conducting other
later-stage phases of the regulatory approval process, selling pharmaceutical products, or negotiating, establishing and maintaining strategic relationships. Although we have engaged a number of consultants to assist us, any additional growth may
require us to expand our management, operational and financial systems and controls. If we are unable to do so, our business and financial condition would be materially harmed. If rapid growth occurs, it may strain our managerial, operational and
financial resources. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We are exposed to product liability, pre-clinical and clinical liability risks which could place a
financial burden upon us, should we be sued, because we do not currently have product liability insurance above and beyond our general insurance coverage. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our business exposes us to potential product liability and other liability risks that are inherent in the testing, manufacturing and marketing of pharmaceutical formulations and products. Claims may be
asserted against us. In addition, the use in our clinical trials of pharmaceutical formulations and products that our potential collaborators may develop and the subsequent sale of these formulations or products by us or our potential collaborators
may cause us to bear a portion of or all product liability risks. A successful liability claim or series of claims brought against us could have a material adverse effect on our business, financial condition and results of operations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because we do not currently have any FDA-approved products or formulations, we do not currently have any product liability insurance
covering commercialized products. We may not be able to obtain or maintain adequate product liability insurance on acceptable terms, if at all, or such insurance may not provide adequate coverage against our potential liabilities. Furthermore, our
current and potential partners with whom we have collaborative agreements or our future licensees may not be willing to indemnify us against these types of liabilities and may not themselves be sufficiently insured or have sufficient liquidity to
satisfy any product liability claims. Claims or losses in excess of any product liability insurance coverage that may be obtained by us could have a material adverse effect on our business, financial condition and results of operations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>If users of our proposed products are unable to obtain adequate reimbursement from third-party payers, market acceptance of our proposed products
may be limited and we may not achieve revenues. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The continuing efforts of governments, insurance companies, health
maintenance organizations and other payers of healthcare costs to contain or reduce costs of health care may affect our future revenues and profitability, and the future revenues and profitability of our potential customers, suppliers and
collaborative partners and the availability of capital. In other words, our ability to commercialize our proposed products will depend in large part on the extent to which appropriate reimbursement levels for the cost of our proposed formulations,
products and related treatments are obtained by the health care providers of these products and treatments. At this time we cannot predict the precise impact of the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care
and Education Affordability Act of 2010, the comprehensive health care reform legislation passed by Congress in March 2010. It is possible that the adoption of this legislation could harm our business, financial condition and results of operations.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We depend on key individuals to develop our products and pursue collaborations. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are highly dependent on Anatole Klyosov, Ph.D., D.Sc. and Peter G. Traber, M.D. Dr.&nbsp;Klyosov is our Chief
Scientist and has scientific technical or other business expertise and experience that is critical to our success. Dr.&nbsp;Traber is our interim Chief Medical Officer who, among other things, leads our FDA Phase III colorectal cancer trial for
DAVANAT<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> as well as our overall FDA approval process. Effective March&nbsp;17, 2011 Dr.&nbsp;Traber will become
our Chief Executive Officer as well as our Chief Medical Officer. The loss of Dr.&nbsp;Klyosov or Dr.&nbsp;Traber, or failure to attract or retain other key personnel, could prevent us from pursuing collaborations or developing our products and core
technologies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We are involved in litigation with Summer Street Research Partners. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On January&nbsp;30, 2008, Custom Equity Research, Incorporated (d/b/a Summer Street Research Partners), or Summer Street, filed a lawsuit
against us, alleging claims for breach of contract, declaratory judgment and unjust enrichment arising out of an engagement letter under which Summer Street agreed to provide institutional investment placement services. Discovery is currently
underway. A trial date has been set for November&nbsp;8, 2011. We believe the lawsuit is without merit and intend to contest it vigorously. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We received a letter dated January&nbsp;12, 2011 from Maxim Group, or Maxim, which has acted
as our placement agent. The letter advises that Maxim has been named as a respondent in a Financial Industry Regulatory Authority, or FINRA, arbitration matter commenced by Summer Street arising out of the Company&#146;s termination of its
relationship with Summer Street and its engagement of Maxim as its placement agent. Our placement agent agreement with Maxim contains in indemnification provision that requires us to indemnify Maxim in connection with FINRA arbitration. We believe
the claims asserted by Summer Street in the arbitration are without merit. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Risks Related to the Drug Development Industry
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We will need regulatory approvals to commercialize our products. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are required to obtain approval (i)&nbsp;from the FDA in order to sell our products in the U.S. and (ii)&nbsp;from foreign regulatory
authorities in order to sell our products in other countries. The FDA&#146;s review and approval process is lengthy, expensive and uncertain. Extensive pre-clinical and clinical data and supporting information must be submitted to the FDA for each
indication for each product candidate in order to secure FDA approval. Before receiving FDA clearance to market our proposed products, we will have to demonstrate that our products are safe on the patient population and effective for the diseases
that are to be treated. Clinical trials, manufacturing and marketing of drugs are subject to the rigorous testing and approval process of the FDA and equivalent foreign regulatory authorities. The Federal Food, Drug and Cosmetic Act and other
federal, state and foreign statutes and regulations govern and influence the testing, manufacture, labeling, advertising, distribution and promotion of drugs and medical devices. As a result, regulatory approvals can take a number of years or longer
to accomplish and require the expenditure of substantial financial, managerial and other resources. The FDA could reject an application or require us to conduct additional clinical or other studies as part of the regulatory review process. Delays in
obtaining or failure to obtain FDA approvals would delay or prevent the commercialization of our product candidates, which would prevent, defer or decrease our receipt of revenues. In addition, if we receive initial regulatory approval, our product
candidates will be subject to extensive and rigorous ongoing domestic and foreign government regulation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Data obtained from clinical
trials are susceptible to varying interpretations, which could delay, limit or prevent regulatory clearances. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Data
already obtained, or in the future obtained, from pre-clinical studies and clinical trials do not necessarily predict the results that will be obtained from later pre-clinical studies and clinical trials. Moreover, pre-clinical and clinical data is
susceptible to varying interpretations, which could delay, limit or prevent regulatory approval. A number of companies in the pharmaceutical industry have suffered significant setbacks in advanced clinical trials, even after promising results in
earlier trials. The failure to adequately demonstrate the safety and effectiveness of a proposed formulation or product under development could delay or prevent regulatory clearance of the potential drug. The resulting delays to commercialization
could materially harm our business. Our clinical trials may not demonstrate sufficient levels of safety and efficacy necessary to obtain the requisite regulatory approvals for our drugs, and thus our proposed drugs may not be approved for marketing.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Our competitive position depends on protection of our intellectual property. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Development and protection of our intellectual property are critical to our business. All of our intellectual property, patented or
otherwise, has been invented and/or developed by employees of the Company. If we do not adequately protect our intellectual property, competitors may be able to practice our technologies. Our success depends in part on our ability to obtain patent
protection for our products or processes in the U.S. and other countries, protect trade secrets, and prevent others from infringing on our proprietary rights. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Since patent applications in the U.S. are maintained in secrecy for at least portions of their pendency periods (published on U.S. patent issuance or, if earlier, 18 months from earliest filing date for
most applications) and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
since other publication of discoveries in the scientific or patent literature often lags behind actual discoveries, we cannot be certain that we are the first to make the inventions to be covered
by our patent applications. The patent position of biopharmaceutical firms generally is highly uncertain and involves complex legal and factual questions. The U.S. Patent and Trademark Office has not established a consistent policy regarding the
breadth of claims that it will allow in biotechnology patents. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Some or all of our patent applications may not issue as
patents, or the claims of any issued patents may not afford meaningful protection for our technologies or products. In addition, patents issued to us or our licensors may be challenged and subsequently narrowed, invalidated or circumvented. Patent
litigation is widespread in the biotechnology industry and could harm our business. Litigation might be necessary to protect our patent position or to determine the scope and validity of third-party proprietary rights, and we may not have the
required resources to pursue such litigation or to protect our patent rights. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Although we require our scientific and
technical employees and consultants to enter into broad assignment of inventions agreements, and all of our employees, consultants and corporate partners with access to proprietary information to enter into confidentiality agreements, these
agreements may not be honored. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Products we develop could be subject to infringement claims asserted by others. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We cannot assure that products based on our patents or intellectual property will not be challenged by a third party claiming
infringement of its proprietary rights. If we were not able to successfully defend our patents or other intellectual property, we may have to pay substantial damages, possibly including treble damages, for past infringement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We face intense competition in the biotechnology and pharmaceutical industries. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The biotechnology and pharmaceutical industries are intensely competitive. We face direct competition from U.S. and foreign companies
focusing on pharmaceutical products, which are rapidly evolving. Our competitors include major multinational pharmaceutical and chemical companies, specialized biotechnology firms and universities and other research institutions. Many of these
competitors have greater financial and other resources, larger research and development staffs and more effective marketing and manufacturing organizations, than we do. In addition, academic and government institutions are increasingly likely to
enter into exclusive licensing agreements with commercial enterprises, including our competitors, to market commercial products based on technology developed at such institutions. Our competitors may succeed in developing or licensing technologies
and products that are more effective, or succeed in obtaining FDA or other regulatory approvals for product candidates before we do. Acquisitions of, or investments in, competing pharmaceutical or biotechnology companies by large corporations could
increase such competitors&#146; financial, marketing, manufacturing and other resources. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>The market for our proposed products is
rapidly changing and competitive, and new drugs and new treatments which may be developed by others could impair our ability to maintain and grow our business and remain competitive. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The pharmaceutical and biotechnology industries are subject to rapid and substantial technological change. Developments by others may
render our proposed products noncompetitive or obsolete, or we may be unable to keep pace with technological developments or other market factors. Technological competition from pharmaceutical and biotechnology companies, universities, governmental
entities and others diversifying into the field is intense and is expected to increase. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a pre-revenue company engaged in
the development of drug technologies, our resources are limited and we may experience technical challenges inherent in such technologies. Competitors have developed or are in the process of developing technologies that are, or in the future may be,
the basis for competition. Some of these </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
technologies may have an entirely different approach or means of accomplishing similar therapeutic effects compared to our proposed products. Our competitors may develop drugs that are safer,
more effective or less costly than our proposed products and, therefore, present a serious competitive threat to us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
potential widespread acceptance of therapies that are alternatives to ours may limit market acceptance of our proposed products, even if commercialized. Many of our targeted diseases and conditions can also be treated by other medication. These
treatments may be widely accepted in medical communities and have a longer history of use. The established use of these competitive drugs may limit the potential for our technologies, formulations and products to receive widespread acceptance if
commercialized. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Risks Related to Our Common Stock </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stock prices for pharmaceutical and biotechnology companies are volatile. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The market price for securities of pharmaceutical and biotechnology companies historically has been highly volatile, and the market from time to time has experienced significant price and volume
fluctuations that are unrelated to the operating performance of such companies. Fluctuations in the trading price or liquidity of our common stock may adversely affect, among other things, the interest in our stock by purchasers on the open market
and, generally, our ability to raise capital. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Our Board of Directors has the power to designate, without shareholder approval, a series
of preferred stock the shares of which could be senior to the common stock and be entitled to conversion or voting rights that adversely affect the holders of our common stock. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Articles of Incorporation authorizes issuance of capital stock including 20,000,000 undesignated shares, and empowers our Board of
Directors to prescribe by resolution and without shareholder approval a class or series of undesignated shares, including the number of shares in the class or series and the voting powers, designations, rights, preferences, restrictions and the
relative rights in each such class or series. Accordingly, we may authorize the issuance of additional shares or series of preferred stock that would rank senior to the shares of common stock as to dividend rights or rights upon our liquidation,
winding-up, or dissolution. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>We could issue additional common stock, which might dilute the book value of our common stock.
</I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors has authority, without action or vote of our shareholders, to issue all or a part of our
authorized but unissued shares. Such stock issuances could be made at a price that reflects a discount or a premium from the then-current trading price of our common stock. In addition, in order to raise capital, we may need to issue securities that
are convertible into or exchangeable for a significant amount of our common stock. These issuances would dilute the percentage ownership interest, which would have the effect of reducing your influence on matters on which our shareholders vote, and
might dilute the book value of our common stock. You may incur additional dilution if holders of stock options, whether currently outstanding or subsequently granted, exercise their options, or if warrant holders exercise their warrants to purchase
shares of our common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>One investor, by virtue of ownership of our securities and related rights, may be able to control the
Company. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 10X Fund, L.P., or 10X Fund, owns all of our issued and outstanding Series B-1 Convertible Preferred
Stock and Series B-2 Convertible Preferred Stock, collectively the Series B Preferred Stock, which are convertible into 12&nbsp;million shares of our common stock. The 10X Fund owns related warrants exercisable to purchase an aggregate of
36&nbsp;million shares of our common stock. We have issued approximately 2.1&nbsp;million shares of our common stock as dividends on the Series B Preferred Stock. In addition, James C. Czirr, a general partner of the 10X Fund and Executive Chairman
of our Board of Directors, owns or controls approximately 5&nbsp;million shares of our common stock. As of December&nbsp;31, 2010, on a fully diluted basis, assuming conversion </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
of all Series B Preferred Stock and exercise of all the related warrants, the 10X Fund would own approximately 44.8% of our then outstanding shares of common stock, which together with
Mr.&nbsp;Czirr&#146;s shares of our common stock, would constitute approximately 49.2% of the then outstanding shares. As holder of Series B Preferred Stock, the 10X Fund is entitled to elect two directors in a separate class vote, nominate three
directors for election by all shares entitled to vote, and provide or withhold consent to a range of fundamental corporate action we may wish to undertake, such as recapitalization, sale of the company, and other matters. Such concentration of stock
ownership and related rights could have the effect of delaying, deterring or preventing corporate events that our other security holders may desire or consider beneficial to the company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>As a &#147;thinly-traded&#148; stock, large sales can place downward pressure on our stock price. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our common stock, despite certain increases of trading volume from time to time, experiences periods when it could be considered &#147;thinly-traded.&#148; Finance transactions resulting in a large amount
of newly issued shares that become readily tradable, or other events that cause current shareholders to sell shares, could place downward pressure on the trading price of our stock. In addition, the lack of a robust resale market may require a
shareholder who desires to sell a large number of shares of common stock to sell the shares in increments over time to mitigate any adverse impact of the sales on the market price of our stock. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Risks Related to this Offering </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>There is no public market for the offered securities other than our common stock. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our common stock is traded on the OTC Bulletin Board and is not listed on any securities exchange. We have not registered any series of our currently issued and outstanding preferred stock for trading in
the public securities markets and do not intend to do so. There is no established public trading market for any securities that we may offer and sell under this prospectus other than our common stock. Without an active market, the liquidity of the
securities other than our common stock will be limited. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Because we have broad discretion in how we use the proceeds from this offering,
we may use the proceeds in ways with which you disagree. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will use the net proceeds for general corporate purposes
and we have not allocated specific amounts of the net proceeds from this offering for any specific purpose. Accordingly, our management will have significant flexibility in applying the net proceeds of this offering. You will be relying on the
judgment of our management with regard to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. It is possible that the net proceeds
will be invested in a way that does not yield a favorable, or any, return for our company. The failure of our management to use such funds effectively could have a material adverse effect on our business, financial condition, operating results and
cash flow. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_20"></A>USE OF PROCEEDS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Except as otherwise provided in the applicable prospectus supplement, we intend to use the net proceeds from the sale of the securities
offered by this prospectus for general corporate purposes, which may include working capital, research and development, clinical trial expenditures, acquisitions of new technologies and investments, and the repayment or redemption of preferred
stock. Additional information on the use of net proceeds from the sale of securities offered by this prospectus may be set forth in the prospectus supplement relating to that offering. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_21"></A>DESCRIPTION OF SECURITIES </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Common Stock </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We
currently have authorized 300,000,000 shares of common stock, par value $0.001 per share. As of March&nbsp;15, 2011, there were 67,666,627 shares of common stock outstanding. Holders of our common stock have no preemptive rights and no right to
convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock. All outstanding shares of our common stock are fully paid and non-assessable. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following summary of the terms of our common stock is subject to and qualified in its entirety by reference to our Articles of
Incorporation and by-laws, copies of which are on file with the SEC as exhibits to previous SEC filings. Please refer to the section entitled &#147;Where You Can Find More Information&#148; for directions on obtaining these documents. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Voting Rights. </I>The holders of our common stock are entitled to one vote for each share held of record on all matters submitted to
a vote of stockholders, including, without limitation, the election of our board of directors. Our stockholders have no right to cumulate their votes in the election of directors. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Dividends. </I>Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of our common
stock are entitled to receive ratably those dividends declared from time to time by the board of directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Rights Upon
Liquidation. </I>Subject to preferences that may apply to shares of preferred stock outstanding at the time, in the event of liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in assets remaining after
payment of liabilities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Preferred Stock </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We are currently authorized to issue 20,000,000 shares of undesignated stock, par value $0.01 per share, the rights and privileges of which may be established from time to time by our board of directors.
As of the date of this prospectus, our board of directors has designated: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,000,000 as Series&nbsp;A 12% Convertible Preferred Stock, or Series A Preferred Stock, of which 1,592,500 are issued and outstanding as of the date
of this prospectus; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">900,000 as Series B-1 Convertible Preferred Stock, or Series B-1 Preferred Stock, and 2,100,000 as Series B-2 Convertible Preferred Stock, referred to
together as the Series B Preferred Stock, all of which are issued and outstanding as of the date of this prospectus supplement; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,000 as Series C Super Dividend Convertible Preferred Stock, or Series C Preferred Stock, of which 225 are issued and outstanding as of the date of
this prospectus supplement. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Series A Preferred Stock </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The shares of Series A Preferred Stock accrue interest at 12%&nbsp;per annum payable at our option in cash or shares of common stock
valued per share at the higher of $1.00 or 100% of the value weighted average price of our shares of common stock for the 20 consecutive trading days prior to the applicable dividend payment date. Holders are entitled to vote as a class with the
common stock and each share of Series A Preferred Stock is convertible at any time to one share of common stock, subject to adjustment in the event of a stock dividend, stock split or combination, reclassification or similar event. We may require
conversion if the closing price of the common stock exceeds $3.00 for 15 consecutive trading days and a registration statement covering the resale of the shares of common stock issuable upon conversion of the Series A Preferred Stock is then in
effect. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Series B Preferred Stock </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Dividends</I>. The holders of our Series B Preferred Stock are entitled to receive cumulative dividends at the rate of 12%&nbsp;per
share per annum (compounding monthly) payable quarterly. At our option, the dividends may be paid in cash or shares of our common stock valued at 100% of the volume weighted average price of our common stock for the 20 consecutive trading days prior
to the dividend payment date provided that there is an effective registration statement covering the shares of common stock and the issuance of the shares does not trigger certain anti-dilution to which we are subject. If we do not pay a dividend on
the Series B Preferred Stock, dividends will accrue at the rate of 15%&nbsp;per annum (compounding monthly). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Voting</I>.
The holders of Series B Preferred Stock, or Series B Holders, are entitled to the number of votes equal to the number of shares of common stock into which the shares of Series B Preferred Stock would be convertible on the record date for the vote or
consent of shareholders, and will otherwise have voting rights and powers equal to the voting rights and powers of the common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">With respect to the election of our directors, the Series B Holders will vote together as a separate class to elect two members of our Board of Directors, and we will take all reasonably necessary or
desirable actions within our control to permit the Series B Holders to appoint three additional members of our Board of Directors, who will be subject to election by all shares of our voting stock voting together as a single group (and will remain
three until there are no longer any shares of Series B Preferred Stock outstanding). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Conversion</I>. Each share of Series
B Preferred Stock is convertible into four shares of our common stock at the conversion price of $0.50 per share (subject to customary anti-dilution protection adjustments) (i)&nbsp;at the option the Series B Holder, at any time, and
(ii)&nbsp;automatically in the event that the Series B Holder transfers any shares of Series B Preferred Stock to a third party for any reason. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Redemption</I>. Upon notice of not less than 30 trading days, a Series B Holder may require us to redeem, in whole or in part, after the earlier of (i)&nbsp;February&nbsp;12, 2019, or (ii)&nbsp;the
date of issuance of a promissory note to David Platt, Ph.D. pursuant to the Separation Agreement between us and Dr.&nbsp;Platt dated February&nbsp;9, 2009 as a result of our failure to make certain milestone payments by the due date thereof. The
redemption price will be equal to the sum of the stated value of the Series B Preferred Stock, plus all accrued but unpaid dividends thereon, as of the redemption date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If we fail to pay the redemption price in cash on the redemption date, then the Series B Holders requesting redemption may, at their sole option, automatically convert their shares of Series B Preferred
Stock into a promissory note bearing interest at the rate of 15%&nbsp;per year and secured by a lien on all of our assets. We have executed a promissory note, security agreement and escrow agreement, which are being held in escrow and will be
released to the Series B Holder upon the occurrence of such an event. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Liquidation Preference</I>. Upon our liquidation,
dissolution or winding up (including certain &#147;deemed liquidation&#148; events constituting a sale, merger or reorganization), the Series B Holders are entitled to a liquidation preference to any distribution of our assets to the holders of
common stock, but pari passu with the holders of our Series A Preferred Stock, in an amount equal to the sum of the stated value of the Series B Preferred Stock, plus all accrued but unpaid dividends thereon, as of the record date for distribution.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Other Restrictions</I>. So long as any shares of the Series B Preferred Stock remain outstanding, we may not, without the
approval of the holders of a majority of the shares of Series B Preferred Stock outstanding, among other things, (i)&nbsp;change the size of our Board of Directors; (ii)&nbsp;amend or repeal our Articles of Incorporation or Bylaws or file any
articles of amendment designating the preferences, limitations and relative rights of any series of preferred stock; (iii)&nbsp;create or increase the authorized amount of any additional class or series of shares of stock that is equal to or senior
to Series B Preferred Stock; (iv)&nbsp;increase or decrease the authorized number of shares of the Series B Preferred Stock; (v)&nbsp;purchase, redeem or otherwise acquire for value </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
any shares of any class of our capital stock; (vi)&nbsp;merge or consolidate into or with any other corporation or sell, assign, lease, pledge, encumber or otherwise dispose of all or
substantially all of our assets or those of any subsidiary; (vii)&nbsp;voluntarily or involuntarily liquidate, dissolve or wind up our company or our business; (viii)&nbsp;pay or declare dividends on any capital stock other than the Preferred Stock,
unless the Series B Preferred Stock share ratably in such dividend and all accrued dividends payable with respect to the Series B Preferred Stock have been paid prior to the payment or declaration of such dividend; (ix)&nbsp;acquire an equitable
interest in, or the assets or business of any other entity in any form of transaction; (x)&nbsp;create or commit us to enter into a joint venture, licensing agreement or exclusive marketing or other distribution agreement with respect to our
products, other than in the ordinary course of business; (xi)&nbsp;permit us or any subsidiary to sell or issue any security of such subsidiary to any person or entity other than us; (xii)&nbsp;enter into, create, incur, assume or guarantee any
indebtedness for borrowed money of any kind (other than indebtedness existing on the initial closing date and approved by Series B Holders); (xiii)&nbsp;enter into, create, incur or assume any liens of any kind (other than certain permitted liens);
(xiv)&nbsp;issue any common stock equivalents; (xv)&nbsp;increase the number of shares of our common stock that may be issued pursuant to options, warrants or rights to employees, directors, officers, consultants or advisors above 1,500,000 (subject
to customary anti-dilution protection adjustments). </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Series C Super Dividend Preferred Stock </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Liquidation Preference</I>. In the event of our liquidation, dissolution or winding down, either voluntarily or involuntarily, holders
of our Series C Preferred Stock will receive $10,000 per share plus accrued and unpaid dividends, payable prior and in preference to any distributions to the holders of our common stock but after and subordinate to our Series A Preferred Stock and
Series B Preferred Stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Dividends</I>. Holders of our Series C Preferred Stock or of any Series C Preferred Stock Post
Conversion Dividend Rights, as defined below under &#147;Post Conversion Dividend,&#148; are entitled to receive, and we are obligated to pay, cumulative non-compounding dividends at the rate per share of Series C Preferred Stock equal to the
greater of (i)&nbsp;6%&nbsp;per annum of the initial purchase price (the &#147;Floor&#148;) or (ii) the product of (A) the Applicable Percentage (defined below) of net sales of the Company&#146;s DAVANAT&reg; product generated during the applicable
dividend period multiplied by (B), the fraction of (I) one (1) dividend by (II) the sum of the total number of shares of Series C Preferred Stock issued and outstanding on the dividend payment date plus the total number of Series C Preferred Stock
Post Conversion Dividend Rights issued and outstanding on the dividend payment date. Applicable Percentage means, as to each share of Series C Preferred Stock, 2.5% (0.5625% based on 225 shares issued and outstanding) until total dividends are equal
to the total investment in the shares of the Series C Preferred Stock, and 1.25% (0.28125% based on 225 shares issued and outstanding) thereafter. &#147;Applicable Percentage&#148; means, as to each share of our Series C Preferred Stock, 2.5% until
total dividends are equal to the total investment in the shares of the Series C Preferred Stock, and 1.25% thereafter. Such dividends are payable at our option either in cash or in shares of our common stock valued at the higher of (i)&nbsp;$0.50
per share or (ii)&nbsp;the average market price for the 10 consecutive trading days ending immediately prior to the dividend payment date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Conversion</I>. Each holder of shares of Series C Preferred Stock may convert, at any time, all, but not less than all, of such shares plus accrued and unpaid dividends into shares of our common stock
at the price of $1.00 per share of common stock, subject to adjustment in certain events. Subject to the continuing obligation to pay post conversion dividends, as described below under &#147;Post Conversion Dividend,&#148; we may cause the
conversion of all, but not less than all, of the then outstanding shares of Series C Preferred Stock (plus all accrued and unpaid dividends) into common stock, at the applicable conversion price, at any time after the closing price of the common
stock is not less than $3.00 per share for 15 consecutive trading days. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Post Conversion Dividend</I>: In the event that
the shares of Series C Preferred Stock are converted into common stock by us or a Series C Holder, as the case may be, before the Series C Holder has received the Maximum Payout (defined below), with respect to each such share, simultaneously with
such conversion, we will issue to the Series C Holder one Series C Post conversion dividend right, or Post Conversion Dividend Right, for </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
each share of Series C Preferred Stock converted. Each Post Conversion Dividend Right will entitle the holder to receive the dividends described above under &#147;Dividends,&#148; but without the
6% Floor. &#147;Maximum Payout&#148; means, as to each share of Series C Preferred Stock, dividends paid in respect of such share of Series C Preferred Stock having an aggregate value of $100,000. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Redemption</I>. In the event of a sale of the company, we will redeem all of the then outstanding shares of Series C Preferred Stock
and Post Conversion Rights for the Redemption Price (defined below), within thirty days after the transaction. The price to redeem a share of Series C Preferred Stock, or the Redemption Price, and each redeemed Post Conversion Right will be equal to
(i)&nbsp;(A)&nbsp;the applicable return on investment percentage, or ROI Percentage, increased incrementally on an annual basis, multiplied by (B)&nbsp;$10,000, minus (ii)&nbsp;the cumulative dividends received through the date of redemption. The
Redemption Price shall be payable at our option either in cash or in shares of common stock valued at the higher of (i)&nbsp;$0.50 per share or (ii)&nbsp;the average market price for the ten consecutive trading days ending immediately prior to the
date of redemption. The ROI Percentage shall mean the percentage that applies as of the redemption date, as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD WIDTH="84%"></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:50pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1">ROI&nbsp;Percentage</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">200</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">before the second anniversary of the date of issuance;</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">250</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">on or after the second anniversary of the date of issuance,</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">on or after the third anniversary of the date of issuance,</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">350</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">on or after the fourth anniversary of the date of issuance,</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">400</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">on or after the fifth anniversary of the date of issuance,</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">450</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">on or after the sixth anniversary of the date of issuance,</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">500</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">on or after the seventh anniversary of the date of issuance, and</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">550</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">on or after the eighth anniversary of the date of issuance.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Voting Rights</I>. The Series C Preferred shares have no voting rights. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Except for shares of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock, there are no other shares of preferred stock
outstanding as of the date of this prospectus. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we offer a specific series of preferred stock under this prospectus, we
will describe the terms of the preferred stock in the prospectus supplement for such offering and will file a copy of the certificate establishing the terms of the preferred stock with the SEC. To the extent required, this description will include:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the title and stated value; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the number of shares offered, the liquidation preference per share, and the purchase price; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the dividend rate(s), period(s), and/or payment date(s), or method(s) of calculation for such dividends; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">whether dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the procedures for any auction and remarketing, if any; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the provisions for a sinking fund, if any; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any listing of the preferred stock on any securities exchange or market; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">whether the preferred stock will be convertible into Pro-Pharmaceuticals common stock, and, if applicable, the conversion price (or how it will be
calculated) and conversion period; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">whether the preferred stock will be exchangeable into debt securities, and, if applicable, the exchange price (or how it will be calculated) and
exchange period; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">voting rights, if any, of the preferred stock; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a discussion of any material and/or special U.S. federal income tax considerations applicable to the preferred stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the relative ranking and preferences of the preferred stock as to dividend rights and&nbsp;rights upon liquidation, dissolution, or winding up of the
affairs of Pro-Pharmaceuticals; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any material limitations on issuance of any class or series of preferred stock ranking senior to or on a parity with the series of preferred stock as
to dividend rights and rights upon liquidation, dissolution, or winding up of Pro-Pharmaceuticals. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Transfer Agent and Registrar</I>. The transfer agent and registrar for any series or class of preferred stock will be set forth in the
applicable prospectus supplement. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_22"></A>DESCRIPTION OF WARRANTS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may issue warrants, preferred stock, common stock, or any combination thereof. We may issue warrants independently or together with
any other securities offered by any prospectus supplement and may be attached to or separate from the other offered securities. Each series of warrants will be issued under a separate warrant agreement to be entered into by us with a warrant agent.
The warrant agent will act solely as our agent in connection with the warrants and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants. Further terms of the warrants and the
applicable warrant agreements will be set forth in the applicable prospectus supplement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The applicable prospectus supplement
relating to any particular issue of warrants will describe the terms of the warrants, including, as applicable, the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the title of the warrants; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the aggregate number of the warrants; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the price or prices at which the warrants will be issued; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the designation, terms and number of shares of preferred stock or common stock or principal amount of debt securities purchasable upon exercise of the
warrants; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the designation and terms of the offered securities, if any, with which the warrants are issued and the number of the warrants issued with each offered
security; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the date, if any, on and after which the warrants and the related debt securities, preferred stock or common stock will be separately transferable;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the price at which each share of preferred stock or common stock purchasable upon exercise of the warrants may be purchased or the manner of
determining such price; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the date on which the right to exercise the warrants shall commence and the date on which that right shall expire; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the minimum or maximum amount of the warrants which may be exercised at any one time; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">information with respect to book-entry procedures, if any; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a discussion of certain federal income tax considerations; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any other material terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We and the warrant agent may amend or supplement the warrant agreement for a series of warrants without the
consent of the holders of the warrants issued thereunder to effect changes that are not inconsistent with the provisions of the warrants and that do not materially and adversely affect the interests of the holders of the warrants. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_23"></A>DESCRIPTION OF UNITS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following description, together with the additional information we may include in any applicable prospectus supplements, summarizes
the material terms and provisions of the units that we may offer under this prospectus. While the terms we have summarized below will apply generally to any units that we may offer under this prospectus, we will describe the particular terms of any
series of units in more detail in the applicable prospectus supplement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will file as exhibits to the registration
statement of which this prospectus is a part, or will incorporate by reference from a current report on Form&nbsp;8-K that we file with the SEC, the form of unit agreement that describes the terms of the series of units we are offering, and any
supplemental agreements, before the issuance of the related series of units. The following summaries of material terms and provisions of the units are subject to, and qualified in their entirety by reference to, all the provisions of the unit
agreement and any supplemental agreements applicable to a particular series of units. We urge you to read the applicable prospectus supplements related to the particular series of units that we sell under this prospectus, as well as the complete
unit agreement and any supplemental agreements that contain the terms of the units. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>General </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may issue units comprised of one or more shares of common stock, shares of preferred stock and warrants in any combination. Each unit
will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is
issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We will describe in the applicable prospectus supplement the terms of the series of units, including: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may
be held or transferred separately; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any provisions of the governing unit agreement that differ from those described below; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The provisions described in this section, as well as those described under &#147;Description of
Securities&#148; and &#147;Description of Warrants&#148; will apply to each unit and to any common stock, preferred stock or warrant included in each unit, respectively. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Issuance in Series </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may issue units in such amounts and in numerous
distinct series as we determine. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Enforceability of Rights by Holders of Units </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each unit agent will act solely as our agent under the applicable unit agreement and will not assume any obligation or relationship of
agency or trust with any holder of any unit. A single bank or trust company may act as unit agent for more than one series of units. A unit agent will have no duty or responsibility in case of any default by us under the applicable unit agreement or
unit, including any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a unit may, without the consent of the related unit agent or the holder of any other unit, enforce by
appropriate legal action its rights as holder under any security included in the unit. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Title </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We, the unit agent and any of their agents may treat the registered holder of any unit certificate as an absolute owner of the units evidenced by that certificate for any purposes and as the person
entitled to exercise the rights attaching to the units so requested, despite any notice to the contrary. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_24">
</A>PLAN OF DISTRIBUTION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may sell the securities covered by this prospectus in any of three ways (or in any
combination): </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to or through underwriters or dealers; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">directly to a limited number of purchasers or to a single purchaser; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">through agents. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Each time we offer and sell securities, we will provide a prospectus supplement that will set forth the terms of the offering of the securities covered by this prospectus, including: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the name or names of any underwriters, dealers or agents and the amounts of securities underwritten or purchased by each of them;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the purchase price of the securities and the proceeds we will receive from the sale; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any over-allotment options under which underwriters may purchase additional securities; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any underwriting discounts or commissions or agency fees and other items constituting underwriters&#146; or agents&#146; compensation;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the initial public offering price of the securities; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any discounts, commissions or concessions allowed or re-allowed or paid to dealers; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">any securities exchange or market on which the securities may be listed. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any public offering price and any discounts or concessions allowed or re-allowed or paid to dealers may be changed from time to time.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Underwriters or dealers may offer and sell the securities from time to time in one or more transactions, including negotiated
transactions, at a fixed public offering price or at varying prices determined at the time of sale. If underwriters or dealers are used in the sale of any securities, the securities will be acquired by such underwriters or dealers for their own
account and may be resold from time to time in one or more transactions described above. We may offer the securities to the public through underwriting syndicates represented by managing underwriters, or directly by underwriters or dealers. Subject
to certain conditions, the underwriters or dealers will be obligated to purchase all the securities of the series offered by the prospectus supplement. We will describe the nature of any such relationship in the prospectus supplement, naming the
underwriter or dealer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may use underwriters with whom we have a material relationship. We may sell the securities through
agents from time to time. The prospectus supplement will name any agent involved in the offer or sale of the securities and any commissions we pay to them. Unless the prospectus supplement states otherwise, any agent will be acting on a best efforts
basis for the period of its appointment. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may authorize underwriters, dealers or agents to solicit offers by certain
purchasers to purchase securities from us at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. The prospectus supplement will
set forth the conditions to these contracts and any commissions we pay for solicitation of these contracts. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To comply with applicable state securities laws, the securities offered by this prospectus
will be sold, if necessary, in such jurisdictions only through registered or licensed brokers or dealers. In addition, securities may not be sold in some states unless they have been registered or qualified for sale in the applicable state or an
exemption from the registration or qualification requirement is available and is complied with. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_25"></A>LEGAL MATTERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The validity of the issuance of the securities offered hereby will be passed upon for us by McCarter&nbsp;&amp; English, LLP of Boston, Massachusetts. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_26"></A>EXPERTS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The consolidated financial statements as of and for the year ended December 31, 2010, incorporated by reference in this Prospectus and Registration Statement have been audited by McGladrey &amp; Pullen,
LLP, an independent registered public accounting firm, as stated in their report, and are included in reliance upon such report and upon the authority of such firm as experts in accounting and auditing. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The consolidated financial statements as of and for the year ended December 31, 2009, incorporated by reference in this Prospectus and
Registration Statement have been audited by Caturano and Company, P.C. (whose name has been changed to Caturano and Company, Inc.), an independent registered public accounting firm, as stated in their report (which report expresses an unqualified
opinion and includes an explanatory paragraph relating to the Company&#146;s ability to continue as a going concern), and are included in reliance upon such report and upon the authority of such firm as experts in accounting and auditing.
</FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_27"></A>WHERE YOU CAN FIND MORE INFORMATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are a reporting company and file annual, quarterly and current reports, proxy statements and other information with the SEC. You may
read and copy any document we file with the SEC at the Public Reference Room (Room 1580), 100 F Street, N.E., Washington, D.C. 20549. You may also obtain information on the operations of the Public Reference Room by calling the SEC at
1-800-SEC-0330. The SEC maintains a website (www.sec.gov) that contains the reports, proxy and information statements, and other information that we file electronically with the SEC. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our internet address is www.pro-pharmaceuticals.com. We have not incorporated by reference into this prospectus the information on our
website, and you should not consider it to be a part of this document. Our web address is included in this document as an inactive textual reference only. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="suptoc309840_28"></A>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The SEC allows us to &#147;incorporate by reference&#148; information contained in documents that we file with the SEC, which means that we can disclose important information to you by referring you to
those other documents. The information incorporated by reference is an important part of this prospectus supplement, and information that we file later with the SEC will automatically update and supersede this information. We incorporate by
reference the documents listed below and any future filings we will make with the SEC under Section&nbsp;13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934 as amended prior to the termination of this offering: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Annual Report on Form 10-K for the year ended December&nbsp;31, 2010, filed with the SEC on March&nbsp;15, 2011; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Current Reports on Form 8-K filed with the SEC on January&nbsp;6, 2011,&nbsp;January&nbsp;14, 2011,&nbsp;January&nbsp;27,
2011;&nbsp;February&nbsp;10, 2011, March&nbsp;9, 2011, and March 14, 2011. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The description of our common stock contained in our registration statement on Form 8-A filed with the SEC on September&nbsp;9, 2003, including any
amendments or reports filed for the purpose of updating that description. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may request, orally or in
writing, a copy of these documents, which will be provided to you at no cost, by contacting: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pro-Pharmaceuticals, Inc.
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 Wells Avenue </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Newton, Massachusetts 02459 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Attention: Anthony D. Squeglia, Chief Financial
Officer </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tel.: (617)&nbsp;559-0033 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">E-mail: squeglia@pro-pharmaceuticals.com </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top">


<IMG SRC="g309840g34w03.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>Novel Therapies for Large Unmet Medical Needs</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B><I>GM-CT-01 Reverses &#147;Galectin Effect&#148; Stimulating the Immune System to Attack Tumors </I></B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g58v46.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B><I>GR-MD-02 Reverses Liver Fibrosis in Pre-Clinical Animal Models&#151;A Deadly Disease With No Current Therapies
</I></B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g50o38.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:2px;margin-top:0px;margin-bottom:2px;border-bottom:2pt solid #000000">&nbsp;</P> <P STYLE="font-size:60px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:20px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:20px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:20px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:20px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>$15,000,000 of Units </B></FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g309840g95a35.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:36px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:36px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:36px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Prospectus Supplement
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:36px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:36px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:36px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>Aegis Capital Corp </B></FONT></P> <P STYLE="font-size:96px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:96px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2012 </FONT></P>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:2px;margin-top:0px;margin-bottom:2px;border-bottom:2pt solid #000000">&nbsp;</P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g309840g08f20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g08f20.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0]T4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````T````38````&`&<`,``X
M`&8`,@`P`````0`````````````````````````!``````````````$V````
MT``````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````#-<````!````<````$L`
M``%0``!B<```#+L`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"`!+`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#U5))))2E6S.HX6"T.R[FU!VC0=2?ZK&R]RH]>ZT<%K<7$`LS[]*VZ
M$,!T]6S_`-%K)QK>E=.O9=G93<CJ&00UUSFNL?OG;^B>T%K:*_YOU%'*=&H[
MC?L&;'AXAQ2NN@C\TG<;]8.D'7U]H'=S'M'_`$V-5ZJZJY@LI>VQAX<TAP/S
M:LBJS*LS+'LN#L7:0TM<UPF!$-_>:]5;!33G^CBN;B9T5@6M!#;"\/<S[50Q
MGH.IM?7;5OW^JR]-&276C_S3_P!TGV\<K`XH$?O>L?7AC#A>D2633]8&.9%F
M+?ZS#LN:QH>&O'TV;MRG^W:O^XF5_P!M_P#F2/WC%^\C[ME_=_$.FLN[K^%Z
MAHJ>187>G7;8QXH-D[?3]?;M]SO;ZC%4S.K9'JC)QAD5-:`U]5]8%1UYW@[F
M6(UV?C9_1LEUV/8V@-#;8$@-)]UU#H_2?9OY[Z'^#38\Q"<C")J0U%_I#P3+
MEIPB)R%Q.AK]`^+,9'5[\F@7X[<#&J?OML-K7E\`M;37M_->X_G?F*QE=9Z=
MAV.JRK?1>T2&O!!</WJO])_85:W_`)O=2R*@\U9MUS2VMN[>6L`WN=MG]#_Q
MGT]Z+C=/OJP#BL>Q[JGN&+;8/4].O=^C_K64M]K5(+UHWX[_`/>L9K2Q7ALV
M>G9%V5A59%S/2?:"[9Q`)/IS/_![59671^U,3/JHR+_MN/DAT6%@8^M[1ZFO
MI^UU;UJ)T3IY+2-7_]#U3C4KG>H_6:RZW[#T1OK7.);ZX`<W3_0-_P`)_P`<
M_P#0_P#&J'UNZJ^L-Z;2[;ZC-^2X<[#[64_]<A_J?R/^,0,&BC!Z8W<YK,W.
M`(!<`_TYT#/SO3V_34,YDGACIW+9PX10G+6R!&/G^\U,;&9C-LR+G>I<_5]K
MO<9/.USO<ZQ_[ZK_`&47W79VUS!MFVRP@!H'L970ZPLKW6?Z/_P1766L+7WY
M%7K,I<TTN=-;`]Q-(J?M]MC*VM?9ZG[Z#GY+\BX.M<7,J:PMJ/T6O<UKO9(W
M>QOT-_[]J;8CH!KNSY,U$PB-FLUQ<\&H`^BZ*=A;],^]OO\`=7]+])Z?K>]:
MK,/+SFX^=7>`7UMHRG@6;MK;76[\>MIVN>[U7,N^T_HJ?Y_'6:UP+V/<S<UQ
M#;03#2R1N:\@M_XRBW_`V^]:MG6,/U1TO%;[7O-%N4XMJ8TN#W67-'M]1^]G
MN_F_42,Q6O4[,9,IBQ&S$:GIPNIAV,_;#W5.:ZO*H)<6$$>I2_TS]'\[9<M9
M8?3L+['F8E,[G;;WO(&T<8]?M9_9:MQ28MCY_GZFOEL\!.A,1?\`@G@_[EJY
M'3<;)R&WW[K`P0VESOT<@SO]+]]60`!`$`<!.DG",020`#+<]UIE(@`DD1V'
M9H7X5M8`Z4S'Q'O_`)VXU@F!PUK&;-VYW[[EG8N+UH9.52W*&-8'-MM#*P^M
MXL!_38WK']%:^RJSU:G?HO4_2+H$T"9[I&(*A(N1^V^GT8]6/AV'(R26U5T.
MW&W=(:_[1OA];OS[/66PH>C2+/6]-OJG0V0-W^=])31`/5!(Z/\`_]'7.WJ/
MU@<;22R[((/]1I]-C?\`MMBL-IR,KKV>8!MJM.YI$%M-;0W%;_4MW;JF_P"$
M_G%GXUIP^HLL(DT70X?U70[_`*E;V)1UC`ZAE"MHS>EW^IDT'>!8UY!MKH9N
M._\`2/=Z7^C_`,)^C52&I/G;HS](B16@TO\`J\/_`*"SZ(ZQU3ZG6B36UPQ=
MI'IET[WZC;[[/Y;UE9[659%A>3Z3]LV.D@/#6L=6^YWY_M:]O_F"/T_,ZR^R
MS+ZEAUXM%C#4=M1KN<YVL5[W_0K_`,)9<BY_5J.B58^,R@YMN4#8R1L;M/MV
MMAMKG/=_H6HR%R!'0,,K.0P`!OU:$:.=Z;AC/S-LXM3FAGM,6/\`S*Z]O\ZQ
MCV[[;/H?X+_2)=%QVY74ZA;LLKK(N.\`$N$N`9_IO4L9N_ZW;9_QG2-!ZATU
MHS,4,?8R;,-Y#MKAJREYCV>I'_6]ZRJ']0<ZO*R&V'J%L5TXMM?IL#@&N95C
M5;O9CXMK7Y&3D_X6NFCWH2AJ"3H.B^$R(R@!ZI7ZK_E\KNX4W=4NM$EF+7Z&
M[L;'GUKQ_P!;:VA::!A8C,/&90PEVW5[S])SC[K+'_RWN]R.K,(U'7?<M3+(
M2EI\H],?I_WRDDDDY8I))))2DDDDE/\`_]+<^LW3W8?4WV@?H<LFUA\'_P"&
M9_G?I?\`KBL](Z^RNMF+F2&M]M=HU@=FO;^ZNHSL'&S\=V-DMW5NU'8M(^B]
MCOS7M7(YWU5ZGC.)QP,NF?:6D-L`_P"$8_8S_MMW]A5\F.0EQ1;F+-"4>"?\
M/KQ?O-I]^<[JIKLJ=U+I&;8WT+:AN..XC:YI]/WMJ:[^<];_``?Z3_@UJ9V'
M?DX[:*KG8K0X%[FCZ3`"WT=P=6ZMKO\`@W_\&N4KZ=UFM_Z/%R&.XD,</^E]
M%7Z/J_U_-<&Y+C15W=<_<?[%5;G;O[;ZTT&9_072CB&O&(Z=@?\`NDM5_3>B
M@T8(^V9UY#(K:&M)!AC(9^ZYW[UG_&K9Z/TJ^EYS^HN%O4+1'BVIG^AJ_P#1
MCFHW2^AX/3&DTM+[G"'WOU<?(?FUM_XM:"EACK66_0=(M?)F!!C"P#\TC\T_
M_05)))*5A4DDDDI22222E))))*?_T_2\KJ.-BVBJTN#G5NL;`D$,_,G_`$KO
M\&S\]2_:&%N+?6;N#_3(G7=[C'_@=G_;5O\`HUG];]#=^D]+Z-4^KZO'KU_1
M^S_G[OYG_">K_P`"@4_9_5_P,]X]:)V9W\Q^;]F_G/3V^S^D_P#=91GW.+3A
MX?Q91[/"+X^+KMPNHWJG3W-<YM[7!C=[HUAH,;M/ZS4G=2H#9:'6$VBFMK`"
M7N+?6_1^[9L]+])O>Y9M_P!GVZ^G]`_Z>>,']W\SZ'_@7_=A2;]G^RT?0V>N
MS^:];?/H>W[-_AO5_P#`OLGJ^M_A$OUO]57ZG^O]:;UO5L2H.U+WL!+ZVP7-
MVLLN.Z2/]"^O_C5<!D`^*PW^A]GN_F]OJ7_2];;]#+G_`(3U-G]*_P"%^T>G
M^F]-;C?HCX)T>/7BKPI;/V]."_'B70#FXS;W4%QWL$O(:XL;IOBR_;Z-;]GO
MV66;T=<YD3^T[8G9OOGTHW;_`+.S^:G]-ZFS^?\`^TGJ?9O^U"4S(`<(O77^
MZK&($GC/#II_>=QF;BOL=6VP;F[->`?4$U;'_1LWQ^8F?GX;'[#<TODC8T[G
M2'-K=[&;G>Q[V[URSMOI5?S4[F1ZF[T^+=V[\W;_`*UJZS=&+/T=IV_1C9Z^
M)L^A^DV?\;^M>I_2$SBS5\@^UD,,%Z3->3NVYN+52Z]U@=6QP8XL!>=SBUC:
M]E6]^]SGL]B3,W#?7ZC;F;-#)($;CM;N#O<QV[V>Y8'M_9>1N]/;NPIV[ML;
MJ?YS9[]W[^Q!O^A?M]*?4T]#Z/\`0/=LW^S[/L_>_P`'ZOI?IDC++TB#IM>M
M^K_T%`C@V,Y#7>M.'T_^AO3#+Q2#MM8[:YS"&D$[F:V5[6^[>S]Q)N7C.:7"
MUH`#2X$@%H=]#>UWN9N_EKG<G^?I_FX]2[;N^CMWT?0_E[_H>I^F]?\`X%!,
M0/YO^>,[9]2-V%_-?]VO^XO\M+BR_N#[5".#3UG[-G__V0`X0DE-!"$`````
M`%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3
M`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``-@`N`#`````!`#A"
M24T$!@``````!P`(``$``0$`_^X`#D%D;V)E`&1``````?_;`(0``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("
M`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@`T`$V`P$1
M``(1`0,1`?_=``0`)__$`,L``0`"`P$!`0$!```````````("08'"@4$`@,!
M`0$``@,!`0$!````````````!@<$!0@#`@$)$``!!`("`@$"!`0""`(%#0`"
M`0,$!08'`!$2"!,A%#$B%0E!42,684*!,B35EA=7&)49\'%2@D.AL6)RDC-3
M<Z,E-G:V$0`!`@0$`P4$!08,!`4%```!`@,`$00%(3$2!D$3!U%A<8$BD:$R
M%+%"(Q4(\,%28I-6T>%R@I+2,],D%A<8HK)#4_%C<[,UPG2DM'7_V@`,`P$`
M`A$#$0`_`._CB$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#
MB$.(0XA#B$.(0XA#B$.(0XA'RPYT*P961`EQ9T='I,97X<AJ2RDB'(=B3(ZN
MLF8(]%EL&TX'?D#@$)(BHJ<_`H*$TD$1^D%)DH$&/JY^Q^17E[*>Q@8'[/\`
MK'@.-6Q2;![)I57L2EB/H37Z)L1VBQVAA6;2.`W]R+[JV30&HFVL=ASZ@YT4
M4O%Y^3O=DHFES4M9#@'8N24S[Y^KR';$FM5I-5:+O6.HDE*`4'O1-2I>6'F>
MR+#>2N(S#B$.(1\HSH137*T9<<K!F*Q.=@H\VLMN%)>D1X\LX_E\HQWGXCH"
M:IXD39(B]HO/S4G5IF-4IR[H_9&6J7ICZN?L?D.(0XA#B$.(1__0[^.(0XA#
MB$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(
M1BV7YQAV`5#E]F^3T>*T[2J*V%[91:Z.;B"I_"P4EP"DR"%%5&VT)PNOHB\\
M7ZABF1S*AY*&^U1`'OCU98>J%\MAI2U]@!)]T:JPSVG]>-@6#%3BFV\0L+24
M:-Q:Z3.=IILIU?%!:C1;QBM>D.FI(@@"$1+]$1>EY@TUZM-8L-T]>VISLG(^
M0,IQF5%HN=*DK?HG$H[93'M$XAC["'[&>I>2Y/M+2BPLCT7D4Y[*,LP>X8;L
M8.&Y1;3">R"?`BMN1+:MI;N<ZLLCAO*RT^^[\K0B(&L>O*[U8WWJ^V@.VU?J
M6V<="N)$I$`YF6`,YB-]:46B\,M45>2W<$X)6,-:>`/`D9"?"4C$-LY_=`WY
ME-5)K,:J\.P+[R,K!VU-#F6EQ'\_-'7H$FXE2845PVR1!)8YDVJ>0DA=*D7J
MM]W1U!;88;:)$IXDS[IX#V&)%3;+MK:TK>><=`.6`!\98^^/2](?7K9NY-ST
MN_\`/F;8L3H\B7,Y&4WZK]YFF50W?NZUNL24).SH\>T1MU^0()';;:^)LD/H
M1^]L6>ON5S:O-<%<A*]>I6:U#*0[`<9Y82$?&XKK16^WN6FC(YRDZ=(R0GC/
MO(PEGC,QT!\MJ*QC&,-S+&]@8U4Y=B5FU;T%U'23!F-"XTJHA$VZQ(CO`W(B
MRXSP$VZTX(N-N"HDB*G/)A]JI:0\RL*;5D?R]XCU>9<IW%-/(*7!F(R1QQME
MMQYYP&FF@-QUUPQ!MML!4C<<,E00`!15555$1$YZY8G*/**>J3V-;W%^XWKU
M==RRF813X]DV`+/9;EMQ\AKH>.91D-O:.!VVI01O&FTB&X/@2,`XB?U$ZKYN
M]?>&\J1NC7.E0VM!(R5Z5*)\E``>'?$Y<M'R.U*E=4F52M:5@'-/J"0/Z))/
MCW1<1RP8@T.(0XA#B$.(1__1[^.(0XA#B$.(0XA#B$.(0XA'E7EY3XS3V>0Y
M!90Z>CI8,FRM;6P?"-"@0(;1/294E]Q4!MIEH%557_Y^?#CB&FUNNK"6T@DD
MX``9DQZ,LNU#K3##96\M02E($R23(`#M)BG_`'?^[CBE5:!B_KKA;NR+$R>$
MLKRANRHL>7XE(%*KHU;AWD^/^85*1+<K0;[1/$_)%2K]P=4;7:VUFA0'4C#6
MJ:43[$IEJ6?Z/F(O?9G0;<.XZAMJX*++BL0TWI6N7$K7/EM@3&/K["`<(@U%
MRCW=]I)5F4W9FP;>`DLG+&@P>YBX'B-7]RTXV-6]-B/4%>\TU$?4/A)3DFW]
M3)TB4EJ1W>6_=V%U5G#B*35+65!M`[@`1/S*SVQT@UTQZ-],TTZ=WU#+ES*`
M>2E"GG#WJ40HC'C)I.&$9&UZ#[:L)#+]BQC/RMB"A+M\RM[*8V39*8(3OV]@
MZI`X2JBH9=*JKWWS6C:V^WU:W[ZE*NWF+)]R1[HVRNIW1:C;Y=%LMQQ(R!8;
M`/\`3</OC;5!ZQ^U&"QFF<,V8%.RQ)^^:A4FQ,PKHR3.FD5_X/L68Q/*+`(I
M$*]H*(OT3F<WM_J#2@?*[P<$L0.<\!^<1JG.HG1"O41<.E[1!P)^6IE&7M!]
M\92QD7[A>KI:6C619)EL!E/FF,2[&@SZ!*:`VW78IP+0I&0,"81^E<B`PX@D
MJ"X*DO,NGNO5ZR+#J+@*QH9I44.`_P!,)7P^J9QAU=J_"_NUHTZ[4JU5)^%:
M$/,$$S'_`$RXSA.?K3+`<!&V=>?N@2&9;51M_6GVZLO%%L;W#9CS,F&ZU\;+
M@2,1O$4_E!T3)U1L@(?H(LKUVLCM77,-/BCW18EL.I,E+:),CWM+`(\EGN$1
M'</X2%55%]Z]/=X-5E,L:D-O@#4,_34-DI)R`!:2.U467:JW#KS=..?W1KO(
M&;RN:<;C6#*LOP[*GGFR#Q5]K7RVVI$24`G^/1-.(GDV9AT2W;9;]:=Q42+A
M:*Q+U,<)B8*3V*20"#W$>$<I;JVAN+9-U<LVYK8NFKTX@&12I/!2%I)2I)[0
M?&1PC9O-O$:AQ"'$(<0AQ"'$(<0AQ"/+N[+]%I;>X6)+GI4U<^R^Q@,.RITS
M["([*^TA1F`<>D2Y'Q>#;8"1&:HB(JKUSX<7RVUKTDZ03(9F0R'>8^VTZUH1
MJ`F0)G(3XF*>;_T#W][%Y/<[2W=LNAPJ]R`FY%;C,.MF9>>.5CC0/0<=\&[2
MEKJUBE!U6"!AZ5\CH&X3AD:F=>O[3NEY?<K;K7AM:C@@`KTC@G,`2RPG,XQ.
MF=SVVTLHH[;1%Q*<UDZ=1XJR),\\9=D:+WS^VUL+4F)6.<X9ET?9=71,K.N:
MR+C\JBR6#";<7Y)L"`S97C5NS";Z<>4'6G1!"(6U057FGNNR*NA8754E2'D(
M$R):5`#B,2#+R/8(VEMWA2UKR*>JIRTM1D#/4F??@)3\QWQ+/]M7V5R+8E;=
MZ5SFPE7EMAU*%[B5U/=!Z8]B;$B#42J&8ZK8O2OT65,8*.XZ3KI,/DVJH#()
MR0[*O;U<T[;JM94\TF:2<RC`2/\`),L3C(]T:+=UG:HW&J^F2$M.*DH#(*SF
M/$3P'$=\3UR["M"X547&?YAA&N*:JQ[YLDMLAG8C2$4%UOXODL$)JM>E.377
M6P0!:$GGGE1!$G"3N6OL6VG;<JGV&DH1ZBHI&'?E^1[XC#+UPJ%MTS+[JEJ]
M(2%''NS_`"$0%SC]UG6]%9)7Z\UI?9K5QE1I;2SN&,)BNM@T2#^G0UI[^;\(
MF@H/S-,%X]_D3Z<B57OVWLKT4E*MU(XST#RF"?:!$GI=E5SJ=534H:)X2U'S
MD0/>8WAH']P/3^[KJNP^=$L]>9M;/?;551>NLSZFWF$O]&#5Y!$;9:.:^*?D
M;DL15<)/`/,U%"V=HW;;;JZFGDIJI.259'P4,)]QEW3C7W3;%PMK:GYI=IQF
MI.8\0<9=XG&D/8OUMWMJ?*LFW/ZE99D57"R.5)OLTUQ329$MU;R7+1^?:TE)
M-"QJ[J-8/RG7W(KC(G$5"^'R;(&VM=>+-=J)]ZX[>J5)"SJ6V#@5'-0!F#/,
MB6'#LC/M5VMM8RU07UA*M`DAPC(<`2)$2X'V]L5Y9A?>\^W'96)98QO/(6;I
MX'9>/)C5Y54DO[E/N6@<K:JJK*,(:@\BBWX"R*=(B)TG4/J7=WUY73/IJ5!6
M:0G2D^P`2]T2JG;VM1!+[*J=)3D2H$CVDF?OBR[T*],+K33TC:VU(3<+84Z'
M*J\>QKYX\L\2K9!NL3ILR77RY4"1;7,9!$0;(TCQB45+Y'#%N9[3VTY:]==7
M`"L4)!.>@<9D8$GNR'C$2W-N!NXZ:*C,Z1)F59:CPD#B`/>8L^Y-XA\.(0XA
M#B$.(1__TN_CB$.(0XA#B$.(0XA#B$:CW5O'6_K_`(5*SS9MZE/3M/##@QF&
M')MO=V;HD4>JIJUGMZ9,>0%55_*TR"*XZ;;8D::^YW2BM%*NLKG=#(P[23P`
M'$G^,X1MK+8[EN"O;MUKI^94*Q[$I`S4HG``?Q`$D".7WV2]LMO^W6;2ZUR?
M84V`E8`[C&NH<DRIJ>#&??&OL[\8@,C?7_C(7R><%5)TD;8$`1.N=]W;UJKB
MI:G%*31%0#;"3BH_5!E\2CQ.('#O[)Z:]+*.W%IMA#9KTH*JBK6));1*:R"3
M)*`!(`$%69,IRE3Z^>KF#X+.Q]W=K$J/:92]"''\0D,32E3WY,YN'76&72Z[
MH8+$N:7PQZ_L01"57T1%(.>FU>F5ZOM'<=S7JA#S-(`HMZDA+*<3,IU#69"9
M`"I`>J9,A[[]ZUV;;KE'LW8-<JG;J"0NJTGF5"OADA13-M()D%^DDGT:0"56
MV08$*LB1Z^MB1H$&(T#$6'#8;C1H[+8H(-,L,B#;;8"G2(B(B<ER4I0D)2D!
M($@!D!%)..+=6MQU94XHS))F23F23B2>V-3[SS:WP3!7+*A-N/;V-I"IH<UQ
MIJ0->LAN5,D2QCO"3+SR1(#@-H:*`N&)D)(*@6!=*Q5#1.OH3-S`#Q.$_*(Y
MN:Z/6BTO55.!SRH)23D">,N,@#YQ$37VZ-@0,PI1LLBL+RKM[F!!M:^S,)+9
MM6$MJ(<B$1-*Y`>C?/\`(`,>#1>/BH]*BC%[;?*U58TU4.:VW%`9`2GA,2'N
MBNK%NV[_`'I3-5E27:=YQ*2"!AJ($Q("4IY91,K;N39;BN-1I^'5RV%B];QH
MLA?TZ3:I%A''ENDZL*(HO'\K[+;7EWT'G_/KEP[0M=FN]V-+?;D*6B#2E!4P
M)J$I)F<!F3WREQBQ]QU]SMUO%1:J(OU/,2-,B9),YF0Q.0'=.<?UR36N%;3Q
M^N38&(5\N;)KHC[ZF!1K6KEO16S?8C6T,V)[)1G24>A<\5\?JBI].0V[6FV7
M`OTM4PA^F"R$DC$@$@*!S3,8X&)MM[<U_P!O.LU]GN+M)5E(*@DX3P)2I)FE
M0!X*!$5]["]?]I^O>0.[/TY>VKE+3NK8MSJQY&L@QZ*!FX<:UA*ILW].P`HC
MI^!@;9+\S*"A&M6UVV[YM*L5?-I5C@:1ZB@'U`#,$&8<1W&9[CG'2M@ZD;/Z
MF6MO9_4ZVLFK=]"75)`;6HX)4%"18<F<""$3XB>F+*?4KW+H-[PHV'Y9]KC^
MTZ^O:)^-\H!6Y@W&;::E6]$JML@Q*<=7Y':_\QLB7;9.-B1#>O3_`*B46\:8
MTSZ0S>VD^M$\%`2&M&`P)S3FGO&,<I=9^B5UZ85R:ZE6JJVI4+(:>EBV3,AI
MT3.(&2\`L">!F(G1RRXHF'$(<0AQ"'$(<0BD?,/8_P!G-4;=OSR>YLV#9NIQ
M)B-W$%W%)E+]^Y]JW41U:;!*YR.T(LS(IB\0IVKBDI]_SNOO5CK!LK?5S5>+
M@\E::A?^%=3.F4UK.D-ID!RRD`)=;(41CK)*I_T4L/27H[O;8MK39[>RI*J=
M'^*95*I2[H&HNJF3S`HDJ:<!2#D@`)E/S2'N-K;;20Z6W>;P?-G_``:2DM9'
ME6V3_0BJTET;3,5XG37\L=[XI"JO0"YTI<Z<Z==>]I;W^7M]>L6[<*I#E.*^
MS</_`)3I`223DA>E?!(7*<<P]1>@>[MCFHN%`V;EMU,SSFT_:-C_`,UD$J$A
MFM&I'%11.42\Y>L43#B$5DZB]?DQ/]P+<.8T5++J\&J<09O(KRL.1Z]<IV.Q
M6O3(-:;G3<N(3T>V>46?Z<54%I4'H>X=0VGY;==PJVFBFEY(/8"M9$P/Z*B>
MPF)5673G[9H:5UP*J>:1WZ4`RG[0!V@1*KV!T$'L,SB>*9)E%G2ZVJID^[RF
MCH7$C6V66[*0F<:B.SG67F(E-6"<QYX?!PW7R844!6_/F[NMJ3=T,T[[RDT@
M,U)3@5'#2">`&)/:9=D:BV7)5K6Z^RTE541)*E8A(XF7$G`=PG&'0/0WU/@0
ME@CJ.NE`;+C+DB??99,FFCOQ>;B3'KY7V7D^)/$FU!0[+QZ\B[Q4[6L"$<L6
MY!'>5$^V<XR5;DO:EZS7J![@D#V2E%6_NOZ/+HYH=HZE;L9.M0>82]KY,XYE
ME@\]Z2Q'@2&I3O4R912Y3H`#IFX_'>5!<)1(3Y!=R[6^ZTBXVS5\JDS4)S*#
M,2(.9$_$B)GM[<?WD307#3\R1Z3+!8QF",@9>1BWSU/V98;=]>]9YO<G\E[,
MI':F]>4P-R7;8U83,=F63Z!]&WK@ZO[P@Z3Q^?I$ZZY8=BK5W"TT-6Y_:J1)
M7BDZ2?.4_.()>J1%#=*RF;_LPJ8\")@>4Y>4>Q[`[[P_UWU_-SC*U69(5P8.
M.XW&?!BSR:W<4?"!#,P=%AEAM5=D2"`@89%5Z(U`#];K=*:T4BZNI.&02,U'
ML'YSP$>=LMM1=*I-+3C',DY)':?S#B8ICRW]T'V"N;!F=BU1AV'4S$E]$@!4
MN9`4P"1I6XMA9VAIYNL"*JI1FXJEY_5$1$Y6U1ON[+4%T],VVU/B"J?B3+W2
MBP&-F6Q`*7WW%N2[0GV`?GG$P?7']RJDV7DU)@6U,6BX7?7LIBKJ,EI9LJ9C
MEA;2S^*%`F5LIAR?2%,?46FW/N)39.FGE\0_5)#9-Z-7!]NCKF`T^HR2H$E)
M/`2S3[2/"-#>-I.T++E51O%QE(F01)0';,8'OP'G%IG)U$-AQ"'$(<0C_]/O
MXXA#B$.(0XA#B$.(1ANP-@8AJW$+S.\[NXN/XOCT,YEG92O,D`$Z%MB-':%R
M1,FRG51MEAH3==<)!%%5>8U75T]#3NU=4Z$,($R3^6)[`,3&9;[?672L8H*!
MA3E6XJ24CB?H`&9)P`Q,<E?M#[0;%]KMA,W>0)]O25LB9`U]A,'XEAX]7SC8
M5T/N?@CNV%E8)#;=F2W_`*_DZ3XV6P`.<-T[H>N[SM76.!%O:GH3P2.WM*E>
MW@([.V!L%FR-4]LMC!=O%1(.+XJ5G(8R2A./=(%1QQB>GISZT4>#XHSNS9<=
M1"&P604<*7&^1M]N,RQ)BY8ZP#CCY_&8F%;%4.O%`D)YFX!)X[-VQ4W>OH[M
M64Y5<'EA-,T920%D!"L9>M1.:I2G/#"6PZH[\I;%;JS9.WJM(M;*":ZH3/4\
MXF?,;!Q^R1(`A).J13,B>J:UWM;U]>K8^PLMRG#JYK%6Y$X)^22XT&RHUB/(
MX7R0I#B2PDH^P)L!X&;A*!,H2F*K;%:S?MMNW*QU"W&"K2'FTJ]*A+4G44DI
M4)*GGQE%"6VVHW,Q;[U;[6Y4LZCRG`THR.K29$IP.H2\1&KM4^_OK+N;8$'6
MF$YC9NY/;E,;HPML:N::!>/0H[TMV/7S9T9L!D'$C&XV#Z,DX@^(HIJ@K'PI
M*C('&)=<MG[@M-$;A74.FF$M1"DJ*9F0F`21,D#QC>6[,&L<^P=RJID;.W@V
M<&WKF'G@CLR76$?AR&''W%0&NX$]X@5?HK@BB](JJF#<Z,UU$ZPDR7@1XC'W
MY=V<5UN2U.7BU/4C)`?!"DSR)'`]DP2)\(B]KO06?AF-!/R6F"FI:BVB6<QY
MZRJY3\C]-=&;'8C1X$R61A)DL`!D2AX@2JB*OTY'+98:IFL:?J@`V@S$B#,C
M+RB!V'9ET9N=-4W!M*&&EA6"@22DS`P.4^,3^Y,XMJ(8^[.<2\&PG6<B9D^3
MX5K^_P!SX=C.U\LPY76\BI,#M(ETLYZ!(CQI<J*;M@Q'!":!3,U%M._D\5Q:
MKEA+)?>6W2<Q/-4CX@W/U$8$X9F0G*<HRJ9BH>36?)M)<K4,+4VE62EB4@<1
M/MSEVX1CF#[9UU@6181"PC;V5[-T5M/)+/`Z2SVNU-9RJLSZ/"KY;#V.6-U!
MJK?*,`MONT@/O.1$8@VBB"/?U%#F34BU4K=)46VX..V]]PMI+D]16!/T%025
MH.4Y$!6$\91J;>_=:IZJI;G0H:KV6PXKERTA),I+"2H(6,Y3!*<9<8U;[+:0
MFZDR&FW#J.-.I:^!9Q[.:-0)N)A^00Y`RX%U$%2>./5RGA_,)!]NPZ*"OY'4
M!*IW78ZJQ5C&Z=MA33K:M3@1DD@ZM<OT3*2Q*7'MCJWI;O>W[QM=7TXW^XBH
MIWV]#"G<2L*&CE:I?&F<VE3U9I!,A&]<7_<OS&33P6;#7F.V%O#B18]K,&XG
M0OO)C;(@].&&W"<;CA,<%30!)1!544_#F+>_Q+;@LCC"#M6F>IUH3)SF+3J4
M$C6"`D@%*CE/$$'(B(8[^$RRFKK&E;IJF2EQ6E'*0K[,J/+(5J$P4RGA@00<
M1&1?^9'E/_2_'_\`B&Q_W?S1_P"[.]_N=2_MG/ZD?G^TFR?OE5?L&_Z\/_,C
MRG_I?C__`!#8_P"[^/\`=G>_W.I?VSG]2'^TFR?OE5?L&_Z\/_,CRG_I?C__
M`!#8_P"[^/\`=G>_W.I?VSG]2'^TFR?OE5?L&_Z\/_,CRG_I?C__`!#8_P"[
M^/\`=G>_W.I?VSG]2'^TFR?OE5?L&_Z\/_,CRG_I?C__`!#8_P"[^/\`=G>_
MW.I?VSG]2'^TFR?OE5?L&_Z\8/GWNU!V?2G09SH[$KZN52-C[B_M&I<%\FR;
M^YKI\>$U,@21$E_.T8JOX+VGTY'-S_B&8WC;U6S<?3JAJ:7,:GG`I!E+4VM*
M0M"L<TD=\Q$DVQ^'>HV;<$W3;?4:NIJK(Z66RE8G/2XA2BA:<,E`]TC$%YSL
M1V9)>KXSL&$X^XY%B/2OO78K)$I-LG+1B+]PK2?3S^,57KZIWSG&H6PM]U=,
MRIM@J)2DJUE(X`JDG5+MTB<=(TZ'T4[2*IY+E0$@*4$Z`H\2$S5IGV3,HEYI
M'W/V/JM(='D)N9YA;`M1VZRSD_'<5,8$;;3]'N2:>?5IAD.@C2/E91$Z#XNU
M+EZ=.^O^[-EABW711N6WT@)#;BI.M)$A]DZ03(`8-KU(X)T3)BB>HOX?MI;U
M+]QM:1;-PJ)47&TS:=49G[5H$)F2<7$:5\5:Y`1;KBFS:S:FLK#-M?#;HLFI
MMQJV[*GF0)C=S'@NDRRTU)CG'L?BEJ(HY&*3',T44(B0A3O/:>[[7O>P-7^Q
M!X4K@(`<;4VH+`Q'J&E8!PU-J6@F8"I@@<$;MVA==D7]VP7TLFJ;()+3B'$E
M).!])U()&.EQ*%@2)2`03";T$]KJ#,\(H]*[`NF*G:>((Y04S%M\<$\OHX/T
MK@AN*VPPYD52PBQ9$5562^#"2$^12>^/'VK?FJJG1;:MP)N#7I`.&L#`2[2,
MB,\)\3'UN6R.TSZ[A2ME5"YZB1CI)SGV`Y@Y8RX"+,N3.(E$><F]B,4J]W:]
MT+0/0<BS;*9MP[E42/-4?[)Q^IQ.WR()E@3;+K16UB_"8!F&1@Y\#A.EXI\?
MR:MVZTR+C2VM"@JJ<F2!]1(2535XX`#SC9-6RH7;ZFY+&FF1(`GZQ*@)#PG,
MGRC/=R8C+S[4FS,)KF(DFSRK`\KH:IF>2-PRMK*DFQ:HGW2149!NP<:+Y/\`
MX:IY?PYE5U/\U15=,`)N-J3CE,@@>^,:B?\`EJNEJ"3)#B58=@()]T>!Z\:G
M:TAIG`]9I(&9+QVI,[B6V1&S)R"XFRKN_=BD8@?V/ZQ8O#'0D0D8$$7Z]\\+
M10"V6ZDH0J90G$]JB9J/A,F7='M=*TW&OJ:PB06K`=@`D/.0$X^C,M':_P!B
MYS09QGU1'R]W$JAVNQ2AO&0F8_1S)TY)EQ>-UCG<:;:6818;2E(!P60AA\:"
M1$J_=1;J2KJ&:BJ:#BFP=(5BD$YF64S(8G*6$?#%?4TK#K%.X4!9]1&!(&0G
MG(8Y9SQC/Y&)8K+J)5!)QJ@?HYPF,VG=J*\ZN4CJ]N?<0"CK%=\R^JJ0JO?U
M_'F466E(+9:26SF)"7LC'#KH6%AQ6L<9F?MBE;W]].*+6M;#W/INA&BQJ');
M8SFCJW)/V]')E2F&:C(ZMMR0XL&`[,=&.\TR@`PZ39BB(1>-:;MVVU2-INEL
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MR?4H@Z$#]):@#I&'B3@)F.8+VR]R=B^U5_$?OVVL7P2@=<=QC`ZZ44J%`D/L
MLLR;2UL%CQ';RXD?&J"ZXV`1VR5MD`\G"<H3<FZ:S<#J>8.71(Q2@'#O4HX3
M/N`RXD]7[+V);]I,J#!+]T=D%ND2)QP2A..E...)*CB>`'FZ'U#,L'DS2]A`
M==#DQX00Y8/@Q]S)8.=^F2$;<:<?D'&CH<Q&R`V&'`9\@*0CG(K8;?\`YHN(
M<<;/W%3+F2?^LX/A`PEH2<3G/">>%WJI?\N--VAFJT[LN%.HJ*9:J.FPUJE.
M8><F$()`TDDB>GU3/V'DOZA4S\BSZ_MYE+CD:1?2F'K:PBTL9BKBF\9#05\F
M'2FVU&:419^W\%1?%!_,J+<C:RR0MHZ5)Q!&!$L9@YB6<XU%)L_;-L:FW:T*
M*4D%2IK4H'`A4S(ZLB)2,Y2D9123OW?UKN>UB5];"=H<&IWC.BQP/!'I,Q]$
M%VUMQC$K$BQ=(B1H!\@8`U05(C<,\"LK7ZUU;CKJUK4<2HDJ4>\F9/MC9TU)
M2T;#3--2M,4C0.AM"0A"`<3)*0$@YSD,)F69)VCH'7<C7F20,^R&`Y.R*F96
M1`IEMHV/U>*R+*+)A`]F-[-%`KKT677/AKT\'6CZ-PQ,?C3,I*`B3KJI*.0E
M,^SC&HN%RIW2Y2*HTOLCXPLI#8QP#BE3`,Q,)E/(F4I&?6N]V;.>S&GJ*URZ
M?HO%WY[NCRN_N(E.8,NFP$JZ;;9J[1E"9$5;DE(-5/OY57Q`LYYEKEJ42`OL
M(`GY</+"-"Q:[3<JEJB>VW3*I%`S6V/@PP^U0E,\OTB<<^$;ZO/=[;&M<LCT
M-OBE5F%!(C,/0K&Q,Z6SLW>@61"K[2"P%6LL>U`&3C.OD:(JDOF`KX-T3+S9
M4%D*]LN\Q#]R["I*:OY5KULLE,TZSK2H_HI)D0>$BI1/G*)7^MGL;-WY)S2:
M=/&QVHQR2<7]+F*+-]6/#(<%H;)%G/I)9D0P4_F1E@!,5'KR0A'8W>VV6CME
MH=H*]UVYNA7.04@)3*4M)`[9\3,8X913)9O]%>+I0W>@0U1MD<I8)FL3,R9^
M_`2.$?GV>CXENOU3WQ75UA'L(4;!<JF!(3S96'=8I7GD=<X7RB#C0K)KVC$^
MD0VC[%>E[YI[C:Z^V.BEN5(MIY;84$K$II4,#CP/\(C;[6NU(]=+?64;R7F$
MU`0J6(()TK2?%)(\XKS]-Z'U\]J/7J!CF_-EUV&;UU_'>UII"ZN<Z*A<"E?4
MK'#UC8](L8L.^6MS"9+#L01PX[K3/EV#2CK;71V"^4CU!=ZY"+K2N%FG47-*
M@DR4W)&H!12I13D20`.$>6\OOG:FY*Y=BI%N65U9<>`;U`D**5A2])*9H`)Q
M`!),6<:#S=W<6IIM;F\*(YDF.662:GV56B7RQG\AQDRI;LC:/^JTW;1C!_P/
MZC\W7X(B\\F3SVGF*E`YB%*;<'#4DE*O(YCN,?27%,.TU72.%((0ZVH8$`R4
MDS[4_2(@/187BVE_:.HP[8U,W?ZYL;Z+5.'9E,AL.XUDYBQ57'WD1^(]\F/R
MY#:R#%Q`[CNHJ=+]*71MBP4F]:2R;FMC=5MVI=&D+*DZ=4PE06E2%#03)4E2
M4,P<(ZZNFZ;YO7H[6;EVS<UTN\K:R2LMA*M2FY%:2A25I(=0-29IFDG`C&+K
M!]1/6\Q$AUC5$)(A"0W&2J)"J=H0JEVJ*BHOT7E]?Z$])CB-GM2_]6H_OHXC
M/7;JT#([Q>G_`.E3_P!S'^_]H7KC_P!+ZS_Q?)O]]\?Z$])OW.:_:U']]#_7
M?JS^^3W[*G_N8?\`:%ZX_P#2^L_\7R;_`'WQ_H3TF_<YK]K4?WT/]=^K/[Y/
M?LJ?^YA_VA>N/_2^L_\`%\F_WWQ_H3TF_<YK]K4?WT/]=^K/[Y/?LJ?^YA_V
MA>N/_2^L_P#%\F_WWQ_H3TF_<YK]K4?WT/\`7?JS^^3W[*G_`+F(0[UO?3C6
M3]EC&&:HJ<XS:&<F%*1N[RAG&J&P8)QAQJSGA=(]92XD@4\XT7Z+T0&^T:=<
MYUZDW'H)M!RKL^W]DLW'<+94A4GJD4[*Q,$.+#TW%)5FVWA@4J<0H2CHSIM;
M>ON\&Z2\;@WL_;=NN!*TS9IC4/(,B"V@LR;2I)P<<QR4EM:3.(28=KS.-Q9/
M(KL#Q$IDJ0_\[\:H8.+0T49YSQ!94Z:^XS7P64_*)2'R</KKLS7Z\\V':VXM
M^7AVDVU8RX\I4REH%++*29#4M9(0@9`K65'M4K/HF_[JVYL*S-5>YKZ&V4ID
M%.D*>>4!CI0@`K6<R&T!(GDE.5J.D/1+"\)6'?[.>BYYDS1MR&J@6W$PZL=#
MXS$3B/@$C(76W!7\TD6XQB72QE5/)>T>G?X;-O[>+%SWBXBY7=)"@T`?E6S@
M<4D!3Y!!Q<`;(,BT2)QQ7U%_$KN#<0J+7LYM=LLZ@4ETD?-.`S&"@2E@$2P;
M)<!$PZ`=,3U999C,M1X[33$=AL&6&&6Q:99:;%`;:::!!!MML$1!%$1$1.DY
MTPVVVTVAII`2TD``````8``#``#(".97'''G%NNK*G5$DDDDDG$DDXDDXDG.
M*6O=3T$R61D=MMW0]1-R'^X;69<9?@4`XHV==:37)%A89#C229<8I\*;,52<
MKV4<E-/N=L";1*#%=;EVBZZ\Y<;4)K49J;XSXJ3X\1VY=D3S;^Z&VVFZ"Y&2
M$B25\)<`KPX'LS[8B'4X5^X`XU7TE9`]I84(@8C081V>R*:IC-.L"C39%+G0
MJRN8!DD$E<)H&NO$E%1Z2.MTV\P$LH36A.0]2@/:3(>V-ZNHVF=3JS2%69]*
M2?8!,Q:AZ1^F-AHAZ;LW9$Z/:;/R6F"&%:T2RVL,BSWDEVL1VT^Y?9N+V>;3
M(R)+:(VT@&TT;@&;CD[VUMQ=K*ZZN<UW!Q,CQT@XD3XDX3/=(88F&;AOZ+D$
M4=&WHH4*F.&K@#+@!C(>9[I,>U&0W>*^NFX[['),Z%=0<%N4@3ZQPV9]<<MI
M(3EE$?;`W([U<Q)-]'!Z)OX_)%%4\DW=[>=8M-Q>9)#J6E2(S&&8\,XT]H:;
M>NE`T\`6U.IF#D<<O/*/*]6O83'?8?5]/D<&7';RVJAP:S.\?5^*D^JOFV/A
M?F_9-2'GVJ6\?CNOP'31/D:0A7^HVX(^=CN[-XH6ZAM0YP`"T\0KCAV','B(
M]+Q:WK56.,+2>422A7`IX8]HR/?$D^;B-5&MH6UL1M-GV>I:F9^IY308TN39
M*,,V'8N.L/3:^'65UHY\J.!:6H32>;9$24&6O)SP0V_+$36L+K%T*%3?2C4J
M7U03(`]YS`[!X1DJI'D4J*Q:9,J7I3/ZV$R1W#B>TQ^-Q:WC;>UKE>MIEDY4
M0\LAQJ^78LQ0F/QHS=E"FR"CL..LMK(<:BJ#9$JBV9(:B2#XJKJ1-=2/TBU$
M(<3(GNA1U*J.I9JD)!6@S`[XS^MKH-/70*FLBLPJVKA1:ZOA1P1MB)!A,!&B
M1F&T^@-,,-"(HGX(G,E"$MH0VA("$@`#L`R$>"E*6I2UF:R9D]I.<?;SZCYA
MQ"'$(__5[^.(0XA#B$.(16W[;_N-ZVT`-QA."+$V)MZ*4J`_5,J__;&'6#;;
M*@YE=DVK'WLALGU_V""X;WFT8/N1E\5*%[CWI060.4U/)ZY##3]5)[5GSR&/
M;*+*V;TVNNYBS6U4Z:RG'69:G!,@AM/E\2I)&8U91S@;1VIGVZ<UL\YV#>S\
MDR6[E=!\AO.,0VG752)34<#S<;KZR+YHVQ':Z$4^J]DI$M%W6[5-Q?>N%RJ)
MG$DD^E([`.`'9^>.IMO;<I+6Q2V:QT4ID)`2)K6H\5'-2CQ)]PC:&I]+S;>2
MW<70-"VRZVC;2*V[]FJ%Y.FT1BXTY/1$1$=\#;8+_51PN^M3;+35[O4%(4MB
MP)5ZEY*>(S2D<$CB3[)X"U::G;VF^Y2MMM56[B@&1Q9HDJ$TK6?KNJS2A,CA
M\24^HV!V=Q,FUE-4Q8--556-P'(-%1U$1VNJXJ/N`[,E/*X]/F2;"P<;$GY#
MAF1D*+UVI*5PTM+3T3#=-3-!#"!(`<`(T5GVZBU55QN3E:[57:J5-QUTC4>,
MA(8"?CD!D!&D]H499KAV0XE:3'Z"/D58Y2&XZC+M<LF2X!0I<2R;$/C?&8("
MC4A61D"BMJ(*:.)E:`M*DY@@^,;6H4LB2CH.&?PDS!$E=L\)&4\I#.(+T.F<
M:T[?E5>=AEV?3H[!0+"90L5H8^+SB_%'QV.]8SX[%_*`"<*Z-UQBN9:(F!)Y
M"Z^J2A0V"\H@@',_E[LS$<NMS4V^*!"%_,J3.0$L^`,Y:LSK/I0!,`JRS>+B
M-O?N0WL;(\JA1%<<LW<1E?IX5$F8COQ5]6EM%&3'9;;CB7WBMO+.(G%===,!
M\-EK2B?,&E7">,^\R^CAPC0)HZBJ+9HR7VDDZRT=.DG)*=0F!+ZTCKF=1)`E
MD-G83<=@,);L['HD<=?B!)L]R5\%X7(@M'(!V$=5\$860>;52)H!1'`7OHA[
M^`D+)TE!\$1E.N.TK:0^BK;F2`558!PSPE(2\)8CMC"W+27:JRQ49.5PS+>:
M!RLR#9F+Y+$L%</Q%I]E)U7'<(R7I%1E#3\0("1"3U`2/B1(]H20?R\XURG'
MG2E-/5EP*(]#E0VX%3.1$T_1/L(,;'M9]IJO((T>FS"^KK=BNBV<2\QV7*/)
M<-;<1A[]"N7U18&5X2GD"K"?-P?B'OP055'?)$GDZB@2G+')7>.Q7?'[?K50
M.I-MN!YJ-`4",7&)C+5]=L3RG,#'QLGTMDC/LYZM;@UW4TM7B>9V&,9/AES-
MKQD-8_:7V18],A5N0LH[\DV%&FJ(*[&5%^W!/%OL$%$P[S45M75)>KZQQYS0
M$A2SJ4$C`)F>S^.*8;M-+M"Y42J1ILTJ7PZ`D2U:5@F8[3+`\>Z4A4QJWV/P
MO0>ILJTCFFM\9Q_>VOMGN7-/GN0ZZP;.I12\>APZ)W![-O+H:RJZI.?5_=M2
M8+[KS;RKXQC$E,XBU4_=-)64R;2ERO-07FGN4V[B92;6%D*0`1@M)PS'&-YN
M/9]UO%YI[S1U;KEAJFM)2AQQ$PLDS&@$%0!DI"P)D'&65NO[=%!G+6J,QV'G
MD:QAS]N;`L<ZKAM6"BSK6NL($(SR=^(8@<9,BL77W6D(1(V!;<Z1#1$^[2Q6
M-,/NUZIUCSJG%=Q5+#W>641^[(IV*ENCI0`RPTEL`8RTSPF,R,CWQ_OOMBGW
M%!A.:,MHAUMG,QR:\*(AHS:1UL(*D2?F\67ZUU!_@A.?X\A'4NC*K=0W)O\`
MM&'9$\9*R]B@/;%[?AUNR&[_`'K;SYFQ6TNH`Y%31QP[T+5[(M6];\T+8&BM
M6Y4\\4B;.P^HBV;QF)NNVU0PE1:/.D(-#\C\Z"XXO0BGYOP1.=(;4N/WMMNR
MW`F:W*=!/\H"2O:03'&'4*Q_Y;WONFR`213UKJ4_R"HJ2/))`C=O)!$.AQ"'
M$(<0BNN/^WGB+V>V>07F;VMCA\NSF6<?%XM>,"TZE2BDMU\[(BG2E>BM(:@9
MM1F7W1^J$V7YN<J-?A9L;FYJNYW'<3SMA6\IQ-.E&ASU*U!"W]:II$Y$I;2M
M0R*#C'5KOXJ+ZWMFCM=MVXPU?D,H;54*7K;]*=)6AC0F2C*8"G%(2<PL81.[
M$L-Q;`Z2+CN'T5=CU-$$1:A5T<61,Q`6UD2GE\I$Z8Z()\C[QN/.*G9$J_7G
M2=CV_9=M6]FU6&VM4M`@8(;3*9D!J4?B6LR&I:RI2LR28YJONX+UN:XO76_7
M)VJN"SBMQ4Y"9.E(^%"!,Z4("4IR2`(R;FXC3PXA#B$.(159[0?N+?\`+[*;
MS5VE<=B91EM.^55:Y9:?<R:6JNXTAH;"KJZ**#4F_DPFQ=9<>*0PRS)3Z"^(
M$BP:^;O^2J':"VT_-JDX%1F4@\0`,5$#O`![8F5FVM\VPW6W!_ETRL0D2"B.
M!F<!["2.R(2P/W']]JW:8_LBHPC8>,7#5C4Y)C=WCGZ&]+I[)DH=A3MRZ-V!
M]HBQC-M">8D&GFODAJB=1=&]KNDJ;K6&G&53"DE)29',3![.T&)&K:%L(2Y2
M/.-NB12H*"A,9'$=O81$>,(I-HL7%ML7UN7.D9IW_*4SALJ9(S/$X%C)?>B5
M.0U]*7ZA;TYC"\/O0CG7S!;3YA9=(HS>HIV:\..W"PJ=T`XA!.M`)P2I(Q4G
ML5(I/$`X#:/NT90W17D-ZR,"L>A9`Q*2<`>Z84.$Q(G:\?V(]Y=RQ6L#H<IV
MCD3C*-H\QA..A470L"OV_E;WV)TU9:C#574%TY4E&R54^0EYL$WC=MR'RK3C
MRE<=*`D^:DI$AXF,%5JVQ0'YEUMI*>&I14/($F?D(N%])O6FWT#A-W;YW(2;
MM78LR+9YB[^H?JR5L:`LQ:FF_4_)T9TUE;!YZ8^!FV[(=\1-P&@<*Q-M69VT
MTKJZM>JO>,UF<Y2G(3XRF23VGL`B";@N[=SJ&T4R--$T)($I3G*9EPRP'8.\
MQ-CDDB/QI&^W+"H-\X'I23%:-_/,+R;)8,Y'4;?B3<>?`PB.-FX@R&+&O8ED
M/@/F!QO\PDJAKG;@VU<J6VJ'K=;4H'^3+"7>)^R,YNA6Y;ZFO!]#:TI(_E3^
M@R]L;NYL8P8<0AQ"/__6[^.(0XA&,9GFF*:\QBWS/-[ZNQG%Z&,DNVNK1[X(
M<-DG`8;\B1"<=>D2'0;::`2<==,0`2(D1?"IJ6*1ARIJ74H80)E1,@!&31T=
M5<*EFCHF%.U3ADE*1,D_EB>`&)PCGV]O?W0,KV.<G!_7J7=X'A'BXQ:YD0_I
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M"JNA36[D5I8!!33),AW<TCXCD93P]HC8V_<UL=KW[+L,`MLI`J;@L?:JF"--
M*D_`"0H%93EB`3I4=VPX46`P$:&PW'9;3H6VQ041/]'_`*)_#EG-MMM(2VT@
M);2)``2`'<!@(WE/3,TR.6RB0)F3F23F5$S*E'B223VQXV4Y15XC4NVUH3QA
M\C<:'"B-_/86D]]5&+75T9%0I,R2:="*=(B=D2H**J>J$*<5I3_X=YCSK*QF
MA8+[Q,IR`&*E*.24CB3_`!G"(.YM*N,HD6UOE+E@\,">PEO&BNB_1XK%)Q4#
M%H:.-?:S<J,3!'E3R9C@ID]YN(:L[1K2V$I;E,C#M/?W#WF*YN*GJU3[]:I9
MTJ&H`^AH3P;'!3IPG]5(F3B#IV=C-)MC=MU3ZOPN%31XBLPX5F51("_7&\3!
MYB,^]F>8#(EQ7XI#Y$<>*Z#LKQ)HFT4D!SR/)82IY9,^_"9_5'YSE&%N'<SE
MOHPTZMI(TZ4MH.M9`'PK<Q!!^L$G+XI9*D?O'1,GUZK:UW5>Q<'KJZSGOKDS
M^>Y#AM9E3\I&&EBO*N4W6/U5G$;<1[^E&<BFPKR*++B>9+ALU352M27@2L#`
M"<@/*9_+.(G:NHRK?3\NK"&%%1*G4IU:\!(%*E9C'X2!C@D2Q@YG<F5='!L,
MQV=@EZX"BW72\!R+`[6XKG7S`!9E4M7=UMU):^1/S"S)>9141?->T[SFE-IF
MEM$O&8GYG"/;_/\`9+U4)16W53:A\*M+:?H4#+N*X]V#$HZEA,;S>MRG'[:P
M8=F8OFES39"QC%O5F'Q-S+RAR5TX;L-N6BA(=88(&VS%?E;5!=(H*)UMD%/$
M`B8/<1[HEULN5EK$O4?S>M].3H)4W(C`N(42`)X$RRQF,X\VRUCEE!6VN:?:
MPTATDVBF5WC91<B@SX+(JASZ]?!PSI8;I`J190J+T(R;=0U$33]#Z%J0WQ,Y
MX2_(GM'&/2NL54**M?<$F`$@%*]1TD$%2%#$)3.8!^K@9D`BU3U!V+)RQR'C
MV$8GBN#T6/QVW=CXU3PX4,?[@F0WA<R&*KCAVDN/>2F&RB*!.LLQQ^(BZ%M2
MRWVMO(L%2NH<J%;C+PY?_;Y>$Y]XQG/&<I83CGK<%#NB@W2AI\H592V9J5BL
MGA^;+"4SQ$2;V)I'45]8R]FVVF\&S78=%7/3*BQL\:K9UM-FU[#CM<PZ^<5U
MV:XVZ*(UYBXX'T^/I>N1FC99J*RE8J'PTRMQ*5+(F$))`*B.Q(QC)<O%VH;;
M5LT52\6M"CRDK4D+,OAE.7JR.&,9K@F2VMGAT&YS*K8Q.>*OLRXL@'JN*#<9
MPFFI+<:S(9$%A]L?(6W2)13_`#$G2KGWVAH;;<ZFDMUR35T:):74B0,Q,]HP
M.!(,C&EM5;4UE`S55]&::H5.:%'*1SX9YXXQJ?VCC5V4>O\`FLV#*AV$:K8@
MWK$N(^S*CHE59Q7)3C;S!.-DK457>^E_#M.0/>%*:K;ET;"9K#>H>*2%?FBU
M>DUS3;NH&V:GF`-+?Y:C/"3B2CZ2(VY^V_?!:^N+%9\GD[C.9Y-5DVKP.&#4
MQR)>LDC0@"QVC*V-!1?)2("+OZ]),^C-8:K9%(VI4U,O.(\IZA_S2\C$-_%#
M;!;^K5T>0B2*JF9=\3IT*\YHG+L(B?'+6CGB'$(<0AQ"'$(<0AQ"'$(<0C\F
M*D!B)DV1"0HX"`IMJJ*B&".`XVI"OU3R%4[_`!14XA&K]:Z7UGJ6#]M@^)U5
M9.>;)+7)78K$K+<A?=?<ER9F19*\V5M;R9,MXW%^5U6P4O%L0!!%,*CM]'0I
MTTM.E*CFJ7J5Q)4K,F?:8RZJNJZU0-0^I21D)^E/<E.0'@(_CM31VK=ST<JC
MV%AU-=B_'=8BVZPHS.1TQN&COW5'?`S^HUD@7A0E^,_!U.Q=$VR("^:ZV4-R
M:4U64R5@C.7J'>E68/AYQ]4=QK:!Q+E+4*20<I^D^(R/G%/7KM@5]ZM_N!0]
M1I*F7=1D55<U46S2`##ESB]IB\G*ZJP)HW%$"J[.F%B4XT77G%?\4\5\>5Y9
MJ)RQ;N%O"BIEQ"I&6:2G4#Y%,CX&)U=JMN];7^>*0EU"Q,3R4#I/M!F/$1>[
MTB?Z?JO^*\M**XBOBE][\/P'-,ET_P"QOW.'YOA=I)JWLUJ\>MG<,RV"G^T4
M]['J8GZMD&/O7%:\RZK*MRHO9J8R$`D`(HC=-)253UNNY+52VJ6O2="QP4)3
M(F)8&8[XDR]MU-33,U]K',IUB>F8UI/$'(&1GB)'NCV-A_N+>M6'8Z[:8WE$
MG8UXX/5;C..5=Q!?D.%Y(CEA:7=9!KZJ&V0I\BDKDA!7MMAS\.?=9O"R4S*G
M&JGG.<$I!F?,@`#\@#'Q2;5O%0Z$.4_*;XJ41(>0,R?R)$5Y>M6<;']IO>;'
M=IV[C]>UC4>SNY46I==6OQG$ZZFFU%=01C>,5*-9S[1MF2O2%(*2^YXIVJ)#
M[)65E^W4U<%`I;;!,ADE.D@)GWDX]LR8E5WI:2R[:<H4D%:R!,YJ5,$GR`P[
M)`1?YRV(K*'$(<0C_]?OXXA'BY'D5)B5#<9/DEE%IZ&AKI5K;VDUT68L&!":
M)^0^\X2]=``+TB=D2](B*JHG/-YUMAIQYY82T@$DG``#,Q[4[#U4^U34[16^
MM02E($R2<``(Y8/=WW-R?V:S:;3TEE,KM-8Y8OM8C0,++@A?HR2`WE621#<3
M[NRE**E&;=!$A,EXB(N$Z1T!NW=#]\JEL4[A%K09)`F-9'UE#C^K/(=\XZSZ
M?[%IML4+=75LI5?'4S6HR/+!^H@\,/B(^(\9`1":DI+#(+%FMKP[,R;5]Y1,
MPCLDX(*OB`D3DAY>P9;1.W'/Y"A*E?7&O10,A6DK?69(0,2I7AG(<?X2(N?;
MUA=OM6MLNAJA:3K>=49)0@9DDX3,C*?>3@#%Z?K7ZUXKHK"X^SL[A.+DD&M=
MMF*Z0`2/[<!X2\'E95H7)&4SFG1`R)51DR^-M!5%7DNVQM@4:D72Y#F7IP8S
MR;!GZ4=AD9$^0[ZZWYOVHW(\C9FTT%O:Z'0A"4S"ZE<QZW3/$%8U)&'!2L9!
M/@Y?F\C9F5PIF13&<=HXXS8T!1@S+-:F$?3H^<:$CC\NRL39:^8O(&1\$1%Z
M%/.?I1H20G$_3$EM-AK=DV<O6VWFNO+ZD\P!02$@`F29B<A/Q)QP$85);HWW
M9BXME=)F<2O(@M"I%EC8T)MH*%_<-1+9:FU;#COD+;ZH4<B'Q4T-4%?J2@`5
M)(G[_"-E9-Z(K:IRW7JC^1KP?2%J]"^T)69#4,/3WX3B(6*-9UO;:LG'L8&2
MEY%LK*OJ)2QGOTG`\7B`2764&8-'YW,YL`CL&OD:.D;8^)DQUL2EMAE*E_`0
M)]Y.0\.V(WN+=1H_G*Q:IU2%J0RG]$9%0_75E/'2-67IBP/5>@=)MX@[D^18
M@3>.T9.54S&\IKH5@>16T"M@MLW937(\5^=+GDX)FR+8BS9@Z(&C38HFZWA=
MD[7M2K!4/4#K+<J@U36*P%`_9ZY]N`&924B4S'-MBJ[IN"ZO;@;JK@R\^2V:
M=2E)02DB2]$\@`,3D0<<(P_8VW]=:1UE=9CAE=C&.TEP\_$QK&=>+%CLYGD2
M_<1:R'/LJ0DDW+S;C)C(\7%8C-(X`@1)V?-;VX]S;NOB+/;E.TE(G%:B"EQ#
M>!4M9/PX'T@2F2,3.+,J6K=:+8J[71\5=21)`U:TJ5C)">W',F<L<(K%<Q"\
MV/8_WCN.Q?N[J3\[D''8SSD&@QN'-<24M="AQ2;5DFW%Z,0<4544\B=)/-9H
MR_3VIM5)9F]#>&IQ7J<<4,-2U'$SS\\)91`G6G[DX*F[+UN?50,$-@_52D=F
M7TSSC[)>H->RV'&?[?:CJ8JB/194UEYM53I#`ON"'R'\4\D)._Q1>?2+O<4$
M*%2H^,C'RJV4*AI^72/"8CTL;R^1K$Z;7.TVI.P?76UF)7MS;)HYF6ZA.RZB
MNW6&7+/QOT?VQ*#IL`BPY0`0*RAETY);;=16S!(16CLR7Y'\N(CRIZFMV_4M
M/TSRS23'$S3W&4O3V\#CQC<6-8&.L-ETVK,OE3[;6VR+EK'*^R8?DLX]?X?F
MHMQ\>V3CEJP15<>PA)(:<E@CA-#\@H0+TJCO_54IYC*)OI$Y`3,Q]669[HMX
M[G<7MAU^BN89=!^T;F-*DD8D:IR!XR(GZ9<8L0]4_73-M.9GGE]E5E26=78T
M=%C&*SJB2;AVM-4$GV=G.85L0:DG7L1P)57M30O%/'HEUU94(=0A"4D*!)(/
M`G,>V(K?;[]]HH5%N3C;8!/`R2$B6)G@,_")T*O2=K^"?5>8$1V*>_9?9&1;
M8S6OQ&MFR*S'WYEFC;2&@E$QRG,8<ZTC@OS--W5TY,1&W53S:9)`3Q_/W$*Z
MXAQVK=5C3,$)2G@IPSQ4.($CA%(;JOSUSKWF4.*%"TK2E.0*A,%1[9XR[O.,
MD]6Z18Y>PVK8CSTG#96`P+5JM==.0W66<R+-B&TGDJ@#DQD?-?HBD+8]]^*<
MV5#4.W*SO_,B:B%IG+`B1B9=*+A4L7&86>6T\TL=QU\.R?'PB8O[5UH3N&[@
MI%;Z"MRS&[+Y50^W';>DDQ7`0E7P\6VZ0/H*)TI*J_BG6=T(=!L-XIYF:*J?
MAJ3_`!1?WXO6%#>6V:TI`2];9>.E9)GV_$!X1:SR\XY(AQ"'$(<0AQ"'$(<0
MAQ"'$(<0AQ"'$(TX]I?'9>]8^^)CYOY%6:^9P&E@)$8"/`9.VM[*RMW99*Y(
MDSI3%D,5I!1I&&4=15<^9$;P%6]E5R1<U8O):T)[@223XF<NX3[8S17O)MZK
M<G!E3FL]I(``'@,_&79&X^9\841SW[ZM:F]BJUMG-JAR%D,-E6:G-:!(L+)Z
M]I"^08AS'HLEFRK?D[58\EMT!\B5OXS)3YJ+K8[?>&PFK:^T&2TX*'GQ'<9B
M-I;+Q76I952N?9G-)Q2?+@>\1`QK]I3&DL0-_=%XY4H^V3L=G$8#-B<9$17F
MFYIW,B*T^9=H+BQS$4^J@7X+$QT]I=8)N+G+GEI$Y>,_?+RB3G?-1H(%`CF2
MSU&4_"7YXL<TSH76&A<?_M_7..1ZU9#;(6]]*!B5DV0G')XV'+VZ1AF1.1@Y
M+BM-=`PQ\A(TV"$J+,[=:Z*U,\BB9"1Q/UE=ZCQ^@<(B5?<:RY/<ZK>*CP'U
M4^`X?2>,;CYL(P8<0AQ"/__0[^.(10=^ZI[:2;&UE^L&&.$S65#U39[(N8TY
MT2LK$HZ6$'$!:C."T<"`+[,B6COGYRD`/$59)2J3J%N,S58:4RR+J@?,(P\B
MJ?A'0/2+9R9)W77`'XDLI(RX%S'CF$R[S.*2"5!127Z(**JK_)$3M?\`Y.5+
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M@)$AMAWW]15/'F;).$YRCJ?FNS4A`25C@9I.6$LY^T1J'5.?7WK$T6593A$'
M(9\ZFO\`%X%$U9M_?Y%-R"V#([RVR:=#AW#!5L*'6MMMH@O&B$:DB(J<RW$(
MJU:$.$"8)/`2$@![8J3<VVZRJME&BK4EIYM:RG2-:W%KFI2EJ!]*4@<-1\(L
MMR+:6H]*X94YYC&"XW13\]H864NL5=74XZ:U#S,>Q>E9!85L-73^$IZBRV@N
M*_)54'I/,QC-RN"J/0TO4X^5:4)!S/YAWQSMN?<OW,A)JU+?K%*(2DJ)R/J)
M)G(=\L3+RC[7>Q3WL5<6F!7>+6F'5DK#+*TIW(]DOW%G6V;BT,VX<;.,VY46
M;02R2$B+(Z:(W"(5-`Y6V_KA7?=]OJ&5M?+-U0#B1-7VJ05I!.`4B0Q$OBEG
M*<;;IKN*AW'5W&B>I5MUP8400H%.@E*52,@H+FH2PE*<5WYCCU`6QJ[6^/%.
M=UWZZQCIJ)JQDLS';?-<ADO9!>6LTV&(\)URJ?E"TB(RV8/,@:+U].;:RO5*
M[8_>ZS3]Z756M>D$!+2/LT)$R2`J1.9!$A&3=6V$U[-JI=7W?;DZ4S,RIQ?K
M6HRD"4S`RG.9CV95A&ABI.*9JB]?&RV;SBEXN'XH#:*ODHM$O7_T5YEH;4LX
M>_",=2TISSCY*ZYCV)>+77?BJKTJ]"OD?BGYQ`B0@#OR1/'OZ?RY].,J:$S'
MPVZES*/[7%=!N*R;46*`42SCO07`)0\B^=LA16?D0D^=O_6!>E42%%3\.?+3
MBVG$.MGUI(/LCZ<0AQ"FUCTJ$O;$N/1&:FSL`S;UMV*_/EV6HKFON\1R!7V9
MLU,4LW5_383!V0S5CQJV3$%09`0;;9>;;'Q5I%6S[%N%^T5E%N"WM-J>`(TK
M!*9RD<`09YR,Y\8C;UL;N='66*N<6&P00I)D=,YC$@]F(E+A%JT5:#!\?J*N
M9;Q*ZMJ:^'5Q)=U80XBN,P8[<=KY'WRC,$[\8)WXH*)_!$3I.:BNK#555575
M!0A;KBEF7I2"HE1`'`">`GE$BHZ0LT[%(PE:TMH"1Q,D@`$R&?:>V(4;]_<-
MU%HNXKJ2119/F3DNS6'.G8_^F!6QH$:1]M:3:^3(EJ=J_",D\`0&8[W1+]P(
MB1)";KO:T6NJ-(I+CKP5)6@)D.)Q4H3([!F2!G%A6WIQ?[C;6+F5,LL.I)0'
M"O6H9`R2A4DDY$D8`JE+&(_Y;HK;=]D.+93KBE;N&Y=?(N*B=*5R/1V^)Y&$
M>;"&58$K$>!;_`31%&>=#P/R(2,0%3^V+4IXU*%)*J"HDXE8(F)XB8/<HSEY
M1R]<MD7MJZUM,VP%-<U4E:@`/4<#/(CCAPPB;FC]''IS!<OFW\Z-:Y[FD1^U
MS&?"[*LCO18$IJ%3TIOL-3?TJL8=4!^554S[)$%%1$DC;#5)2"G:'V:$GQ/:
M3XQ9.UK&BQLLLZM52M:2L\)SP`P!D/XX_G^U?(9<H]VQP#IQC(,.<</QZ\P?
MKKWXD\NOKX?$O\5Z[YK^@R5"@W*L_":E$O)*_P"&+I_%^M)O&PVQ\::!V?FI
MN7T1;'R_8XZAQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0A
MQ"/_T>Y/V"W'3Z#U!FVU+H0?;QFK\JV`2]+:WT]YJNHJP4^1HB29:2FA/Q)%
M%KR+O\O-==KBS:;?55[WP-IG+M)P`\S*-Q8+/47^[T-IIA]H\N1/Z*1BI1\$
M@F.-?(\AM\MR"[RB_F.6%YD5K/NK::\1DY*L;*2[+EO$ID9=&\ZJHBJO2?3G
M,534.U=0]4OJFZXHJ)[R9QV_14;%OI*:AID!-.T@)2!V`2_\8_MBM,]?7]?`
M"*<J.+P2)@@'R(K39(K,=0^JN'.DH+0@B*I(I?RYHKS5*IZ-33)/S;QT(`S)
M,@9>`/ME$VV;:T5]W1558`M=("\\I4M*4H!4)SPQ(Q[@8Z3=6XSB_KWIJ(N4
MVM9CD.L@?W#FU_<S(D"#%LYH,E-*7/>5E@68AJ$9GM554`13M53NT+%:FK-:
MZ6@;`U)3-1[5G%1]ONE'.V\=PUN]-TW"[$+67G-+2`"2&P9-H`QX8D#B28@)
MGOO!K+=>0X[C^+4.;Q*!NSN(U!FEQ4-1*#*WU9B@KM5&&4[;M-,JP8H;\=OM
M'!7I$)%YL*>XTIJA2!2N8N82=)T$I$RD*E(D<0#W9Q+NG3:;-?:MBM<1\PXU
MHDDA10J85)0&4P,\IX1K?;STJ5AT7]$LU@R+"ZJ8\:XA/$+T9LW3D?+%EQGF
M7FO,XXBI-N"JHJIWTJIS>TX`<]29R!PBWKX5KH$_+/:%K<2`L'$8SF"/#@8_
M-1I7=.\7-538^/28F(9)C81+O,G7(01ZZ%+L03))K(+))T)=C7U0M`@M*IHZ
M0(B(2^/IS6*?G@J]85@.WL]D57N+?-*[3H;IWM5:E@H5Z5"2R9*Q(EB`)D<"
M1QC8_N.P=#FL-FZBOQ<-K+S!8]='..95PX=54[0-LQF$`V7JN)D??RM`*C\B
MJGCY$G=?7-%4[<W=(.M5.H-GM5]:1X*EJ[XXSWT*LWQ2WDGDEL!L\")35+OU
M$SC7>L<BL&]E6^<.X;ER8T[K2\8QG*BIG6<5.!2R%N9LVPL7_B*(_:28WQ0P
M5$^5D?->NTY7NY$-.6MBV(KV/F4U:"XWJFYJ4"@`)$YA`)*SP)EF#%G=(K)6
M6A53>ZVA>3\Q3K#:BF2`A)2HE1.164C0.(!.1!B)6GA=>PB)<2W7)%GD=C<7
MEM,>(C?F3Y-E(8*0\9]F9G'BMIVO:_3EBW5*&ZQ5.TD!EI*4)`R"0D8#WQEV
MY2G*5+[AFZXI2E'B22<8]"]F-NR5B&"..-.*ZC:*)%]LV^XIR`%5\?F)P%3Q
M7ZD"+_-.?C""$ZP9`CWRR\(_7E@JT$8_FG],?-5*PZ]'L:]XB9^]-.R_IH@&
MZ^[(%4`>E>/M4`$_*@JJ+]%%>?3NH)4VXGU:?X)?E_''RUI44K;/IU?PD_Q1
MDN1XM!R9:8YDFPB.4=O%N8;M>^VP92(I>0LOJZP^AQW?P-$03Z_`DYB4]2NG
MYVA*2%H*3,3P/9W]D9+S"'^7J404*"A(RQ'YHW)ZN[%K]8>P&S\@?9.9)D:9
MKZ^MK&NQ"PNW\IA.Q$F/#V,=B/&BD3AKV:-=^"$O2+L5W6GL^WG*RI/I#Q"1
MQ4HIP2/''PSC:[7VY7;IW6BU4"?4605J.2$!<E+/A/`<20!G$8?8[?&R-LY[
MLN%>6+;U-7Q6HJ5T43:KZINGL:D2.'YNONL-%.<)M&B<+R5W\W;G:K0NX-Q7
M"^U-87CI;0U@$E4AB,,21,@XF4R1Y1UG9-LV_;%*NVT*=:=?K6M*-:B"/45!
M(,@<$IG)(,L\3J7+:^HM++U[QO+;*3`I_P"VZ^URVP;:*5,J\0E6TR98.C')
M"(GF:1#1ALD_J(G2=HG,.E::6_0"M<*:?TA:LR!Z2H@9S`!Q[93C-OJJI-O;
M;H&PJM%.HH22`)G5I!)D`,1XIG*.FGU]W-J?=>`1KK3UJ=EBV-OM8BK#\%^N
ME5<BHKX*M5[\5]MOKXX#[*B0>3:HO2+VBHG1]IN5ON=(EZVN3IT'1(@I*9`8
M%)`(P((PQ!!$<B7BUW&TUBF+FWIJ5#7.84%`DXA220<00<<P08S_`&-/*JP#
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MO!(`_G10BJH**1*B"**JJOX(B)VJK_@B<IV.BXL@]!=(GF.7,9C:Q0.DQQZ%
M?68OAV,J40S%Q.M$3%1,0=968\*_@B>*_P"LG,?;U#]^;A<KW,:"@("!P4X9
MS/\`-(GY)C<;\O!V5L*GL3`TWR])*G3DIMA)$AVC6#IQ_27V1XO[F^\G<^V]
MA/JM6926/8/`E5-IM:TA&\\V<NP=9EQXMBQ&<'[F/C=4VDGX%^BRI`J71-#U
M9==4M4[:>:\&T*4E)4?JZB!/R&/E%2;:HUVK;]RW0BF#EQ,VZ9)[9'6H=Y$T
M@\)'MC2-8Y&Q=_7&"UK>=OQ)>;XY:8VE[=T60834UE=/FI,D8':8Y-E5,MVU
M*S5)XQP81DP4'/-SZCIVUII*BW6]M56M#CZ5(+BT.-)2G5J+2T$I)5J]4@)9
M&9C`V<E^NW/0W!7RJ7T+`<Y:5H=4I13(.I6`H!(3Z229YC")7YM@L3*Z=VH:
MMI5!]S+BR@.'X$S]U'DA(^0(JN,$#[@B0J3+C2EYJI>7)TTZ6U!6F<=%7"W(
MK:=5.E\M%2@9CM!G,##'P([YQ(G6WMOB.N)N.Z<O\3L:['<8J\9QY<UJ5.;6
M5\VS:^*M2_B$R!POU$Q^0G0<<3S<7H.D7KS72K>"GTK&I1)EX=D<^;GV55VN
MIJW*5\U#*`%+.G24E<S+,CPQ$3YR+&<;R2(3618[1Y"TPVZ3#%W4P+9ILE1#
M_IMSX[X`I$`K]$3ZHG\N:X@&1EB,HKMUAA_3SF4+EEJ`,O"<5C9W:;&"?8X/
M38;$?U?9:2R4DRF(GQ2ZS+@K+*/!JE`9K;`P783;0@V$935QY"1Q!`AYSC1M
M6LRN517J%Y1<D?9$8*:U`J5.685.<SD,IF+0JG+@E7R#%$#:U4*OM!FES20$
MRGD1*4AF<\(KMT^Z#NM\74%1?"-+:+K\4<:LIC9HJ?BB^0]_Z>77=P4W&J!_
M2^D"*HMI!H::7Z/T$QZ>34SDE^/,A-+]RUTOB"B"/@/R*;*I^!FZ3B=]_BB?
M7Z=\\Z5X(2I"SZ#[N^/JH9*BE:!ZA']J*A:A,?(]VTJ*I.DI"`KXDA="V3`(
MRV/71+]%7K^7/RHJ"XJ0_+WQ],L!"9G.,FD3H<6$_9/2&@@QH[LMZ5YB3(1V
M6R=<=\Q514!`57M.8B4*4M*$I.LF4N^,@J2E)63Z0)SC]:BH7JJ@N-I9:T[6
MV6</3+ZO6>0`,'7$5IG^VI'YE[8"<H2G>BZ4V0:<Z\3%5TW45YJGI;19FU#F
M)FXL=Y&F9\]47E^'VV/%S<FYZA&EA82T@G]$'69>6F?C$4)\RCG3Z6OE$0/;
M`R@,JS:X0D\FL?L+Z0[74C/R>3;49J$BS'T,517":4E5`01J`J;#S+*)%3JM
M1[TC$`GL,I>$^V+O44+`YDQK5-1[`59#P'J/?+LCZ,VQ);^+EV=4625N21+V
MUJ\`Q<(_SLOU\6:32L1)D=^'#;JUKH#8L-"VBMN@\1_@J<R):G=0<"M:TI$L
M0)J`(G,SF?=XQX7!*44M;<`X%-I20,P=(25"8(&G2D2$L#..D+U8]=\7]:=5
M5V"XZ[)FS+!\<CRJUF*RKUEDT^!!8L'6D899%J"RL408!?(T!.S,S(B7HNQ6
M:GL="FCIU*42=2E*S4H@`G#`````#(`".0+_`'RJO]P575*4ID-*4IR2D$D#
M&9)F223F23'K>SMVE'HS8+WR?&Y85(4;2]]*17<N/6N`/\U*/(/Z?R_PYX;J
MJOD]O79X&2N24CQ5Z?SQO^F=M^]=^;7I"C4CYM"U#]5O[0_\L;C_`&_<;+'_
M`%EQ)]QI&G<EMLDR,^DZ5P)%HY6QG2Z==1?*'5-HG2!^5$['OM5G'2&A-%L6
MUE29*>4XZ>_4L@'^BD1"/Q*7877J[N)*%S;I4,L#NT-I*AY+4KSB:O+,BAH<
M0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0C__T[)_W"MD
M3=D>UVSG9!L%!PRQ37]+]N0&/Z?C!.,O&;C;CK;CKUJ_)/M%14$A140D7G.^
M]ZY5;N&L!^!G[,?S<_>3'8'3&UIMFT+<H3YE1-Y7BO+_`(0(AO5Q!GVE;"/Z
MA*GQ6G$_FTKHD\G^ED2Y!+F^:>WUCP^(-F7B<![S%N[9HDW"_P!II%B:%/)G
MX)]1]PCHL],L::H])UECX(,G*+:XN'U1.OZ3$PZB$'_U1C5R$G\.S7DNV)2)
MI=M42A\;I4L^9('N`BL>MMU7<^H=Y03]E2A#*1V!*`5?\2E1SH7LW'<C]PMO
M6NR)-L./.[(S5BXDT91TLFF/[@FPX:QSDM2&@::.*T+JHVXXC"&K8$:"*YE[
M-$I^WM7-2Q0J=.LISD$F7`X3(U83`G+&,Z_?.4NR]OM6E*/F^0%)"LB9))[,
M9*5+$"<IX1,#6.,6V0;`Q[`<1Q?YL3U:WDFUY,^!D1YG(NX^0U]+51KJ%:,T
MN/1SJT%F&;,88$:4B`]\WFZ*-AZ6YI*;A36YFG"*"EU/)4'.:'"\D)20O2@!
M.D8#2#,&>,1;9]?145\I+Y>:PAUX\I0+8;#1;"Y!:=2C@M0U*U$92PCU]X.R
M2S+"'F)BQOTZ!,MJXE,0:*PC6,(R%U2$D03%EM%^GDB)TGXJBSZEERW01F9>
MXQ;^YJ@)J*"K0[-IMI3J=)!"BD@X<#,#")6#ZA[7R38\X9TO&*_6^4R<3M\E
MNH-FMI/(<2-`*GJVVV6/&59*TWVX8_&`(J^2*GB6,FK90TDXEU,P!PQXF*XO
M^_Z>M:N;-OIG$_,I0%:P`1I!'!1[HM:Z3KK^'777^'-7%4Q#J;6C62[&D-/(
M*V7*K?$OJI1FB48I'_\`GP2;/_U'SF#<U$JVW^YTV0#I4G^2OUI]QBW+14"J
MME([QT2/BGTGZ(IR9Q<M2[+SS3TATW(L"8F5XA(='P69C5X#3JM!_P"TM9*/
MXC+_`#.>:_@G+JI+@+[9K=>@!S5)Y;H'!Q&'_$F2O"*DJ:+[HNE=:B?LP>8V
M>U"\?^$S$9CS\C]CR;VE@Y#4S::S1TH,]L6Y",/''=\0<!X?%UM4(>C;3M/J
MBI]%1454YZLO+8=0\W+6DS$Q./-UM+S:VEST*&/"/!P/5<W:\N5KO#O.MU-K
MZN?M-GYFX;DB#':B_//8PZ'8KY@Y>W,ML6O`%)P?E^@]`HKOZ=)9;J;W<%!+
M@25)G@,!\9_5$8M)2+N5;1V.@:4MM3B4*TXJ,U2T)_6/NCS-W3;>QC46#QG8
M6&XB[%:EWM[DD^#`:;;@*01X7QE+.2^TPW'$Q::%2><4`[$1+G.US=J[A4NO
M.U`4XZI16H8X3R`PE.?@!'=R:6FMEOH+114Z::WM-I`"I`>D2$\23*0)S*E2
MC2F3X[C<W#JK+Z([5;K(1CX+AN*(#+\FXEQ(PT(9(R2_')?@.PVED$T+?0OD
M@JXH_CA_+LJ=#R$J]*"D`X"0F._AQGEC*/A\(52(=;)YCA"4I&))$AJX3&$Y
M2SPG&W/6#4$W8.T<"T/3/_K%;CN35VT-Q7("X_"@-5#D7[JB"5%!QADFR+[$
M5(P^6;(+I/!GZR3;%F>NUWI6TMRI&5I<<6!Z1H(*4#O5(=\@3G,1!=\WZGV[
MMRHH`^%5SX4D)F)ZEI*5*_DH!,^U1EE'3NB(*(*)TB(B(G\D1.D3_0G.@XY:
MB!OO%E!2*3"M8TYA-N\GR*/.>JXJ_//-N/\`[!31_M&4<D>5I:V"(RB#VZ;*
MH/:IURO.H+[CU%;[)2^JKJWT@)&)D#AAGBHCV&+[Z#4#5/>;WO"X31:[91.*
M*S@D*4,?4<)AL*,I\1%NNKL/9U_K?!<)87R'%\4HZ4SZ<'Y9$&N89EO^+JJX
M'SRA,_%?J/EU_#G2EEMZ+3:+9;&_A880C^BD`GS.,<6;IO+NXMR7Z_/?VE95
MNO>&M:E`>0('E&><V<:&'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"
M'$(<0AQ"'$(__]22>W+Q,FVKLK(D=-\+S/<NM6WG107'&IU_8263,4^@FK3B
M=I_!><LW5WGW.X/3^)]9]JC'=5A8^6L=GIY2T4S0]B!.,?Q'P_NBD\_]7[E_
M_P"W]A,^+_\`5\>1;<,_N>KEGZ?^9,65T^T_YMM>K+[3V\M<HZ3O69UG_D-K
MIQ"$&VZ65\A$J"(*U:V*/$2JO2(A"JJJ\LK:A!VY9Y9<A,<^=3DJ3U`W:%#'
MYU?OD1[HHY]G-(99K#V;G[5U!00MJX'N2VMF(<*E:KLC:BY-D\:0UD.,6D20
MX3,5V44B2[$?4F_C!U#;,76DYL*VFJ'7&7J5+:EI)FE8FE25)*5).!S!S&(.
M4HV"*FDONV::T72M^4KZ,S2I6I)*)@H4D@'%)2`01(CMG%O_`*@Z$N-18E99
M/G[%6.U]@-U!Y.W4?2LQV@H(IPL1PNM;;;CQ`:H*UU?G)IH1<E.'^9P0`URF
M&BTC[33S2!/2)"0$DI`X)2``/:<28KVI+`7RJ92BPF<BK$J),U+,^*C,^$LL
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M.(3:&+)-.*/QDO0B85IO*V6N\/-A#@1=6R!J(.@IF3H61EGF`2/"-=1=2;58
M+@[:ZEQQ3!,E%*00A1D)S)!PX@8><0IRSU=R?8&!XJUEFQB=W#A,B6[1Y^Y6
MNQ2FTEG_`/N-;27C8NK]ZPK<@'1>!7#:0ND0D4T/1&^O[3O5:C_+RFK)4)25
M,:M0!&!<;4)@3D9#B,^$IL;*WN&U4:U7E+ET9)TO2D2DXA"T\1ECPX<9Z*G:
ML]F<3$(=EKZESM0$&PNL3R&-&9E?&/@<F1&GQHKK12"3R1$8:$47KI.;]G<^
MT:R:T7)VG_5<;)([@4E0P\3&D=L&YJ6254+;_P"LVL`'Q"@#[HS##?4_V,W=
M,;K+0J/5F(&Z+=_(;GG<9`,%QH''(PG$CE#1]]LN@0'6U7M?)%%%ZD-IJ*"K
M47;<RZ^D'!U:=#0(ED"=:B)S`TZ3^D(UU7;[@@!%8XVR#FA*M;DN\@:4COG/
MN,6=6>E<,T1ZPY+KW`*U6*ZOKV[&7(=<-9=S<G/K7)MS:2%^8U<D%'%3Z11:
M:!!`?$43F9N/6[8KH'5%2N0K$9X#LP'E$IV`ANDW;ML,!*4_-HS.&)EB<3,Y
M3CG<S^C8KMRV<G8,AS-K&VDNGC>&8Y(=E2I+DZ:"T-'-D2FJYN#`CHH@9!_6
M\D_*)(I=<[<H.O(1F%*`2,9DG`3\292F09QUA<5M453555Q<U)2E2R$XR2/5
M(DRD$@8F4Q+");W/HO[1U6/W.Q9>,LWF<V=2Q78QC&,6D!X\'I[$66I4:*#C
MC#86D2M58ZHTV8M=DHFX2(7)A4;'W"PRIUIMMQS3\*58CN`.F9'CB1G%?TW4
M_:]0X\M^H>;?)THFB24IRF%)*I3'=@#VQ(7TVV5AOK1B^P:"ZP#-KW):K(:2
M5NK-L8@5$_&-9_J3L.EHL/N[*9<P;*?(QGYR<GN18SX),D/")N*/?)QLZTO[
M8LAIZIE;M5JYM0XD3""Y(#69]V29A.,L,8J7?MY9W%?VZEIU#5.MO13-J,E+
M0B9FD2^MB05$$B1..$7#VV055+CUCE,Z2(4M942;R3*%/)/TZ+#.<X\V/T4U
M*.'8I^*JJ)R:NNMLM./N*DTA)43V`"9/LB%4M,]65-/1TZ"JH=6E"1VJ40`/
M,F(,^GF)S?8GV<R;=^10?DQK!Y27$*/,91Y@;N0+D/#*MI5_HH_1P6"F$2(7
MB\TV7XDA)$.FUM>W9O&LW;5(/W=2F30./JR1+AZ0"H_K2\8NWK=>*7IGTMM/
M3.W.C[]KTA52I&'IF%NSXD+40VGM1/PB[[G3$<*0XA#B$.(0XA#B$.(0XA#B
M$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$?_5W)==+<VRHO:+9S^E[[[3[IWI
M>_KWWSE"HGSWYYZS])CO>BD*.DEERD_\HC_:-](UW3R%7H6K*)Y+_('748-5
M_P`$!U>_\.:B[M%ZV5J`,>63[,?S1+-HU(I-RV9Y1DGGA)_G>G\\7]^K3A9U
MZTWN%A,^.:P.:8HC@N*!Q`O8TB7"=\@57`$/U=>EZ1>P7K\.2[8%4*G;5&F?
MJ:4I!\E$CW$16G6V@-JZDW&HT?9OI9>'8?2$J_XD&<<Z'KE[(;.]0-GV$VI!
M\X03WJ//\$LR>:@VPULA^*\U(CJ0+$N:I_S5A]/$P+L"[`C%98E102#E$ZO^
MWK?NZV,.I4!4%`4TX.&H`R,LTGB.&8QCJOTMNS7N_,&K,^UU=,V=7.:;2;`-
MV.EQC]@H>3]/?067GRK[&,7:**JHF/1@1`0DON#,`C*.<KE;:RTUCM#7,E#Z
M#Y$<%)/%)X&/LVCN+5FG*0;K:>;8[A]9*1\(@7<YEJ5;$P(+)CU57V<^W>:!
MT5-N.TZ2(2=I]4Y^Y"?"/FAM]=<GOEZ"D<>>[$@F0[3+(=YPBK3:WM1^W-F%
MC3/29F8),AO/E&M]=T]KCC=>+[+41\'FG'ZE&HTAH4(QCL]N*/D79?CZM5BF
MY@+!![1/\T6%2V3J,PAL(YNE$](4XE4IB1`)42!W`@819'Z[9=IS+-44+>A\
MEK\AP?'HZT,0HTMR1.JIC38S'(%Y'DH$^#:JDP7S;?`#4'1-$\"%5^%N*=6I
MQ1F3$!NM'<**M>:N=.INK)U$$2G/B.!!X$817/(CS8#LB):@ZQ8PG7HUFW*5
M?G9GQ7#:G!))S\WS-R6S0U7Z^2+WRIZI#J*I]#H/-UF?:3//SSCEFL;?:JZE
MJI!^8#B@J>>J>/MS[XLITYC_`):CQ&JR>G;=,(D\EKKJ`#I,PY%O8OU[3L2:
MT2M(-:\TB`0IXCTG7TY8]"RKY"F9JD37H`(5CY&?=%^;<;J::RVYNI"DU"48
MSG,8D@'B)"4;$+$L5..D0\:H#B(`-I%*GKRBHVWUX!]NL=6?$/%.D\?ITG/,
M6:SI7S$VJF#D\^4B?MTQ(S75I3H-8[H[-:I>R<>XPPS&:;CQF6H[#0H#3+#8
M---`GX`VVV@@`I_!$1$YL@```!A&-'XE18LZ+(A38[$R',8=C2XDEH'XTF,^
M!-/QY##HDV\R\V2B0DBB0KTO/P@*!2H`I(Q$?J%K;6EQM12M)!!!D01D0>!'
M`Q6U7^NGK#AVV\ZWOF>$7&#1M=6"Y$S?YA=6+&'-S*VQ=-FRC1)ZBPZI36PD
M0&@<>1Q%#Q3OQ!?"NZ<[=M?W3N%BMIGZI_[3DMKGR%`"16B7I4,I9!0,AA.-
MQ2=0=VW]==MQQBID"&PXI'J?!)&E*\U`^U23B<XC5O3]Q;,]XPV=0>H^#;"B
MY%F=E*Q\<RDTX)<S:QU'&6G\#KZ>;96*R+2/VXW((&Y#3:H0B)=F&*Y=&"Z:
M6BF_7DR2V@:E%79(92XSR&<2"FL-LLK;ESW%<&%,M(GR@52U\`XLA*=(XA"B
M2<!&3ZAHW]#1\U]1?U_,K7.=TX364&S=>9/A4)]AC8N=54*9/SJIS)J:<YVC
MQ&BLWY$YV0S\CLJ,2MHX*"?-BT\U9T7&R5%6XJX5;'VK)1,!QQ(!6A?Z"$X2
M/%.&,5W7.5>YJZCW$BE;32,5)Y;R5R^S;49-EO@HF6F623+*)">U&9V5O.PK
MUMUH4RQM)+E+76L*M=57)C[K;==08W*-@U-`0.I4P31`!OXB)?%"ZKK>5?5U
MM10[2LVI5=4*`6$X^DX!)[)SFK]4=ACHSH_8+9::*[=3MUA#=GH$*+)7@"ZC
MU%:0<%%,M")3FLD`33%MGK[J"NT=JG%L`AJT_/@0DEY%9-BB+:Y)/_VJXF>7
M2$K'W;A-L(OU%@`'^'.B]KV"FVU9*&T4R1]FCU'])9Q4KOF<NZ4<<[^WA7;[
MW7=]RURS-]PZ$GZC2<&T#LDF4^^9C=/)!$-AQ"'$(<0AQ"'$(<0AQ"'$(<0A
MQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(__6D1LRE3'-CY_CZ?)XT>:Y34A\H?&Z
MH5UY.B-DXW_D,@:153^'.5[DUR;C7-?HO+'L48[MLKWS%GM3_P"G3-GVH!C!
MU\NE4%\33Z@7_LFGU`O_`'21%Y@*2E:5(4/21(^!C;M.K8=:>;,G$*"AX@S$
M7`_M\;/9"YG8C/=3SSJLBSX`CY?"W?8Y&L#LV`[)1;63#5Q>E[)?MQ_DO/#I
M_5)H+E=K"ZN4U:FP<S*<_:F1\HV_76V+OFWMK;WIFIA+?+?(R3K*=,^X.:T^
M8$:F_<`_;JO\OR2=NC0%&ME;7;TB;GN"1'(S+LFP)!,\@QI@_B*1,L'5,I<5
M"(C<7S:1.R%;66C5B,XK'9.^FK8P+5>%GY1/]FN1)3^JK]7L/#'A*6M?VP-4
M>R^L=^V8Y)K[/,)UW88K:L9E_=E#<4=7)EL-H[COV26+,9B5;M61H@JVAD,<
MW>_HO?/EL*$YC"-AU%N>W;E:Z9=)6LO7%+@TE"@HA)'J"I9#*4^,0\_<3S_/
M,S]J-E5F9.38\'"[?^V\2HWOG;A5F.QXL5R%,AQW24?*_;-)KKR?_>D\BI^1
M`$?EPG5+@(E?3Z@H:;;E'44P27W@5.*PGJF1I/<F4@/X8C%J_46Q]S9*QB>M
M,2N,KN75:)]NMB.NQ:V,X^U'6PMYJ`L6KKFG7A0WWB!L>_JO/@)*LA$ENMYM
MMEI_F+C5);1P'UE$<$IS)\(Z!M!8P/I!@;^M<>G1LOV)D%C#R79DZT5Y[&J&
MY*J8CLX]C\2O<KWGUBQ4;5UXWS4C(E5>O!L-9<[RU;2EAM`6_F<<!X]Y[.R.
M..IO5#YN\CY:D;+J$:0)GTHF5#609E9U3D)`"6';,W6[.M-SLR,KNL,IF\TA
M2X']PL"<E6'ID5`>@V01_N!:E0I7QJ/;S9$?QJVXIH//:B70W1**[Y=/S"3(
MS&((^GN)_-&@LRK+N5";LY;V_GT*`5/$A0Q![".PD'LX1H/WZ]VI/JK2XUCN
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M6TG-!!FHI,R)$``X`S(QX7H<](J:*P?W9Z_,;'UB@-8Q7VT^JC[%HYV;)41I
M,DHV-1*7(S279#&`U;J&;98RN.&GQ@[\7:I].>+^ODN\OXY&7LB:;$<IF[R\
MI]:0^:9P-3D)NF02!/ZQQ">,\L8C-Z];LT!CMUHS)*ES$=6IH.KP_)KG)X^-
MV<[+]O+=T4B%M;%WG`D.-V=@E@XR-(HBTTS'<<+M43\N!9KO8Z=^U*UM4K]"
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MM*C=ZF81J^J@R,P)3!.7<,(]OQ$]1*%[Y#IGM%:$;8H`DN<O_J.IF-)(,BE/
MQ'#%9U$Y2N*Y=T<IPXA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#
MB$.(0XA#B$.(1__7L$]Y<!L]>>U&X:VPBO1XUYEEAF-*ZZ)H,VFRE\[:/):(
MVV_D`)#[K)$/8_(R2(J]<YQWC1+HMPW!*AZ7%EQ/@K'Z9QV3TZN3=SVA:%(5
M-;+8:5W*1A]$C$3.1B)O&^]`Y],P?*ZRSA$/W^/W$3(JQ@G5:^[;;-!M(':*
MA(V^TBH:)WV+Y=IUWW%[HZY9[S;+\RDD)5)<N[#_`(DDCRBT=L,,;MV?N+9%
M6X`MQLEHG@3Z@0/U'$I5AVQTKT%Y7Y+25.05+XR*VYKXEE">`A)"CRV0>;0E
M%51#!#Z)/X$BIR]6G6WVFWFE`MK2"#V@B8CBRJIGZ*IJ*.I;**AI90I)S"DF
M1!\"(]?GI&/&A]M^LNBMYD,C9VN,>R.S;;88;OBB_8Y&U&CNH\W$;OZ\HUL$
M3S3ZM([X$BJBITO/R0XB-I07JZVO4+?<'6DG,)40#XC+W1G>O]6ZYU55+2:X
MPG&L+K#/Y7XN.U$*L&4]XB*R)AQ66W)<@D%/(W%(E_BO$8M76UE>[SJVJ<==
M[5J*C[28K>V0Q)B["S>/-\DE!E%PZZAK^?PES')L5Q47ZH,B'(;<#O\`$#14
M^BIRMKTA:+G5ZQFJ8\",/X(YTW,VZW?KF'0=1=)'@<1[I1(#U/IYY766Y`BD
M-4W6PZ1?J7@]9%)2P44_RJY$B>*K_%$D#_!?K(-KMK#-2Z?@4H`>0Q^F)KTZ
MIW0BXU1GR24I'>1B?8"/;&L/?CT3M_:F;BV;85E%;0YIB5!.Q\ZV]9D%59!6
M%-<M*Y@)T5#<JY<29*DIYDVZVX+Z=^'AV4G4C5+&4=#;-WB-L_-,/TI=I'5)
M.!DI)&!(G@9B6&&6<5B0OV],?TM%C9O[E;>Q?7>*-/N+'PS$[)JWS?,59:55
MA4;A-?&!?.;:.*RQ*5`[0E:\A-/CEI2-3BP$CRB=5?42IN(73;9MBU/RQ<6!
MI0)YD3D.XJ4!/@8F1B_[@>#ZYP]W'?7'U>NBUEA9,P&[&TNZO"DE-FRY)*T.
MK2OM[BPDRD!QZ2^ZIOJOFZ]TB^:X:[I3!BHJ&@IQEKXBD`@'LSQD,3*<AB<(
MK:MMR7*\)O%]"KF\9R`4Y/A\9*4RGZ4]IP$3O]6?:-GV/K,A2=@]EK[)L:"E
MF3:299QKN),ILCBNRJ:XK;6-'B(\Q*&.XA`30D'BGU7R^F33U353J")A0"20
M>Q0U)((F"",B(C]73ML*3R7N8T9B<M)!22E22#.1!&,2K?CL2F78TIEJ3'?`
MFGF'VP=9=;-%$VW6G$(#`A7I45%14YDQB@D&8SB&FP=<>J7KX#NRBU)@,7*%
MEE+QZIKJ:KCR9U^)*^W+JZ]62B5SX/?F>FMLHK2+VJJJHBZ*\UUILK"[I6M-
M\T?#@G6H\$I.9_,,8F&V+!N/?%U9LUM6XLJEK6HJ*&T##6X<9`9">),@(A%@
M.)Y_[Z>PKE.Z$IG!*^=$?V-D,5):5&,X3#EDX.!T<QIHX[-Q:QO-AM5(5-TG
MG2#I'/&,[2V]<-^W]N_71!1:VE`H009!(,TCLF?><<HMGJ)O&R=&=EN[(VTZ
MEW<%0V0\\"-1<4-*SAB`,!*?I2-/Q$F.EJFIZS'ZBKH:6%'K:>EKX=55U\1H
M&8L&NKX[<2'$CLMH(-,QX[0@(HB(B)SJ1"$-(0VVD!"0``.`&4<!.NN/../.
MK*G5J)).9),R3XF/2Y]Q\0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.
M(0XA#B$.(0XA#B$.(1__T.C3]XG3SLF!K?>59%!1K2?P#*G@!$<1B8X[:XQ(
M=)/]=MJ3]ZRJK]45T$^J?A5G4NV%RGH[LVG%LZ%^!Q2?(S'G%Z]%;V&:NXV%
MY>#P#C8_62)+'FF1_FQ0YRG8Z+CZH$UZLGP[*,(E(A/(ZV)+TC@**MOL*72^
M(R&#(%7^'EW_``YBUU*BNI'Z59D%C/L(Q!\C&VL=U=LEUH[FT)J:5B/TDD24
M/,$^>,6O^H_M548;$<QC*9TE_!9CY.U\T6G9#^)V9*138S\4!.0M=+,T(Q!"
M^)Q%,45#+F/M/<Z[$M5CORBAD'[-9Q"9\"1/TG@>&666VZH=-VMZLM[TV.VE
MVK6)/M)DDN$2]0!D.8G)8^M@1,YV[0IL.RAQ;"ODL3(,UAJ3$EQG!=8D1W@1
MQIYET%43;<`D5%3EPI4E20I)!21,&.3%H6VM3;B2EQ)((.!!&8(X$1_20CQ1
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M,M;8`01W60!B.QX,F!&)?(I$2:*H0Y45['S:2*5IY!TF90MN2BLF23J4#I`2
M98`YSPG>XG5T5$;=8D@6Q5.K0X@C4MTZ=+BU:A(J&K$_!@!ID9RIU=ZW[PV7
M`:LL-P";@\++[JBR"WR'+HM/3XG!;ATN24-RS1XN;*3;"FO@RR4Z43[)N.$8
M1C"A@GFN`S2UJT%5'2*IW7G4K<UA'+3)M:%A#8G-+G,42D@`"29$"<1QQ=/K
M2*RI#[+32D(TE?,5-:%H*W#*2F]``4"23-4P<(N1T)HRITCC<V$$X;[*<@D,
M3\JR1*^+5-3I$9A(T&NJ:F&(Q*3'::,GQ0H3*(TPWWTG:KR24[')2HJ7J=5+
M4J0$Y````2"4@"24@``91JG%A6E*$Z6DSD)DYF9))F5$DS*B22<XP7??M7B.
MI(UA44[L3(<T89=^:(C_`(U6/_T75^[NY@(H$<<P15B@2.DG^LK:?7D:W%NV
MBL?^&0.=<U#TMIX$Y%1X"?#,Q9VP>EEYWH?GW5?*;=;/K?7Q"9%0;!S,OK'T
MCB3E%0U&&X_<O;4;"<1DSK>]R)]'+G)[!Q\(E/CR/,Q9]L^VPVJT>-58R1+Q
M9%'#51;:!#-$**6#:UXW;=T5%U<YCTP=)^!H3&8RP_1`QXS,6KN_J%M;IMMI
MVU;4I@Q2`%)=']J^J1G(F2L3]<G`?#I$=-/K3Z]XCZU:KH]<XNTP_+9;;GY5
MD`QT8E9/DS[+8V5M(4B<?%A7`^.*R9G]O&$&T5>E5>J;1:J:S4+-#2H`2D8G
MM5Q/Y9"/Y_;BOU;N2ZU-TKG"IQ:C($STIG@/X3Q.,;_YLXT<.(0XA#B$.(0X
MA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(1__]'NWVIK+%-Q
MZ_R;6^;04GX[E%<<&6"=(_%>$A?@V4)Q47X9];-:;?9/^#@)WVG:+BUM&Q7T
MKU'4HU,N)D1^?Q&8C.MMQJK374UQHG2BI:4%)/YO`C`]T<<>X-6Y-I?9.6ZS
MRV([%N<6M7X2FX!`W80"7YJNWAD0@CT&UKW&WVC%.E$_YHJ)S-=K:_:;A4T+
MZ2%(5@>U/`CN(CMG;]ZI=P6FCNE*L%#B!,?HJ'Q)/808UKS6QN8]"LMK&EDK
M+K)",NDB"\TX*N190#Y>#<IE"%30%)?$A43'M>B1%5%P:^VTMQ;#=2C$9*&"
MAX'\QF(WMAW'<]NU)?M[OH5\:%8H6!VCM'`@@CME,1-O17MKENNY$2%3VRG6
MJ2E*P?(7G7:.03AF<A::1Y)]A)<<,G$*,39F7YG6C1%3FHH+MN+:2DH5.ILX
M/PY@#N/Q(/C-,^V)?>]L=/\`JFTMYHBW[L4)ZP`E2E2E)0P0\,,Q)P#B,HMD
MUO[8:FSYN)%FVXX9D#XB+E1DIA$BK(\5\PA7J]5,ELC3IM''&7C[3^DBKURS
M;1O&Q7<)2U5AJH/U'))5/N,]*O(D]PCG3=72;>NU%.N5-L54V]/_`%F`7$2[
M5`#6COU)`["<XJN_<B]%LMO,OD;\T;BKN2UV0Q!?V!C&,LA)LHMK$8:9#)JB
MHBC\MG%MHK:++",+CPR`5U0)'3(9(M&KU)SC:[!WE2T-/]RWBHY:$J^R6K(3
M))0H\)'%).&)!(D(KV]-]Q;>T9OK%(N"0LBL2R7(:K'LPUPQ%F._W56/2_M9
M,=^G41)NWJ&9#K\22H@<5P5\B^$G@/Y:F%A)&!B;;RMMHN]AJJJH>:#C394V
M[,8',)U#,+RTXSF",91UZ<]XYIAQ"/PK;:DAJ`*:?1"444D_]1==\0C7>?[;
MU[K*&<K,<E@5SR`A,5+;B3+R:I=^"1*>+\LYT"5.E<4!9#\3,4^O-=<;M;K2
MR7[A5H;1V$^H_P`E(Q/D(W]@VO?]SU2:.Q6MVH=)Q*1Z$]ZUF2$#O41W8Q5Q
M[`^^%O:N3*'!I4S$Z!V.3/A&!A<UMA-#0S?EQY#[&/0W1Z0/B<!WZ*OS+WX)
M6MSWA=;VI5+MQE3-&<%/+$E=^DXZ?*:_".A]N]*=K[-:;N?4*J1578'4BD;5
MJ0.S6)`K,_TBEK@=40EU9J?</M3G#.&X+2E9.B1V$]PG"BXWCL%MWLK?(;5]
M"!7T5T1%2[<>=5$9:\B5.;#:>RWJZJ":9"G'R9N/+X?I2/"?9F>)C3]1^J[5
M%0RK'$L6](DS2MR&J4PC4!*<A(')*9>E(CJ*]7_5G77K#@\2AQ:MBS,LGQ(Y
M9GF\B.R5YD=CXMN/L_>?"#\>AB247[.&*HVT/YB0G2<</IBS66BLE(BFI6QJ
MEZE<5'B2?S1PYN/<MRW-7N5M>\2B9T(^J@<`!V]IS,2<YMXCT.(0XA#B$.(0
MXA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA'_TN_CB$5O
M?N$^FL+V%P>1L##8+W_./!ZAQ:EJ(*NGF=%$-Z4[B;S+DEID)H$^Z]!=%/-7
ME5HD(7$\(=N_;+=]HR\PF5Q:3Z3^D,]!\>!X&+%Z>[U>VM<4TU2J=F?4`L?H
M$R',&'#B.(CF&LJRRI;";4W%?.J;6MDO0K&LLHK\&P@3(YJW(B38<IMJ1%DL
M."HF!B)"J=*G*`?8>IG7&'VRAY)D01(@QUI35-/6,-55*\ERG6)I4DS!![#'
MQ<\H]X_!M@Z!-N`+C9HHF!BA`0K^*$)(J*B\0C*JG,+^H$&6Y238C8H`Q;%"
M?0`3_*U)$@EATGT1",P%/H@\T-;MRW594M*"TZ>*<I]Z<O9*)Y9^H>X+4E#+
MSB:JE&&ER94!V!8]7]+4!V1)#6/MAG6OHPP:/)[K%80/$X-.0AD>.D3CBNNG
M'A2H,MF$3[A*3I"PR1*O:DJ_7GFP]N^QA+=NKR_2#)*I$#NTK,Q_-5&764_2
MC>I6]?[***Z*.+B-223E,K;`2H][B(F)B'O<IVC=U=8!KO)[UB(43]<QV4-'
M?#'>\"=:?D/MY"\(R%`5-M/A!53_`%4Z1.;AGJ1<*:2;M8R.])4CW+!G_2B+
MU?X?;+<$*5M?>P6C/0X$.^$U-*1+^A&_X7OK@CK"G/PG+(<A$7^BP_436E5$
M_P`KY2HA>*K_`!5M%Z_AS<M]2K`I(*VWTJ[-(/O!B'O_`(>-\MNE#+]$XW/X
MN84^XIG&)WO[@]5$;,JO7;P`@DJ2L@RF'7M@J=^)$Q$KIJ&'\5_K`O2=?XIA
MU'4RAGIH+8\\KO(3]`4?=&VH?PY7HIYEZW'24K8STI+AEXE38'MB+NP?W`MA
MW+2QJJ\J,<9)"46<'KEF3)`*O8@_=VC]FRPX*?YF3BJO\N:I_=>\+I-%%1(I
M&I_$1ZO:O_Z43B2TG3+I-MLAZ\7EVZ5$O@2H:)^#.(\%NR[H@ID>S\JR67,G
M2)3T:59/N2["?(E.V=Y-D.JJNO3+:4I*3KW?9$(JXBI]'/YX+=@0]4&LNM4N
MJJU9E1,OX3+(8@2X1MZC?KM)1)M.U[8S;;8C!(0!J`XRP"4DYDZ2J>.J>,2:
M]4/1C:?M!:-W`A(PS6`R''KG8ES$DO%:.#):;EP\5C/H)9%<N?(:D\;@Q6E;
M+Y7?/Q:.TML;*J[MRW'&RQ;$Y&4I@2P0/#CE'/.^>IM%8E/H;?\`F[ZN9(U:
MM)(/J<5C/'A.?OETT:.T-K7UXPIK!M9TB55:<E+&VFOO.2[6_NBAPX,BYMIC
MI*KLN2Q!;3P;1MAM!Z;`$^G+TMULH[53)I:)D(:&?:3("9[S*.6;Q>KE?JU=
M?<ZDN/G`3R2)DA('`"9E&Y.9\:J'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'
M$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"/_]/OXXA#B$5X>Y_H%B'LXR68XK,K
M\&V]`AO-M790FQI,RZ"*$2%FRPXKED1Q&8GQ1IS7R/1FW%0FGP$`&([FVE27
M]'.2H-7!(D%RP/<L9D=AS$^.46%LKJ!<-IN?+.)+]H6J:FYXI[2V3@#Q(.!E
MPSCFRVKI[9.D\HDX?L[$[7%;I@WDC_?1S_3K=A@T;.?0VH"M?=UJD2(C\9QQ
MOM>E5"^G*+NEGN%G?-/7,%*N!^JKO2<C'45BW%:=QTB:NUU25IXIP"TGL4G,
M?GX1K3FLC>0XA#B$?@VP<3IP`-$7OHQ0D[_GT2*G?$?H)!F#C'['\@^`?E#K
MKQ'\H]?R\4Z3KGB:=@F9903X#^",M-QN"$Z4USP3V!:I?3'\T::$O,6FQ-?Q
M-`%"7_WD3O\`ASU2`D22`!W1C....JU.N*4KM))/OC:.JM-[,W;DS&):PQ&T
MRNY=4%?2$V+5?6,F7C]W<VTDF:RHAC_^)(=;%>ND[7Z<VUKLMRO#O*H:<J[5
M'!(\591'K[N:S;<I^?=*Q*.Q(Q6?!(Q/CE%[?J_^U/A^OI]1FV^K2MV)DL%1
MEL8)!C)(U_!ECYJR5LY916YF5G'50-&S9C14=#HP?#\;@V_L.BMBFZJO4'ZL
M<)>A)[@1,^)CG?=O5:YWM#M#:4&EMY.*@3S5#L)!](/8.!QBWQMMMEL&F@!I
MIH!;;;;$0;;;`4$``!1!``%$1$1.D3E@``"0RBIB2223C'[XC\AQ"'$(<0AQ
M"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"/_4
M[^.(0XA#B$8EFF!81L>D>QK/\2QW,Z!\Q=<J,FIX-S!1]OOXI+3$]A\&);"K
MVV\'BZVOU$D7Z\\*BFIZMLLU3"'&CP4`1[#&325M90/)J*&J<9?&2D**3[01
MAW16+N/]H[2>7M%+U#D%QJ*U^=Q\H4M+#.\:?#X/$8346WNXMW7([)3S5[[Z
M0C:$J"RHH()![GT\L]6"JA4JF=)GA-2?#23AY'RBT;)U?W';RE%T2FM8`EC)
M"\\]24F>&&(QXF<X@UE'[0GL94*9XWE&M<N9%LG$!NUMJ.:X2*J(R#%G4?9H
MZ:?5/*2(?S).1)_II=4'_#UK*T]\TG\X]\6!2=:["Z/\7;:EI7=I6/I!]T:D
M<_;!]S07H-;4KJ?7\P["P84_P^CEZ"_7FM5T^W(#)-.V1_+3^<QN4]7-F*2"
MJK=2>SE+_,(]>H_:P]OK&0+$[%<4H&R1/]KL\YQ^1&!?Y.#2R;:9TG\Q9+GJ
MWTZW`OXPTCQ4#]$XQWNL.T6_[-3[G@V1_P`THW=C7[.&X9ZPSRO:NO<<:=<1
M)H5,&_R:9#9^;P)QEEYC'HDQU&$^00^X:0EZ%3'ZDFVI^F%4K2:FZ(3VA*2?
M>2(T%7UOH$ZQ0V-U9E@5K2D$]X`49>?EQB;.IOVF_7C"FF9&QY=]M^WCS3DM
MG/D3L/H"80&5C1Y%%06YR)9,/@9E\DTF7A)`-I10O.66[8-BHI*?:-0Z#FN<
MN[T@R_+*(#>.K&Z;EJ12/II&",FP"KO]9$P#W8CMBR7%,-Q+!*=G'L*QFAQ.
MBCFKC51CM3!IZ\7B!MLY"Q8###)R709%#<)%</Q3R5>3)EEFG0&V&DH;'!(`
M'L$5O45-15NEZJ?6XZ<RHE1]IC).>L>,.(0XA#B$.(0XA#B$.(0XA#B$.(0X
MA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$?__5[^.(0XA#B$.(
M0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#
MB$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$?_UN_CB$?.,N(<@X@2HY2VA0W8
MHO-E(;!4%4(V4)7`%4-/JJ=?5.>8=:+BF@ZDNC-,Q,>(SCT++R6TO*:4&29!
M4C(GN.1@,N*4DX8R8Y2VFQ><BB\VLEMHUZ%TV$+Y0;)?HA*G2\_0ZV7%-!Q/
M-`F1,3`[2,Y0++H:2\6E!DF05(Z2>P'*?='T<^X\X<0AQ"'$(<0CQ,DR2@P^
MBM,GRBW@4./4L4YUM<6<@(L"OB-JB'(E2'%0&FQ4D3M?XKUS#N%PHK515-QN
M-4AFA93J6M9DE*1Q).0C/MELN-ZN%):K31N5%R?6$MMH!4M:CD$@8DQ_:CO*
MC)J:JR+'[*)<45Y7Q+:GM:]X)$&RK9[`2H4V(^VJ@]'DQW!,"3Z**HO/NCK*
M6XTE-7T-0EVC>0E:%I,TJ0H32I)X@@S!CSKZ"MM==5VVXTRV:^G<4VXVL:5(
M6@E*DJ!Q!2001VQ_2PN*FH%DK6TKJP9#B,QRL)L:$+[RJB(TRLEUM'7%54_*
M/:_7GZ_5TM*$&JJ6VPHR&I03,]@F1,]PCYIJ*LK"L4E(ZZ4B9T)4J0[3I!D.
M\QZ"*A(A"J$)(BB2*BHJ*G:*BI]%14Y[@@@$'",<@@D$8QXN29)08?16F3Y1
M;P*''J6*<ZVN+.0$6!7Q&U1#D2I#BH#38J2)VO\`%>N8EPN%%:J*IN-QJD,T
M+*=2UK,DI2.))R$9ULMEQO5PI+5::-RHN3ZPEMM`*EK4<@D#$F,7_P";6LU?
MP.*F<XTLC:$5)VNV?U2-\F90UBL3DDX^/GW8,K$DMN>0=IXFG\^:W_-&W==E
M;^^:?F7%.JE&L3?3(*FW^D)$'#M$;7_)VZ>7N!W[@JN7:5Z:P\M4J96HITO?
MH'4DB1X@QL/F^B-PXA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B$.(0XA#B
M$.(0XA#B$.(0XA#B$.(1_]?OXXA'.=L*1GFO_;KV7]D\#"7.?T-MC"Y.5U$=
MPT&RP7-(EU39`S*`0-3B*E>PP1+^5@7_`)NOZ:$/!M^<O5CZH[_W[94J6NRW
M-A3R`?BIWPMMP*P^$Z4I)^KJU?5F/Z6[;;V_N/HWTNZ8[@4AMO<%GJ4T[A'P
M55,IIQDIQ'J]:E@9K*-$_5(S6UMMG"Y7NEOS=4>Q5W!%]3L.SW[]L1-Y*-F+
MB5L\*L@9)]\TTV39->7:/"H=]IRV]O[GM#G5G?&[D/SLW^6F*G4,^6$L+(E/
MX@`01/XL(HS<^S[XUT.Z>;&<IM.X/\X5-)H.`YI54-C$CX22"%2^$SCS7O=#
MVN#4R>TS>HM7?]OZV:"-`=_=KL5<=7*?[4&V.2)?I@&=ITWY)'5$1?E^%6OS
M\QU]6NI@VS_J0-L6[_)',ER^8Y\UR^=R=9,]/Q^F>G];1IQC+1T/Z0G>'^DR
MMY7;_47E?VP9:^3YW(^8Y83\9^S]4M8_1UZ\(V%M#W#W">Y<%U)H3`,5S&3M
M33^/;#P^7DTF97+5OW3DVSDS\@D,V;,/]'KL;KG%)D/%U91"B&?T;/=[BZJ[
MK5NRS[8V59*:J7<K4U4L%TJ24%S4LJ<(6$Z$-(,TB1UD2)^$QO:G1;92=D7_
M`'CU"W%5T35HO3U'4I82E?,#02VE#(*"KF+>6F2C-(0#-(^(?URSV<]GH^[F
M/7G"-8ZZN]@R=1XIF,Z79VUG!Q_%[^3'%[+)-E,:FNE944:3_LL)IE`=)YYL
MB<,4)"^[GU$ZC(W>C8MHV]0/7Q5L9?45K6EMETI!>*E!1UM@^A`3(ZE))41,
M'XM'2OI4YL1SJ1?MU7-C;B;S44R$H;0MY]E*B*=*$E(T.J3]HZI4TA*5`)!(
M(TU6>]'MCE.KL[SO'=+:WB!HNPLH&X+:WO+(X-C.K9:C)K<0IV+!J2W(JJ\?
MEG$Y+D"J$*LKVJ`L4I^LG4VY;<O%YH-I4"4V9:DURUN*TJ4E6*&4!8(*$^IP
ME:AB"G,`S:JZ!=(+3NO;^W[GOBYK5?VT+MS;;2-:$+3Z5U#A04D.+]+0#:#@
M0O(J$L<KW]MS(]3Z=V5J"IU%CM/L?&4OLFR?=.9EC]!A\U^)6/5]#$88=A3+
MJ=.?=F^+@_TQ;A*I(GR#RR[GO?=-?MG:NX-JTUK8I:^GYCKU>_RFF%$(TMI`
M*5.*42Y(C"3>,IB*AM'3O9MLW?O7:^\ZR\U-;;*KE,,6RFYSU2D*6%NJ)"DM
M(0`U,'$EW`G28BW?>RV4[Z]3_=#&,YJ\/CY;J"`WC]A=Z^LW[7"\FAV<R2U"
MM*23(?E..-&_0R"0T<)MQEQLD05\A2O*OJ#<MZ=-.K-NO-/2INEK;#:G*996
MPZE:E!*VR2J8FTHS!D4E)`!F(M>W]+K3T]ZO]#[K8*NM59[RX7D-5B`W4L*0
ME)4VZD!(!`=0)%(*5!0)(D8GWZIFC?J_H%PN_$--Z^->D[7H<5K27I/XKTG+
MJZ:$)Z=;*4<A:J;_`-I,<\]7$E75;J(D9F]U@_\`R%Q6CZAZ=P;WHF;B]B/8
MN#89S.F9]+Q'%<6>R&_J:?$*:'5UEVU%KQH;.KDJU&B7K,9@%<^-/A<=,3>=
M5Q.?>EVU+/UC=W5OK?C3E8\NM+++)=<0AE"4)<`3RUH,DI<2A(G(:5*(4M14
M.HNLN];]T#8V5TVZ:/MT#"+>FHJ'PRTXY4.*<6T5+YJ'$S4II2U&4_4E`*4(
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M4D?"9<)S4%`QCS?_`/+OVD?_`.@,_P#^*Q3FN3_\K^&+_P"R'_LLQLE?_#?C
M%_\`Z)__`&:B+IN=<QPY#B$.(0XA#B$?%9V,2HK;"VGN?#!JX4NQFO=*OQ1(
M3#DF0YTGU7P9:5>O\.>-0^U2T[]4\J3+:%*4>Q*023[!'O2TSU;54U'3IU5#
MKB4)':I1"4CS)$5:ZZV'[@^W,.\VEKO;&)^M^G0R"UI<'C2<*Q_-LBR1JK=^
M!9UN]D+!M1Q5X5`U:<91'4<`63$$,N;[%?NJG4YJLW)8]S4M@VJ'UMTX4PT^
MXZ$&6I9=!EC@2"D:M0""!,]9;EVWT7Z./4&T]R;0K-S[T-,V[5*34O4K+)<$
M]#89()PQ&H*.G22M)5I$JJ;:.5:(TY)RCVHS3'<GMH.4_H-5D6N,?L)1Y8S8
MA%;QZ(WCU5`'X\EG34D-FVRTW&%`%?(4[7EDT>Y+ELO:CERZD7>GJ:E%3RFW
M:5M2B^%!/*3RD)$G5*U@A("``,1%1UVU+1U`WJU:>DMCJ:2D<I.:XS6O(2*<
MH*B\HO.+,V$IT$*4HK,R)'`1_76?MIJK=4_,,/Q)[+,>SK&\:F7\C%\VQBPQ
M2^_2A;;:&WAQYGFV]'9D2V4)$-'1^02\/%?+GWM_J?MK=SMVM5K55,7FGIU.
MEFH:4RYHE+6D&8(!4GC/$&4L8^=T]'MW;&I[+>KPBCJ;!55260_2OHJ&N9,G
MEJ*9$$A*I8:3I(G/"(W^E?L2U1>H=SMO?FP[.;%IMA997.Y#DDR==6K[8I6%
M6TE>"I)GSY3S[QC'CMH1*I+TB"BJD`Z1;\31=+JS<^]KZXMIJO>2775*<6<$
M%+:<U*)).E([3D)Q9O7/IJNX=9:'9W3S;;3;K]MIUAEE*&FP9N:W5GTH0D``
MK69#`9F4Y/ZA]M-1;FR:9A5`]E.-YC%J$R%G&,^Q>QQ&VM,?\D$KJH:L!5B?
M!!2[7P<^1`[/P\$(DL;:W4[:^[+@[:*)533W5+7-#52RIE:V_P#N(U8*3X&<
ML92!(JG>?1[>6R+6Q?+BBDJ;*M[DE^D?14-MO?\`:<*,4+\1*>$YD`XA$][_
M`%ZL<]'`:NWRBW>/*(^$M9958A<V&#/9=,D##A4+&1QF7&79<V:8M,F+:QW%
M)"1Q6U\^:IKK3L5^]"R4U34NJ-2*</(86JG+RCI2V'1F5*P29:3.85IQC=/?
MA^ZD4VWCN&KHZ1E`I#5&G<J&T50ITC4ITLJ((2E(*E`G6)$%.KTQJ/0W[@--
MMG>&9ZQLJ"U@T\G(JRHU9-AXAD+-B^P]%G.SSSS[B1(9H74.,'Q*3;(]*ODG
M2=I&-F=<*3<N\;MMZHHW$4BGT(HU)8="R"%:OF)DAO(2)"1G.)CU!_#K6[/V
M'8]TTMQ9<K4TRW*]*JADH!"DA'RD@"Z)*.J2E'`2SE'WZ2]E,:P#1.RMJ[.W
M)E^V\?HMXW>'GD<[!6L?LZ1V2./,0\=B4\:PD))JXCE@DC[CS``2038-H+:>
M7KL_J#;[)LN_[EW%NJKNE"S>'&.:JG#:VR0UI:2@*,T#5JU3`&HI"0$X^&^^
ME]TW%O\`VQM':NR:*S7%^PM5/)35%Y#H27BIY3BD#2XH(T:)$G0%*42HRVYK
M?W@]>MJ[,;U5B.2VKV1SQL"QV984%A6T.6I5I*.6N-VDD!^\'X8+[C9.-L@\
M+)_&I+TBRG;_`%BV-N;<*=M6NO=->O5RE*;4EM[1/5REG/!*B"H)"@DR).$0
MW<_0;J/M':RMW7FULIMC91SDH>0MVGYFD)YS:?AQ6@$)*BDJ&H`8CV?<[968
M:@]:=F[%P&R:J,MQUC%OT>R>@0+1N(=MF^-4<PU@V<>7`D$5?9NB*.-F(DJ%
MUVB<R^K6X+KM;I]N&^V2H#5T8#.A92E>G74,MJ]*PI)]*U`3!D<>$8/1#:]E
MWGU1VMMK<-*7K-4J?YB`M;95RZ5]U(UH4E8]:$DZ5`D83QB$T??7M=I3)?5F
MTVALC$-P8/[*6&,0#I8V#56*Y+C']QMXR1K`<H6(86+L`<J:)#)'`=-E6U!O
MY!+E0HWKU,VA<.G-3N/<%+=;/?UM)Y8IT,NM<T,STEI*=13SDF9F"4Z9)U`Q
M>KG3WI#OJU]6:3:FV*RRW[:[;Z^:JJ<J&'^27_C#JE%`7\NH2$BD*"@I6DB)
M66OOKZ[TV=R-:R[K(2S.+LN1JM^GCX[)?<;OXEE&IW[`W0=^$,?&SE"R,@B0
MW20O!LD`U2RJGK7L2EO+FWW:JH^]DW`T90&B9.)6&RJ<Y<O6=(5F3.22`95'
M2?A[ZDUNWVMT,T--]R+M::\.%Y(!94@N!$I3+VA)44`22):E`J$_WLCWO]?M
M999?X;:665W]GB!MM9I+P[$K/(:;#WW3^-(]_;,(U$8>`^Q,6E>\'!)LNG!(
M$^K_`-:-C[>N=;:JA^I?J*4@/J894ZVP3A)Q8DD&>!TZI&:3Z@0/G;'X?NHV
MZK/;KW24M'3TM:":9-34(9=J`!.;39FHB6(*@F8(4)I(4=9^S?OKCVIJ33]S
MK,(6;P=EV51;E<G3W4VC<P%Z9/@6KM7,AR*]1RMB;"5L83J*\"B2&VA)TD>Z
MA]:J';-)M:KVZ$5C-P<0YK*'%-FF*E)64*24_;!29<M7J&,TSB4=+/P]W'>%
M=O2BW2IR@?M;3C?+#C2715A*%MAQ*@O_``Y2J9=3Z2""E4C.-Z9![@Z8QG7.
M$;(MIF3M1-D2)\/!\3;Q6U=S_(Y599.5=@S!Q(6_OT^T?;0B-Q0:4'&U0E5Q
MM"F5;U4VE;[#9]P5+U0&J]2DT[(96:ETH64*"6?BP(S,A(ID9J2#`K=T7WQ=
M-S7W;%&Q2EZV)0JJJ#4-BD92X@.(*ZB>CU`R`$U3"I@!*B-:9_[2:_V;ZW[F
MR[6^R\FUA<X&Q60<ELI&%R7,\U[/F7T&/'";AUB]"<,KIL'8P.MO*+:&X0FC
MK)",>O?4>Q[BV!NRY[?W!46ZLHDH2ZHL'YFF4IQ(&IA12?M`"@*"L)J(.I!`
ME&W>DVX]J]3MD6?<^UZ6ZT-P4M;"$U*125B$M+)*:E`4!RB4K*2F:I)!24+!
M/M#[;ZCT]@FE(FU=AW=S8YYJ]G+*_.)N+.PER9FJI8LN3/L:RN.259<WKSHA
M'A-H\1R'$;\NU\ERT]4=K[5LNT6MRWQYY^MMH>34*9*>:$-@E2T))T..'!*!
MJFH@3QG&">CF\=Z7_?+VT=ML,4UONQIUTJ:@*Y!<=4E*$+6$ZVV@"5N*T@(2
M52X1FVI?;[1NY*+.;_&\BF5#&M8KMAFT++JQ_'[2AJF69+Q6TF(\3WR5Z##=
M12;(R`P\3$244+<;8ZI[.W717FNH*];3=O255"7T%M;:`"=93C-/I(P)((D0
M"1/1;QZ,[]V3<+!;KG;$/.71812JIUAY#KA*1RTJ$I+]23(@`@S22`2,`@?N
M`:"G5-UD"L[,@8_3U3=^U>V.MLDBU=[0K?TV/2KG'I"QS6RA5TB\8?D)X@Z$
M5#<0%\%'FD9ZX;)>IJNN*+@BB::#@<52NA#C?-0T5M&7K2DN)4K)01,R,B(D
M-1^'7J'3UE#;@Y:W+B\\62TBM94XT[R7'DMO"?H4L-*2C$I+FE.H:@8__]#O
MXXA$(-5>M-]2;F]OLGV#&Q^UU][`O4$6HK8TU^5,E4[$+(8ES'N(IPXX02-N
MW$0\''%5>U14Z15I[;?3ZMI=V]4;C?&V'+'>RVE"`HE10$N!86-(TX+`$B>W
MA%\;NZHV^NV1T9M6W':EG<>W$NJ<6I(2E+A4RILMJ"CKD6R3-(X"1F8COZV_
MM^YEJK,=[5.<9#47&K=@:TR35^*RZZSF2,F9H[NZ8F1'9L&16QH<&1#A(9$+
M;KC:R5^B>*KR"[!Z'W7;=TWG2WFN:=VY76]VD94A:BZ&W'`I)4DH"4E*9D@$
MC7D)&+)ZG?B+LF[;+T_K+#;7F-V6ZZ,USZ5H2&"ZTT4J"5A:E+"E2`)2#HS,
MQ'C->J?N8]I!GU$E7FF8^G6[)&'MDL/9"[F+N+AE/]WC!"C)L(WW'ZHB(@*H
M]M)\2O>/9KB)Z:]6%[/1TO<J[2G:H<D:H%TOEH/<_3RY`3U\,,/3KEC&:OJY
MT11OQSK*S07M6]2U,41#(I@^6/E]7-F52Y?''U>L(GZ8DA7>K^4X[[;:HVM1
M.T__`"NUSHV/JX`E6#B9(<NNKKFK@E]@W`2*ZV;,QDC<^4?KY?E_!%GE/TXN
M5!U0VSN6B4U_ER@LXI,5'FZD(<0GTA,C,*229CCA%9U/5:TW+H[N_:%>A[_-
MESOZJ[TH')"5K:<5ZRO4""E0"=)X8QE]?HW-8WNQ>[_<.E_L.QTY$P:.`SGE
MO/UQFQKY)_)7_:(R,/XHI*CGS*O:HGCS:L;-O#?5^LWNHL_<J[4*<>H\SF!2
M#\.F6F23CJ\HTM1OZQ.]"K?TZ2E__,#5Z55$Z!RN44+`DO5/5-0PT^<:7P3U
M/VCCF@O;O6U@[BZY'NW--@WV%E'MI+E>,#)(,6/6?K$HJT#@ODXROR"+;J`G
M\5Y%++TSW'0;(ZG[??53_/W>KJ7&)+)3I=2D(UG3-)F,0`91-]P=7MIW/J'T
M;W/3(J_NRQ4-&U4S;2%ZV5**^6G60L2.!)3.,"R[TSW,6,>I<NMK-7[$L=$8
M5.QG*]6[!L;(L"M;*QCN`EU#>8@*,]V*XX)%\K;?YXC!()BA`NBNG2;=OW=T
MS=IZ>W5[]FI%-/4=2M7RRUKG]HDA/J(F)S`Q0@R4)B)%9NMVR!=>L+-557:V
MTVX*Y#]/7T:$?-MH00>4H%?H"@"!I*L''!-)D8_>"^F&YJ+6?N9C-LQK&MO/
M8&+C$G#ZW#9,ZMQ"HFQ2R"PLZAN*]6H]3U-;(NAC15075<!KS5!1>N?=EZ3;
MLHMO=6+?5-VYNLOB&2PA@J2PA2>:I:`"B:$(+@0C`S`GA'S?^M^R+ANGHC=:
M-RZNT&W%OIJ5U*4KJ'$JY*$.%07)QQ8:*UXID52!,6':+PVWUUIC56!9`40K
MW#=?8EC-P5>\<F"ME2TD*OF_:2'&F#?C_<,%X&H"I#TO2<O79EIJK#M+;=EK
MBGYRDH66EZ3-.M#:4JTF0F)C`R$XYNW]>Z+<N^-W;AMP6*"MN-0^WK&E6AUU
M2TZ@"0#(B8F9'C$!\:]:O:OUCSC82>KEGJO(M3[#O3R*/B&QG[B%(Q"P=$P$
M(BUP!\S41IU&$<!\E?C1V4<;0P[6D[?T^ZE=.[Q?!TYJ+:_MFN>Y@9JBM)84
M9REIE/2#IF%'4A*-29B.A;IU0Z1]5+#MO_5>EN]-N^VTX9-11AM0J$"6*M9,
MBHC7I*1H6M>E6DRCU=P^J&]MA%H[;ME8ZAV%O36T7)*S-L9R^B<'5V9T5_<7
M$VNJ8D7[$UC_`-KUEN45IQYA'7S09*NB\VBN9.ZNF>]+X=G;HJ*BUU^\J!+J
M*AE]O_"/MN..*0A(TX<E"R@%29J(#FL+3-6)LOJ]T_VV-^[-I::\VW8-S6RN
ME?IW1\_3.LMMI6XI6O'GK;#B@E>E(FUH*%23ZO\`V][IRK3.^\/N-7>MVK+S
M/\,@X[B$#54.77G)F,S79DUS+;]:T4*"XB-)';;;-&S$B+\>9*=C;NN.U-ZV
MNKVY8+;65U(EIA-&DI)4%%2B\YI^'X=(`,C,G.,/_4?8]IWOT]O5%NS<]VH+
M=7*>J%UZDKTI*0E(IVM?Q#U%941,$`91]H^K6S!OO0RR5W&OM_7'%6Z?8B?J
MLGY#F!C5'6*N/C^G=6;*RZYQ/(U87QZ7KZ_3U'3?<0KNB]1JI^78:8(JO69Z
MN6VG[/T^L32<]/"/$]6=K&W?B#I=%5S-S59<H_LTRTEYU?VWK]!TK&`U8S$6
M+<OJ.:8<0AQ"'$(<0C'\LH6LIQ7)<8?<^)G(\?N:%YW\W]-JWKI->XY^51+\
M@2%7Z*B\P;I1)N=LN-N69(J&'&R>P.(*3],;&SW!=IN]KNK:9KIJEIT#M+:T
MK`\Y11UAM_@NI=.2_4CW5T?LBVK<%SBVO\(NL6KLD?Q[)W);MH]7385OC5S0
MR77`=N)7Q(+[K+C+XBZ`.MJG..;5767;&U7>F/5S9]>XQ1UBW:=QE+I:=*M>
ME25M.-DF;B],E*24J`4$J3'>E[MU_P!X;U9ZQ=#=^VQFIN%`VS5-/K9#S`2&
MPM*FWVG4@2;;U30E04@E"E(4#'XU;D.^='>AXV6`XGD^,S;7V%MOU.XF8;(M
M\BPS7%A10!<RVFQRWB/*:A,A?"$LVS;;(BZ5")'`^=N5V]-G]&3466V5%.X[
M?5ZW%,%;K%*II'VS;2TGZR=(<((29R()"A];LMO3[?OX@?EMPW>DJF&=MMZ&
MTU(;9J:U#JY4[CS:A]56HM@@J$L)`I.4:`<GY/[I.9;6Y1M_9V-S/7S*X,'8
MFT,/?QF7;NMO%YQ:=@:FJ;.C8D/^$=3:%PGE<%.Q0578[*6]<NK)N=/<;I<:
M!5C>2FJJV"TI9$\$`(2"V"9)F)E6H8@"-5U$33VKH<FSU5ILUJN:-QTZE4=#
M4A]+8('J</,<(=($UR5()TG`DQI2MU9LB_\`V]\6*EQG+'9&$>T%CFV0T]74
MRER1O&XU-)K'[NLJ9$8CG.UDN:"HBMF"(I$2>(%R)4NW+]6]#K>JDM]25T>X
MU/NH0@\T-!K07$((]10I780,2<`8G-5NW;%O_$==1772C#=?M1%*RXXXGDE]
M3H<#2W$JDD+2D_6!.`&*A$F--U.N-O[D@Y5CVW?979NS:K6F=X[4V&QL%BX_
MCF/,6N/7$+]&OK]JDK$8>CS;PS9::-T%D%]"Z5>["VI3V#=6ZV;E0[GW!<=P
MMV^I:0JJITM--!;3B>6XZ$)D0IPE(!(U'.*MWM6;FV9LE^T7+9NU[5M5ZZ4C
MSB*.J4\\\6WFU<UIDNKF"EH!2E!)T#*/L](-VT^GL(Q3U>S?46R(NVF-HO5M
MC`C82]*J>KO+8H,YW;7#BA'8K<;;,2=E='XLP0-HB'Q4?;H_N^DVK:+;TYO&
MV*].YQ<BE213DH^T>2!4K6<`EKBO'TM@I)$I>'7C8E;O2^W?JO8MXVQ>SE6D
M+0M54$N?94ZITC;8F2MX@A*,)J=*5@&<\TTGFK6J_>;V7PO+L9S.-/W3EV+2
M\$L(F-SI=).A0:^R>D6$JT%!8C5P-S![?3S;$A,25"'KFVVC>$;;ZR]0+5=+
M?5I?N]2R:=26E*0I*4J)659!`"OBQ`D09$1H]]6)>[>@?2Z^6:Z42J>QT;Z:
MM"GDI=2I2T`(2C-2R4GT8$@@B8,XAU(Q?)D_;Q]@:Q<=O4LGO;>?,9KUJ+#[
MYV'W@C7W343[?YW(WRMD/F@J/D*IWVB\J@V^X#H5O2G-"]SSNA2@G0K44RIQ
M.4IRF")RE/"+K1=K7_N1Z=U7WE3_`"HV<A)7S$:0K_%G253D%2(,ISD08G-[
M$XJY&]C/VZ7J''7&(E-;9G6SG:FI-N/55<*IP#]/@RSB,(U!@Q0.3\39J+8(
MKGBB?FY<F_+:6M]=!ET5`4H:=>0HH1((0E-+I2=(DE*9KD#(#U2XQ0?36[)=
MZ:_B61<+D%//LTRTAQP$N.*<J]:DA1FI:B$:B)D^F?"-P_N&P)UGZ=[DA5L*
M7837F,(5J)!C/2Y3J,[)PU]Y6X[`..FC3#1&72+X@*JOT1>2SKJR]4=*MU-,
M-*6Z13R"023*K8)D!,X`$GL`G$+_``W5%/2]:ME/U3Z&V$JJIJ4H)2)T52!,
MD@"9(`[20(PWUQ]+=7T%?I[;F3S=B9QG=-A6*V]#$V+E,VYJ<&MIU%6RW6\?
MH78\4*XJF22C&:=^08I`!"*.M@8ZK8723;M$SM;=%Q>KJR\M4C*VTU3REHIU
MJ;0J3;9`TZ#/0%3""`0`I((W74SKCNNXU.]-FVIBVT%@?KGVW54;"6W*IM#J
MT@O.@JU\Q.*U)TE8)!)0I23A7I)BKL3V2]]+VVQUZ-(D[C%FEM[&I<9<?K96
M4;'G2FZN=)8%78<E1B/.(T2@?3)+WT"\TW1^VJ;W_P!:JRJH"E9NLFUK1(E*
MGZM2M"B,4GT*.DR/H)X1ONNUW0]TP_#W;Z.YI6VFR3=;0X"`M+%$A)<2DX*3
M]HD:A,>L#ZT1HU/L5CU7H?:?2VXM?;`MM@9]E^8SL8E5.'V5[`V3%OZ1VNKD
M9M6@5MZ.ZZ_]P1*I"(2S_P#BH0+7VV;\CIO1=2-H[JL=:Y?*ZJ?+)0PIQ-4'
M&RE,E\02=4\<%GZTQ%H;OVTOJU<.DN^=E;CMS.W+=14R7TN5*&ET2FG0M<VR
M9@@#0!@26Q]0A4?'G.J=BZN]#?5X<GQ2_.PU_NZ!L/+Z.#`?FV^-X[97^5W$
M=)D%M/ECO)'GL_,)>*,R'_`U1>^>5ZVU?MN]&.G7WC;7N=0W<5+[:4E2VFEN
M/+&I.8,E)F#+2I4E2,>]@W=MK=?X@NJQM5WIQ37&PJHZ=U2PEMYY#5.VK2LX
M$30K21/4A&I,Q&;^UUS/SS97J_[38ZYN'%-/IC>8TL_,<.Q(W<]P27]W?US5
ML_CMC$GMP(M[]T"`ZZV7S0FS(%1SXN]QU+K7KU?^G?4B@5=:;:OR[[:GV&9U
M%.H*=2%EI84$AR8D2/4V"4XZ8T/2&AI]O[8ZK=)KDFRUF\_FJ9U%-4U`%)5I
MTLK+8>0I!6IK29I21I=*0KTZY87:8K@5]Z_>Z6=ZVRS>NT<DS#&=9LY%D.Q\
M(7'XN0O1,N8**_CP1Z>LDW4ZOBUS@RR^%/@;4%7OY%7FJ?MUDKMD=6KU8+G>
M;C7U5-2AUVJI^4ETA\2+6E"2XI(0=9T^D2..HF-Y2W;<-OZB]#]O[GL]@M-L
MHJJM++-%5<Y3(53G4'BIQ:6DK4L<L:O69C#2!&;S<3M9NW?VOQFXU82H-3K.
M(ELDJGDO1:V7"H*Z2TEBCL<FH<B+(:!Q$=\2`Q1?HJ)S9N6VI=W/^'8/4"U-
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M1-1<<*&5)"0C0ZLE$D%46M<*!TOV'?%;M/;])US%>Y\NTW6-*IJU!IG-=4^`
3[I0&FPM]"U++G,90D+FX$1__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g309840g10d26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g10d26.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0N64&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````.@```/$````&`&<`,0`P
M`&0`,@`V`````0`````````````````````````!``````````````#Q````
M.@`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"/D````!````<````!L`
M``%0```C<```"-T`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``;`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#I.BV_\[^J]1SLV;.B]/N.)T_"D^C:YNU]V;EUZ-R]_P"B^S5W?H:*
MW_S7K?IEI=9Z'Z..R[HE?V2X7T?:*L4"MMU'K5?::[*V;:][:OTC+]OVCV>B
MRSTK[M^1_B^#NCY?5?JQG#TLVF\Y5`/%V.]M=+,B@_GM_0?I/]$]_I_35KZ^
M=2ZKTFG"R.G=1=BV9>55B>@ZNFQFVS?ON8VRKU_49[/\/Z7\A)3TN3G8>)Z8
MR;F5.N.VIKB`Y[@-Q;4SZ=CMON]BA3D=/ZIC6BBUF302ZF[8Z8</;;39M]U=
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M*TTY65758UHLL:YP]C"=HNN_T%/_``MNRM5^H_63I>!EX.);?7ZG4'$L)>`&
MU!EEWVISOH^ENJ;2S]^RU8_U!`S>D=3'4&BS-OSLJOJ;'ZDOGT_1>#_@VX_I
MULK^AZ:AU"O"K^M/U.JZ?L^QT#J%%(K,M`KQQ5L:?Y'I.8DIV6]=HOZUCX.)
MEX-U-E3GVUB\'*W0VRGTL9F[=4ZKWN_U]0X^L/0G"TLZAC/%#A7;LM8[:]V[
M94[8YWZ5_I6?H_I_HUC]7:W_`)^_5]P'N./G!QCL&U;?=_:4.AT4.^OOUFO+
M`ZVIF"UCR-6[Z7>HUA_-W^E3O22])AYV'GX[<G"OKR:'SMMJ<'M,:.]["6^U
M<JW*?]5\6D]0NR.I]7R6E[JK,ASJZF^`WNL:QC?YOU/3?9?9ZG^#_F['U'!%
M_P!9`!#?VUDD:0)+:=RSOK)CNZY5B]=Z2UV9A9-`K<*P7/86N>?=5J_Z5EE5
MK/\``VUI4+OLN&248RB-IUQ=_3_Z,ES/K%3U+!M?=7G=/ZA4!]G^RNNVV3QN
MV-JJVM_PWKL_F_YBU8?V_KG_`')SO\^]==TCK77;_4RNIX]6#TS&8Y]U]K7U
MO]K=TL;:_P#FV?3LM>W8J_UJ^MF?TC+QJL*NFRO(I-I-H?/TMH^B^O\`-0,@
M!93APSS3$(5Q&SKIL__0]*S^E=/ZB*_ME#;74G=1;JVRMVGOQ\BLLOH?[?I4
MV,0\?H72J+_M(H]7)`VC(R'/R+0W]QE^6^ZUC/Y+'J^DDIH=1Z'TKJEM%V=C
MBVW%)-%@<YCV[M'AKZG,?L?^>Q"_YL]!&2[*9ALKN=6*2ZN:P&!KJF[&5.97
M78RI[Z675M];T7OJ]3TUJ))*<._IO3^A].O'3\*D8EH#,C&=N+'[W-IV^D[?
M5M<VZWUO9^E4,/!Z;TS/92<=\8E+74W/NNOKH#S=1^B9F66,PV>E3Z?Z#_!_
MH?YA7?K#Z?[*L]3T=NZO^D[_`$?YQG\YZ'O_`.)_X?TE')]+]JG=Z.[91&[U
M/4_G+HW[/T7I?]Q_^&];>AK:X&-:AJ.QNA=0R1GMQ,IM^6W;;=3Z^-ZE;&L?
M6_)]%^/]JK].UC*?4];_`$'YEM:;-/U>SL?&Q\C%>*<1P=CNJ#JOLYJ>W$W5
M7XCZWTMK<^O^CV?S'O\`YE)OH_LT;?L?]#OC?ZOV?^:HW_3_`.\[_P!T_L_H
M*HSTOV@R/LVV?;_.>E/KX7\]N]_VS;_I/T7VK[-_A$M4_J_%([$^J#7-SOL1
M#L3U!1>&6`@8[?6M^RNEOZ-S?4]U7LR+/5]3])8BX^)]7Z,ZS-IPSCY%AR6V
MWG=OM](BJX^HRQV]KG/_`$/K?]:]--U#T?V8[=]BC?DSZGJ^CN]/)_<]WH?^
M6'^`]+[:B/\`1]>R?LD[LR?YW]RN>/9NV?\`*&W_``GT/TWJ):JN'8IND8'0
M<'/LKZ?B_9,NRH6WM,@N:YWTK0Y[O6LWM_G_`-)_QR\?Z/UWK'176.Z7E.QQ
M:XFVN&OK<0?I.JM:]F__`(1FRQ>SXWI?M(;/3GTG\^IZL?JVW^=]O_AW_"_T
M+U%YI^K:_P#B-Y/^G\45IKHXG7?K)U[K.,^KJ68ZZEK2?0:&UUDC5KGUU!OJ
M[?\`A=Z[3_&#_P`H8'_A4_\`5!8SOLVT_P#B-_\`!UU_UL]/[1B[_P!CSZ.G
M[2]3=S_@/2_P*9D^7>FW\.D8\Q$QB9FI>D&(_1_K\+__V0`X0DE-!"$`````
M`%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3
M`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``-@`N`#`````!`#A"
M24T$!@``````!P`(``$``0$`_^X`#D%D;V)E`&1``````?_;`(0``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("
M`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@`.@#Q`P$1
M``(1`0,1`?_=``0`'__$`,````(#`0$``P$````````````*!P@)!@L#!`4!
M`0$``@,!`0$!`````````````0(#!`4&!PD($```!P`!`@0"`PP(!`<````!
M`@,$!08'"``)$1(3%"$*(A46,3:VUA=7=Y>W.'@Y)#75EC=8&1ID568803(C
M,R6U=A$``0,"!`,$!`<.!@,``````0`"`Q$$(3$2!5$3!D$B,@=A<3,4D=%"
M4F*2%8&Q<B-SL],T5)0U=3<(P196%U<88R0V_]H`#`,!``(1`Q$`/P!H;NU]
MU6C=M3)8Q5A&1U]Y#:4D]0R?-WCE5*-;M68@C)W^\*-%$GK6G0BYRI)HHF3=
M2KTP-T3)ID=.FL$T5FMU>I4CXG]LC>><M6@>3G=TW'7=.7TF*9VBG\/X&X6'
M+\BH=7F4@>Q"%VJM)=5WTK"YBU4!.P9>R7;I@!))R^<BH1!3BI+@,&K1)SV;
M.V\1F"=6XV0^9S;<J1HJ[Y1<]&S>_0;IOY3-7T5<:G;HR<3<(+$*H)55545C
MD`5DU`#PZ44:CQ65'<'Y(\\>TQC6I9_-WZ]<F^/&V4BTYUQFY26681;\C^.>
MMSL&]3CJUJMP8-V"6@&;PZ+V3@I\4F\J=TS.)S_T<J(LE(`=ZTQ]A,K)3N(8
MW.3+YS)S$SE6>2LK)/5CN'DA)2-1B';Y\[74$5%W+MTL910YA$3',(C]WJ50
MYE2KT1'1$=$2B7S)F+:=B>6UCDS0.67*U&$U7<6V:W;$93;K.IC,:$_1;;:X
M)Q1:)%GB(ZNMH\*"[2<(JB\*N+HA@$AB&%2"LC#V43$G;H_E\<$OX-N,/[$J
M/U*H<SZU<GHH1T1'1$=$1T1'1$=$1T1092>3/'[2-.NF,4/7J);-4SSWOVTH
ML).M7L_`#&/D8N6*Z:IF$%#PTHX(U?`D9063HX)+^FH/EZU(K^RGN);6&Y8Z
MX9XF@XBF!^`X'@<"NW>]-[_MVV6>\WVTSQ;7<4Y<KFD-=J&IM#])H+FUIJ&+
M:C%3GUMKB(Z(CHB.B+*3O';]K_&[B3&Z%B5V?4&Y+:_3:ZK.1[&'D%SPLE"6
M]T^8"A.1THR!-PO'(F$P)><!3#P,`"/CYOJF]NK#;&SVDQ9+S6BHH<"'<0>"
M_J#^T?H7I/S#\U+C8>LMF9?;0-IN)1&YTC1S&20-:ZL;V.J`]PI6F.(R50^W
M_GW=3Y*5Z#V#D%RZT'(,@G6Z$E5Z_$4O+_RGWR(6\#(R[<LO0W492J\_1-ZC
M-V[;/7+Q,`4(T*W41<GYFRP=1W[&75[N<D5J<0`UFMPXXMHT'L)!)X4H5]7\
M]M^_MC\NK^]Z3Z#\J;#=NK('%DTK[B\]SMI!G&>7<A]Q*TX21L?&R,]UTID:
M^-N[J#VMYI7XQA:K[]`H&1+8M"LD4WDYAR7P,JHN[7")CSK^!@\4VR**1`\/
M`A?'X^TC86,#-3G$=IQ)7\*[C>C<+R:[%G!;L<<(X6EL;!P:"7.IZ7.<X]I*
MYW0J<]U6LIJ478+CG+Q=JL:(N&<O:Q+-5S&$005<,+%#62!E6:2Y1\WI$06.
M7Q*"Q?`HER##,+1/K2Z_,O3.Z1PUL38EIY#3ELSF?>KM*AI<+4J2A%22J13+
MEB9Q@I5W"M:LOM"BI[1155)8A#F;K+E25$F5H8[LQ6-Q>WMP5(O]3KG;_F&L
M?]W*'^*G5]#>"KK=Q1_J=<[?\PUC_NY0_P`5.FAO!-;N*/\`4ZYV_P"8:Q_W
M<H?XJ=-#>":W<5__T(+G]$6[H7?>I:MR`U@S>P<HH*D5RNNTSN6`X'C5@=NT
M((60D5(V;VBIU=X^D"``IE>2CI01\!$W5>U9LFKT;.K+"CHBI)W&^+Q^9'"G
MD%Q]CV$4_MMQHKUYG'UNHBU:-M-JZJ-GH*II-8IOJ=)Q9HENV7=%_P#;:.%0
M,!DS'(8I!H059;'ZU*4O),NITX1%.:J>=4FM2Y&RP.&Y)2"K,9%R!$'!0`JZ
M)7;4X%.``!B^`_\`CT4%<9O_`"?X^<5ZHVNW(;7:5DU=D'2S&(<VR63;/[!(
M-T0<+QM8@FY7,]9Y-%N(*';1[9RN4@^82>'QZ*0"<E3M7O)]N)A)Q$78N04C
M1C3[@[6&E-*PWD3F%7D54Q2]3V]QT/):S4S)$(N0XJ"]!,$C>?Q\GTNHJITG
M@M(Z[8Z];X*(M-3GH:T5F?CVTM`V*NRC&;@IN+>I%79R41+QJ[F/DH]VB<#I
M+(J'34*("41#J55+>?-1?R^,=_C)SW]B7(;J"KLS6R?;H_E\<$OX-N,/[$J/
MU*J<SZU,&Z\C<*XR4TU_W[5:7E-3%P#)I)6^9;QZTQ("`'"*KL4459BRS`IC
MYP9Q[=RY%,!/Z?E*(@0`G)5*KG=P[>5CMT'1U.13*E6&S'%.N%U[-]BPZ%GS
M@JF@`0UJV3/:)5I/SK+IE+Z+TX&,JF`>(J$\RJ:3P6CA3%.4IR&*<AR@8IBB
M!BF*8/$IBF#Q`Q3`/B`A]WHH42;5ON*<<J8XT+=]2I&3TQNK[8)Z\6!A!-GK
MT4SK$C(E)VL5W-RZR:9A39LTUW2H%'R)F\.B4KDJ317>.[;TH\A6ZW)%O6&-
MC=G8P-KT+*MOS#/9A<GJ>(QVF:+FE6SUVW,1(QRK$DQ1.F'G*82?2ZBH5M+N
M"O)H&W9!E>6R&W:'I--J601<?#2K[29:>8)4U*-L<C&Q%??$GDUE&#AM.2DP
MT;M#IG.#A5RF5/S"<OC*K2N"6>H'>9XQ\@>\)"W!WJE;SCBEA'&#8<YH&EZ=
M(EI$3>[_`'RZ9?*VJQ1S>Q%CG44QGV=08MHYJZ33>K-XDSA4B8J^@C%<5DTD
M-]*8+I7.7AKHM6LMYI?*3!IVETV1AH>V6UOJ-00K5=EK"E(+P4;,3CV5;1K!
M],(Q3DS9)14IUBH*"4!\H^$JE#P6:7#ZM]I2![@=_NG&'DHWU_D[L,7I5H^Q
ME7NJ.E9O68^6EVMDT&1JUBIM1-76!G+DX>1.5L3X_HJG(U)X?^7B6>PV%EN%
MQN4)>9Y-6!(+1J-304!Q])/H7O\`?/,?J3?^F=MZ5OVP#;;81@.8PB1XB;I9
MK)>6X#YC&5(!-5JIN7*_C-QF;,G'('>LGQ\\HS=2$-'7Z\U^O3L\R9*%2>.*
M[77SY.>L)&RIRD/[)LN)3&`!^(@'7;7@`"<@N.R3G3Q'W'$K3R0SG=J6^PND
M6&:JMNT^RGE,\JU=G:^G%K2C25>:+&U11JDFC-LSI.#$]LZ(Y2%!10#E$24(
MPIBJK07?#[55BN:-"CN85+2G7#XL<D[F*?JM<J`N3J)I%,?0[#0HN@)-!.J'
M](-)E;^'B/G\"B(14*=+N"U29/6<DS:2,<[;/X]^V0>L'[)=)TS>LW21%VKM
MHZ0.H@Y;.4%"G34(8Q#D,`@(@/4JJKWR3XUTKE!"YK4-%22D:52==K&ISM<<
M-R.&EN+48:S(QE;D"*>9$T0]FY=LH^3.0Y7+)%5N(!ZOG+H7]A%N#+>*<5A9
M*'D?.T@T!]%2*\14=J^@^7?F)O/EK>=1;MT^\Q[S>;5-91R@T=!SY(2^9M,>
M8V.-XC((+)'-DQTT-2^YKSF><0\Y@ZSG1H\^S:21\G6E':"+UM3*W'`FA)6]
MQ&JE4;N7GN5R-HQ!P7VZJX*J'*J1LHBITF-U'T+YX]Y&)Q<4HO=+S<]&L+ZV
M7ZU3]RLTD<QWT[995[,2:_BHHJ"8NWRRRI&Z9U3>1(H@FF`^!2@'PZSTIDL!
M-<U+O'3E'LO%VZ,;?E=K?1R!'B*T]47;ARYIUM9E.C[F/L,%ZQ&K@'*"`)E<
MI@F\;A])%5,P`/4%H=FI!(R5E>;?<BU;F$"=11CR9OCK-=F]3H,:_&2=S\HR
M\JB,K;YX6K%25%NZ\5&K-))%FW'R&,59=,J_4-8&^M2YQ=ZEG'U=51T1'1%_
M_]&@_9,5+!=UOB`G,`K'*HZ):8A=%V@LDNA)O<YO$0W9+H"GZR+@\FY(B)3%
M#R''Z7@`"(5&:S.\)7IX=66%1[JN@_DKS^RW_P"Q&A:/]FVK9S]B<JK7VOT"
M>]S(,X_V]:K?O8[ZT=-_>>NJ3UD_(W24/XCY?`2+%72OF)N%6,VU]0M>R#F=
MEUWC4FZ[^H:%@S"G61HV=D]5FZ6A;!?8^1(T>I?315]/TUB?2(8Q1\>HJK:"
M5;/B%W4,DYM6&LQV,8!S$3IEI5GT&NUW'"%H+#6#FN1,I*/6LEIC:S2L(1VL
MO%^P221]=09!PBB<I//Y@FJ@M(S4)73M>:-K/=SJ_/[7-=KERP?)JS%?D6PU
M^PEG\K4K9&T5O7T2'0?-QKC.):7Y](6]%\V6%Z,J#5,R7D2]0(IBIU4;09J=
M.[+HG%>"X2\AL]Y+7C,H0V@8YH#'.JG=)2'&SV#0RUJ6&@/J'6G`.IR2LD1<
MD6J[-RS:JBS<(@J<Q"$.8!1M:X+-#Y6J]6FR<%M7J<[+NY2$SWD9/QM-:O%E
M5P@(B>HM%L,A#1_J',1O%GL#UV^*B0H`#EZN?XBI\`4OS7R_-1?R^,=_C)SW
M]B7(;H49FMB^WF[;,.W;P<?/5TFK-EPNXSNW;E<X)HMVS?#J4LNNLH;P*1)%
M(@F,(_``#J54YGUI5KA!RVD>?W=4V7FAKV%[AR2S_!(%TTXQ99EU-@KLPQ5&
M8MI6V<6B3@+/::O',Y[[.P4B]5>@"JZMA<>Z("/M&A4:]JN11M`MB^Y5<Y#F
MYPVV3!FW;UYIRM[G(#ZSR>3M6.YVU:U;2X=PB^K,ZC-IZN]D(`GK)&:O'#4A
MU5(]RX1,15-4Z1Y*JW`UJN\[*DKRVRS@U,4#G=1+SG$OQYF9J/I<[H8)J24G
MAS&N,I^+(LZ3?2#E\2CN22+!(3B'HQB+-`@>"70(ZE<%DUVL+3*=Y#N5[[S&
MY)LPMN7<6X>'#CWB]@(A*4K.'>AV.Q)9RLK!K-30TM-PM<I<F\>/%4@7=SID
M'8"4K1NDD&)5G=UH`3-_-;BY6^:'%W8N--GDDH)IIU8&.B[*I$MYP:K:(Q\S
MG:I9TXMPLT!Z:#L48V7,D1=NJJD0Q"+)&,!RRJ`T(*B;MU<)7O"+B'4>+EVT
M=+="5N;M<J,W)UP\7!I,K!8UY]E7XJN2LO9/:Q40LH"A2F7$IG1U%2D)Y@*!
M":FJ6-[4]>@)#YACN`0[^#AWL0SN/.8K2+=QC)S'-2M>2<:@U*W8K(';(%;(
MCY$P*4/(7X!X!U49K(?`$XG>>/V#:?63TK2L2R+0Z:K*,IQ2I7G-J;;:RI-Q
MB+QM&S!X&?A9"*/*1[>0<)H.!2]9(BZA2F`#F`;+'4\4FOVP<PJV,?,5<B\N
MH]=2J-+ILIRCBZC6&Y52,X.L"Z3=P,;'$6,=4D4VBW*16H"8W@V\GQ'[HU&:
MN[%@3.'='X]Y#M'"3EA+WG(Z!?[S3N+^Z3.;6.Q56"D[74K5`9U9;)5WM3LS
MYJ,O7G+.SQ[=P46SE%,YR^"@&(8Y1L51IH0EW_EJ>*-(WW'-'T/:WSW2<^R#
M?G[K,L"LC=H^R2'U>:SND%L6T6&M+IJL[I=2UIG&1D-]8D5:P9&[EPW3]RZ!
M5&`KO-,EL+W^,6RV]]L;>;;9J17I"UX[%4NQYA9S1;,D]1Y!31J5"/TZ])E1
M]S'QTQ!/EF3MJ00;KH'#Q)YTTCIBJM.(7Q?+T:).:!VM,10L$A(2KN@6/3L[
M9O))8SA<(.$N\M(5Z/174555-'P<),H,&I!\H(-VQ$B%!-,G09(_Q%;:]2JI
M2[O;_7/_`'APWUD(C'_D6IGV>^"X%"+^T-T]T'BJ(I&/]>>[$12\"^'@`_2\
MPCGC\/W5AD\7W%3/@A)5V'Y?X#)VU_"Q=;9WQHM+R%B=,64(U:`Q?`962=R2
MB3!!L!A`!,J8"^(AU9WA*JWQ!.)_E?XE?G1XZ_WVS3^T^M?O>E9ZMXA2#55,
M@O<<K,4<^;7*(0>*1ZTK535BPQR,@BB@X68JOH@7C9-XD@Z2.9(3`<I%"B(>
M!@$6(S4X')?IS,3G-<B9&>L,928&"B&B\A+34RR@HN)BV#8@JN7LC(ODT&;)
MHW3*)CJ*G*0A0\1$`ZJ][8VN>]X:P"I)-`/65LV=G=[A=6]C86LD][*\-9'&
MUSWO<30-8QH+G.)P``))R4,_EXX9_GFXQ_K$RK^V.M3[2L/V^'Z[?C7K_P#;
M'S)_X]WS]PNOT2/R\<,_SS<8_P!8F5?VQT^TK#]OA^NWXT_VQ\R?^/=\_<+K
M]$O_THB[D?'FZ]J/NOU/D/`5Q\OCTYNT+R>QY\@A_P#%2<>UNT?;M`RHCDX@
MW0?5>4<N(SVYUO<!$.F+@YBBX`0J<"LS3J;1>@]FNCTK7\^IFIYQ8&-JH>@5
MN(MM3L,:IZC25@YMFD^8.2>/@HBJ**P%524`JJ*I3)J%*<IBA98<EV_1$BK\
MUJXKI^5?&=LU.R-:V_'Z14G"IE_IY(%?1;%]F0=G\O@+8SY*5%`OCXE-Z@^`
M`8!&I65F139W;1AHN"[=W!=E$,D6#1?B3Q[F54$`$"*2ECRNK6&<>F`QC#ZT
ME-2CARH/W!45-X``?#JP6-V961O,#N<[UO\`S[@NU'P%FXO-+2ZL+VL;CR?D
MH]*:F*2C7X%W:M)CLTA'Q2Q;21I=;C7391^[`Z[R:_HC/V8ID?+17L5@T`:B
MKPW;@#QPXN<0N65LK%7>:#MTGQBW4URY);%).-+WN[22F3VU!](2FB687LK%
M(ODU1*=C%BQ8>0"AZ(B'F$HJ21P6;ORI_P"YUR*_B76_9;G_`$"L_,+L_FHO
MY?&._P`9.>_L2Y#="H9FM6^&E:>7/M8<4Z?'.192%K[?V&5IB\*;R&:/)WCI
M5XMJY*;SI^44%W13`/F+X>'W0ZGL53XCZTL/\K!/A1^4',7$[2Q<0EZD,RK<
MLM#R7F:2#!?*;\_K-KBG+)1+S`^8R5^;E5()RG3%(P>4P>825"R/R"=YZLL2
MA'D-67>GX'R!S*K/&RUIMN/:51V3=%=)5PQG+A0IF,A2.T2+$4;'64DDE"`<
M2"8A@,`^`@/12,PE'?E.[=&PFD<X<LD_,SMMAJN)6YI&.A,W?DC<XGM0KME]
M1BJF58#,)/28Y-7S>44CJ%*(>)OA`5W]B=0ZE8U^8SFH:0?RT4PEHQ]*0"S1
MM.QK-^U<OX5P_9(R3%"69HJG<1JSV.<)N$BK%(91!0IR@)3`(D29?:PBW,1\
MQGW!&CL4A56L/-:4)Z)A.3VTYR!KTTR`1,4@@J#.03`X>'@4_B`"(!XC':LA
M\`3H_4K&DR.$LHVE_F<N5CMH"H))2/(B+-ZQ0(?W,)$0L*\$`*8X"D+R/4$@
M^/B8G@(@`CX!':LA\`327.61:0_"?F%+OU#),8KBUR"D7JI2'5,FT8Y-;7+E
M0J:8&44,1%(1`I0$1^X'QZE4&86"ORI_[G7(K^)=;]EN?]0%=^86E_?)_E3<
MP_\`\93/VL4#H<E5OB"K/\M9_+!JOZ9==_\`MX_H,E+_`!+4GEKRWSSAU7\C
MO6KN6\1GFA;G4<9LEM>.0;,:.6\5ZXN8:UR9SE]$L*RL<"S0D%5#IIM&#A9T
M8P@AY32J@55:NYMP:>\N\Y@[3G!6'Y9<U1D%:RW<KMF36[UN2!)Q(U!>37,D
MW:O?<MB.(M=PH#5)<RJ9S)$<G72NQVDXY+&]NH89I1FYT>XYU8I"I7VKSU.L
M\6H*4A!62+>0\HV,!C$`YVCY%%4R*HD$4U"@*:A?B4PA\>L^>2PTIFI&PGCE
ML?)*WM:;D-*E;,]4703DY8J"K>LUEJJ<H'D[/8%$_J^'8H$$3?3,*RWAY$4U
M53$3,)`%2I`)P"<;Q^C9-V^.*D'`6FTL(JLT=NT<7&XOQ*V^TU]N4RRCA]D@
M;RJKOK':I9M%P[,/,N<#-6P"=3XFUG&I)6=K:`!?SN'_`+BW+/\`0-H_X./>
MN3OG\'W+\B[[R^O>07]:_*W^>6GYUJ\[WKX>OWW1T1?_TW9^5/$O!^:&23&+
M<@Z0RN-0DC@]CG("5G9*A/I(K(,;53)]-,[RO6-@1<Y2+I>)%D3J(+D6;JJH
MG*02,0L8,"X"=T3MD/WM3X8[;D/+3BL[F7L@QP#D@\L.=7.EI2+MT]5"BVV"
M:3E?C7JBR_F?KE4:1KUP<[@(8BRICDC$*Q+79X%7C<[EW:KG"KPU2X$\<<6M
MKGU6K>[;#S)/H](B%BJ&(234J&4XZTM,]'J(B4Y4P>QZY3@8ABB``<S%11O%
M9\R7R\S/D]J5FY"]Q;ESIFW;#=/;'D(O&86MY91:RU8H$8Q-5@U;#%7:0=U:
M"CTP(V(V:0JAE!%58%53+J+J*==,`$P=C^85O$<ER[%Z:>35J&19U2<PJBLT
MZ2?3*E;H-:C*I!'EGJ#9D@\DSQ<2D*ZI$4B**^8P$*`^4)5,TL-R-[.O.S&>
MY-)]P_M[6_)+&^M&D634'E&T^7=U]Y$3^@,I5#3*W.-_9)P]HH=N&:?E*LW?
ML95J5^!4R%6;$?&BBR!P(H5J-*\/>:/-"G/:MW!=PI&:9A,0CUC)\<^%![A7
M(NUNWK<Z+=QK&TW1RO=K'%1@G]4:]#H1<2Y7\`=K/DDRE.5:@9#%9-\-.U9W
M:.(D!OO$.B7_`(^5GCOR#MT6%LY*Q-GN2.LU*G-40A[!.9/7(P\>Z@K[::4H
M+(J3TATV#\@&1D"%(1V90JQ<TT/:K3]UCM\]S_N-5R)Q*'FN#>><?\]UF4OM
M$.]T3?7FF6=K$L;/4L]D;TNIBTW#1,PTI5F<B_9L5GB(R#DXE=K$33,(U4-+
M1QJK_P#;AR;N`<>\PSCC_P`JS\3;!F&.Y%&9]1KMB5SV"7T:27J*E>@Z1&V>
M`O>;U2LIP["DMG2+AZT>`L9PV:@1J!#JG(4&AQ"I9R\[1NL07,6*[D7;>O%%
MS;DBVF'5@T/(M)1E&F3:[(2K-Q&V]XM(0`&=1#Z]Q3E0DNT42(WD'RGU@1XP
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M,L=)!Y8^5F8=:!DW)&<C-(LW*"IBG,R/X>`,54:0:XJB':/[=O<S[:YYO-)V
MP<(;_@FC:)"7.^#&W?<1TVM'291\#/2-&,XQB"K\P[>5^.1*FQDE44!<H$,#
MA$IE04#!2X@\:JW7=*XX=PGF+D^E\8\`4X>UC#]-AZBSF[IK%SV1EK!#0T_%
MVB6CH^"JN66JG,&CF4A&Z2;H[ITJ9H=4/125$BA!4-(&)K51/VCN%_<9[?\`
M3X+CMK4EPQNO'%.W7.X2-CH-RVMSM$&[L4$Y50CX:/GLIK-)L$<O;V3$RGNE
MF2[5FNZ,51P8K=`H(X@XXU45_,]_RW(/^)?+_P`%-*Z')2SQ+#+M?_,-Z3Q)
MJM7P7E%69[<<+K;=O#5&W0C]N.OYM`HF*5K#-PFW+>*T"L1#</19,7CN/=,4
M/*DD\,W11:E@%6<RN(S3-=:[TO:+V^OL9.>Y#9TT,B1)PI6]AH-F@YB$=K)B
M!VXH6:I*Q;ERD4PE.K'.7:'Q\`5,'5J^E4+#P7!;!W_.UCQ_K3AK1M.<ZY*L
M$!-&4'"<^F5$5CG`A42)V">CJ?GC-`3&`51+)&63(4P@D<P%(:*H&'@E1^6'
M=SWGN3\JN/47.M$LPP.H[SG$C1<9@9-R^:G?FNT2@WM=_F#$:%N%Q28JF115
M]NW91Z*BA&J"9EG*KB*U60-`!XI[?N'_`+BW+/\`0-H_X./>N9OG\'W+\B[[
MR^K^07]:_*W^>6GYUJ\[WKX>OWW1T1?_U'^.B(Z(CHB.B(Z(CHB.B(Z(CHBA
M[7\YLVE%SJ.@M%MF=PT#H)++?#TJ86K\];ZFVH]XB6]/2F&[9PX9,W%SF(A^
MY%,45#H1QB$4(8P>.K<P23\AK)W,8U]7:30N&EPTU_"+2?4NOM&XVVV_:$D^
MWQ7$TEOHBYC=;8WF2-QDTD@$B-LC16HJ\$@A9^8Q5[EH_*GN!8U,;SO[.J8K
M)<?(?+%(_49LDG5/REX2RN%C?"Y<>X+.N?M,[%TB60*Z23\`2\@I>)!XMK'+
M/N.]6KKR81Q&,,H\U;KCU'UXXXU^!>^WFYL]NZ7Z"WB'8[`W5ZVZ=/6%NE_)
MN3&P4%-(T#2=&DG.M<5U_(K0K]Q[F^W.A<M=L@)2FF,\LVQ2&;N'\=JTFEA%
MT>%<*PD?"/K7-S,]H<`U-',F(>N\<NBH@W65.F4,U[--9.V/FW+J&31)3)YY
M;NP"I)<!0#,FE"5I]/;?8;_#YA.L]ICJVV,]MJ(!@;[S&*:BX,:UL3G:W.P:
M&ZM0`*N-3N1V+WFH:'>X:ZIQ]9R27GX+475U@K/F[_/9.KQC:;G$+E`:)"U:
MP5U-G"/47@+.FJ2*S14BR1SIF`P].*^M9HIYF2TCC)#]0+2T@5.H.`(PQQ&6
M*\A>=.[S8W>WV,UEJN;MC70B-S)A*U[BUIC?$Y['U<"VC7$AP((!P7T:CR>Q
M:\.;,P@+'.A+U*B,=/EH">SK2ZC9G.>2:#M9A<JW6;;3X2P7*ONC,542.8=L
M^3%V7VWC[@Q4QB+<+68R-8]VIK`\@M>TZ3DX`M!</P0<<,UDN^FMYLFVTD]N
MSE2SF%KFS0R,$H(K&]\<CF1O%0:2%IT][PXJ/*-SWXE:1&RLW3]=;R%=A<OL
M6S2%H>T[0J_4B9Q4'L=&VV>;6NQ5*)KD@XJ\A+M4)&/;NE9-DJN0JS<@F`.L
M$.\[;.USXKFK!&7DZ7`:6T!-2`#0D5`-17$+H7O0G5>W2107>TEMP^Y9;A@D
MB?)SI`2QI8R1SP'AKBQY:&.`)#BI'IG)?'[_`"5H@ZS,VE6QT^D0^D3%3F<N
MU2JW)Q1;`23&$L];IUKI4+:+G%RCB&=-D3P[1^)WJ(M0#W(@D.>*_M9G2,C<
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M%Y]`2"\8[,B[FEF""B#)RL!A1;+J)Y[C<+2V<]DTI#FM#G4:YVEIR+BT$-!H
M<74R)R!7/VWIG>]WB@FL;0.9+(8X]4D49ED:`7,B;(]CI7`.;5L8<07-%*N:
M#T:FZY>30765DL+QW?FV9O=B1KT=5K=**3.;Q[^*BW=EJS^.@745;TTI.<:-
MP;12[QZ==P1,J(F'PZR>^6_/-MK)FY>N@#C5H(%00*.Q(%`2<<EKC8]S.WMW
M0VX%@;D6^LOC;IF(<X,>"X.C[K7&KPUM`2310KH7.'%:;A-5Y!P"]HT*BWG0
MX7,JJO5:-H#MR\M$EI!\PD6LHP0J#N9K?U)8V3U`Q7[1`[MVU!FU*L[<-DE=
M2;=K2*SCO6%SX7O#!1KLR[0:C344-<QB105)"[-AT5O-YOEUL$[8K>^@MW3/
M#Y8@`P0\X%I,@:_4PM/=<=+7:W4:UQ'WW^E4N?Y*89%H;)J-.G+!F>E3D#@L
MKFENJE<U",34A"O[19'=PH$>]B)S/?1*)6"KQD]2%\D)DBIK"5S8SQ/O[-HN
MI&O=&XB,L<`\88G4T4+>%0<1QQI'MMY!TYO<KMGM9H([F%KKILT;WPN[U&,$
M<I#FRU\0:YITFAJ*MZQWRQP-C<RT1>[NS2YM%C\@&6;4J_O:`EJTHJ5LSS5Q
MJ;*K.,R:WLSTY&QXI27*^1=J$;J)D6.5,<AW*S$O),IU:]%=+M.L_)UTT:NR
MFJM<,UJ,Z5WU]G[\VR')]W,^DR1"7D-Q,P@+Q,8J8AXCTEH+@2`2OWH3D5D5
MBT$<PAK%*O+:,W;*VW#[#WUO69"P4--0]UA8B^NJPA0YF3JBB)T9!%I)+':.
M2&04`JQ13"[+ZV?/[NUY,M2/"ZA+?$`ZFDD=M#@<,U@FZ>W:WL/M.:W8+30Q
MY_&1%X;+[-SH@\RM#ZU87,`<.\,,5B%\SW_+<@_XE\O_``4TKK:.2Y#/$O/>
MZJLJ.B(Z(IDXY_O"83^F7,/PW@^B'(KU'>X?^XMRS_0-H_X./>N;OG\'W+\B
M[[R^J^07]:_*W^>6GYUJ\[WKX>OWW1T1?__5?XZ(CHB.B(Z(CHB.B(Z(CHB.
MB+XUCF3254(BHX.FF<Y$$12*JN8I1,5%(5U4$`44$/*43G(3Q'XF`/CT.62D
M`$@$@"N?#X*GX`LTN+--Y`5;F%S-U/2,+M-3H')BQ8W*T6P+V['I1Q5V.494
M\I3MM?X6LZ7-R+->34CV:;$T229!15<3./;IE,H'`VZ*]CW3=+B>S<V&X<PM
M.IAIH9I[P#R<<*4U>FB^D=3WFPW72/1VU[=OD4M_ML=PV5@CN&AYGG$@,3GP
MM!#:N+N9RZ`=W43125RNHNI7#8N&ECH683-XK^-[?(:3?91E8<_AD8Z!D,VO
M6>E08-+7;H*3E)EJ]MZ3X4TD/1%LW.`+>MY$S;&XQ7$EUM;X;<O9%,7.-6B@
M+'-^4X$GO5RR&=5S>EK[;+3:.L+>^W-D%Q>60AB:62N)<)HI:DLC<&M(C+:D
MUU$84J55FX\3]RVW.>Y[ELE3)'*O^Z:Z1MWQ^V6"RT:3C9$U>H.;5AI!V1K2
M[999B`3FYO.1]8YD%B$BW_G$!7(9L//EVZ[NX-_MW1&/WAX<QQ+2#1K!0Z7$
MBI;PR/'!>GL^JMDV7<?+3=([QMU]EPF.X8UDK2-<LSRYADC8UVELV`J*O;3P
MD.5N,2I4?59!Y?H?@C2L&N,?E\I&3[RM,./T9?;A/&=PLL7/<^FL^GWK%_1)
M62AUE3.+)*UXONTXXZC0OBX49]&TB;&3,S9V0RB,@TY8<XX'2TM--)(S<6XZ
M<,Z>4WJ]DNHV6$W7,U]:.NFN:'FZ=%&VCF\V5LK01*T.`I"R7NF0!_A#X9XX
MYAR:R;MK!CD)E%/I')6CT*^U^K4^R2M1G<VFK5*RTS88V6C5X2P6**/`R!K`
M)4VTH+0"2"*B2Z0,O(NKJV-O?VVP^ZLMFLOV,<`TEI:222"*$BAKD:8YBF)[
M'46Y]-;KYC_:\VZS3=.3SQ/?(QLC9FL:UK"TAS&.U#3B6:NX06G75HYO`\;Y
M%U+F#5MIM.46\M6N'&9+)="N.@[M6+O=XV[Q%S"\N[#9X"-DI.%BXZ6>G<-(
M6)J1G42V26!50D9ZBK<E+.UOH]SCNY+=W+=;Z'%T@<X.#M52`2`#B&AE0/HX
MA;&^[QT]=](W6S6NZP^]0[ESXHXK9\<9C='R@QCB`YQ:*.DDGTO)%`9:!QJO
MEF>[+R6[<#3BS2,JE&$-I&^;&TEMWEK;0VM(J%)@N;6@WFR6%I"(6H=0=7R/
M<02S&*9H08M!>>BZ.^33`2ASK:"ZO]B&W16Y#))GUD);I#1.YQ-*Z]6%`--*
MT-5ZC=-PV?IOS$=U/>[HUTUM86Y;;-CE,DDCMNBB8PN+.2(B'!SW&35IJT,)
MQ5N;)Q9<1'+7DYK5XXN4_EC0.1M?R!S4C2L?C4F_RNQ9Q15,\L52LC#9)N(,
MG3+@V;LY(KR#)(K%4]PFNQ.8$C'Z<FW%NY7]S-M[;F&=K--0PZ"UND@AY'==
M@:MKVU&2\G;=3MEZ4Z:VJRZGFVJ_VZ2X$FDW#1.R:7FLD8;=KOQD9+F:9-`I
MI+7C&DB73-];SOE#A>[T/%T-`JT/Q;N_'*T47+[%0:JWSJ6E[EEUVK<K$IZ'
M/Y]'O<X:'I:\:)6"9Y)FW!-1./5\?2+FE@N8-PL[R&UUQBW=$6L+1I)<QP(U
M%HT]VF&('R5S[/<=IW#IG?-COMY-O=/W2.[9+,R5YE:V.:-[7<ILI$QY@?WB
M&.-09!FJSU_C7R62[>,+C<OD@--JR_DXVV5*EL;Y0GL1HD+'\Q7G(1=M1K>K
M/LXQH+RJ2QVS4U@)!JF>H>59)`AP.&C'8WXV1EJZV_\`;CN->G4VC@)^;W75
MID:#5IQS`7I+CJ/IL^8$V\0[M79KK;#;\PQ2AT3CMXM098]))H]H+N5S!I.!
M<116>N];VJ\<N>&VQ%PRTPU,S:A[_"Z$X>7+)G+NJ.]M)F[.M-EV3._*N9AY
M64*"=6>"-*\;("Z(2.7D_(8W6_+'=S;GM=U[FX11LD#N\S#F::?*QII[U*C'
MNER\U97&S672?6&T?;D3[RYGM71`1S@/%MSB\@F*C0\R@1:]).DF1L50OR.)
M^<[CQKKEGP>4R%Q=(P=]O][JVU-K?0D:#(4/3M%>7MQ*62*D+*EJ49H%58S3
MML9BWKSUBZ>MVWIR)45E5FU=N@N[".2S=:ZV\YSA)J;I+7NU5(KK#A4B@:03
M3O4)(R]5;ALG4=Q;;[%NPAD]PBB?;F.7FB6&(1!K'!G),3RUIU&5KFM+JQU`
M#N/RO!-BJ_+XVK5O/[KD%+L^H;_+[K`.M#HUMPC2H)VK<XK)M6SJEEMMCO-!
MW"\A]GY*QJ(Q\0Q6;B_2<"*YB)J8K>SNH]S]YCA?%$Z20R#4TQO'>#'M;J+F
MR.[I=@T4J#BMS=-]VBYZ2&UW%_#=WD5K:MMG"*6.YA<.6Z>"63ELBEMH_P`:
MR$%TC@>66]VI$>=\CB!NW-OA=%XWQWK,=;+\UVRC71:+E++`U5L6OPD!=6$B
MZ"3L;^.CS*I.9IN`)`IZAP.(@`@4?#T!7S)I`-2E!_\`;I]UG\R%,_77D_XU
M]10K)K:C_;I]UG\R%,_77D_XU]*%-;4?[=/NL_F0IGZZ\G_&OI0IK:I)QOY?
M;NAT_7LJML]B]0:P=6TBC6.9<I[)EKE1O$PEGBY.173;-[2HNX.DS:G,!"%,
M<XAX``B/2A4:PGK.8><VO7N+'('+Z*Q1D[E?LHN=5K,>X>M(U!Y-3,,Y9L&Z
MS]^L@R9IJKJ``J*G*0H?$1`.M+=()+K;KVWA%97QN`&6)'%>^\I>H-KZ4\S>
MA.I=[F,>T6.Z6\TS@USRV..0.<0UH+G$`9-!)[`D[_\`1"[BOYI:O^M;./QC
MZ^7_`.4=\_9F_7;\:_6K_N=_;_\`ZIN?W*[_`$2/]$+N*_FEJ_ZULX_&/I_E
M'?/V9OUV_&G_`'._M_\`]4W/[E=_HE__UG^.B(Z(CHB.B(Z(CHB.B(Z(CHB.
MB(Z(CHB.B(Z(CHBY2]_>/<OOK^]2Q?>)]_']4//O-_ZK_P"7?\9Z?6.;V,OB
M\)\/BR^3Z>'I6U8_KMG[+VK/:^S\0]I]#Y_T:K-3LS?N.0'^*O\`C!O_`/BU
M_6_^+UL_JC_A/^:_]4_6W7!Z6_A#/:>UD\>?C.7^/T]2^C^</_VT_P"J_JEK
M[#P^P9XO3\S_`,'*6JW7HE\N1T1'1$=$1T1'1$=$1T1'1$=$1T1'1$=$1T1?
"_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g309840g12d74.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g12d74.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0SX4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@`````````````!#@```>H````&`&<`,0`R
M`&0`-P`T`````0`````````````````````````!``````````````'J```!
M#@`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"EP````!````<````#X`
M``%0``!18```"D``&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``^`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#TC$PL)V+2XX]1)K;)V-_='DIVX.**W&K&I=8`=H+&Q/GHB8?]$H_X
MMG_4A3NW>C9MW;MIV[-N^8_P?J?H]_[OJ>Q)30?0UE;WV8>-2`)#G;2T'=&U
MYV,^DQ-Z;2\L;@8KG"?:'MG0D?Z)4;:NIW`UW,S;L<D$L>W"+O;[M6N::G.]
M4,5S&Z%701;1?;CV.&NVO&:X;O<YAV8W[W[J%>)7<0_='X_Q;5.%CN:3=B4U
MNG0-:UPC^ML8@9[,?&](8^!3DV6/AU<U5N#`'.?:WU8]39'T%;QL>VDN-F3;
MD[H@6BL;8_=]"JGZ7\I5.K=,MSGUD,Q+6U%KJVY5)M+7AV_U6/;97M^A5[$4
M-:S)I:;&-Z2P65L%FVQ^,W0EOTMMMCF>WU7;]FS]"BX[J[<BNJSI+:6/!)M<
M['<T0.-M5C[7\LV_H_\`MM!/U?>]C?6IP'OIV58[C0YP936'L8P^K:]SGM99
M[=CJ_P`]#HZ#FU&G;5TQK<>SUJ]N/8"U[R'9-E9^T?SEG[Z2G9^P8/\`W'J_
MS&_W*%F'B-`+<2M_B`U@/!/YT?G>U6E"U[V5/>QAM>UI+:VD`N(&C&EY8SW?
MRW)(:8QZMK7?LY@F0YL5;AQ!'YCF_P!M-Z-4?\F-GL(I_P#)*O9UG/<_T*,!
M[+PX!['V8[G1&]S16W,K]^S^4GHZAUT']9Z8]PC05.I&L\_I,O\`=0KQ76/W
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M[BS=?8`=@=I+C]%KG5,=L9_+])5L3JC<G-LQ/3+'5-ETBP&=SZW'])377Z/L
M_1V>K^D_T2%@:=UPA(@D"Q'?P;Z2#;ET4W54V.A]Y(8()&@+O>X>UGT?ST9%
M:I))))3D,-3\G/KNMR'>GDL'Z(V2-U55K:XQ?<RK;9^<IXF9B5="P[.HWAM5
MU551?>[5[K`VMC7OL]SK+-WY_O4&Y#FY>>+,MF*&9#`TV000:<=S:V^HYNW^
M5M_?5(59+.E],ZCA.ONN-.+065`65&NRRAUN1]E=;35OV?\`:K<_T*?^"24[
M!Z/TL\XM<^,:_>K8`:`T"`-`%"?2KE[G/\]LNU_DU-_[ZJ.!1CLS+KYNLR'D
MUMLM:_VU#]*VAI+&,]-KW.V[_P!+_P`(EJD`:V:[:?,Z2A=_,O\`ZI_(G>]K
M&E[R&L:"7.)@`#DDIKOYE_\`5/Y$D/\`_]'NL!N0W)R'XOIV6.JQ=S+"YH:T
M5NCW-J=NW?V__1:M=&K9;T7";<QKXKK<6D;FA[8>'-W#\RQOZ-ZAB]*8ZLWB
M^YCLEM3B*W!FW96VH-:6MW[?S_TF]5,_I+<#"K./F9C6LMHJ#?M#B-C[:J7-
MEX?_`(-^U)3O<Z%"QL/&Q`]N-6VH6O-CPT1+W?2<J7[#;_W.S?\`M]RJ8'37
M9)RA9FYD4Y#ZF1>[Z+0P]OI>YR2;-5>[8ROJ^R[.MS:<A^/;D!HLL:`;&;&V
M5L=B6.]M-CO6_2>M7D_H_P";]):H``C6..9/WK&OZ2ZN[&8W,S2VZQS+#Z[C
M`%=M@_J^^MJTL/$&)6:Q;;?N<7;KGE[A(`VASOS/:B9$U?31%.;:^IMPKIO-
MK3`#CF;3NG::]GO]RN=->PU@N>?7L:'OJ-WK;0"6^U_T?ZVU7/3KG=M$^,"4
MX:T&0`#Y(4N,B=++EU-N^VYYQF,M?]H87^N=K1^AH_F75LM?_P!N*QT4.'2,
M+<(=Z%<@<3M'$_FJ1Z3T]QL<^D/-MGK/WDNFR&U[QO+MGL8SZ"S>K=(Z/BX;
M'U8E%7Z?'8-M;0(??37LC]U^[8DM=JZFN^FRBUH?5:TL>T\%KAM<W_-5;IN)
M;BMO;8VIK7VN?6*0X>V&M:ZSU"[])[?S%#]@]%_[A4_Y@53!Z+TU[\OUL*F&
MY#A4-@C9LJ^C(_>W?V_Y"%"[7"9$3&_2>C+JG1,C,NLLJOEN0STK*<B;*&`,
MN#7MPM*LC?;95ZU5SO?LW[_T6Q:;FEF,YA,[6$3`';P"R\SH?3!=ABK#K#77
MQ;M8S5GI7&'[VGV;Q7_+5^O"Q,/'M9BTLI:X%S@P``F-LZ?!.,B0!V6O_]+T
M_#_HE'_%L_ZD*5V/3>UK;F"QK7->`[4;F'?6[^P\;D/#<?LE'M)_1L\/W1_*
M1MSOW#^'_DDE,E2Z7&S)(+S.3=)L,_G1^C_X)OYBM[G?N'\/_)*ETQKZVY.Y
MQMW9-K@1`V@G2K79]#_5Z2F>6^,_!;OV[G6>SW>Z*W?NCT_;_P`+_85Q4\@;
MLS%<2]A87Q6!+7DM_/<';&;/S=RM;G?N'\/_`"22F22CN=^X?P_\DEN=^X?P
M_P#))*9)BT'D`P9$^(3;G?N'\/\`R26YW[A_#_R22F2I=+8UHRBU@9NR;3H2
M=QF"_P!_T5;W._</X?\`DE1Z6*F?:_2<^W=E6.LW`MVO.W=4/4=[FL_?9^C2
M4ES=OVG`W"3Z[MNDZ^AD?RF[?;_QG_?U8N_F7_U3^1!R#6;L8V![7ML)J#>"
M[T[0YMD?F>GO=[O\)L1+G'TG^P_1/AX?UDE/_]DX0DE-!"$``````%4````!
M`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O
M`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``-@`N`#`````!`#A"24T$!@``
M````!P`(``$``0$`_^X`#D%D;V)E`&1``````?_;`(0``0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#
M`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@!#@'J`P$1``(1`0,1
M`?_=``0`/O_$`-P``0`"`@,!`0$````````````)"@<(`P4&!`(!`0$``@,!
M`0$!`````````````0(#!`4&!P@)$```!@(!`0,$"@P*!@@#"0`!`@,$!08`
M!P@1$A,)(126%S$BE-05%E=8V!E!LC-SM=76=Y<XV1I1,M(C4Y-6&#E9T5*2
MMF<*87$D5#65-G8T)S=RHD-C9"5E)B@1``$#`@0$!`((`P,*!@,!``$``@,1
M!"$Q$@5!41,&82(4!W$R@9'10E(C%0CPH9)B,R2QX8+24^-5%U<8P7)#8S0E
M\7.#%O_:``P#`0`"$0,1`#\`L<<'O#RXL;5XB\>-BW;5=<L%NN.JJE/V.<DR
M/G,A+3$C&(N'T@\<&>]I9RZ7.)SF'RB81'*T\%D+W`TJMJOJLN%_R*4[W*]]
M^XT^"C6[F4^JRX7_`"*4[W*]]^XT^":W<RGU67"_Y%*=[E>^_<:?!-;N93ZK
M+A?\BE.]RO??N-/@FMW,I]5EPO\`D4IWN5[[]QI\$UNYE/JLN%_R*4[W*]]^
MXT^":W<RGU67"_Y%*=[E>^_<:?!-;N93ZK+A?\BE.]RO??N-/@FMW,I]5EPO
M^12G>Y7OOW&GP36[F4^JRX7_`"*4[W*]]^XT^":W<RGU67"_Y%*=[E>^_<:?
M!-;N93ZK+A?\BE.]RO??N-/@FMW,I]5EPO\`D4IWN5[[]QI\$UNYE/JLN%_R
M*4[W*]]^XT^":W<RGU67"_Y%*=[E>^_<:?!-;N93ZK+A?\BE.]RO??N-/@FM
MW,I]5EPO^12G>Y7OOW&GP36[F4^JRX7_`"*4[W*]]^XT^":W<RGU67"_Y%*=
M[E>^_<:?!-;N93ZK+A?\BE.]RO??N-/@FMW,I]5EPO\`D4IWN5[[]QI\$UNY
ME/JLN%_R*4[W*]]^XT^":W<RGU67"_Y%*=[E>^_<:?!-;N93ZK+A?\BE.]RO
M??N-/@FMW,I]5EPO^12G>Y7OOW&GP36[F4^JRX7_`"*4[W*]]^XT^":W<RGU
M67"_Y%*=[E>^_<:?!-;N93ZK+A?\BE.]RO??N-/@FMW,I]5EPO\`D4IWN5[[
M]QI\$UNYE/JLN%_R*4[W*]]^XT^":W<RGU67"_Y%*=[E>^_<:?!-;N93ZK+A
M?\BE.]RO??N-/@FMW,I]5EPO^12G>Y7OOW&GP36[F4^JRX7_`"*4[W*]]^XT
M^":W<RGU67"_Y%*=[E>^_<:?!-;N93ZK+A?\BE.]RO??N-/@FMW,I]5EPO\`
MD4IWN5[[]QI\$UNYE/JLN%_R*4[W*]]^XT^":W<RGU67"_Y%*=[E>^_<:?!-
M;N93ZK+A?\BE.]RO??N-/@FMW,I]5EPO^12G>Y7OOW&GP36[F4^JRX7_`"*4
M[W*]]^XT^":W<RGU67"_Y%*=[E>^_<:?!-;N93ZK+A?\BE.]RO??N-/@FMW,
MI]5EPO\`D4IWN5[[]QI\$UNYE/JLN%_R*4[W*]]^XT^":W<RGU67"_Y%*=[E
M>^_<:?!-;N93ZK+A?\BE.]RO??N-/@FMW,I]5EPO^12G>Y7OOW&GP36[F4^J
MRX7_`"*4[W*]]^XT^":W<RGU67"_Y%*=[E>^_<:?!-;N93ZK+A?\BE.]RO??
MN-/@FMW,I]5EPO\`D4IWN5[[]QI\$UNYE/JLN%_R*4[W*]]^XT^":W<RGU67
M"_Y%*=[E>^_<:?!-;N93ZK+A?\BE.]RO??N-/@FMW,I]5EPO^12G>Y7OOW&G
MP36[F4^JRX7_`"*4[W*]]^XT^":W<RGU67"_Y%*=[E>^_<:?!-;N97X/X6G"
M\I#F]2E.]J4QO_A7GV`$?^^XIX)K=S*JR^JRH_\`<E_\5O\`N_?^(RG_`-(/
M[`__`!O_`*;_`/TW\3(H.2O4\^*__]"XSX:_ZAG%'\R=&_`S;('%6=FMW\E5
M3")A$PB81,(NKG)AC7H66GY,YTXZ$C7TL_423,LH1G'ME';DZ:1/;JG*BD80
M*'E$?)FM>7<-A:W%Y<$B")I<Z@J:#P6U8V<^X7EI86P!N)Y&QM!-`7/(:*G@
M*G-8-USR7H.T92/C:U"[&03E&*LBSF9V@S\)7E6::'G`+_#;UN1@4BJ7E((G
MZ'^QFA8;W:[A))''#.S2S43)&6-I\3A_F7J]][#WCMV"6>^N[%SF2!CF17$<
MDH<32G3:=6!P.&"SB6=A#H&=$F(H[4BH('<ED&AD"+&#J5$RP+"F540\H%$>
MN=/KP:=?69HYU%/K7DS9W8?TS:R=2E::75ISI2M/%>4@=G4VR6FU4^*E2+3-
M.4B$I<I@*FT.>;BDYEC\'/!/W,B`L%0,<4A'L#U`?8',%M?VMT;AL,F,4A8:
MX8@!QIS`#ACDNC>]O[IM^W[7N=U;$6MVU[H^)I'(8G:AFTZP0`<^"]@XDVB$
M:ZE2',\:-6KAV88\OGRBR;9,ZJA&J;?MF<K&!,0*0O43&\@>7,L]PR"WDNB"
MZ-K"[RC42`*^4#,GA3-<R*VEEN8K2@9*]X;YSI`)-/,332,<2<ABM;*SR[U7
M:K:2E,8S8[&;!9JD]";U]8(=E$%?%,9HYFGKU!-&*9N"D'L*K"4AOL#G$L>Y
MMNOY^A#'.UVK22^,M:TTK1Q.`-",#S"]UN?MIW%M6V_JL]Q8OM2"6].XCD=)
MI-'"-K22\M.8;4A;(!-0PD04"6C!3<JB@V.#]J)'"Q3=DR*!N]Z*JE-Y!*7J
M(#G=ZT/D_-;YLL1C\.?T+POI;JKQZ:2K14^4X#F<,!\5RJ2D8BY!DK(L4G@D
M%0&BCMN1R*8%$PJ`@90%1(!0$>O3IT#),T+7.8Z5H>!4BHJ!XA0VWN'1]5L#
MS%6FK2:5RI6E,\%YZ&O](L#5=]#6N!D&;=\^C5G*,DV!$KV-7%L^0`ZBA"G%
MNN'9,8O4O\`B`YKV^X65W$V>WNF.A)(!!P)#BTTY^84!R/"JW;O9=VL9A;W>
MVS,GTM=I+#6CQJ:<L*@UIGS7H2R<:=-RJ608F29B(/%"NT!3:B4H&,#DX*"5
M`0*("/:$/(.;'5BTN?U&Z&FA-10'D3P*TO3SZHV=%^MX\HH:GX"F/T+\&EXD
MK=)V:4CBM7';%!R9ZV!NL"93'4%)85>[4[!"B(]!'H`"(X,T0:'&5H:14&HI
M3FI%M<E[HQ;O,C<QI-17*HI4+IU[O4&\S#5Y:QPY9NPMW+N%C2O45',DV9B0
M'+AJ1,QP.BF*@!VNH`(CT#J/7,/K;0W<=B+AINW,+PVN):"`7?"I'QX5H5LC
M:=S=9W.X"QE]%"\,>_20UKG5(::\30_#BO4YM+GIA$PB81,(F$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(N-;[DK][/]J.0<BBI+_MP<A9OM7__1N,^&O^H9Q1_,G1OP,VR!Q5G9
MK=_)54PB81,(F$3"+Q6R8U[,Z\O41&H&=2,I4+)'L6Q.G;</'D.\;MD2=1`.
MTJLH!0_Z1SC]P6\UWLFZ6UNPNG?"X-`XDC)=KMRYAL^X=CN[EX;;Q7D+W$\&
MMD:2?H`JHV=/TR_U&K'A&^C-ZEMB>MI>"%:Z[(=.M;NY4(,Z(M4X-K+@X8-7
MZY.[;@CW:B7:`"F+[(>,;#?,L]RCM-BO3-);D4GE+F.H02T`$$.<`0VA%3Y2
M:$K[GW)N>R[CNL5[+WAM'Z=^I-D'IK5K;EK#(2'.D+*.+007EU0:$T.2QA2>
M.6[7$1/0EAHMAB*U:=FZEL(UQL]68M6$"P<2C>V)F(WF'CAH=%`4^\,#@RBB
M0E,8>UY`T=KV'<G1VMG?V<OI?7B1P)(;TG14I@:BCL'BN!X\5WMY[[[59<P7
MNW;M`_<8-IOH1*6AQ=,YT;H34L`=7S%M6@#$`462-QZNF=/^N*^TZ+^*["KV
M;5C[6::D@N"$ZR1HY*A/PK8[IPX=/1[^2,(E.)S"=$.F;&]VMSM<$]Y`!'+^
MHN8P'[T,\3(30<=+M+JXD:25Q^UM_L^Z6]K;)NEQZA\UE=^K.D5BD%VZYC>Z
M@`;5K:84%'*1;3=;-4=64*OJB<SIA5X@'QU#*'44D%V:3A\HH901.)SNE3"/
M7[.?2[:W99VMK9Q_)#$U@X_*T#CCPXKX-W'?_JF_;SN``#)KF1P`R#2XZ0*<
M`*+47<VIMBV&8Y5.8&`DG!+W2M:Q=5<,U>Y4E7<0J@$LBT5(H10BC9,#=H>H
M#_!GBMQVN^GL]]A9`^LVY1/%,"8PV(.((X#2[ZE]4[6[FV*RC]L6WE[&WT,M
M\Z8.%0SJ:NGJ!!'F-*+"7(#C)LYK/Z]9ZKA+#\1&E4:,T&%>5-*/ZG=5I1=]
M+V%PI-S;0R"SHSDJ@.046,42"4"`4H!G&WGMW=/UV$6,;_TZD0A<W$0!I\X<
M2X$5?YR?-J!H3Y0%ZCLKO_MY^T;M+W'<P?KCKASI#*-+;B$,#8V`1QD$-#=.
MBC1QJ2XKLKWIW>LWONH31J6_5B:T^J3>9O$6[<><VJOF@"1TL1^LI-'21<H.
M53D6;-FR:0IAVS',?V=@[5NL_=4MQ<V#FV1D<Q[V5I(Q\9#7FKCAP>``&F@%
M<UJ[7W1VE9=B;A9,W9IO9H971P/:/R)1+K:&CIY$`%KW.<[A0`K'T7Q8NJ@'
MK*NK;)&Q\(MO1560)+O$&%AD9<S->@R+06LF544R)H@F0IP*!CDZF`>O4>-9
M]M[G^E&&3;I&7$-@\,%2/SQ/J:X4.>BE*\LEZ&\]Q=H%U^H,[A@D?<36&&AI
M=%$QI%PQU64^:KB1C0T!7J'O'C>L=0=CP=38V)G\-5[4$O(,7<FZ?N;3+,8X
M@;#8("]?&%:1>+%`%$A5125[/8ZE+G9W/8=QCVW<K6P@D-M^HMDT5+G21F)@
M)%2-5)/,07#(GP7*M.]^SY]Y[>O=SF@,L9OHP\-#6PM=(3:DZ6X-#*@.#7.%
M:T)79ZZXW[.DZYJ:O7Z+N"U1]:EHF9VM2;@(=>M59Q2GL>@Q.$+,NE6L0]G"
ME,1(%Q'^='[!NF7M.W;V:VV>VW%LC[=D5P2VI:6ZJ&-CZ''S5(%<,!P6MO??
M>PVUWW;>['/;,W0[?;,BE8-8FF;<M<]XZC`"\18%VG[O-=AJG0-UJ=RX]66T
MZZL$U\57>RZZ_6/(K*N:NQ=6]R^I4L],L_+WD8RBU#`4`[9A*H`"!N@=,NR;
M1>VF]]OWUS9O)&V&*1Y)\DH=Y=6/X*CZ:K'W9WCL^Y[1WSMNU;Y#%'/+:S,;
MI`$U+9K;AC:-P<Z4`G+%IH17&5?/HB_.B81,(F$3"*N=XSFQ]H:XY5<&;=0K
MU<JW#:K@=L[_`+E6Z[/RD9#7&M:7LFL;7:HVS1;)T@SFF`TE&4**;@IB`4P]
M>@"(YK[;<PVG<KKJ]DIMS(+:.4$:J1W=V+-[VM.&MHF#VN^Z6UX+H7=O)<]K
MR6]H`-PENW])V(/4BLKBYC82,2'R0M86\=61R.E&GN=6Z-2;HYV\G6-DE[\E
MMJB:HNNG:3L6TS*>K**CNCES9M%ZWG7;,CMRV@*C&4IM&2CT[,I3+)";H;J?
MM9.U-O(MG@V"7IC>Y=WM(73/KH8^ZVYVYR:B:.:UC9#"&Y=1K!EE3<)+6XOI
MMZCUNV>&RN7LCC`#WLM)8;$>7(O=,Q\KW9],N?F*+?RJ>*1R)I^P:YH[>B?'
M.6N<!S*T3HK9.X-22\T\TI,:\WCIC9&U&B]9D)YZS=PMSK+FJ-&3L'9U$?YP
MQ@)[<O38L7PWMQ9,HZ.(F_C?JIYY;5D4D;HSD6.$NEPQ(>QS<'`@:\D1@BW1
MSR'O98V]S'I^Z)KMMLYD@SU"CWBE`6N8[$''7?E7XTW*O5]*;W/4U'U5/50W
M+/E_IES??BW:+S#I4C1%RB8'7BJ<16+&U=KR%LAGSAVYDRJF9]6H`1,O;#.9
M87DDS=BFO6B.&XVN.Y=F`Y[YI&/:#CH;'&QKJN!+NIA\A"Z=W8P127D-L2^6
M.:&,BHJTNMHI'U'WCUGN904T:*.J7`KK>1WCX[AH')VC:\U!JFLW_5S:J:-L
M=O685:\3$OL)';5=@[2\>T.PHK1[2KQT?'3?89A),EEG"B!NV4G7H'4LFBXW
MB]MIFO;8,OW6PP&L-:0.J34M=J#P]K!]T#'SX<B?2W:K&X@=JNY+3K$_=+CJ
MI&`,10L+'.J:/)%"&5=M[XV=MV>QA.%SG55PNE+E5]H[)OJ[.LS,I!N9\FK]
M#W3;+"N3B$<X0&0CWCRJ$17;*]I,P',`AFIUAMO<UK<32--M:6\TLGWF%D4D
M)D-,G$Q:PVO$@K?MX_U#M;<1$S1<W-S91,+O*YCKA[XQ4C$4<YI<!G2BCTJG
MB'[#KO+KF/SIB9:U7K5;_BOM]_I_4\G8Y%KKTQ-*;CT+H>/MJ,:F[<Q<>UE+
M>2:=NGJ).]%NHI[;RB`-N;>VVR;K:S&/]6OMXM.E))4-ABO+O<[:UZE::&MM
MK>WEE`-"36I^8UNG6MS>[2^-SSMMGM[C(U@_,DECL;>]N6`?>>)KE\,=14!@
M;3#':.W>*]S!T['[2TUL*.XH7S?\78^-$91-O:NL=H7XV1#+D9/V&";DV,[D
M5`FHZ1JIJV=8Y4E.PY16[1?X@=K;BB??W5OMMDX0W(W!UN^27"-P;;3758\C
MJTPNC+3B)'QBE746B98K2V.XWC'2VS]O-RQD1!>TB>&WTR'$!NN9LFH8=-CS
M6@JM29/Q8N3W$#6'(I[,$H>W=V[&\0?8NMV-HK2]SV1I.G-J?H_2DY*-Z+$)
M.XZQNZ])NGK@S1F15`&RRRIS=H2F[7,ANP^U[:L[1CV]2"\F>Z05<X1WDD>@
M$'FX%I-0(V@4JNO<VH$VX7-TYI,=O91M;'@T.D;*[6\'$'2T!PS+Z8J03B%S
M-V=R[Y+^'GLVUQ$_K538O%_F2I>]<$6F(VLR5GUYLK7%3C[,C!OU>TJU>-VY
MW;$7`*+-4W9TP.(@81Z-I"UFZ=SZ7ET)VW;Y&-)J8W/EF;(/`ES30CYF:'<5
MS))'':+5KFTE9N[HRX`@/;Z221I%<:>9M1D)&N'`%6`\+&F$3")A$PB81,(F
M$6GVA+FHKLKD]'V&S@=.*VR1G!L9>7+V6+'X`9*"VCF[I?JBV%8PCV4P[/:'
MV.N>8[?O&FSW$SW(,C;VX`U.QH'8#G0<`/H7U#OC:6LVCVZEL=OIU=G:Z1S&
M?,_JO&IQ`Q=3B3DM9[!S.VH_GMH56G.:#))Q="N]HJUHB8BP^:L5:GW1ED3J
MRX%0G'8(F.0>[1*DFN!>HF*.>*N.\]WFVO?YK:2&MO;"9LK&NIHU4):'YG3\
MKB*5&."^B;?[4=M0M[8O-TCO&=>_@@FAD?'4]8&A/3QC;J`-"XN+":4*Z>3Y
MN[@IC;7E=4@H6XSJFOJS<K)(1\-.2/QA+/.'8(L&"S%5)"(?$:M0(LLJ0Z7G
M)A`I>R7R[TW>&YVMW:6;;=LC(XX!(=+BYY>QKG.:X8#RGB"2[5P5;3VF[9W9
MF\;@+V6UMG7L\,+7/C:(NE05>'`EXU&H:T@Z*5-2I$KS5HS;>MVAI9W;*XFX
MC&UD3+79^2K$NU=?!QG*;1R\C5$7!DDC*]E1,1[)A#RY[+N"QBO-OFE,TS'1
M,<]I8\L-=)IJIF,<CQ7Q38=TN.W=Z>+>&VG)?TCU8F2L(U@$M#P0":8'.BC]
MTO/[*J$3HEIK^:-/VO=\#<']FDMJV6UV.+8)4Q\H=,\,Q3=J^8KKM3B4P$+_
M`#A@#J(!GFMMFOK*?;;*QD#FSV++F5TKGO/E:TN#,<-6HT&5:5P"^T=VV&P;
ME==[W&]6O1V_9[Z&"!EI%#$YWJ`?[QQ`U!I:#4G`5H,5ZC6W.:X7/:#N`D::
MUCZ29[:(SX3-%32!JX>N(/#A+3DR8ZT>Y8N%60@HFDF4Z('#RF$/+I[5WQ=W
M?J9[N&.*S-O)*UQ#PV/0*@2.QJ*`ZBT9X!:'</M!MFT;)!<6^YODW8=`E@?&
M3-UBT%L4>#FD:J@N)#@."Q])\S-V6>K[7;5AW1FKVGHU>5CK?&0T\V8N8.?E
MUXM7S!M.=XLX$.B9R.S)ID$G;Z%`P!FC<]V;[<[5-)#)%'(R\AB<\-(JV7`:
M0ZI;C3$XZ3ABN];>UG:&W[IL#]PBNWPW4=P#"Y\9<V2&,/&IT=!E4%@)\U*D
M@KWRG*7D.G:/BZRB]522!+LUUN1\8;"F*\XYI36Q!,B9(ZI1B4G"AQ$H!WAR
M=`Z%]G.K)W/OKKAT,$%MYWW;6$ZL#:FKB>8+1@!QSHO/M]O>R/TWU\]UN+'B
MS9=%OY?]VZ8Q],5IY\L<@>>2Z"V<]MAQL+K0T)1X]U/3]./:["D2*FI5H_5:
MR9HI>-A`8+$5CB+K)B8'"XJ%3[12B`CY<PWW>M_!<VL5O9@M%O!)("UQ+C*P
M/(:0:-`Q`K6I^"Z.W^S&RRW&_MO=X<VWAO701G6QF@!NH/DU#SD`BK6T)H3@
MO>7;EGMV)D+C.0%5J25)H3?44E8&$_\`"R-J40V00Q5XUIW!O,B/&*Y3?SBG
M9`"E_BF$?)V?UW=';F&,AB_3!?105.KJ$2M:X$#(%E?-7F*#`KA;3[;]MWEG
MM%K=;A<_K=]'?]-S-!A!LW8.=7S%KQD!]86;>.-ZVC<KAO5I?IFNOXRJ;"<5
MZNL(QNNV?QS9!@Q<IE,0Y2E/'J-G)1`YNJAE^WU'L],V>TKW<;^UW>3<IVOF
MCOY8Q04TA@:*4X-R+>-=1*\IW]M/;VUVG9[]CM)XWW.V1S2%Y!:YSR_&OXZ@
MU`\H;IIC5;99ZI?.$PB81,(F$3")A%QK?<E?O9_M1R#D45)?]N#D+-]J_]*X
MSX:_ZAG%'\R=&_`S;('%6=FMW\E53")A$PB81,(F$3")A%U4I!0DX1LG-P\5
M,$9N"NVA)2/:2!&KL@"!'38KM%8$'!`$>AR]#!_#F*2""9T;Y86.>PU:2`2T
M\P3D?@MBWN[NTZGI;J2/6W2[0XMU#D:$5'@<%V@````````````!T``#V``/
ML`&95KKY?/V/G/F?GK3SO_NOG"/G/L=?N';[WV/+['L8&-:(<*57T**)I$,H
MJ<B:9`$QU%#`0A"A[)C&,(%*`?PCBM,T7\%5(J8K&53!$"]L51.4$P)[/:$X
MCV>ST^SUZ8.&:#').^2$A%`53[M3L]V?ME[!^W_$[!NO9-VOL=/9QD:'-,\1
MDN3")A$PB81,(F$3"+JYR;B:U"R]CGG[>*@X",?S,S)NS]VUCHJ,:JO9!\Y.
M`#V&[1H@=0X]!Z%*.8IYX;:&2>XD#(6"I)R`YE98(9;F:*W@C+YY'!K6C,N)
MH`/$G!:G[&:\*=T3.D[%LH=57V9W!3KW1=%/YIT1^I?:5LFI`?8$!4R$6!&5
MB[+3R=7A>R/5N'LER\MHWU5]M\L/^+DM?S6?>,#7-=4\FM>YK@X4(<00:T2"
M[D%M;7D$W^%ANV/8X4HVX&IC"T_C'F:!RK4+OV?"3B6QAIRO-M`ZW"!LNKJW
MI6=AEH,CJ,D]64]=9W5Z6Z9.E%FYHJ">+F7;"!0637Z*`?M@!@FX`NVWS;@:
MFW,S)I?[<L;&QLD-*4<QC6M:10@-%,E$,LEOZ7H.T]%CVLI3RMD)=(WQ:\DE
MP-0:FN97D">'/P;2TJYX[)\8]5DTP\M+:[.Z*6$4!BZMS(5@96-Q(>=?#:TN
MS2<J(I+&="=-NH9$H@D82"G:+D60F&H6Y<8_[!?J#B*<7!Q#JYB@.0I6%[K<
MW1A.DSM#9/[306D`^`+6D#@148XK"_(/ASX5.JM*1*'(O3?'S7^D*9<)JP09
MK<3XMUZ#M]^4;DG3QCE!^T=)K6-5DD99JD<45!0(;NP[L!+BFEA;<6DLSQZC
M28F5S+=3I-%,B`=3@""&U<!0.(.:)MP^&9D+286!KG4&`T-;$UQ/`Z0UI.;B
M`7$D`KN'>D_"[WQL?CS>S43CE?MB/Z6TE^.DI%MHT[B7HFL5VKEFM6&,0HWB
MYF"I:KE$I$UT5B-"F!+L@4.R&ZSU$&Y7MW'J;N88R61WW@U]6QR'@"[%K7CS
M>4`'R-IK-TOVVWB%#MK'NB9R#C5SHP<\P7%M<]3LW.)W7V!IS5NT7U0EMBTB
M!MKW7[R>DJ>YFFPN?B^[LM8E:;8'#(G;*EUE*M-.V2P'*<HHKF#H`]!#1F9`
M!-/,!0P21N)_V4@_,:?!P&*SQS3,C$$;R(^K%(!_[D+M<3OBQ_F;XK4#26N/
M#8FDJE1M&U?0<VVDM,;/I-2JU<;LY9G)Z23VBDGMB%;1;HSEK(UDNV1($F*I
M#F^$NG4W7,\[3?17<4X+XI;>S,GC$V)[;(DBA`$9?TG"CL2ZNK%7/J-OF8\@
MQSQ7<P!PJVX<`Z9O_F+:%[34::"E,%[^L^'?P@I^IKEHRM\9-41FJ=A/V$I=
MJ<6O%<L[)(Q)A/$/9-\\6<2ZSB'.8PM#`X`6HJ'[KL=L_:K<-%U#;P7'FBB>
M7L&6EYI5P(H=1``)S+0&G#!8;>1]K++-;G3)(S0XX&K:4TD&HIQI2@.(QQ7S
MCX=7!E'4TQI$>,FIT=23-H2O4K3?@/NHH]M;1,1"A94UP<E?,)4T17VB"JZ"
MR1E4T`[P3=3":)VLF%JZ<5]/JZ9/W-1)=0\`222,CQ&`5HI98NLV)Q'58UC@
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M<RKR=+H\6.'BVN!S7PJ<:]#*MX!JIJNH*(58IDZ^F>-`WP8D9V9\**!A/VS(
M`[.90"'$Q`,8>@>4<R_H6SF:VN#M\?7A:UK'4Q`::M'B`<JUHL@[[[Q'KJ=Q
M70]2:R^;YSI#:GD2T`5%#@LTBW0,W%J*2?FPHBW%`"@5+N!)W?=`0O0I4^[\
MG0/(`9U)&,E8^.5NIC@00>(.:\HU[FO$C7'6#6O&N=5XJ+UCK^%5JZT54X=@
MK2FTDTJAV[;L&@6TP/:E$([VP]RF^'[H'EZYK1V-I#+#-'`T2QQ=-IXAF'E'
MA@/J76N=_P!ZO&[DRZW*5[+R1LDP)_O'LKH<[F6U-%TS31^H6%DD[>SUU5&]
MDF$73>3E213?OWJ+Y,47A%B"`H#YTD(E4$"`)P$>HCU'-2+8MF@]7TMMA:)V
MD2#2*.#OF!&5#QH,5MS=W]T7%G:V$V^W+K2!S2QI>?*6XM(.?EX8X+JX_CKH
MZ*C)>'C=7U%E%S\>>*FF3>,(FC)QQW`NA:.P`W55$K@PF*`C[0?XO3,;>W=C
M9`^U;ML7IW!@+:8'02YE<<VDD@Y^.`6Q-WSW=<75M>S=PW+KJ%Y>QQ?BUQ`:
M2WE4``\^*[6,TCJ6&*T+%T&NL@82B$TS[EH("WEFL:2';R"8F4,(.4HL@(`;
M^C#IFRW:-L86%MFP%O4IAEU123^L8.YK5N.Z^X[KK>HWB=_4CT.J<V:^II/A
MK\U.:^*5X_Z6G(ZOQ$MK6J/HZJ@J6O-5XT@DBB+KBY62:F*8J@(J.#"<2&$Q
M1-Y>F4DV3:9I+6:6PC=+"T-82,6M;2@\0*"@-:+/!WKW9:S;A/;[_<MENG:I
M2'_.ZE*GQIA44-%WLGJ;6TR2P)2=+@7B5J""+8DU69>[EBU@3#7RNR%$I3EB
M!./<```!.ODS8-A9EQ>;=NHS"6O_`+C:4?\`^84&/@M*W[DWVT-B;;=9F&V;
M*V*COD$W]Z&__L^]S790NOZ77+#/VN"K<9%6.TB@-AEV:(I.Y<S8H%0,],!N
MPJ=,I0`!Z`.6MK&TLG7+K6!L;IGZWT^\XYN/BM>\WG=+^SL-OO;Z22RM6D1,
M<:B,',-Y#P7L<VES$PB81,(F$3")A%QK?<E?O9_M1R#D45)?]N#D+-]J_].X
MSX:_ZAG%'\R=&_`S;('%6=FMW\E53")A$PB81,(F$3")A$PB815C-=^'/RPW
M_P`K]I<SWEYJ6HVR7(#85HUFPL-6O*6TE"T<ZT!0F<DY4F6<*764^ZCT5W#<
MC457#,QP*;VX#FOM#9]MVB&XB+1N4UM,\-^Z'W!?I$X.)T!P.D4H0.2Z&ZR6
MUWN;K=X+K")\$;B,#HA$9?TB,/,0X!QK6I*_F_=>\W8G7*\#R7IG(;<32S[:
MK2>[I#5=G3MU,OE$9P=E<U>O:PI%/BX>PT&N2%[+'I3";HSA8J1BF.N*?4H"
MV&5EK`V!X=2X($AU.-R8FM@<Z04:(FN+G-%``]HK4T6:)X9ZR9UQ'4"(`L;0
M"'JM,X#"=74,8`K4D@NI3%>DV#$[LJ?`'CWQQO.O^0=R2UWLJG,^4D72*Y:I
M2S2FN['7KK<ZU3:[,L.KZQQ;"8>P<9++M53`T.F*2A@`#9O;R8+[=[5SP9K1
MD4L=:4$EW'#&V-SAA^47.D<'&C2Y@6KMK#:V5]+`X12S.#V#`NBMWSNZ@`QI
M(UC0`W/2XT7KM.<2]^QUZ\,6,N=@W<VAZ75-@WC8.OG4O(.-<41I"/X=YKZM
MV4P(]ZO;T&MG,S*#MRI_-1QBE)Y##G0MWQQ;SN$D\@E?#M$49D--+K@M9$XQ
MY"IT2/<<3BTX`XZ5Z89]L(M&F!LFYN+(VYF"KY/S*X@8QAHP&)&)"L19R5*8
M1,(F$3")A$PBX7+9!XW<-'2*;AJZ15;.4%2@=)=!<ADED52&`2G343,)3`/D
M$!S#<6\-W;SVMQ&'V\K',<TY.:X$.!\""05DBED@ECFB>6RL<'-(P((-01X@
MXA5$[=HCF50-?<I&NK*C;D93PT=>W+37%:1CHZ45F;/$[EV(\O%IN=#$&CI=
MY)4OCA)1D4@NS(NX;NDU3)@)Q`@:++R\.QP;I>.<Z[F-KMMTXD]06]C4W,^I
MH#V^J>Z`R.:"T1L.G&,N76D@M7;R[;[4-$`=<;C$VC>F9KN-HMX-)\M;9PN>
MFVN+GQM<W$5PYQKM'B$[;XIUZG7#9G)&!H=PYV\:Z'5[K#26U4]N5^D6<EX0
MW`V&\72HPT](UU-V=HN*SE)=HP4,FF/M`(`]X6L5Q?=GVUVXLBDEO-3FN#=4
M0A):'YTTO#A&YPQJZF+13A.FEMK'NVZMHPZ5FWQN:UP+J3>JMQ5@H*5B+@X-
M.0KQ<I0=,4_?&I?%$KW"M#;6[[KH>A0"_,&%M>P=@3=IL4U45=8P^EW.OKE/
M+&0+.M#[@?K30-3IIMBF,44TB]GR:>Q2ON7[[)?4ZNVBXB;0#3(-QEMIK74W
M@ZVABO(8G$EWY9<35V.SNT4=O;;7Z8.K?R0/)+A6,V8O&W(:*5Z<IDLB_AJD
M`^X*YM\;^E5&W\=]9.K*ZW#5I6G[;;VJC[0U9J<^ZXK7-P:U:?91K[9>OD$W
M;J5IL^1^>/$Z39P9%PL0W8'IT'FW+Y(=UVNXMWZ+IL<P:YS=4;@\,:^)V!TO
M>TE\;J9QN%17'>LVLEV[=K>=FNV>(M36NTR#1('MD;B-36/:T/;7$.'"JA8<
MVGEB7CSHVQP&M+/J.R1G#'Q-5X9SIO6%JUHQF)AL+!?7&RHNI(L?A.DV2\G$
M\@S9_P`RN98PF33Z^0-W<NJUT_3#X976>P-Z8=JZ(=NNF:)KA4%K;>A>*D-C
M=1V%5DVH,-G?MFT2,%]>.#R`WJ__`%<[V2%M!1W7.D&E2]H(Q(66-25_FCKW
MD+!NU]^\Q;C4M<\O.%%;AJ]>):<F*[8:?R,T*6V[V7MH!7FH6"&K]G5\U;=5
M"-(7IV#E[[V^;,K1&UCB&OUS=PVM",HK5LWI'TKB^2K7->:ZB!TP!0+E2,=/
M:7KQJ8]FVV5T*#.9\L+)&`TKI:'/+F#$"@=6A*\!IB8W/K[7]+VA:]<\CY^5
MA."'/:$E?5@A+TC:3;X9Y^U\L<E`6AU3+.%<ETJJ)GR"@1CIP+!$RJ*1N@'#
M0O7B&QG;$'`R[?V\VK30`]*0/<^E26,)'5:*&F%15>BW!IFW/<RTL(CWW<7M
M#AJ#FBS&D-Q`JXU#'$TU<Z47C^*LGSFW;K34FH-@[0YB4&O7#GU!PYK2SGME
MMMAL-%6GCC;+(=PG?;?6F$JXK4E8F)!27>L_-VCL0[)`$4P'JVEM%>W_`&S;
MW\U`+7<^MH(C!?&VTEM@[%V>LN8227,<6`U#J>7W"Y=:6W==SML!='IV_HAX
M+W`27DD,Y!`:"X1@!^D`-+=9&EU%:'Y?Z;DI+P]^0FEJE9-DR4VQXQ7VMU:P
M-K"[=;-L,U6Z$_4@@?6!LT%[+3-ED(Q)!\9-(JCTKA4A0**@=.#W7(^XVS<[
MQL0#HQUM#!Y7",ZRS0*ES7!I;IS=6E<5V^U6Q0;WM,,LGY$DXC<]QQ8V4Z"\
M./RNC#RYCC\CFM=0T56\UYWY`:9T-#U[8OB&UVGP?$>KCPT3H%8N+IU>N8+:
MU3[6_P!(W@5:J^=NZI`V-!!C%L9$K1J6#*D)%3D]L?M7K[F3?MZ=:D/W8360
MLF/_`+A]F;>#J22'Y3*9>H)B?,T4.G('EV<<+-IV6.]:V/;^G<&\='_?,N-3
MC&Q@Q(CZ6AT=,'/+Q7"HN9:L6NCG6.N7&R$6[;8B]#J"U];M"@1JA=%:_'GM
M*+8@"(%;I3AERD#[!0#-G<FVC=QW!M@XFQ$[Q&3QCU'0?Z:+G[<Z[=M]BZ_:
M!?&%AD`R$FD:P/`.JO>9I+<3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$7&M]R5^]G^U'(.114E_VX.0LWVK__U+C/AK_J&<4?S)T;
M\#-L@<59V:W?R55,(F$3")A$PB810>6G07CBO++/NZOS3XTQE;<S$BO`1SO3
MLBNZ8PZKM4\<T<K><F[Y=NT$A#FZCVC`(Y"M@NA'CUX\0`(CSAXP``!U$1TS
M(```'LB(^<>QA,%\Z.A?'8<&$K?G7Q87,4I3F*CI]XJ8"&$0*<0(Z,(%,(#T
M'V!Z9-"E1EA5?WU!^.SYQYI_?IXL^==CO/-O4\]\X[O^D[GSKO.Q_P!/3I@5
M-:<$P%*TQ7/_`'>?'B^?#Q@_0Q(^^,A,$_N\^/%\^'C!^AB1]\83!/[O/CQ?
M/AXP?H8D??&$P3^[SX\7SX>,'Z&)'WQA,$_N\^/%\^'C!^AB1]\83!/[O/CQ
M?/AXP?H8D??&$P3^[SX\7SX>,'Z&)'WQA,%N!PWU?XD='O-BD.9/(C3VW:(Y
MKP-J]":^U^[JLJPL/GB9_A!R^67,19GYF!B"GV1$3"`^3IA0:*2')4)A$PBU
M9Y=\KZ5PZUI7]H7V&F)N#G]GZ]U>1*%68(+,9'8<\E`L99XK)+MVR<7&*J]Z
MX'M=H$RCTS&R1K]RVC;*@27D_3:XX-:=)=5WA0+,V%SK+>+X8LL[22X<`*N<
MV,5+6C\1X+RB_._0K/D#=-#O[/"LD:'I>G;IL&T5;-7#Z[915UO-AH49`.)=
M&04!K-DEX$HF*IV2B5VB`>V-TRUH[U;-P>T:3!>16P!SDDFB9(SI_BKK#>9<
M"."B>)\)VYH&M]Q'+(`/N-AJ7EW*@:7>#14K+=PY0<<]?/+#'WG>&KJB^J4G
M!0MG:V*Z042O`2UG@5[378V73>O43,'LW6VRCYJFIV3+-2"H4!*'7*]6.@/4
M%"9`,<S"`90/&,$:Q]VN*""8LCD$3NFYH<#3`M<XM:1X%S7`'B01P6"=;6W@
M=$;3W-OJA;>U/+;(M.O*]>-JV\NTXVQ+0VIVQ$W,%*CYU-/&U2H2JBA5P*@#
M=FHN<%#`)Q`1B)D>VVM]`WR6XN@92?\`;2%[V->XXU_,?TVDT:UQ#`!@IE,M
M]<VCWMU3B!S8P!_Z<>ECRT##.-O4<,7.:"XDBJRTPYC<49.FL]B1_(S3+RB2
M$U(UQC;T-AUE2O.I^(B7,[)PR,J$CYF>28PS-5THCVN\*@F8_3H'7+RN;!TN
ML0W6TN;7#4UI#7$<P'.:">!('%8XV.EZW3;JZ9;JI]W4:-KRU'`<UF"A[#HN
MT:E%7W6UNKM[I<X@JXAK15)9E.04HBBJH@JHQDF"R[5P5-9(Q#=DP]#%$!\N
M7N&OM6.?-&X49JH1FVE01X$9+&Q[)"0QX-'4-.!&8^(42=*\96I6*6CYNR\4
M^1M$X^R&W932I>3TK&5N4U.UN+*^/M8M//U(>6<33.-?WID$>*QVX%044`3^
M3V8VW_[!NSZB(9K^-KK=K\.H7`N#0<@2UKR"<*M(S*S[A%Z&7>(FGK>@)$Q8
M*Z``PDD9X"1A-!DZN55N+7.?7'L\+L2P[2NE4T5#4/?^P^/321V?>J7%-+A:
M->..Z>OX!=":7(5"10`RR;5<4WJ*91[Y(@^3,-I.R\M=JN&&DMW&][8_O@,E
M="<L#Y@,6DCS`56>\LI;.XE@^=C(H'EX'E_Q$(F:W'&H:2,:5TDC!9QM/(W0
M5(LM*IMPW/K*LVO9#<KR@UZ;ND!'2UP:'*D9-U7F3E\FM*-U2KD$AT@,4_:#
MLB/7,[&N?=26+&DWC*:F?>%=5*MS'RNP\"M)Q#+:.\<:6C\GGY3ED<OO#ZPN
M`O)?CT?:3S2!=UZQ'<$>DLL^UI\=('XZM$F[`)1<[BO>>_"*7<QQ@7,`I@)4
MO;#Y,I&]DT4\\3@Z&($O<,0T--'%QX`'`\EDDC?$^&.1I:^33I!S=J^6@XZN
M'-==4>5W&:_0]XL-*WWJ2U06LT3N-A2\%?*Y(QU+0(9<AE[([;/U$(A$#ME"
M]I82E$Q!#KUP][8[1M](X"S)`#S\I)I05RJ:BG.JEL4KKCTK6$W./E^]AGAG
MAQY+W^L]LZQW/6$+KJ6_U#9%2<KK-4+'2I^-L4.HY;F[*[<'\6X<H`LD;^,4
M1`P?P9E='(QK'N80UPJ#S%:8?2L+7L<Y[6N!<TT(Y'/'Z%D'**R81,(F$3")
MA$PB81,(F$3"+SMMMM:H=9G+E<9IA7*M6HUU,3T[*+`WCXJ,9)&6=O7BP@()
MH()%$QA_@#,4TT5O&Z69X;&.)\<!_-98()KF5D,$9=*[(#,K$FEN4O'CD4PL
M$GI+;U+V.QJ@M0LJ]?D^\^!`?$749J223I-JLV0=$:J"10Q0(;NS=!\@YLOB
MDCA%P]M("XC5PJ,2/`T/%8`YKI.B#66E:<:<QS7WV;DGH.G6>ATNS[=H<-:=
MGN$VNOH1W8&/GMM75=`Q1)#E244(Y!=Z/<IF[0%.K[0HB;R96)KI[AUK"W5<
M-9K+1GII6M/@"1S`JKR`Q0FXD&F'5IU'*HS'T<>7%??<]_Z5UY>:=K.\;.IU
M6O\`L!44*94IF8;M)JPJ]1*4K!H<W:-WAP[)!-V0.?VI>IO)E83ZB=UK#YKA
MK=1:,2``37Z@3\`ID:Z*`7,@TP%VD..5>7\PO1US:.N;?9K+3*K=JU8K332M
M36N#A99I(OZ]Y\90K0DLDU45\R57,B<"D.(']J/D\F1&>K&Z:/&(.TDC+52M
M*Y5HDC'1.8R0:7N;J`.9`-*T^*]YDJJ81,(F$3")A$PB81,(N-;[DK][/]J.
M0<BBI+_MP<A9OM7_U;C/AK_J&<4?S)T;\#-L@<59V:W?R55,(F$3")A$PB81
M,(L9[H>V*-U#M!]4(YW+VIK0+:K6XN/[/GS^=+!/O@IJT$YTR@X6>B0"=3!Y
M1]G-#=&S/VZ\CMZ]=S"UM,ZG"OT5JM[;.B-QLC<.`@$C2XG*@-5!WPPTQO7B
M3LZA7RW07(+84?+<7ZS#[18N;.[N`RNW[MM#O&A&D3/3Z47$M=?5A$P.3M^P
M)4#_`/XAAZ9Z)QMXKG=]OA(-L^:UCB>[(%D#W2RN=F&N(:PT^]3#BN<\/N+6
MQW$@"<>I?(W)P:9&=.,-'EKYGNSR!QX+&D!5^6\7XG&Q.04WJCD=+:SJLA?)
M^9B'=I20B6U=CX92.IU;UBTBK?\`%C8$39U4Q<),7T<P<L%3AVW!_*(<W8)6
MVNV;E+=QGJOKA\SS)++\A:<"V)ORR-+?)6K2:+>W6..ZGLX89F@-T4.3-+&$
MEU1BUSS\['!U78`@962(:1/+Q$9*G8/(L\BP:/CQLB1--^P,Z0(L+-Z1%19(
MCIN)^PH!3F*!@'H(Y>5G2D?&'AVDD5&1\1X+1B?U(V2%A;45H<QX%=GF-73"
M)A$PB81,(F$3")A$PBC6\5+B;=^:'&RN:8H\5"3:AM[Z;MULC)Z=/7F3N@U>
MU)/;FBG(HB5P#M2$,H5(B1B*G,/0ABFZ#FKZ:.7>^V[JZCU;?;W6N85H=!8Y
MII0@DX\""MV"Z?;[;W)%!)HOI]NFBA-*@2N`T5P(`J,201S"CCW?X,3ZK6?E
MLPX7:\H^NM<;;XD:MJ=,AIK8%ID@FM[4#=DSL>39RRUKD[-,P\5-UZ/BF:;K
MO_-$U3"/8+V5#"ADW""*X<2U\D6]V=U`TT`Z,,<8D!(`QZG5<`:DB@!`(I=C
M[,7.V38MI97T,IQ)UW$4D<3@,B!J;JI0@`FA.?@G?AF<TN0.[;;M[DUJC1K"
M-VCRIXD;7NVO(78)+=6D]<:9T39M8VN+<C(1;8\N_*Z<,BF0$G=NC**"F(I%
MZB-I&V.U8PEQ8-[?4X:9=P@'IM-/]G-0%V!&C72A""\/Z?;6M0#'%9Q`9DM@
MN9))=1I2LC'%S0,`'AA.H$KR6H_"!Y7Z*UBU+JZAZ$C=I2'#WD%J.[!:'L#;
M*U<;W<.4M<V+KN&L4=-P<O#6",9:BB3LFJSYLNSC52IHB3L!US+N?4FMY[:T
MQMY(=GU--*F6VB<+]P)K21TCW&.3,X$4H`(@=:->Z5[M-P+V]<QS=0TPRPEE
MNTTH=&H-+XQQJ<:E=7Q1\%[DC5XC6U3Y(4G5-DI"7-*&Y$WRHM[;"RE>2HZO
M'RTTF0KX0416ZY!.W,7>'S1-1JU:$;.FX]KJ<A!$VY;FWBNME?+'KCM+;<(Z
MN&NKKD6CHCYB2::)6FORO8)&CS@CGW!EG@[AT/Z<UU'9:0TZ0#;W4LD@HT`-
M!8YI%,VGIGY5.=X=7&RV<4^/M@U!:8J#@4D-Z;\M5*@ZY(DD8>'US=-F6"PT
M*-:"F0B;`K2N/D"BT*'1L(=C[&:9-Q-L>RVEQ(7W\.VQ0R$FM9&-+2=6;AEY
MCB5GNA;_`*KNMQ:-#;2:</:`*4K%&'X<*R!YH,,<,%$_0^%?B02NB7_`BZ:D
MT53>.MCY(6+:=CWX7;J\_=PI+GDJXY#IQT30(V%ZH3TF9NC&HG,N!4!4$YS$
M#J8N3;`UT/9HW*K/TF.$EK,3(Z'60T.R;5[PXG(L86_>HKW\K6;AW?=[>1(=
MSZP&JH#!-;LMG$C,T8UQ;D0\@_=QP%RQ\';EULO7U^0H5+HD[=9#Q`.5N]Z:
MJ\VM#1";/4^ZE&*]<D)"*LU/LM5D)%P:(1!T@J"<BR.!2I&,1182\O;K:YMK
M?MIK@UMU!MKX)78.:'^K?,VC?PT>'5;0D5:X"C0NKN-[9W$UQTW.=;%EB&BA
M::P63(),<:T<TM`<",0YN;EY/EUX*7/O>6V]+VY6YZ^N)#Z/T5K[8L]6+7!Z
MTC]9W'6<0VB;))TB'?:_DY%"OR+HH/&A(0D>8.[,0Z(=2%#NP%C>Y=SOW7#V
MV\MZVY;-F_5TV!X#?FPDC<YC7.+`)`#2CUPFR/.R;7;2-!GB@DB=&0*:3(]S
M"30M+C&\,D<`"7L+LBTK-MK\*GG'>/$NBN4%I::7=:GJ5_G4&DE6YN!HUINV
MN[)1[#7$)*SDK%%96>0MD8O*D3DG;]^Y7<I]D$"B1(@!QK:W>;+?X+NW:'WU
MK?PEK'%L;>NV;HZ0#Y6D.8QQ`+VOK+B0MR>5K1M,=M<.<VUGL)`]XU2'H/MS
M*'.(\Q'3>]K:M8X'10!Q6OFG?!4Y^U[COS6TD9[K/5<-M:MZZ;ZRAV]TK5LE
M[+,:\VK$7<L5)WF(U_#R3"LS-:B%H]4)8KLR[ATDHNF8I%>FW<B>?;=O$C]=
MQ!>Q3]*@:'AL4L;P\BL9(,C)(QI($D0Q`-0AFCCW.=S#HMI;:>,OQ<6E[XW,
M+0:/%0U[)"228Y'4!(H9;/!9X([TX0:KVY'[W4:1=BV5>(R=9TZ*N4+<(>$;
M1$,6-/(ME:[5:M!QKB7$P`HBW2.`@B!C]##Y>K+-"-NL[2-Y<]KY'FH/EUT&
MD$G'Y=1H*"N'$#E=)QO9+DX`QM904H=)<=1``Q\U*DDT"FHS06PF$3")A$PB
M81,(N)==%LBJX<JIH-T$SJK+K'*FDDDF43'444.(%(0A0$1$1Z`&$6*O7WH_
MY7]:>FU<_&.14*VEW)/7WH_Y7]:>FU<_&.*A-+N2>OO1_P`K^M/3:N?C'%0F
MEW):8>('8:WOGBELW3&J-O:O):-FHPU.=/5=A51D$56)B99(6J535=/5$5%F
M,$*QR)]D14,`%#V<UI[9MW/ML,TA9:>JB=*X4)$;7:G4!P)-``%N6=P;(7ER
MR/5<BWE$8K0&1S"UE2,A4U)6A9/#?T)2M;V2"U7SX40OUKD*\K<+!;+I3V$#
ML.L5)I)H5[75OB]=O*B\:U1NM+N%%%8Y9N^4,IU,H;L%`-B[DDF;$UC&.A$C
MY'QOU:99'@-#W4-06`>4#RU)JTU6"TZ<!<7-<'B-L;'MTZHV`ZG!M00=9IJK
MC@*$+`EUXP7&6WI2GSF4XL/J-5HOC_.LK55=R,&_Q'9:'EYFRR^J=:QEE<+S
ML<XV19%&ZPR:ZP=@AS=\<PD`!V[2[$.X7.Y/8\S17)N(\M4Q%NV*&`D4#8XW
MZRX4HYI&%:I=L;/80[<UPZ4MLZ!YH0(B^8ODN.)<]T>EH%:@C,!90V?J:V<@
M>8338E\E]`PNO+O*<>KS(WQ[N>JRUOTS$ZA;EF[%J6I,6RI53O[5;DNBTBU4
M215;JB)Q]J!<IMC+>QOY9WR$MANI9@X5!N`^`111GBUD9+BX'`YBI*RWUPZ2
MR9!`RKG6O1`=E$XS%\DU/O.>S2&\01P6XO`C6.D>,-_Y?W9:[ZHJJ&[MWR%A
MJK!':T;978TN-\Z+%O7TA*S;YXBXEG3Y9R9`53`D)^R`%```)MI&0=N[1M@P
MGC?,YX&0U/I$*YDMC`!)J2<R2M6^:+G>[R_8T]-T,302?F=35*[3DT%Y-`,*
M`8!24^OO1_ROZT]-JY^,<UZA-+N2>OO1_P`K^M/3:N?C'%0FEW)/7WH_Y7]:
M>FU<_&.*A-+N2]16-B4&[+.F].NE6M+ADD59XA7YZ,EU6J)S]@BKA-@Y7.BF
M8_D`Q@`!'R9*@@C,+V6%"81,(F$3"+C6^Y*_>S_:CD'(HJ2_[<'(6;[5_]:X
MSX:_ZAG%'\R=&_`S;('%6=FMW\E53")A$PB81,(F$4(UHX&>*9+62>E('Q:9
MR`A)&7D7L3!DT16')8>.<NE5F<85P:6*9<K%N<J8'$`$W9ZY6AYJU0NB^K\\
M6+_.`GOT`U;\;XH[FHJ$^K\\6+_.`GOT`U;\;XH[FE0GU?GBQ?YP$]^@&K?C
M?%'<TJ$^K\\6+_.`GOT`U;\;XH[FE0I-^)>I]\:;U<-2Y$<@W7)2^C.R4@&P
MGE384Y4D2Z,06,-\%1[AR@8K$"CT4$W:-VO8\F2*\4*V?R5"81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$7GK=68VZ5:Q5"9
M!<8BSPLG`R8-EC-W`L)5FJR=`@N3VR*HH+&[)@\I1\N$4!?[L]X<G_&W])C[
MWIA34>/UKH[+_P`N%X9%.KLY;+-)[CAJ[6HE_.3LL]V@^3:1D3%M57L@^<J>
M:#V$&K5$QSC]@H9CEEC@C?+*\-C:,2>"R11/GD9#$PND<:`5S*PCH_P4O!7Y
M).+`TT;MV^[)<59!@[GD:YMQ\Y/'-91NDZ8NE2G8)B9LX26+T.7J7KY!'J`A
MFR8)A`ZZ+#Z</+"[@'#$CZL?@L)D8)6PU_-+:@5S&7^5-;>"EX*^X-DV_4.M
M-NWVX['HA'JEIJD-MUZXD8Q.-?)QDBH(>8E2=)Q\BJ5%8R)E`24,!3=!',4`
M-S;.NX!JM@0"X98UI]!H:'(J\_\`AIV6TX+9W`T!..&)'Q`-2,PMBOW9[PY/
M^-OZ3'WO3"BH\?K3]V>\.3_C;^DQ][TPE1X_6G[L]X<G_&W])C[WIA*CQ^M/
MW9[PY/\`C;^DQ][TPE1X_6G[L]X<G_&W])C[WIA*CQ^M/W9[PY/^-OZ3'WO3
M"5'C]:?NSWAR?\;?TF/O>F$J/'ZUO3P8\*CC!X?%LNURT+\?OAB^UYK69SXW
MVQS86OP:SDD)5+S1NLDD1!?SIN7J?RCV>H?9PBDLPH3")A$PB81<:WW)7[V?
M[4<@Y%%27_;@Y"S?:O_7N,^&O^H9Q1_,G1OP,VR!Q5G9K=_)54PB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,
M(F$7&55(YC$(HF<Q?XQ2G*8Q?_M``B(81<F$3")A$PB81?*]>LXUFZD)%VV8
M,&+=5V]>O%TFS1HU;D,JNY<N%C$10013*)C',(%*4.HCA%K%_?FX5?.ZXS?I
MTUC^4^14<U;2[\)6N?+CDEQ:WCQMW%J"A\S^*<)9MD4>:I[*4F-Z:X^#V:4Z
MU.P>*.`;V85A`6BQP#I]D<U+RV%V+:)Q'0$\3I!SC:\.>T>):"%N[?<^AG==
M='7(V-^@'+66D,KX!Q!*TIU*[T3Q_P!N;'N^G^7_``(AHB\P>FM7L//MOT+O
MJSJ_7VOT(6;<,8N/L[-DXL3NUH><I$4$45$SF%3VPYU;F[DN+?<[4.#8[J^N
M+@G,M#H>G;M`RHT@!X_#6F*TH88HG;7*\2.-M91Q:*T:9.MKF=7$T<PG2<]5
M*K7+A_5F7%[;6W]RM^<?AS*S=GBW<#6*E$;HA24N5?V:^Q=DN6PI%C)75X[I
MTI(1K-<0C8I5-BH[<]3%`J90RNW2QVVWV]E-7IF2!K@"#TX8P[6V-QQ<7$@M
M:^K6T4[@/4W,MQ%'YV]5[79&21XHWJ#(:?O.;YG?25/<'.;A7T#KR[XS=>GE
M_P#GIK+V?2?,%0JZ7<6FJS]2[S2MCUUA;]>VZLWJIRG?_!EFI\[&62OR'FRZ
MC9SYE,0[IY'NO-W*1DS]A0W9.42CT$!#"BE,UZK")A$PB81,(F$3")A$PB81
M,(N-;[DK][/]J.0<BBI+_MP<A9OM7__0N*^&ZLDWX#\55UU$T4$-'TE9994Y
M4TDDDX-`ZBBAS"!2)D(41$1$```R!Q5G9KWK_F]Q%C+<6B/N0^JV]K,X!I\$
MFM+$QBNA.*0-U'B9CQZ2XJ!V>P94#=?L8!!R*:7<EL8VL=?>/6D<TFXIS(/X
ML)MDQ0?M57;N',=-,LHW;D5,JM'B=4I06*`I]3`'7RY(\VJF.FE?"N5>5:8*
M""`TD8$FGC3/ZET+G9NNF;>P.W=YJC9M5)!*)LSA:>C4TH"46,4B4?+J'<@5
M@\4.<`*FKV3"(].F0""(G`^5[M+?[3A@0.9\`E"'/93S-:'$<@14$\A3BO:I
MJ)K)D52.11)4A5$U$S`<BA#@!B'(8HB4Q3%'J`AY!#+$$$@BA"J""`0<%^\A
M2F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81:T\NG+]GH:X.(^6O$&HD:+,ZD]<6.MU2X-HX)%N,D:)G+8LA"M5!9=OM
M`<W>*%]JF`G$`RC\&\5>/%V2A.X55NL[!YJ?_)^5W-%:KIB45<6UQLN])Y[<
M+HZ8-(UX_B[W2;`[<QL[!S$L9['+IQK-$B*:'?`Y.50H%L`,35''($*3B8L>
M^*!S>V3:K,[N]MXY(<<(N5JM1J=97>,(FWM[C'1L@S1*BN8\_;Y!,Z[H>@$%
M-D)2@'0@B.>P;'Z+=&7)K>/N[=L;C@`R0O9@.#6>0RN^)R"S7K6.BV=]L0`&
MW!E&9)8QCVD^+O,V-O$CF5&A=[IRDMJ?*QUKUUR+AJDPY`5./@82YQUY^.5D
M8PTK?)&?E*4[K\.S3JM`N<DA$PD:DF9P#=J4'#L2D4#-2U<]MAL$LD8>XW3C
MH!H\LZ#FL;,YV`>^0B4@C0R@:34K-,ZW?<[M#&.GILL7D59K,T6HQ-&)$40>
MW#SO+BX"@7JZ)S,\3*C>)7H#C7R.UMJVB<;N20[;?Z@2;.HJQ[,&J:RJ,9,^
M:VB7AK"]\SL46XGV"+P[ALB#I4513+T`>G2W)D,>Y;A';W#9;=LSPU[06M>T
M.-'-:<0'#$`Y#!<3;S*[;[$SPF.8Q-U-<=3FG2*ASLB1Q/$JPGFDMQ,(N@M=
M9BKG6;!49U)1:%LT-(P,LBDIW2JL=*M%63Q--7LF[LYT%C`!N@]!PB@K_=K_
M``O/["[+_2`3\0XHGT)^[7^%Y_879?Z0"?B'%$^A/W:_PO/["[+_`$@$_$.*
M)]"?NU_A>?V%V7^D`GXAQ1/H3]VO\+S^PNR_T@$_$.*)]"ESXP<9M5\0=+U;
M0>EHZ2B]=TY276A64O(C*OTU)R6>34@9=[W#?O>\?OE#![0H%`>GV,*2:K8#
M"A,(F$3")A$PB81,(F$3")A%QK?<E?O9_M1R#D45)?\`;@Y"S?:O_]&W7P7=
M,6/AH:'?2:K=&-9\98IU(+.VJSYHDQ;TU19VJZ8MC%</&Z:!#"=),0.H4!*4
M>HAE3@UQ5_OCZ%#CJ273Y3[7U6SUQ2*+"Z.U_<&4'LU[KO34:>OWPEA7*YA7
MMP@;.V4LT4E(LVYD06!PN1L=0%1`JA>N0P`M8X_+16<<7`.Q4UTMQHME1Y//
M>1.I4(%3L\<7NJH^L62R3S:'+86$W!.JNU:1B*+UC!5Y*,BS@NHW)WQEC=1*
M;KU"UJ3;1;G"`"VXE@->(#2\2&O@UPT#*HQIFL\TL,]OMT<E1+`Z7$`4H]K=
M(\27@U)Q`IRHM$9;PXN1TBAMF06M%+>.[1<H^>;UAQ.2(PFP@&2ODD[F+@X-
M%=6LFQ/=&Y4BB17M_!2?E`!+TAT;!M>U;<P^>`N;K.;1Z9MN)FT^^7-,Q'XG
M'&N*V(K^)MSND[[1IZX#A3.OJ!.8C7[C6CHM/X3E3!:=6/C;MW@9XA_A?59G
MS!Y$;8AN0]ZVE'[%J%[N"KRG()T:OTY=M'P\8B5(%(Q5S:E@[*X&$"(I].@]
M<VKR5MQ=W,[&T8]Y('($U7(MV.CMX8W4U-;0TRRX5QHK4&:ZNF$7G9VWU2KG
M8)V6RP-?4E%O-XTDU+,(P[]?J4O<LRO%T1<J@)P#LDZCY0PIH3D%Z$!`P`8H
M@)1`!`0'J`@/E`0$/(("&%"_N$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3"+6CEUH`O)S1-LT\+F)9GL"\.[0<3GP[\&IN8:3;R
M;<7'Q<E(>5Z"JV``$JPD`?XY%"]2#1[=3:#.JNQP:ZIR6C?$[CQR?TS.:YI*
M]$XA5.G:X=.&#^\05MO5_P!M3]8D)A:5LC"-/+UZ&-'+3!W"H='2O<M#*?S:
M?0H%&PJ<U!TC)2]Y*JF$4)'-_P#Q@/!W_P#;G-__`'+U5@)P4V^$3")A$PB8
M1,(F$3")A$PB81,(F$3")A$PB81,(F$3"+C6^Y*_>S_:CD'(HJ2_[<'(6;[5
M_]*X5X=D<WF/#XXQ1#L50:2FA*E'.1;JG07!N^KR;9845TQ`Z*H)JCV3AY2C
MT$,@9%6.#JK0]S0^+VH>1X<;*QX@FZ]<6NXV&./(Z'JKR(3D):8F$#.6K*0O
M3&J?#R"SIFF`CW[T5P3`.IP[09#1DT9!6<XGS$8J<R&C$X6)C(A%P]>)1;!J
MP3=R3I1[(.2-$"(%7>O%A%5TZ5`G:44,(F.81$?9RRQKLL(H)/$M_P`3OP4?
MSH\D/]WM3X5AE_'(J=O"JL8[5W%K_2L"SLVQIE6$AGTFE#MG2,7)RIE)!9NX
M=)HBA%-'BY`,@U./:,4"^3IUZB&0312`3DJ)/_,&H;7Y*<N]57[1-ZM]]UI-
M5J)J-.@89M;8@E*M\>==Y+F^#W#=IW:TDF'G?G29.O82-U-[3R0",2K$.%!1
M6P.%/*G5]/T#Q_T[M/=:EMV_#TFJU.T629B+.U;REG18I-UA=S\PP3:&,"A>
M[%=9?HH)>UU\N`1DCFG-2@IJ)K)D524(JDH0ITU$S%.FH0X`8IR'*(E,0Q1Z
M@(#T$,LJ+]X1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(JO_A8AJ\>>FQ'M.VO?;*Z>MMOLQCK>U=/92V24=862LS9)=R>V3!:]
M%E;O$!8-E6;=91R5T81`#`F2&?(<.`5GTJK#<9O_`%1,[NL7':*M;1_MJI4]
MA>;+5FR:ZBT+7Y1RBVCUW[D$O-$'#H7*9RHB?O>Z.4_9[(@.7A:ZX@NKF(5@
MAD#'NX!S@2!XG`UIED4F8ZW])UO*9PXL'$AM*GX8_3P6%97GUQKAT+LX>VY^
M!*):TZE)%2K\TLK)//.[$S=R5>329&/.P48M4);SEXV!1!$(UP)C`"8Y5OFA
ML[@^6*=U&DX4:6=1KW?AC=&0]KS1I:00<5GDL[B)\\9C)?&S4:8XZFL+!S>'
MO8TM&(<X`A1J<I]M:QV7XQOA-QFO[[5+C)4Z$YHM+9'UV:8RCVMNI.CZR5CV
M\VV:+**QJSU-FL*950*)NZ/T_BCF66&2WFFMYF%LT;BUP.8<TD$'Q!%"M&&>
M*Y@AN()`^"1H<UPR+7`$$>!!J%/UF)94PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PBXUON2OWL_VHY!R**DO^W!R%F^U?_].XSX:_ZAG%'\R=&_`S
M;('%6=FHD-NL++9?%MC(RN\<"V*#@-G42;E[?64;:ZCU9`*L@$K<=@6J'E_B
MS"/HE@DW,VB'J!#'.V24$IS+$,,-.)^)5S\K?@K)8*$[?==LG>`4#BGV@[8$
MZ].UV>O:[/7R=>G3++$N'SUGT4-YVVZ(CT6'OTNB0]>G10>WT(/4.GEZ8\>"
M4-:4Q4%GB5B!O$Z\%`Q1`0':'(\0$!Z@(#7M3]!`0\@@."K#+^.14[F%5,(J
M3O\`S%7._G!H7F=I&E:>>3]`H5!A(W86MYV*KGGY;=?)5M(0\TY\]79N49`\
M8P=J,?-$_*4BYA$.IP$(5@2`*+W/C':!\2[GOQ)X#;4H.N[Q+R!]=JRF[=/T
MI*1CIF*V%84(5PRL;^LD52=.&BK1$Q"E,4PL1[74`!01Q\4/(*P%X1^G^0NB
M.!&C]9\GW[]WMF!CI8T@RE7YY.4K\*\E7+JOUR0>G45%5W$1BA$S!VC`3^+U
M\F%!X<U)/DJ$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PBK$^$1NCX4YG;PUTP<.)B"D'>SGL?=9OC]6]?SES^";>Y>E5/L]K./9
MJ[I,6DLB)#*($[U`Z:ANG7#?EK3@%9Y\V'-3FV[B['S>Z;3OBK7>6H%\LVH4
MM3G?P</$KF:$2L[2Q$M!CNB]7\N5%F5D!5@,4&X!T'VH!F6WE]/#<VX;6&6>
M&1PX4B<YSF?"4.<'G/&HQ62:;KQ6<;V^:`3:3QK*QK`?_P"9:'-&5<#@M6YC
MPM*!+-K>D&T;8T=2]C=OZ>]3A(=12B5>:<;-7L]1;IG6`DVG-%W%8"%=K]VJ
MW*Y1Z%,*`=O&:/M[6VE%8V,;$ZF!DMXX6P10GEHC8SSC$N%2."V'WTCG3/:T
M!SPYW.DSY8YGR_Z<D;269#$`XK1K>O&#1''CQCO"ME]/:X@*3-[*@N8#K8<Y
M%-S$E;H^K-!UPTAI"PN3''SUZT2E'(@IT*(F<'$?9S9O;N;<+V\O[EU;B>5\
MCR,`7/<7.-.&)*X]C90;=8V>WVH(MH(FQM!Q.EC0T5/$T&:L99JK:6+=J[:@
MM10[*:GH"^6!N_?%8)-J!29Z\222IDE%@5=1\`U=N6S4"I"`JF`"`80#KU$,
MBM%(%52]\='Q$^?\5R-U@PXTN>1.G=-(14>K53M-?72D/+K>U'KDKQI()OXI
M%:;,DCW1$V?MTS`(CV1'V&:D@BE`K,W$/FS8KMIG2#'>^JM[P&\+#7:_'WOO
M-%W]A7FMF='*T.^=RBD0G'L&BY1(NNH)@22[9AZ@4,5&2DM.=0I+LE43")A$
MPB81/8PB_":J:H"*2A%``1`13.4X`(>00$2B(`(#D`@Y&JLYCV$!["#XBB_>
M2JIA$PB81,(F$3")A$PBXUON2OWL_P!J.0<BBI+_`+<'(6;[5__4N,^&O^H9
MQ1_,G1OP,VR!Q5G9J+[;V@^2*?BI5S<]8X_N$M8RFRJ<QDKU!3UI5/8HN,JA
M2O;?8FD=>XZKL6[!-8[8A'D8H<QFP$Z&,<@Y#10FN&)4NH0/@%NY-ZZY/5_G
M3==U15;L-KUBA4'`0K)A;(AG&ST,C2Z8S8T1E#2<ZV096(U[82CSSE9!-`$E
M@$5?;=,S[>]L-K>QSM_,D>X'C75(WI/:>#8HM0>,"2<`5LWKHI[:PCC>`]A:
M1A0M`$W5#C][J.,6C.@;0THL";5XC;OF:?R3L=-J%OK<_M+=M7D8NF1EM831
MWNO*<<)-NY!N_N<='1XVJQNUC2!47*:A6O0`2Z%`!TW,-K#LT5M^88[FXD>#
M\I^>*!I.89H#)*XD.=4BHHLXG@GEW"29Q8YUG$QK@,=1+7S$"E"X5=&*T!#<
M\:J-J^Z7YGZJ\3'PCI/EKO>O[00N&R=R.J%KZO03F/9Z?!G7:*K/5Y.7<2#\
M)QNHG(L6Z:A1#R,>T(CVLZ%\8C>7)MY"^`O.EQ%"17B%Q[5KF6T+7MTN#:$<
ML/XXE6X3J)I].V<A.OL=LQ2]?^KJ(=<UEE7X\X;_`-.C_6D_E81:`\RX&K6+
M;O!<)V'@9LJ?(V13*$JP82($2]4]_<B0/.DENRGYRW34Z>QVR%'V0#(/!7;D
M[X+?TJ[8I0*59`I2@!2E*HF!2E`.@```/0``,E47]!P@/D!=$1'R``*$\O\`
M]["+FPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M10E\'N1/#W;_`"WO\3J?C@KK;;=>97BHKVI)*+.NC6:M/B]<GL4/&G%:ENK)
M*SSDR"3I--PJ")DS>5,"EAF+21E@K/S%<U-IDJJ810D<W_\`&`\'?_VYS?\`
M]R]58"<%-OA%3VYW?\Q7R'XQ>(79>-]*TE3Y/5.L[G`U.Q,;!'SBE\NY9%C'
M.7K^$>-I%NWCP4-)AYB!$%`4[`";M`80R%.`PHK$O*-9A:X;B'.O(A(OPKR9
MTO*ILY)HBLY8?"<-87AFR@+)F%)9'O`*<`Z>V+@\%9N&KX+>3)5$PB81,(NJ
MG9N,K4-*6":<BSB(9BYDI)V"#ET+=DT2,LX6!NS1<.E^[3((]E,ASC[``(X3
M-:ARWB%\/H-BO(RVX&\>U034/VWU-V$Q[XQ"&4\W:B^J;8CAVH4@]A(@B<_3
MR!G)WG?=J[?LG;ANUV(K4&E:$DGD`T$D^`"]CV/V!W=[D;_;]L]E[+)?;U("
M1&TM;1HH"YSGN:UK145+B`%K9R4\0'2FP>,^SD^.>X`>[*DZZNTK24?5[VG*
M(NC.42/$"*I5ONXV258`KYOWJB?:,("&>2W3?V]V=H[O-V3=F:]TZ10.C>#4
M:@`\-(<6UT\^"^U=H^VTGLS[X=B[;^X38'6';_7;+*'EDT3XZ$,<3$9&OC$F
MG6!4@5J%K?X.\'RS;6:]6';#:^HZDGJH1Q#KWYP_*N]M!Y5JHW<1#&7<?"21
M3,1<BL<42D'J'4>O3/!>T%EW;;;GN3MUBG;M)A(_,)QE#Q32"<<-=2,,L5^F
M/WV;[[#;KVYVE![>W6V2]X1W0+O1-:`+4Q.PE<QH;75T]+2[4,<,U/IGZ`7\
MS$PB81,(F$3")A$PB81<:WW)7[V?[4<@Y%%27_;@Y"S?:O_5N,^&O^H9Q1_,
MG1OP,VR!Q5G9J/#8W(#EJEXK$7I*O[LK=?U8YD:BY9TV?=Q]=C'%.1BE7UDA
MXZ%EZ2J]NUME7/;Z.F4N/<@*0=$P3,4T-Q)J5+A0##@I[LLJ)A%!)XEO^)WX
M*/YT>2'^[VI\*PR_CD5+GN+CSIW?K:&9[;IC:X-J^LY<1";B2FH[S-9V1--P
M<IH>2CCJ=X1(H=#B8`Z>3(I50'%N2P/]7!PN^1*,])[Q^4V*!6ZCEIUR<X$<
M2Z_M'AQ'Q&H(YHSM._7\+.HA8;BJ#^-+JV^2!6QC+6%0Z(%>,TS]I,2&ZEZ=
M>@B`Q3)6#B0X\EN+]7!PN^1*,])[Q^4V30*O4<NQB/#UX?0,K'345IJ.:2<2
M];2,>Z+9+HH9N\9K$7;K`FM8U$CBFJ0!Z&*)1Z>4,4":W+<XI0*4I2AT*4`*
M4/X``.@!Y?+Y`R51?W"+KY*6BH9OYW+R3&+:B<J8.)!T@T1%0X]"$!5<Z9!.
M8?8#KU',4L\,#=<\K6,YN(`_FMNSL;W<)>A86DDTU*Z6-+C09FC031?:DJFL
MF19%0BJ2A0.FJF8ITU"&#J4Y#E$2F*8/8$/(.9`0X!S34%:SV/C>Z.1A:\&A
M!%"#R(7Y671;)*+N%4D$$BB=598Y4DDR%]DZBAQ*0A0_A$>F'.:QI<YP#1F2
MICCDF>V*)A=(XT``J2>0`Q*^6-E8R8;`\B9%E)M!,8@.6#I%VAVR#T,3O4#J
M$[11]D.O4,QQ30SLZD$K7LYM((^L+/=V-YM\O0OK22&>E=+VEIH>-"`:+[\R
MK53")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$6/=H[(B-34R1N\Y$V>;
MC8Q5DBM'4^$6L,\L9\Z2:)F:Q2"B2JY$U%0,H(#[0@"/V,@FE%(%<E"%X8;R
M8CN5>^VQ[==86L721N$[!:D?ZZE%ZB@I'V:03=V".W'>R#<YATKWI1/&LS_!
M2`F_FPZ#UPW)2_YL^*VQ/LCD)2^;>V9*RM]GS>EZ[#R3XE7@XT\K5%J&%%UV
M2FO*BQ.+9JYO3K9+R<*^`JQ7`MB"!Q[HB09EVT:[.=MP!U7R:"3FV9]X60Z>
M4(LBQ\I%0'U)\U5M;@U@CLG6^@``.PK5T;;>5\^L9=3U`8R(<6$4S*UWVZSY
M0Q5:Y'WJD7'D#%1:O)^%IE1IDQ:K]-.W]"J<=,6"9?4YU!O%IVGQ.R[A(M(E
M!=J<C5FQ0*!P(GVS9AC8^SMMA;*UL[Y+F9Y:"=738V2"")S\JN>WU#M?E-6A
MQ(P200SS;F^&01M;8Q>8BK1)(^.29S6<XXB8P&^8$.TXK6"]7+EK;?&5\,L.
M2&HZ3JRE1L1RS#1AX"Z.K?<;!7WFO:`K/AL?O4DV<?/PPI1Z8BW,HFNLLN/:
M$"E$=_<8X8MRW"*VG;+;MF>&O:W2U[0XAKFM^Z'#$#@,%Q]O?-)864D\+HYC
M$TN:XZG-.D5!=Q(XGB58FVC1K?>HJ/84[;MPU`\9O3.G4Q3H>C3+R3;F1,F$
M>Z1O=7M+!)N1004`R*2:O:#H)NGDS1->"W13B%'3?O"9UYM+;T!OS8>X[E;=
MQU8[52!O\OK'CTK-,E&)#)LE3E3U.FQ?*-"&Z)&<(JB3H'3IT#I%#S5M3?PJ
M"SQFO$EVEPDWWJ/0L3NC=&U9BESM2W)/2L]!Z)K[*+-'K2K*+9UU.)U"B9S*
M`BHJ;O'/>M"]0`4CCY04/$J:M&3<U8+XWQ&T>2VB]8[WJG-#D-$P&SJJQLS"
M+EZ#QR+(QP.>\2<,G0IZ>%)0[9TB<@'+[4Y0`P>0<8\U!+?PK/D9H#=;*18/
M'?-#=DLU:/&SES%NZ1Q^1:R*"*Q%%6+E5EJ1L\30=$*)#F2434`IA$I@'H.*
M.YJ*M_"ML<LJIA%_#%*<HE,4#%,`@8I@`2B`^R`@/D$!PBT>Y[<7(GDUH*<J
M@3!*G(5A1>[1<F@Q3614=P48_4\S>()]V=1LY2.8![(@8#=!SQ7??:/_`/L-
MH;8,NNC/')K:2*M)H11U,:8\,E]]_;G[VO\`8CW`9W<[9_764MNZ":,$-?TW
MN:XNC<<`\:12N!XK#/A6\7HW1_'QA<',T2RR>Z&4%>%2'9`BUAV"\?VHZ.22
M5,KVW":2XBJH'\8WD#R!G/\`;SLB3LRQO([F[;+=SN!=IKI`:"`!6A.9J:+T
M_P"Z3]Q$/[@>Y]FW+;MB?8;/M\#HXFR%KI7E[@YSGEN`R`#02!]*E&*4I"@4
MA2D*4.@%*`%*`?P``=``,^BY9+\N$DXDK]84)A$PB81,(F$3")A$PBXUON2O
MWL_VHY!R**DO^W!R%F^U?__6N$>'=Y_]7MQD^"UD6\GZ@JG\'.'#<SM!!_\`
M%U/S19=J55`SE%)QV3&3`Y!.4!#M!UZY7@:9JQ^;%0XUBW6>^>(Y`W&TUJ6V
M=>*9LFMZYD'-DXL[24C:\"4,Y";MNM+78KP[HVMHA`5NTHX1;"NN'4Q>\[8#
MD-.5.*N^E*<E9^RZQ)A%!)XEO^)WX*/YT>2'^[VI\*PR_CD5.WA55&7Q5_%=
M\3G0_BDV#3>GYVQ5*@5"?JD5KC6D?6$)"'V;"2L3#NEY=^"\<X<3YYETZ6`#
MIG$&G3L%[(D-UA3RP61/&]\7GE1QSY'<7*+2J16:?):SIE(WR]>66(5F!FK[
M<*D^BIB'3*L+=%.%@VLJ[:&*GU4%<PF$P"0`!B:*2:5`5LKB-NF:Y%\9])[P
ML=9-3IW9NO:[;9:MB*QBQ3Z48IKN$$1<)HK^;BH(F3[90-V#!U_AP%!6QF2H
M3")A%"IXMW&ODKO(-;2NE$YNRUV";N6,[2H:4\P4"66=.%F\^=`[QLB\`K8Y
M41$>ID^SU#V1SX=[O=L]R;Y+M=QM#))K.-A:Z-IR>34/TUQPPKPIXK^AO[&/
M=WVA]N#W=9>X;[>SW:Y>U\-W+'K'2#6AT((:XM\P+N3JXY+LH/1'*/1?!^1M
M,_RCVS4M@Z]U;8+`C48UM0IN#AG4<V=OXV)6>6"KS4L]\V2[!%>TZ,7J`@7H
M4`#/?=A;7NFT=L;?9;O,YUXVIH34L:35K*X_*,/#)?F7]QO=_9O?'O!W=W%V
M)M\<';DTK0S0W0)7-:&OF#*#3U'`NI09\UV_(CC!R>V9Q8<*T?DUMV_6RP0=
M<EG-)FB42$C)YLL1!W(L$7]<K=?DD%@,8#)E%QW9P()3%'J`AK>X^T;OO7:U
MU9;,]WJ];'%K30O8*ZF5J,Z@TXZ:<5U_VM=Z]C=@^\6Q=P^X-G')L#8I6:WL
MUM@E>!HF+*.KIH6Y8:J\%\WA&\>.1.BJKM-7=Z,S7XRS2<%\5J=,R`/EF;B-
M))%EYDA".W*;0)$'**?9#H)^Y[0^SGD_:'MWN'8X=UDWACXK>0L#(W<Q74^E
M<*@@>*^W_OI]U?:GW)WKLMGMU);W5Y9PS>HNHF:`YLACZ41):TNT:7FN--5%
M,7GVA?@9,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB818DWE3+AL'6-FI
MU&F:[`S\\V+'DDK3#/IZ'28.3@C*)JQ\;+0CWSA>/44(BJFY3,BH('#RAD.%
M116:=)JJ[WA,16E:CS0NU-H=V@+JU@:A;HVDR*-'V2T=,.U,FDIVK-;5=-BV
MEL>5B(1W'NI`J;%N"R3Q`>UVNT4IM:'E@I>1A3F?XS5GOLAY1Z!U$.@CT#RA
M_`/_`$9*H@E*(=!*`AUZ]!`.G7V>O_7A%"3S?_Q@/!W_`/;G-_\`W+U5@)P4
MV^$6+=J;DH>F(=E.WY_*,(Z0?%CFJD779ZQK&=&256`IVL!'23E(G=HF]N8H
M%Z^3KU$,@D#-2`3D%6T\5^]^#=O[8O'BQ\B9R-:;%8;+J$99'<G!WJF3KW32
MIYA2>&9(K#,'$A!-I`B0%.(&,0QC`0>@FQGB"I\'*;73W,'B`2`U[K_3LH_:
M5([&"KNOHZ`UG>V5:)%KE0:0B4<\"M)1J,<<BA!!43@GT'M&-[(XJ,JI1V=%
MO1DJJ81,(F$7C=C?_3V]_P#LVT?@1]A2,Q\5AGAG^JCQZ_--3/P.WR!DI=\Q
M6S&2JIA$PB81,(F$3")A$PB81<:WW)7[V?[4<@Y%%27_`&X.0LWVK__7N&>'
M3',I?P^^,$3(H$=1\IH:H1S]JIU[MRR>U])LZ0/V1`W8605,4>@@/0<BE00K
M'!U5"Y?]='H7BUZGH-#UEQRJ<94;14).J).I.K'V)9**[KZS3LLF\G<0L[1Y
M7A:2;PQD&`*&$$$R`HD*A@A@&..2LXN("E%FX/DY6.=EWV>A7]A6C4+"H.7,
M;'P3T5Z].5I"E4INSIL-$/)9M%?'8^P&LJY`YTDS]PKU,KV#``9MO>V.VO&7
M#:R/>X&HQ)=*WHO:>#(HM0DI3'@2MB],<MK8LA<T/:6$4P(#1,9@\\3(XP].
MM<!3"AKIQ8-5<Y';KD6*%=VE(U6V;A&[JNFZ\O6KS(P4M(W5:-HM*9HW219K
MUVGG=PROGK-1B"A$U$SIF`O0-3I.9M6T0-<?71.E!<#0&4Q49-(""0P35H*N
M:6T=04QWF7-C)/?SSL%'Q1AK:8-8R2,%H(S>^$.U&@.NHXU6DEVCO$7B_$O\
M(QGSPE=*RL8WV+M]OJ175Z$BG8@31K5$):3WM5X4$7#U1'X,[LR0B'>@O_"&
M="^=$^\N70`"$R'33*E<%P+9KFV\+7UU!HK7$UIQ.55;LS6658$WAJRWWQI!
MR>L+%2*#L&&DTUDKK:-;0FP7:<-YLZ37BV"<H9NK'J*N5$U.]34`0!,2]/;#
MD$*0:*N-XI]TU%K#;_'2%YO\Q=&S>P*K8%+;"PCOB/#7:4BJX^8O8M-6QIL9
M90&$`O(N".2).N\(<[;O"I")2CD$*P-!BIPM(5CDQ8&>NKW'\M=:;"T[*,X:
M;8LJII2O1#&RU%PV36:H0TRPEE?@Y%PU,4"'3((I@'3IDXJISQS6^62H3"+R
MMV@)6T5:9@(2U2](E)-H+=G:H)%@XEH943E,#MDC)MW3%18`*(=%$S%Z#[&$
M"U0_NN[L^>]O7T?UG^2^1CS5JM_"?K4?GB1Z1Y5TCCT_DZIR!W#N&L'D"EV/
M!R+"KQ_F%731.H,B/Q7AXU^X8D<]`=%,<R8)>4Q>@"(?)O=^#N"?8+=NRME=
M`)?SA%J+BVGEP;B6USIX57[1_8]N'M7M_NI>R^Y<EC$39$6;[PL$#9]0+B72
M4C:\LJ&EW'(U6LE3F^:VA>!#_==EVQN:F.XVTL8+7M*6CX!ZFG`RZBIR6&QF
MLD')S+:((NB<B*8J$*(*)@'9*8,\EL6^]T=G>WEYN>X6TSYC<-9`)M56-<,7
M.#AJ#00=(.9(X%?;/<CVX]EO?;]U6Q=G=D;O96^SG;G2WTMD6=.>:*AZ<)8>
MFZ5S'-U.97!KCB05FKPZ=I<H.;#79Q[MR<VQ3W]&=0`M7U4KM")7G[6:1?E\
MR!-_67"A)%FI&B=3HJ;J18OD#[/K?:[O?<^ZXMQMMTA!FM])$@%`X.)\IX5%
M/J7QS]YG[=^S_8S=^T[OLZ_>=NW2.4&VD?JDB=#T_.#F62:\*C!S74*GQK44
M^@Z_#P\E./[-(1L>U9O+#*)M4I&9<()%35D7J;%%NT(Y=&#MG!,A2`(^0`#/
MK2_$:[S")A%HUR[WS6BZ#W-7]/[VU+%;D2JD[&UUB?9U*83C6=334068MTG,
MZ@JQFB"!R)@H!3)J^0>@YZ/M&39X^Y-GDWX`[2)FF2ORZ:_>_L\_!:M^VY-G
M<BU_^3H.GX\%!]X*VVMKU3:&TW.]=RQU?U.YK[M)9GM79L&R%]L+X4C#IO()
MI89TCM5<K#O@7<)`*)RCV1,)@#I]Q][;_L6[VK:F[%/9R;N)`08"PTATNP<6
M84K2@./T+R/:D.]QSW)OQ(+:F3ZUU5&5<<JU.2L_U2[4V^1JDS1K;6+G$(NU
M(]:5JD]%6*-2?HI(KK,E'T0[>-2.TD7*9S)B8#E*H41#H8.OYK7N%Z?")A$P
MB81,(F$3")A$PB81,(F$3")A%7"\+]6U!S;W/$DD*2Z<1"NW'.[8EHMI<\5`
M7:;V`[<5Y31R6OWBUP"O2D6W)\/*2Q>WYTBF1007*<`AGR4/(?Q\.2L\XY<?
MX^E3DQ?(W5,QNR<X_,)MTIL>OL1>/VAHQX2'.X2BHF=>PS.<,G\'NYZ,@YYD
M\<M"&%5%NZ3.8/+Y+P,-Q!-<1$&-A-<<2`\QN<T9N8V0&)SA@)`6G%6GB?;M
MMW2B@ERXT)#G-#OPES6N>T'%S!J&&*Q1*<\N/4.SV%)OY:SIQ.MMBN]5S<JE
M5))RQDKG%_#"D]'UI1L"JDZC6V=>?N9!5$G8;-6:R@B)2#F*.1CX+"YU!L-R
M7:"<!H:2'2'\,8T_.<,6_B%1BD$UY;AI,T#6EX'`OT:6>+W=1@#>)/@5&5RC
MW)J/:7C(>%!#ZUVAK^_S%'A.9S2[0].M\!9)>FNY>C:T6BF=LBXA^[?5MW))
M,5S()/$T5%`04[(#V#=,\L4MO--;SL+9XW%KFG`M<TD$'Q!!!\5KP317,$%S
M;R!\$C0YKAB'-<`00>((((5@#,:R)A%6,\8KP&]@^(=R$J&^=3[?K=*=C7&=
M3NL)=&<D];I-(]XNX:RU?48''^>%)T<JC<X%*8P`8#!Y0R%/TJ?WC'HR*XT:
M!U3HB%EY"?CM8U".K",U)FZO9-1J!U73Q0H"((D7=+'$B8"()DZ%ZCTZY*A9
MVPB81=!:5;*C79I6FM8A]:DXYT>`9S[ETSA7,J"1A9HR;IDDL[09'6Z`H9,I
MC@7V`ZX/@BT^^,7B'_)MQ7]/-C?B+(\RG!>5O=A\08U(N17FN.+:;,U5L(.S
MHWK8IUB-AB'@+G2*:#`IE"I=1*`B`".1BI%*A8GXH3_/9+C5HU.NZ]XRN8(F
MLZH6)<2=VV"A(+,`BT`;*/$484Z23@Z?03%*(@`XQ0TJ:YK8+XQ>(?\`)MQ7
M]/-C?B+)\RC!;6:^<7]U4XM?9\=6(JZG*M\,,*<^D)*O('!8X(`P>2J#9\J!
MFX%$W;('0PB`>3)4'P7M,(F$3")A%TWQBK_PM\`_#L-\.BGWH0OPHR^%A2Z"
M;O/@[O\`SSN^R'7KV.G3,_IKGH^H]._T]?FTG3_52G\U74W5IU#5RXKN<P*R
M81,(N-;[DK][/]J.0<BBI+_MP<A9OM7_T+C/AK_J&<4?S)T;\#-L@<59V:@[
MY0W_`$E0_%<1E+K;'M.UU$[EU%,;.A)NZZJB7TEM-*DR!*A?(5K-Q*FR6^L8
MJ/403DP9RC=D=R4>TEU`2FAF9PXE6/RC+(*TG$RL9.Q<=-0SYK*1$LR;2,9)
M,EB.6;]@\1(NU=M7"9C)K-W"*A3$,41`Q1`0RV6"QKL,(H)/$M_Q._!1_.CR
M0_W>U/A6&7\<BIV\*J815O\`Q9/`.2\1?D+6>0-1W6GK&9/7(JIWJ*EX-:=:
M/F$*J)8^3@A1<MQ:/BLECIG34ZIG,4INH>7(4X44ZO'+2%=XVZ,U;HFINWK^
MOZNIT-4(U_(G[Q\^2BFI$#/'(^P"KE0#'$`\A>O0/(&2H6:\(F$3"+RMW@YV
MRU.=@JS<937\])L3-HNYPD=!2TK7G0G(8L@QC;-&S$`\6(4HE[#IJLD(&'J7
MKT$"D4KB,%!;XE?]Z3C;H]LX6Y;;2VQ`[&DGU%L\'9M8:$BZ^2$D8IR#LCQ_
M4M7PDZU7=`;LHG1=H"!P]D?8'YE[H=U;KVKL]K+M+:7,\NGJ%H<&`"N1!:2[
M(5'.F-%^M_V>^RO9_O9[B;AM'>=P_P#2+*S,W09(8WW#B=`:'M(<&LKK=I-3
M0#*J^K@PRY+\W]#SDC>.4NQ*?7HJ:/3DJK'Z?X[35+E(B/:MA:%9_&W5,S)N
MC-2]"+"LX6'O2]0-]@,?MWOMWWKVY<-[AMVS.9(6.<YC=,@H'`EH:&U;6F`X
M`YK/^ZCVNV7]O/NS8V_MMO$]O!+:LN(F-F>9[1QJTMZE=9#J%S2XUH:944S>
MFM.4W2-)BZ;3XN,:%;-6H3,LPA(:!<V2610(DYG)-E`,8Z+2>OE"B<Q$$4D2
M";H0A2]`SZ!MNT;9L\+H-KLHX(B:D-%*GQYK\S]T]Z=U][WS-R[M[@NMPOFL
MTM?.\O+6\A7(?!97SHKS"8115^)IS,<:9XLW.?X^;*HKO9H3D-7G"T1:ZW(3
M]3AI`[M*6GF,4#U9PL_9+HHMP`$S'1%QWG0.QU#Z+[6;-LF_=XV.W[\X>C+'
M.#":"1[::8S\14TXZ:<5Q]_N;NRVR>>S;684QI6@.9^A0U\(.5MELO&7F%:M
MKQFH;_L:AP;>P:NLFQXFAEM4M8YAM-+SC84I!)H]LHQ0((O"%.13J=3LB(@/
M9SZK[B]D=B[=W=V=90-CM+>ZD+9XV&@T`MTN_L:B2TG#GXKS^P;MN]UMFY33
M-,DD8\CB,S0U'C3#ZUS^#1O.&NFR-HT/D$UT[*:_5A9&^MK#?X>BQ3R)N$K-
MLBK,(N1?H,S*L)<KAPJ+0H&(F<@G(!0[776][.S.S^W=KVJ\V6TCM=P=+HT,
M.#XZ.)>6U.((`U<:TY*>T]UW7<)KIEXYSX0*ZB,C4>7_`#<%9>K&U.+=)CCQ
M-0V+I"KQ2SI1\I'P-KI42R5>*IHHJNS-F3]%$[A1)NF4Q^G:$I`#KY`S\VX<
M%[BAY++]8N51NS%64IMGK]KC47!FBS^N3#":9I.B$(H=LHYCG#A$BY4U"F$@
MCV@`P#T\N2H7I,(F$3"+\]LG^L7_`&@_TX1.V3_6+_M!_IPB=LG^L7_:#_3A
M$[9/]8O^T'^G")VR?ZQ?]H/].$3MD_UB_P"T'^G"(!BC[!BC_P!0AA%^L(F$
M7E;I>:=KFNOK=?++#5&L1G=#(3T^_0C8MD"RA4DA<O')R(I=XH8"AU'RB.02
M!B3@I`+C0#%5S.#?&RD3_,NSVC37.^:E8S1%\5<4:H5DVA9^+VCJ2]/HO9&P
M(,30%</;6E93LC]Q`KN72YGQ/-C&16((^268#^7V%'XG^?VJ7.:X3(+[VV%O
MBJ[9MU,G[DRD7D*PBXJLNV],O,]6:=2K'=(IQ)13IT]<R]4I#1L+1T95JD8R
MJA"`<_4+6;A:0F$-U#6*'E"ZZ]9-#XMEF+BYWS-:ZC2*!9KJ873(@Z(!S14G
MBZ1L$EO#)X.BCD(`'E=0:@5@Z>\+&IV![L:6<;:LL?,72XR%CAWL)4Z-#(UY
MA/C?FUI9/8Z.@6\?:IN=A=F2[(\Q(IKR1$54Q*KVDP',38XQ;V]L6_DMHQX!
MH'PAG3Z8`P94!KG.9I<Y[6DG!6?=S.GGN`[\US,"<2']2*763]^CXAI:ZH:U
MSFC`J/\`VOPSX]\6?&E\-2XZ6I1JM9-ZL>7DWM"2-+2<B-CDZK0Z$WA7(MWS
ME9NP%L6?>"((%(!Q6'K_`!2]-R\NYK^]O+ZX=6XGE?(X_P!I[BYW\R5S+&S@
MVZQLMOMFTMX(FQM&9TL:&BI.9H,U9;S66TF$3")A$PB81,(HE/%=Y9[LXPT?
M71=.D)#JW66EVTU=EHQ"3)#DBT62K2,;E=D5:MW<F+@Y@.<@^T2,`=!'/D'N
MSW9OO;5IML>ROZ1G<[5+I:XC32C1J!:":UJ0<!@OW+^R/V.]N_>3N/NMW?SC
M<,VZ")T5H)#'U3(7ATCM)#G-CT@4!&+@3@L!3G/3D/(>&D7=3RJ(*;!G;5+:
MSD+$,*H$>:MJQO94NY8TA`;)]\#@[?M]GS?O2";_`*,\\_W#[H_Y<Q;V(!^I
MNN70F70*:0T$2AM--23IRTZ@<."^CV_[7/:-_P"[2Z]L';PX]G1[<R]%OUO.
M97/(-F9*ZL@'T!UZ7`>*SWX/^^-A;@X^/:Y=8M(L=JIY&U"HV!NQ\R1E(-)D
M)D6"@EZ(NG,04@$,H4.HE,':$3!GJ?:CNG>NYMKOCO)ZDD$@#9=(;K!!)!H`
M"6\P,CBOD7[T_9;L+V<[XV.T[#D,5I?6IDDM3(9#`YK@T$%U7!L@Q`<3B#3!
M2VY]77XP3")A%X[8-^J>K*59MAWJ71@JC48EU-3TLN50Z;-@T)VE%.[2*=55
M0PB!2D*43&,(``>7-W;MNN]VOK7;;"$R7DSPUC1Q)6.66.")\TKJ1M%2>04;
M.I_%QT5OZWO:+HC5V\]JV:/C'<VZC8*NU*+5+#LW3=FJ_2"SW6#%PD"KM/VJ
M?:.4INH@``.>S[M]M>YNS+*VW#=XHC:R/TUC=JTN(J`[`4K0TX8+F[;O>W[K
M)+%:2GJ,%:$4J.8JLHU_GH>Z6&ZTJJ<7N1LI:Z&LU86F+:M=2F<PKR2:'<L@
M5*.U`!8!3#J8R?:*0P=DP@;R9X=UM<P,BGGM9&P..!+2`[X$BA76&EQ<ULC=
M0\0J^T+PH\1JY\[&6US4G9%)"5VN2\%V#:YR!9A!TXMA%P1*1"&LDNB15"')
MYOY@D94QR]`[/9-US]=Q]_>W,?MTVQ?-"7>BZ9MM!+^H64I332NK'56GC5?.
M#LV_'N#U-7"'JUUZA337*E:Y84HKAP>P'7RCT#J/\.?CQ?1U_<(F$7&M]R5^
M]G^U'(.114E_VX.0LWVK_]&X9X=*SQOX??&!Q'-"/Y!#0U068L5%P:D>O$J^
MD=JT.Y$B@-R.%RE()^R;L`/7H/3ID<"K'YL<E%':.4:]P\0ZD5_=_&.EUQW!
MV5IH*VU139-3MQ[#,;'8-[+5MB&J[BCM9^PMZU'QPMP<(JE0;BN<!-T*(Y#3
M7,8G_P`%)!!H'8*Q^S9M(]HV8L6R+-DS02;-&K=,J+=LW1(":*"*1`*1-)),
MH`4H````9947TX102>);_B=^"C^='DA_N]J?"L,OXY%3MX54PB81,(F$3")A
M$PB\E=J'3=D5YY4[Y6XJU5R0[OSR'F6Q73)<4CE43,9,W00,0Y0$!`0$,TMP
MVVQW6U?9[C:LFM79M<*A=WMSN;?^T=UM]\[9W:>RW:*NB6)VEXJ*''Q'`KEI
MU*J>OH!E5:37XRL5V.*8K&(B&Q&K)L!SF4/W:1?LG.81$1$1$1R;';[+;+9E
MGM]LR*V;DUHH`J;_`-Q;YW3NEQO7<6Z37FZRD:Y97:GNH*"I\`O49N+BIA$P
MBB3\4&FH:>XIW?9.AM-T(^PTYZ%1E+"A1X&5EH"OR*CL9FQLFSJ-=D</T7)$
M$^V)#&3*N90/*3KGT?VIVO9=U[SL+;?'TM@USF#46ZI&TTM+@00*5.>-*<5R
M-_NKVVVNXDL\913QH.)IQ4?W@Z[,K^Y:KNL_*=CJ&=A*8Z@S56UWB)HT;/F<
MKI3"UEAU1,W9OI!M&(-6Z@=M,YDQ4$A1Z>U#WOOEV_LEENNQ#9&']7G#FOC:
MYSC0:>F0"30DDC"E<UQ^T=PW"XM+MUZ:0-(TNH&\ZY`988K<W05JX<W/1F_9
MZBQ^AK?>ZC<-]R=6C9UC76)W2KB=M4[KF.)\,HLC*Q<DD+<B()B)"D,)?)TS
MYEN?;7<.V[GLD7>D,\5G-)&-;W:J1N>-=#4@$-).G,+T%O?VTT%R[;)&O>T'
M!N%7`8?6>*B+\*?:&V=]<RR4_85-I^Q=:SK.YNM@L7U$J18.E+14/(.8IQ#.
M64.FG$J(SJ;=H#5%0"*IK#VBCT`P?=/=7L;L+9NR/U#:K.*"_88Q"YCB72AS
M@'!V)U`MJ[4:T(S7C^W-ZWV[W9\%V]SH*.U`BFD@84PYT%%;JJ-&IU!CE8BD
MUB$JL6NY.]680,<VC&BKLY")G<G0:IIIF6,FD4HF$.H@4,_*E*+Z`278DKU6
M%"81?.[(JHU<)H&["QT%2I&'V"J&(($,/_4;!0*MC.>#-R(?S4N_;\IK:FW>
MR;YXBGY_*%[M)RY563)V2O>R4"%.`=`\@=,^</[!#WN?^INQ)/RGC_I+]P6W
M[Q+"VMK>W/LYM#C'&UM2[$Z0!4_E9FE5U?U+?([YU-N_\PE??N5_Y?C_`(H[
M^D_ZRS_]Y>W_`/1G9_ZO]TGU+?([YU-N_P#,)7W[C_E^/^*._I/^LG_>7M__
M`$9V?^K_`'2?4M\COG4V[_S"5]^X_P"7X_XH[^D_ZR?]Y>W_`/1G9_ZO]TGU
M+?([YU-N_P#,)7W[C_E^/^*._I/^LG_>7M__`$9V?^K_`'2?4M\COG4V[_S"
M5]^X_P"7X_XH[^D_ZR?]Y>W_`/1G9_ZO]TM@.+7A8[ST=OO7.U['R)LMKAZ7
M+.I![7'CR05:2R+J)D8LS=<B[M1,2D\_[P.H#T,0,Z&U]F_IM_;7OKW/Z9)I
MII6H(Y^*\;[@_N>L^^>SM\[4B]K]LL'WD;&]>-U7QZ9&25;^6,]&DXY$J>K/
M<K\E)A%TT_78*U1;B#LL1'SL.[['G49*-4GC)QW9P.3O6ZQ3IG[!P`0ZA[."
M`<"I!(Q!58OPE[%J^4YNWZKUM*XE/K9#=52UY7C1FOXY2AT]:WMYF00VPZJM
M5@IV6FYF1?*)182;N04:D:'(!Q,8YQAI\I/&@4OS`\5:-R55,(H2.;_^,!X.
M_P#[<YO_`.Y>JL!."FWPB81,(F$3")A$PB\O;:54KY%&@[E7HFRQ!E"+#'S#
M-)XV[TGE(H":H"`'+]@0\N:=]M]EN4/I[^U9+#6M'"HJNSL?<6^=LWHW'M_=
M9[.^`(UQ.+'4.8J."\G?:C6&FG[G5FT!%)5UK2+(@VA",D0C4DDH5Z9-,C3L
M=T!2&#J'D]G(.W6'HOT\VD?H=.G10::<J*S>X]^&]#N$;O<?KG4#^OK/5UUK
MJU9U6+>$L7&Q?%'0P1S!HP!]K2KR3PK1!-`'#][&HKNW:P)E*!UUUCB8QA\H
MB.6LK"SVZW;:V-LR*W&36B@5-\W[>NY-PEW3?MTFO-Q?35)*XN<:8#$K:;-M
M<=,(F$467B$*<IK-QWY&U*/TWK2?ULZIDLFTE6>Q+`:\.8IN5LZ\^1JR%4*U
M4DD%4A,#<'G9,4G\;[&>X]MIX;;OGMN:XN.E$+@5=A05!`!KP)PKPJN9O3'2
M;3?LC;J>8SABJ[7@^5S>ZV^MCR6E*1"3=E0T_:X`9JXSDK58:J.)A_$M"/B/
MV4/+^<3)%""5-JHD`&#MF$2B7/T_[X7NWP=L[8V\FJPW\+C&*$R,;J+N.``Q
MJ.-!Q7S[LR&<WUT]D=`(B-1J*&HHLP\`>,?/O77-&S6:'KK1Y8M7R;U#:YKE
M=E(NM68\^Q?*-F#R69,YIV\-+%$7*)BMA$@%`3=@?)G!]R>]>PMU[$FLK&YC
MEN96-Z#&-\T;FT(U##0`,#CCPJM_8-IWNUW@S7((BQUDG!U>7/GP4RY_$2V<
MENXO'92"XQDVR=R1@6NFW)=P0&45-V4XCX8]67P2$J<_0`0[[M]1`.G4<_.8
M[%[K.QGN,;/)^D4KKJVNG\6FNK3XTHO;_J=AZOT/JF^JY8_5\5(AJ6;WY+JS
M`;IH>O*8BB1H,&>CW>5MQWRAQ6\\*_+)5R"!D5$I4^P)14[8F'KTZ>7R2WS3
MFLU84)A%QK?<E?O9_M1R#D45)?\`;@Y"S?:O_]*XSX:_ZAG%'\R=&_`S;('%
M6=FHEMA.+K:/&42+$[EU+%)U.P46'/&VN7@X&\0D!\75I9U3*I1W\8+VZ.;.
M#I7_`/>&[PITRK"02AW`%&K<SCA56=\H^"D`F]^[OI_.N[UVQJ60FAJS4',J
MO$-*NYDH5&HLZ32I<MV9/(^'7D7U@7NTE)QWFR2ZAC)H=`1ZE[0Y]O,3[6\=
M<TZNMS?%C^JUD#6CBV6,N>XFH!&)`6Q>Q-%M8FW8.H2S$'%[2)C,7#@8BV)K
M<JAW&N&GECY7\C;:VY:R>J]EW-O1J?MREU>HRMOK#N!M;-HUEIAQ>%:FV::_
M?*QM5ER-D(F*.[;/%%#E,X,H`'`,U6.=%MVR3SL+W/NIM0:?.^-L7D:<*->^
M7S-;@`PAI-5GZ$,DVYQQT;*RU807?W;7N>*T%0XB.,^9U35U2&X+2"\<BN6V
M^O$Q\(X.2_$J4XU0=9V/N$=:3DY?6-PF]E-):MT4)=S+LF<7%?`LA$(1S%14
M!3*"AWP@!2]CIF_>L;'=W,;"-#7D"F5*X4Q/^4KCVQ+H(2222T8GG3X#_(%;
MJS665,(F$3")A$PB81,(F$3")A$PB81<#EJV>H*M7C=!VU7(*:[9RDFN@LF;
M^,15%4ITU"#]D!`0RS'OC<U['%KQD0:$?`H0#@1@M*M_<#-`;@U=L>G0&LM;
M42WW6&E$&%ZAJ+`(2T5.O"F.E+"LU:M5U%3..G>&!0IS%$?;=<]#L'<,^T]Q
M;9OUWJN7V\K7$/<22!P!-:4&7):MW:MN;.>T:=#7M(P&55&OX='@]2&@KK=+
MSR6+0-AH.XIS6*U2E89O8(?LF>LG7QK<J28*I(O13;&122*D)BE4,(G\O3/J
MONM[I;7WGMECM.TVCQ$V02O>_`@@$:`/IJ37PHO.=N=NS;//-<37`<]S=(`R
MI4&I\<,E.-0]5:RU<S<1^M]?TVALG:YW+IM4JY$P"3EPH5,IUG!8QJV[Y0Y4
MB@(FZC[4,^(37EW<1Q17%U(^*,4:'.+@T<@"30?!>K#&-)<UH!.=!FO?9K*R
M81,(F$3"+`G(3?4?Q_K-9G7-+MNP).Y76+H%8JE*2C%)N5L<S'RTA'MDS3$A
M&1Z"*I8@Y#*JK$(F)@,80*!A#`Z5YNK2R@@=)<S:RT`@"D;#(\DN(`HQKCGC
M32*N(!N6L9:W=Y+(&P0AFK`D_F2-B:``"<7O;\!B<`M9&/B/:_D7&O!:ZKVJ
MI#66.I#W8]A!G70B]%N=B['GM25",V'UG0=.G<E?JR]9'-$)R"38B0+JF(@<
MB@S%<03N!ADU6KA$(Y*'3)+-;,NV0MKYNH8I83Y@&ZIHVUJ5EEM;B"&5\T>F
M>/KE\=1J;%;/T339T+&Z9#@27".32"6E>;E?$YJ<55J]<S<?]X.X"Q1-YN2+
MIDTIJZC36.O)^%KECV.Z;!:0<?`J<A-%!!J0II)P5,XIMS>UZH9VR]"H+0^&
M"0U^Z+IVF`.&=9*M.'R!PUZ2#3*;)Y?*R.1KBV=\(QIJ?$'=4"M,(]#@2:`T
M\M017XMD>*50]4:UF]@WG2>UJZ\J5]DZ5=J=.2>M(*7JS9C0HG9C&P+RLU=V
M%9EPL5-G6CN-BX]XZFG@&5*FT$S=<$Y9/`Z?;X72:6S&5KS0GI20W$=O)&YH
M!<]P,C9*QA[>D=5<0J"TF>R9T(#W#I&,`TZK)FS.9(TFC6M+H'QG66D24:1B
MMN..VVYC;9]TNY!9DXBJ?NB=IU06:,S,SJ5-M6*C-Q9WI3F$ZSPYIU03',!1
MZ"`"`=,SMAFBMHQ=-TW@GNXWC@#;WMS;@"G]F)M3Q-3Q6D+BWN71363]5E+:
MVLS#C4B>VCFKCCB7U`.0P6Q^55TPB81,(HEN$5'TKJS>VPZ1KKFC'[LGW3":
MM4GJHT#KTDW#QTY:IM9!T_N4%&IVJR$@WI5VJ1'KMPHBB0O:`"B41@4I@K.)
MKB%W2/*S8U9YP[4H]]G!BM+TYC,@\@5:^)D*U4HO7VM[!7MF?#+5DI)/OC;=
M+3(Q?==HZ1?->R4H&3.(YMM`N;&X?*S\XN(!_!,;TVT,%/\`WH--Q4Y:L]*V
M-QB;"VR,+*#RDFH/4C]-+/-)3,=&1C8:#//$D+2Z]\\M[NU.4;C5&TQM-'UG
MO:J49I8Y&.K-*L+0S1U?92_URB,GE6L)74*1G`1\+%O)!HNI*22JADE"@)<U
M;60NL=CNIXG&.:Z>/*07RQ-@=1VD9&2>CHXO*_IM-78@B\\4'J=SMK>1HGCL
MP\ZL&12.GB935QZ<1>9)/,T.(&GRE82L^X>4&VO&;\-=;>FC&.IM8Q,1RJ<\
M=[0K,>=7#9].GM=T1[)R][KP.5`J=BC$$(T5V8(H=VX=JI]![KR=/<K86>Y[
MC:!['"*>1E6'4PAKB*L=Q::>4\11<;;YS<[?8W#FO#GQ,<=8`=4M!\P&`/,<
MU:-S16XF$3")A$PB81,(NHGH5E9(25@)(SPK"98.8YX:/?.XQ\5N[2,BJ+21
M8+-WK)P!##V%4CD4(/E*(#A%"/XE/')GI3CA(VS2:F[%YM>9:Q4[(I[HW#-*
M0=<=M7@OY$&1[<LCV`.F0ACG(8A2G'J'0<^<>Y^\[WLG;PN=C!$KI-+W@5+&
M$'$<L:"O!?J?]H/8OMY[A>[=ILGN-)&=L;;NDBAD>&,GG:YNF)Q)&H$$G1]Z
ME%B;PFM"I[MT[:G&W%=R_!58G6D/1Y=#<&V*XV<Q8-#"XBV3!C:&;'S&(.0A
M$Q13*0@&[/V,Y/M'OV_[YM>X.WJ1TD<4@$<CABZH)<*_>TFF/"M%[C]\?MO[
M9>W/?NQ6_MW%!;275H7W-K"X&.)P(#'!H-&%[:DM\*\58!IE1B:'5X:H01Y1
M2(@F@,V*DW,R=@E3(@HHKU>S,RZ>R<@MVE!]NLJ<W3H'7H`9]=7X@7I\(F$7
MY.0BI#IJ$*HFH42'3.4#D.0P=#%.4P"4Q3`/00'R#D@D$$&A1:-;"XX[0@AV
M)<M0[[M-!\]:RL[$T"G:WU4UCCOF[-5=I%^?*5DTD^!=T3IWBYU%.IQ\N=*"
MXEW"]L8MSOI'6_4:"7N<[2TD`TJ304Y+&6MCC?TH@'4X85*K=\!^0/.?<?,F
M2U^]VCL2M.=J2K@VYI1G6859S`A78Q\W;R2\=,PR\7%+1Q@!L'\VF)B#V`'K
MT$/U3[E=D]A[3V-<[AMEA;0W48:89&'S2$N;@36KZBN=:5JOGNP;MO=UO'0N
MWO=#CJ!&#:##AABMSDO`VV;_`'M&>RWV[VTIK-.\LMA2%C=,UDMAR+U*8),/
M(L[=HY18H.G3A,2@[(8$TRG\B/0O0?.1^^>VL[-&U?H[OU<6W1IATODT:\OI
M+:9\5NGM*4[QZXW?^'ZFO^U6M:5KEX_R5ET`Z``?P>3/S,O<IA$PBXUON2OW
ML_VHY!R**DO^W!R%F^U?_].XSX:_ZAG%'\R=&_`S;('%6=FM--I<P;A"^(16
MM'0O#N!L$<TN]=B+)NJ5ITVYLA(&PP:1H>?J]B:Q8Q":K>3.[[P5G!R)LF2O
M:%-0Q`&!B34<5)%!FIJ>@>ST#J(=/8#KT_@Z_P`&65%^>[)Y?:$\O3K[4/+T
M]CKY/+TPB@G\2S_$[\%'\Z/)#_=[4^"K#+^.14[>%5,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3"+P%[UI6-BKTEQ94WJBFO[K'7ZO>9NS-`3
ML,7'RL8U.[`I#>=-`:S"W:2'H!C"`]?)D,`9<PW;?[Z-KVCE21I8[#X'#DI<
M2^VN+5W]S+HU<_(]LC:'AYFCZ,%K&MP#T4><K4PV>;&CFL$X@W$K68ZZ+MJM
M?1JFS;#M^H)7Z)\R.,\A5+]:'CQD4JB'9!0$U!43*!<P6MK#:,BCA!Z3(XFM
M:34-=#;MM63#E,(&L:7\>FPTJT%;%Q=S70N.J1JE=-J(%"63N#I8J_[-Y!JW
MDYX!\QKZ]?AII1Q4XJF*LK&:$AM66[3K(@3ZQ7):7=IR,L$ZBHX!$!4D5)&(
M1%)QT[29`$H!Y<N86%SW5(+F6[3\+5P=%]1`U?BXHV[E:[505Z\TO^G.'"3Z
M#K-!PP6&N2'!'B=?OCKL[<UFL-#B91I+#?[*KLAA2ZP>O3-%HFN):.G)&;;F
MC8J&=06O(GM*%5;K%<HB8JP`H<@Z[X+>'U,DDNEL\CG.J0`7R/:\4KD1(T%@
MYFA#A0#8MKN[IM\-O%J=;!ACHTEP$77.-,Q2>37X4(H15;&ZLA]%Z<UM/7VG
MWFODU;;7)=FR6Q96\0TA3'+5W`0<.G8V]Q.[3@2P#B)A&QRN`7%`PB)P/T-G
M3O[ES))7WY;$YT\KSJ\GYEU<27#AC2FJ69VAO(M:*X+DV-FV.*WM+*-SFP6\
M<(`JXAEK$V$`TJ:L9%YR>+7%U,5W:W)+CJWC:7,K[\TLC#[(>C&Z\E5MIT9.
M-OLB5VFP,PI;X\Z5K:7I7RQ$128G74!4X$Z=H0#,8:XSLM0T^J<T.#/O%I-`
MX-S()P!`H3DLA($,EP32!A(<[[K2T:B"<@0,2"<!B<%FD!`0ZAY0'R@(>P(9
M52F$7Y.<B91,<Y2%#V3',!2AU_A$1`,(JV'AJU"*IG//8<!"T*I/X<@;GL25
MXJ$/OI-2IR<K8(N)^`K%);,:LZP'G<+"-FC!./[U))%J<J70INT:&?+]"L\>
M;`*R0=DS44464:-CK+)%065.@D915$ANT1%0YB"8Z13#U`HB(`.3E6G.OTA5
MJ</XS7Q%@8,G?@2&B2`Z436<@6.9E\X524[U)5?HB'?*)J^V*8W40-Y0\N``
M*4X&H\#S2I-23B13Z.2A>YO_`.,!X.__`+<YO_[EZJP$X*;?")A$PB81,(F$
M3")A%Q+((N4CH.$4ET52B11%8A54E"&#H8ITS@8IBB`^4!#*N:U[2U[06G,'
M$*\<DD+VR12%LC34$&A!\"%QLV3./;D:,&K=DU2Z]VW:HIH($ZCU'L))%*0O
M41^P&1'''$T,B8&L'`"@^H*\]Q/=2NGN9GR3'-SB7$_$G%?3EUA3")A$PB81
M=4S@H2/>.I%A$1C*0?=!>O6K%LW=N^@B(><.$DBJK>41'VPCF9]Q<2L9%).]
MT;<@22!\`<E%`#4`57:YA4IA$PB81<:WW)7[V?[4<@Y%%27_`&X.0LWVK__4
MN%^'4^)&>'UQ@DE&[MV2.T+4'QVK!`73YR1I7DG!F[)L42F<.U@3[*9`$!.<
M0#[.0,BK'YE%?>)E]OKQ&-8S](T[<*JU@=@T.:LFR#ZMVP:X0J;2`?N%:E>'
M!-FFUO7VTBV<D*J*T*95),Q3`(F$#948FO!7<`&@<:*Q[EUB3"*"3Q+?\3OP
M4?SH\D/]WM3X5AE_'(J=O"JF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81
M,(F$3"*.GGE7]W6ES3(O4MSW)2F$=J3DM;Y-WJ"3?0[N4O=2J%7D=2PLP^8M
M7"BJ;RS&5%%F`E%^!%$![21U2&Y=U/=6TF[75N"Z6#:WR0M(U,-PV[M``6&K
M7DQ&4:7`@L+C3!=O;(K"?])MKP-Z4V\VL4SJEKFVK[>^ZQ#@06-UB&KP1I=H
M-0:+21Z7DE4F<3![=VKS'3U!-N-5WC9%_I#:ZS&TXFXW30\U+SE8K`Z]J\E;
M(2CH[;:(%7BXED#**54(W4*BT,8"[6ZND9/?V]@'?D/W%EKI\W4>UMBZS$KG
M&CVTDO-#YG!CG,:U[_*%JV0CDAM;J6*+K30V;YF.)#8P9KIMQI`.IK@UEJ'-
M95X8YSVMJ37VVO\`:W,=%_2->[.3W4UVS-;'TM<9Y>-I$F^JC+7#_BW6F5S1
M6L$:P3UTUZ;NB)4SR%\^24+)&[8I%;JIJ&I?^IDN[IMI5K8&[H)--"T/<P26
MABU%O58"_3#I)(T%K]-%6(6;(F:':HI([/HZZZW-;?2LF,M`>G(;=L;I=>DE
MK@6@FH&N\1?.:P<?+^@VE.2[^&8;<UDUN>PK#*;?C+3\77=7N2EQ5U^FCJ!Y
MOVJ>;[';5Y.590<78(9!!P*,>Y/'G?+!ENW2FUV3IMZ;.K<AI:2]SR+:$V^L
MD:G1=8S`>H;$YTK0)'"$@G)"+9M_NIC:V27H1D-?Y6-_Q;Q,`-73$HML1T9'
MCIT<P>H#`9%]DM]HRW"GC99-O0\[<+?4K%QJV!O:-C*I)2T_)QM<FH*0N[]>
MCQ3%W+R[]F;H]=QS5HHX.=$X)MQ.!4LW]R=;6^_[9<,\ME'._7I!<UKGVD\0
MTANLZ&W,C"TU=I:`XN.G4N;MO6FV_=X`?SY(Y!#4Z28VW#7L#G/T>=ULRCB0
MTN<2-+2[2.;1+ZMT;B7(M]CZGO4C6)2Y;8V]"ZO2U;*6.:KVI[UR#MEIUMWM
M-7CU&2,I5J]+L'ZE?3[V78(H="LC'3!,>6R.6TV/MG;[N0Q;G9[9802O%)3!
M.;<L;1PZC9#"8S"YT8E8US6EQZ;VN=OR:KC>-\N8I&R03W$[FU.@3B)L39SC
MI+1</+Y6=3IF4/)'G#PW1N:I2X<1K+K1>'VM,;/VQ<]U2NI=BGXUNO/=ZQ$_
M;BOXZA[,:M:$@MQU;;><*(MGRY6=,1C6`><(.6*A1[.PR&3U7:L#(6LFMWV<
MDT6O\MS([UTNIT^HNK"RMTZ/J?-)T0R1NJ(7$K/4;Q=OG_PTQD:R0`&2`FRC
MC+FQ%H:^AU0L<8W%XB#G.#B)#/\`1R:B4>P251(W539M4U4$SBHF@H1`A3HD
M.83&.1,P"4!$1$0#-J<M=-,YKRYI<:$X$BN9'"JXMJUS+:W:]@:\1M!`-0#0
M5`/$#*J^S,2SK`O)9/4BNH;`3>`S@:Y%U#_#`UQ&X+RW?A)MAC?-TZ(BXLHE
M\^[';[@HE`O7M^TZY5U,*\PK-K4Z<Z%0S>%K+UT.3.U*VOKN/9WR,"^?#.RH
MZT\A5$[,U^.,H9F*]-V13HFC1+D[,R8*&8/U@%0HBD7L"&&Y?4I>*?6IIHSD
M3J27W/-Z`8651;:%>C_A"3AAAYE./)V8R+FG$>VL*C$L"]F6,-.,W;AFDX.X
M0;N4SG(`&S)"PSP37,5#%&2":TR<6%P!Q<UKP8W.%0'@M)J**9HI+<6[I6T$
MOR\<PX@&GRES6N<T&A<T%PJ,5B>4Y[<7(="YN'^PG*:=$M!*C-@E4K<X4<R?
MG5@9.'5?2;PBBEE@X]Q4I4'+]B"[1N6-<F.H!4C#E6^:&SN#A#.ZC2<,"SJ!
M[J_+&Z,A[9'48YI!!Q"R26EQ$^>-T1UQLU&F/WFM+13-X<]C2P>8.<`0"HXN
M:E[I#[Q;?!^F6EOK*\4UJ_-)=W($G8SS5DE)4;5"T>=ZL+D",O/4S`*0*]@3
M_8ZYEFAEMIIK>=A9/&XM<TX$.:2"".8(H5IPS17,$-Q;R!\$C0YKAB'-<`00
M>((-0IJ?6?K7Y0Z-Z6P'XPS$LM#R3UGZU^4.C>EL!^,,)0\D]9^M?E#HWI;`
M?C#"4/)/6?K7Y0Z-Z6P'XPPE#R3UGZU^4.C>EL!^,,)0\D]9^M?E#HWI;`?C
M#"4/)/6?K7Y0Z-Z6P'XPPE#R3UGZU^4.C>EL!^,,)0\D]9^M?E#HWI;`?C#"
M4/)/6?K7Y0Z-Z6P'XPPE#R3UGZU^4.C>EL!^,,)0\D]9^M?E#HWI;`?C#"4/
M)/6?K7Y0Z-Z6P'XPPE#R3UGZU^4.C>EL!^,,)0\D]9^M?E#HWI;`?C#"4/)/
M6?K7Y0Z-Z6P'XPPE#R3UGZU^4.C>EL!^,,)0\D]9^M?E#HWI;`?C#"4/)=K$
M7.GS[DS*!M=;FWA4C+F:1$[%R3DJ)!*4ZQD&;I94$BF.`";IT`1#^'"A>DPB
MXUON2OWL_P!J.0<BBI+_`+<'(6;[5__5M[\!IDE=\.#CQ8%'S&,3@N.,!,J2
M4F196-CR1E3%Z9]()MNCA1BT*AWBI4_;BF40+Y>F5R!*L15P'P4&E'W3KO8_
MB'Z1W.VV!&*/-NSU2=V.:J,%O^LU:9>(ELM-JC^5CW%Q2J2#.YO*\NE#G<L%
MRN$D0,L4@&((A7A\?Y*[LOY?S4U,CS-M-?YKVS1]D:5N(U-6(%PL^E7B*R$X
MP*QI%,NKB\O)0SX6I:NHK:%8T$_-@$%VHF[P1$2AFL6LN+6ZFE)#PYX;2GE+
M)&Q-8[B73:M;,L!3'-9KR`0VUG+$TE[BS57)PD$SB6<A$(@'UKB_@*5U,E_$
MQW9UVHWBZ[2FJ$;=&<?5[*\BW:\1185:6V$S+%WA,LXC\)S#UI1T3IJIJ-2@
M:33$""`%[6N2]FT[5?R4%Q("Y[#FZEJVXZ3.3PYQBJ:XM)H#@MJ&P@FNMTC;
M=-Z4-`VF?_R!!U#6GD<T]5H'`4K3%0U<H?$IY.;]Y3\'>0;3PX=[L&G#RV;-
ML#^-;O#.T=C)WV,J$>@:(=A``6$1;'JYE0%0'';(N`=>I>H[EY"VWNKB!KJM
M8\@'X%<:"0R01/<07$`X99<%OO\`O`'([_*6Y'>E"'Y'9K5'-9$_>`.1W^4M
MR.]*$/R.Q4<T6.KY_P`RYL'5[BM--B>&ANJFN;C(GB*LC8+VQCU)Z33.T3.Q
MC"K5`!=.2G?(@)2^4!4+_#DU19%_>`.1W^4MR.]*$/R.R*CFB?O`'([_`"EN
M1WI0A^1V*CFB?O`'([_*6Y'>E"'Y'8J.:)^\`<CO\I;D=Z4(?D=BHYHG[P!R
M._REN1WI0A^1V*CFB\_:_P#F*]U4:NRUMN'A8[]KE9@6IGTS.2UQ:LXV,9E.
M1,SEXY4IX)HH@=0H"8?)U')J$7W0_P#S"^^I^+83<+X4O(64B)1JB^CI%G;6
MRS1ZT<$!1%PW6)3A*HDJ00$HAY!#%0B[+]X`Y'?Y2W([TH0_([(J.:)^\`<C
MO\I;D=Z4(?D=BHYHG[P!R._REN1WI0A^1V*CFB?O`'([_*6Y'>E"'Y'8J.:)
M^\`<CO\`*6Y'>E"'Y'8J.:+RM2_YCG;U]9R4A3/"ZWQ9F,/.RE8E74/=&CQ%
MA8854B,M#NCI4\02?QRIP*JF/MB"/0<E%ZK]X`Y'?Y2W([TH0_([(J.:)^\`
M<CO\I;D=Z4(?D=BHYHI2_#GYY;#YR1&UI*_\5-B<7EM<R518QC+8$DG)*7).
MS-;`X=.HLY(B)[HD(:$(18!`_471/*'V9124X1,(F$3")A$PB81,(F$3")A%
MIYSSUGOG;_%S95!XUW;X@[<FF;0("<[]-GYPU0<E5EH()`[=T,6-@CRG:>=$
M(*C?O>\+T$H#E7@D"G-780":G@H\?#_X?<NM1\D4-Q[C;HUB,M^L[.;9C!IL
MZ2OC)_/.;(:(U9KF/C))HDFQ8:HU_`M#&E4A!:5=R*XK=1*`Y<'!WC_^?\RJ
M23I_C#@MZ7_"]1'?M[W[4-HRM4G[067EX!BG7(672JEYLE2IE$L5G24E".$Y
M9!_5Z0V2(R<)F116544+Y1*!9L]-K`8"W4VI:.'Y+[LWDT1Y]24N\^#F--&Y
M!9KJ5MR(JQ@/%'$XXR1V\EM"_P`.G')BWY7EH+AG7!4SX6=5E6UH(3:4VU>/
M)V16I3PL!&J_%"J6%QME:SUM=$Z_=SR\FGNN=(F\6[*C<#-Q*411]M4T?;VU
MM(*L;$R%],"^WBA9!%%_9+61LK(/,YPJ<R%G??2%\SV-`+RY_.D[YHYY)/@Z
M2)IT9-!<`:4IC#87@`^')M"\RNQK=2=G.K7,O5I!T]8[FV'%H(NG*""#DT<Q
M93B+6,17(W+U20*1,.G0``.@9M7UY-N%]>[A<$>HGE?(ZF6I[BYU!P%25QMO
MLH-ML++;K<'T\$3(VUQ.EC0T5/.@Q7F_W=CPTO[(;D_3[M/\H\U5N5')/W=C
MPTO[(;D_3[M/\H\)4<E'GX@?@G<#]"QO'.>IMYG-.PT]R&IE>V6?8.W]N6!>
MZ:[=HOU)VIU-!HZF5X^PO01*9-WV4"(@4>TL3KY8.8'$J10@DC`+?F&_Y>_P
MP+!$QL[#5W;LC$R[%M(QKYKR!VBJW=LGB)%V[A%0MC$#$42.`ADJ*CD%V?[N
MQX:7]D-R?I]VG^4>$J.2?N['AI?V0W)^GW:?Y1X2HY)^[L>&E_9#<GZ?=I_E
M'A*CDG[NQX:7]D-R?I]VG^4>$J.2QGN?_E]_#DJNH]FV2&:;(ITS!T2U2<1;
M+/OG::M<K<JSA7JT=-SJ7PVZ[R)C'A"+."]VIVDB"'9'V,@F@K52,30-6IW!
MKPC/"@W+K*A42W[@/NKDI%5T1V:OK'D!M2,BY::(H]>J/H*$</X50C-.'*D8
MX)MR@7LB80`!`1D5(JH-`0",5O[^[L>&E_9#<GZ?=I_E'A*CDG[NQX:7]D-R
M?I]VG^4>$J.2?N['AI?V0W)^GW:?Y1X2HY)^[L>&E_9#<GZ?=I_E'A*CDG[N
MQX:7]D-R?I]VG^4>$J.2@[U5PC\)*H\S^1>BN1&Z;9)1#[8E8I/'JE05RY!Q
M#^F/VB\\TM\1>+D=BP@WZ[ITZBRI+'?.$DA3/[<H'\L-J\^52X!HJ:*;]'_E
MWO#.<(I.$:GN-1%=)-9)0N_MIB4Z2I0.F<H_&/R@8I@$,E14<@N7]W8\-+^R
M&Y/T^[3_`"CPE1R6TG$?PFN'G"79SO;FB(#8$;<WM9D:BLYM&T;O<8_X&E7+
M!V\3)%6"7>L".3+1R795[';*`"`"'4<)7P4EF%"XUON2OWL_VHY!R**DO^W!
MR%F^U?_6N"^'G#1UC\/'C17IALF]B)[C_5H:49K%*=%W'2E;(Q?-E2&`2G37
M;+F(8!`0$!RM*@A6)HX$9K%>JO"'XEZ=ML%;JDGL8SFN[+B]GQL3*WB2D8`D
ME78F2B:K`*1"Q?-5*E4B2ZZT8P$.Y9N%!43[(B.2!0``Y(YQ=6JD=D*+2I62
M>S$I4:U(RTE%#!2,F^@XUV_?PAC`<T0\=KMCKN8TQR@(H',*8B`>3)`#=0:*
M`N#CXEORD^(X',<$UO(:W6:-K3'*N=.5>/-?"?6.N%6<Q'J4&FG86%TW?3S(
M]9AC-9EXT`@-7<HW%F*3]PW!,O8.J!C%Z!T')))T5/RN+AX..)<.1)XYJ`2"
MX@XEH:?%HP`^`'!>O(S:)$(FFU;IIIE*0B9$4RD(0H`!2E*4H`4I0#H`![&"
M22234JH````P7[\W;_T"/]43^3D*4\W;_P!`C_5$_DX10/\`C43&MV7]V*3F
M-+47=UCU[L6;LC)*5DY-U,ZY?BE5G<*Z)5*U/PDBNE:Y&.2+YTZ$[9N5CU[!
MNWU"I^9H5VCRN/P4OW'^[6;:6F-<[!OE,CJ-;[96(Z9GZFPD$9MG!2+M(#K,
M6\J1),KU),?8.`![/3+D4)%5C&2S%YNW_H$?ZHG\G(4IYNW_`*!'^J)_)PB>
M;M_Z!'^J)_)PB>;M_P"@1_JB?R<(M"/$]:*..#&^XYI4*]<23,)7X22@K)$3
MLM`+0LM<JZQFGTPRJKAI8#Q\/%K*NU#-3@HF"':Z"4!#()I3XJS0"<1P*T@\
M)OE7R%V5:9KC_L[5U0;:NU_0#OM9;-UY3[E6*8XAX&QFJD=!E^.8.'L@O+-4
M#/6RG>E.#<OMB#U`V6%--:&M5#JZN%%.MYNW_H$?ZHG\G(4)YNW_`*!'^J)_
M)PB>;M_Z!'^J)_)PB>;M_P"@1_JB?R<(OR9!`I3"""/4"B/E33`/('7V1+T#
M"*N7X?6V.25,Y)JZ0KNDJU6])7O:6Q-B;;03UU/5N6K]QNKB[R$K;(^PRUSG
MPL<"Y<52)+\((-4F#A>1[E,"')TR&XC'DK/%#@K&WF[?^@1_JB?R<E53S=O_
M`$"/]43^3A%^R)II]>P0A.OL]@I2]>GL=>@!UZ81?O")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$4"_B^:FN>ZKQI:FL)^B5GX/A[]=*=**/+FRN_P#_
M`$^"4F;JW45BG98$(A>.;MBH]I$7)G0E*0Y0$<H:UKR61I.D@<2I5^'JE65X
MNZ)5I0LAJRNMZXI#C''D5&?FYV@&/W)Y99>2'HX$_:[XYC@?J`CF5U:FN:Q#
M);(Y52F$3")A%I-X@^U:3JWBYLGX\PLW8V-[@I77T7`P"3TSZ8F[)%/F\='`
MYCCE?1Q'2I>QYPD50Z(B!@(;IT&KCA3B5=E:UX!1I^$-Q@HMS4;<QKYJO:>O
M-X5:>MM<K$7L^>L4C/Q4'-UM"KNG<JZ?Q-:B+$O(5\A$D%VL<W11;@0H]M4I
MU#6:2`?%5=B0:*P+A0F$3")A%U\O)MH6+D9AZ)P9Q;%U(.A3+VU/-V:!W"W8
M)U#M'[M,>@=0ZCD$T%5(%2`JI&B]7ZPYZ\SKQ!6/26YX?04C.VC8\3<I6QVT
MM*M$U)2,=)J)P4<WC&C>GR#[X'2"1(ZDWZ2Z0E(V31$3F&&<"<PKO/!6O(]B
MWC&#*-9D%-I'M&S%JF(B82-VB)&Z!!,;J)A*DF`=1\HY98U]>$3")A%QK?<E
M?O9_M1R#D45)?]N#D+-]J__7N,^&O^H9Q1_,G1OP,VR!Q5G9K=_)54PB81,(
MF$3"*O7XO:NO&MQJ%@K&MZI9+_$?#T!LL]@U1;)!W,)6FIH--;RC&]1>N+BT
M<HT=YYP\5:D,';-V"&$!+V<J<PLK?E-5+WPU:3#'B[I!I8):(G)E"@02<A+0
M-:<T^(?.`:E[2[&LO&$6YAT#![")VZ)B_P"J'L9D<:N*PMR%5LSE5*81,(F$
M49/BM-MGN>,SSXD[!/K"F)S#(VUKDQ?5N)GH6MBY:%B'M>E[*!6\;+(V46W=
M'1516,<0(!A`P@-7"M.7\45V<>?\57BO")V1IN0X^%UA2]W);5O=9G[+)VPM
MED:T.RU_/)=03S5B9P<K)'DTCK*@GY_VC%.;H0PE,'9RU,`:8*IS.*EKPH3"
M)A$PBPSR`JNS;KJFT5S4%S'7]_D&Q20=J`P$&-4*(BH8%#-7H)B<OD[7='Z>
MSTRK@2,#BK,(#@2*A0">$/>=&:=Y%[-U0^N=S>[:W0+F4:R=C;R#NHW.9CGT
MK\()TR:DM;TUZ@U-\6WYVZ!5U8Y06RXH=3@?+"FF@1Q\Q!.*LPX54PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB815T?&RL&O)>SZDU;/[!8+6*3<
M/;.A4+/+ZNK]5J3"+8/6XS#F9NU&M<@W?6%1SW*29!*FMW!@$0Z=#5()<*+(
M"-!!XE3@\;.SZ@M0`1PQ=$+0*X0CB,<1;N/6(2/2(0[)S"L(N)7;"4H=@S=N
MBD(?Q2`&66-9MPB81,(F$6LO,B%;3/&3=0G;5-20BM=VN8@WEU^!20$1,Q\*
M]68RSIU845X=D+)0.T59P44B#Y3^UZY5V559GS*$GPAAY8N-I(RM'LD5-<+9
M60MRE^8V*3US+6B)MB-0(6`+`>KMHVC8Y9_;S"NX*0QTE(\R0B!5!-EQ2CJ_
M0H=G564,A0F$3")A%QJI)KI*(K)D515(9-5)0H'343.`E.0Y3`)3%,4>@@/L
MAA%4=<PG)4.>MWCN)%RI[#;=0V':TV]>C)748ZV-05I:'13@',9$086@[Z*C
MCNUI9!XJ55,`)W1NWE8\*<EE?B,:U5M>*^$/@N-^%A1&5\P9_"8MPZ(#(>;I
M^>"B'V$?.>UV?^CIEEB7WX1,(F$7&M]R5^]G^U'(.114E_VX.0LWVK__T+C/
MAK_J&<4?S)T;\#-L@<59V:W?R55,(F$3")A$PBKP^,W(W.K7K1=BNM\UL;5"
MLQ:$*=KN>UY999)W+)0L'\9Y*^3S+;.OXEZDR*=L:(;]2.>]45!,IP[P0K3S
MCFKCY3RKC_-3&<0+)"V_C-I>R5T&Q827HD*\C@9UR8J34&ZC<.P#>N3\E,3$
M0D'3VJ+ATNH4/9.;V<N0037-4X+9+(1,(F$3"+07Q/9&+BN$6Z'LO$.YI`B=
M)2:-8^3FXF2;RSK8-6;0TK&NZXT?3)G\-*+).DDD$CF6.B!!#H8<J[A3.JLS
M,URHM:?"DXO:PJU54Y*$B;,KN:TL+'1[!9K,ZV&D]DX@UL<S[QVYB=A,8F3)
M(2LF<JBRX-B)J`F7N_:AY;#`9(XX^*F0PJIA$PB81?DX]"''H`]"F'H(=0'R
M#Y!`.HB`X.115U/">I-&V?O#:6T+!KJD,)RI6.:L-$/"L4TAI[SX<M=<[B$4
M7VU=IUE$A'3KX2LG$7%(IKNU5`3*H/3(;@T4*L_/^.:L6Y*JF$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PB81,(F$3"*N+XY5\LU=F],]H#TBEUN3";?WIV\
M%_7I:0<"J@W;RU<HUDB=KN5ZXDB=9(B#1^P7*N<#)]Z4@A7[U5E::,*G`XN)
M"CQVTR3XZN]C%'7U=53O#Z+?PCJRHK,B+(22L3*-VDFP[:*A2E3<ID<`4H=X
M';[67-*X"@6$>)JL]9"E,(F$3"+7SE=5@O7&_=5(+8H&J+W#7-JK;.>LTHWA
M8..>3$0Z9-EY*4<@)&+8JJH=I0`$Y`\I?*`95U:89JS<UKMX;&J++J31+B"L
M<[6;&9S/"NPEJEM^=W-#.6S:/:,CBWL4ZBBJPZ+(#_V1/M$2#[(CDT4%2&9*
MA,(F$3"+^"(``B(@```B(B/0``/*(B(^0``,(H5N(W'6=I/-G<FQFNS-5W>O
M6&X7RSFCZAO">E[%$(V(R2;5I,ZI9]:HV<-5$1(HX]J<@_PF#KE6C`>"R/=R
M4U666-,(F$3"+C6^Y*_>S_:CD'(HJ2_[<'(6;[5__]&XSX:_ZAG%'\R=&_`S
M;('%6=FMW\E53")A$PB81,(H&^;7#SD#R>Y4RA-+49'4?P-%4J2?<D[]>7-M
MH-E.R*8Z,1%:#<L)ZL3$K7^Z.FHH_;H$/WP&`PB'DKC6M5<$::*:O6E?LM4H
M54KEPL+*UV>&AF3";L4;!L:TQEW[=("+O6L#&D3812*Q@Z@BD4"$#R`&6.96
M,5ICFO<X4IA$PB811O\`B=[MUIJG036K[8U"CN.G;=L36GR,!-V=:CTEH$:!
M;.B]MUQ:M)!["-RNHA/S444#G6=`0G4H=1RKN`(5V`FI!7:^&1;]073C%'R6
MD]2.-,TYG<+=$GJGQC?V^(7EX^661DIJN6F2$KN=@Y-8.VBL9-'[)>P'3RV&
M053FI"\*$PB81,(L+\@]EVO4&H[CL.E:XE=KV.N1BSYA1X9\TCGTL9))10W9
M=/3`D1%`"=HX`!E!*`@4!'H&5<2!4"JLT!QH311E>%_O1/<%_P!Q))<;-9ZQ
M<L8J-E9_8VKHFWP+!W.RDDHHO0+3'WV!KTZXM#,@^?G<-DU61TE0Z'[?DR0,
M$<37-3.Y*JF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"+`EIXO:
M`O&S6VX[EJVK6G8[*&;P#&RSS12478Q;5T=ZBW9M':RL<V,5RH)A4*B"@^P)
MNGDPIJ30+.Z**+=)-!NDFB@B0J:2*1"IIIID`"D(0A0`I2E`.@`'D#"A<F$3
M")A$PBBM\7B#-9>--:K[*O66Q6*8W!08VI(0KF)1A&MG>/U&\0ZO"$[!V2'?
MU+SI0".$'+%=!0QB@<"EZF"KLVTS5V9.Y47@/!Q9LH;7_(.LA6[W6[!7-Q-H
M^X-;M`UNGIA9_B="&E&=>I]-C(VJP\3%K=6X+,@53D!)YR)NJG9`TU'@CP`<
M#BID<LJ)A$PB81>6O"15Z7;43M'[\JM;FTS,8I?S:3>`>-<E%M'N!,7N'BX#
MV4S]0[)Q`<AWRE2WYF_%51_">7KTCSDJT7!P%U%C1:C=XMNS>5:OU:?I;]>*
M0&0'9<Y"ZRJ2U\CA$_F#9=W*.W)I!,ZHIB`]X,-%,3R^Q7?E]*MPY98TPB81
M,(N-;[DK][/]J.0<BBI+_MP<A9OM7__2N,^&O^H9Q1_,G1OP,VR!Q5G9K=_)
M54PB81,(F$3")A$PB81,(F$3"*)_Q8AH:>N]*J;.N^W*K1U-MHL)&*U'7[#.
M2]KE9*`DVE<8*'KDK%N(]_'31TG;`Z_G#55REW9T3]H,J?F;]*NW)V&"R/X8
M<)/Q''J7<V"^;#V"M/[0O<['RNS=?/-8V9C%/90?,H@]0<O7B$>U8I)]DAFW
M=-E>HF(F4!Z9+<E#C4J1G)54PB81,(M:>7E<U9:^/FPX/<^P)'6&NW<.M\/7
M2*L*M9?1*1$E3$.C))*)F.*AO)YN/:*X^YB4P&Z91X!;YC055V$@U`J5'!X7
M&H^..MM@76P:PY52O(6_;+U\:SN6:U>B:8DRI3>_2D8>4L<%"E)\(VQI:FZ[
M$73\`=H-$R($*5$"];#"H^G_`"J'8T=3P_R?YE-KDJJ81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(M:.5^KS;<U*^J*&];7QV?
MJ24>]C]C5"QMJW(LW3105"LEG3IRT2<,W9.H'2[PIO(!BB`@&016GQ5FFE<%
MV''#6M8UG4I2,K.X+KNI.0F#/Y"UWO8(;'ETWGFR*)F))OO5CHMDR)@8J)C"
M)>N!0*"2<UL/DJ$PB81,(NEL;B2:5^<=0P,QEVT1(KQ@2*@I,!?HM%E&@/50
M\J;7ORE[PWV"]<@UH:9J12HKDH+^%'+?D;L?D1K'6UBV/QSV9"6"&N]EVNZU
MX6N0]_I<M&1YVR%(?Q$2Z?-K!"M)WLK-9=JOWATNT1PD`B4P!_*GUJSJ`>-5
M/5DJB81,(F$7&M]R5^]G^U'(.114E_VX.0LWVK__T[C/AK_J&<4?S)T;\#-L
M@<59V:W?R55,(F$3")A$PB81,(F$3")A$PBT]YH;KOFB]>5RU4G4%8V\5[=(
M6(FF5MOE=H$/6$'*P"PL[J5LG_9#H1\@0@G[OJJD'\X`"!1$(-:@*PIC4K)O
M'79%ZVOK*-N>P:E5:9.2#R033BJ9?(S8\`I'MG)T6;UI:(=--@[%RF3M&(0!
M[LW4HCU#`\5!IP6=<E0F$3")A%JES8HUSV1QKV53M?ZTHVW+9,1"B$51=BK+
M-ZQ*K"FJ`&<*MWL<J1VV$0.AT71_G0#VY?9"CP2V@'%7C(#JD\%&=X5^N-N,
M^0>^MB;)UI!PKZ,I=9T];;P[B:;6+X2^UA2+F5*%*PU!N]LAY2/C*G*1SP))
M\1*45%9,JBBA>G9N,B>94/S'@%.]A53")A$PB81,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB81,(F$3")A%&_P"*=4YV[\6)6N0'']GR&</K-!><UU[%
MV*>2JK))551Q>`K]/=-;;.F@2E[0M8XPN52F$H`(".5=P5VTQJ5YWPHY6;F=
M!V%]*:!H6C(\]XD$8)QK>FV'7U8V(S:H)-'=F0I]N>OK/$NV,F@M'K^=&#O%
MFQA(`!Y`MP579J4+"A,(F$3"+I+,G"*UV>2LIFY*ZI#R1)T[M3N6I(@S-8)$
MSA7J7NT2M!.)C=0Z!Y<@TH:Y*16HIFH%."-7XL,>9#9UK?UP)T-/6CA;B:\V
MY7]M04)/.>^E$-HK:NE+C78>J6.M-*R,69F9JLLN+8YU`[2?0P&C`US_`/#^
M**SC4#EQ^*L#9*HF$3")A%QK?<E?O9_M1R#D45)?]N#D+-]J_]2XSX:_ZAG%
M'\R=&_`S;('%6=FMW\E53")A$PB81,(F$3")A$PB81,(HMO%'KF@K?0=8P&X
M-P/M+W,;399G25E,-`"L25ZA:=*.5:Y;1VW4KKJY*-F(XYDDU95EVD5C`=`Y
M5`Z#4YCG16`J'?AP61?#*U]2-=\4:DPIUS97E].2U@M%[F(RX:_ND8A?)N37
M=6&+C9+5<)6==MF4<N8$TV\5'M&Z8!Y2"<3&&_PR55()D(F$3")A%I1XA>R-
MMZHXF[1NFC[!4ZML9A')-X6PW.?J%8AHDCTQV[M\6;O;^-JK&2;('$[4SQ4$
M@6*41`0ZAE)"0WRG&JR1!KG>884*CU\)K8EOLVVMK1D#=[U;M-RNMJQ;YTVV
M.0FA.0%V<[Z4FE(BR6>%F]-3\V[BZE/U-NQ*9N_'NB.FW1#L$Z$R_/EP6-3P
MX1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$4?
M'B&63<56IVCY'3.R:)K*9<<A==Q,Y*;(?*EJ$Q`RSEPP6KDM`1\S`SUP0EW:
MR28QD<X(\<=>A!#H(A'%HJKLTZ7USI@O><)WSU'7=JI#ZV<>[`YUML"R5-]#
M<=:E;Z35Z;,G>'G9Z#FH"[6RW3"$^O+3"KQ50%R(K`X`Y"B`]1#(<E5V!-<U
MN7DJ$PB81,(O(;!;-GM$N;-XG'*M'57GD'*4N^6BXI1!6,<D5))23?\`[1'L
M3$,(*K$]ND3J8/*&0<BK-)#FD9U55[PE]CUZ]<RZW1%:Q"2GJBJUN:TJT:\Y
M)[[Y#:GKK92.^"'#"L2-\OSVK1:ZT>@5'NO@<AP1``(8ODP`#1W&BAQQ(\5;
M0R5"81,(F$7&M]R5^]G^U'(.114E_P!N#D+-]J__U;C/AK_J&<4?S)T;\#-L
M@<59V:W?R55,(F$3")A$PB81,(F$3")A$PBC>\0!["UF=XQ;!N>LT;IKBF;/
ML*U^MJU'M>S/5U"2U(EH]&0+1JH#AP^"=D#I,S/7#9TA'@;MB0!,!BU/S#X%
M7;\KA7DLC<!KW:-B:0>6*P42)I46?8-Y9T5Q#Z^E-5-[G1&<ZY0KES4U[.&-
M,5IQ,,R]3)N.AE>SWH`4IP`+"M!7-5-*X9+=O"A,(F$3"+`7)S6]NVUI6Z4.
MCR&N(NQSC`R#)_MBF$V!1&Y0*?OE)RJJ.6:<D@5,1'H90"A]GR95P)&%%9AH
M:X_0HO\`PD.)%GXP6;?[:R7J`G575C/7TH>K0<IKZD2*C)E7)Q>Z:LUPF_5J
M;?73OX;!BE(L4""J_:N41'^;$36X`*I&)/%3>X1,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$6AGB$L^/Q=05FS[[W@7CI\0]C
M5RY:JVX5U$)N*MM6%\Y<5APWCK%$SM=GN\.!RG9/F:[9=/J4Q>F5<!5OXN"L
MTFCAPXK'_A<N*O:-+W#:Q-F.]M[7VEL.:F]S71TYK:I7L_#J'KE529-*76*C
M4(UB-&BX]<J+%D4"&7,"ISJ`8<M2@`_BJ@DDU)K]BDSPH3")A$PB\Y<9>+@*
MG9IR<;"\AH>!EI.5:%237,ZCV+%=R\;E15,5)45D$S%[)A`H]>@^3(-*&N2E
MH)<`,U!!X=>\=/;MY6V:?U!QEC-5L1H,$,@AY[HM"!H#>1;2DW#2E3DZ2Z<W
M*V6S846_3)+QW=$;0J3$G>*B=0"B&14OP('%6`LE53")A$PBXUON2OWL_P!J
M.0<BBI+_`+<'(6;[5__6N,^&O^H9Q1_,G1OP,VR!Q5G9K=_)54PB81,(F$3"
M)A$PB81,(F$3"**'Q>>3%VXS<<F=@I6QM(4A>VRLC4I:%W&TL#MY>XF1AUTG
M5>UX$#(Q0)6P$U!4*9PX02*0.O>$,`#E7<!S5AD7<E[+PEML3NX>%.M[%.I>
M;*QCB;K3!D:-CXY9E%PLBNV9-EP8;%V?YXH1/R]^M)]^H`@)TDQ]KERJJ2S(
M1,(F$3"*/_Q/X]I)\*]P-7^Y6NAF'P8@L^V(])-JMF3-`YU',4LWKKZ.EW1)
MM$IFPHHJE,J!^S]G,<ORC&F(66$T?737`J.SP8SURL[0W[K5<U&>W:'B$)QE
M,QU$VK5YI>A/;4^9LJY2G6Q+K:8]MJFESB"[%..C4&149(%3JE.J8QARTPKX
MK"3YO"BL)Y"E,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$477BTQC.S\;8.@+7*GT^2V/LVK4B!-;^/4%R53F)>=!VU;QL10K#
M)Q;!C)`!A6^$P,<[%),QP+]D*G-H5FY/PX+#_@?LX>!XV7>GL;)<9J0J^R'"
M$DPO%6N%*EHI&3AV$M#K,JQ:]A["1B8&:C'9'+-./48M`3-T!N0P".7/\E6E
M%-+D(F$3")A%Y2]H2;FE6YO"QL?,2Z]:FTHN)EDBKQDF_4C7)6C"00.4Q%F;
MM<2IJ$,`@8AA`?)D.R-`I;34VIPJJYOAUZSM\'RWU;9X;1C.@BKK&?9;RC?[
MD5*X^06O[*PBP;.5:]LZ*@F<A9I"<L[CS=H@S7%JI&("HH`B8!R1EX4^Q'4J
M>=?M5EW"A,(F$3"+C6^Y*_>S_:CD'(HJ2_[<'(6;[5__U[C/AK_J&<4?S)T;
M\#-L@<59V:W?R55,(F$3")A$PB81,(F$3")A$PBB_P#$\:[1-2=3/:?5]QW#
M7Z-TL4;M>(X^:Z:;0VXUCI^C3L15+#`U5Q$RR[V+KUH<HN7@(`DH'82,)NR4
M0&IK4<E=M-+N:]'X6]:V36.,)&VPX7:E<;/MA7V1H$!O2$1KVYHS7Z\\Y+7T
M]C1*4?&>9SC@B9UBIF2[9&ZB8"8W3KEL:"N:IAPR4CN$3")A$PBPSO[0>M.3
M.K;'IW;<.XFZ39TDBOVK-^XC'S=TV,*K"1CW[804:OXYST51/T,4JA0$2F#R
M#!%:*0:56-=(</M?Z.OLOL]E;]E["ODK1XW7!+%LB:KL@O$TZ-F75B-$Q;2J
MU2H1I%)2?>'>/72Z"[QTN("=40``R>:@XK;#")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PBU]Y*\;:#REUNKKB^/[77R(2C&Q
M5BZ4&91KM^HELB3F5AK=2Y]=A)I1%AAUS=XW6,W6(4X>V(8.H9!%:>"D&E>1
M76<7.+M)XIT)_2JI:-B;#E9^P/K3<]G;=L32V[/OE@>@1$DG;K$QB(%F_6CX
MY!%FV*DS031:H$(!>H"89&`HH^E;*X1,(F$3")A$PB81,(F$3"+C6^Y*_>S_
M`&HY!R**DO\`MP<A9OM7_]"T=X>V[=F0_";C)%QW#_D3:V+#3]-:M;)`6?B6
MVA9I!&)0(G(QB%HY0UNQ),W10[1"O&#1P!1]ND0W4`@*79K<CU_[8^8_R@]+
MN%OTO,E0GK_VQ\Q_E!Z7<+?I>81/7_MCYC_*#TNX6_2\PB>O_;'S'^4'I=PM
M^EYA$]?^V/F/\H/2[A;]+S")Z_\`;'S'^4'I=PM^EYA$]?\`MCYC_*#TNX6_
M2\PB>O\`VQ\Q_E!Z7<+?I>81/7_MCYC_`"@]+N%OTO,(GK_VQ\Q_E!Z7<+?I
M>81/7_MCYC_*#TNX6_2\PB>O_;'S'^4'I=PM^EYA$]?^V/F/\H/2[A;]+S")
MZ_\`;'S'^4'I=PM^EYA$]?\`MCYC_*#TNX6_2\PB>O\`VQ\Q_E!Z7<+?I>81
M/7_MCYC_`"@]+N%OTO,(GK_VQ\Q_E!Z7<+?I>81/7_MCYC_*#TNX6_2\PB>O
M_;'S'^4'I=PM^EYA$]?^V/F/\H/2[A;]+S")Z_\`;'S'^4'I=PM^EYA$]?\`
MMCYC_*#TNX6_2\PB>O\`VQ\Q_E!Z7<+?I>81/7_MCYC_`"@]+N%OTO,(GK_V
MQ\Q_E!Z7<+?I>81/7_MCYC_*#TNX6_2\PB>O_;'S'^4'I=PM^EYA$]?^V/F/
M\H/2[A;]+S")Z_\`;'S'^4'I=PM^EYA$]?\`MCYC_*#TNX6_2\PB>O\`VQ\Q
M_E!Z7<+?I>81/7_MCYC_`"@]+N%OTO,(GK_VQ\Q_E!Z7<+?I>81/7_MCYC_*
M#TNX6_2\PB>O_;'S'^4'I=PM^EYA$]?^V/F/\H/2[A;]+S")Z_\`;'S'^4'I
M=PM^EYA$]?\`MCYC_*#TNX6_2\PB>O\`VQ\Q_E!Z7<+?I>81/7_MCYC_`"@]
M+N%OTO,(GK_VQ\Q_E!Z7<+?I>81/7_MCYC_*#TNX6_2\PB>O_;'S'^4'I=PM
M^EYA$]?^V/F/\H/2[A;]+S")Z_\`;'S'^4'I=PM^EYA$]?\`MCYC_*#TNX6_
M2\PB>O\`VQ\Q_E!Z7<+?I>81/7_MCYC_`"@]+N%OTO,(GK_VQ\Q_E!Z7<+?I
M>81/7_MCYC_*#TNX6_2\PB>O_;'S'^4'I=PM^EYA$]?^V/F/\H/2[A;]+S")
MZ_\`;'S'^4'I=PM^EYA$]?\`MCYC_*#TNX6_2\PB>O\`VQ\Q_E!Z7<+?I>81
M/7_MCYC_`"@]+N%OTO,(GK_VQ\Q_E!Z7<+?I>81/7_MCYC_*#TNX6_2\PBXU
M=_;8[I3_`/P_R@#^;/Y1MO"[H'M1\ODY=B.#D45/+X[V;Y'MB_XQWQH_\4U)
<_P".?)Q_]4?_`%E_^?\`^GO_`.4RJS?1Q7__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g309840g23k41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g23k41.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0Z`4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````S@```;<````&`&<`,@`S
M`&L`-``Q`````0`````````````````````````!``````````````&W````
MS@`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"^,````!````<````#4`
M``%0``!%D```"\<`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``U`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#U5))8_6.NMQB<+!+;NH.&C>65#_27G^2W_!?30E(`65T(2D:B++I7
MYF)C1]HNKIW?1]1P;/PW%2JOIN!--C;`.2PAP_Z*Y/&ZCA49%](9:_(>"+NI
MVAI<ZW3VM8[_``+&_N?HJ?YM6+<K!=31DLL]\^G9DM'I6LAEEOJ?V_2L]MWJ
M56?^"*/W);TS'`!H>(?UJ]/^*])>;A630UK[?S0\EK?[3FM>[_HK,LLZI8`Z
MQKVBNT"W'H:UQ?L`MW495K\=C<:SV^IZE?K;_5H1<:EF;COJR"]MU3PV[;8^
M"6[;665[GNV,M9LL;_A*OWU._$R*K'7XUMKFN<'G$:6-:Y^G^%L;ZE5;MN^U
MC'_^?'^H03+6M/`L9B(FKU\1]B"WK#]E5P]*C$>_W9%K]K@&.VW4'&<WU/M#
M=CZG_F5_SO\`P:U6N:]H>PAS7`%K@9!!X(*R<7/S0;#E4U8U-5KA;=8[:6AQ
M%@9L:WTW[_49^G];T_\`KOZ)$JZC@XN$U^,QS\"I_I&ZN"QHD#U&R[=90Q[]
MFZG?]!.$NY6D=@Z:2SJ\FUM%EW4'.8RRXTBMHVBII?Z%+C8(N_2_HW>LUW^%
M_P!'[T?`%].(!EO)<USP'O(W>GO=Z'JN^CZGI>GO1!13:24'VU5R7O:V.=Q`
M_+\$C;4!N+V@0#)(B#P444S26%_SC=5UAV!E,:RH$Q:W7VD>I383+O:YGTUK
MXN9C9E7K8U@MKF-P\0@""DQ(?__0[;KW5<IV77T;IKMF3<0+KARP.$[6?NO]
M/]*]_P#@Z_Z_Z/,]'$Q7.QL9X8UH)=DN]^[;[K+GAON]T6>G_@E3]47#K&87
MAECQ#'N(;#;KFU%N]WMKW4_H-[_8S\];.)A78.5558Z:K6;"UFW:?:]WZ5A]
MWIU/_F=C57!XB9'_``6]$>W&HZ2X?MFY&2*03327;)'Z5YW6.D!P;^:UE3-W
MT/\`2_X17.G68--+[,I["[)<&5XQ;N<ZQCF^G8UNUWT'O9L?L_1?\9O4'],S
M,EYNQ:O4IL)-=I<`&_FO]3?+OI-W?1L0']-?^TZ\?)@T"T,]P;NM;I998VB=
M_HN?LJ]3=LK_`)KWV)G'.@0+)6QJ5\4_35[[]N%Z;HYRCD9!RP&WN94Y[6\`
MS<T<%WNV,8M14NF_I/6RX]M[@*CXUL&QC_ZMCO4L9_P:N.<UC2YQ#6C4DZ`*
MQC^4?5K9?FKL(Q^L8\*B`001(.A!6?U*QP->+]G%C;@?LWNAINK:Z^JJ^OV?
MHG>E_+9_I%HK/ZI6W):['K>&7UAECS.T^@Y_Z=C+O\'ZM=+V)TMEL=VGETWV
M8M.`^VY^7<PY-;W$,W65FMUE9:R/2]/U-^.S^999_P`4CYGV/)Z?D=-Q[=CF
M#TY=N,/'OAUCMSW?RWHV`_`MR+GXK&GT-N.VYIW-(#6VNJJ/T6['']*VO\]5
M_K#3U!V+ZN#<*]A'JLB"YO[V\?N-W;Z_W$P@U8([&]?2R1(L`@]Q6GJ>5#/3
MM-=I=>^JL-!9+FB3#K*7GW^SU/W4-Q<:6"YY=6W;O]1I>T@FR`UMGTO?^]L4
MYWL>""<8[OT(;#P]NKGUM^?J.<I.^T.K#`\,<]K-K'Q)C^=?QM?^8F,K.Z_(
MR;FNL]FPD6@C:U[6`M]OYS_T3/>M?ZHL<'6V!]88]O\`-,/<$>]K-K?;]-O]
M=8>Q\N`>YMEH#_6$FN`/TC9;]#W,^FYJT^@=+&7EMR7.+6XH&M9AKR=9J]/;
ML;OW[D8[A;+8V__1V7"OIG6<G'S*_4Q;"]EM1$AU%IWUG;^=M_\`1:N9='0\
M>_&S**9]1C<>CJ#'/LKQW,#:L9CZI<^CU*_T?K_X-;_5^B8O5&-]0FJ^L$5W
M-Y`/YKF_X2O^2N?;]4^M46;L>^II[6->]ACS#6._ZI5S"42:'%$MR.6$XU*1
MB:X31KB;/4NEY?V^C.HE[Z&!I??;LQJG,_POV>MU3['V;G/?[_2165T]6S7?
M8P34`VO-S`7"MS6'=]EQV_GVZ^Z[_`5_\-Z2?&^JU]S@_K&6_)#3I0USMG]N
MQ_O=_9]-;]5-5%;:J6-KK8(:QH``'DT)T8$_-H.S'/+&(J)XB!0.T8_]\TLS
MJ56.]N%C.J.4Z&LJL<YC&EW\TUSZZ[&-W?F4^Q]G^#5/;E96/5@6?:&4MKV/
MM(8!E"L;;&;][[L;U]OTK?YVE;%M(?78QD,=9KOV@^Z/:\M=[7[=K5G7XW7#
M46UW5NR+3N-HW5UUM9_-UU5?IGN?:X[K/5]1G_@5:>0?'Z,0(_WTK7=;;6]M
M@QWVOCTG-W!C"3[VW-<[?;L;_-^GL];_`(!51B-8W=?E'"O?8*\AU#][K+7;
M1B-:_(]>VNO:_<S$_P"$_P!%_.F'3<EU-=8N+&6/;=EFSWWN>"VS8VYCF4L;
M[&4_HZ?YMGZ)77X>,^X9!J9]H#2UM^UOJ-!_=>04JO\`M1=?V.<ZKI=U].+?
M%V<QOI^QI8:BP>J_)K9_VEWV;/TW^$_0_30>O[^H8%AQ&NN^R7EEM;1)<0(?
MLYW[=_YOT/\`K:TJ.E85`>VMGLM;MM8XEX?'Y]GJ;MUG\O\`/5FFFFBMM5+&
MU5LT:Q@#6CX-:CPGK2>*C8LO"TX=V7D'!8^'["&5/<=[7M'J/-D?G;MV_>Y2
M.)<'6;W/Q/0(;<VR=762VG:YGM]^S:S]Q=6SHU%?5#U.MSFV/D6,[$.`;_U3
M=ZL9N#C9U/H93/4JD.+9(!VZMW;?I-3>`K_<%]WA:AOLJ>YMCV:M?<9!EA_/
MU]/;^8M#IG3.L^I1E8]?HUU/+@PDL!8[:[2M_P!+>SZ6]==5CT4L%=5;6,$>
MUH`&D!O_`%*(B(=RM.7L/M?_TO54E\JI)*?JI)?*J22GZ<S?MGVJGT)+(/B&
M[I_/V3])OT?4_1,_X1!J'6IEQ!^CZ@AH]T4[_3<X[/H[_P"1ZGJ_\&OFE)02
M^8_/O^CMLV8_(/YO;]/?YGZ7Q_VM[?5+HV_I`X,G=Z8_=.W^=_T/Z+^<0Z1U
MCT&;7/)TDV!FZ/SG0YW^:Q__`'7_`.'7S8DAI0_G.O?B3K9_FNG[O#U?I8#K
M.YNXP>PAITBOZ<%M?\Y_.?\`7OLZOXWK^BW[1_.Z[HCB3M^C_(7RTDGX]S\_
M^'LQY?E'\W_@;OTNW]I?I/1+PSU7R;(+ML^WT?4]NS9]#<G8.L2S>?;IO,,F
M-XWM^EMW;/HN_P!%_P`.OF=)-'_5/I\J\_\`4O\`"^9^E7?M2+-NX`66[SRX
MMD?9_2GVL9L_T6__`(3])ZJN8'VKT3]IYD;)YV[6_3_E;]Z^7DD8?-^G]?E1
MD^3]#_!^;^7_`'#_`/_9`#A"24T$(0``````50````$!````#P!!`&0`;P!B
M`&4`(`!0`&@`;P!T`&\`<P!H`&\`<````!,`00!D`&\`8@!E`"``4`!H`&\`
M=`!O`',`:`!O`'``(``V`"X`,`````$`.$))300&```````'``@``0`!`0#_
M[@`.061O8F4`9$`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#`P,#`0$!`0$!
M`0$!`0$"`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P/_P``1"`#.`;<#`1$``A$!`Q$!_]T`!``W_\0`Q0``
M`@(#``,!``````````````@'"04&"@$#!`(!``(#``,!`0`````````````&
M!`4'`@,(`0D0``$$`0,$`00`!0($`P8'`0,!`@0%!@`1!R$2$P@4,2(5"4%1
M,B,683-")"47<5)#@6)RDT15D;&"DC35&!D1``$"!`0#!@,$"`,$!P@#``$"
M`P`1!`4A,1(&05%A<8$B$Q0'D:$RL4(C%?#!4F)R,Q8(T8(DX9*B0_&RPE/3
M5"728W.#-#5%%Y-T&/_:``P#`0`"$0,1`#\`[^-$$&B"#1!!H@@T00:((-$$
M&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B",*;(Z&/?P\6/;UX<CL:
MZ5;U](62(=E-K()A`FS8D5SD)(!$,=C2*Q%[.Y-]D77`N-AQ+16/,()`XD#,
MCLCF&UE!<"#Y8,B>`)RC-:YQPA"?V#<VU?%W#):2KR`4#DO([S&)&(18,UK+
MRK2DOHE](R7XPBMD!KH[:=T;RO3Q$*=!_<BN32ONNZIMML4&W0*Q:DZ!/$2(
M)5+D`)3RQE#'MFVJK[@DN-3I$)5J)&!F)!,^>,^Z<.GAUV;)<1Q;(Y,;X4B_
MQRDNSPU_^D-:UD6<6-_4_P#V'G5G]2_3ZKIC8<+K++I$BI(,N4Q.*!Y`:>=;
M!F$J(^!E&QZ[8ZX-$$8TES5!MXE`6PBCNI]?/MH56\S6S95;5R*^)8S0`5>\
ML>%)M8S"N3=&..Q%_J37$K0%ALJ'F$$@<9"0)[ICXQR"%E!<"3H!`)X3,Y#O
MD?A&2URCC!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$
M&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((__]#OXT00:((-$$&B"#1!!H@@
MT00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@C`Y-E.-X723<DRV\J\<H*UC
M'SK>YF@@0(R$(T0D+(D/8-'F*]K&-W5SWN1K4551-=;SS5.VIU]Q*&AF29`=
MYCL::=?6EIELJ<.0`F?A"(67[-O6FONIM6(F<VD.(1PF7U;C07UDUS'.:XD,
M<RTA63@+V[M<\#.Y%^FE9S>MC;>4UYCBDC[P3-/VS^4,;>T;RMH.>6A)/W2J
M1^R7SC8>1*CCWW7X^HLXX&Y)A5G)7'EBEYA&5QQRX%SCUF8;DDX[DU5*%&N*
MVMN5CHU7$`]GD"A!M.-'L)WUC=+N.C;J+57!-6TK4A8S2?V5#,`\<.N/'II5
MU%AJUL7*C)I7!):#DH<TG(D=O3"*^>0.>?V2<<65AC^4?Y*(C5?!9:U/&V-W
M%9*>X;`LG5-U5XS)AD=(:%2,[7)LYSE\;5W1$^KN^]:)99>;5,8:@V%`]00)
M8_H(:J6U[1K$AUE8YZ2X4D=""9_IG$?<#^KG.GLWRM&S/EF)E4?&(MK6V.:9
M7GT>SC3\@A0I`7/QVE#8-C3)<B;$"X*.$UL6$)=U5%\8WP[58;M?:]-5<PX&
M`H%2G`05`'Z4@\\N0B7<KU;+-1&FMQ07BDA*42(23]Y1'+/F8Z,FM:UK6M:C
M6M1&M:U$1K6HFR-:B=$1$^B:V*,IB+L0Y>P_+\QSGCV/+_'9OQ_<+776.6#F
M"G'@2(L>QJ<@JTW[9]19U\IC^YF[@D[F$1NS7/ALUU,]45%(ER52T9%)P,B)
M@CF"#F(E.T50RPQ5*1.G<&"AB,"00>1!&1C>[Z_I,7J)]_D=M7T=+6`?*L+2
MTE!A08@&)NXAI!WL&W=>B)ONYRHB(JJB:DN.-M(4XZL);`F23(".A"%NK2AM
M!4LY`8F*@">S2\S_`+!^'/\`M>X]MA>)@O<*!)8)[07\6UJ[J5F>2,8X89#*
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M>]#2$5!;M55^\60WIUA%15*10HQTIS4H\R<``)2P.9RB\M5X%H;>6Q3)56+P
MU*R2D<@,R<9XCAG$;9%^LGUIM:]T:DC9CBL](Q!!L8.32K-%DN:_QRI4.[;/
M$;QO<BJP:@:Y$VZ?74![9-C=1I;;<;5+,*)[Y*F(FL[OO+:]3CB%IGD4@?9*
M*TK'".3/U]^QF#VLNX/98G:60%9=U/?`A9QA8K"N'D]/.KBG.V-80P2QJX)'
ME8(S@E8]W142S25VT+S2N>854BU`3&`6B8U)(YB<^V1$-PJJ/=-IJ6P@)J4I
M)D<2A4CI(/(Y=DP1'1G*E1H4:1,F'%%B1`&E2I)R-$"/&CC<4YS%>J,&((F*
MYSE5$1$W76Q$A(*E&20(RD`J(`$R8IEY8_9SF5ED5Q1>OF"0[&EK7^$&5WU=
M;7$^S:-Y?+8Q\?KWPFUD`Z,_L)(>0KF-5[VL5W8S.;AO>H4ZZU9Z+6A)EK()
MGU"1D#PF8?*'9[*6FW;K5Z%*$](($NA)X\Y",!Q1^U/+8=M&K^9\*J+2D,9H
MI5]APY%5=5;7.8UTA]-.DS(-J,2(Y5$PL1_7='.V1JQZ#?SP<"+G2)+?%2)@
MC_*9S^(B16[)9+97;JDAS@%R(/>`)?`PY?/7K%@/MG2X[S+Q;F28]GKZ:$?#
M^0*61(%575<(I210738@QV@),-Q""8<:LEQ'(HR,=V>-K-=K'2;@:9N%'4:*
MO2"AQ.1'"<I'L.!'RA>MEXJK&Z]0U;&NFU$+;5F#QE/#NR/SBM'(?U]>Y-C(
M%5V25V4U\5__`"LPW(T>75`^_P`2/CQ;N3&G`_M_=]L9-F]/KTTDO[1W,X?+
M6Z'&^9<,O@<?E#>SNC;R!YB&RASD&\?B,/G%DGIUZ0U7KPJ9SEUC'R+E6=7R
MZ]Q8#BKC^,5\UX_-#J/.,)IT^0(*-/,(P>S7.$-B,[GE<]N;7:LW^I?6%UY3
M*8^E(/!/ZSW90IW[<3EV_P!.RDHH@09'ZE$<3^H=YZ/_`*;(6(-$$&B"#1!!
MH@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@
MT00:((-$$&B"#1!'_]+OXT00:((-$$&B"#1!!H@@T00:((^>7+BP(LB;.DQX
M4.($DB5+EF'&BQ@":KRGD2#.8((1L15<YRHU$3=5U\4H)!4H@)'$QR2E2U)0
MA)*R9`#$D]!%>O-O[,O7;BB8VBQ>=-YDRI[#?]+X])'EU44PG`08IN2%5U>_
MS(5R_P#)-G.'XU\C6*K=TJ][^V_94JU5(><&801I':L^'X3/2--VM[1[QW2Z
MVABWJ90K(K2K4>H;`U2ZJ"1UA,+O]J?.MP1Q,3XBXYPZ(I$4`,LN[W*K1X$5
MZ*X_X9:&(%Q6JU>U.Y6+NBJO\,MK??7\52+99O,2.,U']2?LCT-:O[17?3H>
MOVZ4T[A'TR2)?-8_XHS&*_LH]C1S1RLHXTX_OJ==E+$Q^JS&FE*W9=_!;R;2
M\C-5RI]71'HG\E^NNAKWLOT]2]HE;70N)_["A$NH_M6V:$Z$^Y[351R4&5CX
M>:V?LB6ZO]IT,9B"R;A>?!5"!1C:O,!2CH)>_P"0YX+''JW<K$[58WN1'==W
M-^NIS7OPRVK3<MK/M"?W7`9=RD(^V*Q_^T&JJ$E5B]PZ*HPPU-%,^]MUV7P,
M,WQI[[^O?(34!89#(X]MG&8%E;FX&P`F\BHUA`W4-\VD[%<NRH20-[=MU:B;
M*KU9/=79MZ`3^9"FJ"?H>\'P5B@_[T9'NS^W?W1VJI:S855U$!/S*4^:,,YH
M$G1WHERAQJ^RK[>''L:J=#LJ^6)AHLZ!)#,B2`D:CQE!(CO($HWL<BHK55%1
M=:(VXV\A+C3B5-D3!!!!',$8&,3>9>IW5L5#2D/),BE0(4",P0<0>V/MUSCJ
M@T00:((C^9RIQY79J'CJPRVH@9I(B1YL>BFE)$/(!+\GQFQY!QC@GDG0:JT#
M"J94Z]FRHJJ]1O3:M)N%&U*J^,-;@4A*TLK)25!4].E2@$%1D9("BN6.F4-%
M/LK=57MYS==+8WW=O(6I"GD`*"2F6K4E)*PD3$UE(1/#5.)`TT0KPG/L_P`6
M8S[)%QKB*'?5=?F>$91BO(ER\PE+9TN%3P9+7'D1`D8QD]MQ-KF1W!8]4$3P
ME,B-\??0WFA8O'DT'F)#[3B'#S"?$.^<I?"<7=IK'K5YM;Y9++C:VQR*O"?E
M.?QE#2Y9BU-FV-W&)9%'-+HK^$2MMH@)<J"^9`.K4DQ'281H\I@)0T494:]O
M>-SFKT54U<O,MU#3C+HFVH2(G*8.8PBH:=6PXAYLR<29@YXCMCY<3P3"L#@M
MK,+Q3'L5@H(05CT-1!JV$&#N\*'=$")\A1][ME(KEZKUZZ^,4U/3("*=A"$2
MR2`/LCZ\^_4*UOO*6KF23]L*U[6>H&`<ZX;?V=/C-75<LPJ^7-QC)*U!TY[2
MS&CI#*K(7@'\6UB69$\:EDC>8#G=S",3O[J*^[>H[M3/*2PE-<`2E0P)/)7,
M'KEPBYLU]J[94-!3RE49("DG$`<QR(Z1#WZNK3*B<,9OC&0_,;"PSDJRIJB+
M.0C#5!3U=987=&T1$1T<<2TDND.']6FED5?KJNV.NH_+*FG?G^"^I(!X8`D=
MQ,^^+#>*6#<*9]B7XK(42..)`/>,.Z&5]I>>+7A#"82X9C<G-.3<QF2*?!<6
MAPYMB4QXH$D6MY*@5PBS95;11R,<1C.WR%*)BN8URO;=WNYN6VF!IF"[6N&2
M$`$S/$D#&2>/=%/:+<BX5!%0\&Z1`FM1($AP`)PF>'?%369X)^S7+4B9]>#Y
M/&\[02XM;C>54=#(@,$-\L.^$XS=P9$$R)&3N&2(DA2*UCVJ]4;I!JJ??51I
MJE^:,,$H4E,O\B2#/NGPAVIG]FL:J9'EG'-25*G_`)B)2[Y1F/7S]@'+?&><
MQ>/_`&(/97V,I:#I+JPR&O=#S7!I!#,$Z=->V**=;0H3W]\D$EA)2!W<%ZJU
MHG\K/NZX456FBO<U,SD2H26@\SE,<YXRQ!X1QNNUZ&KI55=HD'93`29H6.0Q
MP/*6'/G%\['L*QA!O:09&M>,C'(]CV/1'->QS55KFN:NZ*G14UJN<9KE@8_6
MB"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#
M1!!H@@T00:((-$$&B"#1!'__T^_C1!!H@@T00:((-$$&B"#1!$%^P'L1QOZV
M80_..1;"0P!I0J^FHZL895_D%@5S>Z-50C'C,(V,%5*<I'L$(;>KNY6-=5W>
M\4-DI35USDD3D`,5*/(#[>`$7NWMNW/<U>FWVQH%R4U*."$#FH\.0&9.0CFZ
MYZ]L^<_<S+B8]$)8XQ@!9,>)7<>8])GRJYZ.-W0UNO`V.[+,B.1=VM4;!CW;
MVC8U$<OGO=N_+C='$4C*%#S#)MA!,U=5GB.))$N7$Q[%]M_:*TV=AZZ5CR$L
MTZ=3]8ZD:6P,TM`Y$Y``E1F)G$`M[P%Z#5=171+;DJ:])"F:8N-U<F(:29PG
MD<H<CO(R$81S7N1/C1=F#:G;Y%W5$K+=L==0\W7[E=\RHG,,I_EI'(YZIYF4
MAU,6M_\`>5JW4KUB]O*3R*$@I55N#_4.'BI,I:)8A)5,@9)3%BM%A&&XP!L;
M'L6Q^E"QJ-1M=4P8KE1/IWD$%I"+_JY573^Q24M*D(IJ=#:.24@?8(PVNN=R
MN;I>N->\^Z>+BU+/_$3"_9C[.UV/7TJDH<8?=AJIYZ^QG2;)*H3R1".!);6A
M9!G$,@I#',[B>)KNW=N[51=5%9N"FI'U,!M2U),E$8`=G/Y1F]TWS16^L<HV
MJ13I0J2S,)`(SE@9R.&,A$RX_:89RGBL7(BT<"PKI*2&2(=Y5PIA8DB&]X94
M<S##D#<HW,56N:JHYBHJ?75JRNGN-.VX$!;2^"@#TD0>L.5GO)J:9BYVVH<;
M"@2"DE*@02")@@S!$+&_@?@3GN'.N<0K[7!IL![(KWTT6'712K(&DB-,D4ZI
M)A'88:+MV."5-E1W:NNK>OM-2VY^GIKM0HIZMQK6E3)2,#AXI"1((REV&-#V
M#[^;HIFWGK==5UM"AS2I%3J7ECX25:DS!S![HA3_`!OV.]-+)<PPC(&W>(J\
MXI[8S9TS&S>=CA!)D^*/DC6,1$<BCD#>YHR(B>9-T1V<,(WG[=N*K;-6FJM8
MGJ0=12`<`5-SPE^TDX<<(VE^X^U'OFRBT;HM8MNY#(H>3H"U$8D(?TX@R^AP
M"<_#,PR7"ON%[*\ZW$G&L0_[01LEBPWSDIKN):5IY\0/;\@]41]J\,[XW=W$
M&UR&8S=ZL[$5R2+-[@^].Z*RHIMMN6)S2)A+J%M.2_A+I"I<2DY8D)R&>;Y]
ME_:+VXIZ>JW2U?A1N*TAYE2'6I\`HAH%!/`*$IX!2LX9KYOOM_\`:>$O_F6'
M_P#9Z:/4?W,_^1V]\5_^)&9^G_MD_P#/;B^"/_#@^;[[?_:>$O\`YEA__9Z/
M4?W,_P#D=O?%?_B0>G_MD_\`/;B^"/\`PX3KVI_[N%KXDCFJOX-B9$U@?PY\
M:D3VY\^,T[4[0#BV!7FK6]SMUF,=';]W8J$VU@OO3_7*Z9AWW!I=N-W60\HT
MZE^M*9\`E9);S_F@H&.DA4HWSV5_H9%4^U[>U6XUVHD^:*A*/1!4N)4@`.9?
MRB%G#5-,X9[TVF>SDB!&_P`[&A>,O$[\=*S9TH>8.9XWH'\"Y6NL)%>A$:JK
M8)XU'_L.VZ)L7L$_[PO4S/\`4B=6S]/X:JO4*J4L/)^^I$Y8O>&7\LQC?O\`
M4_LZS4O?TVO3O'5^(FDTFEG,3\[[B5RG@SXM7\Q,+[[HY'R%ZS^T6!^RN,@9
M:X_DV-CP^XK#_*2#-%4.&ZVQV?,\!`UI+>"04F"\:O>R1$>51O:QS'[#N6HK
M+)>:.]L#4PM'EJ3P,L9$\)@S!YCC&*;>9I;Q::JSO'2\A>M)XB>$P.,LCT/"
M&IX^_83ZS9O5"EVF9NP&V0?=+HLOKY\8H'-&CW^"UA19E--&J[M9VG0KE3_;
M3=-[JCW?8ZML*55>4YQ2L$?/$'N/=%15[6O%,LI33>:C@4&?RS'PB+^3??''
MLWNZGACUH=;97R#FF0UV,AS(-66-04%?).);JYK$G#;-LY,"M0SD*L=D8#!O
MD>1[1M:^)6;JIZAYJVV8EVL=6$A0'A2#FH3SD)G*6$YQ*I=M/L-.5]V`;I6T
M%6DGQ*/!)Y3,N,^$HLNTY0IQ%O#]5Q]!Q$]OQI,C6F.YOE.7Y\>[C*CF75WE
MF16%G<S>YH(^X@3'K%"WL3QQHXQ[KV]RPZ%NE0RIRCD6G5J62/O*422?U#H`
M(E5CE2MT(JIAQM"42/`)``'ZSU)B2'P81)@+`D.*2?%!(C19SXXG3(T:6X#Y
M4<$ES%,$$E\8:D8UR->HVJJ+VIM+TI*@HI&H<>,1IF13,Z3'U:^Q\BL_]D_`
M=)F?%$GEZJ@1X^:\>/A/G2HL5J3,AQJRL(%3(@32,<Q9+Z@DEDD#GH]XQL(Q
MFR/5%3=Y6AJLMRZY"0*ID3F!BI,P"#V9B&S:=T<I*Y%&M7^F=PEP"I$@CMR,
M//PU3W&/<0\64.0^9+ZDXYPFINFR/_Y#+6NQJMB6`S_<[<PY87M<NZ[N15TS
MV]MQJ@HFGOYR6D!7:$@'YPNUJVW*VK<:_E*=41V%1(^423J7$6#1!!H@C6[[
M,L0Q5\463Y5C>.$G;_"'>WE94$F=KV#7XK+"5'=(V(1K?L1?N<B?54UTNU##
M$O.?0B>6H@3^)CM;8>>GY+*E2Y`G[(R51<U%_7Q[6BM*ZZJY2*Z-954V-8P)
M#6N5CE!+B%,`J->BHO:Y=E3;7-#B'$A;:PI!X@S'Q$<%H6VHH<04J'`B1B+^
M9;CFRIQYKN$,-P_+,B(T[C?YAD9Z6-$:-C?"R'"%&8.TE2'.7;RS80A]OW.<
MCND.X+N*&O\`TUAM;W[ZB!\AC\1$NA10+=_]0><0U^XD$_,X?`Q5,+]B?L;Q
M#GQ<4]@^+J9&"/'?8U$2OEXSD$2L(<P76-+,=86E/=1WH-RA=LH)#A*UIV(J
MN:A'>%XMM9Z>\6](3/&0(,N:3,A0^WG#J-JVJX4GGVJN452P)((GR4)`C]7*
M+C\%S7'^1</QS.,6FCG4.3U$&XKS-(%Y!BG1QG6),:`IF1["$]ZBD!5RN"9C
MF.ZM76BTU0U5L-5+"PII:00>W]8XC@80ZAAVE?=IWDR=0H@]WZCPYB-LUWQT
MP:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@C_U._C
M1!!H@@T00:((-$$&B"(']A?8CCOUKP.1F^?V#F*930\;H(;5+<91<L"I65=8
M'HQO:W9QC%<P(!]7.W5J.JKQ>**R4:JRM7).24CZE'D/TD(O=O;=N6YK@W;[
M:U-6:E'Z4)XJ4>73,G`1R@<E\G<K>T/)<K(LMMYEU?6TDJ5T%%.:IQJM*5C(
M]30U8MV1HS-AC&,3$?(-]Y%<]7OUYHW'N.LKZ@U=65.U"U:6FT\SDE(X`#$G
MO.,>WMB['MUOIO041;IZ!EO745"\)`9K6K,DG!(X3D)`1='ZR^N&&\'T]&;)
MV50^2[\$H<(!YHB'K`D`0DB%4M>K?-<.C.<Z9)$BO55<-KO&W=S%M?:SEO8<
MN=6SYMV(FZX`5!L$R2@')(&`X3.&4(ON+[B)W#4MV*SNFGVFR9,,X)+JDB:G
M7`,5J49J`).D2,@J<3*&;Q-ZXXX4649Y4XM4V5D28.9F5]7P'&.08(R"C>98
MJ%[6!:CE:U7.=NKEW73_`'R^UFX*MJLK4-)=0TEL>6D($DY8#CC^H2$938=O
MFC:<HK6T^]J<4LSU+,SGW8?KB7*2\ILDJX=WC]K7W=/8!9(@V=7+!.@RPO1'
M-("3&>01&JB_P75+$Y;:VEJ;<04K&8(D1W161R%A>3T>:WD.9363W65_:2*L
M\>#*D1[0,Z8::!T$H1/9(?X3IWL;NYCD5JHBHNL^N=LKO75"D4ZE(6LD$"8Q
MQ_2<8/?K'=47>LTT;BT..J4DI22"%&8R[9&'LX,Q>RQ7CFKK[F*^'93),^SE
M0C(GFC),.J1PG;NJ,-\00U>WZM<JHO5%TXVJF<I*!AAW!P`D])DF-6VQ;WK;
M9:2EJ4R?\2E#EJ43+X2G&W28U!QWC&1VU+01XD2KKK2_DUU/%$`LXE?!+*<,
M0V(QKCF9'[&(NR)NB)LFKNKKJVO6ARMJG'G$I"05J*B$C(`F>$7-+1TU,"U2
M4Z&TJ5,A("02>)E"4\;\[<KIA&-\U\CYMPWG/%^<4DZYD8)@+B)R+AM1'(#\
ME9EJIC!KD$+%Q2F_EA-<XHH_<9G>C51U=34U>:)%S?JJ9RG6C5Y:"?,0!]6H
M'/3]^64IXQ]?N%&BX+M::2I;J&W-&M8'EJ5PD1B-1'AGGQE&I^P'`TW!)D;G
M?@^<ZIK8"Q;^2#'I#X\B@,3Q.!D>-F`YS754@9^XX6[-$QRN:CA.>UF:[FVY
M46NH1NC;*BS5LG6I*,/\R`._4G(B9CTW[:^XM%N*B5[=>X2156VJ3Y33CN.<
MY-N*..<@VO-)D"<B+.?3_P!DHWL%QZUUS)C,Y(Q9!P\S@`".(.4AB&2MR"!&
M&JL;!M`#V>C=D%)81G:C>SNWK8&\Z?>-F34$RN3,DO)E+Q2^H#]E68Y981Y0
M]Y/:ZM]L=T.4.DJL53-=*Y,F:)XH43CK1,`SS$B"8;G3W&11&5GPWQG=9T+D
MFXQ*NMLQ!!BU\>SLED30@##4BQBAK)!B58Y@D*J-.@?*B(FSDTGUFP=H7#<B
M-VU]C:?OR6TH#CFI8`1/20VHEL*$Y!>C4.!AQH]_[PMVVE[1M]\=8L*G%+4V
MWI05%<M0+B0'"DRF4:])XB)-TX0G1J.<8'AW)..3<2SO':W)\=GJQTFLLPJ0
M7E%OXI,<HW#DPY@>Y>PP7C*S=>UR;KKHJ:6GK&54]4RE;*LP?TP/48QWT]2_
M2.I?IG2AT9$?I\HK%RC]3F`S[,DG$N5LGQRL)*81*JWH*_)2`BJ15-&CV(K&
MA)N@UV&\HRN:J?=W[]$>HV!0K<U4]:XVB>1`5\#,'XSAP9WO6(1I?I$+7+,$
MI^(D?E*&I]=/3/B;UN5^0URR,HSGX9P2LXR!H0E@Q"C5)@J2N&]\*BC'%NA'
M]Q9#AJK'&5BJW5]9MMV^RS<:FNJ(D5JSER`R2.?'K%+=K_77>3;DD4\\$)RG
MU.9/RZ1-T_F#AU9"4$SE+C\4VS\]>.%_F=`R4\KQO80#4;8=XI"INC479RN3
M9-UZ:M55U"#Y:JQH*.$M:9_;%8FBK2/,32.%(QGI/^$4U>MWM=8>G^6YCP%R
MW$LKG`Z7*K9*JVK56;/QXAS>5ME6`*X++3%,FC*.P$T2L7>2L@:/\SD7.;5?
MU[=JJJT7)"C2I<.E0Q*03.?5*LQVD\8?;G9$WZFIKK0*2*E38U`X!4A+N4G+
MNEPBT*/[K>K,FK9;-YGQ04=X$D?&D_DH]JQJL1ZC?3EKVVB';OMV>%7=W1$7
M3LG<MB4V'!<F],IXD@_`B?RA05M^\I66_P`O<U3X8CXSE\XC#A'VYF^Q?L';
MXSQM5'%PSAF$VDRXR&SK2"GY#DDRUJ8U%($AD$>CB-CLE?'`3<TAB&>1C5:Q
M!P[9N#\XNKS%$W_Z<TV25D?4HD:9<A*<N)Q,2[C8_P`JMK3U6Y_KW'``D'`)
M`,Y\S.4^`PAX+BEJ<@@$J[RNAVU:4\*26!81QRHA3UTV/902%`5KAD6-/B"*
MU'(J(]B+IF6A#B2E:04\CTQA>0M2%!2%$*YCX1D]<HXP:((-$$*5[H<_3?7O
MAB=D=`^)_FF164?%L1;+:PS(L^:"3)FW+HCE_P"893UL0I&HJ.%\EP6D16NV
M5?W+=U6>VK?:EZA:M".A()GW`$]LHO-OVM-UN"67)^0D:E=@($N\GX3BISU+
M]0+_`-K)=ORGRSE.2LPP=B2#^2?,++R?,K:.]CYK(UK:MFM!60$51&,K2.4K
MNP?:K'JB#M[;SM_4Y<+F^LTP5(8G4L\<3DD9=N64.U]OK=D"*&W,H%1*9P\*
M1PP$IDY]F><76\2>O7$_!HY(^,L>F8\DZ*V-9(_),EM0V3FO$1)LR';6\V`M
M@CA;(88AO:QSF-5&+VZTZ@M=#;$E-$R4).?B49]9$D3ZQG=;<JRXJ"JMW61E
M@D2Z8`81->K"(,5M_L[XYKLEX&CYTR*-+[C_`"2I,.:R.)TDM'=E?46->21X
ME.V*V7+CR-NY&(X/TW72;O>B146@U.G\5E0,^,C@1V8@PU[/JUL704\_PW4D
M2ZC$'MPEWQ\/ZK9-H?U]RD4PQ"5T+E.[CU#'N:J1Q/QO%)DP041RN8%TR4XF
MRHB>1[E3ZKKAL-3ALS@6?`'U!/9))/S)CGO1*!=FRD>(LI)[9J`^0$69:=84
M8-$$&B"#1!!H@@T00:((-$$&B"#1!"`^X?L#R-Q-E&%46"SHU4"75&OK.1(J
MX=BVS<E@6$*M>LZ.9HHPF1G.)X585?*W[F[)NC[LOU?:JBB9HE!(4DJ)(!GC
M+3CPYRQRQC3=A[5M5^I+C47%*E%*@A("BG3A/5AF>`G,9X'@I>=^ZW,6:1(,
M2KFP<)#':ORS8K\@4JR.K&,<\TR6:48`6.1RM$)6)]VSU>J(J*U=O*[524(:
M*699E,YGO/#I#S;/;JPT*W7'PJIGD%RDD=@E,]3W2AF?5?VVM,KMA<>\JV,(
MEE)$9^/Y=*?$K5G26/%V4EF-C`1"39+2/6.5OC5RC0:M<]R+ICVSNERL<%!<
MEI\XCPK,AJ/[)X3/`C/*4)^]=C-6YDW2S-J].#XVQ-6D8^))Q.D<09RG.<HL
M9T_1E,&B"#1!!H@@T01__]7OXT00:((-$$&B"#1!"T>R'M5Q5ZT8O-M,RO(,
MC*BUII6,8'%E-=D61R=BCAM'%$PYH%666+L+-*Q`"1%ZJ[9JTEZO]OL=.MVK
M>'G:9I0#XE'A(<!/,G`0R[:VI=]T5:*>WTZO3Z@%ND>!`XDG(F6209F.7OV1
M]E^2?:;/09/F3AB#%:2NP_#*A3.J<?AG<QYH\!AG*23-FN"U\J43[RJQN_:-
MC&,\_;DW-47AXUMP<2W3-@Z4_=2./:H\3F<ARCUWLC8U-8646FS,+>KWE#6N
M7C6>$Y8)2F9D,@)DF<S#&>L^'S.*);<T/5Q#942*$U;(MA$,.O69%?VS@P/(
M)%>Z#+5L7R;(T9''[54HW--H69^I=.X+FT4D@BG0<T(."EG]Y8Y\.D:5>;71
M72A7M.VURA:FU@UCS<O]2^@S#2%&8\IA4YD`@KD,TDQL'L3[`.P:(7D'-\HG
M6N3J/X^'X[&/%J5E'BR&20PX`ZV(,T6!"DE:61(55>C>CGN5S6+K%+?*VUVV
MY6ZF=":*K2D.)D"5:3,2)F1RPX0HJ]JME-UUIN+UN4_<*1:E-E:U$$J$CK2)
M)4E.!`(S`SGC2]FF<\H>P^;.ML@GSL@MGC<R'%)*,E/CM4/M<\<=TZ00%56!
M[>\I"$3O>JN>YSETM2=JG`$IF>0X0Y,TMMM#3RV*=IE*L5:4I0#+H)8#Y1:;
MP1S1D_K)Q5581BN2WMK6QYMI?V!YF+5\/'SS;0@2RQTLJ["VS9#8H=FD3O81
MZN)XT5^R7+5`D)"%D:NW'X"$:^V?;EUJ5W*KIJA3ZDB:DS0@@"0D3*9EAJD9
M\H=JL]ULHJ\!!R';X\R_J5CC,:I6)^'NVJLY:\K5EQWFKPC$9%=Y5`X;AHCD
MZ*FNOT84[Y(5)7/A%'<_;RU&SF[6RKJ&SIGH<`5QTR,@D@3^]CAC$JX;[O\`
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M&'7HG-<:++%'AD=`D,8YS0J)C%^J*O/TCEM??M#[OF+9EI4?OM*^A7++PGJ#
M%!3UZ+E3L75A'EAPF8'W'$_6D<1CXAT(A5<A?;^F_LC29IBHIK,)M#_D!U@S
M*.-:8Y)<,.38P1=U$5:QY^^-WM50[@=U5%5<N-0_[>;TH[K1339JE7C3]TI.
M"T_Y9ZD\IX91ZJHF:7WQ]IKGMVZZ%[LMR/PG#+7J`FRY,_MA/EN2.,B3G'01
M"FQ;&'$L()QRH4^,";#DB7N%(BRA,/'.)W_$,P7HYJ_Q1=>N4+0ZA#C:@6U`
M$$<0<08_.5UIQAUQEY!2ZA12H',$&1!Z@X1].N4=<&B"#1!!H@A!/:WC?GOV
M*OF<1\<7,7`N,*6!$FY[E-LZPB?Y/?V8Y!XF.5PX,=\NXK*BK\)9+6$%&>:8
MC"N<X*-:KWVBNMV6*"C>#-$`"M9G-1.24RQ(`Q.(!)EPACLM7;+6@UU6T7JP
MDA"!*20/O&>1)P&!(E/C"'97^J?ENIJI$S%\ZP_+YX6O>*E=&FX_(E(Q'.8.
M-*GED5Z&*J(B>4@6-=]7;;JBD_L"M0VI3%:A;@X2*9]\R(:&=[TBUA+U(M".
M<PJ7R!A2\`Q4%SR+7\"<[BO\+G6-S7XO5Y)*K5D99Q]D,M$B44"7$FN8MIAE
ME)F!&:(XHQ@:1DJ,434*AZ&B9#M8BRWI"FU%02E1'C;4?I'5"L!+(8$$8SNJ
MMXMTBKM:5)6D)*E)!\*TC,]%@`XYY@@X2L+K?U(QF6,-]OS@>14H)JV`*[!!
MP[$AFM"CF0Y<G*)\80C.4CD>\#U$B-;VDW5R-B?;UG6"NYJ+?$!`!^.H_9"P
MK?3N@A%N2%\RLD?#2/MBS7A+B+C;AG"XV)\:0XB5L8TJ+97*$A3;B[M:Z?-B
MSWWUK$$+YD^NL4.!PU1J17M<)&,[5;IXMMOH[;3)IJ)`#8S.!)(.)4>)G,=,
MH3J^NJKA4*J*M1+AR&0`.4AP$OCG$P:GQ"BNIGL@.Z_8-3<58M<S+'&0<>7^
M"93"&]Y*9,ZI4N\VE2XHVF0/S:6)7-@E.J*YI7'!V[M1VE+\Z#F[&[:PY-D,
MJ2H</,$U?%($B>I$,_Y06]LN7!YN3Q=2I//09)^!)GW`Q*'LAPI[#<G-65Q?
M[`FX^!7%:>JQ.NJ)M`&6Y`1U?^9S&JMY5K,/\V.KA)\1D=C"=JLW17NFWJW7
M>M3.WW8LRR2!*?:L&?RE$2TW"V49E6VP/3S43.78DB7SG%8O'7NO['>NG)Y\
M!]@)%SEE+7W`H&5U63,9)R6FBE(-A;S'+P8EDV@FQ=I`!$(>),'T&X:D\J(U
M)N:]66O]%>2IQH*DK5]0!^\E7$<<9@](<JK;UIN]$*NT@(=*9IE])/[*AP/#
M@1QG#1?M#Q2SS;AWC3D[%RQK?$L4LY4VUEPR-.QU3G,6D#0WL<HU<,U:Z3%&
M)7-5=UF#<GV[JE]OJG<JK72U;'B9;7,RY*$@KL_QBEV:^W37&IIGO"ZXF0GS
M29D=O^$-KZ2+2?\`^5^&6T!(Q(;<9,DKXO\`0.\?<VA<C$1.QBI)9?DDH7IU
M)NNZHNZWVV?*%AM@9(*?+QE^U,ZN_5.?6*3</F?G5P\T'5YG'E(:?^&4HG?/
MP9L?#[YO'-A3UN;,@&-CIL@KR6=,:Q`U2A@V,84VO*R-/5OA4S2HH%>A.UZ-
M5CK:I%06'?2J2*B7AU"8GR.(P.6>&<5E.6`\WZE*BQ/Q2,C+I@<82'UM]YB<
ME9])X5Y@PYO'/*T6;9UH61RF=2V5K6%,LFD?&EJ2736X1"<C&O-(#)4:]A&N
M<P;E>S;G-96+M=RIO(N*21^ZHCACB#++$@\#PABNVW12TJ+E;ZCSJ!0!Z@'C
MA@1//`$<HS7NG%Y"Y@IJ_P!<.+<6M9\_*[2DL,YS&?638>&XIC4*6RQ"T]_(
MBI!EV!I@`E>&,\LA@6=J,5Y41LC<C59<6$6BB9)4ZI)6LCP)0#//B9@8"9EV
MQT[?<I:!Y5TK'0$MI(0D'Q*41++@)$XF0G#,\&</X]P5QGCG&^..)(CU`'&L
M;(R(T]Q>350UM;&:G0?RY2JK!IN@A(QB*J-WU<6RWLVNB8HF/H0,3S/$]YBJ
MN%<[<:MZK>^I1P'(<!W")<U/B%!H@@T00:((-$$&B"#1!!H@@T00:((1/WLX
MD-FO'\7.*>,8]SA?G'9MC(Y3DQ6>PGSC#:QCW.+53$&9/HU@7&<OT1%3-YVQ
M=71-UK*)O,&9'-!S^!`/9.-&]N;TW07-ZVU+FFGJA('DX/I[-0)';ICELLK/
M),6M+BAAW=W"CPK&=%\+)TF,CV,DE1I7A$5!M=(;L]5;T57;[K]=1Z=BBK6*
M>J<I6U+4A)G('&0P[LHD5=7<K955E"U7/);0XH2U$83,C*?'/#G$E<(YQ)K\
MI-7W5U)2%:0R)&?.F%>(5J$H2QWH4Y52.X@$*WNW3=W:G\MJK<5O2:5NHI6`
M'6U">D2.GNY&47^S[NM->[25]6HL.H(&M1(U3',X3$QUPCJYX.Y>QW,^(<2R
M>TR.BCV$6AB1,G\]O#&L*SK0_$F&F^<HWQDF+'^0U'HGV%3953JKO9[FS66N
MFJG'DA81)<R!(IP,^64^PQFFX;)46V^5M"TPM39<);DDG4E6*92SE.7:(^.F
M]K.!KV_=CD+/(8YJF6/'E3X-G75$PK4<JMCVTV(&`C?M7M<1[&/7;M5VZ;];
M.Y;*_4&F;KD^9/"8(![%$2^<=U3LS<M+2BL>MB_*E,@%*E#M2"5?+#C##M<U
M[6O8Y',<B.:YJHYKFN3=KFN3=%147HNKW/$0KY8'./.B"#1!'__6[^-$$&B"
M#1!!H@BICVZ_9YB/%)[7`.$&5^=\API#X-ID<IA#X5C)V(Y#C`0)`KDUH%VR
M=H'I#&Y5[BO<U1:SW<F^Z6V%RCM@#U<#(G[B/_:/08<SPC7=F>U==>PS<;T5
M4]J4)A(_FN#L/T)/,B9&0QG'/?E669GRIF=GDV4V]AE.89--),L;&P.XIBO>
MO5[WK_:A5T,2(QC&HT01M:QC41&MUAUVNZW%/W*YU!4XHS).))X)2/D`,!V1
MZGVSM@*])8[%1I0TD2$L$I`S6M7S4HXD\R8;3@WAZ)0RHV2957"NGH\$A*V2
M1T2)+0)E(.+*&@BRDK'.'N06XB2$5%<YK.UKI=BVP_>7&+O>VRW1I,VF#F?W
MW9\^"9=O5U=U4UON%CVG<$!YP%NHKM)).&+=+(B21/Q.ZB-6"02)I:2[MY\V
M?+M9$59AI\F1+EI"00?"XKU>P46(1[&_&$U>QC$?W,8U$3NUJ:4B0`,A'&V6
M]JRVVDMU,E2V6DRGAJ))F2<L22280GV4X-D\KW=;G#LRB4M514;Z^T\];-EI
M#A1Y$VR22E<,PYD*>5IW#<(J-85[&+Y&*Y&)P=I2^I`"I&.+[_D^;5+*?*"<
M3C,!,SB,QV<^.,HT?"\2HJBI2GPYS8U7"+)-+L,@D5M=9Y-=>%WPPO#*5(%M
M:C>U%AA17PZAI6$=Y#O5RV+-.BE1HEXCQ&/>>0^WLA2?K%7196TL!A,Y:B$Z
ME2P`!P4KEFEN8)FHQMV.+?UA0EL*?,Q6YR/8$T7!8$Z2]P57L<2ZR*#,G293
MV.[MWJCF]6INC=]=Z_+/TK3I_B/V"(U&:MHI4[35`?/)E)/^^X"HGMC9IV;Y
MK8`3X.49,U4W[`%3CHR/Z=BC/$C6\-Y&KU^UZ;?Z:ZPVT#BA/_%_A$QRX7%U
M,VJMX2__`*Y^("Q&*IJJ^!CUQFTGLHV5=F`B15F!H0RY:/8]+'%#Q"/7&LE`
M<;7(2/O'.KE;LJ=R+S4I&M+8QF.WN/,?.(7H5U%NK'ZUA`I]4E(5)*5SXHS"
M%SY>%7QAXO57V!B9MS!CM-R.^RR++)%>:OPC,#-97V?RHE;9CDUV:4H%^*6U
M94G,P$X"M&8?4@U+N]DBIN5Q9L+MD9=`M:G@XI,LU82(5G+`$CF(Q._[%MM%
M<_ZCH5*4M#6F2S):!.1!&1(U9_LGN"G<NQN,N$O>OEPWL_BUMEF!\IUT_(L/
MLX4JP$VN/:PD#33U^/:41+$>.3(I`$B-F@5&D56N[D&U^?U#=O:N+=9=J)51
M;_)4B0!)0HD27I!!(X&1F,XN:VDO-XVG;7-MU`;J:9>AP<<"I6."I!85,$B4
MTR,,!Z&9+=<J^P,[*:"HB57''%?$Z\;Q9%,V^=0R0GO'6%1"%/OIUG+FVDR4
M67/.-T@KHC>QBHQ%8BQK<Y4UM8:M5.&J!I@,M`:AJ"53U262KF<3QD(I*RW?
ME=`AIUQ:JQ]XNKU:=4RD`CP@"0P`(`!E#Z>XV&Q\FX;M;A`M?9X9+AWL(O:B
MD;%))!`MA(_97()T&2I7)OLK@M5?HFJW?-`*[;E:0/Q69.)_RGQ?\,X??9:]
MKLWN!9TE9%-5E3"Q/`ZTG1/L<"?G#2>B?(LGD/UVQ7\@@6V.%GDX+(\*L_NQ
MJ$47\2=[&+NPA*B4!';M:JO:J]=^Y=3]K[VJ^;.MKSG\YD%E6,R?+D`3VB48
MS[^[41M+W.OU(S+TU414HD)`!Z:BD#+PJU##A++*'%UH,8Q!H@@T00:((-$$
M&B"*_P#VN]<B<C\S>M?(.*U2MR&MY)IJ_,;,#1"#_AV/N+F26%F50NWD5K:0
M\>*YSOO)+8+9RJ-$5;[9A77"S5C*/QD/IU$?L)\>/9ID.IE#+9;MZ.ANU*ZO
M\);)TC]]7AP^,ST$XL`TU0M163[)<5^Q7#^6WO-_JQ?W4FORFS2XY!XJB067
ML0]Z4+!3LFJL;-&DQIS;5@$=-03636'<I6/<CMA)EZH;S0ON7.Q/*(69N-2U
M`GBH)Z\92,\8;+366JM9;MUY:`*1)#DY$#]DGIPG,<(KWSCVF]X^2PLI'_YU
MCX&N2!)KL#P2UQR9*FB55(R9-AUY;UDIR)_<`R0(6R?[:(J[I]5?MUUH\D-N
M-C+P-E))[9$]TX:J:R[9I#YNMM9S\:P1\)@?*'1]`O3+,..LE3F_EJ$^ER!M
M7.AX;BDM5=<5I;ALB%:WM^BKO!G$K'/`"/W/?XY9'%1CT:W3)M+;=30O&Z7$
M::@I(2DYB>:E=2,AU,\8H-SW^GK&A;:`S8"@5*&1ED$]`<ST$L(MMT_PD11O
M^V>HK@9SP_=@4/Y:TQ;)JV>-C`(?X5-:UAZPIWL:DES2ENI+1^159_;=V;*C
M]9?[A-)#UM>`\92I)[`01]IC1=C.*+-P:)\`4DCM((/V"+2."\/'-]9.+,(S
M>N%81YW$&*T>0U$T)QL+"FXQ$CR:R6(JLDC(*(;PO7=CVO:JM[5VV?+93G\G
MH::I3/\`TZ$J!_A`(/V0EW%__P!5K:BG5+\=2DD?Q$@C[8\<#>OE'Z]ARZCP
MW),AFX1D-K'NZ;$;PPYX</GJR0*T;46CMILB':"6,CAG[WL=&[^]SB/5?EKM
M+-I2^S3.+],I6H))F$'C(YR.&?*/MRN;MT4R[4-I%0E,BH"6H<)C*8QRYPP.
MK6*V.;SV_L3#][LCFX*UKKV#FG&7XQ:U'>0V70:+$$1!M!]ZSFW8T$]&IW*9
MB_5R[KC>XG"-VE5-_-2XU*7[0"?G/"-7L*`=L!-3_*+;DY_LDJ_5C'1^+R*(
M:F1J%4;/*C%W:A.U.]&K_%J.WVUL@ZYQE!SPRCV:((-$$5Y<T>YMOQSR^3$:
M"HI[G%<=?"BY,XS3.LYDTK4+8AK9@IC(\=\$16L:CQN_OL<COMTAWC=SENNW
MI&64KIFY!>>HDY@&<A(<^,:EM[V_:N]A]?45"VZQV9;RT@#`%0D2=1GD1A*4
M3C7^X/`$RIKK21FR5CYY&A)5S:FW?9UYNU'$2='A09;1A&J[>9KG"<O]+EV7
M:Z1NNQ+:;<56A.K@0J8[0`9=N76%QW8FZ&WWF4VTK"!/4%)TJ'[I)$R>6?,1
M'?/ON#$XJL\%_P`5@4>68]D-*W++&X=9O$$N/NFS(#&5IA-\,8[B02N<8O>U
MBC5CA[[JD&];H%N>H$TC*7FW4ZY@YI)D`F7$R_5*+/;>QC>*>ZKKZA=,^PLH
M`*<E@!1*Y_=`(P$N<^<9\P?LHXMPO#:ZUQ`#[:^N("G^-;^2(&D*]KT$U0`&
M9^0G<YBN8V.1D=6*USC(NX]?7=U(J$-MVFE4[5J&(5X0WP\1XGH#W\(^,;%7
M2..O7^O0Q0(/A*"%J=PGX!/`$<2#CA+C$1B_9!FV8XS!L,4PZ@HEG0D9^3L%
MG6,ATH)G"-/AP2$B1X\<[AKV!+YU:U=^]W3:EK]Y7&F6:7TC2'P/$9E<B<<,
MAW&<N<,MI]N;/6M"N]>^Y2J4=*=(;)`)$B?$>\2GR$-9Z_\`M3CESQRR=S!G
M./U64QLAG4_DEOC0CV<-D>%,AV'X^$)%"#MF.$I%&QBO$N^RZN;'N:G>H`NZ
MUK:*D.%.)`U#`@R&0QEEPA<W/LNKIKL6K%;7G*,M!>`)TF9!3J.9PG*9P(C.
M<[^U]5Q%:81#IZF+ET3)8@K^;/BV`EBKC3Y,B&A*F2`A!%GE/&<K%>BAV:J*
MN_T[KWN=JTN426V@ZET:B0<-$Y32>)Y<(C;:V347YJY+>?+"V3H`(Q\R0,E`
MX@`9\8U'D[WXXIP_"`9'C"2LFMIE;)FDK"@DPV8Y\=NQ%R%6`.92C>BJ@8R%
M4K6;H]K7->O"HW=0AI@4""]5NY(^G2?WR<OG\,8YT>P+GYU4J[.IIK>P?$Y]
M6H?N`9X<3*64IX0I&0_M\Q1:Z*'&\0"RU/'$.3-G'M9<*'-<K?*8<-:NK(>(
MWKT4K7(B[[KMMKBY?;RIH^39TH="<U.`B?0)S[Y1S9VQMQ#Z?4;B4XP59(94
M#+J58#J0##?\?>SDC)?6O-^3,[A19-C23;3&G1JBN*V%:'L:^O\`PC2QWOD,
M`&0:W:,[W.\;6-5=MU1J\:'<2G]OUEQKVQYC:E((2,"2!IPQE/5(\([+IM!-
M+NRW6BUO$,O(2X"I0FD`G5CA,@))`S.4<UO,^)Y%)SV3/B54V?'NV17PGPHQ
M3L0@HXHY8R^)CD$X;V;[.V^UR+JAL%PI$6X-N/)0M!,P3+,S!$,^[+1<%W@N
MLTRW&W4I"2D$X@`$&664\><8;&>',IL;F-&R"MET=0G]V;/,^,FPDVV`!R%*
MU9!G*C439>W?=4UW5NX*)JG6ND>#E1D!(_$X#`1&MNT+D_6-MW"G4U22FI4T
M]P&)Q/RA@<^RP7&6-AAU`R%F'%&K*GY+W';'=$B-&27(<3=3O!'06R+_`%/<
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M:7,H`T(ZOHZH:NFVLYR.;]@FN[>Y%>K6]=0;A<J*UTZJJNJ$MM#GF3R`S)Z"
M+2TV:YWRK10VND4[4'EDD<U')(ZDQSJ^W7['.1.>R2<1XY?<\9\6*,L>7`CS
MV#R;+D5Y&J6_LH#1OA5A8ZM3\<`KQ*JN\I#?:C,6W)OFKNI--;BMBAXXR6OM
M(R'[H/:3'I79GM?;["$UMX#=5=,QA-MO^$'ZE3^\1AP`S*,\<\69IRG=PZ/$
MJ:?8'ENW8^-'\CB"8[8Q`>5PP($7_&<CV1Q;_<_?[5S-RK==J/06U@OW$_=&
M2?WEJR2.W&-UIK13TU#^>;CK!0[?3]]0\;O[C*,UJ,L"!(9XP]]%Z\UO%D]U
M-<M!,R"`L8MNP:O,`$PT6/+#&64]&.L#1V'1SR(UH6N=VB3M;WN<[!M!NG6W
M<[VM-1<\TC_EM=$IR)'[1'^,6=MO;6X:)2+&P:3:6HI")CSJDI,BM]8Q".`:
M!D1]1EX8E)K6L:C&-:QK4V1K41&HG^B)T33W%RA"&TI0A(2@#``2`[!$+<I<
MAOIX<NCQNQBQ;MC!OM[DKV+`Q.$Y6/:2P?X9.UA9,W'%`T;S.55>C?M3>2PS
MJ(4M)*>`Y_\`1QB@O-T-.VY3TCR4U`^I9^EH<U8'Q*R2F1)SEA"TX[:3<7RF
M9=2FOF6[J17-3++1D(+(5A'"CYU[WD/*GOG".A05H6F>UAF.<YSF+O-6D+0$
MY)G]T?(?XPH4KZJ&L<J5JU/EK_FKD-*A]2\23JG-+:09`B9F(;OA7U5O^5JB
M9R=RG95>%TBDC-P>AG50Z.JN0Q7O*:3)@F+%E55`0_WB[?[LPKE*5'C:-CH%
M56LTB2D+&'U*)R[SA/[,H2;AO-+=VI]-.W4TR#XTI&E)Y)1*<@#XCAXC]7(0
MMDV1<@19%MC]URUP3$*$I!*@\SX^GQ)<='?:2(=+:QV5Z)NUDF,$C>FZHN^W
M:GTTDK2A9![8EO>[-*IK0]6@+4<4AM!T]Y5C+LB#\-@5[I!Y$4&0\@4=.DR5
ME5-CH9DE*:M&R0Z3>PK+&;BPKDC@.WOW*0(7I]-D57MEK5K$DE*5'(SSZ&8G
M'?;-Q[;5Y+@NH>IR?$W/0I,YXIDN4Y\#+]8W-N!1\TF0&X'91)%3,L`&DH>1
M$A7=/!8-51<CQLJ"CV_PR*C@2QH]T@+T8_NW1^NOS2T%>:/$!W'L/#LAN_+4
MW!QK\M=26%*!,R`I*9?\QLX*D<4J'U#`SSA@/6C+18+DC<.=@V+#Y83(CXWA
M6>RVMF2!-*TRV6/.D6)61VS93#"97R3JPCHA71^]>QC5L+8U9WZYE5]J'DVC
M22L-CQ3D=)ERGG('G*,<]Q[9N:EI*E^SZ5N)<"2A:B4I(E,B>8TX@$X9C(Q;
MQG_#7&W,U%45?+^!8SF:U[!R1BM(:2/QM@40?G+5SF.%.BB,4:(Y!D:A&M3N
M1=M)[@;UK#<RW,RGG+A/K*%VW7*XVTAZCJULOE("BA1$^8ZB>4XQ_%K(6+"O
M<*J.,8/&.$8@5XZ%T".&LIID;Y$EAI+`MAPXW>9@$D.*QYMVD_N.1VRON+G;
M:"BH;54TMX;J'WVR7&T@@LD2\*B<#.?3(X2D8I6;M<;E7W,W&C=0&UC2ZM6K
MS1CXAQPES.!&1PC9LA-C/(>)9EC-3=TMXLRBLZJ<*LLX5BZ&6P@R!1DELAG*
MZ.Y7_<U'=JKV]-+M2RBJI7V%":'$*3\01%Q:;DFDN-%7TKZ2XP\A<TD&12H'
MAV1!GZK[Z0Z#S)BL@KO'#F8?>PXJ]ZH(LT-_76KUW7Q,[OQ\5$1$W<J+OOLF
MU7[#5:O0[@MBSXFGD*`_B"@K#ABD=O=&F?W@VY!O&R[^RGP5-(X@F7[!0I&/
M'!9PX2ZQ;CKT!'C2#1!!H@@T00:((-$$&B"#1!!H@@V1-^GUZK_JNR)NO\^B
M:((-$$&B"*_L@]8\[Y[Y^%R3SR2H@<8\=V'9Q=QU5FC3YUM&:2+(?.RNSB,$
M@@3IT$<@T;R'5^_@16":JD5G[(_=;LBMN93Z)@_A-C&>1)6>I$Y8\LLV1F\,
MVVV*I+<%>K>'XBSA+.02.PRGASSR]7/G[$.*^&<BO<%HZ6WY`S3'S/K[$%<:
M+6XW6VPVO:>LF7)ED2"RZXR(R0./&*@R=PU>A&O1O7=MX6^V/N4B&U/523(A
M,@`>1/,<0`>6<<[9M6NN+**E;B6J=0F"9DD<P.1X3(C/^N_MAR;R^6M9EOK7
MGV)U-HC6Q<WJVFG8N\CSHU#2!W<*BEQZY@'HJF`^8JJU51O5$3OL]\KKCI]1
M9G6FSDO-/STGO$XZ+K9Z.@U>1=FG%C-.2OE,?&49KV*]I[3C"#=XSQ_Q9R?F
M/(KQ%A4<@7'^1KAT>6780[0EPZ&@[B+&>_N&.*A&R'L[5>QJ]^N^\7EV@;6U
M2T+SM81X9(443YE61`Y".JU6ENM6ARIK66J4'Q36`J7(#@3S,4;S(O*7#654
M///)]&1G(64WUWE>)TV:0D'83[EKQS#YY>T1!B*"LAVMFCX('M`IY@NY$0(%
M:3+%(K;6^W>+BW_KW%E2$*SG_P!XH<@3X1A,]!CI"54ER97:J!S_`$3:0E:D
MY2_82>9`\1X#J8;#UJX0]G_:"S+RAG?,O)N%X/(,\T;(@9#:"MLEFQSLVCXQ
M3AL(4"OJHSE<GR_#\9CV>,0B*C_&P62UWV]J_,*VYOM4RL00H@J_A$Y!/678
M(I+Q<;-:$^AI+<RY4#,%((3_`!&4R>D^TQ=1QSAUQ@N.MH+G/LIY%*&44L6]
MS%*E]X&&]@FCKSS*FNK6V`P/8YS3':20JO5'/<B-1-)I*==,REE=2MTC[RY:
MNPD`3[3C&?U3Z*ATNHIT-`_=3.7<"3+LRC?=28CQRS>T=QE]+:9K;5%@D4K<
MVR0-\8HAEG.^;<3`>412M>T1$EO5'JB(_N<BHJ;+K%Z%FEJ[W6-5S94LN+(Q
MD-0429]W='H^ZU-=;]LVZHM3J4-)9;"L`3I*``4DY8RZXSG".4V:YJ"16P:_
M([5C6S([(L9\XJQ?*0S6L81A'*-P7O?LY';M5%ZZ;:FVVTMONN4B)Z3,@8Y<
M.L9_17J\I=IF&+@Y+6D`%6$R<C/ASX1.O-7*F5L$#`S>#X@:`$-TARO(4,27
M-L)LV%!^YH1Q3S9)7JJM5RJ1R;HFVU#8;<U5(9KG75*#2R$)X``ZA/K-1,->
MZ[Q44+E1;&64)-0VE3B\9J)&@@<):4@3SC3N.*6#R;6FQK(K.2R1CC12*(L=
M0).#6F[Q3(B/,$OF@B/XE1J[J-51&JB+MJ1=GW+,^FLHVAH>F%@STE0Q!P.!
ME/MB'M^E9W'2+M]PJ%>93R+9$M00<",09I!EV8<(F?/#9/@N"5K,2)$^-200
M5]E+.%KY0XXP!B!F10D<\*$4Z]SD5']JJFR*F^J&W"CN=S=->%:W532`<)YR
M)SE*&R\&X6.R,)M11H90$J4H>("4M0&4YXF<X6"OY-Y!C?%B1,DL2-9(:X(2
MMCRGD*1S40;R'`4YAO79.QSE;UZ)NNG!ZS6HAQQRE2/#B02)`<<#(=L9S3[D
MOZ2RRU7K/B$@0DDDG(DB9!Y$PU&4\V7$/)<'PRUCA=$APJVL?.E2',970;6U
ML9AQ`:]4&,,>RLC%<]SNU&JJ;)MW:6:.U*KZ)=07R0RE:6TRY34)GM5D(>+E
M?4VFYM48I`%5"FUO+)Y@(,AV)$R3SC3,SYHE4F3V&-$H(9ZJ.<<.862<_FE0
MY`A_((-HT:)@R!*O;NCT5/K]==EML(>I6J]-2?/Q4`!A-)P![QCE'1>=UFGK
MW[4Y1`TN"5*)(.E0$R,)#`X9QBAXAP*CFD_R<A=E8[P+;HJO7N1RC:(,)IR*
M_;;M9]W7IUU(5<-R$%/H)3XZ3AUQ)'QB(BT;,2H+_-=4C.16,>F`!^!G%U'K
M7S7QM(PG(>%++!J[$\8L</R6VL\D/:V%G'FRX%``<V=?1+(*28A"18/>-0D1
MHRL&(0FJY%U/L5VH54U79WZ)++*FUJ4O5J!(3)15A@2!A(RF``(J]U6"YHK*
M#<--<U5%0EYM*&]`0I(*YH2@`X@$R((G(DDF*X<CR&IQ>KE7-I)[($=41KQL
M5Q)#B.[0CCB=VN>0W\$7;9.J[(BZ0Z>E>JZA-/3IU.$]W;V1J=974]OI%UE6
MK2TD"?.9X`<3"9\E<JSLS.L"N\L''8YQ'C@>QHYDDXFKL>6\9"-[6D<JL8B[
M-V15W<G1^M%C;H$^:_)5400>0!X#]9C)]P[H>NJ_(I9HH`01P4HCB9$X3R$3
M1D%('E+!J.56.4\]\JE>R2\BK\-I6QZRZ20G5=HRB>0B;+_2CD^O5=H7UV>Z
MU+;N#>E<QSD"I,NWAVPY7.F;W'8J)ZG.IW4W(\4DD)7/LQF.D:#F'$F*0J&X
MN\7R?Y9:0?EEP3RH,QBH)[1R!>:/X21Y"*[=J.:[N=]OU5%U<T%^JGJIFFJZ
M/3YA\)`(ZY',=1"W=MJ4--15%9;[CK\D>))*3QD<4Y'H1$E<)YK43L<J\:69
MX+VJ9(&V*5SF$D1V&(<1XC]D:]!"(B*U%[V=F^VVRZI-P4%0Q6O5@0?3K(.H
M<#R/(S$,NTKM255MI[<IT>K;24E)S*0<QS$CW=D=,OK1G\[DGAK$LAM5[K8(
MI=)9E[4:DB522BP&2MDV3NE1!"([_P!]RZU.P5RKA::2I7_,TZ3VIPGWRG&&
M[KMB+1?J^C:_DZM2>B5#4!W3EW1/.KF%V/_0[^-$$1YRKR?B/#>`Y'R-F]B*
MNQ_&X!99E>4(Y$^3VJD*IK1G()LJTLY':(`D7=[W)_#=4B5U;3VZD>K*IP)9
M0)G]0'4G`#G%A:[967BOIK;0-%=2ZJ0`X<R>0`Q)X`1R5^SOLUG?M!R%)S'*
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MY%L1,MM)Q;IVA(`)2-(4J4@5&1)/`80N-E?T=I-MLBS[,["AER3OG6-BW#"7
M-2P'B&SY)IPLCJF5X(K&(-H4$]6#8W[G*NF<)."4)GW_`.R-#J5W7:%(Q;[#
M8DOVMEO4I:G)**B253&G/C/K@!*([Y+O/\8P7(LMQBPAY#5Q7'@4V201%6KD
M3FGC1B(9DAC71)]<V4A31#?>Q&_5S%1Z]K3>IU#:Q*?")5-O*GK;95K\OT]Y
M;3XF%D:DDD`*$PG4F1G.0ZB-5X,X<O;ZKC<C97QO=Y7A9#F!34LELH,_.KRU
MKK"/(SN\D?C[,TJ%7E=V5HW!\`2%:J.5!.\S+9J2@KZYRGJ[VS1>6V5A:TA2
M9I(DV`5)$U<<9R&1G&$^Y&\ZNGHDVZS4#M4E;FETMJ(6209K4H!1SR&200)Y
MP[&5XAP)QE)Q[%C8U@EKG%O-6!!R/+*;'I-B:<BK9`JXD<L-HK&T'`7^S'1J
M-"%&D?W_`-#\OW][@5GJ+A64=*@W)24J6VRDI:83I2D+6D3D#A@2-2B3.*O;
M5I>0Q1T=3=JCTDRE*G7"I;IF3H22<9">0\($I17M[)<QYCR/FD_B'"LAF0<1
MQQ@X?(.91)+9,Z=9.8$ZXM1&8T8*=L!K5#);%5B(XCF.8@Q>(J=MYFJJ:1&X
M=R/KJ*MXS895@VE(P\Q38DDSS0"F6`,R3,?;]5H35+LMF0EJF;$G74XK4K/0
ME>8EDH@\98`2,"0>*./H$=D=F-0I':B=QYSC39)7?5SR&D%>[=RKOLWM:G\$
M1.FF)=UN"S,U2AT&`^`A?1;J)`D*=)[<3\3'J9AECA5A_EW#MS.P/,88W^)8
M$HA*:X#V.:^JN*N:LNND0)37*UXWB)'=O_<$1.FIM'>ZAM:459\Q@YSS'4'/
MX]Q$=#UM0/Q:(^54#*61Z$9?IQB2ZRIK^7:(7*N`5LO"^5,9(^EYDXUPJ-(6
M31O$+MA\HXQ113#/&QRR*HTG5P@NC,(Y_8YNZ/5R8J4K0`5!;*A-*CD?W2>?
M7.'O96ZG$U":2YU:F5I!3KF=2#P.)Q3T.'#D0VW$?KQ)Y8LN(>:*2XJ<?1E[
MC^2\K825;%UG4Y/ALFQK@RZYTR5,GQO\GBQT>6*91,$]$(UQ$^QO95A^A1Y5
M13.)2M!+:B"`I)XB8$P#Q$%3NURJ:O%L<K$U2B[BL*22%2(DK3QD>DY#E%M.
MJ*%:*\?<WEG)*L,O"<<*Z"R..I!((PSD_)VV1R(8(`I8T8U/Q]2"2AW"57LD
M/>G<B(-.Y>NE8I54U;TJ*6])6L@R)2`3I'*<L3&8[YOE0V^BT4RRA&D*609%
M4\D]!A,XXS'+%?O66GE8%[#\:U-#86,AN6U&9#SI'R3O%<MKJ2381[6=&4CP
M"4=H1J#V1$;LC47^KN+!7OUGK$K2`PG3I`&"1CAURX_KBDV/45`O:&D*/DK2
MK4.$@DD$]AECUZPV7ZWO)6\Z\XT0NYD05',1[$Z,5]/F:0HG<G_F&&87;^7<
MNHOLPKR=T[RHP/#*?^ZZ1_VH]I_W0)]7[=>U=S49KD$S_CIT*/S1%S>O1\>'
MX-$$&B"#1!!H@@T00:((-$$&B"#1!$><D\L<=\04+LEY'RNKQ:I1RL"2:XII
MDXJ*-K@5E7"%)M+0[5*WN9'"1S47=R(G742LKJ2WLE^L?2VUS/'L`Q/<(DTE
M'55SH9I&2MSIP[3D.^(EX\]R?6SDZ>RIQCE"G%;%*,(*S(XUGB<J60W?XAP5
MR.%61YY7JQ4[`O(]%V143N;O7T>X[+7+#5/7H\PY!4TD]FH"?=$^JL-WHT%Q
M^B5Y8XB2@.W23+OC=_8G.+#C?@WE/-JAQ!6]!AEQ(J#B:Q[XMM(`L&LF]I%1
MBMA3I0RNWW^UB]%^BRKM4KH[97U3?\Q#2B.V6![C$:UTZ*NXT5.Y]"W$@]D\
M1WB*7OUN<"4?+/(^2<D9M'2YJ.-'54FOK)JJ8%KF%V6:>#.L$?W?,!3`KBG<
M-_1\DH7.[FM<UV:[)M;==65%PJAK2R1('&:U3,SSE*?:08T#=]R<HJ5BBISI
M4Z#,C@@2$ARG/X`B+Z<ERG&L-JBWN67U3C=*`L<!K6[GQJVO$:45H(PB2Y9!
M!8\YGHUB*N[G+LFM7=>:8077W$H;'$F0^)C-&FG7EAMELJ</`"9^`C[JNVJK
MR!'M:6RK[BLEM5\2QJYD>P@26(Y6*^/+B$+',U'M5%5KE3=-M<D+0XD+;6%(
M.1!F/B(XK0MM10M)2H<")&*(OVKX]<`YIP/)Y0B-Q^VXZB4==,:A7B2=29%?
MS;2.JO1HF'&&^`_L:[JUR*O55VRO?S*Q<:%]4_(4UIGU"B3\B(TG9+R/05C*
M?YJ7-4NA2`/LB[[CZNJJG`\+K*.,")30<5H(U9&BM&R.&"*JBMC-$@G.'V^)
M$7=%7=5WW7??6GTJ&VZ:G;:$FDH2`.@`E&=5"UN5#ZW#-PK)/:29QM^N^.F#
M1!%#/[%N#+"JR+)I]+!4--GPW9)5E$UZQGY%'.DR[JGK]R"DRI**5C>C=CIM
MT:Y&Y?>Z86?<3-Q+?^C>,R>2C@KOQU=1&W;9K#N+:%39P[.XTZ9`',I3(H[L
M-'0@3BE''ZZ=-R"L@1(;I4U;&.GQ'-<B*H3M<9I_HHA#:Q?(Y=NUJ*J[;:O:
MQYINC?=6YI;T''M&$NO*%2W4[[UQI6&F2IX.CP]AQGR`ECRAD^3^.\DS3)*:
M140X@H7XA1&L3R1C`,GS9L@8',3NDNV"5JL[1K_4OTV79/LEVI+=25"7UJ+A
M<F$@=`)\NW'A&C;GL%?>+A1JI6TAD-2*R9`'43*6>64AQC>N/N)Z_!)AK7\E
M(LK$\+X;G."P$<#'O$4_A&UQ"/5[PM1%5?HGTZZ@72]O7-"&?*"&@J><R>`G
M\8M;'MFGLCCE2'U./J1IF0``,"9#M'./7=7]7R-@V8UF-'?)GP(KXYHY!$":
M0:(X<M'QHY%=)<"7X'#&KFL52(J*U-<V:9ZU7"W/U:)-J(QG,#AB<L`03TCJ
MJ*VFOUHO-+;G"IY(.!!!)^K`9R)!`ZPE-;"ES;*'!B0R3)AI8@BA-[F/.52(
MGA5V[5$CEZ.<JIV)NJJFV^M`J'$-T[KBW`E`2?%RPSZ]G&,DI&77:QAEMDK=
M*P-.4\<I\.IX9PS7(V`Y%E^5XNE55*(+JF.&=9D<JPXBML)3U&<B*YQ'A$[N
M:C45Q$>B(FD^QW*EHJ2J2^]-1<\*>)F`)@=>/*4:)NBS5USN%"JFIY(2SXED
M^%,B3(GIPYSB*.9FN9R!:L<BHHXU4-%[%8C_`!UL5BO;O_4USFKUU>;?(-L;
M(XK7W>(PK[N!3>WDF<PVV)\Y(&,;?@G#%U91,?RS\G7QT>>#;Q*X\<Q_D1Q'
M')CH8HWHUC93&(NR-=]KO_9J!<=Q--.U-$AA2B)I*IRQR,A+@>L6MGV?45#%
M%<G*M"4G2L)TDS3,$3,\)CH8VK-N5L^P/,K6M(D=U+-@>*/":-\3YE7)['HA
M985209138_WL<KAJ02?:BHBI$MEHHZ^W:FGG$5$RE<CA.>13E(X&+"][@N-J
MO!0_2M.4@`4V"F1D1+4%8D$&8B2\IQ>%R7A-8(,SX[B1X=M62AIY!^=T)S6"
M,U7)N(B'5KNO<U4_T5%HZ*L<M%>XHMSD2E0/*>,NN$-%SMS.X;4T@.Z0H)6@
MC*>G"?,8XPAQP$CG-&*U6F`4@",_BT@GJ-[?_%'-5-:<A:5H2XD^$B?<8P]Q
MM;3BVECQI40>T&4-)BB6_%?&][;WZ(.19.$N/UBE57AFS0HT;I*-148KVB\C
MAHNZ-8N^R]-)=;Z:]79AJF!(`DI60D#,D<^0ZF-,MHK=L[?JJBM("E&:$9D*
M4F0!Y3/B(X`'B8@'$<K+BMP^T="CVH9,<\2?!F*[P2X\ES'%1Z)NQ7[LW3N:
MYJ+_``TT5]`FMITLAPMJ204D9@C+]`1"-:;JNV5:JDLI=0M)2I*LB"9GI/M!
M'2&?XR%QAD-W(O\`&*BQJ[Z`!KC0C*Y*Z,DW<#RQ6,(\#7[(YO1=NU55&(O7
M2?=S=J>E;I*UY*FE*P(E-4N!XX?])C1-O"P5E:]<+;3*;?2C%)F`B<YE($P9
MY9X<!C'0GZ&QYH.#Y!)3&MCS,VOI-<Y"J17Q&PZ>(17#5J(!4G1#(C4545/N
M^KM/.R4+39`59*=41V8#[08S'W*6VO<J@CZDL("NWQ'["(=/3=&?Q__1[^-$
M$<S/[,/:VPY@Y,G<08S-&G&G&-R2.58_A?\`Y%FD)DB#9VCY@#%0]=6^9\:,
M/[41[2$<BJYO;AN_=Q+N%8NTTZAZ)A6/[RQGCR3D.L^D>H?:G9Z+3;47^K0?
MS*J1X09^!HR(PYJE,GE(#C%8(@EDE#&`FYY)11PIMO\`W3O:,:JB;JJ(YVZ_
MZ)K-WWD4[+K[GT(22>Z-JH*-VX5M+0L#\5UQ*1WF4^[,Q?=Z&\21</P*3FLF
MO+&LL@_Z53D.AAN_QN$H7K*&)_:Q_P"7LFN+Y=E5[!LV5$W1;G8=L<9H7[O5
MH_UM6K5,S^C[HEPGB<.$N4+/O;N)FKO5%M6V/`V>U-Z)"4B]DX2<R0`$XG`Z
MN9B0_9C*XQ(]?A4:.TUB(@;Z1+\C$?!;XID:+'$BH1$/*1[E=Y&JQ![+LJJF
MVBL)E-1RRBG]K;-4OW%^])=TT[`*)<5E8RQPD,">LHKZRVMR++J,N.PK*IA3
MG&@2SAM@'#**M;:"EHU\6.\C2UY20T^]B[%1-MT:Y=3FU(;7K(,NG41LM>U5
M5U,JE:=0EV:3)0()TJ!R'`RS&<2GZY<RY+A_(E+P9<U%'EU7G&061\OO0QWL
M(+)K"H2>YD2N<\D9]/64\&(P[2,W&C^YRJJ]?C[*'&E/I44E(P'2?VSG&);_
M`+(MNH?NCU8'*F:0O`!.J7TH&>`()GSB4>6/<#+J_)(N+\1T-+-D(X[V%NPE
M-$?6P3^`D^<2)+`E97RT9VQ%:CWE<OTZ;:2W;VVEQU0`%*VK25'-1Y('&7$G
MA'F2Z[\<9JULVYA"F6U$%2L=1'[,C@.L0)RMG]9.X+J.?K*B8_D>E9;+@W=(
ME$6MSW,YY\.L),6"DED.S9\@Y9#!2!F:(8NYC6N:BIE=-35U;O.Y65VL)HJI
MT*J#(#4RW)X"<IID`$^$CD3*-U:NE&_LRT[C;I--4AK\$$DZ77)M$RG)6))Q
M!PQE.$^PO&V8;C,&I>194L:$E6<IJD(Z;9RG*:8=%(JD>WO7M:KON\;$WZ[K
MK2*M\U=0MP)THR2.`2,`/A"?3,^F82V3-69/,G$GXQ[I&4Q!O$T7]Q'J1'(C
MF.<CA^5%;T=]O^TJIOOWHO30FD602<(#4)!$HV4!FR`C,Q45I$[FJU4<U4W5
M-T5.BHNW34922E12<X[P=0!&48_B[.H_%?/?%_-6/V`I5%<WD?`LW;%*,\.=
M1WA'TSY7?W>-AJV2UCM^YO\`<CCW_BBLMG><`>MKZ2#+4D'`@Y_,8Q4U.AM^
MGN#*II)T*ED0<)]QB_&MQ[`>*(M]=C/'QZ!;2HQ[2;:69/BL(TIVQ`#)-,YH
MF?(GD[6HJN<XFVZHC41AO6XZZXTU$;Q6I--2-:$$A*0E&&9`$\AB9G")MFV\
MTU5OLV:A6JLJG-12G4M2E8Y"9ZX"%<YT][>,>-<0O[O`)U+RC:4@0-E#I+J(
M>IK)TRP97Q(EK)BD(9A2/0KW,8G<U@E7^*)K.KMOBSVYL*IW15+,\&U)(21+
M!1GA,D81IUC]M;_=D5CU6@T;+.F?FI4%*U$_2)<)&9RA=:ZNR_WFXM7EO&*6
M!C]C>35Q^TI3V?A;4Y)AYHR,LX4L_275&:*.G8JH5KD>BHJ;:X6E]S<3='?F
M&TH5BA:"3(R$B4GD0K">,8O[E^W-=2;E<1253;G@3/5X3+&1.>(&!'28AQ?7
M3UVG<62;3,<[MX.3<BV\*/4-GUPB`K*6B!_>6N@!44=KY$R6Y223*S=RM:C.
MUNZ*VTE'3T+)9ID223,XSF>WI'3MK;;=B;<6XL+K%YD3D!R$_F8TO]?HDE>S
MW-LMCU:R-4Y4]&^/N0GGSJ(%$\G>B,5NV^VR]W^FVE[VA).]=YR^F1^/FD?K
M,>D?[D4A/M/[4!7\R21+H:9)/V#XQ=!KT='B&#1!!H@@T00:((-$$&B"#1!!
MH@@T01K>0X=B.6C&+*L7Q[)!A$8(6WM-76R!%(<)QQA^?'.H6&<!BO1NW<K&
MJOT3;J=99?&EYI*T]0#]L=C;SK)U-.J2>A(^R*6_V`^FN(\:T'_>[BF$E!2L
MMH%?F6)1E,ZNKBV\AX(614KS'>ZOC/LGAC%AL3Q,><;Q(QJ.;K-=W;:IJ1@W
M2WHT)"AK2,L3(*'+&0(ZX1H.U]P5%4\+;6JUJ()2HYX8D'GA.1SPAE/2/+9W
MLYZMYWQCR?:RKI]6>PX]-9.>OY=<5M*&$6ED2)CWN?+L8$A\A@S/^YS8XT?W
M*BN==[7JEWNQ5%)7+*RDELGB4E(E,\3CGTBGW'3IL]Z8JJ-.D*`<`X!049RY
M##+K&H>C>)YMZQ\H\C\)<H8[)K(N:2(-AA&>,CR/\6RF?0),"RLK[=S?A_,M
M*N>L@$9[F2&N`4;F]^R:Z-KTE38ZVMM=6R0APZFW)>%4N$\@98R..!CNW'4T
M]XI*.Y4KH*VQI6C[R9\99D3PGEB(M0N::JR&JL*.\KXMK3VL0T&QKIP6'B3(
MDABL*`XGHK7,<U?_`!1>J;*B+IX6A#J%-N)!0H2(.1$)R%J;6E:%$+!F".!B
M@_%,PO\`T3]O[+C;_(KA.&)V30TLZF7(^;"D8EE401*:_-'7N:RXQI98_/)$
MP<@[89&;*PG:N5LU#VUMR*HO.5^5N+'A)F`E>1[4GCF0#&E.L-;DL":ORD_F
M*$G$"1U)S'4*'#@3%PWL5Z]X?[(X$F&91)EUDB#-_,XWD-<T1)=+<-ARH8I"
MA)VLGUY12E0\97L0R(U4>Q[6/;H5WM-->:0TM02)&:5#-)E*?7/$<81;7=*B
MTU0J6`#,24#D1R_P/"/JX7I\OXIXDJ\8Y=R#&)+^/H3:.+F4*P/'K[7$JF+&
M%2VER.UAP/PUG&B_\J87EE-=\=I?.]Q5:W@PZFRVG7>*UI%/3(\3JE!*="1(
M*652"3+`XY\<8['65WFZ!NT4;KE34+\+24E2BM1Q2D)F5<QAW81!>2>X9,CR
MR/@_K_BHN0+(<T+;?)[H[ZC$84)LCPR2!DD+$(0/\I1'B$J)N)IMTU@]X]^E
M76]M;<]L;,FYU8<`=J'B6J9*-4E$*)22/_>**4_L)<F(WRT>PB+38W=Q^Z%Z
M5:Z0MDM4[0#M4M93-(*0%`'_`-VD*5^VIN1ASAW],HV*6XIVD5C5(UEG$<QK
MU:G>UKE*U7-1WT79-TUOZ+M;2E)7<:<+EC)Q$I\>,>?5VNX!2@BWU!1/";:@
M9<)X1'W)N&<9\MXT_%\RF5LF$DADR'*BV\.-8UDX;7C9+@2?(1!E\1',<US7
MC>URHYJ]-H5Q<L-TIS35=<P6YS$G$`@\P9X&+*T.[AL=8FMM]&^EV4B"VLI4
M.2A+$?,<(I_Y!XH]0^-BY75XQ<9?D^?%;+8&^HJ['V4T.:]2.=#F25%&=8=Y
M%1#N`Y4[DZ*B[HB'<T6)AM="+G4OOI^F1!0D\!P!ETC6K([NBJ>;NALM%2TJ
M\5S!#BQ]Y0S(GF)Y\9Q4CS)+RJMS,D>==RRQF(VTHF`*L9D")(>08AL''\:,
MD`<!S%>OWO1O<J]=3]OM43MOU(IDAR>E<\9D2Y\#/+(14[NJ+FQ=M#E:HLR"
MV])TZ4F8EA+$2(F<2,8V3A3(<A+,RV3(L9MLR%CQI8*V7+D2BS+-A6K"'&85
M[E:\O8\:JBHGWHG5=DU&W!2424T*?+2V"Y(J2`))XY=H./(Q-VC<+FXNZ++R
MGBEF80I1,U<,^PC#F(BO'LZN\3R2=>U@HT8DX\A+"J>%5A/`:5\A\)&%5YX_
MA(FS'M<A6(FV^RN1;VIH*>MI$4SQ*D`"2N,Y2"@>?R,*U'=JRV7!RLIP$.%1
MU(D=)!,RDC.0/>(WJHY0JA9(";58!3UTFU)\6?(',E2)SSV!?&8\$CA#!"1R
MEW[&"57?17:J:BR.KHU,NW)U:4":1(`8#`$9GXQ?4FYV&[BW4,65AM3BI+()
M*CJ.)!P"><I=IC]\M9%G5/EBUQ[J5#A1?%840ZXBPFLAO<4<9YE`K2FE!4;F
M/4CG?<U51$14UQL-';G:+S13@O?2O5CXA*<IY#(X1SW7<;Q3W(L*K"FFD%MA
M&`TF8$Y8DY@S)'QC<[\%-DV%XMFN>QG5<B-%:TI`O&D[*$0!R084?Q(KHX[%
M6*=%=LHVJ[;9.NH#:JFCNE706I04E>,LPV3+43PPR^`SBU=117&QV^[7U&AQ
MO">2G@`=*1QDK/XG`&<:;.YPOY%="H<4J(N.-$T$&(Z(]9\E@&-2/%BQ!'CH
M(3D3M1%[7NW39-3F=M4Z75U%;4%TF9/`3S))G/[(K*G>M4MANDME(E@"21+Q
M$#(!(E(<.<?CFR8.:3#26$>5%RE<8B$NPG8Q&,:9SW#'W-?OYASDDJJ=J;-<
MF_7IKGM]LH5<0TL*H_..D\9C/ND1'5N]T.ILQJ&U)N7IP5C@`<AVA05AUB,J
MK)\MBMB5=1>7(&+($V'"BSI#!_(>1&B8(*$[/N([^G;957Z:MZBBMZO,?J*9
MLF1F2!EQQA?I+E=T>124=:\!J`2D*,ISP`';PRAF).`8W?3L>I\MEPJW/3Q?
MR$EU&K`_F&#>KSNL!E`H%E+V.<XOVJ16O5JJC5V46*ZO8:JWZ!!5;`K2`L_3
M/EB,!\,IQH55;+555%!2W5Q*+V4ZE%H?7(SDH2,U''A,R,C+"-IY==C<C&GT
MEW=0Z5S_``SHCB-=,FN^`YVR0JX9!.*\R*HT<KVI]R[_`$U`LGJT5:'Z6F4X
M02#P3XAQ/#G%KN;\O=H'*6OK$,A0"DX35X3/PIF)SRSXQI&#IPLVAC5!YE;8
M3K!5%)+>04B6#SO<NPVO5",AL:Y^P^PR_P#Q*NK"X_U`:ERH\M:&TXC09I`_
M7UF.Z*BS_P!(BB:HR\TXZO`EQ("R3VY=)'OBQWT]X>X*R5<FX[RP+\=OID6/
M,Q/((-B^#*F)'8<4Z')^2`U9*FB\@RM\W]PK>Y![;.34FQ"AOCU4Q=WE>K(F
MVK5*0XI2/I'`\SW1$W0JY[7IZ&JV_3H_+TDAU.B<SAI4HCQ'B)Y`YYQ=AQ[B
M>,X/AM#BV(*Q^/U,-`P3MDLF.F*][RR)II0E\<B1,DO>0CF[-[G+LB)LB:A1
M4U/1TK--2@>0@2'&?6?$DXF,0N595W"NJ:RN)]4XJ:L)2Y"7``8`<HW/4J(,
M?__2[,??#FZ1P1ZWYGDE/8&KLNR#XN&X;)C.[)4>ZO'/::='?_Z9*NG!*DM=
M_!XV[=532YNJ[&SV6JJ4*E4*\"/XE<>X3/=#CL.P#<6Y:&B=1JI$DN._P)S'
M^8R3WQR1$(0Q"%*]Y2E>XA2$<KR$(]RN>][W*KG/>Y5557JJZ\W*45**E&:B
M9DQ[-2E*$I0A("`)`#(`9")S]>.,YW)G(U#3Q!.>LJR%7A<U%5`(]BGM[%VR
M*B,JJA'OW_@YW\T35-6-.76XV^PL3DZH*=EP;29F?;(_+G#K9:BGVQMZ_;XK
M9!5.V6Z8'[SZQI$AQD2!T&H\(N]]C_9[C/U"P6@CV,0]M?V$5E-@6`TJA_)6
M:5\=D=D@WD(QL"E@[,::0[?JNS4<[?;85KIZ&GU*(13MIEV`#`"/+U!;:Z_U
M-74J=DD$K==7.0*C/M*E'(9D],8KPH^?^0.5<R)<\B8714)LFQR';4DC"[1;
MZID1*8C*ZQ$AVS9_EE0"2AM.)CD.%Z.1XFKLFBW5[E2LLNL!`*2MM04E25IG
M(XI)`4DR!'"<:[[:7*D:1<+/3E:RA>LS24K$Y#%)`)!$BDB<\8TW,P)><S<?
MCK;!K;21*Q.NH-CE&-S[7)I4"X&1@VN)V^'M0S=MT:W9R?1-,;4PPZ",,9]P
MPB_W/7LV^K1=%+)+#:5)`,B1K5K`ZD"1^<6&\`^J.0\9Y5R)F^87E-<9#?1+
M>OQ$E8Z645,&[(0]A/*LR'%<">911PIXD<B"&J;[*B:@U-4EUI#38(`&/ZNZ
M,,W1N%=_6L-I4AK4M0F1.:NSD/TPA*K7BGFS&<ZRT,7!;`1<O;00*._M$\&/
M4SJ6M,">R3.=WL*W["R`M#W^9RHJ(NZ[9E<FV;9;*>HNI4AAAQ04`)EPK,TZ
M>&,I$F4A'G*U[#W%=KBW;6Z/0J9FM1D@`9JGC/I($QI'--3DF-\?>N/'N5@K
MH5C#SC(),R)32B3(,J/C4*YD4DUYBL&XQI$>6(Q^Y-T,]R_75'M9ZEK;UNFZ
MTBEJ;53HD5@`@N*0%B0G(`@I3^Z!'H*\T;MKL>V+.XA*0TZH229@I;2K0>T@
MA2OWB8C^Y>\5?((-CGN8U7=K$W<K$1?(B?7J\>[=_P"&^^FMD`N)!.$43I(0
M2!$8MLQD\*&:YXCF*1IQHJK&>Y.Q1/V17-5HRN1%3=>SI]$U:>41JD<0!AS_
M`$^V*_S09:AX2<^7Z?9$D43'"B/$O]+"?8B-[$:QS&*C&M_@U$^F_547KUWU
M6OD%8(B>R"$RC1LTJ:FFQZHJ*N"R**;FV,$#!@L7RR)#\@ASI?QF*J[G>$#W
M?P39-M6=J>6NX"H?62$-J))X`)(QZ"(M73!3"*6G;\;CJ`E(XJ4L9=3$Q^['
M-/(O(E_A=966UG6BMKBPE4V-ULTH1PEB,@0ZY7.$H_(<ORBO,1W3?N3^A-M8
MKNK<U=>:E+-,XI-$7!I1T3FI77CTRCV/MO9%'M*AH@$)7?%H5YCHG.9(DA)X
M)'SE,PD4LHZSB[D1K##.;.LRI:;'&[.5UH/'I\V?/F@8C=U`$=@/=VVRN<C?
MKI5::2ENI4H^%3A(ZR4)2[3A#,ZYIHWPD@J<4E*>NF9)[`"#%RWZX_9##;^J
MB^M..X-8TTKCK')=C)R<!Q3*F\G-GA6^FSG=K#QITVWL7N'NI&N&B-W;LU-;
MCLJ^T50TW9*:D6VIAK5JF"%8^(X93421/,991YHW_MRNH*IZ]55>AY+[Q3(`
M@IP\(QS`2)$@\CQBUGZ==/\`&;PG/ZT*YTKDCGW(7?WTCBJ:_P"6-4\+B7%_
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M8HUZHB:^;5H#:+,'*LA"W#YBM6&D$``&>6`GCQ,H^[EK?S2[%%*"M#8T)ECJ
M())(EU,L.`G$[5WMCZVVUQ^!@<SX&6R[T&P9+D<6*8CGH-HH]E*:"MDE<]=D
M:,SG+]=MM6J;]9EN^2FY,^9_$/MR^<5JK+=D-^:JWNZ/X3]F?RB?)$R)%B&G
MRI4>/!C1B3)$TYABB`B!$XQ91I!'-"*.(+5>Y[E1K6INJ[:M2I*4E1("0)SX
M2BL"5%02`2HF4NL<V/*LX?MU[K28>%=TVDRW,J/%ZJQCA(YC\4QJ+#J[+*.Q
MXFE2$ZKK)%@GD:UR!5$5$7IK%[BO^HMT:*3%I3B4`C]E.!5V8$]D:W0(_(MN
M:JG!Q*%*(_>5B$]N0[8Z5D1&HC6ILC41$1/HB(FR(G_@FMIC(XB?F+AO$^;,
M7_QC*R6L80#NF5TZIGFB'@S_`!.$.2Z-W/@3V,1W^W($1O\`Y>UWW:1]^[`L
MGN'9_P`GO2GD(2K4VMM924+E(*TXH6.BTJ'*1QAXV%O^]^W=Y_.+(EE:U)T.
M(=0%!:)@E.K!:"?VD*2><QA%5^0^HN1\39;&)DV$W?,/'-C-'"98X#+E5^25
MS3R$&$\JJ&&<X4EK')W-<TD5Z]$.-5WUXONOL9=MD7QE=WV]4W[:CK@0'*)2
MD/HFJ0*FP%R5+,$%LG#S4F/:=J]]+3OBQO(L^XJ:P[L:;*RW6I2NG7),R$N$
MH!3/(@AP#'RE"'2'Z$\`$&Q_P\R9WL:_L)DCFO9W-1>Q[?AKL]N^RI_/7H)'
M]LWMBI*5>3<!,3D7\1T/@SCSVO\`N:]STJ4GS[>9&4PQ@>H\>41[RCZG^K7%
MV)661Y).R:K5D28VI"_)$-,L[,<9Y(T.N@NC"=.D.)V[M[FM1.KG-;NY(E=_
M;K[46QA554>M2`)@%_ZB.`&C&?*+"U?W#>[=YK&Z*C%$I2B-1%/@E),BHG4=
M('/[8I;Y6S:%B&.S8T*:@KN<%8M1':YJS`C,KAK.>UJ[B8`+';/^GDV1-75C
MMOJJMD):/HVR)\I#)/V"7*)FYKPFW6Y\J>'KW4D)'&:LU2Y#$SYR$:?$PNKY
MEH:'+K@D^NM_Q[ZR4Z`@T`?X,R2Q#*(XB+N1Y%=NBHGW;?1$U:NU=58*FHI*
M9L+IE*UB8)(F`,Q+E**-BWT&[**DN-:\INL2GRU:2`#I)(P(/.??TC[L,X]/
MQ?)RVYD2H=Q5+3'6.$B$B352+YI#A27=0A5&M1.YKG=S]E[4VVUT5UT_./14
MP8*']<CQ'BPPX]<?G$JUV([=_,ZSU27*4MS3P5X252)Q&(PF.V0C53<C\27D
M4/YNB8I"&0YPR:G>4*0NZO*ZTK_[DM%55W[FHY^^[OY:[TV>_4JSZ9_`"0(7
MA+L.415[BVI7MH-;2C43,A3<R#SU)S_7RC]0>,>.I9X69P<C?`QQ)K)S(<I0
MLA.4!7&6".;,>,S&-<!S5&]KC(UJHO7KKD;S>$I<MZZ355Z93`,\1G(8'MRC
M@G;FWE.,WAJOT6\J"@DD!)D9Z9JD0)B1!QX1NUEA^*\HVU7F,6U?*C5,A*T\
M9@PR(%F*JL3F>)[7*UXQR7%=LO5KPN:O;LNZQ45U?9$/43C20IP:P>(*A*>'
M(C+G%@[:[5N=RGN;3ZE-LG04@8*"%$R,\1,'.>(.4;AFF!TN75+*B<U8B5K'
M$KCQ%:,<%ZQ7C$J-:GA?&8-$51]$V8B;IJOHJVLM]2I]LA15]7'4)SX<?G%K
M<K;;[O1(I7@4)1]&!3I,I#`B4A,89'*<(V"LN\;RP$?\9(EV=%<@,D08)+TE
M$KYC"L[/"U"NCR%$BM>U4W:[=%UH?J:6KHBX7DI9<;QF0)3&([1&/^BK[?<P
MTFF6JH9=!`"29E*L",,098=(:GDVAPV]J*;,,JDV%0*((`G,C1W,G3AR>Z0V
MH4,@;2#.,J$5%5&JS=RKM]=)EG>N-,_445$$+U$XD^$2PU"6>$OE&D[BIK16
M4E)<[F7&]`&`$EG5CY9!R,Y\I8QCL,E858@^1@%=C=-)K'H&43*8A#6BN5J?
M$E19+9O>C7,:[N7R.<KTZHG\>VO15,K"+JZ^YJQ_#4-$IY2EA\(Z;4[05+9=
ML3-*R$>'\5)\P&6!!U8]L\\X\8S@>5,Y(9E4_+*.[5C#+8.CR'#E)'EQ31Q1
MQP4$4,6*-ZM1B=[6]J;IUWUWU=SHWK4JB:IEMY!.H>'`@_5SB+062XTU^3<G
MZYI[ZE*TF:L01+3+++NRC%>QU=&6)06@PN?+'(D0C2&(Y6CB$:\P`G?VM:JJ
M9CE8NVW5VC:[FBHJ6`X/+4G4!/B#+[,^Z/F^F`Y24546CYR5E),L)$3^W+K,
M0M%!'%+O::*=IG!DVM>`K8S4?(<PTL0W-"U51'%5'?:G\]-M8M3=)4K1+4&U
M$3RP!SC/K<VEZOHFEZM"G4@RSQ4,H>'D3DB+Q\&M1:]]E+L'O\,=LED9HP1E
M'YBD(K#$:[=Z(S9BHJ[]>FLYM5J<NBW=+NA"!B93Q.7+[8V6_7]FQML%;)<<
M<)DF<L!*9)QYX81:+Z=>^_"L7C#'<$RF384-W4%GC8P4)9[5A29QYGGE"B$?
M,\@"2'-<H@D1PVM<G55:F@6N[LV2B;M]S;6D-D@.!)*%`F8,QB#C(B49+>]O
MU.YKB]=K*ZVLO)"BTI:4N)(`21(X$83!GQBS*EY7XZR/%;;-J++*NUQJBKYE
MK=6$)QC$JH,"(6?+)/KFA_*12"B`>_Q/`A7(U4:U5Z::6;G05%*[6,U254R$
ME2B,9`"9F,QAPE.$BHLMUI:UFW5-"M%8XH)2DB6HJ,A(_29DRF#+K'__T[Y?
MW"<L.N>1>/\`A^OL1%@872&RC((("(KA9%DJM'7"G,:]4:6+01F%$CD1R,FJ
MJ=':QOW,N)<JJ&V(7X&TE:A^\K`3[$XCMCT;[*6@-4-TO;C9\QU8;03^RG%4
MNU1D?X8IM8,IB#"!O><Y!A"S^#C&>T8FK_)%>Y-]94\ZEAIQY9\"4DGL`G&^
M4=*[75=-1L";SJPD=JC*+S/0#AZLQ?#9_(<Z.TMA+/*IZ2=(&QJC@Q5_ZW9A
M5?\`;)8V#G!<[_A''[4Z*NK38E$IYBJO]2W_`*FI5)'[K:<`!VF?;(11^]EW
M12UUMV+;7O\`TVW-!3DOOON#42N6!*4D2Y%1BGW-^?:_G+VKS3DCDN(N0X3C
MRW.)X)"!'67#QZI9.FQ:&V'2EG5H;DHPC)).`D@#9)#JKG(C4;IBNMRH:9ZG
M9KV2NG6%8`:I$2DHIF`H`GZ20/A"]>K/56O:UKM5J>\NO>*7WB3I*\!X-0!*
M1B0"`2)=3#!\6S+25R?64S`40,4QO"K6XQ9,=KY];"DUN:3*BQ_)R(MI86EC
M%G6*L9Y0/,X8'C5@T[$1SOMH6ZJZ>0$M"A:I]3?EI*04NJ"M1"BH@F6()D)2
M&$3_`&NID&XUM;-TU:D%#NM040ILA&D*2`"!P,L>.,302PP!W(#9\-X5Y&P:
M.Z\A/#\L;XA8J-FC,C'-_$SI$<KV.5",*YBN1533H/.2UQ\E1E&E72BL%X=J
M:&L;#E2ALS2"I)EGFD@$Y<^L-9Z?>QO*/*EW^`Y(=1V(;K"S9MCMI504@3HT
M>+<@JCU]L"/VQ%[VRF/&]&-=NBM57*B[=-93,M`EJ8(5(S[)S$>?MR;>:M%/
M;JUE?X52"0DF9`^V&GY?:JU]`[M56_ESL1R)_M$?63581?X?T,<U/_BUEON4
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M*#$,C0O:XDMP4C/(1LAKMD<J]==:Z=\,)JEI_!49`S'V9\(YI>:+RJ=)_%`F
M<#]N4>,+ACS?DB9;2#,?BW&L4[(`VJBBN,ZLP+"[N[JOBQBODED>3_;;)$T:
MKN1$UQNM:Q8]O5;SC@%QJ4%+:?O:3@3+EQGV0X^WFVZS=6\;:44ZE66B=2X\
MY]P*3-023E,D`2&.,XB;EKD>#99!DEMC[A6#:JMJ\-I;EF[PPY-NMG.R"PK3
M;;)+^-#2,,C>J(KG(NVRZP&HJ$M-/+3_`#$R2#U5G\`!/X1[`K*@/5"U-XH"
M0D'E.9)'7@.\QKV&3\$R6RQW$[.K,"7@N)V%V"<*8HJ^5:NAK<3%MX1@D[&#
M.U-C#*Q2.9V.:K.S7>@((IDZ5:FTC/*<A,=98''CUG$6G73/+#*T`:$$S!S.
M<R#\)@XY'"47<?K:XGQ'#/73%L[@4PF9ER(M[9Y'D$D#?RDR*#);2#70!G<U
M'CJPQ8`R,&W9KWN5Z[[IMN6Q*"GI]OT-6&$IJWT%2U<2-1TX\M,B!EQS,>5?
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ML1%3M3:$];Z2HJ6JI]H+=;$DSQ">,P,I]<XF-5U4Q3NTS#I0TLS5+`GA(G.7
M3**6OV$<V9KRES>7@/%G6#L:Q.UI\=C4-:8J+F.;6P:X[BRXPW-;+?!L)S(,
M01$5&%$\C>I$VS/>-SJJZZ)LU,H^2@I3I'WUJEGSE,`#G,QH.U;?3T=N5=:@
M#S5!2IG[J$SR[9$D\L(L(]?OU_\`#G%5%"EYS15G)>>28@'6]CD,4<_'ZZ4O
ME>>+C]'):Z(P`_*@U/(:4Y/$CV^)'*S3A:-J6VW,H+[*7JLCQ*4)@'B$@X`?
M.%:Z;FN%<ZOR75-4T\`DR,N!4>)^4;ES;ZGV'+<")B]/S-EO&?'$2(*`/C7$
M:*@AXNR&V,2.>,U*X=///&E*17.#*+*`G<YK6(U41LJZ6-=Q0&$W%UFDE+RT
M!(3+B,`#(\B2.D1[=>4T"B\J@;=J29ZUE15/YCO`!ZQM7K[ZF<2>N<<TC#ZV
M3:97.C+#L\UORMEWLN*IR'2)&:-HX%1$^YK7LBB%YO&Q2J16M5.VTV&WV9)]
M*V2\1(K5BH_J`Z"76.FYWJNNJAZER30,PD8)'^)[89O5U%3!H@C$WUY5XS2V
MN0W<I(-/20)5G9S'#*5(T*$%YY!O$!A3E5@F*J-8USG+T1%776\\W3M.OO*D
MTA))/(`3)CNIZ=ZK?9I:=&I]Q02D<R3(#'#/G%5'LW[BQ<TI@8MQ?8W-)1*X
MLC)K^2Q:67-$%4\$&&<4U31ZQ4[GG<]!N)LUO1J.1V9[BW4*U"*.T.+""?$H
M`@JY)'&7/GA&T;0V(;:XY<;^TV7`/`@D*2GFI6$ICAB98G.4JN9WL=5WU_&Q
MVXO[VTAQ9<@<:UMK`LNF#)?XVF<%TF45X0RW`:UQFM:CD:U57;JE,]:KR]2)
MJ*APN`>((4258YX<#*4P#.&.GO\`MQBX+HZ1I+)4=)=2E*4$B<ID9B9,B1+'
ME&%R#`<!Y`N'W@K<DF6-8@I*U]A&EQ')$_\`ICC3RM8KP,5-FN8JI]R)ONNN
MFENE?:V@QY0#1F0%)(./(X<><XD5UBM5]?-67BI\222A8*9#@1C(D<!*(HLN
M?+J!=28M155"4$$Y(D2(\9F$)'CG(U#-*$K!@4[=E1J#5K/]>N]VWMMNH82[
M4U+GJUC43A($XRET[86'MYNT=4NGHZ%GT#1TI&,R$F4Y\)@<CWQ-&,YMC')>
M.V,&4@XCI49\&WJ9,D8SL$5C$<:*9KAD='<\FS"-[7(Y-E1/HM#4TE;9*MMQ
M,EI!FE4I@Y_`_H(;**XVS<U`\RJ:%D26C5)0RQ$LTSR/<1"O<E<9S<'E-F17
M/G8[-(J0YNR*^,1V[VPYBMW1"=G]#^C2HB[=45$<;1=DW)I04G34(^H?K'3[
M(SC<5@<LKZ2A171N?2KB/W3PGUXB)1X*O8-S56&`VU8V='$V59L><+)$%\0I
M8PRQ9`W-7QE9(*KV._CNNVRM3>CW%3NTM2W<V']*E229&1F`<1S$AC_MAHV=
M6,5]$]9*JEUI1-8)`*9$C`SR5,S',=D;5DG)6,X#9%PB)CLB-![(Z2C5A6U8
M1MF`&B2`H'LDE,('9_<5['HK=N[HFHU';*ZXH-Q75)40HR2J:IR.1&0!Y1.N
M-ZM5G=%H;H5-I*4S6B2=.H8$',D#,S[XVW*,SBXUA),FJ2MR)BI#B1BFF/DA
M.5?'"4L@[7/>3M\*J1$[7/)OOLJJNJ^EH7:RXII*B;2E3)PD99R`^R+>NNC%
MMLZ[A22?0F24^+4"?IF3CW\2>,01#]@;``3(?&*]\EY.X98EA.A`:-53N82/
ML=7NV3HK7M1/Y:8%[4:*DZ*Q01+BD$S[9C[(4&]_/A"O-MJ"[/`A12)=1(GY
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MS2MHVBJ?J7$BZU`DA(Q*9=>DYGA.0QB,<<Y7OZKS1;QJ97525:I8=P5QRA<C
MD5Q(L@K"O:KDZ*Q_</Z+M]=[2LL-*_I73?@/IR*1*?:!+XC&**V[KKJ36W6C
MU5,K-*S,CL)!^!PB;,9J..,\M:W(*`,JFFX].ARC1(\<4!I2M?\`(BCEC&TD
M=R.,%=GA<SN1%:J(JINMU;]WM;+M'5K"VWDD`DZNAEQ^,.EOIMOWRHI[A0(+
M3U.M)*0`G',!0Q!$QF.R%WY$GRK',LA>>=+GCBVLZ'&)+W10@!)*UL80TV8$
M(G;HUJ(FZ=53=5TVV=IMJWTH2VE*E(!,N)(S/6,]W$^Z_=ZXK>6M"'%)23P`
M.0X``Y?&,QQA@5EFEH4D><:I@5OC?+L@(_SH\BJHXT56N8GG>UJJJJNS6INJ
M+T1>B]7-F@92A;0<=7DDY=IB7MFRU-UJ5.-OJ:8;^I8SF?NCJ>/(1=GPOP]R
MQ7\:<@<D190Z7`+7B3DZNL6RIKUG9%7CP^[CA,"M$BM<K+)B.$<JM[58YS45
M%^ZDL]KN;=!7W4%**%=,]-)/UC0J6'*>1,,^XKY9'KK:K&I"G+FW6T\E`"2#
MYB)S5STY@#B)Y1__U'D]P\L=FOM#SCD"O\@R<A7E7&=Y$*WX>.F;CL-&/:JL
M5GQJMFVW37FG=-0:K<%V=GAYQ2.Q/A_5'M38M&*':-@8`D33I4>U?C/_`%HA
M+#8S963537INT)#RU3_WH\8SA?\`X&5J_P#LTB;C=+5IJ)'%12GXG'Y"-D]N
MZ9-3NJA*Q@VE:^\)('S(CI,XIHSP_7;%::M'M-D\<JZ.Q%[%?97%6>8JJY$7
MM<2;-557KLJZUFR4PH[3;:89(92/EC\X\R;MN1NF[+[<G,0[6.*[M9`'P`$<
MQ7K`W*(5CG"4=&6VFM+'K[N%&FMJ\@KH;IP7ELH4TT2:ROCU\J,C9II`"1AA
M>J&;VKND)Y5<BYDTM-YB?)"5`'2M*2O%:20H`)(&LD%,CC#?[G&B=>MGJ:CR
MVO)"FR05(40%>$@$$E0/A`(5,81;3ZU>M^27F&YQS''OY&1SLHR6P@8>MBFQ
MLDP;%YLVLBVXI*[,&6W.%7PVLVCOBB&C>U'M5ME::;TRZRH=J%.N/.&2SF4)
M)",L)%..``$Q(2BLVEO%O;E2VR];THH%MH"PD'4A4M2B)YR42"#B<YSB$\1K
MZH/L;,B935Y"&O=,R<]K*K8PA2QU]C05<,3'.G!>$K8=I"(P@_JCT5K5W736
MLDT@*5">'QF?U1HM6NZ5->NHVXE"JIR;B5.`Z%-+0C"?/`RY&+%O5#!.`\#L
MLHA<9YE99+F$J!#6VK<FE1TR''*!DATB-6CK8\>,*+%65+0A58C^Y[F*Y4W3
M>!5.5#J4*<0`W/AD3&,[A-Z34(I[PP6UM3`$CI$\<,2.,\#^N&JSFCD7^.3(
M<%HW6(7!FUZ%56L=)BD1ZA5R=6_)C]XM_P""OWTM7^UB\VFLMVJ2EI\)Y*20
MI/S&/2*NW5AH*UBJ`F$G$<P00?D8KD]C,?HL_P",I^`S+BOJ,BRXK0X&VPDM
MA&E9G2*MS7P([B(JLE/)7N$1NW<B.<W^I436";9?K;'?$UQI'"U2DBH`!.EM
M7X:]0Z:OC*-`O[-+=;2JB]0A+M0!Y))E-Q/C3+X?"<5UX1EI+J(^JOQ_B<UI
MRGK\BQ^6-85A%FPR.&4B03.\[1$:U'+T5&.W;OTW7::NG0V4OTRPY0N`*0L8
M@@]1A.,IIWU+U-/HT5:#):#@01TC?-0XE1A,1I\@YSY#@<.\6D1;.U:;_+<X
M#&+.J,$HA!(^58RC1E:,\Y[1J".-2C19+V-1W<O2]MULU%-16#2T,0DYK_V<
MS%<_4J=4::D,W#@I7!`_QY"-K]FJK"_7K#[3C2EEV4&MJH@\/C3@1V2<BR6Y
M3OL\@OI1'RHHX[[.3*/NWN>@0JQB.5-MLIW[7"LO]2V4E/E(2V"#S&H$"6$M
M7RG'K3VOM[=A]O:11?GZMQQR03C]6@@F>,PB<^$Y<)PHV*Y;28IBTB?:XFR3
MC%DB#Q/&+ML2WN,URUKFM2[1WQ!MKH$!G_*[1V.'LO;][U<J)+(0&6VT(`:&
M4QXB9XGLRD2./9#VW4ML-+==9FA7TI,CK5SRP`RP^9F8V;B+B"ZY2Y+K.&L9
MEQ_\DY(GRIO*><)$4T+&ZVJ$2_O*BKC!5J&#5G8*,9RD$PTH@`?8U5[K2RVT
M7Z\?DZ'U)5HUN*&.A`R&>!69@3S,SV*VZKW_`$I8WKCY*7*EQ81B9!2SB4CF
M$9JET&''I_PO$J;`L2QO"L>"\%)BU+7T56,CD>5(=;&'&$\Y$:U"2"H/O([9
M.Y[E7^.O1;##5,PS3LITLH2$I'(`2$>3GWW:E]ZH?65/.**E'F29D_&%#]T^
M4DI<7B<55,59UWG8P$F*`VYZ^MB6L!\0#8C&/)(D7TP2A&F[4[&/^J[)I(WW
M=2Q0-V6F055U:=(`S"9B9E^]]([^4;5[([8%;?'MWU[H:LUH'F**LE+T*TB>
M0"/K4<922)8SBTWA+C\?%O$^!X(@0ADX_CE='M4`@^PMV4+9-T97B<1IE)9F
M*O?W.[DVZKKT-MRTHL5BM5I0!-AE*3U5+Q'#FJ<>0]\;C=W=N[<.XW5$^KJG
M%IG/!!40VG&62`D9")3U=PJP:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@BA
M/ES!XO"_[$\0RS/'C7",WY%J.0ZNWD%<L:,VUL7@<Z:56HR.N.94/R/9NO9$
M:)Z[(]-97<*1-MWG2554?]*\Z%@\`3ACV*D>R4:30U*KAM.IIJ8?ZEILH(Y@
M8X=J<.V<7V:U2,VA8>0_8F/Q5SQQSQ?F,`(\5Y=KAQ,2RB.Y[3568Q;$T"34
M74;O.LBOM2SZT<>0QHD`8[O)W#1Q!TM7=T4-THJ"H3^%4)\"N2P92(Y&:9'F
M<8MZ6U+K+=5UK"OQ6#XD\TD3F.HD9CD,(9[5U%1!H@@T01B[RG@9%2W&/VHE
M/67M784]B%KW#<:!9Q#0I@FD8K7C4D<[D1R*BIONFNMYI#[+K#@FVM)21T(D
M?E'=3ONTM0Q4LJD\VM*DGDI)!!^(CGW]OO1'E2CAS[?&63<EQ>F+.EUTNM+Y
M!?C5(UXVY)6HK"P9L>/T62UKX^[5W<U')MG";15[=JGG?3>=;E'ZTB:T`93&
M?;+#CTC8G-P6_>%#3T_K#37A`_EJ.EMQ1E,).6)^F9!$Y2.<4[EKYP9Y*HD4
MR6(I;X+X:,5QTEL*H'1T&W=7%\J=NR;[KJ^#S2F@^%CR2F<^$LYPHJIWT5"J
M532O4!6G3+'5.4I<YPU?'[*_C:FJZG*!%KK[-;%[Q=ZM(**P30!@"GJA&_#:
MXA51>CME>O<J(G1&NI=O%14/T9UTU.@=^9)'/_"-3L`8V]1TE)<@6ZRK</4#
M()"N6?7$F9B'N1^-+'$9);&(A9]!((XB3&B1JUQ3'>C(,Q$>Y=VM5J,+LC";
M]-EZ:8+/>6J]"67"$U0$I?M2&8_PX0H;BVY46MU=2S-RA49ZI?22?I/RD<C&
MDXQCEGD]M%K:V')E*\P/E/`W[8L5YF#+(*5W]L+&-=]7+]?YZLJZK9HJ=;KS
M@!D93XF6`EQBFMENJ;E5M,4[2E#4-1'W4S`))R$/?E<3&*O"I<+(`-?CU?6"
M`V*XBB(5(06M@@C$16D22\@F-8K5WW7_`,=9S;U5KEP0NF4H/K)Q`PQS)X2G
MB8V2[(MC5I<:K4)52-)'A)D?#D`9@ZB,!$)X7ECK3"LRBXM'A8M94,$DZJAP
M!-DR9$&.)2/-,D2@R"V$PG8X:O5&HCWM7I]=7E;;PU<Z!5>XIYITR43@-1R`
MED,L(5[9=S462ZIM32*>HITS0E(U$H`Q*BJ>I6<SSC1^7HEE99-BC6!?,EVF
M*8_&CG&QB?E)Q2':\@U:[L4A3G1%W5-D5/\`AV75K8G&6Z>X9(0FH62#]U,A
MG\(HMU-U#U9:,"XZY2-@*`^M1)G*7,D?&-^S;&;+$N%X-+'!YW),AR\C*A$7
MXJR'ND%[&]RH08YZB%NFZ;)W;==TJJ&L9KMQ*J%*DG20CK(2'9,3/RB]NENJ
M;7L]%(A&I6H*=/[,S,RYR5I3\X573M&91._#TN#<P\AX^N8DF167(7V8#QHY
M3OA3XXQ,<1S@C>X"N$%KAO=]O>-&;+W[:6[^VMDTUS8<"7VC*1X@G+KUZ0Y[
M3>;J1662J9*J5\3F!]*@,Y\,A+J(W'`_P7$]\6DO[P3[7(!1_*,,<20J8;''
M=$;8V+W^1LB3OLK&IV,W17;HJ.U6W`U=^I@]34LF&B93.*CA.0Y#].475I3;
M]J5JJ:MKYU+X$P!X4)F=.I7,_+X&-JY:X_R'/)5"^E+6-A0X\KREE2'C=WRG
M">PC/&$WE"\8DVV7ZK_+KJ%9+I36M-4*A"_,41(`<I\R,<8L]SV.MOBJ$T;C
M890%3))XRRD#,2$*WD&#93C4M\6SJ):(UVS)48)),(Z+_2X,D3%8J+_)=G)_
M%$TYTMTH:M`6U4)!Y$@$=H,9K76.Z6]TM/TBR."D@J2>P@?;C$L\1,G88+*,
MDR6KL(./MJHP2D/&>`DD[Y@FA'%"?Q.,Y&F555/HB]-UZ:HKZ6;DNBHZ1U"Z
MC43@09"7$\,H:MK)J+,U<KC<&%MTFA(FH$3.J6`.)E.)VQ7(<.Y#AVD6)"?)
M@QRL!8"LH#'NDM.CG-D=Y%W*1_:O5ST>BMWV3HNERJI*NUO,E]10LB:2DXB7
MZ=D.=#<+??:>I33(#C:3)06F05/&>7ZI](?/UY]*9O(6(5F0T]I5X=B);F9$
M+$)7S7VLH$0@/DV%<GW1I;3J1XFO*9.THG(J*C4TP6_;-=?4(KZJK*4%4CJ!
MU$"6*>$CPZSSA2NV]+9M=QRTT-O2MQ*)C0H:`I4\%'.8X\Q++A<8#`,;C<?N
MXSCQ%#BKL6D8@Z*,CF%6HE5I*N2BF14(LDX#/<XF_<XCE<J[KK3114Z:'\O"
M)4WEZ)?ND:3CSEQC%%7*K5<_S=3DZWS@[/\`?"M0PY`\.6$?_]6>\[L2V^<9
ME;'1K3VF5Y%8F:Q%1B%G6\R41&HJN5&H\J[)NNR:\JUZR[75CAS4ZL_%1CWC
M:F@S:[:RG)+#8^"`(]F"D1F40$5=O**:)O\`J[XA#;?_`+0KI4W.DJM+A'W5
MI/SE^N-/]M'$HW2PDYK9<`[9:OL!CH7A\LQ>,?4B!RW(K9%X##>+8-P6KB/8
M$\XU;"#$=&0KD<P"?)9L1VR]C45=EVVUK]IJ$U-JM]2,E,I/_"(\Q7BR._UI
M<K"%A#IKUM@G(360">,5&\$<)>O7NCR_DN?8!F^2</CF2EN.1N#W?');W;9A
MDD6TS%[\%DQX<:N)4DK3>(?FA/5$[>Q[$;VNT=+5K0ZZW-29\2,^<B)@X8&8
MAHW$N[;?M]);KO0M52DITLU.,D@9(4F0FI/W9G+GC._^@H:?%J.IQO'JZ-4T
M5%7Q*JHK(;/'&@U\$+(\6,%NZKV"$Q$W555?JJJO74P````81EBE*6I2U&:B
M9F%CY-X!L+"YL,FPM8973U)*F4<DB1C_`#2D8\[JR67_`)=`RGN>5PBO&UA-
M^U=G(C9*'1()5&I[0]Q?RBF9MEV94Y2HP0M,M2$\B.('"1G+"1A!L6Q'E#CK
MGS&IL/C[-(.02^5A2Y%Y'J9?XNZP&Z:.):UMA-:CH_Q(:BW1")VM[4(Q4^NK
M'6TY3J!<3HT2E/)0R(CNW3=]NW>W5Y8?2JK+Q<0J4CI*<$D'$$$2E*+3>:N1
M)7'.)-L*P0"W=K/%5U/RF*6(`SA%E2)<D37,<5@(D=_:Q%3O(K4543=45KE7
M"WTJG],U3``ZG])Q@VX[P;);552$!3ZE!*0<IG&9Z``GY0C&/*[E'.L;@9FR
MIMYGYHMS0S[*KBC;695'B%+5S&)7AC-C.*4/A\@QJ_N-W/0G3MS_`-(B^U-4
MT7#3UU0V4EQO#6D8E+B9R4"!('`Y8F*39?N#<WKG26V[-MU%/J*VY@`H6D%4
MTD98`RZ]LXW?EGTHQ3DFU;:W.&,/D!4&UV8X??"QZX&@WQW*LOY1HD><JH%&
MM<6/)>UB*C58J]2WV'?&WVO)MET8>I!_REXIXY!0\.<_"I,SG.-?KJC;%X<\
MVNH'&ZG_`+Q!DKAF4G'O28B&F_6N"QDS1Y1FF>DJ5D1T!!L,J&C7@;(:XJ_]
M.);?(:D9%1&N^,YSMNK?JC+2(W4]Y9J&K?3<RE'F+RS`P2,>9,43U#8D%0;>
MK'AP"EZ4Y\<"3AT$6(\0\'\;<'T"4/'N-0*5AF#_`"4\0WOL;4HU>Y"39L@D
MB69K'$7L:\CMD7=5<Y7.5E::\L>)Q2W#FI6)/V`=```,@`(C!+:!I:;2AOD,
MO\3VDDGB8J>_8KPYF#;"QS"#QU>Y^E]E$(U!)IFVMG#KSOKP,>.VJ*U3N`SN
MC>%5\8O*U$>A.[?61;UL5Q-R>N**8O4CJDRT":DG2$D$)\4O#AF#,"/1.QMX
M;?&UJ"R/O!NZ4VN86HA!!6I>H$^''4`0)*P)B4_6/T0H[C"*7ECV(_/_`/<^
M>LFPC51U@T=;@U%$*<%;"92D@EB0Y18P4E$+LQXT(U/L=Y%==6+95&_:FG;O
M3K17N8D!4B@3P3Q$R,3,<9<,5:_>YMW8O[KEGJ&7:)J24E2`I*C+%0`E(`X)
ME+*?&%GX5@X)CGL:;BWU[Y[D8E07%U-IL\]DKW'*NUJJR62-8VM'QSB3[<TN
MD)^<M*LGRYKR@^<1HFA5J"(K[NP;6M5HNBZ6BJRR_5J\;ZP%:$@$H1/!.I9P
M!4<9=!"YO;<-]J;-3U=ZI`Y4-#4W3))29*("W5B94!(S``\(F3+5.+=.(>0\
MAK>(+Z\YBM8\FVXWR;/<2R'*@QPQHV2LPC);"B'>1(L800(2Q=%0*,&U$?(:
MJ-1%7M1B4\JAIZE5Q=2/3J6E:\@0A1&J7667/"$^AI7;S54%/:J=2WZH-^6V
M,5:G`#I[B<^6,0]ZFX!;>R_L+>^P65Q5_P`'P:W9^'KIX&FCV%N."86.5`$5
MWC1,9C**=*^US5E$'_%SM+WMY97=X;IJ=XUS1_*Z9>EA*A@H@$"7\."S@?$0
M(UWWDW(Q[7>W5N]K+14)_J&O:UUJT&2D)44J4"0/^8)M)Q!T))BZW7I&/#\&
MB"#1!!H@@T01\5C8U]1!E6=K-BUM=!"Z1-GSI`HL.)'9U(>3).Y@0!&G5SG*
MC43JJZXJ4E"2M:@$C,G(1]2E2U!*02HY`1]B*CD1S51S7(BM<BHJ*BINBHJ=
M%14URCY'G1!!H@@T00:((Q]M$6?56<%"R0+-KYD1#0SDC3`K)C$#Y8DD*M+'
MDC[]QO:J.8Y$5.J:XK&I*DSE,1R29*299&$6]`O9'(^>./+^FSV4R=GG'=A!
M@6-MXV`/?4ML*22ILY@!L")+(,B!)CG48VM<T8GN1'D=NL;6O+MUIJAJI4%5
M3"])(PU),]*I<\"#+EUABW):6[;4,.4Z2*9Y,P#]TC-/9B")\^D-;REP[QQS
M/CZXWR/B]?D4!GG?!.=BALZB2<+@NF4]F!1S*^2C51=V/1KU:G>UR)MJ]K:"
MCN+7DUC`6C,3S!Y@C$'LBFHZZJH'?.I7BA?'D1R(.!$;M501T%)`KC6<Z>&G
MK8\4EO>2QR+&2&#':-9MK.04<9Y3QC[S&5K>]V[EZJJZDH2&VTI*R0D2F3CA
MQ)Y\XCK47%J4$@%1R&6/`#[!'/Y[N<U5O-GLO@]/QM8-OJS!9-'C%':U17K'
MM\JL+X$NP/3RAD<V1'',6/&'(&C6D(!SF*\?8]V3;GN2+E?:%BA7K#*DI!&1
M65`F1XRP$^8C3=N6]=!9JQZL3I+J2H@\$A)`F/B91T,ZUR,O@T00:((-$$?!
M:BDGJ[(,(<8LPT"8*(*8Y[(99)(Y&`'*>-A"-C/*J(]6M<J-5=D5>FN#@46U
MA`&H@RGE.7'I'8T4!UHN$A`4)RSE/&77E'-_RGZ_'XLY&([-,6KX.5.&EM$L
MH9%/`L(\HCVCLH1&*P$AS"A>/O<Q"L>QR*B+K$+FF[VLKME6X4M$3`!FD@G[
MIY3X?$1Z9LJ]O7P-WJWLI54),B2)+2H`?4,M4I2..!F#%=_+V3)D>9S_`!,*
M&-3*^F$PCW+Y"P9)V2)*,W5H_*951$3KVM3?KOIOL%'Z2WME1!6YX^X@2'P^
M9,9[NRX^ON[R4`AMF;8QS*29JEPF?D!$B\*'M\N%=XY>'_*8R"$%A!3W/.1C
MY#_$"(`[U[A@08G/39R*)XVJW;==5.X&:>C=I*FE_#K"HXC`8<2.<R!UF9Q?
M[1J:NXL7"BKB7K>E`$E3)$S*0/*0)SF"!+.)%M,6;BM+/Q+C)(0LBMB--9$D
M7(PVU=`<G:DIOE<V4J?:HV(UJ>-'.=_4J+JN;J345#=?>"I=,W@G2DZ2H<#D
M.V>>`RBX>HA1T;UJVZE#=:Z9JU.#6$G[PS)'`$98G.%5RJFS>H<@<J%=H%LA
MS`FGGDRX)#HCT[HTEY"QGN>-JJBM7=6[_P"NG&BJK=4G71J;\S3B``%2Y$9R
M'PC.;E0WFB3Y=Q0Z&0K`DE2"<<09D3./6)1XAQVTF8MG%G3-CNM;"+_C$!T@
MZQQA24P1)IE*C7;/:R0-1].KT1-4U]JV6ZZW-/ZO);/F&0F<#)/S&,,FUJ"H
M=M=X?I=/J71Y*=1D`")J/P(EU$2!!D2L!QK&9?),$DV51VY8-(:M199ZR$2.
MZ*I[`[503Q@C([Q#1=WM1B*G<W=*]P-72NJ6K8O0EQO\35@%&<\!G.>??WV[
M*JBQ6NC?O;7FK9>DUH&HH3(@E2L!(B<N[CE*'Y3$,\HYL"/;PK"!915C2!@E
M,%,&T[!.3<!.V0$X7%;_`%,V:]-E_EJG517&V5"7O)(4VJ8,IC_HAB1<;/>Z
M1RG%2DMNI(*9R5C]A&<>NDX[PZAJ_@@I:^1&8DA\F;:@BRS%4`_-*)*ER1]C
M&@"G<Y/M8QJ;[)KF]57>K?UJ4Z'#D$S2,.0CKIJ#;]OI2TE#!:&)*M*B9\23
M//APY1E*$^+ECRQ8P6F0(2>*:VE^(QH#M5XFLDMBM:C2MV56]WU145-=%8Q7
ML^6:P+U*$_$2<)Y8_IC$JW5-JJ/-%N4UH0922`,99X2S&'="7\G\?6>&6#)T
MF?\`E85Q(DD#/>BLE+)[E,4,MCGD5Q48]%\B+L_KT3Z:>K)=&:]KR4M:'&TC
M`92RF/\`",LW-8JBU/\`J5O^:R\HR4?JGG)6)GAQX\A'RXORIF6,-%$B6'SH
M#7#:R!9M66)C6[-0<<BN;)`WLZ(UK^U.GV]-=U;9J"N47'6I._M),B>W@>\1
M&MNY+M;$)98?U4X^ZH:@.SB.XRAZ_P`U4B6#&ERXT6QLAC+$AFF!&0S%&CB-
M"`C6&,K7;]4V_EMOK./),GE)864H,B1D.W#]8C9?4)G3I54MI6XF82?J5Q\/
MBR[C$:<L41\PQR174MFIK.N,.>E'%D1'K8HUR#41Q=S"M>!I%>-RN[=TVV55
M14M[#5MT-5JJ&0&EB060?#V'D>,+VZK<]=*+RZ2H*GVL2V"/%EF,YC,1D^':
M9E'A5,PD)02Y)3S+(+QJ,Y9'S"B5AT=]W>T`6L1%^B)KHO;Y?NKQ*M2$D`=@
MEEWSB5MFE%+8:9(1I<6E2E3YDG$]P$=2F)1X47&,?#708U9"2FKG@@0PLCQH
MK"Q!%40A#1K6HCGKO_%5ZKUUM].$AAD)3I3I&'+"/,U45FIJ"M94O6J9/'$X
MQL.NZ(\?_]:<,L`6+E.2QI#'#/'O[D!AO:K'C*&QDC(QS7(CFN:]JHJ+U1=>
M4JQ)35U23F'%#_B,>]+<H+M]`L9%E!^*1'Q4TI(-Q53%=VM!/C*]W\$$1_@,
MJ_Z>$KM]4]U8-1;:QH"9*"1VC$?9#;M2M%!N*T5)5)`>"3V+\)^1B^?U[@PN
M9_5;+^)[20U&D@9=@AWN3=T6'D$,\NNE;?<KFQB6BJSI_P"CLGTTV;!K16;;
MI6U&:V5*;/8#,?\`"1&>^\U`YMWW,J;DRF27RU4HY$X!7_&@S[8YHSMY?]6N
M7)4<4BZX_P"2,&M21W&CD)'(]@C(J.:J?V+2CM@C:[94?'E`<FZ.:NFSQ-JC
M1$FT;LLZ5*2EZB=3EQ2J7Q2I/Q$=-WIG[C8][+<5VF1WBQ<=S+CV'&3DR.]%
MBT\5"1ID@610#%(]HZ>='KC$5KGJX#AO:[HC57O20H`C.//6Z=M5&W;EZ;%=
M,Y,M*XJ$\B!]X3`//,15_P"Q_P"V/DZ7FEY1>O9:3'L)JY:0ZS++*@C7%]?.
MBO>R38CBW;)5;#K)STW"-T7SH-$<YR*O:G6IS&28T7;_`+9T:J-FIOJEFI7C
MY:52"0<@HC$JYR(`RA=Z7]G?N4&[AR5SFKOO)+CH^CD83C"Q+)/(U/@H*NJH
MLL*2E^U5CO$7K]KD77$.+F,9_"+^H]NMJ!ATBG6UX3X_,7X>OB)3\1'1)R'C
M9^7..,?CO=`H\Y2+2Y$&BGS!C=!MY-:S\M1S&L<4S2"!,,)J[+VF8U7;M1=1
MKE2(KZ9=-K`<F".A'^R/*VY[2S>*1ZWM5*//2N:#/`D$C$9R*9_$1%?#?!68
M4N:0,CS"`"J@T322H<9)\&<:PL31RQP)M!/)8($%2J57.5JN(UG;NG=M36>R
M/TE3ZJI(!2"$@&>8E/X$PI;6VC76^XIN%Q"4^6#I2"#,D$3,L@`3UG*-XYL]
MQ?7KU]M`T')>>!K\C.!DI,=J:VSO[D$4J;AD38E3$E)7B.B[C\[AJ1.K45$5
M=-!4$YF-HM.VKU?`I=NHE+:!D5$A*9\IJ(!/9.%UB_M;]29%G\(MUF,.(O1+
M<^'6KH>^^R;ACL-/:B_S4/37'S$<XO%>W.ZDH*_1H)'`.(G]L6+T]O6W]367
MM--!8U%S7P[2KL(SN^/-KY\<<J'+`_9%<*1'*U[5V1=EUV0D+0MM:VW$E+B2
M00<P1@0>R-7S;&#9`VFELR.TQX-!8+:S%KBJ-)T4+$>4)]G-_H07VN7N1$<[
MHN_2VM=T1;47!"[<Q4>>R6P7$S+9/WT<E#G%77V]=>JC*:QUKRG0J2#+7+[J
MN8,4*YORG['>]'_>C->/<UL<$X1XNB/!$Q6KR6/BTS(*JRAV<AL.9&1ZR\PR
M"\KL?F';%V<P(0$8U&JY$>K/_FM4:\VM+7E4K84LK,BHJ"B$H`S5)*C+*--K
M'[3LBHM5NK:1+EWJ)%2U(#@0<#DKPI2G6@$R))).0P:V;P-$X.X1]8,*]7;Z
MLRC,O8:0F=Y3797B^/7U9>P:G&JNPC9/)B9'5RHU-6\?RITA([B_\P0LXBHY
MY$1$LKA3N6FT6;\EK0Y65RPXX7$(6%)"`=4E)(2ELGP#FKG&<LW%[<^X;Y5;
MC87HI4E"="UI*5%9&F:5#45@>+A)/`1N',MU(N+#C_T_XEE'N9Q;6/57L^3)
M:21D^622/O)Q)\MSV^=T66^5:VI57M\^ZJNXW)K.MQU%7N"Y4NR[,I2ZAU8\
M]7($A6)[?$ONZQZ+]M;1;=D;?K_=C=2$MT=.TH4:#FI4E(*@F1/[C?>99&+K
M.$>):/A#C3&^.J)WR!4\<AK.S<-HSW-Y.(Z5;VQT3=465+(J#:JN40&C&BJC
M$UZ/V[8J3;=GHK/1C\)I.)XJ4<5*/:?@)#A'C+>V[;EOG<UTW-=3_J:E<PD9
M(0D:4('1*0)\S,\8EC5W"K!H@B-;_EG"\6Y`Q/C;([`E-D.>0ITG#'S(Y$K,
MBDU3F_E:B)8#\@06L$)@D\1_$AFG8@E>]5:D1VMIF*EBD><TO.@Z)_>EF`>8
MF,.N$2FZ.H>IWJII&IILC5+-,\B1R..(REC$E:EQ%@T01H7*DJEA<8\B2\C8
M,F/@P?*R703$:(9ZM**=\Z.XCB!:WY$;N8GWMZN^J:C5A;31U1='X0;5/LTF
M?RB12!9JJ8-?S/,3+MF)0AOZP^5,ASKB'*<1R2RFW$GCK(X<6IG3SDDR!8[?
MP7R8%8L@RO*4=?/KI?C[G.\82,&FS&-1%/8]P>J[:\P^LJ4RN0)Q.E0F!W$'
MNE#-O&A:I;@T\R@)2ZB9`_:!D3W@COBR_3K"C!H@@T01BH]]1R[2PHXMS52;
MJI^-^4J(]C#-:5OS([9<3\A7C,Z7#^5%>A1^1C>\:HYNZ+OKB%H*E("QK&8G
MB)Y3$<BA82E90=!R,L#+D83/VW]Q<`X2PN^HL?R&LR#EBWKY=;08_5';8+12
M)071WWN1R(K3PZP54AD*.*=[),LG8UC/'Y2C6]P;BI+52NH0Z%5R@0E(QD>:
MI9`9R.)X#,B_L=BJ;G4MK6V4T22"I1PF.2>9/3`<>$U$_4MB]BU>9,U*TC*H
MR8MC$0BJJLE6,=;2VLF]457$A1Y,557?Z2-+OM\PYIN54KZ%%*1U(F3\)CXQ
M?;Y>1JM],/K`4H]`9`?&1^$6VYWBI\UQ:SQV)D^2X;,FL$Z'DN)6+ZR\JI4<
MS#A/&,B."<2N9VE"5KQ&&YS7)U14T*H9+[*VDO+;4<E),B.H_P!N$(S#H9=0
MX6DK`^ZH3![8J'YRX,_8W9?E,*#R'/Y7P*V8V"2?1V^*X<ZTKC.<-T:_J9!:
M:?'[QI_S06&E17-7M\A$543/KI:]Y.>93-U_G4BL)@I02#P4,#VR)$/%NN6T
MT:*A=%Y-2G&1"E@'FDXCLF`8DKU0_7]'X?MX_+G.=G2SK_&6EMJ+'H<EQJ#%
MSPF%(_(KNT*H(]C,A":I`#1GQHRHAE<\B-\4O;^T$6QP7"YN)4^C%*1]*)?>
M)XD<.`SSRC7S="K@@T-O0I+*L"3]2I_=`X`_$Y99Z5S3^TTE7DIJ?A#%*:]H
M8+7AD93F`K)B6<X4PXWOI:JOG0B,J711C<,TAZ%*I%10C1B*^)=-^!I\M6RG
M2MM.!6J<B9_=`(PZDX\N<FV[++K(=N+RD+.24RP$N)(./0#OY;3Z\?LVK\SR
M2%B'-5!5XD>ZG@@TV5X_\I,?!(E/04>/D$:PF2I,`)3O1B2F/>(>Z*5&-1Q$
MD6;>[56\BFN+(:<49!2?IF<@9F8[<N<HZ+ML]RE:546]TN(2)E)^J0SE+`]F
M?*+:$5'(CFJCFN1%:Y%145%3=%14Z*BII_A(CSH@A1?;7GJ?Q#C%;38G("+.
M,J*YL,ZL%(/2U`%<DBW%#.(T>3(+):T`6D:K-U>Y456HBJ^Y[VNU4S35,H>L
M=,AQTCBJ7$\!#QLC;3=]K'GZU)_+F$S5P"E<$$C$"4R2,9#K%,OL?[JR<S9A
M6*9E6LL<APU3I.R"#`9!F3XMLR`TOY%O<V*\H11?*B1F,&\KE^T?5J*-1^9;
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MIL[5LQ=&&[=3T-*T7ZI8D01@"3CJYXY=,21%!5V.J?O-7=:]\4M"T9A258D`
M8:3A(D9]9@`QC+WE#C;(:=]-=_Y5<PV$::,V5%@!EAD`1[!&%.C&CF(]S".3
M<RO=LY47^6OK-IN[#R:BG0PV[Q*29$'@09CX1PJ;_MVKIETE6[5/,8$!0$P1
M.1"@0<CQC<<"M*0O'.1RL%K#4KX/Y(BQIQTL"2;2'71Y`9,ETEY!$;+8,:.;
M]C&[*C4:B(NH%P:JOS>D9N3@<UZ!-(T^$J(D,.!F8MK/44/]/U]19F5->7YB
MI*.HZTH!F9DX$2$H]V%9X_DNLL(UYB@VU00^&UL338[ZLTGQ(51("0()!O<Y
M6OZ.?XVN15<B]O=]N-L:M3J'6JY7GDS2D#Q=LP>>$\.^/EFO=1?F'67[6DTR
M4R6HJ\!.&$B.6,L988C"<41N"94ZRDE!?0AT;I1DKY4)GY$Y&=[E&'M%(:)"
MA8FSMB.7=O1%U9G=`;:;2JD5ZF0U`F0GSRGCV12)V,7GW7$7!`HBHZ2D:C*>
M`S`F,CB8G<V*XK'HFX#,N#Q@VHXA%A$MFLL)LB.L=),D*3''D*E@:)W$8W[$
M?OV(U/MU0&XUKE5^9!@%39.(2=(G@)RPF`<\.L-@L]M9H19551"70#(J&M4B
M"93QD2,1B!C*4:T?B;&%-'CXC?S<<E@?$2YC5MO(.6SK@G8IF2!)+\D:4Y>K
M"[*-KT3[.NZ3FK_5^6[ZZG2XE0.DE(`"N`RD1SXQ5U&TZ#S6/RNK4PM*AY@2
MLDE/$YS"N`.6.48C-.1>/PV3L/OZBVN`4YQQ)4@K`RA!D1D<Q[D^5(^48XNY
M4>1O8]W5-U3IKE1VJ[O(_,&'T-N+!(`\)()Z"0[#'"XWW;U.Y^4U=*X\TV0"
M2-0!`E.:C,D#,B,:'D3AJ%%)&ATO8-BIV,7&81?,J]>]'D>TB]J_57O8[^6N
M2K1N%Q:5KJ#JY^8</TZ3CK1N#:#3:FFZ,>6.'E#'X_KE&O\`,!ZO*L8QK,Z$
M@"Q84@E)(</O"8*O&P\>.Z.5&%$Z.0)/MV79'(YKG-7NU,L(?HZRKH:M*@XL
M:L<099F?&8/RQBNW6JEN-MH+K0+26FU:,,"`<DZ>&DCYX81#6&9&[%<GJ[YS
M"''#D*LH+']I#1C#>&0UJN7M5_C(JM1>BN1-],-QH_6T3U,"`I0PY`C$0HV>
MXFV7*FK5`J2D^(#,@B1^V<6N\6Y-P=,IC9_R7;9&&/70`V4#%Q5@Z^)D3PC8
MV*"PR!\PA:P,ER(IE6.WN:BJPJN<B:3*)FV-5"_S#S%UK9D&T"86H8#Q"??,
M<XTFY5%[?HVC:/):MKHF77%:5-I5B24&0PF=,CRPBPK@W]A>`Y[,#49/!K,=
M@D,.'6WE%-)/I8#4:@@1;D!T;.@-[F;-.C7#V7[FL:U7JZT6[4BH3276C-,I
M7TG[O0'_`!&'.49M<M@K-(NOL5R36H3,J3@%]2)8'L,CRGE%B_S8?P_R/RXW
MX_XWS?G><7P_A^+S_*^3W>'XWA^_O[NWMZ[[:<M2=.O4-$ISX2YSC.="]?EZ
M3KG*4L9\I<^D?__7;OV0QPN)<_\`,^.F1Z.K>3<T&WR*QSW!/?3I4=[E&JL5
M7QSM=T_GKS#N!@TU[NK)&3Z_F21\C'M_:54*S;%AJ`?JI6_B$A)^8B$W-1S7
M-7?9R*B[+LJ;IMNB_P`%U49X'*&($I(4DR4(M+]!N87T^5Q<;LR-6%G314DT
MCMF-BY'4,F/JI#45R(UMDTRB7^;C#_EJOV=6"R[AK+&O_P"FJ2%-GD0"0.\>
M'M`AE]VK2K>&Q+1O1B1KZ`%#P'%"E!*C_E5)?\*C#^^QGI_PQ[.@K2<AU$R/
M?4XC1ZO*L>E,K+Z-&,K7.BGD*$P+&(QS5<,4D96#<YRM1%<NM?*0K./-MDW'
M==ON+7;GY(7]25":3W'(]1(QJ_#'HYP_P=QYR;Q[BLO*9L;EFH-299>W%C$-
M=/KGU]E7Q@071(,2#%2$.V.YFP5[GOW?W;(FA*0D2$=]XW5=+W74==5Z`M@@
MH2D22)$'B23,@3F8J/O_`-/'.@,I+"QS../)^)%EF6->6<VX@V4:"IG?'2=4
MAII"%F(#;O0158K]]E1-=9:Y*PC3Z?W5MOID&JM[PJP!,)TZ2>,B3,#M$/EP
M5Z!\<^J.)VW*5^^-R5RW0T<V="M+"*BXQ16+$[HQ*"GD,1WF"5K%^5(53ILO
M9XT54UP>6*9AYX"92DGX",SWM[@W.YT%:M"?)H&D*4$).*I`RUJX]F73C$?$
MES"S26;Y<G\F60^8^R:<C)ZRW[]TI)3'-,TZ[K]R*BHG3Z:S(U50:@U/FGSI
MSG/],.D>0C6U2JHUI?5ZHJU:IF<^W]7+"+3L8OKC(N.*G(8XPNO[+%13@,*U
M&1RW#Z]7#5[6;(R.>:B+LFVS':U"G<+S##I$BI(/Q$X]%6RH-70T-4Z)%QM"
MC+J`3*.,7E*?R!:<AY?9\J,N&<A3[R;)RME]')$M&6SRJAQ'C$:SXXP(U!B&
MQ$$,3&M8B,1J:ZU:M1U9Q["LR;:U:Z1%I4DV]*!I(,Q+.9//B9XSSAQ_5']?
MG)'L.UV6Y-(?QGQ97RH[9F17D0T>SO0(0J3QXO#E"8$GQ&A5I),AS(XWO1$\
MBHYJ<T-$R)RA2W/OZ@LI524(%1<9<#X$']XC,\=([R)QTS\=.X]QG&L7X[PO
M)*.PA8I05F/U$&-?5ME9+74L`4,#S,CR'F,5(\='$<C43?=>FN[LC`*OU3KS
MU74M*"W%E1)20"5&9X2S,2%(`*5'/&.WO#("4!F?^81F.&1O_P"ICE37V(HP
M,XIJ!^NGF?A[+'D]?.1L9-@K,NQO-JBLSEQ_S-7>XW'GA@/M&CHK*GOX<;\S
M,8QCAL\@3*PK7[ZJ*FBKDU**JVU8;7YB%E*AJ25-A02?@I0(R(,,]UO5#?P7
M[O1J-<IE32B@R!2K1B,9I)T)GR(F)3,2OG><W?K9'M+[-<VH<Z]@,EQ^%1NL
MZZIKZ?".+\"IC_\`3ZC'\;@QJV'4LG*5SFB&$;3F$CG,[1M1]#N?<U5:$-)+
M@J;\^D(0D)`0VE/)"923CAAXCG@(;O:_VTIMU/5-55:J3:-*HK><*CK=6H'`
M.*G-6`U&?A!D,5"&._6KZXRP06^TN>M,^^S*LL87&M/8`(DR@QF?+4=MDU@^
M4QLEU_EI(FS7_1L!=VN<AW*N@^V&S/R.C7>J\Z[Q5B:E'&0))XY$SQY]DHSS
MW[]T?ZONC.V+.CR=KVTZ&T"0U%("9F1D0`!('++`SG;IK6(\[0:((-$$4K?M
M4SB'!S;@BMHK1\?,<)!E>4$=#,C9-2RYFXG^$D$<UOD"<LG&2O&B._I8JN;L
MK57-M^5H9?M*&5RJ6RI>&8^G3\9'X0_[+I"XS<UNHG3N!*,<C]4_A,?&+EJ6
M::RIZFQD`6-(GUD":>,K7L6.:5%$<H%85$(U1/(K=G?<FW7KK1T**D(41(D`
MPA+`2M:09@$PMG*?N!Q'PKDTO%>319GC$]@&2ZF6;%9<^HR>$Y&>27CUI5EG
M19+(Q'^,K#+',-_1S$W15IZ^_P!OMCI9KBMM4I@Z20K^$B8/9@>D6M%9*ZXM
M!VC"%B>(U`%/:#(CH<HJQ]Q_?O\`[P4\CC#B$-E5X#:1A#RF\M(B0KS)')(8
M=*B%%:8[JZC11-\RN5#RU56*C!(J%0MQ[O%>TJ@M@4*=8DI1$BKH!P'/B<NU
MUL.UC0N"MN)!?29I2#,#J3Q/+@(>7]=7"&1\-<0WV1YS"6BN^1;*#D'XZ851
M2*S&*NN>RF=:A(J#@3#NFRI#V.V>,)&(7M>U6-:-G6I^V6YQRJ3I>>4%2XA(
M&$^1S)[87-U7)JXU[:*96III)3/FHG&7,9`0X4?FKAZ99BIHG*G'<JU.=D4%
M?'S+'CRS22;>..((K!SR&(JHC6INYSEV1-^FF--QH%N!I-:T72<@M,_A.*%5
M!7)0754;H;YE*I?9$FZF1$C\O>UC7/>YK&,:KWO>J-:UK4W<YSEV1K6HFZJO
MTT00F/.?#7KU[,3&U@>0,:HN6JX,^NJ\FPC)Z$F9QVEAEC2JFZJ8=BR5?5/A
M8J%BF["L&U[1E"CGJJ_=+;:KR?+-2E-:`0%(4-8Y@@'$<P?E%Y;J^Y6D>8*=
M2J0D$I6DZ#U!(P/(CYPGV,?J:#'R04K,^8/S6-!FL,>'2XL6JM[:*.2QY0&F
M2[RQ#6$FQT<USV)(43W(J*_;JM,>W[27PNJN!6S/()D3VF9E\X87M\.%DIIJ
M$(=EF53`[!(3^43K[->PF'^CV#XCQ;PYA-)%OKF!.F4M2OG2HQVI$3XI,AMW
M.*2QO;6RL.YHE.9Q)#P%><J]J-):WR\4VV*2GHZ"F2'E`Z4_=2!FH\22>\F<
MS%99[54;CJGZNMJ%%I)&I7%1.21P``SPD!*0BI\WLK[GRF.S9,_Y=95$<Z<R
MUC0+$>*-'T)Y!A96?XVL)B;;(K%$J=%WW7=!-XW4H>K]14>5G,#P_"4I0["U
M;:!]+Y#'F92GXOC.<XMK](/='_O]&/Q[GPXM?RG1U[IP)<0;@U^94L91BDV`
M`_<V#<U[B,^4!'=A6/0POM0K!/\`MC<OYPE=-5)":]`GADH<P.!'$=XZ)&XM
MO_E2DU%,2JB698YI/(\P>![CUFWW(!FUIP-D6)X`#RY!R#<XGQWY=E[8M?FV
M1UV/V!S.:(ZAAOCS5#(*C'J&.4CT[5:CVVNX$U3EK>IZ0?C/%+?8%J"2>R1Q
MY"*VQFG1<F7ZH_A-!2^TH!4!VX8=8UOA#T<X*X>IHK)>*UF?96\+%M<FS&#%
MNO))</M,.JJI@25E7"8YSD'VB4ZM7[R._A'M>V+5;6DCTZ77Y8J6`9]@.`'9
MWDQW7+<5RN#BCYQ;9G@E)E\2,2>WN$1[[)>@/$G)6.Y'D/'V/`P;DB/5S9U0
MW&Q#AT-]90XQY$6HL*%"QZN(EJ=K0?)`T3@=R/5I$:K'1;SM.W5[3KM,R&JT
M).DIP!(R!3ECE,2,2K3N:OH76FZATN4DQ,*Q('$@YX<C#,>M-WD^0\"\5669
MP)==D_\`AU3!N!31*"3(D58$K6V1A]$:2U!$9)=VHUO>5>U$;LFKNT+?<ME"
MJI20_P"6D*GS`E/OE.*>Z(9;N-8FG4"QYA*>PF<N[*)RU8Q`BEC]@5K;$Y@E
M"BQW&DTO']4.ECD>J!EG>^YL1*U>YO8TT^2HG+NW^C_VZR?>B@N^4[;JBEH-
MH$^0*B21^G"-Z]MVRWMBL>80%U"GG"!S(0D)2>W[#%1*Y#6\H5]Q1YI7/KLW
MJ16DVOFUU?VE\-7&>=8!&FD/D%-Y5*C@+LQZ(BHY']=<S2NVA;%;;ZC70K*0
MH*5@=1`U3RY8YCJ)QU)KF-P-U5MN])Y5T;"RA2$XC0"=$C,X8X3D>$C*<4\?
MX+,S>X)#:Y\>NKQI+MI:,W(&,C]E&)B]%DF1%1N_1J(KEZ)JYNER1;J<.`:G
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M832.$]KQD:UXBL<G5.J;*FRK_"WMMS9N;2W&DE)29$'_`!XPO7JR5%D?;9?6
ME:5IFE0XR,C@<B/T,2F>#D>/\=XS5X5#M9+LWC29V0'!$'-[DF0HL7X"*L,B
M0Q$$Y>QZ/8_9'=5^J4S;]&_=:U^XK0%4Z@EN9E@"K&4\3.&5ZFN-)8K92V=I
MQ2:Q!4[(3)*DI$IR\((GRPXQ[K6!;XUP:^JOHWX::?(T%$C,V^3-`0RRU^?V
MD5.Y7"+MMNGC$/\`GKZAUBLW#3OTSGF(#))Y)S&'Q'QCBXQ56[:%735K1:=-
M0`D<53D3.78?A*%V88P^WQF*/L(A6=A'L["HB(A6(UR=I$1$^Y.NF@H0224`
MF4LN'*$9+KB0$I<4`#/`G/GV]8E'+;LN98A0Y#)`@[7'I0L6LI:.(JS@EANF
MUDE%<JHIG.C2%*B=6O<B_1R(E-1TPH+A4TZ%$T[R2XD<B#)0^8ET[(8[E6KN
MUIHZQQ(%73*#2E<5)()0>WPJGUQXQJV$9*N)Y167KV%.&,9[9@A.1"&BG&\)
MVM5RHUST:_N1%5$5S4W5/KJ9<J/UU$]3`@*(PZ$9?X1766Y&UW*GK5`E`)"@
M,RDB1_Q[HFG-N.RY=?$SN/:UM7C%ZR!8V$NP<L637,+71U+)-&(T;"DDE;]$
M?W*5_P#%-UU24-Z;IV!0O-J57-S2`D3U$3&!'SG#/==LNU=4JZ4[[:+8])94
MLZ2@*`)F#+N`[(URXX='*JB7N`7P<L@`:Y)$5$&R>UXD5QD`HU09R(W[D$K1
MD5.C4>JHBR:>_#SQ2W"F4P\<IY8Y=G;EV1"J]J*]*JNM%:FJITY@?4)9\2#+
MEG+G$C<>8[1YQQ83'2PCU)(ML44Z8-@_.:VC*(_SF^3=SU^,=H7->B=J-5J=
M$U4WBKJ;=>&ZI+@6DHP2>`.!29=<9PP;=H**\;<=H5LJ;4'?$H9E0D0H3Z>$
MCI&*R/#.->+XT&SGI.N[P2N/6U<N4QH;20%R=KY0!17C##"]R*Y5W1=MMG+T
MU]I;A>+RMQAHI;IS@I0'T@\C.9)_24<:VT;<VVVS5/A;M8,4)4?K(Y@"0`ZX
M=L>>9K";<X3CMS7JH*6<2`67$&]&^-TFN9)@B*UFS2,`1Q6[_P!*/:G\M<=O
M--L72K8>QJ$@A)[#)1[_`+)QSW@^]56.WU5.94BRDJ'\29I!Y@&??*(7XWRF
M9BN5UDH!5;$FR8\"S"KMA&AR#-&YST54:CHZO\C7?\*I_)5W8[Q1-UM"\E2?
MQ$)*DGB"!^O*$W;ER=MMTIU)5^"XH(6.!!,I]TY@QT">O?,LVTX3YMXBOI99
M+ZKB7D*\Q&5(-WN'6AQF:"PHF*]W>HXCS-/':F_:-2IT:UJ:J;#>%NV:\VM]
M9*T4KJFR3PT&:>[,=)\H8=T[>;8W'MV^4K8#;E<PAT`?>+B2%_YI2/67$Q__
MT+F?VO<-#P#GZ'R+5PG1Z3EVG2UE%9V_&3+:)L:KO!L8GW,+)A_#E/5=T>0[
MU3^*)A_N-;/2W1JX-HDW4)Q_C3@?B)&/3WLY?/76.HM#KDWJ1?A'_NUS(^"I
MCX15OK.HV*)"XVRJ3C-_&4,E\1QYD.3`FM7K7W4(J$@2$39=U,5K&[_1'M9O
MTWTN7ZE>3Z:ZTF%53*"L,Y`SG_E./83&B[#N=(L7#:UT$[?<$%&.04I)21_G
M!`!Y@<XZ/.#N::#F7%F6,%WP\@K!QX^2T97(IX$Q['-;)"J=#UL]P7N`1.NR
M*UR->U4UK%AOM'?Z%-53*DX)!:>*52RZCD>(CS%O?95UV/>7;9<4384267!]
M+K<Y!0Y$?>2<0>A!,UZO(38@KV2YOA^NO#V4\M3<>EY2+''5(64<.8.N),/;
MVT.I!Y)Y(\ML0`B3$>]_B(NS=D:JKKX3($Q:V2U.7NYTML:=2A;I/B.($DE1
MP&>`B'?7+VVXG]S\/R:@JPRL8R@=;+BY%@UM(%)M(M9+&V,RZK9@!AC6E=YC
M=J/:C""(U$(QB.8KN!"'D+0H321(CMB5NK:-;9-=)<$A=&\DI"TSTJF,1CB"
M.1[IQJ,;UAS\MXZMDRZB+3L?UR%AW'0D??9'`K$:R1\QS?\`TWN:-J_^HY/J
MGHVN]Y\EU"?3SS$]4NS+YQ@;?M[7FK*'*IL48/U"941_#(8]\NV'VJZZ+3UM
M?4P6*.'60HL"*Q5W5L>(%@`M5WU<Y!C3=?XKIR2D)2$I$D@2$:TTVAEMMIL2
M;2D`#D`)"$A]V.;>)>`:?%\GO^-L:Y%Y@R&5*K^+*:SIH994B7`)7CLI\J\-
M`E$KJRG99A<Y$7R%>1K!HF[WLZWWT4[2W7#X1\SP`[3#'8[?57#U<JI;-L:2
M%/*!,@#/2-,QJ4HB0X<3("*:<QL^<>:A,NN7.1K#.I2YG?5R<6.L@T>*U;,:
M%2GR`=5$B3H=,841EN`?1I2(!JG1RHU[M+;U1=*U#;M.L(6FH4DLA0"E!LIU
MG7,##4)@<"53(&%HJ\6^WN^3;J3T['IDJ#X!4O4Z%:"J:=7BTF620?#(3QF7
MUNX''R5R]&O.+*%::+B^94\J9R#3T4.AQ[$P8S-E_P#5L?D1YS"3YN:U<)B+
M7#`P0CS"*_M"-BKWTZA6U=144BE@%P`D"3:0VH@J09X^:F4TA(`)).0G3OU-
MQ:IV6:^I*QY9)"EE2U%Q(.E8(D"TJ<E$DD``9F70\JHB;KT1.JJOT1-,44<5
M_P#L9[K8Y@<:QQS`IL.PMU":%*RU"H6LIII6O&T-0!H3_G;4#DW5&HH&+TW>
MY'-:B7_>2:1Y=KLS/J+I(@D?2V>IR)'*<AQ/"-NV-[2.72D:W+NZK]!ML$%(
M4/Q'Q/)(!FE)E*<BH_=3+&%T])/6:_\`;7DA_*7*M1/-PIC4^3/F"N)'F7DO
M+"/*K:^417>>7$AFV-.(U58W9`M>KR.<.Y]N=A/5%8N_7TEY:L=2L=1,\!,S
MES,A/(2BG][?>"E8MK6S=G-BDHV_#H;PT@$24H`2U8>%,S(DDS,=(<:-'AQP
M1(@!1HL4(HT:,`;!`CQP,:((`B&C6"$(;4:UJ(B-1-DUZ&`"0`!("/&A)42I
M1FHF/=K['R->RM^4CQZU)A0:.1E(XR$IHV2$FAI),IA1N='L#UR/FQA'`CV-
M*QKU&]S7*QZ(K5ZGO.#2RP$EZ6&J<I]98QV->5YB//*@U/'3*<ND\(J@YG_8
M]RQQJI\,L^`4X_Y$"(S9,G*KV3<436I)/''94`HM54)>UY6#1PCI(\*O56JC
MD;]R)=-XU]`33KLQ;JN:E33VID!J'6<.MNVI15H#Z+L'*;DE,E=BIDZ3W0H?
M`/K?S/[><EOY)Y#E69,6;=UDS,\TRAKQ2+\4?X[_`,%C\3QA^60E:%HF^%@X
M<,"L3=NXV.7+39+GN&N]?7E7I]0*E*S5+[J1V8<@(OKG=[=8J/T5$$^?I(2E
M.29_>4>W'F3%S/,?MYP/P%+C8_EN1$DWC6>+_&<3A,N[.L$!@48RQ"$X(E3_
M`&BM48SE&1S>K6JFM(N6X+5:%):JG_Q/V4B9':!EWRA`M]CN5T"G*=G\/]I1
MD#V'CW1H.&>R?JM[A1S\6VD45E)GHDH.&<@U(:^3..`<CMDX_*'+D!);0XZD
M<UT.0V6%BN<W9-UU%I+U8MPI51F2B?N."1/\/,CH9B)%3:+S8E)JQ-('WT&8
M';T/42,27@7I]ZX<:7_^3XEQ?3QKL<EDN%-M)=MD3JLXN]1$J19!860:]XG/
M[FN&UKVO:UR+W-:J3*3;]GHG?.IZ!`=!P)FJ79J)E$2IOEUJV_)?K5EOD)"?
M;("<(%[P<C\M\Y<KO]5>#8%Q;U]-#@.Y#CU#?C`L;BP\,QD.^M9'@A0\9I()
MXSR.(9@'RBO:3=P6HBGNBLN-SKOR&TI4H)`+DL,3D%'()`D<<R>D,^W:2@M]
M%^=W-2022&Y\AQ2,RHF8$L@.L0!;_K`]AZ7'EOJRWP>[O(NTA,9J;BPCVNXG
M*]JP["PK8%624Q&(J-\[/NV1KE7KJG7L2[MM>:V^TIX8Z02#W$@"?PBU1O.U
MN.^4MEQ+)PU$`CO`),H<C]?7-G))KG,O7'FM]N',<%@#ML9'E"%;D3*H$IL6
MYI9DF3N6R97$FQC1'N(4BQB$[7.")O8R[2N=<5U-FNH4*MI.I.KZM.1!/&4Q
M(XX'I"_N>WT013W6VZ33.DA6GZ=68('">,QS'6(;]Q^6N:^?>9+3UIX$A9)+
MI\3%(K,QAT11UG^1W1.S\G^=N#RHL6'C-0)6QFL.:.$QW'\GE10HVNW)<+I=
M+BJR68+*$"3FG"9XA2L))&68F9YX1/L%#;K;0)N]U*`I9\&K&0X$#&:CGE@)
M90N%C^O/VRPF"'*Z6FJYUI5J&8*)AV7`3)X)&(YZFK^[\:ACQ>U.D8[S.<J(
M-K^NU(K9NX*5(J&-)=3C)"Y*'9E/N/9%PG==CJ5%AXJ#:L)J3X3VY_,19%^O
M?V`S;DG'<OXMY6D3R\@\7E@-&:^":'DL_'9JGCH.[!,5DV194,Z.@3&(-KU&
M<'D5Q%<][IM*[5=:S4T-QGZU@CZA)12<I@\0<">1'&%'<]LIJ1UBLH9>C?!^
MG%(4,Y=#F!S!X1-,WUKHLV]DLCYHY)I*_(ZREQ7$\:XVJ;11V-:$\=EG-O[F
M;4F*>.^1&F3_`!16&&@VN>0J,4B,(EHNS,U-X<N=6V%A+:4M@X@'$J5+GC(=
MYE.1BN3=G:>U-V^E<*"I:E.$8$Y!(GG+"9[AEA#8-:UC6L8UK&,:C6,:B-:U
MK4V:UK4V1K6HFR(GTU>130EV1^L-?2^T?$//W'%#6U,:,?,JOE.KJ_!6LG)>
MXC?P:?*APT\,0AQ64[LG=G]TRJ%Z,<YI'Z77K&VB^4%WI&TI(*PZ!AJU(4`K
ME,$X\\(OFKPM=GK;75+*@=);)QEI4"4]A`PY8PZ>F**&/"JB(JJJ(B(JJJKL
MB(G5555Z(B)H@C3,!SNAY'QW_)L<.DBL_-9-1(1""*CI6+9%:8W-(QX'D&^/
M(E53BA<B_>`C'?\`%KHIJEJJ:\YDS1J4GO2HI/S&'2.^HIW*9SRG1)>E)[E)
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MF%`G[,I<HXW2XU5HW565C;:=8,I')22D?:,9CC\(E[$.3<=R6W!4T=,_'R'C
MV]G;HZ/7L'8G'"&T`A$BI\@A&O,8CW.1O<T;>FZKM1W&TO4-"MY]_P`US6E*
M3,^%.//F9"64-%GW#3W2Z-T]+3!AKRU+4))FI>'$<@29YYPN_*<"-`SR^!#<
MI&G.":1NW5DJPC!F21(B=?M.=>GUTSV-U;EKIE.82!'<DD#Y"$?=+#;-]K4,
MF>I04?XE`$CXF-_X?PK-H.60[4D*=25@8[W3CS`*)D^(5&JV`,1%:\BG>C7[
MHFS.S?HNV]7N"XV]ZB4PAQ+CQ5A+[I'&?RZSB]VE9[Q37-%4XRMFF"#J*A+4
M#DD#/.1GPE$\<F\*9#G^/&S2$PD.%22HU'"FSB!BU$V7)\DJ5$"XB?*ES&#Z
MO4#2M`UC?(C4(BZJ+)6/VYIRH73DT"E`*5QGP"9D:I2,P,N/"&#<UMI;P^S2
M-U@%U2@E*,2-,\2N0.F>&DDB<L)XQK\7.:OC2!BN&940C[(=2#Y$^$QLF%##
MYW18K3+_`&I2B&,2JJM8Y>UO1JJO7X;:[>%U5=1`!HNG!6!.`.&?$GC'T7IC
M;S=#:[DHE\4Z?$G$`S(D9RX`8RC<<TH8G(.(RX4(\*222,,FIGO?Y8X90NUP
MBM*)'N8C@JK%[479K]MMNFJ^BJ7;97H==2H:3)0R)'+_``[(M[G14][M+M.P
MM"@H`H5F`K,&8YX@GJ8B*N]=*]8$=;:_FMLE:CI*0!1UAL<O51!\XO,_M3IW
MKMNO7M3Z:NW=UO>:KR*9/E<)SGWR,NZ%AC8--Y"/4UJ_42\6F6D=!,3[_E$K
MV7#54#!*S$S1I\"OFL%<U]J0#&29\A'/&ML)[F(*4PK%4>Z?;V?:G]*:@.76
MXLUS-Q=;D5(\*3])23PXRGC/.<6S-AM%1:ZBST[H*4.>)22"H+`S/"<C*64N
M40YDF)<;<5@@6,EDR]R$6QZZKF2V("<9CE:DF6`<5PQ1`O7?9>CE;MU7?5C2
M5UXO2G&4%+=*<%*`^D<@9SF8IZZU[=VRAFI<2MVM&*$*5]1YD`2`'P[X\\V3
MI=MB.-7$![ATLXT4LJ.U[6HPLFL#*KAD8S9'H)'&3^*(Y/\`PU\VXVVS<:QE
MT3J$@@'L,E?'#NCEO-YZIL]NJ6#*C6H%0_B3-(/,#'OB(^+LKFXQEE7XY+AU
MUG,C0+..Y^T<@9)6A:=[55&M)%>]'H_ZHB*GT54U?WNB;JZ%Y11^,VDJ2>.&
M,N_E"EMBYO6^Z4R`Y*F=6$K'#$R![0<9\IP^C8K`!>&&P41OC(@V!$P8F%(X
MA'&\;$:WO<0FZ_\`F_CK-5+*Y*6253QZ]\;2EH-A2&DA*)82X'L^?QBNK+ZZ
M[JLBLH&0F+)M0FW-(*9Q_.PJ>8)AD>JJHBC(CFITVWVV36JV]VF?I&7*1`2R
M1E*4B,".V,'O#%;37&H9KW"JH!S)G,'$$="#EPB;,4KLCR+B#(ZJ56R)(XK&
M2,9<4+D)(%',R6043?M<7PN4OB7KW*16INB;:6ZYVDI+_2U#;H$\')9`F8QY
M3PGV3ATMC%?7[2KJ1Y@DI$V9C%0$E>'G(SD>LHB*NX[S6R:`L;'+1H#G9';(
M/&?'&QSGHQ2/\R,>T3%7J_;9-EU?O7>VLZ@NK05`3D#/NPPG"E3[>O-2$*;H
M'`A2@)D2ECF9XR'.46'<6U>34>.WF.KD!95U8<7\L8^^T^]B-%<<<97"&-7;
M$.\$-#-5']";#WW3;HE4E<S^<+K&J?33Z'"4#B/+5J'+'EE&F5]LJ?Z>:M[]
M9KJ_,9`</!7G(TD<?#,2.<?_T>QG]@'KW)]@O7^ZKJ"&6;G.$2/\RPR+'$PL
MFRG08Y0V-$%'=KN^YJRD&-$<G_,-$J[HFVEK==F_.K.]3MIG4H\2/XAP[QA#
MIL+<?]-;AIJMU4J)S\-W^$\?\ID8Y/)$<\0YXLH)8TF,8L>3'.QPC1SA>X9@
MF&]$>,HB-5KFJB*BILNO.*T+;6MM:2%I,B.1$>R6G6WFVWFEA32@"",B#B#'
MI5-TV_\`R545/Y*BIU147^.N!`(((F#':E2D*2M"B%@S!&!!'$1/'%'.&4<>
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MAF/#%MHP#=[.[HWIOIX!"TS29I(SC)[;6/6BZ4E:$$/,.@D'`X&2DD'+"8,X
MY"[BIY<]:>435\S\_P`<\DX78->,\4Y(DL+D7O!,A2@N4%C5SA(CF/:I`'&N
MR[INFHYU(/6/3S+MGW1:PL)0_0.C$','B#Q2H=Q'".E+T+]U!>U&+VE#D]>R
MIY3P:OKI&2I$$T5/D4"9(DQ`7U.-"E?&<T@&-F`=VM&8S5'NQR(V0E04)C.,
M!WAM1S;56VIMS7;WB?+/WA*4TJPS$\",QUG%@NN4)L0-SIZU\2>Q==2PN3J&
M3/E8R>7(QJ\JK2=2WM":>L-9RU\^"5G]N;\`*%&5A1N\:?;NF^NMUIM]M33J
M`ILY@Q845SK;>'T4KLFG0`M)`*5`8B8/(X@YC@8CFB]&^`:R;'L+VHR3D*7$
M\JQ/\_RFTOH<=\A1NDF2J&2#52),EP6*0I@%*3L;W.7M3:.[0TE04&H9\PIG
M+42J4\_J)Q,A,\9"<1T5+K.OTTFDJE,(&F<LAAC(3,A/">$31E6><6<&X[&!
M9RJ7%*R,%R5&-4T2.&7):CNHJFBKV,>YKB.^YZ,:)JJJO>U-UUTU]SMMFI_-
MKJE#3(&`XGHE(Q/8!%Q8-LW_`'76^BL=N=J:B?B(^E,^*UJDE(ZJ(GPBJ#V,
M]Y+[+5M<8Q(QJ+'"+X&5D-4'>V(O&G=_D=I'.5D"*4BJJQH[T<YFR.[T54UF
M=QW+=]Q*736A*J:T'`ND26H<98X3Z=Y&4>BK#[>[3V`VU<=U.MW#=2<4TR3J
M9;4?I*@0)D<2O">*4G`QJGI]Z79Q[=Y.;)LQEV>+<48X>,RSO1P5"^\.XC5-
MC&&)(=X1R71V*Z5,[3MC-<SN1SWC;IZV/[>I>D\ZTINB!!*E?6X9Y8_]`Y8X
MY/[K^\S^KR6ZA#UQ((2V@_ALB6<@3CWZB<)R&'3UAN'8SQ_BU'A>&T\2@QC&
MZ\-92U$%BLC0H8=U:QO<YQ"$(]SGD(]SB$(YSW*KG*J^@V66J=IMAE`2TD2`
M'`1X^J:E^LJ':JI<*WUJ)43F28V77;'1'P6EK64==-N+FPAU556QRR["QL)(
MHD*%%"U7ED29)WL"$0VINKG*B)KBM:&TJ6XH!`$R3@`(Y(0I:DH0DE9,@!F8
MI\Y8_:LM=D$VJX>P*JO*6%(00LIS"39!;;,8FQB0Z"O=`DQ8[B?[1#2N]S4W
M<)N^VL[N&_D-/*;MU*'&P?J42`>P#&74GNA[H=DJ<:2Y7U)0LCZ4@&7:3A\!
MWQ+OKM^P+CWG.WIN/N5L6K<4S.VG.!1G<$5EAEG/>A/APPGLWFEU-I):GC$A
M4<PQ7(QI$<YK%LK-NZBNSC=)6,ANJ4<.*">0)R/;F<H@7;:]7;$.55(Z7*9(
MQX*`YD#,=F4.GSWR"_B+A;D+/*](HIV,8O,+1"*P:14N3,97T0?"K?&\?Y.2
M%J#VV?\`T_QTRW.K]!;JNK2/$VV2.W(?.4+UNIO6U]+3*."U@'LS/RG%1_#W
MZS<XY(K@9WS;G<[$I62,=<OHHD1EWF$@EB]9*3,@M9\I8=?-DM?Y7B[)1]R;
M$41&N;K/K=LFHK0*R[U2DN.8E(Q5C^THX`])'EA#S7[O8I":6UTR5(1@%'!.
M'[(&8ZS$?3RY^L;+N/JDV<<+\@SLHLL81+T='901TF3,?4]T]LS'KFLE+&DV
ML8@&O`%0QB*YJ=A'/[6K]N&QWJ1!J[35J4ZCQ!)P5AC-*@<QP$AVQ\H=XM5*
MA37*E2EM?A*AB,</$D\#QQ[HM)]6.3K?F/@#C7D2_8)MW>5,^+;/"FPY5CCM
M[:XQ+L$8B(T;K(],LAS&HC6.*K6HB(FGJQUR[E:J.L=3)Q:2#VI44D]Y$X3;
MQ1HM]RJZ1M4VTD2[%`*'P!E&X8+Q-C&!93R7F56TDC(.4<E#D5_82A1_D"9%
MK(=;!IHAAC:;\7#^,0S&/<Y?-((O\41)%-0,4KU94-C\5]>I1/0``=@E\28C
MU%:]4LTC"S^$RC2D=I))[3/Y")0U-B)$-77#-%;<X83S>CDC7V)8?E.)2&"9
MLZWCW18#ZI\DFVW93#=8(U/J]9:==AHBP'*!E=PI[CD\AM2.T*(./9(R[8FH
MKG44+]!FRM:5=A3/+MF)]D?3Q?PWB_%D_D6YJ.^9>\G9_DF>Y+;R0B9+>:\L
MI,R#2A>SN(VJHXYU&%BN7N(XI=FJ16M^T=`Q1*JG&A^*\ZI:CQ))P'8!@/\`
M;'RKKGJM-,AP_AM-A"1P``Q/:<S_`+(ES4Z(<+S#P'CR/[1VO(-9:AA<DDX6
M#3Y-C(FA%^9QV\S&(ZCRXK4>TIY<"5@YZ]Y.UR()P6N5NS4=6)IJ07=RJ0H"
ML-.`I/-)5X5=Q21/_9%BJHJC:D4RDDTGGDI/)03BGO"@90PVK.*Z$?Y6]E`U
MWM'P%P9A=D.TF2LBNY7)\&%($@HL.;BEQ!HZF=)1SF++A$E$M2Q=N]%BQM]E
M(B:6ZZ]);O=JM3"M2U*47`.`T*T@]9^(CD!SB_H[0IRSW*Y/ITH2E(;)XG4-
M1'27AGU/*&@Y7%EY>-,[3C\Y(V<#Q:YD8D031/*[((L(LFJ`-AU0#WRI8FB1
M"?VU[]G?;OJ[K`^:2H]*95.@Z?XI8?$X144A8%53^I$Z?6-7\,\?E"0\/_LF
MX9RBEB0^63R^,<XA!?'O02:JUGXY(GQ&D;*-53*\%A-BL*X*K\:6-A1$=XD>
M941[E>W[SMC[837J+%4G!0()$QG(@'X''AC#'7;2N++FJB2'J8_200#(Y3!E
M\1AV1#GM=^Q?"I^$7.!\"6-E:W^0-D4]IF9:F36U=50RH\B/8.H76#HMD:ZE
MM>U@2K&:,`WO>CD*C-JZ^[SI/3.TMI65OK$M<B``<R)R)/+"0B?9MI5/J&ZB
MYH"6$F>F<R2,IRF)<\<8<CT7P:XX_P#6'C>GOX4FMN)X;G(YD"6,H),,>07E
MA95H#Q3@`:(=M0:/Y!/17,(KD5?X(Q[7I7:.R433Z2'B%*(.8U*)$^LB)]8H
M-Q5+55>*MQD@M`A((R.E(!ETF#*&GN;>NQ^HM+ZXE"@U-+73;6SFG=VAB0*^
M,27,DE=_!@8XG.7_`$35ZM:6T+<6J2$@DGD!G%,A"G%I;0)K49`<R8IR_6[R
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MFTH(G-)`GTF.8.?2-KNE!3[OIZ6\61]"G-(2H$RZR/)29R/,<<(TO!N)7\<O
M=D>5RF"L&PB%>+Q$'#KJUP5FFE*4S&$.\H(^R/:U&^-SD;W;[ZB7B[N7'11L
M,*2T5"4_J4<AARQBPV[MYFS!VX554A;X20=)FE`S5CSPQ.$A.-:L>4>,J[+I
M-S`QPMY(GL`D^\V[?$2/VL&L"OL!HG?VL17D:H7.5$_J^NI+-EO#U$AARI#:
M$DZ4'KG,I^0,^Z(=1N;;M-=%U+-$7G5@:G0,I9:0KYD2GAG$GX;RSC^:VQJ>
M!&L(<ED<DH*SF`:V2,3FM*T?A,;M(QKT=LOU3?\`EJHN%DJ[<RE]U25()D93
MP[9@0P6G<U!>*EREIT+2X$S&H`3`SE(F+J^-N#<(]@O63C:M+865%8XT7(A1
M[2&T,I8]I*M)"6PI40B1V3(DI6B(UJ/&1B(U$)T7=ZMUGH[[MRVMJ<4A;>J1
M&,E3,Y@Y@X']<9?=]PW':V\;R\EI#C;VB:3,33I&F1&((Q'$=(K:YK_6QG.-
MV=F6NK\FRF`QSCQ<MH^ZZ;(A#$B#'+I'FD6,!T4;4:HU54145&$(W9RPZAC<
M=I<4E%,FHHTC`H3+#F0G$'G@1RG$^EJ=G7]E*W:U=)<5'$.+*L>04K!2>6(/
M.45\X]3\BX9FT;%0)D<:K_R8,.;V0Y`:^5#;+;'E37C(AHP$?![G.7N[V)_'
MN37&KJK=66YVH<\KU(:)TDC4E4LL9&8.&4<[?07FW7EBD9\_T1?2"I((0M&H
M>+BF13CG%TG-.)47!?K?Q#R[AN'5TS)K*%2W&3VDUC[TUE(D8\[((M>.!=%G
MT\2+*01%+X8K"J,")W=7]_"IMS5OM5A?I&FT5#RT:W%#5BI.H"2I@`]`,NV.
MVCN[]WONZJ6O>><I*=MWRVD'1@A>DF:9$J`.$R<S@9"25W7LS<^S=P6[M1`J
M+*@QNMHX57"B#B557%$^<X*P8HS&:YCI!7.>O3^#41K4:U*7<@N"JFG?N!04
M:=*=$P))QRX$S_24,FS#:$4=72VD.I<U:UEPA2M2L!B,P)<NW$Q6_EE==560
M64#("E/:`.[SG*5Y_.TBJ89QD>JN<$S"=[?ILCOHBZ<Z!VF?I&7:1(#)&``E
M*6!!ZB,VNS%;37"H9KUE52#B29S!Q!!/`SF(F_':O)<@X<O:Z34R)"17A/C;
MR@<A9$:.8<LB1>[M<7Q-(5!*F_>C^U-T32U5NTE)N&G?0\`E6#DL@2",>W"?
M*4X=J"GN%?M&KI7J<E:<69C%200K`9F6(!XSE$35?'&;6CHCP8_9!CRI(H[9
M<F.2.(*O(C%.5'HTS`CWW5W;MLG35Z_>+:R'`JJ05@3D#.?3E/OA4I=NWFI+
M2D4+B6U*`U*$I8YD'&0YRAM;YN18;Q=*VOB3+ZIA@[+5XQ*\CG30L\+&2D+Y
M_&`BL;W;O<B;_7II)HTTEQO(G3!-*LDZ9Y89S$N./*-.N*J^T;<5IK"NN;"1
MK(!))4!*1G/`R$\>,>_A;UCY-]G:*YG)CQ[&\JH/RP7R2(U;8,KD1_P@S@33
M0H-@647O2,SH<C&KU1J(J,3**L5KS&WV_,IFQ-Q)(T:CP23]X\@<X3JARWKM
MM/5;N=\JM>5I:6`?,TCBM(P*03F1.1'2+-O4WU^=?2L]X[Y0P:ZKJ")CM,P<
MN;#DT=A67E5.&&`E6<L=%84T$YU>C%<-1HB.:YKFZX[<LZZU^Z4UVHEI:4`J
M9!20O5A(]A/=VQV[PW$U;J6R5MAN3:GT$I`20I);*1/4!PF$RXSRE*'MQGU#
MX(QNLF5I,09D2SGO<6PR222?8B8]G8T4.0!(C8+!IU11-:_NZJY5VV<*;:UD
MIFEM^C#FHYKQ/<<)=T9Y6;YW+6/-O"X%K2,$M^%/:1C/OG&!Q[TPX@QS*;6_
MB#NCUMG0W%`W&ID]3U\$%]6FJ+.1&G.9^7202!)*P;E.KA*17-7=&[=+&TK3
M3U+KZ$J*%MJ3H)F`%#2J1^J9!/'">$2*K?\`?ZNB8I7'$!Q#J5^8$R42A04D
M$?3(*`.6,L8__]+OXT01SL_LV]-)N!9%=^QN"1PDP7*;:*3-J@"HP^+Y)9[B
M?;@C-"P?X*[F,:KU:YS@S#+NB,>U4Q[?>UE-K=OE$DEM1_$2.!_:'0\8]$^U
M6^4/-,;8N:PEU"2&5G[PST$\QPRF,(I^UE<;O!H@C,4]]:T+U6ND]@7N5Y89
MVJ>&1SG=SG>%7-<(CEWW<-S%7?KOJKK[/0W'%YN3O[2<%=_`]X,-%AW?>MOR
M;I'PND_[M>*.[$%)_A(Z@PSW$_MCG?&SPQ*>[G4,-2$.>O*QESB<DQ-O*IH$
MACSP7G5J.5XVL5O\3?Q6)3+W1MY(3:JT/T0/\M0GAT!_["A/E%W<$>VN_EE>
MYK0:*\+&-0VHIF1S4,#_`/,00,M43_F_,O!?LO7Q`^P/#M5F$^JCK&JLSP#(
MI=+D-4$SO(2.)GRVN<)7[D01Y9`*Y?\`9W^[5Y3>Y(:(9O=G<;<YIR[=*I$=
MRC%$CV5NUN4Y6^WN]6G*=6:'0""1D"I`6@]Z$D<X8KU3I_23U_#?V_&64V%+
M=97'@QKN3R1/EMN8T.&4QP5(2D@0Z84=D@RN>L9Q?*YK%<1Z-9LX4N[-MU*`
M6;JRF?!9T'O"I1EV[-H>Z]<ZVB\[=J'&V9Z?)0%HQE-0+95.<AGER&,.8;GW
MA4#$(3E#"^UW]/9>0RO=O]$08B/(JKO]-M]357^QH3J5=Z8)_P#B)_QA+;V-
MO-U80WM6X%?_`,!S_P!F(NS#W+X9QE%%53[3,YVR_P!G'J\@X@U^U4\]G;?C
MHJM<BK_L^=45.J)JFK]];;HD$IK?.<X);!5/OP2/]Z&ZR^RGN#>'4)<L_HV#
MFNH4$`?Y!J</<CO$)-R?^Q+)CBE1L0BT^),3R#&D)XLMR5RI_;Z%DQH]/`(Y
MWU0L=4&O3R+MOI6?WM?KF0W9;4&&3_S',>_$!/=XXTJB]G-C[;3Y^\=S&KJD
M_P#(I_`"1]TR*G#VDM#G**Y<NY2RS,;*PLYL^6DRS,AIM@:26;=SG-&-G=*L
M2+WLV8/9$&C58Q$:CMDU6-6)=75"JNE0NKKE<_I[`.(`X8#I#!5[Y;MEN_*]
MKT#5KLR,BF6N7$E60),YG%6/U3BQOTQ_6ADO+0,=Y0YF4V)\82WDL:S%&*HL
MOS*,,A&`-*&\;VX]1S)35>KS;RY(F[L$T9F'UMNUMAJ=#%?=1I9S2WQ(&`GR
M'$?9QCRGOSW6#*ZNUV-?F51,EO'$`F1,CQ)Q!Z\9B4=&%)14N,U4*BQVIK:*
MEK1>"OJ:B%'KJZ$%7N(X<6'$&*.%KBD<Y>UJ=SG*J]55=;"A"&T);;0$H&0&
M`$>=7'7'G%.NK*G%&9),R>TF,KKE'"#1!"9>\&,YKR+Q=CG$>#"5++E3D&@Q
MN;.>ITA5M37`L,JF3+18T62=M8%*!KS*Q$5&LVZHJHJ]N6GJJV@;M])@M]U*
M2>`2)J),N'AB]V^]3TE:NNJ<4,ME0'$DR2`.OBCX.+?U_P#KGQ[0QX-WAT/D
M7(7@1EKDF6I(E++*JN5_P:9)3JJICIW=K4$-2JU$[R/7KKKH-J6>B9"%4P==
MEBI>)/8,AW1SK=S76L=*DU!::G@E.$NTYF()]F/UZX$N-W/(O`L.?A&=8M')
MD4/&:B1+DTUV:K4$SPU4<Y3RZ2V$.*]\7XST"X_:WQMW1S:N];0HUM.5=J06
MJQ`U`)/A41C@.!PPEQBRM.Z:I+J*6Y*#M(OPDG,`X9\1SGPA^ZBJIN8N'\/'
MR!3Q[B!EV)X3D5W4R'2@QS6+H=1D8VD\!@G[(]J)C^Q7;.[.UZ.:JHK8VE%=
M0L>J;"DK;0H@\Y!7VPL.*71UCWIG""A:@".4R/LB5]38B1IN"9WCO(]`[)<7
ME.F5+;S)J!#N:C%),Q7(K/&K`C$:YZ+'-,JGD"[?=X'L=LF^R=%/4-539=95
M-&I2>]*BD_,1W/L.TS@;=3)>E)[E)"A\C&N8-(XVPZ[M^&\0^-26E(&5G;L4
M\KV(RMSK(;JWFVM''.9Z_AER,\MCA`1H89'-&C&,<-%ZJ=5(PXY0,22XF:]/
M1:B20.15/+`&.U\53S:*UZ:D*\&KJA(`!ZZ9=HB5=3(B0A^>>S4>7[?<+\"8
M/*;:,@VF2R.2#U\AY`BF.PS)&QL;,T2*$Q*5K/GS$550!!C8NQ&/1BS5WI/Y
M_;;13JU*FHN2X>!4DGJ/J/*0ABIK0K\CN%TJ$R$DAN?'QIFH=OTCGC#X:9H7
M81;W#YJM?73).$^4HLJ=+Q^5>WN%YSB(C.^+?X[9Q(5FRSCA>9D<=_C9ZU[X
M9%;]R22#<Y&/72QN&Z+LSMLK9DL%90M/-)$Y_P`293':1QABL5M3=F[A22`>
M"`M"N2@92[%3Q[`8=Z!.BV<&'902^>%81(\Z&;L(/S1986'CE\96#*SR"(B[
M.:UR;[*B+IE2I*TI6DS21,=AA>4DH4I*A)0,C"!>[GK;R+R5(Q?E_A.ZFU'*
M7'U9-KG1*ZRD4]G?8^,QKF+%J+&.]BI;P+)2>&.1S`R4E.1SVJQJ.5=RV:LK
M?(K[6Z47!D$8&14G.0/.>0.!F9PS;>NU)1AZAN+050ND'$3"593(Y2S(Q$HJ
M[R3W*]R#52<46]U?U-ZS_IIBQ,;E5/(DHT-7GD,?.C"%8NDN#_NJ(;542;]$
MZJBO;CW1H-"YK2Z,#)!"_B./8(<F;!MS6*Q&E3>>*P4?`_KAR?U^>I><4>5`
M]C.55GUEI(B7/^*X_<L(7(ITF^`^)/RK("RS/F0"EC29(QQSL245Q5*]6-1J
M$8]H[>JF7_SFXS#Q!TI/U>+`J5/$&4P`<<9F*#<]\IG6/RF@D6@1J4/I\.24
M\Q.1F,,)"&2]K/>G$_7*U'A-10+G/(18$>PE5B6@:ZGQV--1[H2WDL(ITWY\
M@+6G9#:%CGQR,(I&->Q77=_W136126`UYM61/2#()'#4<3CREEC%39-N5%W2
M7U.>72@RG*9//2,!ASGGA%'O(O+."\Q<@2LUS'C=F&'O94J;D\OC.WEL/9V4
MLGF+<'J<L)<5QII';^1D<D!A7.4CE5^_=EU;<Z*Z59J:N@\I2OJ+1Q)YD*F"
M>S3VQHU';ZNW4PIZ:M\P)^D.#`#D"F1`[9Q;%ZL^BGKO)@81S5"RV\Y7A'#"
MOJ*-:QXE+2Q+>(1CU_*4U>:3))/IK..YKXAY1`M*-6D:5J=7^Q;5LNFFN3;Z
MJA)DI,Y!(/5(X@\"<\Q"1>=RW:=1;ULI84/"J4R9=">!'$#+(PS7LCR_SMPN
M>%DF!\30^6\"/7&2YCUAK2'D^,VD=#;29*0@VWSZ26QXGHX<3O&X1&/<B/8]
M+V\W"YVY*7Z.WBH8D9@$A23SP!F.P3^,4UIH;=7E3-57%A^>!(!2H<L2)'M,
MOA%/G-GMM[%>U`F<:4^'2Z3'[&T^.;#<)JKJRMKR;$,4;:Z\L7,?+FAAE<BD
MC,%'!Y6(\K%5C>S.+GN&]WT>@:I"AM1Q0@**CT4>720'.'VW6*T68^M=J@M8
M&"E$!(Z@<^LSTBSOT&]7IW!&"3\HSBI;`Y/SCL_(1WG'(/08P+PGK:$BA<\(
MIII"+(EM:YVS_&-5W$N[QM.QJM-&IVI1*N=Q/[J>">WB>O9"=N:\INE4ENG7
M.C;R_>5Q5^H=.V'_`--D+,8BTQ^ANW1WW5)46[XJJZ*ZTK84]T9SMNYT=TL)
M5"KMNJMVWUU.,,O%)=92HC*8!EV3RCN:J:A@+##ZT!0D=*B)CK(XPH/OAB--
M?\#6,R;50I9:6VJ&B*0(?*"OLSK3SXHR*SRMC20SD1XV*B*K6K_PZ6=X-C\G
M54(2`\TX@I5Q3C+`_"'7V\>/]0II'%$T[[3B5)X*\).(XY'..4O-:N'2Y9D%
M57]R0H-G)!&8]7.<,37[M"KWJKW^'?M1RJJN1-]1+:\Y44%*\[_,4@3Z]>_.
M)MZIF:.ZUU-3B3*'"`.0SEW91-?J?"QV;S1C0\J0GX!AX2VSV.(QHJHUW41+
M<A"!((HVI52#(BM5%1RILJ+LNH5\*/*H4/$>F54MA?\`#C.+/:P=%1<W*8'U
MJ*)TMR_;D`GYGB)1V%TU544M9#K*&!!K:F*!C(,.N`*-#$%4[F^$0&M'L_?=
M5^KE7=555WT_M-M--H;90$M`8`"0`C*7WGGW7'JAQ2WE'$J)))ZDQD]=D=45
M\9AZ`8M=7LBVQW.[>AB3[63.FUDZJ!<H&/*.0[XU;,2;7F'XE?VL4Z'=V]7*
MJIU1*O8M*^^MYFM6A*E$D$!69G@9CYSC4:#W0KJ6E;IZBVMNK0@)"@HIG(2!
M4)$=LI1D/=:JP+#/6.OQVSL'Q4Q!E(+#(JB+,L;1V,U!:^7&1!,<Y=\>(=Y"
M/5H_+V(J]SF(LK=%+3(LE+1>:$N)6VEH'B1X9?[I))RB#L>MK7-RUMR\@K96
MVZI\C)*5'7,#GJ```Q./6.6JLR2TQRXFS\5G28"R'28X7(,+RDA%-WB&8!&'
M"I$:UJ_1>UR=%UUO4;%73--5S85I`)Q,@0,9'`RCLIKC56^L?>M;RD:B0,`2
M4DS`(((GEV'*'3X;]7>3_9C'+FU3'I-C>T\,4YET.3%@69*QVS(427&FFAP)
M\F0CB/`-%;)>(2]>C46D936"KJ&MOM>92M":TDC3JXA!.,^DY9PS5*K<J@I*
MC=S_`)->^J3:P#KT`8%Q($M,SF1/*<6>^IWKXN2MY#P/E'!KJOH8=70#!.F1
MST=G4WU9),*,.M(8*$0IZ\Y5)VM>'QM1'HO<S7S;EE76KNE-=J):6CI,S-)"
MYG(]03/A*.>\=R-VYNQUMAN+:GTZDR3)25-E(^H#"0($LC/+(PQW(?I#@S^.
M)]-QG$=&S,-@&U@7&0V+Y)Y[!L41Z23*;':&+".%>X?8)J(=K5>NRNU>U^SJ
M(V]QBW(TU85J"EF<_P!TF6`Y89YPL6OW$N0N[53>'"J@*"E2$"0$\E@3Q(.<
MSEEPC`\5>A>)U\($_ER4_)+9Z(XF/5,V1%Q^*K'L>-231,BV<XZ*S=5:X#&N
M_I1=NY>JU[+I64!RY'6\1BE)(2._`GX@=([KY[DUU0X6K.D-4P."UI!6>XS2
MGI@3S,.UA''V&<;U"46$X_!H*U7^4HXJ$(>4;M[?/-FR2'FSC]J;(\I'N1.B
M;)TTW4=#26]KR*-A+;?3CVDS)[S&?W&Z5]VJ#57&J4Z]*4SD!R`$@!T`$;EJ
M7$"#1!!H@C__T^_C1!&*O*.GR6GL\?R&L@W5'<PI%;:U-E&%+@6$"6-P9,27
M&,UXC!,-RHJ*FN*T(<0IMQ(*")$'(B.;;CC+B'6EE+B3,$8$$<1'/)[D_K+R
M[`+2ZY"]?:>1E'&[AI/E8-#++L,LQ+M3_FQUPI)9,S)J9BIY!JQSY@F*K7M)
MV^1V/[IV(\AQVOLS8+$IEL9CF4\^R/0^QO=2G<98M6Y'2FJ!DEXRTJ'`*Y$9
M3R,5$N:YCWC>US'C<YCV/16O8]J[.8]KD1S7-5-E1>J+K+EH4VHH6DA0.(,;
MFVXAU"7&UA3:A,$8@@QXUQCG!H@CPW[7H5BJPJ)VM*-585K57=4:1BH]J;_R
M77%:$.)TN("D\B)CYQW,U#],OS*=];;G-)*3\008S`\CR,&WQK^S"J(B?>0$
MU-D_AV68)HTZ=.B:K'+):7?KH4=TT_\`5(ADIM[;JI9!J\ND?OA*_P#KI5'O
M)EN6E3M=D4Q&[;*@H5,%7)_-2,K$,UW^K7-UU)V[9TF?HY]JE_\`M1,=]P]V
MN)T_F83_``MM@_$H/RE&-DV5E-3MF6,^4W945AYD@@U1R(BHHG$\2HNWTVVU
M.9MU`P9LT;:3STB?Q.,4=7N*^UX*:N[5"T'AK('P$A\HFWA#UEYG]@K)*[C#
M";"S@A<\4O(I3$JL5K'"&TCA3+V8@J]AD&Y%0+'/,[Z-8Y51%;K/MBZWM4Z=
MK2S^VK`1FNX]\6';2=-94:ZG_NT2*N_D,8Z`_4[];W&G!0Z[+N1!UW)'*`V*
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MIZE."@KZ9C.1_40##%7[3N-.K72`/TYR*<Y'*8_6#*(E]HOV08?$QW(L#X,)
M+O,CLXYJDN>N$P./5<&=%(*7-Q]_R6SI]N-A>T#WB&$)-WKWJU&K77W>E*VR
M[2VL^8^H2U_=2",QQ)Y<(GV;:52MUJIN("&4F>C[QEP/`#GQAI/0/$++$/5[
M`FW`I(+/)9&09=)#,'('):*[NI;ZTI4DO<172Z@$<_=LU'(7?9557+?;4IG*
M:QT:7@0XK4L@Y^)1(^(D>^*7<K[=1>:HM$>6G2D2R\(`/SF(@SW_`..)DRTQ
M#F3B_D.LQ'F?!(3ZG\2W,:?%[ZYQ60^7*214DL;FM)\ZI-.,BA:QWS8TM[55
M5&-CZW==&XM5/<:"L2U<V@0!K2DJ2<<)D8CEQ!/2)^VJMM"7Z&MI%.6]T@ST
ME02H88R!P//@0(KRL/:OWEOJ6/B#[[/%;8QW#!*J,%CPLALHJM:![XUU5X^&
MR,Q6RV(I@D1=W,=W=RHJIKE^W:ZCTY4[-0^ZV`3V*"9]XAL19=L-K+X2U@>+
MDP.T%4NXPZGHIZMW_'5C9^R_/)9F-7HH]N6BAY3+`*7#B748@KW-,LE3B/EU
M\^6&48+&R"#*T13$.GWL5&7:MA?HUN7J[$IJ"#I"CB`1XEJ)R)RQR$YYPO;E
MO3-4A%HM@"F)B92,"0<$I`S`SP&)E*+0;KDSCK'*9<AOLZQ&IH_"^0VUG9#5
M`@E"-9#7NCR'RD9)V?%*U$&KE5PW(B;M5-/#M92,H\UVI;2W*<RH`2^,)[=+
M5.K\MJG6IR<I!)G'/_[G>P/_`/K'EO$<-XNKIUICN.39.,86J,,.5F.09'80
MHTBW!`.$!H,.:^'&#%89/*@F*0B#4BC9DNY;O_4%PI:*WI*F4*TI/[:E$"<N
M`Y=)DQIVWK7^1T-165Q"7E)U*_=2D$RGSY]<(Z`^-L:/A?'>!8?*(,LK%,+Q
M;&I)1/<41#T5'!JS/$0C6$(-Q(JJUSD1RIU5-]:W2,FGI:9A1FI#:4_``?JC
M,*IT/U-0^D2"W%*^))C=-2(Z(]+XX"$$8@`O,'N\)7C8X@NY-G>)[FJX?<GU
MV5-]?)"8,L8^S.4X]CW*UCG(U7*UKG(UO]3E1%7M;_JO\-?8^15)ZR>GD;DR
MPR/V$]FZ-^39'R#;3;?'\.R!\CX]=6EE-6':7D,<ACCG+$"T$6$=7ACPFM\C
M%>YJ#1;/MM-6]4W:^->8^ZLE*%9!,\"1QF`)`Y#AC#E=+^JE:I[99W/+9;0`
MI0S)EB`>&,YD9GI#=YGZ8^M6:T$R@D\4XO0?("HX]QB5?'QR\K3(C/#*A3ZX
M8^X@7#:J,,TP'INU['-<YJL%3MVS532FET#:9C-("5#J"/\`HZ124]]NU,XE
MQ%<X9')1*@>A!B+/2KBS*N!+WGGA6XF&M,:Q_(\3S#!K@H%"MO29G77,1\OM
M0CQ#,)^*MCR!L1K6RP%<W=CVKJ!MNWOVARYVU:BJG2M*VU<TK!'Q&G'KCQB;
MN"N9NB+=<$)"7U(4A8Y%!!^!U8=(?733"W!H@@T00:((-$$:9R%AE9R#A61X
M?;1PR8MY5RHHT.KVM!-\:OKIK7#5",)"G-&5JI_%G\4Z:BUU(U74C](ZD%"T
MD=_`]QQB=;*]ZUU]+7TZR'&U@X<1Q'>)COCFGY(X*HH.6WM/F>-_$R:JL#P+
M0@)$R(\QHKU%YVJ`H@R@R&-1PS=B^0:M5%V5-8JJMNUG=<H?.*?+41(@$9YB
M8.!S$H])(MNW]Q,,W3TR5^:D'4"4G+)6DC$9&>(E&A8=Q/!PK*)=[5VL@L&1
M6G@CK9(6.*%QY,8ZN6:UZ>43&QT1$4:.W7=7+K[7WMZXT:*9]I/F!85J'&0(
MR[^?='RU;8I[1<7:VF?46E-E.@XRF0?JXC#*4^L=2/&9YDKC?C^38]WY"1A&
M*'G]R,1WS"T,`DKN0:(-'>=SM^U$;_+IK9[>5JH*%3G\PLHGVZ1/YQYPNR6T
M76Y)9_E"H<">S69?*-WU,BO@T00N/L]PI(YOX\2DJB1`Y)2V#;>C=.>HHDIR
MQS1)U7),@BJ(4^,;H[;9"C9W*C=]4&X[0J\4(:94!4MJU()RGD0>T?,"&O9^
MX$;>NA?J$%5$Z@H<`Q,B00H#C(C+D3QA8."_UM<28/7-L>0*L%UDLD[I!H-7
M.EBJ(37=JMCLGJT-M)<UR;JK"`$GT1B_58-'MGS6D*O52MYZ7T@E*!\)%1ZF
M+2X;U\AYQ&VJ)NFIR?K*0IT]ZM02/W1ESA_\*P+$..J9F/X70PJ"J813.CQ&
MD>20=S6L=(F2Y!#3)LES6(BD*1[]D1-]DTQT=%2T#(8HV`VT.`^TDXD]283K
MA<JZZU"JJX5*G7SA,\!R`$@!T``C;M2H@P:((-$$&B"#1!!H@@T01__4[^-$
M$&B"#1!"2<^?K_\`7;GV9(OK3'385F4DA#R<KP9T:GE64@B[N/>5KHQJFW,]
M5<KC/"V2]R[N*NR;+EVVK9KN2NHI@E[]I.!)Z\_TG#E8-^;CV\`W25I73``:
M')J2`."9Y<N0&0BIKE;]17..,3"FXJR+'>3Z=4(\0)QXN&9&S[U00'Q[2:2C
MD/1FW<1)H6KU5&I]-9U<?;:N;456ZI2ZCDKPGYF7SC8+/[T6QY"47FA6R[AX
MD>-/4R`U=<C"?7/I'[944Y\&;P-R`=P_D*^7553;NM1D9Z,<3\C4FF0^Q_56
M??NYJ=WTV55I[9NXF3(VY:L9>''OPPEUAVIO<?9U2G4+PVC"?C\)[)'&?27S
MC4&>K_L2\_QDX5Y+0F_;N[$+IHM^G_K.AH+;K]>[;70-J;@*M/Y:Y/N^W*))
MW[M()U_G;4N^?PE.-PJ?2/VPN3O!&X(Y!!V.CIY[.G=512#D(Y?.&58DC`,,
M*(G?VN5R;ILBZD,[,W$]_P#CU)QEXL._LB)4^Y.SZ?\`_+(7X9^#Q<L.WH>L
M,E@_ZGO9_(YL-,K9B&`U1B-^5*L<@BW=C'`O=W$964#IHR$5.U6L=(&NRKW=
MJIVK>T?MO=G5)-6\VTCCCJ/RA7N/O-8&$*%OIG7G983&D3[\><6-\._J:X(P
M9(D_DJWNN6KD+V%-'E";C6*D5I"D0+J:%)FV!Q-:YC7*^<B%\:JK$:]1H\VO
M8EFM^E;R"^\.*LNX8_;&77SW4W)=BMNF<%+3&>"#,RZJPG\(L]H:"CQ>G@8_
MC=16T-%5`2+6T]1"CUU;!CHYS_%%AQ1B`!BO>KE1K4W<Y57JJKIS;;0TA+;2
M`EL9`"0'=&;.NNON+>><4MU1F23,GM)C+:YQUP:((-$$&B"#1!!H@@T00:((
M07V!_7MQ+S7='RVCFR>,LOL#ND75C1UXK&GO#/V\DJ=CY9D&."P*O5YXQ`*5
MRJ\K2/57*J7C:-NNKBJA!+-2<U)$PKM3@)]1+K.&6U[HK[:@,+`=IP,`HR([
M%8X=#/I&B\)?K,XVXYOZG*L_R:5R=:4\ETN+3FJ`TN)NE"*]\&3,K%F64VP=
M$V&Y!%DK'>1J]XWM7M2+;-DV^A>145#I?6DS`(`3/@98SEU,ND2;CN^NK&5L
M,-!E"AB0252X@'"4^@GUB:/>#V!LN!>(^[%AE?GN?3B8GB)A->]:HI0>6TO&
ML$09R2H$)W9%1FZI,,%RHYC7-6SW+=U6BWZV4SJW5:$="<SW#+K**[;UK3=*
M[2Z94S8U+Z@9#O.?2<5/8_\`KM]I>2(C<TR!V/4\_).RY/\`YQDTXN3S'V2#
ME.FVXHE?<'!,,TRN(R05LEKT5I&-=K/V]FWZN'J:EQ"7%8^-1*C/'&0,OC.'
MAS=EEHSZ>G0I2$X>!("1+#"9$_A*-MX;L^>?1#FS$\3Y1BSP\7YI9Q:2P:.S
M+.P8HKN2`3\CHK!6K!AW%#)<AI0E8$Y`,(U[4:\94E6Q5WVI<J>EKTDV]U03
M@9HQ,M23P(.8PF)]#$>X)M>Y;?45%$1ZYI)5E)>`GI(X@C`'&1[Q%^EA7PK:
M!.J[**&=764.37SX4EB%CRX4P+X\J*<;OM(&0`CF.:O16JJ:U=24J2I*A-)$
MCV1F:5%*@I)DH&8BK?.OU3\8WEPMA@W(.1X+6F(\AZ2;4QLMC"1S5V'6RS6=
M+-BB:_KL9TI=NFZ?72+6;"M[[A<I:I;()Q$@L=V((^)ASI-ZUK+814TR'2!G
M,I/?@0?@(FWUW]".*>`[V)FA;"TSW.J]#I67ET`%?6T[Y`O`^344,4DA@9W@
M<]B&.>2]B/7L[%ZZL[-M2WVAU-2%*=J@,%*P`[$C(]23%===S5UT;53E*6Z8
MYI3B3VDYCH`(>?31"Y!H@@T00:((-$$&B"/':WN5VR=RHC5=LG<K6JY6HJ_5
M4:KEV_ENNB"/.B"#1!!H@@T00:((-$$:Y:8=B5Y-9976+X[<6`P,C#G6E+6V
M$MD<9'E&!DB7&,5HAD(YR-1=D5RK_'70Y2TKR@MZF;6L"4RD$_,1*9KJVF06
MJ>L=;;)F0E:D@GL!$1#GWK)Q)R+D-!D=W0)$DTBHP\6D<.HA7L5A5.*'="AA
M&\PA&<Y>\3A&5KE:KU;LB55=MZUW!^G?>8DILY)\(4.2I9B?*1ZQ>6S=U\M-
M-5TM-530Z,U^(H.4T3.!ESF.,IQ/PQL$-@AM:P8V-&-C4V:QC&HUC6HG1&M:
MFR:O````,H6B2223B8_>B/D&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((__
MU>_C1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"
M#1!!H@@T01%N9\1XIGN=<;YSDT=MG(XO7)9>/5,H+#UOYO(/P"1[TP2*K'V%
M$VC58BJUR#(=2)L]C%2'44-/55%)4/(U*9*BD'($RQ[1+#E.);%8_3,5+#*M
M*70`HC.0GAV&>,2EJ9$2(JYIXGH^:N.[O`;Q_P`5L_XLZHMF!8>11W]6=DRH
MN(PWJWN?%E#1",1S%*!Y!]R(]5U"N%"U<:1VE>^E61Y$8@CL,2Z&L=H*ENI:
MS&8Y@X$'M$2KJ;$2#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@
M@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"/_];OXT00
M:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@CU#.$KB
M-$817!>HRM&1CW"(GU81&JJL>G\EV77%*T+*@A8)29&1G(\CR,<U-K0$E:"`
MH3$Q*8YCF(]NN4<(P%GE>,4MM24-QD5'57>3$DAQVHL;6#"L[TT-@R2Q5$&0
M<<FQ)&89BO0+7JWN3?ZIJ#47.W4E51T557LMUE02&D*6E*W"F14$))!41,3T
M@RF(L:6T76NHZ^X45M?>H*4)+SB&U*0T%3"2XH`I0%2,M1$Y'E&?U.BN@T00
M:((Q-C?4=.>MBV]U4U4JZEM@4\:QL8<$]M.<K4;"K0R3").EN5[=AB1[UW3I
MUU%J*ZBI%T[555M-./*TMA:TI*U?LH!(*E8C`3,3*:WU]:W5.T="\\TPC6XI
M"%*#:/VEE((0G`^)4AAG&6U*B'!H@@T00:((-$$&B"#1!!H@C$AOJ.1<2L>!
M<U)K^!&%-G48;&&2XAPS>-`RY58PSIL>,52M[2/8C'=R;+U345%=1+JW:!%6
MT:Y"0I386DN)2924I$]0!F)$B1F(F+M]>W1,W)RA>3;G%E*72A0;4H3FE*R-
M)4)&8!)$CRC+:E1#@T00:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T01ZQ
ME$5'*(@RHQ[AN4;VO1I&+VO&Y6JJ(]CNBI]477%*T+!*%`@&6!GB,QVB.2D+
M00%I()$\1+`Y'L,>S7*.,:S_`)IA_P"6NZ'_`"G'OS>-US+?(:C\S7_DJ*J>
M)#LLK>%\CY%=`<%R/\IFL9VJB[[*FJ[\WM7JJRB_,F/64[>MU'F)UMHE/6M,
MYI3+'4H`2QG%I^1WKT=#</RFI]#5.^6RYY:]#K@,BAM4M*USPTI),\)1]]#D
M%%E-3$OL:N:O(*2P:]\&WII\6SK9C!E>`CHTV&4T<R#,-S'=KEV<U47JBZ[Z
M*NHKE2M5MOJVWZ-?TK;4%H5(R,E))!D009',2CHN%NN%IK'K?=*)VFKFR`MM
MU"D+3,`C4E0"A,$$3&((,9?4J(4&B"#1!'__U^_C1!!H@@T00:((-$$&B"#1
M!!H@@T00:((-$$&B"#1!!H@@T00:((-$$5I^YF1YGR'SGZ_>H^*Y=<8-2\I"
MN\HY"NZ"3\"XFXU2`LIPZF#8(K7A1\7&K!SQHO:8K@(Y'-16.\^^[-?=[[O'
M9'MA;;F[1T=R#CU2XV=*U--A2M"5</"TX2,E**`9@2/J'V1MECVWL'W%]X[O
M9V:^NM):8HVG4ZVTONE"2XI&1\3[("LTI#A$B01$G'N*_KYX^]@<1P[B_.^1
M\1YHQG/@8T:!$D<BF@Y5?5]B^),Q[)SVE.>AE5]@<;PO<$D:.[N[D7;;2M8K
M;['V3?%KM>W;S<*;==/7!K2#4E+SB5Z5-.E:"V4J(*3I*4XSRARW)=O[C=Q^
MW5YO6Z]OVRLV156XOA:A1A=.TM&I+S`;<#J5H!"@%!:Q*4IQ/G/OLW['\12,
MXR6'Q#Q?'XWPR3(6$N7\G18>=YQ203B!)R#':"`_>+%.YSG""5A9'C9W=CE5
M&:=MZ^XF_MKN7BO:VM;DV"D4=/GU834U#:2`76FDG!)Q(2052$Y$X1GGMY[6
M>V6\F[#:WMY796YZY"=7IZ%2J2E=6"4LO/+'B4,`I22E$S*8&,1/S7G5?R=[
M"_K1Y$J8QX==FK\KR6)#E*UTB(&WK<*F)%,]B-8\D=2JQ7(B(Y6[HB;Z6]V7
MEC<6^O[?[[3-J0Q5^<Z$G-(6EA6D\R)RGQSANV-8*G:OMQ_=%MNK=2NIH13L
M*4G)1;74IU`'$`RG+A.4;?GOO)R`_+>8X7#V"<<7&(<"S+&LS&RY!S\>,W^6
MVU"E@3((&!5`]EE+`_%F&-S_`#>=_8K6[D8-;.]>\=\5=-UM;5LU`[:K*I2'
MUU-2&G'EMZ_,33('U:="@/JU8$":@DT^WO83;B;/LI_>FX+FQ>MPH0NF11TA
M?:IVW=`975N'Z=?F)40-.D:@3))4-HROWG/:8CZ_?]D>/79KR=[&@GR<5Q2]
MM65M9C,:AEE@9+*R.>!K2R`5MA#E#8X?A&0,0QW/8@VC)8W/WD74VO9'](6+
MU>XK\%%EEQ>E#0;44.EU0Q(2M*P"-(*4+62)!*JFT>P;=)>?<7^N]R"AVKME
M2$OU#396M]3J0MA+*#@"M"FR0K40IQ#822HJ3`7N7S?[?8_P#6V5U@\3AFWA
M<FICV391A7(!3$G"!!J;/%9F,.B/%,)CV2K8S02AE>0@#UGW]O>C$2/=C>'N
MC1;)IWZVSIM-4BX^4Z]3U))4`A"V5-2(46G=3B5@DE*F?%*<AHGLEL/V9N/N
M)54M#?EWNC<M7G,,55(`$$K<14)?U32'F-#2FRD`+0_X9Z=1W;GS+KL^7^C)
MO8/A'$4Y(O>>BT]8"JSG(),'"&GRS!(D*ZKS4DV-"NY$A30Y;XTQ#A0D-K%3
MM(1JW&];I6N7;V<5OC:%*+\]>BA`14.%-."]3)2M);4$N$S0LI7J3-L#)2A%
M%[>V:@;LOOXCVYWW6';-/MX.++E*RE=5*GJU*:6'4E303)QL+;TJDX3FE)C8
M\@]Q?8*TY,YYXPX?X$IL[G\,7".EWTO(25=5'QP,"7(5MD*1(BOG9-=2HKVP
M(L8K%>P)5[7]BJV?7>ZV^:G<&]-O;5V4U6O6EXZG"X4(#24J/C!*=3KA2?+0
MA0F$JP5(RK+=[*^W-)M?V^W5O3W"?M]/?&/"TED+<4\5I'@("@EAI*@77%I,
MBI`FF8FVGK)SC%]BN&<4Y4#4?@)5S^2@V]*DATP5=<4UC)K)PXTMP@N/$D.C
MH<*JU'((K6N^Y%UI_MYO%O?FT[;N1-+Y#KNM+C<]02XVHI4`9":3(*3A,!0!
MQ!C'O=/83OMKO>[[276>H98T+;=TZ2MMU"5I*DS,E"92K&6I)(P(BI?D6A]?
M<L][?:.+[)YD3%L9J,9Q*9BLYV6V&.20WC,1PI%;3MB&5;&<&&0I!QO$9'.3
M?QN7IKS%?J#8]T]YO<5O?]U--;VJ=E3*O.4TH.!FGP1+ZE!)40B2IG@8]@[:
MN/N-9_8#VH=]L+**NZ/550FH1Z=#R2T:BJ_F:AX$E02"O4F0^\(V3@'VLY8X
M*],J3DK+ZRYY"JIGL.#`,1)E9YWYN9QO-Q\EE,DTLIY%-8EBV]3,!#4Q"":9
M2"[NP36ML-D>Y6YMF>T]'?[I3NUU,N^BF9\XJ\PTJFBM1;5.:M*T+2WJ)2%%
M29R2`*SW$]H]H;_][J[;%FJF+;5HVV:NH%.$^4FM2\$)2ZF4D!3;C:W-("BD
M)7+4LDM9D?N%S'QIQ?47/*W`\:@YBY+Y)!@_#/%4#*H<E]]`M*REDU]O?6@C
M3U@$KK.V2%)"X<8[Y*C8H@->XC-*K_=7=FW]NTM7N79:6-U7"O%/04:7@?,2
MM#92MQ0*M)2M?EJ20A164C2@$J&1VSV7V3NC==90[1]P%5&RK7:S57*O6PH!
MI;:W4K;:00C6%H;\U"@5H"`I6MPI"5?7B_M3SK5\L/X#YBX>Q/'.4,NP+(<M
MXAE8SEI)^(Y3;4U-=60,>N9<GS&JTDGI#")(\B.$H^HE809%[;=[E;SIMS*V
M3NK:M*QN.JHG7J(M/:F'EH;<6&G%&91J+:DE4P4D?3)251TW7VDV!5[/3[A[
M*WI65.U*.X,T]Q2_3A%0PVXZT@O-I3(.:0ZE01*2@?KFE21#GI3SE["V-GSG
M;<JPH=GQ?B'(G)<_/,KMLRDVMIQS-QZG=9GQ+%J@I#/GXU7NC(C'#1&(Q[G-
M^FRJGM%O'?+[V\*O<C*7-N4M=5+J7UOE:Z533>LLLH))4TF6!&$B2(=??/87
MMO34NP:/:3ZVMUUMMHD4E.W3);;K$O.:!4/N``(?7JQ"IF8`.<X]G_\`T5S^
M/CE9S7/XMP07`EIE7X-D&/R+$D<SPZ1UG)I6Y1,Q<:.BL"DV*YWQ>QKG;M:A
M/$YLI>?_`.][ZB@I]W/;;HALIRI\O2*H&O2WK*/.4T,):@?!(3P&K20Y'#__
M`#5MURYU6Q:?=EP/N$U2>:5FC4+:IW0EWR$OGQ3TJ`US(&)TZP6HW6ASC#:K
MWI]H)U)QU3MS#&O7J#EQ^0&9#D1Y.40XN.\;V0:L](683'X$62$T(:GC!:96
M06+ON0O=:4=ZM5+[R>X[]'8FOS2GL0?-3YKI+R4M4BP@ME1;2%!38U)2%2;!
MS4J=)<+!>ZSV"]J&*_<KWY+5;D53BD\ED)84IZM07`Z$AY:DD.JTK44S=4)2
M2B4:!_8;SZO%&-<^F]<*IG#3+:)1YADW^4N%,GSB74FKFRL0K2$68*HB'&V&
MDF0*0)]@CAJYNSD;0I]]-[_TW0;U5L%H;4#J6WWO.D5**RA1823J"$D!&M25
MI+LTS&(#.O\`MN]O!N^Z>WB/<UX[V+*G:=CR)I0@-I<2FH6!I+B@2YH0I"@S
M)4C,38#F#V\S*FY>PWA?B+%<#F9!E''U;R,V[Y9RTN&T4Z#<R"`K,>H%"/OL
M+V0T:N3^XJ*Y',:Q5&]4=MT^Z=VI=T6G:>U[;1*K:BA15>96O%AM27"=#3<O
MJ<('/$S`'A)C.]F>S5DK=F7O?&\KO<$6ZDN2Z+RK?3BI=2IL`K>>F?`T)RRP
M$E$C4D0[N)3L@L\7QVQRRD#C643J6LE9%CT:R!<1Z2[/#"2SJX]K&1(]D"#,
M<\;#L^TK6HY/KK8;6]75%MH'[I1BGN2V4%UH+"PVX4@K0%C!02J8"A@1C&$7
MBGMU+=KE36>O556EM]:67E(+:G6@HA#A;5B@J3(E)Q23*-AU/BM@T00E/N9Z
MX<8\KX#F?).7Q+PN4\<<5YU,Q>16Y#9U<,!ZNEM+Z&Z77Q3,BS.RQ`UR][=W
M-^U55-MLA]V?;_;NYK+=MPW1IXW*@MM062AQ2$@H;6ZG4D8*\8XYC`X1NGLC
M[F[JVAN&R;8LSU.+3<[O2I?"V4+40XZVTK2M0U)F@D"1P.(QG"=>C_#W'F%>
MM,?V]%67%IRMB6'\O7@%F9+;LHIBX\#*(@(DBI&;XJ#/`A()SNU517*]$[D3
M64^SVU+%:=@)]TD4[KFY:6EKG!J=6&U>4'DA)0#*12F1^.<;5[\[TW)??=!S
MV975LM;1K*VW-'2PV74^<6%%0<(U3"U%0$QEIRB?LC]V\LI/2S$_:$6$X\?(
MLANXU2?&"3K)M+':7(;BF(8,EJ_.<[PU:/1KEV1SUW543J\7#W?N='[2VOW$
M3:&#7U#X;+14ORQ-QQ$P?JR1//,QG5L]B;17^^-X]J5WVI3;:9A3@?"$>:9,
MMN`%/T9N2F.`ZQE>3/;;EVBYU@<%\7<.5G(F09#Q+29U2/+?/I@UMK9SW-F2
M<CF2G#A`Q>LKHY-U:X9RR7B&CD[^DG</N?NFCWDULW;FU&Z^N?MC=0W-PMA*
MUJ\1=49)#*$@\0HJ*1/&(FUO9W9M?L"HW_NS>KMMMU->':5T!H.%;:$^%+*4
MS47UK(S!2E`6H@Z8A:M]_/8K)<#SO(,9]:*TUMPC*OF\V3[#*?!CE,*@*9)L
M''XR%':S;:)%BG/+:CY#8H@*[8B/;LHT_O;ORX6:\5MN]OFU5-H4YZ]2GI--
MALG4EM,PM2P`I2Q->A*9^($0\U7]N_MK:]P;?MUU]T74TE]0U^6(0Q-YTO`:
M5O*D6TMJ4I"6S)!<4N7A*3$[YQ[LE!@7K[,XNP%,QY3]D8<0^%X38W+:ZNH_
M[4=MS+OK5H$4L*IL#."BM0#2L$0JO&UBHKI>/=]2++L=W;ED]7N2_I!8IU+T
MI;R#A<7+%*%DIPT@A*E$I"<<^L/L4AS</N,SNS</HMI;86H5-4AO6MW$^6EI
MN>"G$`*QU%)4E(2HJP_''_MMR.//>2>&.<.,J/".4\-XVN>3\=)CF0$N,3RV
MDJX22/C@*5'S(YU?NY'(1_<P1D<T3Q;/X67W0OZ+SN':F\-O,T>Y*2WN5;1:
M<*V7D(3JT@F:@>,YF8"P0DIQY[B]G=LJV_M?>^P]U5%?M.MNC5"\'F0W44[K
MBM.H@22H9"4A(J005I7X?QZG>TW.'LG,H\AE\)5F+\1&JKB#<YZW(!/(?-:P
MSU;%H*>5,99R*)1O9'>7P&:V2PFYF]JC0]L_<C>._P!ZBK7=H-T^URVM+E3Y
M@Q?03@VA2M9;R23I5X@KQB6D??=_VFV'[8,5]M9WV[5[R2\VIJD\D@"F6!XG
MG$I*$NSFL)UI)04R09ZCH'O=EV7YAROZ\>J>,9-;8;4\NW?Y'/KJDEO@V4K&
M!35@.JH\D:=RC=%CS2N"J^,QV`0B*U%35)[SW2Z77<VQO;2W7!VEI;H[JJ7&
MR4J+6K1H!'#2'%%)P4H(U80Q?V_V:S67:'N1[NW6ULUM99F-%(TZD+0E\IU^
M84GCJ4TD*'B2DN%)!B7<+]4^#O4F5;\TX?=9UC-+B&%Y+-S:HDY-*MZ+):R#
M5$FFL;2ME-_N6L!(CB1_$K&>1W:UB;Z:+3[:;/\`;!RJW=:ZRMIZ2DI'55""
MZ5MNH2@J*EI(Q6F4TRD)F0$)M\]W=^^\35'L:]4-OJJZMKF$TKB6$MNL+4X$
MA#:TY-KU`+U3.D3*C*(!A?L-Y!BU>)<L9/QC@$+@[,LJ%C\>/4<C1;3EJ@K9
MDR7!@Y%=XWL..L5Q(;GN$T0U1'-:KV]S'O26O?2^M4ULW-<=NT2-G552&P$5
M076MH4I24NN-8"7A)EI'`3$P3H;_`/;=MQVKO.T+5NJXN;]HJ0O$N42F[>\M
M*4K4RT]B=4E`!14<B=)DH#X2/83V_P#?@@W(]A/5YCV/:N[7,=AE$YKFK_%'
M(NZ:CK4%>Z/O6I)FD[;)'_\``U$A*5)]F?[>DJ$E#=<CV^I=C6N'O96S]?/3
M#U9KL=H*&XRGE+(<IQ>EGYC>_P"-X30?'S&S=*LLEMFM<0,=/GC1J(HT[>]Z
MO^SM?!VM[@U.QO:;VY8H*%AVXW*H>9;4^YY5.U)]4UNKS`\0X@2F2<)&TWI[
M7TON/[W^[-3<KC4,VFTTS#[J*9KSJIZ=,C2AAO(GP&>>.E('BF+0.'<BY&RC
M"X]KRCCF+XWDSYLI@V87D@\IQBXJ.T)JV]I[)O\`>;%GB,K?$7^XUPU=_2YN
MO16U*^_W*T(J=QT%-3W`K('IW0\RXW@4.(7G)0)$E8S$\B(\I[UMNV;5?'*3
M:ESJZFUAM))J62P^VYB%M.(RU((GJ3@099@Q*>F6%*#1!'__T._C1!!H@@T0
M0:((-$$&B"#1!!H@@T00:((-$$&B"#1!!H@@T00:((-$$5G^[^-5UUR[Z\V/
M'7(M5AWM'1S[*3Q?CMO19)9UN;TY3C6?76ME24=M"HX\5X#]I)SP1B@-*:]S
M6HI!^>O>&WT]7NC8U18;\U2>XS*U&D:6VZM-0@D32M;;:TMA)"I%PI04J<!(
M'B'J3V'NE30[-]R*;<NVGJWVGJ&T)KGFW64+I7`#H6VAUUM3JE`HF&@I:5I:
M(!,DJA+D6?[!9?[.>F9O9''^,.)CX]R%>DPB-C]Q?Y)(SR629A+KX,9*6-D\
M.I<`D2O:!+$U>Q5E.57N1CNQ1OK^^;I[A>U"M_T-OMBV*]STX;6XZ:DZJ?S`
M/+#R42*6@GS5-#QF9(!TO6VJ?VYLWM7[W(]L;C=;PW4VUH52GFV64TB0FJ\H
MJ\TL*<F%/%?DI>/X8DD$C4HO,PJ:HY`]M,6S@G$^7Y;?9%8V%9RCRE8YM1YE
M@E6KY\B!08AB%SC#;2^G_#<./$-4L/#8UHWH4D=PMLMW6FEI;Y[F6Z[FVU5S
M>?4I-75JJ&WZ=$U%+;++C6MQ6F24*9"FP`DA2D%,;)LA=;6[=]G[M84WBBL]
M/3(0NAH$4KM-5N>`+=J*AM_RVD:IK<34%+A)4G0EP+FVL>MA_P"1_J:7_(*C
M>#BEDD9OAOM[A/P.%KW5W_1.T2;L1/\`FUBKNY.FVZIJ+;#7YA_;.?6M>"E5
M+!SQ_AL?3^'A_GT9]L8ZY5/_`);_`'@#\N>_$JT:L6OP_P`6I^O\7'_Y?F9'
MI-<[2=Q#@/-O/OX['_6GGJBR/DW(9\?_`+LW\KCO)./+L]K8ENJ/MS&I@?GJ
M>!8'>)2URRPF0#2,*USW,T@5#VV+)N[>GIJ&P7JAJ+@XH>L<53.TJRM96W^.
MA'F(2HE,VO,"M(4%`DB-,I*?>6X=B^WOJKCNC;UPIK4RA7Y>TFL9K&@V@-._
MZ9Q?E.+0`K2]Y:DZRDH(2##!9G'[\T](\S]?)O#8>;JC%<X?CG#N(+D#^-LJ
MQN0[*RY0'$LO!7+CL`<#LO12UGS8A"'(YXW*YB-(\75$[M[17;8SMJ&\&J:H
M+5"QYOI7FB7RZ&7PGRDZ?]2ESS'$$J)*3,2.=61S38_?:R>XS%[5L1ZKI0]<
MJGR16L/@4X8-13%?G+*YTJF_*:<`2`E0DJ:9`]RQ<M91Z;Y).]B9''O&>6/Y
M7QFRP^BQ]^19#4AK`0(\>%CEM:U-?>&??3)2V<CY#6?#1$$-Q&(N[;SW83N>
MX^U->_OQ=#;[D;FTMAIOS74!`1)+2UH2X?,4?-7J_EX)25)G@N>R*]GVGWKM
ME/[:MW*Z6<6=]%2Z\&67"LK)4\VVXMH!I*?(1H)\SZU!*I2/S>QQ^2<CS7]?
M%KS57X=QYGX_8J.25BU/8V]]",$69\=+`#!L:V#<0_G21`9WH60,#"'8GD[4
M(YG7OQ>X*^\^QM3NZGI:&]B^XLMJ6XD@/TFD)4A+B=1`$YK"05#Q2U$=OMFW
MMBV6+^XZCV-4UMRVZ=M$)?<0VTH$TU;K*D+6VK0DDRTH*B$GPS*0J4?6>%&#
M['?L2*.VKY;Y>2X"LB-'':M-5JE5R.J-G.E5D:.17*5R)\8DA-QNW5-V=S%[
M>M-IWU[\*34H455%/,`+FCPU?U30`<_N%61Z35/=)]U?MI_;6E5&XA**6KD2
M6Y.?B47T:5J(R'UA&8ZRV/\`65$!"]3L8#&LX-L-,JS9WRZ\=D..KG7IMQHV
MUKZR7WLVZ_VNWKT5=6/]O+:&O;2A2BH0XGU51BD*`^O+QI2?E+K%9_=.\X_[
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M1Y25B4L1(!,A@<@53^V-^X,>X^[EU='4O7`V&M#B24AT+\ZG*BYYRV\=0DJ9
M*]1Q&9'Z_8535MA;^L%E29=2T/-=#R_!L.&\=R.NR2339S<)<XC\FA/84-/9
M1::3^=93JPTXL2*X;R-4K-U>S[[YTE._5^W511W1IG=[-T"J%IU+I14+\QB;
M94VA:4'S`Q(N*0@@J&H9CY_;A6U5-1>ZU+769^HV+4692+D\RME+E*WY51I=
M"'7$*<3Y1J9I:2XL$)(0<$JTC'?^X.6>\'"N6^SC<,XHS.IP;*X/$/%6-2KO
M+Y>5RS5F3#N[FQR:NKIN+58(E?)EE:.1/"9SXX&,$YSE<^FH/SRY^\.TKG[B
M"DMEV:HWDT5&T7'U/$I>"UJ=0E3*`$E:@%.I42E"0DDDF^N7].6?V&WS9_:L
MUUWL;U?3JN->^EJG33I"V"TVAA:T/N%2TMI)0TI("W%*6``!IOKW'OX<[W9Q
M3YN)VWK-<YKSQ,Y(Y3C.R&/E.'R)>,VS+*IB8K,JXEC;3*RM(%YW1XTB,JC(
M@#&5S$U4[&17-.>[EL#M,[[>.U5Q555@\T/,$LK"D)94E*UJ2@I*M*%(P4$+
M62(N_<=RW/,>Q=W\BL9]TF*&U)HJ!7DEBI"7VRAQ50E:D-I6L*"`M:%R*?,0
M@`F$]XFON,<6Q2JPZ5Q_Z5\GLBS;%D'E_.\QD8Q9V-86YFE&7)<.OZVLS-LN
M.(GC"CXL?_EV#Z/38C\LVU7;?MUMIK4Y8]I7$)6O375#Y:4I)<4076'$H?F!
M@F;:?`$Y_4=HWA;]TW:[UEZ:W'OFU%:$:[=24P?0A8;2"&*EE;E-I41-4G%^
M,J^D^$/5%KZM?>OW(E0[VD04KU38`=<`-SY:Z"[#^+V!F%>*F6K?`&`+'HD4
MYR>,K.UBJCVLV)#%,?>3W9<9K&="MLR"0%^%/IZ(!1DC1I``/@4HR4)`F8&!
M.U-7_P#H'V3:?M[^M&[IE9+4EK]37DI`+GF!9)(\:$)FE4U`:2J*Y-;#7]/U
M)!7(*A(J39SDN5#??C7*OL#>F4;1)2+<=[2.42[Q$;Y&JJ+V;/5>>8:/]K5"
MSZUKR_,5XY.:?_N3AE+R]>>'T2GQEC#8U5/C^\^OJ/RY[S?+3^%-K7_]H:$Y
M^;Y<I>+^9.1RU>&,O[R7M=`X^Q''LYP'@S(:.YXHQ>#Q_P`@W>8V5)R=AMK(
MIQQY5Y%QVMJYN4W^/P)_:<08P?"]W<T['?>S4GWAK6&+'::&\62SOT;ML933
M5+CZFZMA9;`4X&DI+SC25>)*4ITDS"P<1$/V%M]34;CO-RL&X;_35[%X?75T
M;5,AVAJ6PX2EI3RW$L-/+1-"E+5J`D6U#PJBS'UAK)M/Z]\/UMAD<O+9<;!*
M)'Y#-@W=::Q&2*AH[FP\D@5=\.+&CD8$"RXX3D`-CW,17;:]"^W5.[2[%VK3
MOUZJIQ-&W^*I+B"H$3$DNI0X$I!"4E:4J*0"0)QY;]U:IBM]Q]Z55-;$4;*K
M@[^"E;2P@A4E>)E;C14I0*EAM:D!94`2!$[:=(S^#1!$3\]#8;@SF@))`8@R
M\3\BC)*D-.X$9C\/N&ND';%!)E."%J]SD&,A%:B]K7+LBK.]4A>S=VI4L)2;
M95`DSD/P',3($R&9D">0)PAP]O5*1O[8ZTMJ6H7BC(2)3414MX#44IF<AJ4!
M/,@8PEGJ'5T3_P!=<NJM\FAQ\=EX/S1&N<G@0;J7&JJJ7)RUEI8MKSUD.XF/
MJ8A"/<(<=7E</M&C]V[Y%[6TU&?8A^FJK@A-"JDKPX\E+B@A"B\%JTE"5JT)
M))`22923/"-Q]YJNX)_N49JZ.UK5<D5]L4TPM;25..)33EM&L+4VGS%``**Y
M)!FJ4C*N+)H7-<GT/I\:N;7BRM]>\>RKY6)<C!_RZ3>Y],)E=L*#5QJ0=*2W
MHX4>PDS"N/.KXA'-CL9M]V[\$N+6[G/9JCM]746YO8[%5-BJ'G%RI475A*$M
MA!6VD*+BBIQILD)`XX^F;4_L9K^X"NNE#279WW'J:33449].EJD2&&RIQ3I=
M#;JBA+20EIYP`K)X238[C$*,W]BU)*;;UY#IZB5(4K6"M4FN&E]$1):$)6,K
MOCNVW1%D(7KU8FM\MK38]^*9P52"O^F$#3)>J6M..*`F7^:?2/,UU?=/]M-<
MR:-P-_UDX=9+>F?E*\,@LKG_`)-/[T19P]7Q!\+?M!&R]JCLFYE[&_)D"#=H
M&I\N)Y4C_P`@TU.$Y/CH]5?\1DG=&+V=R]J.6=IL-)VE_<2D5C:@JIN<R`Y)
M$V7_`*IH!,IXZ`K(RGA-MWI4O*WS_:FHT#R5(HK-I!+4W)5%/+1)P@3EAYA1
MF)RQE#HZ98N,_KOO^+\LQ2TY[QO%K4F(8%>P\MBTO(>.EF6IIP8M^F/BK:25
M&<*4'_J)H"/0RO:_^VWO544OE6[V,KMN7.F<WM3TZRS3.)>"*EHK<)`<\L(;
M((6G\53<]4P?")NJZWSKI_<E;MUV>L9]O:JK;%15M*IU.T;P2V$E3/G%;J53
M;5^"EV6D)(\1E+E1%RC(/9ODW,/8JPP_`.89/K%EE3@/$6.KDF1,KL/?!N5F
MY3:9="J)6-%0#@SV_'%+-*(IGJ@6H-B/9J=NXUWN#N2Z[\?I:'=2MNOHIJ)K
MS7=+.AS4\MY*%-&0#GA"U+.HR2-(!3:QVU6[VLVK9?;6FK;CLM&ZJ=RKN#WD
MLE=0%M:6&Z=3B7Q.;1UJ;2V-*05DJ40R7ZUHH(?J-@0(]E"MA)=9RY)E>.Q'
M&>K\ON'.&UMI`K9B/$J]KMQ(W=/M54ZZT3V`;0U[865"'T.)\ZH\2=0'\]>'
MC2E6'9V3C,/[GW7'_>/<+CM*ME?D4OA64%7_`-.WC^&M:<<QXI\P#$9>^^/4
M]OR9ZY6.#Y]4XI[,4>3CE\68];TV4V$#-8;K6`KJR=8T%):U],(-P)B=]B^-
M$)'+)0A&,1SVKGO70TE5N'8=19[VU3>X3-0#2-+;>4FH3K3X5+;;6E`#@&+I
M0@I4YJ4`"0U?V]7*MH]K>Y=-?MO/5GM:_2E->\VZPA=*KRU^-*'G6UN$MDX,
MA;@6EHI2I1"3LM]/]H,UX^Y.B^TM#Q9PQPJWBK/(&8V>,SK7,<G,>91EBPKV
M#%J)%\H(-.8CI3@,1\@WC0:,=OMJ?7/^XUXL6X6_<BBMMIVB+;4)?6TI;[Q*
MFY(<2ELNR2@G7I$U*EID9Q5V^G]J;%N/:SOM-<+M?-\F[TBZ9#Z&Z9@!+H4M
MI2G`U-;@`;"S)"9ZIB45L<,Y%QC0T6)8?8<<>E6<NB3Q"9R]E^:.I;6TJWVY
M'-DV^'7%=6Y>.Z%'?L-#QHV[6,[F+_4N`;4K]OT5';+4_8-I5FE8'K7WRVM:
M-9Q6PM*'PL#+4A.`$QQ/I_>]MW3<*^\7JFW-OF@"VR3;J>F\UMM8;'A;J6UK
MIRT2,="UXE4CP#RK`@+[:^]1Q7=2U)7K*`+H;!7'EKHSL.I6MER7#J%A/B,&
MQ';1BG)VN39BKNB;"66#[F^\JT5;0"MNRTR7X1Y#?B,D:=($CX2HR(D#C+!!
M45`]GO8%M="]-&Z2=1+<EJ]2[X4S<U!1,QXTH3,&:@)$QCCUS&Q'T"X/-=83
MPGRYQSOF0\F@<CY7(PI_Y!^3W+J.1A5C<UD>4ZV#W2FF8(#9;FM_LKLJN5>H
MJM%K]D]GKJ[/:+I89O\`FIJGBP=7G+\LTZEI2K6/'J"4ZY#P<X:KE0NWG^XC
M?B*&^WVS;F_TQ8714XJAH##?FBI0VLI\L_AE)4LM@GQXR$,M^LBH=6^O-C(!
ME/\`D--;\@Y%8T-;%A9>"EQ*N)%JQ_X]2SLSI:6=;QPR1D(61&86'YR/:U[C
M-.JZ'_;Q2FGV-4N(N7GTCM<ZIM`2^&V$Z4#RVU/MMJ6`9E2D`MZB0"5A<9=_
M=/6"J]R*9IRT^FK6;:RAU:E4Y=J%A3A\YU-,ZZALE)"4H64N:`"4A!;$6*:W
(B/-4&B"/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g309840g34w03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g34w03.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0M44&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````10```2$````&`&<`,P`T
M`'<`,``S`````0`````````````````````````!``````````````$A````
M10`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"+@````!````<````!L`
M``%0```C<```")P`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``;`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#I^D/K^M_4.H9N:XW='P,@X>#@<4V.K#'W9V8S_M9ZN]OV:J[]!33_
M`('UOTBM]=Z`ZC`?;]76NPLG?5ZM&(14RZH6,^T5FH;:F6^CO<S(J]+)_P`%
MZWI+/_Q?U?L?(ZM]6\H[,RC).52TZ>KC/;533E5?OL_1;;=G\S;^B1/\8'5N
MJ=&HPLCI_43C69>57C&AS*7MV.#_`%+J_5J];>QWI_X7TTE/4Y.9BXH8<FYE
M/J.V5[W`%SH+]E8/TW[&.?M:H,NP>IXUC:;69%#MU5IJ?P8BRLOJ=OJM;N_X
MQBQ\_(QZ>L8&!0T=0^L+<>YV/?DD-;32\M;=DW_9V5L_2655TUMQL?U;/YO?
M13ZURJ_55SQ]9_K,VZYEUGK8C7/8`QKGC'_2-KKWV[=FW;L]2RS]'^D24V/J
M(]M?U4H?8\[66YFZRQQ)AN5D^ZRRP_NM^F];6-U/IV59Z6-DU76;/4#&/:YQ
MK)VBYK0?=3N_PO\`-KS_`"GV5_XM<>3MQG=1>W.<8@4'J%XLW[O;LW^FQ^Y=
MCE](PSU#`S\[/M^T8MCFX>]U58<ZT;;,?]%32Z[UFU_S/_!I*;N1U7IF+8ZO
M(RJ:GUM#[&O>T%C3Q9;)_1U^WZ;U6ZC]8NFX&9@X5EU9NSW':"\-#*VL?<[)
ML<?;Z7Z/TJ_]+;8LKZC-JS>AYOVUHMS+\S+JZJUXDFSU'U^A<'?N8GH5^G_H
ME#JC,6OZQ_5"K!VC%I?F54M89:&UXSJFL;_4V;4E.T.KTV]6IPL?)P[*WU.>
M^L7@Y.Z&OK-6,W=OI])V][]R(WK?1G"PLS\=_HN%=NVUCMKSN(J?M=[;?T;_
M`-']-8_4V?\`9[T1X;J<3,!=&L#T=-W\G<FZ-34[Z\?6.YU;396S!%;R!N;N
MJM#]COS=^UN])3T.)F8F;0W(P[J\FAT[;:G![#&CH>PN:N3;EN^JV+CLS[\G
MJG6+F^I8VS(L]*MI]NWWNLKV-^BS]%9;<_U/YMG\W:^HO'UA\NN9L#_MI9GU
MCQW=<KQNO]):[,P,K'#2:AN>W:YYUJ^G^>ZNS9_-65I4+OLO&248R@#0G7%W
M]/\`Z,ES?K&SJ&%<;*L[`SV`?9SBNN+'_P!;:*:MO^E]6O\`F_YA_J+$_:'7
M/^Y.=_GWKK.D=;Z_=ZF7U2BK#Z7C5OLOO?6^MQ#1N]C;+'.V,^G8_P!)"^MW
MUHZET7.Q\?#90YEU1L<;FO<9#MFGIV5(&0`LIPX9YIB$*XC9U\'_T/2NH=)Z
M=U(5_;:&VNI=NILU;8QW[U-U99;5_P!;>H8_1>EX][LEE`?DN`:<BYSKK=H_
M,%V2ZVUK/Y&]7DDE-#J70ND]5?39GXS+[,<DTV&6O;NT>UME98_8_P#/K^@A
MN^K?0G9-F4,.ME]U7H6/KEDLCTXBHL;O;5^B;;_.^E^B_FUII)*<+(Z;TSH/
M3[1T_!I;C9+Z:,C',['"ZVO$_FCOKV[,FUUGL_3)L/$Z5TKJ->-Z!;Z-=5>*
M\OMM;7ZSKZA337>^UN(QS,:O^9_J?S:O];V_L\[O0CU:?Z5N]+^=J_T?N];_
M`+B_]V_00L[;^T&S]DG=B_SV[U?IY'A[=_\`W`_X7[4AJN!C6H:EV/\`5W+R
MSE''N;D9M;O6LJ%]'JU5"KWY/HFAN54VO(J8QUOJ_P"A_,L8IYX^KN=B4UYE
M/ZOC//HO:'5^B^I[,3]'=CECZ-C[&,_1/V>E_P`"HV;/LHC[!_0LC^=W;/H8
MT_2_[S/^Y'_=;[%Z:'7M]>N/LFWU;(VSZ4_:</\`G)]_V_\`K>S[=Z26J?1X
ML7X7U0:6=4=B!IQ6>I1D!E@VLQV>KNQH_P`%Z3/\#_.J56%]7,3J+\JK'%%]
MGKMOM/J;["TUU/\`T@>6N;^L>G7ZO_H.BYWI_LLS]BCT[Y];?Z$^G;QM_P"T
MG_<O_!^CZRE?L^T6?T&?UF=^[=]&CG_W=_\`0=+57H[%+TCI70NG9-K>G8PQ
M<BQC77-$AS@28?8USCZC]W^&_P#!%XST7KG6.D5STS,LQ19J]@VOK)_?]&]M
MM7J?\)LWKW''V_:/;Z?T7\;M\2R/I_\`LU_PGHKS-GI;1_XBOEZD(K371YWK
M7UCZ[U?&-74\ZS(I;KZ,,K82-0Y]>.RIMNW\WU5W'^,?_E;#_P#"[O\`JPLE
M_I;3_P"(KY^I"Z_ZV;?ME$_L?^;/_*F[U/I?X';_`(+_`+^F9/EWIM_#Y2CS
M$3&)F:EZ08Q_1_K/_]DX0DE-!"$``````%4````!`0````\`00!D`&\`8@!E
M`"``4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`
M;P!S`&@`;P!P`"``-@`N`#`````!`#A"24T$!@``````!P`(``$``0$`_^X`
M#D%D;V)E`&1``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!
M`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#_\``$0@`10$A`P$1``(1`0,1`?_=``0`)?_$`,````,`
M`@,!``,````````````)"@<(!`4+!@$"`P$!``,``P$!`0````````````$"
M`P0%!@<("1````8"`0,"`@4&"`L)`0```@,$!08'`0@`$1()$Q05"B$B%K<9
M,2-V5W@YDR36%W>GUS@RTS2UEK8W6(C(24%"0R;F&&B8&CH1``$#`@0$!`,#
M"0@#``````$`$0(#!"$Q$@5!41,&82(R!W&!%$(C")'14L)SM#5U-Z$SDU05
M%E<9<I*B_]H`#`,!``(1`Q$`/P"V';G;.F])Z*EVP%XO@VJ(1@!21`UH,)3Y
M--)0O`=ECA4-;%2I&!VDSV-.9DLK)A91"<HY2H,*2D'G%E(!)8*7^BK7\H/G
MFL:7/<9MN2:,Z$1![-CKN?4ZU>VR:2'?Q=:?"T4O0F,\CL";J6=21EU-&J0Q
MML3'`%E",T["=7&)5SIAP<IPD*\!WC#C+:(J54<_W+)U7HB>;"MZU[,D4R?C
MDX!%E*'$;-)XW&TYV"Q=HLHFU)@80AP+`NP':95U'FN-,O$H*FD1\P\9^P]O
M:;V(T$FK&FM5L_E]KZP39:0+W1+/.*MLISF.&M*O.+PF`N;AYPUIS3,D(S/H
M!PW)-7Z0=+<G'F?OJ5V]I3I=/H#)]8]T6OR&ZZUQM9'F3`S8)+ZA72EI:77,
M-=%8UQQD1M@N4HU(4XS3^UO``Q.J5D*"U&#JVD,3P95?\E9HX1'"(X18^M:#
M+[+KF80)KGTWJUQE3(J:4=AUNO;6R<Q)0?VY+>(TO=VMZ;DSB0('3`C4IN.P
M0L8[19P()%Y__D;C&TFM7DPK'6NS=Q-A]C:Y53F@)Y#CK5L>4N9:B/2&6-2<
M*1UBHGM1%"7!J?F580(U*E(`JP4%1DLL9H@!J<UJ&,79>B#RRR1PB.$1PB.$
M1PB.$1PB.$1PB_D>>0E(.5*CBDR9,48>H4'F`)((()!DPXXXXS(2RBBBPY$(
M0LXP'&.N?HX)`!)."F,92D(Q!,B6`&9*_1(K2KTY*Q"I3K$B@&#"%20XM0G/
M+SG.,#)/)$,HP&<X_*'.<<@$$."X4RA*$C"<2)C,'`CY+D<E51PB.$1PB.$4
MT/F6\@>W6J6ST$KN@K;^P4.>:&C$T<F?[!5E*?<R5QL*T6-8Y?$)I"Y&Z$^L
MUQU&5Z)9X$X?1[@@P,8Q"\#W5O>Y[;N%&A97.BD:(D1I@<3*8=Y1)R`\%_1C
M\(GL1[4^Z'MMO>_]]=J_7;M1WRM;PJ?4WE%J,+6SJ1AIM[BE`M.K4EJ,3(ZF
M,B!$#)^CK7YE=EF9ILNY=J55#U0ZE$KF1.KH>@U]E3%M-[A%K6N/+*R2IXRT
M*@!ZDK7+J::`0324AQ(PFYY&T1[JOX1N+K<31MCE]W3UR'@-&`\3\@0O->]%
MS^$3VZN[KMWM#VQCOG=%(F-0QW+<XVEO,9QG5C>2-:I'[5.CY8D&,ZL)@Q3Y
MX?'W:,L:=I>IQ*+#7DC$(R3S!)"D3XKP((`X`H3P"(0:-!`#(,YQZ3>4+J+/
M7.<=,8]E2A*G`1G6E.7.6E__`)C$?V+\/[M?VNY7M2ZL]EMMOH$84:$KB5..
M>(-U7N:W_M5(P'B_*DK.X/K0I;6N5/T,6G]OI2"-)XNJ=T?3KU]L3,(W+&$7
M?U^GUD)OY/HZ<T76),^X#+Y5:&9G:Q*?V747)7+0G/<'IMQ35*(+$B[:0$9J
MA<I:DE>'HI0U(2`=YZE%Z*@L.<B$C"46,W&D=!P(8K,ZQB#@D[_BQ^0#]?O]
M5E*_V<<TT1Y*FN7-'XL?D`_7[_592O\`9QQHCR37+FC\6/R`?K]_JLI7^SCC
M1'DFN7-'XL?D`_7[_592O]G'&B/)-<N:_]#$OS"N[[[M)NV_T;&756=4&K+B
MX5BPLB,_U4;[:Y)P4UHRI2E3B,P>ZI7XG[/I\"$9Z29I[RPE#5*`BJ5M`,/%
M75:1:X,.I.I]#Z^,+>D0"KNNV!!)1I``"%VGB]*%WL"0'#``OU5#_,UZY6(6
M<?1ZN`XZ!#C&++(ER2MJ.%".$4Y7F2U<8CMU/$CN.R-H4\F;M\=9-?Y^K2D=
MPG9B>;8:9Q7ZQPR7C\T&.N#$\IL'CQGU/BA)0A8["@Y@\%>)PD/!4:\E41PB
M.$1PB.$4(7GO_?3:V_H;K!]\,OY4YK6/I5WO++)'"(X1'"(X1'"(X1'").?F
MEWI%ISK;'8[`IU]D]@[VL6#PVKP-IY>9$@C[=,HVY67+2$P@&8`V((QC+6(\
M?0(%CPGZ8%GKCD%6B'^"<9R55:2>1#6B?;<ZFV3159SA)!)A*1QY4WKW96Y(
M8V\E,C\@=5D8E*IG1.3H2Q/29*((Q$ISLA."7D99A>!@%U.]V%;<MMKV=O6T
M59,SNQ8NQ9RQ7M/;[N2P[3[JV[?-RLC7M*6L$1`,XZHF(G`2(CJB3@Y&#L06
M*Q9XJ=-;4T?UF55-;L[:IA)GBP'V<$-<9<'1TB4&;7AJ840(TPK7IM:EIPSE
MK4>O6Y+()2>\6&>D`6?44*./V[M=QM-@;:YK"50S,F!)$00,`X')S@SGYGM/
M='O#:^]>Y([KM-C.C;0MXTS*8C&I4,92.N0B9#*0C%R9:8AR,(Q9=SOE\W1P
MB.$1PB.$2M[AT-9-B/(Y#-B+58T[U5%,:[U^UQIA<B"E+1,K7Q9]P/)1#FG,
MR,M8T0=J5I5JE*:#TU*E<CP+O*">4+SMULT+[?:5]<P>VI4(@`Y2GKF<?"(8
MD<21P=?I?M+WOO.P/P^;QV!VQ>RH]T;QO]U.M5@2*EO9?1V%,F!#&,[F<9TX
M3B7A"G6;3(PD-@]S]S*]TUK<N5R<@4BF,B$K0U]`4BK"1;*'-(`D2L]4M]!2
M%HC[0%24)8K$69D'J`++`8:8`&?21B9%?F:4A%2QW!Y+=R[@>E+D?<TGKMK&
M>8-OC-2N*ZOFMK($=DTM*6O8E1$E<@E]>WU%R]4;D..F1=/HYL(1'!9&<CQ7
M`JOR0;FU.])79!>4RFZ0D[!BR/6H[.%BLKJ3UZC2*A2-6J>T9(\_E&A6HSP]
M.@3`XZ]1A$\$$I#BGUQGS+ZZ*M>_YSY6F7MMLHS!,BND6L9BMW=)&%/ZQ*YF
M>3DX41$)6!_."<%7:-)T&3DHX_!0#\^F7;@M-89^*E\N.Q2[;M*=665$8W`P
MS:0KG_,3B12HE@9S%HL#.+1@6'J#<FJC<"/4"QZ91BDTP111)>0$@V`8`+$E
MR2L:<E$<(CA%_]%%=9ORVS-IZ^D\NR%S<;`V`BC])\G9&,+@ME=BH'!ZR:(0
MLF#"K/7F]V<YZY[OR]>56_!>N9RRP1PB.$1PB.$4P_EU\E.T"#<>FO&'I:ZK
M:LL*TW:M6B?W6G94[M)F\5K.A:%M:840XD92-#-'(\HPZNSR4,"O&>I1!Z+V
MAYI\$\%>,0VHI@Z?P^U<JB>6N7;<>0Z6SI8E+^+VLKW'M1#*5;G[892A>D9D
MS@*$HB?6'@1"<QL4A)`467D1@<#R,RC4>02<-<=\-O?'UY8,>,_92\Y3M92<
MWL6#5]!;!M!48ZV:Q*;@:&!SJZ0%RU8:X2!U&:XR1$T/*!Q5*$V#L&J$>2,8
M[3W%E8@&+@8JP#DK-0A>>_\`?3:V_H;K!]\,OY4YK6/I5WO++)3=;L^2^];X
MWBB/BN\=$K;H/8BJ2+&/8398YH;Y/_-HC8FX]XGS+!VY<%0U?%8,PI%(7)6=
M@"@3U@#8E&D4@&IY#\%<1`&HK<9V\/D-<H6J0E;M^1E-;9I0EA-Z#V\LDV5E
M2()&?;.(XT0M10GX60LP`6$B="F."G!@HM27G&#<&4:O`,EM^,GRF;"5SN]/
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M:0$+TB;).:ZPF<_&6-:;#$#B)Y$)44>CPWHE8#"#!#`(!`7+$!;G>*G;Z[_)
M)X\WNP+"RIIRXE#A9=)IK:B#"C*2N;RVQAK"RW?!XV^DKF(2IG7R<)1R4>#V
MPQ]9E8<%ED9]J4&*B0$2HYO,?KE-M=_(A$H%,=D+8V)ETJAM73(ZV+8/3+I:
MW'2"7R1J2,[:F"<I;4;''O@^#420H):4G)@@!*"#Z.0<UI$^5V5J+!HSN0U/
MK*Z.7E=V.D#<VNS<O<&%;3VO*9&]HD:PE0J:%:A'"2EA"5R(+$28,H03``'G
M(<X%C&>3\UFX_16BGF:;O*305+71M11N_)+/2T1>6%>IHN/43`H?,(C#Y)(F
M6($":;C_`/-,HEBQF=7THX_(PL_<CR:9C(C"0`,%U,=)P(Q7"^6BNBW[RU=V
M)E]T6E85LRD.R"I*5(+&F,@F;LF1F5O!EHD*-=(7!P/1-^%2DPP*<K("0"'G
M(0XZ\!)AB&6<_,A6V_C+2]S;*ZS[YR&G(!4U:J)6[T"T5M$FH]S01U*6HEKR
MRWBW8%8#<]J&XHY00D-*.3B.`$HHU+@0C,BHBSL0DW^$G>W?"X:OM_5VHWB2
M7#L++[3Q8JS8C8Q_E5@P'7:L'2+M#)))9)G)[?%\BF<G>7]F**C48($$A2XF
MJUBH>$Y:C`P5I`8$Y)P-H>%ZTK1C+N_/_E9\@JR_W%L/$"8DV2W1>ER)"9@P
MW!C914*;F`49BPU@^N&QND)(20BSVF9S^4WBJZF^R&2^?"!Y'=MO_>/9OC5W
M'G;K;KU#U%JQZ*SF5N2B23N.V)2SRL03&*.4R5AR[3*-NC>T.:DI6Z&J%R=0
MC+``W))WIE!R5I`-J"KEY*S1PBC,\KMHO5D;K6<WKS3L,U:!9:[C"`T>1!1(
M&EJ2KW8T(<#$5W.<F=%RG`L8"+TC"P"ZY!UYR(!HA83+R*7HQ("W5[9VPX8R
MR7)U;T!IA7;ZA9:Q62G&,ONP(/>$)F<XZXSCKRRJJ?/P)M>/UOW/_"0?^2?,
MNJ>2UZ8YE'X$VO'ZW[G_`(2#_P`D^.J>2=,<RC\";7C];]S_`,)!_P"2?'5/
M).F.91^!-KQ^M^Y_X2#_`,D^.J>2=,<RC\";7C];]S_PD'_DGQU3R3ICF4?@
M3:\?K?N?^$@_\D^.J>2=,<RO_])&LYB+WJ?M;)H8^(U?QS7B^7!G5IEQ(/<K
M#ZRG@RBCA`"),0H*<RV<)I8P""2<6:$8!=@@BY5;YA>MDTNK<^M38]LZPEP:
M7EO1NK6O3"[TZYN<$Q:M$L('TQW$J4QP1AS_`-H18Y98+L.$2Y=K-#;&V(FB
M^>U]OYN7K.XJH\0SIH;4\[9R*H1.#>ER2WOH(:)D0.PU:@\>3'$.'@&5G0."
MQI\XR+)2"W!00V9OGY2ZQO&P:"=-W]CU\TKVUY73[C[2V9:4E6RB)R]?"U?M
MLJ%X!EIU#LWB[._IG`<X[NGT\KBM0(D.RNZTRT*O;7>21JP;L\@^TVS,F31-
M8U26!S>5EFTPI?W9&E`J=&V..!#D_B^#*0&^P-/7X,S@6!C"'/4')69(.06^
M4M8*<C;N;><[9:S8'Z$1U<F.N*6MT6:G>(1+`%)CD0;8+P20L8([@"LX1X<J
MR4W0T>1X^L+K*KX)9*KRI.%_R-\K[QK:[S'<1W8EQC,_WJ\K!5#J5#G0L&/=
M$+;7DB$QUF[HUX&`T3:QMIHEI`P#3*1@%ZF(?DK:6]14FNY@MBH]YW:7<-CI
M#5[G>B>_-+WQY6TJU2%MK=F'EVK-?'&B+ES,U3(W%.P-F$Y(U:\(#59Q8C!%
M@P+MQ'%:!M);)>B9RRQ4(7GO_?3:V_H;K!]\,OY4YK6/I5PUFRLZ!UO8,Y3)
M2ERB&0B5RLA$?D825AT=85[P4E.$6((PE*!H\`%D.<9QC/T9Y99+SXO`)4"S
M;/?NW/M;<EXUK*`Z_67::NQ*2G95?V`Z29QM>IFAW+<9!\&=\&M+T7,U9RH@
M!)>33PE"[L!#D(JA:SP"LG_#7_\`GWY+?_M/_P"A.66;^"UL;?`1ILDOZ-[.
M.]E;5S"Z(W944MDN93"WF1Y='>;0U\:Y`SN;ZN^P"=R7"PO9R/4R$\LW(`]`
MC#GIG$,IU%FX):GS8-NO;37&H5&MKB:4Q3>76E9<K;BC3"L*%=>-<-CL-$J!
M@K`%2?.;"=Q!#DSH`TD(A`SGTQ!%6@,RG0^%&.-,8\6NG*%F2@2IUU;KY&KP
M$!81'NTIF<HD3PJ,R467@8SW)S-%U%C(NWIC.<].O`R59>HII7)55QD:)&W)
M2$+>D3($28&"TR-&04E2IR\9SG!9"<@`"B@8SG\@<8QPB@9^8T_>RU1_0W1'
MWC3SE3FM8^E7W\LLDI_SD_NIMP_T,AGWL0#D')6CZ@EH?*G_`-SK8K]I<[[K
M:_X"M/,)R?E3_=N;O_LT6Q_JHX<')5CZ@D$?*9_[/=V/TSH__,EE\!6GF%7G
MR5FH%=#CSBOF>9\64<:6!3N+Y%B%("S!@`H)#&-F5(23PASC!I05"<LS`1=<
M8&`(ORXQG%>*U/H5]7++)'"*-SRT5&^5GN9/WU8G-^SUL$--@Q=P$'.2E1:I
MM2-,@29,QD0,*FZ1MBG&2^O<%.82/.,8,#UY$"\0L)AI);S4O&U.C:Z%EA-,
M;5Z->`H><A`8-&H+4!+'D/UL!&(OIG./IZ9Y953U?QXK:_4+77^DDE_Q?,^D
M.:TZAY+:?33RFW7MA?D5J(BCX6TLBY,[O4PDK:]2%6;&8TSMYR@YR$6>7Z'<
MK<Q)4)/?]42A67C/3&<YQ64!$.ZF,R2S)Y',UHEL>3?>65Z'U-`;%B4%CT]6
MS"Q`0I2W2-Q<FU*C2BC3Z^^](-;`B-,48-:`E]HOJ]H\Y_+C'.@[@WBILUM0
MKTJ,9F<]+$D<">'P7Z(_#A[*[7[W]T[[V_NN]W%C1M-O^H$Z4(3E*76IT])$
M\`&F2XQ<))__`.C.ZO\`=QJ[_2J6?XOGD_\`?5W_`)"G^62_8_\`U]]G?\A;
MG_@4/SH__1G=7^[C5W^E4L_Q?'^^KO\`R%/\LD_Z^^SO^0MS_P`"A^=?_]/<
MGYCCQ6RUUD[IY"*#C!SZUJ&-"1LW%&-((UT9SHXB*;6RY4B`CN,7,PV!,0C?
M_1!@2'"(IP,",HU<>G@A:0EP*9OX"_(Y"-KM5H1KU*Y*F2[(:XQ!NA3S'719
M@+K.:RC!25FA5B,6#_SKN2A9,I&IYS@PY20Y)O<*,`+7)LC!1,,7X)_')5%U
M;X^,T89'B2R-V;F&/1YK<'Q^?'A:G;FEE9FE(<O='9T<%9A21`W-R%.8<><:
M,)910!"%G&,9SPB\JJ1V8T75Y*'ZY(^$8&&VMXW2S&0!@!EF`:)Y?9\I;0F%
MF?7`,*-U!C.!?3C/T9Y7BM\H_)>K3RRP4&_E8VRL/?KRK0GQZO$_=*_U6BNS
ME8:^KF)F/4-A;W(GF81>,3^>RDK.1$2%^;'M:K2L(%6/8(B$Y)@`E&*%1YE3
MFM8AHOQ5Q-6597M)U[$JIJF),T&KZ#,R1AC$884@$;<VMR,':'ZH>IBI:J,R
M(Y2I.$8I5J3!G'#&:,8Q666>)4#/D>LB`6G\P'!I+6TQCD[CB38#3J-&O\4=
MD;XR9?HPLK%FD+60ZMYIZ%4I97=*:E4X*,'@I2484+.!@$'%3FM8^E7_``YM
M#"YFFK@R71@NPUD86S9)`QO[4&9JH8VNJ!B<9<FBXE>'P^,('QU2HSUX2,I"
ME:DHD1F##`!S99*&'S]*DR'S.:[+EAY25&C@NLRI6I/'@LE.F3V[,3CSSC!9
MP$!110,B%G/T8QCKRIS6L?2KI)=&6V:123PYYP:)HED>>HRZA(,$4=EM?FU2
MUKL$F@R$91N4JH7:+&<9#GZ<<LLEY^GAU42'QW>:`O7R\`&Q5WD!MB:O/JQ:
M8)N1*G*1'-D@KAQ(!ZYA2]GGTGBC)AMS@9A1N'-.<$0N@1<J,UK+&+A>A9RR
MR6%[@V&IVA5%9H;6F9,8<KDLB/U'6#.2SR*1ODRL"3C&6TL;4R15H?';T?J9
M$J7&DEMS>7G`U1Y(!!%DC*=?YI?6V461K)1NQ49;E;JEUTG4I9)N2B)$:)IA
M=S)HLA^U*_M#]#<UR^#-*`6>N<@,=PBZ=GJ"#!5X'$A;A_+Q;$,%V^-BL842
MXI#IMKP[RBIYHU@-)"L2H_M`Z2F!N8D&!B4E-SA#'U*F+/%CTU"QO5X!GJ6,
M(`43#%/-Y*JL(UWL'6UJ6C>51PE:YNTEUW=H7'K*<`M9P8LDDTWCILI1QEHD
M>!#0/,@8F;!(W=*5GU&PQ606=C`Q]N"ELE$S\RDUDL?E+H-Z./$6D>M?:7>%
M2E5V$(T@F^Y[;:%!>%(\A*](A(TEG&9%G'9ZOT]`].5.:TAZ2KU.6624_P"<
MG]U-N'^AD,^]B`<@Y*T?4$M#Y4_^YUL5^TN=]UM?\!6GF$Y/RI_NW-W_`-FB
MV/\`51PX.2K'U!((^4S_`-GN['Z9T?\`YDLO@*T\PJ\^2LU`AHE__3W./VR?
M(O\`ZI;/<KQ6I]"OOY99)&FSWD_CVEGEIKW7^\I$!BUUO[4RK5A,G=%(RF.J
MK:37'L&U-TK<Q9SDAOC,U;"4[4\JQ!R%,-(W*33"4J92/D/BK"+Q<9IC6VFI
M=7[F5>3#9D<-O<6\9CU7]@,I:=8Z15T6)RPY6(\",`0[L+N0`L*U$(P!2PH`
M!!&4<40>5>,C$N%G*(D%,%<'BAW,JMW7$--<YM:-DFF_#Y16Z]$[^^3AR,96
M3HPI4)):A69(P')A>49A(3,Y`6<;T[L["<3Q61A(<%T=8^+?=BS'-*D_F@70
M!L.&$*J0V6O111O;RQ#R#)I[8::IE*K&.F<]J5O/'T^G.,8SC.1G$<4$)'@J
M9]']&X!IA"%S>U+?M=8\L"C-G4^5(BTAJWVH.J=A8$O<<:U1A`>,9@"A&&'*
M#A9-.%GH463C*1D?!:QB(_%<76+?6JMM=B=LZ9IM6AE44U33TRSO%E-2\M:R
M2V>6,=;/VJ:(X:1DQ,O886&`)$N%X!Y`K7FJ\%8$G*)//JKD,`4M_P"8H_NP
MTC_3R5]WLTYXGOG^'V?[;]62_>/X`/ZD]Y_R,_O5NI`.?,%_6)'"+__4OU,+
M+.+,).+`:4:`19I1@0C+,+&'(1EF`%C(1@&'.<9QG&<9QGA$A39;P`:WV+:!
M&P.I]D3S12^4+L*0H)'31(5$#3R(1F#!/**`DNL95QA29C&2Q$L3NTMP@#'D
M:08ACR*&5A,Y'$+*L&JSSJ5JW!CHMG-`+[1HP8(1S&ZZAM^-3%227V@*RX(:
M>=(FPB."47CJ8+US1B$+(QC%];+%'CR*^4M;QF;E;K-GV3WN\@2XNG%:@@]Z
MU^U"JMNJ&*OHDAP3B0R&P9>ZS252IN&824;\/=$2I&0H+":4$)H0CP1P,ABM
MB*<\-/C3HY,S_9'52!.[RRJ$:])++`->[$E.'9"I(6)GDEUE[H[8;'$E8F`:
M6)"6E+)'C\T`&,YQPP35(\4SSDJJFO\`)Q\OJT;BWD\;1:\7(BI&WI6-O<IQ
M'9*S.;A"Y-*V=$E1-LS9WV/K2WR#/AI+:1A=@E$X$JSP^Z#@A1ZV5,$*\9L&
M*V0K'QH;IV5$&R">0[R26A>57H$*=N74Q2+$QTDUS-`2F(2'-%IW-%F=@MRR
M(\XIB\@5ICC42E4/\Z8J$(0\"?%0X^R%KSY"OE^8A?<TJ6VM*)?`]3YS4\9C
MT8111-$E*.".0H6YJ'B&RQ(NC/>Z,4R;%9_8K6C1N(W+!9)IN0GEF#4&4B;.
MZVXHKQ\[DPUNN:Z+6WS*F.^EKPB`5;&+_%1L3?J\I*K(3-4DM<83$:<PM@T9
MD@9KVJ\+EAI;7D"M2!4$D2@HXQ64$C##!+AV(^7`O':RWGF]KW\GSC-[/>\-
MA)TA%J4VLA;<B9""T[*VL+1'MA6IG8&YJ*+QDHI(03CU<C.%W'&&&#-XJ1,#
M`13V]1:-VWI1(^-NS.ZQ6W;>-GC[7#3#]=XA2KW&CFH:\+DXO3[&9E*5$V5O
M20Y,6(:H!1H!)LFB&:8<8+DJI(.06LODI\/^O_D8(:9DYN[I3.PT20@0Q&\8
M8W)5K@:D3&94-K//&`:EJS,F1I5BR<C[%S>XH3,Y]!664,THR&4B1'P6(JUJ
MSS_U-'V^O`7UXX;TC[*`IM;K6O%BV+)MY8TDEX(3GO:"OFR/1EU=DI.,8]96
M>J5*AA[U*HTP0QB8H='(K9_7_0J5-%T-FUVX]Y+MI]F(\W.S36AQ<930*D]?
MFF0I\)'U%2]8I5KD6A?G=OP%(ND+@H4.JY,#&,^ED1OJ2H)X`8)A4KBD:G48
MD$+F;"TRF(RQF<H[)HV_(4[FROS$\)#4#JT.K<K+-3+6]P1'C*-*,"((P"SC
M..%"G#_`[V"TWO1YOSQ,;6M=,ADX1II'1-^M[O**V<FC"P3@5&ELE:VN4.3U
M&TIQ@BD/OF<Y\:RQ#&2ZB.,&/D-R5]0(:06ZS?7OG'LA(?$;0OSQY:_,*]/E
M*LLC6ZL;TLZTTA)A`R3S&1INE[8H&A<C.[J6H,).P09G!@2Q=N"Q,5'EX`K?
M_6'66M=3:J15568'M:G->'67S2:2YU-D,_M&QI*,D^7678LE4!`HD,TE2L@`
MU2@00``66602`I.244"5!+I<WEX\0L7\F<:A4DCTW35;?=7(G)IB<L=6Y4[Q
M:2Q=T4@7J(?,$:(XMP1IDKF$2E"X)0G&HQGGA$G/"=C!<$.IC+3\%@6G?'5Y
M6;%J^/ZV;Y;VU\YZT,J=F997'Z`0R!?<ES01HR6'%;3>[))!ZVD3#'G-*26E
M<5J4I<ZNB((R5)X\GFF98J7CF!BLT;Q^,/;C=*.S6G3?(Z55NK<E=68YHH5C
MU)B;H-JCT:-;%D;B[Y9:2W8S+9<W,SHU%*@X-PG+.-`7DXH>2B\A,H!`X8K`
M&E?A0VZT&'(T.N_E*^SL1FKLT/$UA;IIC%),QOBQHQ[<M:E#*+T>S(^['-HQ
M)C%2+T1G%>G@[!OHDX`;Q4F0.<5NIY!=#-L-W&V9UK$M_LZ_:ZSV/,[%)Z>:
M]98O.75W"B$$]W"MM,=F0Z6Y9Y`K*+$>A("G+R4$1!@S2##"Q%`('#%:":=^
M"C;#0UWF#MK'Y3LP4-@)&I'-&=?I?%Y<P2$+")P,8E*MHE=]/"5.XLXW53Z"
MI-@A0$!YA>1Y+&,`C>*DR!SBG@;0UCL?:D*:F'6C9]%JK+2'DU2]SE71T5O8
MQU836EP189D,>ETCCC8SK27-20L`M[E&<93>D(H0#!9Q*J&XA3P0;Y;>\ZVO
MM+M#"_*0_,U^))H^V&&S,ZIH')\4S"4&N9TF>',EVV%7M3N*1Y>E@5Y"M.<F
M6%*C2S2QEC$',-XJVL,VG!4IT+#KA@=:,\:O>YT-_P!E(U;N:\6>W5BS4^D>
M4BQS4J6A&7`V%]D;8V"9VPTI*(P"LS*G)7JBP$0LAQ*H?!0Y_-1?O!Z=_8VK
MW[[=AN5*UAE\U@'QU>?/:31YC8ZHG;>3LA0#&24@8X;+GU4T3F"-A00$IFZ!
MV%E&]')V!O)#C!+2Y(UZ0DHL!*,2$OKGAU)@#\53)5?S+?C3G;:C/G+Q<%)N
MA@DY2]NFU8.DE3)33!%@4'IG&K%$]RM;D^19'@8B2%`RP]?0P/.`<EU305VU
MB_,G>,&%H%:J+S*VK=5DB4`3-L#J.1-!ZP160!),`HM(5<HR4ZK(\Y#DP83`
MA`+N!@7:$1PFB2G&\AWS$&R>W4>?*EHMA-UCIA]3JFN0F,TA->+:G+.I#Z*E
MM>IHE2-*>+L+FGQVJ&]I)`<:688G/7*DY@RQ0ZL(`9YI@WRDO_4`_P"%3_F1
MY(45."8S\Q1_=AI'^GDK[O9ISQ7?/\/L_P!M^K)?N[\`']2>\_Y&?WJW4@'/
MF"_K$CA%_]6_CA$<(CA$<(CA$<(CA$<(CA$<(CA%K[;543JRK`JI:UVG+Z_K
M6)H+!4S]@@TB61I]GCX[IXNB@:)2O1MYIY3`PX+=5AXR5:51[G"8O`32C3_3
MX5S;5J]>V,;B4+>(EJ$2QD2VG$<!B3B"[9XKO]JW6QVVPW2%7:Z-QN565(4I
M58"<:48F9JD`EM4O)$/&0;4<"(NNRI@SN5^2+;#7-[NZ]%-4U74=.RR%L9=H
MR-.M;GN7M;0J?5*A[(.`[.!:DY6/(2SS1@*Z]`XQC&.=';=:IONY6,[NM]-3
MI0,1K.!D`^.97T'=?H;7VZ[5[AH[+8C=;J[N(5)=&!!C3E(1`B1I#,,0'/%;
M3S2#VY4&H6TZ1VN^=O\`)&)ENZP:NLKXTF56#'(NVL"F5PMA<'9;'BD1BUB4
MMPT)HPISLG(_K>K@X>1`[&K2N;7;-Q$KN<JD14E"3^8`!X@EN#-\.+KR]G>[
M3N_=O:\Z6RT*=M4G;4JU'212G,S$*DA$3=I`B0Q#2P9AC_/4':RJ)31>I,2F
MM\09ZOF?Z^TJXNS"\3AE43J33=UJ:+R60EJT9J[*U9+%GO!KU"7./>Y+.P=D
MOL&$66V;C;5+/;:=6\@;R=&F2#(:C(P!/SXD9\5/=O:VZVN^=UW=EL=>&Q4+
M^X$91IR%*%.-><(,680#:1+TN&=PML)];%9U84U&V-.XM#,OQZM,PIY`\HF]
M<^J&]/A8XDLC><;A<[F-R//K*,)BS<D$_G#.T&,BYV5:YM[?3UZT8:LG+.V;
M<VXLO+6&U;ENAJC;K&K6Z8!D81)$02PU$81<X!R'.`Q722#8&B8G7+1<$GN:
MK(_5,@`C''[(>)]%FZ#O^7%.I5MQ3%*%3H4S/*AQ3(SAIRDQQIA^"A]@1=N>
ME)WMG3H1NJEU3C;2RD9`1+Y,78OP9;6^P;Y=;C5VBVV>ZJ;I3?71C2F:D6(!
MU0$=40"0Y(`#AU^&'8"C)0LL1!';@K1Z5U$`TRTB6Z:QY3FO24^7$*E3,!EN
M&2X^D2F,ZP!IJG)991B0\`Q8&29@*%[9U#7$+JF32];2'ES]6.&1SY'DE?8=
M[M8;?4N-HN80N_[EZ<QU2684\/.3JB0`Y(E$C`A?O7U]4M:SHK8ZWM&#S1[0
MLZ61*65@D+<N=RXZN.PF12(+66=[XV/K%.<%E+@%B2F&9P$)F19Z<4;RUN9&
M%"XA.8#L""6YMR\<DO\`8MYVNE"ON.V5Z-"4S`2E`B.L8F&IFU`8F+Z@,67P
MB_<O4MM.D295LG265,25J$,F2I;*B;@J8UJ(I4>X)'),@=%)Z90U$(C1K`"#
MW(PEYR=@O&.8G=-MB9@W])XG'S##F^/#CRXKFT^S^ZZD;>4>W+W35`,":,P)
M`L`03$.)$C3^D_E=9K0SN#N<-*L5MF44<*^/9!R4F=(9$T*X:='"TXU9C^5)
MR%AC(8R%I"Q&B58/R1@L.19%TQUYRQ6HRI=>-6)HL^IQI;F^3>*Z:=C>T[P[
M?4LZL;\3T=(PD*FMVTZ"-6I\-+.^#+Y"!WS2MHJ7A%7=J0.9+8^W)'EZ1,$F
M:G!:VL;@$8VY^5)"5.5!;`XA*%E.N[?:']@O3,%VYZ94;RTN#(4+B$S$.6(+
M`Y'X'GDN7?;%O.V1HSW#:Z]&%21C$RA(`R&<06;4.,?4.(7!)V0UW40)?:I%
M]4N?5[4\&1YSL@FTH.9`FY_*P1DUC7S`#Z*/(W@O"DON3&*`GX]0/4/UL=8%
M]8FC*X%Y2^G!8RUQT@\C)V?P=:'MWN"-]3VN6Q7@W.4-<:/1J=4QQ\PIZ=9C
M@<0&P.*^,O3;BCZ!B]7RN93V)`;KCG%<P^O#OM,UD(),@GLKBS(MF;8[X&>V
MG0^'QV3X?%[B(P"$"$H.,G@$>3WXWFY6EG3MZE6M'35G$1Q#$2(&H'+3$'43
MDW'$+F;)VGO>_76YVMG8U>I9T*U2KY)$P-*$Y"F8X'J5)PZ<8-JU'TG3)OC[
M0FU9S6U=7CH]N='*Z68DJV5LU5Q.=P5=G9J.OC:XL;>SX:S74YQ?HXE=&U0,
MI4A)5$X,*/"'(%`"ST^=Q5MZMSMYANL8'4X@)1^]!!`#.Y#@XA^/'$<O;++<
MK+:^YA<=G5+B'3$)5YTJH^CG$B1EJTM&9B0\9&)8QSB3&6?["N:IZG$VE638
MD1A2EY+6G-"&0/B%`Y.B=M*]=S5M[88;\06HVTG.!*3BRQ%$8%C)@@]<=>97
MNK:VTBO7C`G)R`2V;#PXKH=OV?==U%0[=M]:M&#"1A$D1)P`)R!/`$N>"XKQ
M>E,,$.C=ANUJU^E@DS4)TD.EX98RJ8[+5*I"O=""8P[)%AZ*0#&U-2M7_%!G
M=$J4X[/0LHP04KRUA2IUI7$.C/TR<,<S@>.`)PX`E6H['O->\N=OI;7<&^H@
MFI3T2$Z8!$3KB0##S2C'S-YI`9D!?;Q>51F;,+=*8=(&:51EW+-.:9#'G)&\
M,CJ02H.2F*6UT;SE"%>F]P0,.#"AC+%D.>F<XYK3J4ZL(U*4Q*F<B"X/P(7"
MN;6YLJ]2UO+>=*YAZH3!C*)9V,2Q!8Y$.H+_`)J+]X/3O[&U>_?;L-R2JPR^
M:FCY"NCA$<(CA%9+\I+_`-0#_A4_YD>6"SJ<$QGYBC^[#2/]/)7W>S3GBN^?
MX?9_MOU9+]W?@`_J3WG_`",_O5NI`.?,%_6)'"+_UK^.$1PB.$1PB.$1PB.$
M1PB.$1PB.$7\SCBDY1IYYI9!!!8SCCCAA+*)*+#D9AII@\A`666`.<B%G.,8
MQCKG@D`.<E(!D1&()D3@$B'7+86B'?S'[E*6RXZS7HIY4%$1"#.26:QXYIFL
ML:F^*-SA&(B[`<,MLFD*9P6@3Y1(C3U.3\&%X!D91N`>.L;VSEW1NAC=4S&=
M*F(G4&D0(AHEV)?!ABON7</;^^4O:#L^-79[F,Z%W<U*H-.>JG"1F1.I%GA`
M@$ZI`!F+L0[4-QGIH8M4-D%;TZ-[2F4T?:32F/<5B=$4I=GJ$O;4S-28:@PO
M"AS=W164F2IP=QRA0:`LL(AB"'/HMTG&&VWYG(`=&8QYF)`'Q)P',KY?VA1K
M5^ZNW84:4IR%[1D0`2T8U(RE(MD(Q!,CD`"3@$F:6S&G8UX_O$"4S/4-9RX9
ML;HQ*)DW-HT*9PCJ^#DIEM]R%Z9TP`N:$Z/2)Q5&R)483CTU"ON/%U4`R/RU
M6K:T]F[9T3@-->W,F;#3_>$C/`DZCS..:^PVEGN]SW[[MFM1K3-;;MRA3)<B
M8J$BUA&1P.N`B*40<1%HCREMDKHRQ,?D_BL]NFQ9!6E*S_3H4+I6TVV>G0.$
MBL)!9()9+H09.$JQ"VMKQ)8P%.Y%$G'!+="4A.`#,&245CGW6B'<%.M=5Y4[
M2=KIA,2TQU"3F.IP`2&/BPY+SFS=>O[9W5CLVWT[G>:&[]2XH&D*M3I&CHIU
M.F028PF\"0'@9%P`25T6UL6UPK7Q1;.1"BW-0LKJ7&S(J$'2"0O$H3SVQ7N5
MHWQS-K5RDBE8?+$3F_MJQ>C,:LG)#S4ZE6FR(L(SN4W*G8T.W+^E:2^XEJTN
M2=4C)SI)]3D$AL,"0M^UKKN+<O=/MJ[WNF!N-(4^IHA&!I4HP,8]80`$"(F,
M9";2`,82Q8+86]GO72I_'[.[O;*,@]UPI/04!C3K&H6U-&?YPH>PKD3+'HL]
MR1E1JG`V%0EZ?U:M6$8CP-1&%QN"L&>K@7.O)V-OLU:[C:0JT>C$$1`\T06`
M)&.F)))Y8GFO/['1[AW7OVQV6KO=>RO#?U9QG4E+[JI(&4YQA(@=2I&,8Q9M
M9T!V9:9L=\Q=7OYI/:$JOZ)V(U2^D+DA!;_6<-,9*,0RV6F5JHC51U2_)&MQ
M>IX^%+59>%B!6\NKDC.`48:B:LF#(YU4+RF=YVFXJ7L9QE2G%X1:F\M+0@6)
MD>8,B1@6CDO8U]BNH=A]Z;9:[#5MZM&]MZFFM4U7)IT^L)UZ\3(1I18'3*-.
M$)`D"=5A)9RI>TZ+J3R*^49QM*;UO6[@XN&J>6YZG+LPQ3XBRHM;&-R?T+>^
M/AB$A<`@\8%2E&4<,S\APB^GUN<RUN+2VWSN&5Q5ITR318R(#CI`D`G\I'S7
M2;SMF][M[>^V5/:[*YN:<8WSQI1E-I&\D(DQBY#CRB1#<`>"T<%6MK/_`(K]
MD'&#0Z9AI>=[S2^\JWK5E:7-'(C](%EKQ60_#8]%1HBGHED4@;E[T6D],`U#
M8(1^.\DW`!]1T+F?;U]*C2E]+.[E4C$`OT-8+`9M@9-Q&*]M_J.UV_NAV[3O
M;RC_`*Q0V2G;5JTI1,!N0H3@\YOIU!XTS)\)M'`APVJF6;3Z57U#[6JJVWRZ
M+?S4;TTM<A;[6DUFH6*IW)T;7$UOE_M'%<PQM&XR`98VU*[X(5'K"5&4I8A)
ME62O26L=KJ7E*XMKDU;GI$`B9FT'&$L2!CD#B[MD6^4[Q6[NM=BN]JW3:H6>
MT?5QE*!H0HF5<1(>FX$ID0?7*F\1$QU%I1=<?\ZE=5GJ/YAZ=FC^V-ELRC8/
MR"*(Q4@ADG6.\-%H1)>]P26-,&"+[0+8>LCZKXQEV)3C0IVQ*>I$;@"<S(>B
M^HH6^V]SVM68%S*O<M#[1$XO$B.>EO,[,`">"^A_Z7N.Y=V>T6[V="4MJI;?
MM0G7Q%&,J-01JPE4](J"0Z>@G49RC$!Y!\HWA,8HXZ#>+.SV^1LR^NH+L?X]
MI+-9NB<4JN,1)AABI!'Y>ZR1Y3F&(65'%7\@:!R$H&7[%:6(@[L-"(&.1=U:
M<MF[=N(S!H0KVQE)\(B.$B3P8X%\C@5UFR6=U3[[]S]LJ6\X[A7V[=84Z9!$
MZDJ@,J<81.,C.)$H,^J)$@XQ63=W[IIN0VAXVI:TV'"U[*EVI(F@G\+P@`C2
M5\"'6+$E$X,7'C+"F@"Z3)RTY+P(06I:((#"3S"^T?.1NUW:SK[%4C7@8_4Z
MG?[.F0U?^+X:LCP*ZWLK9MXM]L]QK2KM]:-8[6:>G27-7J4:@IL,ZH@233]<
M<08@N%W$1F['3'E`VX=]B)$S0=KMJF]?PZNS6?NC?'XRK@=>LCP"YX)%Y0]J
M$;26[EV*]%.ZUI+.]T,GHK$7Z0<#Y>E5A:]P;E*]F(1J4J?2E(@#3$'7$$X/
MJ+D9\5C=V5?>/;/M.CV_;SKU;2\NOK:=*)G,5:LH_3U9PB#+3THFG&9&D'R.
M^"X-]$4@OB^IC1KM;2+3M^C[W<TFU9GQ$%C*:B5!<7$"'S**RJ.O9S6UY@EN
MD3+UV1>2$LIP`,"M(<,U0B*65O/I#3VV-C<BUF#,T9:1T\/+($%AIGJ\IXY@
MX@'38I;W3NNZZW<.TRW>A4A;PO:1JS-R-?WE.<)Q$I=6ATVJ1+F+&$P!&9AM
MKH5-GJP-6J\D4AA<2@SKEPG[0J;J\$O%6[X-@L65LHIS6WQ0]0X?S?S\:'+R
MT=XA`RA6EY($-/DDP?9[/5G6V^A.=*,)/(-%]):1&J+_`&9>J/@<,%Y/OJRH
MV'<^X6]O>5:]+32D#5;K1U4H2Z5;2`.K2?IU&QU1.II.!&G\U%^\'IW]C:O?
MOMV&YV)7EH9?-31\A71PB.$1PBLE^4E_Z@'_``J?\R/+!9U."8S\Q1_=AI'^
MGDK[O9ISQ7?/\/L_VWZLE^[OP`?U)[S_`)&?WJW4@'/F"_K$CA%__]>_CA$<
M(CA$<(CA$<(CA$<(CA$<(CA$<(CA$<(CA%U+Y\#^%JOM)\)^"_F?>_'/9_"_
M\H)]O[KW_P#%/\K]/L[_`/Q.WI]/3E9:-)UMI\<EK1Z_5C]/KZV+:7U98LV.
M3OX+MN662.$1PB4IJLLD9WD&\HH)U':_;H\9*]2Q+U'VR7/(DCJFH=G(AI:-
M&\01B0N'QAG])4I&,]*8VN/\5(`N!T5\\WMQF=[[AZT("&JC]I\>F-.<0[C$
MY,<`^:^K=T0MQV#[9&QN+B5QTKYATQ%XFZD:CF-61&F3Q`:0G#S2,#Y$VOGI
M%\I76-GP;HN^#?#.WXFM^)_#/:]/C/J8^(^^]K]'Q/U>GK>I^=[O\+Z>5CIQ
MTMGBW/\`.M:O6\G6U>D:=3^G@S_9Y-AR7'5?9SWRSWWP3XE\$'[_`-U[#WWV
M<]8[U/>>M_&/@GN/4[N_\QW]W7Z>O(.AR[:F_L_,K0^IT0T:^GKP9VU^'#4S
M>*YSE\-^'K/C'LOA?MS?B'Q+T/A_M.W/K>\]U_%_;]G7N[_J]/R\M+2QU-I\
M5G3ZG4AT=75?!G=_!L7^"Y1?9V`]+L]+L#Z?I].SLZ8[.SM^KV=OY.GT=.3\
M,E4NY?-=:\?`_:E_:#X5[+W:;TOC'L_:^^]3'L_3][^:]WZW3TNGU^[_``?I
MY66AO.S>*TH]?4>AKUL?2[MQRX<U^'3X'Z1WQOX3Z/P]=Z_Q3V?I?"NY+\3]
M;W?U/A_?Z'K]WYOKV=__`'>):/MLS<>7%*77<='6^H-I?U8Z<N.;<<V79E]G
M8#TNSTNP/I^GT[.SICL[.WZO9V_DZ?1TY;X9+,NY?-?OPH1PB.$1PB.$1PB.
'$1PB.$7_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g309840g48r20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g48r20.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0RD4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````_````>D````&`&<`-``X
M`'(`,@`P`````0`````````````````````````!``````````````'I````
M_``````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"@<````!````<````#H`
M``%0``!,(```">L`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``Z`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#N\_"Q1TVAS*G5/)K)MQ:18\0-QW5-:[?4^/3=^CL_J+)?B9#*6VG,
MR2UP<UH;TEI,M+6>I93]F]5O\Y_P?J_\758MS/:Y_3L6MK[*R\L;OJL-;A['
M.W;FAW[OT7^Q4Z>FM9M)S,RVMK'-+'Y!+=KFFJ7;6,=NK]WI^_Z:9+)&)HE?
M&$B+`:8I=9CNV6Y3;&DN#G=-8QY:XM96QC7T5L=Z?HVV/9_/>GD?I5*ZD.-;
M:K,JL4L_2N'30386E[-^Y^/]/=Z7\VW\S_A%*K"+,8;<G/\`T9+@W[08<W5M
M;-SZ]GIN8-_L_P!)_P`6M#&ZC;CXS*"UUSJ6LK:^QX=988]KGO#6[GOC=8_:
MA[L*.OX+O:GV_$.2[&N!`.3D.]6NIX<SIC'-;N=N@6,J<WU+*_T5C6?S'\[_
M`(2M6\+H]V76^PY;VB`UHLP:\=P>#5=ZK6V5,>^MU?Z"QGT/TEOYZT7]4N8)
M-;"1S!/'W*%G6+6-<?2;[023)[?V4AE@>OX(]N?9L8_2L6NBNNZNO(M:T!]S
MJJVEQ[NV5L:QJQ^LTU49GZN^R@!K9I9TY^748]2QVUU5?MLL9[/98M*CJUMN
M372:FM#S!.XDC0GP0,[$?DYN0'WY%;#6RMC:K36&ZUW.>QK&_P`X]U>QSG?X
M+V?X2Q$Y(@7>ET@0E=.0:+O281FV>]SV%W[)!>TAC+07,]/V,KW_`.C_`$EG
MZ/\`P2/^C&19E>M9]DHVVNP_V807,>[TV5LL=5ZEK]W^B_XS^:5FS`N])S?V
MGG-]NPV"QD@R[]+K2[:YL_\`%^S](M7[;9^X/O\`]B;[^/O^!3[<NSS)K<P6
M,.;D.L#VL#ATQQ`V%[+6U;ZW[O4_/N<]_P!"MZ+D-IQ:Z[;\Q[*;*20_[`X@
M/<'TUV/>YMGIW-NNHVTY/OM]*NM;[NH6`3Z8,>!)_@A'JMH)_1``<$DB?/Z*
M7OX^_P""O;EV<1Y8&5M;?8V^LVMN<[I3S6_5VQWI-J9_,>B]K7LN_2_]<K6S
MC8F'9TD6NH:^STG!UEM#:7N<T%KGNHV-]+<YOT%$]:N'^":?/<>/\U6:<I^5
MT^ZUS0PP]L`SH!\DZ.2,C0*V4"!J_P#_T/2'O8S!QW/,"&:G@>U5+3BO<&O+
M"US7!SA&G[H]3Z+5;>]M>!2]W`:R>_YJKX[P:Q41`#>W&W_SE5<X]9/@SXOE
MOQ6<P%H#3L(`(\O"95&JV@6L#&G<6%D-:?I`@NT_J_GJY8RRQKV.<!'M)Y<X
M3+=W&S^4JMHMK>P%HL`L]4N:/H@AS'M']9O_`%"BB-[.K-'8KVOM>TUMK+2X
M[-SBWVR-QLAI?^;]'^6H/%IW-+F@$1N:#)G1WTR6M4S:PV[60Z0'$CB(+?<?
MS4SPZ01#1WGW'_OB(*"/!CT\.;U"BO?(;!V\NX>WZ;O=LT_\S6OD1ZKC\)^Y
M8^&R>J5.<\[A8-@:8`:6>X>G_+CWN_XM;.1I83V`$J27\W_A#\F,_/\`X*+7
MGP0W@0```!Q\?+]U$96VM@8W5C1`G710?',\!0+PC<0-$%S1J9)G\(1''0_@
MAGM/(2"4%@]TS\EH]._Y*N_ZY^19KVB3!))UU6ET[_DJ_P#ZY^13X/F^C'E^
M5__1]&O+OV?0UH)WAC3`),;55],M'VEKFBR0'`_1(G@?1<SZ2LY/_)^/)VM_
M1EQD#0-EW*J5V"MC7VL'Z8`L)(VB1]#W_1=M5?-OIU;&*^#3NS<ZQCW;V[FF
M/>W27DPUNSW;*]NQN_=]-1M+@"8)/[K>3"9[K'TN]&IVZUI;[B!M'[S&_2=_
M903E[VU;06WV@$-?H`#]*W7Z;/;[-BAH[L@""@O=8]S@&N>"7^9$;!S^ZB..
MT2XZ,$Z\I'"=:_TJ'[29+2_L8]WN9^__`-!4:V7/'JN<ZPUO<PTD[3[#V=/T
MVO\`S$XCJ-MEQHV;JNC=Z>TC/H<^/5>Z7F(X:?8W^37]%;=P_2GP@+"P;:_V
MABM@ML>\PTB"0&NU6[>0+"2>X`3I#]7_`(7[&"7S_1&1J#]P[:H-NGT1,Z>0
M^*GM#7%TZ:G;V\9_K*+R>T'R4)`![KP@,;MKG-8(/O<=)'T6_P`G=^^@N#7`
M3P8<&G0^/'TD9PTU^]`<2P[F$M)$$@Q(1%:)16'2>5H]-,]*N/\`QGY%E/TD
M#2=3\2M3I?\`R3?\;/R*;!\WT8\OR_5__]+T/+IR;L#%;CM%D%CK&$[06!A_
M[]L2=AW.V.V1Z>K&AP@$Z%_[OT4;'_H]7\]]!OY`I_\`;RAR\%^J[\&:''PB
MJJRUOLN9,EH,<&=255/3,]Y:7L8"YY:XAWT:CPT?\6M/_MY+_MY-A[?2_JO'
MN?U7.KP^I5/9<VIKK&.+7M]2&N:1M=8WVG;_`-MJHWH_6'79%KPU@M<;`QK@
MX$N<98'.;[=C?\)L]ZW/^WDO^WD[T5UX5?K/57#=:_W;_K>EQ>F])ZE7F4Y.
M34QNPP0U^X-;!G9_6>MAU>0<BP[!Z9C8Z?+W>U2_[>2_[>0EP<'6K62X^/IM
M]*8''N(X`GS0W8N01HT'YH__`&\E_P!O*/\`4_UEP]SP:9PLLB=@'EN"">F9
MWNAH(<9@N&GP6E_V\E_V\E^J_K*_6?U7&=T?J!$-8T?VPK^#C7XW3+Z[VAKS
MZCH!G0C16O\`MY0O_F+?Y[Z#OR%2X^#B]-WXK,G'6M/_V0`X0DE-!"$`````
M`%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3
M`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``-@`N`#`````!`#A"
M24T$!@``````!P`(``$``0$`_^X`#D%D;V)E`&1``````?_;`(0``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("
M`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@`_`'I`P$1
M``(1`0,1`?_=``0`/O_$`-T````&`P$!`0`````````````$!08'"`(#"0H+
M`0$``04!`0$```````````````(#!`4&!P$($``"`@$#`P,"`P,&"@@!`!L!
M`@,$!1$2!@`A!S$3""(405$),B,587$6J"EI@4(SLR1T-;<X>)%2)976%U<9
M8D.AL=%3-!C!TU:"DK)$566%U29&AI:F)S=G"A$``0,#`P($`P4%!@0%`P('
M`1$"`P`A!#$2!4%182(3!G&!%)&AL3(C\,'10A7A\5)BD@=R,R14@K)3<Q;2
M0V,UHN*#-$1T)3;_V@`,`P$``A$#$0`_`/1=\0OTQ/B3Y*^*OQO\@<J\78[+
M<GYGX-\5<GY%E;>?YH;63SF;X-@\EE<C9,?)XXVL7KUF25RJJ"S'0#TZ3M\*
M7O=WJQ?_`+1OPJ_]'L-_W]S?_P`4]&WPH]1W>HA\[?I[_I__`!Z\6<J\N\V\
M&93+<9X?4CNY.AP:#R-R[D]B*6>*NJXS`8[E/W=^0/*"0NFU=2>PZCY$\>-Z
M1D:X[WM8$4W<4"]AW-2,:&;*=(V-S06QN>5*68TN*=R@L.IM5`?CCG_T;_E%
MY;H^&/''@GR[C>5VK=^A;O<Z\>>5.(<6P-['XBUFI*7(^0W^9/3PEFQ3J,(4
MGVF61E4=V'4[&QW94;YHG-],-<Y2Y`=I0AIZD'H+U&R)7XQ8)6NW$ML`24<4
M!(Z-\=`+UU#_`/:O^!8CK2_^77#O:N2/#3D_ICRKV[4L3!98JS_TPVSR1L0&
M5=2">_3.VX"7(7Y5[ZCD)6U;Y_TIO@G5MPT+7C/BE:]9V_;TI^6<NAMS[SHG
MLUY.7+-+N/8;0=>@`$D#44%[P%.E1WQ;X`?IE\VSW,N,<4P?CO.9WQ[DJN'Y
MGCZ7,^8M)Q_*783/6H797Y4E?[F2)2=J.Y4C0Z'MTW`^/)B,\#MT(>6[@J;@
M%(!ZH-4M]AIV9D^/(V&9A;*6!R'7:="1T5++>I#K?I3?!*Y)%#4\9\4M33QM
M-!%6Y9RZ>2:)&*/+$D7+F:2-'!!8`@$:=.;=0EQ31>\(IH0_I3_!*PUQ(/&?
M%)WQX<Y!8>6<MD:B(]WN&XJ<N8U@FPZ[]NFA_+KSR[=ZC9W6WVU[NDW;+[^W
M7[*1LQ^F1^GM@,1F<_F>$\%QV&X]C9<QG,E9YIRI*N*Q<*>Y)?O2?TP(KU50
MZ[VT!U&FNO3<TD6/%)/.\-A;J2;"G(69&1-'!"PNF>4`&I/A6CAGZ:/Z>?D+
MB.$Y[PO@O$.0\.Y'5JW<)R&CR?FPQV1K7=GVDD$L_*(6UL&10JL%8D@::GI]
MT3F>GO807-!"J"0X*+>(^=,B4NW[7+M)!2]P4-_#OI3AF_2E^"T"S&3Q=QD&
M"=:LL8Y1S`R+<=/<BIE/Z6[ONYD[I'^VWX#J-DSQXN-/ER`F*-CW':I)#`2X
M-`N2`#876U.-,CG!@UM\@=">P/>JE<,^/_Z2W->$<2YK5XCC\%-SC@O/?)'&
M>#<JL>0<'Y%R/$?&TF2CY7E/Z)S\J>W66JV+E]D2LGW'81[B2`K*ECQ(\N1Y
MW>AAMRI`T[BV%YC#7%++NE8-JJI)"M:XB2[%RF9<>&\`/?G'$:39KIPU[BUI
MZ@-8YQ<B``*5<T&9?!GP#_3D^1/C'@WEGQIXTQ=WBWD+B^-YAQZ#*9?FV,SW
M\#RT*3T[&1PDO+WMT'=)!J&[`GUZESXTF/(8I`-X`)0JFX`C3JAJ$92))XE\
MT<KXS_Q1N+'(NHW--ZEE_P!)KX/QV(J<GBCCL=N=6>&J_)>9K8F1/VVB@;E@
MED5?Q(!`Z9#5)`%P%^7>O=[P`3I1.7]*GX(0UY+4WC;B456&?[6:S+R[ED=>
M*T"`:TDS<O$:3@G]@D-_)UYY?+?72^OP[U[ND\VMM?#XU"G*_A/^FCPOSAX[
M^/O(/&U*IY!\H<-Y3SSBFF0YRW'9N.</L8^KF+%[/GERTJ4PER<7M(VIE&I!
M[=T8[V9.5R&)%_SL6*.21;`-D<YC$[DEIL-*?DBGBP(N2<GTS\CT0ESOVE^G
M;:-:4F^!OZ=B^;H?`8\.6'YI/X^/DR/)HWD%^%GC(R)QNIY6.5G&C(^^-WL:
M[O;^K73I4)$QS@T)].6!ZV_.%"+K;7M7DD<T6+BY9(,4TCF-2YW-"E1T';N:
M0O/'PU_3'^.G&.'\O\B>.Z#X/G'DWBGB/!6.,9#G')7;F?,VN+A:EQ,?R]OL
MZC?8R&69CI&`-1WZ&))FX&`P'ZC)+@SL=K2XJ=!84J&">>'D)V$;,6`RR+J&
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M7+N62518)`$!L)R\Q"8DC1==W?TZ60`B]=+ZTP'O*@:C6LH?TJ/@C8ISY&OX
MTXG/CZQ<6;T/+>6RTZYC`,@GM)R]H(B@8$[F&@/?H(#0'.L#X][#[Z`]Y):/
MS"C-?])OX.W*RW:GBGCEJFRLZVZ_)N93UF1==SK/'RQHBJZ=SKH.@MVA7!!7
M@D<2@*FJ?_'GX^?I4?)_FOFSA/BGQG<MS>!.36>)<WY-GJ_D3CW"[.9I9.[A
M[D7&>2Y#EJ4\W'6R&/E1V78?IU`([])Q-N;Q<7+Q6PY'AK=Q1SEW(0TW3R&_
M10"A-+RS)A<E)Q4M\MC-SMH)#4#%:7:!PW@$?%%`6K:S_I5?`^M!!9L^-N(U
MZUI#)5L3\NY9%!9C"ES)!+)R]8YD"#7521IWZ40`=I_-\>^E)#WD%P_+2C%^
MDE\)IHTFA\18.6*5%DCEBY#S:2.1'`971UY45=&4Z@@Z$=>EJ%"+UYZCCH:V
M?^T;\*O_`$>PW_?W-_\`Q3UYM\*/4=WH?^T;\*O_`$>PW_?W-_\`Q3T;?"CU
M'=Z'_M&_"K_T>PW_`']S?_Q3T;?"CU'=Z9GD+],[]/KQ3PKDGD7R!XXP''.&
M<1QDV8Y'G+&5\BW(<9C:Y436I*V-Y!=OSJA<?3%%(YU[#J/E9&/APF?)DVQ`
M@+<W)`&@)N2!4C%@RLV=F-BLWS.5!8:`DZD"P!-4(\37_P!`OSGY&XOXD\5<
M\X-R[R)S/*)A>-<:K8;Y&8ZQD\G+#+/'4%S-8W&XRH[Q0L09YXE.FFNI'4Z#
M%FRGN9!'N<&N<;]&A7&_8!>]0Y\EN-'ZL\@;&H"^+B&C3N2!72K_`-HWX5?^
MCV&_[^YO_P"*>F=OA3GJ.[T/_:-^%7_H]AO^_N;_`/BGHV^%'J.[TCU?TK?@
M=>R^4P%+QIQ6UF\)%2FS&)K\IYC+D,9%DDDDH27JJ<L,U5;D<3-&7`WA21TE
MI:_U-A!V.0H="0J'Q2Z=J4XR,$9>"`\*/$`H2/!;?&EC_P!HWX5?^CV&_P"_
MN;_^*>E;?"D^H[O0_P#:-^%7_H]AO^_N;_\`BGHV^%'J.[UA)^DC\)XHWEE\
M0X...-6>21^0<V5$11JS,S<J`55`[D]>$!H)-A\:]#WN(`N327@_TJ_@AR;&
MP9GCWC/B^:Q-IIEK9+&<HYE=I3M7F>O.(K$'+'BD,4\;(VA[,".ANU[&2,*L
M<`05L0="/"O7.D8]\;[/:4(Z@C4'QI6/Z1WPJ`)/A[#:`:G_`+>YQZ#_`/BG
MH=M:USG6:`II.]W>H-\??"3]+7RG@3R7@F&X5G,-_2'E'%([+9KR3B9K'(>%
MR3Q<HQE/'YO-XW(WIL.]:3W&AB>,JNY69=#TR_(QX\;&S'R`8\T)E8;^:-H)
M<\#5``25"U*FQLR#)R,.6(C(B<QKQ8[72`%@)!VJY0EZ</AW]/?]-KS_`,%Q
M_DOP]PSC/..#96UDJ./Y#C\IY*IUK-K#W[&+R4*P9?.8Z\K5;]62,EH@"5U!
M(T/4ET3FLA>YJ,D8'M\6N"@_,=[TS,)L?)R<28;<F%^U[?\`"[M:W7H:/>5/
MTYOTXO"'!<_Y,\L\/X9P3@G&*<E_.<ESW)N=04:->-23],7)IK-F>332.&&.
M265B%168@=1IYX,9K'3/VAS@!J22;```$D_`4N"+(R7.9`PN<&DGH``%))*`
M`#O54?$W!_T._.?&/)?,?%?*?'O*^/\`A[C,_,O)%J-O-V(M<8XM661K&<L8
MC/G%9B]0A]HAFJ5[&AT&FI`+N468>"_D<D[<)K@TNU1SB&M!`4A20!:])QF3
MYF9C\?C#=F2GR-4`N^!)`^^F_P"$J'Z#WR,\@X;Q9X;YQX\YAS[D7O\`\"X\
M8?//'9<J]:)IYHJ-[E<.#Q<]A84+"-9_<8`[0>I$.-+D;Q#&7%K2XA;H-2FI
M3JE1Y<@0;?5>`KMH^/915B_D7\//TIOB7QS`\M^1&*XCXQX[R?/0<9P64RMS
MRQDXLAG+.SV:"1<>R68L1,WN`EY$2)0=68#7J,Q\<F?@\8PKG9+ML;+JXV"+
MH-1J0+U)$>0<3,S@W_I,=H,CK(T&P)&I5.@-)&>^+7Z1W&?,O%?CYG(>%4?,
M7-N(9/GO%^$&[Y:L7LMQ'#X&YR?(YJ*_4R$^%@AKX#'S6O;FLQS/'&=B,V@Z
M\=)&T<XYSD'&Q"3)U_287-8'.[^9[0C=QOHE#F3MBXV=S4BS'ED)4?J.&H%_
MQ2H%\-0?H+?('R%@O%7B/GWCCE?/N3V9*7'L`\?GCCIS%V-78TJ&3Y3#A,//
M<D]LB.(6/<E8:(&/;J3CXTN6U[\>/<&LW&Z';W`*$]R@)`N;`TSDO=AO?'DN
M#'-?M/@Y40D*-;=EJWOF_P"`?Z9_QN\<9SRWYOXMQ'Q[X[XY]N,OR7+YKR/9
MA@DM2>U5K5Z.)SN0RN1N6).R05H)IGT)"D`Z0I\C'QC`)Y-IDD#&ZDN<5(``
M!Z`DG0`$D@"I$$.5E>MZ#"X1QN>[0!K6ZDDD#L/$D`*2!5>.5>,_T2.$^"N%
M_);DW)_&V.\)>1,U)QSA?-UO^8;\>>SD`MM:QE;`8VS<Y3#;HK2D-A9J,?VX
M4&38&765E1G#R<7$R1MR)F;V!5W,0'<H4;;@$D@!Q#2CK4S`9,F'(R(+PQ.#
M7G1'$D!MT*E"0!<@%PL":L#D?@9^F/B?"TWR)R''>%P>%(.(1\\D\A#/^0Y\
M*.)2U$O1YE$KY^7(2Q259`PC6$SDG;LW=NF\\MXSU/KOT]K@#J;D@`655)"(
MNM>X7J\B]D>%YW.5.FBJJHB(55$2]9>"O@1^F=\F/&F#\P^#N(<;Y]XVY++D
M8<)RBE=\I8JO?DQ-Z?&9!4H\AR^(RL7VUZL\9]R!`VW5=5()>?!)&V%[V(V1
MNYOB%+5^UI%[VIEN0'NE8UX+F.VN\"@*>-B#:UZE_P#]HWX5?^CV&_[^YO\`
M^*>F]OA2_4=WJM_F_P")'Z3GQPY1XSX5YKH<.X)ROS'F3Q_QK@KMWRQD[_*,
MJ+%2H:]>/`9+*K1B%F]$GOVS7@W/IO['1N)\<^<SC(CNSG-#@P*NTDM!70*0
M0%-T-./;-%A2<C($PF.VEQ1%14`U)`N4!0(NHJQJ?I(?"B1$D3P_AF215=&&
M>YQHRL`RGORD'N#TZ6(2"+BFA*X@$&QK/_VC?A5_Z/8;_O[F_P#XIZ\V^%>^
MH[O0_P#:-^%7_H]AO^_N;_\`BGHV^%'J.[T/_:-^%7_H]AO^_N;_`/BGHV^%
M'J.[T/\`VC?A5_Z/8;_O[F__`(IZ-OA1ZCN]$LC^DK\+*E"Y:7P[ABU>M-,H
M_CW-^YCC9A_^]/YCHV^%&]W>O`MORO\`]L7)_P#^9^0__K+KU!VHWN_Q&O_0
M]GOP"_X'OB)_RW>%?]W/'.BCM5N^BBAT45Y#/E+X`\V<A\)?J?8'$>._(3V?
M(?SL\!9;`1X3&Y:OD.0<1@M8:'-9?#2TA'8LXVK"6]V6,E4TU)[=4?%8Q?QO
M^V6+.UP9'RV891IM8XS[2[L"H0GN*UV=D,'(<[/%(TN/MQC6&Q61H_*/\WA5
M6OU3O@=YQ\/^=_#G`/`/#_(];XZX_P`9X5O#C\?P_/\`RA-P[RC?S]_*>1<E
M9LX_E%;(XK,9&_=IS&>^TD+1J$C`5".K2`3S<]RS'N2831MQW:-&,P(U@=H-
MK]Y<OF.X$G2J!KHOZ%PLFUI#F..0PZF<AH+G"Q1S`P-`L-KNIHC^H%XL^8?+
M/D3X>-/X_>2G\I>'>%?':WF/D'QN#R%E\GY`BQ''>&_TCS4%&+D/]#N&6\-D
MHYTFJ15IK-A]YD);4]/\3+&/=69FR,^GQ?ZDYLC!YFN87;6RAQ%V2BX8U`QI
M0Z&D9;`W@8,-SQ/(<)Q8]$VGS.,>P'\S+#<\DN(46--[RA\)\_A?-GR#\7\:
M\$>;X,ERWY@^'.3?TRPU?F,7'\IX7RM+,6,Y5AS4&0>,VXLSE())I`?=B4,-
MR@$=1?;&,2[@L'*\F#!FYS)`J*T,D;CD'7;M#@O\VX*I-3N8R0\\AF-?NR9\
M3"<TC7U-H,Z]CN(MT0@)4\>"/A1\A?$G,_&G)/#?'/,.`\CW_*GSF\587)YW
M*<GN8OC_`(]I>+<58\.598\S=L8ZCB[',LK;EKW'56GL$[G;8-$,DSY.)D9&
M?^KRN`W26`<9FY6W8#_*_P!!J-`34'QJ0['XV+-R9I7K#CY^,8E*AK9&/]5R
M?S-#]I=J@!'6JY?!7XZ_-W$<K^74^:Q'E#C><F^+?R3PWE?$WN`<UI)Y$YKE
M.(Y^IB(Z_*,GR&]B\[GWY"S/4FH0()#*2N@8=-\BV%_L_G/HXEQ7X\+8V7:X
M.#V$%K3YO*T.W+TI'&;V^\O;TN5*P2Q\HQTDFH+/4\P5=H:;'P2K`\(_3LYO
MAZ_`^+XK@7EZS#\@?TTO(DOF]<YE.6VZF3\OX/.-E.#XO)"YD"F(RE*?!X_V
M*<30JZ1@%2&8&1[F+FXG^X&#B#=!!!ASXZ!2Z9C@YY:?YB2"HN+Z)2^`CQHY
MO;?(9<W_`%)Y?(QY2J?]+)&\*1T!#D#AV!5;UU`^-'A(<G_1$R?C7Q7XW\B>
M+_(_"^'V>64^,\RIYVAR:[YI\76</S87<75R-R2[]AR'/\=CBJJC"$B301Z:
MJ;3W+EF";V]S#&^O#A/PYQ&TW,<4C'21.2ZEF\$7)!3K6?X'&]:3D.)R9O2?
MF13X[I.C3/&]C'@FPVES239$-5#^+/@CY6>4_DSX9Y;Y8XOY$XSPSY"^4+OZ
M@/.\?E4OPU.%<@\0\L\H<>\;>-\J3+$E.]D^,<LXO.:_[KW$QTF^%B6VTF;C
M,Q>%]Q\7$\OEP.$R<F%[!Y9LSG<3=E1-!ON@F,Z)^0EC0&U(S\J3*CP<YD.V
M7,RX<*5H*.CQN)=#'%([HYN1Z5R@+@Y23>J8>,_B-R#B5W]/7RIY8\`>9^29
MK-?%'Y'>.KMC&X[E=F_Q'S-!SGGS^,<GS"M%>B.-Q%?%9=2R2I[,ZR*723\'
M^3>!F^[<7%8=V1[9QW0O`\HG](,F8>[G8\4C`VZ/>P@`W%]R#FSYG'9'K-V0
M>Z\HR!;G%(:^,M\/J'A^ZRM:X*EJZ1?IQ_#/*_''RS^F#Y,X[P[R;@N3>4_B
MYYUQWR<N9_)\FO8^ID\)C?$EKQ[@,SBLG:FQG%UQ\U_(QTJ\44&X1$:$IVMH
MYO1YOW)@Q$?TMW$X;V]=V0)7B5VXW+RT,W!4`T`4UG<^/ZC$S,N0KFQ<[*UG
M_P#CR.R'%`+%J@$.13N))*UT"_5+X'Y0X3D/`_S:\&\7Y'SKR#\;>72+R3@7
M&S8FO\Q\:<FH9#&Y^A6HH\D=FW2GM1SQ@02/JO;3K/R2Y?'<C/DXK2YF=A2X
M;^S7/!=!(>P9,&%R=-2E66,W&SN-DPLI^UV-.S*C[N],CU8O_P"9%N"W0Z!:
MX#?/?X3?,'@7Q1^)PJ8SG/,..\\RG*_+/R,P6(PO).8W<5YH\E1_QS&'*<<X
M[F\?F[5?`PNM.%DD$%>9-S*--.G\O&;A<UB<4YV_"Q..9CX[P"1ZS7$Y#U%F
MN??S%00"!K7D66>0XODN1#=F5D9YED82-P@(#86]%#$&X!"202+5)^'^#/FG
MS/QGX5\2^26(\I<[H\8^('RLO1Y2&ERGA>1QTSSX;*>*^'<A:ME)<I#9B2)%
MAJSV"TZ1JK`D$=><RV2+D/=F9&P'/BX3##"+A\[))5(T#GM:6[A<;E-Z<XPQ
M_P!)XW&,H;C2>X07,TVP/A#7ZDD-W!R.L@*4TN*^$_FWEO&^'J8+BGEFORJG
M^F3RKA$K78<K4R5F3%>:LY[W$*ERU)$E?E-S@%<1U=Q]\Q%=-=1U(YAWKS\O
MD2-W8CYN)DG:W62)N,SZ@-3KN_,!=015E`W$Q,;'PL:1C9(^3Y!L!-PPD)`]
MW=I*H392"M%>.>%+F<\+\*I?'+XI?*KQAQ*C\L/BIF.55_+6>NYW'Y#F_'XL
MW%S?D7'^&Y"K9SV)H5I9UDLY%[CU)$95$:'J>?4/(\--CRM9B#-R3CM-W1Q.
MQWAA<X`;6[MHVN4DW7I51Q4D$;?<,>4"<D\,YDAT#Y/6C):+G<X@.((0)TZT
MQO%WQW^>];]6*EGN61^2<#RVK\AI,W<YS'PCEF8P.:\.CDJV8,--S"OR&/B5
M?`V\'K&(/M?<ATU(/IU$]IM;'$TD!KV12"<.MOD*[RI7<22"TBQMVJ-[@25S
MD+71N9'Z)`78U!M"`A"W0@^-=$/_`/H3X5YB\JYCQ#XY\<_'#E/D2W;XKFKW
M&/+/'K'.LJ..<R62^B<:CXQQK.8G`4K5N%4G7*9)95A("J"-0:9)/ZYDS-#H
MC%"QX>+F1C7.<]H50TL3=8;GDH*L<=T;.*QF2$2MDG<TM)38\AH8X@(YP<I%
MSM:%)JGUKP=\S>2\>\DY?C'"O+-CD^0_3W^*&!YG9%>W@^5<KQ'&^74;/E;A
M.*RULQL.4S\9@GC,:O[Y'8?41U:YYQS_`%66>)TG$N]Q133,;9TF/]*07`"Z
M>J6.<!T!%(P'.;Q/#013-9R+<3.9$7`)'(9FE@(Z+&'M83U(-,@_'KRSS#P7
MYPK_`!F\)_)/PQ\5>3>0_C5A\3XPY_<Y!:Y[-Y0Q_(*">4><X**WD+F?QN%^
MP==\ON"%F7<NW3173`)I>$CSI0[$?SFZ%HUBQO2<';R$0.?8+<=R;F/QKVME
MY/T#Z<PX&=DSBB/R25C+`;$AB`H@)Z!4J1/D[\/?D7X=\%?J'>"?BSQ#R=1\
M#\:^7_A;DM3B!DY5RF7/>%\AXTH'GB<>:SE8^1\KQ$'*K<#W:U6V9YEA*:_2
M>JKU\C)X[V\[DT?BX_*<@PM+5(5X&$XM:A+6E-CM`XM>[0FIDD$$.5DR<>],
MS*X>*1QW6+V2O$[`2J/?&T.(L2TO:/S`5U&_04\1>7N-_$'RYQ7S8>5CA'+_
M`"%DZW`>(<JXOR3A%[CG%+O&*N+Y)C<92S^8R>;AQ%V\[-"QF5DD]PKIJ#UI
M.2@CGX?C\+*1[W,E4AU_2>1L:41"/.EUVENB5FL5\F+RT^9C$,:WTB`G_P!U
MA<7/N2#N'I@A$5I[US"F^$.4\.?$JODE\">:^0>%[WZA_FG*_*7Q7X_S/)ZW
M/N=^#.)\@YYQ_P`8V<93ERT&2LX:LMNN[?9O%+=#+*[MINZH<62./$_V_;RL
M;I.,_I.27,&L?)/R71P2/`N&C&A:W:H:"YKM7$FZS3//R'^X!X^5K,W^IP['
ME$DP?0ADG8PZ%QR)''=<HUS!8!#/AGX4^9O-&9^"7C;S]X[\R5OC%R'S_P">
MLWQ;@G(LYGX.1\`^/TWCW*7O'G&^<\AP]Z')XR*S?J1PK%8F6==Q0G5N]GQV
M.X\UQSN:E;-GP\#(7O%F>J';H&%$#GQ^5WB4!">40\_)#.$YMW#,,>+)S&(&
M,-W>F7;<AR%2&%7?`7\:]A?#^)X+@?%.-\)XQ4:AQSB6#Q?',%1>Q8MM4Q&&
MI0X_'UVM6Y)K5AH:L"J7D=G8C4DGOTJ>>3)FDGF<LKRI.ES\*AQ1,A8V.,(P
M?O*TX^FJ<H=%%#HHHK=I4LE5GHY&I5OTK49BLT[M>*U5L1-^U%/7G1X9HV_%
M6!!Z2YK7C:]H+>QO2FN<PAS'$.[BU>2/Y9<;O<"?]<'D_C7`'A?*>/<@^*2^
M/N2<2X[7QF8XX<GE.!8_,6.'W*-%)<>\M*Y.L[52NY';=V)ZI6NE_I'%QLF<
MQTGNAS'$&_IN+`A_R^&E;1D<+^1X+?&US1[=RW(0"-[693FDC_$"`1U4!*J7
M^I,?E;\2>*_$O@/&/-/G')^(N?>,G\IY#R%RCG_)L=D;OF[-RU[MS%W\UQG`
MY;)"IAZ5]?M,7*J5FB)))8=6F89![FY?C7`,&(&QX=UWQ%#*\C1[_51I)NUH
M:@1Q7*X.R;VSQ?(AFZ3)=NR>FUX:1&P=6-+%=;5Q<OY::7ZAWRK^6[>.?B-B
MLKG?.>-^1F+^.6"Y]<Y;PSFN?X_P#D[3<QY'--D*_"L-P@6.0\EQ^%Q-:3(2
M7KD$"Q:((059G7+.6>[>6<QGH,QY\9DC7H]J.AB>71@$-$>^1[7$[B7AP"(`
M'\;'8.&P(\@"1LWKNC+200!(Y@;*Y"XOV,#@`&HT@W6B?G'*\JX9Y%^<_(L=
MYU\YX/Y!>5:WP'YGQ2+!W.15Z.9XMY,Y[X;L>2<_6-?'C'UI>.7\T:=.NTB>
MS3GDCV,F[25@XFSF..X3&);AN]YF*4V);`_%S'Q%38@N<`=1^G&#H%AG)=)Q
M?]4RFM=,/;,+HR`FZ=F1$Q[4Z+$QSS;\SGGK5R_#''?DGXB^07",O#\D?/\`
MY`Q?B7]32S\5N)<1YIEI+N`S'C#GGA#FGD3D&2Y0JTXSF;L_*\16CALRL8:L
M9*1A21U5\/DY<N#[8RVP,?G<APO+.+2"C7X4IBQ6A38G<]SB;N4%4;3^?CP&
M7W#$^5[,;#^AG!&I,[X6S_%NUS4`_*6&QW%(!_3Z^2?S[Y5^J!C,)Y#YORF/
ME^9YWY"Q?GKQSR;D')9L:.*8O%YR/&1TN(R\93B?%?X35J49ZTM.UNL*%).Z
M1NCC]CO:O,3Q2/=CCBIGO?J]L^QSMRN0AWKJTL'Y5(%FBF_<;9F<DYK86,RF
MY<8C`*,])6`A`H<TPE0XFY`*W6L_COPOY)<@XY\*<UR+Y%_(CDTOS(\(_,7C
M?D?C>3SF0&-X]2\=X'G%[A,.&#0F?'9+^(XN%VL2'WI2=H.TZ=-\@`.+YOBV
M@.;_`/'\3*#CKZJPN0>&Q&$:GS$_FMJY8&1^XN6Y4%K?I?<[\=K`/*8I7O8I
M'^4*6]-$1+]-OTI^#5N>?H]^0/'/C#RCY)E\I10<XH<BL9F]G*>3\?\`D+'6
M;5VIA>-V;D&/FBQTE>M#*?9>2-I)GU;4D=3O=+\E_MGA<K!1FS$CD8YHN[:X
M.>TCL"K`"/R@:BLUP#HL?W+F19P5AR9&.6XV.+V-?VW$>8GN*HIXW\\?,#Y!
M\SX1C9>9>3N*8WYJ<OX'XXP21S92(<(B^-<O%O\`S3S5)UBK?PM^2"CE8Y'!
MA6PX'=]>I>*,7*Y:/TK83I).6!-V^@TSQ,QCH0'.BC)'^==MKMYF_BN.F=KG
M8T7].)0$F=VTF<BXLV3Y!NJU7BAB;EORC\-_)WF;R'Y:XIQ$?(_YH\3NY;"2
M9R):-VKF<L_$*7VF-Q\[QPYN[+#5FD9"'KN=6`U/5!Q8>V'A?2B;)ES>W'.`
M=<&0"5NTK8!R^866M'[H0Y_+,CM##RF*+'^0PQ$N\2U+&Z7JPOZ>?$/+OA'F
MGZ:/D/`>5_+D^%\^^7/DGP?G7B_)22)X\P?&>,7[-C%BIA$JHM>S>MWY9I+$
MY+NVFTC3OH^+<(LO'XZ4>HR7@F2ESM0]FT-#>C4:407**=:K?<D'U'_R_.]5
M)L+DX@Q`!O;,?,7=T2QTKL]^LWQ;.6O''QY\F9#A>8\E^$O"WG[B/D'S_P``
MPE5\C9S?CS&7J,MJU-B8MTN5IX@PM/+"J/JBG4=4K)H<+W-P7(9T:X#63,WZ
MB*61NV.4CJ&GPIB!K\G@?<.!C._ZV2-A#=#(QCMSV`V0I?[JXI\M\^/\B?*_
MS?Y5X!K>-O(?@C)_"/S;BY>5\$^/?(O%>?X'2AQ^/GXIPKD&8S.)PXY%E,A>
MC<[J\4F]8CWT'43/QLJ/VG[M=G$^H^?#<U[2C)7#*:``S7R,/FMK>K3AY\9_
MN3V6W#;M:R9"QP5T8,?G<7Z(YX&T*2!:D7PKXR\_\1YM^ER?EQFN#8_XXW$3
MF7A3F/B;Q%CN/Y^IY*JX*S4QGCORWR"I%7Y-&EN"S"XN2>]#,S,`OTL1KS(^
M/W;G!P#O<$.#)],/RPY`E8P2!19KHRUEG!;DC\U8Z%K7^W`^(D<3)F-&0OFE
MAVR2;7!=6O5R;2$1#H%N=^I-Q7YF_*#"_'GQ'\K?"OB[QCC>8_)>7A?CZ]XN
MYGD>>-D<3R/BV<Q5?.\CCD'_`&//0>6K.H#)J^H[:=8_D(I#D\?D8KG_`-?C
MP.0>U@'E$L>.)(=KNYE:!6MXR?&QN,YQV0-W$_58`?\`XG1',8V4(G6(E4T6
MJ5_%[*\Y\X?,#XN_(_EW&,YC,E;PGR"\*(EZAD0]:KXB^'7)^/WC)+8@B]M+
M7))YP/I`=QV+'JXY%V/)[<_W.S\5B#E/;\N4.I+3G\?&QOQ`8YR:W-JIIXWP
MY'MCC'L+7<;RL&.;JTG;E/<X?:T$Z6%ZS^-_FWXW^:/@=\'/AWXDXW<S'SDX
MOYL\,Y?WL=XNSN+RO`_Z+^:*W)^5\IRW-[.#H8ZSCZ'"8+`F'WD@='V:?E;.
M'UON;VAR7'C_`*+$:QT[P=K6QC&<R5K@4W>J?TA8HYX=T6H>0'8F%_N!BYSO
MU<J7+;"U-Q,DDY..X:IZ;]LIN/*TCPKHU^H?RGYJ2CQ#SCY7^!_&W'?B9\=/
MGEX3\F93DWC;D>1\D\@Y1X4XERGDL%_E7D'A"1VY*M6MQW[2Y:K10N??G:/8
M0-.J/`R,?'YGV]RO,M])YQLV)S`-\;)\G#<R'S:^6<AK')XV)J7D8^1-P_.\
M=Q$A>=^._<3L?)CP9#7S-33]2(*YJ].P4<U/(/FOPSX6^'9\O/XD2?DGG[YI
M_*2Q\/K_`#+C_)).+>+/$?DJM2PG./+M[@]?&V8IZDE&OMQ].>H)A+;#1;"C
M:UT6#+%C^W_;F9.<?F)N,>,F0J\PX,F9)-!$-1ZI&U@(OM:XDIM#K:3-@?G\
M_P`[!%ZO#,R\4PQ`;?6RX<1D;W'0[&O$CG="7M">8D=5/D]X@\=YC]`Z;A_B
M3GO+>5<+XKX,XOD^/<IP]'+\;R'-)<9/CI++W,%DJR92MBLG;,C-3DC#+&0O
MX=6/O/<Y_'SB(LCBDQA&Q=RQG8QF]-3L(=>X=<U5^TGMW\FW<"^9F67E$20B
M1[PSL-P+1TVV%<IOD%)R[XYQ\3\0\F\^_)_Q+Q_QS\4?%G+/@SC?'.)OY*GY
M7\[<KPM3E/)L/S*SA<0]?(O5Y/DXJJUKQAB2#12_8[I.=DY<G.>X'830[W%C
M\A%!CPD?INQHP&-D_P`)=(YI=(;G<24.E)PX\1_$^W'9J1\)D8CI,B1OYVS.
M`+F_X@&-0,'4=1K71CX6\,^17R)_4=Y3R3Y(^4?,'$<OX-\$_&SR1;\9\=SM
MC#\!SGD+D/%I:><K\BQD<9HVH"D[RV:D.U?N7^K]C0S\6#%QS[ESL>3U/3Y,
MPL!NUH?C@R;1U#9`0PZ`!0JU`RY<F7$]JXF1'L,W'S2/(LY696V-2.KHR"X&
M_P!E.+]27X[9OFGZGGQJ\A\3RO.[G+\5\<_+?,>'X2E;67C<'./'+PW.)T(J
MMFI/3KIG,G/']VA(,Y5>XZRV'+E8/+>[Y<)N[*'$ME82%(<9)(RUO@UHWM;_
M`(RO6M%-]/D<1[5BRD&.>5DB>-`6ED;]SO$D["[_``A.E<T_C1YC^2>?\C04
M/$/F[Y+>2_/?-/%GR`/S3\:\[P>2H\1\5\FJXKE"8"/A,UVC6H8O(5,A%26B
M*$C[V8=UU*B7R#6C@>?'$R&3@F<.)&S._P";]3M!+6_S?GW`_P"4'7HSA[/Z
M[PSN1:UG)GF8V.B'_+^E]0!SCT0-2_W=VS/\[?)?ECA?A3BWCGR/YH;E'B_]
M/[Y*X?S!//2Y?B%7R]Q_@?*;522Q>NU*\68S^+G6!XYXFD*N%VMKU)S?^ID]
MV\CC.3!=@87I=PXY,(D+1J"A()ZA>E6&`['#\'"EA_ZIW/O<ZUA"62!C"=$)
MN&^%>EO]*#P?D_%GQ3X+S7D?E/RMY0Y=YNXMPWR/RBUY1S\^9EP66R7&J)L8
MKC]>=$;%XM'8DQ'5BW<GJ]Y5L>+(..@:/2B).[^9Q<`2I[#H.E8;!DDR@<V9
M1*Y6IH$:]R$#N5O\JZ<=5-6%#HHI*SG^QLI_J%K_`#+]'445\N3HHK__T?9[
M\`O^![XB?\MWA7_=SQSHH[5;OHHJM_RS^4/C?X=>!N>^?_*5EEXSP7$R7SBZ
MMBK#EN07BRQ4L)A8[4B+8R-^>1411KIKJ1H#U"S<UF$V$EA?+)(UC6C4EQ`^
MP*KCT`)-3<'"?FRO:'AD3&.>]QT:UH))/B40#4D@"]-'P#\U/#OF[Q'XH\IY
MC.8+P]9\R5KEGA?`O)G,^(X;E^66IDI\:%Q5*3+1G-M/)$&3[02G1U![G3JU
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M:5PM83B,SL0$W'I(>QVS:\'=)L%]7HNP=W)?:+I=*68I6MWNB<&["]4*;`4+
MO^$$@%V@)1:3\YYF\/\`&*6:R7)?*_C7CV.XU<HX_D60SG.N+XFE@+^3B6;&
MT<U:OY2O!BKF0A8/!%.T;RJ05!'7ADC:(RZ0`/>YC;CS/8%<T=W-%W-%P-0*
M/1F3=Z3MNP/5#^0E`[_A)L':$V!6C7)?+/BOAG&<;S7F'DSQ_P`4X;F?M?X1
MRWDO,^.8+C.5^]@-FG_#<]E,E5Q5[[NLIDB]J5O<0;EU'?I4CA%(V&4ALI5&
MFQ*:H#>RA:0P&5AEC&Z((I%P%TN+7Z5`',/FEXGX3\E.`_&[-3^QD.?^'>2>
M;*/D"7*8JOP/'<1XS?EI7)LCF9["5HHY!"TJS^X(1'W+:=(AE;)-S44A$7T,
M<3I"_P`H_5=M:+HA5->]2W84O].P.1B_49D91@8UH+G%PC]1;*H3MUJ;_P#S
MO\+?QSC/&/\`S>\7_P!)>:T:F3X=Q[^G_%/XYRW&WS,*.0XSB?XM]_GJ-PUY
M!%+5CECD,;;2=IT=:TODDB8"96?F`N6V#KC4>4AU^A!TJ&?*QDCK1NT/0WVV
M.AN"/C;6F9Y\^1O#OC_)XBQW(:>1S7(O-WF#AWAG@7',/[)R.2Y!RNQ(;&0;
MWB(X\3QS$UI[UV1B`D,6FNK#IN)WK<G@<9&U9IQ*XGHR.&-TLDCO!H`""Y+@
M`M./C]/C^1Y%[@(H&L"=7R2R-CBB;_F>YUB;``DFJ!>8?UD/"OBSRKR7A.)\
M0^;_`"CXY\<\HH\,\N^??'O#LAFO%OC/D<F0JT,QC,QDH*<LM^;C;7H?O/MM
MXC=RG[2GIOCLB/D/0D"QXDTOIQ2.LV1Q=L&WJAD\@.A-PH2GL[#FPBZ$C?FM
MA]5T3?S,:6^H-W8F/SI_A(KIM+YC\4T['":&5\B\+P.7\D8^ID^"<?Y'R7#\
M>Y)RRG=2N\#X'CV9N4LSDY#]U&K)#"[H[A6`8Z=2G,+<S(P%#LR*[F`@N`5P
M#B!?:2QZ.T.UR&Q2&QX?BPYH!&))9KR$:2C20";$@.:HU&YO<5IR7F_POA^0
M1\3R_E[Q?BN52YNOQJ+C62Y_Q2CR"3D=Q(9:F`CPUG+19%\W:CLQM'5$9G=9
M%*J0PU;A<W((;`X/<50-NNTH[1?RFQ[&QIR5KH&>I.TLCV[E=8;2J.4V0H;Z
M6-17QGYL?%'EO)?)/$\/Y[\8#,>(\I7PW/TR7,,%AJF!R5FS#2CKRW<M>IUI
M@+]B.LSQLT8L.L6[>0O3<$T61BC-B>/I3,8@XV#GAN]&KJ"U2"+':Y%VFG9\
M:?'R1B21'ZCT1*6@*6L)(5R:$(I!N`02BBI)/G_P0*''<J?-?B08OE^2L8?B
M>2/DCAPH<HR].5(+>*X[<_C/V^:R56>14D@K-+*CL`R@GIX`F6*`#]=[=S6_
MS.:2@<T:EI-E%EM3"@1R3$_I,=M<[HUR*A.@*70W2]5$\J?J2^)_$OE'S1XS
MSO%.76V\##Q1<\@<EH"F^&QV"\KIC'H9]06]]\?A%RT7W6@+=_IZC8N0S)$#
MOR,DY/Z)3TEV[@3X'0>-64G&RQX\60'@E^%+DAHU+(GEC@.[K*!VJ^MGEO%Z
M/&3S3(\APV,XDN)CSLO)<IDJ>-P=?#2UEN)D[64NS04JM'[5Q(99'5`O<G3J
M3D?](]\>20QS7;3N(".5$OU6WQJMA7(:UT#2X%NX(";(JIX#7M52?-_SV\!>
M&.,>*^:Q<KP'D?A_E3S#Q_PS0Y5X^Y9QKD/&\%G\[%-8:]G,[C\A;Q=6CBJT
M/NV090T4;!CH#KTT)$Y##X^1I8^:*20.=9NV-NYQ4].BZ5.Q<&7,Q^1GA*G&
MC#BT*7.W.#0`!=23;O5C4\S>'Y.%3>2D\K>-F\=5Y&AL<]7G/&#PNO,DGLO#
M/RD90X.*5)CL*M."&[>O2Y7-@]$S.#!(FS=;>JD;5_,H!(15`/:H;&OD,S8V
M$NC_`#@!2U$7=_A10JIJ*-5O+/BNY7H6Z?DSQ_;JY7C]OEF+LUN9\<GKY+BM
M#3[[DU":+)-'<X_2U'NW8RU:/7ZG'1(1%ZOJD-]-H<Y;;6N_*YRZ-/0FQZ5Z
MR.25C)(V%S'/+`0"07BY:"-7`7+1?PHI<\T^'<=3&1R'EGQI0QYXY'S$7KG.
M^+5:9XC-8>I%RD6I\JD']');<;1+>W?:M(I4/J".A[FQ%PD<&EKF@K9"\*P%
M="X7:-7#1:&12RL$L<;G1%;@$CRINN+>50O90M.OB_+.*\XP5#E'"N2\?YAQ
MK*(\N,Y%Q?,X[D&"R,<<CPR24,OB;-O'W$26-E)CD8!E(/<=+<Q["`]A!(!"
MA%!N#\"+@]:;#FNW!K@4*'P/8TX.DU[0Z**'110Z**'110Z**'110Z**(2XK
M&3BT)L=0F%[VS=$M.O(+AB(,7W0>,_<>T5&W?KMT[=>(-$LJ_/O\?&O=SK'<
M5`3Y=JQNXC$Y&*&#(8O'7X*Y#00W:5:U%`P&T&&.>)TC(4::J!VZ]-W!Q_,.
MO6@$@;04;39YUE.&<+XGR/GO+Z5!,!P;C&;Y!E[SXJ&_/0X_A,=9R65^VA6&
M2=T2E7D/M1_M^FG?J)G9F/@8T^;EN2%H&XHIN0!\;FI&'CSYF3C8>,%FD>&M
M"IYG%!\*:?B#G?BGY`>,N#^:?'E3'YOA7D7C6*Y%Q?+W^/Q4;MS!6ECLXTSU
M;M9;=7VO;5EB?3VV4:`$#JSR<:;#R'P3A)FD$WZD*"O=#K47<"9(P?R/<P_%
MI+2/M!J5?X7C-V_^'4=_W0O;_M*^[[T(8A<W>WK]T(V*^Y^WM.FNG4<6VIT5
M/!=4^/6E*;WUU\:T_P`+P]6U8RZ8S'0WW1WLY&.C62]*@3Z_=M)$+$FJ+H=6
M.H'3.1/%B8N3D3';CL8Y[_\`A:"YQ0:]37H#I'-;JXD`?@*AWX\^9?$'R7\1
M\)\W>&WBR_CSE4&6EXEDK.`;"V5AI97(83)^WC[<$5F@'OT)E8:+[B]^X/4E
M\+HV8[GM02P1O;_P2,:]B_\`A(MTTIS)9+C9O(8,SO\`J<?(?%)=1ZD;BUU^
MJ'K4TT\9CL=')#C\?2H13.TDL5.K!5CED;LSR)!&BN[#U)!)Z1J`TZ"F>J]:
MPBQ.*A-=H<9CXC4:5ZIBI5HS6><DSO7*Q@PM,6.\KH6U[]`MI:R?+M\*]))5
M2MU^?>M3X'!R)'')AL5)'#,]F*-\=3=(K$AW23QHT)5)I#W9AHQ/J>@`!$Z!
M/E07.*J3>MJXO%0+7]O&T(EHM++4]NG705'E&LTE8+&/8>3_`!BFA;\>DO>V
M-KI'%`UI^P?MI7JN<H4W-_'XU#W@SY`>*ODQQ+/<L\6Y6?D'',)R[DG`<Q)D
M,3:QVWD'&+C8[-TC5OQ(T]>*P"H?0I(/3MT1[<C"P<Y@7&R8_483U:I"D=+@
MV-/9F/-Q^?E<=D#;EP[=P!5-[0X7&OE(J6ZN!P=&&Q6I8;$TZ]I=EJ"KCJ=>
M&RNA&VQ%%"B3+H3V8$=*-QM-V]J8!((<"CJWR8O&315Z\N.H2P4V5ZD,E.N\
M55T&B/7C:,I`R@]BH!'1_,'?S#KUKS0$=#6^:I5LF%K%:O.U>035VFACE,$H
M&@EA+JQBD`]&70]'4._FHZ%O0U6_DOR/^/W$,C@L5#E:7),CD?+V&\*FMP#C
M\W,9.,^1.78S+9*"ER=N.U+B<9J24L1.+ENP8X86*QRL&<`MXSV9<F-!CD.;
M,)6M/\A]%OJ2-W?EL!8+=UA<%)$D$\46?-*-IQX6S/!_/M>]C&D-_,22\$!%
MVJ[2I_I<<X]C9Q:QV!PU"T`RBS2Q=&K.%<:.!-!`D@#`]^_?IP$@$`VJ.225
M-S2G8K5[D$M6W7AM5IT,<U>Q$D\$T;>J2Q2JT<B'\001UX0#J*]!(N#>DVQQ
MWC]N"M6M8+#V:U-66G7L8RE-!55N[+6BD@:.!6([A0->O3=VXW<B+U0:"O`2
M!M!\M'!CL>*8QPHTQCQ&(A1%6`4Q$/2,5=GL>V/RVZ=!\VMZ!;2U:K.'Q-QJ
MS7,7CK34BIIM9I5IVJ%=-IK&6)C`5VC39IIIT"SMX_/WZ_;1_+M_E[=*,I3J
M16)K<=6O';L*B6+201)8G2/_`":33*HDE6/7Z0Q('X=`L"!HJT$DHITK]>K6
MDGBM/6@>S"K)#8>&-IXD?0ND4Q4R1JY`U`(!Z-"2-43Y4=$Z5#7(_*_C7@/E
M7@_C"]BLM7YOY6BREC"7,-PK)W<1.N*0RW#R'E&.H/C<2[!?H%N9#(?37I$!
M;--D8<8\T</J.!LW;NVV)L2I_*+I>GWP2-Q/Z@XCTO5;'JKMS@HMJEKNT%2E
M'QOCT._VL#A8O<$RR>WBZ*>XM@;9P^V`;A.O9]?VAZZ]*0(B6IG<Y5W%57YT
MK111011PP11PPQ*J111(L<4:*-%2.-`%15`T``T'7I)-R;UY6SHHH=%%)6<_
MV-E/]0M?YE^CJ**^7)T45__2]GOP"_X'OB)_RW>%?]W/'.BCM5N^BBN:GZN/
MQVY-\GO@AYJ\7<"\=Q>3/(V0QN-M<%XY_P!E1W6SE3+T)ON,=9S-NA0JVXJB
M2$.\R=M0#KU4\KC23'CI8(UFCRX2HU#/4;ZGRV*HZBK;BLF.#^HLFDVQ28DS
M4Z%YC=Z8^._:AZ%#7#_Y7_IJ^=:'D7S!Q[@7P1Q'GKCOFOP_XBX-X(\A8WGG
M%>(X_P")7(>*XZFO*[<N'R&0BM5(;N5FDG,N.VM*Z,2S`Z&QR&39F9S6*R<P
MY4G*^LS,N?\`IP0(XP/S#TV-VM!"(1:PJ-CY$4&+P.5D1>O%%QYBDQ;#]8@;
MG*?*=[CN)%U%C<JW_/GPJ_43X;-\KO"7$OC5R'S_`(3Y)\2^'MA_.N.Y_P`+
MQ>/P^2\&57K<IHW,-G,O7RV6R=FQ(1'WA41('W/NT#C7MRN1QFNB]#"QN>DR
MVN1=[)&1M5!I=FXK?\UM#4W`S#@0\+(96S94?#R8KE*!KW23.\Q30->`U+$I
M<7KIC^G%\"\SXV^6OS0^0/G;P1C\/RG/>6<5E_!7D+._P+*95^.3X&U3S-SC
MDV-R>0L8N.9Y%CD]Y(9&UTT]>E<.F%[=^F_)GOS<ISQU,;YGN8ITVD$%%^(J
MLYA_U?)\:]AWX<?$X;#V$T436O"&^YI:BZ6L34<_J:?`#SQY\^3>*N^(>(6L
MMXL\Y<-Q]7SIGZM[!4JV`S/B2*YE.`K;K9')5+UZ7-7IUBB,$;;)54NP4=4D
M$$^)E<U.R`E\9&;BFR'+CA?$QFO\V\Z^5#>KZ+/Q787%PR$![B[%G)51BRR1
MRN<.B-=&!;S7M7,_Y(?IC_/GGGQC\)^1,=X<Y#E_,M[S9Y/YEYQ\1U;WBOD?
M)%QE_C'$>#^.LFD/.+F1X/EUQN*XK+)L;W)*XO,5`8GJ=)`_%R>/A8\RX+L.
M3<G_`-O)FF=-,Y77&]GI1DLT,0NAJ`_*BRL;D1M$4[9X@P$KZD,488P#H"UQ
MD>A10\G44U?./Z5'Z@]/XE?"O%<7\?<^\BW/'1\OGF7ANS9\(\CY3P0^0>04
M<Y@/^S^5M/X[FKT*E62`BI&STPXC31=>GLZ)XY@N=+Z^,[CH8&O:/^68RXN:
MKO-=KFMWM3<8@3TJ/%*Q_&3L!$>1]:Z4L0`/#F!J@-1HVN:YR'_U":>7)/TC
M?G=G^'?&SAF(PO*Z(X-\5/(>-Y+)RO,<#R<$^??RQ8\@\?\`!?)+>/S$$5:I
MR&""O$TU.-J\,9]MWV;UZ7E/DQN5Y?/$3<N.*'`VQZ-R3!(KFJ[K$T[F[D#G
ML::EXSX)N%P\&3,^GEDY3(>XM`!A9+BF,2`-";2\D.#5*.=:I,\[?"CYI\I^
M>GQT^1?A[X<<AXS)?P7QSFY]-RW*>#N5^,^$V^%2U*7(\;+7RAGY=PP\<Q=>
M143#2L)9$BE1B6V+*X-K./Y[DM\R<9+R,LQ<5+C',`9"US0'*02&L-FN\MVA
M33<Q)+E<#B,BC!Y*/!$;0U``]BAC7-<K4W`%S@I<T[OS5V%_4&HY+%_*[]*#
MR#ET/]$,%\H,_P`.SUA50X[&\M\C>,\O@^&33R-JT1N9F%ZT#::;Y`-02.F^
M)DBB]V9D9)3*X3-BA4?SLD@R'?`F&*3XW`IS*$CO:LI-GP\AA22@=6.>8M/\
M+)9&.+NEJJ7P/&_J/?""+SE\6O"'PM@\\\?\F_(#G/E#Q1\C[OD;AN/\=<<P
MGF'E];D67@\G<0S-A^1VK/$GM7(V$3?O42)P"#MZ@\,,C^C^V.$RF-A/',CQ
MW//F:^"*0N:]J7$CHK%=).Z+4SE7XQY7E>9QW.ECRVF7TP=KV3F/:6J;;/4`
M<`-(SMM5;OGE\!OEGY1^2'R`R\7Q'Q/G[/?)KBWQ_J>)/D?1\C8/`8_XC9KQ
M_B+>.YU23%9>]#FX\9)FLBMVK+256L)!]6XC3KSB\<PNR>-9._'G'.RY@S=7
M28LKFF*%`=P?CLC<Q+*'MZ;=OF7D->,#.EC9/`.';BG%T$>0W=OF!-BV9SQ(
MO\I:X!/-N:'G'])KS;RSBGS9YC:\#6_(?R"R/E[X^6?!OD-\IQR/D'(\!PWA
M/",3S/E/'KMGD5=<8EC+XNS).++03N0=%8:$O\5(_#S/;>5CPF!O_P`GR<B<
M=68LF1(^-=59M<THU2#J`14O_HYO2@SL@31,]LL@NJ'+C8X`#J'%P%_RD%"4
MIK^7?TT_/]OEWS9\>\=^%%W,87S1\@_"WDWC'ES&Y?Q_6QF9\=4?)/"<ASS@
M2T9<[5S,4;016<K8W^VK?:,`K2%=8G%8VV+V]C93-F+B^X))7M-P[&=#,R-Z
M#^6,E`VY270`&D9&4"_DLID^[(G]NB`=QEABN4G^9Y`"Z*T*:EGYR?IF>1L#
MYEY*/!WP4X]Y_P#$ODGXR8+PSXAJX'F7&N$8_P"*WE*'/7\IG/(DF)S%Z!I(
M\B^12>2U3_TAY(2-WYO;<B;+]PXKGEF1DYL4D&7_`.E!&"WT`/S`-_.T(ERE
MUJ/%/%'@^W<B5HD;CX\C)\;3U)7M;^JOY27(&GMM'A21Y+^+'GOXY^&OG99\
MR8:_E*O//AK\8O!G"^<SY+%9&'G7E7$</X1Q:_A<1''D;67GL8?.U)($EGAC
M]U:V]6(.O1RCVY,9P8`6Y>5[HA?$4NYH;&#/U3>8WO()4$D&K/AG")GMZ:29
M8\'B<XSD7],/DF<QJ==K9&`(MA\JZR?*OXU\\\M?I1T?`,7".3^1/(D'A7QO
M1/$>-\DP/%^0W>2<<P&,<Q0WN1)/@+<E2[7T>I9TAM;2C,`=>G?=L;LGE(Y\
M5I>Z'/:]0A'EW-+RTV<TJ21XJ%2J/VO*,3#<R>0-$F(]MUON((:"+M)'7P0Z
MUPP\#_IQ_-[DGQS\;^(_-7Q;&/X+COG5XFYYD>(96KX?P?*I_%F+P,N.YKF^
M9U?'M[%X'(X.NLBQ1Z>Y>E#2#8RZ=2=D,_)>WLC-1S8?JE1=K0]@V;A_B<\?
MRA$U2I&#,V"#W-$UY:V7!8V-45THE:2&D=`T$^8ZU)W*?TV/DCPK&\REP'Q'
M;RUX-\:?J,>6?+N`^*(YAQ;C>+\G^"LS5DQO#[G&!:S,^)BI5(BGM4[H214_
M:BU!'5=AR9$47MJ?DX'9,C..R,9S2;P2OE<YDQZ'R#;Y5-Q\IO)_131Y<'&3
MM@+VX<KB`4E<R,":(]B)"7=`414U_<?^FO\`,?C_`(`P7+N$^#I>"\T\@?([
MRIAT^/E'EG&\L_A+XO\`R#X]_#,]1L9V;+18F6/A]S$57DJ568CWF,:>NC@X
M^%L_!8>;E.R(9\%V-ES!?+']1'/&Q"=Q:QHEC475X\:C1<B0WF\K'QVPRPY$
M>1B1DA/59&8)#;R[I=S9+V2-.H%)7(/TK?D;G/CC\E<-S'P/S;E/,/'LG!_#
M'QPP?'^;\"H9;D_BWQYG,IR^GR[&UL_;R?';F)NY[D$P.)R'LM81-&T`T*<F
M7*FQ,#/?&?ZM/R#99@$<&,AQFXL>YI\I4-+O*I:7JE.,DQHLK*Q(G#^G1X<C
M6%2/4?+,9G`)=I:K6A0C@W;I793]&'Q%\DO"7Q%GX1\EO&^*\6\BA\C\GR'$
M.,U\?P;%\@/#;<&-6E>YG1\<JG$H>0SW89E)K*NZND9('5_G31S8G%-]4.R8
MXBUP&[:UN\E@\W\R$EX'E4VK-X[)6YO).+",9SF%I.U2[8`_\O\`*J;5OJM=
M;NJNIU#HHH=%%#HHH=%%#HHH=%%4]^?/A:_Y_P#B/YI\;843GDE[BSYOBWVK
M2+:/(^+6J_(<5%5,,D4GW%J?'>RFA]9/QZI^:$[,6',Q0XY&-/'*`W4ACQN`
M[^0NMUTJZX"6"/DF0Y3DQ9V/B>51!(TM%^@W(IZ!:\V7A7P=\P?-/FGQR_+N
M!^3>)8GY$\F?Y<<OFS5&_2Q?$.?>',-RO`<)XYG9[<D*XRYELJN.=(28_<CC
M5V1@>K-[)S)GY/&N#9<3#SLG')0`Y/)L<UC`#_Z#@?!H>-*:9+CXV/CQ9+7+
M--BXLFTJF/A.9O<X]1,T?-+563]/KXU_J"<?^9O,\Y/#Y8X-YO7C/FBOY8S.
M7\?<DK\7YWE;V,RE?!?QCR=E^?7.(YYXN0/5GQTM+'@1ECH`H)$:**;_`.-\
MHWA1L!PVL#''8X2%S22`[<XRJ'^=4*N.X;@29#H3ST$O(['@98=ZC0K=E[!$
M`C(+5:04`:$4)2'^G_\`&CYK83REYZO\GP?F/C?([O@?SWB_.F&R_C/ET&*\
MD<CRO!^4T\%%=YME^>97$\NS(S,R&G+C\>-S2;0`#KTSR46._P!G<Y'QT(^@
M=CPM9&A:X.$C""QA!<H1V[2U.8IE9[LX:;+E;]4SD&.=*JC9N\RN!V[2$(U1
M*EOPO\7_`#IC/@'\L/%GF3QWYQXWY6\B_&;X[<C\>>0O'/`\WR/*6?#O!+>+
M&9\)W.,G/\>^R.*FI/!R"C';KY#(8^]8D@BL%/:-K[C,.3$QT;`<G%YR&3*!
M!='DB2,C&<>ICA/E&S=Z4S(WR;0XN$;#^IAY?+?--OQLC!RV0D$!V.1,?J`W
MING:=P+D,L9>UBEK0>Q?Z`/'/)_"_BUY`X?SGQ%R+QCQG"^3[3^/,IR3'<HX
MM:YSC,A3-C-Y*#Q_RWDG)\GPV#$Y<&L4$XBN/K.!JQ/5KF2>KQG$&0@9#1*W
M:"''TPX%CR0`1N+G@-*EH8.A%9^%KF<GR3&@F`LA=N(+?.6N#V7)7:&L.X6.
M]-6D#FKXR\+>:?'/ZYO->=<?\7>9/)U?EGEKG%WD_-^=\(Y5PVIQ3AO(>!K[
M=G'^1:7/\EPCEG%\#7,%;&TC1$DU8QHR1RI[<>.X"&6/V7RG$RAP:>,S(WR.
MM*Z0>JYA?'YM\LLJ,)844[P2"IOO=<F_D!FXP#IOJ,8MC;>/;Y&N#'^7:R.+
MSC<%ML(!M46_$7X/>>/#57]/_P`E>'N">7N(^<O)/B#YD<;\MY',VN3Q8[!7
M*_'N>1^+L)E\=EYOX+Q&DV2>O+23VX$DL.LG=M#U-RWYK</F>/XUZ-E]O8;@
M;*Z<&`O`<?YVL5H"^4`"U:/.'&3<QSO)9SPYT7N:3T[J/0D?)N<&C5IL2Y"H
M-8?&CX9^2O)/*^/<$\7>&/DOXAY/>\+^5L+^H9R[S!D,JG$/(_D:Q1MV/',O
M%Y<GG[<'*K<7)())8;.,2-:^]2PVG=T_FQX\_&\^>&)A]OMQ(78\)"2G)C=N
M:6@C<TM(=N*W!(LJ.H,+)EP^4XJ7D3OYGZUXFE:59]*\%KPOY?,"W:-0G@H7
M_&O@3Y@^:>9<$7R/X]\K<>Q?S!Y?P?A/E,6L?D:\/#^)?%:7BWMY3.-/+$N+
MBY=)Q^_%3D/L-8$ZL"X(UGXC\?*Y>+(#2S#=))RR@7;.L\44!!L2`V$[?%3W
MIO*+^-P)(X#NRX(QQS=I4F,[7/FW=0CWJ1V07I]?ID^%/-7AK]6/FTR>+O,G
M,.+<AS'E@\_\O^4>$<J\>7N.TK=7)7L)/:RS>0.1\-Y]6M7'BI58Z]?5(F24
M!64[6/:[RSV[)B/8UD`QVJ[0F1CK+&X$[WE=S@;%;D%2Q[D._E6SQ.+I'9'Y
M45H86H2UX(&UH_*"%(0:VKH]^M?XVSW/<U\/KG,/&'F7S#\5N.<XYY/\@."^
M$9<@_*;EN[B,#%X[NSXW#Y/&97(5:F9BG*F*0+`=S,R@]ZK9".:=)FQ.=&<*
M1N.0I:S))-W)HK=H!-K'X&<Q\G]$RX\25K9OJ(S,#^9\`U#?@Y2YHN;=E''#
MX^_!+D_F23X%>)/+O@SS1A_"UOY)?+2_Y`X]R%>58?*8GAV3.'N\67F&>Q]F
M.U7CR1IJBS-8(FVL`S=^K'BXMW(<7)GN8Z2'@S<69Z[99'``6"@H42_:E<MD
M-;A\^<`/#).1PMH<=SS%Z>UQ)4V`\?*$!N*;><\(>>:OZEN.Y?XV^*WF+PKQ
M?BV?\B>,.897&KY#Y?3Y+Q27Q=R7%\*LW^89;DV5QV1PN=@Q$(%6E32O2D2,
M/)N*+U0,FR<KVS[E.0'-RLWC<K]#:;3J'%NY%<Y?,UR@$V:HO4TQXF+RO%1Q
M;3'C9F,6S*JQ[@-P"HT!I<UVI3\R'6&.._IO>4&\<37)O%_R#JY')_!6/R7F
M\2MWR%#7S'R!X]Y<YI1XQ!>QXN+#+EL+QRG2EK8YD*(CB01@N6.GY7;!+S\N
M.0\XN;QKL=?-_P`V*(9+VKJ1YVN=JT$A0`E1.(@@S).`BSI"V&=V3'D!4!8W
M<8@[L"=I'<@5,/R\\8?)SR#\MO`G-./_`!@\S\9\@^*(/B?:S?FC%U/(')\A
MRSB];C?CF#-YB"TO*(.,<,."MO=KVL;5QTUJ<M(\X1][%'"E@]TY^5DM]'"D
MY7)9*S4.8Z1[(I"^Y<R>+8=K4;"TAJC;M%9RK1_\>;AM/JS-XUKHG@7:X,+G
MQAED?%*H#G7>YI<`00:>7`OB#FO$/R:O<5X%X(\S8;FN,_5.\(<Z',7X]RZW
MP>QX)_HUY9L5+Z9R:[;QEJ#&9G-U&MNRAT$@#OZJ(?M8Y,6#[?@)$9@/*1D.
M0>8031XS@O\`*6-(!ZJ-25JXYN2.:3WWD%V]N3Q.(YNTW=([(P9,EH3^8OW'
M:-`UP"`5<?\`3P\/Y[AWS1XSE?(7Q^^5\7S.K^4//-GY*^<LER2QBO!.9\7Y
MBYE'\>SSV<CDLOA.<X]</)CX*N.QT5>Q5L!'9V]L[)7MO;'Q.+%C?HXHXL-R
MA)J_,!8I:T^8ETHD<UX(:T:@M-JGW(72<AD291$TKL]CL4Q"S,;8Y`39K0R/
M:U[2-SBJ$'RGHQ^MAX?Y1YS^/OQY\=\;X]R[D53,?-SXXQ<RAX8F3&6QO!+.
M8S6/Y1F)+>)*W,;2H4+Q:2T&40$JVX$`]1L7$QLOW?[/CY!B\69Y&S+9NQS`
M"''H'-W-/@32WY61B>U_?DN"Y.2'$2F$`*XRA\;F!HZN4*!U2O/[^I3\#/.O
MBGY=<$\;^!.'^6\#\?>'<$X/2^*^8X3QCG/EE>`<BDR^1RG-I*N0Q_D#!-Q?
M-R<DMO/-:RGO^_%(@7Z$&AQ4F9D\UFR9#P.7^HC])Z;?^E9&P1,]0^4-#Q+N
M:@*N<X_F!I_.9C-XW`$4;7<>8Y#*Q2?^H+O.XL'F)<STT<"B-#1H0&M^H3PS
MD.`\A_*S)_*CBWFWEWR!3AG@(?';RQQ_D4M'QQQOAM6):GD7&\DJ8[DRT,?<
MR64+%Z$L5J6:6315`(=U<,Z(YN+]*P,Y-WN0F<NNV3&=*SZ=L=K[?,@`"*%V
M[2LLLE3!,SS)Q;>'(C#3M<S(:QWJN>IL7>4EQ7<T;1N4;;E8#X*>5/)_D;]3
M_P`\\4X+S^I\AN,\'X%)\0.66<OG^.8V?.9SP?'C,Q?XH9[U'`Y2^XC6!)I-
MX@E8:%6[]0'PY.+[7Y3Z=KAER\SELG;_`#G#=E/=(U@L1OCT+4)%FF](QYX)
MN6]ILG>PXC.$QW,<;L9E-'Z9?K^5Z%P-NI%44^&OQ2^4S^`?G'A;4?R(\?\`
M"N3_`!]3&\VX=B/"G+Z-_,^2JW/>$YA\E@Z?)?*;W.9YFYC\5>IY)\>:ILXN
M:=D);VXGMLT0?T.0L:UV"<S'="Q$`+'#_P"V/,V+8?,IL\1ZAIVUV+ZS.6A>
MY&Y8CG;*Y5<YKF/"!Y.TN#T<.I&X`^:^KB7QT\[Y_P#35\G>-\CX<\[\'X-Q
M3Y%\/Y5QVYQ[Q7SV[+Y4]SB^1I9O&<I\.93RA%RC#X+#S)6=[U&RR69YU4H?
M:W)YRCG3-]M3S,&^*3(:UGYVEKPPB0D(6.:01&URB[[A;^X+A'+S6/&5B?CP
MDO3:X.#G>0`DA[2H+B$(1MKU:7X]>)OF9DN(_"*KQ'PES_Q?R/A?`/EEQW@6
M1LUN2X^DES)8;/IX\Y/F,?R7,9R7@+Y;-64%>E=M;860./I;4L\G];//SDL7
MESI.`CC`#@2K9PK6OL#(Z)4ON:HN$"6O%3847%OAR'-=CMYV%ZEI"M](JYS+
MDL8]-VH<`=:@_A?QN\UC!\SA^/'@7Y5^-^;P?$KSM@/G9E_)4V9GP?E;RGDN
M+9RMC:_#*^0S62'+<ID.5R5Y:MC%Q*%_:`"@L5RB"3#Y88!]/VL_&QFPPD)(
M)Q+&0X`C<W8%<XE/*'`ZH8W'.+.8X4YKEYYO(O=+*OZ?TZ$$;ORE7(@OT[*.
MI?Z;/P_Y!\6/FUX:RW%.)^4,+Q3RU^GQQ#DOG#+<GN\GRN)R'F^/F-^*S5RM
MG-SVH<;G*F,$>VDK)[*-JJ`,=;.*<,R_>W'-(_I[)L5T'B2QXD+3_,KKN/<_
M"JW(QF.X;@.0<\NY3ZS)BD_]H-C<PEO122`;`[1XUZ8>H%-T.BBDK.?[&RG^
MH6O\R_1U%%?+DZ**_]/V>_`+_@>^(G_+=X5_W<\<Z*.U6[Z**CKRMY<\:^#N
M#Y?R5Y<YEA>`\#P/VO\`&>4\@L-6Q6.^]M14JGW,R1RLGOVIT1?I/U,.FI)X
MHGPQR2`/D>&M!ZN.@'C3T,$V09!#&7%K'.*=&M"N/P`"U6?(_J2_!#$<.XUY
M`R?RE\34N&\PY!DN*\8Y!/GV6EFL_B',>3QU+_1C,[TG&CN4$0/;=WZ=-I<>
M`_\`-E9O8.I:H;N\`I`NGXTR`3'-*!^G&X-<>@)!<!]@)M45\Z_5,^.'B?Y0
M9KX_^6^4\-\=<2K^'_'OE/B_F;.\XKG!<SL^0<YG\/2XOBL'7PCLLE6+!^_]
MX+TJ2+-M,<>W<S>&YV3D<OAO9Z>9BY+(0P_F>71^H3TV[;!+JJK4S)Q/0XWA
M>3CD]2',,V@0,$6Q"2IW;]_8(G5;6MRORO\`CA@SS[^*^8N$TQXMXE@>>>07
M?)EX^*\.Y33@R''N19.6&*2-<9F*5J.6"1"^]'!_'H=+&ULKW.1K,@0.\)20
M!&?\RD!*3%A94[L)L,#G.R6N=$G\[6+N+?!J%?A30ROSN^'F#\B\9\29?Y$>
M,\?Y)YCCL9EN,\/LYU8\OEL?F:"Y/%6:\9B]E$OX]Q+&)'1F0@Z=QTZP&67+
M@C&Z:`N$@&K2T*X'Q`U1:CN:YD<,S@D4@5I[A44?.U(_QA^>WQH^7_*O+7#_
M``9SVMRK,^&\]_`N55_8L5))!M13EL?#9BBFFQ'WA:!9BJAY4;0$=^D8KCE<
M6WF&,(P72.:"?\H#@XCH'`G:M_*;:4YF0NPL]_'3$?4M8TE-`2JM7J6H-R6"
M@*JUS3R7ZZ_&,C\E/*_@SQCX)P?/>'>*?)_"/%ESRUD/D)QOA<6;S7*<U7P&
M1M8WAN1X)D+9K8;)?<)"!?D:Z:^G[EGT5G@YG\RW#F,7I8T^6^%CEWES6^H6
MR!H`M(UF]K5_*X%5!%3<[C3A9&;B^KOR,;!=D2@!`QP##Z)*ZC?M>]$8\$(0
MA-N?CG^JQ\<?-GD+FOB#F7).'^&_+6`\R<[\3<3\>Y[G4&8SW/8>$WI:/]*,
M<HP.$AQL.6>M*8ZDC2,AC($LFHZ<XR3^J\7@\CCCSRPND<P7,8:YS;FRV&ZP
M"`Z66F.7Q/Z3G/Q))-T8BA?O1`?5C:]$4_E+MJK?6VE3?4_42^$%[+\UP%7Y
M->+),QXYQ>?S7.:!SK1S<8QG%K<U'/V\H9:Z1PKC;E=XG4$NSC10Q(U2W(A=
MANY!L@.&-BOZ?J$-C_U$@"FWXN1'E#"?$1E'=Y>OE:7N^QH)/@*+9CYB_!+R
M%X)?SYG?-_ASE/@3C7+L0[<\R64K7>-X?FN$RRRX-@D\)N5LW1RU7W*Q$(DU
MC+IJH)Z7D;,.3BLG(&R220G'<=2]H>UQ8>A`#P>P-]0K<`DRH^3QX%=&V/;.
MT:;';2CQU:26VNI^!1+O_/;Q3D^9_%*AXMR?"?*'B_Y/Y#RW4K^6<;Y'QF&Q
M_%:OB?A60Y=D+U'C]W$V+G,/N)<<]:S%'/1;'H#.Y=!M/H)CSN2Q,P>C'C\;
M]9O-U;ZK(TVC\K4=N]12%&W:MPXV`RX#\O'.^49D./L`U=-OON74;0C45RZA
M+RYX+^7_`,8_DSEN88+P'YLX'Y4S'`)*\?,<;Q+*_?6\";=BY4KM<B>*$M%+
M9H2H'CWH&30GNNKD;'RXK,V-I.(XH'=%(#@/!05"ZW[&H\GZ,QQI;3A;=?*0
M#]A(JR'2:*'110Z**;G)>(<7YE5I4>5X#%<AIX[*T,Y0JY:G#=@J9C%R^]CL
MC#',K*ENG+]4;Z:J?3KP-`EBF`_5C*M/5IT4'H:4'N#)8PX['M1PZ$=CW%./
MKVDT.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT45B[K&K.[*B(I=W<
MA515!+,S$@*J@:DGL!UXYP:"YQ`:`I)Z5Z`7$-:%<:K;YM^6?A#P7X+\H?('
M/\UP/(N$>*,+>R>?7A^=PF>OV<C73;2XS12ID&K_`,?RUQT@AAE>/1GW.516
M80N0SH^/Q8\I['/:^2-C`VY<Z1[6#;T(!>"XZ-:KC85,P<&7/RG8K'-:YK'O
M>76#&,:7N<[K8-*!%<4:T%Q`J/O''SD\9\Y^'[_-#/<>Y9XR\:1<6RO+IL3S
M=,-#R2/%XZ6>*N%CQ.5R6,FGRSQ+]LJ6&+F10=#J!)YF9O"8ARLH$D-:=K?S
M*XH&IU-^EDO3'%0/Y?+;BXMB7$!QLU`%+EZ-`"WOX+5.>*?K4^&>3>&>2^=)
M_!GG3CW!N-^-K'D\V,Q5X-]UE,%#SF;@D,&.AH\OME[=N_%[Z%]L0@.C,)`4
M"\AWTS(S,$D=+!'MZKD.<UO@@V[CX$(M2>,P'\KD,@Q9`CI9F!Q4-/HPMF<X
M67:0[8.NYI4`(3U"X;YO\7\UX'3\BX_FO%:G'GQF$R&8GO\`)L#$.+39V"K+
M3Q7)YTR+U<-E1-;2%H9W1_>.P`G3J1E1'%F=%(]I'J%@<#Y7$%/*?YO!*K,5
MYRXV/BC<I9NVI<`!22.@`!).@2EF;RQXLKXJCG9_)?C^#"9/(38G&YF;F7'8
M\5D,K79EGQE'(/DEJ6\A`R$/#&[2*0=0-.F5\\,?_P!R1I+1U<`0"6C4@%P!
M(4`D#J*<_DE?_(P@./1I()`<>A(!(!U`)Z4IYOGW!>-7\3BN1\TXEQ_*9[;_
M``/&YOD>'Q5_,[Y4@3^$T[]R"QD=TTJH/95]68#U(Z&^>0PMO,`I:-0+W35+
M'[#V-!!$8E/_`"BM^ED)OI8$+\1WJ*>-?([A&8Y5YIXYR".3Q]2\*<MP?$,M
MROG&7XWA>-<AN9[!T<W4M8.])F&9*ZB^M<K;6O*TX(56&A*(9&38L63N#=\T
ML8:3YEA<6D^(<FX)=-0*?G@?`^-B;@Z!LB@%`'D@`^((^%PAJ=,7E<7G,?5R
MV%R5#,8J]$)Z63Q=ROD,?<A)($U6Y4DFK6(B0?J1B.G7-<P[7M(=V-JC@@Z&
MC_2:]H=%%#HHH=%%#HHH=%%#HHH=%%#HHH=%%#HHJB/E+],_X1>:?-E/Y#^2
M_`_'.4^6Z5G#7$Y/<NYR(3VL!.UG%6+N)K9.'$79:\IU)E@?>``VH`Z\X]HX
MN8SX(].4R%ZCH\ZN"Z'K;K?6G,J63-C9%DNWL;&&!?\`"%M]YJ]4,,5>**""
M-8H88TAAB0!4CBC4)'&BCLJHB@`?@!THDN)<XJXFF@`T``6%;.O*]H=%%#HH
MH=%%#HHH=%%#HHI*SG^QLI_J%K_,OT=117RY.BBO_]3V>_`+_@>^(G_+=X5_
MW<\<Z*.U6[Z**YO?JR?';R;\J?@YY6\)>(<)3Y#SKE=SAKXS$W\E3Q-6U!BN
M6X?*9$2WK\D=:()0JR-HQ&[30=SU7Y.,9^1]ORN8'8T.;&^1?\`7=;KKH*M>
M+R8L9O*>H]'284\;?^-\;FM'A<B_2N>?S&_3X\S<;\NX/R3\:OBOX2\^\.Y-
M\=<CX#R'BSE^9PW!L3XAS>3LX+(S>3>/_<U;-+)6I)<2\4\<44=B7W-WNKWU
M=S8I<G-]VXX(^FY&1CHY_P":$1N</3#;':X.WH"U'-'9#$P9A!QOM.26^;Q[
M2)(CI*7,'FW:;@1M4@JTFUU%)^7?I1?-;Q58IX'B/Q_\3?*/'Y/X<\,\!6N4
M<ZYKBL#)P/E\W,N<\@S.:XG3RBWK4T'%ZN?@AC!:(S1JH20$$=*R\?ZN7W'@
MLD='CY4N*&9&LFV"*-CGD"ZO<TJ%!5#<6J;B9L>+A^V9W-:^?%R,V22'1J9#
MFEC`XJ$;=+'2E[R]^FE^HAX[QWF/Q?X7\;\(\R<4^0OP\\%^#>4\\S?/\=Q:
M[PSD'BKB.%Q64CIX>ZT\V9%ZYC7AK,9(HTBVDL=".O<@/RLCD<:2/;@GE<?*
M8\:O$38PY1T+BQ3XDZK3O&\@W`C]J2LD'U.'#E,<'`HTY$LCPXD?F#6O`0:I
MTI0\D_IC?.*A\MO$?DGP-XPJ\&C7!^$X/(_E"SYBXOR/AUF[PSB>'P?(?XYX
MEY+Q:]8M/!7I2UHTJ6S`S;95&I[3^/>(>9Y![GAG&/S)I`"-X<R3<7;='-<\
ME;KM*@6JDS7.DXG'C:K\]N.&`@["'!WE74$-`Z)N&OCU2_39^+WF3XN^;?F5
MAN;^'>)X+QYY*\HR^2/'OE[#9_"SY3D]7*T\=5L\4L\9HUEOX?'XRQ6EL1M+
M+M+R$!!ZF)Q#1C^U\7C)U9D19,Q#?S!T;SY23W:``G^8Z)4GF)&Y?.Y')1/W
M1RPP@V1'QL1Q`_S.)732J*^8?TO//N<Y3\H<WP?Q;P^LWD;]0?PIYOX3;K9C
MCV.L6/$7$IKEODEMF#1R43#;L"3[-]))7U(4GJ)[;BFXU_MCZD;68O,9\ST*
MI!*^7Z=.Z,<T!H_*+5;9N?CY&9[HF;(K,KV]CXS+&^2V&)LJ]E>UQ+C9VM0/
M=_2_^:?)/)?*?'MKXX^)L!PSG'SFR/R3_P#JJQS7#6O(W$^%8W,9:Y2XW!QV
M!%R,ZYV&6,@I9`B$A5XB?J4]OXK\?$]JLRW>A)QHE>X-OZY>V1K8G)H%>"3<
M>5ILA!C<]F19+_<'TJ2-SL#&@:38Q.C&/O>%53^DYMDLXWJ?>(_I3^9L3\+O
M/_&[?BKQU=^0F2^9>1\^<8Q.=NXB>MY;\<\:\H\=YUB.`<DY/5:1L7B^94,/
M+`T4K%('E!D0C4%^(OP\+V-+#C!\N`"9X%1KW/;)'=VA,7J>JPD$;F"U,9KX
ML[D?>##DF/%SHF-AE`4L+6,)\NH$CF&-XLK'%#4.>0/TN?E#Y;\5_*#S#F_B
MYPKQOY/\O^3/!'*?&/Q<\5>;:/$\9XNO>&..9+BDWD6ES>'`W>)9GD>?%UK!
MJ3X^.`0SMNUFC5F1)CG$Q^+&+*^7*=GY,SW?E$$<S"ST6M<NYL@`=(X$'>=S
M0T.+&M13B>;+^H:V/&9@1P-:B^N]DGJ>JXA-KH]Q8P%06-1RD`F3?"/Z=7S:
MFXG\$L?YWXEA^0P>(N6_-B;G?&K_`#GCT>5XSP+S/X1S/!N"\;S?,^+XW%R\
MFR>6S]UXY<C6K-8JP3H6&D0`5FX[<A_.^JT2G(]N'%!:L8=-]:)F,`OMVQ(K
M]'.!)UI>#DF&#*C$AB7F<*=@/G(CAC>V9RH%&]RAEB`4&BU(WZ.'P>^9?Q2\
M]^6+_E3A<GBKX_V.`0\6XMPS-^3>*>8+^1S%/DTUCCUCB^?QG&<%GN-X/!X%
M)(IX++NUTS0M*7>)=EIB9#G<9EMSIMV3)Z):-J.#VAV][G#RD%K@T,`0.5PU
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MRO@:;9R=(IZ].Q,T=EF3WP[`KJ!U/YH";C^2RL,';)RN%)B0A2[&A$\;<DJ>
MCL9SXW#_``M+AYC9GAGMAS<7'R2!MXW.9DR$VGD=`]V*WQ+,AC'M-O,6@V%>
M@/RI\2L)<_28S'QCP/B*M/:K?'K%4\3XOK1,7CYW2QE'*I#!&]S0Y*'D:-*-
M92GNC\NW2/??K9\/(28"R3QO882-1L<T-VK_`(6*`O2O/9,C,/*X[^H.#(WQ
MN$V[KN8[<')W<BI7$#RY^GEYRX[X;;A/B7XZ<CQ]6W^F1PS@]W`X..M''8\R
M6?/?)^6\HP,GO9-B.02T;J6YM&V!'&T_@#F3)D9/N9K`7XYY#C/1"H#%#$T/
MVG4-8[<IU!4U9>U,B+&PO:YS)`W)9-R+I5*$&7&:R,N3_$1M!\*AZ7X#_([D
M?Q]^:N,\7_#3R%\>^+<F\3?$[QIEO#UODL7(LGYE\L<*\[<"SGD/R9A)/XS8
M`IPX''7K,E@21O-'*3IN4#J;E"&>7&?)YN.GY[%EAB1/I8&13LG+DT$CI(_A
ML6JGBWF";CD(CRL?A.5CFD7_`)\T^.1C`+U:0YH47+Q5SOG!^GG@_$/DSQ@O
M#/@-G?DY\6H_C3RGQUX]\.^.>6V,+'X6^2G*.4U^27?*V4JW\_#:MMEJYF$M
M]I)3`Y*J.X'5?DB>3D?=V*A.7DO@_I^0J,Q<>$.;+!;\H?,]DX.I#7-T+D\P
MS&WC/:F5*GIP!YSX$\^3,]K-DR]=L4;H"W0$A^NU:/\`S(_3[^=6+L?!6[4\
M0>0//'F[@7QNX'P;E68RW'/'GE'QC4Y)@?)')L_B>-9'+<ES%?/\,LX+%\@@
MHY'*4M)+M>".5)5>-B+.&27']Z<[FXC_`%/5R,.3U9#M$KXL2"":5KQYF,>^
M%\GI=)"YY42!&`&O]L\9CY1+3&W,`9&`71LDR)I8HW-=Y7O9&^-@DN"P-8GD
M2K*?/[X6_)3RCA?F7GF\(^3^09CD'R<\,<\XEC>#8OAW,./9V&EX>XEQ_D5V
M?A?,<G7Q_+^-XW.13UXP_P!4$L8E*L!U4RX\4,_&'##W0Q<AR^TO`/Z,V2YT
M+G#^5SXT<UP%KBQ2K.#)EDXG&CS3&W*=Q6$V1K#I,PO,C6GJUKC=I-PA4I7<
M/](;A7FOQW\&?%G#O/'CS&^,>986?D<-;B]#$XOC]B+`RY[(3XBYE\!@[-G#
MX;+7:L@DF@K%8E8]E&NG6FY25DPP7^H#D^@T2`$N:"%`#2;GRHO8J*S>(V5L
MW(!S2,?UOTR0`XM0*2!;\R@=P`373;JJJ=0Z**'110Z**'110Z**'110Z**'
M110Z**'110Z**'110Z**'110Z**'110Z**'110Z**2LY_L;*?ZA:_P`R_1U%
M%?+DZ**__]7V>_`+_@>^(G_+=X5_W<\<Z*.U6[Z**YA_J19OE^(I>(DXGRWD
MG%I+F8Y&+9X]FLMASD%@Q]2:&"T<58KO8T8$(&)`9NL3[QR9<=N`(\ET327*
M6DC0`]$K5>V(HI'9CI<=LB!MB`44HM_OJJ'C#)>4)_MK&0\@^0)5!3=!)S#D
M%MTBD;1"5FRSI/,`1N&[\^N-3\YR#YMW]7G:RZ`2/):/@MSXFNHQ<;@11J_C
MH2]VJL:A/Q2P^'6KAX&+E622*A8YGS.FDXFGL2C/WFM1QUXUEG97:]-]#Z*`
M%TT+=OQZ:Q,ODN1?+OYK*]",$G;,]0!?HX*J==*??%QO',&4.)Q7N4`!T;2T
MDE!_+T^^G[]]RBEC4BAY!R*5D7W$:2_D)F".PW!YVGWREE[#\=?33JDF]Q<N
MQS2SF)_2!U]5]FDV7S7/PIR3!XB>9SG<9`U[D4!C=?``(/G6<W),M+4;;G,N
M8:BAWM6,O?J_0[*ADLJEA&C43Z+^T1W[>O2\?G.>9E.;'R^2^!EU=(ZX/?S=
MZBR\9QAB+G84$<[[`!C2A[#RW*46?*<FRT#0_P!)\Q6EFL1JI@O7UWC<![B3
MI="(H*G1!H3^/7CO</+2,<R3FLAKR]2DDA^SS:>%2(\#BL1\;QQ<,D;8_P#`
MQ%Z[E:I^]*1Z%GE%;DW(II^5<@L"''X6K7J/G,BL$2-6:9[C5FLE!-//(8V*
MZ:>UW.O?JSS.5YH<3CO&?D.+"5+9GAR'J4=<WT)M3(BXITC-G'X[6O<;F)A"
MK^14T0:I5.N*9WR+S[Y%>3+.4\A\KH>-N&V*E!<9CN8<FKBSFJ52K[EBQ%%?
MC%:I[DP+11Z!V`UU!.L?,]P<O#B8N*_F)QO'YQ(]4UN553IWKL_(8'MOA_8F
M"8O;N(_E\A3N=!$2UI.C3M4GL3H%JXF+YCE;TUW'C.\BK3&I')7#Y3)2J)$C
M9XQ#::QMDEDCB9G7N-I!.G5;C\U[@G?DQGD<IK'-\OZLA*C1#NZFQ^-<=R.-
MXZ''@D;AX[B);GTV`;240V6W3QM2!5R//ON[,<W+,TR22TFKVGR^04:R6&ED
MED5+@C$FK"1X8U;41NJ@*54RHN;Y>9CH_P"M9$4VY-QE>=`FFZUQ\]::GX[C
M<0LE/'POC0E!&VYU2X[=;6(J-_+/D/R'QRMPGE$6?S=;(XKDU,7,8N<R)J9F
MGDE:C]G=JQWH()(U:S%:!/[*QMJ5'6@]N\]S4<Y9-F3OE"6=(XA"J+<W7MWO
MI5QPG!<'GRS8L^'"W$>P^<1A6N"%;A1VIH0^0.18!;]CE?D'-X3V\5E\?F(:
MO-<WG+]K+YO)2?:1T,?%-+#COX53E:0-$[G:4(<*.^V=GYK&;Y<Q[%7<-[B;
MGLMJN9.#X^?T<?C.&AFB#P6$P1MLQH4N<0K]Q`4&VMKTZ;7(L@>)V\YQ3R#R
MCG&`N2TL16J6>:<BP&5^^QI]^]9Q>1EM0RRUIZ,3-/(XVJX8CL-.D_79;(%&
M;(8=!YW+XD%5J#)Q6,_E&X_(<'CXN4UI<H@C<TKH'-3:+Z`=*D^/E7+AA\<J
M<BS\JV*59FE&4R:6U$BQ/N$DTRB4P]M2-?<)TU[]<SF]P<GZIB/(Y1AD<@(D
MD!%^AW=*II.+XUTSY(L"`/9_*8V;3\@.M86.:\DI8TRV>69QZ-=;,\UELCD(
M#!]L%9Y+6V9[*KL;T#E6/IZ$=(_J_,[-L7,Y,C`4_P"8\.!%T(6_VTVSBN/R
M,EK!Q4+<EP"`,:X$'M;:ORJI.&\W>8?./*<Q1\:\QR6&\;8O*SX:_P`C;+9A
M\E]U5F:&Z^-::6*2.0G5ECD5BBC4D>G5C'[AR!&(G\ADF=-#+($*ZD[M/`UU
M*/VE[8]K<?!D\MQL$O(O8'^F8F$$$*`;'[0BU-V,CYEPFM'1H<NY[RF[D\M`
MEY\ES?+W6A41D&PD\]YJU6L&&I2-@#KZ'JNGY3GY)H7/Y>:Y1&3/1?$AU8[D
M<K@N9D?_`/Z7$Q@QA(+<9C0@\`T*?$TYLAR?D]..<VN7<AB!HS8Z=$Y#EY(P
M;<<D4CK)'9#FTBR':\9'ML`0P/?JQQN;Y;$E#I.5E<]@0?J/<"3J2I3^%9YV
M#Q;V&2+CX?3W!RF-@_+\M#U6H`J<)\AXV:!N/>=?+D&-LPV("EWE68RA:^SE
MS>CFRMN_(4@BE**B:QL!KV([6C/<G+!F_P"MD+"XG\SM!\[^%:F;/X+(8QF1
M[9P6S-`*B&,=.NUHU-[_``J1>.\JY['@\!-D.8\GGS5+'+AK3-G\Y$D_\&MV
MJ,-RU%)?:![MZ*#?.Y^IF;UT`Z=]Q<[R@;Q[L?-E8D339[@"O>]S\5K)Q\;Q
MD^3FQG"A$9D)'Z;"BBZ$`(!T'2EC(<N\AVL0T-+DO)4NTR]267^.Y.,W<7,I
ME55D^[)CNQ2;U$@4N8V&C:KU70>X>6R,,AO(2#)B-SZCD+#_`.*[@?FG6HS^
M&XN+,:'8L?T\MP`QMG#J;6:1J-%K?R7G/*\C/=Y%B^0<GHXR5:=D8^MR;*33
MX_)0TZLDV,A07PDT5RYM5963VP)23IMV]3\SF<_,+,S'SYVXYC:H;(Y6N:T*
M$!ZE`I%UO4?C^*P\8'`RL6%V2'.0F-J.:244HHVCMVIL3>0.=+1QUD<FYI[S
M.]C,5'SEX3QVGDF>M!"5R"`0UH(E1F5=C2N>QT4=&-SF6T0Y#.0R'$.21I>X
MZZ-:"=>A/<UZ_BL8S3PS8F,@'D+6M'Q+D&G;X5#G-I_,/D/(4N(5?-',N$1)
MA4Y%:DBY+DJ$UG/X;D=6O=Q57-&]CD@J6L)#7E99)'55M-])^MTWW&Y<F1C2
MLBR)1*BD.>7%I-Q<GLA2IF-B\9BXWU47#PS%TFS\@/D0J[:A_F!0CLFE23R#
MR+S?*8>EF<!S_EE]+$LI6&KE<O3CJ01VC"QGG:PJ+)]NK.02X4#0,6TZR7)S
M\IBAH9R<Y<'%1O<+#JJZ^`JMPH,#ZG)@R.+@:U+.+6GS&]@FG2M62YUSR.EC
M_M.9<MGGS-*3[!8^39A17EH21BQ7NSR70JO&I65V'U[6/X=.MS>3?'#)'GRN
MCE;Y4D=Y=J*'$FY(*]ZBQ8N`)IA+B1!T3_.K&W4%"T)H-$[TPZ/+_)6*JRW+
M'.^969\FS3SY8<TY!-[,\35$JTZ6%FNM"E$1S$23#:3*VA4]CT9N=RCXF946
M5*`NT!LCK`(EEOXDW4U-<SB\C(&*S!A:T-5/38%U57)K90.U6.^,')>:2>=>
M/XG.<SY+DZ]JES6+)8'+YW(VUK9#'TI7B62G>L3)+!$J[HI(RR[OQZVWMQ^?
M%E8T.7D/<YP?N#G$H0%"*MJPO.1X<F-D38^.UH9L#2T(""4)M9:ZN=;VL75#
M?U"<MR?$>'L!-Q3/YSCN1FYSC()+N!RE_$VWK-C\FTD$EC'SP3-`S*"5)VD@
M?EUC/?&1-C<5$^"=\;C*`K20=#U!%:7VO#'-GR-DC:]HC)1P!&H[U0CQMF/)
MMFO",AY`Y_89]")+',.12$C0[2P?).3]9T[>OX]<0R_<7(1IMY*=/_<>/WUT
MN'B\4D$84.Y+^1O\*NGP^/F1BK26>5\C>(,=TMG/Y.4H9%U`E_TN4=V&@.F@
MZH'<SS<T@/\`7<AL1.OJR?84=I4QV'QD3';N+A,B:;&W^ZG5Q7D/(UARN'R&
M9S<]KC&1GPMBS)?R0%Q&2*]2M16))@;'^CVU21@6'N*5!('2L_W#S/K,E=RV
M2FW02/`[+9R>/XU(FX?BV_3Y$&#!Z<[`\*UA0JC@0A2XL"EKTNG-<BF+Z9C)
MH89`J*^1M[9(HRHW@":.1B20=/VM?S!ZK&\_S;I'/;S>6Z-J*?5D`_\`-1_2
M^,C8%XZ'<Z_Y&Z_9I1.')YVO'(B<AS;*\[V'D;(WY#-(S,S!1-,TD"`L5")]
M.GX=>/\`<W/R$Q?U;*0E;2O%AT7<II]W'<:7->_C<<.`0#TV6TU`:A^)H]3S
MN:DDMR?Q;+FLE=)9S_$[\GL.C'VU8F0`1NS>JGOKH?R$WCN>Y<NG,G+Y9BV$
MG]:0[44`7=WZ^-5_(\;AL@QVLP(!D%X`_38-RBYTZ#IX+3<CSN8E:)FY!FU4
M`^XJYC(A][*I9`#+J%4C0?2=>_Y]0H^;YL@O=S>80/\`\TEO_P!U6,F!Q[&A
MK.,Q_42RQL_^FMQY#R97:1LSDXX^Q"'*Y`@J=00Q,NX$$`Z]O7KP<YSH?N_K
M>7M_]Z1/_-0WC>+<S:>.@W>$;%_"MC\@SPC5OX_E7"^X-J96^&))W`?Y7<WT
M-Z]].E_U[G"T._K.5M_]Z3_ZJ;_IG&#<S^FPAW_ML_A6A^1Y[VXY/XYE0K@C
M09>\7VP]FUC$Y<'3\?QTU/3G]=YQSF./.90:=/U9.G?S4@<9QK0X'CH2\?\`
MXV=?E6EL]R&01NG(LQL`.@?*WXM=2-NNLPU^D?C^/2#S?.E`.;RFF]S-)_\`
M52AA<:-V[C,<Z:1L_P#IK7)R3DT6]1GLMNT!8'+62/;UUU5Q89595]?Q_#UZ
M</N'GP71_P!<R"$LDLA7J@0TVWC.)D:V0\;$`'?X&A#XVT-:).3YX.C)R#,`
M+JP)R^0()`'JHG;=K_-VZ8;[AYL^5W.9()*?\Z1?_-2W\7QS@3_3H4\(V?PH
MNW)>2>VLB\AS#"25HSIELA]+!0Q'>TOX-V(UZECG>=(;-_6\A"H_YLB+\-U,
M'C^,#O1''1;T7_ELT^RB4G)>4,#[?(L_)M#A57)W@VL>FC,5L[MNG;TZ2.:Y
MYS'$<SEN-])7Z_ZM*4<'BR?-QT`T_D9U^5$VY3RH;7.>SL1+-(PES.0VDK$0
MJ1E;1[EOJ]-NO;\>I#><Y?:#_6LE?&:2Y3_BM2#QO&ASF_0PEJ(HC;U[VI-E
MY-RI(527DG(E(@1V<9K*)JVX_45^Z>5=1]/;7ZAKITF7F^;8\#^LY>Q&J?5?
MK_J_"EMX_CWJ6\;C[MQMZ;?X5%_+O+?D;'8[D\G`6YESO-<2O<>Q662EELA!
MAL%F>4S0)@*N<O6K49*2I;C>;[9+#P1:/,J*03JN*9[CSV'DV<IE.XF)'/?Z
MKPMBH`+NG7I4C#X;V\Z?!AYM^-APY._:3&USRUGYBUK0NH1H<6[C8&G5-RWF
M:P$6.5<CC>:-0\,&=RA$,X*>Z$L-;0F)]2`W8#L?7MU2?UKEBYQ_K&5K9)7_
M`/U7"=:B'`XT.`;@0D-Z^FRXZ62Q[TAVN7<J]X)#RGE[LX#1M_2C,QK1,9UF
M<0B=_O9)5`1=7*#0G34]/GW#R18'#E,G<=?U'I\/S??26\?B@;7\?C?'TV77
MII3<FSW+IONU'-.<0OD'6)I#S#-AAKH#]O&MUDJ.0#IH5_Z>E,YOFI`".7R`
MA_\`4=_&].?28$8B/]/QB&%?^4S7Q\MQX4QZL_D;'68H8_+_`)&GX_1BL>WB
M'Y'DF>:>U;^YEEOYVS;L92__`)<B-$DB6)%"CL.K*;W=S3L2+$9GR;F`ASPX
MJ5\5\4744Y-B<1DODR)>#@^J>05#0T(`@VQM`:-%*@J:=)\D<WKQ6DK<TY.T
M<BJGMOR'*3SE$[M*CO;+0ZL-NH.IZB0<]RK&2`<ED$.L09'DVZA3^%Z@OXG`
ME?&9./B&VZAC0">Q0?C2#+S?R!,R3Q\[Y<K?2@"<GS0#$GZ_W+7MKM&/7T_D
MZ<BYCEBQ6\M/;7]1]U^:VKPX/&L<6OX^)#_D;;[J,#F_D-8YY?Z8\MEAIPF6
M69>696..0%2J!1/DHY'&[0D*"X_+JRP\_EI!+Z7)S.V1D^:5POT%W7/AK4+)
MQN-:8A])$W>\!/3:3XZ"U,3-<Z\@V$D:#G_.8`J;HUK\PS\>V5M23+NR&_:H
M&FGIW_DZ#S.?<R9F2)+:2/`\=3I2G\=AL",Q8'*2%+&_<@L?C79GP%8O6_"_
MC*SD[UK)Y"?A^'DMY"[/-9MVYVK*7GL6+#RSS2N?5F8D_GUWG@7R2<-QKY7E
MTAA:225)MJ2:Y+RS6LY+.:QFUHD*#1/"U2[U;57TE9S_`&-E/]0M?YE^CJ**
M^7)T45__UO9[\`O^![XB?\MWA7_=SQSHH[5;OHHKG!^H;C*N3PWC6&S8-<')
MYZ.)ED6.0S/1K&,Q,XV"1&34$D:'\_3KG7O^.65O$LB:I+W=42PU\*Z)_M]"
MZ3)SWAFX-:U0G12M5Y\7)0RD&*%.IF<O&S%,A;P=:2U4I6JNL1&0DJ>W,M::
M3<`X0QL>N-3<!RC][L<-(4Z&Y^==4R?H\4O&4X-8E@[]P[CL:LKDLG@,9-Q[
M;*LEJQD/LZM>5;50*61H[/W44L<;1QHL@`)`W'33JHQX\OCGSOF@>UVT@@J-
MPTZ_'YU!:U_(LR&12`Q`!RV)":(/D=/G3[L`UG]LZLD@*N$21A'HH"?M($<.
MG?77L>L^[#=(\S!UE4V1.W72O1/^GN(\XTN%/RZ)2<@D&3>FJ021K&CF'8=X
MW,'C:5BIC'Y@'\?SZG/'I8[#&#YM?`=OG]E>/VR1"20C<#8^*?NK1E,.\MA;
M)M>U%&RF&$1C75>Q#A%`<`GMVW=]==.HP=OW$':6C35:]@E$1V%I)=8GH/M/
M]E,YLCB.*<JIULKD8:MCF5*;'8Z&2182EG$E266:2/VYUN)*SA=5]M5([D]M
M1"]IXB%T4A=+N(+0"H4:GN%%.C"R<PS?3XI=#!M<XC3X;;HFB]:I9QJ'R#X^
M\L\WYKQ?Q1G.5\(\IY:Y+6CQ>;P]2W$]!*L,F9$.0LK$T-\U7<I*8FV,"FO?
MJ#R+\++A8K_3R&A=%!Z'[=4Z5V++RN,Y?VOQG$Y?+QQYV&`JM)L51EAT4!02
M.XJ<\1Y*M6.3U./2^(^;X2&&B6_B=Q:,]>M:,#1_;5TJS6:U@2QR.AD233Z=
M!J#KU'@9%%ASN&2U\I`L5`":B^JZ$"L/D<!$,/ZB/DH7#<I:#<@FQ(-[(H!%
M23>AY%G<:(*XM\1592_WKG%YC)2J\K[HFQZ0R5::M5)1U:21F.W38=>O!)B-
MA$IC+UNB@:ZE`I\HZ:'6JF#T<6:3ZAS9@1M3S-'VG4JEP!;JE5G\J>,,O%;P
M'(,ARG-\EXTO,^/T\CQV6O6I6XZ^6G@Q$:U<G#)'$8IH["0$SQ'VC(9-?P&H
MX+/A,T..,/:QXZ'5PZ$D+IWK7<3S6"<7)Q!A0Q\FUCRV0[G!&A0"P#H1N4&Z
M)4C6^)-'#@V@Q.+2_P`9JY>I@8,@Z,U/F=?)5IH*N:M1F09Z*/%*#38$+(ZR
M#3=V&Z>X&-96`%MF];]%/6WRK)1\FZ3)R"Z=[8YB-[@#=B7<QMMBN/FZ@)4%
MY3@4U^]F;=;R&M''0P9;)\@MV\<[3X_*7H/<SW]#^.;Z5Q?LH+1BB^YE$+R:
MZ;B3U%&.U[F_]0D:DFRH>J#]@M:]G+,AABBEXLOR#L$?FLYH_*'O`(&XWL"0
M-=*M;Q*DJXBCAI,J<OD,=3I8Z?,?P^U7'OU(!#+):-C;(KM`@=R`T0+:*=>_
M7.>1PL=G*3XT.23,JCR6!-]2?OTK!9^7,[)DR1B>GBEQMN'4Z`#7L.M5MYG>
MRGF_D&4\9<-DO4>/8%1)S#FM6Q)C;$5EK5FB,-AO=KRI?:TM=I)]'AVHBZ$L
MVO3\#H<)AER6KD/"M\.A/8*@[5N.,QH/;T,'+\@Y<MW_`"HR`00@<"2MD6UC
MKX587C?%\1PSC.-P.$H+C*&)HQU%C]N(M,T8VO:E70%;5V4%WD?>S,Q)/?JM
M:`]9FC]0%23J5U"'[JRO*\MD\EG3S9,Q<7FP'3M?L.PL*7](9]LD,B6'*%9%
M%1X(XE1!N74;%+MN[LH_F/2Y`TRE[7E[=JD!J`)T\?$BJAH<&/C<S:`ZQW*3
MT^*#L=:0;>SWP&D$2V.Y1051`/H$:QO[C.&[:Z$DCOUY%('.:[<C2I([-T1#
MWIXQ`;@_S%H`OU)OJ.U)%LF(0K%,K5ZP-:NI#L54./\`2@NK)`69CJ&(8`>F
MG2LL.`C(R%C1&C1+_=K3L3&NE<1"?6<CG'I\%ZIX4Q>'V;&6R/+Z,YDAJX/D
MN10V37EL0-')%2L!G$2/_E6L$A0PTU/5]R.,<B#C99)SZ+8KN2P3H4^XTB5[
M<9YVQ@R/```(4F_X4Z;-CV=_O^SD%&R2E,CG'BCO<H((PJ3O(KL`27_9TU/X
M]5D<D1>QA8UT31N:X':E_M3Q-1WQR!A>QS@2[:X'S+;7P[6IG6AFUR0&,L12
M-/'<^]@00;I6>'4U0(]L87[;<99$[ENZH=`.M-@NP97'%<'MR7`[BP@@JENE
MTUH_1$.Z<+""U"0B#J[O8V`.NAK33M9":J);F.-*S6R,].'V;<4AOTXGB4V:
ML[@QP36*_<>XI;?^RHTU,7);CXSG1X\S72[E!0JNB?'QI.7#`96OCF,D3X_-
M8A%[^`TMJM-+FG+^/<,O\6Y+RCW,=QJ/.9!;]BZ9LJ#AWXIE:]Y9A!%"\R)#
M&0Y5#J^IT8]:OVEZ_KRS3L(QRU%74@(2FMKC3X4C&Q9,J.?$PR#DH2!H6E1M
MO^`J-?`-2A/XLXOGX[MJ1<Q';R$$=M&]M:\TLGV2T:\TY]@-`B.5/KN_:U]:
MOEVL]=C"]Z!`NNO5#H>XISEI<CZN2*3&8V1C1IX:@D"XOK>I1NU:TZ1QK7L.
M!-`69UCAB/OEA)OKI+(0DJIZJX+[>Y`'>*6,BC_3:5!%S:Y\-+U4^H_?(YX8
MNW074:ZI]G:D_;'>M015%G0UFC:.FR,L"-!`KN@<-(J1231[V]SZ=7_^$:^1
MSC*R(XHGELC3N`VJ+"]^W=;4W/`<>*666,%KPA(-[FWV:!*LG\8,O9ROGW'3
MS3SLMBCR&<0V)DL>W))B+<DYC8)&%TD;;JJJ"!Z=;OVMR,F3S[V&0N8YAL2J
M$`JE8OG<#Z3A6G:`=X4HEE"+75SKJ58"J:?-S&?Q3QGQ^#UV<TQTNW37?MH9
M$::>I[-USW_<F4Q<%$6IN,P%_@ZM?[+9OY24);TC^(JJ/"L%#0H4&F*0B66N
MBO*1$'>24(M>,LIUD8=@!H3^?7S9F222*[9Y#I^^NRXT#2XM'YTN/#O5G:52
M*E60F$E94`WEBFT#0[3$`Q+-IZDC3JJ#G-)VM*K;M34A#W>FUP\OVT19J\&;
MJFM7%:QF*@KR2K+[GW,M)II=TB.I7<D,NTR#T``T[#J:]CLEL4<:*S7Y]RM)
MC5N/D&4@L85'1`@%DZ6ZT>R5JOBJDN3M30UJ44L,DOW,VR..2Q)[%:0N-0K+
M.P!4DZ^I('2C"\A[V!0U-/O-M;+\JCXSGY$K,8,)E<"EE-KIKUHI-&YTLF32
M9$]Z%X@#!)N<1B#12H]P@[E/8'T/Y]1F;&F21\BG5MK.O<>'QJ:'':(VQV)1
MRZBVII/NPY<Q*:-VI5D:K)`\4U1+:PSR23O%8G4RQ-;B0R@;$VD`:AB=-)$,
MT;(G-<;W"#^9?[:0X1RR(]KC&""H*(!J!V)[_=33H\SACY`,1R/&6N-7Q#32
M#*:PW./W9)0\`_AN05R_NRSK],4ZQ3;2-1KU(CP7R0#*A7TPY"6A4/B-?W=:
MGY/&N;B"?$G9/"XN\A*2#K<=@-2%%/ZS6#1.3/[C0B0"-DUC#;ET*LK?6Y;U
M!T4?S]5I8-@+Y27M)6R#P`[FJ]LI;(&MB3>ER;_/M;2DCV9*R0))(TS%='E,
M2KM^KTV*&`'<#U/8=-[BXG<WS']A4MOIN4,Z5IGCB*>V'&H)".R-K*`VC*"`
M1'HI[DDZCI3(S,TN#B@[=?GTIK>&/4M()\=/'^RLHHX8T]J0&5]G[@$!$71M
M93)WU`TT`TZ4T[`]DIW.%@/Q)_<E(<YY>Q[`C54G\$K]GKM#3IW2U=!+/-&R
M+(LMF".$I^]DK!067:=4`.KD=3/H2S`QLV/(C!>XC8#YAMZD=%UJ*[,:<C(Q
MS$YVUH*I9R]`?V2DV)J]C7VYQ8A:Q(L,[0FH61)-5L;-$D192/1C].NG31+(
MR&(UV[4D:=5_MI;=[XQ(]ACL#M5=+)6B617EB$IVLXE;10&!90N[82$!8(=3
MJ5/?\>B!KLE[2U0WNH3Y+3C@V-KG=Q\_GVI)NODZMJ>.O6@EB:..&%XYXR7=
M!HONQ_Y2.)2W=@22/P)ZDO86AX&2$)0M`N4T[ZK2&-QWM8]';M;Z!=4/4^!%
M-#.\@S^!FJ6#Q9+F(9K$=V\N1WS4K$85Z7NXN"E<G>A9=3NE#$PR!0R:,6#V
M+C8TS6RR9H8]I0-V'5.NEAU_"ID&+#DQ31QY!&7;:TA`]J^8[U0.&H:=0J%4
MI*SV8Y6F"HRXCQY<FY'E#/4BH9O-X_%18FV;,<"2YJQ5L6Q+1E2431FK[TA0
M$!=S@+-EQ?I'Q8TT;#D$H'`DJJ=-%*A%-M:\Q,?`DRWLFY<-P6@.<6,+BX7_
M`"*EPA!W)]U1QXYA\W8W@M[QISK*\2HX'C_ECDW,VSO%*V3&>YZ;G(KO)(H,
M^F0FFK8W$5LC;:%1#))/+7I0H3&BG=I\KW7DP<`?;&/BB-K06R%5.GF:HLIZ
MGI4GF,7VCD<U#SW%1Y,F1)AQQM9,6AD):UK"6(%<X@*5`:"XD*:DAXY/;=G2
M0(9F`ET4*K,(M2NUG`#1@_22?Y>X[XEA)C/E_3*74V\!W055DAL@:0CM3?I2
M>]=@Q`.BNCH4^IEC(*_4'V':SZC<`/3TZ?8=K7160_&W[=:0]P.WIU^/QINW
M?M::[9W*.[R(Y$P(L,Q^@,65%0$#]KMH!Z'J5CL?>&-7O!/S[>%(*R.W-8C2
MT?+O2=:C*(-8V.[VC!8W1Q0Q0%`9VDHLGOO))[ZA"S)H`3WUZ5-`^('U1M2W
MP\4U^VD->LAZ]3_`'Y4S[,:M/-.LC,I.UP\;CWD0[3M=600%#^(W:Z]>QMD<
MUP)5@:J];5,)#6Q#:CE^2G\:_#"_M[8RL21$ED8C41#782X4$]CJ-23^?2F2
M..UI=<CYCYU'F<QI7:H_?1)PJ,S!W:0KHBE%*KZ;BZ%27)'_`%=#_+IU8XY<
MTW*VM:H<C=XT2_0W^VB]JR+$4#6(Q,((]`)HD51"F\*"R*LVTEF_`@=M/3JQ
M;D3/]-[U7L1T']]1#!Z;CM<07+U77[J[1>"51?#GC98U"H.(XC8H8L%4UU(`
M8ZD@=?07M\[N$XL@)^BW\*Y%S`(Y7/#BKO5=^-2QU<56TE9S_8V4_P!0M?YE
M^CJ**^7)T45__]?V>_`+_@>^(G_+=X5_W<\<Z*.U6[Z**I)\PO'M7FECQCD;
MJEH..93-6!K(Z1":W5JQPF7;(@9`\8U&AU&H]->N6?[HS31<?@F$[5>Y7+H$
M'VK74/\`;/D6X,_+1F[I8V@#J4)/W5&O%^#\9L8:%<KAL>9'B:*Q/&A@FF?:
M6D,5FJ]=EC#)NW*6[#M^?7!X^3R87/&/D.*=!]NIKHW(3R.DC`'D54*$?,%;
MWI2R_'LU8HX[&\<M8^[1I,KR8CF22Y[%V(8RK0#'7+1.7QT^]--\-E?J`)4Z
M=7N%[MS6QMBY%@EC?HV0#\O5#8BJL8."'S3WAG!_-#Y2">CF@[2@\*5(.0Y!
M:,S64;$6*#RPR8CD=&Q<J(U<;6%7E&*KRN*3#_)RV*O[.FYSW/4B7C?;/,EQ
MQ.0^EG<!Y7!SFDGH'"X^=12W.Q96"2/ZB%U]\;@UR=%C**[N`?E46Q>7<C@>
M2Y.KF>*7KM*?[:1IN-S)F6KPA5$1]F*O!8LQ/*03H59>QT*@]5N?Q3>/88F9
MC2"`H.A`/<]JV&/P+.5XN'.@F$;V.(VOM?XK8IW6C>0\VW;L%P<?\8\^Y#9@
MM&&*M!#6QCN`J,7CFORI7C,6NNO?<>J+Z7%]0;LL+VNGW4]#[:8TP_6<ICQ,
M>/S&X'Q2_P#"JO>2[MCY%Y2&IE_'C5,3XAH<AY5?X_R/(5JF9JW(HHUR5_-+
MC;,-D8XQ,6A4-OGU.S0$==$X/$R)..?&QC'QQM+@;#R]R;$^"_*KO`Q<3V>7
M94G*;H\\LC#F*YKE)VH""%37Y+5Q>)WZE+C&!Q$5ZED;-/$XY)*]2.*5X8OM
M8519(:[>[3$<8T"R$$CN22>L#.V5TKWRN2($E2-%*&U9'+QRW+GE@;((B]R7
M14/<B_RIPODIJDBPR5I;40G2!HQ"Z>R9`'#1C1FE5QV)UT&A(TZ\=CPR!D;'
M.<`I%DOKWON'>H#'S$ODD<T/TUU&B>"'K29G,C'3QLLHBCC>1Y4ABFCL.L+1
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M_P"'Y_(\5@SW)^09GD$G'>>YBY%#`V7.6CKW)<I71I?M\+!C9]D2F-DB4+J6
M`)(DR2@#?CR;Y"?,!^WX4YQ^.694&/R8;#B,9O@`Z!I+0+7>H7N:?N=YOE<C
MA:'".#<DBM\XY5EY,/?NP5:D<N!L"A-)E+9A86(=]&*JVXJ'0L?IT)4C&LAS
M)LSD,K-@L`H:"@W"^[[!<7!TJ+/P^'AS'E<V`MX^(;F!Q)W@N\H'4&_Q2I`X
M=PB#QQ5H8RJ9IL=<J5G=S7R`ER.1FC>7)YO)322:/9R%V-P6.JA0H&G6>SC/
M:0O)BD"W4$`=!X+68S^7DYK,FDF<`Z,HQH0@#H/!`EM?MJ1K,;UY8)O:EE2;
MVA.(%7_1ZYT8;C)(S,54!>PUU[].Q-`D<]TVYH:%'860?$55%^Z-S"W:[<0+
MZF_W45N-+'#MH65K,WO-!++$6V3L"(M(`ZM,@/JH(!T]1T]&5F,)4,!W#6XZ
M(!<+380Q[B1ZB;51?MINV,19EGH6LE<@N[(@S"N17*3JX+RF&,R"&-1J-FXL
M`?7\>DS-0F=@_3)352T^)[>%+@D<T20*=PZ[44>'CXUJ`:9F*/K7A#B,-(DL
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M9)6OB)BG!5RD;3=%:GY3<$#[*1FO;%`8\IPDB<$!\P*HI4#H4/PZVHNU=<RL
M44)@1YUD%:JT?V]JPZ.S--#<=:\BX^*!5#R.%2-PF@)?M(#9<QVQ&M?<`(BN
M!U#K62Q7K41T@PSNF+C&.NH`(T(O?J!UOVJ-_,?#ZO+_`![R);\*1XC!XT[V
MB<QV[=W'QR?Q&2F(ML]R:2-I'#I]`<D:[BPZTG'2O,\<SIO3]-NQ;%3UMU75
M19?&G.`S6XO*0M@:IR)`2"#9A-E[#X_A40_%_-G)>%^,UX8HC+BJ%?$W*_OS
M?<U[\:PO"LU>NX6.S,A5@2JQ`+W70]U\L9XIB_TVG<T;;FSM-`=3W.E7'NK`
M]+F<ASYC<[C9`6]4/^$>%ZF>XJPI]J_MR2)(TMF8.FC76C:.*I5,8`*54:1F
M*?1JW<=AU3Y`=Z,3'R!TBDN-D5$#0EO+>XK.P$.F<]$9M1H35HU<?C8!:(0)
M:BAFQT%QEJ^]-9CD!A"^P(]+<CSLBV9*\:KL"[RK-W"]+A#271QN.\KM<-=J
M77N-::RI"2R29I#`BM1?,MD'0G6K#?%#V)O,''YD2.26+'9]9)`'0Q!L+.(A
M$?<"S*ZZ[OI(&H_'K8^R?2=RD;F`%X:^XLGEM;K6;]U.D;QLK'J`2VQNIW7^
M%=7.NO5S*JX_)K'_`,1X3B8E7?)%R2I/&I!;5TJW-.P(_/KFO^Z1</;\(:;F
M=O\`Y75MO8@:>7E#_P`GHE?M%5ZPO&:LT./MY&NUJ6N\<\"F0I#'8`)CD>%6
M]MI(Y`"K?XIZ^9WR2NWO!`:WL>]=C:\8X='"Y"X)HMOC\*D01ER?WSAGVR-&
MI)+E"49TD9BB,H`/Y_R=(+'#;(7D7\+U!?(!81@C1>R]Z+V3'-=J"*;<-R*9
M-)3[+.J[0H*@N7).K$;=>GF;7F=C1=SFWZ!?W]Z\83'$?4":H/\`$E%<[@HL
M[7LU[D,EK&B6+[M!&QB%E)6>FRB/][,28S]0/8:^FO7LGUD)D.,YQVDM)'3<
M"-#JH6_2E8<\4#HG@AN0Z[;H3MN;]$[==+UL-66`UED1!',LD,06,K&L<6TL
M6CU5@-2-!K]6FO4![)XV1.==EP`J'XI^^GVS02&=%]6Q)^.@72@T,LRUO>LP
M&K4BLRU8(ZBQV!+8E,K&>PS/)8B,L8$:Z`1J2.XZ<9DB:+&QW``,4J@7Q5P"
MD6L.G2HOH^C+ESLWEST"*HT2W0&_SIL\CX5@>85F_I-`V4:XDDEJK'/:QL*M
M/.EZ(ZXN>HX:M/"'C8-HF@[=SU98V9F8T(GCF0O/F:-.J6'3X=*F\=GS\7,R
M+!D+/3_(]P#SHA_.'"X*$=:;].+E7"KRX_*VWY/QBX"^*RJ+!%DN,HD#3209
MYC(D65@G1#[4R`.I71D8G=U(&#/S,F_%@:,HL+BT.`#D"DM70H+CK4C*R>+S
M(G3-:8,UI1X0ELBE`6(/+M)NTV*V2G^8_>A$X,:"4%%*[RUF*12\>H8["-/0
M@*?QZK'0,#2]Q$:%+`DG[;6ZU5MDVO+2"[0WZ72M#1QH5,99512D+)LU23:1
MNW;0#V]00?Y^EQS%TD?ID@C1/X#6E/:7,>'M#G$Z'PT13^^HSFY[C8,G'1S$
M4&)KOGOZ,4,Q;L3UH,SD9*WWAD2*[!6K@#_(Z122!I.^H].I^7%!+CX[\?&<
MW+#3NN3OOJAT3M4S'XW*>XB%_J+%ZI8T`F-H*$%"2>]T05(VL,,90M7@$BL[
MRS2>VC(JZD>XY*J&T_/U/;J!CPR/!A`:V8JJVZ*BFP6JZ9SFNW'>6CL.JZIU
M3^^FL]J.\!)1F:5=2J;ZUN!.S;9)]\R0:-].T!UVGU`/7K6NA88WN:;HX"ZC
MXU):&MVEX(ZJ45>R5N:.$.F^)6N21O$DC!1(R)]14D+L"@'T737\=>O72/DC
M,&P-C!TL/G;]N]>,:%]5I5/L"_M\NE:)3]O[32+KM"DMO(![J>YB8,H+>NG<
M=--+MS"\H]NB_;TI#BUV]`2TJ/A1.Y(\@UE!9HY-Z>X6!1I6VR'>[`DR;OPT
M^G7I]\[G%AD".!'S74GQ5*1$P-+FQ_D(0_+I3)Y1F^/8%<=:S>=P^%I--%%[
MN6R5'%_=VGE-98Z\UVQ$#_I,L6FW<=_Y:]WHFR9"L$+G!K5)`NJZ`CN`E2L;
M&S9C*,2!\LB&S6EWE1;@#H%H[,(9XC+$\>0JVX([55XV7V9!<A6=F1X]1,%#
M;%<DA]I8#1M3+E6-6D[HT!*="6Z'JH/E*]:K6[AJPLD:XM*ZHTIUT75.@I&V
M1P.C5DB@(DFD)12^DS!3*Q1BZB8[#J&&G;0#IF%[VMBWE'M?JFAT``TTI][6
MO$F]7`M1+7'QU3YT@7?NI&?[&:.RP!/OH8U-69N\[QO)&=S1L-P4@KJ`!V)'
M4B5QAG?$-K_YBG4]B>W5*(!%)&'S;F-T`/5.P_?383CF/LJ1F5FRQ-B.Q+8R
M,MAY;$BJY20Q`B*$K&2O[H*?0$?AT[%DA[FO<W:\($'AHO>I4N7-"GH[6-#4
M"#]YZT2R"5JCK12,NTK/L>25YVVA1-[)#JSF:)@%`U"JH]-1V5GS,G;)*]A]
M>VX]PB:=ZC8YEDE:]Q;L2P`2_P#`TGM!+M<N%W^U],;;@%#]W+-IM]%!(`Z8
M:U[6@O4-(M2I'L!`#;@ZT6G2-(EELN2'"*(RNDDT*:ZZ;%!2,:;0?VM._?JP
MB:T-:XA&H-;J._AV2H9=N<YC&ZK\`?VO259^X5$LJK(U>9)(9]@*Q2M]4(T.
MGN:I^+;NWKU)+G%CG/NQAMT1>G?2D,#0_:J%POUTUI%,NH59)(4?[B23:$8E
MU*B,J^W>IB:0$!3IW[Z:=/1Y$@#4VKN\3H$3\*]DB!+D+B`S70?'XUVM\%AA
MX>\<!_VAQ+$AM=OK]NO_`%=5_P"CKZ.]MAS>!XD/".]!J_97%>:+3RO(%GY?
M5<GVU*_5W5925G/]C93_`%"U_F7Z.HHKY<G117__T/9[\`O^![XB?\MWA7_=
MSQSHH[5;OHHJ"/-M=9X^-`N1MNV&*DJL911!(S2,W8!=G;U[_AUR/_=J9L?'
M\8QQ/FD=;N@'V5O?8;7?5YDK8P=C`5ZC70=:B=`K16`'58]5A3W%B*R.TT3-
M^\]$"0DEB?S`ZX0V`2";()`>X>4=RO4]`!71GO>V:-KAN:`I/;Y=;Z"OVE7J
MTH;"NC":>:&36-0T3Q)[FT2.P#*H]SL5_+3J)-Z1$[I=PD);LZ@=_AX4N1L\
MTD#HG`1M!4:$DIIW^=;?HEI64G)9)0ZQ]GT`[AU1]"6&GJ#Z]0VMD8UY"ZZ^
M->OV">+:W2Y'?XTU5Q>'XC-3LXF$6(\Q))!9B@W-/!-'$9HK$/W#[Y%T1E,:
M'L#KIU<O8),1L[LHG)&H(/E"@?"]/MR\K.$T+V[(HPH/1P-B$'VK6O.\G>UB
M;LW%L5D,GFX*,TN-@%26)9[3QR1UVF>PL,>R&P`S*&W%00!TRS!.]IGRF-:#
M>Z_8EZ3CAK)6QY$P$#C<]&C^W2J/W\#=MWZ%#D53DZ<NY!>HRYO.6*N0J+$$
MO)+;L6<;'[5<4H+#;:T4HV%=I^K\;UT\O'M;+!DL..`@0Z]0T_PKI6/E8#L%
MSX2##$TAK;$*B!'7*D7)%7.Q7%..<<QE3'8ZBL-%-]C?!5V/)/8!FGMV+$<:
MR?<3LQU)T[=NLI)F39,WK32?K;U))M]G:L+-ESSN>YY)<B"^B=!\JSLY%*@I
M^W,1'.IKI)-'K)78MW]@[#[GN(0`3J-W3OU%@20X?E0=^_P*VJO=&XF0[4N#
M\0?GTUINR5A;5T]Y+N,^Q1%DBBV2NT2']R80_P!<QFD)E=M.^G;0$=39)V&3
M'*@RM:!I9?%-"-%I,+9!'FBYC>[1;HH%EZ:D#[*2>-93))92CD,?:K65_<VK
M4D<3P?<H95DQ^Y/WI^YJR1SK(VGXJ.YZ]EA;B$01`[WM!\W=?,B=?'M26F7(
M.]48TVV]OY5^P@CYTP\5B*7(?(/*^=X]:LV,K7(.*T9IT!2?.X!?M\U<EB.I
M>&K,M>&$]@71V&O<FSS\HP8F+@-:AV!SNZ$DM7N";VTK5R9<\'#18,CTROS=
MAM<J`>)&X_-*6,SQ^KSB?*8ZTOLUJ]5:Q:/[G'S6LBVK20V8H?9:[1D`!9)-
MJ.O8'OTWQ&7D0.EW3%KR]$'\XZCPJGBY.6#+@=&'.@:BDE0PCJ"?Q[U7?XZT
M\9%SC(<EGA@BR_M9OBKXRE2KPQ0-CLO3D;*-(J^]#_$K"A`HUT`TTVGK2YX=
M-A,GBN002+7O8_:AK<>\\V>?BHN-0F$I*'DE?,TC:G5`M_&K</.N4N66G*WS
M&EB>I'>]E#4FBG*HE)@H;VF5VVKH"H3N._?,N+II,ETDHWAI\O6QN!^*5RR)
MK(&P`1EH4#=W[%W8ZUC++-7]M)JDDA:)DC<S#0(^XN2J?4ZJ^I';J/"YK%=(
MP^FA0$CKW&M63@V1K6P/`<HW6ZCMT!K5I):]B,VI()E82^XIU#H-0(79R/:C
M<Z:$:^G7K7@OCVS[7EMB>G93VH<`P//IJT%"G7N?$TD9*2PJS.D:VKL99H6+
M1D:IW+,X`!9`-=Q!/3L,SV/F$SMSPTJB7^=>>C&YC#$-L9Z%1^-:HJ0KPQEV
M/[L-:!F>6Q:D2:4SF?W%!22)FD*A?4+U;>DZ6+>U@:=H(ZDM&COGUJ/)/NF8
MUSBH*>`(LG]]0-@N4T$\J<KX;;DDH2VFJ9O$%TL0K8058(;<44NS;[NPK(NI
M.@UU'4[*@=+QV"YA0L73HOX)6BGXJ<\6.1B`>IVOT*'X+]M2V5^U@6=)S$\1
M?=,9]TIF4M^^C54]I&#@';W8'7MH>H3)PR/U=@$NZY!3YVLJ]*R9B=ZGI.<2
MU-"%UZ+JG8UC=DKR4[,HQ\KV:4I9IJQ%BG;6Q8%.1YJ3$[8M\RNSQLP16W`=
MNIP?#/&4"2,.XD*5"H7%OS6WQ%-L;/CR1,,JPR!$.H*$A#\`E_@:1KSK:K1+
M+8W0V0#H(S7T,7VLL]801JR3>R%4EAJ!H.VO;I@RL:]D;Y3Z+R#IH.H3[+TZ
M(RYX?Z7G8O5;70_`E146^8.9X'BGCGE^4R]^GC?>X]F<10EO^Y(]J]+B9(*5
M#'P*AEFM%SM`52I`/8=SU=\;CSY,P>V("-44]`.WCVJ?P_'RY&?"UG_*;(US
MA\[J>U4?\()S/C^)CYGQ7B63YC2MVM_.ZU7)4*->S&V+HV[?\$CN3PV9\UCY
MT<.-GMD?2ITTZT&8SCI98\7+D3)!!)OUZ+U6M][C.%E2&"><,#6HQ6E;*BHH
MVFWC5R<5Y$Q?+H,8JT,MQM;\`NXC!\AHQT[_`-E78^_)!?(%.W-"7"2JCEP=
M-5/4#/P,]6^G&?H!=I`!\HU*]ZY?+QXQ'RRJ'S!02"2+Z`CMU%./+.K.\,=%
MJE52&[.Y;WWD!6758Q.D)A*@(&T+:G\>H4[@Q8_0,<?7X]#]G2J^-LA+7RR;
MI>GP_C^ZIH^)=N`><L93FM5TN?P_DDD5%)HO>:(XR?\`>&(/N*"-!H0.W6H]
MCL<>68[81&&N0]U!JC]VL=_2G/1;M!\+BU=;.NPURZH=\U5$M\:QZ,)&*YJL
MZ"/74L(;`&IU&B]^N7_[LD-]NXY/_<M_\KJV_L-?ZO,@&WT7*O914(I4DAC4
M&!8]J/)HKJR&5HR%C?N559'`[_XOY=?-<D3`]VY2WN-?V6NJ.FW#R%7:)I]G
MP%9AC%&"TAAC=XB7]M9&&@_^1Z@NH63U(7ZAIT#9J+-/W>-(E897LMYPMEU\
M#THOD4>>O#%K+)&V2K37ZZ-]O]S#&@E2-;#Z(C3L.RA@3H`=.M-P0=]*[`,;
M9'RO+MKB`NT!+FWF[+4+*<(I3DM:CHXB&D70N*&W7;\*4L6L60C%_'^U9HR>
MY%C[*3!7F2(^W'(Y^E4U.A9>Q'H/SZA\IQSHLZ5[<0#'-F#<ET%R?FI':FFY
M+ABQQ33;<I%>-M@";V[I\EK5D(I(&,I72&`JA9V4AY)3N9QL+,=4U&FO;MU0
MSQF)P9("8B=;=NG@35EB$2@-W`2.!-ET%KZ455#)M$A$"PQK*"H:310[.H+:
M!B78:-H--#TW$R%SM\C]K0"B`DE-/L-./=LW!C2XDIV\/NU%;I9('.LPVI"T
MDID2+ZI]S/\`7M4'NX?]GN0>W4EDYG`C]0!C?!"6CQZ6ICTG1`%K5)LFH!M]
MMQ6#U:UZN$M""Q3M*8Y8IH%G0PG3?[E=PX<[?52.D8S'LG$CD:UU@EP/&E22
M/8UWIDB5ER50K\>E(\%.##TX<5B8Y8,5'N]BL\;#[:+W2T<$0D9B("[$J-?I
M!T]`.K*=[71!JD@7<[J>R`_>E-M=)E3R9620<@Z7U)%R2.OXFOV1#'9B$XB*
M,FLZ5]JJ&9=\7J2X9/4Z=19)3"]K@QNX@$H@^'SIZ+]6)\0D*AQ1?#6DBS2P
M]][M>[C\=E-\"0HMN!+`B+,-SH)8V1G_``)U!_EZ7%DEKY;;G[1MOH3^W6GQ
MZT7I202NC<'*2+*!T[@&FQASC<78LX/'X')8>J,C-6I7&HNN(Y%:J1QSWUQ4
MY:2(-1+[9%^D`ZE=>KMW%<A%Q\'*S8[W8LA+5!!W(4MV2F\K).?,9)<N-^1M
M!(7S1@V;N%M4M]]+TL3I)OE)C#OI'&H#!HV4,8?J)+*/;&I([]4'JD.+!&&L
M'[7[UZ&`L*DN?X^'4)I1*Q/)!N1&9]Q$KI'V.T*51"=GJ&U.@_(]`E:YKVR$
M&-1I:@0$GU6A'`)?\:T/N`F=',C/'[?M!$:3]XA5=&T95,<A#-Z$C\NGVS8[
M2[R^3:B=[=_C33VO(:TM.[<J]+']XINW:%VQ4(@R<M8EV@>>*"`AA)#(VW9*
MI[JQ!U7TT]>_7C)HMC9'QB1I*%JHJZ!=;4_Y6O+0Q')N^P@?#K6OQ%RCP_X8
MXAD>/>:\)2>U'F\G[GDGD/'H^50<KIY";[]&S%N&EE)<`V/%@US7F$<!2$-'
MJ-VG=/9/NSV['QL?'Y43,?*98@MW!RG_`!(:H_>7%>YO<7)0\G[>R7&(Q-'H
M1O\`2,9:-OE;N;OW)NW!3=#5<_*WDGC_`/3O!8CX:5J?E##Y.Y-8YO@8TMXO
M@?`5L0P/5RM/D>1AKQPT;M@R;\?4]\IH3&BK]/5#[RA]K,RV96#,#-(Y7L8#
MM/5?!>J5LO:_$\ID<1E2_P"XKW8,D4202E'33N'\CF-))+0B/<BC4U*>.CR8
MI5'R:1QVXHQ'+#C"TU-+;NGO>R\@29P$4]W5=1KZGKFYLZ8P/1I%B2I*F_S3
M[A55._'WN9"KHR=38HEE'9:+W[JQ!G;=&SNS;`C(&BA<_4[*ICU4DD#U.OIU
M&3U'%N[J?G7GIEH!`4(.NB^%%OO%CB^X*A@8TDC9B/\`1X2R,LA_'<_TC3UU
MUZFP-F:USV@%6H.XOJ*;E8US_3<Y'"Y\;:4V<K7EEANO&(ALV,;('O1PS`I9
M##:=W=5V_3HNA(UU[=+C;(#.X,#FA-Z'0'^VB%\0?"TDH;`$(2ECK31O\QP%
M$K!=RE=;#Q+(\1$ONJH]0J"-U28%=5C)W$'I0BE!T)C(0?"G_H9Y-SHXCZ8/
MW]C1F66S],D%))DL(MA%W#:B3Q"0>\S!/WGM%68#<$9M/PZM70L9Y0\D%JHF
MA3J:J62ND'Z@VL#B%4="EA\:3;9ADCDDW35I0E<+CI"9EW[_`-_,94^A%4?L
M#N6].AWT;V%[92UX`\MR"1K\+41^NV5K#&'1[CYQT'04V)0J2NA+R[E)A8'0
M!G7N5UUVR(%4G7\NF(OTWGSJURD=-?X5,+=['%IVN%J[:^"01X<\;`ZZ_P!$
M<1KKZZ_;KKK_`"]?2_ME1[?X<'7Z=GX5PWG?_P!8Y)/_`%G?C4L]7M5-)6<_
MV-E/]0M?YE^CJ**^7)T45__1]GOP"_X'OB)_RW>%?]W/'.BCM5N^BBHA\LF$
M5L0'>-9GFM+`&[NS&)=PC'H6"]_3KC_^[FWZ'C'%5WO1.Z"M[[$DVY.8Q;.#
M?N)J'ZJQ5=1[8>1K#$HV@7<48.[MW5FV-J5ZX3ZKH'QRM&YH5.G1"E=`F+I_
MTR[:"-1>RZ46N5'GJ"$S/')N!$RJ!]"2&0)H25`8G_Y?40RL4R.`=?\`:]28
MGALAVM\J?&Z:UA5@-?W4GE>57(F+LQ4(Q]=JK]*A#TWDR;KM"`D?+QI<C@\-
M<S\P"?'^^H4\ORY'B6'DYKB#][)AIC)%7MR'[%9[R^S]PN_3;*4)4L20-WH.
MKGC,AD[),>9H?N80H%U%77"P09\W].D)C>\=-4;=/A^-3=AIHLO@L9;^NJ;N
M/JR#;(FY+-J&-MA4=R5U.ATT/KU!,+7ASPXAP<FFE9C(WXN5+#JT./S`U2FO
MRA:.)R_#LK*69Y\S_1F=I%*F2/(1.T1+'7W`EFH-.WJWKUZCMDD2ES@=R?<?
MNJPPIYIX,^")JM+!($.FW7[C3LF"/'-%+'(ID!`C'U$JFAUU/TG7TZK6,8#)
MO"60^([TANX%CVD%.M-'(\>AO0UDAM"I/'.AC1XPXD4?M%SJH4:GU'<%>FO0
M:(WO8]&_EJ1ZQ$P<(E`N?X"D*]QFA#6>I?NR3RL\]R2"H\D#W)IT4)'O1@8X
M/;T(T([Z>IZL(!'"'32N#7AM^JA-/!1UI;<EV[?!"=IZGI>Y\4-DJ(>5>+4R
M,+W,#R/D.,ELJ\<N.6_);BDF5WG9E-N0".W-'HJLQ$2;!V'?JPPN6:!&_)A!
M:JCN!VTNM:#!Y011"&;'CD:T`@H&GH@MT!OU-Z2/"''(JG'<]B;MT6J%;F7)
M:<%:PZQ.31]AGL11P:,DRRS-#.S/)[C5PX/?JPY28NF@R9&[&EK0T(I<TJ5*
M:"H_/YS<Z?'<W%#)3'YM;'2QZKKX+4O9*ED6KQCC<=%4/O\`OR7+$R2-*:XC
M@,;)'*PB`T4?D.^FO4-DL(=%-(4`L@U(7[O"JW%QXXI'1RR$.)5$LI[U7#P7
MCY+&8RN8:"C7O<:&0XY)[*F8Q9"6_++D)I'L*5O%TAC190`=FOX]7?+9C\7T
MMFX0R-"$(@\"$N*T_N.-OTPQA(7^H6ONH*(@`_P@:I5@;%!)4LS;D%TRAY&@
MB6([8E1UC`5@O?UW>HUTZSJF:7U-P,C6K8(3U^T5D8V,AVMOZ;BGF*T7786]
MR>20R;&3U!8J5.W1>R[RWX_G^?2'2-<&N<"+_9X+UJ26;'/9&T>F1]OC1"[E
M8<77H0VZE]XY+"4Q?!:>9H[&Y46VD2*T2!_V9`/ITTUZLMK)_2:V(!]C?J-$
M^9JIVR1OR/U%B*_(]Q2=5]C[(QLP@9I)7#-))8DVK*ZZL9B&4S:`D?AU"G+W
MR2-V!OFT'A^XU,QWED+#N)`&ILI2D;G?-<-P/!KRCD$\PK0U:6%IXW'1I/<R
MV3O%:U+%4ZJEFGEOV6"J`-="3V'?K2X>+/D9>&\`EIC#2B)V/Q%,X.+)GR9&
M/&WS%Y=N=T`"EQ-D2J3\;7&>6>4>3.7YO_S"Q7DC"9"'"<,XCQJE%)6Q#4?:
ML"WE,S[0Q!D:11#+"TA6-00VO6ZD9Q>'A38\KQZS`&[=?B3_``K2Y&3R'%#B
ML/':Q_%O&^1SB+K9`-4ZK4OX?R)YHPE%,3S3PI/R$I*[KG^+<JPGW<=4HA,U
MO`2P&6:>,+^\6.?1F/T@=9ICN%RR_&!+7@J"BA?X5!SN.PY)AE8?(&-A%V.;
M;4_S+]EJCV_\JLC4S]#AN%\">1;')LA8D;^'YNU3XO!5KQ'WA)C\H8<G7M:Q
M+I,LFD:PAB?J`ZM<'`XW$@DD=*7,)M_*!H=2NO;0U)C]JR<AC39DO+0QP1L5
M1YR3V+5"+T(O3^GI^6^0UJLZR\(X!C:\R2-5L?Q3G?(99)HF=:\LM1>/XB%9
M0&$I$DFOTD:GMU`+O;\'J%N^1S7*OVE$MKU^%48$<`<Q\;G.(('\H^/4E.E$
M<#XK^WRS\T\D9V+R)R*'W*^!:UBHL?QKC&&#"Q;AXYQUIK=<W&L$1RW)U,Y]
MG1=-S'I_(YUHA8WCF"-JA#W!"E!T*V4J;5Z,F6&-V+`TL82KP-2X6"D70CS(
MO6D_`+7X%RJ'C6+8X_C7(OO+&/@KIN2AFY8I'G@$[G]Y%DZBE47_`!"`.HDV
M_,:W-DD+<AIZ7W#OX=C4W+G&=@^JX;\N,`$*BCO\1WK7S'AT^9QV6CX[=?C.
M3:6.^MJ""*Q7>_$DKQ635G;V:=]70$20A6]=VX=NK3C.=S(?4@G:'89;<%`G
M3]A59BRQ1Y&.[);ZCC9#V[*-0/&H&\?<.\J^1N+KG>?>5>54:T.;RN/K8O!0
MXZE;RM#%VIL<@NY-HV$4/WM>5`\"*YVZD_AU-S',B,8$8N%!-S=4UJZY;-X/
MB\L'CL-DCG1@DE4!.J#NG>NA'PS\>\1XEYFP4F)JF;)1X7/+)E+MJQDLE*S8
MJ>.3WKUMGG<LK-J=5!U]/PZM_:>3ZG/8T7J$D1O4=/RFN7^[<R?*XK(D,:1.
MD;V'\PZ"NPG77:Y54=>3(5FP=<.DDBID(I"L3^VWTQ3:'=J-`-=>N:_[HPR3
M<!CB./>1D-*?^%U:[V;*(N2F)>&K$0IOU%0)*D30IHPAAEE9""WNF25%U".R
M'N"IU.G_`%NOG1V-M,>_R0DNZ[K@:&NI1R[G/MOD:T'L@/4+^UJ)3T9#-#!&
MXTU0H`P_!-$7:K[MS!]3J>VGIU&8P,<\!H*C[NZ4_P#4,+"XV<O]_P`JW%$7
MVZX4[8T6-HRVK/."^LC?LZC?IH3KH!^/0Z3]0-AB<P!HZJ%(N?G]U-A7"21S
MFDN<4MTM:DNE0M5[D\K6(Q2-B-HZ>P+%8?4M.P?5=K221@:_D21IU82<AOA9
MCY`$CF%`38.!_,5[]J>R&P/@B$#'-GVJ2-6]A\+K]U89*YEEFQE?&XF.Y!-D
M)*^3)LQ5WQM%XGE%X^Z"]YEEA$:HFC:-KZ#JI<(C(X_D>Q4"*J^/PIZ"&`,E
M?D9)W;%:4_,X'\J#\JJI--KG'*<KQ&E3R-3#29NI;N)3G4R-5FKLS!8XT81R
MJJF1B=7^EMNGX]2<;"BR'.@ER&M;MW!WRN#>W[ZF\7A0\C+(U^7Z,C&*B;@?
M'IT[:4]HED>"M+9CBJNZ&1HF;>T4LBAS&Y'9I(_3M])/IU!V1[5:A[GP_;2J
MYSDD>UKRX:6&H%OL^^M<0D"HD6U""LK&3:'.K,"2!H%#`=1R7C8U;`J$^ZEN
MVJYQN[2LK4\K1NQ(((D1'^D,'#:J$U[$:J/YNK)F6DCG.`=$`&@I47Z;<&L!
M+9"53^--R61"9'94=XU9@$7:IETTW$]M?K'?^3J&2US@'7:#^^K&-I&UK2@[
MG7[$IE8+(<IFQ;V>2XJG3R?W-@24<79699ZRV76I(KR^WMD-<*S*#^.FO4N:
M2!TK8X)/TD"E+C^-ZFY6+A0SN^CF>^$@7<$\R7^^U?@YEQZU7@X!/F\C6Y?5
MYVG)Z^">O+%-%A;D(D#03Q(8#2D2,^Y^\)!.G73X^7P6_P"W8POJ=V8R706(
M5RA/E5">#Y`<Q)S+<-AXI^,6%ZV+FV0C7<NEO&EYA%&`)7+-&S;7[QLNNFT`
M`N.Z^I_'KE#G[)7.;^4=#UJ<U^YH<T7HD;#.1J`$!T*Z*&?=MU)`[KM[_CWZ
M4XJX@!!T'?X4H-`"*2:Q>4*>[+&$(**B_M;="RCMJI*CU/X](:2YVXO`(T"?
M=\:00`+`E=3VI*GL@2!(U]XJ6D+*1&&.O8:]PFFG\NO\_3S9"7;@0H4IW_A7
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MZ-2X$+XTF38\R&RM9YIJD$<+2EXXD+Q&&/W!#$_TG6=M`"#J1_+U;-8Q[P8R
M7QM:TN_E/=!\[4T<HM8'2L#)R2&A5OT7Y4@9+!/>K7*D]R6JM^J\(--XZZ0)
M8.R3:Q63>"D1T!TVN>QZDL$0D=(V(-8[H38'OXBVG>F?JMCHR`'ECE77Y?'Q
M[5'@X-QJI4LTQ2UFDL/<FM_=SFS/;DBC@]YI_=#I+%'&--OT@^@Z0[+FD#6$
M@H[H+`:5/?G9#G-F#T:&[42R"Z?.MU,Y#&-!5M3V;^/#J(YR4]^I$L?[5A'9
M1-M*@:C4L.Y&O4F!\+-K)GO:2;)IX%/QJLS4F:98(&B1"2._@/C6,MB$EFB]
MV:1B(SJ-!O6361`"JG5@=06]!Z=-R-,:!KE)U\?[Z3&3*V_E"*G7]N]-Z^BE
MRD<AL`A9$:,?4"X;<&WA=TNG9@.PTZ7*P![/3*A-?$]/B/"EPRN#?,W:02/[
M?@?&NV/@]2OB'QRI[$<2Q`(UUT_T9?Y3U],>V@1P'$!VOT[/PKB?.%>8Y(__
M`)G?C4J=7=55)6<_V-E/]0M?YE^CJ**^7)T45__2]GOP"_X'OB)_RW>%?]W/
M'.BCM5N^BBHH\GQ22KA1'%&[+-;*RN?JA<Q(J&(::&1R=.Y`T/7*O]T6&3%X
MQH'E+GCM<@)6Q]HN:R3,)<CD:GBA*KX)5:^)YFIG$Y2HSHS%G!\FM4)X2D%8
M4M\:R"'2(+&T<9.GN'7<?0]<8S<!KVXKGN.H&WLH_"R&NF9#9,+T7-QMD<D0
M*DERW0:Z?"GG:U2*NA)AE&BSQ#5TEVA>YD8[4"DGT]=1U2Y,4#(996-0M<&[
M-;^)IN!SWRINW-()W:)\!UK8]6`1LY[[E8!&#,%0@[MWYKH>W58QKP7.>NXK
M\E_=3HG<7".R?*_[=:K'\D\YA8?'.6XS>RE6,7+6";*5F]V05,-#F*-FQ-+[
M10PLX10A+*3KH-1J.KCA,649;6MCMU354-:3V_#/)GLS((=Q:')=%):1;O5A
M,.*EK$T9L3+[^.EI4&J2P2)[<B!$6O:C/=M8U[:#\CKT_D@8TDL0((;<KU*]
MNXK(Y+I?J'NG:62[B$ZCOX(:CSR_]T<'B'$TJW8.68VQ4C/M*+#U-]E(XY"=
M$DLB)M5T['KS!#9GRR->1.]KU71$U%6O"S203O8(&NB,)!/@;7^`2I-%RI-8
M"O)(L[Q`K&X]#[2N=#KH=NI&FOKU0>5KI&%Q=;]]-".9L0.P;%^VDFZ97JW$
MHM";S4&E@:0`JC.DIB<KJ`5,R^G8G33I(D:]PBVG:HZ=5J0QS"X.)LUR'QTH
M5D1J(EMP-]W`HB:<-%^\"2[EE*CL/=@8/V)`U_DZ]=&T330N8XO991U*J%'9
M*3#D/E(,4@$3CH0;#36FI#4CA2:X9XTFD>22:17_`'8JQV``S%MJZJNXD_XO
M\W4C'@>[<=H=KU[#05-:C084MT3N?ATJG^2\C\=X-Y4Y#E#):?@N8B7^)0I7
M,E?'9J5'2+)U&"M)"F0KTYGG10/<C9'T[:G0NXV7)X_%E8?UP#_I50/B#70L
M/V_/R_&8^,(V_P!39=I6[F%%:[X$A"?A4D<B\\>/^$\?Q/(_XLV=J9R2.7%5
M,7";4S(ZEE><:#[*&)4^II0BCMKU7X6'DRSOV-/U+7!%%@GAUJLC]I<I/E38
M4\7I>F#O+CM`3L>OR)JMGC[R_B.#<[Y"EQ[TF#YA>>Q6HI5%N;!7;[S7JD4E
ME%DC99D#F35P5&A'8'K7Y6!]3AP1R!,EC5ZBW;[:NN3X2;D<"!^)*UTN.&M)
M!4.2Q3K85,'_`)]<1%:3[:SD/N9KULVH(\1D+EUZ[;X*;05EC`]N<Q,!*#L)
M&@[Z]4[.&R6OW1M`:VY>HZZ@BLEE>W<X.C$I`A-KV0]5/36BD7//)6<@JR>/
M_&J6ZZ&2E_&N2YBK0A8)(S*[UY"]L&)GWL`"?\7IJ+#PQ'^OG;PI(:&_;\*0
MS"Q,65K<O)+8@A\H51V!J-.5Y[Y(X>SQE<IEL-Q^_P`AY2G&DMU8L;EL/";=
M>>Q6K)BY:Z6!*_L,5L&4!=NW:==>K;$/'-9)(82(V6)4K?\`=6@PL#VUGG,$
M+7.BBA,FVX<2"`3N5.OY:D_$>*_)UF#*V>4^5LC8R>0A$-5,?@\)0JTD1=%>
M)&KM(9)'W:DMV_`]1)\K'<]OI8C`-VIU\/E6:GY'B(9Q%!A+&TZ$DK_=VJF.
M!X?SSEGF[+<%SO,^19>#C.5&;FR+(T2XQ\3)&D'\(E0+4:S-%:,99%WQ:D_M
M`=7<>8[$P(<K%BV/4;0-%(_=70,^3B<3V^W-Q\5D8EAVIJNX77M<?.NB^)QF
M'XIC,=CL;1^PJ1QQU(8XA+&[SK],LT\CLT\T[LVK2,3N;74D]9_+R7S%L[VD
MY!M\QK;YUQ]TTL\L@<_]/4?`Z`=AX5LFEJQ>[8B58+(#L7WR_NH&C4%64L-K
MF7T*ZMJ?RZ;CR!&OIL`G`4D]`E[?'J+T@0R2'TW/<83U[E=/LIB\IQ][+"+)
MT[$:\CX]=K9'&?<KO6U#-+!!E,&_TL%@S=!37:1PQB8B4?L]2<'E))(9L++>
MYT;KD=`ZP!'B.O>K"![<9XC<"<>0%I(NB@H?_";^-;ZEF&X:[RU3!+,)Z\E>
M61G%+(5[%.M)3DDA)B=*T9GC9AJ6WH=>PZ?`CQY'02L_4WH'=$&@3L5^^HF0
MV1H:89@8VMT&I\;W6BUJN89)X@J$05[$2I(4?VPDA+1UU9R'+>V3_*Q(Z(@6
MN>TIY26E;[;]/W4J20%K9BJN0VU-NOW"F]EJ^/VNUFL=U9FR-9W]Q98)(/\`
M2J]P,`-K0N@;MZCMZ:]36RN,WILDZV(M8]:C@N0N:1<;2/Q'[J,AJE_&-DH)
M*=F6U#%]I(MF0JXD1I2S`R"-F?MO8@*/34'JPA+&LE,I:9B$NHOJO[6JKD9)
M'/$PAS6-?T'2WW5$/C&;(S>-\0]N'2Y#F^94:PA$<(FKX_E^9F$AK@;8Y!)8
M(U3]H=]=2>K;E&>I'@SL+MSHP`B="=*D<EZ8Y&2-1M<`XF^I:`E6^^*$GN>9
M<,TA9G>AR&9>^I21L59%CW'4D.TK=R-2`1VZL_9,C#S[&.*R[7G_`/:5O65]
MU1&/AWIHK!\E"5U<Z[17+JA[S!D:-&GQ6&\AF7)<E2C!7]R=$GGDQF1D5)%@
M!,D86,L0WTC37\.L1[_#CP?E"_J!0J*$*WK6^T()ILW,?"4,<!<2@*`.:%O\
M:C"U%$D05@FJK[;0J6#K*DI,+PJNU(HTV@$Z:N#WZ^;IWQQ-]..,%[E!:>_1
M%T_?72(/4?*2'G;J#X)=>Z]NG2DO:TVUXM\4A8B0;0"6!5HV$HT(3:#J/4_X
M.JUX+$D#',C=;70_'KUJ;Y;!Y:\-N-=#K:DZS[GW6Y'>-V=6M.$^CVU&P>VC
M@E#].G;N=._Y]$K60R/+D#00@!T!&I_A2X'F2%H8U3=%M<']KTH?N(XW:65P
M8'.R'0R)N;=H[`ZE=K:?B0=>W4,2EX=ZA/J!P1+KJEO&U>D2>HWTVJ'-N=.W
M7X+6==?N)5F$RQ:EH@P02`N-VPLIT((4,I'J`1U[-&^.=,IX$H"'P**%^5(,
M[#%^FPN;8]K=4^XUA)$S2#55,232R.DB$UHQ$%,;H7)+F4.VX$:(0-.H[3"(
M20?,]Q47*`(GVW6O&N?ON/+L"$'S$GH4[(/B*%B-3[<KAVC"1/'&R=XV12-R
MOVU(!&O\W34K"V,$`EKKJNB=*=B>-[X]PW`W^=)\ZK#(KL7?W`'$;]O;*`@K
MJ`--68$DDCIX`Q@;77<-/G^[5:?82_=9"/V6D^?[@_0^QBFLP5?V9(&[`DL%
M5'<G\._;KV3&<PQ-WK'?Y?+6E0RL(>XM(=^R41>*.)AM7=[C2*$$[!5/^,2I
M))/;HVAS&!CU<.]K^-28G%9-RH$_843GV_35C@5RAT"EBS:MHP9G9BQVGL!T
M[*AV[&#<0EN_]E)8YQ]1SG';T)Z`>'C6,=&*P[9&&A&<A5@:&29C$TC1`?6Z
ML?V73M].I4CMIKU>\8<>3!S,%D/ZZ+N)L2WXZ6M:JO+FGBE@<[)(Q7._+TO\
M-5[]**S!?;=V#!G[&+:6;U`.YU.T`ZZ?S'J@<`WS-)06^:U/:7$[2`?&DF54
M@1V*M`J*FUP"S!.YVN!N.S0GU/;7KPR?G<YNZ1/LI6P[6M8]&+]OVTU[F?B@
MR,%6:&V:UD!1;2%3$HD72(?7H3];COW)UZM<;"=*Q[W.#Q&%(`TZV[TMS-L3
M0PC>XH`3JG[:TH>]`T4S?5'[<+LLBZ!C(61`01W*QN3J/5M.HH<S]0/)#@%T
MU*@#Y`$TP8W@Q@#<-R?;K1&P5MQ1MN'OI(+,CK&%]RH%(!=#N`9O:(*@::#7
M3J0T^N[8QMVW5+%!=?QI*>@7!UXS:_\`B_LK"=R1&BB0B94E6=]Q23:7^G;V
MU(*$:CN-!^?7DS61QPN)7<=3_E*&O(P7/D%AM0$=B:)6BT<LIW^RMK]U.A.H
M,8"3`'9]2_4JMN!&I7^73IQ\COUGL80UXVD+H+'\0M+C:QS&-==[3N7N=/WT
M@EI)G37:*ZRE/==D]QPKH[1QQC_K`]B=.FFQ1F(.*AS3]W]OW4^X&,DI<MT\
M>YI-M;95DW[FB1I'13*=P`#%5]/0'\=/PTZ<A.V19'(`1U*CM3+V':!M'J'P
M[]*2K3.R/W#/]"Q.'^H`@R;-/1E(!_F[_CU*FD8`)"KO'IU-_G3<46USFN:&
MH?[*;EI(P$T5GM[R=2#M715VH#IM!#`G\S_-TY$=T;6Q6\USW\*6=Q+W.M&!
M;^-:2&=8U1@1+(%E(A^II%_RT88CMIZ:_P"'JP+G';'&P$(%7OU%5K@=VYS2
MG3]QI)OM%-')+*J2LT^Y9%8(5F2-@`-I#N%4>C:J?RZ6'[V;B!O4W[>"4,$D
M=@?(1V_?3<L2-&\)67ZH8A(I9#HH.[W$&S0*5#C7\!UZ'N_2:TZ7^%`8TNE5
MEC8]532NT_@LD^'O&Y9BS'B6()8Z:DFNO?MVZ^EO;1W<!Q!__`W\*XMS@V\O
MR(1$F=^-2OU>554E9S_8V4_U"U_F7Z.HHKY<G117_]/V>_`+_@>^(G_+=X5_
MW<\<Z*.U6[Z**K+\CZ5.]5XK!G\=GLIPY[>13DU7"7VI*E9Z\0KV\BM8KD[-
M*M+]3I6.\C\#Z=9/W//Q,+N._JX_1+W)JBH+E.U;'VHS*<WDG8+FMS`UI:2/
M$J`M@2.]49YPGC/B;XWD_P`;LW-3R>$:W)8XS)Q3DE7&\X%AX(FQ,^9R%=:M
M1HU+%9)4T!U.NO?K#^YG>U\G&8[$R&>LTH``;^%=%]O9//Y,[^/]QP;L:1OY
MBYNZ--'!+_(4JXWY58BY%)CN0^/^98+)8N**3*546I:KH[D`F&PLJ1RP(5.U
M]=&_E(/7*\KB(Y6/?'(/S72UOA6N'M3D('1Y$&3&^%ZAI^'?[:T9OSAY)YA;
MQV)\/<$R,RS3Q&?+99ZJU$H*J-.))I?:@K-(K$(=S'7T'7L?&X40].6=7G1H
MN?G2\/@^*Q8\G(]PYPC>T*&M7S'I8*4[UJ7Q/YAY?;2[F\OB>,5<9<O-1Q#5
MZF7:Y-/&\#WKKZ2F:4I(=N\G:#V'4F'FL3A7N?C1[I7=3KV\4I$G*</CL8R"
M!TKG-!<A+0$N`-*86,E\^>#\J:-7"0<UX0CPQS2+;CD3')O:::U]H@:_7<2'
M0;0T>W3\NH3LSC>;E+9%CR=!_>*T\\'MSW#BPN]48_(D$K?S:!%-C;X4\<CS
MW,^>.3<=Q&!Q$>/@XO?.2R[6+T5JI:G-1(0(2@C>,53(W<:D.=K#4=.2X.+Q
M,<\TTVZ<V`&B?W568_$1>W<"?-R9-T<S2V/RH?S'7XI]FE6XM48LCBECEKQ3
M3QFNQ;NHCM1!5$D;ZJVJDD@=8V/(],ODA">)U(T2L:UQAR1OD(C*H/#X5$M7
MD/)J_D.QQ#)-6AACP2WL!,(?])RALR6(KPM*`88WQR5@RC7ZBQ/5F<9T.''E
M8R[B2#HC'!"->AZ5:S8G'Y'%G,A))]3:\"P`LB=;J0:D:W,<?LT4>Z#'H)#K
M^^CB`]P#335I-6;\!N_DZK2-LI<T[9'?.Y\:A08[)V!OYF#Y(!^P^RF#R^>C
MA\95BRTR08_+WJ6,O@^XX_AEJTTMU(8(MTKSM2C=5"C=J1U=>W8(Y^3Q_79^
MDT[B>R=#X$I5A&,F5LWT@W93&DCXC36UOW53+EG$<-=RV:Q=\WJW'\'?SG*<
MK/+CWGDI5YQC\=QKC*UTE+*+M:T$:0-N&TDC4'KI,6-'+E94A:3&&G_A'4#\
M%K:X7.9F-C\=/`YKLN0L9JA+K^HXV1%"CI4-X[Q7SCC?*<+G^'QX^OCZO(J7
M-<1Q$TI+\T]6H:N2KU,E&\N^:BTL`81'<FT#\].D08QQ\F/.8T`-<J:BUZW?
M(>X^-YKB<OB^5G(R'P&%TE@%(+5!`1;W/QIP>2N;\Y^0/E*A0Y/BL+Q:4<9S
M52BV&=X];/&Z=WDT8LQR15V63(QT)(D8ZF(,1ZZ`SLV?+YG,@F>&L<(W(G5`
M2A^-9'B^#XWV![<GR<2>3):_(9N).C7(TD:JEB>]6C\(<?P/#N$85JF*I0Y'
M(_<V;UV-_=N&::>6*6.Q,^Z1C$R:#0C4D_AUSKE))Q-Z5]Q<>OP"?!163]Q<
MG+R')S[I7G&:QI:U"!HJCXU+LEF-I)A&78[6W+HVWU^I_J'U!?Y^JP,DAW*Q
M`20;ZGLG2LZ'!Z!KD0*/XFH\\B-%9XO>NV%BN1XX1Y#'+&R@5KE`EH+7N`CO
M$==>_<'3J9!ZKY0QI!!U:/\`"FORJPX=WIY6P/(W*''N#8M^=.&+.&2GCONV
M40W,?4>)U`4S3/61YH]`"ZZ_D?7\.O)7NG<(B%8WY>'WU52P#&R)KG=NLM^M
MJ@;A_'<;C_(GE3-UH6DN7+V/JWI$@$1CK_8UWL5XG)+*5G.\D::LW4W/GG&+
MALVGRLTMW3[A6HY'(FFXKC8GE(@U6@FRW4_.IE:=0$C`6,"%9M%;W'5@C)O#
M$_M'<-0-1U"CD+71L=9POK?Q/]E9=[?*\@@C3P[_`+&D7(Y*4PHA82.Z!%D1
ME1U5F<%6#?\`5(]!ZZ=2G;GR0FY\?`_PII@+5*:73H:1);7OD,9CN#LZ2*KL
MZM,$]-%4AP78:?AIU[/"QY9LDVD7W`7*]_X5Y%)(`TNBL;.:N@6BM&0+D<U6
MJ/'%+8H4\RC>U[<<ENM9MU\@[*!JUN430'\`VWOJ1T_&Z1^*1/(0^,NOXM1P
M^:&U3<@,./CR%A+@[9?4-(LGAK\%HM9>.1^\0F<[4:1S[>VT`TMF1D(T]LR/
M(Q_$!1^8'3L/H.!GW&YU.JFY7YJ:BH]D;VL<FT?&P"`#QL/MK3=9YD*AI(:J
MK#*LQ[&=Y-%C=E<[QM9@-/\`X.K&9K&QAC+*`05U%1(26N]1S5<206U&G*>9
M8?Q]#)E>17UIX9RPHVI8I'BKW5BGEEQ^R)'EFEN[@T056^I2-._4K%QW9#`6
MA<EA``Z%IUOX6JUP\2?E)&Q0Q^;5UQ8#0_QJ%?`W,+G)'Y_4KPY"A4RO*[O+
ML1CLC7DANU,==K4<;.?M95C>K':FHF;VF"Z[@VG?7J^S(IAB0QQJUK+(1<KJ
M?A4WW3QL.(>/R(R)&",1N<$10I3Q(5%KH1\4D"^9\"-KA8\5R%48Z*#_`-E3
MJ0P77>PV_P`P_#J3['V/Y^!_\S6O`\?*:YE[J<[^C3*B%S/EYA^QKJ_UVZN5
MU"OF:J\L7"+86XT6-Y9]U+]HCR;=^$RU:%["H"WVZ3SJ6_#TZQ?OLM_HI:2C
MW/1IZ`D&Y\!6S]EY#XLCE(FEFV7&VG<BIO8XAO9Q3\:CJW+8FGBD][=$@*2>
MVH":H=LNO8"3ZV!&O\P[]?,N9]6)`UY798D7%NOP/2N@X[(61NVMU*A2AOI\
M+:UA-$'C]UD=IT9%EE0*H9&!](E/U:>AT[]1Y',R86%L:S+YDT(1/RTMCBR8
MM#P(DL#\>_3YVIE7>4<>Q>23$9/.5*MJ5&V5A#>N3JI5MDLRTZTXJ`NIU]TI
M^/1B\)R&:UTC8G?3-U<!9.OWVJT<V5N,,IF,[8"BJT!>P4A0G9:5L9>Q>66&
MUA;5++XY8K%BQ:IS+(L!EVP5-2?K6>2:8$(VA4*=1TZWC)H8LO)+`[TM?_%Y
M0GB%4?"H4T\C=L4Q='*\@"VJ%3X(@0GQHT\1KSR>U&O[QY5)9?J";H]$!;0*
M))@23_)IU2O:X!T3VG>7*IUJ0TB1L+BZS6]/'^%&]QCG==NJAD!+$,(W/=@G
M_60D#7_#T@M,4A%@^P'7XT@`/B!![_,>/CVHG=$T@=WF3VM5&[:%DTED#1KK
MH&6([0/Y0._2G.D=&]'`,)^WY4N&.$/8C3ZO\-?G1?ZM(1*VBH)S(X??N+%`
MB,G<_GW7\N_7@],111FTH6_?X]`E2"4?(6M5I1+(GC6IH(U$SKJ&?VSH^H7:
MIT4C3L-`3Z?ETH>5[`9$!"*GXT!7$*%^%(U^(P3RRPHY4)$TCS/]2R;0-$'I
MW+=OY.I\<39)'LCCLU->]>>J]H89'"Y*)21.+*>Y99MJR.L<K1MK[BHFX1HI
M(V[==2WXGMTV^67TYH6H&/(O\*7^ANC:XGR@E$[]_P"%%WDC540G]XS-K$&T
M++V*=QV.JG_IZA-!:P$.\W:G0-SW'9I]WPHO:GDB#>R2\1]H2(K!0@W#ZS_B
MMW_#^3J4^1I/Z2A0`>U-QQ.<YKWI8E*3I95#!BVT2^Y$!O8AM`-3N`U5CNZ8
M:';BX)K>I#4+4%R+TG/%7L559HX7]MI5BV#W)-Y?0LK,-RL6'H.W;MU-F<6Q
MLB$B:::K3:GU3+<N3[!28-CRJSLT?MAMY7N"=RCW._[)T/<>G3+YI'D%Y`=9
M3X4H(PJVX-$GG63?'N#D$$C7ZGEW#4CMJ%B70CN-=?Y.I+;0R;'D`MTZZWKQ
MRND:`P(NOA_&OW<P0+&))E9P8WT*.LJ+(L95?\5@P4:^ATUZ::YZ,2,[`-?[
M/"@M!WJ@*W'<5^S0QK&D8U:218R\TH"GW75R`J@A2&W@#\.X/J.I6PF8M#5+
M@I7I_933-00Y&@_LM)4T,&DNTMLTT;L8RQ0AMQ&IT5"?\.G1.UD;Y'0NW-!%
MM?G_`&4MAEVL]1OZO?PI&943O&(]CG5PZZ:L'!_:/=0Q'_1TW`7@$MONU^VO
M9/,@ON'\*0LM,E=/='MR-L#A3H@)E$Z.$9BH58SV'\_Y=38H'2$ACP`3_'\*
M<B:'N$9W7LNO:F\9&E*S*')=.T;%-JHHW,ON1D@MV[C\M.G2&MD_2!0'[4I$
ML1CW1D@WUHB96$J_NP9I611(7UCV2A0P6+]E2%]-?QZE,>'%Q<!ZK@`G9?WU
M$>P7_P``_$4G2HPW:(0&T56WHON;)"2!J=5VK^/X=.ANR(#85W:_N^5,F0/>
M`UP(%-FPCDL`-=@?9M8=F8@:?RJBZ:Z>NO\`)UXQLKVN8`K05U[TYM8PAR^8
MUVO\%L&\.^-R--#Q+$>G^K+_`"#KZ=]LI_\`'^'33Z=GX5PSGO\`]9Y/_P!Y
MWXU*_5Y5325G/]C93_4+7^9?HZBBOER=%%?_U/9[\`O^![XB?\MWA7_=SQSH
MH[5;OHHJ-?(T8>#%[UC>/WYE=7)#'54V[1Z'0COUR+_=<EL'".:5(E=Y515`
M_"MC[1<C\\`D'8+CIK4"15(*40J;I&CF=MZ-$NV8Z,`FFC;%W'U'X=<(,LH:
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M[@@`4LO6FRA)-@1RE^X,(!\`:TPS\KG>`:R:\N(5/=S406_RI<U85+5<2QHC
M%U+."%4EO=B0DEM?3:#^'5`6H'B*/<0I-_O'C68<'O&XHBI\/"F#S7#1S<EX
M#RF)1'>PN8MU6*$F6>EFZ<E*TKC<%(AD5'&X$#1O377J;AYQFQWX>SSNNI-O
M+I\QWJ?A3&'&Y+%)_1>P'_Q-*A/CI:G)9"6:T-V4;WB9Y8B59%/97V;3Z$+^
MT#_C'J)Z4NYVT;BIMTL>E)Q9#&6L/E#@`>]]#_"JA\_S$_+.9+Q/%4Y<E/9!
MX_QZL+'VME;_`-ED,Y>R\+2`:I'5QC[7[[XXFC!U<'KH'M+T=SH!C;GN"J38
M=2._1?C6QQ\%^!Q1Y2;(,<8<KRFH*-:WXJ=/@>E?ODS%C!\6XU!X\QTOOW>=
M\=X_SWC6;K2_Q6?/C$LT:VLA(\J_;V:DQE#@E-P!'?7K:\B/08R.%A`*[@>]
MDO\`#2J?VKEQYO)YAY>?]-D;C$]N@:'*4'<6%)?`%GX[S?C7/.69%J-J]R";
MQ_)Q5H#,*-6O$U''B&?7=`BO!#J631DU8MH>J\.@Q<>,SM<6M*O[IV2K3W!,
M,R'*XWBP/1$7JMD5-QU)/C<Z'Y4M_)KPNG)N*S\_XUI@.68J"/+S"@TC5\OC
MY(GJ7'3;+&8)X#=_>`#5X]0.HF#R6#SD4TV(7,R8BI9X:*/F0HJ%[6]SRXF9
M'[?Y%_K<9*H4ZL<+CY%+'I2/X(GBS/C3%-)+,]G%RW*.2DWB5HK*RQVF27>5
M=I1%.A_/1^L=R<,IY2;'`1Y;N)T*DJ4^%3/=C(8^1]:,AN.Y`Q+@@!!]O[JF
MJP%FBCK_`%"$0-H5/LR?4&3=)*0Q70>OJ=.HD`A9-&TO+@OWZ7/2LNYQ<R7:
M$DM\$\`-:8'D#%6L]PK,\:QLJU[D])*L31L"PC]R-C'^]"K[<L:M]9[CJ0#L
MSH7/>&ZCX#]]3.*R8<2=D\[-\?6QU[V[=J6,53]FGCZ^JHM.I4KLC.LC&:"&
M.-W!)T&FW3MZ]0IY0Z:8M>0X&WR_&O7`R9#D`+'$G[3:F!P2INR'D/,H6D7)
M\WR[2%_6:&C%!225`3J?<]@G\!Z=*RY73G&WM\P#0O<&Y*5:<NX^E@0G_EM@
M``^9-/78]C66-6C6,DQLX4,H4$:%.W[>@!_`=$+XI'2%$#50]TJB(<PM"+N%
MQ\:1,C5:>'W8M3(6?W4T&KM*-S_RKZ'33UZDAY`;&''U".G5>E-.C20'^4=_
M"DKV0T>C;9M&(T0Z#W&?V"K.NB:&4%S^.O;ITRN>UCD5QM\/C28X0V5Y:4")
M>]KG[JPECIG)T&'NP7HZ=^A$RHVD\DMS$RM&_I$%B4,R.?\`JG3I_&(?%EM>
MV[0U#XJ1^!^ZO9)'QQM6\3B5^0-QUHWE*->&M&ON1PN!,L\B1M/*`@+>_HS;
M7>96+$]CM70?GT^UT438PX!40][]?B1>HC)'O?*`YVRQ6P!1+?`=:3+*QK7@
MA:(")M8F8DLK/&SE&4@&2.2$]R/1N_3K7-(A:\G83M)UMT^"4'<7O<T^;6W3
MP/=:@OR5R/CO"L_XJY5S&W37BO'?(M')<A_B%5K56OC/L[2O?,$<<QL&JWU;
M0C$MH`.M;[8=##R.^9X+6=3H@-6N#B9F=C<AB\>'-S'PG:ANO9?&J_\`-/+6
M:\J^8>2>8?!/";]WBU&M2P&3NY"=\=!SB#&5%)EQ%*:M%)3CE@L*@&W=[D`)
M.ATZOO<6=A9\\L4!#7$`:HO8BM-Q/`X_$\#%Q7N;/8W+D)<+%Q87'K?X_;5W
M_@1Y=P?D/S93H8^ME\7FL=C<TV>X_EH#5NX8SX2Q+"+BR(JRM)*A4&(D:C4Z
M#I/LS$$',PO>_P`Y:]!T(VZUS3_</V_/Q7#NF#P_$<YNUPTNZU=NNNP5PZF#
MY%M35<)#)`%,ANQJ&8M^['MREG`7]LA1Z'L>N;_[GY1Q>`A>&*YV0T*I"*UU
M_P"^M1[2@$_(R-<Y&B,E.]Q;PJ#8K$LL;R^Q[;2!X6B$@!29Y`4<1[2C^Z/J
M(_#7KY]AS<B%TLB-)<-NH^U.JK72WXT;C'&7&WF5.G4+X:5J-E8K"PG59%%@
MO6W)((GU71C+V#HP![>O?3J&7PLFED;&6]`U5VNLI7J#>U/B!SX?S`M*>:_F
M'PZ$4BU\Q1X-XVYIQ^&*@W,YZ66LT,Q?IZIG/XE[CQ?>V4605[=>.4Q;&?U4
M$>O79L'W7QK?9F=APF-G)LC+`"/S%W735#]M9GW!@\AR7+8F;'ZCN/VM&QI_
M)ML0T=0450.M56\.R/Q/.\1J9J[!C[W,GS.)RM2/VDJ93(2UI,GALD9EDD1I
M(+E04TC`1O<F'KUR'CX<B?B,@RO<T-<H!!5X55![`A$K88K<O*P^0(@=)%C,
M8]KB"K`NV1H'9S7;B>S:N+8BBC$=?20R(W[]W8]YCHRZ%M692#_)WZJ\ED1E
M9$8W!!YB=25!0=K5&@?*X22[F[3^4#H-.G8TF2R*GN,Z2B02E1&-&D;;]*:+
MZ'0'7U]/7J-^:21@",=JNJ+4K:2UI:X$`:]*VV*;6:CQ"556=/W3`!F56U()
M[AB%/H/RZ<='L$>A:$*`UXR<-D+F@J"5_L_C3=QT>0K!Z^46&0B?2*6L=%92
M&`W(>\9U'IWZ]R/1F>_(8PM8?Y>@/QJ>XL+8_0>24NNM*#[GTC151P`"S'3]
MK4@`'4#MTQM?*0[3<++X4VK(U+B2%Z4S>3V<E%!8KXW$M?A@H293(7K&12C%
MC*]6:+?+(GMRO<><DJJ#3:.Y/6IX#BOKL?DI"TF)C&FQNUQ.J=1^%-29$,3\
M8RSADA?M:-J[UZ+T35?E6UY`L"RPN)TF@AD&BG8L4L:R?XRZEF+=NWX=4<V.
M,>6:*-XWK]QI]LA>2^1A#0MO$%*1VBT0'<`Y)*1A1J8]3JN[]D$$]11&(PLA
MJ1ZCG.1@LG6L7#"N%+(0[`2H-!V5AL[Z^N_3MU[N:QK"I+3K2=I<XMZC3QI,
ML/[BZB331@NFW5B0>VBC]G7;H?SZ6XAZ*`J?;7K6^F"2J&BI*L1H7C&TL)%7
MZ4=5+*NG;4!QH/QZ\+5<V6Z:D^/]](!+0X(%T`7]NE$Y-%"2I&`Q)!1B'652
M-"2/4=^I07;&6H)-4-)<'N)8?R=^U)M94DLDN%7:T<A_=MI*ID9`L9[=E#,3
M_-TY(R5L3)76:]4'@J?BM"@;XV.*M^XZWK=(6,4LKDQ[=D(&W1?;3;H">VDG
MT:@]_3OTT)'^FZ0`@;=OAH!\M*60W<UA`<#<_"D+-^[_``BS8-DU88#)[DX'
MO%*WTK[:D:$,#JX(!*G^3JRP)&'/QHQ"'1JA)/0_'XK2VM5I<(U<18:*=?P"
M4D4;UJUB:KRUVC",R;Q^]:W%$#$)C]*LB2HHDT(U^O3\.F\Y(9)HXT+=Y"CK
MV'P%.N8PNW-**T%#_*NH^(-J+7[=.O7,UFPD$;2EF$FJ'<--B::';H`-!^/4
M>-TV\%HN[I\/XUX(BHC:TDI^-0]R[G.*BL?T?HH+EFQ4^YEFLL8:T5;>08X&
M*&2>[-*!M0:?3JWH.K_BL2=S6SEC2T&Q/?1`/C^%77&<3+(?K9'ED8?MM<JB
M_()J:-TI)6HQ2U:MFR!!"Z`LJ2.=FJD$$`D`'7MZ=0T>[++03ZH)W(.J]J@9
MC8VS2-F+6L!/[?.BBV[$EE_N(?;6.**8%&U61SW9">VWVE'?\SZ=2GP-8LAF
M:Z0N")^^JU\;/3`C_(IK2_[R>-OV@=[)HNFT-K^!([JI].O7[_4!7I\KU'],
MAKKVM]U)%LR(7_=+(KE=NFJ#=N;N.Y*,1Z_@".O8SM+W;?*=.G[+7A&[:"[O
M7;#P/K_Y->-==-?Z(XCT]/\`Z77KZ;]K_P#_`#O#)I].S\*X1SUN9Y(+_P#>
M=^-2UU?54TE9S_8V4_U"U_F7Z.HHKY<G117_U?9[\`O^![XB?\MWA7_=SQSH
MH[5;OHHJ*?*-B"M6QDLYT"O;8=R#VB7733\?Y>N/?[M0NE@X7:#:1ZI_PBMU
M[(8^2;.;&%=M;;YU`:3W,A*[K;6%5$/MQ1Q!@PV:ZF:4!7!_:^GMKUPA\HCF
MVMA4D7O72S$V%B'52O\`=4.^6IH\3F/'_*4N-3:GFFP=B<;#K7RHKZ12$ZG:
MMA!MV@G5CU9X&20S-`"[FA!\.E6W$,)PL_#<S<7-WC74$W`^'X"IX`T0R2%D
M=%#1O)J@9I$&UB>X+=NP_EZI-D\1F?.TL:UQ(\-VE^YK/N?&](PA<X(G6QO1
MR+580T8!;8-LW;<-1J0Q?70%OSZ]BD<YF_>C20#WMUJ-($EV[+5HMQ3.%=&)
MUVHS*X4D'LZ,!].FI['3I$S2V^Y7%UOA4K&D!.U[4"+<=::?+>`X/G&)1,G2
M87:Q9L3D5GE6SC;R?37M021.A8POHP4]B1U+Q\B2`/<V+=BD(X$V/\#XT]%R
M,N#D`-E5A-VHFX=0?`]:9?C_`)1F8<R_`.;3P'EF&BFLP6MJ0Q<DQ?[$&2H(
M@&V5U?29!KM93TC^G2/`R<=I&.IMV/[RG7M5OR^-C.QF\CQ@_P"CD0.%R8W?
MX2O2UC6OR3S#%<9EQU&Y:G:U9R^/D6I0C>UDZM.9WA>T((UDDCA#L=&(T.FO
MIU[QV%DKDEX+!L-S874@?-$J/C8D^;"V6(*`TJ=`2`J+HJ5'N=\D<QY)0;%<
M:X=GZ^.-.T#;N5E2WF=&D0Q0(5058K-E=DCDA]I)7337J\PL?C,::&?+RVO2
MX:%1>J][_*K?"XW%BF9-F93%5JH5V(!<]REP.^M0WG:>&PL7`(*?)+]KR#E.
M28(Y":OCIZ$O$(KCRQ/5KW)5WB2E!9,!=F*^V[G3\>MM%%@P'%EXZ9OJ2>:Q
MT*%:TF)G9G(CF'9V*UG`QPN;&TD$2N:GF('5Q4ITHQY-SW.<?G<YQ6OEX+E?
M-<EQ',>.Y&6:I:R%<X*"/`4WFGBVJR&:J&17^J75AIZZV<LQW>CD&Q(<%-[#
M7QJMX/C>(GQ8>2CB_P"H:U\3V@%K3N1Q`'1`4*:%+TF6;WD4\QY)5Q.'ESG*
MLU4K-D[;TPMNRD5"@;F0Q>-LZT\6\:(HW+H6'?U/3+I9OJI&B/<^0=E)"#IT
MJR?Q_MV3@(II\OT<>)S@`I`!+G(USA=RDU.W/^?K'XLSF0IVE,V1X]>IXFO*
M@^\KM>HSB^_LRZ;FQBAFT(_RB@?CU#XK$;@#,R8HF@R;E/\`E-[_``(^VN?0
M<3ZG/<?!*TM:R9NXCJAL`1WM?M5;_BI>>O@N58*W;2?D5FYC^3Y(.FD56'*4
M8*^+CE#'8\EBGC]\KH1]3$'3MUE^=7*RXLR*-7$(3XBX^Y:W?O#&]&+$("8K
M5:W[?,GP.BU:ABQWF5?;<.I]J/<\>A!<H"-?W;$_2-=0.LZYC'>I*Z4;E!'P
M7PM6+:7,],-;:Z_L:1\K*YQ\\]:+2Q7C>>9`-WO0Q(Q]CZQJN@&OT]>S3QS;
M/U-SW!%Z#Y4[CP#U0QUF%P^^D7%6_P"*5ZENK*J5[`1M$8,=Y_RD?U:$2*W;
M0^A'7D3?1CE9(P.<-">@\*E9,!Q,MK7.(>#]O[=Z8G`K.0LU^88=[#5S@_(&
M<2O&T<7O6J4LPG/N$*)-)`>V[MV[=64J.Q`)"C2T$)U*(G<=*G^X8(XG\?F0
MCSR0-W:H#X#3O4F5S(VQYZY6-CM<.VQ7C9B"_P"9(]"!U7PQEKHA(PMC;<U2
MO4A[FO!D(LE%HL?-)K#6;V-EMDK,-)2:YE)B!9R3O93ZG4CJ1,QTTS1!(D32
M@J*QP9"?5U-S^^BUC&P52T4<9AB2P]HG<(8HYEFL22;RV@:'W%T(]/JU/;J4
MV&9SG/F"*X$VZ_`4TV5KO39"3O\`[%^^J[<M\N8S'>1L+@<-B\GRRIAJ6<DY
M=_`V]ZIAS.U6#!)?M*DL+2E6M.84)E4!3IW'5_CX<<;)&2RI`\@E0A<T7!\-
M4JXBXJ>7CGY,P;%.2`P'4NZI\1WM3N3G^4>Y[T'CODE^#)556&Q-]K2BKJCQ
MPEGCM2+,FZK$I&X!@A]->H>-%"S(RR][71EOE-[)I]@M4&?CVF&.,Y+6N:X[
MAJJ@]O'7QI'F\C\=JJ8LQ%F<+8K-,TPRN-O00,Z)HYKW(898)8U]`ZG1O4=(
MBQYBYD3"'H5L0%I<O%O0RQ%IC<`->I[C453;EN6Q/R3\\\<\=UKENEP+BF%R
M7(,N1':B_I#DZ=FN#1421UY8H&C73>#WW$@=:'':[!P\J9[PV:]E7X"MWQ\+
MO:WMR?E98V/Y&1P#"OY0G:ZFKDXO!4>)TJ^(PM>ICL;2K>W4K01CV"LFH757
MW`N=3NW'<==?RZJ3E3@^I*X.F2^FGCTKF'(<AD\I,_*R)'.D)^")\*>OQA\?
M51\N^$>0\$HQU@<9YAA^7QI(YCS57^CUX8B5HBWMI)6O.""!NV@#73K<^R7^
MIS>*A/E8];_Y#IX5!]T<W,_V7G\7EG=NEB=&NK4>%^T"NU_7:*X;4?\`D;=_
M!(=K!2+\)^H:@_1)VT_EZY;_`+M`N]N8P#D/U+?P=6M]FI_5)=P)'I'\14$6
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M&I>5S/+Y0AB/(O,0)W-``8X'4.(`-E3J$)%+M&+,X*O9J<@FLY2A#)/)0Y%)
M8BFOM30QR0Q92"-%)FB9F42KJ&0?4->HV>S&RF2938]D[CYO,JZ!J#IUJ()8
M998SB`-*#=&`0%*J6GMI;O3CF2LJEI'B:6?:U>9#N`#*`I![_4ZGU_$'JDEA
M]*/:`KR%/A>B*1[W-#5V-51]_P!U:98WCU#RAG0LJ@@!&9/7]G0HJ::C\^HH
M`829"7.#K)8?.I#'AZ%C4:0OR/Q[T@V1.TR.!&L?MR!QM*2MO=`KPG\`-AU_
MGZ])]2.4N>C@01T%[6'6ID3&JP_VI\:URN[+^R8R2%DW`.2@<!3VT_:/X^HZ
M0WR/<KU+;HGW4L-";FM4'J*:6=P>+SG(JF0D,T$-"O;48Z&W9]BT]HQ)[5A(
M9%6>&+;OVR:Z'J]AY.'&BRQB-?#),18$D;>K5Z]U/PKV(Y;,0P2;)&J%>6A0
M1<$+HNA2MUI&$1CC.OM,O[P:C]V!H%7U!_+^0=5+Y`CF'SN4>?2EM`+FR"PN
MHI)F;6(5O;V[9"[N=%+]MY(;UT"_EZD=-2(!M/YU*GO3S`K]RV32B<C!$D>9
MV.\@'8JMN(8*@[`Z:>OY]NAC%8'-<2N@-*ONVM`043G*+JP[NJ#>"6#(S$A6
M!&A+#=KIZ=STMDD:%Q!4_<1_&DD;OTULOV]:)3>S-:H_>3RUJD6Q9UJQ(TJH
MK$N[`D"6:56]3Z#JUBFQY?I&9!V8P%PP73Q[FH>V2(9)B&^<Z;C;X#L*0K-^
M8V35H8K*9C(6/N$QU''5_<LW%IUI;;,3_D:T7M0ZL[D*/374]2L'B)N7SY<;
MC@9"&J#HC0.M/2/;CXC<C+F9'&U-Q)L"2!;J==!^ZD7BN3DRV!HYJ=9Z=JVE
MUI:5A'CM5I99?WM*2"0:HU1R5;0#U)';ICD(IHY98WR$.C5B??\`93TL<4,[
MX(T<TH=PN"!HY?$:4JRG>(2V]H]40*S:(=P#,Y12&W=O0]^J\O?&&@'](!#\
M:4Q"7`(O0T3996B9$F62$ROMJ[`3H5))<D:;48_EWZ6UT37>I=>U^VM>JZX2
MZ:UM<2*"Y92DD:*2FBF(1D;M#H0A(8`]O0=>E\B[D!:JTVK-NU3N'0]:;%Z,
MR!MXCFKR:N08T?0ZKL+$@[OITT]/3I\^HQH>UR+^_I7D;VER-7>/E3)L\?QE
MG(-;M4H;%E516EV['C2)6D0!2=BL20`=-=#VZE0.FC+(P]P8+H"E^Z]#4H\A
M/%!MCF(W46E6*%((H=*E7?+&8XU9F5]`OT2$[^^O===.GVR*YSUVESM=2>]1
M'A\A\_G<BWT^RDV>*2".7TGVO[2/M4KZ!AMU!.X:].*]@DV(0\_M\#33D?M!
M5OA^W2FU:LR1S1+&@:-Y`EA6&K'74H4T'[O<>_\`\KIP.:_<!N+@`/GX4MH:
MYI!%]0?X]Z)6Y9&?:P]IBLBIJ-2VU%V%@`?Q'KT\W>]VUS226_A_"HR%H+FI
MK7;/P2"OAOQJ&&A'$,/J/R/VR_S=?3/M<)[=X8`(/IV?A7"^?OS7)_\`O._&
MI9ZOJJ*2LY_L;*?ZA:_S+]'445\N3HHK_];V>_`+_@>^(G_+=X5_W<\<Z*.U
M6[Z**A7S'A8LU!@8;#SK5BLVGL)!V,L9CCUB=O4(^G\YZY)_NQE3X^!QHA`\
M[W`_!!]E;_V)D''FY%S"/4+&HO=341YW*XW!U;-JQ[L<-6*`*)872+=*\<4$
M:,R[':220`!2>N"1X65/-!C1P.!<$!)4%>JZ)X+6^Q@Z<^8M+B2J:VN?&JD>
M8>629IL%5RG%[M;$T,MDT..EDDBO96S%!!$+,,T<<2005[5B/VB&W,23V`UZ
MV.!P8XB+U\AN[)W$)\$Z?$UN?;D(:[+,&8WUGPM\R`M:TDV3N0"M.K`WO*_&
M[7'8;>(_[)NUJ<<U;D.5QDD4MJ:..-&@R-::S81JCD`;E+$_GU)Y/@W9S(&[
M1%&X!>@).JCJG>J*9O`9`Y"6/(+LZ-[D+&D>4>!37K>I&QW/<O\`QO%0967%
MUX,C:DP\N+431Y&I=D1Y(+&RQ$/NX-8=-ZZ(0P(.O;JIS?;6/AX(EBFWRAUU
M'3M5>_$AE@G,+'AS&[MQTMJ%%AKI4Q35%"*DH56U"'8`JL`V]B=`&W_C^/67
MRGN+@V3RM8P`(/M6J;&>6N<]OFW'J=.U!&6H57Z"2RE(4;;[H"L5_(B4@>AU
M'2(9Q&TL3=OL=4^/RKV0.F=NW;=;E#^PJK'F[BMWGW/O%&%Q-^[@;ROR7)Y_
MD^-8_=XOC&)QTMBRD&A6S)-]RZJ!$VH,@)!!TZWWL[$/*2.Q8Y!Z34)MT`4F
M^M:'!Y=G!<?RDN3"'QN#6LC=H][B`%U&E[]J6/!7$,?!QVQR^O->RU[E%VS?
MQW)<VTEK-9#$0DQXDRR65]^N@KKNV;5'UGL>J;FVS,S/2<]0"2TC5.A3]DI7
M-\EZQQL,AL;(VM#F-LT./YM+$GOX5-#K/"&,X`U$DD:@+[D<3QEO=!#$J-6;
M3L&)/IUEYHW1.8\.!D(4=;GM\U*:]Q4*&:.16Z!4\"AZ_8+_`'TT\I72[2EJ
M7<=1N3ROND>6..8?;H'CC!DD4/HBZ#\"&8_EU(#GPMW2N/U'0BQ5;Z>%3L=X
M;*UT<I;$T7;\U7QO432^*.%W8[`L8N3;--'=5ZUFQ#]S*"7,,;),'BKT@0(U
MU"H=2NA)ZEGD,TO8))R][1Y5U1-`?Q-7[>=S<0L=`YK1M(N`E]"0FI^T]:;^
M4\>XS!)/R#C/(LUQ?)8ZG9FLRQ7;EK[NI[2L]1VLS6)D690#N#?AK_)U(P>>
MY$3#U7ET:WO?:J;0==*EQ<L)XFX69B1S1R$("T6</YK`:?OJ`<(QCGY<N=>#
M/U,GBFMW+CVFNV*,19&%;2:&.M%#--.OOE6"_D3UT+&F<(3N>"TM\=/'[:M\
M^&/)'%SX,3HY1(&V``/B.IMIUIC?&>3'\2YCR:O9]VAC\S-]CA8+WW:!G>=S
M#7QTSHT-C'Q:A0^[75UT[=^LART;W11OA8=D;U=\#6F]]L&?QF(S$(>Z./S(
M!Y2!<NZK\DL:O3(LT4[1%0-45U);<%D&FIU)!.C#]K4COUG`QY$^Z+](BW\5
MKD)VAK3N\X_9**7KT-2I9L68MB05K%F8+N?>L2%G**H)^H#T`Z:80&,#&`2J
M+IK\.YI_'C,N3&UA4.0)IKHM13X_S%'/86Y/BWC>M_%;K1QL#6DB$C"1F]IE
M+A8V8Z$`:_R=.RAS,L,D<=C@+D67Y5=^XL*7!GB;)&3,(VVU7YZ5&1Y-G_\`
MS,S5[@&$?E/VF,AK\EK"_4HT4F6=5I6$DG*F6VR1G?H"`@&O5PV*&&*'ZB4!
MI*J/X?M>K9N/BS\'!C<G,8I"584)0)<6Z=C3\DY#Y6R`*P<.P&"LS,5GL9;D
M:9-9%(C,7LUJ,$9W[EW,-PTT/Y]/8[\+S2RS.?J#8W%BG[ZR<F%Q6,]S#D%\
M:*-H0K?5:5CC?+DRJ\V?XGC,>8!&'QF)>>Q#/[I#2/'=F*[470IH/J_$]/+@
MMB?DPPN=K8($/?X5"$G#[!%Z4CIR="2A:G1.II%M>*J&95Y^6\CY3RN2:9YK
M:6<G<QM*T0(Q(9<;CIZM9JJM%JT9!3;KKJ?5IW(S%C#"]K=#HI[$J?PIYG)M
MQ'!N-BLC`!"HI3LI4KXTO\=XM@N'8Z;%\:Q&+Q%"?+2Y,0XY?MA9F)*#*SDI
M[\MB02?6K]R/YATC*R9'N`GG4M`5/YD/AI^^JS(SLG->R>0%P.BG0'^'W4OB
M=V##WP=Q!]HQJ&)D602-N8#N=Y73MJ1TR^:1-T9(#DUZFXJ*Z-I+MS"HTN=-
M?G>D^I-3L06;!C=Z*>]7KZJ#6L2C3]MOQ2(`@:=R1U.QVLB8=T;W,`-Q:_13
MX=J:RO6:X-:\-F=<WN!\*K3Y:Q[X?R5XMSG%/M1E>0Y"YQ_)220I'#/A4CAR
M!GV.29)<>8G5?0MO/X=NK['?&W%GAD<L9:"%&A\%[>-:?A<AV7P?+X^63Z<;
M-S;_`,P46\#^ZI"FEL0SVXID$L.H,'N?2-T9C_>R#0Z.Z?3_`":]1&1Q.>CA
MY.GXK6)5[0K7H_\``=OMJQ'Q593YGPKK`\9L8S/NS$Z(-,58^A44_@1ZMJ3U
MM?9+6CG,9S6%2QZGMY=/[:S/N9[W<7D,<X%H<Q/'S?=\*ZL]=IKF=,3R%&LN
M$C1BP4W(B2OJ`$<^O;:/Y>N9?[JK_P#'H"`2/J&K\$=]E:KVBXLY-[@`OIG\
M14#WJ]:V)$:)I#+$ZO#H[+(3&`0Y`7L5U^K4::_GU\XQY1B=(D9<"MB3;QKI
M\1FB=&\2;4=K;1?G]E)*UK6,H04:L3O`OMQ^ZD@#UT+E6T7ZFE95^D:G7OKT
MPR5F3-++D%2@VH++XI4R65F3.^91O)*@]?VUM2Q$\:J(5A$9A0GW-Q)#$'0R
M'OJP'?3\?QZ:CD#G.9Z5@2I%E.J^":5%>QY_4,BJ1;P\*48F64F(P`0S1M/[
MKAF<-&NBH6/?7ZC_`#:=28'-D#@Z,-C==2I*`6;460&,;P]9&E$"`7U-9-'4
M?VUM?1`R1*8G4&52T@CEC[-HRM%J&U]=?Y.I1.&S(A#V[&%H"G4*?"VG>F5R
M"V0QC<_<;C0A%7[:0;5%ZN1)H2,U%Z@A:';NC587D(:.,ZB!H]--1V<?AVZC
MJPL<R-^Z-3\2WQ^8-38)`]@=.Q)E!5>N@K:KO/)"0G[OVV2102#"ZIL1611N
M9MRZ?RCOZ=-'<V,N!`8=!UTL*=+61[SN_4!^T$JM[45M5)5[L=S,"%)UT*?]
M4`]P1^`ZA2KLW@CU'6T_9$J5CSQ_E`\H*_.D.RSP*N[W5E$;HC%"T1&NNUU#
M=]NGX`G7KUK7-B<\R"X0`=;]^E30YCI&M:`6JOB+?>M)X-DAO<BBKR:DPE65
MPZ$Z%WW=PSK^'1D.:UPE:U(D'VI?X4]'M.YC7J5O_"B?;W&$\@B"C0JNHW=B
M1Z:`:_S$]-^N#&\DH"G1?[J/1`<P!BD%:29Y&U50T9A.@==!JP![#=_A]1TI
MKBYNTA6GK2RQK2YU]_X4V<MD:V*A:Y*^X+)&BK&OU[K,BQ(H#%5+.^GXZ:_C
MT[C8<F7((87?KNTZ!`+T`N0@M2("YK&*U!;@CL5I0R2$-*2P=HW.C$'ZBH=5
MTU'<=^D^FZ&3;*OJ]4%J\<U`YN@Z>-%Y&B=%)+JTB%9&[.S-N*NZ[2"1IIH/
MSZF%S&^D0/U"GS76HVQQ)_PC2FCS2_F,9@LS?XCE;O'^15,==EP>9HUENVZ%
MY8&CB=*<J/#=+>X4,4BE'#Z,-.K?BN0EXSDX,C$E,9W7/^7J"MJ?QL;'RY(<
M?E,9LV(2-S'%`1_Q"X^(N*W86O-8Q])[=JS*37CFMWKZ*+EBS+K):M6XJX?;
M*9G+.JZ@`G0:#KW-3D>4SIVY/_3EV[<=3W*?N[5%E(Q&,8(0UP4!C5+1V`=U
M"=:-=YM3&?>"JX+1@(1[;::D'0:MN!#?EU2S"1S@\$%`=`EA4AB`$`D$I]_:
MM`#P;&";W/[Q9"0#[;)M`VL2?V5]3ZG_``=+W%D9:8_U"%^1ZT$-<Z[K"WSH
MG--/(CGV=DB.65FD7VWB*:!&4Z+H6;UT)[]/LC<6-!1555Z=J2=C7@JK39/'
M^ZDR1#KMDT1V7VP--0H8:*0W;U)&A.@!Z>;$72!A*M'RKT/`'EU6])%W:FX%
M@&7LR[6;6?\`R:EVU8,I1@`02-VG\O3WIR*X&R:V7P5::<Z-Z)H=/[J:LHF?
M863]X9!,0Q*,J@%"$_#\-1IZGTZ<8TMD:`+)N3J>AI>Y0@-M/"BUF*NE;57*
M*A5H9-QW^ZA!8NG[+"77U)^G33J8L9BV`HY4_>IID2/$I4+K]G8?"FC=:02A
M-FE@;&:+<-^@U??[@'M;&TU&G2&-=&YNW4N5/O6O`0[6S4U^:?;2?9T6,.6#
M^^92`028T4*!HXU)W.S:_EI_+U+<TLCBDW?JN<;_`.7]EIMCMTDC#^5HT\>]
M=L_!.G_DYXUV@@?T0P^@)+=OME_QB23U]+^V"3[>X8G7Z=GX5PSG[\UR9_\`
MS._&I8ZO:J*2LY_L;*?ZA:_S+]'445\N3HHK_]?V>_`+_@>^(G_+=X5_W<\<
MZ*.U6[Z**A_RY?S&/J8F;%XA<PAFM"U`MR&E.B^TGMR0R6-8F(;U!'<=<D_W
M5;$8.'=*[1[T'0V%;7V:R)\N=ZDNUP:U+$]3VT^-<^O,7-+N;CFP.3XGR*K:
M@DK1XB*O(TL]&W(6<YJ*.K)]GDH?:3VE5V41NX;N1IUS[@H,=N&XO)<\:`=+
MUVWA.(;&YF5C9L980=Q*7:B;"MVE;KVH<B\AH^0HV).-YGE^#SF,AP$=+,SU
MTLX2Q4^W^_M8^2G'8L:2&57EW@%?;&K?5H-6,V*65SO1=)BO`"%%!'465#:H
MV)P4V-!DLCSX\;-B?O5H):]I7:'*0%"%/CI3WY?4Q-3/<`P5K"WZ7!O9H4)>
M2&TL#7,IDJD$E*>%#.+"*MX@&7:=2/RZD9Q@=-C,E8_T5%U2Y'3P6J7@<?*G
MQ^:RX9FNY<%SO311M:3N\-.G:F[R/CEGD-;A^4X[)ELG8P^5F;.YZ*ZD;&I4
MLNBP6`S2204XM`VJK]6FGX]4?+XOUF*\8DI>V)2^PN!9/MO5QQ?(GBI,W$Y.
M*-D>0P;&D$HXA5\3T2K2P3+/7@DG)WS(471E=`!'W;?H&)UT(_#KDDKHRZ0E
MNA'76LT^)[)7"-P+1?MUI&ENM6R>/@J53;CE^X%ZRSO']E[7MB/8H1U=I2Q[
M>H`_EZ-C!&\O>0ZVT(J@_@@J68W212*@(1-+KJM8&O4P//>*\@L3PK3OXSE'
M')HK+^U";&3QT=ZJ%^EF$LBXR4'\2/YNND?[99T&+RDS'.:&OB<+]^GVUGN;
M;+G\<Z-D;MT3VN*7*`I]RU%OC+)9!/'W&19$>Z&JSPK7;54QZVY/M@@[,8TK
MA>_J?RZQ?-SS2<CE/:Y4D(`\`3;PM6P?AXWJ%PLP@*NNY-?MJ1;4,EW$/=I2
M"6283&L@=D5VA;5H)')=E*2@KJ0`3^8ZBLQ]Y8\.+8WV^>A*:J/E4".7TY9(
M71AR%?@$MX7UIEBU(UFV88[)KM-%%!'<2);)ADBB02'V@8UD:U*RZ$D:*#KW
M[.94<9E9#C`^B'#74G]UZL,82-B$N3M;,`2@T`['OI1I2C5VJ+_HI,J_M+[C
M&O(D:#;J4*OO#_3KZCUZ0]6N8YDA06*B]]?WTX7F3?O:";HAU(N*;>6DPV-A
MN6\LW^B14YS+-,JHJ01A_=,JZM^R!](![#MW]>HT2OG+8KN7L@UJQ@BF(@>T
M>9195)-K"JGXGP5G+U6AD<MR+'8/%K)9OU,54Q"S7KU!I9;.&@Y++-;^WM-1
M=TD:,(-Q4*Q[=:;(]PRPQQQ-8'!H`7OT0IXUL_\`Y-CADL+,<F>P)W6:4`<6
M!+$Z+TK5)XGYI_`<MEYN78[)74@DM1T8\'5H1>W`7JUK5*PUB3[>:+:FS8NR
M,D#0Z#JVQ^6?)!-+)A-]`-0E=>Y`_=54_P!R\=%G8^,^)[8RXKYKWNAM<:_&
MC&,Y9Y/XSA,>^6J8[EV$JQUUR.8/W$'(*2;4_P!'NP5M]:P(02HL!0"%U(ZH
M_IL+*DR&P2.:YWY5T7L/[:DN@X3DI)#!(8IU*-MM/VW"]14G6N;<9M8B7WLK
M2B]S'S%:EVR(+"S/#O$/MJON&-]=`P!!U[=08<3,]9L#H#N:=5"#QJ"SB\V#
M($L<9+`X:#QJI,$^;7&V<90R4TN2:\\L7\))<R9+(-]Q!1>P4#>W2IJBL=1&
MOJ>K;(>^&9N/Y7,`#G%-/%>XK?Y/T9=!/DQ`,,>T[M0!JX#Q/>IV\8<?S?'<
M+:_CWV]C-YB=)\G-$%6:=-B+&QFCVPF547N!M&OIU7Y65CS)&T6`0'XWO6&Y
MG)@S,I,1Y;C,;M:.EOO0U*2VX`\5A3-+HK0Q_1&0`VUG@E7]H,%UT<'I.*\@
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ML9VLVR1D@DZZ@_V"X^-3(V`K.YV@"`:&B]>U,8HZ^@%6/WHTBA<)`LC,';>S
M/IO73UTT?TZG1O?)C.BC:-H=HMB?CWJ#/Z;<ATLQ60HA2Z=OA44>4<C0Q>2\
M49:RD*RTN<P8JL[R"(O#FJDU2Q]+!U_=G:W;0DCJ5&0[&F`;=K5^/A\JN.'Q
MILB+DHX6^0Q$_!+K_92QG[)CBUL7`LEJ:)-\D\=<P:']W$GN&.%A*0%+$CLW
MXZ=/8CW":#<T&,WVD*>UZS<L$CHI&1L/J(1UJQ?Q),@\R8%1+O0X7--*(V2>
M!91B;*]IXW9=1^>@!)]!UMO9Y:?<4>T$>5]NGY366]R!S>#>'-`*L'8V(Z5U
MFZ[+7,:97.M!B(F8@*MN,DD$_P")(/0>NG7-/]TF[O;^/=/^I;^#JTWM5?Z@
M\`7,9_$5#LP#R!`!K(C$2J2J.C=M%((95`T/Y]?.LB0R%K7@APUT!7[ZZ)&!
ML+G:`Z'4'\#1%XEA+[72,1*YWZLX+'0^C:;M1J>_5:TB&8NC3:W[R>E2M[I6
MM#FDEQ^"5'UWD%['90U8,<]^I/9@AC2HTB7!)M]Z61A[;Q"#>Q_;9=P].KF:
M%GT<<PD:V>1JD"K&/&AF8USYBV1H-S^4#0777KI:GO2MG(PUI8M4C<R;A*I2
M6/0K'+%L.A!WZAM?Y#U3'U8UC>X*/L`Z_;]U0)&"%TG7^/0UOV;3.S%)IF=9
M0GILB10IC+=P3K)KK^/3;6K&2FX]5-Z]#B?3`5L0"+XFZ_<E;6W35YI(C%O6
M,R)`6*@^S#[9A:30#V]RDMIZ#OU,8V1T)<7M5R>7J@Z+HA5::5L4K6O5%3=\
M2JIW[4@-#D4HXJ2Q.M+)BM7FO-5)GJ"Y+51;$4:OK[U=97(1FU(70^O2II7P
M[H7-2(GP)5*F,;!D33.:W=""0T:$A2A/BG3O2<,Q)6L-]UO#':/J<-#,T:$E
MHVT_<^OH?4^G4)C-S@U@4CH>I_LJ<_$88U;8'1-0/&L,I:66&O8J^]9#L3-%
M`J?<&%]@,D0E58E:)22!^.G\O4DQX[8HB\E"ZZ:@4S&V>,S,#`"&C:IL3V/6
MF\1(R#0@RPL[+'.!$&B#D1-88:['$??1==3VZA3MC9))&7%T:*/[:LL9\GI-
M>6-#B1N2_P`4K3:*.K2/'&Q55;W68NP?OKL5`I"KIIWUUZ:8&!0#YK*#^ZGS
MO6Q\O1*8UW,VJE^K4>E76O<E"1RJUAY@C(SF0_0(51'!&GKU<Q8.++ARY)S0
M'MML(1?%>U*9&]SWL;&2C=Q=9/AW6C5^A5R=66">!)X'1#/$^I+[&$JJNT@K
MM=`0?SZ@P.?&6NC?M>TGS=;TDR.B<2*34BA@AB$,0AC]S:L+`#30`:::C:`N
M@[_ETG<^-RGI\_E2))/4<02KD5:TDIH&*DZOM=HF`W:.X]MF<G;L_#0=^GF.
M:\-#=5/[?+[Z:VOWAQ*A*(L^K12-'[@WD["V@8_6"I<*-$()&O?OIU(:YC"X
M/;N*(0NM>$$[F->COPK4X"J74M'#(2IC4@L9(`-F@U`U<R'I3HT8^8JV(C[Q
MT^:TACB=K"CWMZGQ_A6MPK+I%]'N*BF;7ZXUW'1G0E8SO`T/2#Z<C!Y20B=;
M4ZUSVNN[KVH@TJQ[TCAVG3VV)?4G4;BP.FA!)';3U/\`)TF-\;'L46/E[I^W
M:ED%S2=ZG6B\\:JIW.TR^J,&V;20JE1IKKZ?_.Z>`;&HD;8:?`TTN]`RSJ2)
M7BCC=-%,BNTB@'OI&>P5CJI);0!=0.I,;GEAN-3]W1>M)<U'`I_?2'<DFCJ2
MPI,@@F6,D-K)(?8+2(ZMZJL3R$$=@2?QZG-R)(X'Q%X$+P/C8K3'ILEG8]P_
M583IXV^=-$6I;,D=B59@T;^R5+`JQC)59E"ZLD97OWU_P=>1%KI`77=^R>*=
MZ>F:(FEK4VF_PK$$`[S%[B[)`[,`55RS_L]U#(/50>^G4F%FTJQA(*]M?X5%
M<_=;JH^S^-)D\*1,6F<!W`UCTT9X]A;<NO[.[73N>P].G;Q.'JV>NG<)3.[>
M7",>7[E'>D/([TC0DA%BVPKN`?\`=GZ_I4#7MJ#ZZ].EKDC"V_$&_P`J3'LW
M/.NJIW'C7:SP2Q;PYXV8]M>(XC^0?_2RZ::]]-.OI7VV-O`<0!_Z#/PKB?.(
M>7Y%-/6=^-2QU=U54E9S_8V4_P!0M?YE^CJ**^7)T45__]#V>_`+_@>^(G_+
M=X5_W<\<Z*.U6[Z**B3RM8AI5,7?G5GBIR6YY$4,Q9$A4L`H(!.@_'MUQW_=
MY!@\4[TR4>^][6';]];CV2V26?-@C>!O:T=.YJFGG``XK#<PQEJS6M5;,./K
M&&R].;WLK/6CBV[U9)BA4*5/IN)U&G7)^%GFDE;MW-WW:40!.OC79/;+FQ9.
M7Q^0QKF["7*%L%/31:*28#E'$,LO(\+A;>+R"T:$62>1,?DL?%!;(2S+7I3;
MQ+;DE!9I%*J1IZG7KI);+Q<\<L+`)2T;EO\`8#:H7]2Q.<Q9N-R<IOI;W;"%
M:ZUPKK6Z!:C#GG(>-6Y\[C>15<OS#(W2L6$?VK->U7M5MS`1K"((<?'6/[;>
MA`U';JLY')QI8LGZAY4(6M3MV[)6F]K<5R.,[`EP'QP8X=^H2AW`VNMRO2HU
M\6SYJM?FCJY(4[N/HW9IL1-7DFI0URYC@I-M??DYK2.">WT,->JGBH?79E0Q
MS/:71D]B+]^JUM/?$6#-BP9$N,TQ.D:`\(KB!<_Y-OWU<_Q[SR/.1KCK2TX,
MA6T6:LLDB60C)M$[T["++&CS+M"@DZ#7L.L[R_MZ#%P_J8Y7;P[S`^*?OKCO
M*X,L&0'Q@NQG:.&G=%%K"I&MQQQNLNP1M+N,NTA?:0$/O8EM#II_T=9<,D39
MZ9)\3T_<M0HWAC7J^P%O$TA<PJU)\AX^&1K^]C'Y@*5E"NZ22SD./YRECY(-
MCAHBLTWU,/1?Y->MO[#Q()N7Q1,PH=P'Q0@6\*J)\J6#&SW0R[)=H/R#@7*H
MOWJ)?&"7+7%8,5-":>0X[DLYQ9XXRQ:%,1=EJ#3N/<=$1>^IU8Z]4?-0_2\K
ME1N!`:]UNB@G]DK:3N88H\ACRZ&5C'J>NX`GX+]PJ44A@Q=%JHF$EIH]TWL2
M`R1&0.@]Q5.UI#(OU#MKWUZJ6[HRR1Q)!T\%TJ$QOU#SL;MA!2XU3^RFF;*[
M]C+JON,JN'W*&(D;VV(U`>(AC]7;70^NG3C))6.<V0?I!%^)*_%5O\:F/9$X
M!P"N4HO@-?@E&H1'[@265&E7_)O(I*QEU16&[0E_<9!JWX!!Z:G5R:9\X9$E
MP3\NY\1I4<0"$R3%WE-T[]AX$?V5'7*8/Z0YZ##68D?&8&Y6N9")A^ZR%U56
MS4H/LT>2%%8.YU()`7\^I4?I8N&8GR`Y+@22`J#K\SH*GXY<]KLEA(B<@'@.
M]+UU1=$\$M-HA$LFK1R*Z^][8B]TK)KK&8Y&`4]@VA]1U`AG]%P<(U<19?Y2
MFO9?C29(76VSH5NFI&NO2F>F#Q*S'#U<>8K?'L8;,C/,\PD6S-K[D(F<J9$@
MC_>HFH*A3ZCK30"7*P)&1E,B$>9#^8($MH2.J54Y3\<Y3<J0E['N0$VVZ@A?
MB+4GI7KAYHE_?03ZPW$*;4DB9=-S(KJKIL/X#K.N>^.4.=(3('!.B&KN)SCZ
M;V,#0`J]?DM4X\H8:+B>6R]J#/RT4CEAEQ)]N)PHGE!GKV9GALR)3@1BRANP
M'HWX=;'&<9<)TS5^H`NY.OPKI_"93\_'QV21-<U/,-#;J-%-+7QXKXV]E.72
M5<Z,[E5R#QTIIH4%88B3V)+SU40B*5I;;:-)MW*@`[#JMSXI?2CF+/,_5/\`
M$*JO>QR8FXKFP^GB[`#\;_NJTMSW@DRQ11E5VQ&-77W`H`W;".X374]4Q:QV
MT!MB`$\>ORK"M>(F@O<5IC3Y27#[LM;AE6M&#+;BCUFTAC5@LPB0DF2,KJ=0
M&V]3<8P1F3$R&#S`[7`_E/3Y'K4V!KLYC(X7C>;!>Y\:=/\`$QD*M*S4L.\%
MSVY5'M#8\3H7WJ2HT4#MH=-?S[=-M@8TNA*^L7&W3]O"JZ9DL$KXRP-+#?\`
MA6Z6D)D/L?NWD@FLRO&=@8>S(8@H_9#AP!W'<GIP1;W,>\A]@B!$[`^'Q[U"
M?+LWM8W;=/GWJ/.0\@Q>'EP>&]Z>_D^09*&G'612[QQS2ND\EB6(K7AK0)%)
MNU9-2#HOKI98D.XSY%VQM(&A_,5"=NXJ1#QT^1CY$]A%&UQ<2?F/%2G2ES[<
MQ5[<D:Q2-`J!U)5YE@*_<+L+,6D"QS#4C4C\?3HAA,_K@`.>WH#_`"GJ.Y&G
M>JV:8,](;RUA\+*/XZTE112,2C0@5OHCGD5BBF5U$L+:#0!/1OIU##I<39(;
MSM5Q*#M?1Q^=-O?%-=CAN^\)^:J<?)Q,CG^5^+N%\8TGY%%9OY^MK)JM>=)(
M:=.Y/7:$HU:-'?7<5``)[Z=M%Q3&0XDLT[?.#K_BOV^ZN@^S9X<?%Y;*S/+A
MAB::C4A=5L*D2AX_ANQ49N>EN=V:$/LPKD9PE!2J!FJUJE9H(/W5C]Y[KJTC
M#MNZ3#D29,IE])HA#B&M"7*=ZQ^?RSHY<D<<D/J%2@N!WNOW5;/X88ZOAO,6
M'Q^,KC'8XXO/N*D+,T#Z8RSL.CL74*Q)'6H]E3RR^X6M=^4,?\-#6(]Y.?-P
M[II7!TFYM]#<BNP77:*Y)3'YZ!_!HR58A;<9.Q@K`&.0$KJ#J=#IIUS3_=-P
M;[>A<0K?J&]4_E=6G]J7Y%X!`/IE%"]14.$#1&A1V5MA6,R`,$8[!JK=X]OX
M_GIU\W.CW&/</(=+K;I\+UT7<?.'D;QK;]EHK9#)"/>D4)&P:4MH$D"L`R,O
M8[?P]>F`R4.C8UMEO\0:D1.:7N+6W(MX>*T6AI5JLTLD&]S:D-AT>5GT=MW[
M.]B%1/P"Z`#MITK*E9)*'!@V`:`Z?QO7K7/](,<ZS5"]ZQ>G&))S)(1':5H!
M`NNV+<ACD]IDTDUE+[M2>Q';J,^0MV.(#5/2Z]$^^U+]1TC`U%VW4]>WV)6V
M-U]MEW+&S';JY#,%!_8U``W,5'<:]>%NP/1H"V'5/C\:'M<7--RT7MH?[EIH
M7LQ7S&5BXQB;B2-)7LS92S6<-8J4(S]K/`"!^YLV)R4U/U(FI]=#U)GQ)6,;
M.YCFL!#6KU0"Z=:F,QY((79>1%Y5``.A<;CY`??3UR$#+'&:H'LJD<2(X.Z'
M3;&`"W=U.G\^G3,HW./IE`3H;IX#O^-0,*1NYS9_^8I)(T/7Y4S,A6NV&%?<
MBO)+H7:(;%VC=Z'N21_T=)9'(Z:%I<=RDWTJ[8^%D3I&#IWH]9B,$$+JJAX(
M1%)MU4DD$N"?QWZZ@=^O9@'HY-HZHNM-0.+G/:2NXJ%IJ-)(RLKDB0:*2@6,
M$D@KW.I&WT/?OTQ)O#6-0.;]]6#2U7D6[UKE3:@)))+:Z`D^FH]=!O7O^&G7
MLT(:YKD51]OPKQLK_,-$ZTVLF[R3QJL:N(BC;F9D4S!U*1:*`"C+J"=>VO3K
M'-;%,YP)>6V'1*7'N5&/`50>_P`JP]P?2%C6+VP56N)"V]27)5IC];L6/J2=
M`.A8'O:\1?%JZVZ?C39:]K2UTBK_`#)I\J2;;D!4<(&UUV'4%F;0DZKVT`;M
M^';I+2YN_>/,;*:\12TM/E%)TD7N1RO[;:$N/=4?0K$NH8Z#U8>GY'J3$P!C
MI'QDM5%T'A:O3(061EWFU3PI-+"-M65]K/(454=FT6/5R4![Z(I_+4Z=/-C#
MI'EQLJ)V6_SLM>OO'8C<E8M.7%>.$@`,TNR0!&"MN'N-N^I2!'W'YCOZ]$K'
MB,D/W1@_:53\!>O&-`>XEJ%$^Y?WUI6;WGG5DWHJQ[1+I$)XB6[Q;1^U[0.H
M_#>#^'02W;(X:=$^_P#;YT%A:UCM%-$;MJ.&*S,K5TB@C9I)I"(E6,#<6;4$
ML1&1K^)T_,]*8-TBM/1!:_\`?2HFEY;O!4G2HAL^2HGS6'PV$Q]C)0W9X!8O
M_:VTA$,DG^4@853"K5]?K$A!TTZN/Z=+&P.R)6MW-T!!)ZA>RZ5=Q\,'8V1E
M3R"/9HU0I/VZ5(VSN4DJ=E9AMT`3W6W(9`W9V+.=-`-!U`W-"[@[5"$MV)'7
M7M6?>NXD2!.E(5LPHK)&?<=7)D"`J1M5OK;M]6A`!'H?7UZ62`--UZ\1Y>``
M@2WVTW)BT3,ZD;M=2"0-A/<C0`':0?QZ7$XL<71DAPKR0-?Y7BWXT3,F@D9B
M["16C9"045&UWEAM(?4=_P";JP9(&M<?YS45T95!8B_\*("V"M^".DUW(6JD
M%>F7=6*%9U9M@(W1/*%VC3L!U:X>1`^'+BFQ]^5(UH8Y=+]OVM4'*BF#\:1D
MX9CL<2X#K\?G2)E8'QEY*-K9=]W&U\A/-74FO3FD8%J#N7)DM1[CN*C;H.K#
M,XO&P3$(<H2N?"''P*W%1L;)=F132AAC#)BT+_,$_-\#7:KP<0?$'CDC70\3
MQ!&X:'0UE(U&@TZ[][="<%Q0.OH-_"N/<PO]4SU-_5=^-2IU<U6TE9S_`&-E
M/]0M?YE^CJ**^7)T45__T?9[\`O^![XB?\MWA7_=SQSHH[5;OHHJ*_)]VG'6
MQ>.GLU(K60EG-&&Q*D3S3U1%,K0[]?<,3`$KH01Z]NN4_P"Z>5-CX&`R)MGO
M=?JTA"TCX'IH:V'M"`RY&1*CMC`%0+8J"O91UZ52SS!F9+L_%^/274NR3Y*S
M8ONUS%5K2K4I3B")8YI8:81I7`+.44+^.NG7)N)=G964Y\SG/D0`&P'P"V2N
MU>W<&'%QL[.:STV-8`"0XKN-R44JG:](N%RUWC/&D/*J^`IWEEM38B>UF[-:
M_)C[CQ">6E5H-D<?9C@LH&CA8MN+D@J.M3'/*R%[<Y&O.G4D?V?A4/D\+&SL
M]AX7>Z,M`>C?*'!44N0C<-3X4WN0UK7(I<M<PG"LCSB?(4Z,U#.+>EPYQUI:
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ML0`;7"JTG7Y>-7":NYJ#2/22/:KB4K,/K*H-WM%BQW]SZ#^73OUS>/$DDED,
M+-L>I"JOP'6_C:L$S)#7K(54D#HFO[J@#R+Y+Q=+DG"N!55DY%S`^0.,Y.#B
MV$*3WZ^-J33/DLW;D'LQ5\;BZ(D>4N^NK`:'<.MU[/@RX.5PWMA:<9KPXH0M
M@0/XFI<_#R3\3G\DXF/']%PWNL+D6`U*E`+4Y^-2Q8+-^0./BW7GR2<XS?(X
M`\T9DM8+DLWWV.MPJ`7]MX@Z?3N^M3J>W57[WPY8O<&6Z*\;R7J>H-R!W/:I
M'&R_5\;Q>1)N,'HMCL/RN99#W0H2>U8Y*K;$R7(W)BEF66T5]KM$^Z1261Y"
MRK&O=1J?S'8]8YX<]Q1"-;:VT^X$5>0OAB&PA'*;$=[%/B;UHQ]"MC6R$=8M
M+]Y))=J^X[!HWFMU)YE<,#%^^`;34_XW8=CU*AR&2,R/(1(@VDV(((3XJ-0?
MC7N>^267#5X:&^5P;U&TCY(>M%LPTOLM7A<4"HE,KUXEGFKA@Y?V@RR;G[-H
MH[(1Z'<O2[O:A:T'>I`&A1"5\>VGVTQ%Z<+VN=ND9T4I95^T'KUI$CT$FLCG
M]TL7[TDHTD[(JR"8C1FE;0=MHTUZKTL&L)]0N[=*M0X.=NV_H[?V_8TDYK.T
ML)7LY"]<5*E=&FLETDDA0!=I/TH9#H`>P&I]!J3UZ]CL82ME>-1\$I<+/JO3
M$,1W%0+7ILYF6OD_X'.,>F4JVYJ^3K3&\<8<<\J!XYX/V+<TBJ01!VW#4'TT
MZ?9E2F1SHW[2/,$'X5!DQ6QO$<D1<X.+23^\:4PLKS@\&S%FIR"K=O5<B\<F
M$NTH4L-)<ET]G!VV27]R5;N)YO;0`_5Z:]3V8GUA#\<;Y=7`VVN6YOJ.J"M;
M@\,>4Q6.Q'M;+&4<#_A_Q#X=@OA4,8A.)\TY7S&;R+E;O&A42/(T:<D)NT;<
M]*VL\]&U8K+)[4/V@$<;:Z,QU`/72.$&!%C"&=Z3!H6R@D:_WU-Y6+E^.P,6
M+A(&S,<[:YP(!8"$4`]5NG:EJ?)>*J?&^<\V3CO$\9>Q<UV;'7HK>4J9JC)%
MC%FP,E2&K'$TZV[*[9GDA,.W7<3^-@3QN5C9;7A@@*CJH<EMM9S-Q_=HSN'P
M!+(]CVC<H!:6D^8=0HZ!5[5*N.O6<CB\/E!$`F1Q6-RD]F.<J$-BK',\4$@2
M6-X6]PL6[-IZ!=>N<1LP\9LXFQ723J4))`0:!!JNM5F8V=DTL'JAK8W$$$`F
MVI/;LE?EZEEDQ\]Z`*V/-F6I#;MR4Y`N12O]T*T\*E[CU/;])MNPZ::_AUZ^
M'=)'E28X$9*``A5U/4GX$_;4;&S,=N0S&#?.UJG71471!]J^%1UBLUR?@N7]
MO-<?HUN&9:>:)LQ'G:YI8S*6!LCE:J6>W4JY+\B6CCD[:@'J43!)O;`K\AJJ
MTHTHB&_4C[ZTN1#@\MB-DBG_`.M8!Y0T@D#QT<1]I%29:KYFS(_OY-8HYQ$T
M=6""LRB$*)A7:PZN[K(FA9]JZCMV[=0\?+.$YT<;&B0]2%4]+$?9WJ@_Z4L8
M'0ET@U*G7X>'C3?BH8W!K+:MV&MV+-[=6GFC]\UON8B(H(P"':5`C!I3J>^C
M::C61D9D^?CQCZG]0%2!8&QU"#0ZFF79$LI,+6`1HGCJH[ZTHJ[V%1U`V1^R
MP;ZHFC'U;V4:)'8DW:Z$$,=?Y.H+1(V2-[%:G464^#C3,D9B:]LB.!MX)T"=
M*:7.^>X;@'&<AR*_>=[=6-[-*`O7K3RI&372N:\P-J)WF=06*[--2">M3%C/
M?CMD<\F0NLX(``-20;@D:!*C\=Q63R><V&"';"2C^J+=5T\=5Z57?QO%-F+%
M[RCGKL#97EO^BXN.&IJ,;@4F1HZ\$XWF6.^YU:0["NP=ANZ,Z6$L$$4Y+(Q<
M;>O<G[:O>:=%BMQ^(PVG9%=Q7\SO$'1!;KK4HVK3"1?8F$H1![L3Q%'K]FBW
M$+JL>L7X,`2#KU3&5_JQMA)V62R?)/'QJC$;7*]S`'::_MI5BOB&?<\W\?FU
M*ZXCD:*%.Y&B&)L,BG<==5/?4:Z_GUO?8JCW%"%(.V11T_*:RGO!K6<)*T!?
M,V__`(A77SKN=<BID\\;;B(?H+ZW(P=--0-DAUU)&G7,/]U]O_QR#<4'U+?P
M=6G]JM7D)/,GZ9_$5"MFQ%`T;R%1[C>S"'D2)YF((_=@D;F!;30G^7KYS>Z-
MI<`P[#9>_P`NE='B8Y_EW7%S94^-:0JNS12%SO&YF$2NJ[74[6<Z`$?XO;OT
MPQQ8)0]SF.2W<TZXANU[6`W[^'[?"MX@#2/J1[>WZ6`,<JJ4&KL3J-P.I'Y#
MIMS(PYIWV`T3[Z;,AV)_,?F/E0GA1/;94W&((IDD"EU24'MJ?WC?3HQ"^NG2
MGL+8"T]"$7QT\=*(W;G*XH2NG5/N%[7HE:C9`C+$LNFI)A9HGWG]D%6TV1@Z
M%B-3IVT[]#&&)))&MW(0J&Y^'4CPTI]CA)N87ENB+>WQ_"H[QGCZ#%\KM<Q^
M^L):R%>1<A6B2*''V)Y)7:)5`TF00G1NY.]SN.G?IW(S)YL812O5L:[2?P_O
MJ[EY=TW'LXP0-+6D(=7``7\+Z?"I.BMG1EG8.$4@)IN8`G4Z:`N2"?0>G4:"
M5SGM9,I`5!_;X5028XL^%J.)5>E:I[*.$]O1=@W1-(C"2;]D`?4%9"H'Y=.2
MO<-X8Y$T/^)>E_[J5%$1^=27:CH/QIK9"6:6<QS$1M'IM/JC-^)+:[2=K?A_
M\WJ(UI8&%P&YOS">-7>,UD<>YA5I^T4VK$3+J=[!&!"H-NI8/V<%B'5=/P(Z
M5ZA?(-SK$:I]E2DVM*"_:ORQ6>&K%:MZ1K(@>O\`6)/=16,9V>TQ:(JWX$#7
MJ5-@YN-%%D9#=K'#RD]146+*QI)I((?-(T^;P*=5M]E(5V,35Y$U95*;E5@-
M=.QU+#NH'\^H_GZ\:U^UI+@`VYM:GFN`F%NJ4E)&1%L9E<,H`)<:K]8U/8;V
M*`#\=2!U'9&C7W".[_RWZ4Y,\*"AM]_QK6M26W8$-1FEF9D$!CV+Z@I(/WQ3
MM(!WUT"G^?J=B8OUL[H(ANG)"=-/CWJ--D#%@$L@2-"3^[2DVQ&BL8_H$J;(
MV5BP4.25"QLNH=A^.N@'XGJ0(GRN>US0',L1W/RI`D"-D!5IO\O'PHA-'`W9
M9M_MPAO<`<`Z%6TC;Z7&G[)[:$G\1WZ8E:QG_+F\R*3T4=NO6G897;@3&@)T
MZGXTFV(W$4/M,Z,EB46/=C"AJQ6IM99?K(U8L6&GY?@>G6ED437.'ZBD]E'E
M_:U26ECI"H\A`^14TS+TN;JW#,(OOZ=6.>9HH!4@LSR_;AU2N]BQ"H3W%;ZV
M,:DCMVTZDQNQ)MPB:]LI(VJ5`/521UJ:YN*87.>_85ZZ(?MO1NZ]ZCD)<1G\
M;!AK<7L3+5.1IYER+4,<T+F>D):'O"*<':LKD!OY->O78_TCTD3>77N"+BVA
M(2_\>U0\.1N3",G&D+XKA0"W0I_,AZ=J-B&*$1R)&TF\A0^[:%V(N]F+?6Y5
M6].VA/;OTS&Z3SEWF\UCTI,KW.+SN0I>DRU(R31@NR'5.T&YGD!_;)$BG:?0
MGNNA_'OTAKVESBX+;[/'Y4-:0Q0W7O;X4BV947<%`<LX'UL!JH*E][`!D4%.
MW3K7AK2&N1FM,7+FDN0TV;0"K[JE%$<CG<I+ZL="HW'0D#4_@?7IYC]V_>NX
M:']M:=>JM*J"*(W)8XT#,H9D$?=GE12K!6"[`!N]>Q[Z_D.I</HMC)U<>_C^
M^HCO4+RJ[3^ZDZ5V9G+)."$$FW=HRHNAD8LZ[@(AHW?0D=6`9MW#TB'IIU_L
M%1"$%D()^5)VB,T@^J1Y('*(P2%R2#IH7_=G7<K'3N1V['J1`6LD1Q4;?FO:
MF9&N+%:@0HM=J/!9U\.^-SVU_HCA]=/37[9==.P_^9U]'>VR3P/$DZ^@W\*X
MOS0`Y;D0-/5=^-2OU=U5TE9S_8V4_P!0M?YE^CJ**^7)T45__]+V>_`+_@>^
M(G_+=X5_W<\<Z*.U6[Z**JC\HGIO4X=3L&KCY+-W)O'R2]<6M2P4=:K%-.]B
M%=+=@6T7VU]DAT8AN^FG6+]X10SMP8I2`2YR.(4-L%4?PKJ'^VL<WJ\ODQL,
MD<;&$QC\SR20-IT!!O>QTJJO!IIL->6[@Y.,<FO2U<A;R-C.4;V.;%XZ)#[L
MFEA97N>ZTH$<>PF1/KU4:CKEL#VXDDAAD:=O0@J1W1/NKJG,/_J6)'%DPRP0
MAP:`QP(<[L2$`3OTTUI&?*"I/'EK>1J3-2R]N[4I+1=,3"\D,<DT<*6DC@C$
M8,9]D(2V[OKH.LQ]1EOS'9.P[`\V/Y?%/[:NF8<!Q!AQQ.8)(@TD%7E"@*@J
M1K=:F?QOF^4VFCMW\/B:V-RE8SC&XZ:]7GJQ.SO7O6J]P6*E;^(@_NX:X4!?
MK(&NG7O)8^+*^![=D<\ANT`W\3JGRK#<MCXT#YX8LQ\IA=9[@U">K0B$EO4D
MZU(7(^/X7D-,V*]88O)TO<@BR]"",9&M+*/9VC:DL%RN^[4JX9"!W'59C2R8
M,TNUS6&-07#S;ET&J!?A57AYN9C$,D<Z3&DOL<3M('7N#]_RJFG.N"\JX5+C
MZ]FYE8&AS$F4P'DK'FKE*V"EE`!AL<0:+&0TY5LL&!B:1)=Q&A&JFXQ<S'Y&
M.1DL)1NH50T=TMJ>U=*XWD<+EHYCM9N,.U\+@0Z1-#ZMU06NB)4@\4H>=><X
MJQ!EO+1JX.(#&UN483BE/'9N\\4DL&3MTH3;>G+&W9(YIX"P8$B'T):S\C'P
MF-8UH<]-3_*WJ@&O[NM93*AX#`FWLPB<HG=Z;G':.K6D_P`->]'N*^`N.^+N
M583G_CK)Y%N9XV2Y5R][F=R[R`\PQ.5]T9.AD[,J3/B1+8*R)+352CHH*,FJ
M]*X?WB.+SX9X\=IA786D>9R]B`FM,\CFYG-\9D\7G@?2N`<-B-$9;^5`;GYU
M!/ESSOF<?\C\)=RO`['&(\1BX\5R6Y%RJ#.(U!WM2X_[4PT,8M;`+%8D<%X#
M*CN68A=0-)SW,87N6,N.(6!C+^99`X?(!!T`!ZWK9>R?8IC]GYLC>3CE=,[=
M&-A:%:BJ22KCX($1!5R<)9H7:-7*U=+6/FJR9"%K,BJ4CMZO*#N)UL03N$8,
M!H6#:A>N>NP7`@&1@(VAI-@X%3J.O0KH=:Q65))CRR0[7&7<0[:+C;I8]#K;
MM2%E\[4PV/CN79XJY=*LE>E&B/=NV+*PBO5K,%,EJQ-/.J*(U*J=6;1>H\,$
M[HXX9"&,:\GN;"]_&R7J8V-\\DNR)Q<67*V;<K]B$D_*B+6+-ZK%<R$46-GD
MC#,AD$ZUI)VF<0RND<(EMQJP7Z=JL1J#V[L2D9$LDC8TQU`%]"NO\!\;T[`T
M0,]%K]S[J="1:W6W5?MI+"HX-5;?NSK"\U@;BDSEF:!'`<R;]-NA(8C53WZ\
MS(S!(',<`YH5#8D^`ZWZT_%(K%EB.QQ`!`4#XD:#XT67'5$@:*Q)+>B*;)3<
M@KNIFDE0LQ30A@A&HU77^3\.E,8Z>$I";HI<ER3=/AK3AR'-G862;1_*&K8`
M6*]S2-:M'[FFK1)6IUI;$0:5HT>(QM&PE!!1!4G3Z@_<IIH`-3T>C)"WZ=[&
MV*!+D`WN1WL:0W=DN?*TDNLOBB_?58/-/D?'WK8Q'%(*_(9,%KD\I;IV0*<%
MN-@L=>Q8E_<O&BL';9[C,=`%UZT7%X<\6Y\C4.WRIV-U\:Z/[6X'+QFMR\X&
M..4[6`^/8:CYTTJN/KO/@KW)9ZTPD-3,\DCHJ)*T-&Q*LSQUH9XH@MQ*Q*EB
M^]QZ(.M-BX<49AR)G%S=_F'@>B5,G<X,Y(84):BMC<XW+Q92G\J^'SIJ^3;%
M#EF1IXKAU^SC,#G\]_#1]OB:?\1:K;N1UGH+]4$T%>.F@+,2S*Y[`ZGJ7F".
M+U\B&T(4@"]AX=#2^".3!@SNY*)<YD:J2=J@*I&BKHB6JZ6,J0X'"UJ0Q_W6
M-QN.IXNJ\9'N01UJ\4<4TM<,D\\D7MDM]01]>^A&O63CR&R-=+.DC2I71"2N
MG[]#I7'N0$F7F9#F/V3/<XN_S7*B]@"?F*9>7R6-FN>YC)DO3F9(6$4#PS)`
M&#2,:5E(DVIH0[!Y6C/TA6U#=$XPY&DQ90DF<+-`0CXZ!/FM0(W9N.YKI\1S
M&`@$Z@_`WZ772G%"M:U7EHSI%:BMQM[M26'W!+'+"%:.VDQ4[9%?ZE]2-.JJ
M(312M,6.DS7+;4IT*GKVJQ$J%D[)D`NU#IV(([4P:%:]Q*__`$<OO)<Q<E>W
M9XWD+(5GBQ4D3_;<9M:3*XN8:"-UB8NSS0*NX;E.MIDXID8[DXF!4&YIT:HL
M1V3MTJ?D9&)FX[\J-P;D`@2#3<[J\61']4L'>%*CRF2_H741K.IB>`E2I/O1
MQ;1*1&(IXC]>[TT&OXZPV[(YD;8KM+E0$.LOAKUJH=OV.D>/*BIU/7I1LR)"
MK)#[3C[T1!`SF*)S[DTC^WH8R-'!(310=>Y]2M[7C'E:7![6261?P[>-.*)?
M3>T%JMNOW:U3KF^)/F+RO0X;<U;`X&&S/F8:T\,L45>NKM-%/91H6FS%EIH8
MTA3='$'UU9AIUIN-QI(\1SX@?4)_F[=OX5N\')@X#V[-FE!D2:6ZD(THGY1J
M35A;_"J7$K5'`0T[\-/$T*\<]*BHL.E.#1:T\.Z=HD,404.I8[2/JZ)\#(BR
MACS1'S-)<1J0;KVMUZURG^ILSV39[I0Z??;HKKK]OV4EV\=>E@7."*(5[`VM
M:F1I9+<JDUH!(\,(@45XE74,26(['\.FFXDTT0RI'?\`3M*`I8W0::6H9-#$
M[TF,(G(5.W4ZZU.OQ`9X_/>(AL*LLIQ?(A'+L=!`HP]B0QQAW4E0&T&J>GX]
M;'V8UD//P1.`]3:\C7JPFL[[H>^;@I)!^3<U>I_,-*[#==GKE-,;G[E,/`P+
M:B[&=%7<3MCE.G\GIZ]<P_W7)'M[&(*'ZEOQT=I6H]IMW<C*"G_*/XBH"RN&
MAY#!7?(!7E@M1V86CD>)XI-X<:J8M#],?U:KIU\Z/?(YQ?(X/!3HG[?&NG03
M_1O<V!6@M(T7]_C2R*R)"8TV*`5.JH6``!W!_J]"WXKITR7%0XL5RB_\:C>H
MXN!NM]:/1(0A6NP"ZZ,Q/=21JY[HP<$'MW&@ZDLC$K7&(D$Z67X@_B*C2.\S
M3(U3^R5KDD=UDU9I5#`G>FP@%!&R`KW8]SWT&@ZB9!D_+N+G-*_A3D;6M+"U
MH:2.GQ4'PH@ZK%-(BF&24LLDGMR.XD.S:I&X#V_952IT&A/YD]+F5LD,43_4
M#;^!4*?]!*'N4I^/S,]1S2T&U^@__BL17X\1655(!B(F,C$%%^K>Q.QCN4JS
M%M>F$!>[<W<MAJBWZ4XUXV$@H\(G4_;2=(C*D9U>/Z5&@.K%G70F20Z$LR'7
MT['J.\/C)+3MD`1.WS\14QCFN<[0A?DG@.P-;++1&O%7?_1V#+[9"%@QD(&X
M-N)(D`T(&FA'4Y[OJ(H,9Q:U[;@V(OU"Z+U[4U"2V:29IW-Z_+IIT77Y43R,
M(";V7;LU9$#DE$;:-[$G20L1Z>HZ1/%(3M*-C[*MOCWJ3B/5R`J3J4U/;P3O
M34GB19%1P-HT<$RDD@'4*0`"`%T[^O4=FUKO.RZZ^%68W.8YS3TT%,CEV.S^
M1O<:H8/%YK)RY#,U+.0J8*PE:Y+QZI*#?MM=M2US6@HJVYBC(\H!4`DZ==%]
MK<5D<IFQ8[L4RX1`<5\Q:WH02B?+6JYN7AXT6=-DYL4,K&.#2X6]0BP(`.XG
M2ZIK37PF<DR^<Y93P,(Y/P;$YVQC\-S9LM[-[)M3`;(UCA3C4CDCQ>2+UA*;
M),VS4C4'J![KP..X_E\O%X]YD8$)L@!`!T7[:DPPS,P>-EY!OT_).9N,:*$=
M^4[@;;FH4(LM*EN7V()97`C6-M\@E96(!#':J+];,?QT[:Z=9-D`EW$3,:0=
M#U^%2-Z.8TAQW6MT\2:1;>>Q6(H19'(V4P^,>8037<G:CK/4=M0L<ZJ2:IE;
M7;N;4COU<Q\1-&63X\HDAZEI*A?E_;39WY,CL9K"^<`D-`LY/X4A>(^-\R^2
M:Y_E?"/(&(\=\!XMRO)<:Q4\?%Z7.,MS>SA)FK7[]R:SE<95P^#:S&5A2%6M
M2)]7NIJ.ND>VO8D.=C.R\C(<`38`7[WN.]1/<_-\;[.;AX6=Q;\OELC';(X>
MHZ%D(=HT`-=O<ER2C1HAIZ\SXMR+Q_>J8WD\=&/'9*TV-X_R/'26)\?E;<D#
MS?:6J\T2V,-D'6-MD4LDJ.%.R1B-#GO<_L[+]OGZN(MDP'%-P'Y;?S#7X'O5
M?PG,8G/QRNQ2[ZF-NYT910`=6G^8#J0!XBD-8P8R';M&2/\`&TED=%]U"P)U
M]I=O?\3H/0=8,QD,<'N5I&O;N/NJ[]97#:W]NE%I()$4.Y]K]T'B`(&L<;QO
M&6U#+(DQ71E([HQUTZ=:V1K-QBL&*#X`?NKUSFN.P.57@'PI.>M6@$C10)]+
M_O0J:&1D3VUV%G8@A2=3^/\`,.O7M8&QRN\RN0]M%L/O^5+8\_\`*84`!3[;
MT4V;A$;%N-HC'(JU54I-&JZ`22D$@ZOIIZ:[=>_3S';8&.=+N4D(-4&A\*1(
M_P`[F-C(D`N>A\*1[6YG(=2)3(ZQJ[:)*F_Z'DEBU:,N5T*_ETG:"6@7<;+W
M![]B*5N#FJ+-`^P^%(]I'@D>&6%5.P;00K:LY#`%E*^A)/?37IY'1@1/B'J-
MTZVZZ5'\I/J,>HI`DC570-[DJQQEF5)(SK*Y?1259E559>Y)UZ>BAC:YAOM-
MSX^%>OF<YK@2%Z:TV[2(/<5AK(=-REP"%#`R.KJ`OTIV4G5AIZ=2FL:Y2X?N
M'[)0'N`:CE'WGM]](K32Q1R@!VC8A2&8,6C5]R`$GZE#:=O_`)74AV7/+D/D
M%FN"=[=`NO[Z;=#"0Q@;YP5^9U-)]BW#*)&FDD/MF+9*JE1]*R(0Z`C5`=I_
M,ZG^31]CXB-SCY@1H$6W6O#'(QS&MC"%56^M=N?!&G_DWXUTUT_HCA]-22=/
MMET[DD]?2GMR_`\243]!GX5PKF__`-7Y'_WG?C4L]755=)6<_P!C93_4+7^9
M?HZBBOER=%%?_]/V>_`+_@>^(G_+=X5_W<\<Z*.U6[Z**II\N\E]C7\>)8X]
M!GL<V?GN7/?JFS]LV,%2[`(PR20A[,D6W1@=WIH?3K%>])71XN*1'NCW%;*0
MB(GQKK?^U6##F3\WOSC#*(0&W0.W*"MP;:VO59I>4Y;D%C+<IQO"FQG%K$,5
M"2]:MN;44),*3@QLC7E]XH8U?V=D8[#OIUS61_ZSLUL8$1L02"X6U/7P%JZ=
M]+B8<$'"S<H),X$O``.TD*@'1;J0MTIT19+CM["R\9J8!,0N?RU*1TGDER].
M26%]LF2JRL$G29CM#)+VT7\/3J"Z;&(;#Z9:Y[K6U/<']U5DN/RL65]<<S?Z
M$9!-F%H(79MO]HUJ9\7EFJ9M:4PAAL/+/2@IVGJ&P:-"O'%4L358W9I(6V%H
M74[=A`[Z:=5GN*?Z*>+,QVM?D-.TDA0B=OO%9&&$Y6._<X^F1NL#J25"Z`]#
MXT\1$J6B\<@21"6>,1ZAMPW:`ZJ%VL-=>_6$$^V:7(E'ZRD@+H3^-+*^@&#_
M`)9"+\*C7S)!%D?&O*EM>R_LXW[KW)&B<+-4FBLP-*B*P]LSHH*J-677J9Q!
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M3K6NY;FFY&)Q^%Q#9,;%PP0T`]5!WG2Y12JITI!M<+Y7XBMYG->+L=D\_P".
MZ\8_B?C2W=:=\.V-A"9&WQ*WDK%B]+%/#&R?;,'!D4"/5"-+0$<G$Z*8;)6*
M?`'L[P*@KWJ-!R.!RKL*+EYVMSW':V<#\VXG;N:$'E/4$%*W>.\WC?+]_P#\
MR9Z\M>KQ>&;!<6QLRV`^(O6J<<V=LV&>M!-_%+`MK5&H*+'&-A^LGIF=LF/C
MMQ"]?YBO@#M:>H1%7J46D\E'+PT\W'$`N>]7NMY@-'-U&T)\;DG2I-R>.EWU
MU=:;1L^\5U,<JQLCK'`S*CEFG$:MNW$DKIJOYQG-8T1SMD:)!?RZ"_4=3^[I
M51CR@/E8CG!"I/YKC0%!8V_C6Q>//'9NYZCNO/3J5#9:]++8BFBDFB:6U6A(
M2-%KJ1^XT"JJZ'U/5QBX#LTY>87"1T;`=SNUKC0`@'3HE0),]L&/!A#]&&24
MV;J.B.-U7_%XTA<QR%7%0W;(J6+\*2$33:H]N6WLW16*\0`14,DO<,C($U/<
MD=,9(@PY'LB>7-:\*OYB[N/CHB(E.X@S,K8&(TEA3L&Z([J;75=;5#?*./\`
M-N200G"VL;7HE4$E6>$U+31S(QVQRS^[7BA5M2!](DVZ'MIT_B2XC<@ODB<7
M6<3H`3X=0M:GB\C!P2TY41]5/+_,"B:]5(3QJIM;QIG.%U\IQ_(XE,IG+5Z:
MVU^*:*$Y&G>R##&48GJ66KZO/*L;.1[R-K_BCK4862W,A/TL>YS7(>B7TKJ/
M_P`CQ\QF+E^N(\5K?RFZ$-N2H7X=*7;/!<SXZRZQ9_%-B<W/1@R][&EZ]^$"
MTNS9.L4U]+&/J#ZPP"L6U&@]>K3)@S^+*F!6[5O]U-XW/<;[GQY&P2#TFO+0
MZ[24Z@$#S'M2S>\;9+)1X_-<,Y#AN0Y?'2UL@,0]9,=%C9()3=BN8V%7,L>V
M:37?(DFXGU([=91W,.9.]F=B[&/T*VJ*.5PXG2X>;$^+$<"U54FR(;=>B$59
M?BG)3R?C]7(V&E@N1QO0N+'M8U,I5?V;<6NT>_6$R,0!MU!_P=5.0L&3ND),
M!NT@:=D[MKF'+X`Q<R>"!'M)W!;*TW!\"E$;U%+TC?<2+MA4FJ#L3;,Q=2()
MI%<A]A/TZ:`>O3<+A))ZK'#:TJALM5LYD8WTW!WG"6NGB:375(Y:BPP,\]98
M$:2%II3&H79')&2\<(L*B]]58;3IITN:=L4AE<_<]S?*`I0@]>U>1XDAB]-K
M=L0)52EOV[4?SJ1Y6@[36JLL-BI'?Q$LM=#(ES5#3E>`B,&Q#)&&5HU!WE0-
M"23<LG;+"R94F<WS`Z.W!`3T0W%@+I4/$;)B3NCVDP;D*=&FY`/7IKT6FC3R
MD=VG7OJBNTX,,Z:`,DJ,$D+LPT6-9:[@=BNUNW5%+N<YB(2'$%?N'\:MI,?T
M'31@I%J$UT7]]-7FW+L1P;C>1Y!DG+I!%**U)E9VOWK+%*&-J)$@-BU/*JQH
MFTC30ZZ=3L1KLC*9$+1D_8W4_&G>+X^3/R&01L\YU).@ZD]AWJ-/%W!['&*>
M*REN9)^329/^D&7MF)*\\5^Q713C99(=YL5JT9"$QE59UU(!ZMG\NXF-T,6[
M'8\(W12-">MOW4Y[FY+^HR38,#RR`-#6I?RCXVO>I+;+Y.6W;FJ9!ON96N7+
M*RZP169+LX_B<,2$[4:15#DDK^QIITEN=F9<LDOU1]9NYP"(+GS`?=\JR?T&
M)CP,:['_`$U`55-A8GX:6[TR\EB,WDA4OQYS,)6H7EK+C:T]RI#)-;JM']_7
M@WFO9EB4%%W;@-I(&I!ZG&'*;QK7Q9;G1.<`&IJ3UMJE,LEQ7Y<D3\<!Z$ER
M]!]X6K0?$U<91\Y\?BDM9&UD+]'DL=62_K)L^RP-K[JG#K/*T<5=$[2$`/II
MZ];KV8W&/(Q2.+G9180KB+$-.X!.E97W-ZSN+F#&L;CM<VS2NKK$^)KKMUU>
MN:TQ?(*[L&J^H-J,$:;M04D![=Q_T]NN7_[L%/;N.4*_4M_\KJU'M)/ZFY?_
M`$S^(J&Y(I(I49$WQ")1LU$3.J:#5BH&H"'T`_D'7SL=S$D)5@NA.ORUKHK'
ML+'MTD774"CAF/N_O-"I16"J-S"-F.BL(UC^E2O8]V_/I4LF\LDDU/8C3H"B
M:=]:CM8$+6+N'=47O=1\M*W#W)S-)"\5:#_Y),:YF*,H*F1D#1%V"Z#=VT_P
M=3\*1C\D/R6;,46)0D@(;]S?JFE,R-:QC8P2[(Z!;?#^Q:UTK,4BQ;):9J3B
M::6:O*)]WNAGAF]Z-06#*==`-=#U[FQ-QL_(PY@(X-24))#@K7;A=$0@#YB@
ML<Z(R`/,[4`!"!1^8(;*O?K1'[-TE:S'(%>>0,&T.E:NB@1F4.Q1#89"^T=_
MS_E@''?MQY8)._\`X0MB[_B(5/`5.;.TM='*U0T?ZC_E2_E!1=-:"1H5^DZL
M-X==2)$?0;]02VY95D/8ZG3ID![3O8[]4DZ63]UZ421Y2WR'3L1T^PC6M-F(
MD:22C[EF*3%1[S"50-!*H+#0+KH1TUD03'\Q!D6Z%2OC_&G(9`H+&_HHK5L$
M\/X4ERR&-HHY%5D8GW-V@,>T$J5UU(U;^4=1@/3VL2Y'W]:G-;N#WL*$??23
M;R-;&?<R6&!1A')HK2RM"DSI'"[J%F;:\C``Z`:]@>I;(YF&9WT^Y@:I(T'8
MTII;,R$,FVNW)<:GJ.E-;DD^=K;(L!@(\S))7W///E(,7!7F;;[09Y(;,SZ`
M]]%.FA_'ITXV.U[&/R=TB=!;[]:L,3TI"]T\YB8'=MQ(ZVJ-.)GS7QGF=GF-
MODW#IZ,_'[^!J<=H8C)S)AYYI_=JY-LM9MJ<C/!*W[R-HHXW'8`>IV/MCW6W
MVV_(&/AEX++ESM2-$&@0G2CG^.]L<OQT>)%C9#<QLK7>IN".'\S2P"P(T*DC
MK3HQN..+HBA'(JV%#RWPL$51;ERW,]FS8CKUT2"'WIYF?:---?77K'9N=+F9
M65ERS;9Y'*X):_;O]U&UI;$WTRZ(!&E5(`L%)O16>JQW`NH8_4&=6W@!@&U)
M.A"D]_Y>F#&UVS;)]UQ7ID(7](HG>QI$O(EM$A>"O:C61RJSUX98S(X4--*D
MB2JSL$`'Y*HZGP94S6LA@LP*A)Z]2>Z]*;:P,<Z9SRV0CIV[4W/&7E/C7Q=S
MO($Y/!)C/$O/LU%F9<KB\9/8Q_!.2V(4AR5S,5Z,$UB'!<AGVSF95V5Y2Y;1
M"".N^Q_=+,6/^F<E*?,?*X]_&VE1/<_MO(][XF)/Q[MW/XD99L<X`SQB[0PD
M@;V"R:N"=:N]R#EWB_R#X_R]E.8<$S_$,AC7FLY`<FQ+8IJ<9$[3'(07?]`F
MA]O=')JK12J&T[:==3G^FR\.9KGQO@>TJ"1M(ZW_`&2N.8V!SO$<K"T<?DQ<
MBQX`;Z;MRFR(EP>HNHKG5XKYU'Y`XM-DH$R5JMC\SD<32Y!D*/\`#JO+:-6Q
M(E/D.(C;8T]2[4C53*%0.Z$@;2"?F'E^.AAS)X<1X=#NLAL%/4=>RU]`<O@O
MXO*A@R0QD\D0<Z-I!=&Y`2QQZ$%3X#QJ0[`BCC2"1%72Q]<Z-*'2*1$:6$@N
M(S&DQ/T__#K^/58]S(XFXZ]2KNH!0'Y=JJXBY[WRH=H"):Y!L5\11._"*\LE
M<R*WL21@KOUWKK(VJ`,5.T2!AIK_`#_ATZYAB+H"6EL9!3556WV&DQO;)MD<
M"%44EVDB:PKP@;`\W>32/3>N]1M+`N6(;4CLNO2_3B\KXVH]3KV[?:M-.FE:
M"QY.U`G5>_PLE($S@@Z#:TB&(LPW11[U<[=HW,I<KIJ/4C4'I#(7%^X@"-""
M0/LIUSR6"Z>'[J1G>,(X5@B!"CI)I*[L9`@"HH_=LQ.SOVT/4B$%FXM<`$3O
M\OC07;D!;;]O[Z0[2F*-5B*I(9#$L#.#,K,N[1D0#Z0>VOX]20QSF*4W!P:G
M4+U3MXTP9-\FTKIJED^--S)R1PPV9WUD$%>266*/ZYM43?)(&VR$LVT@`::?
MATZ6%I#'1W/CK]VM/-*!J.'QIH5+T67Q\60KQ-#%-&TFV53%*1IV^E@CIHO8
MDC4](E#XR&M;Y@3UZ?MUI;#&2X[E^6AI-E5^P$HE+MO`&BL@4A%`?7:2/YM=
M?7\.G(W?IC>U+?;VKR5Q4N!1"$_?\J[I^!26\,>,R003P_#Z@G4@_;+KJ3ZG
MKZ:]L$N]O<.3J<=GX5PCGD_K/)I_ZSOQJ6^KVJFDK.?[&RG^H6O\R_1U%%?+
MDZ**_]3V>_`+_@>^(G_+=X5_W<\<Z*.U6[Z**@GS93KY!.-T[<4SU9+5V64Q
MARC?:P)96NZQ,DDYL&+:L18(Y[-J.LW[@*_1L?+M@4EWB`%3YUK?:\YQAGSQ
M_P#]2`T-OH22%^2Z].E5<DYQQ'B>=YC#/8GX_AGS])L7C3B[$KTI\A#&]H/7
M@BELQJ\Q8:`;`6]0.N<<AB<:[E<C)84CZ-(/5/L0BUD-=*Q>,Y[E<#!>QHGE
MCC.YP<+AJ]20#9/&D/FV0X[C[+4[&9MW/;J8_(<5EQM)TQ\]_(6IFRCVY:T9
M]F>.M'"/;?0(.^A/I4NCQ&-FQY7;I0X/":!?'I;H+"KOAL/FLOTLG'PPV*[)
M0YP5&A&H#K<FXN:PM7XL3RS'<ERF6.0R6$IT[4VZLKSU\/F4ABR=2)XE&BUE
MVRKH/J`U'J>JGG<$Y$`R&.(FC:2U!<#K\:5!CDX65@-QML4CR%)57B[3KU-D
MJ<N1\CPG$<-?Y9E+<%.K7A]Q9Y4:5FWZ)"JUXU>69I68!0H).OIU@68TTL!:
MV+<6N4E/Q%4N+@Y7(93./@87N-D![7-U0)K4"WQY7\K8^6SB,/0XUPZ9X=N*
MS)-/*\IBL1$R9"58J_W&+IUI"&5&"M*1ZZ:]7\&)%Q\/U4L^Z6QV@6"ZJ1H?
M"KS"R>&X3+]'(<9,T`I*TJV,@V`!/G)T)Z5LXGRKD&!XH:N>XCGZR<7BGQD^
M3@46\3<3%O-!%=BL12R7(Z,AC`WR)HNO8D=09^/DS/J)L<`Q%NYP4*!U4=JD
M9T7'S<DV1F;&1.5"@ARO0HA";K][U+M.U+-1H6[=/[:>U`3+[4OO112/]0<R
M;$UB;:1W`!)].J$%C7/8UB--OB>X'["H<L0;/(QLVYC38$71/Q^=-NQE8\>;
MDV3F6A%3!LO;LGVX$KK(K[3-J!MV]]-=`3Z=^I,<#'M)E<0KO+:Y1/OIUS72
M>G'C-#Y#8H2;D)IUIWXG*4KH#&O%:@M#V5DB55CKP6T57M0F-C*RJC!V.FC#
M30$]7&))%"YT;V[FO\I4%&D6#@EU[I5'F09$;T,KF317MJ0+[2MOAUJ`\)7K
M\/\`*?,^*TVKT8>4I6YAQB@DCO3_`(4HBK9RQ&PVND]?)1LQB?\`Q+"E0`@T
MF<A"3#'F2>:)MFF^C2;+J/GJM:4.DY#C,#)ED<9&^5ZHH?M\ENH(2XLHOK4J
MS>S*8FFD1TJ1V*L4<<0-9%E`LM*T@*R.'N'0NX)'M!0=#U'C,4S(PH<?3*6M
MK93:X)OUMVJA?%)&_(=&2"7-))-REB`-+BX3O2!/B\D\['&V3=A,!39,K0(D
M[1J??60H'D1900%/U:#7;Z'I^.#&C#X1*3Y;&Z%R!3]O0T@9)<T2/A#2U_@H
M;HGA;K2+RVQ%4KQU52P\V7LU<1%.)@)GD,OO22V`ZV7$:"(G4ZC4`#JMD?ZF
M0T-&X.<G9SBW0D]/C5O@MVQR2OD#`QI>AN&@V`")]E?NLM6-:I<+$`4959BB
MJQT5/I"N_MH/Q!#'\.O)'))(2$9H6JNWX]Z<,7JL#]VZ3541>MAH*B7R]6^T
MQW'LU4C>6SCLS5ED]HQ*9JM=I)YUF$F@VKL!"'=]0'8CJX]ORNBS48;`+K;7
MMU/@:N>">)),G&F)#'L(ZE'$`!/XU"F.ESO(N<QROB\NW\3QEO()!DI<;4DR
MN,BBWTY<A?23=#CJLNZ0+"4,NH`0]=&DDFR91&(TB+1VNFOP^%7+X<3A^)>Z
M'*:Z>.5"6@G:3J@.I.BWHADKV>Q,'&U:&W3Q<=N_D&_ARP4;CW?=6&\E6:I*
M,I:QPCB4%7C(+:'N>H61%!+CQP2P[AOLHN#X=Q4[C8\7,GS<F7(;ZXC"@W:6
MI8D:-<JZ7K'$\J?QQR2;'6;4_P!CD9),EEIKT]^Y:OU[UG[A,BM6S5WTIA%8
M7='&P+A20NO5/R'%1F%[8H_,UJ`]QV3I3F;Q+^=P?K(`W?'9H&T!B#0D'S"R
M@GO4VNV5ERS9&O=QV2XS<K(*^/%5H+26"J2+:%MBCL&)`*.J;2?7MIUC90V%
M(3"&S!POJ$&H(K'-BA..]KU&6TGS+]R=/C1^&-S7]V>*,"5'`A+!!`Q;LRE"
M0TBMW.W4MH.DDLWEK6*$Z=^]07R[2UNXJH\?E2!G9(S=QEFQ=-*(7%=\B\@E
MKS09"M+0F&LA,0%M75F!*F,+JNU@#U983YA,YKXPYKV[3903W^1O\JCF%DT1
M8R,NDW*!H0AW#Y5&/$>7<>AQ^9LI:B$&'S5Z&$R(\/\`$*E^VTE6]5KF-Q9C
M:*DY1QJ5`/\`UN\^7C'SN]>!$:UMO\3B4/PT%7/,<?FQOPH'QGU9(^E]I`%B
MG534;8:Q9\L<G;DN42:IP7A69G?B%*X4^XR/)8O:=.1S?4):\5""PXKQD`#>
M"=#V$:9T>+$86/\`U7N.X]`O\H/:K#-:WV]QT6.'+R,T0+R%LVZL\5.I^52Z
M\T4,3/.U6$,)1O5MB0QZB0%W_P`DNX_@3N'Y=)BQG.CB=%(KG^5`/VUZ5A/J
M?5?(UL94`.N/N[U'[<PPK904<*+.6R$)]VP*-6Y/5IEI!&OW=IH/MOVM6()(
M*C3\>I^+BQ8[FRY$@BE\;HG5!>]3'XF7+C>I(`,;2Y`)**$"JGC21=O>0YU6
MD+.#Q&.@R%J[#_HCY._`)1]44,4<B5XO?B42;_<8H3MT[=7+\_%QHFXH898=
MRARH`'5&9A<?'/)*7%TCV@(;:#OU^RK:_#F"3_SFXBTKM9$&*Y1%'))''')`
MZX2<,Q6,`;IE?N3N;4]V)ZU7M"1L_,X[X8FB%K7@'JFTI6+]T[8^)S&!Y5SV
M%.GYJ[$==<KE=,SFZ[L97.A.V[&?VMH_R<@.OYC0]<T_W3<6^W\=.N2W\'5H
M_;*?72W_`/MG\140L574^TX0EBR*-T@T_9=6&I/\PZ^=GAKI0T`B_P`:Z'YB
M/S@O2W0?"M!F=!(PC^M"-4;1':%0-[EAKM9`0-/7OTAL/F?UVE$-E;UIWTVG
M8-WE/74`]!XT7N5I+M:=(XC6CMQM%)(S%W%=M8FCCD=@T,NTD:QGL3KKKU:[
M(H!!)&S?""J'2QT!-T^%-1/:R3]5RR#1+7[D"WVU'W-><X_Q?A>3<XY31BH\
M5PM?C6.JQ84&Y=@@66MAA:LBRT<ER9K%U#M56=(D);4`D;3D^4X[W?F1^GC&
M+-AC&T*H>T:@E+$:@]=*?XCA<O,=A\5@Y.[*F,KG;[-!0O0(MB&G5/,0E*_$
MN=<6\BX"+D/%+39;&2/L:>2K:QUB%Q&)%5J=ZK7E`?4$$KHRC521WZQG*\1E
M\8QDN?AN])Y.UZA#94_:]K5)R,3*XS+=AY!#)FC\H(<#=%5I/]]C>EAA:1??
MLLNQV!ABU56$+2^PP9D_9/X#=W_'TZIBUH1YNUUP`?,!HGS/W4LNBO'%^8?F
M/147]DZT0K9B+(I&(*%M:\L>BR31)',%5W6"6Q%W>O#,B!HV;0,K*?QZL\CA
M7QQQB,C>Z,.#2@*'13TM31=Z,D@E>-S7D64CQ3O>Q[&MY"6(GT1XT&X>CH[%
M=5+E7#:=NVJC0]NJ5[61[8RUH+55+@D=3_94MCWAS7JJZ>`/[+>B"1+&\CHC
M([HJNR-I[D2:?3(Z:,X4C_&ZC;I(PQ'V/3P_;I4IP:\)(A`/W_"B-Y!)V=R-
M0670=UU]4![DC\STX9%:PF\?A^W2G8FZAI\_[J2+4/\`I>Z:036+7M>T5"]V
M""-5]M`(TVHNAU'\OKU,$3Y)MKG-]0M\NG]RU'9Z<$#A$TB,.N;_`#I$E0%S
M%ZR,?;*_5J''96&NB;E_P]0]JEK'-\QM\ZG!PV[F_DU'PI!LU['NA54&`Q2"
M221@)/<]R/VU5=#^[.TEOQU`Z];Y&SQ2M*A+==>]+5?3+43]NE),\3!G1&8Z
M:!HPVDFWMI]7JP8#^733I8:7>9M@;'X"O00TH_7]])-Z1]DP@813:2"N6B#H
MCA=B-J05)4Z%M1]0_GZLH)@GE/F!":H4IDQR!''4CNE1OFO'WC;(9V;+2<`X
MC9FFFHY%;5KC6&%E\A3I)%/>FF-<3-/+.SE"=1H?YNITV;--YF2$7N%.G72G
M<+D.9QH/1?R,ME`1Y1"5`I\8O)RQR1RI[2'L8X]E=(:\4?TE1"H,1AC(VZ$;
M3U&8Z2*;UH7`2K;]]C^^HSV,DC>R8D@B_=3I?5:9O..73<'XQ>Y'#C9LW-`]
M"-:J2UJR_<W<A%5QXMRSZ5JE".Q;433L-L<7U,"H.CN+')G9^,U0'.E%RB6-
M@?GTJQX[CFYV1%B.F]-K@;W)0-4H!<N06'4Z4[>&^.?D9S:AB\CR7C_CKB39
M.W;CS=ZIR=\\M:M!/.(9L92HX^O7MS[E"E#+$BZ'OJ-.NE8W^WF7FSNR<C*C
M9CR#S`"Z@ZA/LK)\K[I]G\9)/C\5D9>0&`;-T>Q2@4.+B2/BAJ8Q\>ZRQ;<K
MY)MWLA#''+6BKT<3AZGW)W+9DG"K:MR1SH`H`<%-/74]:R+_`&^X2.)H?(Z2
M0"RE!]QK&CWWG;IC!Q;!&ZRW<0/#I:J\^6^+\9\<83(Y.K\B.-T<A0FFE@Q?
M*<7#?AD]S=(,-OP.[(.K3(J))[$LBJ.ZD]5/(>S.`QV.?#RC87M!L2HOJ.I/
MSK8>V^;S^6RX8LKVC/+`\`%\3MI'^?S^7Y*!XU7CBW/.79W*RU:N"PV>PU$Q
M+/SO#95JF"LS20+--7Q^$R=>KG;#5'G$6]HO:,@U#=NW.>4XW'XN4M@Y!L[$
M!&T(A/6];')P<%D`?-++!DDD>B]JO`!0;G-);<!454J2YK@C6/97#:KK.ZM'
M[C[B6E!U&]2L@U)&AT[#J.R6$.C*>8M"]5'6_2L\YI<7,WD;3;MX4AV3&R2E
M%CM2':D6V5E75D1C*570L%.H);L3VZ],;"QP3<CB`0;=P4\.]>.D<'-:'[6G
M6U-*W[<`=@J%F9D.T=T;3710`=%T)[CMTT6$$%Q4D_M^PI]L@V[&E&_"F_,1
M)K.S(S(`RGZEVL/J[]@-27]-"#H>I!:6QM<B.7[.UZ\+PP%BW_=7='P`2?"G
MC$E=A/#L-]/Y?Z,O;N3U]*>VBO`<041<=GX5P[G`G+\B%7]9WXU+_5Y5525G
M/]C93_4+7^9?HZBBOER=%%?_U?9[\`O^![XB?\MWA7_=SQSHH[5;OHHJL7R4
MYM9X;C^+R5Y(9CD;UVL<3)5:9\H1#$!%%,H8URN_N=.X/6+]X.!9@0N<C7N<
MO8HEC72_]N.&CY;(Y,R-*11M=N!TN:HKR'[_`"U_(7.2XW[++6(8,LE#*OH1
M&'VQ&DT>GMML(U+Z:*#^/7/\K$RGY&XC]1H"`Z)\*[CQ#\+#XWTN.D7%W.:7
M-[H?S+^`UI[P\6I9>SC[?)N78K$\9-"&U!?QJ2(]RW8B>.Y52/8JF*K)756)
M4%G;4=CTH<:8,LB?(&Q[=0$"_#XA*S,?N/(AQ9X^-XU\F4V0M1W\H7\W>X-J
M8V1N2TFSV:X]C?XG5K!Z-?&0RR&;.4;Q&/2LUJ4F2L34A>0O_P#(M.PZK<_+
M&.0``7D;2/`V(J[A]'+CP\;+E+)7^;=8;7#S!R#4`H$ZU('!?&U#R!7K\LY-
MD,IFL34FBCP&)LW9C!$U64'2<1L!(:S1A%)&K$$GK)9V7!#%+!B,`<4))U1=
M!55RW*9/#R?T_$#&92.W/:`"2X=SHNM6ADGUF:%BU5%KJNY"&5=O[";P1J5`
M_P"CJD.8-\K(9-K'=-=*QD>,71Q2/@WR`];4UT/^G9-6F%BG<0QM6<*8I*RJ
M(7W%M1]6I!T_:.O33WRM?Z\)<T$;45/BOB:L]H(@;(GJL.X%#8KY4^%M:95N
M"?!TLIBJ&1@:T:YGXW-<#E`XD26;%N&E(=X45A&6<:[AKZ=>QMQ\ES_40.0:
M`ZJ+CY5<,D,TF/D/A)9O20`]$(W>"E%J-\?5RG/[UC$Y7(UVQ..T_B=.GMAL
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M3I4D4+&2Y!A,7F\<\5/&Y3'19&K=#1VI+=:S6CMQM+&$2-#(9`VXZG\!^?5$
M\IO@*,+"@<>H%R4'<]ZCY<3<3(FAD5[@X@M"A""6ZKT%D^=;8[>6J4(@E,RV
M)QH]?W8P?;,^\3N9=2(O:(&T:ZC\?PZ3*^:)[3&U&N:J:]56^@/:HWTV/,2W
MU5+2AZ=$0I8D=_NIAKGY4R%C+Y?'68[33/0QT,;*_LU`JRN7"IHUNU9D70K^
MP@(]->H4<FZ)\CFD3F3:T=QJA3J3UJZ=@>5D,4@=CAFYY70Z?8!?Q-*,5R#(
M6)(:HF-J(JTM>4[&@U!W+[NP1/(SC]D-J"-#I^-H<<-C)(V2H%-C\0NE5OKH
M\`.WP@$)I\#W1*AWRSS/#8SC67I?Q"E:RLU>6K6QT`:Q:K7"ND=B9H5;V1".
M[DZ$:'J1QO&SB2&1B[=RKV"JOSK6<'BRY.9#/Z1;`U%)*`CM4#4,I8GFAEOV
M89[]#`UA6N6<A7H8RGBX$%@O6$3/;?*J$(C68E'#=P.NB+$(W1R/!("C45?.
MQ=\4SL7_`)#Y2'-3<XNT'_A[D4_\YY%3-UN*7^+PV^)V.+UF@X^E^NF>R?)<
M[=FELRVI,B]=:]:A*Y`6*34:^G3S^09,S&;C#88]%N2[NO0>%4.)PG]/FY.#
MD)/69,5=M.P,8!8;54GQ%,[./3QN<PF;R>8KR<E@9,;E\-;ALW[/LSJ_W]SW
M6$8%RED-9C755"*-$)'?IF2(.F#Y'H[QT*_OZIVJ[X_-E^ER\/&QC]$5+7`[
M;#0>((LO?6FEQ_+<ZYERB;B?)>8?T5Q-/&W>57+Z0Q4DO\4I6TKQ7%M7F7[O
M*7(I00$V*D:EF#,-.HC>.BR\C_J6-,@!.Y+;>_B2*\Y%O&87'-R\#%]65SPP
M,N4>1<%%1H\=33*P'E?)O`9\7R#)Y(XCDMVK3;,E*V*FX]3GECC@!AB,UG)Y
M"K")D;;J.X`/;JLS>+P8@6Q:/U.B+X59,X$20?\`4XS&DL!.V[@XBY^`-9^1
M_).1\C9!*PKC%\-Q-^:Q;CKR/$:5^.&5C:R4MH5`VR2PB11#54=CN!TZJS#'
MQQ,&\NF-U'8BE\)P$7%L^JE!?EN'E!&HZ"RGO>F5#D]/X=5QF3FY##:BH56K
M8YS7JU+-TR5'J"Q+"BV]J+$2FN@7;IKN/3F+/.YCQ=A!("_#7X5994`/K3SQ
MB*1MU==1JMM!K]OA4N\0XIY!P=-A3R='`4KC17Y*61KIDKE>W[$4#P@5XA71
MI*T<9)W:;M#IZ]5[3CR%C7@/*JH4#X(;DKUZU@.8Y3C\QQCE9ZD[?*'M)`VW
M*?:;>%/;$<?LWEOW>532Y*:G-;2F%*Q48&`&DRPUA`)E56)'N`@$::=/&>1K
MY!&S4$IV(Z_*LQEY&.R-D>&P-!0$FY*]%.BTJLD42A6L"%3[DLDJQ)L",5*H
MRJ-S2$@Z#\%U[])8&S,$DSR'J?-J;^%0P7Q!VUNYH`"'N.HHA*7$2,H.VQL>
M-B$,4D/U.'[:MKN&FW77^7OTN&,>57DL/PO_`'4S(YKG%P0N:M^H72W:I[^&
M;^YYUP,AAM>T<7R6.M.=5JZC"V"R(`6WDQCN3IH1UT?V0"[D,=X:@`>"FB[>
M@K#^[D;@S`O!>2P^.M=ENNO5S"FGS!-^-A34#6TFA)"C7VY/4DC37KGG^Y,3
MYN#@C81N,XU_X75?>WGB/,D>181G\14*V97%FI6J59K9FDD-BU#(BQT%B7>/
M>WDF5)BI4!02#ZZ=<`;!&&3-+ER&K:X*^!T2NBM+C&9'O#660'^9>W:BSUV$
MPW63)&^[=$(M/;39]4)`.Y_<?0EM>VWJO$L;'>F_S@CHI(_#[:DA^YAVQHYJ
M==?'P3H/&M\U^."I&9I5$4:B-6^LD;CHB:(NHUD/<]SITY'E.F:UCU(%@>P!
MT2WXTV,9SIG%C4)-QW^9/[JCGR54XW(W`N1<OQ\.2X;Q'FU7.<KK6Q[U./&2
M8;,XF+*WJ7MNERE@\GD:]N5&#;4A+Z';UJ/965A8?N3CI,E!CN):50W<#M7Y
MU8X+^1&+SF!QDA;R.1B.9&1^90YKRQIZ.>UKF@A-4ZT_//4&2X]C,=Y5XI%'
MDL5Q+C^5_C/&:1I5JO),39DQ4E6>K=$;&#*X."K(]+LT,L4DT+;2\;#MWO;A
MV\UQGT[B1`T;U`!1S=-?!4Z(H[5C/8L\$O(/X+D/)DY$K0R5VXF)PW*"WJU]
M@_0M(:X*A%,3#<@SW(ZV*OV,)F>&)F*\=B&KE:M8V[U7[6M)/,*K,[UHHY[`
M@$K;3[J=AIUPK/X#,X%L>5DN:6S`EA`"$!`>NN@TK:9&/@-ER\6'-9D>@]"6
M$H"I0*@70N3M3HAQ%7#UOX;5JF*"U![$P,K2@I$%1$)=V/[OV]!H1J>_5*<[
M*QW'?>62,M*H4_N2HSDS"Z4O_*\.T1>Y^:U^S?<QI6C*P0P1.[%44EM#IMC5
MMHW?LDG\M>W58\R%K`]@;&VXLNNJU)C$;GO<'DO*#[**M,A,[-$T9>8JH,B[
MD4:%=%0:%&/H>Q`]>F96PN=(8V`+UW?EM<)UO4B,2;8P3H.VM^])-PR:GW-\
M3JB[0R#30@%==G8GOTT^-SC=NU$']M3(BQHW-=N;=:(%5*J)2!,59B'&BL0O
M?;H.Q[?]/2"USG[39X.IZVITN9M\@5ATI`EA!G#Z%0&WHX;ZE90-?VAJ-Q]-
M.G0YKV;0\B0??2T17$!#2/*A>Q+JI1=1HV\.LNI&FNA#1G0=]1UX2`7%SR7%
M/QIUS2V-NU!\.E)KPAV.X,IVJ$(;5OVFW;6"@:$#^?3IQI\Q+0H2X76FCN#1
MU4Z]J0[=9ON8XH=RQ)(`VH!!DDV[26[D;=!V].VNO4N$(QA8H<256XO;[:29
M&D$NN2+?*F[<KKO#:2"(R>V%0AFW*3V$A!T/TD>F@`/0"0X.D84!T[_92B#M
MVM<CR-:28%_?M#'OD9V6/7:NC;B6*':H(0;O4_S=>N+I-HC"N.@ZZ_L:](0;
MG6`ZTIR5:U^K;QUR!+&/R=67&6J4R(\=F"2-H9XIV<*%6Q$70'_$UU]1U.Q)
M',#]C2#TTL1W^>B5'?++#)#-'(DL;@]1X7"?=33H\T\D\HX5Q/C&9O?P3$<%
MN6</(F/LN,URNSBI+]*!LGD$>-8,+_#IX?H4&::6%7:0:E3T'E_>O)'C\/"P
M$8C&[GK<E"H1--+U"?P7`8_)\GG1M,TN20YJA&QAVUQ1O^+<".P!*"FSD.&\
M:NV:UJU1G:[%NBCG;*Y3W%B[;8GTN[2"[LVXZZ]8=W+\F]BC/E7_`(ONJUAF
M$37-8Q@8[4;&Z]+I0@Q&"QLU39@Z'^C!@[>Q!]P^@U+FQ(LCAF*C4ZDD:_CT
MPR=\DF^8N>.H4W\5\*:GFRY&2;<AS2=.WV"DD9:J]]JJS)))&8RPC18XXH^[
MMIM0`[0^NW\=.I+(W`M=(`6%PTJ(]Q<TA27)J>I-8RV%KRR2%1)'*DNU=VQ&
M[_NWVJ"H&H.HU[=+\K)WR!OD(_N_85X6E\3&G\X2_P"ZD1IU"-(`WN%F+F)U
M540_48U7;HQ9AK_];J1ZLA!(:&N!"]D_?33HB9`#=O1>IILV6#JZQ,IW[I"K
M(?JT/U;6!U0:>GX=);^J`2?W4_Z;F&[;)]_2D*=UB[+VBD]=/WCAH]64NI)_
M=ZDCM^74^!C=CHR[R'J;U&>'/<#(2HKNQX#.OA?QD=0VO#\,=0-`=:R^@_#K
MZ(]M@#@>)`*CT&_A7%><_P#U?D4T]9WXU+O5W5525G/]C93_`%"U_F7Z.HHK
MY<G117__UO9[\`O^![XB?\MWA7_=SQSHH[5;OHHJJGR4PHY'D/&^#CMG'W+^
M5RJT[Q;VTKNE.)FWR$;4]T?0NK#ZB-->L1[Q8UYXQI8IWNNJ)85U7_;?-=QV
M)[GRR-T386*U%W*XI;PUJJL?C:]RKR*N'O\`+X^0_P!&<17O<CGO25ZD@G^]
MBK1<<0HU>`R+$6<R#ZM-2=2W6?,4L[FEDF_)C8I6Q'3;V*=ZWL/N"'B_;TTT
M?&F+'RI"UB*X:$^KW'9!6GRCS3`IY-6IBXHK..Q%.K5Y%0<O8I1S8]))L?[<
MD`:)Y&%@(^P`;8QKKU3\GR49RH'.!)*@L<>WCX_NISVOPF:>"FFE"22O+HWC
M4@V<$/9%"][4E<"DQF::)9KK8VA<YJ/XK!"#7CEQ%R*R1&))/WL<=AI"H9.Z
M`]9U[]V='?;&MPJ@#^-6?.8^1AH8\8R2"!&NU(<U`=.@U^-3IXBS6+AQ5K`T
MHI*UFM:R35!&46*S62PY6:L6U5A"K`-_C'U/6-SI<<YDSD+G!R>4BUK5E>7Q
MYWF*9\K'-VA0;EKCT-2->B26L0QW0E"DLGU+O$GTROJC"3W%/8'\/PZCF#U&
M-1&N`)*C2J^&=S)'M)))`1#>FP9)Z]5(AMCKB42J[>H@_:=I'D`8;9#J23WZ
MKIC*2R,.5[AV_F5*N<2)HW.>U`T(BZ?QHFS4KI9):GWL:*TNT+&R&10-OV^O
M8,V_N=?\'4J))2,<?IS]2?C^\_*B2:3#;ZT<HV6T_?6BO@,#A<A<R^,QI@.5
MCCL9\4ED]^W%'%-%[^T-(TEF)4U"H%+Z$>NG5IB!ARHV\B3^4D.4E$5%[A0H
MJ/D<CDYF$V`3;A&Y&@H!J"G1->M-BEY%\<-!):7DN)BJ5Y8X\BE^9XYZZ59/
MM\C%-]PT<AEKN@4CL\9!74$=6N-&UFYT\1E+U_E)/P['N#VI$W#<X9/0QH)`
MY`B(AW!01\5^U*ICYO\`)]3RW8J<6QD<<7`:L;V,G;&1AFLY.S/#+02"6`2?
M=0U5CN.?89PS[P3]/8Z'$QLB*">9C6MD+"`A47/[JZ;[8]O,XR*66=R\FI0;
M41+DKWTNB6[U/W@3G4'-_$$+X(Q0V.+7,AP.2N645O?X_7BK5=A5`8JTM.1)
M&.G_`,D`_P`7K,<@QF//,Z9Q]8G4=";D#_+JM9GW-QN3@\L&3-_1D;ZH%_YC
M<GQ6P';XU)E:W8J1&*V\:V"(81)[4>]99"/\D'3>\8T.U5+$@C3JLQ72>J8@
M20'6LNU3:YNG@M5>1#NVR0BQ"FYN@NH'XUC9@BL6C7>)=ZR3R)MA5)C&5D7<
MNX,@7:"6[ZC30:>O4N>.%SVQEGZP<40:A"/@M189YW#>U_Z*`7-@5&M5G\F>
M0*N(R];BW$I+61SV9MUHK^3C#)1P*6)'II9>4#[:U;B7W`%CWE`/J_#I['XN
M<03S3L<,6SP#U0?MI6XXKBV3PMY'*:QIC#D[NZI\%[I3EX'PSC6)MSQ#&0Y&
MQ2D19[.2C^[FM33%'ELQS6]Z;9_<)UT)&OKTR[,RF31,,GZ(``;T3I<U2YG)
MY62)V"3TV%;-LG;3H*=',?&?!N6X_)2W,7[,S/[4-J#92OQ1M"Z.9$@(BE1$
M_%U93H!U-.1-CB62"1Y:'!0XJ?&WW+43C>:Y7CY\:(2+"1=O0W[^.M0=@:^;
M\;YC!8.VV/N\3@SU2Y@+QPM7W9K;RK`M3*9*R)%QXIQ1J09-(V]>QZUO$\IC
MY7T\9<&O!5"$4_']QJ^Y"6+/@R,EN\9KHRUP!-FZJ`-5\+U&?E&[%A^<W,2*
M4?))ZN17(6H:<;7+"L]II)IZD.+L12Y1@;ACC]L2`N01HNNEGE,D:=LGF?NT
M%PNO2K'A'LEXXS&0Q-])`764(ERX6TZH:A/E.;J9;.5J;8/+)/2H2O)7YCCY
MJN2RAR=T8F&>IBLC!7K4`]RVQACB]T*"Q73;U%(D8?R.#@?YOL!O]PJ]XP8S
MX#ME:X*I+#8)<@D%387-,;E=2?`4J-.+&SXC+6+L5!G6S#%NGAJ0M)+8KSF6
M=;3K=8$G8J1(`H!.HJY]Y<YLX+F%UR?W5M^(]'.WF!X=`&JFOR463MXTZ\!X
M,O<LJ?Q3C^4M5N-BY-]EE<Q/D+IS,#6$EN95:S&`+]UM8)HKZQ,26/8]19'L
MA<QSF*'JA3^7JO5+52YWO#!X=TL&6T/S41P:EBB-Z'YTAY;C7*N)9R:ME[\5
M:U5FL92E"\4*Q9ZY4LUCB^5TXH(UBK_;O2BCFJ@-LU0R#;WZ<A=CY`D$7YD+
M;CH;=:D19^+SN&)L>)8RW:\`W:#_`"'J=20>O2K>X/E='D]+'RKD$GR1Q=26
MY00PK+!9=/:F]J)(XFGC@LQ$-O&I8$#MIU4R,]"=@>?,UJ`C0WL0G;0CJ:XC
MR?$9/&Y&:US'#%,IV$@Z6-SX]*.&6W1:4P6(HZ4XFKR0,R@AWC^M5=@#LG5A
ML![$Z#UZ0V&628&-X9&X.L=52X^?2JQSXGQ%KV.=*S:;=EU^76E?%8?%<@Q$
M]JM+:Q&2Q]FLT>2D*VA:AGBG%F$TY&CA`KK%O1N^C`]:WA>.PLG&VR$LR&)Y
MM3X^%JS7*\CFXV28XF!T+VFW1+(?G2%R3#/B[6N/RE.[AIHF%*W'M]R$K'$U
MNM<68>U!:9]=!V.GIIT<AQ$.&_U<-XDQW*5Z-M=?$TG!Y5V5%LR8WLR!8CNA
M0(ET2IK^'LM2OYTXY56>0RS4>6B$Q2DU+*PX:TS?N2=8GC4[OY=>M#[/CB;R
ML)C)*!]UM^4V3P[]:I?<K97\=DRN`#06=+ZUV-ZZS7-ZBWRO/+!AL9[?&9.4
M))EXXYJJ91<8E0&K9]N],3)']U%#-M!BU[[M?PZRON[D./XWCHLCD<82Q>J`
M`;HX@H4K1>W()9\K(;#F^A((B5VKNN%;X?'PJ/<1C(<5!!3IH:JPZAX80P5W
ML%I;6T.TC:B5SWUU_+KYNS'OES7R02$!SBH`0@'P^ZM[+,Z9A?.CB0+DZ(@&
MB5^3[_<V`;HP742D.C1)JPVD]OJ+E==?PZJ'1[3+'("8]OD=H1>Z_@?&I$8!
M:Q[7`.4;A8[K=/QK3$K:QAE^W+&1T8DNLBIM#MM';<Q]->YZ3%%*/3>^3:PJ
MI7K\*<D>P%S0=Q06T3YT4RN/CRV.R6/LHLM"W1N0W$>,%)(;$9A:NZ,5U]W=
ML8`ZD,>_4O!?Z.4Q\S`((WM<YZ7`!!0?YB;?.E1SOQWPS0%,IKALO_,+K\!K
M\JAC#^%Y<=A[_CZSS[F.1\63_P`)CQ_!Y+IA@1Z<44]^-LTS2\E7&9#+[Y/M
MEM!(D1$0A/I.X]Q>\,M_J\9Q&8YO%N#$LKB2U7!3<#<MOW5=MYQLF1B\])PF
M(SW-'ZF^<!5!*,/I?\K>UB#=M4DDF]Z>N3PMG%WJO(:N0S^3&(QL^*CQ<UA;
M\;4[5BL\C+',L<OO5TI`H-^YRW?4]9:?EL_EHFXW)Y3GX\;E!0#8O2P&I&E0
ML5T#8)L2+'ACDF>'EP5OF:"EU(3S7IR1W+&0=9(:Z/$[02>XFFR6&9=[2_XI
MCVH3V/?=U3.?+(YN^,/>%5`@UI`BC@:X.E(L0A\/Q7\*%JRD$PBC59$B41K[
MJ:C<OKHSDD%=2-?RZBY<SHIPR-P+$`/;X4K&Q_6B]24$/W+\OE2!+9M:367K
MJ1&^JQ5Y$FWI'H-P`("@?EU#.-(^=K@T;575!;^%6S6PM8UGJ&_4CO2.V4N2
MM<GFH30QPOL1"LAGD&A&V(!6C[Z`@Z^G5J[%QY';GYC&%.JH?`>-):=KHX`"
MYJZV3XGK\::<'-</D+K4XFF@L1UV>1;T4E=UGCE:(PJQ!#$CO_+TV_!(+9&D
MN8ETO\"*F2XN1&71$-+K$)V/PH[):KR;9(9-[RLHTW#<-=0Q)/T@A=3IU`AB
M<7*X>87OUI4K7!A8&W2],JBER+D.>>*.P,9:6G)#+,-8UG2/;*(@![@#!#N)
MTT.FG4YP9)C1!I`F`*VZ*$4]S2I+01%[@2M@-?G^ZEN:<2;"40J7V[8WT;<4
M.PM&=&"L`3KZ$CIJ6,^F9VL:&*ECU^!J*PD/,6\ER+<4D22P>_:@6=0[Q5YC
M&(F&Q3)(K,7&H/TH3V[C33J;!L]%N^3;NN?EK2',=N#MGE:HUI+M5S8*R2H4
M6"0S-N95!&UX_<5=4T'MR=_7MTH-+MKFN<1KTU[_``_=1NV-+2%*?L*24CD2
M21H$6/81*LJA68,[`!CZG1(03IV]>O(GN8/4B4.0W^)3[!2GD/`;(=44?;64
MLOLJRM&A`9E=2N]7!4&35/\`&0LYU.NHTZ6R3T9`YS0?#]]-N8V9H(*`BWA3
M1EK^U&Z(JQ,T]AYQ&3($F9U:1G+#<%<`,JG0$'\=.I4D3@UKR06_AX>'A2))
M0'D::?.D28S"7W(FC4;?K$J``JI(&TDEM2Q/Y#J*&``EJJM2&D;2'@HG2D>U
M?2:5$!0,`93^R?<B!43=P21HS?2-3_T=.Q-<P!I98JG2])=$71;U.VD1D2)B
M`=LCQDR/[0T:+4$!WT+;NX!/4EDD@<`UUB$/P_OIA\8)<3WI)1'DF>,S-89Y
M&1(D0(L$9U("NI+NS]M2=1V].GTTC:WK]U#I"UI<;!/M(_A1&QL#^V7LP[(_
M:<$H8BP.COM5"91I^)((Z?`8FTM/J[;_`+?"F6O>7AX0L4D4CW46-U1V5?I5
MV,9(C,BJ=H;L0K$?EV)[=*:Q[7M:U-H-R?X4MTS',+F@HO[)3:M@^ZCB35G5
M0ZHH4+N((=@=1N'?73UZ?:NX%_:])N\$=!UKN]\?/_\`"/B[N3_^QF%[D$$_
MZ,NI(/IU]'>W$_H7%)IZ#?PKAW.?_K')?^\[\:F+JZJJI*SG^QLI_J%K_,OT
M=117RY.BBO_7]GOP"_X'OB)_RW>%?]W/'.BCM5N^BBJ>?+'*_P`#CX%EHZ0R
MEJE?R\M/%LTB+>M?:0BO!NB5I-[3%0H'8D]^L/[RG?`[C',BWN)>`/$@5U__
M`&JPH^1;[AQ)IO3@=''N=_A:'%3]BU5#B_$.0<PY7)Y:\I\">G@4C^OC]:5E
MKT+^QEAO9FA2DBLRS2RH"FJ2@D@D?CUG,/'SIYYN1R<9VY@TT%]/V2MQ[BY3
MA^.X%GM/@.0#Y7R`EYN7#LPG1.MQ4?<ES.'R/-+L/"\&F&QV17$_PVJL#4+-
MB=K<_P!_>N5]OTNZN$`9=0%U(!/6*]R2^G/]1$5:!KH>]_&]=#]I\9D0>V@_
ME)BB.)Z@``!H'@=;5;#DOC3&9C%8Y*`;#Y+'K7D@>D@17,2HWV]F,D13J\B]
MR03WUZP#.0DCEB<)'(7*0?'7XU@^/YR7$RL@S`2XSU!![%;CJ#5<'S=H92O:
M`.`;%Y9TR]V201?PFZD;U;'VU>.3W&HVXR#Z%=QZO!AX&5E?7@%#9W^%=%2M
M$.%Q_3RBHF]6-8P+[Q8W/1P-2/Q^G9YG0:GR3R=E<;E<C<N3<:2E4:ICKE/'
M[6CBMVXV5S(\_P"T3H2A';K8\?P/%R02NR7!LA'EUN>WX5CN2F=QF4Q^#PX?
M#'M]12I:3U`T1/OIH\[J\^P..QBP\GN9?-5,A&:^%HFC<A$-></8R.2T7ZJ%
M>$AO;DU##0'4GIL<5C8P8^/$_58[550_XD/0=JO^%?Q/(39'KXP9A2,13N";
MA^4'_$3U&E-N+R-RCAXV\@Y9CZJ9')>_6H93'1>\^/OR,5LT6HK[47M2G6.%
M@"5;3L1U6Y/M_$]:7+RIQN<57X]OX59S\)AY<6SCL!YB8W;N:;![>CEU4=?"
MGSBO(/F+FF&27C&"K<4UG,,6?SB&=+%8,/9N5Z$RB5HYRI]OZ==6[]NH;&<9
MC.;]1.Y\@`4`*"U5:%K+3\;QN%*^*242-Z-;8;@/,KO`:^%11E_CEY-M>Q>M
M\BP><LW<G;MQ8R>M2K05[>3NI-:5'F1I&EN;5DDD;:="P[;CU98_(M?$UB>G
M`YY#;Z$GIU_AI5YA>[>/Q2X-A>)&1`;PI)#&HT^`:;>-,[*7L+QRER3@'D[@
MW\$/'<9D>2<,YCQ.JE.UD<_"C-D+'(&5OKKXV*1FKP.9$)T4`E0>M1@Y^$["
M=AO&XQ*C@-K@[JH\!I3>+B<H[/P.:XCD_4,SV-EB>5:&DH-OB2BG4:U%?C'R
M#Y#\-7+_`"'$8:AFN&9W(MR/E^*BF2KD!:S3&.KF%CG[[HJT$C@(-)5<C\%T
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MR&3H9_V\?C*ZM-#@KD55)L@]5))Y(BTDUSNR@E67N>W51SV6\R-Q(D#`;A;Z
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MJPL/;@LV;L;*6`WA$`!T]>W>SL6)V%'G2G=(YH`)^`Z=%K)?[G\QFP2XO$12
M$1",.<G\SBI4GK;Y4[OF+X]AY3PO&>3</6KVN3>&\[4Y=4<11R/-A,>)3G,7
M,LH]N:-(918BU#%'B^G34]6/N/!]?%^KB8LD)W#Q`U!\*IO]N/<$L'*.XC(E
M/TV6TL0E/.Y`TKJ.Q^-<3O(,60Y-R1[YQ\V1CY)GIY9+\4,D&/@ESLTMI%61
M)-_^CT#%]('=6T`'7+Y<AN1)-+*$9U\$UK[7]MAG"<62V8"1L=AU*`=.MUO7
M2/#!HL5B,*LFR_2H8];!2L08CCH:T9I0I&6K&.0Q[M/V%4#7L.J;!='*[;%(
MK@Y04-F[@@`.O?PKYKYR5TG(9><YI])SW==54J3^_P`::G*^(\7Y_2I)R*F+
M@I"Q=K6VD>"_3FNQLK1T+->5)X&2&/8>X]S4.?0=29F1;M^,_:]Q*W4DCH%I
M7%<_R?#/D="XAJ!0-$!4$CK\*J#Y!\=\J\9R6.0<3R&2R_'</2.9KVK,L=N]
MA;1N1S9#%>Z["]:H7*9#H6+)%(A&FK=.8\X<Z3%G;N%C\ST7O74>&]S<5[EQ
MF8W(1MCRWG8O1X2SNP*_"Q\*UY7Y!<M&"MX.YQN>E?>K!6M9BQ&2\LP@262Y
M%`:<BZ-,N@"@@ZGJ;%CMQY)=DC=S@A5#K\>M0![1XN3+;)%E-&("2FMAT4%=
M*D[@OD[B?*\34IRY.2KR.):T<N.O[Z,W9!]Y)%'/%")8C*--0!H.HTF&^)KP
MX.=U"'IU%JP/-<'E8N5))CQ-?BE?,+@!?+UU3I3_`,O?_AV/F5[BUL259Y$E
M>-::0,/60E=&8G74GOTN+)E9&['B>YL)4D:]`$K-1X`R98R80[(.A%BOR\*?
M7P@YN_)/E5Q_$X##,W'L7QWE#Y#D4YW"S/)@;@@2FKZ/$DTP#>FI7UZUWM&"
M.+FL0W$AC=95_E-SV6D>\^+=A^U9\C(G'KOD8C.H&X6-=Y.NO5PZF;S=BN)C
MVH7)MQ`:`DJ='[Z`C7MUSG_<X'_X_&6L5XG:1]AK1^V`#R#E<@],_NJ,F'[Z
MO/\`<[)(]LD9*$$MINVON'UZ,-!KZ]<)FB=#DP9'U&V5`YI15.H![H>];9K@
M8IXQ`K2H-_E;M2!F<Y1%E8[]E:4LTB2JK,8X;4K-LD.]?I_'4K_+T`Y/*?52
ML:7.!!D`%G%5)\!86%3L/!D8QCHF%[`H!ZM"6"=?`^%9P6))-LD820D:ZZE8
MQJS*SB/5B/I';^7JO>29)7Q$->[5NH;XTKTMK0R8FW5+GPK1;B(IR!'>7:4C
M6.25HPT3G6:6,C727;JHU]3TTSR8Y#WN+`00#X:N_=3K7$SL\@:7`DD="-!\
M%2L9I`I&U5CDA!WS&77=[B1LJE>X7;JJZC\5_EZ]=)NBVV$BZ]P;_)+"U.,:
M2=28W=$T(*??<WHOOF^LB0^P\>IT?0?L%Y&U_:+:MH`?R[=>)(2D;D81KX]5
M[^%++675GF']P2M$=B2)Y*:,KQ648IJ4B`17[!8]`0L49[:::CIUL^1*'1M(
MV%C050(FAKP0QM#92P@M)/4W.H^VDMZ\A)[@5@X]ERP]QXR=AD9#JR:M^?KU
M7NQ=A^H<I@+D7O5G'DM(]-/^H2X[5C/"L0V*R%#J2--K=MNWMIZ:C777OTC(
M:P1V.UW3Q!\:(9'%ZN!_@:3;$FDGU.DK+&K'3MJQ0:KZ:?3J`3U&FB4L+W`J
M!<5-A/E=M86WZ]J;&5PM+*E?O:5>629?:+[52=(U.NJV$"RJ5/<=_P`.I<,\
MV&8Q&O@J7IZ.=[-YBE3J>M)%'C>(PSRUJ,L@2PR_5---,TTB+V+-(S&,GT'X
M=.R2RYN0722^8V!0`?NI4^3(^(/>P;QJ!K6R8.)4"JY4:G5&&@('[+J!^T0#
MWZ9+'Q-V[D(/QJ,',>IL;42L0[5$K;0-!LT&K'O]0`U[]OS[]>,8B^>RTH2%
M7-`.ZDJRCUY<I*9H8TJO"%8$L$WU4]P`:%9`Y)]`0/Q[]6T^.Z$S;7HT-"E1
MJX*@_"HT<[)&P;FE7$V^!I-EECC#.W[X#887([*[,-6*]QH$/^'J`#'&'$DJ
M-+:'O4AS))`/3LIO\*1#8F,FC$JS:[9%`"R['`V_2/I]Q-"->V@TZ<:;;F9(
MWZ:7/7[/&O7(PH8CM\>E:6L(8I/NE#"0@*2^QE"LV\@@Z.L@<`C\?3UZG8A8
M]8IF!2BG336HDS7M<US"0G3H5Z4W;H4+(U>1_P!_*MAU8,4=XR\-<NI.CR>T
MI.GH!KT^][86L\ZL_,G:Y`6AK1(\-D;=H3]Y2FQ93:\:-H)&,FW3:$8)MU.X
MG37^3\#TT6/>QMO,NO>E!6;@'';2.U&O':EME2))HUKLH?Z(U0;TV]M&U74`
M`=ATZTM,;W.),@T\/[Z?]9YC$)<-FOSK2[(/;_>]Q[DJCUVE596/U:$J$U[?
MCTY&YY>PN/FN=+?LE17EJ%J*;"FQ8T6<>V?;]QQH==A]W74R'3N`%`[>@Z>C
M8T27<-I=XCYUZ\;V[44@?&U$;`!$NW]ZRA0S.`-6<[FU!/[/Y?R]30@!:TJ[
MH?VZ5$<I#1MNNE)\$$0K2R(#+;W@R0,RQPBK&I:23>S#<Z>F@!ZDXT370$!R
MS@W!L"T"]Z9GE<V5K#_R2+'KNZ!!36NM%'-+)#$L1<^X`[-)M3T5?R[/Z'^7
MIHN:U[AL_-I_&GF%YC:'/4!:[O?'Y@WA+Q>P.H/#<*0=`-?]%7\!V'7T5[<.
M[@N)*_\`V&_A7%.;"<OR(1/UG?C4P]755=)6<_V-E/\`4+7^9?HZBBOER=%%
M?__0]GOP"_X'OB)_RW>%?]W/'.BCM5N^BBJW^>^18CBU[@N9RW#\MRT4;F5L
M5DQ=&2[_``R:.O7UNS!%=8]J,=NX$:C7\.LYS^0W&=A2NQO4`<=-1;6ME[3Q
MY<MO(XD7)C&=(&BY0.N;$_&JR\U^1>(SIHY#B]+.8+).;-7,QNB3XJUB-K""
M*82JJFVT\:;&50T>I![=8WD/<^/D8R8;'-D+D<!_A/[+75>`_P!L^1BR6GDI
M(Y,-`YKE0[AV\$U76H#\0_<W/*"<QYE;KT+G(),E5Q&.DK/[,]>AM6*2%VUK
MEI&?0E.X*=^_7*_<,3H0V60$1N<?D!H?%:Z[SV5'_P#$W\+Q#72MQRTO>"A!
M=J#U0=.ZU?4Y%??6">,*LCJR>C:Z@`Z:?4`VFHZQKI4):[15'SKBWT9,)>UQ
MW(0:A3S/Q#CDV"MY2[CZR_Z5CSDGA&V]:BCLH\7VKQLI>5GT#(1HZG0GK:\-
MD1"&)CX-T+G(Y-04)4=_&K;@.4Y&/,$$4Y3:[8N@4(57[NU5'I\]Q57)<?\`
M;L9/$8CBN3MB1%HQY+.W+ERQ)9=H:NW9"LD6V,`!Q$JZGJ\@S`<MABD`BB(U
M_#]M*Z+E\&_&XK-&3&V3-S(PERUC0`!KU.IZ+4A?>X^_S7)\AX?X[Y'G,A:Q
M=G'I+<R4.-097(K')8N9.64[(UKRG0)$FT*3IZ=2<KF>+CRG.D<LS@3;0?%-
M:R4$&=C<-CXN5GQLBCE#M%)8TH`/EW*TY?'WA)>/NG,.<6!ROD$T?O312JCT
ML2B2I'7J5$:1U=H8YSJ^T#4Z@=8;-Y:3-#6@$8S7*;ZA>_STZ58<Q[D$X.%Q
ML0AQT0)JXH5<?B1I5AFAVPZD1D?N3$AT1PE22-(V3:-FD33@D>I&O45I;)*<
MEP2$(H_X;#[+?&L,Z5X;Z`7UB3<?YQ<_<116CE*-YYFF]^IF:60BIO'*-T%:
M'&22&Q92&-5%C[F)DF)UU^H#\.ID4N$8\=\F]LC)@;_E#00XD#QZTDXN5"Z0
M,#7P/A/@XDV`4Z4V>7<9XYSNIE\)G:BPT<G%/`0I]VQ1DO12P0?;VB@+%2\C
M`#:>W?MU:X.3%#DY3PPLCD<$"K^8VN>B:C6I.'EY?'C$FQI@^2(W6P.T74?9
M?1:I)XB\1ULAYH\E\?YM<GY%Q_@57CF(PZWD,"6<9!6:3$5YX*\J_=4<8))5
M'=G:1V#'0#J7G9#9A$A(@<#?J$`L.]ZZ7S'N+Z;VUQV1QC0W-G>YSR#HXZ@=
MB=5TL*FCSSX6X7D?&N:S&!IC`2\:HVLM#'B(Q62ZL8FE:"W6:5(IE>50XW#L
MPUUZCQ"1[8FL)](H+ZWZ^%4'M7W/G1<W'C9[A.Z8@'<514N"!J!5%.'9*M=D
MQN&OXZ/*\DY19B_A?.,KD+=9,%1GKLD=N+'@M3QT<EN-48M]9$@"Z=:'`QW-
M3&<K@?RO)N!V3]YZ5T'F8H8I7Y^//LQL=OFB:T'>3J%U)2_QJ[?!.58^@*G!
M!G*-[*UZZP#(T\<V,2M?KR/`E-6L)_VGK$FY9^QE[^O6>YSAABRX\V/(3+N*
MG5"2O7I6$RX)<UN5R;L<MQ3^5CBI+=2;?EN43I4CQ/9226&^LDLXBFB#@+'+
M-I+I)-$J`I'M(]#J.J$33@OCFB+F$D+8$$G4#XU330PN:Q^/(&D$%+D?`]Q1
M)[DUF>Y4R48CK10^Y2LQ%7D>=M8C6G'?1RIU8C4=NW28W['.9,J[5'6^B']]
M,21,$<<D!'J[D(TMJHIDU<>U6U;A7(22PRAYHXXT8*-VI5F9]?;]HCU_'3I3
M`K'@RE>P'7NO[JEN(G$(,0#R$))^[QJ8OB37J9[QO))7GJ$X[R5Y`_BTU9#(
MF0R%7-VX2SR%E*/M*GL"&`UZ[Y[189.'PV[P`S6VMA:N2?[CMGQN:VSL<KH&
M;5Z!+7\:L?F:KY7C_+,)/6,L5O'9+%R1-M(N16Z,L3;5;;H-)MO<]R/7K6/C
M;)')%_*0E8+!RGX/(X.8PIM<"O9"#^ZO.YY/X]SOQ'Y0Y'Q:/,8Z(<?MX2[7
MJ0[[%:5<C3&5QT<BV#((I$HQB!RNNFSMZ]<8YGCGX^9DP,(NI0>-_P"ROOSV
MES7'>Y/;&%D20.5S2S=H1T/WWJ\W%^21YK"5^08B1TKYG&R31KJK-%%?C^RE
M7WCJ@5'<IV[$]_3K&XOJXLI8T#U@2/@-"5KD'N'`.+/+B3Z,>BI^;J"GCJE'
MC%%'[D4ZC<8(562,[D$C2FKME;</I"GN1_\`#IZ]6<>*'[G.!L%^!5/L^^LQ
M+,YH8(W*3KT*"X`HED*52:GDJ-GV[="QB[D[Q&-Q&X]R&E%#M9MLA2>1G+$C
M]GMU<8>+"R&:1[A=KG=1_E;\0JU6.R9QD8[HP6EKFCQ))4Z:6I$R*1Q7I!MC
ML"`V$^YEAAFKII_HZQG5"%?0-MT[:]^F9@&.W*WRO0J->E_CTI^+.RA'M$KD
M+50%"IIB9S!8/.5IOXEA,>)XV$9O11!,@JHK@2Q6(PK+'.K=_P`-0.I+GRLA
M>8F^5JJ1<BUOB#3^+RN7CNC;]42PH@_EUN#XBJ+>2<CR'&9Z_P`"CSF2RN`Q
M]VC)<B,H69J]FF+5>FT\C:%]Q17"L6*=]/7J?`#DX['N:&S`7/7]C:NL\/CX
MS\/^J#'8,A[7;;6545!\ZZ7_`*>_(L!+YP\=8+$HB3)PWD+SBHRRPB6+CMC[
MDV+#$22LLP*AM#N(U].IGLV#('N&.5Y.S;)^!KC_`+_@R7<+R>5.Y?\`J&_)
M7C0=J[X]=FKA-1WY)N?98>G(3HKY&.-CKH>\$Y70_@=X'7.O]S'EG`PHU29Q
M_P"5U:OVA#ZW(S-[1$_>*CB&VTL,:'8S!8PVI(9E[L%W$'_'?74:=<(BRI)H
M!`^-KC;4W34`'I<UMY<8,F>\$AJG[?[AUJ+?)7%KW*#AQ1`@2L+L1=9`WLRS
M?:NL[,0&D010LF@[ZMKKVZNN&Y#'X^',=+`0Q`@'5P-KU=\+FQX4DOJ.#GE"
MALHN"`.AZK3SQ$$]&`U?=6Q**ZCW7'=F]O9M1`-0@*]CW[^O5(^5G(967-`U
ML<DB^74&WR_OJ#DH\QO>#Z0=\]?[:WO8,T$22P@JB2,P4D.$1PK-KIZ)(P;7
MJH$KGPQM=%Y/O0E/N-Z4V)K)GELGF)"+HNOX6I/C*NX=A[:N[/\`5N+1LBJ`
M'4#M&6[D^HT].G88PZ4->C7KIKM0(A\#KX4_,2(B67:!?HMU5>X[=:+M:CMA
M&KK[R6%$F^$[`0J$:HD@'?T.@['KV60/F)<U76"#PM]O?O3D4;XV,*H!W\;_
M`+=J2\JJY.K-%`J-<JB.6(-.]=8YZSK(I=H1[@A8)M/KJ#W'3W&9.-#ELFR<
M,3P(CFD[3<=/ATITMEA",FV%W7;NL?C9:2,1D<A:Q=:UD:/V-UT+6J5:Q]ZD
M4A=U"),T<?OH8D5AJ%TU_/I.3'BG(>&3[<??8(2@(T\4I^2(1./HK);\R;5\
M4Z5^P6[,SQ@XVU&'&]II6C"^AVJZ`EPR%?R(ZC.@B#9&N>I:?M&H3LE+5R&P
M#.G?Q-8;VF=HG/MC230Z:O(%!<A0!KW(T'\G42*%TL@C;^<@H*>E>(X_456!
M/X4E5R_O3L&?99.P[V[QLOJRJ?JC)';0^O7AQRQQ;(/U1U54IY\GD;M_+\-:
M_+3HM=X1I[@D9E8C:Z;@`>_?]K370]./8\P,A<WR--C\:C`I()@25U^5(4LT
MRR!=P4(Y#,1K[P*C0AM`%V'^?7IUT;FM:V;\_P"R7^%>@M)+@%!'[ZT&1F*Z
ME=REB="3KN_ZP((U/Y](B`%G!$'Q_9:]>?S`%5I.NI'-:VJ@E"#5FA/^5TT*
MR"-M""I^DZ]M>K2=OK20LB8"U+GNNFO;2HT+G1Q.+W)V7IW^W6D29MI=41=8
MWD.[>=KC1D"Z::$#=VZJW[HI#$&_E-R#JE3`26M<25(%NU-_?/,GTUG@+/-'
M")6C)!7L"^TG;&5^L#U`_EZD>FR0QAL@<[<;`=@#7KWE@+G-.T@+]M)LJ:NB
M.WN`NDA"`KV4F5HU<ZZ/)I_@)Z&,WRQN!\NI^73YUX7!K7.`\R?W?92/;G&J
M(ZO7$06/81J44-88!M-?</N-I_\`='J:X-D_3D-P0G9`IO\`-!3#`\>=+G\:
M1;-R)@BMM9M2\?;0Q$G=V]-X8)V]#TXA(:X$D#I7F[S$$(1:DR26%8Q,]@$K
M(FM:6)AW`_RONJ3L)[ZC^7IUC&.8Z0O\Z_E_MI+B[>UC8K)=RZ?*D2_+!&J$
M:SOH=S*"&^K0:$:]E61M.WJ!U)8R%H:`5/4_']DI&Z0AX-ATI`DE=D,LD2[#
MK$"Q"`!!KHJ_M`JO?7^7KUKG;22`0;"O0K7-#7$.UHC)8"@$,WMMV(W!2=!H
M%U*DL=FFGY]/1V;OCDW("J_NIA[7!S_4"=B*2;$BM`P92522)`!^T$;N23^7
MX'\^I#%+$.MOC^QI&WS`[;D4U+4P#RL=%]HLHW'55T(U5R->VB:C^7I;@-Y5
MJ(`%\:6UHV@K<UWH^.YU\&^*SH!KPK"'0'4`&JI'?\>OH7VX-O`\2%_^PW\*
MXISI7F.2/_Y7?C4S=7=55)6<_P!C93_4+7^9?HZBBOER=%%?_]'V>_`+_@>^
M(G_+=X5_W<\<Z*.U6[Z**J+\K/(,_`:G"9JV/R.3LY;)7<?1J8V^F.GGR,JU
M8J<(G:&8G=+-J1IMT!U[=9?W*YK&8DAE+7!Q1-2M;OV/Q3^4FSPU-D;`YQ(4
M`!23]U4!YOC.1V>4M#E<-'@)^3Q0Y;'8RM-!?C]K'M7;).?;,:++9>1=VJ@;
MVT`UZY;RT+,>1V8]I;$[1.X/6OIKVKR^&>&BQ6S&4XZM>2H-UV^*"IFXYXQL
M0R8?/<AD>]?PRS2X#CD*F&IC%LL9W6&3766621]Q#:@'KG_*<A)RC_IG$-B:
MZR549/.QP-RL3CVAD$P222Q+D[]@E3UQZY;R=*"YD\7_``N[[KHM66<2OV8A
M7)4:C5>_\G56['C:\M8[<!U.EJQ.:!`7,CFWQHJ@=*CSS1R[!U>)V<;-<*9G
M(W*46-$8V2(8+D-AI1(ZF*()'`=68A1KWZON#8[(G!VEH:.FG]]3.`XW*.<R
M41!V.Q2Y;ZC]K57/P)1K0>0N?9F\:.2K3+7GPD\T44_M/94_?B!PI29_:4>X
M8P%![#4Z]+YZ9F/DAD9#HS<G6Y[IVK=^Y<U^;PW%8R.CF83N:I%A^7^RK<1P
M5)XC9KPPQQR3&)A&GL;D9BLK*2-S1N`.Y&J]43'OQW.E8U=RM[_FM;[$KG4K
MOJ/3CEE<K?,GP[_M>BEN]55_9>8(KZJFQ^TS!%T10!]3:;2?R7OTR&^E_P`X
M_HER$=O'QZ4J+]9[FQ,_4#01XCYZ=:+7K5I8U2O85O?EWF-E#;IY42$QP'34
M&&1&?7T)7OZ=3H0XB>-T2M<-P6ZE+(FBZTED<+9(9&$[@43L%N2/`?<:U02B
MTRJ9C;L+&4$SQBO'&UF*(747:55_;>`:.Q/TK^1/4AFY\,\<(+@0`"6V%O,G
MB#U\*0]K6R1R9)V-#BH!U&Y6K\N@HVDM8LDT5EI;5H4YG^APR2K)%$[B)P!O
MC74*--=6!]!U*CCQHP(XI7/R'@=R0XH%O\*C3OG+I'F%K,9KB.EP"J*.X-ZB
MQ88>.^=,Y:G#1CG7",9)2ELI''&^0XKDLJV854_R<=BS%EJS.IT+!=1^/5D6
M2LD9#/)N()-QW&J>)")5J'MS?;D3<2.\,Y5#_C1#?4:W^51-R_D]/S!R_,^%
M(^40\(X_+CI6S_(IY(4EY%9FE-6'C>.ED415J\TDFV216!VQMIZ]:+A>*^MF
M=]2\1Q$6/4WM\!5I%!/[9X_$Y\8/KY9=Y6]&#_$>YZ@>-0YF^$IXRYY3Q?(K
M6)S)X[CXAR2%(9YX;G&JTD,GVL<ATK1.DD33!P#.)`J@D:#K09."W'F1A78`
M3V(&G\:N</.?[@XN9^,U[))EV]Q(=2>I'\O:I*\KUL'>Q?'^=^,J:7^$9K"P
M?PK*5T:+*X7+T999BEAGVS9%8&D81^X-R.2#J"!TQGPQSACHF%^.]OV..J_"
MJ_VMFY6#/G<-S$@&>UY5KKA[2$0)9ORUI?X9S/\`I'CJ_P![D*\N8.-KWI/8
MED,TE<:594M1&-/MK:2QGW@-5[_D>N<<MQIPGS2"0OW!4Z_=H:;S\>7%R2QL
M.W$+R`?O7Q%[4>S53+8ZK)E<7D;]A86;)7\8B03NE%%8LM:Q,CJNPD$C37;V
MZ1Q@@GEABR<4[@5<0MAW/[ZCQRP2R^B]C;C:TE0-_BFJ]Z960\H7EXK>KXK%
MRW<NRRNCK5$=0637]M9K=HQD1U$9@Q![*`>W5O\`2PF>;&C<T8[G*.Y/\/NJ
M5#PY?GQ22R%L3.YZ:V[GQJ8/T]N087(\`Y[BL?7DH7</Y'SLF2H6;$-BQ]]=
M2M)=NJ\`6):]ZZLCQJH[(0.NM^U?09B20Q:-(Z^&OVUS+_=_&R6<CAY,[E8^
M!I:X:(%0'Q`UJ^$Y(L1O#$'CGW"S(6"LJKH%&UOJ;74^GIIUK`T@@AEE^RN,
M`J"UYTKA]\U*>.QGRES$$L42ORO@?$[6-M.X"4KU*>U7ED:,L(V]Z.'8Q?LH
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MH6.I;I]\LOTS&Q2`^50=20TV;4/'8SZASY(26MLFB%VKC\/N6H^MV,V)M1,J
M5)X*<2I&GM">ZD`DL6)MBG:EBP[[E&G8#3IO)G$CMSF[FN:"4ZN_M*V%2,>#
M'AB*G]0.-W71N@^RD;EW*;W'\75^S0YCD.7L1XS%8<`*EG*M&R5T)DT45J@7
MW)#^RD8U/5CA^MFOB;C$M<2`YO\`$GMVZ5YA\;#-D.$__P#3@D[NO>P'?\:K
M5PSA4?.O(%ODN6>/)<0X_;?[.X/=@CY7S`UHZ^4R[P!U=J%9V->%.R*D`8?M
MGJ;R;FXY$#)+-%R.M;3D.;CXOAXL#&!&8_[6,4H/CU)\:ZB?"O`86IY^XG9J
M8>E3L5<+RM()ZL`@:.-L'9A=#[:A?:T;0!NP)[=^KWV5+,_DXP4]/:XZ7/E-
M<;]W9<TO$S,EG<Y7,U/^85VSZZY7)Z@OS_EUP_$<?881D29ZG#K(^P#?#8_9
M['5CIIIU@/\`<9!P<3CH)A]X(K7>S`7<J]H.L1_$5'F"R[6J\`!#;M@D(926
M#[UW%="RC</_`)?7SS'NBF)<"(Q_:`OSKH^5!&5<'*[\$O\`.EXM95X_;D22
M-Y%,D>U0I":A05]5W_R'OITX9IVO@9ZN_'.HTTTJ((X'"1QCVR`6/QUH2;$V
MR0,WNEA%O/\`\C*ZZ*`>S!@3WZC2/#'F3'8CQ:_3X=Z5&'D>G-=@"IW^-$)%
MG&AB(4RB7=(0=NU4+K%^*JTC?B?P'2&M)A)W%7!`=+ZGY5(&S<KM&I;[E^5)
MYD]D*@VHPBE;?KO5W1D$FA_^,2Z]QVZC!T@+W,=^HA7Q(.OV5+])K]0K%'@@
M(*6^5%Y;18*]9!HICED,:@!&1G5P`=`HW@-J/YNGU]5CG-'ZA`<JW7N/BFE>
M-9M<&N)VJ6IX(/GU2B&1F]AY)5"I(8[#ND2!B)2HU9AIJ23WT]->W2`PR9#'
M!R*X%$-EZ_`5(A`=$6)8V!)Z#I^ZD;%^ZE9GMVWG9%@VO7A^U5F0%Y-XD^K5
M@VF@]"O4[.APV9&3"T%SF&SA_,=32G23.;`61@`J"#=!H/V\:/)8W2/(@#&R
M1HY).Q!^WM]=CDKWZKV$LWAC`KF];_9^^ER-&V/<H:SM^VE%)K$D5@L2'#(Q
MCEV`E-$V[5737=^'3;7R>J<B1ZIU3[A2BUNST6,L3HOXTVI-BR`%F59-TKF,
MD.[:#\/RZ(Y7$.*V^^I!`_*`A`'B*)VHDD=)#(T>NA*@E@X*@?4-=/IT'7IF
M5/-Y?X4V'EK7,10*2S?",$ED5EBWH!])T"$,Z@:=QIZGIX&1Z'L++2"QH:2`
MBFB5B:24QQQ6X*:33K#%D+H9:L!D"(%F5%+[=S`:^G?J1AX7U,K8W2AC2?S'
M0?&HV1D?31/>(BYX_E&OQ%-VIF;<TMN"VBB>A(]%+,!5H+=>O-+4BMU9E"F2
MM*8-P#?5IH3Z]67*8F?B>A]0X&!S?*YJ(6MMTT^=+A;%-&U[;/=<M)T)"_*O
MQI!WU9I#H>_[(_;#.`5'XHIT_+7JFVM\CG!6G[_#P^-/EY`*:_AXU'_D#(RT
M\+:O881PVJFKJUFP&@IE(V]R\P<JLR^V64J3VZL,/'Q),J-H<Z-CB`@*W=8'
MY]:G\4'2SLBRT=&XH4%R.UM"J7I"XQS.GR.FDR6X(,IBLE=Q68I$E):EVM:D
M@*[6`T%M$66-]"FTZJ2.G,G!?A9$\(C=L:;$A5\5I7(83\67:YNZ"1H+7#0@
MA4^6AZ]Z6[<M;9+*TX$,)D=&;<(U0E]P=SZLFW_#Z]1FP.=9CKEUE[7U/RJ`
MTN+F`,N1^UJ:V0A1U]^-]XD7Z=@U.@"L)=3V4.#I^8Z=CW1N!==MZ2Y"K$2]
M,S.?QNQ5]O#9;^$SQ20S^Y)1AN0SQJ`6CL13#Z8V+:$J01U*B<.L2QKII\*7
M"<>*4.R8R]B(BI\UILMEN24ON!E:,%V54K_:RX]E"V)&9BZ$.0E<I$NH9CM)
M[>O5CZ>&]CW_`%1;.&V:0H^T>%.#'@F](0OVQWW;N@'XWZ4(LC)?J^[8KRUK
M$FZ05W>.1XM-05)3Z"Q'KIU`#F+L>XERZI:FYX&PR+'('-0!1:DZ7(TWL?9?
M=5BYB1O;:81S!6'MH1&2"=3_`(.I3&R!K@UI([]*CF![H_6$9+5-TL4I,D>5
M#*ZL65>TA+#;IN`<D?X^FO4@/>X.)N4O47:T;=UE.E-3+7(:Q;VY`GN$R,K:
M/O"G]Z5)[+O+]ORZ]<UQV/#2A_'O3\3-P(=TT_<*]`'QND6;P+XEE0@K)P;!
M,".XT-1?Q_'KZ']NK_0N*W:^@W\*X?S[2SFN3:=1,[\:FWJZJHI*SG^QLI_J
M%K_,OT=117RY.BBO_]+V>_`+_@>^(G_+=X5_W<\<Z*.U6[Z**Y5?J=1<EL8[
MPY7XWFY,3.V<Y#+)#!![\]MH:5)H'C`.Z(U7.XN`=OKIUB?>4;Y8L)C&DW=I
MJ+"NW?[+9>+AYO,RY<.Z,QL&MD)*@]UTJI'@;-R8F]E5M6;^8ER*8]'S.;MV
MH\KCOL\C1>=)TO5RTL4WN.8J\!4;M&))&@YSDRIQ^;C3#>[;UU`!_:U=D]P\
M:S-=#F8$'HP,)):VX<K2`B'OJ2MK5TFBRMZWF/MQ1D:F#&B6]RNB*5+"0L`.
MW;30=]>N29#W>J90$;O0_P`:Y_)%%C8WG<CROS[TY[7LU(7GGVI7CB,C/.Y6
M-?;!=GD/[21@=_4:=2V,+@S8TEI/7K5:Q_K.(#[KTZ?VU7G%<3Q_D/E7]-^5
MX^63$T)6AXGBIRT,+!(Y*]C)Y"LC!Y8;&A,22#3;]1'?JRR)IL""*""S05<A
MO<6M6GR<Z7C\8<?AS?J.3>1KW0'N.J?"I$S&"AR)D_@]M,"5CJ5;<N/@KE8$
M29GHS^PT)]H0V%!*H`7!T[@]/\?OR\7)E.UK"T!Y/Y=?NTZ5FV\BW#RH1DQN
MR'!SG!I)5$N%ZKXZ4RK;\\Q"R"6;&9EVAC:BMH-AX[K>X(VE:1(I2);<:ZE1
MVC8>A[],Y.'@1XS3+))%(X';J6DE=.PJ]QY^.S,E8V(Q?-MN6A%`UNAMXT7Q
MM_&21V'SF!R7&KPGBLRT[?N7H([L,!K&>ADJ9FK2UYXY6/U^V=`!IU72/CBB
M?C8Z'%)#DZJ`BJ>Z_"O9L!_U#,C'R&R/VEH(M8E4<VR$`)2C=S%"]C3<-F-8
M"LBPN$9FF?Z8J^V(^S(%>8+KZ=M3KIU*P/4EED;Z),FTJ$70'[N]-'#GC*-`
MU%U34^:_<5GC]L,]:K-&TT<]:LEB8N$4_1%*LB1HSHT6C,Q]`0=.^O7C'Y$0
MGC;8N``[+J;=O&E9,4$D?^5I<>Z]+GNM'+S?=EFDG]J18H1.SNX@DJ58UL"6
M:5]CLXDC4E1H2=!^74N624B-^T,=L`0#5K0"I<;JH1!5=C0P,WQ[BYBDH>CG
M6`#0HZ]:JE\H>;TI\CX[QE&>&?)+0Y'>JU6O"&2M[]3&8NE;B9D]RS`T]9]5
M/=U!_+4ZGCWMS'F=Q0LC`O?H/M2MO[*X21D>?*0`'R-;I8W+C;H;]-#6OXXR
M>,K5WE[>5L-1:UG((\;C\A%2NWL-QJACX(J\5*7["*P*-VT5:S)9;T=R&8'M
MUN>%?ANBE&8+NL#=`W]RZK53_N)B\MB.X^/B<A^QAW.82-SG$G144=`.U/+R
M-F?%T&>XMQCAN%_IW@6Q^6P_,[DUS(B7*K;JV)*%*)9XHI[UN.S#&=_TQ@-^
MUJ.I\SL(;&P-]2!%<;]1:J7@L7FA#E3YV3])*TM,5A8@A245`AJ)_"O+LO4X
MORWB=BOBJG$<OY`DP&-JR3*9.$>Q#!>M02QV%$EJ.Q1M!(IE;:[UG&I*]4YE
MD;`?0:D!=?\`RIU^?[JO.8XS&_J&%F/F<_DXX=Y(L);E"#I8Z_$4JYVMQ[BO
M*\CD^*17(>.X7%3VJUJ4>S=O\BAEC=J5>JR2VIJ&:(=!J@BVZ-J!IU`RL&.6
M.8&-SQM\I[GQ["G(<W-Y#$;#FA@R))`"-4;W\"VW6IEP/*L/R#$5<EC)#I8I
MF<4W::N8K-A!MIV%BC9F=6U#:@H=O60#78+]C1L(!4*;D_:H^ZLQR.+D8^2^
M*:[@0%`&@.OA^-$%Q\5&E8AEB/LRUK1N-"T@5&L!VE`;10T)#;=!U'=$()/7
M55:53I7C^0FR7MV.NS:@/5*KW\=<QC?CM\F>9\.S-Z/%\>\N8BMG./9&]:(K
MU,E:O'[:NZ-[@BWSL8]SLNGT@^O70O:?)C'FCBG(\[0"=`#J#\/WU:^]N,G]
MU^SXLV"/=-BD@M&I`%_B176ZMDIXJGOV+"W(Y%C>.:ML9&B;;^^#AMGM:'<6
M!TT'74@Y!N<X%J=*^8?I)S(V$0G>J:5Y]/FMR6ISSSCRWD?'['\1RF!S&.XC
MC4#;Z=O$8:DTUYZVIC#Z7)&!8$Z@=M>W7,/<`&;F3R`V:0UOP'[&ONC_`&::
M_A?;V-Q^3$`V2,O<MB"4`^2=*B^GD[$F%NVX6][$<:QX^^0QK[\JI=CC=HIC
M$)]*E%S*JZ$G01D^O6;?ZL;HV,/D<Y+7K:YK<3UXMQ(EDN#=%*D6\7(/A>GC
MBK'DZ=N/TO'N*GS%C-216,;BL=D<7;RRB&18LS)G*8/_`&)5EF>*..2TL15D
M<=^YZEMXZ65GI^F7AW0:_P!E8GFG^W6NR9.4D:U\:@N0AI_P[?\`$1=4JPJ>
M*OE':J31YWD/C[ABMD(;&/J9>UB[]^>D(`15N?8NL<;R7)-FY3V4?CTYC^U]
MCDFD9&T]'.0I]M<QS?='LZ%RXC9'REJ%`4#EUOK8*E1`WG27AN9S7`O*&+L4
M>=8"[#2%7C]2YD8L[/<V1U6QDD,$B++9WC5?0`ZG0=1,GB,C'RRV`E&*$70F
MUN]3S[;BY+"@Y3CIMV%(U2MD[JOXTB\^?E.-NX2SDA#2\F<^9,#QSC[NQL<!
M\>Y?:<[F,@JJ:[<CRT*+$-2LD,08#N>KF.`\'ANR)D&6YOV`ZDCN:]Q(L8,G
M$0<>/@0N=_ZCV_E:W_*#UZU*^)Q5?C^/IX3&+%'4I11048U*@JJ.ADDE!)/N
M2SN26)'<Z=9)Y,N1O:[<'GK]U97,R'Y3Y)YP0ZY^7:K>?":>W_Y_8A+3M&\V
M(Y$2FQ=)T7#660?2Q,?MGN0?\;K8^SG2MYV&.0@>1Z`=@TUBO=(C_I;RP*=S
M;_$BNU?78:YE55/EU?7'^/,//(I:$\JHI-H/V4-.]HV[0[='`[]8KWW%+-P\
M;8VJ!,"?@`?WI6J]H2Q0\F]TI3],I\5%07XOY-CH:D2F43';!5D*N1)(\FP1
MMJ1K'M9!W_DZX'-&R*620WD5-452OXUU&;?D,;&T@!5!U1!?[15@X[<1KV)%
MT2.RVI]?=C9)&_8.UA)HPT[$?X>JUSX8HLD%@:'N'QL3I4$P/,D`7<Y@^1!`
MU[5I>U"T;2H=8E50NX:NS;M![G[.V1?33I,P!1T8#HM@/<W[^-.1Q2!XC>$D
MW'PLG3PHFUS641@QAX4^N&/<&@65V2,N=H25M3^!)&G?3J.\Y`9$[RB)"`!J
M+I]JFGF1QDR"Y<HN=#9;=M*(3[JWLO&P]V1FA).U_J]T^]'H"=2K*#V]5/3D
M6S'>USSND(3X%4<HZ^%26?K;VFT80_)+&BD#D`QF,&5YI9E=FC6,00K&S:2%
MM%9]-`#KZ#IV*&-\3\6$#>+E4&A*H3HH^^DRO(D]9[B(PU+*3?10.QI+O2,U
MME6J4BFLS0M(\X^H:#8X=`VKR-H`/3MUY$Z7ZEXC'F0L4'47%/M$8QV&2061
MVE$YD8)*2#+Z+$-6!9@P#(H(`U77U[#7J'],6.(W6.E26Y&X-%O&U:BT,85H
MV:*1G9)I&^N*)M.VH74DDGOI^7?KUS/3;&2"UQ-U*BF2\2%S7/#FC1+$^%:5
MLHE2Q$:Z-/*8B+1E9_956U=8TUT#S?\`S.G_`%X&84V/+C@S/(1PU"=OC33X
M99,J.9DR0M51W72^MJ1)6C[['#L[D%CIN4#0E2"1W&G;3J`C6L?M"]/&I@,C
MG,4(/QHC-)J_[L[O<VB,:D!V(T[J1H`/4GT'7K8W,<6M`W5Z""$<+TAV(HI'
M5Y%0/$Q.Y!N[D$%BH/HJZC3IR-&^1Q`"_%:"3HT*PBDTB*2$'<)868EG9BR/
MWT"?B-`5([?ET]YF-<^5=A/[#PH/Y@&A'@?8M)KQ(]Q618JZR`B5C[<4>]$5
M(W<Z#<A0`;CZ`=.A\D[V0"7;V)T"^%>$B.*21[2Y!T^^B\L.^2-692IWPET^
MI6`0R*616WZ,R`@Z?AT,C?'Y9'`@D@)W[VZ4R90`7,!6Q3PIF9G'U,WB\IB;
MD234\A5GI2QOI]<4L8CLJG[.I:*0:Z'L.EQROB=ZH9HA5-".GC4N&:3'FAGB
M)$C7*/B+BH+7QN^"Y1)?MW+V5JY1JE)D4)0>I3CI&)#>GK2*]ET6M%!'H-=C
M_P`AZTD')0MX^=L1<S+W!Q%SN#E#A==OPJP/(,EQ2R.,,1SG7N-VY;`][GXU
M+4#P20RU&9@F@@82*PC:Q"T0((;0?L%B/4'3MU1%KXB2J,.B=_'Y+5.V4E^[
M^<$GX+UHC9E@@1]A;9%(1(FTL-WU!-S::Z/WT'_P]>M5X:=2UR?PKTOW#_,=
M#^--^V2Y&S74(68L!WU8E!N[`(JZ#OVZD,D5&@><:_MVIMS`&E[]%IOV)8O9
ML!V4,8RT>BDJ3[B?0W;4'370CMVZ&[DF9)Y7$*!X_MH:6=Y,1:#:U-Z1MQC*
M["5)&C:*0!W';TW,=1KZ].QM+@UKQ946FY20UQ#J1<A6K7=)I*\2S,LB&4*I
ME`TTT#J-^PH==/P/5A%/-`6G'D+3H::CRI8FF+<=@0IT_OIC4<$^'-B/'7I(
MH9&DFVV7:67W#I^P\I;Z`?\`%/KTL2.>_P!1Z"7IV-3<O-;DAOKQ#<@"@5A;
MCA>)GGF:S*Q,=A)DV&,QJ-^TQKM,<@;_`!>XZ=D`>6O$JN6[3_*?WU"CE>Q6
MAH:P"Q'7^T5Z"?C<(E\"^)5A4+$.#8(1JOH%%1--->^G7T![?7^B<8NOHM_"
MN)<ZYSN9Y)SRKC,[\:FWJXJII*SG^QLI_J%K_,OT=117RY.BBO_3]GOP"_X'
MOB)_RW>%?]W/'.BCM5N^BBN2WZJ%>Q8P/B=:T<T4D>0Y7,V2IPW9<A6B3'4C
M+5HFM+%!%/?0E`TVJ*>_X'K+>YH7S18[6$@^:X^%=0_VQY"/CLW.DD#7,<&#
M:=#<W^5<WO$60BO8RVF9Y'FL%BCCKV4Q5W,4-]NW;Q+*(<-7M1'V)Y[+AF:0
ML=%CT`U.O6!;QZQO,DA#7!5([=/@>]?1<_N0MD@;BXL<DH"%@-K]2$LG;K70
M;QUY>PH\<U^7U:.<P<-#%T*(Q=AFR<W->56;4B7'J+85YZ=6K4C5S(FD?UG7
M]G4TN9PG#\A!*Z.'TI&,"_YG:K\$K"\EA<@[D/I<A[)O6D+E`V^E&!8'H27%
M/E4V>QG^748K/(%&$P\\$5LX!+"7[>0B=5FKPY.W$(88X$T4F.$'4=F)ZQ,T
MD6$]T;2LJ:GQT`&G\*J(HH\5SF8_G.[73:>I`*Z^-.>4R"L?;G6`^V&2%(T3
M>(]JK&K`DJI4?X.H$KW32-^I!:7MU['Q[TA@>T.>OJ!KOA38L\DEH2".^E6O
M9M0M9FBCD3>\$""11[Q(ADD614'^+H2>_4]D<L;7P"0;_*>S?`'I=/MI'H8^
M1(V6-A53N'7LOW_8*)WLW-F)<5`RO<6![#S16O;BEQ\-9ZKQ6659?>:2R)#L
M`&WZ6_,=+SL7(<V)TSRH4EB@EH!%T7JIIS%^FQY)1!&````X6#B5MIT2C$<P
MN)+!-,T48"[(I``\JLA&V0(`NTACM^K4]B1J.H600&HUGD\MTZ?P6GL>-\9#
MRXEZE;V_OJ!<+B,RW)I^'9JVN46M9-^M:L1&-9N/S1RP5J\=GW]M283ZQS_2
M==-P/<`:;&F8[BY1$T-SBC"X_P"$>-M=*T>?)BG'Q^4C\L)'Y0;^H$*[>H`0
M@_;4['_0:ZB8I$(Y_LXH]J-N<ZPR*+!UW+&0XT.H0)VZH)(960N5UP\BX';O
MUZ_"J%DK<J8.8T[',!-]+]O'[Z;/(>44L-A[-NU2CL15(WLM$IE-BU+)*D-/
M'(L@6-/NL@$CU[C74D;3VE8D$DSL.#:R1ZE"2;KX:``_:E>1XCYLJ5T<KV!V
MT&P"!NI^Q35.;,C5.<\LSWD'CT&7R.:ES&$IXTQ[ZF`O8VO76.EB[=975WX\
M^7BCD*J$+L6_QCIMH8'<:)Q+"#N!W)_BZI\*Z,ST)^'XN#A\Y[3`0XN_F<U2
M27-/5X!N>@I_>%L$+S<@Q.:;*XVKQ2%\?G,;C+C0-EG:A!'%(\5:,2-6+2/*
M7W;I"P!([]6.#DL,+_4+A$UI5+%WCW2J/WG(\OP)V.8YTS06N-]H4ZKUL!X=
M*V^2,%2\787(\CX\DL60GM5L!D,;?N!\=:H9VC>@:>J[0S_;7ZZHC,`3^!&A
M`Z:X;E&R03/5PC+BU#H>Q';2JWCLB;F,_"PLAN^%K0YI:$<"UP-]"1K<TPOA
MMBURWD_-^/.<XV!^.<^XG9_@8>R\]E,EQRR,O!EH++0P/#8EJ\@EC4`*08_5
MAZ:?AA%E3R8TC1M<U/W@^'6IW^ZY=A<7@\KQ[B)H7H>FH0M([!/OJ;O*_P`-
MO+6'R&3Y1P#DR^0;Z:38>QF)X\3RK%UX$:.OAJCF4X:]6J0?2CR(CMVU[]^E
MY7M?+9.[(Q\LN`N&Z:=%7Y5@^`_W*X9T>/A<EAB,*CB/,'+J=%!)JMW"?(/]
M$_(YX=Y"Y#-QV:MC<?@DXYEZ?\-N8K-.S69I)Y_;AAM5FF5XVFBEEB(<'7OU
MD^5P)99(97>26,H6D=#XUM>6QOZKQ;\KAL</:XE^X%5:`@'QTL@JU^3H$2U9
MTF>S4$+6"(K<,]2U2D3<LL2Z:O"HU/J9-3^`ZJCQAVRL:%U.J@#N._CUKG0S
M3$U)F`2"Q505'3XG[*H+\KL#!E>18'.U<X:^5X?AIK4^/IUDOV<I!%?^YJ02
MJ)EEIPSV*2J'"LZESZ`=/<;BNC]6<R$[1H+[DZ_/X5V+V)GM;Q\N+/C`XLQ0
M$E-I2YTN;GJE-Q>0_,7(<%CX/B.0Y"K4S.$J7K<"5JU,X?'3B4-B?O)YRSPS
MP%6W1E'"]M#WZMI.5RL6#T?6>1(%#.K1\3H*;.![*QN9/(.@8Y\;T7N>^WJX
M?93`\3\)AKY#R-XAY?6EI\LJ\+R?+:&8L2&S<R.:AM5;RUJ\2ET2@K:A70C=
M'+WT(TZ>Q98,O'=$"1)M)!_S!+5><WF&.7B^9XJ3=@.>&EHL$-KG4$=0=*A^
M_))Q[C)R/W&0R=3+X7$9J2OC$$DV5H9:C7MV?=GW.CUI,M*=S1*HC37T'4.6
M&-LH>6I$TB_?X5M8LEV:TQAS&SM'E[`MZ#X`:&YKKY\8N$\5XYX#3F.%LT)<
MWY)P-KG&;Y%%76M;LSY1;$\<`@$LD]*GBI5,4<(8JK:ZZG77H6!B0Q<1+D,0
MRN"[OB#^%?'O^Y?/<CE>Z9L"9I;%`_9M!/0H?M[U2:[3Y9D^0P3VI[F8MY3(
M5H<7&9G9K4JV6<T$19-=TL:;2Q(52VG;3KB[\+-FSR3*7S.EVM!ZJ5IAKH3#
MZ4+4`'F)Z=%^555\AYB3D?G3GN>AR#X?[SDUO^!9%K%BRN-KX+?C8YU-$&6@
MTUNH[%W5E15U].M].UXED<G4)\O[J^B/;4`P_:V%#(TN/I[7-1%75%[#[:<W
MCRGR#DW(FMY/,P6\I`J6(>123?=WFQ$$D&MB&6VJ&Q--(7`!]OZ6)U[=5O(O
M"%V4USHW%+=M5J!S<_&X6$UN/"5?JTV"^*:(*M%7.1IT@<G>DM3O/*&E>"ND
M2P[I)8:Z>WK('"CNQ)4>@U]>J.4XTP)QX7-/VA>B5S3(F9ZH,+`&(HN5\5Z)
M^/:K4?"G)K8^3/%H8](E;!\OW1AM_N;<%98/J="--.X';K6>TK\OB[F#>&/O
M_P"$UC?<_P#^E9+@Y07M_P#-7<WKK-<QJC_SVNO2\08@J6"S<RQL4FTZ:I]E
MD'[_`)C<@ZQWO=Y;PX:EG2`?<:T?MB/?R0=N0L:3\=*HOXTYBRO%%HDC!%9U
M5R"3&/VDD*_XNFK#U(].N%Y^(TO<&Q*K=`>O=?W5U.":P<7[1N[?=5[N/<EK
M6*%%#)&\"I&\ID&DDDCKWC4C70PMZ-H-?^@]5^8(?3@:;M:+A$)/7[.](9"]
M\TY:?.38]`$_?UIQ9BU#7@2:6&)JLJQLD\222"*P9OHL3PH5;4`[=%!'<'KV
M&6&(M/TS2QS+JI"J4)30@63YTB.%\SR!*X/:[PT30=P=5/PHD^2Q4*H9;>LL
ML!L+'-I'(D)8.[.I+.0JMHO;Z?4]^H3X(&N+(CO?N"`#0*#>^J:5-:W*<0WT
M@`-3W(!T[=S]@K;:</661(P99;`GCKD^W*FE>RBK&Q"H'E#,QT/^)IIW'3TF
M$TPG(B:H=*MU46(_$K\J;@F<)1&\W:Q"1<%2#]P"?.B<'N12&62-2"_MSQL2
MQU9#")'W_LGVR&_+T]>F1'M>R,D.<PD*EO-U/=/C3DKV/87,**T'["2@^=:+
ME-U;WD$9W'>JQ.S1K$2RQ*K,JZLH]-?4GJ8<<PEC6.!5MDMKU^ZF(LH.#VN!
M#@4)*7*7M\:3;1LUDCD>,%M4.UF"G1AV8JN[OHO;TUZCSXLF/+^M'YT%2(I8
MIFNV2(23_=1!AO25D5S')*LA1-"03^T^YMHU8ZZ`@=19(B_<'-<5.GB>U/QM
M,>WS-4#4_OI#=IMDKI:D>-I8)=)DB6*NC?3*H965F4G3OK^/Y=`Q'%KU/F9J
M/']M:=]5K7-:6"Z@)UHE,-YD=Y(RH3M(D9!?0ZH5]>WX:CJ,0YP+=P`%P:<8
M[;M(!#B=%J-\YS*OC<]3P8JV-]Z("3(EGDKPRLH"0E((W,6@.FX[0">_Y]6;
M>/G=B,SG-6]K`+W3O4_'P?6AR9VSM&W^7J:0;G,L;:S%3CL5UJJL#[EIE98K
M\X*@T@\D8D&XZ@$;0Q';I[^E9$>&_/\`1'IDIW+?'YFF_I9!']0NY-`/QIXE
MX%]F&-":ZLY7VWC]M-J*JQE=-06UUU&OH=>JQ\:[M[R7+I4,N>MFC>ES278D
M669U24,^V%T3:=C,?HV[OI^H'3^3UZ=B@+MMU=^/:O'.VZA!^%),\K1.WNJ&
MD1/W>TE?<TUWH2IT#E22--?3I.T"1S2%#:\!:6``H":0WG=HI5_=+7?>^I(=
M5)&\E'`#^XA()TT&FG4C<]CG-:?TG$%/%HM]YH\J,+KO"_?:DV296A>*3ZY5
M34AY`?:@B<F.02#O+K'$#M/U:L>_;I]K;2+^=[2OA3)<06D?D:?XTAVW,BL^
MFT`"$!?VED)T0@:]R"I_+L>EF)[)0U[=P1/GK20ZQ0WU^5)SVC##/$[(2C;V
M+OMW+$S+N$8#;W#..WY`].-A:&N:YGF)_NI()<Z,M-D_&D5["L75W7:!HFTZ
M"17"NN[L-%.GI^`Z3Z**S0@??3VXH'=%I(N.@5)%0-)%N!4@`F-/YCJ3]0_+
MJ0^(@LD!)(L5'Q_C3;2JL:Y&&D8F+0LR%=SAO;W,0-=-WX#1P/P/4B**/\VU
M$Z4S*]Z^F7V'6D^4J[!GV[%)!8DJ'C_Q4T``0J#Z]_3J9&R,"-J#<3;X=J8)
M3<=7?OIMSC?N)7U'T+M;7;]2[@=1N&A]-.DF,[[MOJ/PIPR``(E,;D5Y*\7M
M@-&0@.H(UU"E!]('JVT:Z_ETOTG%Q4:$?M\Z&R-<T$$5Z&OC).;/Q\\/SG36
M7@6`;MZ'_0T&O^'3KZ`X%?Z-QJZ^BW\*XQS*?U7D$T]5WXU.G5M5925G/]C9
M3_4+7^9?HZBBOER=%%?_U/9[\`O^![XB?\MWA7_=SQSHH[5;OHHI*RF#PV;6
M),QBZ&32$L85O58;2Q%QM<QB9'"E@-#IZ])<UKPCF@BELD?&58\@^%)#<#X4
MU>.HW%./M6A):*N<32,,;$DDI'[.U22?PZ;./`0&F%NT>`I]N=FM<7MRI`\Z
MG<5HVG$N+QI!&G'\.D=8,*Z+CZP2`.NQO:41Z)N4Z'3\.D_28O\`V[/L%+/)
M<@22<V5?^(_QI1&)Q84(,?3"JH4**\0`4#0`#;V`'3)XSCG$%V#$3_PC^%(^
MNS+GZJ2_^8UB</BCZXZD>VG_`-+Q>GY?L]>GC>/*+A1?Z1_"CZ[,'_\`<O\`
MM-%Y>.8";3WL-C)=%91OIP-HK:;E[H>S:=^C^FX%Q]'%_I'\*!G9C3N&5(#_
M`,1H+QO`)(\JX;&++)IOD%*`.^@`&YMFIT`Z]/'8!<7'#CW'KM%`SLP-#1E2
M;?\`B-;?X%A22?X50U)#'_18>Y'H?V/4='].P$V_1Q)_PC^%'UV8"HRI%_XC
M6O\`H[@?<,W\&QONE/;,GV<&\QEMVPMLUV[N^GY]'].P$(^CC0_Y1_"O?K\U
M&M^KD0:>8UFV!PKJJ-BL>RKJ55JL)4$ZZD`IH-=Q_P"GH/'X)5<./_2/X5X,
MW,!!&5(#_P`1K7+QS`3J4FPN,E0E"5DI5V4F-M\9(,9&J/W'Y'H;Q^"P@MPX
MP1_E'\*5_4,Y2?JY%_XC_&M+\3XQ(09,!B'*S6+(+8^LQ%BT8S9F!,?:6<PI
MO;U;:-?3IPXF,ZSH&'Y"AO(Y[22W,E!1+..@Z:UMAXUQZO+//!A,7#-97;8E
MCHUTDG4=M)66,%Q_/T#$Q0J8[-$T%#^0SI`UK\N0@:*XV^^L+7%N-WH17NX'
M$VH%<2K#8H5I8Q(!H'"/&1O`_'UZ2,+$`VC&8G_"*(^0SHG^I%F2->B*'$%/
MMK&OQ3C-2U!=JX#$5[E52E:U#CZT<\",H4K%*L8=%*@#0'TZ<;CP,.YD+0[P
M`KV;D<_(88Y\R5\?8N)'WFEOV(?_`*%'_P#>C_YW3J`ZBH0MI35S'C_@_(;2
M7<[Q'CN7N1:>W:R.(I6YTT]-LLT+N-/Y^FI,;'EO+"UWQ`-3H>3Y'';L@SI6
M,[!Q`^XTHKQ;C:)%$N"Q2QPJ$A04:X6-`NT*BB/15"]M!TGZ3&_[=GV"F'96
M2\DNG>2?$TG2<`X/-9:Y+Q+CLEMT]I[+XFDTS1ZEMC2&$L5U.NG0,3%;^7'8
M/D*>;R7(,8&-S90SL'%/QI0'%>-`$#`XD`JJ$"A6[HG9%/[O]E?P'0<3&<5=
MCL)1-!I2#FYAN<F1?^(T2_H'PK[_`/BG]%./_P`2^V:G]]_"J?W?VK$%J_O^
MS[GLL0-5UTZ\&'B-*C&8#_PBG!R?(A@B&=+Z:JFXHO=%UHA'XO\`'$4<,,?!
MN*I%7KFI!&N#QP2&JP*M7C40:)"5.FT=N@X>*0`<=B#P%.#F.6"D<E."J_G=
MKWUI7I</XICJD6/H<<PU.C#`:T-2MCJL->*N7:0P)"D818C(Y;:!IJ=>G1%&
MUFQK`&=DM4.;(GGD,T\SGRDW)))^VM:<)X?'+#-'QC!)-68O7D7&5`\+DEBT
M3"+5&+'74?CTW])BAS7#'9N!4%!:CZB>X]5R'Q-)">*O&D<UBQ'P+B23VHY(
MK,RX'&B2>*5F>1)7%?<ZR.Y)!]23U[]+CDJ8&K\!4L<OR@:U@Y";:-!O=_&M
M\'C+QW5)-;A'%H"T8B)BPF/0F-00(SM@'T`$]NO'8F,X(Z!A'P%-/Y'/D_YF
M9(?BX_QHVW`^%,`&XIQ]@/0'$TB/R_\`H/Y=>#"Q!IC,_P!(IOZK)_[A_P!I
MHSC^'\4Q-R/(8OCF%Q]Z)9$CMT\=5KV$692DJK-%$KJ)%8@C7N#TMF/!&[='
M"T.\`*0^>:1NU\KBWL33DZ>IJD[)8G%YF!:V6Q]/)5TD$JP7:\5F)9`"HD"2
MJRAPK$:^O?IN2**9NV6,.;V(6ELD?&=T;RT^!2DJ+A?$8"##QK!Q$>GMXRHG
M_P"#$.F?H</_`+6/_2*<^JR3K._[32BF"PL0`CQ6/0#T"U85`_FT3I!X[`=^
M;"B/_A'\*4,S+;IDO'S-&3CJ!`!IUB`-`##'H!^7[/IT?T[`_P"SB_TC^%>?
M5Y0O]0]?B:+-@\,\GO/BZ#2[#'[C582^QB"4W%-=I(';KP<;QXN,*)?^$?PI
M7UV;_P!U)_J-;VQF.<AGHU6*MO4F",D,`1N!V]CHQ_Z>E_08*)])&G_"*2,O
M)&D[_M-?AQ>..H-&K]1U;]Q'W/YGZ?7MTG^F\?\`]E%_I'\*]^LRO^X?]IK]
M.,QY&AI52-`-/8CTT4:+VV_@!U[_`$_!M_T<=O\`*/X4GZK)4GUWJ?$UB<3C
M&U+8^F2=-2:\1UT[#_%_+H=Q^"Z[L2,G_A%>C+RA89#T^)H?PG%Z:?P^GI^7
MV\7\_P#U>O/Z=@?]E%_I'\*]^MR_^Y?]IK4<%ABNTXJ@5TTVFK"1I^6FSH_I
MN`-,*+_2/X4?6Y?_`'+_`/4:'\#PV@'\+H:`:`?:PZ`?D/H].O/Z9QW_`&,7
M^D?PKWZW,_[J3_4:T_T:X][C2_P3%^X_[4GV-?>W\[>WJ>EG`PBUK#B1[!H-
MH05Z,[-"IER?ZC6B3B/%I9%FEX]AI)49621\=59U93JI5C'J"I].O1@X888Q
MBQ[#J-H2O1R&<`@S)$_XC_&C`XY@%[+AL8!J3H*<`[GU/['J>F_Z9Q__`&47
M^D?PI/UV9_W4G^HT/Z.8#_\`(V-_#_\`$X/P]/\`$_#KT<=@#3#B_P!(_A1]
M;F?]R_\`U&OP\:X\?7"8LZ=^]*OZD:?_`$/\CT?TWC]?HHO](_A7GUF7;_J7
M_P"HUA_1;C>FG\"Q.G?M]C7T[@`]O;_$#H_IO'_]E%_I'\*]^MS/^Y?]IK#^
MB7&/_M?Q'_=];_['T?TWC_\`LHO](_A7GUN7_P!R_P#U&OT\3XP3J>/X@DG<
M?^SZWKZZ_P"3]>_7O]/P;?\`21_Z1_"CZS*_[A_VFL#Q#BI.IX[AB?S..JD]
M_7_Y%^/1_3\'_M(_](H^LR_^Y?\`::Q/#>)GUXWA#_\`HVI_]BZ/Z?@_]G'_
M`*11]9E_]R_[30/#>)GN>-X0Z_\`YMJ_CV/_`,B_(=>G`PCKB1_Z1_"O/J\H
M:9#_`+37X>%\1/KQK"'4@G_LVIZ@:#_Y%^`Z/H,+_M(_](H^KRC_`/W#_M-8
MGA/#R-#QC!$?D<94(_S71]!A6_Z2/_2*/J\K_N'_`&FOP\'X:=">+X$D>A.+
MI]OYOW7;KWZ+#_[6/_2*/JLG_P!=_P!IK2_C_@TFON<1XZ^HT.[$46U'<Z'6
M'\ST?0X:K]+&O_"*!E9("#(>GQ-.:G3J8^K!1HUH*=.K$L-:K6C2&""%!HD<
M42!4C11Z`#3J0UK6-#6M`:-!3#G.<2YQ)<:,]*KRDK.?[&RG^H6O\R_1U%%?
M+DZ**__5]GOP"_X'OB)_RW>%?]W/'.BCM5N^BBAT44.BBAT44.BBAT44.BBA
MT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.
MBBAT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT
M44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.BBAT44.B
MBDK.?[&RG^H6O\R_1U%%?+DZ**__UO0[\,__`'=__J2OC3_Y?_\`MQ_T&_\`
M(KQ3_1#^F/\`]4Q_2O\`HU_0;!_P3^D?\%_[(_CG\.]O[K[;]Q[^[V_ITZ\*
MT59?^VF_NO\`^M7T7\:*']M-_=?_`-:OHOXT4/[:;^Z__K5]%_&BA_;3?W7_
M`/6KZ+^-%#^VF_NO_P"M7T7\:*']M-_=?_UJ^B_C10_MIO[K_P#K5]%_&BA_
M;3?W7_\`6KZ+^-%#^VF_NO\`^M7T7\:*']M-_=?_`-:OHOXT4/[:;^Z__K5]
M%_&BA_;3?W7_`/6KZ+^-%#^VF_NO_P"M7T7\:*']M-_=?_UJ^B_C10_MIO[K
M_P#K5]%_&BA_;3?W7_\`6KZ+^-%#^VF_NO\`^M7T7\:*']M-_=?_`-:OHOXT
M4/[:;^Z__K5]%_&BA_;3?W7_`/6KZ+^-%#^VF_NO_P"M7T7\:*']M-_=?_UJ
M^B_C10_MIO[K_P#K5]%_&BA_;3?W7_\`6KZ+^-%#^VF_NO\`^M7T7\:*']M-
M_=?_`-:OHOXT4/[:;^Z__K5]%_&BA_;3?W7_`/6KZ+^-%#^VF_NO_P"M7T7\
M:*']M-_=?_UJ^B_C10_MIO[K_P#K5]%_&BA_;3?W7_\`6KZ+^-%#^VF_NO\`
M^M7T7\:*']M-_=?_`-:OHOXT4/[:;^Z__K5]%_&BA_;3?W7_`/6KZ+^-%#^V
MF_NO_P"M7T7\:*']M-_=?_UJ^B_C10_MIO[K_P#K5]%_&BA_;3?W7_\`6KZ+
M^-%#^VF_NO\`^M7T7\:*']M-_=?_`-:OHOXT4/[:;^Z__K5]%_&BA_;3?W7_
M`/6KZ+^-%#^VF_NO_P"M7T7\:*']M-_=?_UJ^B_C10_MIO[K_P#K5]%_&BA_
M;3?W7_\`6KZ+^-%#^VF_NO\`^M7T7\:*']M-_=?_`-:OHOXT4/[:;^Z__K5]
M%_&BA_;3?W7_`/6KZ+^-%#^VF_NO_P"M7T7\:*']M-_=?_UJ^B_C10_MIO[K
M_P#K5]%_&BA_;3?W7_\`6KZ+^-%#^VF_NO\`^M7T7\:*']M-_=?_`-:OHOXT
M4/[:;^Z__K5]%_&BD[+_`/O0_P`+R'O_`/MA^S]G8]WV?_JJ?=]OVFW^WO\`
;HW[?37MKT!:*^?%__=;_`/U[_P#U)U[17__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g309840g50o38.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g50o38.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0T04&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@`````````````!%@```A8````&`&<`-0`P
M`&\`,P`X`````0`````````````````````````!``````````````(6```!
M%@`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"G0````!````<````#H`
M``%0``!,(```"E@`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``Z`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#M\RK#JZ-CW/K>U[_2+KL>H6V#BVQUC8<YU=FUS+O^,6<;/3H^U/R-
M]+G6-9LZ4XR&Q[O39OM_1[]F_P!GJ>F]:V7O/1<-K38"\5-FJQU3A+/I>I5+
MO;^Z@'#86@_:LL[7.>!]K>-2XN</S7.K:X^QC_96F2R1B:)71A(BP&@S+HNH
M=Z5KFOEMH>[IVR*W-:W8!?Z;&_I6OM?ZG^"_[<369-?LJK?;NJ#FW6CI9<7N
M87[[.-K?S-^QG_GS]'?8Z*@6NR7^B+0P_:+/TC;)BQSS[+'?]Q_^X_\`@T`M
MK>RYEK\MXL%8#?M=G(.ZOT',VN:_VM]1[O\`KG^$0]Z&NNW@O]F?;\0@=<UC
M7UFUQLLKJL:\=-W>GNL+(_1ES?5N93;7_P`#;^E_X%(9%7V2R_UB6AQI#V],
M(++`*LAMKJG?I'8[JG^A_P`)9;_.JPZAS`T_:,N6M#7#[7:1`_.U;_.?RU>M
MZY?6QSO29[02228T^`1&6!Z_@CVI]OQ;U73,1M;6VTU66`>YXK:V3_4'T5A]
M9LQ,;,=51D-QK"UC14_IUF74UT.L]1K\9M7\Y7_P_P#@U?Q^M7W9%51J8UMI
M`)DD@'Y*&55;;U+*<ZV]E88VIHKN<QH!].Y[ZZV-VMM<YFSU/?\`H]_^E>D<
MD0.(G2Z0(2NJ<AN76:P\9E4/]1L?LFW<US/1<YSAO^C2S(9_QN_]'_,VJPS+
MP_5LS'7L?AXWNMQF=.>QSFO=Z-+&V6RZQ];W?I/1_P"@Q6KL(OK<RS-S9]7U
M&VMOV.88V[!Z-5=?H^[^;MKL4V46,N;:,O*=#]XK=:"P_P#!D>E[JW?UDWW\
M??\``I]J?;\G(&7CMI+3U`V6NL:P6?LIPC;NKM96QU;6_2;ZEMC]^S_KB-DV
MX^*,89/4&L&1C-=6]O3B=SG2UN1OV6,9;NLJ_5+/?_P:W7=2M`GTP8\"3_!"
M/6+Q/Z)H@Q[B1/GQ]%+WX=_P5[4NSBGJ.$YK'5YE3;-K@]K^DW>F2+-F]M7Z
M.ZMS-[*OZ0_U/YU;U>/T^[IWVFJEAW5%P>:O2=('TO2>UKZG;E6/7<D<U,/G
M)X^Y7*,I^7TVVY[0TD6"&DD0)'=/CDC(T"ME`C=__]#T1KFLZ3BN=P&5_P#4
MJL^S#>02]CV06NL$%H!'MFT;FL5JMP9TG'<>&UUDZ3PV56Q;9`I(``!+0#/M
M),>V&JIG'K)K8-C%\M^*S:V>FP-)80T.@ZD?RCN5*NVEMC-C';]KFNVMB22'
M;NWL=M5U['/#Z]\!HV@Q+BT@.]SE4MKMK>V/T@]1MKH:!MB6'_/K<[_,4<:U
MLLT:U5;9:?8*]NYP9N+QIN&[U=K=WT4-XL(+"]H$$%S1#C.COI%S6J;K0ZW;
M6-Q$%W:-'-]_[O\`)0/M&[-MP]CJW4UUVE\;FO%OJ-VL/M_F_3_.1!6RTIG@
M-V9^+6'^UA;[="=):/<?=L6WD1ZUAXU$_P":U8F(&_M.K<^7>HPM`)$"/W)_
M/V^YWYZW<B1<YWA!_`)\_P";_P`(?DL_3_P4&NFHTY\5"P:`0`!V_P#(_NHC
M:V5L#&#V`0T'6!X(;XYY@:*#JO"-Y[?D5=S0`8[_``@?"$5Y,'L>WFA.XUY"
M(4UW@[CK\0M;IG_(UG_7?^_+(L`UB9.JU^F?\C6?]=_[\K&#YOHQ9?E^K__1
M]")?^Q\8,&KF5@^0+854UM##D!X;:PQK]$P9V?O;G?R59L`/1L:2&C97))VC
MZ*JU6.IK;D.#2+@&@\%I,EK=HW?2:J^?YM-RV<-\&G=(\V"Q[H#ZB`=PT,R>
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M1`\PNBO(%KN29`T[2$IC]7_A?L83\_T_:B.TG<(D2!\_I!"NGEHD\:\!$(`)
M=)/.GERAV%Q&A'S&BA(%Z+PUW$;H<=K(/N@N,B-K2UOYOTO>A;=YAH+G1NV`
M;B/DW<C6"1KJJUA@:?=V3A6FB4-C@1+3/;1:_2S/1K/^N_\`?EBO/FMCI)GH
MMG_7?RN4^'YOHQ9?E^K_`/_2]`LQ,C+Z1AUX[FL>T5/.^8+0WW-]O[R*[I][
MX<XLEIEH!(@_O\?36?1_,L_I_'^!_FO^L?\``_Z+^0I_^Y-19?;L<5VS0]SA
M]-59;8Z=E;I+V$1IS,_G:PJW[%S7:NLK)=9NLY^@1M>UNG[OYBC_`.Y-+_W)
MIL/:_1M=^M\&0Z-U!AKLKLJ-]+O8]VX!S?H.;8W7Z=;MOTE7;]7>HNNNONNJ
M-EONAFYK=Q/N#M-WIM9_-HW_`+DTO_<FG?JZZTK];1VNM?WN&T6!]7^HT956
M1?;2[8\%VS</:/#VK5.+DG*OLW,]*PM+!KN$-:QTZ>2S_P#W)I?^Y-"7M\.N
MUK#Q\72Z_!T3AVGNW\4-V!>1HYGE,_W*E_[DTO\`W)J/]1XKOUO@V#TO*=J7
M5@_%W]R">B96NU]?N,D$NY^Y1_\`<FE_[DT1[/BK];X(W_5[,=,65#YN'_?5
MH8>';A=*MHM+7/`L=+)B';G?G*G_`.Y-1L^@[_E#@_SGT/\`KG_!_OJ3'P7Z
M;63XZ]6S_]DX0DE-!"$``````%4````!`0````\`00!D`&\`8@!E`"``4`!H
M`&\`=`!O`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`
M;P!P`"``-@`N`#`````!`#A"24T$!@``````!P`(``$``0$`_^X`#D%D;V)E
M`&1``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!
M`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#_\``$0@!%@(6`P$1``(1`0,1`?_=``0`0__$`,L````'`0$!`0``
M```````````$!08'"`D#`@H!`0`!!0$!`0$``````````````@,$!08'`0@)
M$``!`P,#`P(#`P@(!0($!04"`0,$$04&`!('(1,(,0E!(A11(Q5AD3*5%M97
MMW%"E]<X6'@9@3,D=#E2%Z%B&`JQ<D,T1"714S<U$0`!`P($`P0&"`4$``4$
M`@,!$0(#``0A,1(%05$387$B!H&1H;$R%/#!T4)2(S,'X6*B4Q7Q<B06@D,T
M-1>2LL+2)6-S@S;_V@`,`P$``A$#$0`_`/H;Q3!N=O+#RJ\WH1>5_D[QGC7#
MW,&,83A>'\3\E6W$<9MEDE\:8M?9"?ATK$[V;LI^Z3GG"<[J5WTIITNT1Q$,
M!)!S%&)<Y'(`:G;_`&_^9_\`/;YV?VZ63^[O2>J?[3?57NEW]SZ>JA_M_P#,
M_P#GM\[/[=+)_=WHZI_M-]5&EW]SZ>JJU\B8-Q]Q)D\O"^3?=K\F\&RR`VR[
M-Q[)/*#$;;=8K<@$<9)^&_@`NMHZVJ*-4ZHND17+9^IT6,=H<6N09.&8..=.
M/MYXQ&Z0EK7MU-7B%(489*"/14K\;>*.1<Q8M&S?BWW(?,O/L1F29<*+D6+^
M0V.76TORX#G9F1VY<;CTFR>C._*8UJ*Z?DZT6CJ6P;J;J"C,*0H[%!'HIAKF
MO=(UDX+F.1R<"@<AY%'`]Q!I^_[?_,_^>WSL_MTLG]W>F^J?[3?52]+O[GT]
M5#_;_P"9_P#/;YV?VZ63^[O1U3_:;ZJ-+O[GT]5<V?`;F&0VCK'GGYT/M%5!
M<9YXL+C94546AAQX0K14HNO!,2`1$U"%&'\:"UP)!DQ'TY5T_P!O_F?_`#V^
M=G]NED_N[U[U3_:;ZJ-+O[GT]5#_`&_^9_\`/;YV?VZ63^[O1U3_`&F^JC2[
M^Y]/50_^@#F?_/=YV?VZV/\`N[T=4_VF^K^-&EW]SZ>JN;7@+S$\.]GSR\Z'
M0J0[VN=["X.X5H0[@X\5*BJ45/AKSJD@'I-0]G\:-+E(ZF/T[*Z?[?\`S/\`
MY[?.S^W2R?W=Z]ZI_M-]5&EW]SZ>JF9:?$3++[D&58K9O<;\S;EDF#K`3,++
M$\A\:=N.-K=`=.W)>(P\?;X/U@,&K>^F[:M-(9<MEB=-&QAA#RTN3#4,VJN8
MXBER0RQ.A9(XA\C-;0<W-!34,,0N"U^VWQ#RV\9=>L"M7N,^9]PS3'(,.Y7W
M&(GD+CC]ZM-ON""4&9.@AQZKT>/*0T4")*%5*:4R;J-D?'$TL8_2XID[/2>U
M.%>/BDC$)D>@D:2U?O`%"1AB`<*>7^W_`,S_`.>WSL_MTLG]W>O>J?[3?52=
M+O[GT]5#_;_YG_SV^=G]NED_N[T=4_VF^JC2[^Y]/507P`YF1%5?.[SL1$15
M55YUL=$1.JK_`/Z[TET^EKG.C8&@*</XT:7'#J?3U4R\(\1<LY*MDR]8![C?
MF=F%IM]TFV2=<<?\AL;N42)=[<0C/MS[T?CTP;EQ")$,%6HU37HG6&*X$3>@
M]NIKDP+>8/$=M+EAE@GEMIG%MPP@.:<PH4*$P48U[Q#Q!R_/PN[F$^XQYH92
MW8+M+L-[.R>0N.7`;7>H!JW,MDY6./3^GFQG$H;94)%T-F+XHIV1-,+PK2F!
M','C7DD<D,KH)7Z9@`2TY@$*"0G$95ZN/A]F-HRNRX+=/<6\T8&99'#EW"Q8
MS*\A,<9O-V@P2$)DJ!!/CU'Y#$8S1#(45!5=>,N!))+%'&QTD;0YP`Q:#@">
M0-#HI&0BX>]("_2''+4BZ53-,4IW_P"W_P`S_P">WSL_MTLG]W>E=4_VF^JD
MZ7?W/IZJ'^W_`,S_`.>WSL_MTLG]W>CJG^TWU4:7?W/IZJ9C?B+ECN;2.-FO
M<:\SG,^B6MF]2<0'R%QQ;^Q:7Z]FXNVU./?J`B.T^4U2BZ\CGZHF,<37",@.
M0?"3B`>1(I3XI(F0R2.TLD)TD_>3-,,4XT\_]O\`YG_SV^=G]NED_N[U[U3_
M`&F^JDZ7?W/IZJ'^W_S/_GM\[/[=+)_=WHZI_M-]5&EW]SZ>JA_M_P#,_P#G
MM\[/[=+)_=WHZI_M-]5&EW]SZ>JHPSGQIF\97_#,5Y!]S'R_P[).1+@5JP:Q
MW_R-QBW7/*KB#\.,<.R1'^/A=FOC(GLA0$7YG13U728I^M<&TBC8ZZTAVD!7
M:22`4Y$@@<T/*O7L?'`^ZDD2W:4+C@`45%[A4G_[?_,_^>WSL_MTLG]W>E=4
M_P!IOJKS2[^Y]/50_P!O_F?_`#V^=G]NED_N[T=4_P!IOJHTN_N?3U4/]O\`
MYG_SV^=G]NED_N[T=4_VF^JC2[^Y]/50_P!O_F?_`#V^=G]NED_N[T=4_P!I
MOJHTN_N?3U4/]O\`YG_SV^=G]NED_N[T=4_VF^JC2[^Y]/50_P!O_F?_`#V^
M=G]NED_N[T=4_P!IOJHTN_N?3U44G>!_+%LC.3;EY]^<-OALHBO2YW/N.Q(S
M2*M$5Q^1Q\VT"*JTZJFO#,B+&S'L_C7H8]RH]?IW4BP_#3-KC):AV_W&O,>?
M,?+:S%A^26'RI+Q?^EIAC!3=<+\B(NE![SE`WU4D@C.7Z>JG+_M_\S_Y[?.S
M^W2R?W=Z\ZI_M-]5>Z7?W/IZJ'^W_P`S_P">WSL_MTLG]W>CJG^TWU4:7?W/
MIZJ'^W_S/_GM\[/[=+)_=WHZI_M-]5&EW]SZ>JA_M_\`,_\`GM\[/[=+)_=W
MHZI_M-]5&EW]SZ>JA_M_\S_Y[?.S^W2R?W=Z.J?[3?51I=_<^GJH?[?_`#/_
M`)[?.S^W2R?W=Z.J?[3?51I=_<^GJH?[?_,_^>WSL_MTLG]W>CJG^TWU4:7?
MW/IZJ'^W_P`S_P">WSL_MTLG]W>CJG^TWU4:7?W/IZJ+2_`WEJWM?43_`#Y\
MXX3&\6^]+Y\QZ,UO-=H!W'N/0#>:]$2M577G6Q`Z3%.6'\:]#'E4>J?3E7Y*
M\#>6H,=9<WSY\XH<4=NZ3*Y\QZ/''>J"%7G>/0;3>2HB=>JZ#,0@,3%)3+CZ
MZ\#'N^%Z_3NHR/@%S*8B8>=_G68&B$)CSM8R$A5*H0DG':HJ*GHNO>J[^RWU
M5XA/_F_3U5PE^!G+EOCNS)_GQYR0HC`[WY4OGO'XT=D$]3=?>X]!IL?RJJ)K
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M.;,6W(4KR1Q"/+!PJ;6SCNX*#PF54HBI5:Z\;*7_``0M.*8!<>5!8\`$O0$+
MZ.>5.1/`#F94JGG=YV*B]45.=;'14_L[T=4_VF^JO$)_\WZ>JDV+X,\GSI4J
M%!]P/S:F38-/K8D7R#QJ1*AU6B?51V<`-V/5>GSHF@2ES=8B:6*BI@O?7I8Y
MITND1WT[*\PO!SDRY29,.W>X+YL3YD)5&9%A>0F,2I,0D+:HR6&,`<=85"Z4
M-$ZZ!*XMU"%NGFF%!:X'29$/T[*]R?!CE"%+C0)GN!>;<2=-54API/D%C3$N
M6J>J1H[N``\^J?\`RHNO!,7.+1$PNY)C[Z"QP;J,GAY\/=2C_M_\S_Y[?.S^
MW2R?W=Z]ZI_M-]5&EW]SZ>JA_M_\S_Y[?.S^W2R?W=Z.J?[3?51I=_<^GJI.
M7P7Y02XI9U]P+S;2[$WWDM:^06-)<595-R.I"7C_`.I5M42N[;2F@2EVK3$T
MIGAEWXT%K@`3)@<OHE*/^W_S/_GM\[/[=+)_=WHZI_M-]5&EW]SZ>JA_M_\`
M,_\`GM\[/[=+)_=WHZI_M-]5&EW]SZ>JA_M_\S_Y[?.S^W2R?W=Z.J?[3?51
MI=_<^GJH?[?_`#/_`)[?.S^W2R?W=Z.J?[3?51I=_<^GJH?[?_,_^>WSL_MT
MLG]W>CJG^TWU4:7?W/IZJ'^W_P`S_P">WSL_MTLG]W>CJG^TWU4:7?W/IZJA
M7@#'.;[YR+Y[>(M^\H?(Z\P\'N7`+V"\E7#D.WO<M8@N16/"<ROT6Q9BF,!%
MB1+M))Z,\"P3W0I#K544MZ>N<`V.4-"E<$P]5>#4=07$'.O_T/J;\!O\5?N:
M?ZC\/_D[ANG'_IP=Q]]`^_W_`%5J[INBAHHKYW_?K\6_'*Y\#8OS1<.$N-9O
M+-_\DN`,8O?(LG$[2[E]UQVY92%OGV6=?"CK.DVV9!%&G&B-0)M**E-1MOC9
M#YG\KVT3`VWN;UYE:,!(>A(5>/O8@''D*LFO=<;1YC?.XO=;[5,8B<>F001H
MY(22$XDU&.(VWR"P_P`_?+#@+Q8Y:LGC9XH>&'&7"G.\?QVXXXDQZ5;N2;UF
M>(7>[Y!B##[$^QMXS!RJXPG'YTQ&ISYNBT(M4121J'=;RW\G^:_-UZTWLNV;
ME/:PP.4-<S3,]@+@I`B,8TM:WQ:Y"7-*+7"TMKG??)7EBW>+23=]LEN);D(2
MU\5S%;ZBT@ASG1R,&HGPB)H0KA1/VZ/=P]P+ECRPP.Z<ES\_R[A7ER1ELOE#
M'<@XFQ^RX#P98+=;+G>(]]X[O]EY`N^1W2VX\<16Y:72%$5QD$]#6HV<WRNU
M^7M^NKRY)BMMIFN1<ENIS9(HC+JZ3"CXW(6M9U`7$QMU-Q))&7-]O%A;V%J1
M/)N<-N+8'!S)9FPEKI7(62,!#BX,<,'^')$CQY]Q?S$Y_P#*'/\`A_C_`,Q^
M5>1^*>:^`N;LRP?D/.O'?%^(V,:N-IM$7(K?-XJQ.!RGFUU<;LDMUZV`D^6T
M8L(ACO54)(5S9W!\M^8H+@.9<V=BR9K]6J9X:6D%^D-:T3,5SB"2%5`B5*=>
MV\>_>7;JUB8^UN=W$#HP$B8U[Y6$![B7/,3@TM"#4B./..O&KGGSOMG$7MV\
M)\.^>\VV2?(3BKS+S[+[K.P&QY7<..Y'$N.8CE=HPZ6T>1C-NUZ%]F7LG27X
MSC*7(S)AQ`$2L-ZN_D[#S#=Q6['VFT>4]NO6@'3U"^Z>PQM<`0S0WIP/<CU8
MQ_A:]V$/;86RR[<)7.9<[AYFOK-R@.0-;&>L02TGJ%TDS6J$>6MUE@)JYOB]
M[@_N#XB&'<J\R<N6/GB%S/[>'*WDEB_%L#C\,8MV&Y=Q&<>!9P;F0[Y=)N12
M,A*1W[D[MB=RBH#0>NHN^73=IL?.T,-KKO[0[;(QY/A8+YP#P&`?IQ->'XN)
M.@J6@FG-J@?N5_Y<=-*([23<+NT>P9R_+Q.E:[60HDD,?3:`U`7C!U5^\%O=
M*]QG.'.9G<UR?DSD'#;SX\YWR3`S/-^+L2Q&/Q?FEM@,W.QEALS&\TRQNXXL
MX4HVA^O98<,!;7:*HJ:/,#/\?L>\F%Y9)!T^E*[]1QUM:6O:`6@O:5P<?%QP
MQ<V@_/;UL6J/6RXN=$D31^4&E?$'$A_A<`$1-)/'&I'PKR1]S,[CXPVGD/S&
M:RFU^>'B-S9F,"V6GC*WVF7PY?,"P8<ELMSL<IJ_.+D=[N'9$9$@_HVT[KJ"
MS^B0HWD0,M/.>TQL>Z[M-MM[IL@.DZGRLZD8&*-TA[`Y22':_"0AD[>U\DVU
M[P6M%HS?7V3XBA#@XRLC?J3$#3K+4:A:UJN!)&E?LPM<SY+[9=XGR_)2Z<E\
MEW^)G#V.2)-LM0WWB[(VBN01[;-EE<;P]>)<FYM(^I2VVB3=M0:==2_,^MOE
MC9W;3$&7`VYDC'@X$$:A'DG@"M)S<JE#5?LIC'F?=!N),D#=QD8]APU(_29.
M!`?GIR"(#67EO]W/S6=A6+)W,V1;78>*6N`<YBR;)`C17/*UV'D=J;O[;X@\
MY'G%DF-B/85%`DDHJ!1=-7)9>=0[>2T;PRU.WG%&.9%;2W@5#@LLC6@J0!FH
MJRBM&6-Q\O?2M>_:KBZ^=/PM?&Z:5EHG'],,<4`]-0MY7YCY1.<7^X:DCF,L
M!SSCJX>"[W*.5XCB%AMM]SEW*(ETM^2,9'D-L2RW`H4*]R0E(KA.IM:5J@BX
M2I3NCA+['I-T[=_V:Z@+/N8!(WNX.+7,7$>,N4D$"I\D[G6NW2.8/G)/+$MP
MURJ6).QSF,XM#V.TX'PYH37;)[AY<\:\[^77+?!?F/;H]_X8\2/'W.<OY'8X
MYMEUN7,S#+&.Q&,;`&,D.SXO;`"X['WVUG..%$%-J*1*-Q?[@W;)/,-TZT_X
MI\Q-B,:IK<]@:Z8DC)Z:PP!/'\2`+"VS;SN]M^W^VF0,EFVJ<L>FHQ([5H3!
M2$TZCCABTDE/L(XLRS.></$O`LUBW=K%>1N3>$L?R)B]VJ.V3%FRS(\4C3PF
MPXLQ)#?88N<C<@'OH/3\NG/,]K);S[S:[8XL>Q[Q'Q1"H;ZO"OIJD\N7;)H=
MNN=P9U(U1_!0'%I.''#4G/"OGIXT]P/S5Y@Y-\=O$7',VG1^:^$\UYLR+S+R
M)BT6]9E]P#A^:@X_;2;^BD1H'[="R3-19!=[P;2]5U[#-!=0O\SPP'_$6FR&
M:2$8AUX0Y@C<Y0Y-;`<$(UDI@*L+JV?8R2['/*S_`"5WNL4<$BC4RU<DAET8
M@^!Q:X+X=(QQ-4M\5?=W]R#EKS&Q6X/L<AYAQ_G/*-SP7+.&'.+,=@<9X5B;
M=T<M9W3&,MAYS-S!^^VEJ,CCRR[8TTJDY6J43186<4VTNCNY.K'-8R.=*?"6
MO+"X%H;J'3!P\173VXU'WV0V]U?_`"D3HY()0UD:`ZP"`1(20CB/$K5QX)A3
M<\*^3_,+QQXXQKFOCOGZT6KA3(_</SCB*]^/HX$$AG)AR2:T=SRF_P";OWOZ
MKZMH#::8B,0@`4:0E=5545A;1<QLL?(6V7L769=[/)IQTB,1L>YN"'4YQ74<
M```$*E+_`,W6LESOO[CW,4@BN+*2*4N`4R`MC:&*?A`:1P*DN*C`5*5K\S?(
MG';=)X@XOY:P;Q69YX]PGE[`LK\B_P!@,?\`P[`[!91=G,(]#COV&!/O%Q?<
MJX_+=1QT11%<&JDALT3KVW\LV;[L0P1[1-<IPE>Q[P(@,@"BH!F0<L"UO^BV
MN]ZOFVQFG=\E$./2;)&USI'',YZ6JH&(3%1($GR$Y;LGD1XT\K9-S/QEY><E
M\+^/'EZY;.2.,(UW9L6=RL%F/S+)'O4*7`@$U>VUC@W.;AJ\Q451MYS]-:X7
M\MI)YLW6WLA'/)M=KABY@+IV1F0$AKG-:':RH:NDC`8TXS;X;K:]OVV>[<^W
M&_#DUZ"VD>(T!<T.<1H;BY"X9TD>U/[H'N$\\>8_'UDY%F<C<F<0\S%DLS,K
M3DO%^,XOBO%2C%N%SM9<>7['\XR&ZSK)"DMI&(KE$C.*V@HH[E54V-G8P-@N
M+:4ES&6[7-F=@_6$^)K5;I>.W,C(5E-PN)!(;B!I;(+DLZ30K=!<05<2'!T>
M&"'(J>-6Z]]GSRY:\<,LQC#/'WR8Y0XUY)QO`97(ETXMXYX*QS-;?D-F)RXH
M%_S?DS)>2,<:QZPQ78#33D2+:9LD&W2>'N=&TR5I=2OW/<NF1+#`^&-[7>!D
M9>&N'B\3I'/UC(-`P;P+CI76L(V_;Q,WIRS]1['-\;Y&M<&.`9X6M#$<02[$
M@\Q6>+WG-SGBG+V?>:\6!CUZYQ<]NWB?(#<6!(=QQB]WV]0\<DY#,MT60KQ1
M;9%G%,=;%RF]M>J#TU:W,+;*?S?M]E,((KC=;.,R.Q$0EB87.[ADTGF"A1#&
MLR;[9/)T]["Z9]N=R<&-35*8G.#6\`I0.<`1@"`1F)OMGN`>:W"2\DX"QYD8
M;YF-Y_X+Y;Y.PN1\:PV#8;GXY<B1K/=WX.'J-NO.0VVY66'(@-]LIGT\AQ37
M<PU1$+W=0Z*V\Q6<$9:ZPN;9L=PN$PED8QT;@B!Q"N\)<C7-=J5Q:R+M0%Q?
M^49YBUS-PED9)`GZ>AI>'@_$6DG1B&XM(`P#G*>`^='N-^.]VEYGRUSQ9_(V
M-R?[;W,?E;BF`+QZUC<'`LZX]L=XF6&VP?H+S-DWZ*X_94<END<=7P=,1;;5
M$+2-TNH+-OF_:X8";NREL6LF_"+N6&.1Y9DD(E<[27(X1@ES=1`5MEI+?0^6
M]VED#;::[N8)(<B]T$4LS6M>`5,HC;&TZ00Z1-+M()5_9B]QKSUY\\J[1Q_S
M+<N2>5^'^3<)OV7WC),\XPQG"HW&E_BP3NEJAX9<<4SK+$G8E/(_IP6>U'?5
M-GRHM=7L=C;1V>Z0/:Y8&L,<KBCW$.#7-D:`6JYIU!'?$#PJDN+N=\VWW,2?
MFRN;)&QOY;6HXZF.)#O`X:4+2K2,5QJ1_<0X3SR\>\GQ?RU/Y&@YA9N(/#7/
M_)+C;BC(>++'DUNLLOB&XFZ]AMJN,N\A*:EYCE%J2XK=VV0F0"<[30&@H>L=
MM%V_9KC]S-UZ(GW"TVJUFC<5:0V>>Y@AC"*0+:023ZA^KU#&X-`U'4[I!%N=
ME^VNTN=TK*\W2\MY`"H+XH8;B24@A'&:)\5N&$)'T1*'%SM+65XA>??F*YS1
MX/YGE7EQQ[Y0VGSSNV=V7DCQ?QK"6;%=/%.':,?NV10<FL=YA9%=[E*B8X];
MA9N"7*'%16U(!0E5'0N=RM_\=:^:MHBN.N;7RY=7S+\'!L]O;OF8TMTZ2R9Z
M0L\2EV)`T`2YJ[OY)+&VWUMM\N\[S!9FS=\1CGG$+GZE4/@`ZKT!;I)"^+5'
M?OV0<F\P_(#@>V>6/DIY57#E:R\C1\BQ_&N(OV!M5D@8D>.93<(29%*RR-=#
ME7FZW!MM6R9&#'::;`*&:UI:WEI#MVW;8QS>I=7=K%.7G#IKJ:6-"G4N@.+B
MF+B`W!2J>X=>>8_,D%NL-IM^YW%MH"$2!K6.:24!;IUH`%R4G%!NIJFJ;0T4
M4-%%#114(>17COQ7Y4<2Y+PCS199^0<>9:D%+W:[9?;QC<V1^'36+A$5F\6&
M9`ND56Y4<"7MNCN1*+T5=1Y[6&Y=;OE:2Z*0/;B0CAD>WN.%2+:ZFM3,87`&
M2-S#@#X7A'#'+#CF.%?%?B?CYQ%X;7OW+/)'AC"SE<G^#_,.`1?'-O-LTY!O
M^-8ZEVBS2D-7RT#E<),E;-T!5%F&ZHT_X:B[;ONYQ[#Y8O8G,-]?;G-:R$M&
M,>O0`!DTH4U(O'.K3<=DVZ;>F;=*QWR0V9MV@<5,S2YP*YHK1X5`JX/F)[P'
MN8>&F"\#8-R9-\55YXYYM-YY=@YABO&_+N6\?8OQ8$>QMV'#7[!;&#O]RS=^
M?)E++E`W]&PUVT$C7<27%RV)F^;ALD)/6VZ,==Q!(FDD<X,$66EK&L)<YZ:G
M%``F-#9$S[%8;^\@V]^0(&_"Z,,"R.EQ(<7%[`QK<@'$DJ$,^07OL^4,?Q#X
M0YNXKR+QDXBY*O=IOC_(/''*F'\NY9G.9R;%+6`5YXWPW';#VK7B<LVB<*3<
MYK!,DJB5!!25N_2UW-K(`9+-UO&_0$+XW.75U'*&M&"-QQ]52;"-MQ82&;PW
M3+AS.H5$3V@-/Y;4+RX+X@G#"H[E>Y=[EG*?+7BSS!C69<*85AV5^(>;<YSN
M.+C9\N*P7.9A]IF'E#DN+'D`Y+N=QG6P7+:PLGM,-N;'#K\RH+8]OW7S<Z?4
M]EM9QR1MST,G`#1P!D#P=3CAI33BM>QZ;VP\O0QC3)+N$T+WHFM\(U+Q+8BQ
MS4;\6I=6"47QGWA_>)R:WXVL"S>&!'R;XU99Y(XA<GK!R(TF+XCQQDE\L&2,
M7V$U)D!.R6^.X\_])%!SZ-H7&R*2B[A1S<9+?;W;ZV9KP=N-L^4A'`LN8XW,
M8S)2LC5<=)!!`!"&E65G<7S=GDA:PLO;A]M&I(25A(U.S1J`X!5520B4J^8/
M_P!PIY48&[P7C7"^,<48IDM^X1Q3ECD&=G&`\B9Y$R:Z7XIJ'C>)0<*205AC
MFMO5!D3'%$2=ZFB#57)(V'==Y;;J=OMI&QMC(_,>=(<YQ?\``!B@![^RFNGT
MMOL&W#FC<)B_4\+TVAKBT(W%Q*@DH>RK%YE[M/N&<TRN%X/B7A'`F#W'/_$:
M[^069P><+-F+Z8U><26YN9'#M+UH>^JFLSVK6:06)$9E*F*N.CU5(=R\6MWY
MJGDD'^*L(H)6\9"R4$EAX%P*A5;@%12E.VT;)MNV#\LG<+O<)K4NQ$9<P,T/
M`^)K7%RXJ>'!::7"/GS[C'E5Y;^WA+M.9\*X'@?*7$V<Y)G6#2;;E3=GO5UP
MC)&\>S^96(4HCN<T$9*R,J\;,="/NK6BK:;?#MX\T[W#.9GV4>U1SQMP!;'.
M`,.<@E85)P$>`1Q-1-T;>6NPV3"V-NXC>);:1P5#)$S6!@?TND]$!4RA2-("
M:4>XAYX^0?B-RE/PK$8W'TRV\F<%W.;P*5^QZZRI:\\,938\5AVR^/QKNPW>
M;"KF1L2G([+;3P,@7S+76>AFO9I]YLHXP;QDEJZ``?%"\O-QJ"YM9&_25`U:
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M]PGV;8KZ=KI-V=YE;&'$@#JQ1RME#N4)`;TP`"NHN"T689#YEEM+)@;8_P#6
MWS-:?[<L3WQJ5_675U"5:FD-*"MT/;3\L/-*\>0N5>)GEW!X.D!8."^,.4^,
M[APR.3G^#8GDEN((-@RJYY,S#>OE^CPVV>^^U';:[HDH*8JBIH1):7T7F!X<
M\[C9WYAD*`,<JE6!24!R5"F8%9(136=KY9GB#?\`&WML[0"29`Z+2'%YRQU9
M!1VFDKW9QB\Q^3WA3X><L9ODO'WC/S-*SF]\AR<8R%S$9>=Y#C35L8Q[`IF1
MMNB<:W7!FYR'39!$<=)H5$A4=4>T11;AYFW6*];K;9[>)K>+(2RN>0YW,F,`
M(`GQU=[A*^Q\K-N;-^F>>^9#+)@L<>DNTX_W2,T*:,<ZQ^@WOAGQY9]VCQ-X
M;XM\NN!K;=O!7,N1K!QAS%F5KR7CJ&SB5PE8]/Y-PN<_>;KF2R<]^J8&*KKB
M-LA%D5-U'61C)W"]GW/R#N)E`ZL&[[>YP>$E@;)-$6VPTX#%[Y)"?C:Z$(#&
MY\LO;[.VVW]P?*#XW.<R82P!S"3%.X!\AN#J/W6P")@`*.ZA5'Z6UX\'<!PF
M?Y%^VOC'CYXN<_>*'DDY>N,.7>0^:^;N8+G&P+G+ARU1+:[R0Y@.'7>_3F\A
M9S$9".18<-L"5EU*CLKMV,`D'F3<'VTS8MHM;*=MS:N`=*3/"!;NSU`"0%Q=
MDTN8X@Z16(N7M=Y9MQ<DS;K=7;!:W#5;$UT4K]:D8'2U&EJ*_0Y@(U8ZP^[7
MY[<%>8OB]SOXT<=VWFFP97QISSQQAF=W3+./KUA&/RFXG*18)>2Q7)G9:MWE
MIR<I&RH=M76*.(E/3#LM)-_@\E[O9.#;.ZOH`P/\+P9X))(]49Q"`>,?=.!K
M=QR_X"7SK97+0^\M-KO2=/B83`6AR/`(Q(\)XC$5E9Y&9WF'-_!/C)Q3>[Y>
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M5L?\'8O,>6LN<]KFEP\7B:`,,LQC4Y>#GNPVSBCV\_&'$>>RYGSOFGD3&>;<
M7XRS^P\?7?,;5D=CXSY!R7"L.R7,\DCSE"W2)UNCQ/O34U<!I7%7XK9[Y<3[
MO$UMM;"UWMVRVMQ+&1H8Q\D+@$<<"Y[(>L[+Q2`H-0%*V_:[?:-VW2T?=&XV
M&'?+JWAD#M;Y(XWQO<4"HUKYC&P!0&LTJ2TFLX/##'96,<T>W5REQSS'F&,<
MO^>ML\M+#Y/7R?DMRRN$<:TV#(YECR-S%I5XB1+86)W!AIQ@=[([Q12+<B%I
M^XM&64U]Y2V^YZ>QR^6XKA[T#C%.V-LH<'8>)[BYN)4-U-'Q&FW7C[JW9YGO
M+37NL?F%MNU@5K70N>YACT^+#2UIXXH>`2YWM/<%XA8?<8S>]^,6;\BY]QEQ
M1Q]F&#^2W.>:7BYA9.?N;IV107G9.+XU(O>10;>W;9#+[I=F238"-$5:UTG9
M97':=QN7VW1V.6*..TB.+RYA&JX)0$-(#@!_,$IGS!'&[<K")L^O>VW4DUPX
M8-CB>TAMOAFYKBWADTJ5PJ/O.)GFJ![T^7\N\@O\?9KQGXJ^.*\^X+A#-TY%
MM-S8QNSM6>,W'!FU3(UGDYI(R";N<)\3MZQ%5217$1-46R;@W9AYQW:YC+]U
MBZ3&EJ:`9O!;X.^Z&N/6PQ.+.RYW2P&[Q>4=GB?HL)Q*]P.9=#XYB4XE&B)#
MS#A4XX#[KGN$\?91PW</).R^+N4\>^:7$W)/(_CM%X6=R65E_#TK%,+FYW9+
M?RY$N[D2)?F)%O5F+**$ZJ-N"1(XB_(MCNR[9:^8-L>=7F"SL/F1(`L#M&,C
M2%U8A=!P5P`&II<YM=9-;>R[3N3&Z=DN-P;:EA/YPZCM,;P?A0)XAF`5*$!K
MM`_:#\@O/_RUXDB>2/E->?'(>)>1+-._]K\7XIQ_+[3GEONMER2=9KA/S%R\
M/2[&W!E-P#[+,61(-*BI*/5-6MW:16=G`R13N$L;)`0?`&N;D<`2Y<<,`,%-
M07S&7<]PAMD%G;W,L+@X'47,<-)!5$3-0I/`5AYR+F?DQXY>XE[AGFYGC/#?
M)>:<"3L$XXXVMS-WY-M<&S.<KQ;=C?'JK;WIK..C:+3:KJ#EZ60T1%($UCT0
MD)*/RVZ1FQRVS"T;]N&ZNM3(?TA(FN0D''I])B1@>(/0'#$W>]Q6MQO%N2'C
M9[/:V709]\M70!@OYAF<2XXMZ>.>`MU/]U[W!/'['_(WC3R7@^,F7<VXIP!B
MGD1Q+R!PC$R2Y\;6ZP7S)\6M5PQ;/K+>9UJN1W6/;LD16GF7&VE>:7JX"H2O
M7LC&Q7,5KJ;=V6ZVUO.YR:)(YY`PF+%0X$@X\"5`(`*-HM!<;GL;+U/D-QM+
MF6,-*/8ZWADD20E002T?"O82JB3^=?=J\C<&OF<6_"2XCN+&-^!F->1D;O8[
M/N)M\DW>3B34J/+<C90T/X"(WM[9%5$<%=M75HM:_=KFXLI_,C(6^"UW&W@C
M49LE^)3Q=R.`'(U*V*RMMQLO*,MP3\S>ON1(`4PB8]S-(Q12T*2JXY5IA[9^
M>^<'+O!5KYC\S+UP!-7E6S8QF_%=EX/M.66Y['L1OMFCS?HLV=R5/IY%\-UW
M?2&;S+8K3N%\-5NME!MLCK`JZ^C=XW`^!"T.:`H!)"H2@&&"YUD=NO9-R9'?
M1(+%S7`-(1^MKRTDXD:?"4&?'LK1[515I0T44-%%9'>-_P#Y%O<:_P"_\:?Y
M88;I3OT8N\T#[_>/=7__T?J;\!O\5?N:?ZC\/_D[ANG'_IP=Q]]`^_W_`%5J
M[INBAHHJ&.5\-X*Y@"U<4\OP<%S%S\6M69V;`\EN4$[D[=L;E+,M-_@V19K%
MR?.U2AW@Z`$`DG728PUUS#<1(;JW=J:1B6$@A>Q02,>!IT/EBAF:I;!.PQNY
M/:Y-3.U<%`QI:L/#/%N,<B9QRU8,'L-KY(Y*M..6+/,PC1B2\939\18D1<;M
MUV=-PVWXUGCRG`9%!2@FM:Z5#_Q[:XLH?#:RSF9[1DZ4@@O(_$02/2:8D8V6
M:SN)`L]O"Z*-W%D;WB1S&\@7M#CV@5#.`^"/AWQ;RED?-G'WCIQ=BO*N6G=7
M,BS6UXZR%WN9WUTG[P3G=-V(S^(N&7=[30;D)4]%5->P.-O8S;;"C;"1NET:
M#2YN/A(.;<3X<N"8"ES.=<74=[,XNNV.#FO^\'#)P/XL,\UQ5:*<<>`?ACQ!
MD`95QCXW\783D87>^7T+S8;`,2>-TR6(]!OLA'T>(MERB2#;<:_Y.TN@)I+!
MT[5MDPD6HMWP:5*=*0,#V'F'"-BJIPSQ*DA,UR;N1#<FX9/J0*)8RXL>.`+2
M]R(@QRRI.X^]N[PCXIO-HR'CKQKXSQ&]6$\X<LUQM%KDLR+<?)-LA67.RBJ<
MUP6UR>U6YAB5T^9MM$2FO9/S;2[L9,;2>V%O(PY.@;)U1$?Y1(2]/Q8T`D7$
M-V/_`%,<O5:[B)$36/YDP7E4IXEXM^/."3L'N6(<1X=8IW&N$7+C;!7X=O*N
M,X)>)#4JZ8M;@>==;&T3Y#`$ZV:'N4>JTTI[W2/O9'E7W+&,E)QUMC;I8UW,
M-:4`Y4E!IB:,&QSNF:F&F5WQ/"9./.HSXT]O?PGX<<S=[B_QJXNPI[D>US[)
MF[MDL:L.9%:+H[W[A;IAN2'2")+=ZF#2MHOIZ:1(T2V!VN3Q;>2TZ#D='PKQ
M*<%/;3C)'QWK-Q8Y+UKBX/&8)Q)'`>JGFGCGXM67(.(8B\=<<V[)N+\9R'%.
M%X#ZQV+OC>*W6V#;<FM&)V]^8DEZW2+51N2@@[M:]53UUXX-FFOGN\4TT`CE
MXET0(1KOY043MI;9)X[?2TD6WS(F_EZ_B(>OX\7$=YPIQ<)>-'`OC?`R.V<%
M\6XKQA;\NO+^0Y+#Q:([$8O%ZDFX;]QE@X^\BR'#=)5V[4Z^FG3(\VT%F7'Y
M6)NEC>#1D@J.YK7W,MVX+<O^)W$J5Q].-,M_PM\2F;;<HDG@KCAJU3>1?_>.
MZMO6M&XKW)#3JROVVE$;Z"EV;>J?<54!%JM/735N6V#=N^7(C99A_1Y1=0(_
M2N6H8&GYGS7K[[KDR/N@QLJXF01X1AW/3PI+Y`\?/"V^8QRG>N2<(X<>P[GU
MK'8?*UZR6X6N'C_(K6/NFN,LWB[2KG'@2UM[KB_3=IP5JO2NF_EX(V16W3`:
M9S.UO.4XF0#BXC%>6-+$]R_0]KW'HP&`$?<B<1JC[&EP&!XBBF`^%OA/`P^^
M0...%>*CPCD#$(6%7M<:`+C8\GPVU3/J8-C=FQ;A*8F6R'-:W"@.=#'UZ:>N
MXS<A\=XPN#I6RD.XO8`UC^\-``/(4FWNIK>2UEMIBV2`/:PC[@?B\#EJXU:O
M&\<L6'X_9<5QBV1;+CN.VR%9;':((*W#MEJMT<(L&#%;524&(T=H0%*K1$TY
M++)/(^:5Y=*XJ2<R>=18HHX6".)@:P+@.TJ?::CO%^`>%\+Y+S;F/%.-<4L/
M*/(\6-"SK.+?;&V;_D\6(?=88NDNJ]T`<3<M$'<O4JZ;@/RUM-9P>&UDDZCF
MC(OQ\1]9[,<J>F<ZXFAN)SJGC9H:XYM:.`/HJ*;)X'^'6-\R3O(.Q>.G&%KY
MGN4E^9-Y"B8^VW?GI<D!!^5N[BQ&Y+HBE3!H2KUK77ML39V\UI:G1;R-<US1
MD6N*N'<3P%>71-[(V6Z/4D"(3_*$'J%+47PZ\6;-B<?#XW"N!0,/M>>/\KQ[
M,D$VK9#S]PD>D9@B')HW=%(-Q.*6U*>FF1'#"+%X`:+2,LB/]MA!!:WD""0>
M^I,MW=7,NX22RN?-=@-F/&0!$#N:($[J9-S\0O!;DK"[YQ5<>(N%\RPO.\FG
M<D7G$46WW6+?\G*0;=QRP6H]P<E'+^I<('GF2$4)=I?9H$$3VV;`P%MJ%C3_
M`,L.Y<@Y>.!7NKQ]Q=-DN99'N$DS1$\G[P8`C2O%H&'$"I"PSQ!\8^.W<"?P
MCA+`L9=XOLEWQO`"M5G%A,8L5_?63>K;;P5P@6/='B4GNXCBFJ]5T^YQ?-<W
M#\9IHA&\_B8W)IX$#E49GY<#;5F$`FZH'*1$U\]28+3)XT\,O"7Q_P"5IG(W
M&7"7#_&G+^=/W:2[?K5#A6[*;^_-=<F7ERW,299..*X;Q&]]*TB"A+6B:5;S
MR6UL[;K:0MM]#58/PMP"\4';@M>SQFYD=>W#-3]:EY'WG=N0)IY<S>'GB]Y$
M9/C&9\W\&\>\FY3AC,B/C%\RNR-W"?:8\H'6WV&'=X(ZR8OG\KB&([JHB+J.
MR*..6>=C`)I8RQQ&;FD%I!]#B%S3(X"G'3RNBA@<\F*.0/:.`<""H](!3+LS
MKQB/AQXNX)+^NQ+@[`;+)_8D..%-BT]X3P5M'4#%W&9;LAERTCWSHV0K^EZZ
M7,T7$=Y%,-4=QIZ@/W]#0UJ_[0`!R0<:\BED@%FV%VEMN][XT^XYY5Y'^XDK
MS6FYQSX$^&W$>,\B8=QKXZ<98;C7+4:;"Y'M-EL?88RZ'<65CSH=U<-YR042
M2RJB339@'Y*Z5*3/:,L93JM&O:\-.6IJ:7=I"!%I,+W078OX3IO!D\9C$GWD
MU(</QCX`M]ZQ?(8G$^'-7G"L$G\88M/6W=UVR\?W7NI<L2B`ZXXTMFFH\:.-
M&);D)45:+I+VB23<)7A9+IH;,3_YC6X`.Y@"O62/CAMK=CB(89^LP#[LI":Q
MR<G&F9P9X/\`B1XT9-?\SX%\?^..+<JRE'1OU^Q6RI$N5P!]\Y#S92'77R8:
M=><52%K8*UI2G33T4\T-FW;XI"VS&GPKAX0C5XE!S)YYTU*QD]R;R5H=<DDZ
MNUQ4]@7L%3)<>).-;MR3:N7[GAECG<F63$;G@5JS*3&5V\0L-O,U+C=<=:<(
MU:6V3IH]QP"!=Q?&G33$;6Q/OGQM`=<Q,BE_GCC>Y[&.YM:][G`<W&G)'.E9
M9,D<2RVE?)%_))(QK'O;R<YC&M)Y-%1'QAX4^)_"W)67<P\4\!<;8)R=G<>9
M%RO-,>L+4.]7>/<7AD3V3>WFU$"8Z-7>P#6]*HM454TEL3&;9/LS6IMDK-+X
M_NN;CX3Q+?$<%3+D$\G<;F[;?S^*\"HXY@E%(X*4&.>?,K+7%'$7&G!F#VKC
M7B+#++@&"6,YCEIQ?'V#C6N`Y<)3LZ:;#3CCIBLF6^;A5):D2ZDRSS3-@;+(
M7-BC#&K]UC51H[`IIO0SKWER&CKW$IED=Q?(X`.>>T@!>ZI'TU2Z&BBAHHH:
M**&BBJ#9)[:WBOE=D\C<?O&-9([;?*C(++DW+P,Y1,9<N=VL`.!;G;4Z+2K:
M&P%U=PA5"KJ'#8V\%IMEE&#T+2Z-Q&%Q$CG:B2>(7A5A)N=U+=_.O+?F/D_E
ME3#I8X)S\1QK\\I/;3\5/,#$>,\0YAQG)E;XBAI;<$R+#LNNF(9?:+8L6+$>
MMG[1VI0FOP)34-ONME\I$E?CJ;<.-SN<N[R$B]D4/(P#P2J.`S`.+5R-5UFT
M6.UQ;/`/^"S3I!Q+2T("T\"1@3Q%1;R3[-O@ERO;^([;F''^4RFN&;&YC6,R
M(F>Y%$GW:P/..O2;1E\\9!RLC@2G7C)QMTD$U):]%TN>1UQ?7&X2)UI8FL<`
M$80T$-.G+4W@>!`/"EQN=%:PVC3^7'(7M)^(%R:@'9H4Q'?1/)_9E\'LKQ[A
M?&)^,9_$MG`F/Y'BO'OX1R%>+;*CX[E#I.W2T7>2P&^[P54E1MMSY0%53KI+
MGN?<373RL\ELR!Q/&./5I7M\1QKQAZ<`MV!(Q<23A,Q)(@<0>`\(04^\>]JK
MP^QB+BD.U8IE#;.&<(Y7X^6-'LMG/$UQMF=XNE\OL!\B:3ZBXO7"\OD$E?G`
M21$3IIN]:-P.\FYQ-^V!LR8*+<,;$G)`QJ\TJ39WDUC'MD=N0&VEPZ>-0J2.
M52>8Q.%,7EKV9/!CF:R\6V;*,/SBUGQ#C4;#\5O>'<@WS%,BD8U#D.2HMHR"
M[VI6I%ZBL/.FHHY2FY=.F1QW";<B?SY`T.'W':<B6Y$I@O*F"]QM?E"G3$CW
M@\6E^+M)X`G%.=6$A>`'C9;LHL.7PL:OC%XQOA6;P#:S_:2X/LAQS<(<B#+A
MOC)5YV3<WF91JLHS5S<5=,743+QV_.F'_N(:)@,`0Q0T-`^$`%,*<@N)+>#:
M;>,_EV5P9HEQ(D**2>(\(PJ)FO::\.XK'CXU;\>SBU.^,EYOM[XLG6O.[M`G
MQ'\CN+-UNL2]RHX`=ZMC\YE#[#E`2JIUU*MYY;7<ANL1_P"9\HRV4X@Q,U:0
M1D3XW8TB]D=?V]U:W*&*:Z?<.3`]5[6M<X'A@QN%6.\@/$#@[R:R/A;*N6\?
MG7J\\`YNUR#QT]#NCUN;A9"R4%Q%N33($ETMYN6YDB8.@$0(NF+9;/=(-XMW
M%M['&]@/#2\(5'%%*<E->2/,NVW.U2(;.5\;W#CJC)+4/#/'G@M027M9^'W_
M`+?\F\9MX9?F,6Y<YB;YSS1AC)YK<R7GC%Y?OD9V'+[:G"M$2;))&H@IVP:H
M"=$TU!!%;6OEJSA;I@VD`6XY(T,5Q^\=(`4\JDF^G=N.][JX@WFX->V8I@1(
M27!HR;BXD)SIH<E>S_X6<K<F\F\L97C>=_M-R]:,<L^=1;5GUVMN/79G%IUI
MN-HF?@30%#;N;<NRL$3]%,DW)T0ETNV8VTB?##@QU[\WCC^=J>[4.05[L.12
MO&WDS9[>X"=6*T^6:4_\KI]+2>?@X\\:M9A?B5PQ@/,\KGO'+1=8_(LSCG&>
M*WI[]X?D0%Q#$FNS9HHV\P1H933?0W:[C^*:7#^0=T,>=Y/UI.UZ$*.0QRJ(
M_P`=KM-FX?DV37B+F`]-2GC\(2O/E3XA<#>9O'!<7<^8?^T^/-3F[K:)L*;(
ML^1XW=VFW&6[OCE]A*,RTW$&7C#N`OZ)+TU'DMHWW%O=8MN8CX7-*%#FTGBT
MX*.*"I$5S)%#<6X1T$K4<TA1AD4_$.!X55KB+V?O!SA3C3F#C3$,`R*8SSIA
MEXX[Y$S?*\SO&3\DW/!;V,3ZK%(F8W0G9L"S-/PQ>9:;'[MU2*JUIJ7>O=?[
M>=KE1MFZ6*1P;X=<D+R^)[CF2PN('\J#@*:LGNL-RMMVA*WD*Z"[Q!@/Q!HR
M&I,?XE9BSWV]_&KD7!?&W`K]C^01H7B9=,1NW!]_LF22[3E^*O89%@P[9'+(
MH[:RYL"9'MK"3&339)[:;M/&ZF._V_F4D?Y*-I;_`"/8[2"Q[,G-(:B'F[G4
M6.VBBV2\\OL;_P#QLQU$?>:[4YVICLVN!>2".SD*F3R,\;^+O*?CL.+N7K=<
MKIB3>3XUEXQK5<WK1*2]8G<F[K9GOJV!,U9:EMHIA2ACT74,1M%YMU\/_46L
MPEC/`/:"`HXC'*IC9GLMMQM0G1NK=\$@YQR!'`<B1QX56:Z>UKX>75?(<W\&
MO#+WE#GO'7(_++\3(YC#UQR/B[*6<TQ;\(-&U_![<.2,_4R8[=1D&9UINTY8
MG_'#86V@TMVW<9+V#^6>6)\)7FQL<CVQL.#-13.D7#OFGW;[AH<Z;;FV+O\`
M_`TL*#DYQCC+W9N+&KE4$<P^QAX&\X<OYSS=FEJY@8S7D>]-7[,`QGE[)<;L
M%XG-,,Q:2+);>W&..Y'80"`E)"%53XZ18,CV]G2A8'0]5TA:_P`327N+G`@X
M%I)*CEA2[B:2Y%L'NTNA@9$TMP(9&$;CFHY\\:U-P#C+`>+./<;XIX^Q6T8K
MQWB-A8QG',2M486;1:['':)ENWL1U4ON5`R4MRJ1D2J2JJJNI%Y/+N$CY+U_
M4>YK6E<?"UH8UO<UC0T#@`!42SMXK"-L=HW0T/<_#\;WE[W=[GN<XGF35`N/
M/:$\'.*^1>3N4\(X[O=GR[E+'\FQJ?)#++H["Q&VYB#K63?^WD!RL?#I-W9?
M,'G(R5("5/CJ*V,-V:\V(./R,X8UY57EC':VQZ\]`<AT_P`K>53GW,DFZ0;N
MX`W<;BX8>'61I+RW(O1?%VFDCQ$]G7PS\(>3PY;X'A<K6[*0MMVM?TV2<I9!
MD>.FS>G&7;@^YC\I&[>Y-=<814=4=Z+7[=3XKV:&&6!FGI/CT(BHU04;RQ:,
MN%0)[>.YFCN)23,V36JHKD(5W/!QSJV%[\/>"<EYVR;R*R#&9-XY%S'BI[AC
M(OK[@[(QZY8%(D1)+]M>L1!]/WW'(0(KM=VVJ?'5:VVA$>ZQ%@,=Z(Q*#BO3
M^!.2=E3S=3%^U2!Z/LR\Q$8(9/B7FM55X7]G'P3X%R_/<XP/CO(%O^>V#(\7
M)W(LQNV01<,L.6-RV+];>.X<]28P^/.AS385(Z=&:"G1-/2`R[1>;+(XFTN(
MV,D/_F.8PJUI?GI4`D<2T>EH/+=RM]T:`)XI#(T?<#W%2[1EJS0\%-7;\=?'
MSC;Q:X?Q'@SB*!<+9Q_A#,]BPPKK<G;M/9"Y7.9=I7?N#X@Y(4ILYQ4542B*
MB?#4FXNIKHPF8J61M8/]K0@IAL;&S7D[0DD\SI7]KWE7$<AV5%64>"/C7FT_
MR)GY=A3N1?\`U21\?C\NP[I<GY$"Z_LO"9@V1^UQ]H_@\J"$=LQ<:7=W00M5
M_P`M'\C+MX40/NC<8'Q"4@#4UV8RR[ZFMNIFWT.X`CYAEMT!R,2DZ7#CF:@C
MAKV@O!O@WC/FGBK$>.[W=,>Y\QMS$.1+EF>673*\HEXRHG]-9;5?[ENEVF!;
MWU!Z.#71IYILD_11-2;T_P"0V]NVW'_IA.V;#!QD806/<[,EI&'>>=,V<CK&
M^;N$!_Y#6.8U<6M8]I:YK1D`YI(*9BH]XT]CGP!XHL^;67$\,S[L\@\?SN,L
MHEWCD:]WBY3<1GW.!=3A-S9@FY'<CR;:R+)A3MMCM1*:;NF"\@?;3DF)TD<A
M'\T95I7W\Z=M+A]E<VMW;M:)X7/+"F6MI:X?[4)0<#C6HG&G'F,\2\?87QCA
MD9^'B6`XU:,3QR+*DG,DQ[-8X34"`T_*<1#D/!'9%"-4J2]=3;R\GO[F6[N'
M`S/(5`F0`R[A5;9V<%A;LM;=I$+22./Q.+C[2:?&HM2J&BBAHHK([QO_`/(M
M[C7_`'_C3_+##=*=^C%WF@??[Q[J_]+ZF_`;_%7[FG^H_#_Y.X;IQ_Z<'<??
M0/O]_P!5:NZ;HH:**^,'F_)^8?'[W8?<-\Q\Z3C[E:=XL<#QLDXFL\R/DS$[
M&;3G=[M]CP&!`?22%M@G96+F2W=PVS:=3<3:;EKJEV/<)-NVO?(H,-[O]XBV
M\RX!C7W#6N#W+CT6PAK2,]848$U=[O80[CN'EYEP"=JM-J=?],!7.$!+7A@"
M+,^52T_VT:<0*L,_[D/N#>,<SFKA?R%Y$X&YPS_)_!WD/R]X7Y0X5@R9%FXO
MFX:C[`XAG]GEMPTEQI?TY&R^*T<>(015154;W<#&S;_-%K`US-RVF6R<^4C\
MN6*ZO(+1S&CA*TR&0`Y,)<<-*U.T-^8W3R-<7(:[:]ZN9;<1`_F1/AMWW.MQ
MR,;V#0H^^U`OB2=>2O<YYWMMGXTD85FV"W*?>?:8YH\KLJ;B6R'<EB\TX=@=
MMOV/SGFV)Y+"MH7!YU3A%^F*4W)34+>I)+2?]P6VY2&PFL&P'-&W,H;(2?O*
MT^'EAG3GE]K;X^0&W;1JW#>'02C)8FK@WEB$6KO^T?G'F_S5X[XSY$^77)7%
M^76CG/`\#S?BS&./\>N-HN6'VV?:26X_M3*ELM1)<^[N=N1VXY.MLJ:ANZ:T
MV]6$.UZMN(7</!(7CX6LFB;*U@!Q)9U`TG!=."JM9O:=PEW8_/Q$-L&R7,)8
M1XC)!<O@+U!(#3TGD#-'`E""*SFRCW3?*KB_F"T\1YK/Q67<>"/)[EL?)R:F
M.K`;F^,D#,.*\!XWNMO`I)_A$R?<.;[;-^I)>VY'MCZUZ*BYCR_*_<K;R[>7
M+VMB.WS07GX6;I))<0V;=>0:'V<I>WB9(P,ZT?F3I[7)O\-O"[K/NK>>Q:/$
MYVWMLW7=V7C\0!:QIX.!PJIOF1[S/G5QG@_CY9L&N%CQ;+.=X/)?-MJR]OB^
M\9RH<0EFDFU<8XPQC]D.2935QXVWYDU:"I*%.A:]LY);B>"TEC?'?6>UV3[I
MA'QW5U#UGZ79,9&$:`<RX\J?NX8[:&[N!H?;S[G=0V[FNP$-J_I:B,W.E>'.
MP^%H&:T2\J_?L\O4X8\2V>*\)/A?ECE?`;_G'(4^]<;Y%FW_`%6)9'/Q1ZTV
M7&(S(7&/!OSL49HONBG::<%.M:ZG7+6OWZ^@M"EC#;0R:#BXOF:I:79`,<UP
M!/Q#24"U%A8(MFAFN/%=ONI(@]"UI;&A#P#BKPYOAX$.&*+45^1'N8\LWO*_
M;*\U,CXTO-LYHQWB#RNLKMA7&[FQ%F97&LEOQ=G+RL\EMJ=%QMPI'XB\A)]T
MP))5::9DA%GO7F0V$[8W7>SV@!?B(2ZY1Y?V-1R<_#SJ5:/^<\M?*7<3Y!!O
M\/PA.J&P2O;H7BY0T\BO*K)>=7N<>XOX[8WXDW#$.0L(FX7R%PYCW(>;<VV?
MBJZ9A8,JO]ZCQ+E.L[%ELC\J;CULM,200I(<%-_;55VKTU(`B@\R;OMMR=-I
M:F-K54"5OWIM630XY-Y$&H\;6W.P[=N-NP.NKA\A<`?TOPQ:<W%N1=Q(-:X>
MX1Y,7.9[1V5\\\>Y-%F3N3N+,`*W9;B*3FK>XWR!/L%LN-SM'U;<:X,0B;N+
MVSN@#@AT)$6NHOF?:P[>;#R^%9;75_%&KB%Z3R'M)(P\3$RP(-.>3KYDMM)O
M+_&^VMIGD-"'J1AS"@.3FR`J.!!SK-4^"N#N?O-?QD\/_+F6$KQEXV\#<2S;
MB[B&[9-.Q+C[D/D21;L=CWS(;K'MMPM`W6[V6(\[*;^\1T74WJM-XE8,B@O-
MR_<>^NP#N-E=0P0-_LVQ#@Z2,'`8M8S`(CDR:E5\LMQ:;#Y$AMY$M[YT\MR\
M!#-,$<UDB=KBY3F2>)4/V^Y]BG@3P!&X)]L[GFQ9-<N7_+9SB/'KGROD#U]X
MM\;I=TA7*\7&QP&T<FO_`(;%=C+VTWDCQ&JTW)U8M'7^\/\`+FUBX&@P3R_,
M/'BE9"<68`>)2`T<A@BU*NH++;/\[N;K?3*!`WH,/A:^482E50$!3C@2`2:A
M7(/=3]PK#>/L_P"#)-_X7R[R;X@\K,'X-F\PXS;9<WB;/K+FT)YYAYF,B-2[
M;-MSU.Z@MD>P?T4*J:BVTO\`F9_+3[!A@AGGN;>5K_O.A:YPE80O@PX*N"9U
M*?:_XUOF1EZ1-+!MT5W&68:6R/C;H<#FX!QY8]V,`>3GF[[I\CQZ\EN-LKYS
MP#%>3?'+RGX=P'+<^XSM=XL;.0XMR3.N;5KMD"0C;4V':[9=;,*S#<1IQ^.>
MSUK6))/:WTWDR:`R"VGW">VD:2@?+$6NC<Y#^GX)%:N)+<$45(CMIK&WWY\S
M&&1^SLO(2`I9$7!DK0O_`)KNHS241H#L5(-6]P_R^]T*=Y*\R<9QN9^#[CQW
MX@\+X+RSRFC>&WB5<^1[?^PULOMWLF(RV^^X$VZO2J(])5H05%6JZM+N^MH+
M7S/O\MJ76EM?OMV1@@$O70#A@&!ZNYZ,A5?;V3[C_J6TPRZ+N]L3,9"KD#7%
M00JEVA`!Q=QJ/..?<L\]7QX5Y!YXS#@3D3@GSJQWD^V8;Q1QE]4G)'#3+-@R
M$[8>0OO,MM7'Z5(0C(H2[:K6B]-,;WMK;>VW'RQ>OZNXNVOKB=N$0(:'D'O!
M3O4*4-%G<]62#?[5G2L(MS9`8G8R$.?I:>P@A2#CV8U'7`62S.&>-/9[YHQ5
M7861Y!Y:9_P9DSMN:VS+_@F>Y!>69=FN+C>UR7;(LETWT:-5`750T2J:G[6X
M,\T[/9%H,-_Y<:QPX:HV,=&\\RUQ!!X:1PISS$X/V_S[.\NZECOK98TYR.+'
MM/)I:""!F36NWO@>7?EIXB<(\7Y3XL18<&7DG(?X+F^:2,3EYV[C=G&SSI4-
MIG%;>23I:7*8TB$ZV)=K914^;5(R>4[W!9R>&R-N]VI"=4@<`&89(U2ISRI^
M.VB=M-W<L&J\;*T:51&$%7=N*!!B,ZQJR[R8\DO-#-O:<Y'X>Y'XHN?DY+B>
M1.(S\VOV/9/8,,Q[,+);K<U=3OV*O6YV\Q[I`BDO<B@V3:NDE"I6EE<0-M/,
MFY7=B=-G)Y>9*7*'*&S2ZPQ,U<TM"HG'*F+6[;)Y3W:&]CUF'?(&.;BTA6.+
M%[$<TX9CMJQ]D]SWSXSWAGQ_X$Q[+.%,2\K^6?(7E[AF]\^9C!EP>*K1"XB?
M=D2[BU9Q:<D%-OC2@RRTH;MJ*5-RTT6IBWNYVUVVDP6HV@WTH>A+_&^(1L3C
MJ;K=R`'`DA-_;OV)FZLW`":X^>BMXM"AK.I&R8O>3P#7!C5S<3Q`!5,1]V;R
M^PS'K?<^8Y_'EZM_"?)O,/!O-^:X7:G)6(9]E=CQ"^7CCO),3N#KK!0&KC>H
MK$1R,0)N=54JB]-09KA]W!8W=C"Z-NX64S+=CQXA>12=,$I\4;E#_P#;B%J7
M;V<4,^XV-[*QS["ZM9)Y`2&FTG:'%K1PD:J%>-$^./=#]PCDW$SLV'6;$;YR
MIQ+PQY%YYR[;%L`QPNUUQNZ3X'$B08SDT'+=]='BJ\H*G_4B@J/Z6IE\61V]
MW>VJNM8;*TB>1CHO77,L%V2,R(A$7:,\4IJQBB,L5K=L_.GO)'1%=*VIMHKF
M##AU!.QA<<B":G[V.?<<\A_+W+.7>-/)_D'&;]G^+V*#E=GQ>-QOD7'F1VNT
MNS8\"8\ZU<V/P^ZVQF2^C:.M.*6Y?14ZZN);6U=M;KFV.J:.8->0?NN"M5IQ
M!)R[*H7SSQ;E#:SMT-DC<6A,RQR.1V110OOJXON@^0_E=Q'F/ASQ;XE7C`K+
MG'D;RKE_',V?R+;9D_'H+$?`[G=H5VDG;@?GLC9I3'U6UIIPGE;1NB(2KK+V
M?S-_YH&SMG;':_XZ6<N(5'1N]NH#0!S<I.%7,[H+/R[NN[20N?-#<6K&@<II
MFQNS(P0J3F`"@)K+?'_=%\]5X)'@2\7[AICS"G^XCR;X&CSS=HDRV<165S"X
MS=T+/)UJ5A92,T>*/&9)M#=`1(A0ZCJUA;'OS?(SMH/R[;_;+J\FZF)2SD`=
M&P!?'*V2-H&.+7D'$5%N=6QS>;/\JWKMMW;>(!'@@W&-YC<\G$,CZ+I'$HAD
M:PC`FM4_:^\K.>N9IGD?P!Y+S\&S;F#Q5Y"@83D'+_%B/#QUR1&O]GC9%;YM
MF9D-,O0Y]LCS4CR65%**"+ZK34IK+:]V"PWVUC=$'W$UN]CD)+X=*R-(S8\.
M"?S!PJ'*^:SWVZV2X>U[A:PW+7-R#)M0#'`XA[2PKV$',I6M.J^IE#110T44
M-%%#115(?//R@RSQ$XHQ7F"QXM:LGQAGECC?%.2/Q&9)B/6'",RRJV8[=LCM
MZLLNM.2+,U<%>5'2!O:/5=-V[P_?O+^V3N#+.]G,)?\`@>YIZ9/#27H#QY8U
M)^7?)M6_W5LPOO[6T?-''^,1^*0+S#`XCF163V+>]]G^2Y+=L:8X;L3LD.?&
M<5L+T6YW!X+EPA%3(COF<D/TO<&[06L5E[6T16550132M=-6\Y-AM5Y=L+7F
MWNIKIHQ,+8HVR0H.<H<%5$7!:ERV#!>[K;P/UPM?!%;O&4DLKVL>#_+&78Z5
M-0-XV_\`W(*\M>55CXXS#C?"[?POR1E4_$L#E8OD<VZ<I8Y*COK$AW#/K%(@
MQ[5%A3WV#5/II+I"!CZJBZLK"W,UJXW92[^6=*-&+%`UB,DIXBWPY)J7A55N
M3FVT\ORI#K:.8,=JP>03I+F-"J`['$@Z>W"C7CQ_]Q7.YC\Q\=X3R'CG![;Q
M!R5GUTXSPVXX]DL^X\GV*\)*?MEGNV7V-Z!'M<6US)H"AJS)<-L55:+342*T
MEO\`:+MCI--]+8RRQEBZ01&Y[6$X$.("!/O4;M-%MLL\L>-K!*UK]7QN\0:2
MQH50#B02,.VFE[8'N2<PJ_F?`>*QTY>N^`9%Y"<L\KW#D#+<@N.7KC./W&4Y
MCF&<;MRDN;UXO<MRWO`D<S:890PHJ5TS:32.\IV>Y],&WL]HMR2,7R32`HO\
MK<"]Y*HN=7F^V]N/.VZV39-+KG<1&T91QQL8-:<-15&M"!1BE6Y]J_WC>5/.
MGR%S'B+E##N%^/XL.Q7V\8[C]BS:Z.\G0W[1=VH2V[(,7O%IA`3X13W/?3NF
MK:T6E%54NX+&.;;)KH3:YV-8[P>)A#ACCF$YHG"LY?3_`"E_':EA8QTCF>/!
MRC+#+'DN/"G][OGNN\M^WSF_#V#\:<885>F.0[5/O5WY`Y4O%WQ_!+<,28Y$
M"Q1[G:;=<C_&R%E75%P4%&S%?CJCLI_F=UN[*0M9%%&QV)1S]1*Z>!`&?;5Q
M+:-CVJ"_;J=(^5S2`,&``)J/!3EV52#FGSB\K[EY><'\S>-UAQODNZY+X*2^
M4;SQ\/+-PC\*PW8'U]VR&[MOQT6)=Y$5F*81U2(D@R%!+:J:3'__`!6X>?W2
M.+K"W^6?J>,6QD$G0,<7+P*%%I3>EN6P^46`)=3;C<1C0@U/#6!C7G`Z02I!
M&'*K$6CWBO)KG_%^`,*\2O';"<G\C.0.(<GYTY)LG(>9%C>`XQ@F%9!,PZ^,
MV6\M,29EPO,W(F@^E;)H15BJDJ+TU8WC60W>Y26ROVBTM8I9''!Y=,UKVL8W
MBC5)*C$@#C4-MM-#%!;WJ-W:6]D@:P8M`BP<]SN`U%K0@/'LKC"]\O+<BX]3
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MP@6ZXVV8ZCY)L<;VD(HHJO6EO>V3+>WL[B(N+9`548!S3D#QP0\"%J@@N^K=
MW-L[2',#2BXHX9D=ZA0HJG/N7>?'DY"ROR@\8/%?B:Q9%;.'_%O-L_Y\Y&O>
M</89D6)6#)L)R+\.N'&:Q!)^=DUF9BNR6T4V"5UH4`T)45,=<.?N6S^8+R60
MP;5;W++;J!=9F+F\!]Q2T.*KI)*<*UME$W;]X\JPLB$^YW#V3B(IH,37@AI)
MPU2`.:T$(J`H,:J[XI^XEYNA;_"#Q'X#XRP'ES)\L\/\`YFR_/.8^0[W;+DS
M`<N3MLR"1.NK\:Z/7"4S%9$FU,R-QPNJHB===(]M[OOFADK&Q;?MQBU%N"M=
M$UQ(&`53ZE)-9V5K;;:[*\5[KZ^W"\C8TY-,;E:U0IXIR"(*>-@]\OFVU^<%
MS\6<^X[X$OUEO6)\L7;#KIP_R;*SFY6.YX'@UUSJT#G$ENV1;6Q&N,.RO1W@
MC&ZXT\75*"NJ">]Z7EKS+NK(R;VQL'W#>$3S&07-U9XM)TD#%R#C5JS;R[>M
MAL7NTVEU?P0/XRM;.\PAP;DK)-)<"0C%.:5%EI]\KW`[KQT&5,^(G$;DW+?%
M+(/+7`Y@<DS$M;/&O&K3\KD>;D;)6U);5Q<CM)^&PFJN.'T,DU/O]-D_>F/<
MAV^6TZRC`1WH`@#2,WES@7<`P..82J^R`O7[&R%A<[<)I;>$`XF>)V.I<HT!
M`.9<6A$*U+WFO[Y7+WCYQOXT\U<>8)P)/P/EWA[C;DS*L2S7DYZ)RVS.SZUL
M7DK1C>&6NW2W5AQ(C,@&I<EQII]S;2E%U+NX8K+S9NVR/+I+&&Z$<;F!7EI#
M7:I!DQVE[$:JYG(BF=N+MP\OV&X-`CW!S9A('%(P^*0P^!WQ/;U&/4Z<DXJD
M-<W^>OG'G?/WN'8==K%8H?B_QQX(6SE1O',?Y"N&'9MBN.9OCM_OF#Y;8;S;
M;5*FIG^2786H4]6U%+;%;0@[BIJJDM>EL'G>3=9"ZZM-ZLK1CHR4;(;GP,;S
MCE@=)),X_$Z**-`"35AL][#>[_\`M>=M9IBW#;Y;ES9&CQ#7%'*Y_P#-#*T1
MPLP!9))(2J"K&X?[DOE_>K3Q]Q?X8>.N.\S6OQ_\:O'W/_(:5R/R6_'S22QR
M'B\*=`LF$3Y\=LLLR1NVVZ4K\B:49''D$U5$5=6<LXFW3S!>W,1&S6^Z.LUC
M`UF1I;U"&*@:T2-(QR6JV&(1V&U6L4G_`/,7-I)<@/)+&QZGB+4]"27N8[``
MI@*^A=W*'UX_+-$MC\&26()DR6:XDV,J&^=G2Z?ADXHYOM)(C&O:=5LC'<*[
M55*+J#O;SM,6Z.C>V4V^M"%TNT$A0H!1R*,%3A3FVEU\VP=+$Z)TP82THK"Y
M%:4P5JH4***^9;'O?&\L;/XJ\B>:'+'CWQ-8N#8=^G\6\82K7G5R=R'(.65S
M(,=M_P"/6QZV(EIPUB`U(>DRD(G4-I!`%W='9Q\O:["R5P;N6Z-:Z`'X&M`+
MI72',(&'0`"22W(*:FNMVOW7S%!;J;#:I7-G)^,JT=(1A$<YSWL#E(`&HYBD
MW@[_`.XQN68^/_.N29OQ/BEVYLXO7%VL6MO&F12KIQYETG-[NU8K"PMZNT6W
M3XCD2XO)]55E40.HJOIIZZMYY(MKBVN,NW&YOFVP:_!JN!<'@\6HTCO3AC46
MS,/S%T_<)0W;XK1\Y+<7!K"UI:1P<2X)F$6GQF?O(^;'![ODS@W/OC;Q1C'+
M/CUP?B/*!VO&\YN&08]?[AEM^MD6$PS<FK>V34(;5=@WHH]P)`$/4:+J!>74
M+()9;)^M[-TBLW`\"]A<YP/'$#2<,#CC5AMUBZYFVEES$YD-U:SS@J%2)H(:
MG!P*A_+!":97D9[Y'ESXL<5\+'S-P?P/B?,GD5;7^2N-8TGD2\/X#;.(8EML
MLWOY9=(UF<GQ<QN+]Y!IF(TTXV.U5,TZ(LZY8V/=;C:HG`SV;-5RO-Y2)D2?
M$2CG/)0`!`IJNM$GVF'=WC_C7+@V!,SI4RND7X6A6!J*27%4`KARQ_\`<+\A
MPO$WQZYQXLX9PQG).2LNR?#>0+OR%?;M`XLQF[XB,IN6S;<AM=NF3'DOAM"]
M![S+:DSNW(BIHE8!NEO;,\-G):=8%_A<7!P8Y@&(5I4GL2EPM:ZPO97NUW<-
MRV-PCQ8&N:7M>24*$(,OB4<J4_)SW[N8^)('BF_A/&?"4J#S7QA;L[R_D')<
M_NO_`+6C=7;D_:[EC6&95:K+)&9<+<]#,G@DMM&RIB!HA(M)+K6-N_7VWF4"
MTC9"YJX2.$K0XD#(M:3I4%"0::C=U-F@W!K2Z=TTS':<6,Z91H<<PXA"B9$$
M*#4AY=[D%KX=\F_(#GNYV7(,J8L?A!Q)R!;;'C7*4^_\>WK)\ZNV'VBR6RP8
MR[%CV"$+U]R)H7+H#O=*.AJH5)4U20&2U_[/96T9?=R;U#;0A_%SXY'-*GX&
M!K2XM"@IA5LZ*.^VSR9=RRM;:BWOII7,X-B+004_4<20UNI-*T9<]Y#RPX>L
M_*V-^4GC=@6'\KQ/']/(CAJ/A.9/Y+B>0XNY,LC;5GRF;],Q,M5Z"'>A(A;;
M<#>"C74C=96V46XV\'BW6RN88YVGX-,C@S4P\2'%$[^5,;/:'<+[9.NTMVR_
M;+TB/CU1,<]'-R"AN!4YU.WA5[F_E!S%Y0\9<&>27C_AG%]CY_X%B<^<-7;$
M<M>R2XKC+[4Q1:RUIZ+%:M\V05K?5&0WD`D%5ZK2X;9VX?YBLI)S_DMO='J:
M!X2V4-<,>8#@#_,'#A5)\Q.^RV7=880=MNI'Q%Q.(E8H(3ADH7[I!XI6[FJR
MIM#110T45D=XW_\`D6]QK_O_`!I_EAANE._1B[S0/O\`>/=7_]/ZF_`;_%7[
MFG^H_#_Y.X;IQ_Z<'<??0/O]_P!5:NZ;HH:**K!.\-O'6Z\C\R<J7GCR%?,M
MY]P>W<<\K'>IDZZ6C*<0M1"<*U/V&9(=M,<6S`54VF@,E%*KTU$-C:FTW"Q,
M2VUU,)9!SD#`P.!S:0T!$1"%SJ6+ZY%WM]ZV1+FUA,49Y1EY>6D<07$JJJ"F
M50;X^>U1X*^,5@Y5QSB?A*WPH'-./RL1Y"?R6]W[,[I=L1FMJ$K%(]VR>X7.
M?:\;>.CA0HSC<=7A0]NY$74R])W#9Y]BNBNW2O#W@8%[@`&ES@CG%B$L4^$N
M<0A<5BVA-END&\6QTWT01AS#,2XZ&_"W43XD'B`:#@T5'7%GLR>W3P@SD4+`
M.&W[&YG'&G(/#U]=EY_F=QN-XP#DJ"EORVP?57.^R)2@]!7ML&!(Y#!?N5"N
MO+@F[L[G;IBMM-TR\#`GI/#V%1BK7`%?17MNYUM?V>Z0A+JWN6SQE%#)`"`@
M.`&)\*:2<46M#N'^)L&X(XNP+AKC.TG8N/\`C3%[3AV'V=V;,N3EML%EC!$M
M\1R?<'I$V8;3`(BN.F;AKU5574N]O;G<+AUU=OU3EK&J@&#&-8T(,,&M`]%0
MK*RMMOA=;VD>F(RRR$8GQS2/ED./XI'N=V*@PJN7)?MZ^)_+F5<_9MGG&@W?
M)O)OC:P\3<Q70+[?(+V1X/C4V!<;5;(J0Y[(61]J9:HKAR(B,ONE&:WDNP:5
ML-O%!8WFVQA+*XOX+Q[%P-Q;.<^)_9I<]Q+1X7%Q4%:LGW$K[JPO'.'S-M9W
M%K&Y`HANDZS>W4@`)Q:`C2*9?D)[8?A%Y+X#P_Q?S!Q8W<,<X3L;&+<6#9\K
MR/$;_8L?AV^%;QLD>_X]=;;>I]O^F@,J;+CS@$X*&2;NNI-RYUWNDN[2G_G/
M:0XC`.!((!:,"&IX%'@!(:BFF;?_`(NWC;86@60?J`(72XJI#CB"Y?$A\2!5
M047YI]JKP:Y]XRXOXDY%X:8DX?PW#;MW'HV#(\DQ:^V2"+9@]$7)+!=(%\FQ
MYIN$[(!Y\Q?>7>=2ZZ]N9'7>YOW>8_\`.<W22,`6A`&Z1AI:``T(C0,$H@<Z
MWL3MT9_XNO6AQ1V*N!.()4J1G3R@>W1XAVU[A5Z+Q5&1/'[#<QP+C*.[>;W(
MB6S&L_M/X+EL6YQ7Y[C.02+Q`54<?FH\[O530D)572+O_G3;E/<C4^[MFP2\
M`8F$.:T`8-TD!"$-.6TTEI:Q6<#D@9=-N1Q/68"&N4XG!QPR/$5`G)/LP>W3
MR7C>`8KF_$$]VS<<M3+;A[47DC.K(]'M]QF'.*R2)5OR&*_=+4R^:]B(\3C3
M(?*`H/32P]WS#+@E9A%''CB"V,(TN!P<X#`N*DC,UXZ1[HY(_NNE?*2,"'2%
M7(1D"<4&`.56C\A_$;`N9_$;,/$K'X-NP;"[G@<7#,0AVJ.D2UXJ%D&*YC:1
MH[#+O:AVZ3!:J@`1;46B*NH>^-O-W6Y%P!N+962,><@YA!;ED$&D`9#(84_Y
M?DMMBF@:R(_)AKFN`^(MD!#RIS<=1<2<W%35?LW]M#@#R4\=>!>+_-S!<4Y!
MS;AG"\?Q9K-L.R/)\:ELR[7;(-JF+8\NB)C&4-6N]);VC>C'VP<-$0A6B+J?
MN!M;O=I-VAC,=Q(/$%121XFD`H]H<26:AAF@-0K`W%GMKMI#]5FU_A7Q'2UQ
MT.4@:7EJ!^G#,*13K:]KKP3<\9E\0F>%;&?"<>\_C[ED9N]V+(@R579#XY`]
MF(3URG\?%)9@,HI7?1HMB%MZ:1=2/O39OE<G0/Y>GPAO,>%,"OB'$YTJV`M#
M>&(8W`\>KQ:A@GQ+DGA3+A73"/:T\(N.N*L4X:Q#AYJTX/AW(L#E>ULAD61/
M7J7GMLJD&_W[(W[DY>\@D1VUV",MYT-B;:4TN2>22ZVN\)2:S:]L28!HD!#S
MI&!+@<203ERKV$F"'=+=A_+O&ALJXES000%.(`+0@")Z:6L_]M?P^Y.LO/\`
M8,RXS?N=M\G+UC>1<P`.4Y+$?O\`><2??DV"?`DQ;FT_8'X+LIQ46$3.Y#5%
MJFJ]EG;LAL[=K/RK>Z=<,"G"5X<'.[5#G898Y5,=N%T\M<YX46?RN0_0#FNT
M>MC2N>&=+O`?@)XK>+MZRS*>*<$>L=RS+#K3@F53+]E.09*S<\4L<9N)`MLL
M,CN4]CMA&;0#-4W.#T)5U/FN'SV]Y;3D.@N)-<@(".=ITKZL$RJ$`>KM\S%$
MMJPLB(P+6N=K("?S8]E0UP_[3_MW\(<G9/S-QCPW8K-FF3Q+_'DS2RJ]76SV
M.+E;4B+>/V3LD^[2K-B0S69CC:+`:8VB:H--,M!9MD^TZB;26(1.4DO+!B&Z
MSXD].(I<CG37T6XN`^9;)U`@1NO\6D>$D9Y9TW+M[9N)-\P>'ZX$-@Q+QI\4
M,AR[E*TX5^,Y%>,POO*M_5_\,>,[G#F6_P#9N"[(^I)PIR2$='8+>PMR+VV2
M6SW:[W.='%NV"SMQGI!(#W.5$(8H:1J)(:3QI[<9FWNV7%HPN%S=WXN+EV"2
M-:%:P`<W@$_"`%1<C:KRU\)?'/S?PRRX'Y%X5*RZPX]>AO\`92MF1W_$[O;K
MBD9^(91[UC5PMES".^P^J.-=WMN4%215%*1^A$+EEX&_\AK2U?Y250CB%"A<
MCE21<2MMY+4._(<X.3M&"CD4P*9BF!QE[:OAOPZ[P<_QUQ.SCC_CLN5.<8/Q
MK]?G'K=,S5D&,GN5Y=>N#AY-=+LVV/<D3U?=541=U=2II7W$\EQ(?&ZT^6*8
M#HZB[2&C`>)Q)("DDXU'C:(K.ZL&_P#IYKEMP]<2Z5@1KM1QP&`"H@`1!3:S
MSVM/!?DCBF\<%9EQ'&NF%W[D.[<M%$7*,ABY'`SB]S'9=XOV/Y'&NC60V0IS
MCY`Z,5]MLFB5M4V]-1&6\3&;7%&"&V3"R-"5#'*K''-S2JHY1J#3FT5,FO+B
M>;<;F8AS[O1U%`0F,`,(&37-`0."%"X+B:<H^VGX:-^--O\`$=CB&'&X,MU_
MM64AC,:\7IBX2\ALUV&]P[O<\C;G#?KG.*X#N=<?D&3PJHG455-3+B:2ZN]K
MO97?GV3@84P#".0&&.9YG$XU"@8+>#<+>/\`3NF.9*N)<UV8)./##D,!3@M?
MM^>)UGN_.=\A<60TN'D=C%MP[EHWKI=WV<@QVTX[$Q>%;XL=V835F%NU06ZE
M$1DB>17557%4M1W,:ZPN-M(_XLMY)=.'$SRR.F<_5F#U'.<T*C2<$J0)Y!>V
MNX*/FH;9ENTI@(F1MB:PC(CIL:TKB0,:0?$3VV/#_P`&KOE60^.7&3V*9#F<
M1JWWZ_WG*<FS&]2+:R\$ANV1[GE-TNLR%;DD-B:L-&#:FE:5U--Y.;9UH'`0
M%P<0``20$"G,IP7*H1MHG7++IP)F:PM"DH`2I09!>)XH*L)R9X_<6<O9IQ%R
M!GF/NW?*>#,GN.8\:SPN=Q@A8[_=;/)L,V8[%AR68UQ%VV2S!&Y`N`*KN1*H
MBZ@PQ,@OSN402\Z#H=7_`/6XJ6IEB>.=2I'NEL;G;GXVDKXW.'-T3@]A7,(X
M`X9\:KAEGMD^%V<\><T<7Y7Q#&O6)<^<P9'SUR&Q,OM^.Y/<L96XVY><PQV\
MI<$NF)W!TFT[?X<['%E%5`1$5=-?*0BSV:Q:"(-O7H(2"P.<7.&K,M<I#@20
M6G2<,*?=>SON[^]>X&>YMH8)%`1T<#-$0+<E8,6N34'>)5QJ;/&#Q/X'\.>,
MXW$GCY@T;!\,8GR[K(9^MGWB[W:Z3G%.1<K[?[O(F7B]3R':".R7G#%H!!%V
MBB)9W%Y<7,=M%*_\J%FEC0``T*24`P4DDDYDE35=%;10OFE8W\V1RN)Q).0Q
M/`#`#(#`58S46GZ&BBAHHH:**&BBH6\B>!L%\GN%.1>!>2OQ<,)Y-QV5C=^?
MQ^5#@WV'%E*!C-LTV?;[K$AW.(\V+C+CD=X0,4517TU#O;*.^BCCDD>PLE9(
MUS"`X.C<'-()!XC'#$+4W;[^7;KD7,+&N.ES2UP):YKVEKFN`()!!/&J;<9>
MT]XK<5\B\7<EV0N1KM>.)^);CP]9+7D>16.?C]ZL5W64MSOV4P8F*V^3=,MF
M).>0Y3;\=FCA4935G+,)KC?[F2%A?N4$44N&`CBC$8:P+X=30-:ZE.(2J]K7
M,M=EM&2O#+"=\L9!Q+WOUJ\Y.#7?"$"#-:C?@WV5O%+Q\YL7F;`LY\BCBL7:
MZWFT<.WKDBQRN%[!*O#KTB6U:L9@8/;+^4-)4AQT6I-VDAO-:U&B)Y9SOM+*
M2Q<!,QT)BU2^)P8<,#@%#?""6D@8_%C3EX3>73[LGI2.D$A$?A!=AB<SB0I`
M("Y(,*Z<)^RYXL\`\^CSY@&?^1S3[&07C)[=Q/<^2;"_PY:[O>UD')>A8U"P
M:WWXV67Y).--/W5YM"1-R$*45NW>^#;Y]N+NI&^!T(<_%[&.!;X$1H(:4:2T
MIGGC7EZE[<.N7C0]SP]P9@'.'-5./'$4K8A[.'BK@DO!+IB>3<WV*_X#F'(>
M7P,FM6;8[:\AO"<G=I<FQG(+E;,(ANR\9W,BL9ME(\N.7S)(5>NFK9@M((K>
M%Q$3;`6A_FC:NESD0&1I)(<$;S:1A4V^OI-QO+J^N8V&:6[9<8`HU[`B,4DA
MKQ@\*24"$5R\9O9R\:O&#R$:\E[)R3Y(\J<B6Z!?K?C+'-/)-@R['\0:R-YM
MVYN6"):,%QBY_4&VWVA*9,F4;5:HI_/J;:W3[2&>.)C-<D0C<\CQ:,]."-`)
MS\/<E5MY"+Y\#IGNZ<<O4#0?#K1`2JDIPQ[UJ6?.'VW.)?/)S%GN2.6/(OC-
MS%8DR`R/!_(UIQ&'>(4TB)YB^VK),/S2T2U^=41UJ.R^HKM4U%$1*YENQMQ-
M.27"1@:YIQ:0%](4%"A0\EQJ>+N0010-`;H?J#@H<O>J$!%"A1SIJ\:>TWXM
M<23L0FX3,Y0@)A?`E]\=[9#D939)D65AV2-3PO-[N:O8HLN1F$MVY/.K)!UJ
M(CA=(R"FW2[R)M['O<4GABOXHXWAN`8R($,$:JF975J6FK69]K%M<3/$;2]?
M=-<[%SI7Z=6M$!;X1@`T]M0WEGL9^(V2<=\58):.0/)7CBZ\10LCLF/<I<:<
MEXYB_*-UQ'*[E*O%[PG)KVG'\VR73%Y-TEJ^C06UAX#`:.TW(2WM$ERZX=]^
MV9`]GW)&1IH+V\7`8*"%!0@HU'IKV:<3ZTU/O'7(*8QR/;I=TSP:0!@=6(4'
M$K,5Z]I+Q$NV*>+F%0K;G&-8_P")67CFO'D;'LAM3#V27,Y-KG3(O(DNY8Y=
M)&1VRYSK.P](;8*$9N(JH8HM$FF^N/\`.6V_-(;<Q0&%K`!T@P@@#3FK-3M)
MU8$E5JO$,?\`B;W9W#5!<3,E>\XR%[2I.K+QX!_A*@`!$I-MWM&>--CXGYXX
MBQG-.?,4M'D'R-,Y,RK)<8Y%MEES#'KO(F2I<2S8;<H>)!;8.*V@)9,18,Z'
M<1%A!%PG%3=JJAM8[?:O+^SPN<VUVY@:PKXI$:UBS$@A[BUHQ#6HBM2K&:^E
MGW3>MWE:TW-\27C'2Q7ND_*"JSQ/<<RJ^):EKP9]O'A#P!Q[.[-Q+D/*>;W;
MDJ_Q\BS3..8<JM669G>I<*($&WQGIMCQK$[4U"@1Q5&Q"$)JI*IF72EH^\D?
M9Q6+8V,MV2.D1H*E[TU.<22I*`8(.RJH6K/G9=P>]SKAT3(U)P#&*6M`08*2
M<5./+"H@\P_:%\9/-+D^1RWGV8<]<=97>L-?P#-@X6Y$MF%VGD;%'([T:/:L
MXA7'$LD.ZQX`/EVA9<C"551U'!51U4P6<=L=P$3W"*Y>'O84+.HW*0-(^,%#
MBH4`I5K)?2S,V]LC6E]L3H=B':'$:HRX$'0X!"B.`)TN&!#OX.]KGQSX`Y(X
MVY0PR^<JW"_<7>/4;QHQ^#DN2XY-LTSCV-).2,R\,6W#K1/D9.X3BB4EF3'C
M[5Z,(O74USM<GF)[V@_Y0-$PX(UH8-"(6J!BI/8E1"?R=H@:-+;&[EN(B,^I
M*FH.506A!I"`\R:K%Q[[`_A5QGR+9>3<:S3R3*_8U>^1;GC,&Z<F8W<;!CUJ
MY2Q&^XAEF(6NUN\?"+6-28]^.8&\SGI-894Y1LB;)PY[5EQM=SM,SW&">QDM
M)'8:Y(GM:UNHH@=!I<Z'2UH#I'E[9$9HEQWLL6X1;C$UK9([V&Z8T:M#989#
M)@%4ME=I$H<22UC0PL5^N<K'[1/C%8,*Q_!(>3<S.6?&_$GD#PR@/R<IQ([B
MYQ5R0PY'O]VE/-X$S'<SED'56-+%H(3:_I0S3IJ7?D[BWS$V?#_)NLG2Z<$-
M@$@Z:JB_^9JU:N&FHNW._P`9<>7KFW:#)MEU+/%J4@OF<U[P]"%:K0@&D@+B
M:@;DG_[?[PBY2E8E(O\`E_DE`8Q;A#".!)5MQ[DW';5;<PQ'CFSM63#[KE\9
M,`?6;DMIBL"2.12AP7'4W'%).FESS23W^\[@7)/>SLG<!\+)HXV1-EC!5'=-
MC6^,O;@H:"22BW:VVM]NMXV^&V$S6DKJ<R>:2X?&X@CP=65[AITNQ`+G`"I9
MY/\`9O\`'#E3DV\<I7;E/R5L%VRCQM@>+>:6'$^0,.MF)YQQY:L=OV-6NYY7
M:IG&]SD7++;=$OYO,OI(;A-RF&7$B]#1SRX?\R?,>MC0S<[J*XE:!X62PF!T
M9B!72GR[0IU%'RA4?@K;C_C!Y7^7Q?M$/2A<Y2YS#(^5S9""-0<Y_B`T@AK,
M%:M-OEGV0/$WEFX81<'>0_)CCPL5XQPCB')HO%O*=FQ*%S!@W'\"/;,>MO+#
M"X/<?QMUNWLFTXY;UM:D+[FU!5144-#!?[E?/B:^.ZN!/)"Y3"900=8:H()0
M+XL=(XUZ'R-L;*RC>6OMXY(XY0G5:R52YNH@@M!)T@M**A485K-$PVPV["HG
M']KB+;,8M^,1\/MT&&>U;?8H=K"S0XD4W1>V_26]H0!20OT4K77N[.DWMVXR
M7\A=+=.>Z1P0$ND)+B,$!)).24QML$6U06%M9L2"V8QK`22C8P`T$DJ4`&)*
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MSHPPC5&X%/"0$(!3X@5!`R&-4K\&/91YQRJ;Y$N^=]OR;C;%>6>*L7XKC6^R
M<_6/FKEV\_@5]@WI<DNW([F(N8Y'!INWA':CI:Q$&MHBWT(ULKJ*QN-O.N9Q
MO7;C'<AK6Z6M,3"U7N*EY>XJ4QSQ:`T5$M;NXL[S;W6ULUL%O;2Q*YQ<7"4!
MND-&G2UC5TH<#P*UL'Y2^TYXS^6>%\&8KFN1<QX/>O'C'F<3XWY,XJS"PXSR
M1$QT;5!L\RU7.[77#LCLLZ+=(MN:60B6]M>XBJVK=::B3N?/N]QO6LLNI@1(
M&X,D"J`X%2=)Q:001B%()!3:):;/#LC6A]G&YKF%V+F.;@K2$&(P<""#@44`
MAF<B>SCX^\B\#\:<`2.:_+3%K!QC.N-P@Y?B7+UFAYWE#UU60LT<RF7?`[WC
M5U`UD?(K-JBFT@"@$([D)=S)\S>LO7-#2(1'H;\"#BA).HXJ=6*Y(@"X'N@M
MGVS2NJ37J/QJB(H0:>0(*)@<ZC7-/86\0LLXOXJX?MG*?EAQ]A'%5DNMDCVW
M`^7['!#-1OUYF7^^W/.8M^X_R*US;O>+K<'W7WK?&MJ$CFU!$!`15--U[@32
M1MZ0B9&V-/RVMC5`!\6))+E<025`%-P:K>*2.-[NJ^9\KI%\;G/0%?N^$`!O
MA5!B25-3;"]G[P[B-YA`=M^?W''LV\?,=\;;KB]QR:VO6:/@V*E:WK->+:;6
M.,7B+F<:;9V)*32EN-(^&X6!3IJ+/$VX9N;7DAUS=1W&H8.BDA:6QF(_=#04
M1VI1@202#)MKF2UBV>&)-%DVX#5QZ@N?U1+P<#PTAJ9C$`B+N-_8R\0^.\8Y
M6QZ1GGDGR1<>6,!'B^=FW*/)>/97F6'8(W/M]P:QW`YP8#;;598;3MK9$>_"
MF'VPVUT[?'Y^T=:38%UQ',][<))'18M#W%06KB0`%YUYMUP_;-PLMPMT)MP\
M11N4QLU@AQ:T$$$AQQU5;S%?`3A7#^:.">=;5>.0W,Q\>N#XW`.#PYM\L3N/
MS<*B-SVVIF20FL78G3\BVW%RK\>5$87I]QTZNB9XO]]W$)U]PT=4?=&C+0,Q
MVJ7>BH[&AFT6&R@?\2VN73L/WM;QI()R+4R"`]M7>TS7M#110T45D=XW_P#D
M6]QK_O\`QI_EAANE._1B[S0/O]X]U?_4^IOP&_Q5^YI_J/P_^3N&Z<?^G!W'
MWT#[_?\`56KNFZ*&BBOGLS/W!/-QWSU\N>)L!@\1CXY^&N,6WDKD$+Y;9Q9W
MD>)+BC-SE6+'I,9IYM+O,NDH-KKFT6F@7U]-55ONL=IY>WWS'ND1?;6M[+;M
M:S`EVK3&2>`!"N/%<*N+G:C<;AY<V;;I!'>WMD9R]^+0&2%K\,,=(\(YU1[P
M-_\`N!O(/FOR+AX;S!QK:;WQCR;C7(.08>[A^$97C\KC25AN(9!G-LMUZR&=
M;W+=ET6_0K2L)7Q5GMN`CB5W;=6^X:-GV'?;NZ)DO+.Q=.UX&ALCH@LC-)^'
M4S4]IYL#0NJJF%C]PW7;(;)H;;7%ZR`L/B<T3/#&R:AA^6Y`\'[KBY1IQ+XO
MY;^<?D-Y6^TYS7S9.XTQGAKGCD[EW.N'<1XOR:ZMWZ+AZ8:PK6-\IVYI(L&_
M.PQ%@@=/N;'5<11%=,73'^7_`/L\MR\2;W:^6)[G`+"3IZC$QS!"$C,8*H-(
MN;QEYL]T_;V%NUOWJTA!<4E'3GTD\TD#CJ;]U`N#A5TN&O=BYMS;Q7]N[FC(
M8^"'E?D[Y+<B\5\FVRV0106<1PR=R<T+F/V\7R?BW-MC$X2.'1?F<6J)O32Y
MY&6VYV%NXEUL[R[)?O3,R1LB)`Y-UN<T\B-.8J=N=N()_.T-LU#8[NVSA+C@
MCI8VC4>+M#B[N"Y"F/P?[AON7\_P+3SA8+'XR6#QVY]N'-O'_#%DNV7P+1R7
M@>7839LEE8O>+O$NQ1)F=O/3\:(';5;FWIO9=)XFQ!I2TS?0W=CLSH;F4'>K
MC:'7T3X\6L:&Q3:"P$N/Y<FDN33&Y#(1@#Y!)8W6ZZ[6-_\`B;7=8K28/!:^
M0$OC>X$^%AU-UM:2KP$8H)(J-XJ^4GEKDJ>UYGOE#E-LY!>Y+\@?)IZRW:T7
M7(X%\9L>,XFW(N<3(H33\>!=7&[B!!#8=!QIAE$041=3I+C;]O9;;@V-QZ7E
M*2\>B'J1ZA(Q5PZI:#J=S(0H*9,-U<VWG#;PYO4;YEM+,#)K)#.^)^DC*(%-
M(PP755D.'O=T\WS?\>O(#F/!>%I/B[YE9%E6*\-8A@]U?D\H<?S;8]>H]KGY
M6^41&[RT+F//+):':3?=1"VJ-->RVLEB]VRWD@=OC]M-TQ[4Z0\`E#7!3AI<
M&K^((3J!%1IIXI8;G=K-A&TP7S;=S782%7=/4.1U>)#PQ&"&BO`_NM^X+DW)
M_BKF')^&<--^-?D#Y(Y[XY!%L3,UC/7+EC\[((L#)C-UCZ:##:2`VB-@1]Y6
MRKMW:]VIMM-/LUE?//SE_M3[I@;DPQL!(=_N)#@.#3FM/;TR6W9YKGV^+\C:
M;QD<FK,L>YH!;S^+2N>HY(*T2]WGD:X<=V'P\>M\9Z260>8/%M@D=F\W>S]N
M/,_$=YF5IDQBF`FWJR]N:+XHNJVT<3YJV:'@8+EW/X8B<LC]$J>T!OEKSA.B
MF.S!'IE8,\QZ*S4M7NR>XH=XD<OS\-X2=\9<5\S[]XQWZ(#$^/GU_B'F/[.6
MF?`58YQ((6ILP[KJ&1/&OZ*:?\M307UOY+?NKSU=WMWN:&?=<QCGJ>0<B`8_
M"<EIOS':.L[SS79[7&CMLA@E)?\`>9)&USDYG%3R!`"UI'[VN4W^Q>#]MOF-
M7N\XY<)7.'`H+-L=TFVJ:D6?G=I21$67`>COJP^T>UP-VTQZ*BIJ&_4SS=Y(
MA7\L[@\.'!P$$I0C(A0#CQI[9W-FVKS'/IQ_Q,SAS!TM((Y$+F*SUQ/SHY:\
M?.3/(3.;1:;=*XRL_FMQKQAR]*O$R]7J1;L,RS!V4'(83UQEO1,>"%<F@5U6
MQ!I4+KU75AY==!-:;!'?R".RNKF_C!5-,S97])7''2C2H]650-RBF,;'64+I
M=P@V6SF0*=49`ZF`^\%!U>NN'.'O@\]8)PSY%\]XEAN+3N.)'DS)\=_%Z].V
M.X72/.CV*+]1?,[N_P"'@X[DL)]6U%AAE$13.F_Y5U!LIIY['RW'=,,6Z[CU
M9T(/Y=LPHUI:BE[B0-6&3BF%6-W9VT%YOG1?U+*PBBC<00>I<2!26N&`C`QY
MJ@.=0_B'OO\`EWEGA?G>=Q<!Q&/SQ@W/O"_%D#);SAF08Y@V9V7E=_)&4F1[
M%>(K#]OEVU^RM`YL-V@.[J(M*S[R.3Y_RK:V@#3>74L,@<5(+8];'-X@'%>2
M)QJ#M[(GM\QONM3V6NV/NF%H0`MD8PL<<B0'$CGZ*MQ[J&1^X#CWM(W2^\A9
MYQOC_,-URNPM\B7?BY[(+!##"K]<#2TVK'9\58D]FXB3S`2SJ`F(E2NJ_P`Q
M101;IL-FTN-O\V(WXIJE&O3_`/Z\"2#GAA3_`)=E?-9;W?(W6++JQ88M9X2_
MGXT/A/#&LIN8;CRGXX\3>4G!J7JXQLTXQ\9O%6\GDUHY(SJ2$J\Y3FF&WN6$
M>X7BYD_$COC>NVXZB":A45J/34F_G9+N-XVS;ICM_,L=L&NR/3A#7*?PEX)`
MXA"<:F;-&V*R\IW$C0\W6UW\Y7@NM/2``>PY)5S&?=:\^/&K"^9>,N;;+PID
M.>8?XAXEY!\)Y!AS\RZV^):IEXPFRP;'FZ2&P>N=P<M.1*;LA23>^W5-R%77
MNZW@=)N<5HS3?VNY6\,I/P.;/(UAT#@07CN"X57;'M_4?Y<ZY+K"]M;I[`OC
M!MX)9!J/:8T[CG4T1//+W5<F/QWX(QR)XR0?(WR*P*Y\\6?)[TW<8V!XWQ7#
M9C#$QV1!<B]ZY93+=G-N&;54:$53JE52=/!IW+?;"-$VJ!K[@D_&9`',#%1`
MUOQ.."YD"H%O,R3:]JW1Q);N$YCA:!\`C):\O.*DN'A:,2,0#5<>:_?5\V8/
MCGQ)G?'O#&/8S?H7*')W#W/7)R8I?^3..(>;\73(]M*/8(]CA"L6%EJ..2X[
MA&O;!DA'<B5TR#;S7FU7$3C'M5YMS+F-KP=;G&1['M7ATPP.YI(%RQG-MWQP
M;S:R-ZFZ65^;>0M/A#>FQ[7Z<R'E^D<BP\Q4Y#Y^<B\@\X>/?-''UEL?,/(-
MR]NWG?DRVV/C^Y92U9<EY%PZX9!])C,+%C1L7)LB[6D6#;=BG)!Q5;!5^75?
M>:]NOO/3[&-SHXX;$M)\0#)9(VR2\?#$U[I"B:@P@YFI5D(+[8_+K+N0-+MZ
MFC=]PK';/>V/'(R.:U@50"X.2IA]FWW3N<_-'/\`/N-/)"\\<6O-K3:1O=AP
MNVX7DN`Y@S&:,PN`+;KU&&/=XL`AVN/`:*A)Z:TS[&U=MLMU;2%\L;@I!PTN
MR<0<0IR.1K/37$MO?V]K.PQ]0.`!!74W,`Y$@9BOHDU2U.H:**&BBAHHH:**
M&BBAHHH:**&BBAHHJF7GKY@VCP>\=,CYRGXC<,_NT:[XYB6'81:Y(PY>4YEF
M%XB6'';0DPFG_IFG[A-#>:`2H"+1*ZCN==37VU[5MUOU=SO9Q%$W@79DE.0!
M0<2@PSJ7!#`;?<+^\G$6WVL)DD=R`P`':YQ`7@JU@QY7^[5YJ2/&KRNX9S/Q
M@D^,?E=A/&</,HRV'DG\08@<:Y`LFWS\PQ_((\5MT+_8G01>R![D4DHHDFF=
MT8RYM-5C=.T07L45R1@6"1PZ6D_>;*X%JC!,0N-2-J'1NF.O8`L]I++;`A=;
MHVJ\.!^$Q@AR'C@:TF\/K?SAQK[0<&[\K9AR#/YED<.<@YU.R/,<XDYGE\&3
M>DO-WL3C66&:R7&F+8<=V,.Y2CB2!6HZE?N.?\=M][;V9Z<MM`UA<W!VM=;U
M(S+7/+-7%K159Y)/S^X65Q.>I!<W37`'%I80QH0'X6G27:>!)YUD[Q![@'/O
M$<VU\@6^'R)S[E&#>`6&<L7O#,FY+O:8Q?V4RE^/E&0NV88<\CR&V6(G912O
MF<<!A47IIR>Z@LW;_-,T-L67]G$]QQZ;)6-!>WD-3FJ,L22<*M19.O+?:X8W
M`7<ESN/3&`UF+%L;CQ&D'3R(``4UI+E'O18Q;;HW=L6XWBY7QAB_B=;/)KEG
M+HF0NA(PYW(+6,RP80TR$%V*5PF2T-DS?("!$KM]4U[>&.SN/-$;G+#93QP0
M._ORS>)B_A;H+7$A44BH5I;ON8/+SRUS)KQLKY&D$=**$Z7O[2'!S=)3ASJG
MOBA_]QY;O(&^\O8KDG#6#V#(,7XDS?E?C5K#^3RRN-D+&%PG;A(QO+:VB*[8
MKO)BBA(K7<1.J;?32-R+[#:-QOF`27=L&.+1\#FN<&N+7?RJN65>64;+O=MK
MLG/T6MU.(@3\8<<6JWD0#BN=7F\:O/;S/\F_#CF[R0F^)N/<8?2\67S*^!([
M7)`W-[/I<:S3WW)4Q7H#16-F"ZQW&U<&KBC2GQTCS5;R;3L5W+UBR^Z9)3_R
MXBU3*#Q<P*X-XHG&O?+[X=RW^SM0P/L.L6$DXND:Y!&0F`>4:7<%7A7SV^'?
M/OEY:,6X.Y'YFY8\@;C=?(N5Y$9#C4B?SC>+ICB1\4Q.6K3S..[71C0K?=)"
M=F.1@@$VA#37FZ-AM-IN;:UF/S+-C=.IQ(4AK'AWXG`$KF/34W;#\[-?7MQ$
MWI_YJU@+0``%D.M@"8`+I*8.%7U]N/W7/*#!..O'W%?(W@W)<BX@Y?R#D+">
M/O)?*>07;UE&6<CV/Z^]A9+E9I+,B3&L06^*33+SCB$NQ=M=JHDZ^D8VW#6Q
M!FXMVHW+(^$C86MUEQX..H$\?$"F-5VX`Q;EN\[!_P`(;NVW=PZ9F<0QK6\0
M-).&&=3/Q_[Y/DKDO!$KGV_^$%O@8IF^6VCB;QWCVCDLIMPY5YAOURGVZWV%
M^(]:QDVBR-E$$G9"ANH5!KZIX;>77LEBQA=N^X`211\.BUH=+(X\-`(0<54X
M`U[*(8YM_D$O_P#&[=(Z.5Y^+JKIAC:WBZ0@\>"!212OEWOK\J\.<1^0H\^^
M'DOCOR>X"G8,%VXM:S)R[83)L?(+DD;-D\S,8=MD'"L\,8J_4F@F(JOZ245-
M1)KBV?\`)"PF#RZ[=;S%WA;$]K=8\7$O:069+@0H(I^WLIRZX%XPL_X@N(0W
MQ.D87:#APTN!#N28U'5Z]U;+/*[Q"\=N;OPV'QO?I7GMQIQ5>;3P/S@EXCSK
M3,Q3,+JK%_GV^&U<OPN<L=$=MLMH0D*V!HJH.IC[46WF/RH&O<^*>WO'.:0K
M%B:S!,GG$%O%JY8U'LYFS;=YQ80P26]DUP*^(:I8AJ'%AQ(4<%'.IA\<??*R
M#G'S^O?AO/X8X]PK&[9R#E/'L"_Y!RTS:^3)3^,W%^UMW$\&N]MAA,*Z.1E<
M:CQW2=,"11W:5L<#=XVL;@7Z)'6_5#&^(CCH<,VN`/BY$%:8W<C:+D6I.IK9
M&,+G>$.4?$TY$$_">(3'&OHJU%I=#110T44-%%#110T44-%%#110T44-%%#1
M10T44-%%#110T44-%%#110T44-%%9'>-_P#Y%O<:_P"_\:?Y88;I3OT8N\T#
M[_>/=7__U?J;\!O\5?N:?ZC\/_D[ANG'_IP=Q]]`^_W_`%5J[INBAHHK(G"\
MU]N_&.<N?.;[/=[Q<L_\B+1#Q7EEJ[1I=RQR[VJS1VK8D%BTN1@:C,O1V!!V
MIFCB5]-9K_.[#;;;>[5)*MA-</F>UP4%[E7'EB2!P.(-:)VV;U<7.V[@V)+F
MT@Z4;FE"&%^OTG5QY85$7BUX;>V!XV\FWOF+B`N0Y%WO=KOEAAX_E657Z^X3
MC=IR876+K!QC%76HT.W178$@XR":O"W')11*T+38\^;`-JNMGN+WJVUQ&V.0
MR-+GO8TKI+CP<0TN0!2UN.!!=E\H[[)>QW\=F(Y62&1HC.EH<<50<CEVUXXA
M]MSVNN#>=L6YSX[MN;VW/L0R^^YUAMO?RFY3L6Q5Z]17X4ZR6/'G(7TULQ@&
MY1*U$`DH5*FJ(B:B0?N'Y9@@DV[_`"#I(76SX'A[2[5$]`6N)SP"#L)556IT
MOD#S-NPNKQVV-+731RD@AH$C':]8`*!SG(7X8H,DI4XW]I[VR.'>8;?S-A5A
MS2VY=8N2Y7*.+VYS,)TC$\4OEQ<O$B9:\9QU80PK;C;[U[<WQA4B56VT[GRK
MN\L?W$\K[79QV4>YET,-N8#K!>XQENDM<3B5&)YG$J:B;GY2\P[W=7EW>6*R
MW;^H[2=(,FL.,@`.#U;GP!("`X/3B_VSO;AX9\D'/(_#,-O[&=N7&^W;'L<N
M%\FW#C7"+]ET29'N>08?B#D8(5@NQ094EH'T<-61E'1-Q"J.[7Y^\MV]E-M]
MIN9<QT#XM3E,C(I`0YC7'%K7,\!'%GA--;IY9WN^N&7]Y9@/9.R4H0&R2Q$:
M'/:,'.#T>,O&`0@"44XQ]NWV^."LOPSD/%G>2!G8+RMF?+>'6Z]9C-N]@L>6
M9]"*V9`Q;[,Y;P9C6)R,YM;C"HH*HBJ1:9M/W"\JV%EM]O%?+:PV+K-@<W4L
M!TJURY_",\,3AC4VX\G^9=TFW:.2S'6N[B.YE1VG\V-[I&N"%&G4\KQ.'*D7
MA7VX?;"X;Y\R7EGCO$KZWF;#-PEVW%[M>9UTP#CYW*VU.3/X_P`7?BI#QR:^
M!NJ!@9JWW7*4KT>_[[Y>L=I-H_<7FUG@=%K(+I.F3BT..("8<T`QXTW<>2_,
M%[=_.2V#`\3:RT$!CI`GB+<BY<>_+E3A'ACVZL%#A[B[ZO,&7O'KE^X<X<>V
MS\0FR9C.=Y3)N4F3*EF$)%NEM>>N3RBRB!MV_I=%K['YW\MPOVK>6WQ!M+-U
MO&Y,.DYH:01Q*-&.&(K1M_:WSWN>W>8[ANTL-CN3VON#J`\3'->",?#BT<UJ
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M!0/+7-*CB-+B*;LO*?F.WCN;*"R'3FMW0N4YL<`"`>:(AJOT_A?V^UP_G3$+
MK'O%TQCRS.)E_(T>8_(FC+=C18MJA72RN_2UL3T48S:MFFXA<ZHO6FK&;<]F
M_P`;:;:^9WRL4SIF$?$U[WE[G`][CZ"14VP\G^;'W_S=M9-%Q#:MMBI&DQ,:
M@:0?B*>T`TE95XY>V],\6+!X07FS2&.&L7B6RX8Z$)V2QD]IN4Z:Y<8N3P,L
M:B]]C)9TMTU<DH"$>]15*+J9N7FG;-TO[2>XN--U`T",L!;H:`FEIX!V.H<2
M2<Z9VS]O?-%C97QL]N!M97.$K2X'6[!2X<2$"'@@IBX5X&>W#:N('O&6VN<G
MW'%;=R9AW+,R1D^8WNZ9-,R_"GY$G'7G;Y/C&V[;XRRW$-EIH$,3ZK6BI'W+
MSKLL5WL5[=W.B:P>YT)#2FIX1Q=GJ4)QX4U;^2_,EK:[H8[0&"]MG0R`N7\L
MH2`%\)4!*NYY$8]XR>3G$]PX#Y8G72;@]V<LKLJ#:93UKG[K&^W)MZC/1E_8
M+;C*;OE6J:I[WSUY5NKNVFNKX_,1SB9OA(&L*A[1XCA2+#RAYAL[.>*TM!\L
M^W,)Q!\!`!'?@,:KES%X;>`O,UWY8N7(,7)[G)YAPC`L!SO\/O<J/$EXUQN[
M:7<:8B"$0TB/,K98Z/.(I=Q!7HE:Z\=YU\J2RW:WQ+Y[\WCL#^L0A(Y#'*EV
MWE[S'#!M$<=DWI6=O)!$#_;E74#CB<2AX56_&?;Y]IO@K">8\2AIEQV[G3'8
M^'Y9<+UEDW(<EAXO$O-NOK&-XG<GH)R;);&KE:8Y=D4-%1I!6J)J?=^==AO(
M8+66Y=H9<,GU!I!=)$587N^\`>&56^R_MEYW?=0WVW;7JD9%(QH<X:6ME86/
MP)P):2%J9^>O%;VZ/,/B3B3#<^CY:U:.);1%L?'688E=;ABG(5GL%LC?A:V<
M\D9B.RW+7,$!)UH@VN.")=-1KK]P_+$^[W&Y2WQ%^]FF1&D![<$#@,T3#E5:
M[]O/-&R6;-B?8`6T<FIK2X.TO*E6G@2I6F%RO[?OM>YUP;@G#DZV9Q@^"\!6
M^X7"SO\`&>4WK$\EDL7/LN7Z3D4^&R\F23;Y)<"1+<=:5UQU*H2(FW5B?/&S
M;CN(NOGCU6VS8PQ"(Q&TDM:&Y8$N3B=155J):^3-_C@CLXK-OYMP7:B1K,A`
M:27YX@`%?PA$2B.!\2>TY98^&-8P5XL\+".%,TX,M%N?N%VMPO<?\@/W.9E3
M]TV,LS)%ZN<J>^:SD<;,7'45$K37L_F39KI^Y2NN"TW;(F.#0@:("#%H'W2U
MS0>(48BKQO[:>==MMK.U_P`8#''=/N`2X.+I)&&-^L\0Z,D$9H56GOX:^)OM
MQ>&&;RN2>%9&>7?.,RL$8(>6\CY)=,WN5NQVZ&I!!LTV9&CK;(<E2^</F6GJ
MNIMSYVVVQM1;S7(9'.A)T^)P&0<>0/"LO+Y&WB2Y;/):++;ES0-6#2?B(',C
M!>5:9+Y&\3#';E+D)I'<=DL(\L-[8#L1?OP<+T!13KU]4ZZKF^;=C<QL@NO`
M7(J'.AWEO=VO=&;;QAH=F,CDE<#\E>)6XD.:=]DC'GQW)40UMTA%>8:=-DW`
M14JHBXVJ?\-*D\U[)$R*1]R=+U3`\,*(O+6[S/FC9;C5&FK$8*%%<!\G^&SV
M[<F)=S/>K]$_00I5-ZTH!+\$7U73+?.7E]VG3>%#V&G7^5-[C:7.M0`.T46=
M\JN$F$57\L%A$C_4EWHKK>UKL%(2NZGS$`*B)\22B==6$>_;;+((HYB7'+`X
M^FFV>6=YD<&LM"22F?HI!Q#S/\?<Y@7&YX_F)2(=JNTVR3''K?(8[=QMYB$I
M@4.N_MJ7JGP1=(N/,6U6LG2GN"U_)#3]QY1WVV<UDMIXCR(-*K?EIP>ZIBWD
M[I*`;S3\/D?*FX0%%^Q3(T1$^-=,1^:]DD+M%T3ISP--3>5]YMTZML`J<1QH
ME=/,3@:SL.2)V5/M@V`&HC;))N%W&A>$``4J;B@2?*G7KIYGF/:9'%K)R2&D
MG`X`!<:]B\K;S-A';`XD9CA0/S$X&:C)+=RF0TVK3+ZBY;)0/"V]381-*F].
MJT7[%TTWS5LKR0+DKW&D2>6=WC=H=;A53`@U+?'/*F%<K6Z?=,)NBW2';)@0
M)IJR;!,RG&`D@VHGU^9EQ%_XZNK>YANF=2!ZMJEEAD@=IE:COLJ1=2*:K/?W
M&<:\8>7.$;AP!Y-7V[8]8^1%8N6.7FP-._CEAR'%Y\6YVC(K-*:__;7&S7-I
MIT.J;J4JE:ZI-WOK2PDL;J2\=;WT,G4AD:%<QPP)&6!!((48',&KC:HKJ87<
M45NV:UEC+)6.R<UW/M!Q!X$"LI.-?"?Q!7BSR`Q?D;R\YQ\@.4_(;#X/']\Y
M[Y2@/WK-L?PVWJ\<&Q6-JXW2X[8K;SI$>Z2B&B(E$1-1;_SAY=EL#8QR"$/N
MF3RN:WQ2OC<'-UX#`(>>:\*D67E[>H[N*X=%U1%;/AB:YV$39&EK]'>$]5;#
M1+UPE>_'X/'^'F=T<L#O'2<9A?$MBI<%@A9!LJW#L*79^H[/S[=VW=TKJK\T
M>?\`RKOPW/YS<>G\PXEVEI**5PIS8/*&^;'_`(UMM9ZQ:Z44C'3DJ54WQS\%
M?&SA_D6R<F6SDC(LYC6[QY3QKEXU?K##;M-YQ>(Y/"?-G]M]USZF:S.-LV=J
MAM^*UTJ]\_>43;[W97EZ'0[EH<X:3@&LT>'M(QY@Y5,_ZWYB;+M72M.G/974
ML[#J'Q3'5CV-.1]=(OCY[9WAUP#Q3Y+<3'DN1Y]CGDT$^T9$]D\5G\1QG#R"
MX-V7$;`\AR""VXZEQ58ZJHHJMC\J4U&N_P!R?)]SLMCLT^Y_FQ.#^KI.MTK0
M`R1W\S0.U:6SRQYB;OMWO,=GXGK^7J5C6O)+V@<GDE?:M5R\:_9U\9?'>7RY
M;%\B^1L]'D?C')>/;''O^'8S`C\>X_E;2PY$BV2HJ/R9]R9C(@`I.,;A3YD7
MX2+_`/<;RIN>R7.US[E^9,6ETNDZD802`,@'$!<<L*\LO)_F"PW*QW>&Q'2@
MEU-CU!"54*47"M4N#>.>)>#?%_&_%VS9M=KUC=FP2Y<>Q\DFVX&+G(B7:#,M
M[LYR.R;D=M]L)A$@[E&J)UTWOW[H>4/,4-U;3[@6=>W,)1IR+"Q0O'%:8V?R
M1YAV2[9>068<YEU\PA<,]8>F'!0E42M_MF^.&/X3XTX*7,^;.1?&RS\JV>P2
MUL$`7\B:Y2CE'NCUR;2401"MHK5E`4T/XTTS?_N'Y1E,[)MS+3)M;;(^$_`U
M2'C^92<,JD[9Y8W^.&[CM[$.;)N;+TJX8/8[4&=QR7.HF\?/:'\=^%LWPJ_7
M3RIYQY6X[XS8R>X\=\,YLA.\?83R%ES#D6Y\@V&V?BDF)`NY07%;[;;`U]5-
M?32YOW.\G26=Q"_<?^0^S=:ME+"7QQ.34UA_F3)4[*1=>2?,4]U)*++1#)>-
MN7QAXTOD826EW,M4H[/UU/T3VY_&!/""U>%4SD_-9-OQK)GLYX_Y9@0VK1F^
M#<@,RI4VR998_I)"M-3K))DJH"CP=Q$IN'U1V\_=#RI>R[%=Q;JZ&]V]C61R
M-:0[2$#P>QX`U#F`>%)B\F[]!-YD,FWB2VW.1[Y8W$$*Y4([6'$%,B1QJ,L2
M]KGA>P\,<XX+>?+OR%S+FKG\[2UGWDU?;BY,Y&N=NQQ'&[18)K,V?/;N6/,,
M.*#L1Z2K;Z(-:;431<_N5Y.N(;2TM[ML,3+ATT@#%$TCLW2`@`D?=.;22>->
M0>4_,=K/+/<6YDEZ`BC)>AA8,=,9&(!/Q#(C"FEQ%[/WBUQ1Q-9N.UY\Y%R>
M_P`;R.P;R,ON?W''K5"N-_N^`V*^8]8<:.S0Y/T%MMH1,@>(WFS-PC1%II__
M`.5?*+;K:;J*_P!(L_F"FDG6ZX:QKW$\"`QJ`4S%Y&\P`[YKL];[ZT9;$D@:
M&,>)`@X^(%5X'LI7M?M2^/7_`-;<'S%S/R>Y@Y#F6+D4^3\;XWR6W6YZVV7(
MFY'U5M:/*Q>*]3K9:37:RP;8HC2"%:#I&T?NEY0VF-HCOM<X8]K7EI!\8(+B
M`/$X@XDYG'.O=U\C>8]UCZ4EKHMRYA+0X$)&00UJ_"U0H`R&%;A)R]@:BI)=
MUHBHG_(<ZUZI3[=(/[C>4FMU'<L,/NGC2?\`I^_ZVQ_)^(]HKG_[R8"AB"W<
MD(JTK&=1.E/5:=/72/\`Y)\HY_Y'^DUZ[R=O[02;3VBO'_O/@'7_`/JSB[=R
M+2,ZOZ-:T_-I?_R-Y3U:/\CC_M-)'E#?BTN^4P[Q7)>;>.T%"6\E1?1/IG:U
M2M4IZU2G77G_`,C^4L1_D?Z32G>3M_:4-I[17-><>.44Q6\N5!M'53Z5W]`C
M0$5/M^9=*;^XOE-V(W`HB_":1_U+?,OE1FF8K@O/7&:*8K>W*MJJ'_TCU!5`
M0Z*M/7:NO3^XGE0(NX?TFO?^H;\B_)X=XX47_P#J%XLZ_P#]>-*+M5%AO5K_
M`$4UZW]PO*K@'#<,/]IKQWE+?&'2ZU"IS%?A^0O%;:`IW\D1Q*C_`-(ZOKZ(
M7V*NG3Y]\L@-<;XH<O":2WRIO;M26N6>(HD]Y*\1,$8NY"X/;1%,OH9&T4+T
M4B1*)KUOGORV\%S;TH/Y32_^H;Z4_P"*,?YA2=)\JN%HD<Y3^1R`:!!+_P#Y
MLI3(#_0<`-NX@+X+\4TL>>/+A*"]Q[C7O_3]^U!ORHU'^84C7/S(X$M*05FY
M3*;_`!%UAF,@VJ6:D<AT&6]]$HV*F:55:(B:=@\X[!<RLABO%D<4&'&GF>2?
M,,@N"VU:D0)=XAPY<Z,,^87`,F?)MD/-&YLR'(?BRFXD1]]([T?>CHNF"*`T
M4%2M>JZ?O/-.R6)(N+L`@IDN-0H_*V^2-:\6+@UP4$X*#2P?E%PRW'"263$C
M9F3:?]&]O0A1"5"#U%$14U&_[GY?Z0F^<\!*9&DGRUNXE,)MO&`N?"DS_P"K
MC@U'#:7*'D,/5%MTA*__`)5^.C_NGE_3J^<P1<C3@\K;T1J%MX>\5V_^K+A&
MJ)^TSU52J)^'2*KUIT2FEL\X;"_%MT4[C2'>6MW;G`/6*2)GF;P!`1%E97(;
MJJI3\+E*O1515I3TZ>NE'S;LC2AN2O\`M-)'ES=BI$`([Q4^X1FN/<AXS;<N
MQ:84^Q79LW(,HFB9)T&W":-5;/YAH8*G75[:W4-Y`RYMW+$[(U43P26TKH9F
MI(W.G7J13-#1161WC?\`^1;W&O\`O_&G^6&&Z4[]&+O-`^_WCW5__];ZF_`;
M_%7[FG^H_#_Y.X;IQ_Z<'<??0/O]_P!5:NZ;HH:**^4_#L1C3,EN31-['HT^
M<_(9"KB.*=Q?%AZM$'M*T2IT^/KKYWWB]C$36:%&LKVD9>JNW[393"3K.<D9
M:-*Y#GZ:OUQYBH$JL0RC+].XBN-JQW3J\R@OL.N)0&FT-@"!.I5K\%UC+V^9
M''I<W$GGXO\`3LK26[7&1Q<"&@*N34^LU8G'H-N-B7$;9:66%R[;Y''12CQ(
ML<'80@\B5-N:3ZN$*+Z`B:]O+BWCV.VDAQ;+(0_#%H`R7A3I?<,W-C&O(A;!
MJ&.#G.P)3L]YI9G6Q\"BSHXQ'3C.&C;*@:@K+J(@H0U3[QP`W)UH*^O763@O
MX1,':2YI!4$8`9#OI\MEE#XW>`IFN)/W@.6/KHM*CRI#++9QY$PS>*.Z".-C
MVHX`S+68Z:KU91\&V^VB;SW)Z(BZDVS8X8KATDI#RK<..(*]R4S<2L+[>$P#
MICQJ>!:H`[SF.XT3[-N%V'!NK;:O&\I/T!7'U+MJXJ.[3V*V#R)7;T5*Z]$Q
MTAO2!(XGEPI[JW#C--9R(K0H[>_F`OII)L$>`=ZS%N$)(ZX]:ICSI4;%Q@[>
M$<6JDBD"1C`J#Z+O_)K0WL0FVNT;!(0YNHM4X'F*K^I*V6*:XC5KB`6C,+B'
M=YP6J3<26^U9#Y0\SY1.%^1?L5EE:[1`ENJ#`0&P:$#C"Z*@J+4A0JIMWU3U
MU$W5SK6QL(FL.@IK!R5%]5=SWB>]L_(5C%"@@G`U$(I**"3W\*M]`O=T8N<:
M<]%5R$3I-.1S;-9;1')%A&P1%$5B1D-=Q+ZBE::K;6(/NF3B92`J<AV]G"N-
MS,#K"Y@T`/<,2>)'+M/"A<,5@/3CN0HH'%5T9%!$$<:0%85Q&MPHCII6I$OI
MUITT]%*ZW?)$I="G)/HF5-F$3V\!;'_R3D"<2>1.7;4<YC=\0LECOT:1?@1)
MMO?`H+AHXG_2QU)USY2)#%WNT5.@KTZ^FK3;X7ONX9+.$M\6.&#<,<>WA4W;
M=IW::5I?;_"Y5!*]@3D*K1QX%MFXG(ENK?[JD0)+-TA6QUJ-%C8RS/"1$,GG
MT=5YIQ4`"0:;2UTVVC(C+I'.<4RXBMENCI0+:)\$4.&#B,7/RR&78M2C:.3P
MDO1ES;#[7:,%S*ZRF[9<9+R?B#5FMT=&6(+;+:JZLP"80FW51`Z]$TADC-6A
MS=+,4/.JRXV1Q@F-EN9=?,:%8A34<<\DX)3FX_OMCNV5WXK9>9,V"];G)]LM
MET,BFVZ#]8D)HF5!$<=-YH!K7I54UE?-$BQP<(22%Y'A46]M+VWM8"^V`D:$
M>0,'>W.I,.(C+[9D`NM=U"[$E%%YAM%^=6W*J0UK5:[D55UD(;B0PO9(`YK7
M<<TY@U0.A:7!T,A8XC%#@3P4573FSE:=C4(\1PL?QCD6\NI$M%D9(H\YF+*?
MHKH@1=LR1A#/>J[$'KJSCMC&MXPEL#3][CV#GC6L\I[))?2MO]QC:RSC"N/`
MIE2EQ#P=;<6C,W_*VIESRV\,*]/%Z0$YJVSW_P#J2:B`XBM*\PZNTR3HM5IH
M=N,U\'VSHWB`')N!7GCPJQ\R^9WLC=;[6]D<8P!&&H##%/94L)8WW;VU*<D2
M(EJC0_HAM\4`(Y,KNH0H2]&Q_16J(GPU'B99]9S2UW2(QYKP"UA9=PNI(5G:
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M::K+*=T<$L<S7_)N])U#+N^RFKI@DGAD@8PW3'<<M!S`'%!PHJ;H.PK=9+K-
M>,+2PXW8Y*D-%8E3$-R*\Y5%^F'O(=:5"E*+75I;OEG@CM)E`858>"..1/I]
M%1Y+?IW,E[9Q*9$$@[N0]'JIK"U.9@WJ)*D1C:N<AM7$9CBI0Q@F90X;#B'3
ML,/.(9*BKO3^C2H;B9CYK=S`87`JF:#@.XXTB[@MW/M;IFOJ`\\"3@21R3`4
MR,LL)RL=O*2C9FN2HL(9T("%LT@XX['O5KC,="2-)E1"EMD2%5$>W%UZ)IMG
MW)T'R\4\@.IP:!^$("%/-<Z59R`W;FQM(8W42<U>5!_\+4'J2O$+(N-\)RBU
MXK9;`-GM&4XS,RJ&S<&1:A.W6]LL+"F1W8:*LIEL_O":,=_<%P5)=R+K0;JV
MW:\3N`Z@"XY$$8+],Z@WFW;E=6KS#<ZW,<`2#B&@^((>..'8AX4I6"-"BW4G
M;HX\Y9KHKPR%;;-H8SA1#9A25%4)[M192B\:]5]41.FL39/MF7#8[@.-J]=7
M8>![@<:1N'S4]NV6W:EY'@%XA5/I3"FT<-BZS+8[='2>F09TE=K;1A#@QHS,
M5N-/D$HJC[DAUDG-J]0;#JG5-6<#HP0>JXN)TN.0TMQ;Z,?52#+/;PR"*-&O
M8J]^!:/;Z37L;([<UO`0YS,@+1`>G-/79W<^\XDX2&W3)`MM#MD[E[:BB[6R
M&O5%T_;6EO<[A.YLZ01@G'@<P.T&JJYOI+?;H!+$EQ(X#`9C+4.T#`]HK4CP
M&C-Q\4Y,*,QV(4O.&9D4$DL2Q^]M+(NHV\P@IVP-N@BJ(HHFNG^7RQ\-S)&0
M8G/P3+*N?;VH=:->?S`PK@ASXU?K6@JCK(;W.[-^,7WAQNB$C<?)"V_%5[D+
MTUS;S_)TQ8N.2.^JMKY2CUB\"'-N/KJKW'.#FPRPG;$FW%#I1*(I+M5/R?\`
M#UUQ+<-Q+1GB.5=)MK0.)3``5=_#\4@PV&W"`E>;V.D"B@"\((F_8J)]VE"Z
M:RDMS!(\O<%<N1JU+9X8T9D0B\O12M88WX3E606R,B-P979O%D;,7%/NNAV;
MD/>7:TB(8I041*+UZUU[?2:H89F?""BG/LJ<YPFL[5\@)N&@MD1`"/NGOYTY
MECH4AY7W%5OLT5JJ5;]=Y@JI\RK7JB5U6>)[FN>S2W->=#7M;&0PJ]4[N^BC
M[#$1:F"-M*B+O)"-7J_HJ8K\03I^329>L7-+<TY\*<B(>T#47."X#!#7(PWB
M`"2`PIMN;P/:C`D5.XO2OJG5-+8R0/:P!4&?+&C4P-?(\H_).>&5>;N3A272
M`4<C``-$^'R=P*40P`JJB.?GU-OG&2Y:"%:P``_75;M0;#"\%R3/<21R[*+#
M#.5';:(5::H:A1T14E^!$/PVKZ5]=1G!0`H+,<>[A4ML@9*YY7J8`C[*X@C;
M3HAM,D0A4?O*"1"J*2)Z)7:OPTV$+?#D,ZE2.<F:..6%>7=R$/;0T:4Z45:&
M25555*]*JGII8<&N0?":9+=2N?\`%7"4X(/%VQ+:I"T'=6OW)IN4TV]%023U
M_+I6N%H<P<3@>SC2!U9`TJ,,^^O1-L[MVQY"51WDVHDB5HA=%HA?+Z:]2-C@
MZ5I<T$94A9G`MC<`Y#G10F2WT`3W-J*@-1120:I0]WR_#JOVZ2&M<7!N"DH2
M<NRE]1S(XW.*X>)![115XC544@5`<0$15,13<X2"VJ^JHF\:)^77K&.0$0$M
M&)*Y#*D/<PA=8!5$YG.BKS)"(`H;'!?H0H2+N!07YT)%I3>OK\4U*!C#&N*F
M1<NRF-3S)TP1T=*D]O*B:-&Z]\J@&XG76W%"HI&!3:,OTD)>X9)\*Z=C8`'Y
M!,<>67UTT9R$!*J@])Q'LI).(X@.-$Z3H*@`8T03(1>)QH4-?T6DV$E?COTI
MDK8X_$#I&7;CB?6*47.>\2,:`[V+C_"DV0QV%>>WN-]V0S()"`C,0H@LE(W*
M@U#[$^!==//:'Q`!IP*GL6DM>7/0G'2G8HS2FO%AWG,<QL?'&(?0Q;]<(\^\
MWJ[3B5YG&L2M"1FY]W=CKL^I?>N,MEMII%^8W:^B*NM=Y3\OR[_=FSE9H@8-
M3G#MX5&W"[M-HL;C=KS4Z!J,8P9OD.35Y("34:<?6"9:X=_<N^4MY?-N637A
M1N$?>-N)J#,?AQ$@L%48Z*PUN,=RBI>BZ1YA%O:[D=O@(,,"-!]OIJQO-Q_R
M$5C+#MGRI$0&G[Q7,N/'LIUNF:@:&@*)_I"=`!*"B;U5")1<IT6J4U4-G+9`
M6IKX_55<Z+6FK`@8)2-+!X@1V4^X<A\A===<1#>5*;6P;5$1`;`$1$1$H@II
M;I'!X#T!)6E-TZG$*0,%SX4D3(D::RZP^P,ONM"T(N(C@$.U:JX@H*MCNHE/
M54U+!$1$C&GJ@X)SX4CJ/:58[2W/N^VD.%:[?9&$9M,*+%$#<JW&:;9:1QU5
M,T5?ZR[JJJJJK5=)EGDED,DKEE)Q/;2Y)I+@++*2W+'B.SE20_)9<9';OV"X
M;9D=2)TD<(C6J(JI55HGVHE=/ZG-8&]@PX$\^RD]-S2[Q`DXY9#E7%V/&56B
M<$T154S0E2IBG_Z:4H2*BET+[=2&N9I:7!'CZ)44F9CGAN(-?A"P+,I6I#Y2
M=JA&C@T)(C9)U1UUPAH>Y/5$6J:M;,VKF7+9=8+@C0WGV]]5UP9G/MB&,0%7
M$E/538NMLDD%7&%59+("!(H/B0*JU052I-*I"O1>NEZ;J)ND/:6N`[_]:)'P
M3*QA0AQ*9?ZUMYX@,#&\>^/V0#MH$.8B@OJA?7R-U>J]:Z[AY8";)8A,=)]]
M<KWX)NMT%7$>ZK+ZOZIZ&BBLCO&__P`BWN-?]_XT_P`L,-TIWZ,7>:!]_O'N
MK__7^IOP&_Q5^YI_J/P_^3N&Z<?^G!W'WT#[_?\`56KNFZ*&BBOFQPB1#>R>
M5<K+:95WB.7&XVY]^)%[C0Q_JWGFI1N"BJZW5M-HHGS;EU\W7]M:R?EW-\&3
M%Y/=W]M?4=KML]K;".1@TN8".\BKO\;WT("-6VZN8J[=9I&^Q"M=R.WS78H!
MO22['N4>/NE,`*HX"$JHB:H[KRKUP)-OO6/<"I!(7'CVU77^YB.,POLY6Q#`
MNTJ!V89#D:D3'[P](S6_6J?;9=C;<AP/P1);*LMW96E=:<D-O**,N.+04%!4
ME0"K\=4VZ[5N-E91130.$1<XNY+@,_;7L4EG/;Q7<%P))VIJ'%H(5$Y<Z?2L
MR&I;K;K"-Q3H32DI%V&W&R%1W;4!1;).B^OK76:#((RV1KQK)1.(3ZC2GSND
MT`.+D^(Y+Q]?925C;)N.RI6]U&7YKXM=\MR._3JFX!%:*#:A2GVJNIUX"C)H
MQ^6%:._CW]]+N'L'3MR5ETZCW9#U+[Z\SK)";<1Y6D)]Q[<A$8HC1N&*&*$O
M5O:E51/C74(2M<QX<?S4"(<Q1'*]CPUH_).!P[,"O;4%<A<I8GPGF&.%E3R6
M^UYW#GP79SK1FP]+M=$BT`&R(#:;:4%IT4EKK;0V]Q=[+:B"U(D:XE3DX$8I
M5CMFV2;TZ_EMKEA;"1X5QYKVKPJ#F>'.3)N7ES1@.56RTOYM<7YLVWS;6X]"
M3'9<6EH&4@NBLC?'`'>HBHF5?AJOO-PC,#;*ZMM1:-(*XJWZ9UO8O,VTNV@[
M%>1E[(0/O9O!Q3EC4EN0/(I+S:"1W$IUCBF27!UB,]%=F[T)"`F#WH`HJH24
M):[=0[2XVZWAD>8G-)&DG//%*IG#R_+%)'(]S;AWB:,"B95*@V>^W`7F[S<(
MS45Q*OV^WQU`74$5Z.S3)'2WUJ5!3UIIBWOXHXW$-5S<G.Q)Y50EL$,HE@;]
M@/=4=9=Q1@=UL[[,RTP8BI$>C1K@VZH/QW'"0FE1Q:$?>D(@**UK7[$U.L]V
MO&`N,P#=2]A3[:L+/S)<V%T)XY2CQI<._L^NHWXRQ*3/Q:-BP/1X]X@QKQ`D
MVJ+%)B3'CVB\E,:>NII3ZV-<FU'=O2B"0TJB:ZK93FXBAEU*"U2`.?:*9\P7
M;S<FY`/R[BTASG+B0B-Y$=E)'(;&+.1!RF[,(_9LVEN0[0Y.[2M8L_&,F)T:
MR6,51"=4HZH#@[$1"JOII3CJ>731HTG`>BI^TS7#1T8$;=1`$KB7\B3P[12C
M@6*8SCEW.79K3=95QBQ+#!>GW">;,R0QDK3KK$=YI!,$APCCB0`*T6NJC?&6
M[=JG<^#46XCM*TSN]UN=["CI&M9(YV"8#3F13^YAS=,"QN-/;A,7#*KQ.:M-
MGM+;QHX^X<8T4^VV)O+L(>M$6GQ76*M;2.<LD>!&GQ!5")Q[35;Y<VJ7<;N:
M*4K:1MU%Y"!1P'9VTR>*^)SMWX?G683X>0\BSA*:_<9++3Y617VNR=IARQ4S
M2-$C_*(+3YJK\=*O-R?<-9:,B#8@<!S`X_PJ^W3?(PR;;[!ACM6C2=.3L<ZG
M&2:T;?!GO`CRD2MU!4VJJ'\M:@IK0MR)T345CF:HYB23BH'(5C#J(=&]ND)@
MN)).2=E=>R;K2NLME%V-`:--O*;GS?\`,-21$55-5HJIU2ND.5H>Z%@!.("\
M.^DL:US8V3O5H<CBB)Q'V=M,V2_"8N2Q#;0C)*HUN%$KM3OF3U%VEW`)$^T4
MT]"]H>UVE=+43F3F5IY'=-Y!S=F.#1EASI.G,N&;;S+;R*\FQ0WI\S`N(FQM
MH:DX("E$+T4M$_0.ET8\1&/9C3D;7ND<QQ`8U"J8Y8]U1_C#4@\ISYF;VDA6
MRZQ9+$:1(5A\VG[3!J++:"9K1U%151/Z=:FZMX9K#;)BT%K6%1Q*'A42XGZ,
MJ1O61Z`88#M)Y4YWG49-Z1#5]AY]MP'D/<^;U%^Y9^\3H"K1*TZ4KJ@CN09H
MPPD-*^$^RE/MG/BE5H5I"%$[S3.NMM&ZL-B)2.\CT64^X#8@5([PF4=`$JHT
MXB*I4IN5$U?6>Z-MWLBT!^O,.&0'*FHF.C:Z3`("!CQ.3O17!FRW6VSI?=F+
M+MR001(ZM*J+)1WNH\R]U[:+%=$2W)_5I7UU:7TT#7`PV_C(Q+<OHE,NO+6]
ML_#'ID#D4E%X9<EKG,:ER;*^TPC+K,&!.;3M1@%V0ZZP;A,/FVA*Y-49@)\Z
M]&U'X:A[;;F207!ET6X<'$YIBFGOXU$=<1PW$$3P>J[P@#-2<^Y?;50N->1?
MV_YMQZP7*P-Q0XUXED60I$]Y)`2KBX^DAYYI@P1&7;?`22"=:B5%1:4UT#>W
MA]DK&M/A:%Y@XE??5MN.WRV%C/=,NW".9X4(B'+/MP7LJU4DOIA-M(W;[3;C
M:*_0C0U3>B!15!TR0DVI\=8R(:6O?TAF4/96:>3('%LQ4@$@=N!I&E.O0WI:
M(+)/OR3AE'1%!'4."+#X=M>A/*Z:HOQ4JZ:EE<R25L;E>@"9+AC[TI<<391%
MXB(=.K'@=2#T85^`S*MZ2NXP+$F0;L<K>:";AH;0;3<`OFCJT\2$->JIZ:E6
MLXBB=<EB2N);IS4(BD577MOUY([74L;,=628DI]M:7^W^.S`<S:[:MJWDD)%
M10V;E*VH7<V__/N]?CKI?D9Y.VSM1`)/JK"^;XPS<(B"H+/KJ_6MM62K-[SL
MLJW?(N+$!I7'6H]_0*)5%W'$J*K]JHE?RTUR3]T93''MN)TH[ZJZ'Y%8'"_<
M40%OUU"6.VR-9@M+,@")R3(BQV&600W$=)U!(W1]1:!5^8OAK@-V7R*X2`JN
M'U5U^QA$A>C5:T*O!*L[':^D806U;1P$1)+*44AWI\B5ZDB*B5Z>NJ!P>KD(
MQ3V4V\B1^+3HX<J1[L<QN1:)*-J:?4_2.@@"B!'DE1QXS3J#35:]/5=3P&S1
MOMGN1K`#CSI-JUH=.X/.DCUID._E2O<BC1(DB2^2H$6.^\)"@[NVP"F"A_ZB
M*E-OQT\V..1S8V289`\R<JK6/N.J/"5<X*,<.^FO8;M'R&UQ[RTW($)1*!,3
MFR!4$'#;--OI\RA5%U&D8(+AW4:"Z+`XY]U74\3[=Y@U@!P4%N/KHVML;EL3
M&W$D''1M77`9WHY'8;)5[KJAU)L56J_#2X'2&5\D<1<T`D@!4'TXU%FE9$(F
MR/#9"<">)]-,*_VO)+-!G7K&+@+Q$".NV^[@\]:Y91$W*K9H2E`56EJ2B))2
MBTU+M9([J>)L[=,9(;JX#DO.K*S=MTDT=C>-`?FK4UX\4X]E*&$Y]9,L<E6P
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M(S7,G^%&4CI25!"(.`_C0F-,MMP),5N1<!:B,K/8,>PV[(W%W&&7TJ7:-/0J
M>NK.Y9MKH[-]J]Y?TQU%RU\4JO;)N'_*B<&L)<>F54Z>[LI%BEVVHHRP[#CF
MXW&ZB:_*M11LE_3)LJ*J?D5=1WDXOB7H-!U)RX=ZGW5)#20"\A\V"(./&BCD
MCM/QF2:5]SZ=YTE5/FH`BX*N(B?,+Q"@]/MTJ")SFB>?PQ`C,>^G'.:H#`LC
MN`Y\4[J3[C#?<EC*A37`%(S;8L.M(C*FK0JZ[7?N38XG1*4II][K3Q>$XE0>
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M3))(""`2K4P5QXKF*NKO?K$;;)LDFP6Q@C,;V%X#G:T*OQ&)*]PJ3X%NMEJ;
MAVBW-,6^*P1A&CH)(T@(V1N$A4H*HI;B5>I*NJ5QEFE>Y[UD.))Y_75!<3RR
M@W#W*X\$YUV<C$8(XX"*#I*`F*4"0J#UVJOZ2(B:<TNT"0@D$H#SJ()1JT`^
M,-4BD22<:/&"7(D,M`PH(AN.`B55%5!HXJ*M`HB4^":?#'.5SF%TC4(I,>MY
M,<+<7*H%-`K[!>N+\%%!M6Q)WO4)L"0FE-LA/:C;I$I"@@*_,J_DU80VSIHG
M2-E`0$D<?IV4XZTF9$USF$KA_K7F91*(BH]VF.S'`&D8[FP4-3>3JBNJJE\Q
M>O34-[H06@$.:3GV_P"M-0MD5R^$C/L'#UBFZ48A=%0!14EV$HEN:^<-P(0?
MHHHBJ)5/CJ1X!"X:P3J]-/F0&0DM*!M<W601$,U5'`+Z?:OHI5ZJJ>@BBI7^
ME=.18N<"WP"H<TCL"W)W&B#K9F8Q@:07GSVMU5!(U$5+:!_U:BB_TZL8TB.)
M11ARJ+I#P#\2')%I.5Y\F@4405155-BK7=Z"WN]$<Z?H_E_+J7&'%K<<5X>P
M4Q)%&'`("2,>RMO/%157@C!%)%$EA25)"':2$LQ^M4^VNNZ^5W%VQV))Q0^\
MURG?VM;NUV&_"H]U6'UH*IJ&BBLCO&__`,BWN-?]_P"-/\L,-TIWZ,7>:!]_
MO'NK_]#ZF_`;_%7[FG^H_#_Y.X;IQ_Z<'<??0/O]_P!5:NZ;HH:**R!P3CN/
MB%W&);(XMI#D3&)!-`J@9//`X,HC6@F2"*I_^5>FOCCS!.YMY?.N'DS=0JF0
MQ.%?4EGN3[^RAD:!TC&W23G@$0U.=SAV20D9+A!ARI#'UFUV;%:=WM41MT>\
M;>YAK;Z(/JE?R:IV3W;G1BWD2,]I&0S/U57L?(QD^N0AB@H.WX>_(K3(<PO(
MK:W-N&,7I9UME"DQ<#O-7[)(9%&W`9MDDU.3:I9;=H.LF"H):TVW^<I6`VUZ
M.I:#PN#L<L%Q^JD75C87.@OC,4Z)U6%"">)`S[0:.Y!/OUJM@O,72[V(C5B%
M])=68^0VE#./O%!GN*W<HI(241%10^"JNI\47E#=Y&/BBDAO""Y%5IQX*:@V
M[-RMI9`X131C$$>%R#B0B%>51+@N=<KV]@XS&+Q<JM;;LAB-,9>^B=:02>><
MDFI-$LF+)<5%I^D)T3TU1;E;[8RY<R*=S2"5&?#ARRKH>X[/M;K:VNS<].XD
M8TN"]GL/+O-*LK*.?+S":9LF`XQ#E&;N\+_<W@%6=Q#0NRR1J\0+^DJTZZJV
MQ[0QY5[U'(84AEAL-LYHN;Z0P:0I;C]!59[E,S/E++,@NN=/V''[EQK9;@XQ
M87R65#M4E)#+(?A3DEM0G7*ZH>Y$1*"M==-V6W:[;7Q,NQTVL+PO(G``5/,.
MW^6VV\UG`^9EV6M\(QQ"JY,@T8+5K<!R^R2<;M5KL$V1-D6^#;HLHU0FVF+@
MD5!DQGGC3M&^)"J*@HJ!2B:YU>VLD-S,^<Z27.)QQS3#O%9S<+$NN7W!MPUC
MGG2#RX4^I;UUC%WX;:DXH-DV9&CH/*:IWH[8JBT)$7UTV#;/:QHB(C7%>7VU
M3`2-DDZLJD<LQR]%?LFY2FV)#SX[)+;#2(PT0?.9-H2`XFU**-*5^-:KJ*Z)
MC%*#H`X\53`)4R%^H!H*RN!(Q3MQJ*XT2+D%SB'<5F2$(WAEC)WLQ%>;D`C*
M"+!]LC:(E$52@JB574AS6CJP.8"K5:G`(JISJ`T!CXY0]Q*^-<<>PU%?)DNY
M<5\G6K/[<U-C66?;EM,CZ'[Y9,U``QB2XY_*B3([2HA)555.NM9Y9W.5ENV$
M2GJLR[6K71=KMK7>]HGVJ>-AE:=8)X=H/8M1Q9KA;OJ8-^_9.[Y0%TNS[;)W
M;ZH;?C<.XBZL^,W$)/IADQC<7[X$ZUUJAN5EJ?'-<#42@'%>"\J7-:S21M;#
M(R.2-BN((5^GBO(\J_+5EL3!K]<IF>FXW'^NC1;'%@S2>DN06S=?L[T]H:`Y
M'BL(FTE7</I2FJG>[:_NK;I6\P$3LQS!JYBMK;>K*&"RMF]48N<1AJ1'`=IX
MT_N.L*D\JY%<.4YSTB2W+"Z6?#`)5<&U10%-]T$'U[*.N"R8`2)T0EHNJJ\A
M#(+;;P06:?$1FHXN-8W?MTCV."XVFT=TW@#64S/(5-.+(,9';&R6QJ"Z$<2,
MQ-U6.P+E24111/N5]:K^767>";AK[AQ+2"`0.`Y5FS,Q\+GPIJ`&I2JDTK$V
M^U.<'Z=IZ&XT;+*B]60CZJBNKM451%0$5$1%JJ>NIEL8F1AK%5[B$/:,*;N"
M9`T./C:`Y>8_UI-NEN<N1(PS)G15$F7$^A=-@P!H55QHG07JT:*JD")UT[9J
MTRK&TR,)`!"COI,I9+&QKWN#"%)!3N%(RVNWQ;@3K+R33,&EHXTJ.`K3)CVV
M5)?FH"K6OQKHE:=+'QG\MV8'`_57L#W%A8\$$%,3\0YDT0;;1PW#54`S!6V(
MP(2$A"E=_<6E$&A*M/CIDQETD@;@@'=C]=3)G.C#6$X/&9]QJ.;`WW,GSEQC
M8S/6[Q4:?5QQ2,3M$-2$#)5$:-[D3IU76K+V#:;!^4F.GLQ0^NJJZ!Z[0X'I
MM8CL/2,NVG(929<R)&;4UCJ2MR)#X-MJU*;=K5W;]X2NK^BXB]*T5$1-5D,/
M7<#K_,!1"$Q7/NIN>\E@35$=!:J@X)CAW]E$YC*NOSHDN(U'[AR!&0/="5$;
M[!HR=1H)B+E#45_23\JIJ9H?)<N9<QMS^(8%O;W#.O(],-HV6"0N<&DEIQ#E
M.6/T%%457.ZVKDEZ*U]('U4,5`WCVHA1P#<A/]]Q[MF14VUK\-2RNLQ1O+H`
M`01F#V<UX]E0'M!8V8M"E00[#_1.'.O+</MBY"9FQFX<V3'E724"JK$7Z-2%
MB$^J(A/O_3/;3V_IFBHJ[11=3+8-B#H!,TQ/<KNQ.![0,*B279EDBFZ#A)$/
M#VDXD@<E]59_W"1:N._*.XDB-V^QY!8RQO\`$T"B3+A=`FW>V]YM:H#+8-"+
MB^O:$JU1:+JW!ESM<H@>0Q,%_EQ3NYUT!L$FX^6(Y)07W$3M1'+'$]Z9=J5=
M&4CI2E<(PG2HIBS&BBV&V3*CE4'%`$V?1QR"J;NI)T]-9V(NFNFRR.UEOPM&
M1([!AI';6!E8V"/I0G2'8EQX-.:_S$8)35F-?6JZ$EPCD"NQ'=B(JW$I;KKI
MJ:T,&P-4K\51.GKJ-@V27J?&2?0Y5/JP2GVZC!%T`.FF(/%@4>LUR>(11)2F
M??(G6:JIFZ8`V1NNO]Q545<W4#\B)UU+D(TB9S4<21VGM-0H0[J&%K5`Q4Y#
ML%:E^"YJ[A.8NHFQL\BA*TTM%-D%M@*C9DB)N5:[OC3=KJODYX?8W#AEK'NX
MUSKS2HNX&NS#3[^%7DUL*R]4O\K;.5UN>#]OHXPS=R`MU%1*QNXG3KU"NN*_
MNZ_2-H`<A(?]5=0_;D-__DG/"M5H]:U&]FLD>,S'D]EEUT!$0=<1#<:Z;#03
M5-VVJ==?.\DKG]1SGXCASKJZAB1M4+RIV(#1*%=V]P2%"]`56R011SIN]*HG
MY%UX8V.BU.0A>%0I)I&N<UH`';]5%+B(ELV-.B$9!607;04%I*BH@E:"*>N[
MUIJ7")9>NZ*)6!F)X#LI+'-B:WK/4O<C0N)/`T9F0V9R`T!`30(AMN&XG;<`
M`3<V`=4(BK3XUTV^%K260/&+54E,AEWT13=,OEF:=6I"`,5)P/=1-;2L6*J-
M"K+;`;FHB[4%%4JT#9T0:JJJOY=1'0N<R1[Y4(S.:FI3+UO68W2'$X*!PH.Q
M?J&W`.5,C"<<6GRBO*WW636IL.*%%5@OBGQTW#>36W5+"A<$*<>P_93%Q;PW
M3F=2-K@UZ@'Z9US6#$</9)!TX:,(TS'$W.VXXZ.QRH[OT3&E?R:FVWC<T:CH
MX\@3QIIY$;W2L:T7"X'CI'"F??N/+)D++2Q'G,;NMK;[MJO=D`(]QC$V=!9,
MP04F133])IW<BHFI<-[-`^6&1[3`X%0[$."CU'D:M;;=IK5@<&&6-Q&J-Q);
MEGV'M%%<?O\`=QG1L<R0X$;).R^]$6&?W-PBPG.T4D6S;;%IU[<ADV->B_8F
MI=QM@AMX+RTN621R9M'Q,(R![.51;AD,W6FMH)/E0<2[^8*AYIDM/F2PU%?=
MJ1?I.*A&*(B[_0A$5IU3XI357+TX)7:&N+N)/&HL,CY86@$(0,NRD:XDC<)]
MQH72?99<E,.,JAR",`50%O=T.AT^5>E5_+IVS+W.+](5I!RPSXT[("U\8#D:
M2&E>WE42VWD?Z&\6JT9N^,6[7>R!>'90P6XD&/.)Q`.V2#B#],RZ`."HIZJM
M:ZM-RMW[A*^>VC:QY.(&7>!4VRVHRP7KK`E\$$@8%*N((/B"XD*/14K.W>$[
M#&2,GZB&H'],<-L70D.*1D@-D%$4G!5515HFJ^.W=*QS)9"S2#F,%6J:9KXI
M',?$LA(!!*$?0TW#59PJ[V940S!''^_VTVQA6,B!VA4B:-3':XH^J*G7UUXT
M%C&!KRXM)4\",AZJEEPC#=31H.`')V>='4[@HW'`*H9F&^FX&5-242,UZ]2]
M*UI3IKQSI9`1([\M<.WE2&&,J]I23V^BB+VYEL4!!/\`2)02JE0E4S3JBK1%
M*E/A733&J6M=B,\*\<XN<^0#Q#B>0HDXX3A*:$BF:*OH@A4FB3N;!2B/-(XH
MHGV%^74@ND#&M=C&50=O`TP@+B(_"0,?KIB9)DMCLUN.-=9PPY#Z)\C2./RW
M0>!8ZM1F&!)W^LE5V]%34_;K>^OGM;91.>_4/AX`<#4D6DDCNHUGY0&9P;V%
M330PS/,7SZ(\MG<DA.M9@,R!/AR+?*!M5>9)UV)*$77`>>C(0G14V*GVZLKG
M;IMN6&>(QREWA!XMQ7TJ@I-]87UG*U\P:^!S?C!#@J`@*/2HIP2735XFR<!3
M>17!%L4_00"!4*B)M7YT3X(J:A-U]5DH")AZ>=06,!C*JBXTARD:5D4=*02N
M-T;44511RJ*BJJ$B-("!ZIZZE,+6P22%Y$P/A[>T5Y*V1UP&,C&@C'NIKW"P
M?62&G[@#<IU@B.&"@J=A2$=RN@7R.JY153<BT1::\CN)VH(CAQYKQJ8V:.+5
M\N"QR9IP[*ZOQ8JQ'@)MI1%0(W49;JTXTBDUL%$1$)':)1*)1-389C&UTD;4
M'$]ZCWFH#Y)]3(Q([%<%SIJ&\[,D2&:B+H$!(*`H`HD*$3H]:DIDM:>@^B:C
MS'J/B>R,!KO4M2+=HBCD!D7[.5<WXY(.W<2*CCE4)*$:;B'H0K047:J]/MTO
MIB,Z7!2M,OG<2HP"4G25;;V"**XXB?,8I5H-Z(([:UWD*5ZK\=6+"&(YWQ$G
MNQR2HB/?J80C>WC2//C.-L@2K04<4`(7%[N]*KOW=5V[573Q<YD6HE<4"YTE
MFCJ%H:A3%*0C>1M.T\XZJK([H[1$D0P!!0_A\Y=%IZ;=.QR2$'3(5U>ZE/A:
MYZM:,&9]_"MP_%1%'@G!JJBJL26JK55JI37U555>M>NN_P#E0$;#8*03I/O-
M<=\P%=VNRB8CW58C6BJEH:**R.\;_P#R+>XU_P!_XT_RPPW2G?HQ=YH'W^\>
MZO_1^IOP&_Q5^YI_J/P_^3N&Z<?^G!W'WT#[_?\`56KNFZ*&BBL^X+#$$Y2@
MAU=G$TR!N)WR!3)H!)2394U1**JU2G77Q5NCQ=W]VV-?%([/OY?77TA:LFCL
MH6R!H+8]03X<>?V4J2X@RJ-*\DDF_I143%5<-6(IN/=L$3_EF\)"B_:/Y=0[
MEC8V/9`Y8RP!>.H8D]Q5.=.6DKF-'4C1Q*]FDD`*>?9VT=D.QE!&HS;K*?3Q
M(]'B%T5%I.U_TB"(]H3K\:]?75?=&WD#&QM<TMC&I>)XD=E>VMK-"^66>0/!
M>XX*$7\7/T5RN4.WSXL>)=40V5(5D(^TKB['$-QO?M14-M0)$KZ(J:0QLK'1
M-:"UXQ[4.7LKQDKHI;B:)J\!R49]U-5Z5;L,N#ML@QW9EE_"FKT(PT!'[=V7
MDBSV6HE=[L(B=$Q4>J?-Z]-7=U;02_+_`"UP27$`EP3Q%JH3V(0O'"G8I+N]
MMGW-TD<H>6IF"W-I[\*2LNR:_P!PLMV/",:N,S(0BOQ;<3[;<2/'?DQ7/IK@
MJ23`9?TCR"2-BHJ2]-,V^WVS9(G7=^T-!&`4D\TY4JUZ4<K(+B4_+'%Q[N&&
M./.J.N8FVL^SXM<,3R*-<I+L*1=KU<8RO7=ID70^KG3G1>>!N9,D$IHB(8@A
M=/36DEFDLQ\S%?1F!"&HH!/`>BNDLW"QFL7SQ#QM:@"^%41`.P5>Z!8+-8[5
M`MUO@O);F604!%KH*."AN2)1*B&;SQIU+HJ*JZQ$EU-<RR2SRCK%RD^FL&^X
MD>YY.+\1GZDHA-N+$"&,B&IL@#I@O?\`O6``U40<;$4KN;7K_1TU);,/$3('
M%IX<5J`]DCB4:`2%'>.'IIOOI]=(%;=<2?\`^I-^7%EMHH-E);`5?;--KIHZ
MT5`1:B%?R:F.N&_*1QRCQ*H`3#E3-O&_YULD9(\"%?:/J6F:]+NEDO3X1;-+
ME1I4IMZWM@^RTVY$;:?&[?4#4JOM.*VZVB*/052BJO2861?+-O'`F4$8\$R`
MTY\<:9<+A\AAC:D:8@`ZE/$$X4G\DL0\V7$L*;?5RXS)GX_)[VW>-FM+1A(,
MD;7>$AUR0`)U2BUU+V^XDLK>\OG(7'P@C)79!/0M:;8M=@7W!+OE@W3I.8)[
M>-*ETE2;59T@0U3<^C4*`$>*V4:`2F#;C,MQ3/>1I55)1JM?756PRR3Q/<H`
M=XUS/%?LJLO+HAUT\.U22'P:3B@.`]'&JR<YXQ#Q>7A0P499MN9W-ZT9&\PT
MK:1WGV01^ZLN/"\\PXR#AH*4I]GKK<;3=B5SF&1SX@,''EDGHX5M?*.X7#K6
MZ,C"V\B:'@<"1CCV.XU87`)MJA\;6.U0&[@$"%MMS3P2@"4^##SJM/&\VA-(
M!-HIJ))\=JT751N<4L-S=,)2)R'43CCEZJQ&_=2ZW1U_,UO7<2=(^$<Z=\3Z
MF3$@$V$9QW[Q)+C9[)1=EPAC=TMO4G&]I+7I3XZJ9V,$,1C=U`[`I]UWU<^V
MH=M(QDKVR-+-/`Y$'C],JX.29:F]'.(VR0F)D\"]X^]N5*K1:"IHO54KKP/C
M9"6/:#(2%*J?]14PQ]21LC)/R&C`(@'UD5Z^E;DN%(5YUMUAA64%'";B&M45
M2':BN_4!6BKZ:]"2&2*.XT/"$+Q[%YTTXZ$DD@+HW<!CZ>24V+JLDV0%@`(U
M4/J'S<5%*)W76W%0NA[R5%HO_P`RUT_;3AL<HD5Q^F-+=!BTQ@`X$`]RG"OU
MJWL6]AID5%EN$V+C,5&7'G6F5>%QI])9N*I;R*I(O]4M6[XI)HY'N02("0,T
MX'M[:A/G#YV%Q\6I%.2IB.RJYP\N@P>9LCQ>Z*<1J^MVJ9:G7V%%@I#$!.XS
M4"5$&2R!5Z=*:LIK<W&SV:.4L+LNTGW5IW;3+)MCKZW(,C<'8J?1W<:F=(C#
M3+J`ZVVC+[I*9N/.NNM]Q2;;.J4;<&.5$]4(%3K5-0(YG"-Y<UI<$`)Y#GV]
MM8M\'2E:W4Y25+1SYX\.SFM>([X216$]#&Z-OMD##R.$Q<([W:>=BB$DCVO+
M]2V((+@].G6B:EV\\4[1"X-)=@.:G+'D.VFY8)K<.NHI=+VE2$4(,P1P7LI&
M28<F*KLEU^,ZRJD]'E-`#;+!DT2.."SM4'VR*A(BJAFE4TF1S(QKUN.G`@X8
M<_7A3LC"Y6",%K@H*KXN6.:\#PI+[\*&PX"B*,-,ORY#SIJVTTC$<#>D/$:[
M`8CN(2I6@DA*BKT74NW:^?I1VS-34!*YEV9]5>N@DEEC#2!(H:.[`>LY5FQF
M-\L?)_D)=#@H_G=D2?9(-KMEF,K,5[E1L5O<>[/6V[2&3CQ8MN<;;5\]J]Q!
MVAZ+K=0-%A8BXO7^`9@<W8(!ZJZ1ML3=OV46P<DA*$YIBHU#CQP'8:L+A^<<
MG8HY!P3/N.9UPO4AF9^&YUB\Z(^U(L\%LX[T1VUO/-%*N:--*1J)HJHFX45=
M1([6VNH97[2X?-.)PR3F!Z*QF[65A<_FQ3-Z8Q<"H"DX=PX5,EEO4.\1I=RM
MJ!=Q>%`J\+C;S90CCMO_`%<10!^%)J`A\]"7:5$5.JU;;2[M'R&X@+I7!4/X
M1F?2E9BZA=&8X8G:(VDG#%5R`.1&=(]R^I5A]UQ02630]]PEHKC:NT,T==(4
M$>R-=M$Z:BO<YY\3#UEPY'[.RO86D$Z5T+GR[_36G7M_7&W7'`,U<M]PC7%0
MRJ,$EV,^V\#;R6ME$:5&R+MD(IZ+KJ_DMDC;"X,K-+S)EZ*YUYPC,5]`W2C>
MGAVXU?O6RK(U6OGJ`,RX8H:-&Z^T-P1FG_+!55E5)Q.G_I^W7"OWF>&NV-O,
M2?\`XUU/]N`X,W5Q(Z0TJO/%*BHHSK0DJ-MCVQ)P5;).V+Q"5$<)$_Y3BHE:
M=>FN!/8S60X$L7AG72'2Z@-!5YYCZ95X)5:9-5-T&'090D95%(TKM>"BH1TW
MI452BT2F@.87%P;B4I$T76=&'@:VDG#V=E$[W'6;9Y\9MQU''EA]QQ5)IHXB
M2`(D?>!2(!-/E)$&NW6AV)_R[98>H`)W:2N2<"3PQJ+<:FSV\G2!Z37.',/3
M(#C]M';/)CW5V0%N"*U'MA#'E0U<WN19:#M>CBXJ"@L@0?(0HHT7U73^^V%P
M98I'6T8C:T%P!"$\<5RJ!9W#F6SGW<K^M(XZ"G#MYFE2=%=(0;00W'5QTP?#
M:(`JT:5$JI"HK55^*ZS-Q$^)9`T!_(.!`'`5-LY&DG5(2P9*#J)/L'92(#CQ
M@I)M[8D+1DV*B9$A+MINZ((I_37432R3P@:0F)S3MPJTE8V)S0%<[-*.B:0T
M4&5-U?F5T2&B-$="4AJE23=]B^FGS.V!S66[W!F"DU%Z1N27R,#<4"5Q!8RN
MA&9)P''!5TW#%.VJD2?=H2THZA*JHGV+HEB=*T,;*"YV*KBE>M<]@<^1G@;@
MG;S[:+3;5;I:,%*C.ORXT@7(,EAL".&H)U?%PJ$BD2(A!6A#5-3[.1C6*Y4!
M33@A[ZAS2743GMA<`US<57U)EW&B@%*>=)3?%FJ*IN/`/9".*DH`(E^BI)T3
MXIHU.=,'8![PN>&GEZ*><R&*!&KI:BI\1<?JHDSVT1\9"B/SB\VZX6Y&@%47
M;VQ12'Y:*J=56J:8%PX.$8:T-YC#.I;FZVME!.IH1$5?31'M09T4H;S<1QAV
M6X\\Z;`HZFVA[B5T=A!TK]JZ>CGE,1AC`UEQ)/'`<#7A+[>9ES&YS3&P!H!P
M)/-,Z:.,W@Y\6"RYB5XQ0Y$(KK:+;.89")=;&#JLQKU#<C*;?TLALA(FE43;
M4D14UH]RV+<-IAM;FXLRZ&>,.&*YA5/=45\D%S+.6;DR5S'EKW#-K^+2O'D:
M7#C]@FB>(U?-^1V]JB).@J@^J41#^[1Q.@UHB"NLWU9'.=J0,;ER'HIX1L$7
MA:22B@XX#BO.DZ:1-(0-$;Q*!2";'>@[P`Q!DE2FXD(EZ?D77K9FD/$C@Z-1
MV+0+;4#,T:7@$#B$YUX14'_J!)]'1;%SL;ZJ2I\SL;<@IV^ZJ_EIZ:?CN(F.
MC+0`UOJ//&F)6OT.8YA<"?5A@4IONVPY+$AE9,T"!I7S-N0+#D=TW`CH*.H!
M;D&B(`HBKN6OP77L<S2V60`*W%$X`Y4\3TS`K?$XZ>>8I&XWG1>$>2;]F<W'
M)^<6/,K3$&^S77XUTR?%"LIO?3/8_!?".,JVS6Y1J^R*HXA-"2*J:Z7Y&\X6
M>T226^XV;&12D(Y@R&.??4'S)MT_F;8K;;8+_HW%J]Q8T^%DFM%#W#[S=(3A
MC7CR.\BO'//L,EO\?W.]3.;K:KS.&6>Q8A=X>4-7(VW6V[??4F6^-;ALTJB*
M:./J.VA(M4UT'S'N?E7=]L,D]PUQ&+2B%?LJH\D>5?.^T[CT+^!K?+S_`-9S
MY&EFGB6(XG6."#LJ">,PYGFV6-+Y<B8W9[K-CM(S8L?!4N$%*HKHW.X*Z]#>
M><JJT#T7I\=</O'V,FD6D9#AQ<<QW<ZWN^-\OVUY)'L<TLL`<NI^`/#PA%3O
MJ1SW,-?3MLOB"O**]S8:;&@6JH%5)55:I3UU$E)U+U=6(3#Z950L:)M3W!#C
MQ[?KIO+,1Z03([T1SYVR<1P7$`4H2F*_HJB)1$ZJJ)I440.DL.)P^AKW0YNL
M.0:1Z*\2YH$GTQ=MH.R9B))\[X,&2J>Q.I&;BK1$^'KJ6YDG39&]S1$UN?I7
MUU'TQJ+@-<7%V0X<`/MII70#AI"N#SA1P;-0)`;%SOLO"E1$JIMV+\W2JH@J
MBZ>8V0QLU,_+>/">-/0%C^K"BOX\$--I<RLDF2,&'-9G2">[#+;#4E`<=)5!
M'1>[),N1:JJD2+TIJ1!;RME8R1N&I3V>NF[BTGAMWW!8<&]F7VT8>*Z,*3;<
M5EX4KO,T(`<;$D0`#?0Q1TJ[5^Q-3G,C87AI<Y@.&&%5S7]41&=P87#FI4CC
M29-[!(X\V#C$EQ]NL)5[S$=E`VE1VB;GB-*HB=*:]D-D]IE8YPE48<,,_2:\
M@^9$@BE`,(!\0S/*FP8MLOJ.TG44:-DM155)"3MK7_EF(=57X4TRQ(Y`X.5I
M4H>VIFGJL=P(P]%;E>*(J/`V!BM>D&0GS+5?_P!X_3K\?Z=?0GE`)Y?V_P#V
MGWFN+^9<-YO`O$>X58G6EJBH:**R.\;_`/R+>XU_W_C3_+##=*=^C%WF@??[
MQ[J__]+ZF_`;_%7[FG^H_#_Y.X;IQ_Z<'<??0/O]_P!5:NZ;HH:**I!+;C/R
MW#:-EV.W,*AM;3;`^\[U&E:O@:[:)Z+77Q)?@-O;EK"X.#CPQ5<17T?;7!=:
MP/9XE;ZPGNHX:H[VUCBC8LRS-#$:FZAH(N;JH)`C2B2(GI\RZ@23NZ?0<@`<
M2O?V<?JIJ$-5TSG%Y+$3@$R';SI&G6PI4E7&Y#S`JP48FP7:@@*JZ9BE:B2F
MB?,E%HFD1W#&$M,(Q'+'"K&*4M8W7F"#@<R3Q/=PHZ##9Q!COKL(6UC(Z1$N
MY`%`5LE544D=6JZAND>V9CPX@@*OU>C*FY"`\E@!8NI._%?15;<]G7'CW*\3
MN,/O2H&5WRU62=]:Z3SC=F9NT5F?!@N.;B8%P[E'=;`47=V#3XJNM9;3QWFV
M7;)(P7LTO!`"JAQ*<LCWUH+&T@W6SO`'%LT#2[D"7!`O/`.7E5I9$5F2#C1.
M*RKNV/&)IZA*XN[NJ@"B;20%6O7Y=472:Z.*5I(<XGT&L5'*^.32G@:%*\N_
MERYU'F4I;+1D&'WXT1%N%R<QN2KH;"<:F-.$UN6A*X+;T9-E?2NG6ZG02P*7
M.;XDX+D?95Q9W%Q+;7MK$U6EH>"#DA]F!QIY.*"B\T\VX'=W-@VE5J`I6M5H
MBI44_/JL8UNMY(1!ZP>=)`<`US'!P"$GMIHW3'X4^W/1^^5O(E%6C0$,]^]"
MVTH@*B>BU^"Z]C8T.=(P^%OUTY*]TA:R-OC*8]@I%+$8D!I\KA<Q$I;+4=7&
M$(#!AOMDH,J)HHFBBB5Z+J3;-U:0]-(4@KV\N-.&XU.#XH#U`4(3/Z9U'=_X
M\L%^8EMQI5XM$N.0N1Y<2ZSFW7!;4R)*(\@(V\'Z8I^EJQ@W1\<KVAK7VXP(
M(^+[,:L=OOI8'NE<&N!*%I`.?O(Y]M0;8L#EXUR=9E*^37Y4FVW5SZV?)'MN
MPFA8<0U4B[P11<5`-HE03(MU=:)UXV_VZ2.*$-B:X:B@P[N9[:MKS=F&QG@^
M1:&9@HHU?5S[*M(%JM<<P1J/$*8\V#X$*(,<Y"L;0D*E51QK<M1KJ@BN0]N@
M.):00IS1:RC;</6=WA8UW`=G"JH\WL9%:[AA4^]I9W8C\RY6:,J-.2@9N=S8
M5N(9PWB1LVT(MV]%JV2(NM1LLEN^&[@A),S6@JO+@/KK9;-#"ZVNBV5V#6N5
M$)0J5/+LY5/6.V%;%B=JL8=IJ)'AM*ZV+##PJ3J"X\\BD!$I...+6M5ZZH9]
MQDGE>KB'@E0[$>BLSN<3+B]EN'`D$X%I(]E')L%(\P'XA$TTK?81IE=C8;$W
M>B)4D5%I^3X:B,)BA#P=37'/D>/\*;A;&]SX7AI("@'E7!UB.<1YG?*$WE;/
M='>()(D!(ZJBXBJZ'SC1:=:+32XY&-N(WEI.(P3/T5Y(USX'QD)@?1Z:;EZR
M!CNR[3,@RXLF1:CD1WFT=6'(?B$V2(CS6QQJ02)1Q*)5%5>JZMF1$R=>.-JL
M56D`_3"J)QD;;NA=*=&H([BBY5U<[2Q([2N-,N-LLDB#0P4G`#:P1.*IT:&M
M:]?55U6`O?("!]Y4X=QJW$P;'J5!I3M[338Y#SBQ\?6B3E^3.O\`TR#"LUOM
MEM5IR9=[M.[$2WVB'$15*4[-E."B`B5VHJK\NM59VUQ<7\+@"0YB%,@,N&?9
MVU$VZU??=>WC`U%Q=J/``*2IRJD^,NX?RMF/*.0<A1>2(>=VSZ.U8?AV'LNN
M!:)#;`*+\^\QW&;?&E,@*"8)O5HJHJ*M4UT/I;=M]G+;R%HD8U`,"3S6KR[N
M-SVQNVV]EI-B[&1SC@>X<:DZPYWSMA\)RWY)Q/$S>WN$T,"1$R=JWY$U#%I(
MS036?PZ0S+N#;0;C/</<<6G366$NQ3ROME(<<,!@O=2-PL+6]>R[M[AT3U4@
M(6]N*X!>%,W*O*Y<->)F5P?R$%VENL1+6W<6V(U@F2'S!DOK)\5AU]A&E<51
M5!$U(:BNI]AM&WLF,WS`>P9@#WGAAQKVT\O3;H1$V[8(B<2N(',#C3N@7WE_
M.;9]7;\7Q?CARY,%WBR2XW#+[BTRVR*;OH!9M<<25H:[5<)1-:^NO)_\#'/J
MD+GR$?""H4##'CSJJFLV;;</@,AEB8?B0`'Z984CO<499DTZV-9ER/,N^)V]
M`=N6-V6U#C3&1]JC[HY!)BS'G)ME<(`CK'4J&.[=7?KV+>MO@C?%9VP$@*$G
M!`0H)/?38EZ<ANHXPUQ)+3GCD@[>-*V88I9&83$_&X%JQK),9:%ZRW"U6N)&
M2`]O%Y6`B1&V!>BRXJ.-DE>B$55Z]84%_<W;NC=2:[=[L0N6.!'=]53+*^=&
M][+E[C"X(57'^(&1]%&H5\@Y=BENNSD9'Q=CU<ARE%TK1<(QJ,B.R\@]UF2U
M*4J*"BJHM5TU&;C;)'QVTYZ@*AW#L3OJLNXG,NW,#4@YC[P(XCZZK9S%CW(&
M.W2QW;!<QO%J#([[9+#*AMN%NW7.:L)IZ=L<%RY$/5K>57!:HFY=J:UUKN+]
MRBCCNX@;EC"Y>8Y&KC99-JGAN(;V)O3#7:2>)`5.SF.VG[;>$(;5R*3E>9YA
METAPOJ2;N=\GQ[%'+M(+34:U,NHV]'WK54<K2B]=5[KGQ.)#8QV#U51W>]PM
MA-O:V;6L'8%./$ULCX!6:S67`,T8LEOAV^.>5,*3<-AMAL]EL:$#/M"*&Y2M
M57KKH'DB;KV=Z\/<1U>/=7)O.+YG7MMUFHX1_75]M;:LA4(\O,`;ME><:<<%
MEN8GR.*TC>_MBKAE5!H*=:*NN'_O##+*[93'#K`$B]GPXFND>0YA'#N33*UF
MIS,^*+A4(O"R;+-#;CMO.$.P2[J$^/7M$0I1S:*]:53KKA1MRWHNE\,+E0C'
M$<ZZ3'*'.E`!DE:T9X(#Q"_3"B4Z`>YMI'4$/NE#:X-41%51'8!(J&1#\?MT
MRT=-Y1K7$CUBGF7#7,=BCEY<?3PKH38,(#"BOW2*DD"5%)XU-%+H2B*IM6GJ
MM-)EE`?$V.`M1N*%5*YIPIN-7]65T@<"?"4R"<Z0RL\A;H3\63]$UM)92M"B
M(Z7Z33;I(J(XB)Z_9JQCW"2&%]O,_6PA5.2\L:E#Y5UF0Z#\XE!V<W#E2A=9
M=PB1)?X9"8D3`A5C,$ZC037P_1#ZA6S&.COQHBTU7SNBF>W6QK(W9EH44S9V
M[/!UIWN:'<<P.?:E$FWKNMH&44%6+TW".6Y;`+OPUD""GV$D4#NHA)3H*5TE
ML8#^HV1KHPY"N&',#C3\@@,Q@$I^7<X`/^\/1P]=-CCW,+IFD6=*EV=NUG"D
MN0S-PRI(=12$]K1`AQC!1ZHN[4B]L+:SE8QMP)`YNKU\*G;M8Q;:^.*.[ZC2
M`<!E]H[J?3@"VK=%`U;%UR@T$&S"E'7BI7<OY/MU6N!#FO:0'#W57M<H<7:M
M*@*>/8*Z`<AI",G13NF!"(4JB[5]!IU'=3IHMY^B)'`H[WFFY81*6,8"@X\A
M25<#<%1W*VB`CC;HD*&"_/\`=H8(*U*JK_PU+,ZV[8G-`D:![>%)BMVF5TK2
MXL)]OV4PLNF7V-CEQDXE%AS,B5$2`W.^2*ZN]!>;-42J+VT545/R:+,V_P`P
MTW*B''OJYL8K>::-M[(66V.K3FB5^-3;C'C0'IMO64^8`DN-!<;,8S_;%7%!
MIY0[C1N(HHE?32E9-+)IE#8PJ%,^^F#!#&9&1/)C+L"<PU:2X&6XKD=GXKQ.
MWY'/FY;Q[:[]9LJM3R2AGVUQM(<=6+FY3LDR1BBLIO,31*IZ+KL/FW>+&X\G
M^7XH9]=P@!0XA&X]XK/V6R;G8;KY@O[FQ8S;YW-?&Y!H<I)!:.:9Y)3@7M"+
M2NGO-O<@FJH)H:$E41$5=J*E*_!:47UUQG66/>6Y`Y'+'*K9LFI@<T8D</31
M%9)N*B_*@@J)1=HD:DHH2DB)1*(JJB_'2SB]V">C/N%*1K/""2</57EUP4,A
M4A;!*`&T%K7KVZA3H1"O4OAI#1K*%Z(,.7^M-.#1CI)))XY#E27+E"VB[!1T
MGW$4J=3`6P^5LDIU3>:K553J5?AJ07]1VES](P]W+EA3;&HTN:Q7`:L?9C2*
MY+<;=>=-ME"1L!:0JN$#>Y`HCB]"(U]?ZJ=/74@/4/1OC&'8<<*\=&US0`]%
M*FD1BV-.24NQQ(;5PE(H/R&F&?K))173;`GW]@O*2(E%$J[4V_#4YWB:T,>K
M!GPQXCT94A\[V-,+IG:!P4IZ!E7>6JB:O(C)-*:.*+KA$+)-DC>XU_2+<:[D
MIT14_)I36?F:VA!Q[*B//Y1:2>H<DXBF](1P#4^K;BHX=#W.DAD2UI\J+]XB
M^O6FD/U"0Z"A[>?&I+`PQ'4,`0/12.]%CK&5PS<1X&7.TC(HKANJ0(.]RA*`
MB.[\M-3;22*1FISBWPG`8J?JI+WSQS&-C`YF"D\!2=(M4M5:JB"4MLEC.$C9
MJ,;H)*"_,8/$XB*/I7KTIJ;$UK6_G0:@\!.P?;3<ETPN(BD#0P^+M/"FG>L5
MCW:)':E2)9)!?62K:RB9"0Z0_25-H:#VQ:-5)$^.I+7F&%VC2'#$',YY`?73
M<-X63%X9@X)EZ5]E-65BUC&'%9@0V[84%IF-%<MR]AR.W'2C9,JVHDJ&JU45
MK5%ZZ;^8EE<-17PY\T_C3[KN=KGN>_6UY4@X@D_97Y%?GQG%BW,W9+81W>U<
M!<6@JA(,<'6:&YN(26JC\?2FIT3[<LZ3I'LGTE%*A3P[JJ[X$_GPPMZ8(4?>
M*YIW>ZN#LA@Z+&%QW>0^M:D(BHF`U1-A"J5ZT73#P8T#1_&EM64$N=I3@.'?
M2!/%M"(&7?J1(`=;<&J&F[K0U)"4GTIM+X=-/S-:)&=-RL15[>7:E$,K]*O9
MI()!^WNK<+Q7%1X)P-%2B_A[RTJBTK*>7U37T%Y1!'E[;@<]'UUQ_P`RG5O5
MZ?YOJJPNM)5%0T45D=XW_P#D6]QK_O\`QI_EAANE._1B[S0/O]X]U?_3^IOP
M&_Q5^YI_J/P_^3N&Z<?^G!W'WT#[_?\`56KNFZ*&BBL^,XN[^.L6*4W/BX[%
MF9E:8;Q.,,R5D+<7Y391T==:5&)4PS0U5/C\>NOD5]LZ6]N7'"0AP)7B#[_9
M7?MMA9<B6)K72-;&2`/#@`%[VCAQI\?2I&GJVB=]MOZCZEU'$I0A%IA.GS&!
M.NDJKT_Y?36;?8Q0"8S-U.#R-2X-*88\BJI3WS<D[&M:YL908$8GT=@&)[:\
M!]Y*=;5Y76V]O94142:03!6Q5=RDZXB4K^5=5]_%\N[I-)=*6XD<%I^)SS#K
MT`!>/'#/L%>)4%H`1M4!UY"9<W$JHB.COH3:KNZDJJJZBAI=&8P<3B>[C3\<
MY>X/+48%3^/U55[F>[VBZ<A\!V2==;>Y`M?)SU\NIK*54@W*+BUX8QNW_=JC
M*)+N#Z[@-51%%"VJJ533[#;2OM]P:UCF@Q%K>[4"XGU"KK;&2V]EN]PRW<=<
M**.P@N(QY>O*K.K'=04$#D(B2@6,2;5^GE$)";^_JIC(5.J+5*:AO<(P]@:T
MQQD9Y*>+>6/LK'.D<7]9[M#Y`1S\*A`1V5$'-#DQRRX^\T\\,N/EL*0#",BA
M[(YFX*-$I*"]\$5=J(BI_P`-2=KC9(Z:2.3\V1CU!R'=5WLETZVGDB=:#28D
M5?1[`E2XS+CRSCD4@T==8CF++@_>(KS'>0*;J]%%=W7X4UG"`Q\C9'EV"?53
M8;*V-VF,!JX]RT5)1WB:(VXXYW%`:)15WH!*(JJBJBB^OJBZ1U&-/3`[\*?!
M#_""CFIQX4C6/N2F"9O;!?5,OR'$)@1-L&^^^VT*&Y\Y[&A#<72I+]FG)HXH
MW0@Z@UX!!'`<<*#=.,SQ;O:"T`$'F0O#W<*1)MM&5<7'B(0:AM@Y&+<@._4*
M1-@&P:=OY25:U6O5-+C820UH)&.',<S4M@<U[97-&LYIE_K5;_(6Y#:+58+E
M`E@SEENN?>:;1KNI+M9"ZV_;Y0=5*/+Z5%47JE=:7:+1TLEU;N!;'H7/C@00
ME:;R]:MNWSLF9KLWM()7(\"%XBG3AW(N'9FPU(L-U9B2X$5IRXVZ3L8D1@98
M#>*-$M3BLJ2B*HM%1-5=W9W=HX13@Z7.S&6)X<J7?>7+^P*OA/1=DX8@GAZ:
MKAS?RQAF>VQNU8M=9(WS#+X4X[PD86K4WVE-F4.]U]/J2<V[0H"I7T]=:[8+
M2YMIO&P"U<THOQ8YJ>ZK?:=DO+(ON;HZ6S1:=.K$KD@]IIZ6/R`PV[8E:&)\
M\HEQC.0K7=&PC.-L(ZV.U7`D-"KABZTWO7HM%6B]-,WFQN%Q))`T.A=XAC[*
MI+[8=PANIHRWPY@]IHW>^=<1:E.L?B)2OIIP.P[?9V),B9+9!![9N2M[,;:Z
M/PZ#TII@;/>MMR-(CB>1\:('=E4C-DNG2/DN$ZC"F&"]G/"DA_DSE"X)</\`
MV_XAE@T3)RH5SR61&MXHCJ]QQ\6VWI1R#)"4FQ5!3[>G33O^-L8S&^]OP^49
MABX)VX5.M+>Q+W"_N$AR09]JY>NHU_;GR)N>8_LC#D62U7&38V[R_P#C=I@2
MMC*/@T\ML.&VJBP+B;51U7"W=>G35Q$S:(K83O8>FXD`*?$1P-6_^$V1]D^^
MU+"U^D)PP7'M/.I`A<9<S/X[<7KKR6P>237WIX#`QZS1V8H$`.+"9<&&T\*"
M*[5+;O(555K6NJZ2ZV\31]*P:(@/2>:^BL^V\V<3@&%8P=.)[<^VJ:8O9N3,
M]Y7GX??\VNLZ5B-T3)#N**^J8\[;D2$?X8U].,$9DMF60`ZVFYI?F14)$II!
MN$>WV-O=VL6D+X0`BD_96XW*+:[+:I)X(6MCEC#?]RA:T5QRQV/#[3;H%JC+
M;XK(`R)M*X#LB:9J3LB3))>\Y+==<4R-5)255KK,7ETZX(N95ZQS',KQ]%<F
MDN99I7L#CH&1Y#D!WT<>"$3JR10D?`FB8H^X2]UO=WG7VE,$VDH[M]>B>B::
MAFB`#NG^>B@=JXX4R63ZG1"0Z7*IY!,,::F10W<LMLBRS96\9+>^`XZXKC<:
MXV][\0M$T'W$)[?!NS#1BG42!"0JHJHLNQW>XANGM=)X'JT@9%IS7ZC4F$.V
M\-E;J(9GS1<?6*;MIGR)T%AJ_15C7.$L1JZHQ1B+<$,VX\F[P"842^FGMM.$
M@T#:XE*?:\YMO!(R5S-5J6DMY@Y9]E/W3'.$QLY@KRJG,+BA!R3^-*%PB@V(
M.L-J(36VR00)2"0#8,L_>+NH"JZ)$8_`DKTW43UX&MA:FE[!E]Y`,^W@:BP2
M&6-T<F+HY'9\"<R.83$&D:4W'[KJO-(*LNHI-B"`T+;S`;#5Q*[U(%5%K6C:
M%\::F"0Q-$@TM)<B#A@GMIAQ;*#&W,A%/-5P[DQI#MS4"([*MT'ML_6`EQ=C
MF^C(%+)?HW9S+0[:FZC8)5$^8NI)ZZE1NDE8S4]82H0]F7OJ+=]0Z)B#K:0U
M<53E[ZCGEQ)-GD\?E;X@OBSR7@D9T7#62:'*N[,5&VWS(CC2!<DJ>]$Z*J)6
M@HB:/;!&V\8UH`6(M4%2H'TPIG;AU8-QC<_`M.!"8!<OKY@T\;F2LR7H2=]6
M5W1C4D%!(VB4A1]P#0E1N0J=24J[4^&JB5AB?+%K<@P/`<U-0(6BX(E:QH<'
M%![,*T[\$B0\'S$E7<ZN21!>)$V";@6X4WB%$1*A1%5/54KKJ'D1['[=<EF?
M4"]Z5@?.#2R]MVJ=.@HO?5Z-;FLC5;N9)EN7-<+LTS?(>N=GOQ0[><PVHK[T
M9^WN*\Y&1%;<<CBBJ)DGRI5$]=<H_=%KC:6?A)C\0(!3DGH7.NA^28I_EMRN
MHCI;&]BN14#M0]M,66T*,@94(%:;14[BB;<D254^GC!]TR%4^9>BDB_9KY^F
M?#%&QK&Z@\'`Y@]G*N@6YE,TC0]"TYIFU/O..)[.5)!#WD1R.IMNDI-N*H)W
M!H*JTK9C1$15KU7K35>7-8XO9K9&<#WGF:L"TG2V4-<T'4$)3M[:3IQN]U3:
M.DQ>V&S:A,(`K\[BH8[M^VOS4ZKZII4D0B<'/"1H"BXE<_11;2M?&YK0H4A<
M05X"E%H$,3$Y1`A@CCBI\P/(@]4[:BFS?_\`+1-0^J7221D_E@%#P3NI3R]H
MA?T_S%1.1[^ROQ"&2J-LDWL;H0D--J;"VD"@J53<*]=>2LF=`QSVI`3X2<%'
M$@5ZV9C'N:XGJY$<<>VC,I'V=I"X"DC1DVXT!_?(B?+')E*"WO3IO3JFD-CA
M=.%>FD:L_949\KNF=$)/B`()RYE>/=7AAI&HILMH$=]!`E(`0]RJJJBN]*N.
M=52J]5339`E<YS2J*2!R_A3SWXM<7*PX8G(]G91`V`VNLQR6.:[GE403MJXJ
MIO4>XABA&B=$5%2NFHP9'N)7+CRY5*UEH!<%&`[:)JZ[M0HH"XZCB&:$:#0-
MU%43V*0$VE2Z41=2FQOG>T=1"SV^C*O)']$`$$M<.&7:5I*>!)/<4OG!^AQW
M@)6OE51'YG`(2<6J52M.FFVQN8[\QVDAR%<:DN<P,_+7X?JP`HL;(FIL+]21
M(YO)Q7D&@IU`142HB#7\FGVQD3AQ:US<NS'C2Q,&P!^HMPY8_0T0D.BXZAM1
MU4FDWB0"BDV@HB+5*DA&M*E5:(O77KV`O+&8`GAR^JD-D?T]3\QF3[NVN26^
M&Q(F7BW6M1<GHB37$:;5]K8:]E5<$$*2#R*6Y7%51)!0>E=:5AMKK9S#;1GJ
M0G5CC@?B1W?P2J>2>]9>1QW%T.@1X6KAZN![LZXOH`LD1J*HXBDC:BJ.JA&H
MFAJ*HB*J=*?#UUFBC3J8_!/74\$E6N;XLE^RD@VP9;/MUCHTTTVRXJ54FT)4
M%HQ)"4FU1:=5]%]=.=0$O?*TN>BC$X=N%>EKPT,A>`U4[^>=-6[Y5;[9(B@^
M4@V9)"@O1XZOM@!*BF1FJU5"7XJO3;2NK*TL9[H`$-.&HM&8"*OJX4X&".%[
M@[BF*8DY4?:<C/*+0_/5QC[\FP141#-*MJF[[\FMI(B_HC\>NFE9U=&K3BBH
MGAXX<ZB/9*QAU#)2B^KU44)YA\9`.DCX-C(:C.**HX+KBD0-'M(1,D$4^?U%
M4Z=-."1C6AB#Q+CQ"X"O-#VN8]N#B`4[.)HC'4H3"B9NO/L..`^VU\JA(-XT
M<=)$1*&5**M*K\5T_P!(MUB4II&/HP4]]()#S&8FA'HB]N8HF\VKC(#1:JZ;
M@.C5.I-D5*JJ[5,15"2BUTF-S71=-H(>7<\$Y>FG-(;*'2?`![>8I'E2GB(7
MR<5]]]1;0&_F-Q$!6Q%1(A!I%#[/CI;G]:8/>"$P/VTXV`:3"TJW$X]N-)9(
MXVPKI_<OD;*-MLFA(`HW]X#CB(*JM51:4^.@QB)SQ$XIP&2#F:\=JD+&Z03Q
M/V4DO;FWNX&\)&PZ*IHJ"`(!4JJJNY%Z_P#X:L;9VEKAU$<2./+&H5Q""NF(
M%@SYKE2/*5PD'8)"I=7$KN#J6]7$_I2M4^.FWN8'EA)Q/'UX4]$UH8)"`.RF
M\\VTTX/87>YL%'W57HBD.XE5?11$52E/2G34Z,E[HPS"$#V\Z9<#T722#Q$X
M=U>%WB;2MDT@-U=3:*[G=B[@+=3H.X:KU]-3'/.M!$"T%5[JKB%U$D@H@[#2
M).!EUON.A4U==?1YI5;$C)*E780J^*5]#JE=.AQ<P/`63'%</]:]89&(S#1W
M8^ND"29-%'HX"N--`X*?H"(D1*J)LIM6GJE.FE!YTQM!5,12&M;KF5I`.!XJ
MG\:VY\5S,^"L&,RW$4.4M52G_P#-?HG3UHGQ^.OH+RB[5Y?V\G/2?>:Y%YC:
M&[Q>-`P4>ZK#:TE4=#1161WC?_Y%O<:_[_QI_EAANE._1B[S0/O]X]U?_]3Z
MF_`;_%7[FG^H_#_Y.X;IQ_Z<'<??0/O]_P!5:NZ;HH:**RCE\5X9S:U<+_FG
M.%P<F6*Z.2YN-2#D8+C=BO3#T@$@18$M^/.<DQZ(*R76W6R1=PD5>G-;#RYL
M,C)YF3-=/(NHD@8FNON\Q;KY?F9!:[8.@6@-(\1<W-21SY<*CW%.?RXLN:81
MS]/BP)#,3Z['L^L4XLOQJZXV\X\Q;X%YO-GB(<:\,N`9M@ZPB**@I%4JKRKS
M)Y99#+-;6KFR:B%&H8!<QBF''CRK<V]H=\MX]TVN$B7$/C+2$=X2HU<'9%,*
MF.+Y!<*SW4N;')=H5E&#D,@%OO!/&R*D:JD9J`KN[:WN):?#\FL=-L%\;C06
MN^%&Y8]F='^/W**V?!)MCB_4CO$/#Z5J)+SY3_M!?KIC>!XO>[S:HMM.5+R.
M)'E,RXDHFS>;B!;WX9#%&1%_1<)SN#N3[M56NK*+R^(.G)<7$<<WX5[\_P#3
M.KJ'RO%!8V^XWEXPZR`(^)`**3Q0]G"HJO7'_+F?0I%W_P#:^SVVS+9P#%H$
MB5&&XV:44J))3(6RD3`)^^''`U1TP;,1<4**E=75ENNR[-#-;.>9)7@ASD4Y
M@^A.RIL5YMUG=P1?Y*0ELGBT@Z7*'-T%%P!X<TIQXEY09)A%SBX;RMAF2276
M9`1K==8[3$-T&K:P8.2)#DF0$*XLOLCO#MNHX*="15U27.U6>ZZY]MNVJ3\.
M6?9G4W<?)]I>M;=[/<-#M*O:?%B['#DF*YT^.1^28G*658E8L#C72^1[/=SN
M5Z$8TJTOQI`1E".PT4UE@'B95]2,5(4VI5%5*5(-JEVJ*YN;Z<1O(0-(5.>5
M5>U;0=LM+FYO]+6F-&E0=2GAWI@:M!+M4>?9&S<:D,S!CPW-T=Y6ID60TC9&
M'<!5%04DH77KU3XZQ<4K(9Y7L&LJ<Q@1W5GFS2MN!&7Z85.>((^VHQ<SBY0<
MSM.'OV1&GY+,JXC>DF--PY<9A*/P&VC:5Y9[ID*DE42@JJ:GLLF?*NONH#$Y
MVG2AP)R4\DJR.UPOM;B[AG31@6HIQXYHG?4B-$0L_4NBC1.HX91FQ--H*NUL
M$(UW*0@E5)53K\-0)W.EE9,1I<`B9``88>@55V]MI:X%Y/$G!2O$^G"D.2:T
ME3VFR:9`6C5:B9.JT)HH4)$0=X]55:^NEAYDE#7X*4)'+@15E!&8FMB=XDQ!
M.9/;W533E082$&5R9@;[K$NDN=:`D,OSH[X]RV66+&;$A$%D-?>%4T)$7TUU
M2WL([:PLVQR#J%%=SXI6IV"_D=\Q;.MCIB=X4P)XN<2<"AJK>1<6WO'Y-L6T
M-!?LM9CQCN5FL][:2VQK,['[C4:ZNKVECSH;CBJZ-25%HE*:L+VPC<Y`#JS7
MACP%=(\O^;(;RSDCO(VMM5TA[P5U`YCF"*DGC'E*P<>\<Y_CW(O""9?E>2_6
M-6V^0KA9Y`0T?B/L6V,^#S0N0VK<XHN`X"EO,:*B+35QM]];V=BZTEM>I*X'
M'DH2L3YN\H[MOOF+;MQVG>NCM["U6C)002F.*C@>%19@N"73-KIB$^Y%<&L>
MRN>[M9C;8\MURU.N0[E%F.H\#C6WM$(C_7'KTUG[OYBUL6RZ0%721CQR[ZN;
M_>;6Q=N5F)M5W;QA=660(..!%:0V/%L)L=N.UV:SP8K$<OF1V,TKH(@AL`GC
M$U<4!1.J*HU^.L!=WEU=N>UTCS&I3''O-<NGOIKHBZN9UE<!EEW#E2UWFP[6
MU6W>V9*"`*#1H`HB)1#0^BTIT54ZZ1&_X6.!.*C@24XCE4.1\TH>[4"N&)5!
MWU$>5_36K,,/RDV&XMZ?N98X+8*K8.6V>CLI5<=0%5.V]'%41?7=35C!(][7
M12M\#/&.PCAV5:6+I)MLO;)DWA1>/Q#D.ZI$EW4)OUK"B+#C3AM&BHX)R!:J
MT!"6Q$3Y!$4+IO#KIF5_6D9I\+0WAC]#6<MF=)W4*.>'G#+CP[.(JK?&V+P[
M!GG*E["2(29UY:M2;''I!VR&4:+,#MF5`5?J*D2"GQ7KTU;[E>N=;;>U`6M8
MO+'$+ZJUV]7;[C;;2V`+HF@$#\7->Y>=3T;S;C;+1]QY=HN`]+]0<2M2%$5Q
M%:540E1=J_975='(2Z,NP<J\T_A64=&V-CM+1IR"?3,4E3+B*1T-YIL%$7!9
MD`*N@:)\A(HT'Y^BU3JG]"ZD3!KRQSB-0*J!F/1SY4Q&YP\(4*0H^A2FV4HG
MF4%RBHJ@#;@HV"B)&3:H*BY5-RDBJGZ2)\-/S6HT`M#>J40C((:\%T-4KFM)
M:'8@\<.'92<:@MUM%P==91V2:6%]U7%<;=B.#(?A1W8X_<ND,Y1VD2BH$O5:
M:<M9I@);:9`0`0<^.)%3F-BFMYXVN)8FM$\6`Q"_576:XZ0JU+;6.<%THC48
M#`GG&UDR)4MQ:$C(FVZZC=:_,O3X5TXQA=H@=*-41+4`Q"G43VIE4.,@/=(Q
MRLD0@=S=(Q_FSI*"0Q%CO&)$;/<:5IMRJ(\^A&B//C0S&,+0/*2T45(4%/5-
M64<#7,=(YVI@[,^_D*BS/>^9L)9IF!7#A]OV4W+I$E-D5RCLQI-UA-OE":<`
M65('FR[D(W%*H$XS14HE$<7_`(Z4Q[A*YI=JMSEPX9]E/Q3Q`=,X.=@>/<>V
MH.YJSFQVK"(<B-=8T:]G?K7,Q9QS><R1>;7>84MF-'C`RKS+L5]DU=0TVC3U
M1%2MWM=N;6\;J<2V/'4,C@H'?CC5SL^TRWTL[RT"#ID%<,$</;@0E28W>/VB
MBQ;JVU'9BW%L+FC:.!1V0\.Y]0V`@J7U"$J[Z*B]$Z:;W%[FRS"5K1&J_6/2
M:RAMVVDLL2$R,=IX\N/(#LSK4SP.5"P;-"`U,"R>+L1!40!$M;2*(J2DI+5.
MJ_;KHWD",1[?>D'!TH/=A7.?.+B;NT#FH1&?3C5[-;VL=55^9$<#EOCJ2CC"
M(WB>8-1XS@"KLZ9)EV=IN.VZ5.V@LJ;GKU($UR_]SF/?MT0@5UT1X&)\1U!2
MO!`I[:ZAY'N&#9=ZLWP?EON(7.EU)TPP/PT\=1("\*;DQUQ9:(#4<8QT$E$$
M^9!2N]PE!2!1):43T^.OFZZN"Z5KA&`Y.2*E;.UC,4*/D<7#TI]JYXUR>;$@
M60+@1WQ0.XTV+KC*@2J+9&7R[:B"^M4JFD3.BDMM;21J(5F)'>O`TY&YXF;"
M&:V@'Q%`<>S*DTMXO(#@BH&2`KSKD>.&TU5$,7'7!1P1Z*M.JZ@]*YF/39&5
M3CBH[QRJ>'P1QZ]8!!R0G'N3C7Z]%)AM''FR=)QQF."MN"[\QEMV1U;7:O1*
MK\$T\S;IG3"%\9)'+CSIL7[2%80T!3V=Y6O$J*TRXV\VA&/815$"[*J+;FUH
M"+JNU55=VF)9=<H;*X]-C2UH(R"Y40ZI(90&CK/>"2.)3,>BCJ.EVP<15!"/
MMDRB*7<%>J]IPU0JC7IJ"8D":2A*+V4O0KRTH2&JO(]J5T>=+L&K#`N(^!B2
M*1"\XM-HBIUJ"CUK5-2&R%KHSI0@X)QIDP->2V1Z#V=])+92&WZ$!HV6T2;:
MV+V@;!40*N)4W$5>JK\-#!KN0Z5I#2"NG/[!4L1M9;N#7!SQDJ@>S&N'81UA
M"[H-.NM$(&`D#@@[TIL-!H8U3UHE=>@.82&8L/!<Z<+]60)(XGA_"N3D=%7M
MJ\,=%CI_U';%P:B*[14-XT(E3U3HFG86LE;^8Y(P%)&?<10YSF-<YC"]ZHF7
M'.FP#AL_*++L@R162,NT"O$V)J5$-2J(CU7KUU)9$-+9M)T)A09'.UQKI*Y=
M])W<>;!&B-0!ZI(9C0W"<W*K#>U%+M*@T%:]?R:)I=5O'''"0YH.H\QP[:"V
M-TDCI)06-0`<SVU[4U`&0%TP9=`34$2M").B%147HO3[-,LDFB:FK2PYIQ]%
M>.9%*XR$!S@,"E$I<QR.I1SZ,&3`MFC:&B_>DB=Q-JN-(A(-%3])"2JIUU(>
M6M;)'&\.8>"9$<J1'')))%*6D``K]./U41-PNZJ[C430VR11$:DB>H(2B"H"
M]4KTU':K7KIP)3T5(TM=&U3EC3>>M$&?"&+)CDXW&<0Q=>4=BEVE'>R`JB$C
MBD1$BHB(1=.E-6;99K:'5$=,K@5*XH#A[*;>[7+'(HT-Q`'$\57E2<7HVTR]
MVE%QI%W$1MJWVG1[["BHFCSJH`DBIM5*]:Z:?.Z1K3(PE[02O,\#Z*"1U-33
MX'>OM6O,AQ6C!I0:<.K;;+:#M$^XB[GE02V?*)$*I5.J^M%TY;-)<'A-2XCE
MQKV:1H:NDJ1]!1*,ZK:BZCZFV8")(KA+*<1!$=[R&@*0DO557T)/CKV2=QDN
M'2N)D<<?]*:;&Q(6L:B*GTYUZ`!D-.&Y+08[#8*C*B:ON*ZJ$H(2H(N(W5?3
MJGVZ6"#&.F@`/#CV4AP<UY)75Q[/IQI*E10)2)4%L:IVU5]$?)*J@BV&RFX5
M^TD1$ZUKJ0V/JQ23!00B#,'[*5KDC,;=*L<JD<.^D>9'$E1'722O;503Y10A
M!`1-^T-Y+MHO33+G.#W,0=5<<>`X4H.09*P>VDY6P,D%&4$N@BYOW""HI$9D
M)41%<%-B#U]:ZE`:V@"/Q`4R"X/<0_P'/MY"FW,E,130"WMJXZBH[4W6T1$,
M?G!M"5*JB^E4HO74F.%\I9U&@1@?%V#@E/MA,K'")P+@JC*D4W"%"0D0UK\P
MMJJ@B]$%HE)`(5%5JO2BKI^)^@XXM3+E4:5BZ6IEQ^NB).BNYM%>>)YLFB1X
M>T#`@A'\FU"5P5]*5%$]=2V_IG,N=A@<AQ6HCXP7!VI-/MI)-:CT6E"`23MK
M4:C\R-".Y%2OP54^W2QH9'&-7B7+&DO\<A:`H^G&FU)W(J;MS?:0UW%\U=Q$
M(IT6E3KUK_3I37OT%I!0',4GIAK@XE5P3ZZW"\5?_P#1&!]%3_H9'141%1?J
MWJI1%5$ZZ^B/)X3R[MW^T^\UQGS-CO=]_N'NJP^M-5#0T45D=XW_`/D6]QK_
M`+_QI_EAANE._1B[S0/O]X]U?__5^IOP&_Q5^YI_J/P_^3N&Z<?^G!W'WT#[
M_?\`56KNFZ*&BBJ`YCQKB&4W*+=+KCEHGR8\I]3.YP([CH4)!1$`P7<9+555
M:_'[=?&T^ZW]M/-%%</;-UB"%(&9KZ"LY0Y@;,CH.DH0+G]E1]F?#^"S<>N$
M.W8Y9[*L@F7@8MEOCK%E+`<=-!E1B$&74?$MJ51%%42BUTFVW:4W#F74SRKD
MY][E]25;;5N%S97$#(I!H:I*E,"`@3B1G4&<$<)8K?L?7)LGN3E^@1),Z-;[
M/&;&-$C$V](C/L7-MAS?+E-55%5SJB=5U8;QN4MNZ2&%QU-9@_B3R'('LK4^
M9-[N8;B*"WA#)'%7.XE4(<.'?5R[/CEBQ.W$Q9[+:K=$(1<>"!$:C=P%;0%<
M=%INLAU0%/TJK\-9UE^^0.C#G/<]H!<2I:IQ3LKGUS-<SRQOGNG*QQ(Q.)54
M`X>CE2I'=)5[*JXHF&T5?:($;;`?F0=RE0AW"(U^"TU5W"B>1J.,IR/V5*8U
MI@CG8,%4H<22J?63VTWY^#X_>(IL7B#&N<9T"1`E,-O]MQU%!'FU<%29,4+J
M247IIBQGN[2<R,D+7<`,T_A5@-WN8O'#(YCP!B"04&/I7E5;^)<1;XNY<RW"
MYCK,E9=M2Z8K,?)/J9L20^+LQN6A&;DF3`$A;1W_`-"(G36KWF>:\M(+EZZ2
M4<AS/`^FM'NN[?YK8K"2WC#&1E'-`P:@3/#`G%*MJ`]@D9J(I)H;A501WI4E
M`57J6ZE%3[-93IQQL)+L"4[OX5C)GEY#B"2W+MJ#^<K$\[#Q[+[3N2XXKD-K
MG/=AH%1VU%(%FX1T)4KM,#0U]?T=7VT7T!@N+9[OC;I3GR(Y$5:[)*89;BVE
M"QS,("DX'@34JSVTN#,F."`T3>P0=:4'$<1%1?N]JHJ@J>J:I7ERC4"6)QJ-
M:2]&3J8YXCL[:A'E/)EQO'VK5'F''D7N0W$:=92CD&(RM+C/,112VHBH*+_5
M(DUH/+UI:W-Y')<N`@!0KSX`5?V=M/=71D;$#H!<!P/94,8/B(9+9+ID`W2/
MDMJPZ[K=X6%LML,7&Z@#"DMQDJ\BOR6F7E0*J.TB15377VVMM'"9F8M:,%]X
M[*8W3=98-QM[0PB*:=@:9&_"U?NX9+QJ"K%EDW,(,\,:MK[&?9M.FA<TD-BK
M3%PASW7I+D.6@@@]U@!3I0005K]FHC9'W%X'EZ1@*?X5N9MNCVO;62S3+:1_
M"T'-4'B'UU;"T\:8GGG%5AME\@-P<I"VRXLFZQV&IC\"X0)20W2GO@#9.M2)
M";U6M-O72'2VD<K1)=-$\I(8I'#GRK$,\R[KMF[33P,+K)K@[220'`XHT'D*
MI?;6,XXUY=LO&M_<!FSVB_.OVMQEH4;-+F^DI7([R%N:24+O<]53;TTQN[;A
MEE/;O<%;XNP)CAS6MG__`!/F"RNO,<+0)98D(S*Y(1V$5>6-;W!E"3LAAUE`
M5)"(ZFYPE,U0=IKN6H;?M6J:YK&^25NJ!J*,2<ZYP^,Q@MD:-#2$X<./8*YW
M!I#;-F(90XZRFB<CM-N./.,@YN=)":V(R)B-")5_16G74ZWA:YTLLQ5[0.TG
MT<.VF)B8VQ-A1VK$I@/2>-1ARP,N1*XY&W"K3"YO$.X.4<W-1F+7--L41!+N
M-*:IU6B(6G[`))?L<T=(L5.0YU>[5H%O<K(1,&%,L33X!A)=P:?=:62L50CM
MR#0A!U-R&K9AZ&`."J(OV:@]22'4Z/2A=B!D@RJICB;<3`/:=2Y]^?JJ,<"9
M5S]L)\A`-F^9;=2$P051EJ*]].($5"1&P<954HJKM34B_FZC[<,=DT!._&KC
M=WH+>!@1K(VX]O'TI3Q?J3]&2[Q!0!VF9(Z(C\R;B7J`[:IUKTUXV,22'Q^,
M50:@U`X>!R]U(=S856B>:#Y"5")D2*C0B"`:)1/FJ;=52OHJ:F1.(CQ11B%X
M]U1Y&/:YH4J!P]GLI!99(P)?F52H*&2*2`:E7KNH@@38K6B57[*Z>$S'1ZG-
MQ&?IIMS'MFC*HU53+!,J_9%J&9!!&)"!,&XVPH;JB)(9,SX]4,"4:`H'1%]4
MK7KKVV+7W$4;\`[PCN(/#OJ4)3;M>2SP`%1Q0TI';G)W>D.MN*;;3BMJSL+N
M]L4=F.JZJIW7>XYN2GZ.]$^&G(HFB:9V.L<?3XB?3E4.2<1]$M01J@7D`@'?
M2&Q#42?^IVQVSB$C1+MD41DF7&P>4!0FC)UO8JT3:FY>J+UF1HTR!C],<C$[
M0AXCO'JI,SBY'AJRM<I3#`]ISPI-EMJ4GO-MH7>DH9-R2W-LF)4V=U:HZT*(
M*U5$7T&G2NGH]3AU0`(W%,U`(I+0`YK"X`C(CB#SY5%>'<<</7[CCR(Y'Y,A
M6V+D>.9_G>,V[)LB)9$3#VV\9QB;C\FQPW'$;C/_`%4]'25E!-PR]:4UUC8;
M.T=M1DN"-8;F>ZI]]N>^0[AL>W;>QWRSPPG3F@<00X\<.>0JOO#G,UG=LL;"
M;[._#95M!QNPW.XM?0Q\BCAN=<.*Y(0&5E,.(6QL35""BIUZ:QF\P.=*3&"8
MTQPXC(\\:T'F'RS<RD;E;L<7O36!P.67)*WC\#)02,&S-$..;@9)"-SL*2D*
M/6L#!'D7Y1.E5Z>J:Z%Y'@DAV^XU_>>"/5QKY^\YLDCO[=D@(>&$>VKW:VU8
MZH6Y9_#FGK+(E0&IDH`E!%<<CM&;`D31.D$DT4X^U!KT]::XW^[%XVU_Q0:\
MB=P?I"8')2O`\JWODN*:5E^&.(A!;J0]Z`MXCW5#C3T96!5A>Y&-AYR*XX!J
M9JKGS(3_`,NPE7T7XHFN%PW5LXS/N8-4;FH`0I'IKHDD%P2&QOTRAPU)EEAA
MQ`%=!=11;3NB;#SCB$X9FVJ]M-WTQ-J*E\M4_P#EJOKJ(V**.=_2G'RR$@D9
ME/A(I>AY#BZ,BX`&`X9^('MX]U)&#X%AN30\POW)%K7(KQC\F?,M]ADRE>@,
MV9AA)$)^W0"4(JNO$*HKFU51Q/77?_)5AY>?Y>NKWY-C[J-CB\%%RX=]9WS;
MOV[[:^QL=LN.E9R,&IX^)SP<0YV>&"!:HYQCF^0N9/=,E@R+K"L,?)T9?QN[
M3S.#!LDJ<XT]<&(3J.*W(9$D2K2(@T37(H;J>YN;\6\8ZH#BT!%:W'/F@]-7
M%A<_-0P[??@/?(S!X^(N:%`)Y'MJ^Z1U5DWWG01L4$&&U%$-P"7>)[T^=T4K
MZT2FLI=1I"Y\CQK#D09E<S4^.<!\<449QQ)7`)P3AZZ)45"::5Q$(-S@HJ+^
MC]B#3Y174*35&Q@=+J'$?54L%>K)TD7!:`*741H\M1$^T2[T-2W)N5$56Z*O
M5%]=>M9B96M(:<@F0I+?&$>4<!GSII7N;.M5RC']+)>@3'1!YZ/4T9>13$U=
M!$W(A`J*A?D73\444L-QJF2Y7P@G,<:L+9HE8&LTC2TYYGDE+8*VM'.[N0]X
MK2AH*(B]%W="6BT2OHNHH'1P**1AQ]5(<KPX-8A"+VT54C<,@;(0%14%<=3:
MA"@HNP45*57X:&!^`:2-3<^=..1H5X5'9#A3`DY#;Y>11;'!DONRP6:Q+CQ8
M+ZQ8DIH63!AVX_+'=DNQW#)6T15"BHJHO36I_P`;-)LT-W&]-1(+$QPR(Y@G
MU)3(`CFF?/&C"`X.+AB,CX<P!P/&E":2]L`>W]\!^Y(25.P((J-MKMJB(J>F
MJ*3J-C#7$N<1GR'*O860E[GL:``[UGG2*X+@[9"B8=X2HNY:HO3Y13JB*:JO
MP2FDM:7*XD8<Z>UL;JC8SU5^/*2QQ`P5/JB$D<515P586J]%ZH)B-*+2JK72
MP`PM#D4XBD.<Y"&'!N8/TQI*ECOHK;0DK;B&"51!;<0A4R553JB@/KUIIPAI
M!#%!(*U["',4N(3"BHMBB=I@U%)#A&J.$J&;KIJBN'545#W"J)]J?DT2N?(8
MW+\28<D^BTVU`YX<5TDXIZ128^*;C>#M]\.TXZSU%!2KZJH]*"B&R(I\%W4U
M)#`^-S@U0N'JIMTC6-:TMP.1YTA2VVGY(JVV^F]!!L%<6I&ZJT;1?EJ*'3I]
MB:>C(TGIL0@8CN[>VO6M>$+W`KEV"CP,(G8:`0&0;`F3Q[=@]M7!>141%%$-
MP.E>J=/RZ1K:7.<,'$C/N^VO226N>[($Y47[B[T8V"@ND[\JC\T=&A-0,7$%
M0544]J)5*HNG];"R4O\`#$.07TT!C3B'$O11V]E,S\7>:O`QKHVC$)\C:BB-
M72*6'WCA*8(JM(;"*8HOQ2FK4P12;;;W,;SI5'</93K6-<96QO69H!([#Q]=
M&7S[[ABB*V0N$VV.Y#V!N144MJ=753IZ:JG/87%P9XN'?2>F00#\**3PI+D-
MN=U51>TJ+5$/HB]M24B7^JBJGK7JFGVS*&M#1J!%-N:$<!Q^@J)K[?(4B\1X
M$";5X'A^ID-.F5L0E;<=<BN/)\G<1!JJ#51):*FKN%B6LTKHW.)"`<,\?55Y
M964S+2:XEC`B3/[R<P.7"C3UR88%2?DH2F9"@(B&;Q[E4!$PZ]P$]4]?MU'@
M:_J/C8P2`>@\\JJ)+?JZG,!9WY4GQ[@W+=>=:-4%DW8Y&7RN$X0?>-@B]:"O
M3K2E=2&12P].21I!+C@:@7$1TB+B@/?1-7WU>'<ZZ.ULA%LG:5-5H*+ZK5$^
M-?33YD=JTN`T@9+481!FO2P*3G2%)?0"=$R<:3JJ;E$C1=VU4+K\P].GY-.1
MG0]Z./V\UKTC6(T&-;@^)RHO`N"*E:+#EJE?5:SI"U_)77T)Y/\`_P#GMO\`
M]I]YKBGF91O=Z#GJ^JK&:TU4-#1161WC?_Y%O<:_[_QI_EAANE._1B[S0/O]
MX]U?_];ZF_`;_%7[FG^H_#_Y.X;IQ_Z<'<??0/O]_P!5:NZ;HH:**IM>[@,1
M7G9"++=-QY6P`%)PW%=VJH@E4H*+\>G37Q%<=662Y;(X`F5SE..*E37T'9P!
M(NDTM`8T%#@B4@1B,E>;.&3+;A=XP=>1"D(B#M0J;]I`@[U%.B*J4TPL#V:F
MR%Q:,NW@O/W5+F,C9(7-(U%R*BIS3V!<RE0?PJK^.Y'R)AJ0VP:M^1R[T#PB
M($Y'O,F3+8><!OJ3CK547=^DJ:M]ZDC.UV5P2DW3'<2,/95[O;6W#+*\+U#V
M`'$X$`!`N2'E5A6W'VE:(30Q=6.,=3J>Y28:4W7!V[";4JT'H*+\-9Z)XB)G
M9$`$:.[GWKFE9R:/5X"[(N7+#$H`1D1SHRK;`_>DXZ_WB;3:KQ`K52+8`[:*
M0[C7HJI1!I\-+#^H8?">HT%#DO*H\<AC?(A:!QP7GP.1045=E/07'&V$!$,N
MS0]RJT3:@(D*+45!!)?Z43473HT2EI#G'T+4Z..*[#57P@GAB"*AGE3`;_?+
MC9\_Q:ZL1LBQ@".,QV4)N?%1=\F$#@"CB%+,**B_*M=7MI?1.BDV^]<.DY$<
M,VN'U5/V^^CM&26#XR+>1R%>"G!R=GKI>X_S*U9M;H\H&),2Z19YQKU:I+CI
M2+;<XX*W+BR(ZD2LL-*M6R1$%15-54\4UK<$*'@KXN;3P'-<,\:5N=A)MNII
MDU0R`.8X#,9@@^\<*4,_FBSC5[8EJ(PVXPNB@4%IUGN`'9<W#U$AZ?!>NF]J
MB#K]C0U7!QXD</=41BF..YA!ZO$G->8I+NN>8WBENE/7Z7""YRGU$+7;Y+4N
M7)(E^Z-IL-ABKK*`I*O0!^--6T.WWM_(UT43BN&IW!/LRIRVM99RV.!@#<23
MBF?$GZ+56+RQD/*4G(+Y%MQC:L:5YF5D#(16$MK3[3[JV=))JX,L*,BIH*?,
M:IU1$UNK7RX;8,N62?EM35P\79RK?V5_MOE]ME8S-U[E<!&L5<,/'S&>%*=A
MY)B6[&^-+[E&,6Z/`AW&;8&+S9$5BZS[7#M<JWC^(1FA:%6)2B&X-Y!O2J]=
M:V*Z$D+8Y8QHRXJJ9]U9S=O*TUQNMY!8W;S<AO41Z%K5()`/XL>(5*AO&\OB
M6G"H\/'[,Q9[CB643"M>4.1"."-GO3DAQVV.@*OFY/<%]:H0*-43TU%EBCAC
M<207N=@['+DE:1NU7-_=M@?<%\3H=+HQP<WB">'=5C>"\LQV-(R0,86YR(D=
MQJ7=TNLDWY4JX79AP[F^U$-UQ6HHS038"[11*41/367\Q[1;7QLKF'4V;4`4
MX]W)*QOF+;-RMW-M=PT-:`=&G[H;EBF:57'R^O<9O*,)AV:'(<R8^VW]:T-'
M8[YR4=@1S!"W$TL(E(]W01UK#%;G;NA(2Y_1TJ[F./>E3?(D-]\O=F1X%FV3
M+\03''OJV9RXC[%IE$XA(<)'&GF@$X?U2[2>:5&]JM"1542HJ_#7*8GOCBDM
M2XEC241`00>>:55[A$T;A</"C4[$%3APPRKF1(+9$:]MDZR-P(57"(U1`=%*
M?*M?A7I^5-%NZ>&6-Y;X7@KS3E3)8Q\<D0'B:0G\*;%T-BVE$$C5&GW%-F2[
M1P6G74.D8=_WP_IKZ_;]NEROGC=*Z)R2'@#]WM[*7;P&5S$:J`E4Q4<DPKFW
M.F$CL5A'755AQM#-U4!5V*B*M45$%%)-J+545--,CB-N)"[2XGX1DG\34RUU
MLNP)F@L)Q-1[Q]=D;PMAN%$=)P+]>;;=_G;<8"0=QD?>BWM04782HJD/7JOK
MJSN8(Y&F2)OYS0IQP1,"E2]_CGM;V(3.!@+&Z`F*<<>/.G_$..(CVR;:84R%
M1HM!-7%I\O7<J^HTHG759$'#0UKE>[.JEZ.<]Y!T-I,[#@+<65091Q9+K;@-
M@@BZ!"#\90;/T<5IP5)47XKUU.N]4!A8!JD08\*BQ/,PE>_X5PY_3E1!RTN@
MLB06QIMYITXD=S8C,1T(JN."JH.Y0J%55=RU6FG6RAQ`#2"0A'!>?HI)!:'/
M<\.T^M*9>=3H=@Q2X7B9],/T42")&[(=8$>].9AB)O`HEVQFDA":T)*:L[*!
MWS=M))$2$7O15/KI<`^<D?!$4<XHX``D88(M+#E]M3=M@BW?K4<96X[?UK4Z
M.,-J,ZRV*L"9$#4A61=:)TT155PE156M=*N8)[>2%C@4D(*ID,M*]V-1([;J
M.F<8R0S5A_,.('#$8#OK@DFTNW$PLET@7)D4,WC:EM2$409-I=[8&0&KBM"J
M#2GKI;XS:7+&`$L3B/HM,MBN9('RR-T'#!."9#WFFC?;E;,?LEUNUXF,0X%M
MA2;A-<>,T%&6$,U!Q%1!WCM^1?7=32[9IDTQ1D>)WPJ?74NUAFN;R"!D9U.(
M`P&',K6?&`\1S.>[O(Y;SAJ0W@MQO,B=CME.1,6'>VF#^EDW25;R=&(8OOPV
MFB=,2=+L4Z"FM9>;D[;XH+(:M18F?#F?2OHKH>X;A8>6K6/;X4DOVQX.0*U<
M4!/:35N,DXSP#+[&U9+UC%G..+3L>(X[!80;8V+"Q&Y$.0C828#L82WMDTJ;
M51-5MO>S,+6B4EZ_>*CTKE7.[;S#?6U\^ZDF)&)()X]HR-7]]IJSY#B/%/)F
M!9`XDS]D,\CQ;1=11S_^H6:=:0EPR-UU.X\\S\R&JJO5?775O)<AEM;UYS,@
M_P#MX5B/W6EL[G<-GN[1@;U+8EPY.U5J[K:5RFH7Y:;9<*S(\V3@FDELMJ*J
M[2)I53IUZJFN#?O.2)?+Z`_?Q'#X<:Z/Y"+@S<BUPPTG'TU#`]YJ0;*,JVRK
MRNHCB)1RE5%*DJDH?&B]$KKATLLP?TF%VE5Y@_ZUT0-ADB;/J_-T@+Q'\1SH
MN;#[TYV0?WC@'M4A?V@UT16B1M-J(2B6U/Z->.!<'2E0U1J/T]E.M?''`R,%
M!IRS7FI]"T7FV*W7N8!2$<*4U%-BWRHTAR)-MY."J.JU(8(3%%W+5%W(2^J4
M75A9;A+#=/MK>Y>VW>Q"`4![*A7`T61=+;L<=:N#AJ:X=H/U5!%RX!O=VGNV
MR3R"U#QIR:_(;99Q&Q?C`4=W-`EZ9C!(8,R%%(T]22M-7&VWEA#/*V6,-<03
MJQ)4<"1D'5.L[S:]MA9>V6PAU\&C.5^C$8D,)0IP![JE>U7JY6>YQ\1RT&0)
MB`B6+)UD..!?F6=C+@W)5:VPKIZ*([E%Q$5:HO343<=OL[P"?;RQFE7.:2=>
M/(XKV'/G4<@&)]]`7&-SP'1AH`8XX^''%O/E3T^E)Q66C^Z--P]T?F%&^M*G
M\2Z^BZS)MWEY#CX6G&E"X#0XMQ!"IV]U<6XY0B=!IHE)4VN/]Q1[R_$RI7<9
MEZZ0Z>5CGL8YVDE.S_2G/RYQ'(\A<T3+[*+RG%0"![N"7Z941#6BB5`4Z]>B
M5HB:]/A'C1TVKARXJ>793D+3JU1_"`?9R'UTA1'6GVA)$5`?%$5'T1E[NET5
M$:3Y&^GP32)=3)W'IA0<$^%/IQJ8.ITFDO*\THRT@.@^V+Z,(RRA!W@0FG7Q
M^5!;KT;51_(B:DV\9F:\23B.1%:O$\@>%1YGB+0_HF0%R.3-HYFHKMT;(ICL
MF-,*WMXU8<PGW;'QMT>1$GW&40FT\]<9+1MMR8C;DAQ4':JD2HI*J(E-A>[S
M/#M&W;<(F/G8S!XSTDXM[P<30;7;3=&\MWRB>6+1(UY!:T\"`511@*69W;16
MA$!/?5[J-":<_JJGJF\56HU]-9-S@Q#&]7%5';3[6JXLD'A:B'NHE+[8]@FR
M[CS@I]02H*(6Q$H*`B;:I7UHG73,A)#-3E<?13\;3KE1`.?$T57>;1$B*B=5
M;53'Y&Q(#V&J)\XDI"E%1:]:Z\TNTC6S#[.=#"T/<A5WUTF2F4%OYDHR57`;
M53-LC12,6$&J*@N.T&O1$6FI#`2=2A!EVCB/10\DM1/%EDN-)<WN`$1(4='9
M#SKZ/(:!V@<)]$:;C&I!N<-LZDIHB!2B=-6+8('P11PJZX<2"3@T<D]U00Z0
MS3=8@6[6C(J2F9/97Y+;>B2G;:^0-O1R<28TCH&N[<FU0<$B^[/Y4146B?9H
MN;2XM)FVD@TO`7-03WC/"E03QW,`NHO$PE`2$[\.RF<$V+<[E<&(11I#EI..
MT[(:<5_LW!2))##)MN*R)@TJ;NB*BHE=2=3X+1S.G^9(03AC@<$[,:4Z%Q?#
M-*\B-"@[#Q-+TAXVG7B:9:%1)48!TE)$$U)RI%5%D$V)IU5%ZZKVN;&Z1X8-
M(P15S[:6&EP8U[RCN(YBDEN2]$>:D(A2T=5SY`'<(N%38NTEW4VUZU]*Z4Z-
MLC4CP*JA7V4Z"&.)1#SI$*WPW[I+O)L.N7(FP1`)UPV&#%"2@Q=_9`ME154&
MM%I74]UY,RUCMG2_DARH!@O,]M!<XN#0A09\>Y:_)S$841QED$(-H]Y$VR*F
M(FXHBE4%*_&O5/74>,M<YY&+O;]E(+GL.DN3L[*85WM3$Y79!2+JO<`@^F&>
M^C+3B_\`ZG9$Q$514ZHE454U,CE<PL:Q@#M2ZD7*G8IC'X7-:2M1K;..V;>"
MJEUDJVV^4P67G7G(S$ER1W4?;CF9(4@T_36JU2O35U_EIKADC)&,$98B$>T=
MM6EUO\@:&MB_-(#5``)`P2G7-`2%Z.U$`NR`N$1-(BBKCBN$<<A5"3<OV]43
M4:V(B:C!J)&:<N([:S<CGO<"^4M"Y`Y]CJ0R8CMMF8MJUWRJ0"H[G:+N7>2H
MI;E<2J]>J)IP3:F!TCG&54"G!#V<#7DCY5#6D:1]!Z*2%ELMR09-4[KHFHGM
M$VMBHJJA[DIOK^2NI#P]7O.GAVUX1KB5KR1RR-)TQT"(6VT0]J45-HDH$";U
M0243J/V?FTXPLP:`&A/H:AZD\3R4^GMK<'Q/5"X%P(D6NZ#)+T1*;IKZTHB)
MZ:^A/)P3R[MP)QTGWFN+^:,-[OL5Q'N%6+UIZH*&BBLCO&__`,BWN-?]_P"-
M/\L,-TIWZ,7>:!]_O'NK_]?ZF_`;_%7[FG^H_#_Y.X;IQ_Z<'<??0/O]_P!5
M:NZ;HH:**H-`CWN[3;K+N<:3%MS"G'ACW6P=DNA))2D"K3Z[6:#T1=JK7KKX
MPWE]H;J6"S`<S4[5P3'MQKZ4=+;PVUK'"YOS+FM))QPTY$(B^NER6`-B(OR0
MC;"[I=U0!P&#`4<<5[=M0&T;]*UHJZS<;7NZ<<$9)(.7''/#U)28R7.+]*L.
M`3+4."=JYY"J@-9O.M/,V797C\2)D=EFOVG#G[>U+&-(F7-B)+N%IF0HPBX<
MLI;[),[G.V`HHJA;45=;^UV(W%G;V]Z0R=2@(U#Q#CVUJ;NQ@=L%J)GN9=!K
MI"<PUH(!"\P,3SJP6/\`)^&7U'FOQYFV2+-LBS[7*"3"?)YM?EFQED-BZ]%-
M!4-@;OF!:HE=9;=-IN(YH[:S@<Z)BC4,>H5^+^7DE9<[7NUJK[J`DSG4TX$`
M.QTY^E:>EFR_'<C.ZL6:X!+>M+D49"M,.?.CPF;+@H8(9,*:E\U*)L7KZ5:G
ML+ZS;;?,MT#3X5Y*A&''%:A3V<ML6OE@P?F%Q4<^[FO&EE\9!@WM%IY1-OMO
M$V@(Z6TE*FTCI3I2OJGPU&NVQ"9[8W%T;/4O92+&34QSWC02,E4IP7*C<9&T
M8:8-6E$#HCB"K8$E*[%4:HI(7Y$]-.0-BD@>'-:'YAQ./=QIB[<>OU"7:4^$
M8X\S5/\`G.ZS>)LTPODG#8#LH\ENLC&LAQZWE1,DE/,JY"5]&FW7$>!(Q(CH
M@1(1)6J)K5[%9PW]K+9R-)D`#@44M7!!WULMG?'N-E=[9N$OA8T.8]QPC`Q)
M_@M%HLG.N>+M=K5D]HE\=8G9&FXESQKZQN9>[E<C(3094QCLC'C--5HB(JH2
MITKI%[;V.S2N%I$/G517<.T#@:',LMIL(IX9A<ROQ:[)K0,N:D^ZI#A<-\:Q
MG!-;04J<B,$$VYN/SINUAH8W:*0XI*0KM1%ZTHB*NJ.YWC<?&V.=S8US7CQ"
M=_LJ/;[C=EK5<T!P70U`,2H*]U%K[Q7C5SCS;!:[G=\3MSY%*NENLEP=C6^X
M$K!M`_)AMN`TKSB]$54JJ*NI]CYBW)D+K:*X+PXA=07'L_C3\&X2VUQ_D)K=
MDUP!I:7`%S5/`G$)V5"]YXUR9C'8>`V*Z6VXXO$5U65D1ABW-GN25DN,C,-M
MT$>EO%3>)50$KM75[%YK8;8Q36W3N.#AXAAV85<V]S&;U^[7,SQ<$8M7`KQS
MQ0=E-$>-N0&+!,LC^)XY-)R<<]B0EV1JZ@#8;6VVF0C?0.=M!_3,Q<-?LT['
MYIM.DUDX<7.`&I$1.*<%J[;N&V_.VLUO?2`L8-6&&)X\5]=$+KG$+"[;CSUF
MXXGXWE=IAE:;[)E3&(\;(G'=@K(NH!N2:++P(XTNY:?`DU<VEY9W+8)(@.B%
M&K$DGM'#LIJ799MUGW(3[J+B"0AS&IBP!4`^OGRJ$N=_VA*/:LY:F0\B<G1W
M8TV8VVVU(K.81'9%FD,ONL"[;#3MU<02%!U-W!S9&0Z':4.(^VIWDC;XGSWN
MW.:Y@8-1Y8%$3D<ZMYQ3/<G<8XG**0U*0K:U&,B-L]Y,-JVCCCBA5Y\%!=_4
M4(EJE=<ZW"4_,WT;6-86R`J`.7UUC_,=K'#O3VC6&$'#W8>[E3TWL.B'<)`1
MP5:3<A4[HJFQ31$4=B^BIUHJ^GQU7RR2O@C<QY0%#V+Q'.JEL(;(5'B/=]/K
MIOY?;!E8S<V%D`U)C-%,8DBKA''DL5-DVW54"IN2E$5%TN$F*YC?(\N+@F6=
M6.UAPNH^DW$.1."'.DBSW)P[;;9U6WB*&U]2I@*`^Z0(+Y=5;<1P7T--JHG]
M.C7JZT08CM9]'8*1?P="^>_X6AV'+L6HSQB]VS%,MR7$[B^S;+/.>/(+/+F.
M--QY)2W0"X1QV.&3CC#[Y4[E%W>E4U<:9KB"`M"N324Y`KZ5RJ[W7;W[GM=K
M?0L<Z1@1PY$`H1V'LI]W#-<,LK!/2[[9+?!4B2-(<F-.R'7!5':.-QG)!U:3
MY?D%2Z>FO8K)TS_RK=S1DJ9'TI65BL]Q>XQEFIX^[EA2*WR]QKO``RR/<9\I
MDY`LVVU7>4X30@A"J`,0%(4;H!.%L3I1?6B2?\5?=4@L+@N90##/$FDMVR],
M<LAA#86YDD`+EVFF?F7.`19MCA6W#W`/)[I%QO&IF87B#AT/(<AE0YCPVJSQ
M9J3KA(=<MD"0[M[&XA9)11:(NI\5O;N9/(4)8PEV@%Y`"`N)R`4C%>-1V[7!
M;](;EN#&%S@``22?O(.!*#(4S+AQOFG(E\BER[?[,N)Q892V\"Q=J0$>7<1<
M?*&_?;D^4=RY0(;VU!%0HKB*2II<>XVL-N?DVR%X<A<[-/Y1C@3RJVDO+#;6
MN^2:/F'!-1.)X+E@1GW84_8/%_'T&&$)S'F9+3B&R824.X-,;E;VQH;;YJVS
M&8-/E$!%*"BKTHNHCK^YFTRRRN0'+D%Y<ZIIK^=VCIEFI,#DKCF3S]-"=QOA
MKS;#35FC0H[(%],L)L[>\T^;!LO*#L(FG"4R=7;6NTU2GVZ&WMQ<2HV0]+B<
MT3/`TTR]N(FO)`,A(&)4)P^S*HOY&\?0R^P2[.N39<!S8.Z!:I5[FR(@R7FS
M./\`6M*9B[&=+U1ST1*HE:5N[6ZF@,37V[`,#J`!<BYX9>NI^T^8X[3<NJ(&
MEBE4[1CI7D,:;'!=YM]KXV@X:PZ\DK`$D6.Z19#9F=N65.NLD`D&/W1$_,^I
M0!$:[`$E2JTT_N4<CKIMP)2Z-S,,,A],:1YRC<Z_9=N!<R4!P*YX-R'!`E2F
M^K4EM.V_M!^,AQV=N]U$0B;05%%)T]Q@JT5/3UU!B@E)UAN"8<_MQK(F2(?$
MWQM./+FOHK3/P.81C!<R$A%'ER6+W5WB9K2VAL0]JJ@[4K1*U1/778/(@>VP
MNVOS$@[_`(>-<^\WRB:[M7->7,T%/7PJ]FMS61J'^5!-5LZM`3A(;NYM%015
MM#;4R4E_1443I]OVZX5^\@'4V(XJDF&0^[F:Z'Y%+4W$.<`$&/;CPXU`]VBS
ME9DL@8GN4G6GI)N$VTH-T$7.T>X6G%5$78BKTZZXQ;7#70.MW:&D%=1)U'L&
M!RKH]M);MF@D>QW2(#2U@`Q7/%%/):*P9BI:._=FVFI9B"R`;461)8QGVTCD
M;BDZ-2J*JJ*N[X:@2AUQ));6DCGPH"5PQ&-2KJ&.*[_(=^2"C2<<P,\,/JI7
M88,FA<W-M/.DAJPV2(8@OS%W#H*(HC\47UU#9$P.P>'.U8#(X<^STXU&EGS&
M@Z`,SB/0*.]L'C[G>&*3K1"VB+N-PS3Y2Z)1#Z=$^&K`3R%8B]K$!)3'4O#L
M[N%02TJ20Z1H3L``S[Z#D1MV']/+9C/(1]H2D,"^A*G5%-2%5$E+\E473L?S
M4$0E8]H4H"1@A^RD.?&Z<%KWJ`I`*9#U94WY`7/'X<AU6WIL.1*1YM@2$9$)
MEV@/(R1)MD"W3<@*H:)&N4Q28-<%#D^*I,;HKF1IC`#VX''U'OI39DLFR9MO
M$^T*[V3(:&Z)#U126B)3^A.NJ^1@#VG%L).`XIQ7ZJ>,<F`+1U"$.."\/7QH
MD\F]H2V]U'1)&T5PEVF2+]X2T5%VHE*==,OC8-38R=1Q`^O^%2X2X/!.&G/#
MAR%)!H".-BX@N*O0J@NYMQ$5`)#IT]?7X:;?,KB'.Q("X9)5@&GIJTD-!4=H
M[J3),AMMI1=<&&\0D)F9"K:H#BH+J$0D*(J+2E*UT]#'U#$UJKI7'*O2`LK@
M`6ZL$S3M'.B>YN.TK8O.[3W&R1(I`(F57-JJ0B*FHZ1')XM1<4]W-*7-%K8F
MGQ\>WDO;2<:B;9;&]R,FI*8DM*5K\Z'M3I]B+I:M8`YJZE/<:2UDA=I</#I%
M)3@1Q)6V3^]^95'86S:I(544TZ$I5]%K37OQ,U-S^JO6AX)<0C*1731Q4:=-
M.T**IJF]MQ31[[A14404;-6#14]=R(OHNE"21L0?H_*7#U<:,!J`?^::+R")
M-ZF2@+RB#(H1G0$,=J`*IM[E5JJ?&E/CHB!=I3],Y'[*\0@E_P!X%>^B$D>X
M@$@FVT?=[;>Y-U8Q?3.D1`B[3W44NB43I5::L8V.:QA&$"E%-0W%7+J'4.:<
MCE3;N5L%YG_JF2=5X([DEGZAV.[+81UN0W&<D-*+S0N]D0.E"1LOZ=6-G.+6
M_M;FZC$D49!+3B"#PI;)]41BMW"-_BTX*`4Q*=E->S7/#[I=,GR/`<1O."6F
MYSTB/6BYA'9)^\VTW(5UGP&6'9#7T1R&-C;_`,IR1'>0HJTUI_-]U9RWEC=6
M4)9#)"HP&93`=@J)#:;G:6PL-UOV7%Q$006%48[$-<4SXIPIQMDH(N\5%U41
M-C@J0H!(B"HN'NH0BM?Z*:Q4B,8'.4.3X2,UXU,!,CU:FCL.1Y454W1=;::4
MF2&NURJ[21`.I**(HBO6B=4K7X:3"`XA#BOJI;G`@KP]M=0<;:;!U'!1Y5[;
MBHBB!&7_`*U/HHJ70O6FG@&B7I@DK3)+W,4MP`X4BRWQW;-Z-FV;@$R)*0J@
M?=@X+B_\S]!>J?I>J=-/Q`12.<&X#`\L,*2YID8U24(PYX\*17VMR4HV+A@X
M-4WMH)*B*V:IM)%(E.O7UIUT]$27Z](T_3&EZ1I#6N5S?HE(<CLML*AG\E41
M341[CIC\JN(0]!VKTZ?;I]A""-HQYI4<]3K=3$!>?"FXZKG>:-I5[RL)M:WD
MB[DJTJ.]Q/F($&JTZ56NGX=3E#7(6MX9*N=.O+`'M(S/L2B$T"0&5)I":$G6
MS(-N\7D'<A$@JE$5?T5^*5U+E86!K]*\%Y]J5'&AVHAQ!+<!V4TIC382`4U1
M51U%VHHIVQ)/G15Z(H57\JZ($R>%QQ[:3K+0=(Q2B3XB1*O1DFS)-B(2`X75
M:B2*E?D5.GPU+:C2V;1^4%"4QJ!U1C%QQ[A6XWBE7_V&P+<@"OT$CHV1$-%E
MOJBU+K5?CKZ%\H(?+VW%H0:3[S7%O-`3?+X+]X>ZK$ZTM4%#1161WC?_`.1;
MW&O^_P#&G^6&&Z4[]&+O-`^_WCW5_]#ZF_`;_%7[FG^H_#_Y.X;IQ_Z<'<??
M0/O]_P!5:NZ;HH:**I[<#M;$29+*<ZU:Q9?DE.CS`1L6FR)Q70D55HAVBO3X
M^FOBM]JR2^E$T*LDD<-*^,8YKS[Z[U%+<R"`-C:9AIS;AR0CEVU5J;)_;;+\
MPQK+,?RIVS0,+QS,;.WC4F)>+BS:X=VN<=%D@U)9;>E9")*XXP!$0LL!N^1>
MO0]CV*&RMKB+Y<.EP>'(K@F8[@,>\U>RSRV%K87EK)%U#,^&0/5C-1`(0\"#
M@ISQ&=-?%.+VKKDF-YC;H-JRZWY7=ID:-C]TDRH[F-O2W7%M+MW@P6E<[T*W
MLN-*K8[&%JB$BKUNH]N^9GBNVO+F.R#1XEX-[SSJ;NWF;Y/9[O:I7.@NXH\3
MF),,=)/`G$JBCA2W<;19+/E&8,6W#8+N.6)!M5\6Q?33+G:G[F<*1"?BR[B@
MFROUH.@*;Q="H[NG56'VSFSO=#"1$@*@*FK$J!R-0K>^N+C:[%^XWCA=.4L#
MR1JT@_40>X&E&Q77(<:YJQ?'+S;7W(TRP7**U(C1;>TX-IDE#?A2,IF1G&^]
M=4FB+:"VC@U-5Z(M=9CS.X21QL>W4]@U8\ETGVD58"TM;SRO=7UM=#J-<-32
M24<,`&`\"%]E6H<W$BFV"[&P<<2K:T+:GJ-404)/5$2NN:RM>72(U-3N&6'%
M:R43P'-C?\0S[%X40)PWI(LFK4<'$W(QN9[DA`&A*TWN$U1-U5)$736):UZ%
M0:E.C;"P.:\$KB<<">"U%5VQ>/D'-7",>\`Y])`N^93;>Z3+3D,;C'PZZR[:
MB]XD[4UAZ/O`T`NB*-4KKJW[6M;-NTL<Q!!8N..+<D[JK_,-[)9[+=OM/"Y^
MAKD)4A?%EP-(?#@0[;C>2*_<'[Q?&<^S!B_7:2X#LJ3)BW=\!;5\4HZ#;&T4
M15541*)JE\YW,7^8GATDZ7E3S*X8U:N%U<060T"*,P,T-Q3X0I]-2N^[&-2[
M#7S$*/.["0WR:-$54&B)0$<7U3KK(32.,;=+/RB[`HI7D:]A:X3&-[TFTC`8
M##CZ:94V:SW&0<8<82:;J-/.,F@F#)??(,D003%K<B+U7;UT^R%S+<R],MB3
MXNWNJ<V9W5Z396NG&;1CD.(Y^^B@PP>DU'MA&$1-DQ3Y0>`5)'$HN\J"JHB^
MFF6KT"7!R\ZLC(S05>"3F.0X@#A21-4E5THAD1HB(CRDXJ&=>J.IT03,EVHG
MK7\FDRMB>(W:P2B%<UXFFX))&&1KF'L3(#AV]M5=Y[<N%FNE@DW:?9K9;\AA
M2+5^(WQC;"MLJ*(2&XA/)&DG'=N0IM%=O1?BFMCY8FA#I6*F"]GIK6^7F,F:
M7"1Y>QP.EIQ<IQ(QR'*JU7^X6"_V.&M[E3+)8&G%AVMAIB\L2;Y<8VY),B!(
M2WI`A6XBW?\`+)7711%V]5UIW2Q73S`RX:7C$XA:U,$C]HN+B2T(-RXC41DU
MIX''XN=2?@'*=IP9X(5SN$RZ8K),8K2K:)$>;9'1`&TGRV5891+>040G4`%)
M4W;:UU3;KL[)HV7=L]CI`/$T'%P'U\JH]QLCNX?/;PZ;AA*N).ER\!Q7V59B
MW7['+K\MDO5FO(/M))[=NN$28[V7%38788<<='YB2N\1.JTIK)W$3XHF%]LZ
M-I/%:R<]A>0/26)S6@YD<>7IY4T.66C#!+^\Q.EP&(K`3)#\=QF/,8:C()N-
M@#I@AF:?H"2BA=.NG;.,"YA!!T<.:GZJL_+;XAN<)D8'NU$(<CR]7.H:A\IL
MXSBEL:GP9=T0+=%-)[,<#>@.2T>>;&0X;JMRYH121TQ$JT):5Z*M@-NB%UU8
M+E)2I<WGPP^NK_=?+OSU]<O#D:'*&$G'C@,](.5%^,\=L.9#DF79,S$R<KO(
M9;L,>XMDVY!BL=D2;8C*X:,+(D"I&(HJ$7Z2ZD7[[B%L38)`PM&*'V&H&YWL
MNUN990%S>FS%"K5/$\.[E4P,X1BD20'T.+6**V1=N2Z-@AFL9U.E$<-@NT3A
M+3>BHNHUO<SN!:^>5...2^G*LG=W]W*\2&5N03'$\Z=1,,QV?IX]FLKHBTX^
M4I6XS;D=2!`;!DV&D78!"@F*U1%143KIV.:1I=;2R!S7A5U$H3@M4TLDS0U[
M;AXBU!1CCQ1,O37QH>[5Y\<H7?S/XPCX,UE-GPGQ?S['+_C=(USBVS)\_P`?
MF0KI>KA%4@;8N+(-"4$43=6/O141#)%[MY&\L6MOY=O&W3F.N+R-P=B#IC<"
M`.Q?B[^ZN4>;M\EDWN$6KGBVMG@M5<7A"3]7=WU]-WCUY/8MSUAV,9Q8"-(6
M48_;;K&CRP8=DVYF:HE(M#NXU>5R!.[C3R%5%,"I5*:Y/NNRWFV/=;R(.FXA
M>P.^+ECP7A6XV[=(+\"1KM3I`J<CIRY^KC5E@D4(/G;8<[8&:,+_`-,#8-"@
MB#B@**8C5LE1%%#&GIJCC8TN0O<002IP"K@/JJV0=%H#0'!V0*GD#].-(P3V
M)%TC/S7!&VPFY3OT\=U$?G38P*XTC*JB#]UU7;1$51546J)6;:VP$ACG=^7F
MX@H2.SM[:<G'R]L\L:MV\HW4/".TT:9G.R)C(HX3<.2VB[7'4^=!3N,#W%-!
M5&"'^M2M*(E:)J9$`V9[6$Z3AB?55>("PQN>UJM=BF&//Z9U`/&]O8MMFSO\
M08!;@_R5F0W'Z5E#<E/MS`<A$\2]7@2&\VK:G14$ZBE%ZS)Y)#,T.<>F(F]W
M&KKS#.;G_&%$#8T;V##ZU'<`*7'WP8F,1>TXB=I7E+>V*-$2.*+!N-'0'2(*
M*/HNY/MU*MXC-')+%*W2UV&.)P%9*60LDBB4>)5/=SK4SP,-AS!<S)A#%%R>
M/W`.E0<6W"JB*)Z!M5*:ZCY$0V-Z0Q%E'NK`^;&".YM&@KX#[ZO;K=5DZB;D
MP$<*UCOV5&1U5>E*M[JCZ+T^W7"_WETEVR-<.$F/+X:WWDEVD7QTKBWAW\:A
MUZ*B*I&X\XV>_:TAB&Y:41"5?D[2T^W7!!`T@]1Q1"GVUT*.=Q`#&`2!%.)3
MZUI/DV^-+;$)D9NB(NVE#-L4VD*]47YDI\/LU&A,D4H5Y:3R/#ZPE2A,YNHL
M?J':,%I-";%;G+&4Q*0+*G&B-O"C\@?3<`/JTCQDB*JU]$34PV+6E]PY^J+F
M,<1PI1?*Z%NF(Z2?$3D/2!E2XG:%M#<4E)ET714B0!JA55%HOK7T34:)\0>X
MA=:K49SG%Q8$#'!*]K)-7`;9%!>?W2#W[U1-B*BN(-%`5VJGK15^&G'7#Y0Y
M@!S4N)./+"D"")H<Z3%C?"$'/@37HT.1&!F4\C@D6T:INIZGNH5=I(JT1=#+
MB5QCZMSBFD9D)2-$44KS#`AS/"D;[A9)1XQ_?`P!/Q%-IQY(Y*0HKC9&BLJZ
MH+M):)7XZ?C#=?4+2(E13B!VU/+GMAU./'`HF/(<^VN$2\P39<9&#+"2R+BE
M`<!M";`#V(0$A*RXBKUJ!*GVZCS-(E#HWZQDN7LKT6]T])'D-8>/$GZ<Z[DS
M'E,[PW.*9;`%!VN45%14(@7Y5Z_I*NHS&.+Q(W%3Q^RG^I+$XQN\(3''W?PI
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MWA<8L)B-<'V9$AE&&0<VF(B3;8`IHJ5<<$7QW;EJ2HM5ZZ8>8GRZ@"P+D#@,
M?<*\F`:7&(^$KWI7AS<WN5*$(NO;^T0D\3JF(DG;`^WL0S^8JTW]-/.8_06D
MY.TJ,5`_AQJ(7LUL"#4<<>SE1&>*FAMD;HF!H@]S=N1QMM'5:WJB@1NT).JU
MH*JOPJ\`7AA3\M?=]5'@#PT#'/E2!:++%QQ'1W/R&9LV7.-V2^4AP)$LRDN$
M*.*C8M./NI4$^5$Z4KJ9/<7#Y;?Y@AP;@T<`!D`.WC1+<1W;9-#0V0-`)'A7
M@"2,W=M'W4>?-LU4P9[;;*1WR$6Q"@KM!YQ!WBRXJTK511:5Z:;EE?=.?(]J
M+@!D@'#T>ZF8F,MAIUJY5)SQ[:+&?<*1V&`1L21LR,W=K9IN6B(5$-305HOH
MB)TTP&%HDU1(2B'E_K4@EOY8ZAXG+/OI,EI'%4`F]Z*@J*M?-0E)/BE45$2J
M_;33[&&,@H"'?1:\U.=X0:3GU5"H48$Z"@DI;%2J(J&CB;C(BIN7X=>FI2D+
MU`&M^NHS=14-<KE7^%$'W'&=P$)&+B-HKC7_`#6^NXW6]ZB`%44]55%1?MU)
MC+&^$@$',\NZDD^$G4&XXKQ[Z;EP<B_<H<E76W109")M'M/=WY=J$H"M6NNZ
MM%)?R:DO9;,9"Z*0D%=7,8Y4U#\RZ25KH@$.!7`\Z07)%7I"=DFR:150W!HX
MV6Z@#6B$B$*_#]*M4]=>L8\]1P9@JCLY=ZTYJ#6L&&.!HK(<<D-GN)EMMA`)
MX2KN=!%V['1VB2FNZE*J@IJ1&UY`ZCDTC(]]1B&M*MQ+O?\`3.FPY&1UYSY5
M)LB7Z>/M56@^5%2AT%%1/MZT]-/!C7.;P;P[Z:ZI8I`"A%/929-3:S'13)%%
MLE<)05$[Q&J(@J*+5-B>JZ>=I,<07CZSVBFHWO;-+X<\@.7?6X7BC3_V&P*B
M[D^AD]:UK_UC_6M5U]`>3PGE[;Q_*?>:X[YF).]7I<$.H>ZK%:TU4-#1161W
MC?\`^1;W&O\`O_&G^6&&Z4[]&+O-`^_WCW5__]'ZF_`;_%7[FG^H_#_Y.X;I
MQ_Z<'<??0/O]_P!5:NZ;HH:**SRR3B7&K_%NTFWA>L<N#\B5):EV;([XP:3N
MZZX3CT'\1*VFP\X:J8=I$)%^&OCA^Y7-ON$SYD5CSFAP)X88FOHO;]UDM9(&
M]2.:/IAIU-"(`$0@`J.=5%Q:UR%EWB;9[QF<>^DQ*N-VLJSY5AM:6%R;:W)?
MX4-K78X<^6RJ]K<"N(RUN)4$@7<1WLUX1T)'"0MQ;D7-&2=G^E=&O(K;Y>V%
MW;P_*.+=+R=9;(A'B7)`5)Q52$J0>*+3BV)W>X\J2<LF6&Y3I%QCR\4>9ER\
MH;LTXIB/S@ER#%S\2,G$=*2XB,-JJ;11*)J^VYH9&ZZ;-H<TXL!Q[P,L.7:*
MQGF^>>YBMMB^3$Y+!IE`:UA>`-()`R4(!GPIM7.YW?C[Z[(L,L%]B89F=E.'
M+.\Y$Y=[B%ZA7$0B7^YC.<=6WSAB,.(ZFXS<*AKZ)JEN=P?82.GMVES71G%>
M).!3M%:S9-CL_,,$&T[C=1?Y*WD:1I:4#"P%S!CX@I"$(@PIZXEE_'F<WX<G
MDPI<7.(!1";GW*]!(Q^>S(,+=?SAL2222Q=RC,AVR;[8JBI5$0BK5;K=MO=A
MN'2LD==N<`UPR\..EW9WYU3;GY?W?RU>BTMY(SMKVN!:T'6W$.83@FG`CBE6
MVBD9MQD;<$&VX]!:W_(A+1*B()VVZ#1*BOQURJ82QM#71."DG%</76/E$8DE
M5JEQSXH.W,^FFO*M(/WB)<Y]7Y5L;D-P5$&3::9?,$-5`T7<]\M%K41^'74D
MW$C87QP.<(78N!S)^PG%%2I<18Z.1N@`/Q.)3L*<^W.O.:2)D5_![E:X<*5?
M8V76ENS_`%J-@CBSA=A7`6MH+5UZWON"@#MJE:^FM9Y$N[R#>K=ULQ9"HQ&&
M15?X513PVLMO?1WD[VVX:<CB"H3VH5/UU"W&(MM8]<S^D:CR).;YDY=X\0B9
M.%+?N\E3:16R065'I5$1/M^.HGFITCM[OC*U'N?@!VG+NK80#39VS!*3&V)J
M.(S1N?/'FM2QC-Q?=;FQE:<?C"2#$>J(.`+:[31R.36UQ"1*"2D2[?LKJC+X
MH%A#=3AEC@.?8?3E5?<0.F>)I7!K79X9\L<Q36GVN$=T62V4H5C?5_3LN&X<
M>.$XP^O;BQ3?-F,$@PW&(H(D0HM*ZF2W9FCCBED/3:``/X>ZI5K;,@!FBMV]
M5^9&>&6)`X5Q`%8)I&R<&6VJDVB$@#N)27:W2H@1-JB$G5$IIQC!H($FEHQ(
M.3CP2D33R->UTD8+B<$S`XJF>-&GU?\`I%1Z4+38`\:M]]SZ8%.ID2-*BCW5
MIU6E23U75:"^:1EM&\M))*<ESJPA=#&MU)%J.D!>)]%0W8+>6;WMW*+S`8N%
MHQIZ5"Q.).I(:*4I*S<L@*.XI-=T.V(QU(24`JH[5IJSG=_CV?*QDZB/&1QP
MP!/9GRJ6^<,CTP*Q[CCAP&(`Y=IXTH7WZ^9=;)`8M93Q&Y$\+<<61<95AIQ&
MI;(R5&.FZM!^*_D]=.65B7/899Q^:$#2<4',C(GAC4:7=7&*[21PDC9B4PQX
M+Q[:CW*[7^TS]HN,VT0X%RLPN"U.)X'SEFANLMNMMLL-HT!QRV.-N*ZHN(O5
M4IJXN[F*T>8[9[HP!I(0A?XU`V>[WB,3M>\ACW8`%0G<>9R2F%>>/K9:19S/
M%(B66_VPSN%\AVN/$98N!@TJ.R88`(.#/*E=JHC9JM%%:Z:M;^.X8^SN]3K5
MXP+L\T&.9K:6.[33%EC?O:YA0`G$@_4.VHHO_-$R\6^;9[Q$L+]LDMMO/*=G
MN$ARY)%>"041XB`XD.8XK>UT11WXBB46J65KM-I8/;,\>,GPZC@.2`>JM1%L
ML`GAEMU,H=F",R.:95ZXULD3DJU.W*=(V60KE(%Z(++5O9O=S)1=.##<:`'F
M;58Q46"4$;)QQI02@)18-TZ2&:65P2X)PY-&0/>?8#SJ#OF\NVNY,4125K=(
MRU$<23F22I]562AV*VV*"-OB18\:#$HK$"+5E67*[C[!@B/,(I4)=JH)K^DB
MUU5/DNB\N=(3)Q![LCS[ZQIOI;A[I9'$Z@<^/>.-<%N+CLEJ&LB2#RH`-2@<
M4$>:V(O9>7>B*;7PK7TU+LX9G,EG8SQM&*'(<<.(/&F)H8G,8]@:&C%$Q[QR
MI=DE!8B(VX6YP%JJNHK@N*1J:CNH3BH2%5>O1?\`CJ+"'"61[8\5RX5!EU/:
M-;D8OIK%+W'8,G(O++V^\8C*UVXN7<MY(#3"T`!<P-8#IJV(`B*?:IU2E/CK
MJGDZZZ>Q>:+H8RED32.&+B/<:Y_YGMA)NVQ6WW-4B'C\*X^FIMX"XVN4#)9S
MY.21`7W77E1Q]&U)K<C9$#SA`JH=/A11_+J)N]^)H61.8$>,A2MNLG,GUM<K
MFX*:OQ+-ZYL`R0]ON*`(1/FVR^RB-B3CB1G`13$R+<A5H0U5*ZR;HF1ENG42
M6\<DX(%S!5:U=N[I:I9$`#O2IQ]1S%%7XOWPAM8>`&D&0C9DCCC35!0$V&*-
M-AM_22JT]:Z&_ERL855N*<2,\#WU[+,)HWR%_',Y`Y8]^295^-BZ;P,4?D(X
M?<[I/.N'+4$1UPW.XJHJ,HV5"JB+MZHFIY:'21EC$DE"X9D#'%?;QJ)"R1[]
M%Q)@'!5Q#>Y*IY@G+5G@9CRI&O%8+=SSQ^Z61F/'-^4XC%IC61R5]&W')"8E
MK96NT8(J=Q3%5%1JM[)M<DG1G+PTLC`<'8!,P>['*MQO6Q!VUV$T":FL4E1B
M2=1`7B%J0F+OE\B0[?8^!L_A2S8^QZ;D+5LN460H")R?P1EAT.X401-"5]'$
M2G2NB")K891UO"J*W!N'+(UB+FQV\/BZE\/F2U?A7!,BY<^X5L!X!O-/<>Y<
MH&^KB9,QWF7T_P#VY%;P+8!]P]Z$M2Z43KKIWD7_`-ONB9"X]3,]W!:Y9YS:
M67]NTL``CP3CC5]-;BL=43\FN.M_A?9!5/[Y1+MHZ.[>VB`0+_5*OKZ)\=<1
M_>!SFG9G-:I:'G($X:>?#F.-;SR6R-WSPE/Y90''3FO$5$Q;5>WH#B)1!5LD
M+MDOK]V.]4$4)5K2FN!3RNDF#PWQ'AD%[`.%;]H+8BS6W-5XCOPSHJ](::`I
M`"VN]5$!!I-@D54541*`G7X_;J&X%Q=*[2'.P&'#BE.Q0ER0*1IQ../VU&=X
MQ1,HN$MJ;W89-G&:"?\`01G)#J-.(]VH$I[N)&8JO1T`%U5K\R435[)=R65K
M#9LB:XYGN/-/K7NJPM;]\46N-YZ6H^!3I5$5S4Q[C@,Z=4&,=H=&W.2),YEX
M]\!):]YUF.U3>#LJFY]!545%<J5?BNJ:4,(UAC6!`J?9E2)'BY#IM0#_`+V'
M'LY4O,O./T(6DC+N+>+HHI(@EM0JU41$Q'X+Z:9`(D(T@@^A>[E4,M;&PF0E
MV'"O+:HV;A,(UM5%7YP0]QC\4-Q#$05/7I6FGH7M@$LK8]6*8^(>VE2?F-9K
M+E3@4P[42DJV2K?<9E[N$6W-,*A,0G+NV""DXFD-3::?`4[K,9PE05]$5>FG
M'OC=$TNA<'.//`'_`&Y"@LN(?EH))]:*0WB.TKCCQYTGW*,T\WVWWFTVN(;2
M[B!T/C07F]IH-::A"1/`9"@/LJZMG%OB9"3AZ._OI)MCD\[FL8)K+HMMFID;
M0J1`VN\.\UM1BC2I]E23U34N!X<T31Q)*'+F<4KV[;"V)W68<0B#@N!QSHO,
MA-$X[*>?E,R9)H$I@)1MV]\F'#<CJ['HC$G83A**JVA]?5=`OY6R2-U.TO)7
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MUHO356ULK).D(5D7V)E4=[FO896N2+^(QI$>`FF``'%=571)#,U[AH"U1"(:
M('5.BHE47IKUH#]99@T#U]G?2'.=U&$NQ*^OG28]W%1P`%=M55LFWC:!&G$;
M(FWT1/F1I25.M>J>NG8FO>4:%!1>:<!2PQFEKL%;AZ:1:H0.?=F!*0/`@_.Y
MM?WB-#<)7.XBJI$JU5:HB=-2)':90-(U%H[_`+,*26N*%?!B#SP[:Z[0%J0K
MB-"V+-$0J[-V[>I(([D0G%2M:5JBZ>C?$P$2ZB[W<J8>'DM+`.F3EAZZ*D9+
MO<=D"XX^[O=`ZF0N.NF;U-Z&K8D7HH_H]:4]-)#I'DOD>H<32RW0=#1E163'
M,Q2HMM]E*-J3JJ9-[A%QM$HN[:2_-14ZIH(()>'$)SS]%*$B(=2FDU72CFL<
M%$T?0NY15Z$@JM$W`2[UV^J4^RNGHAX#'(X%,:',>X"4!.'^M)[JH2GV>V>T
MQ%-II]VE",C+:A`1"1>B_;IP!2H<K4!&:TG`,61J%<\J29(/_*\>QY%<<%'$
M)1[VX:_,BJ;9&B(@@1`NU4Z46BZEM>U0YH.GW]ZTP0QP<B*?9VTV[I'^H9<:
M_P"2)@HGVT5$V(*_)WD7ND^*^I]%^S3I>\.&AH#%RKV%&'Q/4\^=(2QT$>CI
M_(W0!-">`SK0C)72-WOT3H2=:I\-/P/:YKBXH>&'T3LJ/<->7^%HYD\NZN'R
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M3OT8N\T#[_>/=7__TOJ;\!O\5?N:?ZC\/_D[ANG'_IP=Q]]`^_W_`%5J[INB
MAHHJE[H3XV0W!AVYVZ'"$":;MSRH3DV2Z:/N.V\&6D5^K)[>X;H`O5=J:^-[
M[:60[C>"XW2-K8W$D:7%SEQ`:$TD'\2A*[I!>PR;=;&#;Y'W#LB-(`3#QXX8
MXZ<356H@8TSRIG4FYC=X5N-RW8[:W,<D!(9MDB6](8N;MYM5R=88>B2I;#)M
M_3@^VPB;E03)*[/RU)%;VK9+J0F4M\)`"J<AB<D]M;7=6;E/L&V068:9<7O#
M@02UJ$$%H(\.(Q0GMIW2\7:M#DZ:Q/O-KN4FR72T7%<[BF^EV.#N)XH\@W=T
MV*Y%!RA1W&4`2$D%?T=39'=%P>T`:N7_`.0Q(QPPJKMMU;=QQVUU"TQAX<QS
M#BT'@!ACQ4FJKY-&R"X60DR*[Y"QB+D:)<H$!JT26[4ZD]'''KA=+T\;CDI&
MS>V(B*K)@JFBKZI7W9O;B.&W);'$UR:L%T]O'N[*ZSLDVTV=PZXL(HW[@6HX
M-*E0`!I")B`I'W3@*?7$6,/YS^T]@E/V"-=V5MTAJ9.@,"D>/$V/0XMI@#]!
M&<64W&7>X6Q'&Z&2?*-9FUQNN+:\B<&N)>$(099$#)<ZJO/6YLVMVTWUM%,^
MV0@M4E2Y=6IQ*H%0``H>^IXQF?D_']RAV/.+.-MCR7&&(-YM\]VZQ)JW20D=
MH[@T`2&8ZSY5%:,#%EM$055%6B5/FG;+A]DQQB`='CJ.G%O%`,^>.`-<]D9M
M.YM??[==>(*L9:06GD'%%TC`X*<ZG62TXZC!L(I(W\X+O[9.$O\`_D7MDBH5
M:JBITUS%L49+V/<\(?A/Q=_954R4D2!@;XLR<AV`8TS.29:0L>M5[COF-RLF
M88H_$4$:DOPGWKO&CON1V2#:>Z,^2+N5$0%_+K>>18I(MWM7ZC@\!"1B'9(.
MX*:I+QX:VZAT@QOC<IQ'P\R>U$I@X=CS-OS[FRQ0I".VR)R++FJV;CB''6Z@
M4N0T*EU50=3[?T='[@6[;3S!=-C.3N29GV5J]KO^OL&T2S_^H="F&.00*.%2
M!<+I'M)E!9CLB-5*5.[PMN+N%?D;:%OY`0NJ)NZHB_'UQ/3)8I_4/)/0O\%I
M^!CYY.I,2@`0</\`7GE3`?N;<N\C;A)\G#AK/9EJA&+B=X(Q1Q:;HJIM>12J
MM:?EKI^*WZS82`2XNQ3/+AS%6LK)(+>6Z<YH@:4`7V_3G2NC,EH**VV1`ADL
ME'%%HNVJ@32=YUIR.8_8J=4^*Z6;>=[5:X)B,T"C@5Q!J`+BU#DD.HX%=)X\
MDSS]'&FOD[Z7RWOV:#*:BW!'8RW%R,Z2.#;31'G1-QKYP>?:101?_2O32K:5
MEDYDC8M4NGPD\#VCBGMJ1';SR2.EG&FUU?#S(R(/;RHE%AP8]J::BDL4&59!
ME8PN1]K(+M4#)&T(A=%$WJ@]?C6NF)KA\DI?,[Q)ZSSJ9H*D-8H50ONKU,1$
M@ON-27:A'((DLW2)F/*</:TZ79VR$:"JT1.OVHFG[8.#GN746A05R]%0;ESX
MPT,#&.>Y'`C,<NVH^2\+'C#;KE&N,*;:&19?OKT=)%BO;;Q$3-PB2X9+]//<
M4J.L.BUT1"4E):+H;V:RNXFR-\-VUN+<]?\`,.[EQ2JJSBO9+Q[`'&%QS.!:
M1P`P!![,:,L@3<.1<72;0/HW7Y:N;B9^G;`C-U0&.X*$K8[D2AI3XIJCBU/N
M(@,N&'$G##Z)6@;!)$]&L_,+AQS^RJ-7"7=[_?K/;<*M%FNKJWJZ2[?;+@;T
M-A)*L/JX^]+%M\&D5/F`.TJA7YU$>NNDC:9[NSC;(XZDQ]';718;ZWV^!DUT
M_3J:!J:A7LTGWBI:X;<RK&,?&%G^"9!;K*Q=Y4>U90U`L\C'6[F^XK<BW/2K
M=,=?B"]<-YLR2;474-$78M-5N\[)<"#YV-OY36Z7@'%1@">82LAYC=ME[>AU
MA>M=<:0XAV#B$S:N:<JF><_"4'%D=R,'U"-?6J9_*1`K@->@#O5!1*"2D0EK
M+P03S$F.)SF@@$@$KV=B#&L_.3&QACD;B"@4`GZ@M9VY[G.7S.9\WPVV<O\`
M*V%63&[3BTFQL\><&.\IL'<+O&<<E/WBZM\99O)M5':?=.R6!0*TZ==;BUL(
M[/;[:]BVV"2Z?*]IZMP8?",@&F6,'U&J"?<+P;G#8R7-Q%";=KB(X6RN)+G+
MCTY$P&'"E/)?(S+\=F67%K.><9YE5KY:Q/!<KQ9C&L#A7C(85UX[AY&"8>MR
MGXU!BL7B1):DOOW1^V+#D.NL[FXX#2RVC8K._FN)IK1D=C):3R-T.E=H>Q[F
MJ_%Q+8R"FG7J:`4)*4GS+<R[9>1MMNO)&#;@@M9XNI"V1!\*/.H%RZ0URAJ`
M5URGGK@C.KU9;[=.),GNN8X#A69YK.R:YV#`7;KP_8K.Y=K5E$6X3).9_7G=
MG95F=CC'L/XF4DG6]BDV2DC%IY<WB"*X9'>PLLW31L`#S^:Z1'1(W2G'$RZ-
M">)*@SW-K=BUG9:2/DZ,CU+03`UA<V1SSJ)1H!)$8>2T*`<J0;7S](QK'LI1
MGC?.K!F_U]FB6W!,@>XV=R6066B^MCG09D'D21Q\U!E?3/*CLR_Q18*.X+Z"
MZK3;UB[RO--=0+N%O+;,=*'.87O:'0LUO!=H"HSQ#IAZ_=6G]IN;.U8Z;<[:
M5ATL<(P8];P\HU"'F-A)!42OCP&**W5-D#E^V6"R8W=LD@9Q"<A<2Y9FM]QF
MZ0<?.X.%AMRQ2T7P)4F#<YH+?3NUX1(#D";)L<QA]V2DMUCZ=XL\=NFGO=%L
M()G=6W8UP,C03<!Q:T![&$!``\O`<QP"`J:=W"_@:(9G+;03RW0`1K_T1$3K
M+"]I#=8T/B+VO5Q+BT--/+`,WC<CV1^^)B^3X093FXIX_F3V-2+J+3P`YNCW
MG!\FRW";@RK3H.,O0[D^(EN9D@R]O`'-QVFULYF!MZR64$X-$@TN:\M<QVMC
M'(4)#M.DX(34"&\O'1!\MJ6C!0K'`@A6N!8Y[5RU-U:FXJ`<*5,^RF'@>(7>
M^]P'EA1YK<)E7D"4LM\?I8;,@W"^GC-O.NU<V*ZH#N]>FF+&U$URQKI,0XE<
M00W-#PJVL;>2\NX8&L/B0NTXM[2#F4%5OX=X[@V6QLY-?XD1W,+Z$B;)[I@0
MV"V2U22U#9D$LEXYTPP-URO0=Z"*H*=9NZ7AN9>DS"%I&(.!3,]O("M'ON]O
MN&LV^U=_QX`APQ<X8*4X)E[:F&8$<@1EOO`P)D%5=%5>:,!)))HB@2NJVO;$
MUHJ(*>O1=,FX@=&]D0*C+N/,<SV5B6->TMGD'B.?>N0[JU(]OPP/`,X$=]6\
MN:`D=2CBTMC.TUJB&B&/HBJJI3\NNJ_M^6G;;H->I$N/JKGGG8)?6I+-)Z9]
M]7]UOJQ=1/R:)JEL5HS;<VR$%Q"^4>H+U:6HN*O_`,-<)_>AQ'^#T@ZOS./^
MVMYY*<P&]$@!9X<$SSX\*B0T0S0"[M$0"5QITJD2=2J(BG9`_P`M47XZX7X/
MB9&00,0OK(7*MXT'3F$)P4)_K19XQ[+G8;%Q&P+:A&V#?RJNT-N[:*H55541
M.FH^F&33J<6AJG/AV)[:?9U`]I<H)3+GWYI7A2>(6JA0NV.Y0<3<I)^D`F2_
MH=5]:::E>9'(A0GPXXTXT,9U"#BN288U^$:$SW8[:OBI4W[F@V(BT)Q4D&VB
MC7U0?F^Q->-B+VRH4D'`\3_&D:QJ9K*`\OX>^O!=X#,]G<%1%4%26@T2BHV*
M*J`*JOY:Z2CBQCBQQ=DHR'HIYIC+0TO3'O)[US-0AR]G]TQB'"@PX3`QKVJ1
M3N82_IW[<9NBW),(KS`&[MBU6J**_P#I15U?[;86TC9'7%QIE8"1&!\13#'@
M:OMDVF'<9)#U"7,X'B.`]?.IMQTK;^#0V+>0);5@L+&;-G8#S"LB0.`!T4>X
M*[DW4):]>NJ<$DR-<\!54'C_`!K-7\<[+G6Z(]9KR%!Q&/'ZTKP_9D=)0:VB
M9+W6B4D/[NJ(H"55H:>J(J;:?&M-)9&UP&*/7`#%>U<AZ:E0[D6-!D4L`0\,
M>T<NT8TGQ+0W"5UU1962BNIO+<I.#2JB:@OSI3X+14T%S&,CC:Y9%*I]=/R7
M0FDU,8[ID#EZPM->[JR\XXK:$B`:BAJVBBIJGRN>CB;!5:)\4T0C67:4#%XX
M?75FP.9$QSOU$P3@.[CVTBJZ*DV)&K@[/E7N&@H:*HJ>T4VKLIUJJ5^S2&,C
M;*)0`!R_C3Q<=&EV)3%`F/=7*2XBF*"A$*(NPNWM!Q15$15%/F;4EZUITUZY
MH>^1S7(5SYTVP%K&Z@[3R/"FM<&&63.6[1_Z@VB<5O<I[`4^P3;8*1`@(M:(
MF]:U5-22V0LZ#7^%5`RX>^EPO87D/B1X;B>WE7)#163HF]E!$R5MU5=:&K@H
M0]!(E,JEN]4&O]&D,>][=>)#<R#B.SM^RD3:6N:H1YP`(P-)DI&ZMM(;:-.;
M&W'7R5%:$PW!]XB$1;J+M/HJUJJ:5H<PO0$@$=U(;XT)0/"H*)$A+]Z22A-U
M$<1M@`)M1,&407D<<:+8K8UVHA4JG74]L)B#R21(4TIDO;3#GH6L:FGBOU=M
M(SX_*XXVM7'2::3[AM'&$8-2H0&K:E\BKMH:E1?C3KZ"`_%N&DICQ'%?JIT2
M?$QS4;F3[/;1(R<,'T;>^I1>H(XTD)&6$3:C9("DCAQD<15,O7K6M:ZD"1DA
M`=$',`&7%.)Y(M!A#2S@3CSSY43?DQA[9LO"L>*I*TT+HDDAD%HINFZ3:MC*
M0$4?C2O1/33;8Y&^`E07%"AS7*G`T.5SF."KZ$KDY+!Y`5L1;8)2=5%W+VQ-
M%[@B[MI155%2B_E]>FAP>H!\1<?4G.F&L&HDX`8+3#R&/DEP)]BR3+98XSK"
MB3U9DZ\*>Y!20P3(!&C-)N_0<?!21:JO2FK6V=9P(^\@,A/PA=+1]9]56L#K
M9D8DGU/0KI`0$<L:(XAB4C'($MN;=W;D[/DI)4X]N*&S',-Z.DRP<^80HX+B
M*JJ2;J5IUZ*N9^L&EL?3#<D.K/,%4[A2=VW*&^D9T;<-:`B*,N&0`IPNO,HV
M[L?5UT%0?^H-7E$D^4D7:J*TG1$%$ZI^748/E'B<I!'%/6.ZJDM3-H`YCW4@
M25-15UX7$)$0S:9$G`HB(C:(J.(BE5?BB)]NG]/B;^<A(]5(C$>+1GP/?3=>
M^8T0T4'%3>J[EH6Y5VD#@[%4C!46B"G7XZ6%8`HRRKPM!+@7!%0FB;Q[5V5-
M-E45=CB-()HN]Q32J=$']'J2KZ574QADD8$!TK[:BNT`/R/OI$>$'2>CRYDK
M\/>,2,8CAFXJH"CW6X\CZ<`-$7HJK\HZLH)98V&%\CVV^H$@9*.SZ"H$K&O+
M9HH6FY:$&K[:(WDFI]QC2;<PEHBP[4W;_H8JQUC27&$HEPENT4I,Q[;Z_*J>
ME%]=7MYN<>XF#1:,C:V,-P`4IZO=4"TMY+.&Z;<3]22276"?N@_='96WGBHI
M+P1@:F2F7T,A"(DHM4EOU2FX_3^G79_*R?X*PTDD:>/?7*=__P#=KM`@U58?
M6AJGH:**R.\;_P#R+>XU_P!_XT_RPPW2G?HQ=YH'W^\>ZO_3^IOP&_Q5^YI_
MJ/P_^3N&Z<?^G!W'WT#[_?\`56KNFZ*&BBLX;CS+C!B<AZWW9F]-R'8RV<X\
M:3*:4">049%9"=A.Z-!0D`Z]%'7Q_N.Q[@ZZ>9@K-1#23P7+GA[*^F=IV"]D
M:(XBSHANHD*`5`4G#%>RH+BX+<)UIMF095'OEFL\G*KI<UOZLVE]VWO70VXZ
MC<9+3PWIDY:`#0`(/,M415$:KK5&P;!8-FGETL8X##NPQ[*TMQOL,6Z2[?M,
M;9;CH-:GBQ#"3@/A13CD2G&GHEVNUUNE+!9)]WMV*R&&KW)OE\DWNTHQ*65"
M&Y,-()W-MN9$0U?=!'#;$Z@"4TD[@2Q\L$'5;&?$F;@!@>T'C6>GV>&UBUWU
MR(;FX83&&M0J,2PC!J@D!H7'G27=N$\SRK%+2W'SX[Q:8$>WNV6PDC,J&#S4
M1IB6"7$0:=>CH@J$8'E(6&4%%W*E=9Z\\P.E?IEMORER(1S4X8>RK3:/,.W;
M)N+G"RTOQUR<PN!:%(7BY,S4.WS`>0H,ZYJXBXW>;6PP[!61*2+=,FB.R"2:
M,&=&,8<](C+*FH/&KIM+L$*+JQVZZGF89[=Y;)&$PP)!Q4@X''*MJ_>_+5]\
MN!IFLYG(Y02R-V"`M^)JKB@1<>%.'CG)%=Y`Q"%F=\AS[?<K0BVVX0[I<DMD
M2ZQ`%RT6V]1K@U!B1G;=';<V"G=;21T7YMBZD>8+NYFLG]%7R.:T.(S:#B0!
MS)&-9?>=OACL+[_';<^+HS.P(4O;EJ8BDM*]A05>>\WC'[/`WWN_6>WM$RLM
MM^X76%$1Z-3>;X$KZ;FR:2J+T&G1%UCXMKFDD?)(USB<6GXAW%%Q3*N7VPF#
MQ%#$[5J1V:_1:HA?N<8_.G(%GX.X5G@;F0WT'',^D-LNVJW,XM*_%;BS%!2$
MY3ES:@E'CD(EO<5*?)\VMWY6\O2?Y*TN/S&SC$`Y*.?HR';6JO-KCVW8+W<]
MUTNT1_`W/Q8#5QXJ?;C5DLXR"W8!RS,:O7;@,<GPX<UQIN3$<=A9!`V0SD3@
M%26"-Q8)2%5^Q>G34G]QMDFNKB'<W1+&`CP"KCZ!QK.^31+N&V2QV8'S%LXD
M*J%F8'(I2M.;@3!ELN.=UYLFT-QL4>IO%/IT9<514Z]*UHE/Z=<D,1T,<`2T
M%`1V98=U:L3.:]H1NIP4MQP*8XHB+19(;K?T_P#T:_6P`)MEVB"33*CO-75;
MWT`D&JI1::7`;CKDQR#ILQY$)BN/&G)WQ.M=+\2_/'`K@E<YX;8QOCW5%UQP
MB1$V@T:U(E1$VIN(EKU3XZD*"XW+RK7$X\%^VHL;@`VU8QNM@3`>CU4R'6V`
M18X?3,+(^G5L6ON7BZ]QR2ZV7;(V^XFU"JJZ:+@>F]C<6C%0?HG*K",7+6NA
MG=X1@,CZN%>I5R8:)(Y(!/.5:`5<0MR@*EO(?A54_P"&DLAB?"97_J.<K4Y_
M94@.FZD<,;2(FCQ$_;34C2KZ]D3<0K2GX`41POQ!7?NW)1J@MQV6S3KU55)5
M2B*E$TEX(ET:3K=@.WOIYT<3[=\O689`?AXIS%)3-N.:-WB7*7*GPS)QLH+@
M1VXB#38:1V6F0+J24/>JHJI5-3(RZ(P/#`)QS7'ZJ@6\CHI7RF4N8H3BGV57
MV]7'-+1,N.")=6`L96V:_'DLQVG;LU`5AQ8UL><<)!"+14;J*J\H_*GKK16M
MK;S:;QZM>UZZ?NKS''.NCV%OM=Y`S<A'_P`@-"_A)R7M/9DM)."9_>K-C08C
M!QINXY(Y<Y+MIR"`@M7B$[<4-NX,O26'U<>08R*(LDA]L>O14UNK;>'OA,+(
MP9&C@,4^RJ7<_+MK?WD5^Z]<RR0+&]=*C(A<,3Q!I*S;D"=8N,&K2]%N\2\2
M/H[;(.?>'A@S;6_DY7!B?:XQ=T7KN1+VB)X0-L`5!6BZ>%\)+66+I+,]I#N0
M]&50F^2XY]Y_R3;EKK.-OA&*AVG[P3+N45/D2+(>CPIQ?5B?X?#5MIP11P7G
MV@/<Z"$\7U;@DB(X/SH%414]-8;5>P1/MX94A<3\//)21CW5D;UMN+BX:]H+
MV..>"IP`[,TJ.(_']CM&:YQF[UQO!Y'F3%DM[ED.!"_#6[=9+><49#5S%XY;
M=P<=*J_HT7JBZF37CQMUI:.7J1O+M7-47U55QMG=N[+IKQH;`UB+R)(P[5JM
M?)?C;9`O:YGCG,\OCK.+MR3C^9XF%S=QMQB3D]JPNVXN.,6[]H9`%>'I;%L)
MSMHI.(:JB(@I75KM7FJY@TVK;`R6[8)(WO`+?!*XN<XH$:FHA?3G5A?1P7UT
MZ>[N^B^26$M(`<=4,0C:$/Q`AJD>BEK!_''"TM>6_BM]R6Z9!E^!9!QYF@7R
MWV^/=FIU]O-WNMPOZ"QW&8<IT[NIQNU5KM@!"JZ8W3?KV.2U8VV8QK)XY6(7
M%>F&AH*_$':0O,GA27;-)8O:T7!,3K::-SFH!(R<N+\1\)1SF(,13#R&-QK;
M\NOO!N:^0&/W+R%Y%QFTW.+"RG!,/'\?P/'9<X;=9!P*Z1'\5OL-RYMRW7&]
MR2G"1'11.TFK"'=+UEJ+RWV-T>RLN)'N#7O+6RRL#20Y=<9:U`T@H,BJUGI8
M;8R2;=<W['7\L#&M)`!TL<2TEI5KR<00<\"BC&3\/X#B8OCV.62'D\N$_9\#
MY#Q.'<(]NMBVY"Y(RNTY9=I%IM1LR+/!MUHN-K[$*T(U]!&MQA&%$:;!$@7V
M[RW]U.YT34/RVH/>YQ/RT98T%WQ$N:0KB05&%6L=C:B&V<7*Z*6Z>=+=+=5T
M(VN#6)I8UAC5C6C2%1$IT\-<46_@JQWUAFX,7A+K<)>225MN-V/#[7'N35NB
M08HVC$;/VL8L\!U+>#DO8`"\:O/FJF:HK\V_0;K-9"YB>UD`<&J]\KB'/+T!
M>22T.=\/"H%KLT_7T1.#I9.FPAK0R-`C0=+$`=^(C%SL35?Y.;AS+RK%&7$?
MEX59`&\/QYD<FK=)DH;A(KK44!^H)R<J+_6$6V^G3IJ9*Z2TBF?I:^XESP3O
M0#+#ASKH3]NC\K;4X1E+ERM!7Q`'#`GLX\S5AV9"N!-6/%C*W%9&6("6QR5&
M;C_\B/W^P#TL!;H.Q52BTK\-4SHY))&QQM;BQ4X`>GC6`,S6M,SW/"O`RX\,
MN=(Z@NQ#`"8:<HK[9.&T#)?I]IQ3)5$W>B42J(J_9IF"-T9EU'$?0*:D&1C@
MQ^"+QX<ZU>]OQP7<#SDPW**Y5%%#)KM[]MK;&J+Z&B(B=?\`^^NR>06N987H
M<$/5'_VURWSLIOK8JHT%/75_M;VL744<E"9NVA`)$JDA%1:(A=0Z*2]!14^W
M7#/WC#C+L`:`IUXG`<*WGDQS&Q[@7M)`T\^W@,Z@7(LABV%822DDJ<Z6D9MR
M*T+HL*I(*"?5$[2;O@NN%/9<`O5V/+D.Q*Z/9V_S!=H:-#6\<%[>^E%LB=4'
M0%!83=WD<9)'21:46G1$*J^O5%348!T+I&D:ER/#&DR8@-#T>N&.'=W>U:/-
M-`^YWP!!*B`I5(!H/5$1LJ"BI7JM.NO"U[B`YC=0]&-1Y)#$W022/6?779]H
MS"GR;=I$:CL,NM4$>O2O3UTX6:6%RM/A*C/L2FHI6!V154Q4#MI*-MH@2.2&
M+CR&2$*N?-VT^;N52B5^SHB_#344,;6ND;@X`$XGZ=]33(X/:[`M',!!2/(L
M-MF$XMS88F.OM"VX[,C!(:6."JJ,"VX)MM!N7T2BZ\<^0:7@Z6YYU+CNI("/
MERYI'`%"OUTH)VVU%H&E!&1;`&0H+;;0BB`NT:(+=!Z)Z)J&]A<]S]):,T/T
MXUX-3@7%ZKQXKQ]-&0F.R'!98)M1-OY5$B4A(2V("J%0;`J_DKJQB$T[(X6.
M`D.7!._O/.HQMXXEF>,!GV\5[4]=)LD.^)LM[F9"(B(VCBI\ZKL(E.J[47\B
MZB&,/F<C"U[2G`8CG4^$F,-D>0Z(^[D*:;K8@*BNS>V7;[HKT3MJJ*B)M]>G
M55Z:'^%Q!`U'Z9<:MHW!VDM)Z2<L?X4BJTUWAC-[&FD)3)10!&I&B$5?_4HT
MZ4ZZ>M8VR$,G=I8XHI^[1.\M:9(\4"ISI*OE_L-LDQX;ESAPCDE*2$Y='0@O
MS`C(/<%MAW;W'&MR?+T]4KJXGV236WY&-\UO^,###/Z&H-I/=2Q22W,>ES0"
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M&(^G.DYQP7!&C(I#BNFPZA$@D4D'>VI;JB0;6GA501?A5?7296H1`V)`OK].
M>->`N^-\BDC`<AGZ>_MI.=07BE(@L+')MYAYLDW*T@/MT^\W(2.IMZ4I5!6N
MFX_R.H`U)%1,^-3@\O;&>U0<J:MWQ^+<8S<<P+:P(-./U4G7&Z$+:B\=%#NB
MNXNJD7_'4B"^NHG.Z3U8UQ*'%#W?5PJ=!>=)S"2$3+WTG.VQ^+;SV7J\2IH7
M"(U;[=#B0&;(EN0#;?.5<&D6:3S3P(FU1HOY]3'26N@3/PF*KRRX<L4JO,[K
MB_T"U:VV#22XDJ#W#"E&$W(_0?CA')46H[D-!$202-S:B">U>B)U74(ALP:`
M$<W(GD.2T_,YC071O+@!],*X&7>W[S(BV(2*I=M!%1$&P'92JBW2J+U33LK"
MU?$"]>'$$<*B`#6,`&)QI%,S17!%!W%L06P%%<Z$K:$1(/2HK1/71&7$,:GQ
M'U43N8GQ%`5I&DJ8;G#1Q&]J-HJ*J5H241Q:$JJM.E4ZZ<TN;@YA1N?VTW$]
MCG'2A*X+3?E"UWA*@[A1.\N[J&U-M!(4ZT3^CUZ:?@=(8V,!!QP%>RD!V!0'
MCPI#G3"V@N]T$;<$*J;B(T)*2"M`4BH=*BE>M%Z==643B\Q1*F("\`">-13#
MI#G`*H5.)[J)F\2@ZZ$A#!";(2!E%)XB3;MVN`CB-FG4E5.FK`Q/#IHNH%:<
M3S[J@NTCI8.QR'VT0<?2(ZG<,&U4$^\802)"=1=JBTY4?153X53K32V.T2-<
M`A`S[>=(Z)E8X!I)7V5MWXI**\#X)M+<*0I*(5:U1)CZ=>@T7\GPUWSRG_[!
M8+GI/O-<?\Q?^\7B<Q[JL3K1U24-%%9'>-__`)%O<:_[_P`:?Y88;I3OT8N\
MT#[_`'CW5__4^IOP&_Q5^YI_J/P_^3N&Z<?^G!W'WT#[_?\`56KNFZ*&BBL9
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M7=18MA:75K,4<<E(!3PC/^%+N+_:)]NN;J[9%<VC=3`"/$7DH&AI"!#@N29U
M9C`[;<[):92Q[E?KA`>ES9<9,C="\WSO$X]]9*O%Q=5N6<V[7`%><:14^D$N
MT*;1IJMNF6U]=[A-T7LB8U'.S.H`9KF%'I[:YI?R1R-M&%D0G*#P>!B8Z0T9
M%&E%(Q.*4X,ALEMSNV-VF_VJ!>($XFOQ"!<@;E-PP:;^K$VOJ8SPF1R60)%3
MT44U0VUVYHZS)7/O4"%2K0%7#)#V+1;R3[0Y\L$^AC1@X``/7#$=BIB,ZI7S
M3Q8YB5O@1+P%KROBJ/)&W1;%<89VFX6MZ\/-@=M&ZXS&AO3(+C<=217T-%4$
MWHM*ZU&S;L^^BD!<.NQ%'$KBHKI.P[S'N1N"`YN[NC74JM<U@1=+EQQ`0<Z=
M'%GCGQ^MA"\7ZSO7.WW5QF9#Q2\7B]7"Q-VV*ZXW;'+G;)TUV))FS&E1YX";
M^FWE0&A1$34+=MZ=U'6EI*`P'$#PDD9@GAV<ZSFX[NZ&3Y>&%K90OC:,=1Q)
M'8.S$5.V1X;BM\MMKLKMDA6T+#+C7'&',>6)8Y.*S8#H%&G8^Y`9:.U20;14
M%6]ORJHJBB2IJCM_,%_9WD=U$\MN0X:4*!..H#`X<ZK8&/?'-JFUPO;X]8UE
MY.0*YXU1GR3F<TY9R99,-LF;/9PYC,9O)F[>./6"%.:814C]K)9U@BVMVXBR
M+R$VX8$XAT.F[KKH[O-EW?QQC=;D-+<B``UR\2!GZ5KH7D'8?+>T;3=[M<6[
MH!*XQDN>XCGX&DHWN`[*L1Q#RE:\Z@LVV;*:MF8VHE@7>T2FQC7>/]#2.KKL
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M3*YJAJ'F>(P';1M(41Z,U<2@1Y;/;%MB7*CMJK*O`CF\$J)HXJI5-NZGQU!C
M9+'('P*(2$\0XGB!4@SO.NVGPD"DM:5!`YGMI)GR'&0^FB!%!\2;;^=I=AQU
M3>^RKC@HC:F"JJ*I454U/?9-=UG2RNTM14&*\O3SJ-UB(XA&`&N)P[.8Y5%U
MZY#QWCNW7.X7N9.F=I46.VRS(<N$A''.S'9=,MHM,`:(`D*;%1.E=2;;;;F^
MDTCX<,>`]'`U>[9LTNZ3Q0VX`:0A)P`3/L/HJG%\O]TS6[LY%=[P_;;3?KPX
M+\..KB7"/96Z[F7I2MJD=EF.&P@9`G22JK76OMK`V\$<+FJ&YD^^NK6>U,VN
M!UI;LZDK8U&6DNY)]M218<UBV6XS,OQ>VQLA)FV3[1%BOL5;"`<0HBW`Q:;:
M*.Z+;:B)N"IFI=2ZKJ_M!\LYLL4'@+$/9VUF]XVVXNK"/;KVX<R5\@=W'X@W
MCAV"H_;L]ORKE#!TG6:WM.E,CR5C/(C3%O.+;OJ6XC8191QAD22(7G$>'J9H
MB?,BZKMP>&VEP^W\;T[CCV<2G&IKC/:;%<QW$Q+&M.DZE=B>8QT\O35S[_<%
MQ&S7.\SKO!LEN99I<';O(CV^`U;'W8XJRY=E?1&6'9*"@AN':YMIM5:ZS5G(
M]NB&W:[J.^X,2>.?'M;Z:XI>=*9[GW[DB;DXY!V0_P!:HQY;^8.!>.>*1I5X
MMTZ[9WE[L6+QIQE8)$7(LAY`NSIM!'AP&X+CL]BW$2H:R7S1E&JJ>\D1%T>T
M[:[>WNCM[(Q1-_5E<48P>Q3R3&LYNMT_96,=)>LED)'38U=;^6'`<^'&J9\1
M>/V9<FY_CGEWYZO0[_R;;'6+GP9PA$D(>`\&6%R0LNSE*MT`VX5^SQM[YY,E
MX7S!X14E7MM@U:[A?16%L[R[Y9)99.'YTQ4OF)S0E2UG`-">U3`LK>2_E;O>
M_$ONVG\N,8,B`R4#`N[<?J&F,,IUSEIF5JB;)+JL-Y`VT)5O%EAJZ<=X?O$=
M=ND0Z=I&Z$X`(VM4HFL^_;VB%MM=2#JZ3H=RY(>WESQK:[5O0N62V,L2PXZ<
ML'GVH>-1-Y.>,G#GE3A4:Q\IX2WD:QD25C62Q'I%KS+%9K4E9<>Z8ODT?LWN
MR2U=0-X"XK3A#1T#2HZ9VK=]SV&8.L[@L51('!6OQ/Q-*A$_A51NFTV>ZAT5
MU"KVY<'MPX.'U9\:^7WS@\R_+GQ+S2W>*MB\DIG(ECXZO^$YY;<EG6@(?)5E
M9L\D+U8>.,ZREAIL<M9C!'ARWWS<?E2VG4&4ZN\F&^R>7=AV+>H1OYVKI3RQ
MN86KX"2-+GL;]WB!@`.`XUS'>-YWG;)#M'^2,D4;VN!^\@Q#7.X\">/,\*W0
MX<\Y<3\KO'K![]99PAF&;I`QG*,39%T2BY,4KZ6[P;H[%8*0S8W$C&YV6=O=
M9=%:D"*B\^E\K7.T;O-$]@=`Q^IKOY3D05PSQ[J[/Y"W>VW)\.XZ0.FSQJB!
M^6`."\0>%:'<1X;:+/Q<Q<&)D)ZZS.RA@3?TOXCD=Y9?<NEA"IBS#BV>+]VQ
MOV@!-[45%5:^FQ;<?,S1S#J,P:N6M,0.6&(-5WG+?GS[Q%%TW=$*W#'P#)Q'
M$DT$MDN*Q:V#CVJ)`N$LYC,X>R]<8O9HT\Q,<><5EB&T8J2"OZ5/B--5;;<_
M+6X<\%SY"A52$S!6JI]T'W,[H5:R-B%J:0Y0,<,>-->Y6NV)+G6YFY1[B4#Z
MA91-WB$^TY.;CK+=;-U29;%40!7MJOW:THBTIJQ^2A@E=!J\6A20<%Q/T%1S
M>2R,CER\8`"8IACVCMK4CV\3=+CS-0-Q76V\GA(T2DX8[2M+1+M-QQS=U7U1
M43IZ)KHWD1[W6%WJ!PD`QXX5A/.;6MO;8M<JL/OK0C6YK'5#W*IDV-M<00^5
MN2B&:K\JDK8HB(@G^E7UHM-<(_><:G[$"U0DG_XUT+R-I/SK7..;</742K'C
M.,_3O;C[:MJ8209?0NNY2^=LVR5%3I\NN$AAC.J)02G&M[U'O>2`TL*Y*.X)
MA1XV$02%06AB);72-!VA5*MC7:V7_P"5$KTKKR6*:,",YHJ'OJ*V4$@AX4%/
M"F'VUU$-Z$"[FU$6T5=J$J@JI2J$);JKZJG74N-CGH)(@0X)]APY4S(X,`+'
M@E2>Y,_H:Y`WW)#P--HA-M[",5/=VZK3=T1M"54_*OY=1Y;=P<8HHS@,>SOI
M?52,/E>JN4!</MHE*<;85L2.0KSQ*V;=15HDJBAMVINJ'Q6M*+IDAGRHC$?Y
MH/B*X)]T#M7&I,+7OD<Y6]$#P\UXDU^&.X-A&*.FVJHJJJIL6J)\E*(E?BO7
M2'PN88R22[F>/8F5.,>KE`):#DGUUQ,?NA12)6NVVVB_^I53HN[_`)BB/YM>
MS0R:&RR`$.X+[^5.L>!(X-'Y@)/TX+1=A3:,U!$:.A?(E0%X$HB@C@+_`%_A
M7XIIB%W1E=(UY#T1.![*>F`>QGAU!1CAX3S0\J\(Z"N25=_Z-*@)$JJA/B/4
M42BE0B]*IU_(NI3#"6O<9"QSOB09IE_%*7ID`A#1KS3+`G[.1I'GBA$A*BHT
M0*H_*);52JH`D:U.J?'UTT806(P^(K_H#4Z%X:PJ<0>>?:G"FVKAMJ7<<<W&
MG9)Y5!FK3O1:K10VI7TZ+5*UT]:RN$P)3'`]G>N?U4]<PQN@(:<`">WNIIVZ
MT27<GRSD\&+3DF&\6XCD=NS/&DCA-OF9PW(7XA)MEK<=>8818[$8@[;Y;)'<
MVT^WN?D'9!';7FZ7+VRV8'PDG$-7$(<*R6Z[G926MGY?`?#NES/&8Y%1L)5`
MYV9(Q7`$A*COC:V92QB$"==;PXPS-8*="Q&5;[4,7%(]P<.3!L;$N)#9GR`L
ML0ACHKS[JKMZDJI77+MZN[>[W"^GM8&LMS(4`5<\\^-:Z[$,4\=NX"21@T]4
M+^86A-2'(...`I?N*F,0C91UZ6VXYL89;;:;=38UV2)_N`NY7B=0TVU0-JHO
MP2IB;9EGYX?UE*$9`)[UP]5-K-U6EC&=$@:B3XLS@!EDF--V[7>XVJWQY\B!
M-GO,3!:FVFQP34Y`MD.]^V$".R)C;+5"=5SMFFY=B*O36ABL=ON&1W-K,6N*
M8.1#^(8#VTPPNDN7VQ+6MTO+7D_#AQR'=QI(\>..,&\I<NYAG\R8_>+S9^.\
MAQ_'\3XNOKUUQRT6L)=F^MEY+?K)99\!F^W6?/CN?3.2">;CMUV")+TZ[Y-V
M';9+=]Y+#&^X**?NXKECR055^=?,&Z^2MK\OV^Q3MBNKN.1TLXTO<X-<C6`N
M!#6@'$``J,:L?R!XZ.XU:RNO%)W6;%M<.,TO&]UN9W1)4:.+@$_C627A]V\Q
M[HRP2+]-,DO1GP;VB39[:N^9O(=GN4,ESMH+-P`P'W78Y=AY5C/+_GDW%VVW
MW]S`QY/YX:A!3#6UH32N!(`(5<<:KQ"=9DM-/,LO--%]04N,^3C<AEQI49?M
MLA#J828\E5%X7$WU%4]=<,N+1UK<2Q7#"RYC<A![*Z,XO:C&.#H^#AD>T<P1
MD:_9`-.*\XX[N)L:=LE-'72KM<?^5*$*%5=OJFY*IIB%CG%Q8Y$X9KSI6M&M
M!Q))R]E$7'&]Z]G8GSND\2(@`B*VC7>1MO8T3A;U52HJHM?MU*C8L[VN`<X(
MG$(A]QI()9$.!S/KRI,<".;HMRNX<%LC"D<B22)(!*H`[N!2W4_]2(OKZZ;A
M421]9I1KCVTX7G270N!F(R.5$'7Q<C--LJD8&S4VU(.[M$B4G&5]!6M$156J
M4U(!#L0#TE\)3$&F6NDC>"X#61XAP[Q2*Z31U5QT8K2BXK;2(X4<_2J"*-FJ
M&"]$7HG7UHNEQAKP]SY`URX89^BDR.+2T!NO#CF*0Y*HVRJ/J0MJ>Y3$2<%P
MA)=HH*$GHB>BT2NGVMG?HD(5@PILD-(:%I)?(U^H&K+8OE0U5H=Z-`6YD&T7
M=M#M(*+5:]-2VC0948%/LY4RY/"'$G3ZCWBFM*,:)TV"V1.(B-BK;BN!VOE;
M4>V*(-%2O_#3\3^FC@4>"H(S6EXN."XA.X+PIOO.*VTH"85%5J-"`4057U3Y
M**/P]:KKUC7=0O>Y21Z>VASM9(.7.DXYO;%[:R"!4%%HB[E/6E%JJ]PT+JO_
M``]-38Y4C0,PPSQIN:%Q?'^8A'+"MU/$\E+@7`B7XP)"TK6E9;ZT5>M53[==
M_P#*978-O)..D^\UQ3S($WJ^'\U6+UHZHZ&BBLCO&_\`\BWN-?\`?^-/\L,-
MTIWZ,7>:!]_O'NK_U?J;\!O\5?N:?ZC\/_D[ANG'_IP=Q]]`^_W_`%5J[INB
MAHHK%)J^\JPUGXDL6$%SRN\]N1>+F]%VQ7C=/L*+[?X@[]_!;7:49HU,4Z)7
MIK@]^VZCFNFWC$C7Q/.>>*(/]:^P61>67P6>XV>MS8(\(F*APR<J9'/@*?L.
M#R%B,HV+P%OO<IUN!`CS5LD>X8W+8!NX"%N8E/-6R[0W([:DZ+7TH+O4B=.J
M)JF-PQH9%;R"6-I5IR".X$G(\>^JB6YVS=(G3MDDA<CG/9J#7Z@F(#=0>W@<
M<`0G8];-,NN4WK(N];@B7JRXI(LEFLLBYN,6YE^4VENFH#XQ`DLDL03<9)X.
MVP_M0E02W:+>>-\\PGB+7L;D<27'AV\QP452;K8FQV^V?;774AFF:7%C41H*
MKF0JH",T4U)^$Y#%N\G(K9;KBY,"PS+;:KP\L25!=6]Q+)!;NXW%B6VVJS79
M8DZXJ;FR)S<)&BH2X7?9;IMY<-MWZ;=S&ZFC)1AXAS[ZKI[/HP037$!$KBYS
M%(*M<5;H1<$P'9RIUL%&=&2XP15%KMOKW#(0$'1$/NVB0R+K2J45$]:)K.B0
MLB;%&U)'98%4&84C),O73=Q&X%C9?@<[`9!<TQR.&67:M1!SVY&F<49&\3O<
M44C.6XF(Y*^W/"2`M.0.ZK0]^)&5TA,ORK5.FKK8F-;N44\)+8SF"#EWG-#5
MQY4ZL>[QQPL)>`X8%,P<".THJ&G:)Q_PRU.P@-RU?0P2981HW):L/Q62A`X@
M/"XFP"1255+:OJM=4=U!IN;BY7X3QQ![_IG420S=9\<A`F+RN)P*H4PPQ[:3
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M)'?5978,5`NVJ+11H4Z6SM[.UN+VT!1QT@_A!5<>!X`U>W[+9MI;;CM@(,C#
MJ!)+XC@H`P4<R!@*LY<H++S$E!E'#;;12;:^G5%004`[QJR)QP;;)=J*=%IZ
M)5=54("/#R][,"`BCT]WMK+2SN!BE(:)W8:N([EY_P`*0PMD&5$>8F`S*=,U
M;$Y;;)(RR3M'4:.0"G'D]%521010Z4U["(W.,6DZRX(N2=G+G3]Q<2MEA<UV
MEK6*2W$DIQYCLI4<CM6R-=F1D,WB/'6"EID."VL>%$?&CR*RP[1M]NE$)!,Q
MIN44IK17L5E;1S2:Q,6AH!7X=0QRP)JBMYI[J1@:UT1>YQ=FK].2+BG,>BH<
MN[U_N-X=LRL=M@XBE%NT>2<>0^)FA"BHX1J3,<%78A`I&J5^6M-5D<[6F1HB
MUQA%50I3`'F`*OK6R,>BY=.T$\$5H"XG,H3RJ)<N\=2R&#-C3LSGNE-*/):;
MO$)]UWOQ2!QOLSK;+BNMQMPT[9!\M56E=6D6]-M8AKM6!Q0^'`IRP7+M*UK=
MK\SBTEB;#;!HC):=)4$?B0A%[JBZW<=Y/D^0VS%&;I8;)(`Y41^5<RDC`M]M
MM24E&3H1G98C<`!!;>KW^JJJ4UL+!G^3%M()&B%XR/#[*TUWYGM]LM;J_8R2
M5Y:"-.9)XGAARHJQ:(]CN5Q8%'TM42ZNVB[W+&I)NHL>,Y0(]OES/H7I$-'U
M%#=1!+KU&B*ND;A;;C9B1MM*WQ%!QJPL]XAW>SBN)F`WNC6&.:@4\2G93HE\
M8V2]E'O>`WZZ8U,8CL7>1:KC$>-RZ*!)V[A'6?)B-RT?<B*G<8?-LB2J$BIK
M,?/[EM\OR^Y0DQR9.`7#L3_6JUF]1M=-#>P"5A5OA`1IQ5I(5$7B,C6,WO=^
M3>;7#QVX_P#&SC"WW^Z<B\Q9"Q.S.UXQ#N4^X1,-Q28\L:*J0F'B83(<JCL.
M;4>(Q^B5%J)HJ[[]N]EACW:\WJ[D:+*&-&%Q":W9NQRTL4?^*N`?NG*ZS<S:
M+%C]4[@_`'],8@*,U=_]M5)]L.-G^$Y5>,M\L.&,^F\GPK5!M?'?*O*UT2]2
M['8V(PPX^/6?&[_/.\X_VXU$22PPHFVM%5*T70^:Q:7<$<6S[G&RTU%SXXVX
M.<JZG%N#L>!.=8K83=V\[G;C8O?<Z=+7R'%K41`'8C#B*WZQVPW7/%8N;Y[H
M(JA,N.$$=IL%+>D9"1#)15LJE\B)1::Y?>7L-CC$"^XQ!&2<BM=%M-MEO&ES
MW!D6';AR3C5FK?`MMBML$R0X#,5UAEZ.CO\`TLL2=`6#;)MAQZDB88BA[@1?
M2B5JD6UNY)HS#<,U%Q4<\,4[CWT])9""8R6S@TAI"Y=F62\J:L.:VW<;U:0)
MU5B/)-C"ZY]Z83E5]&7OE)6D9>%5057IOVKU1=0[HDESB\DN;\1!P3LXGAC5
MTZ/YBWMKL>%J(Y,<L,_LJ!>9>!N-<_MEVN%]XVP>Z7:3$DNS+C<,5L<B:8*V
M+CLB3.D0SE/]I$1=RD2+14W?U4L]KW.^M3;Q,NY2QN(`<1GBB+D,JHKW:[:[
M?(&6L>MQ14!7ECV\ZS@X%\=DQ[D%_.\/QB%CN(K<W?V<6R6^+:&KI(CN?13,
MA<A1W8T8@1YI8X$8U1M5)*]$UN+_`'QDD$5K+.3,6^(G$CLQIE^UW'EZ+H0`
M"9Y:YS0$Q.`&'H)Y5J];V_PJQ0X9$KP.D_)[`.K'BI/DLHJS%%`%YPW%^=%/
MJJ_*2)76&FN[@_E2./1!*`%%49G^*U[#;,FE-P&CKN&9"D)F"IX]E<I,<Y$:
M.C+STP);B(W`0QBFW<E8BQ9;`.D*QOIW7B$VPZ*O=6FIMK#%,^U<`XQ2'`?A
M?@"`>',+GPJ/=RN@^8`B:"WCS;S(S)S[,J0BQ2Q8[/NK96]FXPP=;!R')?9A
MS&IEP%KZJ,+L425QXY"JX1)7YJIZ4U92VPM[XHTR0L0$'B3F,,3WC*H@N3-9
MQR@ADKBH("X#!4.5:S>`LMIS#,Z@,PV8@VO(;9'K%5_Z5W?:U<3M#)57E)OT
M(UZ&O5.FNL>4Y8Y+&9L;0-+T('=[:YUYJADCN;5\DA=K83C@<^7"K\ZU59:H
MEY/;[GX4--U>_N"J4(44%5"ZHM%_)KA/[S-<7;$6M5!)_P#C6\\DNTF_4H$&
M/;C42.,.?4=YMX"%!^05%#0514(=J=!0B3TJ?3[%UPQX;'XVN!D!P`'UY>BM
M^V0]+I.B1O$JA^G;1G<2.HJ*;I$V3AMH*-B!J2)T-#4E<(4]*('_`!T/>K`=
M0<\E41P3N/*HX`/ATZ6#`'`KQR1<#Z:]*7><^]D%'1!44;1WL&8_UNT0]`7X
M52G7TU)MWS![+AZ=)I4!0`0,Q@H"TV_1&PQ,CU.=F45.WG[Z3(MPA.4"#<9*
MMF^[V0>CFT9A#<[3X_5&+B3Q`^G<$EW5K1-7F^V%W;,L=Q;;.CVZY8'-PTIQ
M+7$9]G`TBUC:XRPR1M?+'@2JXG(@*$/,'*CDIMIYY9"$H=D3;CMNJ`H3CFWN
M/NE1`:`!1$1$^9:ZH9&P2MF.AS`2-`)`4\2>`;RXT_;]6/1&2''[Q&*#@!Q)
M/%<!19M8Z(J@X1HH_*^*&2"Z/51JJ+1NOQ]-12V-B`O)`'#)>7=VU.=U7$$L
M`QQ;DHY]]=-T<2WD\FTD041IM3V*:+0R&O0"7I7U_)KP11KJ?<AJ\@3GQ/9[
M>RFCUB-#8B7#'$HJ<`>?T6DLU;JIHBM$B[.V3N^J_P!4D`"(T)5]*HFHKHPT
M_$%.6.?:./KJ?$7.;I51S3U@G+VFDI^0/TSS<M[8K>]XG2!`(6VEW*B=3&HI
M^6J]=+C:9-3=0:],CSY5(3HNBECB+F$@89+SI.8N#\MV.!0I20UAA+BS#;!A
ME\'-R-M$O62+R(/S";8J-4JG74X0:6P?.2CIZ21H1Q[`Y#AZ:\+HQ+<MMP>L
M"`0[`=I:.7OX5&N3XWFF0L2(,?-V,98>?>)I<;QEF7?P`A5OLL3[Q<;@VP\J
M?.I#&J*@BBHU6KT4MHU[M-EJ(R#W9^@#$]BI5M;W5A9M9<S6_60`$N<0Q<\6
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M5$Z_I$2IUK]NID4KRC!(&QC!.0YCOIOIL8'.>S4\Y]_+L`ID1<LRWA7*Y7*F
M`XU(SR7<(,7'\UP=+K'LCN46&)*(X=VM<V2+D,<IL;@N+#;=1$?C/$V;B52G
M0/)_F3_!R&&1'6C\\RG:O\$KR_VO;_,^VMV7=)Q;"-YDAF35TWGXF.:,3&_[
MR'`H0*M/;?-WQPN,<AON?3./;PW#27<<9Y"QC*<5R.TMF![R?:=L\FW/M`K9
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M`6UIX@[;O?<C.4!Q.B[2WBM-FTFT5"VJI:\8P-BZJN;*YR99\T->OE<9VQ*#
M&1ZJ2C=$!>9%DG-SX]IQ2[)HBJ5&B!`4D5=VI432'E@87,#EQS]--2N+XQI1
MKP$QRI%<419!L'@D;77VS0`>0%1M=NY$)L5ZJBH0[$6J=%5.NAS%)#'D8TVU
MTFL.+"&:1B?JI'D.DE'";2@%L;:_2CH"J*;Q1`)UPP<%45%&J)5?5-+Z'18W
MJ$YYYY\.^EAP+R8W*#[>ZDATE(50:N?\QP^\*-Q`;`E5V@JF_<JIT143KZ5U
M(9&2C&*N>>%)<]`XHA)0<^RD24*.&*M$X30MB3BN,$V`F"JG:&IN$]0!3YNB
ME7TIUU(9&V01N;(2$\1(1#R[5ID'%XFCT<L57M098X4S[_*?B6Z=+@17)\IL
M4=9B'VP)YP2H",*Z0J*()*J=*)33S`>JUCW-`/%%IUS@&@XHE(33SDN(R])1
M(\A6$-R*M3)L_P!*A[1V&:(OJBKI$C':M+7`I7K'@-+M!#3Z:0WP`"V"9@KB
MJ;B/*2#5"04#MJ"U6B^J+TT_$7-:T/:OO[J3)X];@,^1]IK>7Q(55X`P&NWI
M"E#\GZ*;9KZ43HGIKZ"\GK_U[;]6>D^\UQ;S,G^:O$."CW"K(ZTU4-#1161W
MC?\`^1;W&O\`O_&G^6&&Z4[]&+O-`^_WCW5__];ZF_`;_%7[FG^H_#_Y.X;I
MQ_Z<'<??0/O]_P!5:NZ;HH:**S'SU6+-@U[<&QR&[C/R.UW*3<6V6N_9;C;[
MS(9<-]XE6<_(<:WH3WS"J+2NN373K0[?=6\ZR7#T<2<VHOIKMNWR3W6\0?+W
M`9`QCF-:%`>'M&7#/A7JV\CX?E5SOEC2XW:W3[(PS.B2)2M+;KA<(\1[L-$\
M#YN/2%3N.-B;8BCBE6M*:R<MK81V?2C>!`S$KB7(%0\SCX:T4NP;YM,EE,86
MO$Q(*9@..DN3@,$=S"5'5BGV*^7RRVUB#?+)-=MCT7,[C.G$$FZS76C_`!0H
MTP9"BIO,HJ;4401M*)2B:],\,KXY8X"UQ:BIB4(]W^E7LFP[E9[=>&ZGAFMN
MH'1L:<&`8-#AP4IZ<Z=/%N01H5YC/Q9,F;!R<Y5DGNEM)MZ]V-HH]BNG=JJJ
M5WL-N6JJNY5$45.E=8[S1MBMDNF+U`]'$<251:C[C;OGM(HY&!DD;`]HY-*=
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MM;+UTTUO<,TIJ+5Q'$IP-3+J7;/\G_ZDZ)3@HQQ0H2%QX`U,5MER9%HM,V6S
M')^2P#L@XY+L1'FQ7O(!$I_)W$7IUJB?#6:<X-D<W0-&7?PJ/-#&VYF9$]VD
M$(#[`M($J2Y'FOI*14BNBXZLI=JM-"(D2$YT4D)$J2U3TU,BA9XW2APCP`XT
MIY+XF1V^DW`SP]@H_C&70KU%C3[1+:N<-`<:B/@`HPX;#I,N#M5L=Y=P5Z%T
M3U34Z,&T>U\<+A(U"`<D/`KFO*J[<;"6(F&]4:\2,B%Q7L[ZBGG>-$LU[X_Y
M8D;+="Q:Y.6[)@CLNL2I43(FOI8_7:+$J/;KJ;3U"7:B"M-:*WB=>P7#(P[%
M@>6HBE>`RP%2-A(?#?6#W_\`^-Q<HP&*\1J&%2$VHNQ@"1+;D).;1Q6V6T8%
M0<%'V6ZJFUUG<HT#KUU00RL:9XD(3!!QQS]!HNK5I?"Z*+!IP7$#`@X<^VB%
MQBQI[0L"4QB2$=F.';,6WV7$4E<-\Q<$''GB+TKZ?'5F6VSB^5S/S```!R&9
M/;58'SV[VL:\.B+B[45Q7)H[!7"'9Y5M8+\1*-(=5AN-$--J(P&PQDNON*F\
M3=&E31:K1>JZ;NY80(W0M+7/"=B)BHR-/P:Y9'Q.3IM)<<U[`U,NZF#!7\2O
MEWG"R<9B"35O:>1R634H6$$C**IGV-IFE%4/FHG741FH6SGNTEI*%QS'<*NY
M'1]2&W;*[6FHM0<>!I;8H3__`%#J$@T6JHB)7>O4W/4F4%:)6JUTPH#!&F`*
MK]IIJ:#2!(P#4<$3AV#G5;N3R<LF>NSK=;G)PW:U,6Z0Q%N+L,YLF7(;6,#4
MAI=[0(Z(H7H#GH2*BKK<>4[A[(_"\8.1.?'%>%:7;HHK[;#;71<UH.I4P:@Q
M7MY5'>/6J^DUGJ]MAF[VZ/&C/,RYH3"8/OBY(CV.U`V<9)KS8DKSX`%$%5KK
M6$23.D=.0@R'`KDE2[^ZM[1NV?)EXA=F<LN+CR[%KQ?8]Y3);+&NT6;=&XMA
MMK=MM#4DY]QL]HN@NO)0&`;<!N0Y*-U$(E4-R*M/@W.#+\O"Z$DZ<%&('&K'
M:G;='9[A>-E:V7J$/=]Q[AD<<^`6F1);9X^R:?"@6Z/&E_AR1+@<2WD=VN%N
M>>56`DR-[SKLD3D`:`);34>O75?=VFN(QM"-!\/:>2=M>;ALS-^V^2_86_,@
M?%Q:$Q`('P]]1Q-\8[A?\W'-#N[[D%UP#*V2XY-MC]V-4<%T%=8>`Z;A):51
M=0)M\=9P_)F("3`*F(2N3LV!DAE$H5X)Q4K_`!%7)PO'RQRSL-.*P!1U-E!]
M8X@'Z([D#:HN42G3_P"&LS=7!N)Q(T:L>2*N=638_E8V0@%0W/NHSD0,NVB8
M#@MK'.))"3(04:*$V*#*.0Y^@FR*K6]M:J(JB+TTJVZT<L+HGJ6N7#,=GU4L
MZ7.DU,_,<$"Y'A[:B@,LQ\LY*'%F+*M4NRP4G79P_J(P72.)W`H[CS**\^\+
M?;4B1%^=4KU76B=9NO0&/.E^M3@B`C+"K7_%W4&P]7I(X..E@52%3(]JU'V;
M97=<ZR6WX'CZNVV-,C*&57LC[3J64U?E.V^`/S/-/OPW%W$B`H53XE73!@;8
M@/N!JE8UV@<<3@34G:MM&WV5UNMV#@1I:G)!CV+P[*DR';K59XT:V6AMF%:H
M$=UMJ+V*[668SC@@*FE#[B,U-5)$55]:ZA6H9=S+-*?$#WK]M8K<=PF<^65T
M#G.#@0>\\>P?52!?<HL]L9)^8KKSK8U6)`AO3I*&B$@``,`38$^(T3KT7^C4
MV&PEDTN>/R51Q."(,C[J5&RXEE:(AXG`$*4&)0^K.FK^)9/>;8Z5LB.8R)NP
MI317-&^\X+;A/%)5ALGE&3&%=K54$Z=%6FK2WDVZ(:1*=0`+0/A5IYYT36,4
M;Y([MXD=I();Q7).&'%:30BY&4UV;D&33;O(5TG1;C1X]L@QS!NG=9..@3#<
M5OU55J15ZTU).[]21Y=;M;(GAYX\?IG46:.U=:B")OY3<"@Q3BM;%>W\Q]/A
M.?-;D,1RJ#M.J*1(5G9.CA54E,=W6JJNNG^3M9L[ISR%+P<`G#E7*_-SV/N;
M,,5!&1_55_\`6PK(5%G(H(KUK-0$E%N2E5K7:J@JCTZ[24=<._>$NZFQ`(GY
MBC'^6MOY0(T7H4ZE;]=122E155G=T7>R!(E>GJ*U3JE?CKA:!T@&D@>ZMX0'
M`Z7H[@3],J+J;RBX(T!Q/^6)K5-J!O,3,>M1'THNAL),DC6KJ'P_73NF(,C>
MY-!S/I3`5XVR93)DV(1%>%1&0TB(6T1JH*M%4U5%JG2B+JR+(Q&R2%N)5>`.
M&2<:8#HXI2R8ZP#@#B<\^RFG>G[G8(T6>4FUL8MAEDNTQNU,QVH3DEY6ED.R
M)<YT?D)19]46A$OS:V3_`#=%O=GMFP7]DWI`!@<W`M=@`[[:+;;(C+<RP.?\
M_<2M"J2-*Y!HSSJ->'_(/'^8F75M5@R.SF)2F6IEY@.EC\N1%/[Z);KXVJPI
MDIH50B`5JB+\::A;IY0W."*;<(+426S1B,<AQ"^VKK==F?L3HX9[^%[\%TGQ
MA?Q,S`X+4QNQWWG4,7%88:2IM-&I=Y57YD!$_27_`(I1-80&.0O+2UNGAB5I
MIDC(XQJ:7RNR)P0=M(TF]NP990&8?<,@,BFFX(,MJCJ`PP;"*KZO.+7:2"HI
M3JNK:PVUEW;75P_\MC!FN9[*1*T_E/,@<"Y-/'MQR[Z-)*?=[7>A''F.KVW6
M72:=,6A%55\FU,E1IQ53::)5%U"N;(V9$I>PL<$`*EV(543VU[#*V74QCR-.
M.&`&.2CW5YDL`)B8"JN*%%,C.B[514$>JB%23KTU5$M?H8UR?5VU/A>[2X..
M'(461L0!-H;`<&@TZFB#5$HJ^BJJ_P#'3;'D.)7`T\6M*@E7BDAP-[Z&CCS3
MX$2)(`S'MIM,"7>/5%0?CZ(FID3I.NUOW^!Y'[*7+'#);NU!81F.?&D%6&P6
M1$9HJLMNN]T51`-MHA1$1PZ$X9*M43U73S8];+@-F!E:5/:!RYTR9.F;=SV%
ML)0)VGW)2,HB\X30)4G452&FTU(:J1)ZKUIUIIH-<\AB>(^^I;B6A3F*;TB'
M,64X:/-!;OI`:1A=RN+.5_N(^1I5":&.M-G_`*NJ^FG(W:(9XBU2'MS]25Z[
MQ/B(*H#B,\:2)3";C9:0D*J*C!50'`Z$@MDO2JB-"5%JFEM:9`7!`%Q[J`>D
M6ARG#/MI)G&JN&@]P!'8T':IL%!92C9*M"3>H%7[51:ZL(901(T-/($4P^%X
M`>7`G'/E35N#HF-L)QM7W(=D"SR3D]IPITH[K<93L][N@XAM,QY7902]$1:4
M3UL7SOF'3)Q&'N05!MH)[9]R\SDM>\.`!(0HG#CA7)NXO*\(N/``1-K3#;:[
M&%%15&Q::0$'<9(J+1*;?R:9<,(RXY#EQ^NI`!U.+UU.XKG2E*?=??0B=WR(
M[#,-E"=<)@/IG718C@"]1[+8)LIT05Z:07S.9'$9"]`</37K(HB7N:W2PE3]
MM1SQ;;.<N9L@OK5ENV'8WBMFEW>U.6"^LW69>8DV'(8'\4=-F*L5EF41`HH+
MB$;9>GKKHNR>4O\`+[?"P7:,1<LCQ]-)\S;GY9\KPVHN+*YFW&8-<'M0,+4R
MQ*J.ZK0V#QV9MD19')O*#DVZ$VZKC6-G"QRU-"A5$VC?7ZXG6@14W$J)\=;>
MQ\B;':H;LF29,3J(7W5RW<O/%U=2%NT;:8X.&L:W?91?)>(_'>UL+<9^:NV2
MT4;)E]C/+@[*_$A^?OC+>N,KN@Z*$I,[%%5^"4IJ=/Y=\M1@ND@A9`GI7FM%
MOYF\YW$S(XK-TDZ(AB")VA/;5%N6,BPG'\A-GB?EW(LC:")*E2K%^Q3^107)
MC0`L&WLW^,PV+#L]]5[A%51%%7IK([EL?E)ITP[AH:5*`J%X<:ZCL;MZN]O7
M>?+44<K7-`D$H8X-/Q$LXIV5XQ6=G<J`W,R^)8K:,AIDW(%G?DR7`)50B^JD
M26HY(;:+M4$14W+ZJFN?RBVAE;'"\O8'9GB!V4]?1[8USFV;I'2<R@"]B'U&
MG/,F/&;BOD'TR].Z)&H@6X41P0V[5-01!6GHB:?;*QQD9BA7N[Q[JI&@'0\!
M)!BG$]E(,D^XTB,"RI*:F^^8J1-B)&(IN-*@3@+\.E-+,8Z;#IQ(SXA/K-(,
MBRD/<[3RX4TIKJ-C]W0D(BJB?I#M7]):+2BIZ4II`C0MYD<:D-D#O"I#1E2"
MXJ.B3ADI4$253'TZ+Z$7S+55HE.FI)81$IP/9E3;GZ%C15-;Q>(JDOC]Q^IH
MB$L&4JT1$K_UK]%Z=*JFN^^4B3Y?VXG\/UFN.>8P!O%X!^+ZJLGK251T-%%9
M'>-__D6]QK_O_&G^6&&Z4[]&+O-`^_WCW5__U_J;\!O\5?N:?ZC\/_D[ANG'
M_IP=Q]]`^_W_`%5J[INBAHHK'7),^R?-@O=G!B3D%KM<N3)NF0VZ.5O?1B&Z
M\(JXX9#5MM3W4JI?EZ+KACHGS1W,\#B7.75Q(')>5?6=CLFU[/)M4EPP-G?I
M#&.*MU$!4'9SI!QUA95^&):IEAMQWRQ2S;>5K8_<ID9@RMMJ`3:*MQ=DOJ92
M50$;(/F-4*BQ;;:KB:.>!LH$&E<0I<<P%J?YFW1EI%;7,T<KY&3:4_""5<_L
M`&"<>^EAS&<5M..72[9-?H%RSZ>RZU&Q=DI'X0W.N;"Q%5QG8A`<,G50Z.(&
M^OY%U[;VXA@4/\;'8K^`\N256'S!N5W?6MHVT+-JP.L#Q$@KFI4$9894R+A=
M9%IMT%EQJ8=IO\UVY2'(+ST$,8<Q]LL?MM]!V.ZRO>DW=N4TC/S-NMHI*/1%
MU2W5XQSI+1P!@.)YEP\)/IY<*N1:V^Y7,SH7I>QC2"<G-=XW1D98!"N:U8OC
M'A*R8]+M6>WEE^^9I*<=GQ9=PF.2EM[<EE&6P;>-*_4C$54<(B4$(EV(/364
MW#=FR]&*!C6V<;SJ'XL.*?=7VUBM^WR[NF7FW6SPRV#6L1H#5#2OIQ`SX85.
MI.`\[*%\W&1!`HX*[04F_4Q42ZBT*(M%]%3XZHF7)(>R.<AJJGNP]E4HMW-$
M,AM0Y_'TY]HIJ1*MS;H/?5]B6;A'%<ZL'&&C`*6^J504V_+ZK5=)E+@_YB,%
MI/A0%`@YC,G"K%`XQ-F<#(S%4/Q$J$3(!:9KT/\`9]NZVR'<V&AG1WG<9>F=
MQ6H%P<0S>M9JKB_]./JU\P_%*]$T\PPW+_S@`[3CAF>![ZMP]TQAN'0EQ#P'
MH<2T8$CD3QJ((BY/F=V;QN?>6([<=M)5XC0E6%/`0W-/-"K9N]QXR/<!U5I!
M_P#4NKK<8K?:[2$P0J][5"XIR4<ZTENZTM62;C'$0YKD:2%;Z>SGQJ=[7:++
M9(<.VP&!;".4APP>-72D?4EWN_(5!%7)+AG\QI2B?D357)#<NE;<W#EP!*G#
M+##[*QE[NTM]+,]SE>\H"!D&X(.0Y`TWN<;)#RGC'+;1)>E2&W;"DAILWQ<%
MJ1$)N1$CP";#[Q!?:2J_*2(O5:ZTU@&/N[)[7O$I\.)5J$9!.?;59LMVZTW.
M(=)G2ZGB.()_F<#]503P?R#D'(.,/VYZ(#.28VS'@7R+(F$8,MDRAPI4<057
M465%[;A#NZJOV:B;A:#:KAP16/<21P'9_I6]\PV,,4L5S#*.B\*UP&?8>[*I
M9;A7F'<@&1(*X`D7N.R7A!H(AFBHK0LAM:$-_P`R"0KU7J6H!&J*4-(<Y2[!
M1I7EV=E9EH@?XG@LQTH4(<F/>O(BF[E%\R98[T9BVJ`3GQ8^N,F3%J*:MQWI
M"@W4D<<9,A:1$H%?1-1733+`'$DDCVX'/V5.L=NM_P`Y'`(,,2I3$>W.DIO(
M[1'B';F(DZ#"MXDV)BM18054!5W:BH^9DBDB(A%5?34N*(2W$G1!=;M&.I%!
MY=OHI<T3K9C9KAX;<$\,<.?8G;A73ZEEN*5T`FVK<*-D,Z0ZK(MCM1.Z^!HV
M0-$JK3<.Y57JB:=N;;JN$+7D*!X!A_&F;.=VL`L+W$GQ9KV88"JP<Q9M`N$S
M'[18[K!GS&[XW*=G1VWB88!`(FHZR![;;KCCZ#M`B4$5*KTUI=BVZ>*</D\,
M>E`3Q_TK;;1:="WNY[F/2US,EQSX4RH-Z@12=N]WC_7QV[N9Y"97AJ+?KP<D
M76'+=978!@Q'@2!3[S:".(J4W45=:]TD`#'O0O8<<QAP3[:E2[?<7%NRWAE_
M)D8=&"AO%7+Q7#-*?>6\B7[*L@8R/&YESQ&]_AD7%,6Q*`VXX\&-1(K,!X[E
M=G`<;FRI39&J(ID:42E*:?DO77$L3X"&H$`Y#OXU1[;M5GM]I/:7[6S,#R][
MN!=J7!O!,!EZ:9$]VU8Y?+3=V+I%*]`1V>[V1YJ7<C;M,IAQMZ6W(FH3\B1;
MYK"/.`I`0>C:4ZZCN@89=3R0[FON[?JJ[LMPN)K>>W;`/EBI!'AP&0SR.5,6
MR2LXS3*8>%7W+9%CARFYMT"8#BP(\[&K<IFV_-G7$W`N,UUAI`;1=B""4<W*
M.FVV3)YF=:,.E"H2`B<#W\J]OG;=:[=)>6L`<\(-`"^(X)AD.)II1,R8:F9G
M:<=R/(9L;'LLGP<,?F3$:LC<"',;&-=KD3`,!+^MW$'04!4HHIJ)?6%G'JE8
MP:G*N"895+L=MEFMHG7-O&-3`7`!2I&(%.+->6<DRZQ!B=OB16CD06F<E2`D
MP)EU:KV59;E22:[,%QU55ZAHI,BJ(O5-48L+?;BV<RZ@[X>S[:;L/+MO#>27
M<NKI-/AP"=N&/"HX[EL8C/LVR_&3HR@8&S0GG'''(_8`W"D&R#K+`,212E"W
M(B#\>NB.64S%I8X1D*IY\JO96.G<WJ6X;'BAQ0<L#Q/UTZ,<QC+;H_$R&QM'
M95!BVRXLZ=(8?CODY'>21L;1MZ2\XS&)`<):]Q42BHB(B)N9&-GD$SP\D##'
M4AR4Y8<JR>Z;G;69DM9W,DA4@L`*X?6N(3A4D.VK-GY=LAW3*'+A%?DN1W_P
MUB/#,$6.9[:O12>%G:*BX:+5%552G2GA=&VWTPQZ6C$=_'TUBW7&VM?).+;\
MTY`J1ZJ=OX1:K,4>/:8PVMAD`>=;;$M[IJA=YUYQTS-UQSYA2J]?MTCK2OEB
MZC?"4*%<?]:I))'W+Y))'K("6A,$[`E)YDV2-MM/..2GE<5J(YM1P&FDWU4J
M"G<,#2J)_61=*=%&"-+B"N0RYC'TI7IE>T:)$#0!CS3/U4@W9]0;=12-0!09
M91T=[F]6E^4.OR(HFM$KZ^E%U-A2,*5)R*XH.0[JB/`<-.H-#B2HR/?6KGMU
MM]KCW.0*-(C.KE4,R23_`,UP2M3>QPT2HH?146GV)779?*3=-K=%"`7@C_Z1
M7)O-#FFZ@#2,&'WUH=K65F*C/D$$<.W)5!7MR512+:GRH*JGJG5437&/W9@D
MN#M+(R/AD./_`(<JV/E67HMNGE=)<T9+SJ%I<ASZJ!%@PGIK;QF4B<P30MP4
M!$45>5Q=SP.K5*"B_EUQ2.*'H2AKP9VK@B.7O2N@`O##)+)H:<`#][T<*YN1
M#%]HDF.;%($5@0$!CBF]3$&T1%,GDH)+5>GI3KJ`)HX7!K@'AW87$<^STU(#
MQ(R1HB0@8%<^6.*`<J-%+;CQ54W!&.RB[EH?W3554D$!2J+5>GV:]CN3(.F=
M3F#`?RCNIIUO(Z34T)*47M]-,;D>U_M3QUD=KC1TF%-M3A!&[BM#)`-KZL#T
MW?>MA2BTJJT74RPEAM[ZVF?@QLK5/<<<*L]LEEL-TM9FOTN#LT5"<%]%2JY$
MLO+_``1;(F`W3\)CI%@C!>L[4,'+1<+,ZK4B(Y#D1S:%&931@\&T2(57:O5%
M7ZSDDCW'8HW69U1/8,DR3'.N7RON?+WFVXEWJUZK];BX/)\;78@J"N(Q%5KQ
M;D?+L@'(;3=<'N-O>Q"YOVF]Y%%['X!'>B".Z;$G.."X;3V\:-()&BE14U\_
M[CY$N(9+R>SEU6D*N<"`7`<4RPKK5W;[5;-VV6/=&.==L!9'CK0Y!S4X8XX#
M"I,@8_'E`U=[F+MXN+38.-S;DVR,ECMU,!;;;!M&E95?ZJ)N7KK'7$UP_J!?
MR0,@F*<ZKB8K<FVB(:"[@OK7MI4`I)/A.:;:20@`TX\X"$ZC3"$C;:*@JJD6
M[K7I3U6NHD^XW=T89FHL;`UN`P3F*\9;00B6%QP>XDHHS^RDXWI`L.B\G==<
M?;4E8V@#2;EW+1Q%^ZZ_,B574+\O1,R0A2%"X(5X<ZG-8`^)T6+<BOTX<*\N
M.(IJD9H][8]$:-'$V;:[JGT4:UZ)Z:8TH\NCB``!0#'#F:DL'A663!QS.''*
MF](W5#L..(O=13;(.J@*GW!"HTH@^B+6J:2(G:E`1R+A4UKV,:DF(."FN,A&
M2!Q!45V[$(#&KE>JU%40:55.NDM:'#4B)GP->EY#F#[W/@:;'9`724D41%5(
M"$EW*V1$J(1*F]30*5^%5U*)9*T%KR'\1]=>XL1J`@TC=LB=,C;[2":`*(2&
M#BJHNU0T)5$?@2*FZJ>M->#2-2$J2%[UIR56M!#@`>5)KT9'A('=XB8[44'%
M1U%[A$1-FB=*(B45*JB:?8XB0/8!AF.!J.X/#-(*@G/B/X4W;O'$7.VP!@(N
M_4R$$4+<1J6ZJK790G%_1ZK7UU,MPC-35$FK/L[:;,K7(78K@!3<ND-1)XD0
MA5IQ$>(2%SN'VB4B)53<((/S43HJJGQKITZW%P>,`,^^D@@,)XGV4VG!!IYM
M!5XMU"VEL56Q$?TE4@W;E4JT1=/&0$.TH,A7C6/#2PE23G2I'WB#1(CK;S@M
MR>XJJA*T/Z*(-*(X?6JKZ4IKV#4Q[0YI!S]'9WTB1R-)U@L&'I-)D3.,WP#.
M;BN$1K8I\E8NENE7"[B3MOA3[#+9E,W6;!COL&]-8M#\F.PB**$3M3Z(FN@>
M7?,,VSV>Z&-H=*[3H:3AGGRPQJOOMKVS>-OL(]SF?JM)RY&X%S7`J`XJ1X@"
M1ZJ9(8E:G0=_'XX91*??E.R[G?Q"XNOK+=5V4R+3ZN-1H*&2HTT(T!NB576:
MO=[W6^N#+<7;P22@:X@#U&IK'V\+O^)$(HL$``P3`'M/,\:)6[#\0LAI*LV+
MV&W&V1*J1+5"9[2.)5!%!:$1VT1-P(BK35>^XNG$B2=SF\BXD>^I,UY<S-TN
MG?J.!3!4RHS*N(Q(3Q.$D40=4T>38B"PV)$38@@*@DXY156B51*:?AQ;H9&#
M+^+WBJJ5K^HTND/33$<5^RF_!ND:8R;K+NX%;-M'7`%>X2$E`5LA0=IC7JJ?
MT:G1-Z+G"0!0W!,NZFGETI9H.*@^BBTB0L=I]C8*FI)M5TB)04^KM=^X:DA5
M2B?'7D.J'4UH\2X<J7*ULCFN&#4Q[>VD9]]L6T(4/:@?.X)HB$HU0=S:"B*T
MV*T_+I_7(C9`4S7O[JCMC=K<"T'D/>5IL2?F%6V2`@1$-0<;55VJM#5"]1ZK
MT1>B:6T!X!(*)3PC<QS@YJ#@E(;Y]E4%M$!AU5$D#:3JJBUJ2*JU%"3KJ?`U
MC5:'>$\ZB/:Z1PZI.H8BMZO$A=W`''ZU0JP)"U0=OK,?^'P77<_*H`V&P#2H
MTGWFN1>8P!O%X!DH]U61UHJHZ&BBLCO&_P#\BWN-?]_XT_RPPW2G?HQ=YH'W
M^\>ZO__0^IOP&_Q5^YI_J/P_^3N&Z<?^G!W'WT#[_?\`56KNFZ*&BBL?HN#W
MS]F,@RV)G,;&<2FQ\A=D,.NMDU<SB.N/)9!2C'9<N*@0LN5`C'HB+77%]N:U
MKK@M<8XB'*J$$`KI[SPKZHWC>+=^Z[;MTMD;C<(NFA:H+20!KR0AO$#CB:=W
M$^$1N.\%O>=<B1A1R\8O!F,R4>COM66U3E5\[<_()Q"2<\I@1$SMVJ*"2]$3
M4ACY-O!$K'""0-TD%0KB<\2F`]%4WFS=7^9-TM-KVH#KPR%KVD%9',3Q`(`@
MQS^):KFQET%S%\F;F1H5R=E"$"QW:4XZ-S=M]J=5Y)+"*R2A)N!KUJZ)"`(1
M+K//N8G&>$C7('H'`X#/$CM]];IFUR_,;?(&OCB:PN>P!0'`!0O\O#!,<*D_
M\'MEUM%P=E74)-MA\5XQ>;?;U!MF/(ORW&>Y<";4B4Y80I<YT":I\SA575%`
MXD7;W$$+Q(7'$C'@#E6=NY9K6Y-O';N9.;ES7.0_#I&EQ(R+P`5.`%6MQ#(+
M9?<7A%:7Y+9A#@M2&704';<X8`CS4X75`V1-&B4:?I(J*-4U@GB&-[D+S(YN
M"`%I*A0O+/'G69W"VN8KZ4RLB+=90@JH&*A,"<OKH[=&FWF7`)>W'>`F".I,
M@VT8*BO-NJ0DIDA*J%2JJ/2NO76_4TF'2"&`E?"`N6?JIN&Y<ULS9'.$BX:4
M)/9_"FRLB2W$89)MMO[[?O!%)5CG]Y57%`=J(Z2UJO7U^.J^X>\N#55Q`(PS
M/'#@:N[&$)J>U&M"(N6'&B3Q6R6X34MDIK71QQI(P/-MFV)FCC`)O,G%IZI]
MM>NI</Y@;"SP7*XDKZ<>_"O9)9;%IG8\=+#(^Q*32QBRPIXY78K<`7U^&,=X
M4;<8D38S:@:Q9!.`0M.BBT2H_*2474^,2&2&'<B[HZD55(3!1V$4U_EIKBTE
MM6S_`)2ZL<E/UUX3(<,.ZS8D'(K:<N,^\T<6YS/I9;1""40H\KMNL?.BH0*/
M7X=.NKSH,CN'N>X26C2C>[@1S'-:I_E]R,,#V6TC)'M+D#5!Y^(<>(YU`_-_
M-]KL6.W#&<-9_',CN#35NE2($AL[5:3EMHZX1J3KN^2G:,D1E%1%'YJ535UM
M]FZ>9DL-MHMFG`Y8JOPI_`UK?*WER>:>.YWAVEIQ1S?$0"B=V(S[ZA3Q>O=L
MQK/[CAY.I^*YC93O+DIU4^I<N%H5F.4:4;A(IMI'<51+<(_+1!32=_ADF`EG
M:.FV1`.83CP"5I?--E<16?6@:D<93FC3R[?MJX<^5=TNLEQT&3MR-QFHKINH
MI3J`G<64)-D#*LN+3;4E6E?LUC9I&!S7V\Y+`XCQ<N`(R-8RWB#H'L>P=7`H
M%4'T\>ZNLF8#S;AT:)&GF6U;^F4A9%&B)PR($V"VII\J?,JKUHE%I81-:Z%K
MW`%BY$(G:.SE41[Y[<N;J+7N!+<5)QP'8::ESB6H;;*E7"7$M,)>ZX])+L_A
M^P%)TT26Z#!)1!JM$(ZU1.G74=]OU'.9:->YQ.&D%/MJPV]US+)&V2/6J`J?
M%W)]!53'\M9Y4O5SQRU.76+A5D92XW"X25=C/9(<8A:CI$;?HX[#7:A)M0A,
M4JJ5Z:NW6TUD;>YGQO7C##X4]YK5RV3/+]C),V-CGN=\*@Z%Q.`J?,&QG#(E
MH8)ZQ6\X[[!&-Q:M#4^:T@"B,ND#C)/H2&J"=4#Y5JB4342.]N9)Y([BY?I*
MXMS:G$!:RU[?7UW$QS9BH((:"0'#D>VF;R!P;AM]M\:;$I8;BXX4@7X;#20$
M=9)U8WU,-DE%L#=HI*.TUU+AW.:TZ)>XN@)/Q8DKZT[JL=J\Q[A#/-;3C5&`
M$`)PRII8->+]:LKQ_&,EM%I:NMK9GV2PLV^TQW9%ZBRH+Z1LF:ND@OIG4<==
M550B&0S2BIK=[?=6][H=;EI+6H&X`KVBG-U$1M[B>*X<.J0Y^)`:A"M08\.P
M%:@_/9L#&<MF6JX0@NIVNY-NW"3]-,08:#M8ER)/T)(\\NR6@-?*O<D)L%5K
M5'KB.1H9U1XE."\:O=JDCN+.66.72#'Q"*#R)[N%17?LEQ^X76WK;OJ[Y$MC
M4Z3(?O<5IF1-CN&3$D8>-&ZV_;HHRY*]IMTB1>BB*^FF!K:I`<O:M6%E'"^$
MQDMU$CX2OK3L"FFE=H[%GL#CXVFY09J$+&]J.+$9Q7Y<ER,DDI"CM&(W%$66
MQ;0#<55JJ:@3NEZLC9?$#Z@$X&M?MW2G<QEN\:<CCCAW9@]M><=X[O>5/+^#
M7&=+N4B/'F7IYZY.M0H3RH1,V5^,TVV8QR0Q5XS/:`HNT"Z(L64P1-$A8L+4
M3!<>SMI-]NMGM#WF](`;\(P4CC@?91N^8!F>&/6Z(KT$1*(!1<A@-OC:6W''
MC<N%AEN.0F)$JXS%9W-J>U%4Q$:DFW7L<UG,X,+_`!D`IR^G*HUGO]AO+)66
MHQ:[`8*>T#L&?=4V\59,J8_,QNXW"+$<L\YN+9D5R,HR;7*?FK%95UXFI#0P
M-I,F8H2N."B=$)-0[^WT&60@!DAS`"@_S?RGGZ*YKYQV>5NX6]_:M<2YI,@0
ME$`4\E*<,Q4CR67W2#Z$D&:BDD17B$5)\6R<<9-7"0'!D(VO:6M74541*TK'
M(,K6QPA9!DN`P&()]HK%"1D!>Z9Q$6"X*0%X#LR-%3NL9Y^*=Z:?D4;06XL0
MP3ZP&735&7'EKV1WE\R%0D#YJ45*OV5N>I:27+M<1;D,<.1X@BHMT\0,N_E6
MD/U*N2+@HYBG6_@#:2[@%LO<1L19DR\>@70?I%=N+K,64Y#?O+YBT90ED]D$
M!%%$VJJU)13;GR[:7#'AEVU@<-3!PU(./9RK'.\Q7;70.GMG%@\#B,2A)"I_
M-]51)<(TU&71F)';=CF\KC&]M4&4P_L?H]N%Y3W?,'RJBCZ+J@-H(GNBD1@:
M3XCQ(S./`\*O/FHY`Q\;R5`PR`54PR[ZUC]O=QD\%ST&GYCA,Y7#!QF;N5Z,
M7X6*H"&2KO;.NX53IUZ:ZCY1:UMI=!JIK&?=P[*YSYD;()K5TC0"6$X=]:"Z
MUM9NJ[\UW!(]XQB`6'9'D2W*)<F(MSMLIEJR6683T5MMV],G+CN$BMF1@=%%
M$!4]536#\Z[CLU@VW.YV['W#F/$9<%0X+SQK9^5K>[E@O9;:^9&QCV:FGXGC
M$^'!,$Q[Z;MLM\>V,1X-O(F8\)MN*@B+E#!1^<Q[A$XOSU55^U=?-,[GFX<Z
M.7PNP)`QQ[,ZW4\KIFNDN(U>Y7!4P(R!3"N<@B%P01!>!'%%'14Q)MNJ*:U1
M*HX/V+T3[>NH`8QCWQRXQ:"6.'`]OUBGV-<]@?&0UY34#D>P?57`$4_NE#MD
M;B@)N%1E\T&I>O0]H]5^S4>*.=(W8@+B5R'.GY'QM*EX*MRX@>^NI"2KL:47
M")4;501/AT)=JHB[?L5::?!<R?3TFR:B@^TBD!S3&2XEH:%J`H7%.28ME<_(
MN.^3,APMC);C<IF36>WQ4E6<HNQAF&W$M,Z2Y;XET>D`XZ<II&S(5HH+ZZZP
M/.$>R['MW^)O-5V=3)`51J9'3WY&K-VYP;Q`;+S#Y<@G$+&]&0NTO523J>T:
MG-`0:#ESI;#B88&+77&;7F67LA?R=E7.?(N)2W9DZ4Z!O7&0S(105QPFTJV*
MB%$]$UBH_-V]M,S3=:HIB=03%P=PQQI]^X6]QN=IN5QMEOKMP&L:&H`&C`!.
M2YG&G=:LB-QAV"466[*M[[4%\I$1R(Z5!1IN82NH(2&7]FY3:W`E:(NJ29HA
M\3)&F-S22%5P/X4[*BR6I<_63H:Y2U,1S3#+L6EQIPA8D27P<8(2=884D<1'
MT.BHNU"5:_*2U5/1*:B!P$,K@W20W/)2:;E:LL$37!RD*B8(OJI(ESWD8V1H
M#;[A$@&31-,FBFJ;C+N$.Y5IUIUZ:@&1]Q&C@"1Z^ZK."SCBE5TQ:TXIF#2%
M.O"VAIU3C2W7":J/88==1/F5M44VA(11"Z%\$3KI[;[:0E^I`#Q)3O`7.I,D
M<<A#V2#2W$A,^(_A2)-R6/;H#4^Z@Y"9(1</Z=')KK(D("XZ^VR"O-LBGQ-!
M1%KJ<W:WZ>I'<QN&K+6`]>2<CPI5KJO9GQ11N,@:H#@C3FA'`G@F=(T#++->
M5FNVV4R\S$F+'-WN$RZ;9)O1X8SB=PDHM%^'Y=1Y[)]N)"[5B%:@7'D:6&SZ
MXP8?$"CAR3NKJ^XTV8")[A<(D56UW$#>W<1'ZH`C2BK6E=1X6$M<_EPR/JI<
MP=@&L05'^//SFI^2P>V^=M&]NR($V6J@BE+89DG$C(N]78:,!N1Y%2CA$%$H
ME;*Y9')';OC<WK&'Q-'\KD5?Q'B.6-+G:6Q0ND(S0)GEFX</3F$IPOR1)6R[
M7W?=Z=IP"$C42[;>U50A[O6B?%4TU)"\QNF;$!&$!((-0HSH>8NKJ>>8(I)D
M$V$DA%^.CC]O>4&$;,9!FP;`;MJ[AVDI)\55%74RU\4.LR:=6&/934C7:T#"
M=)!]?V4@S6G)2.QQ;-25I&R<;)%8?:5NE0Z`XXJ.)3=T]:>G73Q:,2R4G%"@
M48(B>^C5H1SV^`GU?PI!>8$'10&=YF@,JK@)TKU=*A$6T@!.J]:*M->EJN<B
ME$Y>M.=>LDP(R&/.OU#=$1)]I%5.ZPVBKVR;!@S%&2JB*"@HUZ)UJFG"]\AZ
MCN!]E,AK=):W'`$^D4@7)&I4R+(6.RAQFI/:>%1$E<[-)"&PI*JFH*E%%?F1
M%Z?#4V$ON6$Q`-"8A45*;<&PQ/4J2??3>=54$OO*HZGRU`S7]%?F^1***IZ)
MIA[`K0_!*\8_4ND!R4G+*=9:^_!JA)]V@+4C'Y2!'!78`'15JE5UX6'4&AJH
M?33YT.+`V1VH\$^F5-V0H2Q+:K;C#CFYL>B@0CW.\T:?,*CTZ5Z:F,<1I=D[
MB>WNIJ6%P<Y252DMQL!8-N,3(`.[MIVD:07-JT+:*U)`7X5U(9(YZQNQ:"OT
M-1=)8DA!5*24`W&R0WCEGM%YQP`1OJ*HBMBFXP(6Q2E:_-IT$N<"T8@#UUZ^
M30T:@&XG`\J37:.NNHV^[L-1%IE\0!M5#J(=H$-0(B1:E5474DMB<"UI*KG3
M,<CHW:I&X!O?],*298(+Q`2@VHIW"`'01M20*D@D1"M17^JM*KZ:7&V0/:T-
M&D<3E2G31ENMKB6KRIL34,7`>W@F\$JVR-:[EJAF!=`*OK_1J0W%%)5.ZFR2
M[4T!4.=;X>('^'OC_P"9#_Z*94DZ57ZZ1\-=Y\JI_@K!,M)]YKCGF3#>;T=H
M]U67UH:HJ&BBLCO&_P#\BWN-?]_XT_RPPW2G?HQ=YH'W^\>ZO__1^IOP&_Q5
M^YI_J/P_^3N&Z<?^G!W'WT#[_?\`56KNFZ*&BBL/<ESBU,XY.XOC8U><FRF^
M3I,^V/1C[L&--M\B2TQ.8C-R.HQVW%7:8_H_!51-<+&XL=`;>*/Q'`N/I]M?
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MO-CO.*R]][L-:"J*E%KJ-MNZ=:Y=;W#@YI:`O-`GTYUD]LW)N\6,FW3*W='O
M5LF&*`@-(YG(&F#CV79!;;L\&-2",AQ]Y)T]^K=LR)FU)*F6JX,,R0$]QQ^^
MTE$%:.?':*:D6FS1,E>TS![%)C`*(%Q`/%%!'IJ*_P`N0,VWK73"'=9HT_>9
MJP<'(<C@3W"I(A0^8^0+'$N=ISC&+-<&P&YR,.AFV]<'H$=4&.#;TJ,/RSQZ
MH7RHFY$3UUK[3RC9S6<\KG9#$$G%,?HE92XO-GV?<6PR6LDD*Z=:>!3APQ4=
MM1AG68\IX]:++=[W<(+,)Z:Q#2R_1HS.NQNN$AQG215<"*TB4(FRWJB5HFH4
M.Q[;`63",N<#Q&&H\.ZMCM>W[;N<MU:QEVEP\)#LA^(IQ/*N^,<IYG!BW9Z=
M9;//MS%R48XL27H$J-$E/DT`Q6Y;8.3V83E!(D55[2*76FH-SY7?<W;[DG0<
M>X`\NRB_V';X8H;6&9REI"D*KV8H[-%&7;3AB^1[$Y;G:,9Q>XY!DEIDN0Y$
M5GZ<K<4K?L-1EMN$:LNNBFTU04IU6FDMV8Q]-UU>1M:TD!<R#],*S;M@%L?S
M2(X'M4G,\\NRH&S?`^<<ZO%]RNX85:88718#<QB+*!ZXJ$(12.VP[",5`"%K
MYSWH=25/35Q9WFV6JVMJXOB``)(4+Q(/?G6BVW<=MLX[6">4ZF%Q:#@@.:^O
M`4Q[/;L%P>Y1X/*_'LRV2<I!+/:\O*7)&+A#[QEW[_<(J.HX_P!P30$%Q'1V
MJB_'IIMHDMV/N/F-+VR!`GQ-[4I.\W.];H1>[%>@0V[@=.'Y@`^$5']X?'C?
MDJ->./9*<@KABR%M-XC-L17I\.XBVCD:>TW\CVTB5:^E"2FH.[1QN<88T?&3
MAJ'OK>;&6[_L'3WEO0FD":5X\P:NIA/DKQUR)#M<:YROV,^_<MV1I?B9@NPY
ML&*DHFR=;,R[#Y+VP>&J+Z>NJ;;MALY)6.N&-:QHQ!/Q.&1'(5S7??+^[[)<
MSZ5GB(5I:%P)0]Y&9%30YCUON$!JZ<>7JWK;IH_4&^Y.=FVR:*DG<,'G2>[6
MYFJ;D]55-W34B\VF.[&B%S6#/DO=]M4,LTVC5=0%SVA`@"CO[C5`.:>3+QEU
MYEX;B<&;-C61\&6;S&ELM69F\,N(U,;0$W)*;;==0#/:HH737NV64&VVSI7J
M)6KG]7?6_P!@V8]-FX7#V>(9'XDY_P`*G[C/!8.#19C$^*V]D-T6/(G.R7Y$
MM6R&*T!QHH2T1EN*CB$M0!!55HFLGN.X37=TYS]3&-(+0<_]#G5?N]ZZ^)$;
M@Z)JMP0`XX$]HRJ1Y;S++"'&;H`(I$C*M-(R2=40D!`04+;\$JJ:AND/6:]D
M9(3AF,,:HH;01->))&@DX*5'9VTP;A<+U,DCV7V8T5'67![Q(1MF"4<,F1#:
MXCK1*H47HJ==2H',$(>[%Q.`7(A<Z7*&P$F)'2)B1RY"O>10;#<;1._%1"7"
M"&1LNR"*(_%2''`WGXCD1SZN+4^HD)BJK1/3II^/K6SX98'^#@[)#GCS'*DV
M=R^2XZ;5;(\@EN>K@/\`2ECPNXJQ/*G+YS;>8S-[)R3+QS#H]P$I#<.W6U_M
M3+E)1\B^OFR9C9]LWMZ@/Z-%UVKR[9-FA;=W0UN/J7BG?60_<?S-=6#X]HLW
MF,-:"[3@24R/(#D*6?-OA6S9-@:<AV.QPF;UQI)A7J2,.,$<KYC,>6T=SMLP
M8J-JZ,05[X[JU0%JOPU+WW;FFW?-"U',0GM%5'[=>;[AFYC;KFX<Z*9<>(<1
M@A[<JR3Y?R>+>\DO%ZDBL*#=IK$VUVV-)>=5+:$2,W:C;;5-C:'(?4A!.@I5
M*HB4U@)IX[B4AC2&IQX'E7UKY-L'V%NR23Q/`4E.!4X]O`U:[A2&-HX\@L.-
M`U-F//[!5X/JY4V9(><AR)I=1?%IHJE4E04HGPIJD>#\W+%U-3%"`'C]E<J_
M<.]-YO+Y(WD!N>&`:`":=>1V>W938;ICE];:EQ)+;,)Z)&)QISZL2"23K<D-
MA-JRI(8%O0B=JG0=/R6S3HG:Y)P!@,N]>7UUD-MWJ?;+J*:W<<'*O9D</=55
M\ZXCR'%69%YQZ_/WJQQ$&/<;),BMO3V67G4-Z1;)L8!EN3+:@[AJ2J2MIU)*
M:\CN'-</F&@A4/IX5T_:?.>V;JYMCN+=,S@-!.`PP\7>??2/BO/3>/\`?M&8
MA(FMVN:Q`C.Q023)<DJ^ZXR+I_*O;.$.]:*IHJ^E:ZE2[>R4:K=VEBX#@I^W
M.F-Y\I6\Y^:MBT:PNG@B9J.*X4OVOF&S7W,W2!6;';Y3#;<!98`WW);58LBI
M*X8*CR;2142O7[$T_<0RZ8WQ0AI8,0%QQ0GU5F=R\K7$&VMF<`Z1Q((!5&\.
MX5,DGZAU]T4GNS1ADT[%-U7#;)\E%\S,5.A`&S>/K7UIID2N9(UOS3RT8M'`
M*BUSM]NPAH^4TM.!7/!43O--/(;FVZ;ERR":VS'ABI/SD9!A5:$1(DV#M1TW
M#'Y47JJ_TZERSR7\D?6<"T8!!XDIRRV[%S+.)Q=(<&DX+6G'M<9;;,QXVY-N
M=IB2V8;><Q(R2IG1V<ZU9FNXX@[B06VT5!2GYDUTKR9&^*RNV22:G=3U895C
M_P!P;&6POK"*9.H822G^ZM0M;&N?5%W(SC;96E53[U3?V%TZ(B(2T1?4A5*_
M\-<5_=TL8=CDTDR!SD]*>VMOY/8]_P`^`1TT"CG_``2HZ)N0$EEUM64[1=QQ
M-R*+WH:]!5:57UUQMT-W;WK96AHF:=1!^%W'+WUKA+;/MI62:BQP0<V\*2[K
M+:D&ZD=X8AFOU3[-!W&M4:-MM#1?NRV)Z==>7$QNS<20Q-:'`ES4^$G`Z>PY
MU(L[5\+8>LKF-(#7#CQ&KM%%DD4)*@9@TJHC(4.I(J`B(XJ(B&7V5U#D1KNI
M#&>@4&EV:_94AL3G#\QS1,24<.5>U1]$>4'"0E%Q\FFT#NJ")T9$BH*$E:>O
M734!EU3`R`*"O8.0/V4IYB`B6,G$-!X+^(CVXTGL*BPD[I2E,D<1I"!$-'$)
M2,71%5':"*E-M=*B,?PEO@0HF6&))YU)<7MD&G2H(U=QP"5^N2)`(V2#0P,1
M'<*J@@B;JBB(J(J_"O332O`$OWFG#L[0*5HC.IHQU>WOI/E;D=2<@A4!W/BK
M2*ZJ#0@1`$2J-:_HZ>;/(ULADC!D<A:3GV^NDB-FL-;*X-;@0,D-"YRG7P;E
MMB\:;@:2.(J)&9`IJX+2TH#0IU7UZZ8N^K<MUANEA(P[>P=E2K)D,+N@7#40
M2JY!>)YDTD!$==(C,13:8[`-4%=Q+4E2A=5VHO34>*%L8U.!Z@.('*I\UP,!
M$[@0N=>51Y7$!&NNUP5`RHB-#4R)=JJ($2)7UTGIRMFZ;"'-'(TIKXC"7O<0
M5&*8K]E(TDA<8-)#:O"[]VK;@BX)`H[E0Q55%1)$]%34,1NZH=JTRC'%<$Y5
M8,<&-!C^$#`C-?X5'%PP&U3GG`MB.6.9)=-XID(S[8]TA5T'&GS5H!($5.B(
MB5Z:O[?='L.E[0]AX.Q])I<=W+;MQ`<WC@%/IXFC5JQ\[9$6*LIZ8K*F[]1*
M-%DF)+N,J#TV57T3HB:BN=+=2S/C#0X_=&24BZGC`B=ITM*5Z>=V/C&WFVFU
MQQ&NVNQ17M"1[U14(E0T7;6O3\FDCJ,C!P0N3'Z>VHA(=K)X`$(:).QT%4=5
ML10.V2N51*"*^I;>OW:=4^RJI\=>L:\M<Q?"N/+OKWJ`$N)5R<J278S_`.)/
M?]-\S$&%*:(NVJH4Q"?/]*IHP\`B?S*@E\M-6QADC<QH&;=66`PP-1A.QT;G
MN>BO+32:X2%VP?5.R=35635%BH+)D@=.J*KBI3KUK3[-1F-`TAST;QIQ_P`+
MC&U4IM3);;;@?=BPW4%:)$JI)(5&Q)TUZ;G#'YJKJ1''/(N@M).6/`<:;5K&
M`R$]R9+P%<5E$XX`2$%Q"4G7>@HM#/<XJ$/RD:BJ55/BE=.PO:9/^2U<>''N
MIF8`-/1*>$`>JD6>R!FVXV^OW+A3![@H*@K.U`4P4=I=#HB>A:M6P&-VJ(C`
M%R'@*C]4N8YL@S"%,B>=->6;IO.FZGS$IJ3B$H]7%4OF`:"`?8B)Z+IHO:XM
M&97'O/U5Z(>FQAC<AY?73=DQTE,F*DM3%0!Y$J@*H('0U44H(]/M326:XWG2
M"`?;4ELKVR-+@I;1"/"2-':81Q5)I%;4]M$(U*I&A*E3JGQ3XZD.#8W:6(YS
M\^PU[/*^9S9CACB.RBT@4074/LH"[>E%3:0HHH0=/TEZ=-/1*X2`(1]E0G.:
MY[$)U>Q.5-E%<:(F(Y$'_,%45$1%8K3>XM:_,JJO34J!LB%NI$'HIJX#7N+W
M!1],*392B@$:(KAJ6S<*FG4$5%<%41*"A?#_`(ZD$(WP-1R)W]M,%P):!@T_
M3&B2Q02(+[I]\I#RB;`(3CK6P>KI*2;41:+3KZZEL@!@8]023B!F.WNIETQZ
MKH2H#0H."%>%-B6++<APVE==!51&T<+95H4K5:_HJA_#2%C#GMQ+3E3D;Y#&
MW4`#Q-;W>(2U\?./UJ*[H,I?E]$59TBJ?TI\==U\J_\`L5@@^[]=<@\Q?^\7
MG>/=5EM:&J2AHHK([QO_`/(M[C7_`'_C3_+##=*=^C%WF@??[Q[J_]+ZF_`;
M_%7[FG^H_#_Y.X;IQ_Z<'<??0/O]_P!5:NZ;HH:**SQXXC\`6.V26?VMM<S*
MKS+<<>NMQ<B2Y-MN#BNOMLQ7FV6%CQK?MV"1N5<050J[EUSBQ9L4+.FT@/+\
M53/CPP2NT[U>>>-SD8]\3G6D;,!'@W2`F*'%>2573GGEB'?+;)ESK/CE]R^'
M<DQ2U978([9K="!Q(GXO'[ID^PR['C`R3(D+1+3=5$%4SOF7<W7SYHHYFZHD
M'A^\>!)Y(,4KIW[7^59MON+:^.IEJ\EY9($TC3B.TDE6\0F%/OQFQH;1BLNZ
M7F&(7J0])@OR=PFJ--F1$SV$4T9%ITJ(B?(B(E$IKC6]2R27$S7O5T?#+$^_
MOX5>?N9N?S6Y6UI92?\`"`:YK?5BO:.%60D1[=>(4J(XR)Q9<0V9<:B*VX+X
M*W(`A44+YMQ*BTK3KJDC,1F9(W!0/?C7-UNK22-SG(]KE!]V/JJF'*7&L?&'
M+#%MU]ND6RQI-YG`EWFQSMQ-0K6KMLM4>2;#*02:GLM=X'%))#)FHI5%UTW;
M6VL[8XW/`NHFEP7)P5%'KQ%;3:?,UQ?Q73I+5IN'B-I+0=2KXG$*548`C*FM
M8,N><R_$7K3.B/1+9C5JMEVODNYA8K//[$=@ID@MC34EQABX&B-"V*$HBB+J
MWMKMSKMC.F70L=B!EZ.7-*F;CL44&P7TUTW3?R2%S&IK<U5T_P!.9//LHS=,
M@MEISR_S\AY8._6QFR2TB6]QM+I%?N=P1M^/`M,<(!238;878KJHA$0^J5U/
MD#.I*'3:6%2&DYC@?35-8RR-V>P;!M6B<R`/(\)`;@I*^E%3LIOXUQ;DW*,N
M!D/*`.VG$09[=ALT,_P^6_"CF+H299QU20SO98!$W$);25$HJZQ6Z[^-'RUH
M\&34FH<`,QVUJ[S>;':HI+;;7ETSD<]QQ&OL/><ZM]9+#9\>MBVJQ6\+=;8\
M=X6EMX(B.*XHG]:Z\X#DAUYUM*FX1$X256M=9NYEEFF;ID+T:6DG'O/9V5S>
M6[-QU[B\<KR\.0\N`[EI9BNMW)';6W<&8Z0FG/Q('#.DAOLJ<7MQF^VHI+<;
MWJ556G15U8QL!;=QQ736M#<5S0<N\^RJMYD9+#/):ES7/P`1%.2D\APYTU\V
MQK'<OML:V7RW,W%O\/0'V76^V_"4'&286+(':8(XNQRK:J0[:+ZTU,BD,%QM
MA9=*_IA0`GH)&?/LJRV^\NK1][+#X8>H4*Y\\.8.&25G3R_Q]E_%.76]JS/-
M3X&<9+:1M5].2[+O$*1&AF!0E.8X;KC3R!1RJ4V`FU$IK5R7<;X))'/4C$I[
MP<ZZ?Y7W&UW*W=+<$QB&(AP(S!(.0RQY8U8N-XA8=/V7W*KY?;YE3ZK,^K1Z
M"S;&91-CVEC0%CJ\ZQ$>6HJZ9*I)76?%[.'&7P=,MP'$CM_TK.WOG>=\AM([
M5GRK'(20=0'K1".`JJ6573E/B++\BPPLJ6);+K+:>N,J(C#MO8@ONHTLENPD
M+RA)E13W.*UM;(A6HT75K9SW#FQR1'_C@^)IQ3M'=RXUL[3;]AWG;67T%K^:
MUF1"*4R)XCDM.+";9"G7M+?C:9%GN('<')=ZFSCBXVKUZ&IF;IQ1A0X\2,8D
M;;"GM<5!54KJUN[6YN[<LM)T:XXDC,<>Y:I9Y76-D_Y\,ANV-\#5U>$X!.U$
M4YBKA+>+?*A1KE9HL>5$=0>Y(><>23!,2[;RT%P633N#\S>U155J*)ZZYOHG
MLI+F&5H>&G`DXC'!.RLQ+8^*)MP7,D/W4P<OTSKVR\##22Q-H5.0ZZC9MU^H
M;451`94T+<?<ZB)44?@M=*Z\$C72PC3<`J1BB=G;4.XAG8\P2@F%$PP(/,\P
MF!I%N+[M]MLB9`<>;,73A?325$9"2VM]4!A!4%5P?4B2J+\=+0/B+I<7`@(,
M"O`GGA3:&RN8P4TZ5!.(3DO"H^86ZA;IYNQH;<N+&E;35D$??<1E$..8BT>\
M7-W]41J55]=/!ITM<6-`7-4)X5)?%'\PTP//40.1,!BN8X5/'B7:"7AG!4M`
MRV(\^YY/<[VJ/(P,<PO-Q1N,+8D!FV,II-M*HG6OKKOWEX2';;%D;<!GCD/K
MKB_[@W!EWVYDF(UZ6Z4&!P"G_6K..)#G6_(K1-`#8FP9]ONS1]Q1%F="<9<)
MSN$:T.,[7HJHB:T4D74A?&XJH]]8*QNG66Z;?<MR#P?5C7SL\@NY%QUE-TP>
M9C3DR"$<7[>-R@-LN2K*U<9:6>Y1)Z%W%CORQ-.X-%)`37(-SL765[.QC2&N
M<N-?H)Y3W&TWO8;2X%WIE`0H>*!0>:88<*MGQ]?X60XS8+HQ$;!EJ-'%RW.T
M(H#T=]$>9<4T4D:3:JHB(I*GQZZQ36]&[>2"`TDK7-_-%F^VNKQD@61WI4'C
M_"G8_)<FSI$DB6*DR<:(C&UJ*($(LL-*/1I08;:013:B#151=6I>^Z<YP=I#
MP`0,,.%8,1MM8@'M+FQE<<22<311U)+2%,`G7P1QQQ2(D-OMLHD=@43N*X\C
MKD<A&BI5*IT1$U)AM))Y(XY27L8JKCD2B<Q5=)<QQ.EFA:&3N3+/Q<<51%Q[
M*CRY<>8R4_(9=QL=LN176[-29[]S8%]R/):M("K48VT0XJ-O(#>X5$P!2Z_%
M;62!\+F6^IW3#@B8>)%]A2K.V\U;K#%;N9<N2)A0+@FHC'FH6F).XRXRD1F0
MDXA!;=F,ILN<9R2DY7C5#:2+,[Y.QVS`]M4Z*JJM$KI-I)*`ID<I*$*"">"8
M84_+YIW8R-)GUA@RR"9^(<4[::%YLU[XXMTF?@5SG2+1:PD2'['DLEVYO-P.
MVVZ^\T\;C9;V7$<IUW$VBI15II\36LLT,,T`T.4`_>SX^G(U+M;J'>Y.E>0@
M7'A1S,`O+N.&'"H0MF8S^4\ZAQKY+6U6N*]],MMM^\$E)]$LJ7)J1.`PBM%M
M%U45P5KM)%]';J,V,3I+9B(4!.>/^M:*\LH-CVQSH(=5T\%RG(%4"U]!?MGK
M;V^,\]AVKZ<($/+XC;$>.:&D=#M+9$)JBJ6XEZU+YE7JM=;?R&7FPO3(/$9>
M.>5<#_<)T[]PL9+@J\P_76E.MU7/ZA_D^>D61:&%I]ZS,<3?5056U:38J)UW
M$AJB*G5%UQ;]W96QMVI3P>4X'X>%;[R5;=<7KAP<T=H5<5^K(TP">:<0"5M4
M*C8DJ(0B*IN57$`*BI$BHBUUQ^6>WNXFR2L(N$`4+@G$CBN5:QL4T3WL8X=-
M2<<\>"G),Q4)<QQYSS-A2T.2&W%D3$>=8[C1/$+"%&B$0`KH?4._^E41:=53
M5]Y5CL(G7NN1OB9\3AA@JA#C6FV"73),+F/P`@I@4'$KEAZZ?&)%<&8,`;RR
M23"BM&0`1$2GVOO"=5:`+BDGI75#>QV4FYRS[<KX4R.&>!T@^RH&Y$/=*R(M
M`+BA`P0%12^DIIQEQ%[C;N]44@01VIU11HFY41$__#5.V5C62L<':@XIR!'`
MTV8)1(U'`LT]Z]M);KBBH"+Q.HTAH2@E20RHHE2B4JG155--A@)+6NPQ4A<.
M7KJ6T>$N,:.*8'CSKTM(R"M5`JHKKE2,7!5/42W%2OY.BZE.8V-@&C3-SSP/
MTPIICWS%Q<0YHX(B&B(NM/-O=PT)711!^8A)!ZBH4%!*NU?AJ,[24TR`D<>/
M<.ZIF@HPB+2!GA[?]:9PWERVWU+%)E27$EM2Y=I<2`^+(08Z,?50UN";F4?;
M)Q*54345Z>FK^2"S.W6U_87KW[@UR/C</A_F"A.R@PNN1-KM`RW":GAP\1*H
M-.:<:4I5V9CD*/3&F5<WB5#J7;;05(U;=$S^Z$D52ZK35*;:X5\[V%2Y''AC
MQ(IR-T&AK`5C:WT]P/HHHEPCO,N.LO)(9%=BN"144!K7YDI4B^WIJ+-:F%S2
M5!X=O;4N,ZB@:F"D$<>5%'#5(QO-"@-"1_,:H7WKH+VTH?1%;0%5?Z=-ADC?
MS&@ZP44XK3JASQ"Y`",AAWT0C.OO,DCIHKYGN<>'>/<C?;\ZU0Z+U37A8]7O
M#G%YS&"#G7KWL86MCC`:,J+2Q!MMA]L?^K5M0-34B$JE3<-%^533U1=/N<`(
MOEU8YHQ3B:8#GE[V3D%CBH'U4C.2E[C2"SO`B?%TU45%EP4%OM")(AIW!<]4
MKU3U33Q87M:XX*"?]>X5XS3JDQ3`)R3^-%C?5T6Q(/D1PMS1;D':B+4@HJ_*
M*?!?^.O(FM<$!)P4T/\`"Z1WA#RJ$?72)=64%U6T==CG(CQH\I$14(HK;`)!
MJ5*FQL#HB_H47[=75P[IL@_,<7EH!!_"F!J!`=9>'1!`XN!_F7%:0S:9C`;#
M14$&@!IM$5QHFCVO*B*OS(VV05%:]=R(FJYR1./5),H&"C!#SJ<Q[RUI:`&*
M<J;DF3%1V0P#@HJH)*Q\RFUO4A90MU5%ES:M1)5K2NGF6^N,N;$$3,'ERKUT
MJAI<[`?04ENNF1&K8FD?J($BH@*U5"`@)5HJK6B?DKI9:YD0#EU#E3.#AX7C
M22M)1$#+;Z=P3>>:KM55$F/OP,'-RI]X1;42E:(*_;JQB<_I@2E=03VX>BHT
MI'4`8,`5[Z2W'E5$W"A*KA%0"VH0_,A=#146M?14TJ-CX97D$$D^CT4HN`:`
M5TI2&2"UN8CJC@*7R=PJ"BI5%;2JIM3=T6B?!-*^(([XSPY5XHP)*=N=$7P<
M%QT76]CY.(1`2BXV&P"W&!U6B4"J#6BZEFWE+V1N02)R&7?3#9HW,<0Y6+]!
M3=EO@P3J=]T@1Q'4;W(AE4>J[57:GW94].FI`CZ8<A4`TV78,,;4)PI$,VU/
M=NVN%N1>FYK8A&O;H25H*TZ]*Z4`U`YC4>N'=2NHYH>PM!!&//OH@ZXB@3-&
MP1%,Q(E=-=Q57HJ+3:J+\>FI()CUZV!3Q&51`3\;2G!#28](<;8VL/'&1XDC
MNJ#AB+H40C`T1?F)22OI34F-[V-6,EI.!(Y4T6,>5>-0&*<J:4IQ'#-5+<(`
MJ**(B*X->J(B4+>A?\::'-:7HOB`IQH<BCG6^OATJ+X[\?*-:?13/5*4_P"O
MD=/Z$UW+RH"W8K$'/2?>:Y'YD*[S>=X]PJSFM%5%0T45D=XW_P#D6]QK_O\`
MQI_EAANE._1B[S0/O]X]U?_3^IOP&_Q5^YI_J/P_^3N&Z<?^G!W'WT#[_?\`
M56KNFZ*&BBL4^29W$QV=]^T1^.[=D<,T?C6W$7H93KE&>=-MR%?H-O$H".(-
M'!>`R%%2E>NN,;O:.FMW$PADS"2HP)["!7U%^W4M_;;I!#<OD?8R-0B3)IP1
MS2<^ZHSLHLK>6'/P1;S$AW"ROVFQ,P&7(=]<!I]V?$%L?O6XS:N,NFXK>TB:
M1/15766;=1V(?<72:R!@B@_[OJKL&\1-N+-L-O=B&!3J<J:`%TD'(DD$(M6/
MXG@W+CX+_<\YN;-A:R&YC)A627*WLVSZEQ]P6D13<;3[HDJ@JHB@56FN>[H7
M;E?F6RB)C:"<D])[JQ/F.\L]SMK&*PMS))"TZI`,7(B=R=N9.%62M[8,2CEH
M\K@.I4$%56@C4E5/DVH>U4HGI\*^FJML,<;VE^`&:=M8.]D<^(Q:$<!D</XY
MYU`GD'%9?A86W))F8U/OMUCG;)4YJ+%1M[%KH+4IQ9!`P)PKAV"#N*@J9T5?
M36XV)C[AQ:(VNC:S2,0J$KB<\_75QY4D9#>3S.!86M#B0U<0X+EF$"(,LZJ[
MX\\=XWR/!O\`,S=BY.PK!<G8,&S;UBQBE2'''6[D32&+KBT8!!6NQ?ZJ*BII
M-]?R[9*;6*5S7XDIB=1/NYFN@>=MR>R2SEL&Q_F,4N"_".'+CA5M+7QUBE@=
M*1:[3!WNONNA)FPH[BJX\1$AM..LGVT:+_\`3HFU.B45*:H1>RS3OEOIWDZ"
M&H4QX8]E<\O+Z^N(HHK8AL:C5CD,S@,UYT\Y!%V2@B33PJ"!VW*;116S:/M(
M@5$"WHJ_!$34"%2XM#44H">/!.\U%=I>?U`=(4^M<>RBKUS."PT78=-I!8^F
M<BDCCJ*H&Q((T%55YD`4JU2OV(NI]JUO6DA#TE<,$QQXKV)4.>U?)^9(6]/%
M2</#F/;2"C;%R<;N+$=Z&ZXPS&"Y$X;8RH;#C;R;([!@X\XXPJ;=R(-"6NGK
M6%@1LN+'`HX'%!R'/LJ7<S/9JCMPTN:6N+2/Q#GD!2J8O2CBR&@56XTASOJH
M.(CVX%[(BWUVH!$A>J(JI5>B:=M8;B3Q1,2V#BFI2Y>!*9?1:8NGP6PC,\I^
M;<Q4:0B<1C4)\Z6=N38\!O7:.MBSZUDLZ3(%Q6X[QRF'Y(-_.6\*T1?T5%>O
M75Q:N,?6A,!+=)`<JCGAS3&K/R[.YUQ=.;<:-<)\!"8X`+V)CWU*>29%9\:@
MOWJZ7./;+?$9)^1<);["ME%1=[7TX*2$;C^Y!1*4KZ?#1#$T"-[0[J."#`$I
MP0=M4L%K-?2OLHU)+L=*^DDIPK/3E&%F.<9M)Y%NV&76W8YD%C^GPF>K,GNR
M+<JK'_%IJ1(IL0TE@8O`V^XRX3"?=U54UN[#9[B.#7(T-:\*">W$DI70-KW/
M;K2SBV>TOM5S&[\P`\ONA<\<":=G!'%X9GBV0VZ%=;C'"T1WI]TQ9REK<O#D
M1'`2[X_'F)N.4:5+;(4%*M$155-3K:-[V2Q`98IS''TFJGS+N\VWW]G<R0->
M'(`]-0;V.^M*XX1GL;$+BS;&9DFYXY=@?:F0Y$:2[-LTYC<T#DF(K;KK,UXV
MD)QAL50:UZ)K*;MM?79+/!$TSD9*%[S6CW**VO;)MS&XMG:A!0HYIQ.D\AE5
M@!N9NQ>_`**X$ULY$:4ZCOTW<)LJLMD3*_3U):$B()`71$Z:Q<C'VY8ZX;I>
MJ'#W5D6R1RN$;2Y!AVYY\_73*E9),MCI1K_9W+>8Q4E./_B$4&Y7?D--)^'@
M\\U(N,H4<0B`/G1M%)4HBZN++:&7CWNAN`1I5,G?3ZJ4862,)BF!\6D`@E..
M*`H"F!."T6S'*<5Q[$Y-V26XW-DPI++C[LEH7%F2B[<1((=Q0:C5>%>ZO3HI
M+TKI=OMW5T0QM69K_$3EZ*]V^.]DW).F!;@`\\!S[^53YX(MO1^"K=;Y-VBW
MIVUW_)X[D^WS8]RB&DJ\29R,!<(Q$T\K12%0D%:(2+KN'EV-T5ETG/!0\*X_
M^ZQ:_>Y+B.#2"UN")@@&56R?:B1Y3JN$T/XBJ!VU`4[S@MH!;E7YG5[:4I\$
M36B`#2I.!KDY>Z5H`*.;[*QO\^+"#'D'B0.2DBQ+KP^W'CJ2.$+TFTY)?I42
MVQA:`D:>?DDB"2_(FY$6B:YYYJ#8[YCB<"/K-?7O[*W#G^5YF-C+Y&O*H1Q`
M4XU7+`<PG8#*D1IJ-S+3.([P4>0X#<RU`W%$U:0GE6/+4G6R#M;J[DIK$WEF
MVY>R>(AKQZBG"NC[[M`WBU;TWI<@%N.>/M'?5KUG1WFH[T1])$(VH[T9N87:
MW":"J&0I4.VRZ:HJ(JHO7[%HQ"Y\4H>\`Q@9.P/T]]</OK9\/5MY&F*Y#RWF
MJ<>XT6*4$9ALWT??AHXP!@TT1O*PA-+],T)@T(/)(=0WCW(V(]$):KJ=;RF-
M[W/^$@.48D`$D@<%-5LT8.D(->7>Y``3V?6O*HKFYG/1B]N2XER&7$N4>D)V
M&PU&G2+I*9<$&T%[O.!'M5O<=<-54=XH']9-.&Z;<13/<'ME:]>''+#@@%>C
M;2)K>WB<QT1:A<"1EB>_$I7D;U^)NO,,Q5W.(TY#CM"[LC,MN=Q2$6VT;8D-
M,LT[:*J-HE2H/77D#@7S+*U7(6@8X\PF1'+A1=6G2;&Y@)+5!)(0C),<PG'T
M5%W*64Q_PFYV*.\\%QEV6^3K\37;>_`\1@1(:7*XSG2/>U)F+O:B(:B3K[JB
M%4IJSM6&\EZC[8-+%4]P'UJ5[:N/+>VRQ7<%T'DPAS=/:22,%P08+CD%XU#7
M%?'CN1VH\MNLF=8+9<9PN8O;8`K%G1;1%:[+(71QP!>:.4\"FZ%25RM?1=)N
M;QY)B+5B;Z<:T_F;>(8)?DH6ME<GC/!>0^JM^_;%QIC&>.N2H\6>_/8EYK"E
M(<L024#A6=L70<-MIL7&ZHFQ>O1/771O*,D4EE.8F$#6%7B4X5P'SW>R7U[9
M22``MB(0<!JK3;6LK"U6CGR[Q+9<</!^5V7I"ST:915J]M[2HBH(D6TW-H5Z
M=2]=<=_=:WZS=M=I!(9(B\_#72/(#R/\@P#`EA]]-VWW&.\VV0N"IO*/47-J
M(I=1W`OZ1=/3UUPFV<6S.:#WGA6VN+9[4<YJ-X*,^XUZD/-*@"_&-Q-S:@KE
M.X#@DXA*B;=A(@]:5KI\W38F=`V^E\@343VX^A#34=O(Z0RQW*!N8&1"#TJM
M=7&"9)'T4>V@4`-]%>3=6BHM4$D'X+1=1RQMI<-E$W@!7#%?IVUZR;JL,9;^
M83CV=O\`I1!YP1,GT:(6T<1XVMA*1E_5`$:0E,J_#KZZ;:>O)))T@&O=J^VG
MNFX,CC#R2`BCESHB)MJKSE$:W&`=KYD=6J+N(U14(D5?E1*52FF'/)+6AA\.
M!`7%?>!4P,<W3Q4*N"5S)F(KCLA2=;(E!ET"-U6A$4^7MC54:6J_!-/&1ER&
M`G2&G25!R^G.DQME@+M`#B[Q+@JBB+Z,38P.[GV7(ZN'L;-&G'!1/E%P@Z(H
M;>O6JIIAZ!0UJO:44>P]]26&10J=-W/(<_739N=R4)5O:^DERG%@/.(3#7>;
M;+ZA@!;>4.C;KVZJ&5$)!5/@NIUO#)/:32O>6,;(`79#$%`?33\;&12EH<W$
M8`G/F1V"E)^."`Z[(B05D#0HY5:?-1,4WH6U2V(XBT7[%U'EBG@+F.F!#NU5
M]'UT02Q3%N@$-:4((3VU^*,4(ZL@P+BMBI/BTV+:*Z252@M+0FP1$HI45=)?
M+%I;X7/DT\<E[^(I($Q?(XO#1JPXX=O+T4CODP4&2(B3INN-IM).XTR0B:;@
M3=5'51SJE.B)U]4T6TKXHIG-&!3ADG?]5.S-9)<0DO`+>1S6DAEUX5V(XT:,
M@(ON.40B3H*H@=`+IZ)ZZ]:Z)`X-*KQ]M+E8'#,XY)23(<G(_P!%0F4$R1P1
MH2$)5V[2^54$53XZ<!8XM`8A!7A[:2XQN:<@X"BJ.LON"B(K?0>@DFY350[K
MM24555W)1/Z?LTN1P>\NTX)BG=B*8#7-:TEZD%/1P[Z29EP"'N56GGG@<$/H
MV4*5)DJ:?(,:,P)N.&]\!%.JK1>NO8H))G`,C\13"D/D;$UTDCQI&*T@P[_$
MN#H&A.#*C=QN='E@ZVK;I&7;29%?%F5%-&#"C:TH55I1:ZM)@RU9$Q]L\3-"
M'5S7$IR%--#IHS)#*#`\X$9CGV8FB;KSKKJE3L[GT;%3-*(VTT1&"#5>V#:"
M%*K3YD1*_"%*#*_6\J]?=P'KIZ,Z6AG`>_F:2)X]J(_-:>@J;K!]T2W=^,T`
MKLD2$4!W(V2U7JHI3UZZ<%L]H:YD@<H32O.E17$3GF)\9T\TS[JCJRYE;LD^
MLCQ2-9%N4H_;=8[`R(\'M1`N##*+\T9]20D7HJ$=*=-65WM]S;21ON&-#7!`
MA52,ZEWED;(1R:4B?XA_+JQ#3R(I8?-'V&%[2*A"H(A='1-%!45XDHK=:)MK
M1.GVZ9(?X&`?;_I5>0&ND4A<.[U\:;DN.8`XG5'J4)$W+\RKU!*5ZKZ)37K7
M%I(TE1A1I:]K27#337-TVB-'-^Q!4ZFJ=P25?F"B+W!02Z4IU7TZ:F`-<QCS
MFM,%J+IQ::9ERS$+?<W(T^P7QB*H-]BZQQ2=;Y"*OS=SZ9TWH[PDB*@D%:?\
M=3X86RG\N1I<?NDH5Y]W*I#+(R0->V:/J:DTY$5P_'K))CLS2EL*$EHS:*03
M<=7-I;%V]XFS(E,:*E%II<EI<V\8=-`Y#ZD[^=,_*S.F=&V,DM(4!3VUSE/F
MZC1"J;2`!V@0=-JJ2]`55522O]/322UY"NY(4I@#07X>)5_AZ*1Y$@BW(#GS
MM"JDW\W4$-*(=/D4MOP5:HFGXW,:P-<,%'I[Z8E:<'DX4C.3"5";?0517$,*
M4[@N=%141.BBB)1574DEJ.TH%*T@!Y+4Y9G*F[/=*.3ZF0N*X7<16=OR*XM=
MJ*E-BBB]::]>[%2B&O6-U@:0B<^-?0)X:*A>.7'2HM:P)?6J%_\`SY'Q2M==
MS\K$'8[$@8:3[ZX]YC!&\WH.>KZJM#K051T-%%9'>-__`)%O<:_[_P`:?Y88
M;I3OT8N\T#[_`'CW5__4^IOP&_Q5^YI_J/P_^3N&Z<?^G!W'WT#[_?\`56KN
MFZ*&BBOEVPOGVZVRYY>=BP>T[;E=IOU=SR2&+_X7`=EG!C1X31BXY("(E.T`
MH**@TK37%GW4D=T2\ZV%Q0GMK[9/E>WOMMLIX[OI30QLP8XC40%7TUHMP59,
M:M-KEOL=F6EML5B,+JY+:>?3]H6#N$D7CCDH-2C.(!&VBJK0NH%:536`\YP,
MAF(AD_+>QI3D<0O\*R]]NNY7;612G2.L]`B!P9@J'-%SXYU.<:WV;(&D1V/'
MN;:.L.MA+1'D9)"-*"I*NWN@M.O2FL-#<3-,D3"040\,*@S/EM3J;(YK2"ND
MYX<1V4N2C1J(\Z[(1A@6C97U14$'%5$!$H@?*"*2KU5$TZ`7DQ,<BH>_G4&)
MO5N(M,9<Y5]B*>RJ?VO"\AYGRBXY5/N[]MP*"<ZW6)7"[TZ>2S7&9<NVQ'Q<
MBM1W(\5L0>--ZHJD-%ZZU7^3@V>+Y6%@^9+0Y[OPE?J7+@M:R:]M-IM66D%J
M'W3@-7)$!`<<\UP'II[,XP7&;MTCXY:[K?6;C-2Y.E&F,J4Z,(E^($Z;Q-R"
MNZNF!M[5441%%*=-0;AC-PBGN)WGYA1I<,D.)7V56V]^_=;BW9=31P1:"W2[
M@1DG\O#U4O0^3,=6,ZR<E^V1HI(Z;]W:)A.](-**IFKAD^RXJBXOHBUJNHES
MMFX-A$GR[7L^(EI5<<%I#=K/S!9%+J)\+0.P8IV<J,@S=[FY(E-W>')C.%;Y
M=KEQ"[C,V&2']9%-UM-I59<0Z^J$---EL3;>:"ZPNE:YJ8`+B1WIRJN,+[2]
MAD9$3"`]KP?BPR]M*4Y]Q8@@TXZC_P`C:]M41\751!(6U1:-`JIU].BKKVU+
M#+'I`4<>*]]++`[K!SCI)5#D6]U($*4XA]UTFH[;+ZP_G!R.P"QT2,B,,KU`
M4<';U2J[=2F&&.\Z98',U$<DYI4E]L9;5TX"$L"(A4<%/NI?DO2@8(`<4Y2O
MH3S++Q(#\<`0@,15$::V`BHG_J^/73PEAD@>8Y'-=K/@"X@9K52RWG9.!+$'
MQZ#XW)@2>>92F/R(L6?Q3F!79IEXF(,R0R39D#\1QM2>BOU)4W*R2"B$/]&K
M:QDCFM6LB8`X/PY^GT5)L;.>#>[412%Q<B_A(**G\:HEE>;WSDBWV#!KO>8L
MNXO.XY:8#++;80'RE-1I)WB;.96HMP8R+N2E=Z:U^WV,,4L0#?S2@"\.[E71
M8K*+:FWE_:6NJ,!Y<N![@.TY5?YKB'EVW8\O&YYPQD.#WNQM'-O,U$8DX^EO
M@D8Q(+H@+CL*2-$$]RD`@BZW+K2ZT=$2`Q)[LZXJW>MNDOCN8LS%/'(?"/O$
MG#TC/M-45R$CXXBXERI8\VCE#QW(7K%<L?@293\^[2H\E]F4C[O1)K)M,J1"
M:J@I2FJN:`'1-%*%&"#`]QYUTIMT_<[>3:I]N(=*W4'D!`",.XU.6=XA9>0L
MAM%TXP)N-?KG8H>7RI$;8T%IE*;BN]]]E:-R2:2BBOS+_P`=0)WP%Y%O$-?%
M,QSJKV.[NMKM[F'>W:K5KRQJGV`'A[*:W'-[GD],M%SFO2V1O5QAM2WGVU*)
M?HVZ3(MKC1$BNM3&Q-UM:?"FLAO.SZF"[PTJ@7F>RINY-M26SVC2'EBN`&!;
MD"$R3C4D9?;(-RL<QJ>+7<C&S,@22?,9R7$AV-?3@B*#8.B:HJ53IJ':=.R:
M\-PN,/$,U/!.59ZTOI+>\88A^620X$8:5XGG49S^.[-(L,R,U"8<NHP!^GE2
M77G/I9'TP$KC;1[P(2;J"_+Z=-*MKFZBDD<]RM`!08=IPXFK?_.,CN0R(AD)
M<02BKCSSKQ[<V67;&+IS/Q-?"9C.8[=!R&U6EK8*K'DJ/USL9C:&UDB=$EHG
MJ5==6\K7<<H<TOP<T.`.=9+]WMM;>;?9;I:M5Z:7.[@H%:CP[O%N0;T942:J
M8?4`E0)?7:I;E%?Z-;4([P@!:^<R-)!^\<ZQF]R6]2I7*^(?0]KZ?!\+ASKO
M(VB;S97BZ7%Z.TB?IDV31`M/MZTU@?-;!-/H:U7M;CZ<:^Q/V!ABCVB0W#RU
MTKT;R*`"J;,W2)?HL.YSN_,=*2L:`[#V`+H2OG,'8R;4$`'N*J$BC1*^NL@"
MV)FF1ITC%.VNU7EL^&1[K8-0D`KR'$4_L8S:5A\!(K\Q^7;Y1FW;0DS$EDKJ
MLK)=!EUUQ7F6^Q7:B_(I+T]5T@VT4LBN84Y^ZL1OVQ1;HX2!K&W31XL$5,%I
MYQO(+$&X]O&X-W5D[OWFV6H[;4TED1ABR'F@1IXC9<122JJB?.BCUIJ,ZSO&
M2R:'`QN]U86X\I21J[6W4PX_;V@43QGEO!<GO(6\W)]MN<Q2>9B7V*]!=EHV
MAM-@T3B*#DAY'45$K\R&J?'4B2RNHHW7+VZF$!4..&9/N[JJ;O:IHM8M&!W3
M54RX*G9S[:7,JO\`:\.M*RE;D2I;[XQK3;XKINSKM/F.`RU#9C-+W1!Y74$U
M^`U7TTQ:V[9GPM:TB7,D'AR[*KK:TO)Y).IA$!BHP!''E4&O65+K>EP.X;#R
M"U2XN5<XW.(I&S.N$EF-/Q;CQMUNBG:,9M[[8FS\H.2^Z1(6Q%UK;Z0;?8"U
M@`^9/Q)[/4N/;5R^1MI;NN1A$2D7>/C<._G4XC(BPV0;5LFV0:8%AAD11ME`
M_0:`0H(@@HB+_P#'658YCB))''2,ZQTQE,SWH2YQ53CG6Q?MQNB[QMFY["%T
MLMC&Z2JNTE*TL[1;'<0@#:)1*>OKKJODR0/L;A`@$F'JKFOFIKFWD(<X'P<.
M^M%-;&LM5"_,NYNP+OQY].\K4@6+Y+`=R"#BQA8,0)?TNITHB>JZY=^X[(Y1
MMC'M)Q<?1@M="\B%S77SPX!J`>]*2N.[JY<6`-]YHR5H'&1H+:-FE#07#3JA
M;B7K\4UPE]IHD(<`UB=R$&NBWCP8FEFHN5#Q50F'=4MAM+OMFYN)M26,BT0#
M)%%5457])2I1=1!`2VXZLH<YJZ?7Q]%5Y);T'LC0%`[L_P!*XG\PJT>X"<'>
M2;MZMJGS5JB]$44ZIIF2/00UV#W!>ZGF%JZVXAI3DM%G'V$!04T(B<1>HJ("
MBT5%0A_KBOVZ9:^&*,M4F5QY8)3[8Y"\.`1H'/'_`$I*F[W%<,1HRV0)N6A*
MJI\ZHTJ^A*G72`UTTB@$!44U+A+(VL!^/$IV98TF*XU*E`+2N;'1550_T445
MJJJ!40M2V6W_`"#I/Y."D9]X[*]F=H@U.;^:A3@O90DT".I1W&V1)UU"&H@K
ME$VJ(MUZ%U_XZ:>WPRZCXB4![CQ%>Q%O4B#F'X04S1:;"I'5U)C>UQ!$8Z&V
M\XB`K9$:@X"$@KL<6OHJ5T]<S.9:L@@;^2Y'/"KJ<,`?1RJ7"G4<V5Q4$Z<.
M!KT8O&^@LD".H@[0$4%/GW+M5*4-%^U>NH@#W%H0:OJY4HNB8TN#3HU>[C0.
M6<=285>V[W"W+\W:14]1)1K\/^.O2QH(C?@6E*95Q<91BU*+3VFV&XVU\)+\
MAI9KC3.Y!84EH+1ETJZJ)U^RFI>X;>R".U,,S7ZVJ0/N_P`:C65ZZ6:X:^(A
MC"FH@*>WNI"):&"DI*KJH:BB=`04W52GV5U!T$L;CXEP^NIW4'B`^`"B+K]5
M(C7J)%UKZ+5:?)Z=?_CKQ@"-).)%(,8T@-3*FE,8?0VNS(-6-KZF-%W$CBCT
M%:?\QESK^1#_`*-3XR-``:-1PPX<\*2YS?A)(?1!UZ6H";#KL.8+PO1Y<9XP
MF1C:<!T7FWJH0[7`%4HM%HJ+J5;7$D+W/A\,@.!Y>GA3$]M#,`R8:HB%(YT@
MW09#U]F7>1**Y7&^/NNW">XVT+DV6ZH(ZZZX*(;R$VPVC0JGW38[1HE=6EYN
MT]["R*Z8U\K'N<7)XG%V)Q&>-%M;,AB$,`+8FM``X`-R0>G&BK[YH(N(1&0N
M(A@2;50!0A4Q5*5W"B)]O353"6O!C##B<%X&O7D*[5BVD>4XX3AMN$HJ:$S4
M?E10-%WJHJG4"3^JNI+&M8]B/TXG'AW5XUS4#FA0`M56RQG+,?RM+A98,UPG
MKS.*WS(C380'+5.B1E?M=P9!4W(Q+C*\!J*JBJJ(O5=:S;(X=QAMK21'-C:<
M"NM<40UI67$=S"R.65KH.GXVG/6#@YI/,%$J9['*NK\<7;B_'?1T0-M8SCB@
MXRX.Y=YD(*1J85^*(GHNJ6\Z#)M4$;F1_A.*'C6=FZ+)!$P9*J^Q!1QUF2$Q
MY\9#J@6P194E4`%$W(K8_%Q5]5]=-]0.T,,:-S3OKS6QT4<>GQ<32-*9:<-5
M1OYB(Q2JKNVJJ_>$JK5:T7_CKV%K20IQ6F9'=-6J%]F--E\P`2ZD(H!`ORUW
MBI47>*IU7XI]FI1+6M<04/T]U-,8[JM+^?.FG<[-;"%HW(3#J.55O<P!A4"4
M][0DB@V5?6B(J_'3CI9.G$CW:3S)J5'>SM+HVO((*X%/;QHF?95PVS<4`7J*
M^C@;:HAH24V+TITTN-C0X.B5*@SS/(5P\1^VFK/8ND(ICL.XG(-Y#-F/($%9
M:<(5[8[D;4C:*OQZIJSA=:L#V3P$N08@^_G4AMQ:S,A9)``@0D<?XTV8=XN(
MQC9N\6LP*FZD:B`H(2T5IQ>FY4ITZ:&MC4D?HGB<Z\O+>#4'6DQ,8&"\ZX3V
MWY-7'!>C`0(K?<(:&AI7<6Q5%:5ZTTN1NDM:(R&Y@G%5J)%+&A&K4_BG!.%?
M0KX5-$QXV<;M&XCI#`F(IIZ+_P#U"2J4_(B:[=Y83_"6*9:3[ZX]YGD;)O=Z
M]K4!(]PJU.K^J"AHHK([QO\`_(M[C7_?^-/\L,-TIWZ,7>:!]_O'NK__U?J;
M\!O\5?N:?ZC\/_D[ANG'_IP=Q]]`^_W_`%5J[INBAHHKY%8>6,M9#):=B3._
M"O<IJ?>K1*&3;'YI3C;[(1E9-#9,.H)U057HNN,W\;6JR*)VH'-5K[8\N:+B
M(.DN1T71X,.8P%:!\$95/E7IG`['8X\YC)K:+5N[\AJU1IC6,Q9<JZS6Y;B`
MV_.;9N"`2^I;1%.@=,MN_EVYW=\<,4J2-;F<`4Q%(\QNV>"Q_P`J^X32=):T
M%Q&I`,$4`D8^NKG8M=\?A6TGF&GH*/`\XZDPG&QDA;._%??C/N;6I45MQ4JH
M%145"36$N]COK.Y!N(W"-RY8J1D!W\:YWN`G?(_Y=X<X</PEP!`3AV>JFYD5
M]_;_`+N.68GXUAD;F<DOL8B;9%I`1$MEIE#3NSY)`HNN"A(`(M%15KJ5#;0V
M3A/=$=74@:,1CD>P#VFI-E.;,17I"N#=0!"E>.H<L<!SIT17;;9HT2)#;"%$
M:CA$!N.QV(D*,`EM%&U'95&11!7U]:^NJB[8;ITDI&3D)'%>/<H6O&2.NI1*
MXJ2TG$\<"/LKDS<&31LDELORVYWU%N>8&AMQ=BQI(=>A&,=P"4EJBK1=7=O=
MMMK)C&,1Q>!K(7,$'#M&7*J66RN);PB=<6.1H*9>)01VX'G37R)BRO.0TA1(
MCOU3#+<QB[Q8SHO""B+HM*;.U)!J7SIU^9%KU73%Y.X=.*T,K&@)@5!]'JJ\
MVV6^87.O)6$C'PJ"WEBJT@1L8L]H*7^SSEULKKZ[W[?;Y3OX<#CA$IG]%))Q
MEAM!)%1&T$53TU'N(W%I=-*'.:T9C%3R3VU/CW>:[+&3P-<S40TG`H!]XC$^
MFHL8Y+?8_'+4CS@W:UW)V+,>NK2U0W)'T[+4-(FTS-6RWMJORJGY=7FV;#;S
M,;?&4BU:U7`=G+OJTNX71M@2V:YTK?#C@%"E>P5*-GA2#M<%F[J`W%A#1Q!,
MY)..=POF-VK@$]M1%,B_K$M/353.8))KB2%I;&%TJIP/TS-0)Y71=-K0K"@P
MP`0>Y<J<#JH2T60#01FE("5U&T6@B`M.^ADVH"M!3JIT7TKKVW=%)'<M:`)`
MU0<N*)SQJJN'31202$$M<_Q#/#'$<,*K+Y`Y=<(]B#&K?<8C=TRPVX2PV(V_
M\*L[*5.:^**@']20@E"K7<JTUH-ILTFCEUM!52BH,,.^M=Y4A==7$MV;9_3B
M:2"Y/$5R`X)QJOCW'\S#;U9['<)EGF2I%EB7D9]B;9[DF)--T"B13/[J&ZV#
M1;J45*436X`#;L'J8``]P2M.S=X;_9+DMMS'*PN:=7,'VCE5B[I>>:QPVWV?
M%KAFJ8O<;4C<*%>[E;7[K+B41I^'%DM]J2$9V,5!`R0E!:(NK*;<IX.BP/?T
MGA`O%?IA7++/;]B?>W,]]%&)&N4N`<@([,CCQ2JI<HLV6R8U9;<TX3-Y&\OO
MWJ.Z3<5[&Y$9'I"L)#42C/?5N,CO<+<X2$J5ZZ>E;&_HO8\AGJQK=[$VYOWW
M2I\MH\*8APYKF$JSUOMF0EQNSS)B<&X77`^0K*U=K[%P6*C=\L<Y5[$VVQHZ
MDC@06[DPI*K8KM9-1TN7;R&"\A:H3Q`<:Y_<;K;MW$['N#A\S&]&.><"%P)/
M-,,:JZYE[$U(MME@MA?.\1+O9&K"X12GK^W)%/J<E%]#DMS&8.]"$%1%/I2B
MZJ-,5UJCEMW-`''+U5M[6U!+C#*R0!B$?RIPX?1:M%A>8QLRA39$"3*NL>W7
M"1#)V9'98[DN/0!.0RXWMKN51#;1.E=9>YM3#>2P1DD-&H89KS/(<*P6]Q1[
M=(S60'OX`J@)X<^VENX$:R2B#&DQW2C!*&4\?Z4=7"0F01M40#=$55-U?DI3
M4>>*25@G>T@H/4J9<B*KH7AC2W4U[2XX'GGC5*^6<ZR'ACR&QWDG!VA@2;U8
M;>W<$"*Y(@R66+@S;YC-U$5_Y<N!O,B)=M6:^NM!LEU+%,)(P06GPG,8I@:Z
M=M6V6OF/RQ<[;>%I<%4<>*:>ZK:1/<6XD<PB=<[]$N"7Z'$`G;=9XS[<:XS%
M?V-K"?*BM1W#%")554$:ZZ#'YC:YCQ+$DS1PR/<:X[)^SUP-T9$)/^*Y_P`1
M.0Y$<QV5G;.R_+/*#/,VS"Y-,P9%^:=;M5F;)7/Q*QXS:REVJ'#B.N*\#!M,
MDT;B*A*Z*DG5=44KGWHEN2/&X>H#A7;K"SMO(\&WVD8<86N`])XDCO5.51QC
MLYFT79''(3WT4,)!MPNID`QP<;F=D?TC.,X*M_-UI75'<P.?&<`&N&'"MXZ=
ME[`-,_C))PR[JG#QYXJO?+-TO&++'M#&&]@)699'<(/UF2623)N$MR-CN*RR
M5684J3:VHRND(&C39KU155-7NU;6ZZ(C:T`(I7L'"N9^??-T/E^V@N1<EUR`
MC6Y*>.KG5@,IO_&7`=T3!L+XEQ:7=K7],V-\R*"%WGOORMVZ8_)D519#[2@:
MD*"*;]M/EU"W>_AV6Y-I;V8=,BJ[''B@KA[O,N^[WKNGWTC('*NDI@#5=?*#
M-F<YX-M>0W#'+3;,D3E7'<<LT_$8\:SWAD3CWB0ZTV\R`GVP^E3JJJ(BB$J=
M-/V]^[<[(OEB8UX>`$"9C(UJOV[NKR3>;BW?.^2`Q.)#B2#CG]M0=Q[R?"PA
MR[WJY1[EDO),T'86-Y+?KD,O'\<^H1N"TY:[6H$J7`C4MKRK\BKN3KJ3;_+V
MG5D;$T/;@,![JZ5NNSR7CVQ6J"V*%S1@21BA/+LJ0>+[JU:(M_D7@G9U^R&^
M1;I>;LU&-_\`$)]S$VX\5YY1W/.PF$1:*M01Q?5:ZH;RVN[NX,K7>#1QYJ<*
MR>_VA,D30`(HFX-)R"`DIV\ZF<7`)76C;:,VQ5QT705A`<'>2MJ/1$;VG14Z
MUIJ`R,1R&*1H5WL/&L=(`U@>V0HU0`,5!XUK[[:4H7^.>0F@3:,3,HC"!550
M$_!V21$5?7HOKKIGDZ(Q6MX"]?S![JYOYI#?F;4C,L*^NM)];&LM68GN&74;
M5<>+76]Z2B2\;20]H(PCT)7MP_%43K_1K!^>6Q&VMW%@,H)1>6"UKO*<LK;F
M2,/TPNS/:,A4(\9YL]]VR4P2!QYAX4KM4T;_`$NM:$-.A)KANXP3!TK=`)&)
MY)V5U*WF:YS7//%`@R/.KK6JY-2K8PI/BT](<,60/YE5'$9=!>J*0"BFJ"J+
M\.NJ"ZM9(H6]-Z/><0G#.C6U\[CH5K0%/;B/3VT;>1YEMYAJ0T[+-MTF.Z2A
MM%M-[PO$E"^4$7;]JZ7;VCYW0Q32-`TD`D\LU-)FG:S\UD!0$$CAR"?72:!/
M2.PK)."RB(O;04[<K>'_`#")4WJ(KU3KTU%,#XC-;-C:X+FBX#B#VU,)B<X3
MN>6N':GH2C#HN(RH5:1"C*O5%41<;W$+KB?%2'IT^&D=&8-8QC48YB^D'/ZJ
M4'PN>YP<2YD@]HR'OIONJ&P04:5#MFZAHAMB255QO8N[;7X?9KR,.<$+B',:
MJ?B/*I4VM=0(()&8R';7NX-@K<95:C.IVP^G$44'!H&UQ7%0JJ2(O4E^.I,J
MW`B+PQH:%.D9]_/OJ+;R&-TNASBKN)RY)2,SVFFT9H*(+A&@H*"/;0D3LD0I
M\PBJ[JKU5=*>UK8V-#0J+Z/X4X]SW2EYE5R@=W=7!]2H;S))]0!MU7IN!IM:
M]$14VDBT^U=,L8-!=(P$C(<:'2/#VL"@8J3B/H:(RWU8%]T!<<91$=0$;5PB
M/9U5!_25Q>O33!8[649^6\\?IA3L95@#I/&,/12<[+CJ0`V;C2.1^^.\%%Q4
M,U'=3X%N3T_ITAS7%Q<5_CRITL`:@`5:3#D.F2K426J"KC:*A)2FTZJNVJHO
M5*:41'JB))+12VAI#P6HH4"D:;=&XIF,AL$=;4R"+W0)PT5=K9NH/5%%%KM^
MW3[;=9,$Z9[,CRIII=I)((?C3>NU^:BJS&1%<G2D1QEIKH,<G:M`Y(<&B`V9
M@I5^T=.PP2%KI"\-:TIAF<E]E)P=+BSPH%)]U<Q*4+++;@@<M3;9<=#HV*["
M<5&QK5!113JOKMKH<CF/BB81V\^^O5:T]1SAT].`XTB2WNTXBMHA.#L?W*B[
M4,5[9JGP;$46G3JM?RZ5&#^7("<`!Z:\#O"040CTXT0E7$I*.5!AUQU%WT#L
MD`MDV0N-(%$;VK\JHG0A74R61TKY"6@/<F03N3MPQJ'%"&L:KG:6\\57#'GA
M2'*D@<Q777$'<(J!I5U`7<-2,:U)!$:?\=+#(]3!<$AAXYX@8'UU[&HC<R-N
M(]"TB2T:FM/1'F$H2BJFVXJ@8DV*N("C0F]JFE%^%42O33\&N)T<D,A;+J4D
M<.0%&LQOUK]T(.WMIOA#:A,,--F;06[<RPR#BH#K:BK0@Z@_I=IM545JG7KI
MY[D=/K&I2I7M^VD22.E>QY/YA&*#UUX<N3QH#!*H;5$P>1*J0J"T127U*G_Q
MT@V[D:-0Q(->=0:RX?!BH[>=)TUQIJ0ZJ.DC>XFT;-Q35M!Z%\R+_5)::=?$
MX.(#$4K28Y`YJOQ=2+()31M`H`57>XJ55>I)\OK\M:5T[$T$AKFDX*#Z?LKV
M1Y+B]N?$4VY?U!*ZTX:(C9$0`B[1)2J/1%7Y:HJ:<C:271KB"J&DF2,'6UA4
MX$\J2'!,T7>(HAA4E(45=HT5-B)UH*?_`(ZEQ1O:TH`,$J/+*US@UI5HI+D"
M:J0(B+1JH$A;=P#UJOKU%%]-2Q`3H).;<ZC-<@7(+[:;YFHHX@=LDV[54A1>
MM-R+NZ*BU^SX:&M+2@'@-.O<"0XE*;MQ=6,P52(F]R.MMJ2*(*8_,(;ZE1"_
MX:?5Z:-2L!4#E25'Q`#5Q//E7T+>%3B.^-?&SB$IH=OEE5:5ZSY%46G3IKMG
MEH`;+9)^$^^N1^827;O=DYJ/=5J=7M4M#1161WC?_P"1;W&O^_\`&G^6&&Z4
M[]&+O-`^_P!X]U?_UOJ;\!O\5?N:?ZC\/_D[ANG'_IP=Q]]`^_W_`%5J[INB
MAHHK#A?:@Y!*_0YG_NQCT>TL.2^Y'C+>PDDTZXX<?:`VMJ,3PJ:;B*J_8NLQ
M)Y?=(YGYS=`SS7[*ZMMW[D"QCE6S>92B9:>WBM27%]O7FGZ_`FI?+>*1+/@+
M=SAVU^R-WZ#>G+=<&R%6C<;M[32ON[U;=-3J39+ZKJMN?*UY*T-BNHVHJ'%?
M=5S:_NALT;93<;3/)*\`%=!!3+`GAPJ?S\1\UN>38Q+O^76"5A^'6M;+9,58
M.\I'^E[+*G*F[HS8RI4J6WN=`E)L@$4Z]=5]_P"3-RN[>*%EY`'-XD.R3NS6
MH+/W%V>)EXZ';K@74SM3G>#,'`9X`#VU+J<"W5B+'A0KG9(D2,2=N.PQ)990
M:*A+VVHZ"AJGQ1/36,=^TN]2./6W:V=&23]]2>"^&H__`,@[:-3VV$XE(3[J
M9!>/,5PG\"7^X1I,-^\60XTA14@(9PD5%4MI."PAHFY:=/ZO32XOVFW>&<RL
MW.V+"B@AZ%/_``UX[S_M;XV-^0G:X%5!;[,:9MS\:\[?ESG;?D>*QXK\/M1(
MQA=6UA/NR&GI':<8B;@85M@0&G7;\-3A^U^Y`O6^MG-<[X2'H!V>',<*\B\_
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M)#`@636#N[VB,E:N!#06W@>4:QMU7E,5IZ)MKIIG[6[JQKVF_M2IP*/_`/UJ
M8_\`<;:GO8\V-R@&2M3WU#%[\#LROS,B7+S+&$R*1,NDD[LB7D_N";;8L<`1
M.%5N)#90NX(IU*BI76HM_(KX+6*`2Q!XS(U8GU5:V7[O6UB]S8K"<VA":/`,
M_B.!SIO%[>N=%'@R',]Q>5>8%VB2FGY07HH_X4RR@.VI5&%W594U(A2E$5?Z
M=(_Z3N'5,@OHPWEXOLJT'[S;,UMPQNS7'3D80A,>#CQSJR,GQCR)^,XPF168
M5*%"CQ55+AV[6ZR@!)<@-)&01[@)056BI1/33.X>1=TO+BTE;NC&Q1E2WQ8]
MV%8D?N!9`N2QET%</#BO/&JO9K[<V99OEU^OERS'"/PV[.`X,=85W.:1,L,,
MM'(+Z%&D<56=Q$*JM5U9_P#5MQ0M-W"6\/B^RMAL7[P;)L]FR#_%WAFXH8]*
M+D%<M6L\7_'/+>"^.;E@F0Y#C]^$LKO=XLIVL+@D2#9;K].86IQN;%85%CNM
MFM!%0^;[=:7;]MDMH#%.]KG'EE[17+_.?F:U\P[L=RVVVDA!:,'D*N/X2>%=
M^1O#CBODAA\[ACEELU\W.28.1X^P5JNT*Y*2NM3^]$:;%]T'OF7N(2$G1=%U
ML]O<QECF-!/$8&F-E\Y;SM4S7NNWO@'W25!'(KP3"J=\>>`_D1QWE<M^/R=Q
M?D&(2I#Y'%N<+(XET?9D2ED*])B0[0=M.<T!*`FAT7XZS=SY2N)7M+)HL,%*
MJGH%;S<?W$\M[G9=.?:;H7B!'#IH"`B+J5/15@IWB'ELB0XZQD6,-(J(3)$M
MX4V"5S>;.WZ,A=85#-$W+41HB=$U''DJ?3(#<1:ON_%AWA,JQS_-<!TAL,FG
MC\*]B(<ZKOR1[=7+?($VY`N?<>VFU/VYN#`..WD17)FJ34DI(0K5V%;<2::#
MM)5'3EKY/NH(I(S<Q^+EJS]5;K9?W4VK:((&C;;ATS25*L0\OO9^BDZ%[4<-
MH+?&FW_&)L"V6D($:*XEVVF^>\Y+SJI`$B$WCW#U54]*:3<>3]PD;'%'?L;$
M!C\2D]I3*E3_`+PB6::5MG,"XX?#@!Z<^VDJ)[76?XURYA_(&$9Y@=FLMFA_
M1W>SO,Y`;QM.M2&I26IL+:441D=P2HX0HA;E^.EVGE7=+;2#>Q.`<OWLCF,J
MER_O#MU[MC[/<-MN7W*G2\%GH579CF*;EZ]JKE6X2;H</D7CJ&S,O-S>8(`R
M5I]+-='#>=:>[=G40GM.N$H[54%^*Z?D\K7,BN,\>H`I\2=G"K"P_>O9[*.&
M,;1<HP?_`-:GFOBJ<_%WP'Y1X"Q[+,=O>>85E#-WREB]6>>U^T"SHL%R$,:X
MQIARK:TA/$Z'<:05,$4UJJ=-7>S;9<[>TBXD8X]BY(B8@5SK]Q?.>V><IK>;
M;[*:`M;X@_2A*G+2313D[V\\\Y"RR^9(698.R,^/#:@-/,WL'8Y6]A68W>5F
MW&-*_.:BJJ1>NJ3=/*D^X71N1-&"F"K]E9&RW2.TMXK<"32"5RQ4KSJ$^2/:
MDY0RG$,7L5AY"X\;GVEV[W>Z.7DLI;@R,DFI"@6^XP$@VA]QK\-M#;Z"1`A=
MYRM**JZ=MO*\EO9L@#X^KFXXH7+@1@N5;KRIY]VK8+N2YN+&=RJ!HT+I.*%7
M#C3$3V>^8PBPH!\H\63XD-A76W)5NR%B<W/$M\<`E,60S*'&(`+<OSFM:HE=
M.#RY.=0=+&A[_LK6/_>':S(9H]NN@\YXL0C_`.JIDL/MB<F6NT6^W2,ZXY)V
M,VCDE^*QD3:2+@)*(RU$K4FYQ657YUH2%Z:IY_)NXR/>8]P8&$DHK_1PX5C[
MSS_;W-P^;Y:8AQ*KI5#PSR2CDKVTN5GG'U;Y#P)&W-^T'4R,B'>*)U<2U*2_
M-5?CI0\EW>;KR,GMU'WC.JH^;K72@M9/Z43D,:O%X@>.^4>.N*Y=8<IO]BO\
MG(,A8N\5^Q#<!98CLP`B=F1^(1HSG>4QK\J*E/CK5[+M<FUPRQ22!Q<Y<%Y)
MQK-[SN46YRPR11N:&M3%.:\*M[JZJFJE7EIXR97Y!3,+E8UD=@L28PU<VY(7
MM+DOU2SG(Q"C7T$22FT195"W4]=9KS!LD^[_`"_1E8TL5=2\>X&KW9MUAVUL
M[98G.UHB)@G?4#XMX)<FV(Q*7G6&2!0:;6!OH[2K5"#=;@IU]?MUCKG]O;NX
M<2;R$`C+Q?96DB\Y6\(&BVD4'L^VK-6/@?-[9$:9E9)8)#K0-M`X(W$A!EL&
MT$01R,E%W(2JOQKJHN?VOW:8!K-SMT`(Q#U0^BI</G>P9(9'V,N)4@:<_73S
MG<0WF;"%E;O;F)8MJ*3&0DBX+E/D)51I%<%"3JB]%340?M-NNEH=NL"C_?\`
M_K2V>>=O9(Y_R,I:3@#I0>VDISA_-6H\5B'D-D=(7466_+&>!$TM-R,-L1R`
M53K05H.EO_:O>I"0=UMPU$P#U_\`MIP^>-G+BX[=,JK]W/UT<C\/Y(U$,7+W
M:79KV[NDK<M(]$4D;;!%94T%`I5:(M=/P?M9N$1>UVXP.C+4`1^'=A3,_GC;
MY'AT=C*T`KAI4]^-<V^%;H!`Y^(VI#)%[Z?]8856E>UO8JB5^W4=_P"TVZ$-
M:W=+<-'8_P#_`%I9\^VJ$?*2H@_#]M&6^';N(&V5QM))U1HU"23HH2U6IJQ5
M/3T3IJ3#^UVYQPRPG<+9","CE']-1)O.EI)(R1MK,$*HH3WT1+A"Z*;CB7*U
MJJBJ`BK,$55?ZSB"QU7\FO6_M9?=*5DE]`7G(H_#OPIS_O-OJC(M90AQ^'+U
MTF%P+?5>)P;S9Q$U4B%`F=5ZTK]QUIJ(?VFW3Q)N=NO#!_V5,;^X%D@#[*4_
M_3]M<Y/`>0F8G'OUK!4(5)36>BK0-O1`8IH_^)=S\9.YP%R8?'A_37O_`,@V
M!&D[?)IQ_#EZZ(.>/.2HK:L7RQ*6U&7CD?B!DC%7%JTGTRHCH[Z)7I15TI_[
M3[FZ)C!N5N'CBC\>_P`.=)_[_8%\A?93:2B?#@G#.N3OCID9"H!?[(`J:%^A
M.150?T4*D?KJ./VCW=H#1N=LB\G_`/ZTZ/W"L`_4;&9$/%OVU$P>&_()91.R
M5S/,?;*:I[[>C5TEQ"0_1%&3$%0[:`.W;Z=?MU>7/[93OMK:V@NH48,7.UAR
M\<AEWU8-_<_;!9?*.VJ7-5\'VTEQ_#+E:/E(WT^0,2F17^VQ/CR6;PA.Q%7<
MYV&1@$PR\R2KVJ*@T):Z>F_;:63;6VS)X6732K7#4F.:X*5IIW[D;2^!L#ML
MGR*D:,UP^]3]7Q4S)PVW7<GQON`9UV)=MI`>VJ$BQ4W$>Q*U]*K35.?VJW7%
MHW.W#.Y__P"M0#Y^V[4OR$R(GW?MHH]XF9J;@FF5XTHBTZTK9,W(4(35%3<H
MQ%5?2J_ET['^UFY-SW&!%Y/]'W:2[S]8%H`LIEY^'[:*2?$#,'"0F,HQED@5
M=GR75=R4%$1PDAUHE*T3I77C_P!K-S=*'?Y&W$8X>-?_`+:1_P!]L]#@+2;6
M>UJ>^DO_`.C+,U,U+*<4V*1$%`NZ%5514$Z0J$'KTTL_M?NA;I.XVYY*'_92
MO^_60RLY0</P\/31=[POSLC4VLNQ,"J@H:!>!+M4!2;5!@[:*8_FTMO[8[FU
MK@-PMU/^_P#_`%I'_>K`E76<R?\`ASX<:*.>$N<N&A)EV)`*=%;$+QMV]/1?
MH?CU]?33_P#\:WY9I=>P9XX/R]5-?]WLD/\`Q)5X?#]M$W/!O.S$D3,<2JKJ
MF**%XVB.U1$:?0?!5KKQG[:[@UK0;Z`N!S\?V5Z?.]D7:A:2II3[N?KI+>\$
M.1'E15S3"1JR#9B,>\HA.`JEWR7Z!55PU*I+\5T[_P#'.XD.6^@U?^/[*!YW
ML!I'R<J#_;]M<"\"^1B117.,-H@_)1N]I0D452M+?T0EK77K/VZW!H_]?"H&
M":OLH?YXLB5;9RH3_+]M$)/M^<B2CW.9UAHKO1546[W511.@JBV^B_,G_'2C
M^W=_JU"]AR_F^RAOGBR:$^3E_I^VBKGM[<CDB4SS"Q6B_P#Z5[H.Y>J"OX=5
M15/MT\WR#N`:&_.PX?[OLJ/_`-RM%/\`Q9,?]OVT3<]NWD@A40SO"!4Q4356
MKZGJBHJBB6W[%TZ/(NX!R_.0EJ?S>S"D_P#<+,CQ6LO]/VTFG[;W))4$<_PC
MMT'])N_;T5$HJI2V4T?]#O%)%W"A_P!WV4'SC:$?^DDU?^'[:;%V]L7E>>FU
MGD;`&DV;:F&1JNZJ]:):E1*I\=.CR-=@N_Y46)P^+[*\9YQM@U'6LFK_`,/V
MUJ'X[\8W?ASB'$>.[Y<;==KGCT:0Q)GVI)*09"NRGGQ)E);3$BB"XB+N%.NM
MWM=FZPL8+1[@7,&8R]M8W<KIM[>37+&D-<<CG4V:L*@T-%%9'>-__D6]QK_O
M_&G^6&&Z4[]&+O-`^_WCW5__U_J;\!O\5?N:?ZC\/_D[ANG'_IP=Q]]`^_W_
M`%5J[INBAHHH:**&BBAHHH:**&BBAHHH:**&BBAHHH:**&BBAHHH:**&BBAH
MHH:**&BBAHHH:**&BBAHHH:**&BBAHHH:**&BBAHHH:**&BBAHHH:**&BBAH
MHH:**&BBAHHH:**&BBAHHH:**&BBAHHH:**&BBAHHH:**&BBAHHH:**&BBAH
MHH:**&BBAHHH:**&BBAHHH:**&BBAHHH:**&BBAHHK([QO\`_(M[C7_?^-/\
ML,-TIWZ,7>:!]_O'NK__T/J;\!E1/*OW-/\`4?A_\G<-TX_].#N/OH&;^_ZJ
MU<JGVI^=--T4*I]J?G3110JGVI^=-%%"J?:GYTT44*I]J?G3110JGVI^=-%%
M"J?:GYTT44*I]J?G3110JGVI^=-%%"J?:GYTT44*I]J?G3110JGVI^=-%%"J
M?:GYTT44*I]J?G3110JGVI^=-%%"J?:GYTT44*I]J?G3110JGVI^=-%%"J?:
MGYTT44*I]J?G3110JGVI^=-%%"J?:GYTT44*I]J?G3110JGVI^=-%%"J?:GY
MTT44*I]J?G3110JGVI^=-%%"J?:GYTT44*I]J?G3110JGVI^=-%%"J?:GYTT
M44*I]J?G3110JGVI^=-%%"J?:GYTT44*I]J?G3110JGVI^=-%%"J?:GYTT44
M*I]J?G3110JGVI^=-%%"J?:GYTT44*I]J?G3110JGVI^=-%%"J?:GYTT44*I
M]J?G3110JGVI^=-%%"J?:GYTT44*I]J?G3110JGVI^=-%%"J?:GYTT44*I]J
M?G3110JGVI^=-%%"J?:GYTT44*I]J?G3110JGVI^=-%%"J?:GYTT44*I]J?G
M3110JGVI^=-%%"J?:GYTT44*I]J?G3110JGVI^=-%%"J?:GYTT44*I]J?G31
M10JGVI^=-%%"J?:GYTT44*I]J?G31161_C>J?[BWN-=?_P"?XT_RPPW2G_HQ
M=YH'W^\>ZO_1W7YVQ/VWIGDISM+O/*/,EJY=>RJV%S#;.+;)Y@/6^)DW[.6I
M+8%U>XIQ&=B;D]<<^E5%9>-=E*K6NG8S/H;I`T\%3ZZ\(;J=B:C[]B_;I_B_
MY;_J#W#/W'TM;GDW^FO$;^(^VA^Q?MT_Q?\`+?\`4'N&?N/H6YY-_IH1OXC[
M:'[%^W3_`!?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?
MZ:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\`+?\`4'N&
M?N/H6YY-_IH1OXC[:'[%^W3_`!?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?
M\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q
M?MT_Q?\`+?\`4'N&?N/H6YY-_IH1OXC[:'[%^W3_`!?\M_U![AG[CZ%N>3?Z
M:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ
M%N>3?Z:$;^(^VA^Q?MT_Q?\`+?\`4'N&?N/H6YY-_IH1OXC[:'[%^W3_`!?\
MM_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?
MMT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\`+?\`4'N&?N/H6YY-_IH1
MOXC[:'[%^W3_`!?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%
MN>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\`+?\`
M4'N&?N/H6YY-_IH1OXC[:'[%^W3_`!?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?M
MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^
MVA^Q?MT_Q?\`+?\`4'N&?N/H6YY-_IH1OXC[:'[%^W3_`!?\M_U![AG[CZ%N
M>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![A
MG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\`+?\`4'N&?N/H6YY-_IH1OXC[:'[%^W3_
M`!?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^V
MA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\`+?\`4'N&?N/H6YY-
M_IH1OXC[:'[%^W3_`!?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG
M[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\`
M+?\`4'N&?N/H6YY-_IH1OXC[:'[%^W3_`!?\M_U![AG[CZ%N>3?Z:$;^(^VA
M^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$
M;^(^VA^Q?MT_Q?\`+?\`4'N&?N/H6YY-_IH1OXC[:'[%^W3_`!?\M_U![AG[
MCZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_
MU![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\`+?\`4'N&?N/H6YY-_IH1OXC[:'[%
M^W3_`!?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;
M^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\`+?\`4'N&?N/H
M6YY-_IH1OXC[:'[%^W3_`!?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U
M![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_
MQ?\`+?\`4'N&?N/H6YY-_IH1OXC[:'[%^W3_`!?\M_U![AG[CZ%N>3?Z:$;^
M(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3
M?Z:$;^(^VA^Q?MT_Q?\`+?\`4'N&?N/H6YY-_IH1OXC[:'[%^W3_`!?\M_U!
M[AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q
M?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\`+?\`4'N&?N/H6YY-_IH1OXC[
M:'[%^W3_`!?\M_U![AG[CZ%N>3?Z:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?
MZ:$;^(^VA^Q?MT_Q?\M_U![AG[CZ%N>3?Z:$;^(^VIAXAQ;VZF>%?+2'@')G
M*TN!,N7%2\]74[+Y7M\K6J<UD6%.X$+;-WQ5CE5]F2K<!M/PIAYM(;A*\HQT
3>(4.,^MB@+BF2=O92@`A0FO_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g309840g56y77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g56y77.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0W\4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````^0```@8````&`&<`-0`V
M`'D`-P`W`````0`````````````````````````!``````````````(&````
M^0`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"U\````!````<````#8`
M``%0``!&X```"T,`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``V`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#T2C!P!@5V'&HW"EKMSV-C1O+O;]%8PZA0[?%?2`&@0=SG:ES6>[]6
M9^]_UMZZ/$!.#2`2TFIHD<CVCQ5<=,M]/8<_*)@-W[JP[0.U]M+6[G;TE.2,
MW!MV-QJNF6/+V5V`EPA]H'V=K8QW?SSFW_2V(0ZEA;F.(Z1Z#W%OJ!SCP'/V
M-_0;/5VUO_1[_P#!K<;TZY@=MSLDEP<!N-;@-VW:[^:_P>WV?UTOV9;,_;\K
MB(W5^)=_H?-)+D#)K=7O&/TOV;1:9=M#W-]1K/4&/MVV5&NZM_\`UKTE>Z4_
MHO4*R*Z\.Z^L-=<VAH<T!^[T7!SV,=M>UBMGI]I<X_;<F'$D-FN!+B_:W]#]
M%N[9_41,7%?C[MV1;?N``]4M,1^[L97]+\Y)"W[-Z=_W%I_[;;_Y%8V7E8-.
M4['95TL[7EI%MC:[&@"?=1Z+]SO8_P#/71+-LII=?8W]I.99:XM%0^SRUP&X
MLKW4.L<[8_=^E]5)(%]+<UF5CEC[#C=*V,!.X7`MT-=?NM^S;:_TMGI_]M?Z
M11LS,9E=9-?2`YQ<XS:(+`?:ZK]#N?[/Y*T150&Z]5?IM=N)QY#8<]C?YCZ#
M]C[/^M*9P]LUNZG;+2&P?L\ASITAV/\`X7=]!"T\)[%SQD8CW[*:NF6/#"YS
M&N:7`_HZV>QC'_H_M%NSU_W'UJ+,[!)]]'2H:X>H67-=%9?M>_\`H_TV5_X/
M_"/6K9TR]Q+J\^^MT0R&TEK=&M^B:-SF[F;]N_\`]%[+->-6VIC+`VUS8)>6
MM$N'N]7:T;6NW^]%:T*[_JQ;8VJMV&^QSMC6#TY+H:_8T?O;7M<K-O3NGBIY
M&+3(:?\`!M\/ZJM"NL1#&B.(`37?S-G]4_D24__0].POZ'1_Q;/^I"K9O4K6
M6G&PZVW7M`<Z7M@"8<T5M=ZUES/I^E^C]G^&6#]8,_*&/CX-3W54#&KMO<PD
M.L+YJJHWMVN97^BMLN_TOZ.O^;]1<F3TMH:'4!LZC]$9&F[<75@N8G1QF0NP
M!XKQP1^:R2-A^C>W_HKZ#]IS[RTO9G4AQ`(KKQVM`(W;W>J_)M_S'+'ZGU#-
MZ?U5KJ7.>_;$6ZO/YGN%?Z/W_P`XWV*[]4>I9-WKX&5:^]U0%M-EAW.V$FM]
M3K/I6>G:WZ;_`/2_R%7^M+ZQF"VFG]-1'J6NXU`+7[?S]C?9_P"JU'D%:'<&
ME\;LCIP\5@?HNKT'J6;G56OS&UUBLAH:)#_ZUC2?:M=>>5Y3W8MY<_=:R"TD
M`Z.(:KF!U3JF7>*[,MX:-C=P)!!<X,!AOTDT3(!L;*.,$BC\W@]NJSNF]/?:
MZY^/6ZQQ)<]S029&P_2_DA874?K!U?&S[\>K'<ZNMP#'"BQX(VM=]-OM=])$
MZ'US-R/MSLBI[J\9KK'.<TLV6#W'$VO]WT??M_P/^$_G*T[B!EPUK:_[MEAC
M.7BB(\(EI+U<,G6R<;$JQP[[+]I](176T!SSN]C@PVN;]+U';]]BY?J&!UV[
MJ=MPZ=%1NJ#A6]KMX,;[*W7!K=OM_3;ZO_1BR>I=3LRKB_-M<^#[09+`-?H,
M;_5_=6M]4NM6#*9B![K<6Z6,:Z?T;V^[V;_=L=^XI9\O8^;4:T%N#FI8B2(B
M7$#'UF6Q_NRBZ_7ZKL7I=EIRK+G!S(%NP#G;&VAE'[VY4.D]?ZM;;1CEM?I&
M&>K9(&GM^E/TUM=?-)Z98RUGJ"PAK=.'<M?/YOT5QE>597>RE_Z.IAV&K0P#
M^\[\[^NH);FMZ1'6(XMKK9]$!!F#,:%1N_F;/ZI_(N#;U3J--K\?%N]-C[(`
M`C6=F[]]=;TLVNZ6ZRVUUI?O(W:P!+-NX^[\W<G"5D"NEK)0H$W=&G__T>NZ
MSTG)R,?%S,=KK6G'93D5,U>`W])3?2S_``GIO?9ZM7Y];_T?\VN8=8QEOHNM
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MIO25KI_0,7#L]5^VRSL`T-:/[/NW*W3TOIU%XR*<:ME[00+6M`=!#6D;_I?1
M8Q*,>I%,$YG82OQ;2@^FM]3ZB/98'!P&GTOI_E4T/(M--%EH`/IM+H<X-&@G
M5[O:Q/8WB>I]!S<!Y<!OH)]MH,"3^]^XK_U6Z9:<K[;:#LK!#'=MQ]NT?O;?
M<M.[J&1DTOJ?@S38""X9%0.CMG[WM=]/_KC$L090QFNMRWX1!VMIL./8`/HM
MVV55L_.]GTU(<Q,:KZI$1WKS;W4[74X%UC7^FX-@.'()T]O\I<%^T+_<Z&$N
MU+BW4_UM5V6;TKJ.96QCLYHV/#P?1F8^DUWZ8?28JM7U4I#YL>W;.[VL]VIG
MZ;W/VJO($GY;98F,8Z3%V;H2:?3\+$MK;EOQ;LBRTA[A6ZL;3/I^F_UWTN;_
M`%F/_2+H:2W[`0VAV*UK7!M+]L@"1_@G6-]WTOIIK>D]-N8QEN-78VK^;#VA
MP!AS=PW?G?I'^Y%=573B&FIH9777L8QN@#6C:UK?ZJ=&-,<YF1/:]G__TO2L
M.UXQ*`*7D>FS66?NC_A$;UK/]!9][/\`THOEI))3]2^M9_H+/O9_Z42]:S_0
M6?>S_P!*+Y:224_4OK6?Z"S[V?\`I1+UK/\`06?>S_THOEI))3]2^M9_H+/O
M9_Z40[[F>A9]HH/H;3ZOJ&O9LCW^IOLV[-OTMR^7DDE/THZ[H45[J,>(?Z4G
M'XW'UO3_`$G^F_G=O^$3&[H'ILW48WI[3Z<G'C9N=NV?I/H>MO\`^N+YL224
M_4;+CL;LH?L@;=IKB.VV+%+UK/\`06?>S_THOEI))3]2^M9_H+/O9_Z44+KK
M/2?-+Q[3K+/#_C%\NI)*?__9`#A"24T$(0``````50````$!````#P!!`&0`
M;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<````!,`00!D`&\`8@!E`"``4`!H
M`&\`=`!O`',`:`!O`'``(``V`"X`,`````$`.$))300&```````'``@``0`!
M`0#_[@`.061O8F4`9$`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#`P,#`0$!
M`0$!`0$!`0$"`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P/_P``1"`#Y`@8#`1$``A$!`Q$!_]T`!`!!_\0`
MW``!``$%`0$!`0````````````@%!@<)"@0#`@$!`0`!!0$!`0``````````
M```%`0,$!@<""`D0```&`0,!!`4(!P4%!`@'`0$"`P0%!@<`$0@2(1,4"3$B
M%5@905'4%I;6>)AA,B.W.#FY<9%"4A?P@6(S)$-350KATC24)=57UZ&Q@K+"
M<X,8$0`"`0,"!`,$!@@$`@@#!0D!`@,`$002!2$Q$P9!42)A<10'@9&A,B,5
M\+'!0E)B,PC1<B060Y/A@I)3TS15&++4)?&B<S57PM)CH[-$9+07_]H`#`,!
M``(1`Q$`/P#?3P+\K7AKE[A)Q&RC=\"8VL=SR!QJP=<+;89>&4=2T]9;'C*L
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M_]#L&\K?^6_P2_"+QS_<_3M*J>0J>6E4II2FE*BSR`YI\:>+\M"5_-.1'-?L
M5@AY&QQ];K=$R/DVR)UJ*73:OK/+U_%M0NDS7JRD[4[DLC((-F2JQ#ID5,=,
MY2XXR\?K3P&4!HD#2$\$C5KZ3)(;1QZM+%0[*65'8`JC$9D>WYLN/%DQX[-%
M),(DM;4\A&K1&OWI"!;5H#:-2!K&1`TA*C;JO?JO7[M2;!$6NH6N(83]:LL`
M_;2D+.PLHV3=QTI%R+115L\9/&RI3D.0P@(#K/R<:?$GDQLF,I.AL0?K'$<"
M"+$$$@@@@D$&HS&R8,N"/(QY-4+<CQ'(V((-BK*0596`96!5@""*M?%V8,<9
MIAI^P8QLR%JAZO>[MC*>>(,):.+'WG'-@>5:YP)TIAA'.%E82>CUFYEDB';+
M='6BHHF)3CBXTB9>W;5NV.=6WYN.)X'Y"2)F9`X!LP!9&%F`/"]K6K(E4P9F
M?M\O#,Q91'*O/0Y1)-)(X$Z)$;@2/5;F"!DK7NJ5A=GR%P_)RXP<-;_K!(I9
M=D,#O`K4!:+(SBLKQ-5)=):ISDK`PDC%P)HJ`.!G3UZLA'-W0^$4<%>?L->8
M6&0-M:+C'F0Y$L+6(5X\2:7'G8,;*-,T,J*K$-*4)B#K8GW+&\'Q@E6S8[0+
M(.;*<F.*6&ZCU$/'-%)<`A4<,Y4<:S1KU7BHM9-YK<7\-YDI6`,E99BJOEG(
M(5T:W6%H2V2#</KA-.ZY40L=GAX"0J-)-:YY@LSC`FG\>+]PF)$.\-V:\84B
M;CGS;9A.),V,@%0;>LQ23B(,;*TQAB>40*3*4TL$LZ:O>8CX&#'N.6-&&RLP
M8\?0LD<32E1=EA661(S,P$0;4I>Z/IE+KW7BFE*:4II2K'O.2:)C5"LN+W9X
MRM)W.[5;'%3+(**`M8;S=9).)K-:BFR":SAW(R;Q3L`I1*BBFHLJ8B*2BA:Q
M`S9>-@1>K+F69D7Q(QX)<F8^0"00R.22!Z=(N[*IJP*X^1E,+8\73UMX+U9H
MX([_`.>:6.,?S.*OC5*I6)6V=<4.\LW/!K>WMU,JX]Q_7<I7&I>S9LJ\+0K9
M(3L57[`I)GC"PCM*0?UIZGW#=RJZ2[GJ42(4Z8GPFW'"3;^X-T:<#`VJ01Y3
MV-H7;'^*"D6NUX/Q+H&%N%]7"LAL6=<O9\%H_P#5[A$TN.MQ>1$F^'9AQL`)
MO1ZB#?C;3QJKXGRMC_.6-Z;EW%5B1MN.L@P;6R4^RMV,I&HS,*]ZO#/2,)MC
M&2S0%.@?V;ANBJ40[2AJ3GQYL9D2>,J[1QR`?R2HLB'_`*R.K6YB]B`;BL..
M6.7J]-PVB62-K>#Q.T<B^W2Z,MQP-K@D6-7=.SL-5X28LMCE&$'7Z_%OYN<F
MI1TBRC(B(BVJKZ2DY!XX,1!JR8LT#JJJ'$"D(41$=@U@9F9C;?B9.=F2A,6%
M"[M8FRJ+DV`))\@`23P`)-JR\7%R,W)Q\/$B,F5*ZHBCFS,0%`]I)`KQ4^V5
MZ_5*KWJHR:<U4[I782V5B811<MT9:O6.,;3$+)I(/4&SQ!-_&O$E2D5335*!
M]C%*8!`)/-PLG;LW+V_-B,>9!*\<BFQ*NC%64D$@V8$<"1Y&L+&R(,O'@R\:
M0/C2HKHPY,K`%2/80015Q:Q:O4TI32E-*4TI32E-*4TI32E-*4TI5.F)B(KT
M3)S\_*1T'!0D>\EIF:F'S:,B8B*CFZCN0DY.1>JH,V$>Q:(G5665.1-),HF,
M(``CJW--#CQ//D2JD*BY9B%4#S)-@![ZNPPS9,T6/CQ-).[!55069F)L%4"Y
M))X``7)Y5@_'7+3BMF"RI4O$O)CC]E&XKM'<@A4\=9FQS=K*LP8$!1\]2@JU
M9).44:,DS`950$A(F4=S"`:R$AEE69XXF9(UU,0"0JEE74Q'(:F5;FPU,HYD
M5CO)'&T2R2*K.VE02`6-BUEOS.E6:PXV4GD#4@=6Z]TTI5-B9F'GV?M&"EHV
M:C_&24?X^)?-9%GX^&DG<-,,?%,U5D/&1,NP7:.4NKK0<HJ)'`IR&*`<4AD'
M].2-)$/@T<B"2-U/)DD1E=&%PR,&4D$&A!#.AX.K%2/$,I*LI'@58$$'B""#
MQ%5+2E-*53929AX-%LYFI:-AV[R2BX9HXE'S6/1=3$X_;Q4+$ME7:J)%Y*8E
M':39J@415<.%2)IE,<P`)?5)'"O&9]6E1S;1&\KV',Z(HWD:WW8T=S95)"Q"
MNY^XMKGP&I@@N?"[,JCS9@!Q(%5+2E6[.6^IUAW7(^RVBNUY_<9LM9J+*<FH
MV)=VFR'CW\L2OUQL_<MUIR;-%Q;ER#1J55<6[953HZ$SB'E65YTQ48'*9'<(
M.+%(P#(X7F5C!!=@+*""Q`-5(*Q/.P(@5E4M^Z&<Z4!/(%V]*@\6/`7-4EOD
MW&SJ;@*TUR#1W-CM86PU6K[>V0*TW92T.0")O(P$4F_,_F`IDJ/AI;PZ:GLY
MQ^S<=V?LUZB(G+"$ZRN-%D'3QM!-IZ,YMRAEU+TI/N2:ET,;BD@,05I1I4S-
M$+\+RH&+QB_.10K%D^\H5B0+&O?=;S2L;5B6NV1;A5J#3(%%-Q.VZZV")JU8
MA6ZSA%HBO+3\Z[814<BJ[<)I%,LJ0IE#E*`[F`!M2S0P!#-*J!F"C40+LQLJ
MB_,L>``XD\!5R*&:=F2")G<*S$*"2%12S,0/W54%F/(*"38`UC@W)SC82AU_
M*A^0F#R8PMD^%3JV1S98H1:'9;299ZV+6J_;QGPKTS/F<1KE,&;9PHX$[=0O
M1N0P!D]*7XK!P>FWQN5_1CL=<MS;\)/O2<2!Z`>)MSJRK*\6;.K`PXPO,P^[
M$/3QD/)!ZTXM;[R_Q"][I9/QJXR"ZQ*AD.C+9585]*V/L9I6V`4R"SJRZZ;5
M&RNJ820-8V]?6=*E3*\.V!L90P%`^X@&K43+D#*:!@ZP.J2Z>/3=E#JCVOH9
MD8.JM8E2&`L0:]RH\`QVF0H)@3'J%M8!924O]X`HX)6]BC#FIM0<I9YP;@U"
M&=9KS-BC#[:Q+NFU?<92R)4,?H3KE@1!1\WAE;9,1"<HNS3<IF5(@)S)@H43
M``&#?RLD;9"8BR*<IA<("-9%PMPO,BY`N!:Y`YFO8AF,+Y(B8XZL%+6.D,P8
MJI;D"P5B`3<A6(Y&K*O/,+B1B^P+5+)?*7CGCRU-VC"0<5F\YNQG4K`@PE6B
M3^+>K0L_9X^22:23%<BS=0R8$62.4Y!$H@.JAT,F1"''5B<HZWXHXM=''-6%
MQ=38BXN*\!&,.+DA3\//&'C;]V1"2H=&Y,A*L`RDBX(O<&LD7/+^)L<TE')>
M0LH8[H>.'!(I1OD"YW:M5>DKISH)C"'1M4W)L8)4DR"Q/""5<0<=8=WU;AJN
M41A9"XF:1#E-*T81_0YD4,S1A6L2ZJCLRVU`(Q(LIM3'!RX6R<0=7'$8<NGJ
M4(Q55<L+C06=`&O8EE`-V%ZU(7ND1'U2]JW*JQGU_DVT+1/:%AB&7UUF'D6\
MG&D34O$O$_K))NH2.</$T&??*G:H**E**9#&#VRLF7^7NI&?ID;IGA):+C*=
M'WK17'4-K)?U6KPK*^-\:C`X?H_$'%/Q"!'ZON_B$@)Q]1("W->A&WU-S:G]
M%;VBNKW:*A(ZS2E.1FHU6U1M;EWC^.B;`_KQ')I9G"2<A%ND&[M1$J"ZS94A
M#F,F<`MQLLPR3"P80NJ26XZ'==:H]ONLR>M5:Q*^H`CC7MP8^@)`5,JLR7X:
MU0A7*W^\%9@&(N%)`-B12(M]3L$K9H&`M%=FYRE2+.(N4-$34;)2M2EI"+:3
M;",LT<R<K/(&1?0L@@\10=$245:KIJE**9RF%&RS0_$0L'Q^H\>H<5UQD"1-
M0X:XR0'6]U)`8"]'!CD$,@*RZ%?2>!T/?0]CQTMI;2W)M)L38U<6O54JW8JW
MU.=FK-6X2T5V9L5*=1K&Y0$5-QLC-5)[,QJ,U$-+-%-'*SZ!=2L.Y3=MDW2:
M1UVRA52`8A@,-(R)8?B(CJQ^H\>H<5ZD>GJ)J'#6FM=:WU+J6X%Q>KJ8W2.0
M%9&C$@!X$HS.BN`>:,\<BAN19'4&ZL!<6JU2FE*:4II2FE*:4II2FE*:4II2
MH&\K/XF?+*_%UDW^GOSFT\ZKX#]/*O_1[!O*W_EO\$OPB\<_W/T[2JGD*GEI
M5*:4II2M*O*JE\DL-<IN0>=L28RS%DAGR0XS8PQ;2[Q@:LXBON0<)7[$%FN<
MLYB)>E9MD&%,<X]R-&W$AEG>STZ#E%7_`*)4_=J$@.EN.+M7>VV88OGYVY1Y
MT!8`X\@3`@PVQ<DD.Z#7CA@R1L>GDS%;.EFV`OM^7D]F[EDNH@V[$R,.:,:A
M,/B,E\E,N`@HK&+45:-W7UQPW+1NP75IG7B_YE.2\@<1KM>L'6B1R]ANA<++
M&A>\4PF,4ZBC-P65$[#G>K3IG,I`,,3RM4B1(#>-I,3'L)I,RQ9%=9%)LD7:
M-LZ>#W]%F!A^7+O.)%/*Q8I)@G;((,J1']<LL9SI,D#'?1!'`TN1'$N0Q,FO
M;I)D9G8LNVQG_P"I2;9N3QJ`BO%EG,EFQ4;[J*SX4<*'(75,V4(H#)\/J9/Q
MG_@%RYLT3!I6G&>;+#A=+E'YB5RD,48GK&%\@VM2RY6S"_LV$LKO:=E^0-2'
M-9GZ>5VS3E0/[7@DWPG;I&%RJD?2MAVW+AV/M7#S8V^-@[*QL.)2VA<?-3/R
MY,J*690TF.)X9<1A/CK*W^FL5(`K8<W)ADW7?)\:5%QINZ!DRL?69L0[9C0P
MR1Q&R2G'GBR%:&9D5A/?F`:E$[XB9[K.8<#+9KX]YZY4NH'`/#NGX/R/#YRC
M8F4XT92QS>'KS.,K?\ILBP,E%&EHJ08KNI6(@7RME;Q7@EDVY3=^GNF&['O'
MN3*G=%EEW:"1<RQZ<NW+MJXT\+QF[2:\E,S(;">T,[9Y8R1EF!UV6*)NV^WL
M6#4,2';=P5\=B.HN9)EMD8K+ILL96#X;&3(1C)C"`!5D$2EK?QQP;ROC;+CJ
M*Q_QBM='9POFUY`S8^O,4G6XZHV7C5.X*S3!XX>13U"TGE7\94K!8#MEV[AD
M@9NM,(@GWW4IW.HY.+F2=L]OX.-$RMB]I=UX,D9(!.=DZUP77B1IGQ_AH89"
M5(Z)#A`%9]@W+(BFWG>,UIUE.3NW;N2KCPB@&WMN2O<`ZADIE32*`P?42I).
MD5O@%P:Y1<<9/B'<J3C!EBK+<KP0SW2^05GR/[0L=.7S6AE/&[_"\=E^&JUT
MC)FPJ,*HV>E9%8NTCH-$3$!4@D$H[KE9$HW3NV#;IHTV:79.W.BK*3$<V#J+
MN91`5*Y`A9D,A].MP?6-2MK#1Z\#MJ3+1VW&/N+?S,490XP9Q(^WZF-PT!R#
M&_3%VL+>@V99(<P*GS*R?)84Q1)\:8.Z9D@\D\>LJQG*C$Q(^.XS)25.RM)O
M;C!9>QOD:;GKLTC:!CX%7D`15U8^]L#Y-XU"-7;IGU&[8D#]X;'G&!L?`P\U
M3,9"&ZN,^$5RIL<JHZ>:9`^'`=(DCQ991\2!.\;26XR2Q=K;UAP3)D39V#+$
MJ`%6BG69#CI+<D/ADL,J>Q*R/`(SCL565<O><O@G)?('BW6JAC*EY(ODE%9=
MK=EDX/&H4F=?D9L*]:VD7)V'%V1B-Z=F"J1=G?L%WD&Z?Q9MB%=I.2J-@(>'
MS\>=]YV+*CB)2)<D!BJR(DCP,J,T3%;%AKB7(1NICF0Z4<2,!(;=/CIM^\03
MO82C'NH9HW9$RH7D$<@!&I577TI%Z<P6S%2JFM/N7>$/,V]\8^!]=R-AW+)<
M:8QIO(.O6CC]A6"QSDBV5:Y3-I<.\(W"P4/D+<+?5(IDXHK=>/6\/,2+BG>.
M%".%1%0R`YNY8LF3O^9E.3(TO:^#CXP#GIP9<36RH7RBHGC$L1Q0<I(WF9\1
MM:L0';&P<A$V^&",)#$G<<TTQ91KFQGA/2F7&4]`F/)^);X9G6+IY2D%2++)
MIUQ&SY5\Q8%7S3Q\SURG=P&`N'=0P=DB&SG'1$KQGRGCB\/7N<):_949%@9.
M*/*Q;]BX<RT1`O5;*A%`R63;E-WZ<Q@S2+WIW%FR2(F0^[P2KF6(CEV]=M7&
MFB:,W:37E)F9#83VAF;/+&2,LP,;-%$_;7;V)#J&)%MFX*^,Q'47,DRVR,5E
MTV6,K!\-C)D(QDQA``JR")2U(R/Y=.<Y7BYSXM51QY88;DIE7FUFN::/V;J"
M=Y$R)POE<^0EVE<:4527?/*Y[&R#6X]T[;14D4C:2464:.BE0=*%'6H<4P]M
M_)C!:-UQL5X6W>)$5Y':/(W(1,R26CF;'DFP\D`MI*1`AM2@5.3YDDVY?,%U
MDCZTN!$FW2,Q6-9!M6W13>J,&1.J8\S#+`:@7O;2`:Q=$^79>V/&O"[R;XWY
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M#&.*A5,@GK"+Y]DVMV;)+F]I-X^`MEJ09"_D90KT#"X$KE-R5TH"*K@Z"4AW
M#C9>7V5\Y=M@D$LFYY@?`A`TL(?RR>#1IOH0_$,3IUD#JCU'C:#V]DB[@^5>
M7,EFV_;)(LV7@0<@Y\,P:_WG!@4>LJ#^&00.%]?.!N`=Z0PQ4Z7D["-OX15^
MH\&<VT/F;G3)U^K57HN3\ARA*7*<:[$QFV-Q>)O%,-S\"5\X<22$8E#=T+%$
MSE(>]4R^YL]L7`[KWK"RNE'#M.RMM\-RC'>L">.7J!+%?QS&V*65FEG.48Q&
M"_JS-D'1WO8H\B!L@_G&YOERHH8_D^5#DI-`#?4S:)HI%!"I`,,RA[M9)]<2
M,+W[EOY8'+7-N6:0A/YM\P/'MHM#"F/%UU8]1MCO%R.,N/K2."04112!X\IR
M$ZW7$"%46DBJ'$P>L-WOG:QC=M2[1M4#G),^5NHCX:X\G<,@YJ0H>%FQL7X3
M$"MIM)`UPI+57LO,&)W?M;[MDK^6X!Q-J>0,S)+CX2?#9TS`WNN3ER9\I*WU
M12I9GL&,'LG\7^5=?X_3V/,1<,<Z,4LU^65QVX\1M=KX4:,#&^=<29LMUSRJ
M[OK0+_W<,TNI9ES)QKI@=\J]%XF19)L)U`1E=Q:'*[J[S:&0+MF9W=L6YXK'
M[D6W8G15L8\RLT"Q*KQ*&C"`L)6(`;$[:+[;B]FY.X2J^9B[!N^%E!3ZI,S*
M@C2+(`(56B=B?Q"5D&D_AU(/D)Y<63<LWWE/DR0PM99:_P`KS/X*O\.W!"9:
MDE66$(VG8!JO(J4JHC.$0CX?V?$RK:9ZR$5<IL/5*<$RCJ#V*$P2]FP9487#
M?O+?)-Q!`M+M63%E&!)_&3&F9T41"Y`D(*@%JQ\J7*&S=R?#R'\QC[-VV/!L
M?4FZ0S+U>F;^B9$%RYLI`%F/"OQ9>$V:*(TR?02<;;U?^#]*\R13(Y>)V/Y*
M(15RCQVEL%5R*AG=%@Y.V0L7-UNIYL5+-.H5^_8).G+51<QBJH@;6-M!RW3M
M#([CC?(?&/<D(4A7,!GSFDVB<J2%T+B'+@1PQDA&6K:6L5J3W3H#([K@V)HX
M8\C$[>D#@E%E>%`-VAX`GJ.ZXSOJ`23X<J&L;U<>'O+XRI?KWP8A\_8;LSOC
M54[9YA=M6Q!>)QO+-,)8BR/-8^D^+&%[ZW1L#XJSJM-X8%FK%BL\:QCAH5$J
MO=H`8TSV\IP9(I=WF6;?<?L_`@^)N7#[C%NHG?0[*&+PX3)#K=4U+"0!8`5'
MYL\FC=!M*&';I^Z(YEBLJLN(-IS8)I-`+*B3;@QEZ:,^A<E02?41TFHHI-T4
MFZ"94D$$DT44B!L1-)(H$33*'R%(0H`'Z->68LS,QNQ-S5I$2)$CC4!%``'D
M!P`KZZI7JFE*:4II2FE*:4II2O.Z:M7S5PR?-F[QD\05:NVCI%-PU=-ER&27
M;N&ZQ3I+H+)&$IR&`2F*(@(;:\NB2*R2(&0BQ!%P?>#7I'>-UDC8JZFX(-B"
M.1!'(BN:C+.-,HXUQQYNMDP!3+CB[*#_`)R\:XK$5SQ=2Y.`N+6D3T3Q%AKD
MKCY_78QK*+U-6.7DR218\XLU$0<E7]7O=8?:D;2X'RKV_<)9(\7([WW./,]3
M(3A2;EDE.JUP1`5"&,L1'8(5X6K)W]Q'W-WQFXT"RK%V-BOCBVI3F1;/E&T=
MN!G$VD$)^()"!]ZU8ZY_P?-C#G(RN8CQ3R0Y15'%,#ANL/\`CG/HFY-YYN66
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M`Q=FB<QEPYP1!9.YPXSKD?C'S%9;/#"LW;/&.GD/F*FWG'LMBV#)8'*<69K'
M.&S].09$CECLY!T_DR)*'.ZD$QQM]W#+_)NZ-UVT,XQ/EOM,^WC2W_Y@FJ/(
MC$/`N\3JV.L#+=,:.!47HI"U2D6'BCNK`VS+T_#97?F=#E/J#7V]Y<MX)FFN
M0.LHCEDG#7>5F:0ZV85>N-)SS(*%CC&<]CF\<F<DYFSUY3F5,N66.R[,WNXU
MRM\F:W)X]0I"=5K=X.[K>/[VE`2[P$X\I6YI5Z/>.2*;CTY7=[Y,$_S$VO`]
M.W0XFP92RH/Q`V5FY";TN/(MG4)BM)(F/`0<?1"(E71&!$]ME,A.Q-QSHQ^8
M3;SO6)(C<(^EC8NK:VGC/H"R9,<2//(+2J\EV.M[XRH%MYW#PZY*2]-Y&\H\
ME%6MW"6-JDTWI?)^N7>K7"Q9FJB&8HRHVK.]VM689#PU%?)-[*T8MT*HF4W>
M-%%2+.Q&=&/"_<_8F!D^K9,CO)(GE5]"/@?!3"8M:TJXCS=$Q-E%)4G27TZ6
M1C!S292;!W#FP`KO"=I9$O1*EW7,$@,''^D<E0)@5Q0R/&8R2&4"LGY[QAE5
MDZ?UG(V0>9MJQ#QK\X3!K>I6U[=LY7.]16!K7AJBVFSV=&P099:[W-E2[J\5
M+$22)7BD*LY73;"F*JA1P>SIVFSOEYNNZ*$W'XKN7"%UTA@GQR;9UEM:V198
M'GELDV-(T4LG0:U;#O:,DG?^V;:B-@-M?;N8@N".L^7AG<$B8GB(8R\_PZ$]
M*>&.54ZL:FI<^8'%<SD.2#C"V`LFYUAZ?S<H6."4ZZ5>P7!M'<<[KQYFY"S9
M,/`S<64Y,>(9>H9HMLON9N$DZ!T00.<_J:^\VX8Z]SJA:3)VZ1]V@4J;3Q_E
M.Y1#`U#^I&-WQ=LD:'B.GFRZ5L&O)8S;<,7M[<I8U^%"?E^0`%+`Y&X[?HS6
M5@2TL>WY.ZE9+61L+'#V)2\?<=V'F'R//QNSY?Y3D;2Z]R)YSU:B#BMJ[OE8
M6Q'AW'7$++&.KA9$6:'</*$E?,Q!(RP2!BMCF5)'+F4%8J1@FLO$@_.\3!QY
M6DP\W;>[,M7)TF./(Z:;+C,U]*2Q8<4<B(&X33S:;N&8ZZ[;C@[7D+,%.?MD
MG;F,ZZ5<33QS13[K.;#\>%YY7@)8$?#P`$A'TB(_&;C=<;FT\NZG-9?E_2IK
M'F-_,\1R;:82?SA0[CC;)",O2Y>IU>"O3IM&OH*NVI%O'NP;Q;HT;,NW;TA3
M*++.R!@;GF9$&T]];]LQ83Q_*_9FP[`@RY<$IZN,T5@TOP\W42/&=?PX8H.F
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M9MA=^W8Y7929),8[S@_%XLEU7JKCX#=.9U01D-,58HMQG'AHKGJ\\Z0YNQ^`
M+0XOV;N)6<G$;3<@EG<8,?:N-9GB]B.MT"RWR6J$PG53S4GCJ9EF8K1ZQA0?
MG5(B<IC*#+Q@[;D=\8NU1K+AS_!92$MH61<K?.XC')<JUYHMF&V=2+BPZ<43
M,EPPP,[&?\M[+P]UR2,S;9I,)RH$EFAV7"R).3`&.3=LO/B6864J-2AM!!D-
M>;:?&G-:\9Y\Q+CL^0H>6N(-)HN+J_3ZI:^7%4H=SIM[R`ZR3B]E)TW&I'+.
M=OL3.1$J21<P\6P5`!;J.BBW`QHS$CQ8,7YA;9/&^5FYN=ASP($"O-BC;5AE
MQDD=EC7I9O6`5YHU8Y`F]`9RN;D?F&1-V-F[?EIC[9A19,4_XALF9+EK-!EO
M$H+L#BIT^HB2,O1,9'W`V6<^84Q]9+MY0<E1N,[BE4MGG(R<W1K%C>&4G<>8
M]0XIY@;5ZIY,3BE+3&QC6`<&:M11<2#IHB[*0A%3'Z1&4ABGC^92MF3++#_M
MS>!)(#>)I[[8L(+$!3*`KI'XG2W3)`O4#ERQS?+C+&%"Z2_[BV=HTM:00_$Y
MCSNJ`ZEB8L)).``#@R!6)`QWSQF,]/;EQ@R+R%XU1]/XQ8(S]D9M9(O&]FE>
M3"ENKUPP7E&A8TOEAQE5\40<K7&,)8GS1N#1%"8,U5F2F$Y"H"H;3M\7+RL7
M+EFAD&^Y_:^]8B(I+I'G3QX$T"=?T@O,(,N))G2-491J=!/Z=PV\XL.+D8F'
M,IQX-\VC(ZC#IL<3'RI%F;I^HV7J02O$C2,0ATJ^CC$^A\,\L4DWD%93R,AF
M"5RACNR4_%UMHKM::D:7ANGAB3--I?2,I7V'BXJ`L,GWD!&24DZ$IMH=NAUA
MVEUT%I5Q/FH!&P>')[<SOB)F.H#(Q=IV_$CQTD^Z$;(;/F5029I9Y6&H**T1
MXOBOESEVB*2Q=SXKPQ`:6;'R-US<DRO&.)TP+BJ21^#&J@A2S"KO\RH]OJ/.
M;D/=JU-\M*'=9#@%BR)XW6/CE%Y.3A+OR6ALBYT?T#'-[E:%&O(V5A';MZ15
MQ'3AB5XR)A._.0P-04T[9FW/'A[^39X@=^F[IV=X(Y`O2E@&)CQY+LDMH'1`
M2K,]RHZBH&8LIVG-CP)I.S9-V:VQ1[7N29#QZNO$6F5TZ1C_`!5D(1BBJ0K2
M"$O9!K6S;,XY*TW*/(.PY-6Y`XCQ'D+F7Q=7Y>Y&X]Q%\B\E-:XCP8QV@JXH
M4MC6+>70:4;.C9K'3CJKD<.4D0\/L9$RZ9I+`7;\>?%V^.65.V!O_>,D`O(-
M4QRL8[9UM(ZG2EQ?BY(C(O1DG2$N196$61N$V%DYT\"-W,=@[923A&5""7*&
MX],L='5C<PJPC/46%Y=(XV-,DLG<ID:5A]7/.6.>U2XPO6?,I?`^2\+Q>1G'
M)*Y2<!D6"1X@M\RMH5@VMT]*6+%R<DLT:W7PT7)KG2/.+)*`*B=O;WW,9.Q?
MF$;#NG_;VUR+&BPM`^:V?D#.CDC+?!O)\'^5:Q,2BA\LQ.9'F#R$L.%*F3#M
MQ4[.W<61%))(SJR8AVZ`Q,DA'Q:0+N+;@(VC7J-'%!U$"K%:[G[_`):T3S!\
MXWI:L9PB.)%GY(\('V?[O1F4K6,VV27-Q>HM>IA',92HU9A+8GB\E.$BY!:5
MQ94INKPF_@DW"#B8[;$"-B;=E&-,4]R]Q##1&<XYRI?AC`V3U+.V*\$;)B//
MI@::02SZFCC:.)W=99MKAR\4L<[_`&SMIR6=0LXQXMPW1ITQBET7,_&6698A
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MECFKQ?P;DZJ8=RIEF+J60KB$`>,B%X2V2<?&(VR<-6JJZNMIA("3J6.6-GGT
MSM(Y>POHM%\LFH5$Q^[/T^<%EW+<)-KP3U,U6":>0,C1O*L*NUD?(:)"ZXZ,
M9RK1D1GJQ:_>5&^%AQ9^4-&*ZNX)Y].-E224J+LL*,X5IF`B4AP7_#DTV\PY
M\<4IK+<[@BOY6:2^5H1];(,L(%8O3"LS5LI$4XF+/2JYE!_54,7V6XP;5HOX
MR+C9AW(-CM'1#H`=HY*E$Y>\11]O[MW#@Q_$08N!DY84'098<4E9'BU"[QZP
M!U45TTL)06C]598P7CW+"VW,;HO-E00%CZA')DJ'B20J2$=D-Q&Y5BWX=@YT
MU%#!WF[XBR-`!=<JU,<%4%KQ$PURMFK7*6AY=BQR.8\CW?&L7CQE!U^F-IVP
MSC>8J*0-5&*"SJ36?D029%4*`J2[/'&=X25SU<;.VS$155G>>7<]NCW!`B*"
MWX8DZ;6#>E'F8QQJVG`&IY,)(ENDL.ZRLS%46*/:\SX21F9B%M)8R#B+<(QK
M=A>2]AYYX7=<1,]\O<./'&7*I@6H9.G9RLKQ]JQE8%K)C"`<3TM29N+OM3CK
M3395=(B0`=[$"((N$UR)JIF*)H_?<Y]DVO"W5\?J09$\,<=F%FZN:N"S7&JW
M2EUAE(!O&5X7!K/VK#&Y[G)M?4,<Z*Q:ZFXM!\0O`Z;AXRI5@=)#7N;$5C5M
MYHG&ZS8GDLAX^M$+,V&L6#`T#=J)<RY$QL]KG^NU]KM"A)5F[FL6O92VP'M2
M963CI>*C'4%+.6O=`_;IG,X2F\S%.-ONW;/#()4R-Z.W:AZ9%EZ;R@&`^M)&
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M@F%U)5T;2]HPO4=@C*3+?CIS`X[\KV=J>X'OSFW_`%)4@RVAA*TC(6/IV)1L
MT:>7KD@I7,DU2H3[B'GHY,ZC-\BV49N03.":IC$.`2DV/-CX\F5-&5A2:2)O
M-98DC>2-E'J5U26-BI`)#BUZCTFC>2*-&NSPK*IXZ7C=G171ONLI:-UNI(!7
MC:XO&#'_`)LW$FWUK-=SL4_;,>5G$&?U./C12Q8WRD[L>0K,9DU,P6IE+B:&
M[M$Y(R,FWE2C#Q[9_*Q\?&B^D$6:2P%)B8\\61M7;&Y*QU[HF2T<8#,ZKC2S
M!F8`$A/AXXIWE($43S#%9S/&RU(9F#D86X;W@2J/]`8!(^I0FJ9("%4DV9NK
M/T54$M*$,\0:!ED,PZ=R7P1?L*/>155R77W^&(J%L4_.7EUXZ&9UMA4"O#6Q
M*U1DXSC9ZK2]8,P6)(1\BT;/V:J1DUD2*!TZ\Y^3C[9@IN>9*HP'A65'7\19
M$?[ACZ>KJ%V.A4CU.TGX04R>FK6%!-N&:VW8L9.<LQB9&]#)(ILROKTZ+?>+
M/I4):2^@AJPE2_,?X8W^BVC)%;S()JG2[1C*G6=S/8ZRO3YB)G,RS$5`8N!6
MJ6^BP5L7B+M+S3=%E)),5(T^YS&7*1)4Q,MH94R=KQ&0C*S=P;!A7]YLM8Q,
MT!'[CB)E<]32+$<:Q>K'T,S*U?Z:#"^,=_W?A@S+UE;DZ:D9?06-Q:W$7K%U
M\P'B)CR.M,I;<O(L&M,SBYXUV%-E2<CSS]MG)K57%U/CIE$U^GRDK-3*M;:G
M71.Q1<M7"FR"2IW!BI#AQ94,YP!"6=LE<LQ!58EA@R/%EFP%P(7C<,6L"!J7
M4I!,A+@94,N5#-&%D@@Q9GNRC3'F&-<9B;VM*98[`&ZZKN%`:T4J?YP>"KAG
MG-M!)7K!7\(8+Q]1K79<YV>N9C@Y^8M&0G,"UK5(KF$7^$D;;(/Y!>PHHMR>
M-++/EP-X2,70*=<E_&)DPMRSLH=-8]R.%"J_BO/(L:22'2@NH0==GT=7IPP'
M(F,,+JU>9\202X$.(.JSX9R9RWX:P1A\A!ZFX/J,,84W17>80QF29&C,A)GS
M-N#D!CJAY6E<Z-6])R2YN;>K/$J%E-[-"3',P>O9`D;)3F-'<W.C0=)G">%E
MI&<CXYA'KG(5=8@J$ZJW3XW"P.K'ULC'AG1M:]+I9#JD$CSWZ,:S.VB,R2)K
M9)0MS#+HLF*40Y4_2:T.0T#+8]3K)&97B6+^J[I$`[JB,45D+6ZB:KAN7.;A
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M4H[`*Z%KDF--!C19+0GI2+,ZA1J=E@"M,ZQK>1E36+L%()N`2RL!A;'?F%ES
M3RYY%\6,-XF-;4^/F-FME<Y'FK1::A$7&_2C)H[A:5$-GF*'\"VK4@=Z0A+#
M[:7\0F!G+)B]:`*^F*,S+V;?MW3$TG%SFQ8HW)1Y9(U0R=0,H,.ES*FG3*PZ
M:O((UFBO?R8,;%SNW<67+!AS,:+(ED0!Q##,TVADTL5G)2-'X-&MY&C#]6&5
M5^G$KF7R+Y%9FS1B^^<3*?A^#X_W,^-\EW*,Y+(Y,=-+VXHU4O\`#Q<'5T\+
MTH9J*D(6X-04>^/1!NJ50O=GV#JO[:V/N.S_`)TDK+BO/E01C3<O-AY/PTZM
MQ&A00[*_JU:0+#5=<'<.K@;Q^2N@;*7&Q<A^-@L.9"\T#*;'4QTA63TZ=1-S
M:QSW(\V>+<3GI'C+)9=AV>9EGJ,0%<7AK46#1L3FO*VQM4'F0_8(XW8WES6D
MO')02TNG,*-C$.5L(*)]6/B9$&;'N$V/,IAQ5F:1B0BZ<;1\2T9?2)5Q]8^(
M:(N(-,O5*=&71?R8)L-L5,B,B281%0/41UV98-86YCZ[*1")`IENG3U=2/5@
M.V>:?Q2+BWD->L1W1/+EGP%AK).:1H_L>]8];9&KF-6KP99WCJ\7.CM:W>JX
M:2;I-U)FO#.,6Y';=81.DN@*L?N&Z?![0-XAQFDA$N`K*;QR(FX3I#!(\;J)
M$4ZRWJ07*Z"59A69B;?UMVAVC(F$4KMDH&%G1I,1&>:-74]-W73Q57)M=@"J
ML13JMYH^#"%S4_S(W=8?@L3Y$PMC*&>)A9LFSN1[1FC"%0S5%1=8I%!I4C;W
M4E%L;,LU4;M&D@)D6"CPYD4A,1.7<Q1ZXS(3E?G6[;>D:JS,WY1+HFR#I!T1
M,OK):R1$HC2,\B`Q&+*V5'!.D>F!MGV[/9F95"#<2ZQ0BY&MPZA1I]3W)"!4
M8B=F(<OXXSUCBKY:Q):&UQQ]<F2KZO6!LSE(WQ:39XYCGB#J*G&,9-Q$C'R+
M-5NY:/&S=TV72.FJF0Y1*%R6&2'H]0"TD4<JD$$-'+&LL;@@D$/&ZL"#R/G7
MM)%=ID%P\<KQN""K*\;%'5@P!!5E(-Q[1<$&LDZM5[II2FE*:4II2FE*^#ER
MW9-G#QVNDV:-$%7+IRNH5)!NW03,JLNLJ<0(FDDF03&,(@``&XZL9.3CX>-D
M9F5,L>+$C.[,;*J*"S,3X``$D^`%7(89<B:+'@B9YW8*JJ"69F-@H`XDDFP`
MXDU`K"_F(8QSK>*=7:AB'DBQH&3GEE88CY!SV+VB6#<I+5I)\[.M6I^&M$W;
MHB-FXR*=NHY[/PD,R=(MQ`%2JJMTULO&AFGLD\+8V6<7XA8IAHD:+\,ZO%58
MI+&XC=DETM;1U%9%IGJN$9"DT>1!'DICN\#"1$E8,"I(-V"2(T,DD8>-9!<O
MT[25?.1.>/%ZAX_LF1HC*E1R[#TW(>,L7W".PE<*/DB>J=KRQD.&QG5VMECH
MFTID@B)V*9`SDKI5)<C=NN9-)51/NQQH)ERLOM;%QP73><Y<7&E7C"TK1-,"
M9!PT"-=1*ZC9D-K,#5<F)\+'WZ?+4QMMN)+D3HP(D5(2`X"$7UACITMIX@@D
M6K-T;G7"$UDR6PM#YDQ5+9C@&RCV=Q-&Y#J+_)D*S2;,GBKN6HC675M,<V29
MR394RBS4A2IN$S"/2<HC[QV7+CFFQ&$L,98,R>H*4?I.&(N`5E_#:]M+^@V;
MA7B=6Q7BBR5,<D@72&]);4G472#8G5'ZUMS3U#T\:PCE?GYP^Q!BO)&8)_D#
MBN?JF*)EI5;FC1;_`$RX3D;>))RZ9Q5!5C(F?4%G<Y-TQ<%38NCMCD(V755%
M-%NNHGXAG@R#V^T4R'&W/+B@QY=0Z+M*T8,G5OHZ4,<JSSR`D1P?B$$%0UYL
M7(1MWC:!Q/@8\LTZ$'J(L0>X*6U!W=##$A`:2<K$MW8"J_'\S>.2RU\7GLK8
M[H]8HUEK=82OMSRAB>*I%S=VO&D;EN)=TV:;WQ^=RS6I$B+PI7Z,>Y6;MU7*
M"*K(I7)R2J8[S?A9'Q.5#TGL)-6&R).=()&E3(NH7UQW`F2-B`?#1.)`D8ZB
M&&&34O%?]0SI&IY'46C91PTNW"-G(8+G6KY`HUYIS'(=%M];O=$E8]S*Q%OH
M\PPN-=FH]F=PDY=0DO6UY-E-)I+M%4_^E.L(JIF(`"<-M>\]CMD,\^=')&D<
M/5(T.6Z902!E0*78,A#(%4EP04!N+TQ$.=-#!BLC2/)TQZE`UZM!!8D*MFNK
M%B`I!U$6-17XI<[<7<N;%D.H5"BYGQK:L<PU*M<A7<U49I29B:HV1?;WU)NT
M(Q96"P+(PM@^K;ONT)((Z52`@"JS3`P#KWC#XK;Y,]2JM%.L,T1(,D,KXT&6
MJ2:2R$F'(C;\-Y`IN&*W75XRO])G0X3@E9H9)89`K".:.+(DQI'CU!7`66,C
M\1$+!E*@^K3(1WG3"3#)*>&7V8L6,\P*QQI=+%+O(52;Y)4B2L%I4THG15I<
MEH/'%BVZCD5P:BD#<AE.KH`1"T)HFBW"995,.(I:=KC3"H",6E/*,`2(27L+
M.AY,+W6AF0XH>)@9[=*X(ZEV9!H_CNZLHTW]2LO,$51J/R6XXY->S49C;/\`
MA/(,C6Z^2VV*/H^5:);'L!55"(JIV:::P,\_7BJ^=-PF8'JY4VPE.4>O80W]
MRLL&%E;E,P3;H`#)*W"..ZLXUN?2MT1W&HBZJS#@I(\I')+DP844;-F2L0D8
M!+N5<1L%4>IB)"$(`)#D*?5PK&>'^;W'?/V<;Q@G#-VC<F3%"QC3LK2E\HLW
M4KCBN2@;I9K54V49!7*KV67(_L<3+U!T5^V,@F1N4Z8`H<XG(1A=3-Q]YRDA
M=(,',AQV+J5UO-`<A7B\'C"AD9^%I59+'235O+:/#R=IQ'E1I\S%ER%"F^A(
M9A`RR?P2%F5E7C>-E>XN!61S\G>-:<I<813D+@XDUCN)L,]D"(/EFA%E*-!5
M&34A;7-7&/-/@[K,36)A$[21<O2((LG)126,0X"75I<C';$&>LZ'!+(O4##I
MZI7Z<2Z[Z;R.-""]W?TK<\*OG&R%E$#8[B<@G3I.JPB$Y-K7L(2)B?"(B0^C
MC7]'DWQM#&09K'D'@\,-&DO8P9;'+%"#&0R_C!CO907SV_\`549+V@`H=QXO
MO>^#HZ>KLU<F=,8X@R&$9R"1%J.GJ$!R1'>VL@1R$A;V$;G]QK6X5;(&48%+
MB``R:>/3!*`%[7T7,D8&JURZ?Q"]@6/G!Q8K61./>,%\TX_E+1R@+)NL.C`W
M"KRT-98:/B)"1;6)*;;S/LY6#L3]B6*B%6YW!Y:67(W:D5$JQD;N+')E[AF[
M7"A^-Q\'XMU(L>EKA50!S+NDQG10+''@GFN%CXTD'2V^'=&(^!?+^'##B.H$
ME=^/+3'T]$K7M'++#&UFE0'(D'R4XZ6=?(C6M9]PI87.(6LD^RPW@\J4667Q
M>RAE7Z$P\R(DPG7"E*:Q2T6Y(Y4D@;$0,V5`XE%,^V,N3CM@KNBY"';#HM,&
M'2/5%X[27T?B`$IQ]8'IO5WX>?XY=LZ#_F18J(K'JEE8*RB.VLE68*1:X8@'
MB15`?\P.)475SWB3Y1\=8ZE)VE>C'N#_`#;C1G5R79JP]JN:>>P.+,G$EM+>
M+#Q*D>*WBR-_V@I@3MU=D98I((I6"RRH[(IX%UC8)(R@\65'94<BX5F"M8D"
MK:H[QO*B$Q+HN0+@=4,T=SR'45'9/XPK%;A3:Z;ER&P!CJ5IL%D'.6'J)-Y%
M(U4Q]#W+)E+K$K>TWKEJS9J4V/FYMB[LY';M\@DD+$BX**+$*7<QR@/H*6SY
M-J4$[FA4-#_Q5+LR)>/[XU.CJMQZF1E%RI`\%E&$FY$@;<P8B7_AD*JLQ#_=
M.E71FL>"LI/!A?SY[S(O@G'[K("6)<M9D18/$T7]6PS$U*:MC*.\*\>/+`NS
MN=THL2$)&),_^H.5Z98HJ$Z4C!U"6.W'<L?:H'S,T,N#&DCR26&B)(T:1GDX
MW"V4CTAC>W#QJ0V_;I]SG^%Q64YC%%CC)(:5WD2-8X^!!<E]5F*C2K&][`X]
MXA\L(/F/BUAF*H8DS5C"C6!E"3%*?YE@J5`KWRNS\824C[+54*=?KV"T,*"A
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M\AU'ZY1U/N5U?EEK##V3V<BP91]&>-UC-CNETGADTS)`43G)B9^Y0[=*T63%
M("-JS]P!T\&Q]NC$F05)(U,1=8P/2SAE++8FJPP'(ADGCE0JN;B8I%^(ES95
MAA!`O8:G5GO8A"&`:X!J^.N8>`[[QIQURSE;S"XCPODRO0MBA;%FR?JF.$HU
M"P+';14=/R$I85*['R[IR04R(D?K`H?8"&,(ZE<^,;;/AXV7-&LV1'$T8U"[
M=:`9*JM[:G$1+,JWL$<\54FL;%8YJ9TF-&[1X\LT<A"FRF&=L9V/DAE&E6-K
MZD'`L!61'&?\$-8Z>F'6:\2-HBK,J9)6>4<9(IR,=7([(Q6I\>OYY\I,E;1#
M*]D?(##*N#)DE`6(+85>LN_AT>*88\B%<CXHXNDBS?$J%+8^D\>NH928K=0!
MENO$5["LT4<ZJ3"^.V0K?NF!=6J8'D85T/JD'H&AKMZ3;"^/N?G#[)$#F2VP
M?('%<=3,#Y)'%F1+G:+_`$RMU2-L1D8HK)ZG-RD^@T"N3,O)*1D:_7%!&3D&
M+DC3OB)E4/:26)]LV3=NJHQ-P,H@N0"[123(5M_&T<)RD0$L<62*<@*_"]/B
MY&/G;EMTD#_%8@0RBQ]`=(7N>'`(TRPR$\$R`\#6D0BKFEN7N#X[(^`\=,K.
MA9T^2%(RQD3&V0ZG(UR>Q8XJ.&XBMSELF)*ZM)[P9&"\;9T%&3AJ1VV5!-45
M%$@*43%=>OOT,Y$`VW;(\^=Y2$1<>6=(%;4WM<.2;((KOJY`V@A>#`G@_%.3
MN*X,:QW=VR&ARIPH"@\EQ)4(!U=32FDW)7[%Y=8#"S2D0[R-2(ZJQV-,=950
MRS(9&Q<WQ;,UG*EHFJA2AAY\+P>374FIJ%[MJY58HQ;XSE%-F[<+BHDG195Z
MF?#/^%/CY46.5>P9Y)H#DH$%SQZ2EM+Z)"`71&C!>C+:/%FC(DBEBGDU+Q"+
MCR+%*7/"P5V`++J5""LC(]E-RH\GN-3C&TAF5#D-@U?$$3+EK\IE9'+-!4QM
M&SQG+1F6$D+R2?-5V<N9Y(()`V4=%6%1=,O3U'*`^YB,88)R"(QE7Z.KT]6W
M4OTKVZENE+?3>W3D_@:U4CDD;+6-"S8_]4`$F/BH_$M]SBZ#U6XNH_>%\I52
MV56]UR&N-'LU?N51L;!"5KUIJDS'6&N3T8Y+U-I*&G(AR\C)1@X+VD605.F<
M/0(ZN21R1,%EC96*@V((-F`93Q\&4A@>1!!'`U922.0%HW#*"1<&_%258</%
M6!!',$$'B*N#7BO=-*4TI32E0-Y6?Q,^65^+K)O]/?G-IYU7P'Z>5?_3[!O*
MW_EO\$OPB\<_W/T[2JGD*GEI5*:4II2M9^7^&><Y?E59\_8,S)CRC5[-%5P;
M3,Z0>0,7-<CV%&)P5=Y6SPDAB966<J52&FI^(L#V/='F(Z33;"8CEJ5%T0BR
M>-LF,-LW#<GR',FUY&YQ;AH%EDZ\>''AM%U.:P2ICXQ)33.C"7IRH'L<W<\E
M=PQ=I`0KG8FVY6$IYH8\B9LA)2O,R12R.0K$PNH19(V&J\6\'>3@SPSR=D\L
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M6/T!!I6-!$K$%[DLY;@*R-KS3@]Q9N]/$HQ94*K#&-*)JAD1W&HL=3R2L[`$
M(%5$15L2<:2GE1YQR0TL,SF//F-9*_(4_A_ANAR%%QO-5NMM</\`%3/<-FTC
MRWQ+NQ/UY3)=T5CSM57#-1G%-1$O<-4T]R:F#D#_`'-%W,%/Q$O=D&]9*7&D
MG'PLG#C@A-M2@_%22.TAD)(4`A;`0IPU_(F[?1].'%V_E[;`;78',DQW>66Y
M]>E<2!$1-``#L07=F;(E>\JZ68FI+:<RC"2$5`\\>5_+>?185Z18/9.H<E*%
MDVDI4./>>TSF:3T`G>D5%7QMT50;F`B91`F^LIL<,NP=K;!FS,<?`[(W+M^1
MDX-)^82J_P`0E[A!&H(T$,2Q!U6J<DW"5,WN/<,.RY.9W3M.\QZA<1G;$C7H
ML+^OJ-'<.-(4&Q4UC"@^5#G^/F,7L\@Y]P_*TK`_#O/G#+%"%=PVLI-NJ1E&
M*K$14K3DAC<IFR5*VV*(:P0A*M?!)1+T@%*1J4RCA17.S8<K<5[NW'+>+_<&
M[;1A8DA5?].),+*7*#B-M3!)7,BL%<,BLIB,91;4@R,;#RNUHL195VC:]\S,
M]`6M.1F1-$8^HNE0T0T,C:#<J1(&#5(/RR?+XR/P85S"K=,H5"P0V1CU<:[C
M'%D7=X+%=(=1#NSREAGX&`O=LM[FOR5LDK*/?,HM1G$-TFR8(MB"([3?Q,0V
MTX(1R_QDDJEF+=*-T0"%&:\C*&5F+3/(Y)7U\[Q$D<LF;BY&M5BCQ%B8*H7J
MR`J#/(!Z`^A$`$:QI<R,5)86QP^\M7/<)<;=D7'.9L1L;?7>=-_YJX#^N&/K
M;-PC%YF.JOJ1E"@Y>8,+?&C8(L]>=)FAW4,,8^9.D1.9<P*`"<3@I/@IVE(I
M1LK;,#=-N-P=$F%N&6<Y3P(9<J+(T7<,(GC4H8B&;5-;EE8VX+W#"5D3'W"7
M:L@V*EER=KQ<;#6Q*V,$L4+ED(UAY`P<:5M*7#?"R9QWQ&S=@6>OD%+9(Y$S
M'(&_Y*N[*F1[VBM<E<A7\W*6)2NX[M@ST<O1H-Q*IMVT9)"[!PU0V<&4.H<1
ML;I@"?M/8^U=M?3!MNW18T+2A7+F.5IV:4*JBTDTDE^F$*(1TRC*K"WMF:<7
MN?/[ES`3)DYJSLL1*:%CAAQHUC8EFU)#!&=3LY>74SZ@Q%:Y\7>3-F2C\=^0
M^)'.?L?PLKDRW8(ON+ZM1JM?BX.QU<<)Y53R\M,A2KA=+'*QJ%ZL*94'\?"N
MHZ-;M4B>&03-Z)-G,4O:^;B+?.VK?AN$(E+/&J=(PG&O<3,FF25]4DKR:^GZ
M](<-@,BY,>ZX66Q7`S-DEP).DJH[R2*H^):X:(2#I1#2D:(0925U,I7-V/\`
MRP,MI2</;\M9@QI/W-7S-(;S#+:2G46PQ55<>S\7/*2MC^N1TY8Y:28*)3C@
MCIH[=.7(I()%!3O%=SC7:>CL^X=NY..KM#@X>^0$,1J<[PV0XDN``.DTUV4*
M`W$+I`%9&\9$N\KOG5(23+Q=GA72#95VK)Q9N(+$GK18V@F_!F+6*^FKPY(^
M6]DS+TYS*LM'S-6JP[Y0WWB9;$*W8*Y8'M3=USCM7UJ];<:Y/)`S\/,V2E91
M9.U".T(]PP5!``2,H)3GU@)`Z;?L>"5CDCQ.X<[<75P2DJ9>!!B)$R@CU0RP
MB<$DJ65.`(O6:<Z-I<N9>I'+)V_#MRNA`DBDBW',S?B(V-P"R971L1<`.;G4
M`(Y8D\H/D!QTKU.?X(SYA6!R3!M>5%$?C:L.REHQBPQ/R:O,)D(655I;VQ*$
M2M>.Y^#3+'!(&>PSEJ((O&;@A3`HQ<5X%P<63-EDQ3M&'@Y,C]-YY#@;AFY<
M&0A*",2R1YTT<X>-D+Z7C5"JE<=LB"25\B7%4,N]2;BD<>I(@V3M^+AY..?6
M91"'Q0V.4D618V*NSM<F\)OR;DY#EY(Y[//8,M-2NF3L29BO4MD/#*5DSA%V
MW&D%!1LO!8TFR23;&]9IEZD*DP=+)*P:[N).LX]F*M.E+;*V-(MFGD:*,I#'
MNN?G0]-FZA;-=YUBFE<NS)C94KRQ/'TYF"HDLCKK#8FZLVZ8NB=A)DR[3B84
MO453$/A0(C-%$@10\V,JQNKZXM0UB,&UL[\M.`>8\Q93SE<<+9<QS1JORVX\
MP_&KD=$9&H<W<YQG3H->RLF5HPY)1-B@VM>MPUJ[R;<Y)-)_&&<$;K"W%0HF
M"(CV>&2/>]MSG+;-G;MA;@X3TS++C)CQ21JYNG2EBQ,<>I#)&W4:-TUU+'=Y
M8Y>W=QQ5`W;;,3*QXM8U0E9Y.O&[H-+,\4S2$C7HD0JDB,JVJ1/&;B$''',_
M([(D=:T9FK9DKW&BKU2NJ,G))>JQ7'K%"N,DQF9=9TJE-.IT@D<`<B27=@40
M-U".X;5D;I-F8NY)E(OQ63OVX;BS+P7_`%T>$O3"\QH;%8WN00Z\B#6NP8,.
M)'V_!C.Q@P-BQ-N&JQ9OA<G<)Q(2+#UKFJI%A9HR;D,`+6K7!LZ4US+7L>6\
MAP$7RFY!5C-<5)81NUPP[D"F-*YBW'-"^KREXJTLUEEROWU)667!`R:"S5<J
M9RB(#M`;?A##[?VC9GFD,F+NFYYFI6**_P"89,TRQNH/K6)9;$-=3(JR!056
MTIGY/Q?<.X[VD:"/(VG;<(HRAF4X$>@R(W[ID(%M(#*A9"6#&L+U;R],OT#,
M>14:?G>O..,&8\B-,KY-K][IB]_Y$2=F+A)OAB8A8O+]H?R35C$6-K$L9%U+
M`R"S%=%6*D_3365*IBR;1#N&Q;]V]NK?_3LD;P(A"JQ%!O+R32AK#@N/-D9#
MP+%H#+THYQ*BE:SOS5\?>L#N'"4C<XH=M0]0ZT!VR1#&R@\^K%&L<@EUA2SO
M%H8(1$/#GD<R&,,89SQH%JX\QZMJXLY9XQ8OR!3,*O8C(\DUR4DO'H9`S?:9
M2?EG<Q9(N$:,VRS>N!#1SX3+*+H**E24#)W?'GWC9I\5Y%AW&9]L,@B!7'M@
M9$.3,50DR%LJ6%&;7(\<913%&EW#8N!-B[=NN'DQ1-)A09&=*IDLTX&4DD42
M:^$87'CED4%8UD=3I=R*R3F#R@[GD3'>>J@TR7B686R]ES!F16<5D?&,C8*N
MC&8JXTP''V7BWSJ.G(ZYUV=D%HY>6C9>NR,7(L3@FCWYDS+`>YF0-E2*PTZ#
MON^9Y!N&"[O*)HU1T*NLF,ZJ#=C#,I821,-(&/M+#;(HUULSKLFTX/(%6;;9
M"[F1&U*\60IL5L)(R`4D!N:V6\(^/MSXN\:Z!A:_Y,?9:M=74LKJ2M[M2850
M$+!9Y>?:0,.M8I*9L:T#66<DFP9'D'CMZ9!N4553&'4QG92Y7P1"L9(\:&-W
M;3JE=$"O(VD*@+,#P55&FUQ>Y.#CPO%)G.SC1+.SHBWT11\%2--19B%50269
MB7+&]B`)8:P:R::4II2FE*:4II2K=N%;9W.I6FGR"JZ+"UUV;K;Y9L?NW*3.
M=C'46Y5;GV'H731=&$@_(8`U$[_M,>_;%O6Q2RE(LW$F@+#FHFC:,L+\+@-<
M5([/N4FS;OM6[PQJ\V+DQ3*K<B8G5P#;C8E;&WA6A6@<,_,?KS_B?B*-LD1C
M+&O%"FV3&$CDZL\A;M(8[Y"X^KM"N5:Q8VNW$9O$1E79S[V7E(EQ+O'TG*"8
M&!@2*FF)$BY.]G.W\]S;I.L<>7F;%EX_PK_CPOGRXXQX)T9QIAB1VER&C,3Z
MATHV-X[LP_R[:)=JP\*263"AWR#,ZXM#D)C'(7*R<9NF+RN=(QHY`Z*H,DP2
M\I`B;B'RC>;D-!90+:H?'U?DLBP'!M"4BPS0ZMD,XN/'#D_%Y-R!/04>WID+
M#4>IRU-*Z7A*_'MR,H<1!BCU`8RNI+"D$&^;+N$A8X6-W9@[F%/KD3'BV[,Q
M,A6E9BT\[320R:V"ZHV$=_\`3@O$[O%)N&)NT2R+\3+V_NNW@\51Y,G)QLC&
MD$873$F@212*-1$D1G-SD%8\Z89\HW-51Y2V"S6\@/:LPR_R5RU7>0KGD3DB
M3E90N:H:XM:M'Q?'I@2'K=6NM=<Y!71DY=U(2+*2:,3@1FBHL14-6PMBF7L#
M_:YR^AN<?;&5M/5MU3+).#`,D,2O1C:'\>6"SN<G0ZS(4(;9,K=H&[L;?OA^
MO@R;_A;B(K])8DQNG,T!4!NLR3)T8)"R*L!*O&Z^FOPEY:?)^=X5Y/X[S''O
MB?3\AU;`V`\-X[R;7+(^D+KGF:POE5K;'=MN5B5A&4;CZ#GJW&_L6"K"4DTI
M%^X.K(*(&!`FW?F#MN&S]R-MZ#+3?MKSY<)6`BTX:HN0C2E6#EE+I"5C0+"I
MCD$I<.(7'QX(,?=MJ.>[0S;;OF*N1H.I3N,<@Q66/4&4)*PDFO(UV6)X^F8R
M&RA/>7+R`O\`R'C<M6.DXH@:7+>8)QKY0S]`"VI6*/@\:XWX?(X@N-:;$^JD
M9'SCF*OF[1DAX5LB]9)@N)$2F[L,#MG'78]TP),N8SXL#]W7>WJ<;U\/\$^D
MDV/X3&8%B8S:Q?G5C?C+NF-G_"VBGEB[?"BYX':\R>;)]04?>CD4Q\/4Q*MI
MM<RAXH\,^3>#<9PM5BN0`8=8UG//)J_J8IJ5*QK?*!?ZAD?.=QOV.8JP3MGJ
M1[G4F3>KRS=NZ;0#V.5135.0BA52%4#%P%W'![6[4P6F3(W?![9QL-DEU&$9
ML,4ZF8R(4FE37)$2"X!$(`"ZGU9V8V#D]T=X;AT&3:\_?ILI&C.F7X61,91'
MH8/%&ZF*4K96XR78L`H%7X7X1Y8P_(W./(KD?5L58A5R=C7&=-G,:X9N<W<J
MAD3*E->S9K!R`<$FF;1>IO)JN.(^&:Q:BC]TBQ8D!=XN)2FU);:L&%M&ZXHU
MWR=P3(AB:Q&&G1)R8U<660Y67+)D.RHEBJ@ACZCC;I)/E[IMT@F5X,3%FA,M
MBK9`:9/ABR&YC7%QH5C52SEFFE(*KI18/Y%\NGF#<_,=8<EO!T7_`$_K7)=?
M(L+:8W)B]9))8<F\%2F-EJQ+8BBZJ#)]D2!F9`P.;&]?NGTM'BFT`4&R!"ZU
M>';,X;+O>!(RB7)VON/%(^\K-N7Q#X#*?2((XV:,9"*C&29_B6+/%ZYG=L_'
MS<C:V@+""#(V.<7)#!MOFA^+0\"9>JFN3'9F`@6+H*+3DQV#5O)WSPCQ^PAB
MA17&]$M,+Y=7*?C-E.UUN7,LH^RGE+(5$MN/BO%FD2Q>6FM"QA'C=\Y4,4[=
M%0Z:8"!RCJ=[C67<<[N;-PU5X9=J[62&%[A),G9,E<G*CE`X)'D"-8.J-3,K
MDLMA:H_9I4PH^V8<IKF#?^X9YG`)*X>[X\\$#1WL6DA,_5Z1TJKKP8GC4VN"
MO%3D#CKEWF/D=EG"V&\"5B_<9,&8;A\?XFO25T12M&+K'<E9J9>N&M2J3,$Y
MJ/DFSDABMRF3*J5N<5U$5'"LAB-'CQ=],TTC2;KO6/F1H;'I1Q8;8S1EA8$Z
MK27"*"7;TBW&)R(I)&[&0!2FU;+/A2/Q!EDDRTR%D"V-AINA!9B-(XD'A@W(
MOE8Y1N'$CF1CF/3IT3F/,G/#)/*2J/HNRO(5:\XV<9J@,DU?&5DR!&QR,]32
M6>)KQ"*>'[Y&+DNY<B"AB&`8*+$DBV;Y-8QC9I>W]'Q<2/TA/^+N2'1*`W&.
M+-2:)V0_B1!-(YU/2Y?7S?F$3.%BW3!AAQI&3J=!HMOVZ(DQ$J"'R,2:)P&]
M4$S&_$K6(+)Y4F<7W#FSTJNXNKT-E2T\JVF=&]-><L,K3UYI\9%XU>XOA[+!
M\CY5J>+6RC'D5(^%56KC!N(\I6BL>9P0'`9.7!.K=L+B3`KC#<#(\:B%HFS;
MD*@;JB6(B.%<I&L9I'EEB;'N5JUBSXOQ'<$^1!<3Q;>@60F43##ECD;41TS"
MPU2C'=+M$JJKF4$6RGC[R\.4M:KOESO+-`8CF;A@-7E;6,M*5V3K%*=T6I<A
M6DE'TFRUB0KU`9P-SN.+/:0R2PM8R)))2Y3+)BV.J98+^\8R;G%W%M\4_07<
M^S&VILA%*_#Y*G%>-X8=1(ATPOC*HE'20E@2AZ=-LSCB"'*R$ZCXO=,&Y1PN
M=8GQX\?.@ECGFLNJ6:2>+(D8QD.PTL+H'K%=7\K[E-)8P:8VFL:X+Q2_P7P1
MY9<4J;>*#>32#OE=<\Z5-A3ZK=LD1Y:A%.Z!%QX0!95VB\=SC@9*2.<BA"IF
M3'$WJ.;=L?NC<$QEAS=QV_:,9<4&\4!PLV+,G=)+*"`(A!`G34B-B'D?F+NT
MSP[;O7:VO(:7`P.XLG<'R"")'BE6>-(A'QL7$XEG8R,&>"((B<;W[RQ\J[*%
MKK?"E[BBFP]K'`O'N<POD3$E;SI8..#-];K#3Z*S-E)ID:J5Z4>6-1"8I!6<
MJT=-`7F6*B7[=`R?660[D1-V[Y[_`-[Q@#M6[XIA@ZERF,4S<C(4R8P($T4T
M>41+$LD1#0(>H;BT;V\\N!VGV3M6?.1N>V94<L[)Q:=3B+"X2=A>)X98P\,A
MC?TS2C0`36)>5OE(\F;`AQAB<`5K%AWN+.-.,L(S-Q>9.L;:&C)"DRU@>NX:
M\8URO%Y:KV:L3MG-D*^BVBZ;&>9N&`?_`!$VZ/=7H9I4[SS]V6<KMKY^WRJY
M`8NF(@A+RPC2?BXTCC>'(CE0!F]4;R+U#ZQV@@[:Q,(XH;-2+<+QABNA\MXY
M0B3V;5CR'J13PO&5922A16T#I"L<#*R^.9ZK@NT<3<G292!!R!!9,%Y5[!+Q
MX+@F'?F:-%':G5TAUBF0=NW;6O=Z;=)OO;?=FT[8H6;,P<J&(.W`&6)TC#L!
MX%AJ8#S-O"L_L_,79-Y[6W#<GUKB96-)*46VH1.C.42_"^DE5OY"_C6O#!?#
M?D?3^(7$W!BO)2;PK(8CX^06+LMT:B5#&-YK%\G$*XVB78FNEOJ+RY0C=@8J
MB1%X5U'J'(?K*)5"D.$SWS`O='^Z8(,IOA<_:#B1JPTB*4XCXYR`4*R,0[HX
M0OI(A6P&N2\;V9)_MMMIFR,96R,;=YLLLK7,D;YAR$B(<%!9+@G1?5(P8L%6
MVN)QY77*:Y\0I[C_`"^)>.6*KCC7&?'&AUC(>.+W9&E]Y4J<?<FJ71XAD&YQ
M4?"AC.JW>+CVYFZ!FDI*1\XX%XJ_623*W)XSV?<<[9-_D@,4J;UB9L^%%(8T
M*QX$^%*.O9@TD;9)DQ66)1&L`1Q*SK(N1BK%AX.][2F4)&GPMR@BRGBU&,Y.
M5#E0:82P(5S$T64K2,'20:-`5E?)N)/+&S74X'!\HA4:Y0I>(YW/N2%^J,SG
MJ\9KEX:A,N.M\PU$'?9(MC%!*YW1])RC)17V?&0S4K$Z9#)"HW.H>)WC;<C(
M@CQ<::-X_P#;O<F*;)TU7)WB)8\=0+NQ0=-#/(6XRF65(U$A0>XYH#-F3M&R
MRMN&Q2`LYD+Q;9DK/,>2JILTBP1Z;Z%1'D:P(OU/@5R,IW#ORTJ='TO%>6\G
M\)I,LCD3!EON0PV-LGH3F.+MCR3:(75U69]DV?5<UM*_9K.(ARFH*2A`(!C%
M-J6WW5F]Q[?NV-"DN$>WI=LE23AH:7%P%ZX`/K"38)B9`59X9W*O&1>K&!:'
MM_?MHDFZ>5+OR;A%(H+76+.RYQ$?NE3)%E!M7%5>(*5<$5'"8XA3\SS9X78,
M94"ETB$EL(T&V\_,<XEQW>HO`D6QXQW0V3N.\'6+?:TWT'82R=^M"D6NV2DW
M[XS2+`ZZ:"?=%#)V7X8]T=SYYEDEVK;?@LJ!Y-2,^\)MT^UZHU)OTUP\K'R8
MP`ZHV%$C3-.CU=WTL_;N!`D*+FY<V9B#[LEMKS<Z//E#Z;!)-6WY&/(2%UON
M<LB1*CJ1DU_Y>/):L6JZ6NMX:P?D"+H_F/Y"Y@4''-BR`T@*OG?'&5:;,TP*
MG:TOJ%*M<?6'$!Y+VG#+.4YEHJX67*5LGV"K@;8LN#'V-(\`9]MVS>-NDC#6
M&G-S#EX^<C%2.H$"XCPE"P@9PLPN`N7N\^/N`[JCBR&'Q\^S92.4)97V_$Q,
M?(QB-5]$TD4N1U0>,HC+1DW)Q1>_)IY'9;J.&H!?(<#@XJLYY@^2,CQ&/IM.
M7A<;ON5<_1[/C_!5<;NH-JA<\6M%JT:/L0D2CTGK,[@A401<BCJSA8LVT8F'
M#C%,K(V_MG`Q8C*OX67FX>Z'<BN1&Q<K`"^F)B92K01,;D"K?Q4.5E;M/DHT
M,.=W"F2W3<B6#$_*<G;)I(I`%!RIA()'.F-=63,5`*B^0^0?ER\NN1$;;)J7
MIV$:98KQQEX%XKEJ=7+:HE2XJW\>N4TKE/)K*$23KJ9&52&DK)JQJ8$-NJKX
M0.KN^]-*[;T<+O=.X&UMMA[UVW=R&.N1<:#:)\2>,D_U)(\B8(I-A+&O4]!/
M3$%GXTL_:[;+!*@RT[9W;;58#0K2Y.5CR8TME%D62.$O(`#TG;0`P&JO/R.\
MJ;.%VF<R6*AQ<">JK<^X3DQ2,,4_+DK@Y"]XY><;JCAZP-2WNL5]^;%]PAK0
MD_D&:A&+Y)1,BA3)F\0&T#L^#D8$?:SYFJ:3$E[C1U60KICW7,7)PY58@ZNB
ML*QR0Z0-$\B*X`).P;ME1Y^9W')BNL4>5A[`$8IJ+2[8DB9D;+<:5GZQ=);L
MW4AB<K<"ML'E\\<YGBUQ=IF*;)%1T#9"S=WN4_`1-SMF0F,%*WRW2]J<1!;E
M='SV9L3UD63*1X]*#9L[?`LN@W034*D79)Y%&+M&"DPDCQ,.*$,(Q$I*@L^A
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M0=\V+;)\\H;6:"')7%N`/NIU+J92Y8R2(@@"*97LVB^:!RA=Y2@9&Y4#",C@
MFP\Q^87$9G`4R&R`TS($AQQJ63;Q6;:2<DKI,U-V6Q1E&29.F1(D%#NCG52.
MD0Y$B1$&^+!VELF_[AC-)F9W8^?OZI$="HVW2JLF.=0=F$R$B-@048@MJ"E6
MR9=O23=]WP,:<1X^'W7MFSLTG$E=SBB*3W!4#HO(2X/!D`4%22XMGC!R\Y89
M\YR<!Y_*EPQY`8QY%\->0N=8'$&&):[-8-G"/I/%AZ8URW%V&TS<=;;_`$PJ
MKINC--VL>V%15VDBU0,18H[#M6')B=P=^[5N,YR,_$[<VR;4HMC"2;.96EQD
M8NR&1=:L_4?J0=&QL"6B=XR!)M'9F=A0]#%G[CW3&*GC,4QL3A'-(`BNJL%=
M5$::).H2.("W)DSG9R'QSRAS)A_$L?09&;NWF'8*XM5I_E^2RI<:E4X3(7#Q
MEDQ2<C:NPR!$MX`K"U1A%%V4/X!H\247.=+QBPN@B>T9,K>UVK;]:(9Y^ZY"
MS!G8#9FQ6B0,6U:9!(X*DE(N'25%U`Y7<$F-M<F9E/&S)#B]OBRD*"=SRLB"
M1BMM.I`H(:VIS_49@%`P*]YS<XLQY;X3RV.K!BRAY-&M>9O5LITB22R8^XWW
MR>XLW:`J3>Q.J'$WR*L[E99C!.#PWBY=PI%NWQSBHHF)TS8>-O<<>T=W=ZPP
ML^T#Y>;9O0QY3J>-I<R43"%UTHDKF,)U"A_`O$=1]=9LNV]3?=J[,EFT;DG?
M$^T]>,660#`ZJ&53=S$HDU&,,"9D60$+Z*Q]G_S%\Y9&QDIE6GSK_#TY;>(_
ME<YW*,)DR_PE6@)[,7,%S6L@1'@3V4*W"U::AFYV4B]3:)R3J(.+9ZY<(ID*
M6=BPW3OV':<;(;X)>^=JQ566\@?'RMAR<T1S`%=2!^GU(XNE'*R=0H'((@_C
MUR.UY<N3&/Q)[<WR0F.RN)L+<<?$#Q<&];>MHFD$CQ:M"DC5JE78><_)^5S#
M2./-P)B9OFO&?/&HX)EKYBJ1RY7,)W%ADKA[DG-%,<R](1R,>>F&U;EBM$9J
M$E):19.#(D73307!`Z,7B9;;E+MF=@WB9L#NJ-E=NHOQ&SICZ)`@`30_74`,
MK2Q21R:)%+$+GYO3VV'/AS/Q8!+V_,"@Z<@Q]QS)(9(]1U%9`,>1T8$1RPRP
M,\;(?7&VN^9GSXQ!P:XHY,<ML1YIO.;Y_D;9[9<I>GW.ZV2L4RH9//7HLSW#
M]7RY4KY8(..M$\J5[,5Q-ZSK-;:M$/9"AP*<V?NN2N#/LN(@1,>/M;;,J21K
ML&ER,?&,4F1(MSC*8FODY,D<HR<QY#'T@.FV?'MPGR>X4!9LF/N3/PUC0`>C
M&GSQ,N,C<)RIQU&/!U4D2`*':9R7&V_-/..P5#@YA+DOC>/QW8+AR!DN-].I
MTA)/+*\Q#7[+R%L-8K*%MF53I5*VRE%K+J>47[@PQ3YV1,B)CME#B8N7OT+X
M/=FR=L8!*_'[H^/&\JZBL:8V3F@E$90\DT.,8HM+VZLR.!(J]-XC:FCR.W>X
M]^S'5_RS;I)Y%B;2KRI/'BE5=PVE4FEUO<$Z(V2ZDB18AYH\S'E%QIBHDF6J
MQQ;M\M;J?R+QA0IC"]AMELKUCYI8PN,1$8MQG+,2VEV\J++(,)8$_'5I=TO.
MQCV.>$,^`>E(D=%/D[ID8>V[/BC\VS\7;I<-7=7CD,FY)MNYZ9%T=:+$Z\&6
MLJ!`D77B<2-"TE2AQ</"Q6W'<\AEVW#S9US7L8S'C#:Y=SQ&"%7*2S+C3P`.
M761GQ)(Q:<1UC29YQ\Y<'YDYV+Y%F,(W%U1YG@CA/'-,]C7J`Q=C/)G)5NDC
M%6Z8D%;JZ<)4"$>65\O9CJ')(S"[:/00>L4$R@3.QRD^/M&WX+EYMU[VS\""
M:12S)CXV#!E,K(I4L7QHHTQHD9;9T^1(PD$RQC%R(UAQYMQRTZ8PNS8-QGB5
M@`\S9>=BMI<@V(R8V9V*D#!BB6RR1R2O;G)SS&N1N,UZO"Y49'6O7%CS'L+X
MTRNKQ(:WEI6N1-$O7&;(V86F/(2D3L]89T\CUN8]E)1+Z4?-C/T$'1NX()2)
MQNV[C'+D[)OBXS28S8O=&.V.SW1\C;8$2'()53IB6296U%)&@:*9QJ90@N3X
M3JO<&TODI&XQ=BRUFTV>*#,W?'BF32S7,ABAR`H#)UX)XE``DNUS9`\RG-47
M0^.O)!J&+I^9N?`OGSR8;U>EV/*Q,5L9G$[;&DY1*1<*P>Y13>VV.HI2!XF=
M=OFC=ZWDDG@,"QI55$1L[Q/D;!NG=6(LJ9$V)LVQ.9+-T9GW'>(L62?'C+MT
MHFAEZD+!S*RE5ED=/15=OCCW1-C$N-)CQY&_9\'3:PR(4Q=NR9A%.VE0\HEA
MM(ND1"X9$+`2'[7#S:N5&':!FM?(^*L.7?(S+%?"K)>$D\71%TBZXS#F=9[#
M4(>'R;'6W(2ZTVM19*((=19G+0#:4.8K<%6??`X2F=U1\??,WM?;XGDW;&[S
M.QL]@R2*,`[B)8X@R,)&BBE@56E(,TD3`61DDB\#(@EV;9^X,UU3;\OM&3>=
M.K2T;1Y,>&T;-9PR=69)B0FI8(Y`;L0RS$XW\WN2EWXJ<M,I9QPO2J-F3C,X
MO[1E7W]AK>-ZO:W==QRQOD0TN4:YRMEDV'7C=>139R"<M85@!#NWO4@DN":4
M=O67\+VO#O.VO$VX/+-#I9M48=,D0+(&'3#\6T-CAP_Q,,N/U%9E82>U8;9'
M=";-N"2)MY3'D#A=+Z)D+N"OXA`&G6L^@HT,B2"-M#`P*IOG2<B6O&;D7=\C
MXGQV]Y"8UMV!Z52L;0-$R'0S1CW.UP?8[B['>J_:\C6:O6FCL[-%+N(F6@+P
MFQL38R2!U8HY^_#+S6?J=M86U1229VX=POMQNAU1!,8Y>F2`M')'E2)#/&L+
M.0&>!]3^N*L:%(X8-TSMSFCCQ,?83N``<?B6DCCU12@2++C*<G'=Y`BL%6==
M`*JPS!2?,KYK6ROX^Q7.X9PYBKDSD?E59./$18\EM'R&,8AC6L+/,V.GEOQ7
M2,W7BXU:Z.6;4L.C$N+>*JAU4Y$`[HX-`Q9,L32;5#@S0B9]OW?+E#-J1EVN
M:"#1'(`BH7;*4S,PE^&.'EHZM=7CO28QPL;><S/CD^'BR-JAB-@C7W/JDNZ$
MN76)<=S';I]<3PLI70ZOENO<Z>6%WSU2,6UJ$XNFK4'PLI/+G-5CJ<C;LSQ\
MZ(9.O-"O5)PA;*C=*[!R2LZTJI%X)TY;/DF3DJR#D7?J&#WN6XXNW;1\Q^Z6
M@F?9=D^&:.'@L\JY.US;@HZA!1@K1!%E6)5FC(E5%U@"[B;>V3F=J;&\RQ[U
MN65GXY<\(8FP\G`QP[H;.GJRV,T1<M&PZ9>\;%X98Q\UOGKGG#^9K:3"^.</
MQ=GX=9GY,X`R`_AVI%*TPQZ9LY217BE<[V^:S`56$D#-"S:$#6&4;86R7C(\
MZ3@6J6'W%#F8/;G<$67E]+=\7"P97:.Z,R99*R=-;R&`R(3+A3/*ZNL4O`L@
M-97;J8NY=T]L1XV(TNSYF[Y.&!)]U7A8B+J/Z.KHD41YD$:(X#@I(H]5?>O^
M8+R2PC%57ZUN*ODK*-GX(>7H[K=ALMERBRQ0TR)R;S)=<>0V0<G5N3O4G&M4
MXB&<1[JS2C+P,G-OT#H^,0;J-BM=EW57?OKO;MO"BCBG;O;&VQ;*S11__2LK
M/R>A'J#HCG%DAQ,='`UR0&7K2`Z]:VV:-^U>W-^R79\9>U<W<C=E263ISX,$
M*RL%T.X?($DTA3TQ+((^FI-9SM/F0\QJM=F/&Y>I\:WV?V/.3&?$:>R4R@LG
MJ8.DXS+^`)_-<!982I&OI;C%6"F*(,F<NQ6G'H+$`XD\.9PGW,5L<C]P9>R1
M8NF&'(A[CUZ_6>IL7P[!D*Z0(YQ.8R"&9)(V]7`J,W=3'LD6XOEZI#'^22(%
M]!$6[94N*RR*VH]2,P/+&UU5XI(GTV-VV0<!^15\Y.\>D,AY1A*G!9$@<H9J
MQ-<4*(G+MZ:_F\.Y5MF.'$W6V,_)3,U'1DRG72."MW+QTJD8Y@%0P;;9&/-C
M;AL7:7<&''(F/NNT8N8$<AFC,\=V0LH4$!PQ7@+*0I+$%FMY"RX>_=V[!.RM
M-M6YRXA=00LG35'5PI)*^F0*02;LI86!"B:&J5ZII2FE*:4II2FE*^2ZO<(+
M+]TJMW*2BO<H`4RRO=D$_=(E.8A#*J;;%`3``B/:(:L94_PN+DY/1>3IQLVE
M`"[:03I4$@%FM902`21<BKD2=66.(NJAF`NU["YM<V!-AS-@3;PK1=AGSP:;
M>F'*&=RC@67P]%<9L46K+$S7G&16TSE]PRK,BR;)5:T8@L])QO9*O89V/G(Q
MRT=QZEAKHB\%(\H4Z8=YA9&Y#&[6D[ATI)D=7`@6.-F:-LG/;I+$9=`=!#D-
M%%*[P*2)"\:.4=!*+M$K=Q)LI8KC:LPM(P`80X8=VF5`S)(LD,,\B+'.Q!B*
MOIU!J^F,O.F<WC&E^LLYQ+OE6O\`$6C!E*QE53SMX9T/)MLY`VT*-3X%3*&2
M,'XL<5I["6`!/,F1@99NUCC)N&ZCLQC($E9TD2?;L''"MN63NIPU1STU(7$G
MS7G#69]"P8F6-+1*W6CBC;0LPD2&@9),?<,^74-MQ]H?/9T'4("S10"$BZIU
M'DR,<J5E=3$TK@EHM#Y]M/F`\@ZY;>,^'C\'Y%GR!Y$K\AFQ<>6G.\'`5:L%
MX]K55U)3['(L=CRR%LM-N-<L9GD6^5BHMP95`B!VH`N54OK;U3<]QR,7&<C%
MQ]IQLZ=G&F6%9LM<-XFB!8-)%(=8TRD21%&]#,R)>DC3&PVR<N4*QW-<./3Z
MUE+XF5EK(K>D@:<8HZL@*N7L65%,F%L7><L.:.14M@_&_%N[V"O.+EE7&5&R
M:25OJ43+W_&#"P)&5N9SX0"A4G'=CME6>1B$PA:)E\V!1JLXC$A561;0^V[B
M^[]NIOV%"%7(VN7.Q@YTJ\2_B0I(S!2DLV->8*BRH)`8.H6*N;^XXJ;3NK[9
MG2'5C[A!B9737J/$\FE9F1%-I$QYFT,7>%FC_&"A>%8,PQYMN5XO%_'K.'*2
MON(2!N>#N>.:;#!8SDZ?,PMNA<#Y"I432VY8Z3H4;9H*;CUK$YK\<@C.(H+%
M;%?22KLSDOA<K+R1@S9&-$C9&<O;';V0L;6429F[Y./APN&47C^*DFCFF!$D
M6,LS11Q,T/4?(7;VR,]<+A%%_N3=<1G!U&*#;HLZ:=&#6$@QTQ2JNO3?(=`Y
M,:N8Q(&^>;E>,+57(R.=>(+NBYEIE.X[Y/@<8P&<H>[P5NQIR&R_&X6B94V0
MDL=00P%JJ]L=+^-B5(==(Z:2?0\_:F%'-@1LW>L+8<$K)FOW'!L\C$Z8TERL
M2?+@E1K$R1LN-*C>E"ATGU7($%)E1P;/+OLX(V_\DRMRCMQ=EPW@6>%UX".1
M1E8[`AG!$AY%>,E<:<^9*P8AYA7G*N&&N*<@<,;A8J9D+'Z67:U8ZS,2$=CR
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MO"OVYN>];+E-'MJ]J8^[_$O&-<*YR9`QE&.2RRNCXF6SJTB`I#'S,S+%LNU;
M5H[@PMHW6`/F?[G?:3"K$)))CI#--><6:-&BR,=598W.IY.724R8TB.??,-'
M@7Y5>9("OTS*64.6^4,#4/+EEL,O#8_"0=W-Z\?N86'B(FE2M?A5+\UA'3->
M21:%3AD@$Z+8ZJJ:C??YL*(=]]N;$L6G:9]KDR)3<EBR;.V4Y`/&T3ELL*&'
M5:!<:Z)*6&H;5.<GM'N3><B?_7XN<L2#3Z1&^\I@@FW,E7CQ[6]/6.22QAZ<
MDGJOYH,;9+CAJH#AA^R5R[R;YD<;B/?KXW<DK[GB*RM+QW;CH!4T!DT;V%:Z
M4V0'0-'"ON*[GH]?2CO2CM?;NYOASTLCM/+WP1WXA<6>*'X?5:Q9^KJZEK+I
MTZ&O<;$NV.<C>\9Y;2X6_;?MC<+AGSX>KU1QX+%]W3S?G=>51KI?G%YXO\?B
ME_7>!+'ISIQVO/)C%?M+E-'LT)+'^*UH1'(XVEPA@U[]5'L::9`T87H>&E"B
MEN5L942IR6\9D.R0=SRY;7;9]GQ-TRM-RJX67'*R&-K`R3J\:HT.E1I,C]3\
M,+)8P<,[CD;%!C/_`/F>\96UXQ(MJR\5U602"YZ<14LRR7;B`I7U$KDJ9\WI
M>8J"&1,(<99K*]'I7$S'O,?D1*2F5(;'LEBC&>1(N5GXR#J<0\J-@+E*\M:]
M5IEVHT\1!M#`T1(#KJ<'\/>W2>#:,_N,9;M^2;=N>+@M,JWDDDRHX)PZ07`Z
M<>/EXDC$S7U3,EAT]38^W8\^Z8W;R8BJ=YW*'+DBA)LE\2=L0IUK$ZI<J.:&
M/\("T8<\'TK(K!G.RV<B^3&2L-XRP(1SB?$C/$4K=,WSV44(9\G%9OPE"YCH
M2L)C(M&?*S$@<)88]^W]M(^#`I'/6H"G<DD(]ORHX-UGW`+#\-NNX;>`IZFN
M?;I88Y?!=*-U=2MQ^[8BYX8:Y>)/C;+D8,QD;-VO%SU4KITPY4V5$MS=O4!C
M%K?O%BO#3J:*G$KS-K3E//\`F[BG+)L\FY5H?(?F<I89-.2K-"0PSQOP]>%Z
MIB\4XU"NK#DFV24NH@R(T3(#E-GUOI!T`>'3=ZO^822?+6#NE2PEQ>V),S+F
M!76V8V1FB"**(J5`Z$"&25E$,1Z(TSR2R*DSDXR8O=2[2P'^JW+!AQH2&`Z#
M[;M^1E322W!_KSS=*-2TDA$JCHQPAJAFGYH'*B9HE:MM:R"Y9LYWC)Y<63&Z
M=EJ6+Y><+9L_\TYG#N5GTF]AJ%789RK9:$R*R!-NP:-60E!=HBW<"909G;5E
ME[IV[:LIPV+)W5L>$0HM_I<[MV3<9TOQ;4^0%<N""MBL>A#I$1NF0D&S[GFX
MB$2Q;)W!D`MQ_'V_<X\3':W+2D98!3?4"#(78:C+:`\T_*L?-,<:U+!DEG_(
MESRYYA,;`_6W+%.Q6Q@ZMPXR2UBU8GVA6\./6CAB[JLF8(XRS1:0!1HFDZ<N
MU5SNB0.W;V)>T$[BR8C\/A]H8^]Y+DWD>*;.RL0J$550RIT0QT"-&4V"A@2T
MW/MRMW-^1P26FRNXORJ!;>@2_ET68#J)+"-F8KZB[*26U:0$'MN'G.O@Q5+Y
MAP[Q3F,GU''7#K'/,'-YYS+\1CUY0('*\+8)2FTVNMAHMN4OLIWE9=^T'0!&
M)M&@%7(FN<3($E][RX]ES>XEE!;:L'<\+`$O)Y<C-CQ9H[1<0B)%G89=NJQ#
MRR(%(B#R8>TXK;MC[*8FTYV9A[AE:#]Q(MMEG@G_`!.;.TN+D!%Z:@HL;%@9
M"L>Z.C6<EVI-.N:;,T<G;JM7K.G'G7!R=B2?B6DJ5F=P5)$K@S8KOH$X$(!Q
M+OTAOMJ9W7!.U[IN6V-)K;'R)(M5K:NFY2]KFU[7M<V\ZAMKSEW3;-NW)8RB
MY$$<H4FY42('M?A>U[7MQJZ=8%9]-*4TI32E-*4TI32E-*4TI32E-*4TI4#>
M5G\3/EE?BZR;_3WYS:>=5\!^GE7_U>P;RM_Y;_!+\(O'/]S].TJIY"IY:52F
ME*:4J,63^%W%/-.0VN6,K8%QS?,CLXN$A6]PL4$D]F2Q=:FBV&`9G7$Y2+)Q
M$T0'#<3E,9,X!L.W9KQAQIM^6<_!'2S3D1SZUX-UHA&(Y+C]]1%&`>=D4'@+
M5[R)'R\9,/*(DQ5BEB",`RB.=725+']UUDD##EZR>9O5T17&/C]!NX-]$8BI
M$<[K65+CG"!<-89%-2+RYD%A-1=VR`V,'ZMDLL?8GJ+I<=Q4(X,&P;%VICPQ
M8L>W18\86/$P9,*$`<(L29P\N.G\,4C@,R#@2*I.[9(SQ.=0RLJ')EO_`,3(
MQU"P3/YR1*`$<^I0!8U9V+N$?$K"=^4REB?`&-J#D)0UK-];*W!)L99,+RK%
MK6U-NL50Q&J,XI"-1633*0FR)0*!0W`?6$J[=C'#P1TL8PI"57D8HRK(A\U5
MD4@'D5!JN8[;AD#*S3U<@3/*&;B1*X97<>3,'8,>9#$&KR?\9>/\I<CY#D<1
MTAY=U,F0&93V=Q#(J2YLIU:GCC^NWLSHP]0V*%I@^SFZ_I3;]@!OVZIA11[<
M\,F"O2>/XO25X:?CPHS+>7Q.A>M_'I%^54R6.8LB98$BNN.&U`&XQ',F,#?_
M`+AV9HOX"3:O+"\6..E=F(*P0>&Z)&3585RRO7Y)K"($=1"V=I89S,"C)0=^
MY-D.5'OI/;_GF';L+V:QQ@X8P,C:QC(-MEVV/;WCMZ&P8F+QXI7D84<EE3D"
M2?$U>.5D'/7=#*?S)<\YPE_?&84Z1R0W,3&,!"_,J+'A5K.N$/$=]7$ZB\X^
M8R<UI*C8YQH2%7KR"C$*#B*RJW'&E4[HQAZH>FVA<[YDD(CT.#"81'61-&F1
MD2Y4RZLE\F/(9O$SPP-BQ2W_`(X\9F@5N8C)3E5F!CC)''``B+'-&``."9$H
MGG7E]V691*XY%P&YU[Z#PUXLXM@J56<>X)QU4X/'60'&5J3'Q,$BBG7<CN86
M2K:US8*',HO[?-`R[EH"YSG,5NJ)"[``;7=;=?#RK_ZC'@FAC;Q2+)_KQC^6
M;_B#]ZPOR%K91#%E0%`89Y(I)!869X"IA<_S1E5*']VW"K"F_+DX,6.G-,?3
M?%[$LA3&%SL.0V->5KP%8LKG;4$&MEGV@)+IK-W<VW:I%<%(<$E`2)N7U"[8
MRXN.J;:BQ`)AXIQH1_W<!8.8E_DU@-8WL1PK-ES\R>3.EFR&:3)G$TI/$O,-
M8$C>;_B/ZN?J-2"M&$,0W3$ZV"K5CFI3F'EJ['U(V.7T0V/5"5R)2;(142A%
ME*1%JUC$V:7A^[Z#(BF42"`E`=7MP`W69LC<1UIS,LNIN)ZBL'5[^#!A>X]W
M+A6+@D[;&(<#\*(1-'I7@.FRE62W(@J;$?3SJ)UO\N?"T],<6(FLF3QS@KBI
MDTV:*IQZJ%4J3>DV#*K)&="M7"7GG,6M=&J]?>6-TY%JW?%:/5C%,X3.9,AB
MW,:6:#?4W^68RY<.W28F.&L%@293',R6L6,D6A0'N(VC62,*Y<M[G=)MIS-I
M$81,F5'F<$ZI5BD@DC1@;@*I@TDJ`S1R/&Q*6`SO<N(G&7(=HR1=;OA+']HM
M>7Z0TQODV=F(1)V_NM(8&9F8UZ=4.;I=,V)X]N9$VP*I&03$IP$A1#%^&@Z&
M3C=(=";*BR77P:>$!8I3_.BJ`"/`6-7OC<N^,W7:\,$D*?RQ2F0R1C^1S+(6
M7D2['QKXTGAYQ>QQ5J12:-@S'E9JN-\BERY1H6-@D2-:WDU-C)1B5YCQ4,HL
M%C1CI=R@1R<YSD25$A=B@4`RA)()\3)#D3X\,T,;7XI%DAEGC'\LH9A(.37X
M^%8>A.GFQ%%Z>0T1D%A9S"\<L1;VQR0Q.A_=9%(KR+<+>*#AG(QZN`L:G8RT
M?EV*D&GU>;E;N8W/;A@ZS(Q,D02D(UR(O%-S21"@4%>Y*`=(!MK!&!AC&CPQ
MCK\*F-!CA?`08V0<O'B'\D.23-&/W)/4MJRVS,ILELQIB<LY#3ES8L9G@^&>
M6_\`&T'X3-S9/2;BJ]-<5..-CC[?%3N&*#*1M^QK4L.W%D\@FRK>?QC0AE#4
MNEODQ[!A:N>:=&8D)TF;F5ZB&`2E$N3E*N:^X298ZDF7G+FS$\Y,M%15R'/,
MRJJ(H;GI%N5ZQ\<G$7;DQK(F)AOB0@``18TI)D@0?NQ.22R#@3QJJXWXXX)Q
M#B]]A3&F*:73L42B4ZC*T.(AT"5Z52LQ5DY\DHT6[X9()5)<R:W?F4ZDMB?J
M`4`9ZKNF)\#N(ZV'TC'H;BN@DDK;P%R3YW)//C7K$D?`S/C\)C%F]17UKP;6
MH4*U_,!5`]@M6,Z3P,X;XXQYD7$U(XXXNKN.<MM6S+)-295Y(T7<FC)%5!@W
MF@<*+KKI1Y%CBW`#E\.H83I])Q$VJY`&7C0X>3Z\:.<3JIY+*"A$@_G'33C_
M`"@<KU2!CC9$F7C^C)>$PLPX$Q,'!C/\A$CW'+U&OJKP3X>KX7;\=UN.V,%,
M*-+":VML=FKZ0P2-G,Y4=&GR>OXT)8RBQBBOWW>=T/=[]WZNJ92KG/@298ZD
MF*"(2?\`AA@RL%\@P=M0Y'42;GC58'?&&<(#I&3IZMOW]&C3J\].A-/E;AXU
ME2E8"PMCB:C+'1,95"J3D-C."PU%2D+$-V3MABRL23V8@:(V43#]G78R5D5W
M":'H[U4QAW$=7I)9)6W1I'+?&RQR3@\I7B1HHV<<B4C=HUX<$.GE85X/'X2X
MXP&8QGQ0SM&TVD\QU6AB9^/J9%)XBL>X_P"%7$[%;[)\ECO`&-*@]S/'2T/E
M!>&KK=N-RB)Y:1<343*$$3I%BY1:6<&7;HE214[SM+L4O3BG'A.T/L)C!V=D
M"&']PJJ&-5(\0$)4>0)MSK(&7DC=(=[$Q&[1RM(LO[ZR,ZNS@^#%U5B>9(%>
M.(X-\0X&H3=!B>/6,F=.L>.6>(IRODKZ*C"2QK'6&>MD?3G!5CJ*##L;-:'[
M]$H&`Z3IR90I@,!1"YD(N6,@9"Z^K-CS/?\`>EQ8UBQY#YO#&JQHW,(-/*K4
M4CP212PG3(D4T:D`7$>1;KH/Y9=(UKR)`/.JI2^&O%C'5<H51I&"<=5NMXOR
M(;+=`BHV"130JV3#,)"+^O$:<YE%PL9(Z470*Y.<YR)'Z2[`4H!=661,G$S$
M<C*Q\>>"-AS2')_\Q&I\$F_X@_>\>0JRT<;PY6.\:F&>6*212`0TD!5H7/\`
M-$RJ4/-2.%9AH&-J%BN#=UK'-4AJ;`O[):;>\BH)H5FS<6>[3\A:;9-JI%$0
M,_G;#*N';@_^)54P]@;`%J)5@Q-OP(5"X6+`D,*#@L<48LD:#D%4<@*N2DS9
M>?GRG5FY4QEF<_>DE8`-(Y_>8A5!)XV`J]]>JI32E-*4TI32E-*5\UD4G"*K
M=<A545TE$5DCAN11)4HD4(8/E*<AA`?T:LY$$.5!/BY$8?'D0JRGDRL"&!]A
M!(->XY)(9(YHF*RHP((Y@@W!'N-:XL9^5%PUQA)7Q\QI]NM[*_XTMN''5<R3
MD&SWRKUC%MX>MGMFHM%A)YZX:U*OR(L&J7<M>GH1:I$*(`3MMR8<4VSY>S3E
MGAGCQ4>1C>=AA?\`E29OOZH6TR(;W61$<<5%9'QLPW7"W=0JS8\^1-&@%H5?
M*),Y$/\`3'5#.K#38I)(O)VO4X3RPN+L7BR_8HE"98O$?D(<>C(7/(67KO<L
MG5TF(UD7>*$:/?YF37GJ<AC623,ZA",5$BL'"IS)[`;8,K-OGR8N3,Q7/AW$
MYPG3TSG+*+&T[RCUO(T*]!F8DF$M'?236+C$8L,F)&@.WMMYPN@WJ@&*6,G2
M6(^A5ZA$@``_$1&YH*R)BW@?Q]Q'8\17*M,+I)W+"[C-LA6+=;[Y9+99)F<Y
M#N89UE:R7F8F7CAY=+%8E8%M_P!6^,HJET#TCN.^KF/(<22=\1$B23;8\$HB
MA4&/%DC+554"RL<B\K,MBS.^J]ZID'XM`F22Y&;'E:B3JZT6)+@QF]^*KC2M
M$%-P`$(XJ*I]#\OSCIC?.#W/%68WMM.+6R[9`BJ&ZR+:GF&ZED/([((^]W^G
M8J6?C4:Y<;4V5<@]?-T"JK"]<"(_M.S%P((=NVZ/:X(P<2/%?%C#C68<6283
MOC0EKF*`R!3TDLMD46LHJ[G32;A//D3FTDT\4\NCT"::&'HQRS!;"614_?<%
MM7JO>K+J/E=<1:C$PE="K7"U5>MU;/=%@*M>;_9K97(:D\DW%>>92J$9$RKQ
M5LQKC]W6T5F;5(")L5UG"J8`JN<XV)<""?$EQ)M3Z]KQ-O9RQ,IQ\"89&&>H
M?5U<:14Z4H.M%CC0'3&H&4VY9#;DNZV09(W.?/L`!'\3DK*F0QC'H*SK/+U4
M(TN7)(N;U3XKRK^*3.AW"@3J.6<A-;NMB!.9M&3,OW>]7U"O8(M;&[8NHT-<
M9Z1<S$)0ZQ9&(N$HEL=-KU+JAT^OV2D>1+%N6W;NA`W+&W==S$EAJDS5A..L
MTY_XS+"S(.IJL&-JB9,7'EP<G;9([X$FV2;>([D+'B2L'DBA`/X0=@K-T]-R
MJW^Z*S59N$O'VX5'E/1[#69.0KG,B=&R9P9JS\EURLT6F5:C-GT"L"O76U6,
M136"J'AMN[>)=\':.P18P,==HPMDCU)@X^X29L>EB&7)DS!GM('^]_YE5<+?
M2`-(%N%2B;ADIO4W<`8?F4F#%AL;>EL>&!\9$*_=_HR.C&UVU7))K$=!\KWB
MKCV:@+-',<F3]FK^<J5R-2L=URI<+;.2N6Z!C^2QE7K+/R4P_7<S)RU.4.DX
M36$Q72A$SJ=7=E`,_";\NR<;+PU5)H1N6FRBW_U9(4SR1;U-.8%D+&["5I)`
M=4C7C<B"'+QI<6=-43IA(>+7T[=/)/A*#?@L!D,:*++T$CAMHC4#[SWEB\69
MN'K<0U99+J:E8N.;+>UG:-E.X5"S22/(BW.KMF"DS\]"/VK^;QQ=)UR`NH1<
MQV1T44TQ*)0'>*3:,&/!P=M2(_`0;/'M?3N2LN%$VJ**<'^MH8N5,ER#));[
MYJ5.YY9W#<-UU@;CD[K^9&0"S1YACZ1FA/\`P2R!0PCL#I6XX"KQD>`''A]Q
MUP;Q@;-+W`8VXXV"B6K$#ZLY`L=?O=2L6.1?_5>8:7B-=(3WCVQ9-<#J`H4Q
MP4';;8-IV3,R)-WVG?&D_P#J&&H5"."F,8QPVBD4<)(I,<F.5&NL@^\#49AQ
MQ8.W[IM<,2_!9A)D5AJ]1RTS0RDW*LN3&DB,""A`"V%637O+`XL5C.;//\4T
MR:%LBLA9/RI!5MUE.W.\:UN^9F@Y2!RA8:[C]9Z:OPSZZ-9911^=!,@KN")*
M&$12)M$#;\4;-/L'3OMC[=D8`6_&/#R9!*^/$W..)7%XD6PCU-I%S>L^3/R)
M,ALDL!,V5BY+D"W5R,1%2&>4#A)*%0!G8%F!-SQ-7]3.`G&VA1^)8NNURP(,
M\*8`R%QGHB;FV33HS3%.4'%=<VZ-D%%7'7)2KM6L-NZ>J#WR`=8$$.H-O>YX
M<&[P=RX^<I9-WVG'V[)L;%\7%61846UM#`2O=ULS7%SPKQAY4N!/L.1BV63;
M-WGW+'\=&7DF\SF]]2M;@C75?`"L3SOE0<1)NOXXJR<9D^N0&/<.U[C\\C*?
MEJZ55IE/#%7<D=P^.<U(PLBT3RC5D%!7`6LF"B1B/'!1#938,R9AD;CF[C.B
MNV1/B3R1L`T+S8*JF-,T)NAEC1$42$:M,:"_I%8N./A</'P\4F/H_&".121,
MBYSF3)1)0=:QR.2V@'2"S6'&I>8TX]XNQ'?<OY'H<(O#V3.+ZA/[YM(.EHM8
M^-*-&XZI[>&B5#BQ@V<;5HE%$4FY2%4,`G-N/H]1S3)AR8)E9H'S\K,.HW8S
MYAC.0Y8^HZVB4V)(!O:UZ\=&!7PWCA5.A@PXB!195@@DR)8D"\AH;)EX@`E2
MH/!16"XSR[N+4+;XJ_PU-EHF\1&<<L\@$;;&6>88V%U=LWI2*.2XN2E6RZ;R
M0HEB)(CUP:AQ8%[E+8GJCO&C;L8;5#LMF_+$V?(VPI<@/AY+O(Z26_J.DCEX
M96O)"P5D8$`U(/G9#Y&1E,1UY,O#R;^*S8,,4$#)?[@Z42I(JV656D#@ZVO9
M4=Y6/#V*K</5&E0M98:#QY@C%[!(][L1UB5'CEE=YFG&351<77>*NV5\?*+N
MUQ_:.T!!$X@0-M9T5X=Q@W6,_P"MCW##S5/A\1@X)V[':W*RXI*,OW6;UD:^
M-8,T<4^+D84D0./+C9V.PN?Z6XY`RLI;WN"TZAE;F@]*D+PJ^ZQY>_&6HWF"
MR)"UFPI6>NS')F=C'*]OG'#9.1Y;S#:;S0JJS.Y[E8DN\:E!D00Z8\FX);#V
MZBX]GP8MBS^W%1ORK)V%-GD6YN<&/(ER4C#?>#B69SU`=9!"DD`5G_'S_F^'
MO@T_F4&[C<D:W`9:XRXFO3]TKT452A&BXU``F]:Y.5GDRR^4H^I8RX\7F@88
MPJPXWUCC'</:SG.4ADFX4"MN)A*(;6E:K93K>/,A$IK*3!U`$L4+(`RE146-
MUD%,B>5+C?F.[;GF[NU\++S,&>6.(!=9P5A2-V5P\?Q&B(1"<('6-8@"'C#U
MYQ\A=NV_$@VR.V=!#GQQO)<Z!GM))*BLC))T3+*\C0ERA9GX:6*UO5J=<94^
MJUJHQIUE(ZK5^&KD>HY,!W!V4)'-HQJ=<Y0*!EC(-2B80``$V^I;<<V3<]PS
M]QF4";(F>1@.0,C%B![+GA4/MN#'MFW8&VQ.S18\"1`FUR(U"@FUA<@7-@!>
MK@UAUFTTI32E-*4TI32E-*4TI32E-*4TI32E0-Y6?Q,^65^+K)O]/?G-IYU7
MP'Z>5?_6[!O*W_EO\$OPB\<_W/T[2JGD*GEI5*:4II2FE*:4II2FE*:4II2F
ME*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4
MII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2F
ME*:4II2FE*:4II2FE*:4II2H&\K/XF?+*_%UDW^GOSFT\ZKX#]/*O__7[!O*
MW_EO\$OPB\<_W/T[2JGD*GEI5*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4
MII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*_AC%*43&$"E*`F
M,8P@!2E`-Q$1'L``#7AW2)'EE<+&H)))L`!Q))/``#B2>55`)(`%R:U,V/S.
M;=*)WNW\?^'.5\^8/QV^GXN<S-$VF!JL/(NZDLZ)9W=3@'L9+3%I@V2+;K0=
M->H71A,GW9%"&*&BCO>7H)NS[!.G;3,I^(8D-T25#3&$(=(%RRAW2Z`,YC!.
MGZEQ/[;=LQ,K:.WN]/FUM6S=_9L<3)MSPRS/&9P##'/,K)'#*2;.CVT<&NR,
MK-5N1OFE4S!N.>-F4Z_B.WY`JW(^#M-HBTG\HG0YVIUVHQL),2TA,1+^%G#.
MQ0BY15<024!,R383I**IJ$/J<W#?CMW<&Q[)-BA8<M(WDE=]`@226"*[H5-R
MIG76I9=)!#$<2([Y=_VV;SWWF_,O:I^Y\3"W3MO)AQF54.1'DSSMDQHD<JR(
M%#28X0,RD_B#4JE2M7UG7S"X##/*+!_&MEC=[>?]8E\:-W-^C;:Q815.4RI9
M;!`UDCJ*]CR2LLHY9UIT^(!'*'>(%#80`2F'WB[T^7WA/VK'AV2&(F28O]V5
M8)LDQ=/3SZ<2'47']3[OI]4+VA\BLSNOY2=U_-1NXDQ4VU<QUQ'@9I,B/"CQ
MGE=9.HH1=>4D7%&LX/.Q"S&S5F*B\?\`%MSS#DJ25BZ71HKVI,.&S<7;Y<57
M*#"/C8UH!TP=2DO*.T6K9,QR$,NL7K.0O48,K>-WQ=DP6SLL.RZU140:I)'=
M@J(BW%V8GQ("B[,5568<N[)[-WWY@=T[/V?VWCK)O&;(50,VE%"JTDDDC6.F
M.*-'D<@,VE3I5FLI@;CKS%KK-9*Q)4,N\.\PX2IF>I$8;$F1I65C[8WG)9VT
M1EX-I8:S"Q+>5IWM&`.=VMXLXJLRHJ=XF*:+A5&,VK?L_)W:+9-WV1\/<7BD
M=1KZJ?A"\EWT(MEX*&75J9DX!3J'8NY/D/LV#VQW7W!V?\U]JWS+V(*V?C1H
MT#11:S$TD4DDC)DA9@J#I75]2Z&+O$DM#Y`>8EGC`-X;UJ9X&WR7K=GRZUPY
MBV[DS!3(]CDNRS;U^WJ)8J,]@OWD4>T-H\ZR1'9B%1#U5%`'TQ@[IWPY\>V_
M[4<9<AG,:F:QD2"[.X_"*_TP'TZB;&PN:ENROD!V1WKLF3NN#\\,%,K"V;\R
MSX/@,AFPH42,Y'4?J*LGP[R"-C&"6(U*I'*9U<SY+Q_'6=S[GK%\W@9:H5RX
MVJX8_EYZ'M<W"0U2-)+$.G*11649(.YR-8$6;)%Z!ZUR)&'JW'6P;AO4>U;`
MV^9\#*RPAFB'%NHQTI"I8*"[N512=*ZF%R!QKC\W8D6X_,7#[`['[AAWE<O+
MQ\?'RUCD@BE><1W8H^IXTB=V61B#81LX]-JCAQC\P^.SA<I&B93P[8>-LZKA
MUAR"IJMZMD%*P]NPX[6*DM<!E$&L.G`^#36364;."F43;@JHJ*0)"!K6W;ZL
ML.^+O4"X&X[:R_$1.X8(C+<2!RJ:D#!E=@NE24LS,Y5-[^8_R*R.SMOV_>>U
M>ZH.Y-HFW>3:F?%@D1X]QC!/PW2+2&0LH]#H2KFRKJNI.4^*?-?'?+ZT9VC<
M71SQ6H8:LM7KL;=W+DY6U_)88E^_4F8R'7CV;R(C&[F-430%8ZBCI$2+"5+J
M[L,G8-U7?MJDW>/':+'^-GA0-?4Z1")EF((!02K*&5&&I5MJLQ*KK?S2^4.^
M_*:/M"'N3)C_`#C<\%LB2!0#\*5E:/HM(&99'``+E+*KED!<*':1N3<I4/#M
M1?WC(MB95NNL!*D+ER)U'+]ZJ10[:*B(]`JCZ7EW@)&[EJW3464Z1$"[`(AG
M965CX4+Y&3*$B'B?U`<R?(#B:T7MGM??N\=WQ]B[<VV3*W*7DJC@JW`+NQLJ
M1K<:G<A1<7/$5@;C1S!HW)-[:X./A9:CVVM*FD4:E9G+(\Q,4ITX\/$6]F#,
MPH&255$$'[9,RQHQV8J2BARJH*K1NU;WB[MU5C4I,O'2UKE?!N'#V$"^D\.1
M!/0OFG\F.X_E6NSY.XY$67M>6@'7A#=),@+>3'8MQU+]Z-B%ZR7=5&EU7+^;
M<STS`N/9G(EV=*%81P)M8R)9]"DS9Y][U)P]9@&AS%\7+R[D.A,NX$3(!U53
M$1344+G9V;!M^-)E9!.A?`<R?``>9^KQ)`!-:5V1V7OG?_<F!VSL$&K,F-V8
M\(X8EXR32M^['&O%CS)LJ@NRJ<;\;^5^/.1L6JWBRK5+(<0S3<VG&DXZ1/.1
M)1,1%20BG29$$+-6Q<'`J;]L0``#I@NFW5."08NU;QB[K%>/T9`'J0\Q[O-?
M(CS%P#PK:/F=\HNY_EAGA=R09.PRN5@S(P>E+XA6!N8I=/$Q.;\&*,ZC54HM
M2U<KII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*@;RL_B9\LK
M\763?Z>_.;3SJO@/T\J__]#L&\K?^6_P2_"+QS_<_3M*J>0J>6E4II2FE*:4
MII2FE*:4II2FE*:4II2FE*:4JBV2PQ53@)BS3CCPD1!1SJ3D''290Q&K1(RJ
M@)I%W.LL<"])"%W,<X@4.T0U;FFCQXI)YFTQ(I)/D!Q-7L?'FRIX<;'0M/(P
M50/$DV`^NM9%Q\P"S*.G:-+JL)'LRJ"FV5F@=R;_`*"]("J=1J]9L2*G'?<@
M)*%(/8!S@'4/-\OOV4NXP<)>GX%R;GVV%K>ZYKL>!\J8!&C;GN;=;Q6,"P]F
MIKW]]A5H0'/'*#65;*3+.#EHTRH>*9KLTF8]T("'0W=L$VZK<_4(;*'!8"AV
MB0WHUB0=];DDH.1CQ/#?B`"#;V&_/WU(97RNV:2%EP\N:/(MP+$,M_:+#A[C
M6URG6F-NU5K]NAQ4]FV*)92S4BY>AP@1VB50S5R3_`Y:*"9)0OR'((:ZCC9$
M>5CPY,)O%(H8>XBXKA^9BS8.7DX>0MIXG9&'M4V-7)J]6-32E-*4TI32E-*4
MTI32E-*4TI32E-*4TI32E4Z7CRRT3*11EE6Y9..>QYET#F360*\;*MA61.40
M,15,%.HH@("`AJ-WG;_S;9]UVH2Z#DXTL6K^'J(R:OHO>LO;\LX&?A9ZQJ[0
M3)(%875M#!K$>(-K$>5<V;&W93X[\6&G!N_4CFACC)>(KA;GM%RCQ-J9IB#R
MS5W\O<']:]L6TB[M*!A[-)SX@[;'16713:HK'(`_LQYMNN[;MO&S[5LB8.;B
M=SXT"X_2C.C'ED6`0PK)*70F)[HSNH*WNU@;QI^A4NT]K=Y?-?=?G3LV^=G[
MEVCO<$!GQM[GT9&WR`8W7*8YT&6?'2`B-PRJ_4DC4FW4-S2''KD;D"I^67C3
MD5"7N:O;ZO\`.*GY8FY@'-K<U..R'1K'!4LEJL33VA%1QB5^09MV?>K@F`I%
M23$1)L$IW'MV7N67#C01N<Y^T<A`S7)^,Z6.PNSWO+UQJ]1N6!/A47MOS"^7
MW;F1_<?W/V#E8</;\>^=I96!`EH>NN%EI)E&"$Z'=3*DLDFE;Z7UN%U5B+%]
M"SID)QQHS3D#&>0XVVDYO<-\9RT=)T^70?Q-(XX835K<Q<WZ)&(K,:S)W>R2
MRXO5NAJ)C;@?;81D-@EDS>[.U^Y)(V4;L=\S)+JR],R86-BP1."!I8+BD(K!
M6:Y;3J9JG^Z]V[*[9VWYK?+_`+?[EV^;9<3LC=W@>.="LF1NF\ODC'C):TDJ
M8D>&FA=3V3CQU`;!.6W$WG/EW!_(NL6#/E1S%#RR4?:<0XEB,9PE$D$)6IY,
MKEUB(.0M;5RDI-JGJ<.YC4R.3$17?+)+*&)T]08T^W=S8F'M&XY\Z[GNVW;I
MA92*JK$KK%U8\A2JJOWA,LH!+$=+0INUZXU\J_FC\E.V.^NR<[;^R\O9%,<^
M-GYKYDF4-&3ARX_52(J>D%R'25V34PA#H%:]C>^.^?N0\UY'P5C3'_#O,$1)
M.)5-UG2<R[4GE,JN+H1C##&S#NB6=P59O9Y1G.270@<$D3.F:)R%1`'`KM9;
M;.XQOV]8ZX&VRKL_2E9YIET2*2MX0J7)`>Q5]0#`E5*BYMJ_<'R-V3L7M7O3
M?.X/FMM,\L:+%MD.WSKDR9LAFU+\5&I!@C,,>IAJ81R,K:V,0CFO'S'JO9;,
M;@Y]6Z[.V#V!Y@/'FQSOL.)?RWL6O1@VH9&=EO`-W'LZ&CP5+W[I;H02Z@ZC
M!N&LV16'>W:$Y4]%8-Q!;]T%L6R@GD"QX*#Q)X"L7Y!;GMNV[5_<$FX[A!CO
MD_+S=(81)(J&69Y,71%&&(UR/8Z8UNS6-@;50.7'''FKERO<C86#S_4YS#EX
MQO>HRFX&2QE"Q5D6DG%.52KL.IDP%TY$1/;$2+&.IL15,W<G_9B.M6[CV3N3
M,V7N*&?,&8C.DN/$BJC+T<Z#)500HUN,>)X5#/9Y&#-;F)3Y3?,/Y.]J[U\N
M<W)[(RL3N?#SL<Y6YMF22PA"Q2>7X/25`Z;'@O%;:E]0`J+_`!(@K-R7Y+8Q
MM5IP??*1B[!7`UAQGR2TRY45H)&X7Z7<-8RQ5F':/5-K!6#1:+@P/"D[M5(I
MBG(05"AJ7VT8W=7<W>?>38SIM&;BPX<4<JZ7D59WRVE9;W0J9`A5A<@H>!#*
M-Q^9V7A?+'Y:?[7VKO3#S.[\KOR7>\:3`G$@Q\:.`QX\S.G]+(,@5NG<E#R8
MA=32SX34>5IW*?S&E%*C)5BL2^5\2GIRJT$[AH.6C(_'3IJLI7%E&J#&09,U
MA!,YFPG(F<=A$![-979B20[!NL4J%)/]Q;JP4BQT-)%H('\#*/00+$?=X5S3
MYT;MA[IV;\B%AW./(S8>W66<+(LCI(<F0Z9;$LKD<;/8VXU`;G4[R"PY//5,
MHOY&5JDFB0<(*NMT:[76Y8]I]8JPV9)`1BE9UWK11X#PQ1<O6?2F)O\`I`ZM
M:[M@S(\U<F:0MAL`$\D-N(MYD\;\SP%^``^F?[6=T[/W#L?+V78L"/&[NQVU
M9_C+DQECT9U8^KHH&$;Q`Z(Y+.!^+PCU#7*R4NTUO(5$DDX>\TQ_[2K[]8%%
M&;DIR]U)0$TBF=-1Y7K"R$S9XB!BFZ#`HF)54TSEUG%W"7"GCR<9P)5/CR(\
M0?8>1^RQKZ`[@[4VKNO8=T[9W[':39\Q-+@6U(PXI+&3<"6)K,AM;FK75F!R
M-G#D=<^3-SB[G<(<:A7JPR\'1\=A(DDTX)\Y;)I6&S2CY%-!"3GI9P4Z+=0$
MR%:QQ2$(4JBK@RDAO&^R;K,K'TXZCTI>_'Q)/"YOP'``#D+W)TGY6?)_:/E1
MLV9@8>4,S?,MR<C+T:-<:L3%#&I)*1J+,X))>4DDE5C"X@0D+8[N=*CL5KR3
M3,CZ6Z,>RD&NX;R4"X*!4I*??N&QBG"L1;-R(OTE![AXFH#40$RY0'&VQ,K*
MSL>/!<KDZKAAPTVYD^RUP1R(-O&MD[ZS>UM@[,W_`''OF".;M58],L$@!^(<
M_P!*"('_`(SL/0RB\0#2\`A-=553&7&M003[D7LT2*8IRKT4$6IGL@FV3([>
M&;-BIMVYG+@ICB1,I2$ZMB@``&NSH"%4,US;GYU^/N6\,N5D2XT'2QV=BJ7+
M:%))5=1N3I%A<DDVN>-7#KU6/7R771;(K.7"I$6[=)1==90P$3212(*BJJAQ
MV`I$R%$1$>P`#0D`$GE50"2`!QK6AD#GXZ;R;UECRM1JD>@8Z364L)'KE=\`
M'.";TK)H[CP8$5)TF*DH*QP*/K])A$A>=[AWV(YGBV_%#QJ;:V)L?:`+</*Y
MX^RNO;3\K6EQHIMWSVBF8`Z$`)6_@S&XOY@#AYFL3,N=^7$7R+AVE`NFW>IB
MNQ4BTBMA2`X"J5,S86SX!$FX%W7W`=MQ'42G?6["0,\$)3RL1]MZGI/E?L+1
M%(\K(66WWKJ?LM6T3$F28[+-#A;K'("S"0!RV?,#'%06$FP<*-'K<JIB)BL@
M91/O$5.DHJ(*$,(`([!TO;-PBW3!@SH00CCD>8(-B/H(/OKBV];3/LFYY6V9
M!!DC;F.3*0"K#W@@^SE62=9]1=-*4TI32E-*4TI32E-*4TI32E-*4TI4#>5G
M\3/EE?BZR;_3WYS:>=5\!^GE7__1[!O*W_EO\$OPB\<_W/T[2JGD*GEI5*:4
MII2FE*:4II2FE*>C2E1QR]R\XS8'2>&RMFJA55VP$2NH52:1E+&B8-_5/6H4
M)&=((B`AN+<`W[-]1F;O.U[?J&9G1HX%]-[M;V(+L?H%=`[5^5?S%[V:(=L=
MGYV5$_W9!&4B/NFDT1'_`+=0*L'G"XYDSJ-,&\?\[YE>=X8C-\-?0HU5DT_0
MFO'6*6-(=\DH;;]9NF8`'<0U#GNI9FD3;MJR9V`X'2%4_62P_P"Q76$_MMR-
MH'4[^^9G;VRQ@>I.O\5D(?%7@BTL"/8QX\*L93F=YE62#J+8VXOXJQS$J]B2
M>0IRQV*R-^TIRB52#4:PB_5MT&W3V`#"(=H!JAS.[,G08-NQX$//66<_88_U
M4;M?^V78-,6[?,'?=XRQ^]@XT<4#>'_'_%'._P!%J\(1GF]WOK!WG"CX_;+=
M'4QKN*JZNJ'28!+W4L^`SUN`'0*8VP^N54Y![`#5'P>ZYW0MO442>(1%X^7W
ME8\_;YU4]X?VT[65&!\I-TSW%_7D;A)&/IC4%3P)`\BH;F:\O_\`REYE,D'A
M)/FADMNR4[55(M5I'OBB0043!)TDAU)[J%`#?YB[A\NO9V;=W!5^XYM/L50?
MK`!^VO9^<WRIA_%Q/D!LYG'+J.[IQYW7A?AR\C8U(S'>`.0^.\%YYC<N9LON
M;'\U#Q,W!IW.1+(K0R5-6<3;]A$'!),2&GTTBD4*.X&,D3].JY&TY<>S;MBO
MN$F1))$=);F+`\![S6E;_P#,+MSN7N7M'/VGL#;-B@Q)B)!B*5$VMH[-)<G^
MF`=/^8UK&LDY%5./>2DZ\(T9,E.Y44`#*G67,<4TF[5),!.X77.`]!0](;B.
MP`(AQ_&@FRY4AQXRTK<A_CY`>-=7S,K'P()<G+F"0)S/V``>)/@*PHOR*J2:
MH%0AI]PCOZRXE8H&`/G*B9PH)O[!,74^O:VY%;M)$&\KG_"M3?OO95?2L<[+
MYZ0/L)K9CA3G3:Z]CV!C(*/KDY7D$'/LIQ*,)$LBAWK]VX=-'(LY5B0#-7:R
MB?28IC%`H!U"':,EC=U;ELL2;7-AQEH`%\0;#ER-CP\?&HG-[$V7N3(DWW&W
M*94R3KX`$7//F+CCX>%959^8'?RKB+ZK4Y1L)MQ(W932:H%W[2IG//'*&X?*
M8#:OKW]FW]>!$5]A(_QK$?Y4[:5_#W:8/[54C]0K/-6YYXZ?Q95K37Y^(E"F
M*11M$>`E69RB41[PJSU[$+)FW#UB="@%`0]<PB(!.8W?.U21!LB.2.6_*VKZ
M;\*U?,^6&^Q3E,.6&:"W!KZ3[B#?C]-9VQYR0Q1DN2)"P,Z=I-+`7PT5,H%8
MN7@F!0P)-%DUG+%PYZ4C#W)5N^$`$0*(`(A.;?O^U;F_3Q<D&;^$BQ^B_/Z+
MUK.[]J;[LD?7SL(C'O;6I#*/>1R^FU9WU,UKE-*4TI32E-*4TI32E-*4TI32
ME-*4TI32E-*4TI32E-*4TI32E-*4TI49>4?'2J<B<;2]3G6P$>]T#N(E4-DY
M")E68@XCI2/<`'6V>,7:95"'*.X&#YM]8F;AP9V/)C9"7B8?5Y$>T5M'9W=V
M]]C=Q;;W/V_E&+<\5P1_"ZG@\<@_>CD6ZNIX%2:Y7U[%(P$U:*G,2$?*R5+L
MTQ4G<[%&*>)GUH1<&RDM'&+ZH)K'W(J4NZ:;E-4A#'(4IS<&W*(8&=DXBRAP
MC$7'Z<_.OVM[3RCW5VMV]W,VT2X39^(DQ@EX/$7'W3_*?O(39C&REE5B0/@\
MO@-&;IV4BCHS5LNX!JV`IG+D44C*`@W*<R9#+K"7I(`F*`F$-Q#6#U_;6Q)M
M.IE70!<VO?E68.%%FYEIIO<N8JXZ8[D9BZ$,6,N>3YF8D4V591773BF%:8UA
M5)%H5B83*+I.#&.=Z*G>@`^H7I.R8V]8F'&^UX,&N2Q:60EKCR"@I8#WFYY^
M0^$OGQW%\H>X>Z)-I[_[PWJ/'VJ1HH]OP<=1TY1_4DR&GL&DEM97C](BT:"P
M]3;%^_\`-]OIC`IE'&V+VKDARG9US%\-,BDDKN!D&LA-];M`Y".!*1;?O""B
M0WI,;4Y)B=VSZ+[M!"+\="#EXCUA_P!?@./GPT]S?VQ[19<+Y9[UNDBD6?(S
MF@O;D62,%2"0"5Y'41R`KSFXO^9M*B;VES+O;=-^)C/AB6["+%('.XN/9H((
MB#`"=8]R!=P2#;;T:]_D^],+/W'+QYV51[[6`M]%OHJY_P#]A^4,`_T?R!VP
MZ/N=69Y.7W>IP&OPU<M7'SJ27''C-RBHKO(O^KG(_).6HNV8YL%1BH*ZRY9&
M,B965(EW$ZV*"*9DGR":1D0-OMW:QOEVUEX>U9>,,D3;M+.)(RH#?ND^(XUI
M'?'S*[8[KP]LQMF^5^T;)/CY:RM+B*RO(JJPZ37)]!)#>]16M6R/$(0TO(39
MR12#$5WDB+D=@8%$>]416Z`,(K(F4[L2E`3"?U0`1[-<47'FZWPHC)G#:+>.
MH&UOK%=;?*@,!SFE`Q2G4U'D%(U7^HU@%YR(IZ*G2SBYY^3JV[WNFK,HEW_6
M*15=10=P[=A`H_/MJ?C[7W)Q=VC0^1)/ZA6IR]];)&Q6-9I!YA0!]IO4_.-G
M-J=J5(/'U)C#RD":4<K+LY]B\&0BY,6C%%5OU,))F`)F;MTE`W,H4W6(E$-]
M@S\3?MS[9C_*Y<6-U!+`\>3&][BUQ>_A>HO<.UMD[UD&^P9\T;,`C"PX%`!8
M@@V-K<C8\ZD$GY@>0_$B96KTL6P[>H1A.`<H?.4PV#]8?T[A^C64._LZ_'`B
MT^]O\:P3\J=LT^G=9M?^5?\`"LVTSGQ2Y!HM]<ZU+1#U+84C01VLB@Z+U=(B
M="0=QIV9NW<I05<;@`[B78-YG#[ZV^1#\9`\4@\O4#[N5:YN'RNW>&1?R[)B
MGA-^)]!'O'&]_9]59MI?*W#=WE&T,TG'4-(O3%(S1L#5%DDX5.HFD1#QC9T^
M9(*JJ*@4@+*)]9AZ2[F$`&;P>YMGW"588<FTQY!AIO[`>5_9>M;W/LON+:87
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MM/#A<:VXA?=8MQ!TV-Z[%V!\C-][LVEN[^X]SQ]A[`0^K.R^`DX$Z<:+@\[6
M'#38'CHUE6`UM.KMREYA9*:X=S3RVQ7QRFK&0IF'%O%.1*I7<JR<8^B#RQ6T
MI'OYD^0IU&0@2&76;@@HB")#K)&!/U@P<?;M]W\SG)W#1#&3KBQ^)33ZF$C*
M2PLI4M<@`&Y4`UN>3W_\EOE3T!V!V.=YW@VT;EO']-FZAC5\;&&E.$BE8Y!8
MLWH92P(J:%`\L+BC@B&D+]?D8!)M5XYU/6&^9"EVYF\%%QC<SR3E9BU6=V9*
M+B&:")EEU5UR())E$QA``UFP;'L6TQB1H(U6ZKJD(XEF"J.-A=F(5?$L0!<F
MN?\`<_ST^;/?&O"SNZ,D8;@_Z;%'0A(`)_I0A5)`O<VO:Y-;$:?B3%D+&,5J
MQ`P2L8Y:MW<<\8IM'#-RT<I$6;NV;AN!D%V[E$Y3D.01*<H@("(;#K8G@?'>
M2"2(QR(Q4J1I*D&Q!!X@@\"#Q'*N.'*.8%R3/U0X#!]6K4#Q!#7-P1Q!OQO6
M2",(J/1,<K9FT0;IF.=02)))I))E$QSJ'-TE(0A2[B(CL`!\VK,TL./%)//*
MJ0(I9F8@*JJ+EF)X```DD\`.)JJ+)(ZQQH6D8V``N22>``YDD\@*M^#R#CVR
MRQ(&MW>FS\ZI58*]IPT'9825ECTBSJ.DJU<B1S!ZN\-5;"LP7*QD0)X1V9$X
M)*'$AMKYC=9<V%HR)L:413+;U12D%A'(.<<A4%@C68@$VM5O4`N,]_1,A:,^
M$B*0&9#^\JEE!*W`)`/,5>6O-5K&<!E_#E[M]RQA5<I8UN%^HY#(9`Q[7;Q6
M)^XTXBRGA#)7"JQ<HZG*Z"BJG=[/$$=S#T^GLU2&V3CRY6/^)BI)TV=?4BR7
M=2C,+@/>.0:2;WC<6NK6K,&QIX\:<&/):,2*K>EBA",'"FQ*E9$8,!:SH;V8
M7YCN5%=\%"R[)F`]S3[<@U73[=A38G>5M=4__$D\6`WZ.W7&]ETX?<.1C$<V
MEC'LLQ(^Q;5]&]S:]Q[0Q,U3Q"02M[05`/VM>H%ZWVN2UD6K93M]/BAA8==A
MX`'+EVF1XP2<JHK.S@HOW:IMC=V90.H"CN`"([:ALW8L'/R#DS%Q*0`;&P-A
M85LNV=U;GM.&N#CK$85)(U+<C4;GC?SJ\X_D+<VQC#(,(25()#@4GAU6!RG$
MH]V?O&R@%,4I]A$HE]8.S<![0CINU,-@.AD2(;^-F]]2^/W]N"$_%8<4BV/*
MZF_A[+7]E6\?-V1A>@^&80*D10%31R<>S*Q.F0P&,WZ#(G5Z3D#IZA,)^W??
M?65_MK:Q"R"-NII/JU&][<_*L(=[;ZV0CF2,1:AZ`@M:_+SY>VMC-&B+18K%
M$,*8W>JV%XY0]D)LS*$<)R`_MF1R+$`1;*-EDP4[X>Q`$Q5$0*0PAHF!#ESY
MN+'A`_%ZP5(\"#S]@',_575-VR,#$V[.EW,K^7],A@W[P(X*!XL>0]O'PKHW
M8D=)LF:;U0BSTC5N1VL0O215T5(A7"A"_P"$BBH"(!\@#KZ"%["_.ODDVN=(
MX7KU:K5*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2K8-=*B2
MWIT`UF@RWA:!4M*52&3:!8E*TD_+%J3Q(D5?&FB221P0%?H[OO?5WW[-6NO#
MUAC=5?B"NK3<:M-[7MSM?A?E?A4@-IW0[4V^#;YOR83B`SZ&Z0F*ZQ%KMIUZ
M/5IO?3QM:HE\K>>N$>*(,Z]8'$E><LSJ0FJV(*,B$M<94YTCJ-W$@BEUIP,4
M8P`)EUP%04Q,=))4I#],7N>^8>V,L+:I<UK:8TXL;FP)\%'M)XV-@2"*Z9\M
M_DSW7\QH\G=8##M_:.,?]1N&4W2QHQ<`A6-NI)Y(O#59692RWY[>8OF.<U+E
M*MZ5*SD9QX@9IH62D,<8^=&7O4?6G@'/')W2Z]0O8^6EVI^D6C,Z2*[0_?'(
M0HI@?F_=/<^\8R=&>=<:607$49]:J0.,DG,'G8+H-K7%K$_?O]NG]O7R=WAI
M]]V[;,G?\+#DT?F&6NC$FG6VI</&-A)'&PN9I!J1QTU+'45UPI7E)DW(BD<$
M&[=,"D*!@`B:9`^41'Y@W$1[1'M'7+OB2[<"2Q/VU]]G8T`OTP%`\@``/U`5
MZ#7MRD<Z+I)\Q<I='?,Y!NLR>("HF19(%VKDB:Z7>H*%.7J*'40P&#L$!U>R
M.MB2F'(0I(`#8^VL#;(-JWK"BW+9\R'*V]RP62)E=&*L4:S*2#I92I\B"#6S
M[RRN>\?@C(26(LFR#5/#&19@O@961,F1'&]VD5"))R@.3^JWJUD7$J<@0PE3
M:N1(Z`Q"BY[S?NR.[5Q)EVO/G_TCGTD\D;W^"GQOP'/AQO\`&_\`=S_;8W>N
MQR_,/M#`)[QV^'\>-%N<S&0<?2.)GA'%"+ET!C()Z>GK`3[E0A%$N[.F<I3)
MG)TB0Q!#<HE$O8)1#T;:[;PYU^0?%20>!%?75:I32E<VG.*KIM;'G&%C$^[\
M'/RT[X=,-BG*><"W*(=(>A,&#H`*'H[`UQ[*T8/>,I8>@Y%_=U%''ZVKZ(PN
MIN?RZQPC?B#$(]_1<\/^REJU,^GM]/Z?GUO)X&U<J'$`BKYJ&1+/1T7[>"69
M@WDETG3E%ZS3=%!PBCX<BB1C=)TQ%(``P`.P[`.V^HK<-GQ-RDCER"X=186-
MN%[U/[/W'N&R0S08BQF)VU$,+V-@.'T"KZ8<@KNW6(=^VA9-N!@[QN+061SE
MW]8".&QRBF80]`B4P`/R#Z-1DO:F"R$0S2*_@201]7_34Y!W]N:.#DXL+Q7X
M@`J?H-_U@U1Y'-^0WSPSEM*-XE'J$46+-BU.V2)N(E(H9RFLLX$`'M$YAW_1
MK(A[9VQ$5)$9W\6N1]0'"L3([XWR25I('CBB\%"@BWM)XD^=3@H"\I:XRJ.V
MS5164G(V'<&:M4%%C*.I!NW[Q%)LD4RBH+KK=)$R@)C]0%`!$0#6A38[KF2X
ML`+2"4JMN9(8@6]O#G]-=7@S(FVZ#/RV5(&@5WO]T`J"U[^'$\/HKHXQ8PLD
M5C:BQMP5.K9V-6A6LX=57Q"P2"+!$BZ;AQV^)<(B'0HI_P!H<HF^77>\%9TP
M\5,IKY(C4,?-K"_VU\I[F^++N.?)@IIPVF<H/)"QTCZK5?VLJL&FE*:4II2F
ME*:4II2FE*@;RL_B9\LK\763?Z>_.;3SJO@/T\J__]/L&\K?^6_P2_"+QS_<
M_3M*J>0J>6E4II2FE*:4II2N;CS&3<C>-O,+_47C*F]&S<O,6*86D'+1%=56
M*LT!(1*T?:FZB8BFSFV-6`R3-R8!\(B@LH78P`.M)W]-RQ-QBR-I2\N7'T6_
ME*FX?R!"WL?"U?;_`,A=P^7/>'ROW/M[YKY*KL_:&YKNT08C\7'G1TDQ0O-T
M;*TL\8_J/+&IX$UL`X`\!*QQZH3:>O"1+;EFTJFGKG;)<HNY&0F'H%56)W[D
M5%RM&HCTI%$PCV"8VYS&,,YLNSP[3C!!ZLIN+OXLQXGCSM^OG7`?G'\W=W^:
MW<;9KQ_"=L8PZ>%AH;100KP4E193*_WI'MS]*V0*!J93FK;A+V/@ESQGIV5^
M7+_S%[)<L@M,K\<<OWIYD2GWKD&SM.,<XXMY`5"0K^.:6QHN-'J+@4IN34,V
M-%E;#'E(43*YO9XR#'\H]M-A\%A1P;A(OX<N)DQ13MG99>32LXFO-("BRR2'
M+B(XJX7F?>!&KYF;@C&2#.(DVZ(MU8IL1A''!@M&H+0-',B*49HXXEAE:[!X
MV,<[YE/FEE.^<ZX*74Y-3..<I<4?,<J<QA6YQ><;)&4&^4M=%#&$4P3D6;7#
M8R-A@&ZJL`%*BFC;V:[!HY7?OQ.L;6$.1N'8TT>7`[SOB;!G*S?U%RCO&)\9
M#9[3!X8IS)DJJQXH&@X\,,>.Z),YIAQ.]-O&W%$Q(MRS<5]`_#?&.U9)Q)@1
MZ!'-+"5347R.JC'(D=LB(OG).?\`,$#F[0JFOF/,>,&<';.*$+A?$=<QQGRQ
MT.V8#-0*@M?)><2AKI5^-1&J#A"QH696WM5K,Q53`T<"HMV*:/1<)Y,GNKN#
M,W!Q/*>Y]Y.0A8!%PD>8XC!Y"8Q'-B&`P-AAI1FMKE47D>N?R0]#M'9<7$0X
MZ)VQM?0DTDR'-;2N0ACCLYECR@ZNN45A.)I4$``'()%<SY@KO-/'62LC\^U.
M2<QC+GBTR#B6(2ND=QOB*]6)YP_XV_4>:>GCZ[7%K-448MI'MJ*=TZL"+E\C
M-@F14_?\_"967\L99IXFES%V?$FRQ,+NNYQSO\;%&.,DBLWQ`.,H."<58^G^
M(D,:](P_A<?YFX^B1(MG_/E@QF0A0=NFQU$4Q(]"&/2KC*8KF1Y3*QX-*U8&
M?R_)BM8+9,N/%EY91T8RX*>65`0LPW0S*RM\-?7'+^PUW.$#$N9Z,965LI`P
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M:6)C,^1BR-F!9;D1].5(EZ*J0A=CZ2"'Q/QW2QU-^:1&V?`7'F_8^BX'%O)V
ME\AVUWQ-)XU8XNO+W+<%8$K;`W!BK]5<N.N1%H27?%5![-G91C!!1+V:99RV
M/C]HHB;?W!+"AAV:3:MO&.&]+QO'D2A=L,.K2GPRME94LJJVN25(OB9(XHHX
M[O=+NT^Q8N1&LN[1[IDRRNAUI*DV&I;.ZU@3U"<7%BB8J=*RR-CQN"[X0YH1
M\?$2&=6;(HG;!8[:4A>KJ[M=:]O2%`3&WV*V6,`?V%UR21`O>$J1FP^+)^OU
M']9KZ"BE+_+N*29;G\O`^HZ5/U`&M5.M^KDM?S2E!$`V`1`!'T;]F_\`9JMC
MY52XY7%ZS)A_'/URE32TH40KL&Z1%=+80&6DB@1RC'@;Y&B!!(HX$.TP&*3L
MW-K6NX=U.%%\)!_YF13<_P`*GA?WGB!Y<ZW7L_8%W*<[CE#_`$4+BP_C<6-O
M\J\"?,V%=-'"/$\+7J,&1UQ:O[)9UI-D@N0R2_L:*CY%9@LT1.4/V3J2=L17
M6'8#]V*20[@F&\UV9M<&+ML>?8-DSB]_);V"C]9]ONK7?F/OF3G;U-M5RN'B
MFVG^)[`LY\^=E]G$<ZG+K<JYS32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI6AOS83Y:X_9>P%S)P<Q/)WJ#1L^%GD?X-:11DF.0HF32K)'
MK%,=G;6(LJQU44C;D.]62Z@$`UJ?<HS,23!W7;H]64A:,BU[B06%Q['L??7U
MU_;3D=J]V[-W]\HN_L\8_;&7'#N:2%@G2DP)$;(TL?NM-C<&8<1%&]N-JR!Y
M=G`J2J[*2S]R1<N;YGG)3H+!8)JQJGDWL;XH3.213==WUG`$SJB*QPV[Q3YB
M%(4N3L.RG`1\K,;J;I*=3L>)'L!]@_PY5IGST^<D7?>=B]K]G8WY?\L-K!BQ
M,:,=-9=/#XB518%F`'34W$:^;%V:.7F:>6)/WBR6+/6%2)EL\D5%Y9JP`"1C
M/F8L4&15VP@`@QE2LFA`*8H=VL)-C@`F`Y=?[O[*CWS7G83:-Q`X^3@?M_3W
M]C_M?_N\S?E2F!V/WO"<KL#41&Z@=;#+,6)'_>1%B=2DZEO=3P*M`/RWO+^N
M>><JFLV6*Y+06/L=S8)/(698JLSV2QQZO5X-4%R@"\-&JD`ZAB=2;E3I*!Q3
M*<#:MV-V7D#,DW'>(=*PN55#^\P-K^X?I[/HW^[C^[#9,+M/%[+^5.]19.Y;
MQB"2?+A:_P`/BR#@BD?=GE!((:S1+>ZAF4C8%YJOES^U:Z7-N%(CN[+5XLJ5
MCK\>AN6RP+),YMD4TR]02\:`"9`=OVA!,D/I(8NV]\=JC>\,Y>&@&Y1"X_G7
MR]_E_P#8*^9_[/?[D6^57<*=F=W9+-V#N<X&MC?X/(:P$HO_`,*3@)A^[82#
MDP;79P6\L_)7(^7CK7DZ.E*GC!-9%88YTDNPF;*B!BF435*<$W$7'')ZHAZK
MA01'_E@7U].[0[`FG,6Y;T"D/`K'XGQ!/Z?]'U#_`'*_WK[3VPN5V;\HLB',
MW\AEFSN#P0<QIAYK+)XZN,:@"VHMZ>R"KP;>LUV%KS,A$F<)&,HMFBD7I20:
M,6Z;9L@D4.PJ:**12E`.P`#7;D4(JJHLH'`>0K\ALG)GS,G(R\F4ODRNSNQX
MEF8DLQ]I))-5[7JK%-*5H?YUL(Z,RQEA=$HG!W%&?/T0-N/>J8\@%%2!U;@7
MO0,)_1MN?7'>ZD`[G8(;,W2/T\!^H"OHGL24GLI#*+HGQ`'M7B?UDBM%20;)
M)`/I!-,!^7<0(`"/^\=;VWWC[ZY0GW%]U?35*]4$0#TB`;^C?LTL3X50D#F:
MR%C>A+WZ=%D<ZC:&CR).YMVGV*^&4.8B+!J8>PKI^9,X`;_LTR&-Z>G4/O6Z
M?EF,"@!RGN%!\+<V/NX6\S6R=L[%^>9C"4D8,5C(1S-^2#VM8W/@*Z-N`V'Z
M\5@_R.[39KNH)RC6ZQ&D,FL2'!.(9.%I(R6PF1<BQD$VS?JW,F4BIBC^U';Q
MV/MD+Q3;O,0^0SLJWXZ;?>/^9B?J]]7OF=O4Z3X_;V.#'AK&KM;AJO\`=7_*
M@'+E?W5LYUT.N14TI32E-*4TI32E-*4TI32E0-Y6?Q,^65^+K)O]/?G-IYU7
MP'Z>5?_4[!O*W_EO\$OPB\<_W/T[2JGD*GEI5*:4II2HD<AN<_%SB\4S?+N5
MH.*L'=G.A38@5+!;G!BID5*F>&BRKFBQ62/U)G?':I*``])Q$-M0^Y;_`+3M
M-ES<Q5E/[HNS<;V)502!P/$V'MKJ?87R6^97S*(?M3MB:7`N`<A[10"Y(OU'
MMKL18B(.1X@5J+R?_P"8:Q)#/SM,58/MUN8`(;3EOL$=4@$P'`#$"%9LYTYB
MG+OTG\87;LW+\FM0G^843.$V[:9)3Q^\P4\/$!5DN#[2#[*^I=@_L/[EEQ1D
M]V]\86#)?C'%&TPX\OQ7:(?1H]QJ']H\^^_V2=AY9;CCBEPG".`<,3RCVR/)
M%JL85$EE6KM.40105.T4Z`'NQV$1WW`=M>#W9W#(0Z=M2=,?R2GWV.D6X>RM
MJC_L^^4N+')BYGSE*Y;BVD9&&@(X%;HUV(U"_/P%N(O6?:1_YB>-%PR:WSCB
M<K4PE3>/JE=RI&:)"H;]NC&2<0],Z`B'2'=BX3$QMQZP`0#5/]_94$B+G["T
M<=^)U$'E?@K1@$^S4/.]1F=_8G!FQ2S]K?,Z";@2H>)9`UN%B\4H`]5^.DVY
M6O6T+`_FU<)\]/6,+'9*4Q[9I$X(M(#*#$M7,X6`HB<J4T1R_K9"]0;$[]X@
M=01`"E$1VUL6W]X[%N#)'\289F'W9!I\;6U"Z7)/`:KGP%?//>_]K7SC[(BF
MS)^W1G[=&+M+AMUK"_"\=EE)\],;`<;FPO6RA)5)=)-9!1-9%8A5$EDCE425
M3.4#$434((D.0Y1W`0$0$-;3>_$<J^>&5D9D=2'!L0>!!',$>=?32O--*4TI
M32E>5^X.T8O'2:0KJ-FKAPFB'I6.BB=0J0?I4,7;_?JA-@350+D`\KURQ9]F
MY.<HUVG'I15D)[PTE+*&`1$%IN:9/Y9Z`#^J)W+M17YBB;?T!KANURG*W^#(
MF;\1YV8_YCJ-OKX5]/[Y`N#VGEXF,EXH\5$'^4:03]7&M>NNEUQ.KZQS3OKQ
M:6L,LLHWCTD%Y&471$`6!BU%(@HHF'?NUG;A=-,#=O2`B/I`-16\;@VVX1FC
M`,S,%6_*YXD_0!]=3_;>T)O6YKC3$C%12[VYD`@``^%R1Q\KU-!IC*@LVX-4
MJK$&3`H%$R[4KA8^W^(ZZW6J<X_*(CN.N>/N>X2.7?,DU>\BNO1;)L\,8BCV
MV'1[5!^LGC7KB*3$5L[P]8[^#3?'(JY9-E!5C%'"9.[*Y!@X[Q!)<4]BF,0"
MF,4H`(]@:M3Y<^44.2^ME%@3SMY7\JR<3`Q,$2+AQ=)&-RJ_=OYZ>0/G;G4N
M^-/(>S83LW<S133=&E"*)3<<Q6,@NFH1NL9G*,6;DRC?VD@Y(FD.RB156YS%
M.(B5,23_`&YW`VSSF.8NV`_->>D^#+R^D>/T5JG>/:2]QXZS8RQINJ'@QX:E
M\5;@?>I\.7(ULX8<S,#.T@4<V*2BE13!06KZ#?++E`0W`#&B2R;8#=GH[S70
MXN[-BE74<W3[&5@?L!KD,_87=,#Z/RPN/-64C]8_55A!SHH;F^QE<80KU2JN
MW39FZM;MR1HHW\29(II(L9W2H>S&?>]:HG6(KW1%#=`&*!#X([TVY]QAPXD8
MX[$+U.0!)L.!XVOS/#W5)M\MMYCVC)W&>1%RD4MT>;%5%SZ@;!K<0.-[<^-3
MFUN-<[II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4K"M^Y&X+Q>DX5O
M64JA!"T%0'3<9,LB_;G3#<Z:T;$%?R":OR`04@,8>P`$=9F/MV=E\<;$D<>8
M!M]?+[:\EE7[S`5#&T>8YPFN!B1TA+6&RLXU\DZ0=FH\@DP%VS6[Q!9N6>",
M<F,DLF!B'!(-AV$!^74Q%V=W#D"XVX@?S%1^VO*YJ0EM$Q!((-B>((L1P\".
M!'B.=9(J?F.\.9IPC#ER;]5UB@1-$EGK=ABH\"[?K*324:Z@6I"`'K&5=)E#
MY]8^5VUOF&"9MNDTCQ6S?_#>BSQ/Q$@J9\)/U:\0B,O6YN#M=?D"#X>4@Y)C
M-13HHE`1[EZP6<-51`IPWV,(AOJ$9&4E74AAX'@:N`^5?J#K$'7"KEAHYLQ*
MX5,LJ""1$P,H<1,8P]!0W,81[1UYM52;U4W\>SE&JK)\@FY;+D,11)0H&*8I
M@V,`@("`@(:K5+UXX6!B:^T(QB&+=BV(&Q4T$R)E#^P"@``';JEJJ3>]5C5:
MI32E-*5SC<H;),3]MS=-NFYC2?M#(#4C90!-^RAE)2!CT1(/I\+$Q2".P?K=
MU\XZX?NLIRNY,IIVL/B@ON56"C[!7TYL4"X/9F&F*FH_`L]O-G1G;[3;Z*U"
MD`"D(4H]10(4"F_S%`H;&_WAKI+?>/OKBJVTK;E:KBJM?7M5BB*^W5[@TF[!
M)5ST@<6K5)-1R\<@0>PYD6J!Q*'H$^V_9K"W#+&#ASY16Y4<!YL38?1?G4IM
M&WMNNY8F`&TJ[>H^2J"6/OL.'MJ<<7BN@Q+4C9*N,'0E(!5',BD#UVN8``!4
M677ZC"<X]H[;`'R``:YM-NVXY#EY,M[GP!L![@*[1C[!LV+&(H=NC*^;`,3[
MR;WKVQU!KL$_6DJXW/7W3E$$'98U0R;-XF4_>)>*8'ZVBQD3B(D,).HO4(`/
M:.K$V;E9*)'D2EU4\-7$CSL>?&LK&VW!PY))</'$3./5IX`VY77E<>!YU(W!
M.9[GA6Z1LTV62E(!9P@UL<6151C[2AU5R%=E42V<-CNFB)C+-C@4AB+E`-^@
MZA326Q;U)L^8LJECBMP=.8(\Q_,/#ZO&H;NGMR#N/;W@*H,Y!>*0\"#Y$^*G
MD1X<QQ%;8H?FG@R2;HJOI:8@5EDP,+:2AUW*A#;!U%$88\H4`*8=@$W2(_-K
MIL'=VQ3"YRRA\F4C]5Q7%,GY?]TXS6&W]1?-&4C[2#]E6):^>%`BYV,CZM!R
M5IBU3D]I2IE/99P(=0Y#)Q3%=!1=RX(4F^R_AP,<Q2]@")RX.7WOMD$\44"M
M+$3ZG'`*/8"+M]E2F!\LM\RL6>?)=()P/0C<2Q\B0;*#R!X\?"IP1DBRF(V/
MEXQPF[CI5DTD8]VD.Z3ID^03<M7"8]FZ:R"I3!^@=;BK*ZJZFZD7!]AKG+HT
M;O&ZD.I((\B.!%>W7JO--*4TI32E-*4TI4#>5G\3/EE?BZR;_3WYS:>=5\!^
MGE7_U>P;RM_Y;_!+\(O'/]S].TJIY"IY:52J1/S\)58.6LMDE6,'`0,<\EIF
M8DW*3..C(R/0.Z>OGKI<Q$6[9LW2,<YS"`%*`B.O$DD<,;RRN%C4$DDV``XD
MD^``K*PL+,W+,Q=OV_&>;.GD5(XT!9W=B%554<2S$@`#F:Y3^=_G,Y!S!,O\
M-\,W,U4J=XD[.1R<S(JPNEN(@IW9SUXWJKU.O*JB42J[D>KD`O69(JAT-<XR
M]^W?N?-79.U()#K-BX!#$<KWYQJ.=^#\ONFZG]&?EO\`VV=B_*7M[_\`Z1\_
MLW%:>--2XCD-!$Q%U1E__N<BW[B@HIN0&T"2M08X4L3Y\=[=Y1U-VR3*#UVB
M^>.UP8D=]2I7TT\.IXU918PB=%$#)G5`1$Q2DV,/4>U?D5CJRY/<>09\H^HH
MO!%)XDL>;&]_8>9K0/F7_?#O$\;[)\IMFCVK:$]*SR(C3LH_@BL8H01P(L[@
M@$.*OF"P95(L!5=$/(/%`_:N%0*3??TD333`J:20"'84``/]_;KN6U=D]N;/
M"(<+:X4'L4?X5\:=R_,KOSO#*&9W)W9GY<P)MU)G;3?P47L`/`#@/"KO)C2G
ME)T##MC#L(`82[CZ-O3J>7;<%1I&,EO<*U!LS,9@S94A8>.H_P"-4B0P_3WR
M1T_`%2ZO\GZO^\H^J(`.L+*[=V?,C>+(P(F0\[J/\*E=M[H[CV?*AS=KWW+@
MRHS=625U(]Q!K#-JP`]9B=]6G9UN@14,R./KCMN("U,(E*51,3;@0!*4W2`;
MEWW#DW<_R/[<W.-Y=IC^$R^8T?=/LT\OV^VOJ#Y;_P!YWS4[.GAQ^Y,L;YLO
M`,F2?QK>)6?[^JW#UZT`_=O4PN(?F1\E^$\]$1<S)RN4<)K'\.\H=ADG;AHT
M;E7$7?U6E'15W%5GV9U#@J@)11,H8!425)W9AX'G8/=7RWS4Q]P0S[.38'CH
M('"RDW,;#^'[IN>!)N/JN7M[Y&?W<[#E[AVOT]G^8T2:GLJ+.IL!^*BZ1E07
ML.HMF7A_3+@'L4XT\F\2\K\9QN4L13WM2&=&\)*Q;LI&T_6)DB2:KF#L$>51
M46;]N50!W*8Z2I!`Z9S%$!UO6U[IA[OBIEX;W0\"#P93XJP\"/I!Y@D$&OSO
M^8?RY[I^6'<>3VSW7@]+,3U(ZG5%-&20)(GL-2&WB`P/!@#PJ06I&M%II2FE
M*>G2E:%>56$3X\N]@A74>9Q2K41ZYA51(/A5H5^8Q5(H#`&R:\&*X-!#]8"%
M15W$5=B\6[DVN;9]U::$$8\CZXV'@;W*^\'B/9[C7TEV;OF/W%L2XV19LN&,
M12J?WEMI#^YAP/DP/F*TRWFI.:/8WT$Y5,X;I%([CGZ@='C(MP)_#+J_X072
M%,R2VW9WB8CZ!#6X;5N"[EB)D`6E!LP\F'E[#S'U5SG?MH;9-PDQ"28"-49/
MBAX"_M4@@^Z_C6<>.]:DT7<O:W*"C:,<QH1,:94@IFD%#O$'3ETB4P`86;<&
MI2%/V`H<X].X%W'6NZLV&7X?"B8-(C%FMR'"P'OYW\JW;L3:\F`9>YSQE(I4
M"(#P+#5J+6YVX`#SXGE4HEUT6R*KERLDW;H)F57<+J$1112)^LHJJH)2)D+\
MHB(!K4`"Q"J+L3P'G70B0JLS$!`+DG@`/,GPJRH[)E$E9,D0PLC)9\LH"+<A
MBN4472PCL5%LY702;JJ''L*`&W./87<=9LNV;A##UY<1Q%;B?+WCF*C(-[VC
M)R!B0;C&V03P%^?L!(L3[C5]:P:E*_H"(>@1#^P=M*7/G7Z()BF`Y0W$H@([
MEZBB'RE.`@("0P=@@/8(#MJAMXFJ@$\A>MHV!^:E=85-A6LJB_;/X)HDR9V)
ML@9\#^.:I$2:$E$0.#L\@BD4$^^3*J+@"]:@%/U&/U#8^\\1L:.#=7*Y""VN
MUPP'B;<0?/A[:XCW/\N,],V;*V*(28DA)Z=P&0GB0+V!7RXW`X<:N'(?/6IQ
M0>%Q]!.)]P)2F&5FMV<:3K!7I%!@U7\<[#<A0/WBK4Q.KT&U>W#OC!@NF!$9
MI/,^E?\`$_9[ZQMI^6.Z9)$FZSKC1?PCU.?J](^L^ZHBV#F=G*:5(=M94H1(
M#"8S2)C(Q!#<0V$I%E&BDAW8"`"`'6,(?./;K59^\]\E8].5(U\@H_6;FM[Q
M?EQVQ`H$L,LS^;.1]BV%?FN\R\XPCOOG5E)-MA$@BQE8]@Y0-TCV@=;PY7X%
M,`]H)K$$?G#5,?O+>X7!DE21/)E'ZQ8U7*^7/;&0A6*"2&3S5R;?0UQ6R'`/
M)FM9J2/$N$4H&Y-4CK*1(JB9K*-T0`5G42HH/>=XB4>I1L<3*$)ZQ3*E*H8G
M0MB[CQ=Z5HP.GF*+E#XCS4^(^T5R/NCL_/[;=96;J[>YLL@'(_PN/`_8?#RJ
M3NMBK4*:4II2FE*\$H]"-CGK\2]0-&RK@2_."91,(?W!JAJHXUK;X#<[3\AZ
M?2:KF`L37<SS5-A;-&N&)`8U_(\<^A6TL[=0*)S=#&S1"2P^T(P!]9,@NVP"
MAWR335NW>X1N<44.9I7.*@\.`<6O<>1'BO\`UAPN%^F_G_\`(*;Y:[EG[YVL
M)<GL?XAHS>[28;ZBHCF/,Q.?Z,QYDB.0]32TFS/6U5\QTTI32E8CS#FRB81K
MGM^Y2!@7<]XE"5]AW:\[/.DP+UI1[0ZB8%;H"<O?N53)MT`,4#G`QR%-FX&W
M9>YY`QL.(M)X^0'F3X#]`#7EF5!=CPK1)RDY_P"0;2"\6U>*U^+D@<>Q:!7'
MZS7QS(JQ2%>VR<3(@^D(](2=*VY4FRPCTIM^L#'#JVT=FX&#TVRT&1FGC8_<
M7Z/(>9N2>58,N2QO;@OVUJJF9N;LSX).Q2*DD\)N#5(.I*-BTC#U>&BF/49-
MJB'RF]913TG,8>W6\P8L<(%E&K[/H'A^OSK"9V?GRJG;C\^LFO-![2B4>TH@
M("4>TH@/I`2CV"`Z4L*RSA_.V5\!SZ=BQ;;9*"/WZ2TC!E<G-`S::1T1,W?Q
MRH+,C=2:`%*)DCD`>TQ#@&VH3=.W]MW6-A/C+U/`C@?K'+]+WJ['-)$19KK7
M2#PXYX4WDI&LJ]/%;5G)J*?<.HSK!-C+/4$.^70:$4.<[&5[@!5!L8QR.4`%
M9NH<`520XSOW;F3LTC.MWP[VU6XK?D&_8>1]G*I2*995!\:V!ZUNKU-*4TI3
M2E-*5IMYJX>>5&_.[NP9F6J]X77?'4*GU-V,XL459J-<!MT@+U;O'Q!'?O07
M6#L!$.KDW>>T/BYQW*)?]-,1JM^Z_M_S`"WMOYBN^_+?N"/.VT;-.X&9C`Z0
M?WX[WX>92Y!'\-O(UHKRG1/J+8Q1:=1H*7*N_AC"`[M2$4*#N*.8?UACSJE[
ML?29$Y=^T!U*[%N9W'%*RG_4Q6#>T>#?3R/M]]:]W5LB[/G"2`6P9[LG\IOZ
MD^B]Q[#[*NK`=;DG]M1LQ43IPL,VD"&>F*)4GCYZT49),VAA#9?NB+F45,7<
MI.D"[]0[!A=T9L*8GP(8'(=E)'\(''C[3X"I/L;;,E]P_-6C*XD:,H)X:F86
MLOF`+DGER%3/$0`!$1`"E`3&,(@!2E*`F,8PCL!2E*&XB/8`:T*NK581LHX_
M+(A%C:([Q(J`CW@=^9D"PFZ03-(`B+(-S=G5WG1O\NL\;5N1BZ_P;].U^7&W
MNY_944=]V89`Q3N477)M:_"_EJ^[?Z:O[_;L[0$/D$!#L$!U@5*D6X&@"(>@
M1#^SLTI>W*OZ'4([EZNH.W<N_4`AV[@(=H"&J&WCRJHO>XYUL2XS<NXZD5UO
M0LC)/#0T6!BUZ:9I%77CF9SJ*J1SQ`ZB1G$>W4,(H&3$RB)3`B4ADRD[OH7;
M?=T&+C)@;FQ"IP1QQ]/@K>/#P/'A7).\OE_E9N9)NNR(IDE-Y(CZ?5XLE^'J
M/$@VXW/C6;KWSOQW#,REH\;(6I^L03$</2>RHMN`&2*(G(8QY%RL4#B/="FW
M*8"]BFIK.[VVO'6V(&GE/EZ5^DD7^H5K6U_+3?,MP=P*8L'M(9C[E!M]9^BH
M>VCFQFN=44]FS#*M(&6,8K>&BF()@D!S=!`7D$7\B4>['8W[<=Q[0V[-:ED=
MZ[U,QZ)CB7R"W^UKUO\`B?+7MO'4#($T[^9;2/J6U4&'YA9UBGA7*EO5D$``
M>MF^8QKI%7M`>TSEFLHF'9MZ@E'8>S5B+O#?8F#-D*X\F4?L`/VUE3_+SM:9
M"J8;QMYJ[?J)(^RI_<?>7$+E5ZA5+6V:5ZW+@1./60,<D1-N.C<6J)5U%56#
M]00'NDS*'37$.DIBJ&(D;>MA[JQ]V<8LZ"+-MP'[K?Y3Y^P_77+NZNQ,S8(S
MG8LAGVR_$V]2>6L#P_F'T@5,W6VUH--*5`WE9_$SY97XNLF_T]^<VGG5?`?I
MY5__UNP;RM_Y;_!+\(O'/]S].TJIY"IY"(``B([`':(CZ`#YQTJE<E'G!\[[
M9G/*LAPVPE*G''E4ED8K(3Z)6.G]>+NR4%5_#.G:9MU*M35B@FJB`=*\BBJ8
M05!)OMSG>)]Q[JWS'[1V,:M3V<CD2.+:B/W8[<>7J'L6OTE_MY^7?:OR:^7.
M3_<#\RXM.XM`9,1&`+0POZ8C$AYY.62-!)],3+]S5+43*+B:!P91T9UVS:RE
MTDC(,XWQ:91*M,.DSJ$46)N)@81B!%%U"@/8FGT[B8VX_4W9?9&V=G[;!B8D
M2MG,!KD(XNWB2?X1X#R`KX@^<GSF[G^<7<^3O>]3O'M2,PQ<4,3'!'?T@#DT
MC``R/:[-?D+`4DA3@955991TZ<K*.7CQ<0%P\=+&$RKA8P?XCF'L`/5(78H;
M``!KH4<:QJ%7_P"WVUQLDDW/.OWKW5*:4II2FE*MR4@8YT5P9:+;R+9V=(\G
M&G32-XONRBD5ZV!4!1"4;HF$``X=VY3$45=R&W"!W_8,#?L#(PLW&62&1;,#
MX^T>3#P/T5.=N]Q[UVIN^%OFP;E+B;ICN&CDC8JRD>T<P>1!X$<Q3COR.O\`
MY>&=H+(=`?NIW$MV.U3N=,65<!'V"OIN`))1P@J;I2L5>%54T:]-^V(<!(L4
M0%PD/Q=OVQ;M\L=^5[,^T3,0#X.H/%3_`#J+V/,'GP)!_57MS>.SO[S/E9E[
M+O<4>)\R]KB!UJ`&CE862>/Q;&G9=,\7)3P]+=)J[C\?7RKY0I%5R'2I5O-U
M2Y0498H&4;&W2=QLJT2>-E!*/KI*@FJ`*)G`#I'`2&`#`(!T6">/)ABR(6U1
M.H(/F"+BOS!WO9=R[<WC<]AWC%:'=,.=XI4;FKHQ5A[1<<".!%B"00:O'5VH
MNFE*:4K`G)6AP5\Q%:F\RLR8KP,<[L<+*O3E11CY2,;+*)D57'8Z;631$[18
M"CU&36';UNG41ON!!N.V94$Q"V4L&/#2PX@W\!Y^R];#VONN5L^]X.5C!FNX
M5D'$NK&Q6WB?$>T"N=>2I<-9)]G9;#'IN#1#9PTAV#P"=RW;'<>*%[*)"8R*
MCT.D1`IA%-N`B':;<VN)Q9N1C038\$I5)""UO&PM8>SC]-?2^1MF'F96/EY.
M.'EA!":N(`)N21ROP^BHTW/,]G"R236JRK9C7HUR=A&"S:-%DWJ+8`2.\,HL
MB<3IK+`;NP#8@)@40#MW'<-M[=PWPX9<V-CDN-1XD6OR%AXVXGWUSK>^\MQB
MW+)Q]KF1<.)M((4-JL.)N;\+\K<.%8TL%[MUH1!K.3KQZS`Y5/!`*;=F8Y.T
MAU&[8B22IB#VAU`.P^C4SB;3M^$XDQ\<"7S-R?HORK6<_N'>-SBZ&9FDPGFH
M`4'W@6O]-6E_8(E$!`2F*(E,4P#N!BF#82F*(;@(=H#J1(!!!%P:A@2I#*2&
M!N".!!\P:V`XJL;RTT:(DY$QE)!$SN*>.#?K/%HQ86X/#?.=RB!#''Y5.K7+
M-WQ$P=QR<>/^F""/8&%[?1RKO';^X2;IL^%F3?UR"K'S*$J6^FU_?>K\=N4V
M3-X^6W%%DT=/5@+^L*31!1PH!?3ZPD3$`_3J.52S*B_>)`^OA4PS*BN[?=4$
MGW`7/ZJUX6*_VJVNU7TE+/"(+G,HWC&KA5O'L4%-Q3;HMTC%(84B"`&.;<YS
M!N(COKJ6'L^#A1JBP*TH'%B+DGQY\O8*X5N7<>Z[I*\CY3I`3Z44E0H\!PYF
MW,FJG5\H7.I)G;QLH+ID<PG\#*D\>V3./I.W%0>^;B.W:!#E*/RAJUF;%MV:
MP=HM$GFG"_O'(_563MO=>\;8IC282P_PR>JWN/,>Z]JJ*&:,C(R'M`T]X@HG
M,8T<NT:FC!*81_9E;$3(*92@/8)3`;L].K+=M[48NF(F#?Q!CJ_P^RKZ=Z[\
ML_6:=&3^`J-/^/VU[39WR&1X5^9Y'F11V.>++&MBLEDDQ$YTA-T^**=4@=/6
M"G44>T-6SVOMAB9%UA_XBW$?1R^RKX[ZWOKK*PBZ-Q=`O`_3SN??4X4%>_00
M7Z#)=^@BOW1AW,EWR95.[,/9N9/JV'](:YWR)%=?YV-K7%33X7XRLUBRE!W9
MLDNTKM-=.7TE(&(<B*RR\-(,6T6@H.Q5'KD9,AS%#JZ6O6)NGK2Z]Q[+V[)G
MW-,\`C%A#7/\3$6TCSYW/NKG?S(WC#Q=DEVEF#9V04(7Q558-K/E>UE\3<^'
M.6G._DY?.,U,QG)8XBJ?)V3(.4$J08UW9S3^%CXI/'V0[H\>E:P4S!/57QEZ
M:B@GNN!"E7,(E$0#6]=S[ME[1@PSX2QF9Y@GK!*V*NQX*RF_IL./C6!\@OE?
MLOS6[JWK8]^S<N##Q=J?*!QS&'9UR<2`*3)'(NFV0S'TWNHX\ZUT_$QY:_\`
M@?'+[(Y*_P#N;K1O]Z]Q>6#_`,N7_P`:OJS_`-GORW_]<WW_`)N+_P#*4^)C
MRU_\#XY?9')7_P!S=/\`>O<7E@_\N7_QJ?\`L]^6_P#ZYOO_`#<7_P"4I\3'
MEK_X'QR^R.2O_N;I_O7N+RP?^7+_`.-3_P!GORW_`/7-]_YN+_\`*5XI'S).
M6$DQ=QZT+QV(B\;JMU#)5+)`*%(J42F$@FR6<H&`![-P$-/]Z]P^6#_RY?\`
MQJ?^SWY<>&^;[_S,7_Y2H)U.//6*A2*ZG*N4I2D0U891=BB55HN383%88,FS
M*>AW2*HNHQ\@Y9@LD<A^M,=@W'6OQ3&)8@CD.@%B#8@CD0?`^5?4NY8D.YR[
MI\5A))A99D$D4@#H\<A.J-U(LRD&QN/;PK>WPJYKM\P)ML396>,H[,D8R.:*
ME"D18Q64XEBD)UI>)1(!&[*UL6Y.N3C$P`HE`SIJ7P_>I-.H]N]QQ[DHQ,I@
M,]1[@X'B/)A^\O\`UEX7"_FO\^_D'E?+O(D[H[9ADF[%GDXCBSX3L>$4IYM$
MQX0S'GPCD/4TM)L>UM=?,E8MS+E>OX7H$Q>K`!G!&?=LXB)24*DZGIY[UDC(
M=J<Q3@F+A0ACK*])@;MDU5C`)4S:S,#!GW++@P\9;RN;>P#Q)]@'&O+,$4LW
M(5S?YOS38;9(6?)E[DEI9^J(G19IG.DV+UK=Q"UF!:J'/X"-377*DBF`F,'4
M=943JF54-W;:=IQ=EQ%Q\9+R'[S>+-^G+RJ-ED+M=CZ:U\NG;^3?/)>77!U+
M22@+/5B[]TGL4"HLF91$12CV*8`FB3_*'4/K&$1GXH^F#?[YYG]/`>%8I.HW
MKY:N52FE*:4II2JS6K-/4B>:6JK.CLYED9`^R;E=F1^FU7*Z;H+.6QB.&R[9
MR0%6KE,06:+@"A![!`</-PH<V"2*1`0RVL>1'D?TX5[1S&P(Y5U+<*>9=5Y)
M4J(BI9^5AE*,8G;348\(DU4FU8T@>(?,P3$&QI4K3H6>MDP)TB8RR!!;;&+P
MC?\`8,C9LAV"$X+-Z6\O'2WD1_\`>'$>R7BE$B@W]53NUKM7::4II2FE*L?)
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M-DV78\?+Q/C,]':1V-@21Z1R/F;^WPM6E]R]U9FWYXV[:9(UBB0:B`#ZCQ*^
M0"BP-O&]ZQ)-Y(O%A:*,)2Q/56*Q>A=H@"+-%P7<!$BY6B:(K)CMVE-N`ZGL
M?9-LQ9%EBQAU!R))-O=>M3S.Y]\SH7@GSB(6%B%`6X]MA>K'V#;;8-MMMM@V
MV]&VWHVVU*UK]AY5-K`]D>SM/782"BBZU:?DBT'2@B8ZT>JU3=,DCG-N8YV9
M3&2W'M[LI-<W[CPX\3<+Q`!)5UV\C<@_6>-=H[.W&;<-G"Y!)E@?IZCS9;`K
M?S(!L?<*S:4O48I?1U&`N_\`:.VH`\`36U@7('G4!;[DBQV><E"$E'C*$;/W
M36.C&:ZC9`&S1=1NFNZ!$Q/%.G/=]9C'WVZND-@``UTK:MFP\;%@DDA5\ED#
M$D7YB]A?D!7&.X.Y-QS<[*@AR7CPDD9553:X4VN2.))M?V51ZQD&VU%912(E
MEA16V[]@^$7K%80]!Q07$W=*``_KIB4WZ=M9.9L^WYP'5A"N/WEX'_`_36#M
MO<F[[6QZ.27C/-7]0^WB#[15>7S/D9:0*_+/>'*4Y3%CD&C8L;TEV_9';'2.
M*I#`':)C";M].L5>V]J6(QF)BQ'WB3J^BW#[*SG[UWYIQ,LZ*E_N!1IMY&_'
M[;U[G.=,BN%TUDI"/9E3'L;MHMJ+=7?;_G@N594X=GH`X>GLVUX3M?:PI4B1
MF/B6XCW6X?95V3OK?&=73HH@\`MP??>Y^JIBU295L-8@)U=N5JO+Q+)^LW((
MB1)5=(IE`3ZA$W=&/N8FXB/2(=H^G6@Y4(Q\K)QPVH([+?SL;5U?!R#F86'E
MLFEI8E<CR+`&WN\JE!QPQE9LAY+K(PB2Z+*!G(*>F)4"'!O'1\3+M9$ZBBP;
M%*NY\`9)L7<3'<;"`"4B@DF>VMNR<_=<5X01%#(KNWD!QM[SRMY<:UWO3>,/
M:MASXLA@<C(B:.-/%BPL6M_"M[W\[`>S?9KMU?,U-*5`WE9_$SY97XNLF_T]
M^<VGG5?`?IY5_]?L&\K?^6_P2_"+QS_<_3M*J>0JJ^8IR%<<9>(>7LEQ#\(^
MW&@OJK15RF*#E*X6Y9.`AW[,I_54<01WQI$2CN`ILS[@(!MJ&W_</RS:<W+5
MK2!++_F;@OU$W^BNO?(;L1/F-\UNT>VLF#J;6V1ULD?NG'QP995;R$H3H@_Q
M2+7(=PQQG[2))Y2GBJNWLB^>-XUPZ,"ZBR*2W_7/^]/NH==W*E5*H)A$1%`!
M^4=]P^1/:L>-M$W=65'?-RV94)YB-6L2/\[AKGQ"BN^?WR_,S(W/N_;OE9MD
MP38=HBCEG1>`;*ECU("!P*PX[)H'[K2R#P%L_P"89`7=O81A5-T(&"(L9(!]
M5.0GG*AU#B'R*!&QR(!\Q%1_S:^A(1>1V_A`'U\3]EJ^"7/(5C'655NFE*:4
MII2FE*:4JCV2@H9&H5YK)4NN7AD4KO6#%`#*IO3)+,I)FF([#W<@X9I`8N_3
MUN1-Z0#6A]_=K8_=6P[CM;H.N4,D1\5E4&UO>0`WF&-=;^27S+SOE5\Q.W^Z
M\:9A@I,(LI`3:3$D8"92/$A?6E[VD1#X5N)_\O[R+?V7'.3N-EDE%'#K&LDU
MNE%;/%SG71JEH670L$4R2.(BDPA+,W!P(!MLK,"'S`'RKV#G2/BY>V3D]6!^
M`/,*;W'T,#?_`#5]<_WS]BXN#W%VO\Q]J@7X3=8##.Z`:6FA"M#(2.;30-I!
M\5Q[UT6:Z#7P532E-*5IVY=<BW%_G7%$JCXY*5`NS).%6YQ`EBE6J@D/(JF*
M.RL>U7((,B[B0X!XCUA.EW7*>[>X7RYI-KQ'MB(;.1^^PYC_`"K]I]PKO/8'
M:2;=C0[YN$5\^5;QJ1_30\F_SL./L'M)K33GVXSJ<T2FMU5X^%&,:OG(HB9(
MTX=T97O"*+!L91BS[L"&2*.PJ;B??U0U:[8V_%DB?.D`>97L`?W;6XV\SX'V
M<*N]\;QG03Q;7`S1XSQAF8<"][C2#Y+;B/,\>%1M]'9\VMSKFM-*4TI4N./U
MO8+PZM*6W1E6"\A*L^K8$W\>Z7(LX[H=]_$L5U1ZR_*F8#!Z#;:%W/@RQY9S
MP+P26!]C`6L?>!<'WBNL]C[G!-MPVHFV7"68#^)&:]Q[038CW&I"/4$G3)ZU
M<#TMW+-TV7-Z.E!PW416-O\`)TIG$=:N"5*LOW@01[QQK=RJNK(WW6!!]Q%C
M]E:P4P*4A"E-UE*4I2G]'64``"GV^03E#?\`WZ[*"2`2+$@?JKYP*A695-U!
M('N!X5^M*I32E9?PS1T+A9%7<FD"T)72-WCE`P;IOY%90WLUDK\Z!.X.LH7T
M&`A2CV&'6N=Q[B^'BICPM:>:XOXA1S/O/+ZZW+LS9H]RSI,O)6^-C6-O!I#Q
M4'S"VU$>ZIW-$@<.VR!A$`7<(I&'Y0!50I!'^W8VN=DV4D>`KL*C4Z@^)KH#
MP#68ZJ8;QW'1J:10=U:'G'ZR1"$!Y+3[%"7E'AN@``>^>/#=/^5,"E#L`-=]
MVC&CQ-LP8(AZ1$OTDBY/TDWKY0[@S9MPWK<\J=B7:9QQ\`&(4>X``5K.\Y%Z
M$?COCJ\$>D$<^G[?F[S"F:$O_P">M7^8#:-GQ6__`,I?_P"G+7UC_9'$9_F=
MW3$!Q/;D_P!F?MIK2!]<R_\`>_[?WZY%\0/,?I]%?IO^5O\`P_8:?7,O_>_[
M?WZ?$#S'Z?13\K?^'[#3ZYE_[W_;^_3X@>8_3Z*?E;_P_8:?7,O_`'O^W]^G
MQ`\Q^GT4_*W_`(?L-/KF7_O?]O[]/B!YC]/HI^5O_#]AKXJWGP9VTJC*N89]
M".D)F,G6+U2.D8*1C5`=-)>/D45$UF#Q@JF"A%2F*)1#YM7(LMXY$>%R)000
M1S!'*UN-[\JLY6P0;ABY6WY^''/@3QM')&ZZDD1A9D=3P*D<"#74?P4S/DO.
M7'ZMW'*\&2)M0.'<:E)%1%@I;X1CW2<5<7D)W*):\^G$A$RK,NY`,7O2E1*J
M#9'O>Q9.?E;;CS;C"$R2/^T/!B/W2?+EXBP-A^+/SH[>[*[7^8>^[/V#O!S.
MWXV%C]X0R&_4QTEN>ND1]*R^(]-W*]1X1>8ED9W.9/B,>MUCA#T.%;N5T0$`
M(K:;.W*^>K*E#M%1A63,"(&']4K]P7T&'?M?8&W*N/E;FX_$9M"_Y1Q8_22!
M_P!6N/93\0GA6G+-TB8R]5@B*;$ZY&PNT0']?PA$HR,,</\`*59\X,7_`(T]
M_DUT:,:IE\E!/T\A^VL%SPMXUA3695NFE*:4II2FE*:4K-7'VWS%-R.BO!R:
M\1(.T&\U$R"!S`>/LE5<HN&4B4H"!5/^@=*%53'<JZ*/=G`2"(#&;GA09T,F
M-.EXI5*GWCD1Y$>!]@J[$Y1N!XCC77CB>^(9/QM2[\@@5H-G@&,B\8E$3!'2
MO=]Q,Q?481,;V9+(K-]Q'M%/?7SMF8SX>5D8DGWXW*GZ#:_T\ZF5(8!AR-9"
MUC56FE*:4K6%S/Y$K&<OL14YZ9)LU,+>YOVYQ`7SL``5*^FH4?\`V!EU`#O8
M?VSC=`VQ4E2J<Z[P[A>-GVC">S6_%8<P"/N`^T?>]G#SKL'R\[1CE6/N'<XK
MQW_!0C@2#_4/F`>"CSN?`5I'S]<Y^$2B(**6<,$)YN^<2,JB8Q'#CN5$TO9:
M#D.U$RA5!45Z1`YR"`!ZO5K7>V=OQLN6>;(`8Q6LA]M_41X@6MY7YUN'>N\9
MVW8^+CXA*"?5JD',`6]`/@3>_G;E40P``#8`V`/DUO\`[JY'Q/,W--*4TI4C
M^/MO81KR1J+[=%Q//$W\2X';NE7;=D*+B/4'?<JRJ"`'1'T&$#%]/3OIW=6#
M+)TL^,7C1=+>8XD@^[C8^7"NC]A[G!&,G:93:>1]:>3>D!E]_"X\^-2W*(E,
M40](&`0_M`=PUI)X@BNE@V((YUK5L[9NSLUD:-3]ZV;6&;004_S))R;HI>WT
M#T[=._R[:ZWMSM)M^"[CUF%?U"OG[>(TAW?=(HS>,9#V_P"T3^NJ'K,J.II2
MK\QM3@O%K:1#CK+%MTE)*:.01*88YL9,GA2G#84SR#E4B/4':4AC"':&HC>]
MP.W8+2QG\=SI7V$\S]`X^^U;!VSM";SNB0S#_21KKD]H!L%_ZQX>Z];!$$$6
MR"+9ND1!NV12;MT$B@1)%!$A4TDDR!V%333*!0#Y`#7,22223<FNX`!0%4`*
M!8`<@!R`K>7PZJD96\(PCUFFF9_99&=DY9V4A"G<*,II_!L$CF*`;E:1D6D3
M;_/UF])A$>T]I8\<&Q83(/5("['S))_4+#Z*^;N_\R;*[IW-)&.B%A&H\E4#
ME[S<_34IM;)6F4TI4#>5G\3/EE?BZR;_`$]^<VGG5?`?IY5__]#L&\K?^6_P
M2_"+QS_<_3M*J>0K5G_YB*]NV>->/6-DE#E9V.\VFXO"%'8IUJ;`-(EF!PWW
M,`!>E1]&VX!OV@&N>_,29EV["A!X/-<_]53_`/O5]]?V#;-%/W=W[O[`=7%V
MZ&!?8,F8N?\`_5'U^^H?XCIQ:'CZO5;HZ%HA%XR<]G2)G3>4?INC&#_.9T!Q
M-_Q".OKCM##BP.U]@Q(%`C3$B'TZ02?I))/MKXA^9'<$_=7?_>?<60Y:3,W/
M)E%^-E:5M"^Y$TJH\``*CU:7)GUNMSPP]7>6.0;I&'M'PT6*4.W('S`5./\`
M1\@B.MIQ_N,?-C_A^RM%;[U09Y`XUH4SEC`3^4JL.^>6[(TA$6=PX;`=2<C&
M./+,X9L9(=P\2W;+L43D*/ZIDBB'H#6GY6T[;-WWV_#+AHT63A;E)*/!WBA@
MZ;-YE+^D^%969/,O;F1,LA$L6=@QH?%4DFDZBCV-?C7AS591DQQ=7[#2[71\
M.,,FQ\%D-:SIP\;79*`0AI@E8!TXA;!*@G3/K"S:^(,\\,D`F0`X;".WG<<Y
M-VWOMJ3?L>7'V&5<QIER2J`Y(A1\7J%79>+F4*"VDRJ/$*:N&*7#VS<XMJL^
M=')`H,8O;&UE<DI<`_T]/$*&"$VL"PJV[UD"&QK38-CQMF8QE5K)E5Q`V"V+
M3)24>F+##J2*K6NSEGA;'3XN*EY%$B)G*+=U')N%%2[E7/U$Q<S<YL,]O[=L
M.4$V::3//6E<(H>$!A!').CJ(F9I'B"KIDZ16%[,QJ@A@Z>ZY4D>K.7X12B`
ML`LAT]4A"!K"A%D)-U$@:1?2HK#F2+A=+34:S.VN7C9&7=<>>5!0EZXLY)'S
M#.-/76<7*]0Q-?06=*MT0$RS9HDT5-^U;AW1RZ@MYR<C)P=YR\DVS).U<!WL
M&52S;WC`.JO9EZL>EV5@I5G90H4`5=Q25R]NA5P8H]YR46Q#<!M\QTLR@(Q1
MRR@K<$*"3JU5D);.N0JWF&B5`UP9_4U=7%\)]6HJ,@7\N"4Y7X`CE.;B)IC&
MVYX,F\E5%TY2&?NVC-)J(+-Q-UAK>,G>L^3YC;SMDV2'Q&W;+A6-52RA8R41
METK/%H)Z[9#EX'`TK^&?1"PQI!VKM66JE9%VW'D)XEF8L;E;DK)J"B(1II=2
M03ZKD['];/5ZLG8;2[Z[O4MMR'JKDJNX;E$IYV$!(!#8=QZRF_N'6--;J1\.
M.D_LKW'S;Z*JOEI+/\*^:C5:3'J'397NLV"*DDTSF*12,LV*$<NM$SD]!R$D
M8QJ(%'L`2AMZ`U\1/''MGS0W_"A&F)Y9@!X<1U?V&OU'[ZR1WS_8QVOW%N!+
MYFWQX6ECQ)?&S/RHM?S:-F)/,WX\Z[.M=!K\U*:4K'.8'$XTQ1DAU6B*GGT*
M/:%8@K<#BY!\2&>"@9L5/<YG)#>LF`=HG``#6)GM*N#F-!_7$3E?\VDV^VL_
M:UQWW/;DRR!BF=`]^6DL-5_9:N>!UV.%NPA0ZQZ`3$!2!+_L>Y,41*9#NMN@
M0W*)-A#LVU\]B]N/.OK=N!('+P]WA;V6Y5;%AJM?M34K2?BVTBDF(BB98NR[
M<Q@V$S=P02K(F'_A,'HUD8^5D8C]3&F9']GC[_.L3+PL//BZ.;C+)'Y$<O<>
M8J#^3:(-"L)6*"JKF(D6YG\.X7'J7*B17NG+)R<``%%V2IB^MZ3IG*(]N^NC
M;)NAW/&9I`!DH;-;D;\F^GC?VBN.=S[&-DS46`DX4H)2_,6-F4GQMP(/D?96
M.M3-:W32E7OC>P,JM=H&:D1$D>@LY:O5B[CX9M(LUV)W9@+ZQTVIURJ'`-]R
M%'Y0#45O6+)F;9D0PB\O!@//2;V]Y%[5.]LY\.W;WAY.0UH#J1CY:Q:Y]@-K
M^RIB9:L"D!CZ:?,C@9>13;PS1=,>HJ?MLWAC.R&+N!BD:'.8@AZ3"7;6@[-C
M+E[GBPO]P'4?<O&WTVM76NX\Y]MV7/R8_P"KI"*?(R'3?Z`21]%0#``*`%*`
M`!0```/0``&P`'Z`#74SQ-ZX.!8`5_=*K32E3!XY-P)5K`YZ=O%6,$^O;]<&
MD4P#IW^7NS.!_O'6@=UM?<8%O]V$?:S&NM]A)IV;)>W%LEOL51]E2&(<Q#E.
M01*8ABG*8/2!BB`@(?I`0UK'/A6[@V((YUOZXV/%GN#,<&7.<YF<$>'3,H83
M'%K!2+Z%9]1C"(F$&D>3MUW?8)&EV3:Y'^\85^P6_97RUW9`F-W+OD,8]`R7
M(^DW_;6N#SFZ-?;OA?$)<?5:4MDC7,S-)Z38Q(LP<M8@V.LD0)WP^-=LDC)D
MD)QLF(`<3?M-P`0`=H+OK`S=QVB&#`@:2<9"M8>05P3]HKZ+_M`[\[.^7GS+
MWK>N^-Z3!VB78YX%D978&5LK"D5`(T<W*Q.UR+64\;VOSP_Z3<BO_HY>?[H#
M_P"?ZY+_`+5[F_\`2Y/JK](/_<__`&[?_J)C_P#)R?\`P*?Z3<BO_HY>?[H#
M_P"?Z?[5[F_]+D^JG_N?_MV__43'_P"3D_\`@4_TFY%?_1R\_P!T!_\`/]/]
MJ]S?^ER?53_W/_V[?_J)C_\`)R?_``*_AL3\B2@)C8=O!2@&XB/L```/G$?;
M^G^U>YO_`$N2G_N?_MV__43'_P"3D_\`@5@Y'(A%FJ3P%S$1603<@*H@02)*
M)@J`J?M!`HE*/;V]FM;,K!S&#=KVX7XGEPKZ.7:(FC64+^&5O?V6O?ZJW$^7
MSP)LV<Y.(ROF",=QN/F3AO(UJJ2"*B*T^JB<JS:8G&ZP`8K4AB@=LU.'JCLJ
MJ'7T$3Z_V=V@46+=-VCO(>*(?#R9OV#]G/\`,7^Z?^Z"!VW'Y:_+'/'0&J/-
MSHS][P;'QV'[G,2RC[_%$.BY?I[KU?BZQ%-(>(:HLV3-%-%)%$A4R%*F4"E`
M"E`````-=2`M7YP$D\ZY[>62[AQR.S$9R=0YB7!%(HJ;[E20J=5;-B!OZ"$9
MH)`7_A`-=R[."CMW`T^)>_OUM_T5&9%^L]_9^H5K&R:Y,ZO\WN/4G'L8.+0^
M7H`C#VHX*'S=3B6'?Y]@UMD`XRGV@?4+_MK%?F!4/.4S)ZEAJ\VV)LUPK,Y3
M*K/3,,ZJEIFJX4[XC8ADS2:,2[;)RB2)D0$A%P.4@B;;;J'?4N^3/B[0=SQ,
MV>+)CFQXQHD95*S94$;ZE!`)T,P4GBMS:I3:$CR)Y<66-3&8I7O8:@8X)76Q
MY@:@"PY&PORJU+MD=OB#$%JBZO*W:?R''8^D+C%.+,SN]R`CE6'%^H[5MLM'
MR$(=",224<%:*/-@[OHZ-S;#D=Y;LNQ[?O>W;1-+\9A3)&6=9&98Y<F-7DZK
MKID:.*?4&U/I"A2+1L!@=MP_&Q[3EYX!&3C=6P/!G$+%4"J;H'DCTZ1I)U7%
MBP)^*DM'85H<CDY#)ERR`\2Q,I;C4:QW0+']:#MT&;DEIB4)51Y(PK!)P]Z%
MS,`39E25#K*(D3`*]PY*]F0=P-A9[YCQ+"J12R=5D+Y/P\>2S$]3IL7`?U"-
MPAL0]F#:5;>AM&3F1]!Y1*[Z!H5B(>M)`JD:`\>DZ;#6MP#Z20<3SF=LQ3E!
ML!+#$ITN5C;)@I_&SM<<-(1TZB+I?8=D]C7,.TN]SDDF;]@13NG1UD47S94Y
M02#H-U6X=QW*?>NW,'/C,$\?=.%C2*/3U894=VCEC#R:"I4%T:1@Z21,!8$G
M%GD"[5N>3#8I)LN1/&W\+H5`9";%P=7I<*NEE8'B17E/R"RK2ZHY7AT&5L<.
M\N9U9/9"Q%D;3(PT'6+G[,@FC.L1=@A;$X@60/B%<.6A7A8UHEN+<P"74#C=
MS;KA]K=FS`1R/)M,T\TTFN1M?Q\\*-,4</%"J+9IBDH-E15!6S2IQ(I=SWZ,
M:KKN"11HMA9/A(Y6$:D6=]5R$#+S8F^KA/:CV1*XTVJVM!5DLG8Z_$3158U1
MPK'G&18H.C^"4>-VCL[4#J"!!5234Z0#J*4VX!U&3IEM4-^BP#+<@DHP#*;B
MP-U(-P`#SL*A<:4S1!BREP65K7MJ1BC6OQ%F4\.-O,\SEG'/5_J#5^C?J_\`
MCPB/R`D%>D@4W_0(F*']HAK$R+?A?YOV&LE/O'W5U2\#'SEYQOKI'!Q4!E:<
MA-4!$!W*B>[3;T2;CZ0(N\.`?,'9\FN"]W*%[BW(#D64_6BD_;4Q!_23]/&I
MD:URKM-*5\'1ERMG!FI"J.2H+&;D..Q#K@F84B&'Y"F4V`?T:>[G51:XORKF
MOG%I5S*/',Z54LRX747EN^`06&454,I*"N!NT'0R1E>^`?6*MU@;8P"&OGC*
M:5\K);(OUS(Q:_.]S>OKO"3'CP<),0CX40H$MRTZ1:U6K,P<1861XZ;CFLDR
M.(&%!TD50I3AZ#IB/K)J`'H,40'7B&:;'D$L$K)(/$&QKW/CX^5$T&5"LD)Y
MAA<5#++N-F]&?,7\.*IJ_,'61116.992-D$2=\=GWQMSJ-5T.HZ(F$3%Z#%W
M$`#6_P"P;O)N"R8^2;Y*"]_XEY<?:#S\[UR;NWMZ':7AS,)2,*5BI7GH:U^!
M_A87MY$6K#FMCK3::4JL5Z4)!V""FE$CKIQ$O'2*B*8[**I-'22JQ$QW#]H9
M$I@+\X]FL7-@;*P\K&4V9XR![[</MK.VS*7!W+`S7!,<4JL;<[`\?LK8#8+4
MUC:5*W&+53D&K>#5EHQ9/?NG(J)@#)0=PW*0%E2B<![2@`@.PAKEN/BO-FPX
M4@*R-($/LX\:[MEYT>-MN1N<1#Q)"9%(Y,+77Z.5ZUSB)S&,=4XJ*G.=150W
MZRJRAA.JH;?MZE%#"8?TCKK:JJJJ*+*``/<.`KY\9WD9Y)&O(Q))\R3<_;7\
MU6J4TI4F.-K<!?W!WT[]#&$:=>WH[US).#)[_P#$"`#_`+@UIG=[<-O2_P#&
M?_A%=)^7B?\`YQ+;_NU_^,VJ5NM,KI%;L.$;YPZP:T:KJ'4)%V6;;-S*&$P@
MF_386!8`$1'U0>S2VP>@/1KLG9DC/L.,&_==U'N#'_&OG3YCPI%W5F,@_J1Q
ML?>4`/ZKU+S6U5HM-*5`WE9_$SY97XNLF_T]^<VGG5?`?IY5_]'L&\K?^6_P
M2_"+QS_<_3M*J>0K3[_YBF%=K(<9;$5$PL(Y[DF&67];H3=S32F/6J6WZ@F6
M2KZPA\H=V.WRZYQ\Q4)PMND\!*P^M0?_`-FOT,_L!SX8]X^9FUL_^HFQ<*51
MYK#)DHQ^@SH/IK&4;-IV:-9V=$2&;6925L;0Z90*FHTG)Z5E&ZJ92]@)K).@
M.7;_``F#7V#VK,F1VWL4T9NC8R'[*_/SO#;)MD[M[GV;(4C(Q-PR(6'\T4SH
M?M6H=6-N=I:;8U.&PH6>9,7<-A,D]<C*(*?V*(/RB&MEQS>.WDQ_7?\`4:UA
MOO&J$HW06.BHL@BJHV4%5N=1,ASH*F(9(5$3&*)DE!3.8HB78>D1#T#J[I4L
MKE1K`(!\0#SL?"_CYU2YL5OZ;@V]HY?5X5_'+9L\1.V=MT'3=4`!5NY23714
M`!`P`=)4IB'`#``]H>D->9(XY5T2QJR>1`(X<1P/E559E-U8@^SV\#]8X5Y?
M8\3X+V;[+CO9W5U>`\$V\%U=?>]7A>Z[CJ[SUM^G];M].O+00NB1/"IC7D"`
M0.?(<AS/UFJ!F4L5)!//V^_ZA]5?L8N-,FFB:.8BDBV49HI"T;BFDT5`I56J
M9!3Z2-E"D*!B``%$`#<.S56AB>^N)3=0O$`^D$$+[@0"!RN!Y54,RVTDBQO]
M/G[^)X^VOR:(BCNDGQXR/.]0*0J#PS)L9TB5,!*F5)P*8K)E3*(@``(;!Z-.
ME$)6R!$O7/-K#4>%N)Y\N'/EPY52Y*JA/H'(>`XWX#W\??50U<JE9WP='BU)
M/V]PF(ME%DH]ETEZCJQM<%R]EUTP#?K36D53I%$/UA:_V:PY)`7>0GT*+?5<
MG[?U5=0<`?.KBXZQQ7GG7U!C$)=:&.VC:JS/=@`@V?T'C&WQK/\`>=`"`"G:
M6:B9M^WJ'8>W7Q#)-^8_,W/RU/I4NW_\K2?_`+S&OT^W?'?M[^P3:]NS_3D9
M20,@\Q/O(S([>^#U>[C78)KHM?FW32E?P0`P"4P`8I@$!`0`0$!#80$![!`0
MTI43KQPWQ)<9)>6;(/JP[=&44<$AA0,R%550RJBB,>\279MCJ*'$QA3(`F$=
MQUK.?VGM&?*TQB,<K&Y*&USYVY5NNU]_=P[7`F*LZRP*+*)!JL/('G;V7J(V
M6>'E.Q\P%\&68J-.NHHHR86E(J4B_3(4QC),D8=/O!(F!!ZU"M%@+\OR:U;=
M.SL'"B,J[L(AX"2UC[K6/ZZWC8_F)N>Y3KCOL!F/B8;@@>9O=?KM6IG.5,<V
MQBBT@%6\A.5:4="+$IS-U)%FZ0(DZ%D+LC<ZQ.I%)5$PE(54I1`>DW8$!LN;
M%M6=,L\@;'==)=;D7!N".1MS!X7%ZVSN7:Y]_P!JQWQ(F7+B?6$>RM8BS*>8
MOR(XV-O"HJM\;WYTMW"51F2J;].[A%%LD4=]O6657`@`'SAOV:W)][VI%UG-
M4^P7)_57.(^U]_D?IC;'!\R5`^N]9*B^/%G=-P6E)>+BU3!N#5--9^HF/^55
M8IVZ6X?+T@/]NH>;NS'5[08K,GF3;ZAQK8L?Y?YC)JRL]$<^"@M;WGA^JJ<^
MX_W=)V5LU7A7S5;<HOA<+-B(%'L$5FITU5#@`=NQ3>MZ.S5V/NO!*%Y(9%D'
M@+&_T^%8\W8.Z"4)#E0M"?WC<$#VCC?ZZE?]58UY4VE1FB>U&"41'13HQ]R'
M7%@W;HE=)F`>M!<JJ`*$,`[D,`=O9K21E2QY39<#:)=986\+DFWVVKIYPL>7
M!3;\I>IC]-4:_P"\%`%_8>%P?"M>\_$J0,[-0:IQ4/#RCZ.%4P;&5(V7.1!4
MW_$JWZ##^DVNJ861\7AXN5:QD0$^_P`?MO7!MSP_R_<<W!O<12%1[N:_817B
M:,GD@J*#!F[?+%`!,DS;+NCD`>T!4*@FIW8"'HZMM_DU<EFA@`::94'M(%6(
M,7)RF*XV.\C#GI4FWOMRKZ'C9,CDK(T7)@]4,!$V@Q[PKE10P[%(FD9$IC"8
MW8`^CYQVUY&5BE#+\3'TAS.H5<.!GB58#A2]<\ETFY^RI]8QJZ]0I<3$/"E)
M(J"XDI0A3=14W\BIWRB`&#];PJ()I"/H$4^SLUS#=<P9^X9&2O\`3)LO^5>`
M^OG]-=PV+;FVG:</!DMUE!9[?QL;GZN7T5F2H52<N=@C*_7XQ>5DI)R1!LS1
M`Q>^-U$ZP.J!3@@@0#@*JH@)42#U&^0!L8F'D9^1'B8J%IF/U#S/D!65N&X8
MFU8<V?G2A,>,7]K'P51XD\A]?*NA''%13H5#J5-36\2-=@F$:X=;;"\>I(E&
M0>B`B(@+Q\=140W])]=\PL9</$QL1#Z8T"_4+5\I[CFR;CGYF?*+232LY]FH
MDV^CE5R2,3'2R0(R+-!XD4>H"+IE.4!#Y=C`(:R"+UAWJB_4>I_^!1W_`+LE
M_P"KI;VFEZ?4>I_^!1W_`+LE_P"KI;VFEZ?4>I_^!1W_`+LE_P"KI;VFEZH5
MGI563KLT=."C@4+&NQ((-4MP-W)MA#U?2&EO;05RW^65Y9%CR7(0.6<ZP3R)
MJT0=FZKE+EVJC9R]<-03,C)SS-P4IT^Z,4#(-E"@*8@!U`Z^DJ?)^S.R5AE.
M\[M'>1F)CC/@">#-^P?LY_IG_=;_`'<?&X<WRL^5VXVPA$(L_.B;^H0H#X^.
MZG^GS$DJG\3[J'1<OU>5ZO158BFD/#M$6;)FBF@DD@F5,A2)E`I0`I0````#
M76*_,PDDW-5S5:I7/;S-:NFW)3*XN0+LXG8%PW,4H%`[=3&]"[H0``#<2D`"
M&'Y3E,.NV]E,I[>Q5!XAY+_]HG]51N3_`%F]P_56JC)#<[:_6(I@V(Z2@Y%(
M1#;K(XB4&1Q+\@@1Q&'+_:&MP@/]5?;?ZP/\#6*_WKUC>;A(BR1$C`ST<TEH
M66:*L9.,?)%79OF:Y>A9NX1/N51)0H["`Z9>)BYT!QLR!9("RMI87%T8.IMY
MJRJP\B`:K%++"^N)RKZ2+CR8%6'N*D@^PU[0:M@;`R[A+P@(`V!L*910\."?
M=`@*8@)!2[OU>G;;;LU?R%7*$RY*B19+Z@W$-JYWOSO?C5J%5QUB2`:%0`+;
MAI`Y6MRMX>56!7,18PJ!I8U9HM:A1G6@L)?P,6W3"08F[T3,W`"4P':G[XVZ
M?84=^T-1L.R[5CXF5@0X$:X<RA9$MP=0"`&OS`!/UWYUD-D3ME)FM(?BE8L&
M\02021Y$D"_NKYQ6'<60D,[KT30JRPA'TG&3+R,;QB!6KF4AG#=W$O5DQ*/>
M+QSEHFHB(_\`+,0!#8=7H=MP<=<18,5%$&0)X[#[DRV`E4\PX``#<[<*L-Z^
MOK`(EB,3W_>C-[H?Y3<\/;7XF,,8IGV*<9,T"KR+!&7EYY)LYBT#IDF9]<SF
M;D2[`!@=2K@XG7-O^T-VCK%DV'9IH<+'DVZ(P8T;QQ+;@B._4=%'@K/ZB.5[
MFKXR9PV0PD.J5U=S_$ZKH5CYD+Z;\[<*R$P8,HMBSC8YJ@QCX]L@S9,VJ946
MS5HV3*BW;H)$`")I(I$`I2@&P`&IEW9V9W-V/.L9$6-51%`0"P`K,F&(9:0L
MTE-=&[>&9>Q6AA#_`)DQ,G;.'94Q]`^#C6Z93?*`NMOGUARMKD"@\%'VFW[/
MUU=0<"?.NJOAU"^P^-V,2=R*'MB/F+84IB]!SM[C9)FT,%#@/;U&CY9+_=MK
MY^[BG&3OFZ2@W'5(_P"SZ?V5,1"T:`^529U"U<II2FE*C5DKBKBS),FO..V+
MB$FG:BBSQ]#F33(\75`H'<N6*I%&*SL_2&ZIB"<=O3J`W+MK:MTD,TT.F<\V
M4V)]]N=;9LW>F^[)",;&R`^*.2.-0'NOR^BHEY,X3TJG13F9+E5K!-S"4C3Z
MW(-$R++]G_2,4XOP*SEPJ)@V`I%C`';TCMK5]P[*P,>%IEW,Q*/%[$?L/VUN
MVT_,K=LN=,=]D6>0^$6H-;S\1]E:I<XTQ.:BYFGQ4I'OY:-?-)2(6(=PBSE#
M-3JE!-HX>M&2JA'3191,3=T44U1`#%Z?6'4L"9-GW2.1IEE@`*EDN18^/&W$
M&QM]5=`W3%D[BV.:!,=X,HE65)+`ZE/*XN+,+B_MXBH3!CB_"X%M]4)L%@-T
MCU((@D`^C?OQ<=R)?T@;;6\?G6TZ-?QR6^F_U6KEW^V-_P"IT_RR35YW6WUW
MK(4+Q^MS](%I9[&P>X>JV'O)!T'Z5!1.B@F(_,!C:BLCNO$C.G&@:3VGTCZ.
M9J?Q.P<^1=>9EI%_*!J/TG@*_$IQ_NC15,(UU$2Z*AND3]\K'J(_\:A%2N`,
M7Y^D=P^;58>Z\)P>O`Z$>5C?]5><GL'<D9?A<N*13YW4C]=2;I]2""H\949<
MR$H5*/=,Y$O0(M%R/W#IPX;$(?<PMB%="F7?M$I=^S6GYV8<G/GS8@4+/J'F
M+6L??PO[ZZ+MFWC!VK%VR9A($C*MPX->]Q;RXV'LJ$>0JTC4+C-0+7O/`MU&
M[J.!4QE%"1\@V2=MDCJ&]90S<5#)=0]H@3M[==%V?,?/VZ#(E-Y>*L?,J;7^
MD6-<<[CVV+:MXRL2`6Q[*R#R5A>WT&XJTF[=P[6*V:-UW3@X;D;M4%7"Y@WV
MZ@21(=3IW[-]MM_EU(221Q+KED54\R0!]M1$,$V0_3QX6>3R4$G[*^[J-DF2
MA47D;)-53[=":\>\3.??T`0ID-U!'YB[CJVF5C2`M'DQE1_,/\:NR8&="RI+
MA2JQY`HW'[*FIA&I/*O4U7$HW.UD["]"26:J!TK-622!6\:@N4>U-<4^M4Y?
M\(J[#V@.N>=P9R9V>3"UX(UT@^?B2/83R]U=A[3VJ7:MI"Y*Z<J9^HP\5%K*
MI]H'$^1-JSI%Q;^9?M(V-:N'CQZX2:MV[9(ZZRRZPB":**1`$ZJQ^D>D@=H[
M"/H`1"&BBEGD2&&,M,QL`.9/Z<_*MBFF@QH9<G)E6/'079CP`'Z<AS/A6_#C
MSCESB[%%:J\B0"3)BNI>;3!0%O#R4LX.Z,P[X``%@BFIDF@'```X(;@`;[:[
MKL>WG;-KQ,-C>15NW^9C<_::^7.YMV&][YG[B@M"[60?R*`J_20+GVFLV:EJ
M@::4J!O*S^)GRROQ=9-_I[\YM/.J^`_3RK__TNP;RM_Y;_!+\(O'/]S].TJI
MY"H_>=!@Q;,/#JSS$:U,YG,5OFN1XTJ91.H*,$DY;SQ0*4!.?JK,@\$I2]IE
M"E]/H'6^[-O_`##8\M%%Y8QU%]Z\3])6XKZ,_M5[X'9'SF[:DGET[=N9;;YB
M>5LDKT3?D`,E(2Q/)=5:#^'-Z+;L2MX5RZ%>7I;DT2L110#+!%E(B6*`B)0V
M09-V()))".QEE"+B`""9AUU/Y']R1[KVJ-GDE!S<%BMO'I,24/N!NOT"IC^]
M+Y?2]H_-W+[BQL4KLN_1+DJP'I^(4"/)2_\`&7"SM_\`CBWC:MYA@CQ\^SLJ
M1!\!/(MXN04`/5;S;$ARQJB@AV$))QW[$!^55L4/2<-=KB;1)I/)OUC_`!'Z
MJ^/G'[WE6*M9=>*:4II2FE*:4JK0->D[7*I0L6)D"B!%I:5`NY(:-.8Q3."[
M]BDBZ[LQ&J?^<!.;8I!WLS2%;(G]0_8//_#VUZ5=1X\JF-&R-1QI#)3DV1)G
M2J(P+*/V@K%1*ZAZZV6F',&"RGZSRT-HP\8B([F5?/TB_K'UJ'>.[P;!VSNN
M?*^E5B*CSNW`6]IN;>9K<>Q>T]R[[[P[>[2VB(MG9V4D0L+Z5)N\A'\,2!I'
M/@JDU5?(LQG/Y0SOG'E7<P6?2"KA_#HRK@@F))6>YRHVZZNRB8.QP@*;,`,`
M_JNCE^?7R+V'C29,^Z;WD"\DCE0?:QUN?KTU^@O][O<>#L';WR[^46R%4P\>
M-<AXQS2*"/X7#7W$&<D'^!3Y5U6:Z57YS4TI32E6;D*Y,<>TJR7.13%=O`1J
MKLC4IRIG?/3F(VC8Y-0_J$5D9%=)`@CV`90!'6-F946#BY&7,?PHU+'Z/#WG
MD*S=NP9MSSL3;\<?C3.%'LN>9]@'$^P5S]Y!R#8\@V.6M%GEE'CMZNJX55.<
M46C9!/O!31:IJ'$K..8HF$B)-]DD@[1$>HP\'W#<,G=,J3*RG)=CP'@H\%`_
M2YXU]3;3M.%L>#%@8,86-1ZF\7/BS'V\_8.'(5&Z9RUB]-<6SR6))'3-T"NQ
M8.'J*8CN`]#HI"%.`?.F)@^;?63#L>[2IK3$(7VD#[#6'D=S[!!(8I=P5G!M
MZ06`^D"WU5=\:XJTI'!+1<NBM&"GUG=(RZR2"!2AZP.0.NF+0Q/\150(8!](
M:CI8IX93#+$5EOR(X_1Y_14O%-BY,(R<>97QR+Z@W"WMX\/IM7[CEJW+`J>)
MG$WPM]N^,QG3KF0^85`3<F$A!^01#I'Y!TDCFA($T3*3YK:_UBJPRXV0&.-.
MK@<]+ZK>^QKX)3#+QYHV,M<3(R!3"`Q+Q^T<.#F#TI)+(*`Y!4/F_:;?*753
M#*L8E?'<1?Q6('VBU47(QVE,"9<;3C]W4"WV&]5UO*ME!%)R/L]V41*HU>&*
MD("`[=2*QNE%RD;TE,0>T/2`#V:M$'PXBKUQ>W)O(U@2_86>VRW*3T+*L&;.
M7!L:5(N0ZRR+Q%)-JHZ9D2'H<"Z01((E,(;*%$>T!VULVU]PC`P?A9("[*25
M-["QXV/N-^7A6D[YV>V[;F,Z#*6-'`$@(N;@6U+;Q(L./CQ]E9NK5/BZ3$-H
MB-:>%12`O?NW1"ING[HVW>NW:YRD%198X[_,4-@````U`967-G3O/.^IV^H#
MR`\`*VW!V_'VS%CQ<2+1"HYG@2?$L?$GQ-7&V9^.=)HM4D73PP]*)$105<',
M'^%$"B90Y_\`A+N8?D#?5E5=V"(K%CX`$GZA62\B1J9)945`/O$@`#WFI_8J
MX,S]J@F,_=9@:NG(@FX;1)69U)HC,PB)7#@%S^&9F<I[&(BJD<Y2B`GZ3&%,
MF];9V1+DP1S[A.T1;CH`%P/:>/'W<JY9O?S.@P\J;%VG$6=4X=1B=);QT@6N
M!X$\^=;#<680H6(F0HUB,*:26(*;R=>@5>5=%$QCBEWPALV;`<PB5%,"IEW'
M8``=M;_MNT8.U1]/$A`)YMS8^\URC>>X-TWZ;K;ADE@/NJ."K[E'"LO:DZA:
M:4II2FE*:4KY+(IN$E$%2@=-4HD.4?0)1#80TIRKR1L5'Q#<&L<U2:H`(CT)
M$*4-Q$1']4`#TCI5;U4-*I32E:??,:Q@YC[=6<JL6QS1EFBT:O-K$*(IM;#`
M`\>11U>G?8\Y`N54^LVQ0]E$)N)E"!KI?8&Y*/BMJD;B3U$]IL`P^JQ^NL/*
M3[KCW5I6S3!'[J*MR!!,2-(>'G!`-^[BWBY5F#\VWH3CY,PD4,/ZJ;D3>@HZ
MZ<K=.16/W3P/[#]?#Z:P&%Q[JP:(;"(#V"'8(:S*MTTI32E-*4TI7J81LG-2
M#6'A4"KR;X3`D*N_A63=,2`YDWY@[2LF0*%$P!ZRAS%(7M-N%J63IKZ1=SR'
M^/L'C55&HV\*F_B_'BAUZOCVL=\K(R\I'PC-X(%\4ZL%DDF\<69=;=@F"3?E
M<*^D$T2"`>J0`U$Y^4NW8&7F,?Z:,WO;P^LV`K(1=;*@Y5U/0$*QK<%"UV+3
M[F,@(F.A8Y'T]TQBV:+%HGO_`,#=`H?[M?.[,SLSL;L3<^\U+<JJVO-*:4II
M2J?+2C&$BI*:DURMHV(CWDI(.3_JMV+!NH[=KF_X4D$C&'^S7EW6-&D<V102
M3Y`<Z]QQO+(D4:WD8@`>9)L!]=:!LTY=LN6[I)SLLX<HLN_4;P\**@]Q"QA%
M0%M&I)D,9/OD^@IG"A?^<YZC]A1*4O"][WB;>,R2=V/PP)"+X!?`^\\R?HKZ
MB[9[>QNW=NBQ8T!S6`,K^+,>8!YZ5Y`>R_,U$ZPY3QS&KJ,)270D%T#F(LBQ
M:J28-U2&Z3$,NF7N`4(8.T"G$0'TZM8VS[GDH)(<5M!Y$D+?ZZO9G<6R84AA
MR<]3*.84%R#[;<`?IJLU^1J%E9>/@)0KAN4H]Z1%^Y:KM=O6,5VT4536;=(?
M*8H%$`W`1#MUB9./DXDABR8BK^T<_<>1^BI#$R\+<(1/A3B2+V$W'O',?2*]
M3)S5Y-PHUC9YN^=H`85$6<^+A=,"CL8P$2=&,)2CZ1#<`^77AXIXE#2PLJGD
M2I`/UBO<4V+,S)!D(\@YA7!(]X!KY+2T8R?%8(W",+('$O1&2<BS<B<1_52W
M%8CM(Q_0``<!_0.JB&9D,@QG,?\`$`;?7:U#D8R2B!LR,3G]TLMS]%[U6T90
MA3BWD2!'.R#L)5C_`/2KAM_S&KLP$3.4?E*;I.4>P0^4;5O%>(J]>QLPLWZ<
MC6&LJ8J<WF5CIR"D8YL[*T)'2978F.BNW05459NDCH"(F6;@N<ABCL!B"780
MVUL&R[VNV13P2Q,\;'4MO`VL?H-A6I=R]KMOD^+E8\ZQSJNEKBX*WN"+>(N?
M>*R+1\>1M`ARM6Z(K/5P!:3FG2!4EGRPAOV',``BT1*'2DF`[%*&_:(B(QFX
M;C-N60TTK>G]U1R4>0_:?$U.;1LV/LV(N-CIZN;.19F/F3Y>0Y`5>944G*J:
M10:K+&,!4BBHV.83F_5*03'V`P_)VZP@&OI`-S[ZDBP`U,ZZ1XDC]=3;PMPT
MM61X4EFL;X*I#N^R.2>,W!I1^GZO4[0;F40\*U*.Y2G5*;OC`(E*!`*=3<MG
M[.R=P@&3F2-!&?NK;U$>9OR]@Y^=<X[A^8N%M.4</;H5R95'J;5Z`?(6^];Q
M-[>`\ZV*8CXX8[Q"!'D4S/+V'IV-8)8J*KQ+J(0BA6*2:9&S`JG0`G[HA1.(
M`([CVZZ#M6P;?M"WQXKS$<7;BQ_P^BN2[[W7N_<#6S)].,#PC7@@^CQ/M-S6
M?]35:W32E-*5`WE9_$SY97XNLF_T]^<VGG5?`?IY5__3[!O*W_EO\$OPB\<_
MW/T[2JGD*FE:JZPME>EJ])H)N6,LR<,G*"I2G25272.D=-0A@$IB'(<0$![.
MW5"+BU>HW:-UD1BKJ001P((X@@^!!XUQ(\B\/V+RZ^6\H<(N44PO<GKM:)69
MI`9$(20.LJ>)0,<2HC*U1TIUH)',7Q3'=$QA(JOMS6#/SOEQW9%O6`C-MLA]
M2CDR$^J,^T<UXCPXBOU*[:S=E_NZ^1,O:&]Y\4?S*VM5];<76:,:8LNW-HLE
M"8Y]/`.S\%_"O,%TTKMWJ[5PW7:S]2MT020CG[)0YFSZ.54`A'C%<P%5(JQ>
MDZ!$0*LT=)BDJ":Q#$#[(V'?ML[GVN'<]LG#X\@Y?O*?(CF"#]H\P17Y>=U]
MJ[YV5O\`N7;/<F`^-N^+(4D1A]3*>3(PLR,.#*0142K-6I6FOP82XF<,EE.B
M(GP(!6LF0=Q(@[$H=VRF"%[#IFV*L/K)B._2&P13$^B7[_@?/_I]GU5K++IX
MC[OZJHH@(#L("`_,/8.LBO%?S2E-*5\U5DT$Q55,)2%$I?5*8YSG./2FDDD0
M!.LNJ<>DA"@)C&'8`U1F"*68V44]@YU*'&-8<5FOKNI5,&TO.KEDY%`XEZH]
MLBCW$9&JG`>D56;3<ZHAV`NJH`=@:PKEBTC"Q/V`<O\`$^VKRJ>"`78GZS4*
M,Y7VR<CLAUSC]A=NXGDW4J2/>+L.HS:;EU':!ESJ.$BB'U<AA:HJ**&ZDQ60
M[PN^Q-_DSYL]Z?[QW7$[1[=D,F!#*3(ZGTR2<KCSCC%_5>S,21<!2?U&_ML^
M5>W_`"([/WCYX?-0KB;E+AVQX7%I<>%_5ITFW^JRCH58_O(EU8KKD`[%N$/&
M>O\`%K`E.QQ#I%%VTCDG,X_%,J:\K./"@XEI-R`;CWKMX<P@&X@0FQ`]4H:S
M=MP(=LPH,*`>B,6OYGQ8^TGC7P5\Q^^MV^9/>6^=X[PQ^)S)BRI>XBB'IBA7
M^6.,!?:06/$FI@ZSZT>FE*:4J)/-AO(.,%28LB**-T;#7U90B13&,+4ZZS9@
M82E[>E*P.&1]_042]0]@;ZU?O%96V#+Z?(%"W^4,+_\`36[_`"[>!.Z\#K6N
M5D"W_C*-;]H'MKGISJ]=LL<2(-%#I^.DHB-=F((E,+)TY$RZ74`@($7%$J9O
MG*80^77,^W8HY=WQED%P`S#W@</JYUVGN^:6#M[-:%B&9D4D?PLP#?7R^FH-
M``!V!V!KIE<3Y5_0$0*<@&,4BFW>$*8P%/MVAUE`0`VP_/KR54D,5!8<C:O2
MR2*K(LC!#S`)L:_I3&((BF<Y!,7I,)#&()BCZ2FZ1#<-&56MJ4&WF+T222/4
M8Y&4GG8D5_"B)#%.F8R9R&`Y%$S&(H0Y1ZBG(<H@8ARF[0$!W`=59592C*"A
M%K'E5%9T<2(Y$@-P03>_G>IG8<R#]<HY:NV(Z;FP0Z)5$EUP(928B@$J971]
MP]=ZR4$"+B':<#$/Z1,.N=;]M0V^=9\=3\)(>'\K>*^[Q'U>%=E[4W\[QBMC
M9;@[A"./\Z\@_O')OH/C4^^+F"(K+N14&CYFV)7J^A[:L`D2()U6:2R2#>-(
M`@()JR[A7H`X@.R":XE$%"D,%[M;:3NVXWE)^%ALS>TW]*^XV)/L%O&L;OG?
MOR'9[8X`SLDE$_E%O6_O%P![3?PK=4UQ;CEB8#-*57$#`/4`DBVP>MZ-^T@]
MNNO+A8B?=QD'T"OGM]RW"6XDS93[V-5=K2ZBQ<^+:5J$;N?3WZ4:T*IN/R@;
MNNP=7%QX%.I85#>X59;*R772T[E?*YJYM7JL4TI32E-*4TI32E-*4TI32E-*
M4TI5CY'Q_7LI4J>HMH0,M$SS3N#JHB!'D>[14(XCY6/6$!%M(Q;Y)-=!0.TJ
MA`'5_&R9L2>+)QWTS(UP?T\//S%4(#`@\JYXL[8)L^&K,]I]Q9IR$;(HN@BY
M8C80A[3$'*<BJ[8A@%(J@H;^*:;B=L;?L%+H.;NFQ;[B[YC:TLN2H]:>7M'F
MI^SD?;&RQ&(^:UKBNE+>T=T<X`JZJBRFT;+&ZE#Q93FV3BIH_:8@([]*#HWJ
M*$`"J"4X;FV"*71:.0\/`_L/[#XUCLG[R\JM3YOT@`A^D!]`A\X#K*JW32E-
M*5^3G(D0ZJIR)I)E$ZBBA@*1,A?UCG,/84H:$@`DGA2I!8?K+EBT>VF104;.
M9Q!!K%-ER"FX;P*)Q<E773,`'26EW9@5Z!`#%132W[=P#"+=1C);T\A[O/Z?
MU6JZHTCCS-;:/+ZQ8>UY4<Y`D&PGAL;,3NFJAR`*2UOGVKN+B4B'$!`3Q<"L
M_<+$[!*9RT4#TAKGO?VY=+%Q]KC;URG6_P#E7[H/O;C_`-6LS%2[-(?#@*W:
MZY36=32E-*4TI6%.1J+UQ@[):;$IU#A6EUG::91.=6(;KMW$ZD!"[F4[V%2<
M%$H;B8!VU%;ZLK[-N:P7ZIA>UO=Q^R]3W:[P1]Q[(^3;HC)CO?E]X6O[C:N<
MO)SQ_%42YO&JBB$@UAGA2JE$050.J<C5=4I@[04226.(#Z0$-_DUQ/:XXY]P
MP(I!>)I5O[1?E7TMO<TV-M&ZSPFTZ0.0?(VM?Z.)K78!0*'2`;`'9M_Z>T1U
MUFOGZOT4QB"82&,03%$AA(8Q>HH^DIND0W*.O+*K6U*#;S%Z]I))'?IN5OSL
M;7H013$IDS&3,4!`IB&$A@`0V$`,40'80U5E5Q9U!'MHCO&VN-RK^8-C7\$`
M'??MW'<1'M$1^<1'M$=+`"P`M7DDEM98E_._&I4X1R,K)B%&LCCQ2Q43GKKU
MV;O%7"2)1,O#KJ*;F5501`5&YC")C)E,3MZ2AK1>XMH7&(S\5+0DV<#DI/(C
MV'Q\C[ZZKV;W#)F*=ISI=62JWC8\W4<U/FRCB#XCW5.;"6'V^6,C0-0;-VK5
M-VX,[DG@()',RBF*9W<@]!(P"10Y$DNZ3Z@,3Q*R0'`2B(#%[)MK[ON,.'J(
MBL6<^2CG;VDD`>^IWN;>8^W]GR=Q$:F>X6,'D7:]K^P`%C[K>-;UH?#>,(-F
MR91])KY$V#1JS14/'(*+&39HD12,JH<IC*J=*8")A[1'MUVN/;\*(*J8J"P\
MA7S3+NVY3,S2YTI)-SZC5Q)4:FHN".DJO!$<)[="Q8QIUEZ?1L/=?)MJ\,;'
M!U"!-7N%8YR\HKI.0^G_`#&KH*4I"E(0I2$(4"D(4`*4I2AL4I2AL!2E`-@`
M/1J]6/7ZTI32E-*4TI4#>5G\3/EE?BZR;_3WYS:>=5\!^GE7_]3L&\K?^6_P
M2_"+QS_<_3M*J>0J>6E4J(7,'B90>56,)RF6N-15=.&JAXR2(F0'T;()E$S5
M\S7Z1,DN@KL8!^?T@("(:P=PV_&W+%DQ,J/5"WU@^!'D16X=B]\]P_+ON;;>
MZNVLPQ;EC/?^21#P:*1>3(ZW5@?>+$`UR/VZE\CO+CNJU8NL&YO.%'DLJX*F
MIXA*)4%V!6BTA$OB`LI3[49`"!WA>IJ\Z2)K$72,HAKG>#G=T?+7<?C-NF+[
M>S<1QT./YAQTM;AJMX"X(`%?I(N1\F/[R.W1C9J+M?S,QX2%XJ,B,@$@QMP&
M5C'B60^I!JX*0LADA6,QX2S!&&0KUC:.O%I$(_J=M:MHN=:B*)15*Y9'55CI
M)`''45-PQ4.)P**JC9FF&OI3M#YL]M=T"/%R9EQ=S/[DA"ACQ^ZU])Y7L"2!
MQ-KVKX6^:']M'S1^5\TL^9LS9VQ`G3E8H:1+<;&1`"\1L+MJ!0$V#DUYY/"]
M<6$3P[V3@A.`*)I-G!'T<)5"@8JB39Z#A($CE'<HIB!1`=P'755+K;1(;?6*
M^>RJGFO&K0<89L20B#2>AW9?\)G;!VV4[1_Q=PZ.F.P?,4-7%EE',*?KKQH\
MC7S1PU:%#`5S,P39,1[5$&CYRH`?\)%'"1-_[=P_1H9I>051]=5Z8\6KU/@Q
M/A8A9^[6=NZFFY1.S]HG06>I*&(80]CP+,NS91;IV!82!VB`"H&M:[@[JV'M
MJ'XG?=UCBX75";N?\L:W8_YK6'B0*Z%V)\K>_/F/FK@]F]M9&7<V:725A3P)
M>9K(+<RH)<@'2IY5%NSYARQRCM;?$>!J]+D82YA;.#-RF3DY!HJ84EG<T\2Z
MTH>&(D;UR`83'$1+NH82%U\T]W_-+?.]I9-C[3@DQ]I;@[<I)`>>M@2$0\M*
MDW%]3$&P_0SY>_V__+;^W;9U^8_SIW;&RNXX?5#%]^**1>*KCQ-9LB?5:TC`
M*GI($=F8](/EE^6E!<9($+W?$&TWE";23.[D54`Z(IML"B<7%IJ=9D$4C#NH
M??J5/VF[`*4MOM[MZ#8X#Q#YC_??]@]E?*7S]^?N]?.?>HDCC?$[0Q"?A\;5
M<ECP,TQ%@TC#@HY1KP'$L6W0%*!2@4H;%*`%``]```;`'^X-;)7SS7]TI32E
M-*5@CDS.1<%@S(RDIW!BRU>=5U@DX#J*>6L`>RXY4A`]8QF#AR#H1#M(1`Q_
M041U$;]/%C;-N,DUM/286\RPTJ/K(K8.U<6?,[CV:'')#_$(UQX*AU,?H4&N
M:_/$@U0Q]+D5*F!Y62BV;)$=MP6&13?F,F'I_P"G:LU![/0`:Y%V[&[[MB:>
M2!F)]@4C[20*^@>\9HX^W]QU\Y"JJ/YBP/V`$U!773*XE32E-*4TI5?JLVXK
MEE@IQL)@482;4RI0'8%F:ZI6S]N?;TIKLUCE$/GV'Y-86XXR9>#E0/XH2/81
MQ!^L5)[+FOMV[8&6AY2`-[58Z6'U&NB#@X%5L$CE?&%LCF$O%9"I1(M[$OTA
M4;S,-'JS#*>B'8=@'0DXVV"`I[@)DT5!]!>R`[(&)E+NVV9<8=)D4E3R91<$
M?1<5M?S/3,Q?R#>,.1D?&F8!AS5R5=&'MNAM[16KEK2L:<(''F7\A./E!H^+
MKE@#GAQOQ34[LC6V,NCC3`>1(CBNAF"#:I3J,K&Q-9?P5MF%W;DZ?6T%RJX(
MJD<`.'1.V-QR#MGRU^+R].#N?>.ZX&?(Q"AL&'/R1!')(;"-$DAQD1[J00BZ
MKM8\3[EQ`-][XBPL4ODX'9NW9V)&JEBN9)@R-+*B+<N[J79UL01J)6P-9R;\
M]^36<+>\J6&N2,!#5:\^;C:N)E#RG3Z+BJ],F''Q/C9.9`BAJZLI79:N6APA
M8V19!C++@[,Z$"%.JLT,9(]W94R\S=.T<'/:2,96V]RY$@TA69MNS&7!N&6Z
M`0A4<`*S`DM^)ZJR^XVP=MCWJ;;XTD2&/MY5]98+)N`5,PW#<6ZA:RFXC9=(
M4`$51\$<T>=D'9.,5FR-F\V<XK+G)KFOQ<D,5FQAB:GM+"7C9%9?5IE\;V"H
M4V$L<;=K--T!N@X:).2Q!43CTM^LPF")BWW+D[?V;<X-K67=-T^7^;OL<0+E
M8LO"7"*01`'7(F2'<N)"S+),PCTHL:I>S=NQ,?=>Y<.3-,.%M/>NW[,TAM^)
MCYS2*\\MP0KP:E9>GI!$0U7)?59%(\Q_EBKC.8N\-R?IV=;9<>!7+WD7E3'T
M/C/&<4[X#YAQ#5F\WCNFR3*"ATIY-%6T2SB#-&WL)-^_-#=^03D\0HKG;Q(^
MW[?W,F#G_$86'M^S2X^?92,F;,S8L>:,:`,<]7'>3)Z:)U(-`#A.*M3:H(LW
MN+M;'S<,P/E]QY6%-A$L"F+$)F$O$]=!$\44!D9]$QR08RS+==\_"TF8G_'K
M'=WSAE]]E^[Y0J5-R6X>.:?1Z:PIR=RIM?F'%(@&E'@(!&2@X:2<+BW=OR+R
M"I5=E53`4NVX]S8&-M&^[OLV*I,>'F9$.LDZI!',ZJS#[H(4!?2`#:YXDUJ6
MPY\F[[-L^[N-)RL*"0KX!GC#,;VO=M7$?=!'I`'"I7:@:EZ:4II2FE*:4II2
MFE*:4II2K#R+C.EY6KJU7O$*WF8M0Y5T!.)D7L>\)_RG\8^2$CE@^1'M(JD8
MI@'61C961AS)D8LI293P(_3E5"`PLPN*TW9_X,7;'B$A-5%-;(=*$#^(0;,"
MK6..;+*F())*';D%.6:HHF#J5:D!78`#N%#"8^NH[+WMCY07&W8".8\-8^X?
M>/W2?J]U8<F,1ZHSP\OTYUK"EL,U9<YSQOCJ\J)C^K%N`,Q%0AS)G_Z!P"[,
M!35*)3`4H"4Q1*.P@(:WU&N`T,OH/*QN/H\*PRHOZEXU9+G"\ZD8?`V&-=D[
M=@?QRS=4/F`QVCD$A'Y]B!JZ)9;F^D_6*\:/(UY4\.6LQ@!66KZ)!VW43;R"
MQ@#Y1*F*Z8"/]IM5,TO@J_;5>G_-5\UW$,)%.47\T[7L;UN<JK=)TDDA$MEB
M#N19.-2#H663']4ZPJ&+Z0VU:;4_]1[CRY#_`*?IKT`%Y#C4BZ+2;#D2UPM/
MJ[`TC.3KTK-BVW,5$!``.X>/5B@/A(J.0'O72X]B20;%ZE3I)GP-SW+&VK$D
MS,EO0O(>+'P`]I^SG7N-#(VD5T580Q#"82Q]$TF'4\8X2$S^P31TBI+SU@=)
MI%?R:I"[]TELB1%ND`]+=JDFD78I`UP7<<^?<\R;,R&O(Y^H>`'L`J450BA1
MRK+FL&O5-*4TI32E6I>I^*JM,M-BFR)*Q4/`RCYZW6*!R/$46:H^![L?^<=^
M?9$A`[3F.!0[1U9R9H\?'GGF-HD0L?<!<UD8>/-EY>-BXX)GDD55MYL0!]M<
MQV3WK:-HUO6==R=,D`[CP*7M3<NW38L6W!/JW$PKNUBF#Y>W?7!-N1I]QPUC
M%F:8'W`'4?J`KZKWF5,79]RDF:ZICLIOXDKH'UL16NKT=GI_3\^NLGB2:^?Q
MP`!\J:56FE*:4K[-WCF.<-Y%DH9%['KHOF:I!V,FZ:J%70,`_-WA``?G`1#5
MN6%,B*2"47C=2I]QJ[!D2XD\.7"UI8F##W@W^WE6_3@;;HU#+=?<O2HHDNM-
MD8IEUE$12>S;6'L3=,I]A!,AB01VX".W4=8A?2;6F]G-%!O>1ASV/4B>/CXE
M2"1](!KI'S'ADSNV,?-@'ICFCE/L5U*W^@LOUU#?,''7#?'/EEYF&4<`89I=
M7R7QM\OS&W(?`;N,JZ,Z:C9ND%>2;I_>H2`DTY2->S4FI7V??D7;KHK%;$*9
M,2EVUNN/N6?LW:G?>;MDICEP>Z-NPHV`!Z.!/M^WC+C%P0L1BFG9V/W`S/<6
MN./9V+#O'>'R[Q,].JNX['N.5,O&\^9%N4@QY#:Q,H945+<2;*`2:]=T\T'/
MUQ8\J9#`^?:/.0M#@O*P8X]M=<K..[C!5^W<E+]"U3/)%W*<0];33ETL]6:N
M&CA10T0X2420!JNF8"[EEXM^\=MVB*1DVC+[^?;49=+%MO\`RQ)UZ;,&#?CZ
MW2;U%Q:S-&5K7!DK!V?MF[RPJV[)V5D;AD(Q92,Z++T`2("#&1"5!B]-@0Q6
MYO54D>4_/3#EZRHZM?*YWE.I<>O,:XV\27%>E\,X.KHY;HN>(_%<I//[>_JE
M!B)*MR]5;WTY(Y2$69=Z<O4X[P"@48SMS/&YR?+V3*Q5MO._[QM+("VE%P$W
M(P98-]1F9X(Q)&3T=$2V0,TA?)[BA7:XN_TQY&U;-VUMN[HW#5(V8V-U,9P0
M5$0#.%=0)/6;MP33>^+N>?)JR<CL?-'6>:K8K3?N9V9>/F1>`*=%H#6S<?<'
MT6/OQX7-3J;8Q[;,)U46-+BI166E7KBN27UA%%JGN+=-&'VS/S,CMG;=PD8/
M+D]H;CN61-86PLZ"/JQ8A"@(A3(/P'2R09I-)D&H_B#*[D@AV_<>X8,;T)A[
MS@8N,O'_`%N/D=!))E#7=M44DF=U(2(HUB,;:;A#._RG[]R-SGQ.QSR1Y%9P
M=Y/G<TUI*7CZBE0<<TZOT$(.R6B`46B'E,K$#+S#FT,6+5R\+(*N$VS@IBM@
M33$2ZW?<L.#;X]MQ4N\TF#A9#2-S)R<'&G9-(LH59)'((%[&Q-@*C\B5)MUW
MU,>/I8N+NNXXJI?5=<;/GQXR2UVN$B"\^(XM=KFMG6HJE-*5`WE9_$SY97XN
MLF_T]^<VGG5?`?IY5__5[!O*W_EO\$OPB\<_W/T[2JGD*GEI5*:4K$>5L)X_
MS%`O("Z0$?+-':"B*A735%8!*H4Q!`>\*/I*8=6Y(HY4:.1`R'F"+BLS!S\W
M;<J#-P,J2',C8%71BK*1R((L16@;DKY&<%(R+FQ8-FW%/<J&65"-1*+B)*<X
M"(BDSZTU&I4R;%*1NHB381W`1'?6E;GV-MN6QDQ&,$GD.*G_``]O.OK_`.7?
M]Z'S`[9QDVOO'$BW[:P`-4IT9&D>!E`(>_,F57/(`@5K1LO![S`<&K'CJRXF
M9Z(256%LC%23H2J=V'6*IXY^!VJ(K=`%`._/N([#L';JS@K\QNW0L.S;_(<4
M"P762@XWX1MJ`]]N/*NP2?.C^TWYEJ<GOCL1</=](+.^,C'CPTK/#I=K7OQ1
M1POSJ.:^9N7L$NO$2+=RT?Q[ERS>-9.O07CV[MNN<CANZ!<@JE524[``W^'I
M$/5$HCL\6_\`SX:(''+RQ,`5<18I'F;$I<^1N.%14NP_V"93G(DW<1.>:"7<
MU'`6^ZBZ1ROPY\SSJW'%HY673=@M+61HDY*9,Y$%21Z"A>DX"17V<"@B50#"
M`]@_)OZ-7I-L^>&]@8^5NTD43'B0XBX>WI*M^?+QY&LE.]O['^RO]=M/;:;A
ME1D%`,9YVU'D0<EE`TD<^8O<`W-9FP3Y>6:\^7.*@2I/7[IZ=)9ZHX.N5I%,
M3J`*TC,R2IEC-(T"@;80`BRQ@Z4BF$#"6J_*##VM1N'=V]//(23TDX&0GP))
M+<^;`UJW=?\`?-G'$GVOY8=E8^VQVTK/-ID90!P=(E5(P1_"XD%=:G#KR_<0
M<2:BSC8./:S5N<)I+V.UN&J9'4I)=V0%!0*;O#M6"(E`J27480*4!,8QQ,8<
MR/&Q,>Z86(D,'(*HM8?M]I/C<^-?&/=/>7='>NY2;MW5OF1G9['[TKE@.?!1
M>RJ+V4`6`X"LRY^Y48CXW-(U.[/I&1GY4$EHRD5%DG-6YQ$%<@B^G?97B6J;
M2'CD2*J&6751*N9$R2'>+;)C@[CNV%M:H<ESK8BRKQ:U^)MPX#B221RL+FPK
M8OEY\I^\?F;D9$?;N&BX<((?(F8QP*^FZQF2QO(YL`JABNH,^E/56=*M:*_=
MJY"6ZJ2S.=K=CC6<Q"R[!3O6DA'/T".&KE$^P&`JB1P$2F`#%'L,`"`AJ0BD
MCFC26)@T;"X(\0:T/<]LS]FW#-VG=,5X-QQY6CDC<69'0E64CS!'N\JC]FOE
M[AG`=PJ=)OTI*%EK*B>1?J0L8:7;4NO=X=HVLUQ*V5\;&PS^3+X9`R2*ZRAB
M*G!/ND%CDC<[><';I\?'R7.N0^`OI'\3>(!/`&QX^P$CH?8_R>[W^8>T;SO7
M;>`CXF&0H#MH,\IXF''N-+R*GK8%E`!47U.@,D8J5BYV,CYJ$D6,Q#RS-M(Q
M<K%NT'\;)1[Q$CAH^8/FJBK9VT=(*%.FHF8Q#D$!`1`=2:.DB+)&P9&%P1Q!
M!Y$'Q!KFN3C9.%DSX>9CO%EQ.4='4JZ.ILRLK`%64@@@@$$6->_7JK%:@>;&
M;$KI:4<?5YX5>N4]PN#YPW4`S>3LXE.T?K`(=ADH5$RC)(P#VJ*.O204S#RK
MO7>!E9";7CO>&$W<CQ?P'_5_6?97=OEMVZ<'#??,N.V3D+IC!YK'XM[W(X?R
MCVUINY((2QQJK@J:QX)N61*LH0IC(H3#@[9-'Q(EW!,569!*D8VP"(G*':.P
MXO:3P+)F*S`9+!=/M47)M]-K^RLWY@1Y;P;<Z*3A(S:K<@YL%+>RUP#YU%W6
M[US"FE*:4II2LC8VH4I=9QBH1LH2O,'[=>7DSE$C<R354JYV#0XALY=N13[L
M0+N5,IA$P@(``PF];K#@XTT0<'+=2%4>%Q:Y\K>'C>MG[9V')W7,Q\EXRNW1
MN&9CR;2;Z5\R2!<\@*W><)F;QWG:"<H`<$8YE8960,!3`D5@2NRT4<YS[=`%
M3D9QH&PCZ3@/R:U_LM#^="6]HHX7+$\`!P''Z>/T5MWS*FC7MF2-_P"I+D1A
M1[1=C;W`$?34R:-S4X,YDR7+X)J%^J5HM]VE;$Q7CWV.K='T;*<[3TDX^P,:
MUD2Q4N/Q=EN8C&,1L*,5+2BZC-@H=,#(ME#)]APT7<L56Q4UXXC,ZJ1I)CU*
MQG2-]+,FIDDZJ*5(=)=6EE8_/VX)D[1D$9X:*</'`S<]#R1L4AD=;B-RH9!$
MY5@X,)4272I!75QA#`6-K5DNUPU-H&-\514UDVR3+"H-P9U=E7(%R,Q:F\77
M(=U(GD&->042ZV;=1X=`!2(!@$"#CYN?C8$<>9FS:$#K&K&Y(;(D6,*+`D=6
M610W@2UVX7-5Q<;)SIOA<9"\KB]K@7$8+\;D#T`%A?E;AQJC8KR=Q\R]+VV&
MQ:\J]BE\.V.'7LK=E5'48>GVC)M,C\B1T@T7E(..1-)VJGW1)ZLZ8G4,<'JB
M:YP6%5,,Y872-YE2T<&3DX)(X:)<218LF`?RQ2!5:WX;$#26`N,(9,<YC7JZ
MCD8\&8/'7%.&./,?:X1BNKUBW$"XODUCCR@1BE@5C:-3X]6VD<)VI1C685HI
M9DW9G!W:=@.@R3-,D<G=JBH#D5`.*IQ'?J'>QTX^C\-TU^'X>FPT^G[OIY</
M#AP\*O\`5DZRY'4;K@W#7.H&][@\[W`-[\Q>KK001;(HMFR*3=NW2300003(
MDB@BD0$TD44DP*1-),A0*4I0```-@U=9F=F=V)<FY)XDD\R3YU;50H"J`%`L
M`/"OKKS5::4II2FE*:4II2FE*:4II2FE*>G2E0BY$<+Z=E9)[9:8FSI]]%-9
M8YT$02@;(XV`P$FV:`%!%X<"@4CQ("JD]4#=:0&3-LVQ=SYNSNL98R8-^*'P
M]JGP/V5:DA60>35I)M=3L%(L$I5[1%NH:=AG(M)&.=E_:(*;=::B:H`";MFZ
M2$#H+I_LUB=H=)@.0G9=OW#%W/%3+Q)-43?6#X@CP(J-=&1BK#C5NZS:\U<M
M3I]DO$['5NJP[V;FI58J+&/9)]2JNYP(HNHH8.Z:L6W5NLX4V22#TB)Q(0^%
MG[CB;9CMDYDH6,<O,GR4>)KVB,YLHK?%Q>XQPV!8`[^2,TF,BSC=,D].))CX
M>.:`<5DJ]!BINJG'MCFW55'8[I;<YM@Z"EXCOV^Y&^974?TXR_<3P`\SYL?$
M_1RJ2BB$2V',\ZE=J"JY32E-*4TI32E:SN<^;$NAOB&O/"J"FJVDKDLW4`0*
MZ2Z'41`J;>DS03)OEP[.E7PH`(B"I0YYWOO`6-=G@?UM9I+>"\PO_6YGV#VU
MUWY9]NEYG[BRX_PDNL(/B_)G]R@V'\Q/E6DKD,C++4^.,Q364C6\VFYG.Y*8
M_=()-%P8+K%+N8&J3P^YS?JD-T&'L#<-6[8>!-R8S,`YC(2_\1(O]-KVK>.^
M(\N795&,I:(2@R`<3I`-B?8&M?ZZAIKHE<>II2FE*:4JYZI3IJ[R18J';G%/
MK(61DC%$&46V.(`JLNMMTF7*F(BFD7<YS;;@`=NH_<-RQ]MB,DK#JV]*^)/A
M[AYFI?9]DS-[R!#`A&.#ZW/W5'CQ\6MR`\>=JW"\9898V8,61$217I8V2K$0
M*0IC"#"OOV,H[*H8@;%Z86&7.81V`0(/]FM%[=67(W_;BO%^J7/N`);]/;75
M.[W@Q>U-X5K"+H"-1[255![QP/T5LIE^<G">*S?(X3E\F5Q+*DI/QF)IYR>A
MW1S3U+4NBNO%8RLN9D:<MBAM8^_ECMDH1]/$=$?O/"`B#I<$3]OP1'NJMCX2
MB1)GD`4C2L[1J5D$>JPG95C=#T]9/3=!<QL%^:,^/)VJ.+-SE:-(X4EU<S%%
M)(`DCZ;M"C.5<,^@:624G0RN9.-<=XNJT7(ECZ#1H*(Z6DC*(1E2@F+17V`X
M/+1[MTU8QR9'"L0\`SAN82F.BMN=/8_;JUFYN/M^)/N.;-HQ,56F9S<Z!&GJ
MD%KFZHMKJ-6D`#P%>8(9LJ>+&@4M-*>F!?[VL@:>/"S&UP>!\:PGB#D7Q/Y&
MRB$1B:R5.^2=GQ_1.2)6Q:5,QYY:EV68E*U0LCNE+'68M)624EZ*NW;@L;VH
MS%@F)TTB=R8<J*-C\68DM\#+"'MPZ4F9C?%Q6\FFQY.J2M^#D.0Q*U8DE4-"
MDDEVR5G0"]]:X<XQYU/.ZQ36CL>!/%+J+U(5O2:8TL;RX-:C6&UMD$1;O[2W
M@(I&QOFYDT$3(/)M-H63<HBBU2*)3JF+TIE#;8H;6U1522-5`C>^H#D;G4;C
MD;MQ-^9XGC7IF9RI=B2MK7XVL+"WE8<!Y#ARJLQL9&PS!M%P\>QBHQDF"+..
MC6C=BP:(@(F!)LT:II-T$P,81Z2%`-QUZ\%'@``/8```!Y````<@``.%"2S.
M[&[LQ)/B23<DGQ))))YDFYKW:52FE*@;RL_B9\LK\763?Z>_.;3SJO@/T\J_
M_];L&\K?^6_P2_"+QS_<_3M*J>0J>6E4II2FE*>G2E>!Q&1SO?Q+)LMOZ142
M(8>T-OE#5+56YX5K*YM8?XC1TO3[-E*[PF%K7D*:+58:>?QQC5NS3#=H1=$E
MD7!FI'Q:R$<VZ/&JKM#F2(4HJB4FP2N#WH>U5C3(G3X.1[`27TAK$WU#@G`<
MR0/IM6T=L_+_`+J[\&[_`.U=DES9<''ZTRQ:2ZQW"W$9(>3B;60,>0MQ%[5Q
MSY=>/;"1A84<L0EIJC@.]0>X^0CUVLF@).PJ,R9]-(E(/4405;'(H7TE,'9K
M9Y?F%E9,(.#CQ+J'!@=7TCPK6<W9<S:LJ7#W/$G@RT-FCE1HW4^U6`8?2*V7
M8YQ;1<401*]18!I"L.\.NX43`57\@Z5Z15=R3]7J=/G2O2'4=0PB.VM,RLO)
MS9FR,J9GE/B3^G"K8`46`L*I^:9>\P6*KY*XS2C%L@,ZQ,K4].:16<1)K`FP
M<*197Z2!R*BV,[*4#"'4!=]Q*<`$HX.1UNA+\,5Z^DZ;\KVX7Y>-37;OY'^?
M;/\`[F6<]O?$Q_$]$@2]'4.H8[\-06Y`X7Y7%[CF$96Z1MDA-6^U2<W,7Z9D
M5D[Q(VHX'LR-@8]+5W#2210[B.2B!3!%NU;@1FBV*GX<.Y%,1XODRY!R)CFL
MQR]1U:N=_+V#P`'`"P'`"OV$V+;-@Q-AV?%[2CQU[5$"MB]`?A-&_J$@/WF=
MS<R,]Y->H2>L$5)?COS$MG%V-MU6;P,A?J-8VTI)4BM(N4TBTG)+WO%BE%PN
MH06&/K0[4%>0*D"AF+LIED$C"Z6#4SLW<9VJ&:"2-I(2"4`/W6\N/)6/$VO8
M\0+DWX_\W/D#@?-+<MFWS!RXL#?(Y(X\R4@VGQ!PUZ0/5E0J-*7MU4(1V'34
MU'U[89NQ3=AN%SF#V2ZW*14F+7.N2[>/>J)E119M$#=96,'$,DR-&#0G[)LT
M2(0H=@B,+/EODSRY$SWE<W)_9[@.`'@.%=DVGM[;.WMHVS8-BPAC[-AQA(HQ
MX#FSN>;RR,2\CGBSDGV5.?RU;_DL,L6+'=6?.'^"HB(D'-DCI$JCN*KE]D';
M-U'QM%<"<IHQ59!9PYEFY3"R3,JGTI^(54.EN79[Y[&<`G\M'*_\9/)/+S;P
MO[2:^1O[M<+L3'Q-HRIH`OS*R'5@8K*6Q%5E,F6.3,6"K`;"0A6);IJH;9?R
MTRO(8KQ>96#64:S]LDOJU'/D@-WL:DI'/I"1?(G*("DZ\&R%!%0!W267(H&_
M1L,YW/NDFU;5)-!_YAV"*?(FY+?0`;>VU?(O9.QQ;]OL6/D_^4B4R./X@I`"
M_2Q`/LO6C=54ZRAE5!W.<=Q^8.P``"A\A2@&P!\VN)$DDDF[$W)\SYU]+@``
M*J@*!8`<@!R`]@JV[7#IS]8L$*HF"OM&(?MTB"'4/BA;J'9G+\H'3=D(8HAV
M@(:OXTQQLG'R%-BC@_0#Q^RL;,QES,/+Q'%UEC9?I(-OJ-C6MI(%%.Z*!#F6
M5%-,$4R&.H9=00(5`B90$QU3*#T@4`W$W9KKS,@!<L!':]_"W._NM7SPD<C.
ML00F8G38<RW*P'G>LXQ>`+H_9D=/',5#JJIE.1@Z%9RZ3Z@W`KDS<2I(J;"&
MY0$_2/9OK69NZL*-RL4#R(/&]K^[_IK>,?L+<I8E>?+CBD(^[8L1[";@7]U>
M0<#9!!<402AC)@;8'?M(P)"&^W7W0M>]#^S7O_=.VZ+Z)=7E8?KO5H]B;SKT
MB6#1_%J/ZK5DRK<>H]J=-U;I$98Q1*;V6P*=K'B(=HE<K"873H@_*4!(0?E#
M4-F]T9$P*8<?24_O'BWT>`K9-L[&P<8K+N4O7D'[HX)]/BWT\/94F(&!,NHP
M@H"-`.HZ31C'Q[4P@!E#`1)%!LV3,<ZAS=A2E*)SCV``CK6@)LF4*H:2=SP'
M,DFMT9L?#QVD=DBQ(UN3P55`K<=@OC*]I6(;S%2KP\/?LFU&6@5I!`2G<U%I
M)Q+UFQ1041/L+]NZ>^*<"0PAWI")@8Q42&UTG_9\LG:'<6SK,(]TW'!GAU\;
M1F6)XTY6-D+7-N)-ZX3O'?$>7W9L>Z)"7V?;LN*18^1D$<BNY-[@%PMA<&PM
M[:A;PJ'DOC/!^`N$<UPYN%8O6"L=VO'TWRAL3^A-\*P$E6*S.5ZJ90Q&];O+
M%=+Q/75^[9J+L',97SI(NG9CNEBHB1;?.Z9\_NG;=[R]HD.W[I)L;11LY*S1
MY@QHH$CC"!@8#,C.9NHI5(XFZ3E[)SO9\3"[:S<6#-E_,]O.\K.X2X23%FR)
M<J1I"Y#)+%&XB$820&4LHE51K;4OQ^\NWE[7,0<PX^=H'(\,MV_@YR'Q=DD+
M<&$H"C9]SU=#.V]?<5!_3T%[MG`TD_:O)-I9K6]C9"/-(BB*:P/%5=1>]XJ3
M=JSXNRX6C"D?8>GC.`LL1Q<N&?(80H>C%\+&CQ"17=\E)'#(C1KJD,"5D[EV
M_+W3-#YD>7NK//'QB>.:*6.'5*XZS_$,\<G1*+'"\897(X5F#D-P;Y063$G*
MB(2PQEJ1"W<D.)ESKT=1%<<V-U/1&/\`A;3<=R4Y*8NO#H]0R_4*IE1DFA(0
MCY]$&%5J+M!SU-B@?,W!6?)ADC2Y'=7=.2I*B1%CSIM>',T;%;">+J)'D*W5
MQNH?PVZC*(W8D&-BI%E\$_VQV_C.`Y1S)B3$Y<2.NH:X@58Q.IAG`L6&E36[
MKRQ*/E?&W"7#%&S-04\87*MM[4P2HY7\N\7@ZO\`7.P+4]%ZUF;5=W-?>K5M
M9LH>)2EG[6*ZP:MU.Y2(0NP;G)%+^6,C@RC`Q5<!BX1T@1#&)&57ET!0K2.H
M=F#%BQ]31^*KK-NGX6F`YDK1FRH75FU-(8T)2+J2&1UC0E50K:URHGSJ,K,I
MI2FE*:4II2FE*:4II2FE*:4II2FE*:4J"7.*F\=DZ2UR7FZW_P"EP1KZ+K#;
M(#9@Y?`*LT[.VAXF=:M8^1(YC"R#D3)JK$*#43G$BA!/VR&%W5+VL'RC.%Q&
M90RL"5))`!-KD?YN%AS-JV+M?LKN#OW=EV'MC;&R]W,3R"-616*QKJ<C6RAB
M!QT@DGP'`U&S'?!*AY"0;6"M9ZJMSJAUDS>T\?A'37>$`_49OXP\I-QI5#D*
M)3`9,#E'?T"&ML7YDRY>.),&"%@PX,&U#WBQM4/NO;6[;#EG"WS;,K$RQS2:
M-HF]]G`-O;RK9!B3!>.,+19V%)A"-W;LB`2DZ^.9].RJC=$$2'>R3@3N#$*7
M?I3`0(0!V`-@`-:CG[EF[G-ULV<N_AY#W#D*Q%55%E%A68-8-5II2FE*:4II
M2L/YYR.KBG%MFN+0I#2;9-E&P_>I=^BG+33]O%LW:Z.X`LA'G=>(.01`#D2$
MNX;ZC-YS_P`LVS+S@MW1>`\V)`7Z+D7]E37;NT_G>]8&V%]*2/ZCXA5!9K>W
M2#;VUH$EY5].23V6DW*SQ](.G#QTY<J&677<.5E'"ZZZIO657765,<YA[3',
M(_+KA$LLN1+)/.Y:9V)8GQ)KZF@QX,2"'%Q8PF-&H55'(`?IQ\SQJE+-T':*
MS1T0JK9TDHV<IG`#$407(9)8ABCV"!DSB&K=RI#*;,.(]]7;*UT<71N!'F#P
M/V5K)D6*D2_D8Q<!34BGSV/5`_8)/`N56VY]^T!$J0#^G?78,>89&/CY`/!T
M5OK''[;U\[YN.</,R\1A8QRLOU,0/LM66:Y@ZY3[!&36.Q@V[I,%FJ,D"QWJ
MJ)P`R2JC5'H%J50H[@!S=>PAN`>C4%E]S8./*T44;2D&Q(-A]!\:VK`['W/+
M@2>>9(`PN%():QY7'"WNYU]'&!;^BN*2)(9VEOV.B2!T";?.9)5N90NWS;CJ
MB=T[<RW>.16\K`_;7J3L/>%?3'-"R>=R/LL:OFL\=A!0CBW3`*IE$!&,ANM(
MI_EZ5Y!3]L)1]`]V5,?TZC,SNN1P4PH-'\S<3]`Y?KJ;VWL*"-EDW3*ZA_@3
M@OTGF?LJ2T%`Q\0U;0\#&H,6I-B(M6B14R[B(%ZU!`-SG,(AN<PB(B/:.M4E
MEFR)#)*[/*Q\>))]G^`K?(8,?%A$4$:18Z#D+!0!XG]I-;AN'''A[0VI\D7!
MJ9O89=@9M`1;A,2.(J,=]!W$BZ2.`*-W\DD0J::9O71;=6X$.LH0.J]I;`^W
M1MGYB6S)%L!_`OE[SS/T"N$_,#NR/>)DVK;WOMT+79O^\?E<?RKQ"^=R?*H@
M\58WD%Q6&S<3K!PYO.:U)[F!D[*$/R"&4HD;@Q?&N4\GR64FN0[99Y=],7-G
MDVAQ\JH@2*2K[@KF09())2#<%042VSMN-T[=^7^PY3=*?9ML3#GF?A<XZSA9
M\4+J,IG#1`JS0D&2:[GIZ9-`[@"'>^^.X<6;KIO&4<N&!>:&7H1'%G+:0B1&
M-Y.H@E#((R(P6(2$''7@MROKWF!6?*>3(OD"ZNJ.8N1]LM^9D$<+P>&,@X@M
M4)8&V+ZLVO:#*3S3?T7<=-0\<:H2!6$7!GBBJMG1BL44@UO%VW.B^66?M1CU
M[TW:N=B9*/P.3N,Q92\:I9)A-+?-7*F9)(W"IH99&*R>Z9.+D]V_'+)IV_\`
M/L&?%,?$P8<2(Q21W]<71C#8;PPJZ3*=193QK'-/X%<KF'&NV4^Q8.RPW=OO
M+(XA8<DH.CVNG5ZY2-RH/)+)-UR-0(D\O]8*_/2L=295)9W#ODBQTRV<^!4<
M)=^*B>P9Z=5M^;0S12[_`-N3KZ%D!CQ-CAQ9I6@<JDZ8V8H#Q.\9#()D8F--
M41A!XLC!?4@9-O[FC-W*>O-W%IL=!+'=XFG@)*2*K`7T.`&85M@\F'$6<L)<
M8+=1\V8Q7Q:=++]BDZ1%2,2G3YJ<KK^`K`R5HEL9Q5XR#3<9K3%K2?G+&0+Y
M**/L+E-JW,N8HSLTBOM';Z2.OQD<4RNBLSA`<F9U];*K$OK9]!U")62-&T`*
MN"ZI^<[R^+"PV]C$4=@JL["(*UTC)2R(L4?4&EI71W=03=MN^H^K]-*4TI4#
M>5G\3/EE?BZR;_3WYS:>=5\!^GE7_]?L&\K?^6_P2_"+QS_<_3M*J>0J>6E4
MII2FE*:4II2L'YVP!CWD)45Z=D2$8SL0J('!I(-DG;<%2=I%`26*<H'*/RZQ
M\G%Q\N)H<F%7B/@1^EJFMA[BWSM?<H-W[=W6?"W2.^F6%V1Q?@1=2.'LK5;*
M^40UIDH:=P-EO)^(I0A^\1=4FZ3$:=`2")D@9ME7#A@S*D'ZI4TB@'S:UR3M
M+`!E?!GFQI&'.-RO_P`)!^VN]8O]T'?&3BC`[QV79]_P;6*9N)&Q;_.\81W)
M\2S$UYDL'>:7C4IDZ7RVDK&R0W[M'(]/@KX\=$]4YDE'TFD19'O3I`4%"^LF
M03;=HZ\MM/<,(48?<3$`C@Z(UQY$E6;[;^VKC?-'Y&[R5;N/Y$1Q3D\3@9DF
M*@\+A`&O8&]B>)`KZI9C\W&H)'9RM.X_Y,0Z105=V&&L5:563V23%QW-5711
M*H8$!.!=ND#+&#80*78_^\80!$V'-RYJP)^D2*+_`$?1Y4D?^U7=!U)(>ZMJ
M8\=$)@R0.?#5,;D<;7YV4'Q-:K.2<[R8A,@ES-?N.<'CZ!EA:1F1W5#F7Z\-
M(+NW16D),)1DV85C3K`RA4/V9^\=D/W0@82H]WK?<.#NF5$VX9N#'#+&OJ97
MX,/"X/B.0X\>5J^G_D'WA\M-JRL;Y<]K][;AN>!F3$XL65C6EQI;:I-+1`J(
M)+%G!],9'5NHZFNE?70G_>!_?_Z=:%UA_%7UU^4__P`.L>9"R\YKK6&81D;8
MI63M$NA"-?JQ%!,2C))0.]?O6;(YRHN9!NQ(H9ND<>DRA>HP&*0Q1R\&/XO)
M2+U%>9"V+6'.P)%S]-1'<&C8=AW3>6^'5H$]/7?IP]1O3'U7_<BUD:VX&WI!
M#,"-O'&SS#^,'';'$)1HGCORQ8.V"`FDEFV'?:RCU^N8RSJ1=RQK"@M(OI!1
M05EE3AUF54-U"(]NNDP=TX&W1)AQ[)G*J"U@D9]M[]3B3S-?FUW3\C^]N]M_
MW+N?=_FQV?DY^9)K9WW2.,^018]!"1Q@:(T'I5%```X55^0OF:<7\TX\/70H
M7(Z)L<4_)-082F'W*/AY-%J\CW#!^9*:<&;%=L7RR0G*"G<JB13I-T=(XF][
MUMV];:V,<;)2:X9;Q_=8<KV8^9!M?GPJYVM_;UWMV]N\.XQ]V]JS8A4J^G=(
M_7&UKE3H\+!E\[5I$O\`S4LE0R0@]BH69>X]<MFZ*U9M=64JLPW4)VJO&,DH
M9==1=V4HB!%.\23V'8#>D.<R121KJ=&4^1!'GQ!M[OJ\*^K>U/DGL_<6R9>U
MY.Z8:]S1$NF1BY:9*,AX!98%MH"$CU*;L2.(\9UXMRA7<M55I;:T2119KG,B
MJWDF:K-PW<I`454RB8!1<I`)O552,8AOG`P&*'BW`7%<$[L[7W#L[>LG8]RE
MA?)B\8G5UL>5[<5;AQ5@&'E8@GTQ^,Z7&6!:SM(9(DJJX5=D,<ZBC9H[7,8Z
M[IFU.84&RZISB(F*`;"([;;ZSY-SSI<5,.3()QU%K>P<@3S('MK1H=EVN#.D
MW*+#49C$G5Y$\R!R!/B15^ZP*E*``B(``;B/8`!VB(C\@:4K)^-\0WG*,LG&
M5:$=.R=\5)V_,448Y@`F4*<SU\<AD&_=&2$#D]=<NX""1@U)[=L^?NKA,2`E
M/%CP4?3X^X5"[SW!M.PQ&3<,D"6W",<7;Z/#WFU;><#<7ZGB!NSF9`C>P7D$
M![V741`&L6=4I062AFZ@J"@)MMC+&$RI_1U=)2`7K.Q]N8FSH'MU,PCBY'V+
MY#]#7!.YN\=P[BD,=^EMP/IC!X'VL?WC]GD*E)K8JT^FE*:4II2FE*:4II2F
ME*:4II2FE*:4II2FE*:4II2FE*:4K'.4L7U/+U0DZ5<XUM+04L@=N\8NT2.&
MRZ9PV$JJ*A3$,`?)V:MRQ1S(T<J!HSS!%Q6;MVY9^T9N/N.UYDF/N$+ADDC8
MJZ,.(*L+$&M2-I\GJC14J>?PQ<[IBF8(H=5FYI-GEH1-EU&ZRE9Q[=S[,;B4
M_;N"._\`=K6Y>T]K,G5Q1)!+:UXV*_:./VU]`[9_=!\RH<5<#N3X#?-NM8IG
M8\<K./YY;"5N'F]4DG&_S,\:'.&/^9%PG&J9C"F;)\)#Y'6,``=+U@ET4RG'
MNC_-_P`S8WR!M9.R[[!%HPNY);@?\15?ZRZN364?FW\G=X4#NCY!X*R>/Y=D
M288\#X:SS'GRX5]6^4_-ZHIC%>1N"\HII"/[6Q5B4JY5@V5$>H*FL@<H%%<`
M[![>X+_G-OZ9>\(4_"GQ)F'\2,+_`%.GZ?:?*_M6W87FVGN?:&/A!)%E6Y>,
MWN\OWS_"*]B7._S#*VJ*=PX>X^L@(BN*IJ3:[%'`L5,@))@W/.^+*43N`$X=
M0=J0@'8;MUZ&?W3$OXVS0NW\LA7]C_I]=4'97]MFY`';?FMN^$6`M\7AHUK\
M3?H^0X<#][S%58/-)S[&);V/R^LC-@13336=QF4JL\27=B!0.*#0T$5TBV.8
M#"7J$XE#8!$1[=6AO^^*[+-VQ(`/%9-5_KC7]M>5^3GRBRFM@_W%[9<DD+)@
M92$+_,Q;26'`&UK\Q7M0\WYJS.!+1Q"Y`0W=I%*[&,1B[$*+P2EW;I%;)M/$
M(@<3!WH"`;!OMV]E[_<DZ"\NPY8\[!#Q^EEX?I:KH_MZV/*%]I^=O;<Q)NO4
M=H+KYG63I-K>D\?"JTU\Y##!"&"9X^\L8]SU"*:+'$I)A(Z&P`50SDDZT*FH
M*@&#HZ1$``!W[=8\G>4$)"R[-G!K7X)&>'_,JT_]L^[N;X/S/[-DB\2VYI&;
M^5BAN+6X_1X59&5O-3XLY3Q[8J/,XZY,P3F41;JL_:F%UN_CI6-=MY2'>+MD
M[`;K;@]:IB<@'`5$1,7<.K6+G]Q[9NNW9&'/A9:"1;<8Q<$&X/!B.!`/.I/9
MO[<>]]HW/"W7![R[2F$3WNNZ1E6'$,M]'B"0?(UHIS-S%GJQ9*_*T*(L:%81
M*HC-5^\4MQ#!)]:NQ73:85.#I,Z!3=!0)TE..QC%#M)KF,D$D89F5@!?FI`/
M*WAP/^/C7UCV-\G=HWB//V??MRP'W.8!H)L3/CF>,J+M&T`X.IL27Y@`V`YB
M6.$LY5G.%?6F()E)QCM@=-&5C9!N?H;.%"B;H:2)4RM)!(.D0$Q>DY1#UB%W
M+O:%R`;5R7O[L+<NP-W&U[AEP3!QJ1HV!)7S>.^N,G@0&X$?=9K&UX/,9TN0
ML@VIY#I.)4RB3A7O%%!9KNT"D(D\79=7AU7)"IE]82]HE`1W$-9Z;GG1XAPD
MR",?R]AY@'G;V5S&39=KFSUW.7#5LP6XGE<<`2.1(X<:OS6!4ISXFFE*O2F8
M^MU^ETH6K0C^5>*&("A6R`G*V(<4@[QTJ82(-2`18IP%4Z8'+OT=0AMK-P=O
MS-QD$6'`7;S_`'1[SR'Z_94=N>[;=LT!R-RREC7P'-F_RKS/ZO;6V+`/$&OX
MZ!E9;P1G8K@BJ#EHU`O?P\*J7?NE$P5(7Q\@D!MN^.4I2_\`9D)U'WZGL/:N
M/M>G)RK2YWG^ZO\`E'[>=<*[J[[S-\+X>%>#;/('U/[7/E_*.'OJ:VMNK0*:
M4II2FE*:4II2FE*:4J!O*S^)GRROQ=9-_I[\YM/.J^`_3RK_T.P;RM_Y;_!+
M\(O'/]S].TJIY"IY:52M4>$.4O-/DU.RF8<*TCCHYXL0_(2Z8:+3+<XOT5GF
M>J.-;H_QM=\GL[XUG%Z!$*HS\4[DV4$K77"SABW*U%V598'">/LL_P`9LW:^
M_P":I.W[O@C,C$7!X()4D;'UA[B:1M"=1%,04RZ0Y$9=\G>HX,/<>Y=CP)&.
M[[3,,:7J#\.;*0Q/,D94ZHXA%+I25A(2Z&0Q@.(E^5T\W'#<7C-Q<*'B3.=^
MN?U"Y3713&J%;JT3/4LW$RP(U#(C?*JCRZ=S3F*EF=$3:KH>T3+-R*G*GWA"
MHGBLS=]6RY.Z;5H<?DV'N*.]Q$(]PF;'QQ):SZTECGZ\2C4%QLC0S:!>7Q-C
M+[_%LF9+9OSA]O/3!8R2QX_Q;&`D!'62%H1"[,JO)E8P.E79DH\'YNN.HO%V
M,;3D+!_()S;7O'&E<CL_LL<4*M3U>X]8]LZ!R)W^_+NLE`[;4NP%C)*7AT(P
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MP3C.`;NCUCB)D%"LVX\FUO.9TT5I*/@9!)V9Z1X@A(D;N%"-61Q2:&@L#><?
M*[=QM]F#+!'V[!N^5)8+''C3Y61BK(%U,Z@/!ZH]4K*"&UM?2LM/M\B[Y+L\
M#`SR;Q^70)<EWR!A1YG3U6"MJ5R%>R`L0A7@7/FRMYXO!G$C;$;V9F+M,L\L
M8=I>>!6AFU`CW%`QI?A*-=EKE$W3(M1G)25611=JJ158:V.4(DQ4-X<05:>)
MF9>G#ONZ[$\RZ\+)QX))1<Q"3)59([`#K:1#)#/(YB"QQ31EB&UJD=%JGVK"
MW6)"5R(\ETCX+(1BN8I1=B(K]9)84'4O)+#(%N`K-E^3\TOCBVY81O#^)@,K
MW&^O7./VS^TU.M5F3I4`&3(%A8ZM)2K%Q=&63G%9-&S,?XR;85I]"1ZD@B5R
M[3'O>[K@1RY^9N.$(C%+BY.5`^NP'4PXC),/269`&#0QM*L:RS#3$65XW>F0
MR08&W;BC]3&RL2')32#<PSRM$C#4%#D:3*Z1%WCB!9U4JZKL4E'$5&Q[V3F%
MF+&,CFJ[U^_?J(-F;)DU2.LY=.W*YB(MVS=$ICG.<P$(4!$1``U;8JJEF("C
MC5Z"&?(FBQ\:)I,B1@JJH+,S,;!547))-@`!<G@*Y$?,)YXLN3&4/J]0W1T,
M(8YDUR5)(B9FA+M8D"J,W=^?MC%*J9J!#G1ATU@`Z+4QUA(FJX.0G">\N[!N
MF2<+#-L&)CQ_B;EJMY>5^-O(DBOV<_M:_MN;Y8=M#N3N;$7_`'YN40Z@-F.+
M`UF&.K<@YX-.5X%@$NRH"8!FR%T_]JH?L,8P)E45$B9"B9190$R&[M!(H;G.
M;8I0](AK3(6FGUB&,MI4L;<;`<S7U)E;=@X0@.9/'$))%C360NIV-E1;D79C
MP`'$^%?P]^4ZVZZ#YPS>,G3:0CW[18R#V.D6*Y'+&09.";'0=LW*93IG*.X&
M#5(<^7'ECFAD*R*000;$$>ZF=VG@[GA9>W;CA1SX&1&T<D;J&1T<%65E/`@@
MD$5U'^7=R%Q!S!QT>)LT17&6<J"S:-KW"HM6S3ZPL-B-65^A&)2D3]ERZI>E
MVDB'2Q?"*8E(FHW[SZ"[6[D@[@PP2P&=&`'7AQ_F'L/C;D?``K?\3_[E?D'N
M7R4[L+8F/(_9&>[-AS&[!#]YL61O^\C'W"W&2,:@699-.P=3C_BA50RBE0B3
M'.83&,+-#<1'M$1'HW$1UM&FOG`3S*`%D8#WG_&H`9<\JC#V:\YJY-NXR3ZN
M(Q#"+BJ65Z9O7XGPI!2<NH]HW!/H6D!_:*]?4'>^N7I,.^H;+V+"SLP9>6&>
MR@!2?2/:!YGS_777NW?G?WKVAV9)V;VK-!M\<LKO/E1);+F#$$(\W%@J?=&F
MQ*G2;CA5ZN?+9HE?CB1V,[$O7VB20D1CY9H$@U2,'4(&*LU49O5CF$0W,JJ?
M4#G]CXF0Q?%RGC/D?4/MX_;4;M_S1W.$:=QQ$R#XM<JY/F3R/U5C=QP%R4B;
MI0F:\^`/2L#U5@4P]FXE14:/3E#T]@G$=0;]A[@#^'F1D>T$?MK9(_FIM+"\
MNVS*WL8']E5:(\OZZN'"0RUK@8UL`B*Q"HNI0Y@`.PJ9T%([H$1#TB`^G5V'
ML+*)_'ST`_E7_$U8R/FM@J/]+M,C-_,X`^P?MJ1U%X.8NK8IN+(YDK@Y`%.I
MN\,FSC0[PP]2)FS0B1GC;N_5Z7`J?+V[ZV'![+VG%*O.&FD'\7+ZAPK4=S^9
M&_YRO%C,F-$?X!ZK?YC<_4:E_#04-76*,9!1;&)CVY0(BT8-TVR)"@(B`=*9
M0WV$P^G?TZVR.*.%`D2!4'@!85H<TTV1(TL\C/(>9)N:JVO=6J:4II2FE*:4
MII2FE*:4II2FE*:4II2FE*:4II2M5<ARAYEYFS;R2J?$.H<=G=#XF7ZM8LN4
M3FLU^1NV8;^M5Z_?;;$4BT5>PQE<QC&1\%9FT>U?RD5/`=^!W!DA1*"`XVSS
MOG[=!O\`*@;:I=SR<18U.F4+A9(Q<F9G8,G]02-%&$N4C%WU2VCS=SAQ,+-.
MPB=UWI-MARW=E#PCXR%I<.-5#*[$A/QW+*%,@55_#+R9#E_,GQ##V*7H`XXS
M5-Y7A.1CWC"ZQ=6ZS6GUJ?7QCBESF0;/"$D[C"LWV+G]*;`LUF55&ZAQ72[Q
MLD!Q$MD;CC3PQ9&WAYHY,?=9EN`C*-GD$62DH)(CD9W@$0!=7.3`-8U&P[?/
M!)TL^2*%U3;&=@7>,?FC:8=+JGK$96?KG2-`Q<C@2@5H\8.\WZ%R'@_#M[LO
M&CD!+Y<S2\S1,U;".':O3[;95,7XGM;Z*D,ED=SV2J_#?5"'0<QT0\=.GC)Z
M\L7B2-(\6Q.LF5G9&/M\4!FD+&'M_#W+,<#T8ZY,2$,03JT9$@GEPU42.<6,
M--HDNIH<*8SY<=@J?G63MT`8V:67'DF#(2+HLD*1J,H%@B3.%C:1+/7H>^;Y
MBAIFJ%CXXA;I@W)'$S#^;L'H4VOR;C.V6\K99S/<\81N*ZI59N=AHQ](BVK'
M>':K),Q8*-W:[IV1HD8Z>5B03RY'<6WO&9-Q@W/;L?&6+E)CYF!-GR9<A<KI
MABA1)C(W3TQ'05>>2*)L*22(86T9Y?HXKQ;HV2TMP8I=OFV_'3'"J&9IY)\N
M2#0NLM(JZ=,:R/5_6OS.J=BW)V6*!=Z5D6[2L-R8QIQIQK1\58\B379Y=LB<
M>8_-\="S3ZRY;0@;`Y>B5VU3>MRQ"+=<Z+=1%0A5'YH_:<D[HN/CXR&?-ER=
M["E!I0P[*\(G:SG5<+*&#7_&`)$<1&EKN8J8A,L[]"!<7:W=9.++)NDLL,0)
M4%;:XP&47Z?'\22XM:U]\['AYCO%N*,DSK#*"<GEN5RI$1F*GC;%M4R35G.%
M+.]I621N7^H&5Z?C^/-`6MH5B1%I/OG3Y9<OA$ER)N#(>'W+"ZF(,6<9&--M
M$&Y+)%=E^&R;B`A2%E9Y&2952.-S?'F/W>FTF0N#DWS8IX^CE8^YO@/&_!AD
M1H))`6XQA41XF9V=0!/$/O%@M>OWG'\2*9.X'@(>,RYE%;D+BRJ9GI:V.*E7
M7RC;'EQEUX>,EG<!:;I4[?8Y!HK'O5GL96HV?DV39@NHJW*!2=<K'CR2]P9?
M;RV^(AFQ8S)<=(G,&N%E_P"*8A$4FDFZ0BCCD74X99%CP$D#[+B[W&"89AE:
M4Y/JPRJS1DFT75ZC=*.,2EY'4Z%*LC/M6`C=PF0_=D.10I3EZTND>DP`8-RG
M*!R#MMN`@`A\NK!%K@BO2M<*Z\B+_I>O,>*C5`$#L6IP'T]2)!__`!VWU2PK
MU<^=4Q:HUIP(BM#,#[]H]3=(?EW^4NEO;2_+A5+7QO2'`""M;BS;B`B/A$=Q
MV_\`T#I:EZI*^'L>.#=1ZS&[]GH;)?('Z"AI:EQ;EQJD+X#Q6Y4%5>I1*BAM
M@$QFB(B.P;!N(D$1V#5--7%FE0:5D8#V$U!SDGY9.+.1.0J//3AG[&H5%@X0
M4IL<Y\%`R;Y=SX@)5XV0*0ZK\B8]R(B;H.D``8H[!M$[ALV+N<V.^7J:.._H
MOZ23XD>-N7[:ZKV+\X^Z_ESLN^;;VH,?'W'/8:LS1JRHT"E3%%(;Z%/WK@:E
M;BI%S55:^63B:HQ:;#&$F[JB92B`L7:)9&/$P@4`$5"BC)"!`#8I>^`@!L&W
M9J$W#LO!RCKQYGB;R'%?J-8F'\U-^$TDV[VS978EI')ZC$\22U^))\3>L?/.
M`616YSE:6"O21>HW2H"R\642;FZ/V2R4B<!Z=M_7UK\G86<#^%FQD>T$?MK9
M(?FIM;*.OMDJM[&!'VBOM'<`+^X52!_9:_%I=9>]-NYEOV>_K])$0C3=6WH[
M=5B["S21ULZ,#V*3^VJ3?-7;5!^'VN5F_F8`?8*D#2."&/H-=-Y:IF4LJQ%0
M5!DATQD<0Q2%*4"*(_\`Q$Z8GW$Q%%CD'?80VU.X?8^V0$-E.\S>1X#ZA^VM
M6W'YF[WE!H\*./'C/BHNW_:-[?1:IC5:FU:DQJ4358*-@V")`(5"/:I(`(`4
MA=SF(4#'$0(&^X^G6WP8T&*@BQX52,>`%JY_E9F5FRM-EY#R2GF6))JYM7JQ
MJ:4II2FE*:4II2FE*:4II2H&\K/XF?+*_%UDW^GOSFT\ZKX#]/*O_]'L&\K?
M^6_P2_"+QS_<_3M*J>0J>6E4K7!6/+X>X^R/*26+>4><,7X%L&:W^?[%QMI(
M56'K4ED";E`LMG0;9&;Q!<IPU(M=M+XZ2KS232B'A55T%$!275`;>T1+M6+L
MV"0)L#;8VCQ(V]*0Q'JZ(F5-(GCB,TAC28.J_A\+Q1D9&ZSC<WW/)$0AW#/"
M_%3)Q>:0,FJ8%M72GDCC2-Y8=#D!FOJ=R<(X#\O&==Y;\RO*^:Z[%XX1YIDF
M,84RHTZ\#?AI>,INGJ0]]N4?+N8"OM(FPY:N+U2>>1Y&0%:N$4R**.!+WAL#
M'VX/\OG[6RI&3.S,B>>8@ZN@))9Y\;&C=A^(F)-EYCH=*(_7/X:\14E)NK8_
M>VR]RX@$L.VQQ"+4"@FEC,,3S21@V0RX>!ML)L6<=`WD:XMZI+RE$'=6C*M'
M<L<QP#:P<=JQQ3Y`.(>I8K0-R!P=2#R4=3:U/MSU51M2IJOTN<>P1)J"*TEE
MF*_4JN=4#'/*[CTMVW3?L_<85EQMSW+&W')A-PLF=CB-7G#*0Z#($,/6AC98
M&$2KT](M43@ROMF%V_C;<QBR-JQ)L7$EOJ:''E*LJ`/J1FAD#212LIE5W9@]
M^-75,^4?@);-=BY%5"S6_'N9E;Y@6WXZO=80A23&*(3!N.H#%7^G=<4=,EB2
MM(R%2(91I-,Y$KE-8'`B!?V90&[A9>5AYJ9YFZF0^Z[AF9!('^J3<@IR,:8#
MAT@X,D3IIEC<ZE8$7K'?'QFVK'V=8;86/M./A8X)U?#G%R)LB')B)!(G!E"-
MJ+*Z1A66S->XJ1Y7^,:1E&KY29Y'OCV3JUCYLV1M&.6]>(P=.>;M@9SUR;KG
M2CP<%0IAF8)1G28#*`;J7$^VVM<BV*"+M;=>U!,YP\OM2+8F?AK7'BRY\M9E
M_=ZQ>=D-P4T@64&]Y;\Q8=Q;=W&(A\5C=P+NZK?T&9<-,+I'QZ11`_`APY/J
M(X5A[X,^-(IEB5G1LYY*HIZ5@/&G''),E%5G'4G-9@Q[BM]XJLKJ34]7)*3Q
M?;T6[Q\U]LUA6/D2MG?=@KTI%`=C,RMO&[;G)"K8V;E8>3+#Q"M/A01XR-U%
MM+HEAAA2>$.(9ECTR(P9A43!'\/@8&+$Q^*Q8\^.*5K,4CW#(?)=.FP,1,4\
MDDD+E#)&SDA@>-7_`)G\J:@YMY3TCDI9<RY'28T:Y8YOD1C(8JG2C2*GL;IU
MXC-M4,ARD.YR/0:W8E*E'*2T7$2#9D^425,H01<*".-LZG:-SFW35UL@SY$J
MZN!!R(NFT;LMFFA1RTD44Q>.,G2JA1:K^X.<_:!LREHL8XT4#Z3<LL4DC!UU
M7Z4KI(T4DL6B1U-V8MQK8AE_'<;EK&=UQK-$,I#7:NRM<E4B*J('5CY9DLR<
MIIKHG3614%-81*<ABF*(`("`@&K>1#'D0RP2K>-U((]A%C4GL.][CVWO6U[_
M`+1/TMTPYTFB>P8+)&P925((87`N""".!X5Q7\R>!69.+-K7&/BIFY8\D'G<
MPDU&,G#Z18G64Z6T9*-&B2BJIU-P!%=,H@<?5.!3``J<"[J[$S=MG.3M:&7!
M<\O%23R/L_3W?M-_;M_>%V=\RML&R]^Y.-M7>F/$2Q=A'CY*(+M)&[&R.`#K
MC8CS0D$A=S/ES^6/#0>*)JY9T@&TE=\E5Y5BM$2:2;I*N5Y^B!BP!"&`Z/?K
M]0&>&*(]XJ`%ZA(F373NT>U8-CV\_$('S9E_$OX`C[H_;^E_@/\`N?\`[E=U
M^:O?$$/:6XRXO96SY.K",9*-+.A_\XUK&]Q^"#]Q.-@S-6F+F+P<REQSS:C0
MJ?7K%;JI=)%;_3IRR;+OEP!18!&O2#L`%-):.*J7H7<&(!VP=1S"*:AM<Q[J
M['SL3=8AM,)DQ<ACI'\)YD'V?I[*^_O[>_[M.S^\_EQGY_S(WC&V_NC9(1\6
M7(09$8%DR(DYLSVTO'&"1)]T`.@K>9Y6/EW3_'Z52SEDAV*F0Y2`<1#6/045
M".K\5*':N'K5N4P$\6\<BV3*==0N_240(4A3'`>F=H]HQ=O1=:5]>X.MF/@/
M&P]WZ7KX"_N;_NFW'YVS_P"V]DPO@^P<?(ZD:L!UIW74J2RGCH`!)$:FP)]1
M8J"-Z.MWKX^II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4I
MI2FE*:4K71D3R_W\WEO*F3,-\G\T\:XOD&^J4KR#IF*4*@F3(TU4X]I7D['"
M7&9AGUSQ3:)2I,48]U)5IY'NU0135,<RA"B%C;L=,"(8-R^SKG/F+!<H%GE=
M)9SU(RLC1SR1H\L3,8WO(K`K*ZG,S,OXLIE=!%W@8GPQR"`[-"J,D"LCZHRV
M,KN(9-.M05%_PTTV%0N%EP=^9_DSFA=ZO#5>BP&#:WB3%C=I?G-SE<BW(3.X
MZP9JL\0M"1!*=96N/B-:V1(RDBX7;$.H+H2G[LOO:5^'VSO5<U`,O=\YB(U^
MY!C%($F5"``OQC8>#.Z(J]-H=!,E@YL;KHR%[1Q,>9GQMNA]3M</(ZK(<97%
MSU/AFS]T`D<LS]<.`G%:M6J>4\IC2K8K88CY;YAQQ>\,)9CJ5!R7%TO$TK+L
M<+9LGD[=9\/2T'.51]7K%%,;DB648RKY!>7:NA-W:Y"]V">+D80S,=\?*F9U
MR-AQ=JRSP4Y,&""F(YTVZ$L,+R1!\?ILRR.68LQ)SLC<1/DS9/PJ`?G>3ND2
MW++#D9C2/E`*^H21S-(&:.4.HZ:!0`+5XK-Y)_%>?+4E&4I<X"3Q=QIQ_P`?
M,*V*.<,1LV(YO'&1)_*$#FVJ3YT`DBY)6M<\HJZ,=3PJZ?60R>RAM2;9&2FX
M;ENF%-\/GS9V!D1NJ@]!-OQ_A$QE5KJ^/+C!8I5D5BP4<;\H^$Q_!XF!GQ_%
M8@_,FF64W&1)NC123S26XB5)8VDB9"NAI6L."VRT[\LRARF8V&;9O*^0)6W-
M^5&(^6,@"K"K-FDQ>,28#)@=G$NDF<4@5O#V)@4TH\[DJ9R.SBFCW:0``6-H
MCBV3/@S,&(".)]^*1DDJJ[]TNNER=1&/TE$!))(OU-9XUC[A'^9X<F+ERNTC
MP[3&S\`6.T3//$Y&FUYFD(F`%K6T::Q=9?*`QZZCZ@]HF:[UCW)%/NO)>P-,
MD$I>,KN\>U3E%D.7R5=J&\J][K4[51:0MA?H*1,F5L638':]ZBJFHH8P1NW[
M5#MV#MFW0R/\+#V_B[1)QTO-CX<CRP2=5;/!,C2SVDQVC:TK"_`5*Y>X'-W+
M==UGA5LC(WV3=4!N4BGFQTQID"&Z2PR1QQ:DF$@O&IK[<HO*!QOR=C\3UN7S
MEE>NTG&>.*GC1>KNF=/O_M]C3UWPQ]OCIN]PLQ,4');QE,/6[NPP:C.2<D6(
M)U!%%/:40(O<>1W`R#UY./.L0N@B..3:.*12)8X)$T+)"KB)M&HJ6)-8L>1D
M0[/%M<4Q$PBR$:6P)?X@QL7>-@8C)')'KB?1JCOI4A0!6W"/8H1C!C&MA5%M
M'LVS%N*ZRCA84&B)$$A675,95=7NTPZCF$3&'M$=QU=FE:>:6=P`[L6-@`+D
MW-@.`'D!P'*L/&QX\3'Q\6*_2C14%R6-E``NQN2;#B2;D\37LU:J]32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E0-Y6?Q,^65^+K)O]
M/?G-IYU7P'Z>5?_2[!O*W_EO\$OPB\<_W/T[2JGD*GEI5*:4II2FE*:4II2F
ME*:4II2K9L=0KMK03;ST4SD4TE$U2`Y035Z3I'!1,P`<HAU$.4!`?D'5"+UZ
M5BIN";_H/U57FK5NR;I-6J144$2@1-,@`4I2AV`````'8&JUYYU;DW2:S8GS
M"2EXEF]>1J@JLUET$U#H*"4Q1.F8Y1$ANDPAN'R#_;JA%>@[`,`38CC^GOL?
MHJZ$TDT2%32(5-,@`!2$``*4`[```#5:\U^]*4TI32E-*4TI32E-*4TI32E-
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MKT7D=FD>,Z&8J`!-RQ0+W.N`,=.E'W-F8[<!9XX^W/BD4K;2JK.1($4!-:A[
M:R2=]>;<AY;JGET7?+&,[-$QV7:SQ15R)$VNXQSRR-B34-C1*RRLJZ9)/F2K
M^:70;.#M3K*'0!^9-1=-9(#I'W?YHZMMF[P3;VZ$$69,GX?I9(NLR$0D<$=4
M-HVL0A`-N%0/RNC7>6[%BW'\:3*BQ0=?$/+)&FDR^+1F0@RJI5F34%96(8:L
M!\SKDQ@7C5:U;DVQ!D*^X?\`++XG<JXJS2S*\HKWBWYER)*T)9M<BO+XO(R@
MIU=I&K/%6ZR"SB>6<*@H""R+=*;WZQ[I[]PX\:.(;?WKM>T!8P1'ISC&<IXU
MN2HC+2G%4D].)%ZO4*LQQNTX4W/$[)$L\C1;CVWN6XZF*]4'!@1X5<@:278_
MCL%`)/H"5?&<_,EYJT^]Y\6QE2>-3[&>#.2G%7CRI%VZ"R6ZR!:WO*"I8C>,
M)5G+1618>N19:E9,B*"KWC)4';,4DRE342456U_:9I-Q;MR!RHR-V[EW;9XB
M`=,#8"9#Q9,H))E0B(&6)#&S68(Z:@5]3RP8^V[QN3HQCVWMK!W>9;B\HRI%
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M1$U1+WMC8LE-SW3<DR`1ML.\Q;8$2QR.K-@QYB3*#<3:CD11QXJHDDO0R"LP
MU`17-TQFV_`V0(P;<\K:LK/)/"()BY!@:,@>J,6BFD?(9F2)&0M&0C&2)V&O
M-1Y59IY*NJ@7CM#U_C-:,Q\@L$5:X.DHZM7>%F,,15M37L(VR6S4Y4N<\61I
MZCE_7&5&CW<:P?$5!XN1H95WK$VXY.X?+C,WZ>1L3,SNU,W=,8K=7C"(6ALH
MULZIJ7'ER`T0CS"ET56TB4GPX\'NI]MQ$&3!@;]AX&0#8HQE*"5M9T*FHMUH
M8B)#+C`@,7XU$7C7SMY7T;%"N2V5QD,W7B/\L'AM=:[4LTY)<_52;RQDODIE
M7'LQ=)'ZRVZKM9VZ241X4@HA*QTA/'9-V1795#)"&U3S2PR=S001!G.^=NXZ
M>DRR1Q9';\.5DC'A#*\LDT@>3IHP)D8SL)!&R-!1".6;:VR)M$*X7<TS<1&C
M/B;J8L42R:'$<<::8@S*0J?A@IJUKNK\LWF+=.9F$;7<<F,:C#9&H^296CVB
MNU>G9!QR]@2^PJ_9X6/N./<D/[!,U&WIQ-A3!VW;34Y'*])5F[PY%.[3D'BA
M;;-GW''DUQY"2ZF5@R:XYY(RJD`$%8Q'U48!DE+K=E"L?$PFQ=UW+:\D:9X.
MFVDBSA73FP#,I5I$EZ3JUI(@C:5)(K8QK$KW32E-*4TI32E-*4TI32E-*4TI
M32E-*4TI32E-*4TI32E0-Y6?Q,^65^+K)O\`3WYS:>=5\!^GE7__T^P;RM_Y
M;_!+\(O'/]S].TJIY"IY:52FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4
MII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*P!<>*W
M'/(+#(\7=<-T.S,,O6RIWO)C:6A47)+I<:*SA(^GV.<$1`[F6KK&N,4FJH"4
MR:;<H>CJWMXL4>$=N.(@C.'FR9D&GATLJ6_5G3^&22YUL/O7-^9JZ\TLC9+R
M-J:;%7&D)`.O'0DI"_\`$BDDJIN`3PJC/>&G%>1;231]@?'#EM,,<QQLHBK`
M(&*^8\@W[64S6V<=NYT\E/V22LK\K@R8=H`&VL==OPEQDPUQD&*N-#CA0/2(
M,;(.7!$!X)#DDSQKR20ZA8U5<B9)EG5[3"<S!K"_5:#X5I+V^\V..BQYF/TF
MXK.;RFU60ISK'SZ`BW5(>UI:G.ZNLU3/#.*LXBS0J\"JR$.Z-&*Q)Q;BEMTB
MD/3Z-9>X*-V&:NY#KC)U]77QU]2^O5YZKF_OJWM[MM+X+[8>@^,4,6CT],QV
MT:;<M%AIMRL*B'/>6KP+M$/2:_8>*V(I>&QS6WM0I$<]KO>MZ[5Y&5D)UY!,
M0\0!AC59B5<N>[4$X%67.8NPF'5WK2_&MN6L_'%8%+_O$8I#8]__`,(J-)Y\
M`.(KTLTBXZ8JM;'5Y&"^`:4*LA`\-810W@;"LVR/&7C_`"YK4:3Q)27IKQ>L
M?9-MPKPZ)AL-_P`4IUU+'-KDQW#Q$O3DJE&E9*#V)%:$#80WWLP(F,^#)CJ$
M?%S)LN(C_AY.0K+/.G\,DJNX=AQ.H^=6G`D@R\610<?(PH\212!:3%B;5'`X
M_>C1N*J>`/*K?NO#KBYD:`R+5[S@S'EF@,MWMAD_)$;*0:2R5NR%%Q\7%,+A
M*G*8BYIYM&PK9`%TSD,*2?2.X&/U6%P\5(<+'2!5AQIYYH@!8)+DL[9#K;DT
MS2.9#^\6N?"LELK(>?*R7E)R)\>&"1CQ+PX]NA&Q\5ATCIC]VW"KDIW&K`>/
MC8J/2<2TBLGP=!6FM8C4B(5NU4H$'>"1Y+@PKJA?79IV8L4W\:;<RC@4P$YA
M$1$<T2RB?(RA(1/-BQXSM?BT$3K)'$WFB.BLH\&%QXUB=./HC'Z:]$9/Q`%A
MPGT2Q]4>3E)Y4+<],C#D:IV2N*?'#,>0Z-EG*.&:%><DXU4:JT:YV"$1>SE=
M.PDDYACX-T(E[PC&52!PB54%"I*[F(`"([V<55P<V7<<,=/.D0*SKP8A0ZBY
M\PLC@'F`W`\!;(EFEGQ4PIG+8JZ[*>('4"AP/8P4:AR-N(XFO!!\0.,%:S'9
M>0<#@W'D5FFX(23:RY%9P*"=BEDYEJT92YW"^XH$<2C1DFFX633(JL7JZS#U
MGZK*8N-'MN=LZ0J-KR4=)8K>ATD8NZL/%6=BQ7D2>7*JS9$^1E8N;-(6RX&1
MHW/WE:-.G&P/FB>E3S`JG%X4<32525HY>/\`C,*C-XOKV%I6`^KK88][BNI3
M$I8:S1U4A$1"$@YV:=/&Q"B!TG*PJ`;JV$/<T$60N0DR:EEFQIGO^]+B1K#C
M2'^>&)%CC;F$4+RX52*:2&2.6)M,B)DH"`!9,QR^4HX?=G<EY!R9C<\:R%A/
M`.&..%./C_!6-JMBZFJRSV>7@*G'E8,G,S($03>2;K<RB[IZNDU2(*BAS&!-
M,I0V*4`#+DGFECQX9)"8HE*H/!069R![W9F/M)K&6&)))YDC`ED(+$#BQ"A0
M3YV50!Y`5E_5FKE-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*5`W
ME9_$SY97XNLF_P!/?G-IYU7P'Z>5?__4[!O*W_EO\$OPB\<_W/T[2JGD*GEI
M5*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4
MII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2F
ME*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2H&\K/XF?+*_%U
MDW^GOSFT\ZKX#]/*O__5Z9/+=YP<+:7P`X6U*X\O.,%4M5:XM8#@K'6;)GS%
M4'8(";BL55-A*0\U#2=K:R,7*1KYNHBX;KIIK(JD,0Y0,`AJA(OSJO@*FM\0
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H32E-*4TI32E-*4TI32E-*4TI7B4_]M;_`/\`6K_^0ZK^Z:J.1K__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g309840g58v46.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g58v46.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0V84&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@`````````````!"@```=,````&`&<`-0`X
M`'8`-``V`````0`````````````````````````!``````````````'3```!
M"@`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"OL````!````<````$``
M``%0``!4````"M\`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"`!``'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#TG$PL-V+23CU$FMLG8W]T>2)]CP)CT*9$2-C>^C>REA_T2C_BV?\`
M4A8/7,;!R.HO;=1CWV-J:YX=;>VP5G?1-E6)78WZ>1^B>[_A/]"DIW#AX`YH
MI''+&]^.R?[#@_\`<>K_`#&_W+E@.D![*\8=..4Z3:3DW.:#7^E^DUGO_1UT
M._2.J]3_`*R@V,Z/;]IO9^SK*[0UUCSE9!`LO:_Z3FMV;77LR?1]/TOT6S^9
M233UWV+`F/L]4GML;_<G^PX/_<>K_,;_`'+DZ&=!O_5*F8#G9'IAM3<F]I-P
M/NK8YU7L;Z63?Z&W_"_H?2_<Z(/^L(>2:<,L)&UOJV`M$MW2[T'>I[=[OH5?
MZ/\`X1)3:^PX/_<>K_,;_<H?9>F^KZ/I4>KMW^GM;NVSMW[8W;=RM+F_K-;A
M?:ZJLW[`Y@KW5LRS8VR2[<[TW5M>W;NIJ_X3]&DAW?L.#_W'J_S&_P!R;['T
M^0/0IEW`V-U_!<EBX?0<AS,;&IZ59FN<6UU`VD/J+;'.;J-S+MM7_"_X5&J?
MBC/HM]/IK,]SP:Y]86GV-H_FWUM?0[\WWM_FOTR27HQ7T@MWAN.6Z>Z&1[CM
M9_G.<GKHZ7:`:JZ+`1(VM8=/'V_UERQR.BXKF/Q#TUEQEWJN=>'`ASK<+:YC
M7/=MI_I-F_Z?Z'_"+HND5='>QV9TYM)<XEEMM(@;@&-L9_)V^FSV)*;?V'!_
M[CU?YC?[D+)PL-N-:1CU`ACH.QO@?)7$++_HMW_%N_(4D/\`_]#T_#_HE'_%
ML_ZD*OF8G4KKM^-G?9JX'L])C]1_*>K&'_1*/^+9_P!2$9)3F-Z=U8;MW4@_
M=6YHG'KT>=FR[VGW;=MF^O\`/]50_9G6=K1^U8<(W.;C5B0`=.^WW*65U[&I
M<&MTEQ8++=U=9<TFM];';'V6/8\>_95L_P"$5?(ZW;]BOOQ[:GOJ!]C&/D;2
M/4]UVUOT?Y"!*[A-T:#IX>-?346Y=PRK2XN%GIMKCB&[6?N_O*RL+I'UD.?=
M7BG'<;=LVV`C:(Y>?HK=2!M!!&ZE2S,//OO;9C=0LQ*PV#2VNI[21N]Y==6^
MS\YOY_\`@U=5-O3[6DG[;D.G@$UP-=W^B_LHJ`!W-(&=-ZHVP./5KWMD$L-5
M&H!W;/;2WZ7T')QT[J>Y[CU2TEV_8/2IAI<[=5]&L;VTL_1_I/IH/5\EO3Z+
MW-OR77>B^QM=;19M;NEUOT/HU[MGNL_FE7Z!G]6S'Y+<@EEE3JP^NZLMVAS=
M_P"CVBMKG6-/[WZ/_KB;Q"P&48)''++8X8]_F/E_C-ZGIO462']4M>TM>-OI
M4-]SYBR64M_FW.WM_P#!-ZC7TSJU;V.'5K7@6-?8RRJHM<R0;*AM8Q]>]HV-
MV/\`T:RQ];+<7)R*,NKU3786M+8;P8(B%TF/:ZZAEKF&LO:'%CN1/C"(D"QR
MB1V2(67_`$6[_BW?D**A9?\`1;O^+=^0HK7_T?3\/^B4?\6S_J0N4^M/5\E^
M6_$INMHQL<ACQ22US["UMC]UM7Z;TJVVULV5[/?ZOJ?X-=7A_P!$H_XMG_4A
M<Y]8NAY+\I^9B5.N9=#K1607ML`%1=Z3RSU*K*F5?S;_`%&65_X3U$Z/#Q#B
MV7PO6M)5Z>C@=/ZMF8>2VW#NNM+-78UC[#78/SJ_UC>UECO\';7^?_P:[?J5
MF-E=&?80Y].16US-H,G?#JO^^[EQV+T_*OL<'-MQJ63ZV5=6ZIM0^BYS?7VN
MMR/S*:V,_G/>NSMRL.K`NKQK6M&.ST6AADM=MVU,"6;AL\-#36MEX$ZB97(\
M7]XU_7D\=AY=E.2S'UI].6M,Q8'<^Y[?WU;P_K#U:PMQQ8UK6R[>1N=!/MWF
MS?N]SEFC-R_4,'<[<21M$F#^<Z-RZ##.%BWU5T48K\EP;L;;DAEI>[WO_5GU
MO_2,?O\`H?V%`(F^UCNN,A0)U`/4#[&WG=;ZGBY=F/7@69#*]H%S*["UTM:]
MQ;L8]OTW;?IH>+]8KW]$?G65$N8=E5Q$,M/[X;]/]'M]_P#@W_X+_@^@5;-P
M*<S#=B.&QA`#=H^B1]&`I(BI`DW'LMEEQG'P#%&,]/UEROT_-I_6>#L^L/41
M?ZSLVUMDSM`=L$';'HAOH[/[*[;HO4CU+!;D/9LL!++6CZ.YO)9_(<N4R?J_
MU#'R1C@&S=_-N8"=PX_JM_E;UU_2L$8&#7C:;FR7D<;CJ5/EX>$57A79@#QW
M5'LQ<^^S&K<&W.(:ZT=Q]/:P^[Z7[ZFWZP9V'M^SO#JW5-AKY<&^5;7':W8G
MZ_GVNZF\U6;J@/T9(!&GM=Z<S[=P4^G_`&=^,<G-JJ>\.V-=?;]G;MF6ECMC
M]WZ1[&.9_4]-5`-1]>K9)T(UZ&JMZ/H61EY.,^S*L#W!VT``""`"_P!PV[OI
M*[E_T6[_`(MWY"@=+M%N('LKJKJ)/I>A8+6.;_I&V,:QON<CY?\`1;O^+=^0
MJ0"@`6"1!)(%/__2]/P_Z)1_Q;/^I":ZO,<\FFYE;(^BZLO,_P!86UJ.);4,
M2@%[?YMG<?NA&]:K]]OWA)3EY_1\G)QLAC+:FVW-.QS66,&\D'?:VO(VV?\`
M;?TT'$^K(9C78N5D/LK?:+*G5.=4X`!GT]CMF_V_F,^@MKUJOWV_>$O6J_?;
M]X0,03=,HSY!#@$O3?%X\7]YI4=#P*7[X=9!D->9:#S]!H:UW]I7]K9F!/,J
M/K5?OM^\)>M5^^W[PD`!L*8S(G<VS53J5^310U^-6^U^X`MK8VPQ#OI,?;C^
MW=_PBL>M5^^W[PEZU7[[?O"*'(M=FVWBJZE]FUP:VX4;0`8W%EK,QKVM=]/<
MC8K*\BTL]'.Q@UNX/MM?M.NW:/T]ON_KL6CZU7[[?O"7K5?OM^\)4NXI="0Y
ME?U;Z?7]%]IU/TG[C#CNV;WAS]G\G<M&G'IHK;74P-8W@<Z^,E2]:K]]OWA+
MUJOWV_>$!$#84J4Y2W)+(``0-`AY?]%N_P"+=^0J7K5?OM^\(65;4<:X![?Y
MMW<>!16O_]D`.$))300A``````!5`````0$````/`$$`9`!O`&(`90`@`%``
M:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H
M`&\`<``@`#8`+@`P`````0`X0DE-!`8```````<`"``!``$!`/_N``Y!9&]B
M90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!`0$!`0("
M`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`__``!$(`0H!TP,!$0`"$0$#$0'_W0`$`#O_Q`#I``$``@(#`0$!
M````````````"`D&!P0%"@,"`0$!``$%`0$!`0````````````,!`@0%!P8(
M"0H0```&`@$"`P()"@$%"`H3``$"`P0%!@`'"!$2(1,),11!42*4U!57EQEA
M,B.U%D=W.,B)%W&!0C,8D:%28I)3)"7!TG.3--4V5I8W<H*BLL)#8X-4-46%
MQ29&9G:W"A$``@$#`P$&!`,%!`8&"`0'`0(#`!$$(1(%,4%182(3!G$R%`>!
MD4*AL5(C"-%B,Q7PP>%R)!:"DJ)#-%6R4V-S@Y,E&/'3E%>CLT149'07_]H`
M#`,!``(1`Q$`/P#T><'?3RXI[5XB<>-BWC54!8+?<=5U*?LDY)%>.9"6F)&,
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M*;V[Z?A9<*?L3J?S9U],QM\*;V[ZJ0_V3M&?MG]0_L0P^J?Q3O\`9Y]Q\]][
MO_A!_@)_B1^P_9[UT^H?VU_ZQ\C\WWGY?MREO&K[GO/2O__0]C/IK_R&<4?X
M)T;]3-LH.VKFZU-_*U;3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I5"'[RO[W/])>6U+V5_]'V
M,^FO_(9Q1_@G1OU,VR@[:N;K4W\K5M,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE
M,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE
M,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE4(?O*_O<_T
MEY;4O97_TO8SZ:_\AG%'^"=&_4S;*#MJYNM3?RM6TQ2F*4Q2H^[_`.5O'#BO
M#P\]R)W/0M0Q=@>GCX->YS:$<K+NTDQ56)'L@!5\[(@0/TBA$Q33$Q0,8!,4
M!A,\*S)C&0>NRE@O;8:$^`OI<]>RI1!,T+Y`C/H*P4MV7-R!\2`3:MC:RVAK
MO<]'@-EZHN=>V!0;2U,]K]LJTDWE864;IK*-UA;NVQC%\UNY1.DJF;M425(8
MARE,40#+EAE@8),A5K7^([QV$>(TK'22.3=L<&QL?`];'N-B#KV$'H:^47M;
M7,WL:TZBB;A#/]ETB#@K+;*8W<":;@8&S'<IP$K(-A(!4FDJ=FJ")@,/<)!]
MF11_SHI9XO-"DOIL1T$FT/M/CM8'X&I9$:+Z?U!;U49D_O*K;6(\`VA\:V#B
MK:P>^[+H&KJY/6W85N@JC7:Q7I.V3\G,OT6R<96H4$C2\XX1ZF<C&QP+D\Y4
MI#%()R@/B8.L,L\,"EYI`J@J/Q=@B_\`6=@H\2!4^/BY&5+%!CQ,\KMM4#M-
MKV'C;6W=61P4Y$6>$B+'`2#>6@IZ-8S$-*,S^8TD8N2;)O&#UL<0`3H.FJQ3
MD'H'4I@S)EBDAD>&5"LBD@@]01H16*CI(BR1L"A&AK66[^06D^-E-#8.^=FU
M'55,-)-8=.PW"42C&*\J^!0S5@V$P'6<NEB(G,!$RF$"E$P]``1S'>>&.2&)
MY`)9#91VDVN;?`=3TK(C@FE2:2.,F.-;L>P"]M3\2`._LK8];LE?N-?AK75)
MF-L-:L,:TEX.<B':+^,E8Q^B5PS?,7C<QT7#=PB<#%,41]N94T,N/+)!/&5E
M4V(/4'_3\^HK'CD25%DC8%"-#7=Y%5],4IBE<1_(,(IDZDI1ZTC8YB@HY>OW
M[E%FR9MDBB95PZ=.#IH-T$RAU,<Y@*`>T<LDDCB1I)7"QJ+DD@`#O).@J^..
M25UCB0M(QL``22>X`:FONDJDNDFN@HFLBLF15%9(Y5$E4E"@=-1-0@B0Z9R"
M`@("("`]0R1E9&9'4A@;$'0@CL-1JRLH92"I%P1T(K!KMM'7VMW-/97JVP]7
M=;`M3"CTM"6<"@I8[;)IK*Q\!&`!#>=(.TVYQ(4>@"!1\<L1EDR8\1#?)=68
M+VE4!9S\%4$GPJ412&#(R@A^GB`+MV*&8*+_`!8@#Q-?E/:>O%=EKZ<3MT,?
M:#:I$O:](*X$9Y*GGDB0Y+"=KV=`C329P0[^[_6#TZ8B=9OJ3$=PA95>WZ2P
M)4'Q(!(^%'BDBB@GD0B*5F"$]&*@%@/@"+_&L_RZHZ8I3%*8I3%*8I3%*8I3
M%*8I6*WFYP>NZ;9[W93/R5^H0DC89DT5%2,Y)%C8MLH[=BQAXEL\DY-T"*8]
MB#=)150W@4HB/3(,C(CQ87GEOZ:VO8$G4@=!<]34V/CR94\>/%;U'-A<@#\S
M8#\:K]T9ZM/##D7MJ/TAJZR;1D=BR"_NXQ$WHG;]6:QJHQZDHB$[+6*G1T9`
ME=,$Q41%VJB"I1#LZ]0ZYF/$^4LC0V*H&)-P!Y;7%_XA?Y>OA6/.WTXC,JD!
MB+:'6YV@_"^E^@JRS(JNK\**)I)G55.1))(AE%%%#%(FFF0HF.<YS"!2$(4!
M$1$>@!E&954LQ`4"Y)Z`54`L0JBY-8Q2[S3MC5]M:Z'98:W5IXN];,YV`?(2
M44[7CG:S!\1L];&.@O[L\;G3,)#"'<4?'"G='#,O^'(@93WJ>A'@>RCJ4DEA
M<6EC8JP[0PZ@^([16596J4Q2L2<WVE,[K&:W<VF"1OTS`R-IC*<:2;?M&\K<
M4Z;,9"=3B04%X$2W>O$T17,0$S*B)2B)BF`+499))HHVW21H&8#4JI(4%NX%
MB`+]=;7L;7.CQQ13.I$4CE%)T#.%W,J]Y5=6M\H(O;<+Y;EU6UHZT<CM/4>U
M72I7:V)TYU0*M4[C9YNT1\E!T]I#W:9?U^N)MKA(-4*[)2SZ6C5$18MW"CM,
M3)B9,`4)UB$T965MUMDZ0V/4R.JLJJ.K7##501>XZ@U/]--MA<+=7CD>XMHD
M5O49CT4*"#YK7%R.E=MKK>&MMK6G:]-H\XI+S^D[9&4G8C4T=(,TH>Q2]8B+
MA'M&[IXW1;R:2\!.-EO-;F43`3]HB!@$`EC_`)L`R5'\DRRQWZ>>%S'(+=?*
MX(OT/9I44J&)XHWMN>%)1;6Z2%@A_'8VG73QKLMN[>UOH?7=GVOMNV1=)H%/
M8_6$_8I=0Y&K1(ZJ;=NBFDD15R[>O72I$4$$B'565.4A"B(],Q\G*AQ$5YF/
MF8*H`)9F/154:LQ[`-:EQ\:7*D,<*BX4L22`%4:EF)T"@=2?WU"[6GJM\)=K
MP&V;!6MDV&/#2FOWNU+[`W+6NPJ-;FFO(\BPO;;$52UUR)G+##-U6YDC*LD5
MR^=\C\[PR><C&P<CD)/_``T4BQO;4HS[=H91J-VX;;C77NJS&B?+S<3CX1?)
MG!,8.@<+U()T-NW6N1(>JGPEC-3\>MUN]HR)-?<HK?)4;3<D2CW)5]/V.'L"
ME7DVDE#$A32M<193J8-U%GZ3=(ISD^5T.7KD_33'E</A0H/(3PK*B@@@HP0J
M2WRB_J*+$@WW#JIM$I#<?F<F#_P<$PB<G0AR)&`V]3Y8G:X%K`'H1>4'('DA
MIOB]KMSM+=MR:T^HH.VL:U6,T?2DM-2[_N!A"5Z`B6SV9GIIZ)1!)JU056/T
M\"Y@39$4#PQ.299&VJH!+,>IL!<V`U)Z`"YK(@QY<E)I(@/2C3<S$V"KWDG0
M7.@'4G05%B%]5GA59--VG>5=V!:YZH4>RQM2ND/#ZJV5(;$J4Y,&>!%H6+6K
M:L*7:)0?D8+'3769%1,0@CW>&2SNN/'AS.;PSLRJR^9=R"[!B+A2!UO;K5D,
M4D\F5$J$20H'8-Y258@`J#;<"2/EO6:<3O46XN<UWEE9\?K)=+"6IQXR<S(V
M+5VPJ-"D;E>'8+$9S5NKL/&2#MLZ3,55%!4ZJ7:/<4.F3&)ABOF$@8ZVU)`T
M()!`[18'4:5"[;,A,5E83F^ECI:UP>XZC0ZFNVTEZ@O$SD->=FZZU=M5G+6?
M4C*5EK@E*0\Y6XT(*"E3P<W8H&:GX^.B;+7H>8(+9R]8K+MT5ODF,`Y!$Z2\
M:W+JP&"I6['0C<"R$J;$*ZJ2I(LP&E9,^/-C9PXV6,_6$V"C6["UU!&A87&Y
M1J.T5N_1V^=6<CZ(39FF[0A<J.M/6*N-;`T;.V[-[)5:6<0LO[D+M%`SIF1\
MU."2Y`%%<G0Y#&*(#DWIR"##R&0B/(A65+BQ*->Q(.HO8Z&Q\*A<!)\C'+`R
M1.4:Q!`8`$BXT-KZV[=*W!EE4IBE,4IBE,4IBE,4IBE,4JA#]Y7][G^DO+:E
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ME3.Y.NFD5OF5G?4K+P&-$&AR<?BS==_JQJ%R9`8$`(C64((YM[%@58@*6=C4
M,!A+<KDR;9<:;.4$A1'(7]`VE;JYBW6C*JH)V_,EE-979D?4(#6&_-L:]JV[
M/\;K5P'].-E?[8O4=@PMSFOJ\7Y-Y,8UY%,6=H7N<6V44^LDXL_UPD0RATP(
MJ8@YE<LRK!E#%M_ETON19)0NX$POQL95U"68(<KTMP&BC?&VBL*MXT;L;C5F
M-\V+C>02+<!8,.0`53ON-WTP?TRQNY"N+W!K]:DG.>3KA]K93D;8.9!^-RG*
MJ71V`^TC#<@6G)B!U@75KPU9C8M>Y1QMPR5.+M($17<J'='-W]@G!(#!E^:J
MKD>WQEL^WZ+-*F/;K/OQOHQ+LL`/3.8//UM$6-ZQ\-9/3YHXJ1[O4Q+A]U_2
MO-]4T>Z_F)^EL$Z+ZQ`O7YW1JS:,=?66U(QMZAD[8=@>ECMNLZ=F;[$W9W;5
MK[6Y;93:#K^U&-%;/X:$D'^M/<Y".9OSD?NIA1NY5+[\<0S798R8HO<^.ZK]
M=-#P\K[1Y3?)C3)4$>3U(_2#.D9*HLDI'E<UN^';$ES_`&9-?_@(>4SXR&T*
MI>)H'(;S;':61/4D%W2.-6_PQ:0TUJ_EQ)2.^-XL]@<Q(2SZ.N7IG-]+ZYA)
MK8C#7T^SN.M^.5>WLL_HY69VUQ8M0E94\L0H&0CWJ#A5P4J@+#FRC=\?E^-F
M2SC(]R<A%+O\R+B[,AHKCHB%Q'LDZ$65?F%:5(DR./P\>?RK_D)DNOE<9,<^
M2PN?U.R*J;#K9@>Q:EQS=LO,9#4%Q;\P>-^MMA4&;O<W5]2;+X>52Y;'W-H:
M)FX2SLX#9TOK^[Q-W3L$\NU,WCG0Q@1Q6QGJB@&`H%+FGSX4R,*#'E5X^8EA
MD4R(+Q$@1L,?L=4F8.K.7L%"BQ8WK8<?*8)9LB!P^"CJ?3<V<J21ZO\`"SQ`
MAP@!N;GH+'=&J:=O>M>BFSI#>&MNA]UPG%Z6B(-K3*S.RU[KK]K!.?JJ1:52
M,=JV-.SR#8"J*MFJ@O$%U#>4'F`4N;?WG)),(Y8WM/\`\/ZJH2R@J4$L0=-=
ME@5+K>P).MJUGMM(X<S*20;\?U9_39[!F4[C'(P:RE]0=IL"0!I7GXK&P?5#
M'T[=APU.J/*`QX'D12BW78,H_P"42]NM6N9*K%2FVU;A[<`;VAV</-M6RLJM
M`+E053=%*W31,FJ8\?(L)#P4DL8CPQ+."H)-W*J82QC._8K;@!)=2]MQ*W%3
M85E/,116?)^GC*L1:RAV$BJ'\ID*V/EU";K:VMN.!E^>"_'3B4;E-8N;H\;U
M['O<+5-<:X3=C7D$R,E%D)IB-M"<['I[3=PK6WE.FDO)^:#AM_KU3)_*RF2H
M3/B7(,GU@XT?3E-I1I_6N3,!9`WTYL`]NBDZEJDQA_P.48$A]$YB>J&W;UBV
M:^ENN]C+J^V]@3MTL*DA5]7\U-F;@Y-76'M_-R*LNG.&VF[7QMKVPK'/TV+M
MFW7E$<,');_780XZ]M%T33*"LA'-E#D)(J=RX"H7,;+^J@X[W3EQ%6Y'_,$C
M"K<@0O&#D&%3V@@[62ZJ]Q'H163!]$\OL[&<#Z%L7)9BPL?42=?IQ*PL0I!Z
M/YFC%VZ&JP:30/4/WMPNYQ0FSO\`:6FZW"4"DVM&BS3#DXI:W^SXFVMUI`L`
M&TV;V1L*3F!*^!Y%PBIHX3I)*%1#H01NY.&'_+<+(C3?$O(X_I`:D(;I)Y3_
M`#"@5E;?)<JR@WONJ/C9)$SLR.0JDCX64)"38LP0M&%(.P$NNVR`;U=E-P16
MWK]8/4D0Y9Z.BM(R'*>#U>A$Z*0T`_N<'R:>(*U#R(YO8F6QXR'9*T9225G2
MO4I,UM:F=)-Q(("1$"CFVQC--[BY&3(9&F^N=B"1L?&M>*Y:Z`&+5REG]7?N
M.ZPK79$<2<1QL<<8$8PU!VW!7(_[P^6S763Y`;IZ82P(O4B7%?WU<.<NI5-N
M0?-VP[LK/J+1\[:6LK7[S)<2*QHIE[XGKV=I2Q(U2GQRQ(Q5/S72!R*%$RGG
MB'4<U_MH1KF<),M]PP\T9#3:.N0RS!5C)Z*R;;`>4]G96;S#/]%[@A+:/%C>
M@(;;'B#0EO4':P<$F_G#`?IW5MSU<JQ?&G..T7J!A>9\<HKPU9U[5MQXIP%[
M.W=[J#8+Q[4:Y>I^HQZP&K!Q*95TV55!N(@F98`+VCFJXX9L>1[F&$".0?*Q
MC"'TB:RD.6OH;*2-?*-?U6K9LV(_&^VTS&OAI/E&6VKJ"B;2`/,+L`-.H_&M
ME\>FO,B.]133.AMRW[9*\._I=6Y:VML>VSRL>TD66OAI-GHDJBG(BU&#<W@$
M7@L#%]S!P!^TG4<]!@KC_7\[%`2^/QWKA6)OO^N$!2X.C")DG$1ZH&!%JTF2
M]^(XJ6>,+FYJP]+#:<1Y@]AV"2-XM_:S:MTKTPY#6/3%*8I3%*8I3%*8I3%*
M8I3%*\TO.7B)R+V?9O4_+4=2WF=BMW;&X+K4%W!%]W4N5?HT9KUCL1U!.D7B
M"_E5M-@Z*Z/U(9/RC"'7IFGXS$OB\+C9D1$2^YYYI`>S'=7`<_W&N!^->BR,
MR,0P/CSCUT]OY,0UU$[2S,B:_J-U(^(JO[U`?2[Y<5_D'J.!XM:\V>VT3!:\
MHR.J7FNJB&S5]-[!4>`^V!+NY*P[7H[NC2LE85B/5GZ9W8NBDZ#V@D`#ML/U
MVYWD'DE"D9*>C(19!CH+1Q[AKM0ARR6UWWN2U::0PMPW$C8I;T6]:,]3,;;G
M(TN6&T`WTV6[*S7:_"KG+M3U+:KL&R\;[-'4**N,%0=F;3J43)$;;9UK,4MY
M5YNV6&ZRFV)MT9"4;OSMI*&C8IE'LVQ""!C*@8Q\7!B25.=$\'HX^7'FIZ0/
MD#.)/2;IN=7LK;V8;7(4`#I-D3O`O%>E/ZN7C'$<36&\[&A+"UPJ%"&T"L2N
MXECI4>Z]Z7N]I;556U^SX=[WH\QK#3?+)*7DE'#J'97/>"UA@)?4%LK"L=:%
MC.T7C)BU(P*H5(AG#(QA3\.X9T;)?#Q<II2N0N!Q*(OZXY%SY3FGNOZ,K.3U
M"-I8Z5D;L1<R3&)4XK<AG.6OY3`\*#&6][Z.GYV)O6Z-Z>G=SBKNE>2>N-&Z
M_P!M%H]BV5Q2V!8JL[3<[`E-K,RZ(<L=QA'PDW<88;B]:;5?MUI%DM(MDSJ-
MNX#"")0&/,C7U,:".-3Q>/R>:(XU4>5&$7TTH&ET4"0`ZD%PUKK<4B:!<!)!
M-_\`5Y\!?5=FN69)Y0T9.NUWC])@>U5*_KK;&B/35Y#;+@O31UGRGI.WK3I^
MHN><*^QX&:CG.M5=9TJZUG6A=5Z\M497-AVU2(@'4U!.B1C$C\Q"-TP1%,A0
MZ#+R,6\<W*IWYJ>W4CA8&^_($TK1KJ`#+"K1D7N`57^&PU^,[P\=E+&X7?S&
M+)Z>T#^4D<JS&US='8W<BQNY/4WK/^$?![;FJ^77IN[PW)QLVM-2\?PSD]5W
MR[+BH\/IS;E/M$\QJDGLA5S8"'9L5-8ND8UJ5-)<IA$OR!$#&)FXF2R\][M;
MY8,KC,*19+65IRI3)C[_`%-L,9;L\PZ&Y.1S4.)_EG#X^%('7$YCD$"WNWTA
M:)\1NXKZLL[WZGS7T`%;;YO\7.7,#RDVU>..&N;G::-#N*-SCH*E:7\IM+\D
MXMS!ZFNVKF9#NT@5EK-KR(=21BB7RNU]U-W"`!GF^/Q)L.#.BV$^EFY$<5SY
MGQ^96&')8/T1<-CD2!;&R&XU:XSLO(ASFXYI91MEQ$6;=:RR<6,B7#`7L^H,
ML$6ZYW-$U[`:PUY&^E?O(VC-J:U8:8ONU#53C#PUF:T$?WN75SW'`;TVM<]V
M1$`495L1W84(/8\CWI*&[").R=!ZE*)=KR,>+%GSOB0O)@8_.88B&FY\*+CX
M,1F[!T0[CH2P)TO>L;!S,C(XI#F3"/D,KCN3,H9K[,B>>'(A4G4V$B#9U\J`
M=-*VBW].J[2:^QN0%/XU[DU_LJL<L>#D_P`;Z_*2TJQGJ%IB)I''^O[5(E"-
M+$ZASN(&#A7L9.N%#.%3A%B3S#E2*(Y./)/B<WPV3ZP;U.9Y5LEQJ#!,^0T1
M-QI&Y9&4`#S-<]:QL@0Y/'9F))\B\'$L:W__`*J%L@K:QU8%@5OV-I:YJ[SU
M+M)[-W-H6H.]15EAL"[:6WWI;D"SU?)O$6#+:+'4MT8V65H8O'0&9H.YM@B<
M&XK%,EYY2@8!ZY@/)+A<MP?,)`98L660N@^8I+#)"SQ]\L>_?'_?`.MK&Z%8
M\G`YGC'G$3Y6-L1S\H<.KJK_`/LWV[7\#U'44SW?7G/GE'?N9VSVNG>5=,U5
M?.&F\=>1.I.14)J>(L)-@VHC9W0]>Z>9TPS^PRM0CC@Y4%5^_`/>ENT4RB'<
M>R3#DBX7G(GG$\D\^,T9U]4F/)+OO`\H2.)P(S<DWD'9KL<#D(3S7M>7TACQ
M8[-ZMC>(+Z`3<"?-OED`:2P5?*I'6PCI+>GOS#]Q3I)=#W5W1],6'C1:M0(I
ML(XQ5I3=FQ./FU>1)H](KD%6ZFM)[7DJW?C\D$TW)_SN[-WAND'N#@\URJ_3
M<VT&Y;V''(>6RHV8_J1I,S%0FVCP@=%KSBQM)P\F,R@"7BC.RD^<9XAP\$J3
M>VYXL>:6PL+2[C=FJT+EAQKY_,KAJ_D9:K+7.9T+Q[Y4#MW7O'S7FN(?6UNA
M]0R$=;(=2OMY!U*NX^_7BMQ\K'&;+N00,JJS4$#`*PB738#2<;G\+R&5$V1F
MKAY&-/*@MK,L.V6.*]EM)&^X`D[)`+^37<2F#,X_F^/QI!CX\DD4L2/K_A.6
M]*23JWD("Z`%U#'K:IP\.;SN7;R'(G8&RN'2?$]A<)]H-$9V$8QMN+8K)K`O
M(QW+[5BHD[UBUE&;M`A61R.U`.V7`O;\@5%)LK&9>!EA#*<I_7/IIJH#*-AU
MMYW-]_B!^.&<A9.1@*B0PQQQJ7>U[AF8A+7_`):@Z7.AN?U66!W$'BCZ@M>X
M=Z[UUK_:=>XL2#';'(&3VE2=F:@87^;NE7ME\EWU;^IY!2::&JP.HYP*A%D^
M\QRJE-X=.F4>'U\'A\?*_F82\5%%)"#L;U`&#?S-2NA`M;3K6XY/,Q_^8>:S
M<;5VY`2)+\RF,11#1=+^96UOX5H[@EP>W9-[?J%#Y)<=)>GZGXY\:]Y:$M,]
M;E8YQ7-_2^S]X.MA0KFEFC'PO']80@UB*N5')$Q*X*9$2B!@,,P6++P>8SIX
MMLF1QF!AI`?G$F&L.Z9NRQ>`!/X@X/8;ZV::3'RN(Q\?(W''Y/+RFF'RLF4D
MBA`-2&`E.[NV]]K6G^E=IJY:&XK+:ZNU'>Z[?L-W;YDH>KOFJ+(6E2F-GV!]
M4UV;5N=1)&->02J*C8`Z!Y(E\`S,:9I>(]JI-(6RX^*QTEOU$H#;PW]X$ZU@
MR1HG)\\T*@8KYTS1VZ&,D;2/"W2K(,Q:NIBE,4IBE,4IBE,4IBE,4JA#]Y7]
M[G^DO+:E[*__U/8SZ:_\AG%'^"=&_4S;*#MJYNM3?RM6TQ2F*4Q2HA7SGEQ+
MU?O=SQNV#NNG5#;4?K>2VQ+04_(I132&I46W</W+Z3F'ID(U!Y]4,7+_`-U*
MH=<C!L=PH4B788\,4\4PY!HW'IXNP2MT"F1E15OVDLZ`VO8N@)!90<DX>2#Q
MJ^DQDRV81*!=GVW!(`[+@JI/S,KA;[&MG]IY5<;*0SD)"X;SU?66$37Z5:Y-
MY-W&%CFS"M;(DCP]!GG:SITF1"*N$HD9O'KF$$W2I1*01$,NEFBAF^GFD"S^
MN8=I-CZPB:<QV_C$*-)MZ[%+=!5D6///",B&)F@],ON`N-@=(BU_X1)+&A/3
M<ZCJ174Z^YD<4-L6.-J&L^1FFKW:)BLR5SC("K;!K4S*O:I#N5&DK8$63*05
M6-%1SA(Q5E>@%3[1$W0`ZY(!=<AA\L*!W/8B-MLS'L4[UU.GF%1,"K0(1YY7
M*H.UF%_*H[3H=!W5U\!S>X?6JL;"NE:Y,:3G:GJ8[5/9EABMB5I[$T4SY^$6
MS&SO$)`Z,2FZD1!`AU1*4RH@4!ZCTRSU$^FQ\S</I975$?\`2S,`54'^)@;@
M=2.G0U>(I&R9L-4)RHU9F7]05-Q9B.Y0K7/9;6MNZQW!JS=%0+L#4NP:CL:C
MG?2D82V4^<83M?,_A'!VDNT+*,%EF@KQKE,Q%@[OT9@$!R213%''-*-L3IO4
MG0%3?S#PT.OA4*,LCR1QMN=6VD#4AK`V/C9@;=Q%:UKO,3BG;H/9%FJ_(G3L
M]7M/'$FU)N*O];>1FOS`N=K_`/FMXB_,A#%,Y2,F45C%`R@=H=1\,C,D8PTY
M`N/HF(`?]))M8`]+FXMWW%3F&49;8)C/UB@DI^H!;W)'A8W[K:UIW9?J':&I
ML%H:VT29C=W4WD!L:4UM6+=K"RP,W`,92(J-CMKMT\?HN5D5D2(5M1`4TQ\P
MJBA1$.G7,;*R_I)I(9(6\N#/E`]C)`!N`\3>P/30WK(P\/ZW'RYXYEM#+#&P
M[=TTBQCX6+`GPZ5_=/\`J.\6=EZ]T-<+3M"C:=LW(J$936NM8;&N]:B[O+%D
M)$L4U:,F!GJ8R*RT@H1(HI`)3*&`H>.;1\<C+^AB<29/IHY5=2`Z[P".M[7^
M-JQ9T;&?,$JD10SRQ;SHK&)MK$>'3X7K,N7?,O77#:,T_/;+8N5*]MG<%6U(
M,^23BXJ(IQ[*#A0]LL;V45102@(=NV.JX$I@,!`$0]F84<T3<EC<;(X0R0SR
M;V-E`@C,A!\6M8>)J>/$DEX_E.0CU7%1&*C4MOD6,!?&[7^`K&Y'U`-!'M^C
M(VFV^E;!USNYAM"3;;CK6S=?&IE89:IK[V?L+AXW=3R4S.))IL%$U1CD'`,^
M@J+]B8";*F019&7#D_RDBQ1/N;H5+A!XC4_,;+V7O5T6%)/A/EXYWR#)CAV`
M&Y:2]M>FEOEON/8#6QZAS5XB[`;W-W2>2FE;4UUU`(6J]N(/8E9D$:C6W)$E
M$)R?5;R!R1L8J18G1902DZG`.O40#+Y6$./)E2G;C(^QF.BAS<!2>\V-AVV-
MJQDBDER(\2-"V2P)"CJ0.I`\+Z]U:`H7JF\/KU9M\H%VWK^"UAHEOJQ5_O.4
MOU5+K"UK[40L9XME`3A'WD^]QKBM+(K$.;N,H8.T/`<LBD#8HR9AZ6[*>%5;
M0N41'++WJ0^GP-338S1_2^DPD$D#2MMU],+)Z=G[B38CP(J;E3VMK6]Z_;;6
MI5ZJ]KUJ\B7<ZTO->F64M67,/'IK*O9%&69*K-%&K1-N<5#`8>WL'K[,DRO^
M"1Y,L&-%3<2VEEM>_P`+:UCPJ<F1(H!OD9MH`ZEKVM\;U%>B>I;P8V!JN6W7
M%\D]8P^LH6[2.OG]IN%DCJBT2LT>^58%9BC/+LG:99(Z(JLQ.F0SAN)52AV&
M`1L#CZ?CLE_*F4&,8.C-M+`Z=AL-UCJ%920";5+)!)'/G8^W<V,P$A&J@D+V
M]H!;9<:;E8`D"]2>G]RZFJVM#;FL>QZ7":F+",[(.QY*Q1;6F#`R":2S&7+8
M%7)8T[!XFN04U`4$I^X.G7KEV21AOZ>4?3?<%LVAW'H->T]E1P*V2-V.-Z[2
MVFOE&I/P%1QU-=^"$[L)MO#4%]TQ8]B\A#/JC%7RNW=E8I;8?[#($D)2MUYP
M>7?I&3KZ#DJ[EJQ(D4@'`ZA1$0'*)&N!'/CHOIHZ'(<?Q(I(,A)U*J21>^T$
M]E7R&7+`RI+ND!6,-V(9/E7N!?;IVM;MKN;;Z@'"6B1T5*V_E/HROL9UC(2,
M$O*;&K3,LTSBI5Y!2"\4*[\@/2-9J/7:'$G4"N$C$'Y0"&1^O$?D8,WIJX`U
M)5P60CP8`E3VU))AY,)83PLFV0QG<+6=;%E/<5#*2.P$5%GCEZQW$?>M0M6P
M[7<*GH.@1NQ)77E)M&U=GZY8H;*=Q1S$5D(&/8SZ\E')+`3O(B]325,F('+U
M*8!&:#=+BX$TB^GDY"[EB/S[;VN>S1O*1U!J&=#%DY449]3&B-C*/D+=;#MZ
M:@]"-14YY7E7QI@[W3M83&^-41VQ-A,F,E1J6[O-?1L=K82B?G1KR"BS/O>I
M%O()?*1,F405*/4O7*QJ9LC(Q(ANR8K[U&K+;4[AU%K:U:X,>/#ER"V-)\K'
MY6[-#V]:Y]5Y+\>[SLNQZ:INZM96C:]1(=2SZ[@KE!2=O@R)&`BHR,&T>*OF
M_DF'H?J3J0?;TRR!ERHGGQF#PJ;%EU`L;=1XZ?&JSHV-(D.0I25AH&T)TOT/
MAK6[\NJVF*4Q2F*4Q2M$\G]S*<=N/&Y]ZI02=G4U-KNS7LE>6?FBTIDU>CEG
MX1ZDB5L\,R(Y\KM%0$E.T!Z]HY@\CF#`QOJ"H(]2)=3:WJ2)'?\`#=?\*V'%
M80Y'D,7":38)&M>U[:$]-.ZJWY3UHN-TUQ\>[2TW*Q&S=FU=SI5M?]1*_ME4
M'-:#;%NKU/>/HZ=LU,CFMNA8"2FCD(_BR.V+E1(`!8H'`<VDL5N1XS%@._%R
M,X8^_H5W)(X8H?,+A-`P%[Z'2L;`A^KCRVE/IR1XDTX'4-Z*W*AAIKI<@FU^
ME2TB/4?X7R>YV_'0V]ZLUW:9PWB75.5C;6G&M[.H@BJXJ1+VM7DJ`YM+0ZO8
MI&DE!?D,40,B`@(!%"4RCEG%</'#ZES\H(C-G9=UMX7M*;@-==#4$@>!,8Y*
M%'E5"!UMZ@NFZU]NX=`UB=.\5'_:OK#\0HC6>]K'HG8]>W;L?1T*E-26NTVM
MTIS>=:$N$14)%U7[78*>V@[-&QSR3$3NH=210ZD`.[H/=F.LS2Q\;D8Z;L6?
M+@A+'RE5G<()"ALVWJ5)`5N^MEC\>6Y*3C,MS%.L4S=-PW0Q-*4N#MW:`$7W
M"_30UM*7]5+@[4Z&E?KKNI&#B27,-:/#,=?;9LP+[&:Q"4O-UBM$KE!E'-S)
M`H'$';Z)3>1[<Q1*JL0_R<F:2$RPQQ.6$OJ&,E2-R1L$9[$"R;B`'-E)^4FL
M!(9S$[R1A2BQEQ<':95W*I(/S6U*CS+^H"IA-MQZY?ZF4WC'V))YK$E1>WDM
ME(SD&Y%*VP9+OW+T(]\T:2B2A&[<_P"A41(L!@[1*!O#(>8G3@L?+R.1\BPB
M[#0];6`L;$L2`-;7(UM5^!`_)3X^/B:R2-87N/B3?4`=3IT%ZJ?U[ZG_`"+M
M5TT+8;)PQC:IQFY+S\(VU9?E-_T1;;A:7;2A^R&QK3IY\C%N8NM2Y5$ES`B]
M<+HH+I@)?-$29G8N/)]:O%<F/0Y-HG;:/.L;*"_IRL-5<H"!H09`5!J')*C&
MRL[CR9L**4)N-D+V8([Q@FS*K'<=;A+,=#>I`[+]5;B96V').M:]V&TOF\N.
M^H=U;0=ZJD*UL6F(69;2E8D9ZQ0L)=[%26=2G00<LR(N%8IW(F1(H*@$,4HY
MJGS=_'-R6$GJPAX0?TD+-,D(?:;-MNUP0MCIK8@UL<;`+\OQ_$Y;F)YYUBO;
M<`S"]KCRWV@FQ(Z$=0169L_4IXE1,WI;7FS-M5^A;AW-2:#;(^B*Q]MF6$$X
MV%$M9&"B;+=XNM.*94G,HNY\E@6:?1JKXPI@B0PJ$`VV>%7Y7-XG$?U9X9FC
MT%@66YV!CY3)87,:L7%UN/.M]2KNO'XO(Y,>R&5-X[3MOMW$#S!+W&\@+Y6U
M\C673U0.#-"V+LK4<_O6/'9.I82?F[G58NH;`EC(!6(UI+SL)#6%C55JA9+9
M&L'R9UHB/D7,BB`*"HB0$5Q3U7U^.V!E<E"QDQ(@22HO<!UC)0&V]0[!2RW5
M3\S``VV:<=E-F8.`R!<C(*A02+#>K.N\Z["RJ64-9F%MH.Y;Z%U9ZQ'&K:#5
MAL4LRUI^B"\:I/D):;;:8W8"-UJ2$1L']A9",>TME0W:,K%-%5$S&?1[UV*B
MIA*DDHD'G9F_X4>5)F,L>P8.VQN"V8KV1SIM*.A3=JK6+DJA4F`0-,,(8@+R
M2Y>7%8V6ZXJ+)O74_.C;RIL5!"ZO=1-7C?S.XR\NAOQ..VUHS9"VL)IE`WEJ
MUA+77GD&^DVZSJ*6%E;H&ONY*&F&[90[.1:$<1[L$C^2N?L-TF^GF^CAS_3(
MQ9)'0$Z'?&%+HRGS*RAUN&`.OQK#$\1G^G#?SO362UCJCWVL#T-[&]B2-+@7
M%XN-.?NS6/J`U7AM>N-;JE5#9*>QAUAL9UL:N2MQLL?K6O.)Z1V$_P!9Q2;I
MW!:KG%FAX^/DG#PKA1_^B.W+T,(8W$O_`)BO*1SJ8LW'QQD;/FM$TZP+ZC#1
M'D8LR*-P*JVNAMF<I$F`G&SQ2B3&GD$6[Y;S;#(R1@ZN(DVF0D+;<#8@B\J.
M37,7CGP[K]?M'(K8*U"A;3).HF#79TK8-[=/';%D>0>G4B]<U2VRK%@S:DZJ
MNW""35,QB$,H!SD*:,Y,"Y"XK26F*%^VP4$+<M\JZD6!()U(!"M:BX\SPM.J
M7B#A>R^Y@2`!U.BFY`(&ER"1?0=J]6CT\:5.0M=LG)>N,92PQVO)F)*WJ.RI
M5@XA-K1:<U09U69B*4_AF4%/1JQ%/?5W"35J*A".5$3G*4<J&-\C-?CH5OF+
MD&`KT`E%O)N/EN=PVF]GUV%MK6BD5HL6'-<6QY(3*I[2BL48[!YP58$%2H8'
MJ*P'?/JT<;=9;IUWQVUY9X7:FY[)R`U=I.ZU!D2VQ;:D-]A3K2'>306TU3<T
MR;F(`KU-52*;R(NN@_+!,`$0@X^0\EG8N-BJ6QF]?=)J`IAC9[`&V\%EV$K<
M*>M9,^,N)A9V3ERA)8\82QKH2^Y@%!L3LNI+#<`2!H#5JF25BTQ2F*4Q2F*4
MQ2F*4Q2F*4Q2F*4Q2J$/WE?WN?Z2\MJ7LK__U?8SZ:_\AG%'^"=&_4S;*#MJ
MYNM3?RM6TQ2F*4Q2J/N>WIV[EY&<HK7LO6,)J$*?M_@WL3B]=;?<95^PN5$N
M#]W;Y>I6ZNQ+&OORSJ4C]<-HEX<[M!1!@*O:!NTI3:B;#R?0]T0P!1]2F%+%
MJ1NGQLCU'1]/+'(BQ>8;CN746`K?X')X^-D>TLJ;>S8&7D,X[X9E@"[3VM&R
M2L%-AY^MV-0ZE_3`Y^;JK-Q_QQ@N-T/+S%#X&ZQB:Y4;[9YJ$<5;BQNY:V6]
MQ//):H(&5?V&I"9RBDFF*)EEP;#V]@J&V4D,<_N'@^9F6\2>XSR$Z$`@1'BL
MK!V)_&WJR1M9MHVEM?*`VNQ\IL?@>3X='LYXF7%B87N9'S\#*WO_``KLQY%L
M-Q#*IZ.=NP(/T:-C14^BK7T=6ZV3F=H>I"ZG;=5)!W]>Q6M.4$),PFD&;%LE
M!M!>#5T7Z8NX\%4DF)0$$CJ#XYJH^.R6XF+CY,C;(?;F/B2&Y(;+ARTG9F[3
M&Z*%+_,1<;>E9:YV+'FYF8(=S-RT60FEBL(ADCEV]BR;V5E'RD@&]:E?^D%R
MYV)K'9,-9Z+Q6T[/QG%ZD<8:/7-.V:S'@=TE@MITBX2^RML/Y&K-?JA\6$J2
M@-&A$7:OO+PX'5[?'-[,ZY67+R4D`1\KD<.:2`:Q01P.SR>F>K.V_P!-=`/3
M2QU.NIQ!](N'AB?=#BXF?&LUK23/E8S01B0=%56M(;$^=V(%A:O1.RT97X+C
MZ^T;1649K5B]H#^J-STYFA&M(:4E(0T>[EV"2""917]\4%45!)WJ#XCXCF)[
MPQC[DQ>?Q,?(:)<H2JC="BN25L!TL#T&@[*M]JR/P7^139D2S3XRQ>H.H=D5
M5;4V)O;J;'I7GM;>D9R\L/$?;6@I"I\4=072+U1I[6.M]CZHFKD6Y[M7U+MJ
MN;#^O=L6)]#A'5AE86,`<#-THR1<IR3@JIES))BD:O)K)R#X/)QW@RX^0AR#
MCQFT)6/%RL9D+&Y-CE>I'91M,0#7W`KF8<L6'+EXC.9L1\3(B$\@O.#+/!.&
M`%@-WH>G+YCN5SMM:Q[;07I`\I=>:PTDRL\Y3U;M!<J;%O'8L6^V?(V^-8PK
M_3]DU\U5@IO_``]KAGTP]D9!N==#W9)(B0"8#B8!`;>0@]:-8<:Q3_*\Z&Y%
MB)<K;M7MN@*EF;J"QL"*DX_*2`<DV0[&25\/;;4;<>=9&/98[;@=;V`)%:RG
M_1OYO1#KA),:G?ZCJ5]TYKVDTG:M^':$VZ8(_LI>`L"1!U_,ZXFX2\1+-FY7
M,FD12-,Y,8R:X"'88-AC2^CSDN:K;,)SCLPMN+-%&$?RDBQL-H(:VH8`&]X>
M6G3-ASPEVE>?*:/78569RR:B_:;G2X-Q<@BUM/JB<0-V\L]6\=X'4\=JFVVG
M46^]?[8LT)MI_)0M'M4946KHTC&.T8B*EG*K:8>'*F9`I"`"*@]#>'0<&1=G
MN3`YC'QU.'`N19&))_F+:,7[P;>8WL;,01<53#D"^W^8XO*F/UF3CQ('5=-R
MR(SM:XL"%-A^&G6JQ:UZ/?+0LK3[Q*(:+J4M+3/-6UW#6],M4X%(UR\W]J1_
MKRBUJCN7%7(M+QQ9`$7$@L9)L"`*F["'$O0<.;!9>-S..BD,N_C6A#MH3(^4
MLY4C6T:(-JG4W[.VMUA\OC+++/D1["W(X,NU1<>GBQ['/9YW.MK6OVUVEI]$
MW<#FD,*O06^FJ,Z<>GY1]#VU1M*2ON-NWG5K?JVVR8V`C."1<253L"E/?HK2
M)C`XZ+E'R>AA`,[),HY'E\N"-9,0\C@Y$$+Z(R8J2(R.!\NX,O2^[J3>YK`@
MGPAQ^%BNSIE;LU7E47=8\C<8RI/4J3J#:PN!?2L)NOI$\Q=F5#E!8)K4W%[7
M6P-JVWC=<-8T33^V[C4ZI2Y34<?>8F<D$)X^O7J19-1"Q(*IE<1[ANOWJ>!#
MD*<8FA>.+"]*5VG3/R9B21Y8\B)$*+U!'E(.@.MP1J*A&3&T21/&@082PD`'
MS,D@968]18=+7`L%-^M7?^GMH'>.B>'=0TKR5L=9M^Q(\EK:R"M>.A(13*OS
M3UTI$P#N73@:X%E>1[%P)'#Y1DD=R)OE`/3J.QY0PYL$4(U;Z8(YMM#-YA<+
M<V`4JOB06MK6KPO5Q\F>9FLGK[T%[E5LNE["YW!F'<"!V52[7_26Y@Z]@:2Z
M@-8\3;^]TIN3?TQ4M<WVVV(M+VK2-VJVTD?:K:Y8TP1@;E04+,0&;?R7:9DF
MI2@H0>@AI\7&FAP^/CD"O.>+;#DO>T1]4RB:(_J9O\-P;>3H>[=YN9!D9/)/
M$66-^27+33Y@%5#$X[`+>HI!/F)N#VSZM'IS;!<>E`EPF\RHWC:#>"C))%NY
MMMBI-)BK<A.I61.*K%D8Q,Q*L(.L//T,<+EDNDH1(OG)=IA`,[F5.4>"&$Q+
M8/HJ)&-G;TT9#(=""S;CY3I;M#`&L'BY1C3<Q-D`*N696**+HOJ,&$8Z':MM
M&&M^RUQ4&M1>FSZF^H*3QBN+><T#?=M\?MW;5MD11+O>9CZB8T/9U.A:PN1_
ML6OZ]B)&RRT>]BSNBD48$,":A4BJ="],LS4DE=!&RD2\=D8LK6L5$KJT95;D
M,5LVXFV[0>-703JF'RV*X/IR9.)*BWO<P>IO!:WEW[EMH0+$]M;)X@>D;N#7
M^U-%V[DE7=(7>O:ZX_[=HL['-I)Y9FZ.PKON6S7R%?PD9,5ILDK&HPDV4IEU
M#E515$Q`*;IW#-C1PXR\JJJ;R<;B8\1-KAH5*O?N!TL1U[A4_+9\O(R8LV\>
MI_FTV3(`"`8Y(HD``-[D,AN">EC?6M![B]'GG;/<7-8\<=5S/'>KP836X7^T
MDB+LHR8.ZMU\L]@J$K&WH^L)JS.(]O77S1H\CFBD>4_02&4.0H".JCQLMEXF
M+)8-#CX$26!M_.1V9[VL75P0!<V5O-MN!4_UF+%-R<^,"LDV=(XN+VA8*$VW
MN$=2"38$D&P:Q-;0UWZ4'*O76RZ<Z<4KBCM&K6:J<;F]TO.TY>ZS=UTC-Z6K
M+.#F&NK8^,C8C]H4'JS85F"ZKQH5-02BLD<`$H[50),CDDE8Q8\N=/DK*G^-
M:="OI]P],FRL=P*ZE;FL"2?;AX'IJ'GCQA"T3_X7EE#[P;7(<:NNAW="!71<
M&_1FY0<<><<9N#9&PX>S:FU[;-C6BE66+V5(*SD\2["](5C*:[<4!-)@HJ@\
M*#HQYE8HF2`Q/'H&7<&_T.$$R4`R4Q1``OF5@+"]S8J-`P&I#6%R+WIS<@Y#
M*R'@F<X\LXE.[1@1K8VN#8DK<$`CL%>H/+:QZ8I3%*8I3%*CYROTW*<A^-.\
M=&0DRPKLOM?6EJHL;.RC==U'1+RP1B[!!^];->KA=LW.J!CE)\H0#PS7\GAO
MGXAQXW"OZD37(N/Y<J2'3Q"V_'6MCQ.:G'<CB9LB%DC:Y`ZG0CM^-4D*^C3R
M5O4?).MP;_TK)6BOZYT1IC5Z]!UY8*I"H:YT_M*M[$=/KPT4<.EY.Y3"5>*V
M(JW$K4AC]W84.O7;+(HY./ERO_%OR$.1,/T%88Y458QU#$REB6)T%N@`$&)D
M#&@3$()QX\/+A3^+=E*H+-V$+L%@`.VL\<>CMM68V@2`GMYT%7BBAR8F>6"-
M8CJ(_:;R/L2P.'3V1K*U_!T#`*8B[D5Q1,0@/0(!"B;H'3,"'$A;#Q<+-NT6
M)BY&/CE#M.R92@:7^)T5CTT8V8BX&U-ER"7(GQ++)DR023;AN&^$JQ]/^%7=
M0;&^T74:7OBC/T@.52_'^_<7+!R.T<XTXVUM*:RU"E#Z:2C[VI%2-^C;<E(;
M-OSAJ\LX/&+-HJ@"4(Y;-UE3E.J0XE[AEG5\\8,_(V;-CDQ-VSR)Z>,X)*V\
MV]U%K,2BG4`&Y.1BY<&#R#28D;#`/U1LQW2;LB%HP+DVVHS7N`'(T)M8#H-J
M^B+MJR<:PXP5#:6F)6B4/<CS8VAWVRHK;86W7L!:8,"7"O+6^A6^MS3QR-E6
M75;*JF=$7:*`1<`,4,I,)LE^*GF<?68T<T.]18F!G#0"WR[D`LUUL2%8:WOC
M0R08RYL4*'Z>?T7*'51*J6E8'1@';5==PNP)U%KC./?&25USP\J7%K<5^?;@
M>,==2FOKA='(.6CF?8S!)!NL1L9=55ZDBP8/@;MSJG,MV(E$PB;KDGN.'%]P
MPY6+.C>C+&JDFVXLH%G-K#=N`:UK>%JQN&DGX>:'(B8>HDK.!KM`+$[-3?;8
M[>M[54(^]%_?U[NO&:`VYO'15JTSQ"F:0UTO>6.J[&TY.HZRUO8&%AJ>MINR
M'G2T/W`OU:@R<NT6/O:K9(#&.8YC@;(P9W7E8N?Y%BW+JOG,9VKD,%>-6F#7
M-[.93LM>7M()J[+V-QV9P^&+<;(TC(K^8P>J4,@B(MU"!`6#60"P!`MC#WT1
M.25IWAO?=VQ^45*OUEVGJCE-IR%E9N,V&XET*OO37LS4*2\FD'DX]KD8ZH:S
M]%`S:&8LVZD>D(=5%0)VZ7!P9,/AO\O>4/F210++)TWOCSX\HEZ%MTPCD]47
MVJWI^F`-]]I-R$4G.\=R2Q%<'%STGCCZE8[S%HAJ%LA=?28@L07WFY%?C;?H
M%36QN3.M-S$VA17]-:UO1+':=>LBNW6DX$]IR%AH-=_KP*3<ZQ`J,YE*`;+H
MEF4ES-EP'I\GY([7C%AXWE^1S%#'$EY"?,37^8LD[M(5-[IM$EK$"^TE3?:M
M:W.<YW&X6*__`(F/#7&;L1D1=BD6LP)0E6%[$C=>[&TP];>FWOC6^V=CP47N
MG50\2+?L'<6VXZJ/-6(3^]QMVXJH>ORM<E=C60DFW85"-?/5G*3F,%M,'(BF
MB9?RE%29J<3CA#[<AX"=MZXO'3XF.1Y?++(TJR3$`,S1LS:*=CBV]390N?-G
MJ>;CYK'0K)+FX^3.#J"T"A&6(7VJL@5>HNAOM(NQ>-$=Z-7(:0TC):HNFZ],
MN'C/@Y(\,:E)5RK7!DR3BV^TV]WK-DL"3U1==VY2A$1;/C)=HJN1[B$`F;,J
MLF]IU#-)-Q3N/TD<<"C@#_VB!;?WMQ-@146-DQ8TG'E%;TH,OD9NRY^OCVVO
M?]$A8_[E@-14O);TG=>;(W7RHMVX)AP\U1ON)XM)UNGZSL=PUK9JU-\>*C:*
MVY=RD]6'T4=S'S2E@*=)!)02B0@@J'4"Y<EO1<SEFS!S&5FJUS;_`(F.--K+
MT8@HQ-P1J"->F(',>)PN)"`(\?C!B2:#S%9O45E/50%"KV'2W2NFJGIN[TB.
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M5HV[0+V8;2"3U-A8Q&K_`**]\B]![UU0^VCK1W9=I\=N(&D:]925R>%M7GG&
MR#)$STNY*L4[SW*U*H)JH$1'S""7])[`S:M([20RV"M_G<6>X'0K&B+Z8_W2
M)-A.@5A?6]6XN3CX^1Q\K0EEAP,S'/34Y,SRJW6WENN[M+"XKN7/I(<B&.]6
M,S7=\ZB#CTVYET#F,K59C7DLIMA2RUR8C9&=K);HV7]R^IG"+54&@&(8X',4
M#F*0!#+>,9\1^'7*L\/'KEI#M\I*9(D_Q-/,RL^A[NM[`#&R9$DQ^42`E9LW
M%BCEW`,`\0508^U5;:">T?IM=B?0'BH*8I3%*8I3%*8I3%*8I3%*8I3%*8I5
M"'[RO[W/])>6U+V5_];V,^FO_(9Q1_@G1OU,VR@[:N;K4W\K5M,4IBE,4JM?
ME]ZEU#XD;%4ULMI'>V[I>MZR:[HVN^TU6X2<C-.ZJ?3LM7F-PNRLO/PRXH.W
MT"],1LS3<N12;&/V=!#,6+,QVFR_7D]+C<:2..;(;_"BDE`9(VM=MVQED:PL
MJ,K$@&LF3$R!#B#'C]7D<@2-#CK_`(LB1:,Z@V&TO>-23YG5E&JFM'\4.=>\
M.5OJ([VUQ78:1KO$+5&HJ%9JE(/];0ZY]@R.Q("NV&M6I;9*6PS2<&E88Z86
M>1,:6!7(ZCFYS+K-5DP*KLL+&E7']RR\E89./FC&CBZ,C!(Y&9B`1)==S;?*
M!'D0/N)#)6'G30[_`&TO'/N@R,,9,DG4.KF50JCR[`C@1LWF)FAF3;L*O78<
M\KCSTT]M70Z^GN56J*MKSDGR4I/'V`I-BXJH7&8UF2QT"\6EW:WES4W5"FO1
MDWM#4*5C]7Q/R7P?](#R.BNOPO6EY6+BY90?5@R9@P%MJP!&$>V_F+;[;[BU
MK[3>PSY4A;CL[.BC*G%BB+`G=ZC//'$2#8;`!(#:S?+:_FN-N[;]1;57'^CZ
M[K\;8B<W=]SME9:M<:^XJJT"7NUCOT97I>:M,DYI)=@/V=!9(,ZT_<G9O9(Y
MD/*%$IU#E$<D?*AR<C&_R_&=L:>&292IWJ(81%ZDF\`!E!GA^4$_S4TL0:@B
MQ)8H,HY^2B3PR+&0PV,TDCL$C"$DAK(][VTC<FUB!'C=?KG<<-$(ZL3N^IMY
MQT_>M:LML7:FS433*5<=,T]Y8YJJ^;=JW>[C6I65E23%;?@5G")2;A9!`%DR
MF353$U4FQY,]\6.=6Q$]$-,+E5>=5=$*#^8'".KN-GD#+NL3:C8^2N(DQ@(R
MWDE5(20&80L49PY/I[&<%4;?9BK6^4UK;9/J?[7A.0$S!5"2J;_31.:G#[4T
M(]&L@ZEW>E]Y\/YC?5K6*X]Z*HK.N)]HD=JOV@9!#JEVCUZYC1328^1BQ\E\
MJS<RLH7NX]08MOXDEC^K3H*V4.'CYO&S96%<R-Q&/D1DG3U9N1&*=W@(S:W8
MVM3+X'^ISK;GY8;U$:WU7LJG1--9+R3:TW&2UJ\CK`Q2G#PB1B1=0O-DLU<=
M/#D%9%"69,E#I%-X=Q1#-G'CR/QT?(-9=Q0;3J1O3>/,+H;#0@-<'LK2S2)#
MFOA!MS`OJ-+[&"DV-FL2>MK=_45AVS?5FUUISDT;C/LO0F\ZA*R,5=Y2EWB7
M2UXG6[XG1ZS+VAV>`B$;RO<T8V5:0JR3-\[C6[118`*)P\>FIBSXY,/E,ID*
MRXL$DS1FV\I'J>EU4E?,%8@D5L),&1)N/C5U:'(GBB$@N%#RL$`UL6VLRAMH
M-KUJ75OKI\?+_"V2T6C2'(?4=6B]"V#D+5K!?JY5TV.RJ96)E*N3#>D!"VJ4
M6?2*5@7*T2\XJ*2R@]2F$O01R\F5<7%R9WN9XVQ@(A_B/]6=L!4=/.VFI%J1
MX,TN<N(EO0]6>-IND:-C`M+N/4;54MTZ5LC@MS_V;R[Y0[^HMBU+>-):_HVK
M--7.GT#:U9BX/931S?$K`Y=R\J\AIJ;CI"&GF#%JZ8@17JDFH)3@4X&*&5C8
M\GT7*39+K]3#G&':.L8$2,4<?QAB3<7%B*Q,N2%?\E&/&^V>&5RY'ED"N`C1
M^%B00;&XU'2M:VCU9F>EMG;QIULI6W-\R$7RO0XW:SH&K-7TZ$L3&=<T>5MS
M2*:R#S:<@:]-'@1!TPD%V\.LFH<`,V!,#*!KL+)^IPN+*Q,^3/\`6MN%@-N+
M*$8%;D+93<-N.X`DA20M;//X\8QEF,B1X\>)B2,"2UVR6V@@V%KFUUM9>@9J
MTY/^MS)S-QXV734_'_=%TUCL6A\E'>Q=*1--K;[=T-<M(S%<CW`*NU;2WK<3
M$P39XZ7>'%X8AR`4H#W@!1J<F+'EY&:>59.,7C<?*21?E19)9%=G)MH`@L!K
M<Z7[+?H'.$$:%XN5')#'*,#=KPM(JJ!^ISMVDV%O"NGY">L5:V]+MVU>/;N2
M4A/\!...XZS0[5JB%=/F#7:6RIJJSZ!K.SV"\>SMC7;19VA(WZH;MFRQ"JIO
M%_,$A$SS8G)08KGUHO\`.<?&;8-3%+C"?;&-=Q:XLY*D'R[2/-67A\?!/A";
M(A:*;Z+D'())(DQ=JKO%AM"L=0"VX7OMM8[CL'K`L["UJ#"!UCNS3>TX#D14
M=6;&T9L365/F+]86%FIC^WPC)FJ79\5&U./M[))(4)5(\FX:&,!3,C"8>V1Y
M"L\4T(];&$69OC&A67&B:0QL^NU@`&%E8./U`:UKL'%$^-F)D$1SC'QY4D).
MW9-/'#Z@0#S@EB+%DMUU(VG6E*]?VM?L)J::VKQ,W)6+ON2>NB-5J\1.:P9P
MYZK5)=&+//M[3?K[4&,J"3AR5LHD0J3I5RFIY;<"=.N5C(N2W&PQR@S2XL<S
MD=%$KE4VCYF5K7%@20"2!<"L?)B;';D7;2&'+DA6_P`Q,8!;=^E6'ZA>PN`"
MUB:]",4_+*QD=)E;.V19%DU?%:/DRHO6I72!%P;NTB'5(FY1`_:<H&,`&`>@
MCB6,PRR1%@2K$7'30VTK'C<2QI(!HP!_/X5S\CJ^F*4Q2F*4Q2F*4Q2F*4Q2
MM%<G=U?[./'G<V^?V9_;/_"/7=FOO[*!,_L\-A_9R-6D/JD)SZJG/JKWWR>S
MS_<W/E]>OEF]F8')9O\`E^(<KTM]I(UM>W^)(D=[V/3=>W;:UQ>]9_&87^8Y
M^-A>KL]1K;K7MH3TN+].\52/N/UX[7Q^I6H)S<O$:CZ]MFZJ,ZW!4*M8>748
MUBE]0HLF3AE)?M6312HJ;)FW+WRF=:]P*FH!#&/()CT(.;EN,//R^.?S3XJ*
MTX75E+L1&L0T]4E5=G-T"64>;<2N)BQG+X_&Y!&58LB3;%NT!VCSM(;?RU4E
M0+!R;L=-HW9D3UWZ5,[=T!0ZYIFL0U)WIKG5NPV&PMS\@8K3SA1+9+E=JO"T
M"O.];6:'V*]J;EN*#PXSD207(@F';U`V9.+`V3R/(8&X`PR!$MJ\@:)94?T]
M"J-N"@AG-P;`VM4.4RXV#C9A;=N5]UOD1HY&C9?4UW$;=Q\HT(/0WKJ]6^KG
MRBDVUZBK9Q$I]OV7/\Q;9Q;T%2:;O%M7H>:EZPS4D)=M=;5*4*;-`QU=BF2B
MZDRFT=E?J*E(1F@4!-FJXS)?D,+AEB7?RV1#D9$B_*B8^.P61@=2661A$J$7
M?Y]R@[1L^3Q(<++Y<B4CCL>2")&M=I))T#QBUP`'2\K&_P#+`V68C<<TKGK+
M7S9%JT;J_4_#56Q;BV39]X4K8](MV_XVCQFI;/H!Q$#>$DK:CJJT-KO#*14D
M=RS=$;1BBPD(F*!14$4\J.:"4KE12'_)_P#+1F&8BS",2O%(OI:W9'0@6>S>
M%JQ6QIHDR8IEMR<?()B>D-5,DD1F0^II8,EOT:7\-=?::_\`]!NK-P;Q>:EC
MM(*G92+79*-$_9/;4==-LSECUG$.I5]#VG3R-%AQIK.R?5KI.(=)3DL=UV)B
M=!(5!*3!GY`X_#9W*G&9GCQ3D*BG=N3>JA6<#R2!&$CJ%<(H?S-M!;+3CU;E
M(./^KC6,SK$SL;69E))13\Z!@4!)0DE+JNXA9Q^FCZCC/U#J;>K/^PVO-;2M
M+<UD'%/J&^8_<UCCFEFCW;Q)O?(LNOM<RU"L<<NR4;KLE6KM#SR*$3='.DH4
MN^DQ/3Q(LE9E<&1D)3S1W`4@K)^H,"2MU4D"X!%:7Z@?628C(5<)N`;RO;<5
M-T[-MA>Q:Q8`VN-V8>I9$[BC>+NW-T:9Y';*T'9-`:8W1M-!E0X76\S&;!DZ
MI17EE@XBX%OU+MCA&)9O8`2_]7'9+&(Z5[CB()B3S_)33883,CD)4R0Q;#;;
M_-GC0O\`Q;@K&VMN\&M_P^/#GYF)QDL8'KY$8]07WJOF!5==MFW`FX)NHL0+
MWBC5.?NIN$G'=,.2W+NS<C.2=ET5%<FX75-V0HE=V/)P$Q2$GR-2I:-&H]6K
MY*\XEX)\9!P^*X=)F%43G.4A"9N>4ECAGY'C^,Q_7R,/.CQFL2&]3)FQX(%D
M.JJ-V3!JJZ"2Y!Z5IN.@>8869R.1]/B9&,TH)%U6.$3O+(H^9C:*06+6)CL+
M7)/#W3ZN^T.+^DDMB\H.%Y-*76S[,HVO-7PTUR*A9'3EU1N]'G+Z%AD=YHZM
M:+5=&L1E<<MI1M^S+Y1!\=!,AE`4.=+&R94AS<7C$=#R3-/O1SL58\<0[Y$:
MS>H"TZ1H-JEI-RD@*6J?'C,V+D\@RL./6*(HRC<S23-*J1.EQZ;;8GE8[F`C
ML=20IB?>/5XV#O\`9\:-@<?YO_"V'M&K/4O9;2J4-+US9%><[,XV:>J\]1YF
MLWIU6(M:RU>,FY,TA%O081GU@W7*+AH4/T88O(>M!A\_EQ2MZ8X7&R(KKM:.
M5\TPRW%SJ`I47)!6S6!-AL^%BQLN7%Q\B)#,.<PL=]K%@T,R2.5N-MBR[=XM
M=&!4,0-QLSF.;5OTSP8XB[>?TEQOC>O(>/XXZYIU--9HS7;:][>W+$PJ22\Y
M;/J"<85.']\<KNG3E*+=`B0O0B`A^;NN;00>YCPG'XX+RS9&P%K!8\>*2>5B
M2&/DBB8@?J(`N.M:+C-LO$Y?)YV1LA@74A=Q9Y)A##&!<:O(Z)>^@-[,;*=,
M7WU7MJZ@:5^+W1PCL.K-C6ZFSKFH4FR;D9JM;9LZO;=H>L7-&KUEC-9/$Y*M
M3$;L-E-14Z1I[P\02<)'BT/*\TV'&5RLN/"P29,EUP&5&\C[,K+;%R"5NQ#8
M>U96&HE26+S1ECMR&C>*"2?(**BOG)N#71FQ<$YL`5B!?ZE4FB)L/1>%S_-%
MJT_5?5PY01DYNNN[!X@U2>NX<TH7ASQXU_2-X-V+>;OSZG.[-(1=[N$Q0%C0
M\+"Q<2+YQ/IQZ_G*/@;IQR0(&.:W"$O(P\9#QP$_(Y,F=(;_`,N-,3!:-9Y;
MV<[HRXLFOJ%[[D0:7YXQ^/ESI,QVBP8,;!MIO=\G.C,D$0%U'\P;M=/26.Q$
MCFYT!OKUN;OK;=^@)N;ITCKJ/@QY4:CWUQH=6ZMR<5-\A=52U:JU>@8O<)Z@
M19:L)SLKYC>83C6A3M#BJJSZAY>1\<9,SDY(<8>JN5@XWTZ2?RBD[Y9@F#_-
M;TMKACJ"%O92;#8208T7`9D^4/2S,?DD5W0&4M`<:2<;%\H8R+Z9`T()MNMJ
M9`7#U2]N:3WUR.I\AI:P[;M$/MOA[IRLZH;;PJC:F05KY`0%E4<EHMB0T##3
M9F+28CTTW"DNN^!_\E5(6!"F2/9A2MD#&Q<93+)/R69`KOY+""-7!;2RQ]>H
MW(MV)<^479N"D/&X?(R%8U7B3E.J`ON_GK'8G<;L`UPR@*?EVF^^L?N_K[,-
M;:S826P^-4!K_=BF\]E:1F=<WCDA'06LH)[J^NUVT3$ZXW>GJ.05<)R<=9FR
M+%L2L@99Z/E"H4G14;%SH,B/C)L%O4BR,-\AMWD90LSP;$7S>HY=;VN@"[C>
MZV;'GXW(PSG+G#8\<D:I;S!Q(F\,3IL4+>_S?I[SMM\X4<KJAS:XU:YY(TF)
M<0$/?$)M)>`<R3:94A9FM6"4K,W'IS#1!HA+,B2<2H=LZ!%`7#8Z:@I)B82%
MVV5C?3G'8,6BEB21218V8:@BYLRMN1A<V938D5J8I?4?)B.WU8I"C;3N6XL0
M5:PN"I5@;#KJ+U*K,6IJ8I3%*8I3%*8I3%*8I3%*8I5"'[RO[W/])>6U+V5_
M_]?V,^FO_(9Q1_@G1OU,VR@[:N;K4W\K5M,4IBE,4JO;E1Z;VHN5U^=;&G]G
M\@=33UBULUTYLQ#1U_AJ;%[AU6QFI2?8T?8S6:IUK6=1;.0G'OEKQBL7(`FZ
M.3W@2]@%QHL3'27+]6(2X.1)')-COK#+)$%5)'4;7W;%6-MKJ&C`5@0!60^5
MD&/$,,IASL=76&=-)HEDU9$8[EV[KNH9&VN2RV+&^Z=(<1M3<>MA[,V'K3]H
M8U;9U7U#3G]5=/8Q>I5J`TG2TJ'36E4:(0S68:BI!H%%X9X^?"LN'<3R@ZES
M/:>61N3>5]TF7F')<G_UAAB@LMK`)LA0@6)#%M;6`PQ#$B\9'&@6/$PQC(!T
M],333W:]R7WSN+W`VA=+W8Y-O'CM2M_2.CY.XREIC5]!;MKV^:<2LO8EFC)6
M^M5FWU1C&V4LI"3)WE;5CKJZ.JBU,S=&632$K@I2G(?'A40<A!R2?X\<$T0!
M^7;.%#DCKN`4;=0!K<&LGU6^CSL*P]+(5`Q[0$E24;>P>:,`W!\I(%C8C0N\
M_3CXW[C0K\A5(N4XQ;$JUZ4V-![EXL1VO]4[4;VAU%34'*.WTXM1+'$V!.8B
M;"]1<EDF#PP^\'.0Q%![\A3'6)L4X\C11PPR0JB':GI2^EZD>T"P5O0A/EVD
M>DEB`+5(<EG7*&1&DS2NDA9P6821LS)(&O?>-[BYN"'<$&]1QVAZ*7%S;$KK
M"S6/8W(8UYUQ14-=R.P).U:VV)<-I5UO9I>WIALJ1W'J;939R_+.V!^H1>%0
MA3)(NA03`B":"261`D&-F-E0XL:PLL0:*Q]-S#&L2,QOZI<QHJ.WJW<*"Q)`
M(A>267$7&FF9Y%DE=9#\Z^LQ=D4"T8C#DLB;+(2=MMS7W%->EWQYE]@GV*C8
MMJP$D&\]&[_:0U=FZ;&5V,MG'[2CO0U'A(QH%"6?,ZFYISPR[Y`'/OAY$I5$
M'3=$!0&)(MDT,XD8RH^<P-^WD`!-T[$L/2M;;^K?61'F/'B/A+$GH-A18QT_
M[N+*&6IZVWF068VVE-`H;S5Q^,'I<:&XK\A;QR=J]XW#?=I7B`GZPX=;%D=9
MEBH:%LUC:VB8;Q[/7&K=<NI=XZD6*("]FW$N^$B?45A4,<YI\,C!PY,.%1M=
M$1F/4K'8J-HM&NH!.U%/8++I6'F7S<F')F8_RW=U4=`S@J3N-W-E)4!G(L;D
M%K$:44]#OB4.^;1R&0O._P!I<[3;;S<UHY&T:V5@HV4V17)FL7!LP7>ZG=VU
MS%2<=-&$B#^5>@U513,@*8"J537X_'Q8W&3<3'(_TKP2PF]K^G-?<M[6)5B'
M1F!8%0"66ZG/FSY9\Z+D&1!.LT,NE[%X&5E-B38-LVNJE5*DV"M9ALC\(?BT
MYIU$H<U-;=L59H'&JW\6HMC*V>K)*2%"N5@0L[R>E7</1HEU^W$9+-DSLG;0
M[1HD!`[VJ@^.9&9`F;)G32$K+.N*+J;%&PV+0O'ULX;5MVY3864"]Y4Y;)C.
MB(5.7/D,""0QR4:.6-A?6(JQ`&C#^,UM+B5Z>NNN(E[O>RX'<?(?<EVV)4:3
M2)^>WU=:E<'B=?UZ21;55K&GK>OZ4+,(^.D`:]H]Z9D4$Q[/-%513,6=U@RH
M=JDSY!FD:WF:0J%+$C34*.SX6K52*)#A7)"8\;)&MSM5&(;:`;Z`C0]3<[BV
MEL?)Z8NA";M=[Y"W;>_:]YR40Y3*QHS],_9LNP6]/EZ22'39_L"$H%.&*FE5
M!;B\%[[P4AO>P(`IFQ,.%<*+%BB)*Q19<8OU(S'#RDVMJI'\NU@!\P;K6QR^
M1FS(LF&55"RP8\1L#?;C,'C(N3YB1Y[W!'RA>M=!J[THN.^I;#!66N7/=#U]
M7XWD3%LTINQ4=RT5;\F7K%]?#NDV&NHU8ZT2JP($0)%"%0*)O>`=#T$,5^.@
M?BLKB"S_`$TW'1X3&XW"*)W=6!M;U"7-R5*VM9!J3E9/.9>5F?721QB7ZZ/*
ML`;>I%$(E&K$["HN1?=NU#`:5K!YZ)G%AY07FNQV+R):Q#S4>L=,C(L;CKUK
M.MZUJBY3%YK<HS?I:K!)M97$Q-JD=."I>29`A`1114`5#94T(FG3(+LLJYD.
M2-IM:2"`0(._;L`+"]]^H8#RU8>8R3ZMXHR'3+4Z-TS6#2_J_219.X?-OK-:
MIZ17'JNRD3:9O9W(G9.P6&[ZOO:3V9LB\4V?O%KGJ77E*M5ZI9'[37$3&JT>
M(A3^41NT:-'QA*!CNS&ZB,B`1M"R*!M&1N`&DCY2&.660=K[39=NU5L!M(TK
M7I/(D65"?,)8(803U2.&59D1.EAO47W;K@FUCK6M[EZ(^@+UJUCI>>Y"<L7&
MM(JX6^V0M67L6A9=C`HW5RHZE:O`!8^/4V>%@6ZBQP;+-A2ETR&$IGQPR)((
MUBXV%QO7%QD@4M\S(A!7<R[6OIKM*@]U[6DDRY7GS\A`$DR<AIFV]-[WN0K;
ME/73<&([^M[;:%2*_K6DU37U4;KM:U3("+K4$V=.UWSE"*B&B3)DFN\<G.X<
MJE02#N.<1$P^.9V5DRYF1+DS6]5S<VT'=^[_`&UK<7&CP\>/&AOZ:C2_74W)
M/Q)^'=66YCUD4Q2F*4Q2F*4Q2F*4Q2F*5K[;&KZ;NS6EYU'L./7E:-L:LRM1
MM<:U?O8IP^@IIJ=G(-D9*.6;OF2BJ"@@"B*A%"#X@(#F/DXL.9%Z$ZWCW*W4
MC5&#KT[F4'QZ5D8F5-A9$65CM:9#<&P/9;H=*C!M7T\>,FWX;4$38H.^UYWH
MNK(T?6]LUIMK9.KKY$TU)DR8FJ[R[T&S0%EF()PG'('5;.G*J2JR8*&`3>.9
M<KM-R,W*N?\`BY0`]M%<`[@'0>5MIOMN-+L!U-8\/\CCH^+C'_!H^Y0=2K6(
M)5CJ+@ZV.MAW5U.T/39XO[EEZ/)[%:[?L3*A1M6C(VI.N06[/V$FTJ<LFO!N
MKI2?VY&MW24352*99W)-W#AR(=53G'QRU2%S9.0**T[2B0;@&57``#(A!5+6
MN-H%CKUO579GQ?H][+#Z9C.TE69&-V5F%BP-[&Y.FG2L<L_I5<-+:KL9>4IU
M[06V7LA+;\FM#;@VA`JUC9B0=AKKK=6'M+)37$^Y1$4EG$,+,ZR1A*<1#PS'
MCQHHH,:!`0(9975KG?\`SKF5"_S&-R26C)V$V-KBIY,J65\AY+'U8T1A8;2(
M@HC.WIO0(NU_F'?K6Q-7^GOQ3TW.Z8LNN]=N(*:T+'[#84!^-HLL@X%3:P(A
M?I:UJR,HZ4ND_8SMRG6?28N7/?X@<!',HR$RRR;5`?$7%V@`(($8NJ*@&T#<
M220+FYN:QK'T/0+$K]4,@L22YF"L@=G/F-E8@`FP%K=!72:T]/OBIJW9=TNN
MLVM^K,G8?KX\_KR`WKM9GK&%=W-,J\O)1.HF-U2I56E903F7*Y;,$%@45.J0
MP&,)LQ4@C7C)N,4L<-E]/YF+(H;=MC>^Y-IM8*18`#II67+ESR9\?)2!?J[A
MK[19R!LNRVVO<"QN#<W/6L]XW\*=$\6)V^6O6#2_R-OV4A!,;;<=H;6V-M^V
M/(>LGDE8&`:V'9-DLLI&U^+<3#I5)F@JF@518QNWJ.9:2-'C-BH`(V<.U@-S
MLJ[5+MU8JI(6Y-@QMUK"DC$N1'E2%C(D;(ER=J*S!V"+>R[F`+6&NU;]*WUL
M_7-3W#K:_P"IKXQ6DZ1LVEV>@7"-;/G<8XD*Q<(5[7YYDA(L%F[Y@LZBY!4A
M5D5"*I";N(8#``YB9&-%E1B*9;H'1^MO-&ZNO3N90?'H=*R\3*FPLF#+QVM/
M&P938&Q&HT.AK'IO1NL+-I1YQXL590G-1R%`)K%_5)-R[<I/::G$)P9(QP].
MO[^HH6/2*`+^9YP'*!^[N\<FY!1RC3-F>9I)`Y(\I#A@ZLI%MK*X#*18@@$=
M*BP)'XQH'PSM,>@OKH0000;@@@D$'0@D&H6-?29X1Q6NK!0UJA?G2$S::K>G
M.Q9S=VV9+;\).4&)D(6H.Z[N.1N*VP:LRJ\'+/6C1!G(H-V[9XN0I0*H8,2L
M&6%F;8\<K2;U.QV>1$C<R.+,^^-(T8.2"J(#\BVMB&QL@*@9)85AV$;D$:NT
MBJB&ZIMD9G&T`AF8]IOGY_3RXL6.OZJ:2L=?+NTU92]S4ZBV.T[EV5=YY:L<
MAZXSK6R_K2VV"U2TO9E)R`9HI-7#EPL9D4H&;"F(]<IE1)D_7+-&!]1BQX\@
M`VWCBD]5!I:S;_,S?,U]214V'E387I_3R'R9:9(OYK2Q;@AUOHNXC;\O>-*V
M=L'AWH39_'VK<9+=5Y1SJJC,:.SI;>,M=F@;74G.MP8A2IRN7J%E&-MA[+7S
M1R1D)!!V1T4X";OZB(Y?G,W(9J\CD,?K5E,@=3M(9@0UMMK!E)5AT*D@Z5%A
MM]#!/C0*/IY(V1E8!@5;4W#7U!U!Z@@$=*AC9_2XH"%SX=U75M7HM6T!QOW=
M-\D[?(V.Q7JW[MONUW,.^9M0=RLXE(H3[>P2Y(Y[-2TM++/UO<$TR(B!0,-<
M61XN:PN2D5%QL+C9<;'CC4*+S%K[@``BPD^O&5W%IR=P4>:H\A$?BL_!C+-D
MYV='-D22'<=L:@>0G<6:5?Y#@[`D-BI8^6MT[`],#A_LZ>V_9;=3;DYEMUW^
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M)5UL_,5R4P'3>=Q1<^8(!F2)6.3]4I'U"S33$_W\E/2E8C^^O?\`JNPUUJ,Y
M$WT"8!/_``0Q?I@+=(O4$NP'P8`@]0!8::5UUR]-_A';$YF-DHN?KMAD]QSN
MXCVBF[JOE"V-";,N]<C:Y/JU^XU6V0]JKK6QUR%106C6KA)LNB4WZ(0,;KAX
MV-!C0X$.,2L>/')&EF.J,YE='-_.H=M]FOM-CI85/EY^7F-DR95F]5(MUU%K
M0^6-AIY2-5W"Q/0DU-#5-;H>NJ76-:T6P.Y>'KD2HWB33]ZEK_:'K)N\53=O
MY2S668F[)/+A(*'*JY<N%3`I\@3!T`H9TTSY$C2L%O9?E```M9=!8:@=>WKK
M6N6+T1MLWS'K>]^I&O=W=@K9V15=3%*8I3%*8I3%*8I3%*8I3%*H0_>5_>Y_
MI+RVI>RO_]#V,^FO_(9Q1_@G1OU,VR@[:N;K4W\K5M,4IBE,4JF?F5S]WSIS
ME/+:0U9+\/\`750UGH_7^[[Y/\NK)<:<ILME>MC3M+4J^J;-7K%&Q=><U]C7
ME%5W[R-G"G>+D1]V(!!.>#C9UR9^3DR;##QL_'Q?34VFD,\<<GJI<,NP>J(U
M&WS2*R[A>XRLW'$.)@B'=]7D8V1,)"NZ%!`67TW`*L9"5WMYQLB9&LU[5$;=
M/J5<Y;'%\TM+ZS:Z1UYMSBMI??VR]@75K2KG/I-ZFDO0YKCG/:Y,^O[B,;SE
MUU?<7;TZ[]I*M3R,;YH-FR)A0+AY$DI]N<ERLTC1_3A,>55&R1,U<Z:*<#<#
M:`8D!=3\ZR2*PD9+7S,"&%_<7"8$022/*D,R;KLC8C8"21-O4(KR)R$B1R@6
M5H5=`@<%QA,AZN'+S7%!\H9WA78G/'GBGHW=VV'][D]BL;9R86V&P*X5@=#"
MTO\`[O%66/CT`:/WKU.P$7GQ5`K9%/HD&]SBD?*<MD>ANX^'E8\$8\/_`(AI
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M(9>3YL/&R.-@LH`=AEP8Y)O;:#&9";E264`&[W<Y4O%')Y<8&*Q^KRN2Y.(,
MUM@.,\9C+*H6WJ%R&V`(NA55`VG<%N];'DJ3EG$ZCH/'6$F]=0A>/25SA_V(
MND[=K-_C7KVDWF6FZML5GL2#K5.C:HC=!]V;NJQ/*29(TY?.;F7*9"?!C^JY
M7+@DNN`O(Y&*-+2(L#O&)7.H?U&57"*B6A8-N.[RZ++_`.'X[!E37,?"CG8]
M4<N-WIQKH1:QC9B[6E##;9#NNJYP[JVUH'BQM';^C:56;WL^JP;=_5ZK=7Y(
M^"=.5W3=%<[]$U@JCF549-E3J$CV\@T=/5"`BD<#F#-=GSRXK8BQ!2KY"([6
M+;4)\S*H*ER!T`/;N.@-9G'PPY1F]8LMH691<"[`>52Q!"B_4GX7!(JA*P^N
M]OZ.X]4&7KE(UG;=_6G=]EU1:O=]%;>BJCK\("IL;8T:R.L'V[#34U.3S9R<
MB"C2Z^[ID(90Y`,0439.2X;(XZ+!UB>"9W8^8%X616C6VS8?YB,S$.`-!NO=
M8X(@,?DI,L,)HG@"J-++/OM(Q\VY;QLJ@;26ZV%MVU8[U=.86P(K2T%#TWBA
MQFOT_IG8^WMCSW+Q385;US8$M?74:DG":V-#7Z'>P"UA:D^L!4>O9OZO2/Y9
MB.!()S72.J3YDA95Q<?&Q9'C9K2LV0TBL$:UML?IGS>F;[TZ7UNB@5L>$>=I
MY<J6))%7^6%CC1P62Y8LV\`+O'R.;]@[VP^J?S38$YM[?@JEQ4LG'_AQ$T5=
MS7JW#[7LVQ]@R&Q-7URRQ+FMWYG?F%/7K$/9[$1=9X:"2.\ATQ(FFBL(+Y!+
M+)C\;)FRH1))R4N'$"I&PK,(UDF4G4!3=E5E+,-&0'2:'%CGS.-PT>[/QL>7
M(00P:_J;TBT%B?3(0MNVWN=UK&'MS]6WU%-P<9;=-0\!K_0=AJ6X>/K8VY6^
MM+G4:G9Z)LBQK1<G7B05CV;?WU<6C)`K;W]\69*H\C!6%N5H<>XN2\3#+]N!
MY-B/RBP2*Q\L@(+1L;6*QW0B6,,6-U&\*Q!QH&B.)SSA"[KQ<LR$#6,JR*P!
M-P\C*]X6VA5()*D@$2!J_J";QUYL+8^KM<1O%>F;(VSS#F]<O-V[7L&]I;CY
M'GJVD:C=96Q/XF?W;*/&;FU+NSMH=A"2D%&%3`IS(*K>8=3!XV4Y&#QT.*!!
MCB/D)MLQ);;!D[!$K$[C*=P=RQ95"ML15LHVG,XZXS_4S,TTIQ\!`4"@*9A*
M2S`+;TU"[5TWL[`/(=*YL!ZM_.[;Y*=`::UYQ.C+.EI;DCL*^6>ZQVUK%KVP
M2/':X!`.;!JP]=V#`2;NEW1J42-$'2JZR#GN$SQ0B0E4NFRMF+G\IZ31X,/&
M8^7Z;C^=>62:-HR191N]+U(W*@!"+ABP(QH\#7&Q"XDRWYAL+U$(]*WHQRK(
M`;MH7V/9CY@;`6J]OB)NF7Y&<8=%;UL$/'5^=VIK6L7.9A8<[E2)C9.78)K/
MFT:9ZJN\]Q(Y[O*!5110I!`#&,("([KDL:+$S9\>%F,2D6W6O8@$7M87U[!6
MHA,I5UGV^NDCHVV]KH[(2+W-CMN+FI&9@U-3%*8I3%*8I3%*8I3%*8I3%*8I
M4>.6MPV%K_C-O.[:GF:?7=DUC6EIF*3/7]RS9TV(L+2.5/'R-@=21B1C=BT6
M^7W.A!J!P+YP^5WYK.8FGQ\!Y,:4))ZD8W':+*TJ*^W?Y-^PMZ>_R[]N[2];
M#BXH9LZ*/(C+Q;7-AN-R$8K?;YMNX`MM\VV]M:\J$/ZO7.J,X3;`EVNWWVS=
MQ1&^=84*V;Y_8WAG(5'4=)O=4L,R[E*U>M87ESQAFUT9N";L_,LQFY8P'O1Y
M^D.D"6QSF5FX:.#=!CO+,KRD!2[(J211#U?Y?\P,VYXV.D;1J/5\PQL-!_\`
M53*HEFCQD=$4W"AI&C>5@A]0;"!9&`)WI(08P0VS6_J8\ZY[1/&1IM7E1J[B
M-";`N>\(V;YTGK'&O>,/<HG7;"L+Z^AIJ(UU/;'T95;5:_KYV:128D0%11B!
M61"`54BB?RY2K/+],\?%^NL>UF&5-ZCIM0[3(0J*DA6(%V:3RBUE-^+&K8LS
MI"9PV9'$7W*IQT90Q9@&"G<Y:-&DLJJA,EB=XW5#\Q_4&V5N;?,SK'E!'V:A
M<:^'%`Y%,-6UCC)`QD?R)MR^N7LRXAFY=ET^"W/1:_>)EN1R=(JA)!,I@39^
M20Q<LR7GQ>-]T<JV.;X_(+`D1((A25(B9&93=AC!VEV,0S!2LC#L8\6/DY/L
M_CQ-_P"+Q)I7E&C2M#DR(J`,NQ3,%6+<JA%)W@'K5?49ZAGJ5<B.'?+]W,\B
M62,+5->T'9;C9U3D>(+;8^L73G8L##VO5W[+:(OTI:*]2EZ])"Z%[8(Y"P)&
M9K-W"H)JG(,/(P"'CL:>2=FQ8^1Q8_4N")DF98B)&C'I`J[I*!'Y7%U;R&PG
MXU]_(Y<2P6G?#RV"6_P6AC:52@<F1BX1X?/?9N61#ZB@F14)S#W-KF>WRXI/
M*K6[*)N=UX3:_O7J`FT9J&41U_2[1QU=V.9VG9&<#7TZ_:52V&$:P39:PKR$
M;'%<=A02_1@3/R#?,;#8#!PWY?-N=+,8HX6CB&^R!LG<S[SYMJE5-RI6V1`G
M`\3FJC9.6G%@A+N2H;,F1Y++N8K```406+N)&!`>^V*CS3]1/?5MX>Z-UERN
MK%8:[2V+SRUPERUCN/\`KB=C.1NO./\`#:[D-9;W@=?6&*-7X:2?'F'Z9/J@
M[:OO3G%8&[EN5(N84\F2<+DN1DQ_IGQ_;ZYA@-[^HD\T:."XWHF8D<<C+("T
M2R-L2-K*N+&((H,]5F^JBCYG%@$PL/Y<\3R3Q`+Y';&DO"&%MQB%W-V=I\U[
MG'L=?T9:CR_V9LMY0ML6+4<*E,[:I6L*=<74)<IBQ%IB5W9T&U3=1UDU4]Z,
M5VLI+.6M=CC"9=PB9JF+8TWN=DQ<GC8L!C!]3)BA1Y2-TB+)Z;22G;&DC7C:
M5K[%?RD/M=9N/PY89^=QLRV0<$Y:L;,"1$S)O5(QN=DT=8U'F*C>&7<#5MQ2
M]0#U)>3U8T?J5KRBAJ7LB[\T>0VB)'<LEIOC]<IE_K"K<84=OU.;D*O16[S4
MDE,1,HY47B7T`Z+%OP30%R>0;%5(XLG=I<>#)C;TA'Q6;-*J@_XV)/$$4^H-
MR.V\13(5`2)S(BB781"RIC_YN+F5$GXTQL2H(CRI)8Y=NRZM&5C]2,L68L67
M>JVV]),^I%RTV9QJT1"[EY;4'CNUMW''EO+W;:TUHJKV-KRMV9JW<=BTU"Z:
M9Q2+1E$TN6FJ6U-,+%KA8Y^+@ASHE%N!DB:SGFBS,/E)%PMZ?Y9Q\L>&"]YS
MDK?(D5Q_,M`R+Y4)MZUV4HK%-LF#+Q'(Q8#YA#Q\Q-$^;Y`(!$J2PQ%&'I?S
MO48;G%RL`57$S@2V-W9_M2)__P`[U)L>FMAS^L;[6N`6G[(RM-5:M5)PL;$:
MYJSV?BX]P[,16(-,0J:[<SQ`Q734B@G2$#@&;;[@,T69GR;R,<92+(M[;T=U
M0J2-0/,+[>O3H36-[."39\H=092^8R-;1'5IG5PK=2"N@;H=>HJ"$GZJ>W=*
M4_DKK=_S<@M@6^*X^\#;)P\N"NM]4M'.QG]\D"QF\K'5&,32I*&MJ`=@LWQG
MJK]M'*(&,E[NIWCFTRF&9S(QHTOECW4()@!;=A.L+(]@`%2:[R!TL4$B*&`:
M('7\;#CP\;[>DG4I#)[?RI6#%CMRHVF2*.Y.YI(MJJ5_4$:212!(PZTW.'U/
M;KM39D73^8E?J53EN37.C0-3AI/CEI^QOM=PG'#2+3>U<M,/+_4T4>?GU",S
MPB*4LD\:)MW*KARF]6!'R?)Q964?;F)R$LEYSP3Y[,H`8MC\E]-LL0R?SPZQ
MRL%`6%`852?=,VUDQX/\UEQ(HP$'(X^,`VXBV5`26)#!OY-C+&+^:7RR%HOY
M==I=O5(YAO\`7&I;G)\L=?\`&>QQ7##4>^:939O155N9^?.Y+0M-(VK6T,XD
MV!W%>1;/8%JR%C4"M)5):7,H``F"(I;O*D:'FN7^CQ3D219N+##@#=NEAF@B
ME:<2`&0;I))(%8MZ49@+2%;W.`^*L>-B8>5E^A$4S?5SR!MCDQ\B2%8S&;1W
M$:).PMO<3!8[[&"V/>GGMSFYR@Y,\E;OMGD$ZINH-(;*CZ,7B:WU!JE0C61M
M&LH"S.8J6VPE`M=@)%HD])G31`KA99V8AP76,3L*&:F/!C8^?,9_J4/(9^/$
MWR@)C9)2.3RVW%H]+'30,;F]\+(EDF?B(UQSC2MQ>#DRK\Q]3(C=I$(>^VS)
MV:BY`M:H^>L7M[<FCN8W%K8FD&CY&UP_'+D>$O=(Z+KEA>ZJI"\_K%*Z;2:U
M2T>=%VQU2*\*[U*/.W=E743+WH*)@<,\[QLJQ\_SL<^4<?`DCX])I0H8QQME
M,&T(/S7V[B+("6)`%Z]+Z3R^V8A%B"?)7/=HXRQ4/(N),44E2&.NNU2&:VT&
MYJ)6U=@&O/+;JTML#L.!8\Y^&;F"V(PIFN:Y.W=M,:"MCY2P629H54K)K$Z?
M*#WI@Z\TK(@BB@5),.S)<6)X\A%EQ1!(L_.)Z8O90N)';3H2;W+]7T-[6`IE
M,C^W)I(\AI5DX+#<LW4D\G8V'Z`+6V+90;FVXDG1&EN0FW-":?EK=IZ8K-4N
MU*X)\K[I4;:OKG7-@L<38R<_G,.D8;!9*I+S;J#%G(*`I%JN#QBB@@J*`K$(
MH6JSY*8.W'<+(R>WX^FA66/:X:UBUQH"?,@)V%2:VW(8>/E<VL<\9>-^9Y*X
M+-;R80=2-?*0P!)6Q8:-==*E5<_4!]0C2$=R)U9L;E%3IB5@[/Q,D"\FW>@Z
M+%L^.]#Y#MC.[G*#1H2/4K<_7Z"9,J3-U.)/UC`KWNE3=0[-B3CS#$Q#D?3H
MO.9&(^0UB72&'U(@5/D1Y7`0D6`W==`P\I%BRQ8</)F(Y$D_##)3'%P%D$JQ
M.UU&]P@8R$#YMHLG53:'Z0G)O=/)2J<G%=P[RB>0J6L-^O=?Z_V5!:_J^N8F
MP4MC7HURQEV,%6(J.3%&:45%WYBRCH1%4?*4\GL*&0J[^#X/.EQ##F3B8R*2
M204F9%%C:UE`%K`_Q7:YK'S$2#E<G$AR!)C)!`P(%KEU8L2;D$W%B5.PVN@`
MJX/,6K:8I3%*8I3%*8I3%*8I5"'[RO[W/])>6U+V5__1]C/IK_R&<4?X)T;]
M3-LH.VKFZU-_*U;3%*8I3%*T=L[C/Q[W5;*/>]MZ8UOL>Y:S="]U_9[E4XB>
MFJ>Z,Y1>"M`2$@V6<1Q_>VY%/T8@'>4!]N(#]-E#.Q_)F`6WC1K:Z7_$_G2;
M_B<.3CYSOPF-RAU4DBU[=+VT^%:NHG#JF0.W>3>YKY)MMFV+E!$5*E6Z(E*I
M"1%7CM8TB#>P$#121;87BTX@JTDG!GSM\LJHZ,IV@1-(B:1,>+&A7B\SC)XQ
M*N3E-D3EAI)(8HH!Y>BJ(X4&VYN;L=229Y,F<Y^%G0R&/Z7&]"$*3Y$]668G
M=VL7E.H"^4*+:7KLB\$>&14M7(AQ?TAY6DC"?428Z\KAB:Y$9-29']D@,Q$(
M8/K94SCHEV@"IA-[1S*1FCS_`/-(V(Y'TEB]0?/Z:`A$W==JAB%'8#I6/(!-
MAGCY1NP3(9-AU7>VV[6Z7.U;GML*SE]Q?X[2;^8E)#2VMWDC8-BQ^W9M\XJL
M4HZE-GQ3`(N-OKU<S<5%[2SC2@@F\$?.*E\GKT\,QQCP+%'"(E$2I.H%M`N2
MK)D*!W3([+(/U!B#4TD\TVLLK,;0C4WT@<2PC_X4@#I_"VHUKJF'$/B]%P;Z
MLQV@]5LJ])ZR)I>0AFU.ATHY[J9.7EI\FNG+4C8$E:@6;GGKH&(AY'GNE#]O
M4XY)(BS)+'*H9)'B=@=0S0A5B8]YC"J$/Z0HMTJ1<S*2>/*3(<9*2R2*US</
M*097!_B<@;CVV%Z^$OPYXJ3^P*%M6;X]:CE=DZNC(:%UU>']'@G-FID37DCH
M04?7I95H9W&M(A%02-R)F`$BCT+T#)4D>/+R,Z-B,R6^]Q\S7!4[CU-U8CX&
MU8S>?&APVUQ8[[4_2MR";#LN0#\:W+>Z#2=H5&=H.Q:K`W:DV=@K%V&JV:-:
MR\%,QRX=JS.1CGB:K9TW4#VE,40S'FAAR%"31AE#`@$7U!N#\0=14D4TL+%H
MI"K$$:&VA%B/@1UJ/I>"?#,NI3Z&+QATD&F%)P+,?6(:]KH4PUA#LZ3)H/W+
MW(9(`(`>;V]_0`#KDLQ^H^F]?S^C_AWUV7Z[>Z]S4<)./]3Z!V>L`'MIO`M8
M-WVMI7,M7"+B!>*CKV@W#C5IBR4K4Y@-K2KS%`KSV$HP@<JG6LL%F1D(K](4
M##Y0%ZF#K[<N=WDS$Y!V)S54`.?F`%K`'K86%OA55)3&DPU-L5VW,GZ2==2.
M_4Z^-;,C-$Z9AC;&-%:OH\>.WO=@VB#2NQJ);\#*&2KS0+40B`$F"MH)`C0@
M+`8"MR`0/`.F1NB28TF&Z@XK.[E#\I:0W=B.]CJQ[35T<CQ38^1&Y6>*-8T8
M=51+E5![%4DV'07-:FA."/#*MZUM6G(#C!I*'U7>7S.3N.OX_7U>:U6S2$>M
M[PQ>340DR*T?KLUOEIF4*(D-XAETQ]>+$@F\T,#[HP=0C?Q*.P^(JD;M$\\D
M;%9)5VN1U93V'O'A7.D>$?$*7H<_J^5XVZ;D==VF8B[#8Z6\H<"XKLU.0D<S
MB(B6D(Q5F9LX?QT7'(-T53!W$22*4!Z``99+&DWH^J@;TY'=;_I>0DNP[BY)
M+'M)-ZD$\R[[2MYHUC.O5$-U4_W5))`[*S&.XS<>XCZ@"*TSKF."JZ]E-35L
M&55B6P0FLYPQ3S%%C01;D!I69,Y0%=H3HDH(=3`.73@97UAR!O\`J$5);Z[T
M2X16[U6YV@Z"]60R/CQXT4#%(X9C*@&@20]77N;QZULRF4RIZ[JL!1J)78BI
M4ZK1C:&KE:@62$;#0D4S)Y;6/C6#8I$&C1N3P(0@`4H9))))*YDE<LY[3UT%
MA^RK+:L>UF+'Q+$DGXDDD^)K)LLI3%*8I3%*8I3%*8I3%*8I3%*8I7S512<)
M*(+I)K(+$,DLBJ0JB2J9RB4Z:B9P,0Y#E$0$!`0$,H0&!#"XJH)!!!L:Z)&H
MU1M'.8AO6*\WB7AP4>1:,+&I1SLX=H@=RR3;%;+G`2AXF*(^`94^8`-J!TJ@
M\I)70D6K^JU*JKQJ$,O6:^M#M3^:VB58:.4C6ZGROTB#$[86J)_ECXE(`^(X
M/F*LVK#IX?"@)4,!H#U\?C7/0B(EJX5>-HR.;NUVZ35=T@R;).%FJ!0(@V57
M32*JHW1('0A!$2E#P`,=C#L)N?$]Y[S3^'^Z+#P'<.ZNO;5&J,V[]HTK%>:M
M94!+*-FT+&H-Y(HB(B5^BDV*F\`1$?!0#>W*6!4(1Y`;@=EQTT\+#\JK<[B]
M_.>WMUZZ^-$ZC5$FCI@E6*\FQ?)HI/62<+&D:/$FX`#=)TV*V!%PF@!0`A3E
M$"]/#IE3YM&U%[_CW_'QH"1:Q[+?@>H^!KF(P,&V^K?=X:*0^IDED(CR8YFE
M]5(.2E(X1C>Q$ON*2Y"`!RI=H&```>O3!\V[=K=0I\0.@/>!V#I5``!M`LM[
MV\==?CJ=?$U^OJ2&^JQ@_JB,^I3(BW-$>X-/JL6YA[C(#'^5[H*(F\1+V=O7
MX,,-UMVO3KX=/RMIW54,02P)W&]SWWZ_GV]]<=M6JXR4069P$(T5;*BNV5;1
M3%!1NN+7W$5D#I($,DJ+$/)[BB`^5\C\WPREAYM.M[^.ZQ:_QL+]]A>J=@'9
M8#\%^4?AV=W97S4JE65;-&:M:@%6C!5PNQ:J0T<=LR7=F.=TLT0,V%)LJY,H
M85#$`HG$P]>O7%A<&VH%AX#N^'A56);<&-]QN;]I'0GO([Z[((V."/")"/9!
M%`U!B$8#5`(\&0)^2#,&7E^[`U!+Y/E]O9V^'3IE6`>^_7XZT4E3=38^'CU_
M.NE/2:8I[N)ZC6#BT:E9-.^`BC>[,B*F7(T;]6@^2U(L<3@F7H0#"(].HX!L
MQ8?,;:]NEK?E86^`JG8!V"_[>OYW-^^]<PE:KB9Q43@(0AS.7CPQR13$IQ=R
M"'NK]T)@0`1<OFOZ-8_YRJ?R3"(>&4L-NVPV[=MNRU[V^%];=+ZU6YO>^MP?
MQ'0_$=E?A6JUA<L:1:N0*Q(7I]3E5AX]0L3VF*8OU:4[<08=IB`(>5V=!`/B
MRH)#^H#_`#+=>W\^M4/F4HVJ$WMV7/4V[S79-H]@R4=K,V+-HL_7]Z?*MFR*
M"CUSV@3WAVHD0AG*_8`!WG$QN@=.N!H-H^6Y/XGK^?;0ZFYZV`_`=!^'97S=
M1,4^6*X>QD>\<$;N&9%W3-LX6(T=@!7;4JJR9SE;N2E`%"`/:<`\0'*;5.ZZ
MCS"Q\?CWU4,PL`QL#?\`'O\`C7!2JU80$@HUR!1%-5!=,4H>/3$B[5,R358@
MD;AVJMDC"5,P>)"B(!T#+B23<G77]NA_,:'OI<VVW\MK6\+WM\+Z_&OX%4JX
M)F2"MP`)';*LS)!#QWEF:+N??%VIB>[]HMEG?Z4Y.G:93Y0AW>.4L.[N_P"S
MT_+L[NRJ[WO?<;W)Z]IT)^)&AK5.]./]7WM0)N@O[/L+67UZI&*.;IIBTFU]
M?4BQ*G>U;$GVC)XF[CQ((D.U=MW+8Q1_U?<4IBPRP"5H6]1UV/OL#HQM8[@;
M@W[[7!`((-213M$'4(I!3:+C51<'RG0@Z=FA%P0:P[B?Q`U/PYI-AINKW5VG
M5[E:W]WO%UV1:%K?>KI:9$I$59>PS1FT>V672:I$13*@V03*F0.I1,)C#FOD
M,^-A8:QHF-CH515%@-S%V)[268DDD^`L``,8J6GGR9)&>>3;<L;Z*+*H[@HZ
M`>)ZFI39!5],4IBE,4IBE,4IBE,4JA#]Y7][G^DO+:E[*__2]C/IK_R&<4?X
M)T;]3-LH.VKFZU-_*U;3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I5"'[RO[W/])>6U+V5_]/V
M,^FO_(9Q1_@G1OU,VR@[:N;K4W\K5M,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE
M,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4KA/Y*.BT/>9-^RCFW<!/>'[
MI!FAWF_-+YKA1-/N'X`Z]<L:1$MO<"_>;5-!C9&2_IXT#R/W*I8_D`:^"DW"
MI-VCM67BTFC\Q2,72D@T(W>'/^81HL94$W!C?`!!$1RI95*J6`8]!W_#OJY<
M/+9YHUQ9#)'\P"M=;?Q"VGXVK[%DXT[X\8208FDDT@74CRNT#/B("!1!8[0%
M!<%2$#EZ&$O3Q#X\J&4EE#`LO4=U^E^ZK3C9"PKDM`XQR;!MIVD]P:UB=#I?
MLK\2,O$Q!$U):4CHM-8PD24D7K9D14Y0`3%3,Y52*<Q0'J(!U$,M:1$*AW`)
MZ7-K_"KL?$RLLL,7&DE(Z[%+6^-@;5QWUBK\69(DE.PT<==(%T2/I-DT,LB8
M1`JR17"Z8J)&$H@!@Z@/3*-+$K;6D4-W$B]7P<?GY*L^-A32*#8E49@#W&P.
MOA7(0EXETR/)-92.<QR8*&4D$'K99DF5+KYICNDU3(%!+I\H1-\GX<N+H%WE
MQL[[Z?G5CXN5'.,:3&D7)-O(5(;7IY;7U[--:_J<O%*L!E$I./4C`*)AD4WK
M8[`"E/Y9C"\*H+?M*?Y(CW>`^&5W+8-N&T]*H<7)$_TQQY!D_P`&T[N_Y;7Z
M:]*YX"!@`Q1`2B`"`@/4!`?$!`0\!`0RM0=*^9%T%%%D4UDE%6XD*X2(H0ZB
M!E"`HF"Q"B)DA.0>X.X`ZAXABXZ7UJ\HZJCLA"-T-M#;0V/;8Z:45710*4ZZ
MR2)3J)HE,JH1,IE5C@FDD43B`"HJH8"E+[3&'H'C@D#J:HB/(2$0D@$Z"^@U
M)^`&I[J^N*MIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4JA#]
MY7][G^DO+:E[*__4]C/IK_R&<4?X)T;]3-LH.VKFZU-_*U;3%*8I3%*8I3%*
M8I3%*8I3%*8I3%*8I3%*T=L_D1J_4KDD=9Y=PM-'("@0D0U]\?II&)WD5<&5
M4;,6I3AT[046*<W7J4H@`B&GY/GN,XDJF7/_`#3T506;]G3\;5Z+A?:O-<\K
M2<?C`P`V+L0JW[KGJ?@#6DXCGCJ21DV[)W&6:*:+JE3&0<-6S@C<##T\QPW:
MKJ*"F7X?*%4_Q%'--%[WX>258V65$)^8J+?C8DV_"O1S_;+W#%`TL;P22`7V
M*QN?@6`!/XU-1D]:R+-K(,5TW3)\W1=M'*)N])PV<)E5063,'YQ%$S@(?D'/
M8*RLH93=2+@USQT:-F1U(<&Q![".HKDY6K:8I3%*8I3%*8I3%*8I3%*8I3%*
MIQYNN-8M^5-75Y21M>E='IZ%EE=4,=H2,E%:,>[J2F9X[UG?I)NV>0T<^=L@
MC4T5Y!NX!)(P';D,J!BCS[E&P5YSF?\`.H8WR/I8_HA,VV`Z/ZHW6(60OU.T
MN$V_IVU];_9]/=$GVPE3[99.3%[I//J.2?!1).23`,<7IMCH661XU/K$K$Z;
MGW+(P0WJNZR?5VT^/&DZI3=:H46O5WDUMI?7[6#O]KV%2YI:"UK;;O$2^O)V
MV5ZO*$IK:P-038I-V96P)HAT[NHF'4\A/(F%[/Y"&.2*;'ARY%#WD=?0D6S7
M<;FW*EUN/D86%J[OQRR>W/?GW'S>5]Q?79F7[?XQ<MGQH,::/U\V#%DCR8H)
M95^H])KREI"Q9KFW2MZ\7=CVF]\RYSE+5J+*;*LFS-(;03J5483%<JTC9H'7
M%IUCKZ-:-9*SN(6OQ8BYA7:H'<K)D,!NO<(CX[/VS-FP9?NC.CP'GRLP1Y(7
M<BDQ2Y,ZX[!F(6RXJPZ7O<$==*\+]SN`XSB/M+P?VQY7G(N-XWB.9PDGF>.6
M=(9\G$RLN<E8!+*]WE"V0&Q'0`:;:V=9=(6KDA;IGU+Z#'ZMI[_2%:5TS0]Q
MV&.M%4A'J<A8$MEIUZ:I4C*TQ]L!4"QJA#,G"DF5(Y0;"`@H&5F/#-F>X6]R
MBV<5C,*GYUA,()7'(ZR+*7#F*Y+;"Q^2O/\`M[C_`'UQOV_]O8G].?-2<CFQ
M\SD#D,G`B:&:4VB.$9X\A4G3$MZP`F40W#&46VUE?*72/&.Z^G6KLNNZV<6,
MU1U97(_5]QW!!2#[:T#7#VN/.BT7E+8D>?9]WUBN(%`P)=BH^7^C$,V'.<=Q
MTD7M_+^D4RR9F!$68#>T)F0;'/4W5B&![S?MK6?:?WG]P^)^_;>V<SW$L&/E
M<GE29>/@2*N#).,>2[(D)])AY$L;7NHW>8&OMRF8SVL^,-RTSKOBJXUEQV8G
MUM,639U5L>N&U,F*U(7.G2-]1/KZNS2FPV+=^W<.2OUU8]),4$U3*'\HW48N
M>8K!B8F;Q@QN`AY*`2%F1HI(!)U8*3LCW;&/J!>@![JQ/M?+C^X/?O'>\>1^
MYB\G]RYL?+2#%EBRCDQY"XLR8Y^JGC&*[)8")1(QW%-@W`6A]=ZE%V+A3S#E
M=-W:9K?&BI;S4F=75RE"T;4FZQ1S4EDNQCWYTCOOV'C;$N]6%HV,1JZ>#U,(
MBETS38\&:_$<3D2Y$@XM.9MC1G3=`V6!$SGYR$&[8K]ZM8A4KJW%<M-Q_P!X
MOM]B>YN&@G^X>5[:5,Z>>YR,><193.64$*,J2,1*9&NZ1C:-'-6X<N^0=XT!
MI&GRE$A4SR5F;Q<`O=GJ:+R*UV1Q&-2MI]]$*IG"5,NY.#=`AO\`HZ;@Y#+_
M`*+NSWON#-R<#&R)\6'<^XW/\(O\Q';_`*7TKYA^R_L?VM[^^X#</[IY;T<9
M2SICC<KYC*Q)@24:1FWF)^9E!$?GM54.EN05JTGM5/9YI>P6=K8':26W&;Y\
MI)REWA%%!,M*#[V;R5+-7S',XC^P$2]@':$%)%7H7G?&<[-AYWU$\S/'(?YF
MO7Q^([+6TTK[K^XOVAX;WQ[)_P"5\+CL;$S,*,GCV10B02`?X1(U]*:P60MN
M.ZTQW.I)V!RLY4$Y'6J/:5%[-L=/50Z;JN(K)OX!_;+0FJH8EX<-A*REXYK'
M(F*2*27!)RBIWN#$34%,"9?/<^,V9(L24C%0WOTW-W]]AV>.M>6^R'V1?[=\
M/E9_N7"@D]X9JE)%.R5<?'(`./?S1L\AN9F7<I7;&&9=UYL>G[R/V/M%2W:S
MO)W=Q;4%DR<1VRW0HDD5/?U"BWI]C\ENBE*S4<R-YQ7Q.BAVQDP<`98?-5]-
M[:Y/,SX)!DKN5#82=_@>\CO_`-=?./\`4M]N?9OLGE>)Y'VW,F+F9X9I,!=Q
M6-5T^HC))]..1M!$W1@QCL@"K9MGIZ^7:XKY\SC&3R2D'*+-A'M5WKUVX.5)
M!JT:I&7<.%E#"!2)(I$$QA'P``RUF5%9W8!0+DGL`JY$>1TCC4EV(``ZDG0`
M?&H>V/G+IF&<*MHPMAL0I*G3][91Z;-B?L,)1.07[A&0[#"'@(M@Z@(#[,\I
MD>]>$A9EC>24C^%3;\VM7OL3[:^Y<A%>9(H`1T=QN'Q"[B/@=:V=IOD;0-U.
M'T97A?Q\Y'M3OEHB42(159@FL@@J\9K)'.FNDBNY3*<!`BA1.4>WM$!S9<1[
M@P.9,B8Q83*+E6%C;I<6N"+^.G;6E]P>T^5]N"*3-5&QG-E=#<;K7L;V(-KD
M7&MC:M_9NZ\S3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*H0_>5_>Y_I+RVI>
MRO_5]C/IK_R&<4?X)T;]3-LH.VKFZU-_*U;3%*8I3%*8I3%*8I3%*8I6MME;
MAU=IV%4L.S[Y6*1$)]`!U89=I'^<<P")$FR*RA5W*RG:/:1,IC&$/`,QLG,Q
M<--^3.J+XFO0>WO:GN3W9F+@>V^$R<W*/Z8D9[#M)(%E`[22`.VH)3?JD:@?
MNE(W2NMMR[Y>@<R:;RDU`(VM'$O4!4+8K0]A6:R13=.OE`<_0>H%'-+_`,QQ
M3:<=@SY'BJV7_K&U=5__`.$<KQ2"7WQ[OX3@EL"8\C(]2?7L]#'65P>[=8>(
MK'4^2WJ#;#.`Z^XQ:ZUVQ-U$CO9ERF)QTHF?_5B+&LQ:!&ZY0\3%,J)>OAW?
M#E?J/<<_^%A8\*W_`.\<DV^"`_M(JUN#^PG#"W(>\^;Y:;M&'B1P("/[^3*-
MRGL(%_"N[28>J19TA*YON@M?>9TZ#!:XDIQTB!@$.I'ECL+IJ82]>H=[(?$/
M'PZ@,PAY]K;\_'4?W8V)_`LUOV5AMS?V,PWOB>P^;S%'_P#<<A'$#\4@@W?E
M+7,8:A]2-P]:+2_+FOM&J3A$7#2'U!K`B3EL50#*E.=_57SDJAR=2]2*$Z`/
MAX^.7_1\L2"W+V'A$G^NK)O>?VF5'3&^S<98@^:3D\\D'L(V2HMAUL0:B]S(
MCI&L;6GY.R.2F3<Q[66._'H!5$2L$1<J%3*4`3(DJD8`*4.@>P`SFGNW%F7G
M'O=C*%V_NM^=>H]AY^+)[:38`B0L^X=VI/7J=._6JWG'(VN).`!I`S3I`I_%
M90S)L8Q0$.ADT3N#&'K\1NW+4]J9S(2\\:MW:G]PJLGOWBDDM'BSNE^ME'Y`
MF_[JM4UIS[MS2@UII&5N"?L6T4W;Q[ITD]3<&;HE\LA79$WH$!9(Q1*;M``\
M/#-DOO#D.-1<"3#B+P@+>Y[-*T\GV\XGF9&Y:#D9A#D$O;:NFXWM^%;?K'J#
M/??$"6ZEMC,3"(.%H1P=%RD7X#(I/5E$51Z^T#*)A^7,O&]^G>!F8-D[T-S^
M1M^^M?F_:D>FQX_D[S#LD6P/XK>WY5ORH\V]16>6:Q+E*=KAWB@)(NY=%D9D
M"AA*4@++,7KGR2F$WYQ@Z!F]P_>7$9<JPDO&S&P+#2_Q!-J\OR'VZ]PX&.^2
M%BF11<A&):WP(%_PJ81#D4(11,Q3D.4IR'*(&*<A@`Q3%$/`2F`>H#GK.M>"
MZ:5^L4IBE,4IBE,4IBE,4IBE<)_&QTHA[M)L&4BV[@/[N_:H/$.\OYIO*<)J
M)]P?`/3KEC1H]MZ`V[Q>IH,G(QG]3&G>-^]6*G\P17X")B@2:(!&1X(,.ON*
M(,VP),NXADS>Z)@GV-^Y,XE'L`.I1$/8.5*JUBR@D"WX57ZK)W2O]1)OD^8[
MC=M;^8WUUUU[=:-8B*9&2.RC(]H=!)1!`[5DV;F1164!59%(R21!3255#N,4
M.@&-XCXX"JORJ!H!^`Z#X#L%),K)F#"7(=@S7-V)N>ES<ZFVE^M?F1AXB7*D
M26BHV4(B8QD22+%L]*D8X`!S)%<I*@F8P%#J(=.O3*-'&Y5G0$CI<7M\/RJN
M/F9>(6.+E21%NNQBM[=+V(O7)69M'+8S-PU;.&AB%(9JL@DJV,0@@)2&04*9
M(2%$H=`Z=`Z9<0#:X!L;_B.A_"HTEEBD$L4K+*.T$@_F-:^BJ""Z)VRR*2S=
M1,4E$%4R*(J)&#M,F=(X"0R8E\!`0Z=,,JN"K`%3U!JU'>-UDC<K(#<$&Q![
MP>MZX98>)(P^JB1<<2+Z"'U:5DV*PZ"?S!#W,$@;]!4^5^;^=X^W*;5("E1M
M'0=UNGY5*<K*,QR3DR?4?Q[CNZ6^:]^FG7I6.7ZC5C852FJC;(UE)0$O'.6#
MYH]115:F:KHBFJ50BQ3)`GV>WJ'0`##JKJRN`5(U!Z$=MZNP\O+PLO'S,'(D
MBS8I%='1BKJZFZLK`@A@;$$&]Z\F.V`C-/[6O6K(6TMKE7Z9((,(BRMWWOPJ
M(J)&.>#?O#',+V6@`*5)PN`G*J)B]3"J"H!PGW`N+QW)S8^'D!X>M@;[;_I)
M[;5^T?V?Y'W![\^WW!^Y_<_#-B<S.&#@J%$P6P&0J#Y%FU.TA;$-M&PK6H;3
MLN?2BO*J31K(3[]]'1C`CV00CV+4\B]1:&?O7;CS$T6K,JHG,82G`.G40[0'
M-9B3#(R88#(!N8#4V'Y]E>\Y?C_\IXGD^4.(\OT\#R;$0NS;1>RJ+%CV[002
M!8:D5<[QPI?J%:LUU#T_6NO>/5(B!(H^6DY]>Z76RR3M\J=T[D9E\"T(UD7C
MU=8RAE2J"!NO^YV3#Q>=QXD@@^CAQE'E`WN?B?E!).IU-?E1[Q]U_9KW+[@Y
M/W#[B?W3RG.SO>1O^$Q(O*`JI&I,KQQQJ`B)L&U18"I$GH?J>S`^]J<A=3UH
MQP`!CH33\(9HEX>THV!S8GQC_E%<2_D#,U<;FR+R<I&&_NQ"W_:8G]M>47W3
M]F(!LB^U.9,O\4W*2[__`.#'"EO^C?QK+(W57+B.U[M]ONG?".VF,A0GX0,(
MC1Z/5!:2,><DHX.5Y4Z[".G0R3-H=J*2QCI""O7I\.09N#R#<9R<,O(&5G@8
M*-BK8V/:O?TK69/NGV1F<G[>DX'[?P\0\.8C2.F7EY!=+VVE<B615VGS;E`-
MQ;I5,U[V%"4%)J:4(Z>.7QU@:-&)$SJJD0$GFKF.LHDFFB45"^(CU$1\`SD?
M'<7D\F[K!8!>I.@%^E=;YCF\+A(XY,LL6<D*JBY-NIU(%M>^LFXX<O/V-V2U
MD8"",A*KLGS)JG,"FX8O4ED1%9J<63E-9%<R9>\G^B)DP\?@'?P8G(>V'_S6
M,Q2@+L8>;0,1\.T#^RO)Y/(<1[XB'!2B>!BPD4^4W*`Z=3V,=/#K5C@>H)>@
M5*)J?7/(\.\`!^"@_'VF%[VAF8/?N;?_`,%';XFM<?M3QUC_`/4YK_[J_P!M
M;;KOJ!TY=B3]IJ?-M)$#`4X1#B/=-!)X_I.KUTR7*(?"4"F#Q\!'-M![\P60
M?4XDBR=MK$?G<5HLK[5\HLA^CSX7AMH6NI_$6(_;4IM3[UH.XV[HU4?+D?L0
M[WD1(I%;R"*0F`H."IE44(LW$P@'<41`!]OP9Z;B^:P.71FQ)#N7JI%B/PKQ
M/-^W.4]OR1IR$("/\K*;J?"_?X5N3-M6AIBE,4IBE,4IBE,4IBE,4IBE,4JA
M#]Y7][G^DO+:E[*__];V,^FO_(9Q1_@G1OU,VR@[:N;K4W\K5M,4IBE,4IBE
M,4IBE1VW_P`C*UQZ<:E/;(IZYA=H;1@-8KSR#A!NQJ3NS$<H1,S,"N'RXY65
M(BV/VB`D\[O$>THY@YN:N%],72\<DH0F_P`NZ]B?QL/QKV_LOV1F>]Q[FBX[
M*1<[C^+FS5B():=8-K21QV_6(RSB_7;8:D5`NX<S=Q\H+U<-3<)"14)3Z,]<
MP]_Y'V%H:48M99D!U7\10J^<$&\HLU13`3O5E?*`#AV$'J4V:2;E<KD6RDXM
MUCPH;^I,1NU`N0BZ7(':3768OMS[6^UW%\)S?W6QYLWW-R$0EQ.'B<1'TFT2
M7-G\QB5C?;$JES8W(L140]'U'4%F;2G('EE7]A;(HZ5.L6PZ[NS:-]@=@+S\
M'!6E.JIKM-)L73FP4]M8'*P+1*39@X(JD7JH**Q@*;*Q>%X],89W(;ILPQ02
MCU+RDKD;3'8"ZJ]G0LI4;=U@Q(KS7/?>3WIFR/[>]H&'A/;WK30F#CE^E`;'
M!]7U)O+/,`T<B>H9"7V_+L86EM3_`%&N!U/>R2<'#D@M9Q.L*??H6_,ZJZ66
ML#BUW&9HS2EQE(:Q`VT+,QE*^X\U$4.X"I&^2':(YMEEBB^IC<!"DT*(!J)!
M-`^0K+MT"JB'=?IVVM7),@9>4T>1+D-+,ZS,[,260PR1QL&+&Y9GE%AVU(:7
M]2SA]"L()W'WU[81LVOW&Q8-M5J=9Y@5XA..F9&/C7ZT?$*MH6QSA*^]28L'
M9D7+E9JJ0A!$ANEV3,,:/.<H6,$7J$#]0V>I93T8A/.P!.U?,UA4.+BR9<N'
M$K!3/*8Q?2Q#B,[AU`WL%!(U8V%R:U73/5WXO6*!A[+8@N-,CK+!4V6K4:\J
MEIF;=+O+FG=7#"()4XBNJR)5Q94=RJBHF*I'(&`"?!W3$@39&/>\L:[B!K9!
MC)DR,3^D1QM=K]@+7M5'Q9%].W1F*ZZ>;U_IU`OJ=\A`'0@FQ%ZE3L+E%%PW
M&E'DUJ2G2>[:I(5Z-MT/'PTQ%4\[NK/3$4>SKZ1M7NR46UAV/F+.$SI'<=4A
M3*F)_#(N3DEXQU6:`L+BY!!`5@"K:7W;K@*%ON+#H-:<=CKR3M'#*!)<@`@W
M+!BI7LV[2#N+6V@'M%J@'S'L3'=>L=*;0:P$G766W-6-;&$5,)I!+PJ$]#1D
MDC$29D#"D+Z/^MQ34`H]!.0>F>&^X6/_`)?R6`ZL&:-B-PZ&VTBNJ?:J7Z_C
MN<PY%*A@+@GIJR'IU'<>T6->?,2F(8Q#?GIF,F?\ITS"0W_NBCFV!#`,.A`/
MYUY=E*,Z'JI(_(VKOV=LM$<V39L+%-,FB/7R6S:1<I()=1$P@FF0X%(`F,(]
M`\.HYB2<=@2NTDN'&SGJ2-36QAYGEL>)(8.1E2)>@#&P^%<Y[?KI(-$F3RSS
M"K9$1$I2O%$#F_[LN@*2RP%^#N,/3(H^(XV*1I$PTW'O%Q^`.@J>;W%S4\2P
MR<C)L'<;$_$BQ-6/\0=773;R%;KI7#CSW0*R"TH]466,Q@@,GV.UE3F,J8`(
M?Y`"/4PB`![<\D_%#EN>FQ,`!8U/F(&BV.MK>/3QKH,?.G@/:N-R'*LSY##R
M*3=GN+J"3?2VI)[*])\'%EA(:+AR.%G1(QBV8E<KCU67!LD5+S5.HFZ&/V]>
MG4>GLSL<2>G''&"2%`%_A7SK-*9II9BH!9B;#H+F]=KE]1TQ2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2F*5_!'H`C\0=?]S%*K>V=ZF&GM1I;O9W*#GFELU'>H>APM
M-;'0=3FQY&R0R$U7W=>03+^@9OVZA^\RO4$03ZF'J8H#YW)]QXV(V;%-$PGB
MD"!0;ERPW*1W7%=X]L_8+W+[L7V?E</GP-Q')X,N3+D-=8L-()6BF$Q/5D(%
M@/FOIH":JJYW[9YTR^D$=O[!GK-J:DW1]]7P>J]22;B-+581XF#HDELBZ-C(
M3<PY]W$B()M2-FXKF$#"!!$!\U[FGYR#BIN0R"X!Z11&P4'MD;J?@+"_;7T5
M_3QP_P!EN3^YF%[)X7'P\EX`6?D>20.^9(AMZ6!BG^5"&.N^5G?9J%W`&J5Z
M)(66\V:N4*F,W,K8;))M(>'8IG544</'BH$!5PJ83&\L@F%194XCT*!C".<:
MX^/+YC/APX!NR)6M<_M)^'4U^HGO/-]O?;SVGS'NSGW2#A<#':1K`"X4>5$'
M:SFRHHZD@5F^ZZQL;05W?:ZV:P&.G&[9)XF9,5#L92-<F522?,CG*`G0441.
M0Q1^44Q1`<S>?XO-]NYWTN38W&Y6'0CO'Y5Y3[.^_O:?WJ]I1^ZO;"E4$ABF
MA>WJ0R@`E'MH00P*L-&!KT5^C/RRV!N>A674-Y834VUU<V:JU;8T@X5=^_1+
MYTH0E2DG;D3.7DE"]>J"HF4$6G:0X@8@";K_`-O^:S>4XYX<N)B(M%D/1AW?
M$?NK\R/ZW_M1[1]@>]<#G?;6?C19/*[FGP(P`874#^>JKHL<O:ME\]RH()M=
M[G0*^&ZXKU$KED[;F+W%7:N$3%$.H&*JD<@E$!]O4#91A=2.\5<I*LK#J#7D
M?Y8P?ND@R>^4*!V$]-0XHB7L[$3G,LD7M_T>SW,?]W.3>W']'D.3Q+:7)_ZK
M$?ZZ[W[SC&1Q'"\A^JP'_70-^]:B`U=.F+A%VR<KLW3<X*(.6RIT%T5``0`Z
M:J8E.0W01#P^`<]=)%',C1RH&C/4'45SN">;&E2;'E9)EZ$&Q%94VV%>6BI5
MTK7-B<H]>B[U1PF(_P#&17%1(P#_`),P7X?C)%*G"C`\!8_F*VT7N/G(G#KR
M<I/<3<?D:R&@SENFK_7?^N9EZNM+MEGA%'[LZ!V1%2J/?/0\WW<&_NX&`0[>
MGL`/@S"Y7$X_%XK)MC1K9+*;"]^RQZWO6R]O\AS&=SN%?-E>[@N"QV[1\UQ>
MUK>%>C3@SIJ;C%5]L2KA5DQ>LWL3#QGR@-()JF1!=^L'4`!LD9,2I]0ZF.`C
M["@(R>RN'GAW<K,Q577:J]X_B/\`JJ+[E>X<7),?!8ZAWB<,[]QL?*/WD_A5
ME6=#KD=,4IBE,4IBE,4IBE,4IBE,4IBE4(?O*_O<_P!)>6U+V5__U_8SZ:_\
MAG%'^"=&_4S;*#MJYNM3?RM6TQ2F*4Q2F*4Q2L*N.R-?:]8+2=[O%3IT>W3,
MJJ[LM@BH5$B90$3'[I!TAW```/LZ^S()LK&QANR,A$']Y@/WUN.)]O<]STZ8
MW"<-E9<[&P6&)Y#?_HJ:JDYJ<M_3KY":5M.G+9R;HHH3HM#-)>JNQLCJ*D&#
MY!VUD&9XQN^3!1)9N'CUZ"01\>@]<\SR7.>V\[$FPYN238XMIU':"/$&OHW[
M8?:+^H3V7[LXCWAP/VZS%SL1B0F0OI(ZLI5T<.R&S*QT[['J*SKB+R3]-[5.
MM:UJ'5&_M5,&:+4K/W:=L#""DYEXL@3WI=V66+'*.';SN$3]0#J;N#X!#)<+
ME_;*8R<=CYT0AVE=I-K@C6Y[SK<UH/?_`-JOZ@^7Y[E/=WNSV3RD_)S2>I)+
M'$TJK8Z!?3WA40`!1>P%JZM;TI^)^R?K*:BMJ[:EX-U1+/KJB)5>YZP=Q>L*
M=;KU`;`EX6BS;/6SN>DXKZW@"MT6=BD)]BA'N7#<J`%4^3Z#"]&/&R$QI0_K
M08\+/=6+0XTD<L49`'ID`Q1`L4,A6-1OU8MPWDXN0Q\^$\EQ[X^1#-/*(W1X
M]LV1#)#-+9K.&=996L"$$CE@NBA>I;>B7Q!:UY.ODF]NKD9-H1*&?/I/6,D:
M"=0%ULM[92,?!R&J7-.66-*6UZ@=N[C'3#W,Y4RMRF*!\I'BQQ>B49MZ,A!-
MF-DBD@`)8&X,<K!C\UPK!@02<5LMV65"B['#[@+@$O)%*6T(L=\*D`675AMV
MD`;[KOIOZ8ILLQD:5>]STQ@?7T1K>Y5BKV:IP]8V="U]I9FL([O4:VHH**/X
MX;A(*%3BU8M@H=8`5;*)D(0M\N/%-'R,+@_39*D%+G:A,7HETN2=Q2WSEUW*
MK!0PO5T6;-%)@S@*9\=B5;:+V,JS;2!8;=Z_I"MM)4FQK"*GZ3W':ISVO;(G
M==V3<IK)2F#6E)RS4HZ?NU!C[W%5MA()Q6NXH'+1JPV"\3/VBFJH"*`B?J50
M5;X4$,V7.I)EGQY87)[5FPQ@NVEK-Z(!!&@D\VW;Y:IDYDN64,BJ`N0DP`N+
M-'EKF`=3Y?674==A(N#8C9;+T\-)5_645KNB6?;FN)6*KL+4T]J4NZ,V>R7E
M>@W0N$8J2/*U^8HCUF]1,9NY3-!=BJ!A#H!OEY3*C&6C1.Q6!PH=5^60+$(1
MO#7_`$#L(LWF%C:T>/D-CM(X56<N[`L-4:25IB4(M:SL;7OY?*VX7O%SEA5Z
M7I77FF./=%!\2L:KHQ8:--*O!D)<8QFV:-F;B0>@D@5R^<`T456,5-,@J'^2
M0A>A0\!]P\WZF?CH-J@JH`4=%1$6-%%R395`&I)-KDDW-=<^T^$T,?,Y[N2)
M&-V/5G=VDD8VL+EB3H`-=`!I7GD.;N.H?J(@=54X&'VF`ZAC%,/Y3`/7-RHL
MB#^Z/W5Y.0@RRD&X+']YK+Z92)J\2"C**(0B3<I%'KU<>UNU3.;M+W?"=0_0
M>T@>(]!S7\ER<'&QJ\MR[=%'4_[*VW#<)E\U,\>/98TMN8]!?]Y\*W2VX_R,
M8^CWQI!A.-VSMNL\C#D49"Z0(H4RJ)5E!4('4H>P0Z#[,\W-[H$T,T2P-&[*
M0&!O;]U>TQO8IQLG&G?+6:)'!9"-MP.R]S5M_##>5;UM;%JS9(]M#L;5[I'D
MG71#-@CU4#=&J`N1`6@L5#F`H@`E[1`H^P/"3V?RT.!E28V0%"3$>>_0CL/@
M?WU']Q.`R>5PH<W$+&3&!_E@=0>I7Q'=W5<DC/03E`73>9BEVP%[Q<(R+11$
M"].O<*I%A(`=/RYU<2QL-RR*5^(K@S0S(VQHF#=Q!O75UR\5"WJR*%8L<1.J
MQ*_N\BG&/D'9FBOCT*L")S"7J(>`^P>F109>+DF08^0CE#8[2#8^-JGR<#-P
MA$V7BR1AQ==RD7'>+]:RK,BL2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5\EET$"&
M476213*`B8ZRA$R`4/:)C'$"@`!BE5S6WAKQ\O?+J.Y06&PU^0FXJO-HEO`&
MF(0T<:89#Y3:;71\XRJT@@R'R2]?S2@'Q!FL?A,>3DDY9XF,ZI8?P_[WQMI7
M3L/[L>Z^/^VV9]K\/)$?`3Y9FD(OZC`C6&]["(L`[`#5JG79Z74+[6G59GHR
M-FH!\S.S5:*IH.FIVRB?EBF!1!1(Q#$\.G00$,V3(K*5=05(U!KFT,\V/-'/
MCRM'.C!E92596!N"I&H(.H(U!J!W''TS=$<<-Q6O;548.W+^7$I("/D54',?
M5FYA$[E&$2\@JK8':@AWB8YQ`I0*7M#J`Z'C?;?$\3F96=@XVR>;KTLO@NF@
M/;U_*NR>_P#[_P#W.^YGM3V[[/\`=W._4<3QQ)6P*R3-T5\AKVD:-=$.U;7)
M;<=:SOF%P-U-S`;U8UT;NF$I691NZ;RT0=!K(*Q_G`=_%JN#H*F,R?)AT.4.
MA@$`$H@(=<FYC@>-YR**'D(-RHX8$:$6.HO;H>A%:K[6_>7WY]GL_E.1]D<F
M()<S&:&577?&00=LFRX'J1DDQL;V-P002*D3I?1NNM"TZ-I6NJ\Q@HB.1\LI
M&J*:9U3&,)SJ*G*4IE%#G$1$P]1$?$<V6-C08D,>/C1*D*BP4"P%>"YWGN8]
MS<KF\YSW(RY?+9#[I)9&+.Q\2>P#0#H!H-*W!D]:BN)(/48Y@]D'!@*W8-'+
MU<P^`%1:HG75,(_$!"#EK,$5F/0"]7(I=U1?F)`_.O)QRZG4[`HC+%'M^M;7
M)/TDR]>T454')P/[`Z"4JQ0\?^%G(_;\GU',<ED`>5@Q_-[BN_\`N^+Z3V]P
MV(S>="B_';&0?VU"#V>(Y[:N95O2K:*GK!%-99Y(-H=)\@FZ:-UD5%W!VZQ"
MJ(*JD(8OD^:F8#`4?E``^.>8S/<T&-.\,4!DVFQ-["XZV[Z]QQWL?*S,6+)R
M,H0[U!"VN;$7%]=/A6[]5T=UK9U(K/V+>5677:G1DVO50QVB(B8[,[00!=$@
MJ?*-VB/?X?$&>;Y?E1R3P.H*HGZ3TOWW[;U[3V]P'^2Q94;L'ED/SCKMMH+'
MI;KXUZ)>-/(&F;-H[1I[Q#5N<KQ4(EU`'=)LA%%)`@-GC-N[,DL*3@I3=P=!
M$IRCU]H9U+@.:QN3PD^6.9/*4N.SM'@:X9[K]MYG"\E(#OEQY/,LECK<Z@]Q
M%;\L5]I=2:)OK):8*&:JJ$125?235`%5%!^01,#*]QQ'\@>S-Q/F8N*GJ9&0
MB)WD@5YW%P,[.D]+#Q))9+7LJDG3X"LF:NFSYLW>LUTG31VBDY:N4%"JH.&Z
MY"J(K(J$$2J)J)F`2B`]!`<R%964,INI%P:QF5D9D=2&!L0>H-??*U;3%*8I
M3%*8I3%*8I3%*8I5"'[RO[W/])>6U+V5_]#V,^FO_(9Q1_@G1OU,VR@[:N;K
M4W\K5M,4IBE,4KBO7K.-:.7\@Z09,6:*CEV[=*D0;MD$BB=599902D333*'4
M1$0``RC,JJ68V4=34D,,N1+'!!&SS.0%4"Y)/0`#4DUYNN</K+663LC_`$QP
M9Z2LDT=+1T[M]2,0?,Q6(!D'#>GL)1J=!5-NN(A[^L44C&3ZI%.00,/C).6Y
MGW%G?Y-[/Q6EF_5+8;5':;G0#Q/X:U]N^QOZ?/97V^]NQ?</^HSDEP\!U#0<
M>';UI#U42"(EV9A;^4FH!\[*1:J*[A4=O;@G'=@VKL:P6Z??.SN9>6G)9S*)
ME==QO-;L45%_(`Z(B).J9"()A\D@>'0.B<!]C!E;<OW5R;SSMJRJ2%OW7ZD#
MP`\*UWNG^LMN$B;@OLM[-P^&X6(;(Y7B1I2H[=@&T$Z&[.[7^:YKDM>/M52*
M`.%G2YNT`$P*JD$1#VF$"G``Z_DZ!G3<;[3^Q<8!5X&$@=^YC_VF-<#Y#^I;
M[Z<FV[)^XV<-?T"*/_\`EQI7$D./5?53/[@[<-U!Z=HG.=3IX@(_GF'IU#,;
M.^SWL;-1E_R9(V/:C.I'PLUOS!K9<+_53]]^$FBDB]^3SQK^B>.&56TMJ6CW
M_DP-_P`:[_6&P^5?$^QM;)IC9<_#M&Z@"9B@^%Y7'B0=W_09BN29G,4NW6[Q
M*4PI]2F'J!B'[1SD_N#[-\]P#2<A[/Y)GC47])SJ?`$^4_B!W5]!>W_ZG_MI
M]T,6/VW]_?8^.99"%&?`EBA/ZSL`ECU[49Q;Y@5O7IW]/[U9=?\`)Q2&U-MM
M-+76_0;>[^YNTS-J[='C8$R+*03H4R(LI%<PB?W)02FZ`/EB<`\/*\/[F$^0
M>*Y:$X_+H2I5A8$CL\#X?E7/OO'_`$X9WM#CV]^>PLU.7^VTP#I+&P=X4?5?
M4`)+*!8>H.A^8*:N/SUU?+%,4IBE5P<\]5/I:/B-CQ;,SM*.3-$V`J1!.HBT
M5`3-'1R@/BW`_<0X@'@)B]?#J.>`]\<9)-%#R,*DF/1K=@/0_@>M=8^V/-0X
M^1D\/D.!ZUF2_0L.J_B#I\*\V.RZ0M2+"HU*'=%R'FO(E7Q_U/>'G-C]1'HH
MU4.`?E*(#E.%Y(<AB@L?Y\=@W^H_C5/<W"MQ&?:,7Q9;LGAWK^!/Y5(;C_!R
M$96Y-^^:G:EEWZ*C(%2]BRS5NAV>?VC\HJ)U5!`G7IUZ"/LZ9Y3W-E0Y&;$D
M3AA&EC;I<GI7O/9.#D8G&323Q%3+)N4'KM``O^)Z5MJ:M=;KHIEFYEC''5Z>
M6DX6`%3`(]`,"1`,IV_EZ=,TD&)E9-_IX&>W<*]/E9^%A6^KRDCOTW&W[.M=
MRS>-GS9%ZQ<).6KE,JJ#A`X*)*IG`#%.0Y1$!`0'(71HV9'4AP;$'J*R8Y$D
M19(G#1L+@CH17<DEY5-,4DY%ZFD(`44R.5BD[0]@=I3@7IEZS3*-JS,%[@34
M;8V,[!WQXR_>5!/YVK=''W=;G35Z0F%C*N8:1`C&=8D.7S%62BI#'63*8!ZK
MM^G<3V=1\.H=<W'M_F#P^;ZK`G&?1P.[O^(KSONWVZON+C3`A"YL9+1D]]OE
M/<#^RK1YCF7HV-AADVE@=2[L4R&3AV<:](^\PX=027%PBDW;=OPB<X!\7P9T
MR;W;P<4/JKE[S;10#N_*VGXUQ7']@>YY\@P-QYC4'5F("_&]]?PJ+5G]0.>5
M7.2J5!BT;`J8"JR;H[A<Z0"(%-V$0*F!C!T'I\&>9R/?LA)&+@@+WL?[!7M<
M3[50A0<[E"6[D73\R17.I?J`2`.R(WFJMU&9S]#.X=82+I$'_2%!5,J1^T?@
M`P=?CR_#]^$N!G8=D[U-[?@:CY#[5@1EN,Y&\O\`"XM?\03;\:L<I]PK][@&
M-EK,@E(Q+\G<DLGW%,FH``*C==,X%.BND)NABF`!#.@8N5!FP1Y.-(&A8:&N
M39V#E<=E2X>9$4R$-B#_`*:CQK)\R*Q*8I3%*AMLCF)4]4<BXG2=UC5(V`F:
M16[$2]^>!F$3,6&Q6B#;Q\RV`@J-8Y7ZB3$'744TSJCYG:4.[-!E\]!A<NG&
MY"6C:)7W]@+,ZV([O)U\:[%[5^SO->\_MWR_O7@)1-FX6;)$^-;SO''##*7C
M/ZF'JFZ=2!Y;G2IBHK).$DET%2+(+$*JBLD8ITU4SE`Q#D.41*8IBCU`0]N;
MX$$`@Z5Q]T9&9'4AP;$'J#W&OIE:MKCNG35BV7>/7"+1HV2.LX<N%2(H())E
M$RBBJJ@E(F0A0$1$1``#*@$D`#4TJJWDQZCM?I#&4C-7'3=+(`=H%O=M_.05
M>B*I/(@(I9+OD51$H=BJG8F(_*#J4.N>[X7V5D90CR.2)CA/1!\[?V7_`#K'
MDR%2X74_Z?G5'.T>3^\-OO72MKV!9S1*YC^7")2RS=L)#&Z]7B<?[HT.<?#Y
M":9$R].GRO;G2L'VWQ&$HV8,=_$;C^)-[_NK7OD2/IN-JTD26E$R>6G)/B$\
M>I2NUR@/7VB/13Q$<W`Q<4+M&.FWNVBW[JANU[[C>MX:JY3;]TM(-GM!V38&
MC1%5,[BO2SL\Y6WZ28&*+=:*E/>T6I3E,("=MY1_9XCTS2<A[5X3D%;?AJDI
M_4OE/[-*F3(E0CSDCQKT)<0N?U"Y&H-:K82I4[:*::::\&X5*9C+J]G05HIS
MVD`!7,41(F<`[_803&*<I.1\][8S.%<R?/B?Q#L_WA_KZ5L89UE&FAJPO/,5
M/3%*8I7%?,T9!D\8."]R#YJX9KE'V&1<HG14*/L]I#CE&4,K*>A%JN1BCJZ]
M00?RKS1<L]!3M??3M->,S-Y.'>*2U77.`@VE&`'631%NIW"!D9!D`E*(CU(J
M4`,`"4P!QH)-[9YIXIU/T[7%^]"="/AI<?&OHQGQO>OME)L5Q]6EC;M651YE
M/@P)L>FH-5EQ4'*S,JC#1[%=Q(JN`;F;%3$3(F*H":IG`_FHI(FZ]YC"`%Z>
MW/:9&7CX^.V3+*!%MN#WW&EN^]<SP^/R\S,7"@A)GWV(_AL;&_<!VU9.B0K1
MHD0XD33;-TR&,(@1,A44RE$>H]`*0H%_S!G)"=S$]I-?00&Q0#T`_=6/1]VJ
M4M(#%1T_&O)`!,`-D5P,<XEZ]P)"(`142]/$"B.9,F#F0Q":7&=8CVD:5A0\
MGQ^1,V/!FQO./T@@G_;^%9>BX7;'\QNLJB<`$`.D<Q#@`^WH8H@8.OY,Q@2I
MNI(/A6:RJXVNH*]QU'[:^[B2D'0$!T^=.`3\2>>X44`G0!#J7O,/;X#ESRR2
M@"21F`[R3^^K(H(823#"B$]=H`O^0JS'C%RWI\+365(V-)J1BD"D9"*FSI*N
MFBS`I@%)DX%JDHH@=L!A`AC!V]@`7J'0`SI/MOW3B18<6#R4NR2,65CT*CH+
MCM'36N->\O8O(3<A/RG#0>K#,VYD6VY6/4@$Z@G73I>MBW_G9KJ!%1K36#^V
M.R@)0=G(I&1Q3=""`D,X2]X<%Z&Z]0(!1Z>!NN9V=[VXW'NN(K3/X:+^9_U5
MJN+^VG-9=I,]DQHNX^9O^J.GXD5'5?G_`+$,[,HA6H!-IW_);F.L<13\/`RH
MH]X&'\@9H3[\S=UQAIM^)_LKU:_:OC0EGY.4R=^T6_?4J=*\Q*?LJ0:UNPMO
MV5L;LP),A55%6,?KF-T(@FY\L@MEE.OR04Z%,/@!NH],]+PWNW#Y.1<:9?2R
MCT!Z,?`]_@:\7[B]@\CPL3YF.XR,%>I`LRCO9>[Q%ZF5GK:\#3%*8I3%*8I3
M%*H0_>5_>Y_I+RVI>RO_T?8SZ:_\AG%'^"=&_4S;*#MJYNM3?RM6TQ2F*4Q2
MO-KZSO,>S6&U0_!K24RZ0DYA!G*;BEHEVLW%-NN87D92U7;-4%2HBV0*[D2=
M.TR9T4A[N\Y0\ARHY#W'S.%[.X5K9$VLK:V1!J;D=``+GX@=37V__3M[2]N?
M;OV7S?\`47]Q,0/Q^&3'QT+!2TLI(3U45M"Q=O3B-_+:230*#58D?KZ'TQ3H
MRKQ:2"EJG6QUIN;\LA7;:/*8`<>[+%*"I7#U8X(I^/0B0'-[2AU^GO:/M'C?
M:W%XW%8,2[@+R26`9V[23VDG0=P%J^3?NI]T/<?W5]V<A[GY_)?^8Y$,.YC%
MCQ#18XU)L+`78@`LQ+'K73%*4A0*0H%*4`*4I0Z%*4`Z```'@``&>V&@`'2N
M9U_<4IBE?@Z9%2&34(51,X"4Y#E`Q#%'V@8H@("`X(!!!&E*UQ:J2K()I2-;
M47AKG"+EEZG88=4S&52?QQ1<HLU':`IN04`J75%0IP,!B%^$/E<0^Z7VTC]P
MXS<MQ*+'S,6H(%BX`)VDC6_\)[.E?4/].GWZROMKS:^W_<K-F?;[/_E9$$A+
MI$'(!E1&)70?.MO,I/;:O4IZ5'.8_+[3;N#NCDA=QZK+&P]R34,!%YU@J@*,
M=:")F4,H<SM9JHFY\`[%P\>@'+UX_P"UN;?E,63'RP1R$!VN#U/8#\;@@^/Q
MK8_U*?9Z'[8^Z<7E.`L_LKEU:;%==52]F:*XTL%963O4^!JU//55\V4Q2L>M
MAZ^G6YLUJ.T3KPQKLLN9_P"7[J#$R)BK^:"O4@@)!\`'VCD.081#+]01Z.T[
MK]+=MZGQ1D'(@^E#?4[AMV]=U]+6[:\S&SV]!CK"_L$HLT=5V"?ORUE61;E.
MH9%<X=BPM%0.*\@JFF4"EZ"("'7VCX<*"R-E9.+Q+NT3M;32Z@Z7\!7U*6A3
M`PL[W!'&F1$ESNL0K$:V[V/=WU"&<VK<9&6?NX^P2D='JKJ`Q9-E"-TV[,#"
M#<GE@4_:IY8!W#U'Q'/<8O!<?'CQ)/BJ\P'F)[^W\*Y?G^Z^6FR\B3%S7CQB
MQVJ+"R]GXUKYX]>R+E1Y(.W+YVKT\UT[64<+J=/``,HH8QNA0\`#V`'LS;Q0
MQ0((X(PD8[`+5YV?(R,J5ILF9I)3U+&YJ47'25?+-Y^(64.HQ9BU=M2G.)O(
M47,=-5-,HB/8F<"`;H'AU#/%>ZX(TFQIU%I'!!\;=#\:Z7["RYI<;-Q78F*,
MJ5\+]0/#MK<NPYMY7:9/2[`0*];,Q!LH(=?*56.5(JW3X12[^X/RAF@XS'3+
MS\7'D/D9A?X5ZWF<N3`XK.S(1>5(R1\>E_PJ`2LY-KN_?EIF55>@IYH.SR#H
M5RJ`;N`Y#^;^C$IO$`#H`?%G3UP\1$])<6/T[6MM']E<-;DN1DE^H;/E,U[W
MWM^S6LG<[.OSHC8A[3*)@U`H$,W6!`Z@E'P,X,0O5<WQ]?`<PDX/BD+GZ13N
M[];?#NK:2>Z>>D6-?\P9=O=I?X]]=Q'[2V,]EXLJ4VZ<K"Y;MTV)$B>0[$ZA
M2B19$A1,H*@>T>H=/;F-/P?$0XT[&':`I.XG4?"LW%]T^X<G-Q$7(W$L!M`T
M;76_X5/N/9.Y)RU9-D3*O'1TD4T$@$XF74$I?+(``(F^6/0/CSG2(TCK'&I+
ML;`=]=AEECACDFF8+&HN2>@`ZU>/HG7<QH[2D@TE5R+SGD2UH<MP,*B+%P:.
M3,DRZ^'>9(&H>9T\.X>@#X=1[7P7'2\/Q'H2N#/JQ[@2.GX6KYL]R\OC^X_<
M:Y$,9&*62,=A(!M<^)O5)++U!.5LDV2?_P")M=:`Z[E@:DHC!0C<ISF$J)5%
M)/O."9?#J/B/3.;K[LYQU#_7@7UML72OT>Q_Z6/M.^/CN>'S"S1J2?J3J2H-
M_P##KE?[>_*W[58#_P!`HW_QGE?^:><_\Q_["U+_`/:M]IO_`"3,_P#U)_\`
MRZ?[>_*W[58#_P!`HW_QGC_FGG/_`#'_`+"T_P#M6^TW_DF9_P#J3_\`EUH6
M\[5N>U+D[O>R[*TLT^YK<95"F;PS:'9IP\4_F9%%(S5%=R590[F<6[C"/B7H
M'3PS79/(Y.;D?59D_J3;`E[`>4%B.GBQKIOLW[:\#[!XJ7AO:^'+#A/DM.V^
M3U&]1DCC)!LMAMC73OO4]N%_.`NOGD1J';$LHYHCM<(^GW!\X4<+U1==4YFL
M)/N'"IC&@#**`BU7#_P8.Q,_R.AP]A[;]SK"8\#.?^2=%8_I\#X=W=\*^:/Z
M@?Z=).5BS_??LK"`Y11ORL5%`$H`&Z6%5'SZ;I$_5JRZZ5>0BLDX23704(LB
MLF15)5,P'343.4#$.0Y1$IBF*/4!#VAG2`00"#I7Y\LK(S(ZD.#8@]01V53E
MSIY'/;!8W6I*G(.&<!672[>T.VCI1`LU-)AY2\>L9)0H*1T28#$,0W4IU^[K
MX$#KT_V7[>C:,<MF(&)_PU(T`_B_LK!R)K?RU_&J&;C95;9/.)$5%#1[8QVL
M0B8QO+*V3.8#/!3ZB7WAZ?J83>WL[2_!G4(4_P"\/4]/A6O8W-ATK&<GJRF*
M4Q2NT@YR8K$U&V*O/EHV;B'*3I@]0451.11%4BQ4SJ(G36!(RB11^28IBF*4
MY1`Y2B&/E8T67!)!*@*L"-1?K_JJY6*,&7K7J$X.\U(3DA6&=;GTSQ.RX5H+
M.006.0Z$^I%-&QG[UFIW=_O8$5!91,2@!DC@H41#N`O"O<?MO(X64RKYL)F(
M!_A/8I_#H>VMM#.LH'\56"YY>IZ8I3%*KU]0']D%*57RK.FJ=_0D"G@4>PIW
M!X9<PIR1W1B_I4VB*A2J)]?`ZA1*'3N$Q?#>^1A'`A]5@,P/Y!VD?J'@+:_$
M"NG_`&O/)+RN1Z"$\<8SZA)\H;JA'>U]+=;$U07LFT0NOXMS!4Y9LUMTH_%U
M+OVJ*1GR"3HZKMXN[=``F3<KJ*%*BF/4"$'KT#IU'R/#X$_*3QSYP9L%%L`2
M;&V@`'<.TUT#W'R^+P>-+C\843E)7NVT#<`;EF8]YTV@_E85'20NUOE6YFDC
M99EVU.'11NH]."2I?^"J5,$_,+^0>H#\.>PBXOCH'$D6&@<=MKV_.N=9'.\S
ME1F*?D93$18B]K_&W6L?:.G#!TV>M%3H.F:Z3ANLD82'261.!R&(8H@("!BY
MERQI-&\4B@HP((/C6N@FDQIHLB%BLJ,"".\595"NU7\1&/ER@19VQ;+JE*/4
MH**)%,?H/Q"8<Y#*@CEE0'0,1^1KZ'@D,L$$K"S,@)^)%1BW[:9IM-L:^R?/
M&,>6.(\7(S<*MO?%7"BA`!<Z)B'.FD5/P+UZ=1ZCUSV'MC!QI8)LJ6)7DWV%
MQ>UAW'OKGGOCE,V#(Q\''G:.(IN;:2"Q)M8D=@[JTC!7*T5M8Z\/-/FPJ%$J
MJ)UU'#97KT^4=NL8Z?>`AX&``'\N>CRN,P<Q0L^.NG:``?S%>,P><Y7CF9L;
M,>QZAB6'Y$]:[5IL^_,UG"Z=HDEC.0$#E=*`Y2((]1[D$E`[43`(^';\&0/P
M?%.J+](H`[M"?B>VLN+W5ST32,.09MW8VH'P'96_=%VJV6)>=2FWSF4CVR2!
MTG;L`,=%XH<>K<BI2E`2G1^4)?:'0!^'/+^X\'!P_IOID"2->X'=W_G7N/9O
M)\IR0S3G2&2%;68C]1ZC\M:L<XTZ9G]K7ADNQ/[C"5MVRDYF4.(E*BFBY(HF
MW0Z`/G.W)DA`A`^(1$0`!'(?;?#Y')YT<B';CQ,&9OAJ`/$UD>\O<.+PG%S0
MR#=EY",J+\18LW@/VFKVBE[2E*`B(%*!0$?$1Z!TZC^7.V5\U5^L4IBE,4IB
ME,4JA#]Y7][G^DO+:E[*_]+V,^FO_(9Q1_@G1OU,VR@[:N;K4W\K5M,4IBE8
MI>[2SH](M]SD#%*QJ=8G;([,8>A0;0D6ZDEA,/B(%!-L/7\F1RR"**25OE52
M?R%ZV'$\?+RW*\9Q<`_GY.1'$O\`O2.$'[37B/XX/);<^TMO<B+CWNYZUVAX
MNBLYZ*G3-(J*NEBD5$`$0:M_)0`0]H)_DS:_8KCOK![A]V9*WR)I_20]H50&
M;7QW*/\`HU]F_P!:7*8_M?&^VGV9X9BO%<9QJY$BC16=R\,=QW@1ROKT]06[
M:S39#\7]VF>@]4HPC*(2\?:+9L1VY'X@`';XY/\`VF?1D(-I'`UOI^'^VO@9
MNMJC?4-CS=GN=JJ+RD+0A*BJW0D992P1L@DHL^9H2$>5!HV1(N8KEHN`F'K^
MC-X#US#XOD)^1.<9,/TD@E,3'>&O(%C<J``--D@.[I<$6IDA(,B/&5]S-&)`
M;6\C,Z@_$E#IV7O770&Y49ME(V=6L/HS73!.Q+?MTYDXP[06];.H1T\<1)%`
MD6K1UY"GDFZ',;L\2EZAF+C\ZDF`G+9.,8>)D@]:.0L&W(2H2ZCS*TE[HMB3
M:VAL#*V/?)DPX'WY$<OIN.FUP#NU.A"$69NFMQ<7-8C8.4U`C80D_"-Y*RL_
M=[.JY3114B7C)>L1+&96:.F<LBW<IG>LI!,R)A+VB4P#X@.0Y/N;$@C:6*)I
M(PA)_20PR<?&9"#J&#9*N0?TCQ%6I$'9$+V8M;\/1EF#>((B8`CM^!K9]3VU
M1[I892J0,HHYGH5L=S)LS,7J2"((*MF[Q-&05;D8O%6+IV1)4$E#B0X]!S<X
M^?AY>1G8^+-O:"0JQL0#M=XR5N!N7=&PN-+CQJ'S*F.TB[3(@8=O5%>Q(TOM
M8&W7\JV:DN9JNU=$#J=J[;.2A\`BBN0_0?R&`!#_`#Y/,+QM51H0?&I&<%+2
MMQF]2JHQ30QT:CO0KNGNT2F%)`SJ:5!6.#RR]2JBVF?(Z=?9YPC[<^0/>/&Q
M^V?N:IQU"XN>A:PTL6)O_P!H"OT+PLY_NW_2%R:YKE^:]IY"E6.K>BB@]3J!
MZ1<>.SNKV'`/4`$/8/B&;ZOA*F*55KSFW-(*RJ>IX=<[9@Q!L_L)DSB4SUPL
MB"S-LITZ?H&Y3]W;_I'Z#_H^/-O>W+R;UXJ%B$M=_'N'P[379OMG[?B]-^>R
M%#/<K$.[^)OCV"J9MS:^L5Q^J7T&JFY"+1=)GB5500$YUS)&!RV.<P(F6[4^
MP0-T'I[!]H9YS@.4Q>.:=<A"-]O,-;6[.^U>P]V<'G<Q'BOAR@F+==";`DVU
M!Z7[-:APY;KLW"S5TBHW<MU#HKH*E$JB2J8B4Y#E'Q`Q1#.@QR)*BR1L"C"X
M-<AFAEQY9(9D*RJ;$'L-?#+ZCK:.HK,]KUQCT$#%%G-K(QC]$_0"&35.`I*E
M,/YJJ"O00^,!$/AS1\_AQY6!)(W^)$-P/[Q^->I]H\C+@\M#`NL,Y",/W$>(
M-2GW!)-X[7\\"X%,9^B2.;IF]AW#E0H$'_YL"B;_`#9XKA(6FY3$"GY6W'X"
MNE^Y<B/&X3D&D_4FT#O+:"H#YU&N%#H*8JM2"X]PC9[8I.8<$*H>'8D*S*8.
MH$<O%.P5P^`#D13,`#\'=GD_=>0Z8^/CJ?*[$G\.S\Z]_P"PL2.3+S,QQ=HE
M`7P+=3^0M5CVBGK"/VQ2'4D@"[5.>8B<HE`P$'S0Z*B!O`03'QSS?!.D?+X#
M.+KO%>S]TQR2^WN62(^?TC^0()J^F[_^1MK_`/X[,_J]QG<Y_P#`F_W3^ZOF
M/!_\;A_^]3_TA7A];[`!HE[KYPA[NHNCT[A\/+74+T_WL^7_`*O;Y;#2OZ#^
M+]OF7C..DV_-CQG\T%??_$@/^?'_`)0X^M\!6=_RX?X?V4_Q(#_GQ_Y0X^M\
M!3_EP_P_LI_B0'_/C_RAQ];X"G_+A_A_96>:S9W'=5SBM<4./-+ST\<41*H!
MA8L&0AT<OY(_3M(T03ZB)?:H/R0]OAM^&P\OFLQ,7%7XMV*.\USC[H^[O;GV
ME]KY7NCW%+HND42_XDTA^5$'_I-T47)[CZQ]7U:P\=^+S6"G;))6V;U[0I1P
M$O*K'=.E7#&/<.FC;O5,=0&3-4"I(D,8PIHD*7J/3/H?A^/^GBPN/]5GU5=Q
MZZFWY#L'97XD>^/<P]X>Z.;]S#BX,,9<S2>C"NV-+]P[2>K&PNQ)L+VKSI[.
ML:_U7;;`NJHH]D0D5?..?JJH]EE%0\Q0_M,H*K@3&-[1'QSZ6QX%Q\6#'C%E
M5%4?D!7/V-R6-0-LDV%6@'LS]5R,NE%MC+K,HDK4[P6S=,3KJID=N6B)BH)$
M$PAW@/0/`!'PS(Y#-3C,.7,DA=X(U+-MM=54$LVI&@`[->X5;CP-D2I"C`2,
M;"_:2;`?$D]NE86VVW!J:]3V2^BYV)A716`QK-\V:FE9099PV9Q!&35F\=$,
MI).G:9$RF.40$>INT`$<LGY./'P\;+FAD#S,JI'8%V9CY0`#:Y'FZZ+J;6-6
MP)]09-C@1H"2QT4!>I/@#ITU.@[*Y*&UJLWC1D+49U01"5^IRM;D1"*66>F2
M*X2*T6*NX9ODU4#@8#HJG*'B!A`P"`47EL,)$<A_0E=V0))Y6W*0IL.T7(L0
M2#<6-#&_\PA;HH4DCI9A<:]]@;CJ+:BNK+O&AA97U8<O5F"\:-F]]D7J::$0
M@E5&U?=RBYWIE>T$!1LK<4S=/E_*^+QM@YC"F.?ND]-,9'9R^@`3).*?Q,HT
M\-:M=2DD$0&YY&`6VO6+UORV?MK94'/0UFC&TU7Y-G,1+P#BUD&"Y'#5?RU#
M)*>6J01*82*$$H_$(=,V,<B31QS1,&B<7!'0@]HJVXNP[0;'XU,?AM=G]%W!
M#S;%=1`8Z9K<J(D,8.[M=N8J13$"^`DD(9X=JK\:)Q#-'[BQ$S>,SX''6$D>
M!3S`_G4^.Q606[_WUZZB&*<A3E'J4Y2F*/QE,`"`_P"X.?/-;BOUBE8];;$T
MJ-5LEJ?`(LZW!2LXY*`]#'1BV*[TZ91Z#\I0J/:'Y1R'(F7&@GR'^2-"Q^"B
MY_=61B8SYF5C8D7^)+(J#XL0!^^O/=LV_P!BV=:I>T6%XHH_?'430#N$Z<>U
M*=7W1FT*(@!6S(%!\LH=`Z]1]IC"/!>1Y&?E,N3,R#<DZ#L"WT4?Z=:^JN'X
MC$X/CX>.PULBB['M9[6+'Q/9W``56;L'75GJ3IW*20!(QCR06$LTB?O!59TH
M=8HO4S"*S==7J(")NI1,'0#>S/><1R^%F1Q8T8V3JGR?#N/0]_?7*?</M[DN
M.EGS9CZN,\A.\'7S:C<.H[NZM99O*\O3%*FSHRSOY^KN64B<%EH%TDR07$0\
MQ1DJAYB!%0^$Z)BF+W?"7I\6<X]Q846)FJT(LDB[K=QOK:NS>S^2FY'BV7(L
M9(7V7[UL"+^(Z7K3&_I)L\N:+)$"BK%QC=%T</:*K@QG)4S#\::2A?\`E9Z#
MVM"Z8,LK?*[Z?AI7D/?>1')RD$"_/'%YOBQN!^7[ZT;GIZ\13%*L-UQ`MJY3
MH9BW*`&6;E?NU```,N[>%*HHJ<?](P$`I`_XI0#.4<GDOEYV1,Y_58>`&@%=
M]X7"CX_C,3'C'Z0Q\2VI-70>GX\9*4>XLDD03?(3C-9RKVEZKI*-5"HCW!\H
M03$@AXYT7V&ZG`RT`\XEN?Q`M7'_`+J1N.6X^4G^6T%A^#&]6"9[JN74Q2F*
M4Q2F*4Q2J$/WE?WN?Z2\MJ7LK__3]C/IK_R&<4?X)T;]3-LH.VKFZU-_*U;3
M%*8I47N;97:G#WE`DP\P7JVA-M(-02*8RAEUJ).II%(4GRS&$Y@Z`'B(Y@\F
M">.SP/F]!_\`T#7O_M0\47W1^V\DY`@7G^/+7Z;1EPDW)T`M>O*'PW^KS:1@
MS,R@#DCB42E3`)1ZO_VELRJ?=V^)1^JU&W@/CT\?8(9[K["LI]DRJ#J,R2_X
MA?\`5:NR_P!;T,\7WUSGF!V2<9B,E_X0C*;>&]7Z=MZQRU%.2TV8BG7S"STG
MWB/M'S')EDQ_+U05)T_)TSND'^&/B?WFOCYOF-:?5UA4W<G:).0;O)`]M?Q$
ME)M7#Q1)JF[A&"4<Q.S!D#1RD4$$@$Q3J*`8W4?`/#,2/C,2,3@H6$F7]3J>
MDOIK%<6MIM4:&^I)[K5=V>83WL_TZPZ="BNSB_CN8W/<!^.(!H&I?5,_6CS5
MO5IM@;6)LM2SRK`M=8!9C">058)I1"<D)T53"=N5PY<)(&$1*3->WMO#?`_R
MR3)G;`6,)&A9=L2JZNFP!!<QLB[/4WV%QJ":G&4ZY#9*1JLC,6>P/\PLK*Q;
M6_G#'=M*W.O45CYN+6N5:^6NK/;(=OY<^FJ\04KD<\7+8HEA"NQ5)$UIA'=S
M=C&I@B)6Y1`XF,?O$PY6;VW@31O&[R`,"#;8MRV1!DDV"!0=^/$NB@>F"MKV
M(ACD,90@`[;6O?H(I(;7O<^65R2226(-[:5E]2TA5*9?)G8<5(6%69FV"\<Z
M9NWD=]4E0<+LW)U/(913)X\<)J,P!)1VNY,B4YRD[2B`!G87&08&7R.9$[F7
M*9BP)%@6D:0V``UN=NYMS[%"[NMXY?YHQ%;00@!;?W8Q&+]I&T7V_+N)(4:6
MWA&,#RLI%Q:8"8S^0:MQ`H=1!(52G<'Z!\":!#&'X@#,R<VC8=IT_.KEU85O
MFS1B*',#T_'K,04D7^\4';A-+Q438L[7K<B)U`*'>!/,(X#J/@'8/Q#GR?\`
M>.3UO?WM6*/_`!$,=_AZH)_97WC_`$WJ\7]/?]3,TUQC/QH52>A;Z;+!`\?,
MOYBO8HE_JT__`&!/_>AFPKXKK]XI4*>0W$AOMJ;/<*Y,)0]C<)HI2*#X@F8/
MBMTP215*HDF=5%8I"]!Z@8H^WP^'R'/^UDY:494$VS*M8WU!'[P:Z#[3]\R>
MWX&P,K&]7!O<6-F4GKUT(/=4%;SP^VS2&:TBLWBY9BB'<9:+?E6,!`*)C"*+
MA-JN8P=/S2%.(YXG-]H<MAH9!LD0?PG7\C:NE<=]PN`SY%A8RQ.?XEN/S4FJ
MD>0%7=,[4E--6*IFK]F5!^N@D91).49*JI*$7,F42I+&0[`$#=!'M'XLV7MG
M+5<>;"G<+,CZ`FQL?CW&M-[WP'?+QN3Q8B^/+&`S*+BX.A-N\?NK3<35K'.K
M%1B822?&$?$Z+1;R2`'M%1<Q2HI@'_&,&;_(Y#"Q03-DH/"X)_(:UY/$XCD\
MY@N-@R-X[2!^9TKO'NN+_$*('/6I?S!4)Y"S!`SSL7`>Y,>]H*OE'*8.H";I
MF+'S/$Y"NIRD"VU#:7'X]:SY?;7/X;QNN!(7!!!3S6/9TZ5)Z]U*:MNN(\)%
M84;!#-/K5PAV]2NG"+8P.&ZH%Z]JQD@Z@(>P_7/&<9G0X'*.\:WQG;:.\`G0
MUTGF^+R>6X..*9]N;&H<@="P&H/Q_?4)O][\@_!_ESI-<5^-?WH(>(@/3X_@
M'*7%[7UJMB!<C2I?<>H1RR@I68<I*)%E7:1&GF$,3S&S5,>JQ.X`[DSJ*#T$
M/`>F>!]T9*39<4*,#Z:Z_$GI76O8V%)C\=/DRJ09G!%^U0-#^-ZG7H2FRMUV
M?6(R,;K*E3D4'3U9-)0Y&K-N;S5EU#D*)4P*4GM-T#KX>T<P.`PY,WE<2.-3
M96W$]P'?6T]U\C#QO!9\TK"[(44=Y;30=O?5_C]DC(L7D>Y#N;O6R[5<O_"2
M<)F24#_.4PYW4@,"I&AKY>1F1E=#9@;@^(JMQ[Z47$9Z\=/%*24BCMPLY4*F
M<")@=90RA^TO:/:'<8<\^?:GMTDD\3#?X'^VNMQ_?S[S11I%']R.56-0``)C
M8`"P`T[!7&_"8XB?^98_]]#_`+3*?\I^W?\`RB'\C_;5_P#]P'WI_P#W+Y;_
M`.<?[*?A,<1/_,L?^^A_VF/^4_;O_E$/Y'^VG_W`?>G_`/<OEO\`YQ_LJDGG
M5P?&N<Q-;Z&XV51\@PM>N8&9EEDF[EQ'Q;E[;+3'NI:1603,1%-)DP)T`>@G
M[``,YK[I]K')]RX'&<+AB+';'5G(!VK=Y`6/76RC\J^]/Z</ZB4]L_9+WY[V
M^Z?NB;D>5@Y5H\2*:4&:8C%@98HP;';O>[$`A=Q)KT"<+.$U`XJ4A@@Q;%E;
MS(-$E+)9WJ29G[YX83G.4#^64R+9+S!*FF'@4H?[O4^$X3#X/#3&Q4\UO,QZ
ML>\_ZA7Y^_=G[M>ZON][HRO<7N3)/IEB(8%)]*"/0!$4DZV`W-U8ZFI0;C0!
MSJ;92(IG5`]&M'R$QZ',)(9X<O;U`?88O7_)GHL([<S$(/25?_2%<L;Y3\*\
MINWTE/V1>@0I@*C(,#*EZ=1!,JPE$#!X>PPAUSZ-0Z1$GNK3MT:HFR\>66BI
M2*44,B23CWL>=8A0,9(KULJV,H4HB`&,F"G4`$>@B&2<AB+R&!G8#.56>%XR
M1J0'4K>WA>]5QICCY&/D!;F-U:W?M(-OV5IR1T5"R5-AJLI8+"FO7XRO-(J1
M3?.`9(/JP\:/XN5/7C.!BE5P=,R^8`@!CIB8H'#J!@P,SA8\DPRIDR)E1/$Z
M,2657B4*"(R=MBMPP%K[B;@ZU;CRB&%L=T#0,C*PZ%E9BVI&MPUB#KT&EM*Q
MV\<?'6QD8=Q;KXO)S42M+)%=?LVS1A@B)E!L@ZCFD$20[D5BE9D,1==TZ^6)
M^Y,Q3`4N#F^V4Y&6+(S<TR3;&1R46Q1I%DLJWLNW;8%M^AUUL1-'EO%&8T0!
M0P9>NA"%#>QNU[W.JZC3MKA2/%^!?/95VG8G2"<BTM#1%DK#Q[QHU)8V=.9E
M`R*IRIN$H\M.2$"]""?S3=!()2CD[>WU*\H/JCOR=VI6^TMFG-OH0=&.RX*M
M;S`AJQEV*<,[3:$`"UA>V-]/W6Z>:UB+Z6M6W=5Z_+K*G,ZD6:=3P-'<@[^L
M':1D3B+]THY%!--1T^<^2AW]"BLNNJ;Q$QS".;;`Q!@8.+A"0OZ:VW&P)U)O
MI\;#J;`7)-R;6)>:>9CK(^ZW8-`+"Y/=?XDVL+`3?XLUU:<O34R8'[)"Q5JM
M-CE`1\QV=^FNY*ETZ]QB&>H)^'^F/3VY@\S,L6#R$I^5(&_.Q_V5-`+LOQKV
M`)D!)--,.H@F0I`$?:($*!0Z_EZ!GSG6YK]XI72V2`CK57IRLRZ9E8NP1,A"
MR"91`IS,Y)HJS<`F80$"J`DL(E'H/0W0<BFB3(AE@D%XW4J?@18U-CSR8N1!
ME0M::-U93W%2"/VBJM[;P"N;9V\5J-DAY5EU.HU3DSK1[PP"(B":H)-5T!4Z
M?$(%_P`F<TRO8>4KL</+1HNP-<'\Q<5VG!^Z>$\:#D>/D6;M*$%3X@$@CX:U
M"_<>D;70VC^O7>-0;H2S9>.26!=NNU<+.&QA3!-0AS@54!'N(4W:IT+W=OAG
MF<OB^2X6>*7(CMM8$,IN-/W?C7M..YSA_<N-/!B37WHP*L+&Q%O@;>!-5(NX
M>48/5XYTP>)/6RRC=5`S98%`52.*9@*7LZF`3%\!#P$/$,Z-'E8\L23+,OIL
M`;W';7&YL#,@GDQGQI/55B+;3V&VFFH/8:RN/UC?))M[VVK4B5$2]Q!<I@S.
MJ'QI).C)*'_S!XY@R\YQ<3[&RE)\-0/Q%;6#VMSN1'ZJX#*MM-WE)_`ZUM#2
ML!=8*YJ$>0\K&11V;I.6%ZU7;MCF*B<[+L.H0$U5@<]O;VB/R1'X,TON'+X[
M+P4:*='R`PVV-R!VW[A;]M>F]G\?S.!R<RY&+)'B%#OW"P)'RV[";]W96/;P
MJ:L%:%)HJXKM+*HJ[(!BB!VSI%-!)=N)OS3E$``Q/A[>H?!F9[:SAD8?TI6S
MPC\P2=:UOO7BSB<@.0#DQY![>QE`%O@1J*TK[?`/$?B#/25XL`G0#6NQAXUS
M,2T=%M$CJN7SQNV3(0HF-U55(0QQ``$0(F4>IA]@`'4<Q\J=,?'FG=@%52?V
M=/QK+P<67,S,;%B0F1W`^`OJ3X`=:LL:-RM&S9JG^:V010+T^$$DRI@/^?MS
MD3,69F/4F]?0BJ$547H`!^6E6\<!JG)Q-(LMC?(*MVT_)-D(X%4E$_>$8\JW
MG+I]Y2]Z8++]H&+U`1`0]H#G5?8N+)#@9&3(I"ROY;]H46O^=<*^Z&?#D<KB
M843`M!'YK:V+&]OB!:I]Y[BN8TQ2F*4Q2F*4Q2J$/WE?WN?Z2\MJ7LK_U/8S
MZ:_\AG%'^"=&_4S;*#MJYNM3?RM6TQ2F*5B]VKK2W4^SU=^F"S*PP,M#.T3`
M`@JWD6*[19,0$!`0.FJ(9:ZAT9&'E(M^=9.'E38.7BYN.VV>&174]S*0RG\"
M!7BOTK`2N@=W[FXRVD5&+F%L;N6K;5UX>^(`FF4'#=8P!YX.89-N8!Z]!$IA
M#VF$'V8Y8<%SW-^SLN3:LK>I"#VD#4`^*6/C8U]P_P!56#%]T/MM]MOOOPD'
MJ6Q1B9K+_P!W=R4#J/E"SM*OAZB@]166[;@E(ZP$GB)F!A.D0175`.J:4PT0
M*W*13I_JQ>,4""41\#'3,'7J(`/T]$VURIZ-T^/_`.%?GRX[:U;F35E,4IBE
M?P1``$1'H``(B/Q`'B(XI4@=64L8\A+7,%!-TZ;&&,14.4",8QPFFJ+Q7V@F
MZ=(AUZB/Z-(>G@(CF#)*"&E<VC4$_AWFIT0DJBB[DVT_=6T>$$"7E)ZB=>M$
M>BK(Z]XY0!3-GQ2`1E]?%<.O+6`W:`*G7E5U%"B'B/NX"'R0SXPGY`^[?N!R
M'+JV_"QRVPZVZE5_/4_`>%?HA[RP#]D_Z6.*]GY`$/NGW+.LDR'5Q'M1W![M
MJA$/9YB.IKUE@````'L```/\@9[BO@>O[BE?!TY19-G#MP<$V[5%5PLH8>@$
M21(90YA'\A2CE&(4%CT`JJJ7954>8FU4)\A^0LYL2P2LM)3BD;38@RWU8R*J
M9NP;,"#T!TL0@_IG#DH`81-W&\>T`#V9Q3FN9S.:SFBB9OI]UD0=OB>\GQKZ
M4]M>W./]M\:LV1&@S"FZ21K';VV!/0#PZFH*J[FULY?^[BXDTRKJ@"DDFT=(
MLS"(]/-63*/<8G4?$PIB/3(O^7N6$?J>B+C6UQ?_`$_&L@>\/;YF]$9+6)MN
MVD+_`*>-JR=:^T!F9NW/<DB>\`0R0(.143`IOS3*'0:'(B`C_P`,0$/AS#7B
M^1<,ZX3FW73^VMD_-\/$T:-R<8+=/-?]V@_&OZYV'3F;E-JG=&!W*P@5,BYO
M>6X"(]`*JZ;(%(CW=?:)LHO%\@Z&083[!UTU_(]:JW.<1'(D+<G%ZIZ"]_VC
M0?B:S-.1051[7A?**LF8HF#JLU724*)1,BX2`Y#IG(;X1`<P2"#8=:V@*GKT
M/Y$5IFF<<TI2RO7:8*V6,;+BZ9Q#!)94_8*O>F62["`)TB"8`$I1Z&^'/4R<
M]G96*F/B0,)]MF8"Y[M+=+UX6'VGQ>#GR9F?E(<8N2B,0HOULU[7MW?G4E!T
MO-.4T6IM9OE41,4B*0U-P9(!`?D@3_H`D\/R#FH7$YF^Y8,C<?!JW[\A[<*^
MD^7AE5[+I85-[3'!V:LT2WEKTHM48XP)`PAT4DR2!VP`40,*`%$C-/M\"E,`
M&_(&>HXGV9/EQ^OR4C1W.B_J/B>MJ\1SWW(Q<"7Z7A8DFVBQ8WV`]R@6N!^5
M60:NTQ0]11QV51B_*<N2D*^EWA_>9-[V=>TJJX@`)I%$?`B8%+\(@(^.=`XW
MB<'BHC'AQ6OU)U8_$UR;F>?Y/GIQ-R.1NM\JC15^`_UFYK:V;*M-3%*8I3%*
MQP]2KJEA"U*Q+-2P%:)L"RAT$S/"-$E%54VY5A+W@D11<Y@+UZ`)A'X<MVKN
MW6&ZI/5E],0^HWI`D[;FUS8$VZ7(`!/6P'=61Y=4=<1^Q;2;%[&O4P69R#1R
MQ=HB(@"K9VB=!=,1#Q`#I*"'^?*@D$$'44KS.<BM3/*1>+YKV9052:G>21(M
MTH`#[U$/%558>32.`=IA.W,F8>@?).!B^T!SOG`<BG*<5BS!AZH4*W@P%O\`
M;6KE38["VE5J+M7;%PX8/TO)?,ECMG:0_P"BLF/03%'V&34+T,40\!*(#GI8
MW#J#V]OQK%(L;5\\OJE,4IBE=A$Q$A/232(C"%%V[,8154$`1:MDA(+IXKU_
M.(W3-U[0\3&$"A[<CE?8NGS'I5P%S;LJWK@-JII);II3%HT,:"HR;RV2:AA+
MW+.8U$QHU=P80'O<N+,Y:KFZ=.H)&#V>&>&]ZY@Q>%D@#?S)V"_A?<W[K?C6
M9C+>0'L`KT)YQ>MC3%*8I48>5NX'NI=<&5@7)&MHLCKZJAW`D(H=DB4H*2+]
M-,_R3+(HF`B8B`@4Z@&Z"!1SSON;EGXGCFDA(&5(=J>'>?P'[;5Z_P!E<!'S
M_,+%DJ3@Q+ODMI<=%7\6M?PO5!NR=L1;%R=Q>IMY*2<J8[L6ZOGR+YP/7M%P
M8!$WE%[B]`,8Q>HAX>P<Y/!B<GR\DDJ[I&OJS'2_Q/[A7>\KD.$]O00PR;(8
M[>5%6YL.VP'[2>M8-!;(UY.%561FUHE9`!$S>44.V5*F4/`R*CHJQ%"`4/84
MXB'Q9=D\/R6*0KXY93VKJ/V?ZZLP_<G"YRL\6:$8=0_E/[>OX&NU:[`H;PCA
M5O=4R^[AU5,NX\H0#QZ&(FY9D%8/#_0`PY"_%\C&55\%[GII?]U9$?.</,':
M/E(R%ZZV_>-?PKG0=WA9U91*$FFDZ"`=5FZ)#MY$A/\`GDVZQ$`<I![1$H=>
MF1Y&!E8@!R<=D!Z$]/SJ?#Y3`S]PPLQ)2O4#J/P-KBNDV55&%^AF[)*02823
M!V#IDJY(JFF`G(9%=%<@I]_:HD;PZ!X&`!S)XGD6XS):79NC9;$?M%OQK"Y_
MAX^;PEQO5V3*VY3W'H;^!%99KKCX[@XEJY:U*0L+]XD5568"(7?E5`_0.QB0
MJ"H)-BF+X="]PC[1S*S<KE^4DWQP2B#]*J&M;ON.IK!XW"]O\%#Z<F5CG*'S
ML[+>_:`#T`[K7[ZW?1..=QM-F:LH/7CF/?N5DT'$HO`C%D:I*F[5%G#UPV;E
M32(7J)OE=>GP#EF/Q/-YTB8OH2[+CYKA1XF^FE29GN#VUQD,N=]5CF0*;!-I
M=O`;1?7QJS;7G!.B0#AK(W.1=V9PAV*&CD5#M(Q10"B!BJB0I'2B8&'KT*8@
MCT#Q^#/>X'LGC\=EDRW:5AV=%_9J:Y3ROW+Y?+C>'`C3'0_J&KV\"=!^53CC
MHYA$,6L9%M&["/8HD;M&;5,J3=NBF'0B:290`I2A_OCXY[-$2-%1%`0"P`Z"
MN<R222N\LKEI&-R3J2?$US<NJRF*4Q2F*4Q2F*50A^\K^]S_`$EY;4O97__5
M]C/IK_R&<4?X)T;]3-LH.VKFZU-_*U;3%*8I3%*H$]7?A+<+7)5SE;HM@F.Q
M->M4DK!&,FX`\L,,W<*'3-T1(!GCAD1TJ42*#T50.8GQ!GC_`'-Q68\F+S7$
M.4Y7%-P1HQ`-]#WC7X@D=U?6G]-GW;]O<!#SGVL^XR>K]O\`G+@E_-'CS,H7
M<5.BI)M0,P%U=4?L)JMW5^RZ?OVIKQ_E)M;,@P50N-)>#V2D4[:*`@X>LDC]
M57#$%@*LDN0.]$P]J@$.7Y7;OM_]SN-]TXL.!R4@@Y]!M96T#D?J0GMTN1U!
MOV:US[[Z_P!/ON+[3<K/R.%$V;[#G8-C9:#<H1Q=4E(%E<7L#\K@`J=;5K:Q
M:[L=<75!%JXFHLORF[]F05G14NOR2/VA0\TJQ"^TZ8&(?V^'7IG7DFL`)/SK
MYP*=J]*P,5DRF[#F\I0/`2+`*)P'XA(J!#`.3B1&Z,*M-QU%!71*'45D@#X_
M,)_VV5+*-215+UF]/I<C:7:"RJ!VE=24!5](.0.B#I)(0,+6/*<H"N98P=IS
MCT3(3N'J)N@9C2S!E*H=.T]EJD1&8C34]!VFNNVUM^2N4NVT+HMJYLE]L[DD
M`JXA^XS:*14$6[A%NX;&$073#H4YP^0D3J(CU\,^?/N7]RHI(Y_:/M63UN4F
M\DDBGRHIN&56'5NPGH!XU]Q?8?[!1\+C1_>7[PJN#[+P$$\,,H_F9#BS1EHV
M'R']*GS.;"UM:],/IM\+F/#_`$PE$2)6CN^6D[:7MLJDB0%%'@MB@5H1<R1%
MSMF8G,4G</PF'X1SQ?M_AH^%P5QP0T[&[L.UO[!V5QO[W?=G/^[WO/(Y^9'B
MXN(&/&A)OZ<0)()%R`[Z%K=P'95C>;RN.4Q2NAM,2>>K4]"IJBBI*1+]@FJ`
M]!3.Y;*)$,`A[.AC9%/'ZL,L=[;E(_,5/C2B#(@G(N$<&WP-Z\M/(:+>L:C9
M6"AB%7CI5!-\"1OT8BTDP0=$((?GIE6*/;\8`&<3X-/I^:BADU969?QL17TK
M[GE^L]LY.3"2$=$?_HD@D5`+.DUQ>F*4Q2I0Z%O"AU%:9)K*+=2G=0JJIQ/V
M`0!,Y9=3B(@7I\M,/@\0SQ'N;C%0KGPJ`I-G`[^P_CVUT_V3S;RA^)R7)=1N
MC)/9VK^'45<M1]R4'ACQU;;SNFK-I[!C[3,G:3$OJ^N52PK5AH$@TAHI"7)8
M;=5#-T9&4<=I/)%<3&,'<!0#KGJ/9T&/C8N`OIDY6;)M5K"Q8W"QWO>YL2-+
M==:\-]PLO*S^5SXQ*!B8$6YEN;[0-SR6M8@7`.M^EA4V8CE_QX=0+.8L5\@=
M>/SEL)96I7F1A8RU5B0J,6>;M</86,;)2[!G*5R(3%P\32<K%22\>X<]I)+C
MQAF]=&C5;E@;BV\1G6PZ2,(S_?T%ZYY%C94R*ZX[V+*-1VNI=/\`K(-P_NZU
MQ*9SEXA;#GVM7I?(;6%@L#P9(K:+96)`'"AH=L9Y)%_3E13(9HT**I@,8!%,
M!,'4`$<O;R+*[Z(B,['N539B>[:>O:.VHQ&Y:-0I+.P4>);Y0/CV=]?-MSJX
M?/*V]M[7D3J]Q6XZ?0J[R62L2!VZ,^Z;NW36,[`**ZCAVV8+G2$A#%5*D82B
M/:.6"1"V.H/FE)"#M:P#&P\`03X&I$QIY&G1(B6C`+?W06V@GP+>7XZ5*.-D
M6,Q'L9:,<IO(Z3:-W[!VB(BDZ9NTB+MG"0B`"*:R)P,'4`\!R5T:-VC<6<&Q
M'C6.K!@&4W!KFY;5:8I3%*8I3%*8I45^3G&F'WU!-W+11M%7>#0<EAI91,"I
M/45"]X14FJ0AEA:BN4#)G\11,8P@'0PYO^`YV?A,DNH+8[VW+W^(\:CEC$BV
M/6O.KO/0-G@YQPPG8E>M7.,2\L4GJ9DVDLU(93RBJK)D,5=(X@/DN"=P`'@/
MAX!VKCN3Q.1B7*P9@P/4=H\".PUK9(ROE<6/941)*(F(8XDEHI\P$H]!450,
M=L8?C3=)`=`Y1^`>H?Y,VXF0]38^-0%6'975`LB8.H+)"'_="?\`9')`RGHP
MJVOHB(N5B-FB:CQRH(%3;-$S.5U##["E32`P]1_+T#+6E1/F;6J@$]!4E-9T
M9S7DW$O+@4)F223;I-"F*H2+8%.*OD=X!T%VZ5$#+B4>T.PA0$>T1'%9B[%V
MT'8.[_::D"@?&O0IP'T\]H6O)*ZV!B+.=OJ[5:.26)VN&U49(@>..H!B@HDK
M*O'*RYB_\R"`"'<4<XK[QY9.2Y(10/?&A&T=Q:_F/[A^%;/'C*)KU-3VSR-3
MTQ2F*57IZ@E<=.ZA3+,DH7W6*F'D4X1,;H85))K[V@H0OL'H2,5`1^#P^//!
M^_,9GP<3*!\L<EC_`-(:?M%=3^UF8D?)\AA%?/+%N!_W#J/R/[*\WV^4ED]A
MNE%#=4G$1$*-@Z]>Q)-`Z"A>G^CU<I'-^7NZY@^V&4\98#S"1K_L(_96R]\J
MXYP,Q\K0I;PM<']NM::ST5>.IBEJ["+E'T+(-92-<*-7K-4%45DC&(8!#P,0
MPE$!,FH41`P>P0'(<C'BRH7@F6\;#_0_&LK#S)\#)BRL9RLJ&_Q[P?`U:1QZ
M*PW)/4)H;M02L,RQBY),1)U:N!<E0>)AW=0$/#N)\93`.<YBXHCFX.,E/E,@
M%^]>O[1^VNQY'/*WMC*YS&'F6$FW<X\I!^!U^%6GPG.O2M4W38.,LMJO;^M'
M>L(F`5F;K<:U18?6$;7IZ57K--F0GVNP'\N=A;IAH+=B/U<"RJIR^8FGW9V[
MCEBGQU]!1'&DRP!6T/JE=R1`"]W==5'0CJ0:^:.1,\>0&R)?5EEB>?<"2#&I
M'J2$FUE1FL_<>EQK6X[3S9XCT5..6M>_]95].8?3D='*/I]ND1V]K,R2OV!`
MAB%,`&AYM4K5P)NA4UA[1'+XI(YF5(F#,45A;^%R0A^#$$+WD:5;+BY$)=98
MF4JVTW[&"AB#\%()[@;U^5^</$5K48R^N.0FLT:A,V5_3HV=4L"16CJS1;=!
MW(PY2B3W@CMBU=)*J]Y"E(FH0PB`&`1J713`K,`94+KXJ&V%O@&\NO;I40CD
M(F8(2(V"MX$C<!^*ZBW9K6R:CR`TK?KU-ZSI6S*E:;Y6XY*7GJS!R:<A(Q<:
MX0C'*#QV#<#H)HK-IIHH0>_J8BY#!U`>N7Q@RQS2QB\<<A1CV!P2"OQ!!![B
M*2(\2X[2+995#)_>4@D$>!`-OA6X,I5E,4IBE,4IBE,4JA#]Y7][G^DO+:E[
M*__6]C/IK_R&<4?X)T;]3-LH.VKFZU-_*U;3%*8I3%*XSQHW?ME6CI(JR"Y#
M)J)G`#%,4P=!`0'PQ2J).:OI"L=AVY;=/':Q+:YV6BX^M#ILDC`R?/B$$OG`
M"*Z1VK@X"(&,0!`X?),`@(YX_F_:4'(3?6X4WT^>#?<.A(Z'2UCTU'Y7UKZG
M^T/]3W-^P>);V=[KXI>;]C2*4,$C?S(D8W(1F#!E[0C:`ZJ1:JBKE,\S-!OG
M,5N+2SVW,XI8&SJU0+9RD#Q%,13(Z*=DU6;G<+`03#U3()A'J8.HB([OAON1
M[Z]I1+B\QQGU_'1Z;P;,%']\`C\6%=!S/M7_`$R_=^7_`##V+]P?^7><R+M]
M)D`;`YU*A79=H!/Z'9=+"PK`#<T-8.^Y"TTFQ,'!2]3-W;!F]5*;KVF*/F^[
M*%#KW!U_)GM(OOY[<*JV5PV9&3X*P_,E;_E7G\G^A7[A.Q/!^[N'S8OX@[)I
MWZ"3P[>VL??<Q=8MC'&IZR?RKXO7R!4;LV@=0`1[CD32>*`4`]O3Q#+)OOMQ
MLJ`<1[9S)YV-E#64:^(#_EV]]38O]#_N#!(F]Y?<;AN,PUU<[BY`\-[1"_=?
M\J_52+ROYDVR.UKKFL+UB/G3@DJDP1<&!%@0`%T]D)0Z9%$F#=+J)S?HB@'R
M>HFZ`/GN:Y;[E^[L1QFPKQ'!,+$:AW\!?SF_<+"VITK><>W]+OV(89^#GR>\
M?>T)_EVL($<=IMNC7:>T[VN-`+UZ<N"?IHZSXC0S&=D`2L^RUV0#-61TD!>Q
MPJ"2CA)F0YU/=VJ2B8@'0>HAXB/CFFX;V_A<+&?0&[((\SGJ?AW"OGO[N?>_
MWA]WN2]7F9A!P\;7AQ(S_*C`O8GH7:QMN/X`59C$S,//,RR$'*1TQ'F450*]
MBWC=\T%9N<4ET07:J*I>:@H42G+UZE$.@YNXY(Y5WQ.&3O!N/V5R'*P\O!E,
M&;C20SV!VNI5K$7!LP!L1J#VU_5IB);R;.%7DX]&8D$'#IA%*O&Z<B];-.WW
MIPT9'4!PX1;=P>88A1`G7QZ8,D8=8RX]0BX%]2!UL.NE$Q,J3&ES$QI#B1L`
MSA244M\H9K6!/8"=>RNRR^L>M/[SV8QU5KJ;LCE1/WY1$\;"MSF`HNI9VBJ#
M<@![3%1*4RA^GCVE'-7S'(Q\7Q\^4Y\P%E'>QZ"MW[>X>7G.5QL"(':3=CW*
M.I_T[:\OO(ZQN"P39D;N.K8I119TL/PD9B1TIW=`Z=ZZZA1'X_'.6>V83D<C
M+E2-=D!;XEO]#7=?>V2,/AX,.)++*P7X*@!M^.E0PSW]<CIBE,4K9>H6+M[L
M&OF:$.8K%R+YVH4HB5%JDF<#BH(!T*"@F[0Z^T1S2^X)8X^*R%<C<]@!WF_^
MJO3^T()I>=Q'B!V1W9CW"W^NO03JG4(\I>(MZT;-6-W5(QS;H)=I/LXU&47:
MDC9.'LAD$V2SIBDL19Q&^6(BJ`E\P3>/3H.3[)+SXO%Y#MI@9ZS*/XMH/E)[
M!YCKK;NK"^Y`CP^7STC6YSN.:)_[N^Z[O$V`TTOWU@VP_2*0V!M"^71QR)EH
MZH7*0V]-LZ*GK*+=.H.>W)0E:-87IK8:W(*2C1F17WENW,Q1Z"'EB?I\O/4K
MQ\:XF1B[S=@55OX5.6F78C]1W)MOIH;VN-?$)R\D:PHL0VJ86;7YFAA:`$::
M`JUR-=>VNZL7I%4&SOYMQ(;:L"#*P;(JU^DF<;58]DN9M6M,R^G?V?0?$F3"
MBF\9RYGWO'EF\I4OE^68H]V9$V.DOKF]FDESY#_O9LB27/?Z10`?QCK:L>'/
M>`PLBZI#A1]>HP]UC_\`$#6/\/47KZ:Y]*-A5K-K>X73>KR^3VKIO48UQ1OK
M*'J4>>EZ6KEIKM.K#^/:6>5*YEA2M!E74MW@94Z!>UN3N,.9L$SP\J>7T.7(
M\KR]@=I,?Z<6&NP*+M87N3;0`5"V2QX^;C%%L4Q;$[U!R$R&N;7?<4"ZVL+D
M:DU;QD58U,4IBE,4IBE,4IBE,4K76R=5TG;$"XK]SAT9!NJF<C=X0`1DH]0Q
M3E(NQ>D#S45$Q.(@'42"/M`<R\/.RL"=<C%E*2#_`$U';5&56%F&E4U<B.%]
MNU&@_M%<54MU$1[EG+I-L)9*$;F4`I"R[0IE2JH$$P`+@G0G_"*7.J\#[R@S
MV3%SU$64=`?TM_8?"L&7'*W9-14#'%<@G*@G<PL:JIU\3'9H@/\`O$#/;V4]
M@K&KF,XYBP+Y;!DV:`;P[6R":0FZ^'013*!C?[^``.@I5@_#SBG([*EXW8UU
M9JL]?1+U)W'MG*8D/<'C-4BA&Z!!$IA@TEB=%UNG:MT%(G4.\0Y_[M]SICQR
M\7@/?(86=AT4'J!_>/;W?&LJ"&Y#N-.RKN"$*F4I"%*0A"@0A"`!2D*4``I2
ME```I2@'0`#V9RBLZOUBE,4IBE53<\-KLYN:B-8P[A-PC75#R,^LF<IB$FE@
M,@E'^'7HK'M0$5!Z^!EA+[2FSF?OGE%D>'BXFOL.]_CT`^(%S^(KM?VPX-XH
MLGFYUL9!Z<=^U="S?`FP'P->>?:4VI/7NP.S$%--JZ^J6R8^TJ$4'N8F,'P&
M673.H/Q=^9O!8XQN+QEO=G&\_%M?V"PK4^ZLULWG,UB+)&?3`\$T/YFY_&M?
MYMZ\]3%*8I4_.(ZTQ64X2?0(HFJ-L1D8D#%$!4*U,@D*J8&]I%5DA*`]/'IX
M9X3F<OT^>Q9<<WDB*7^-[V_(UU7VY@-)[4SH,M2(9Q(1?^';:_YBXJY7>7I^
MQV^;EN;9([4E*A.[FUGI^G-44*FRF6M/D]37):^0UA`B\TP&>(]DEBI+,S^Z
M@"9!Z*]3>'7((VAB7TVM*.4@SE)%P'ACV!"-+J1<DW!'=7`,B9)98Q)'>)./
MR,,@&VY<APQ<&QL5MH+$&M%-O2#AEZ5+5FR[YE)Z6GJ+N>GRU@3UO%QJ2SO<
M^T83:$M--8?]J7I698IY#BT3;`X,"J2O<*A1+VC;%B0PRPE`?0080VG6XPIS
M,MSWN3M.GEZB_2I\GDI<J3+FE0>I-]1>VEOJ,;Z8V']T#<.\Z'OKO[7Z517]
MMOUXI&_W].L6P;/?7LH:1UC$V^*:4O9&N:!KRR5%C%N[5%E1D/(U^@Z;2H*`
M=$5CI"W.4.HPR\?'/AY.!.Y;&G$HD["RR9/U(`/Z=K77MW`WL"!58^2EBGQ,
ME$'K8XQ_3[@T$#P;B/U!U>Y6XL1U()J7G$WB)5>);/9,=5+)(V%CL&PU6:`)
M2/;M'<0WJ>O:OK]C''=HN5QE/,:UH'!E3%1Z'6$@$Z%`1VOK.<;Z9M1]3D3`
M_P#OW#E?^C:P/;U(%:^5O5?&<]8\6*'X^F7.[H+;B_R]!;K4NLAJVF*4Q2F*
M4Q2F*50A^\K^]S_27EM2]E?_U_8SZ:_\AG%'^"=&_4S;*#MJYNM3?RM6TQ2F
M*4Q2F*4Q2L<FJC6K"D=&9A8^034`0.#ALDH(]?#VF*/CTREJK<U7ORQX)<5;
M3KR8N=HCJ]K0:2Q?32]V]T10CF$<0I5'Q)U-!(IUXX0(!Q,`@=,P=P#TZ@.1
MAYN%Q,DF9EX4,N*%NX=`18=O0D$5Z'B)O=?,9^%PO!Y^:_(Y$@CBCCED#,S:
M!0`PN3V"H2:C],75MW-'3U4V5J>QUEQT53F*A(-;.X52.EWE!-%`Q$T'/0P=
MQ%3").H@8.N>PQ_>_`^@'X;BH-_85*6'_5%_W5#[@XOWEQN1+Q_NE.1BF4^9
M,@3`Z'K:30B_0C0]AJY32''C6>@8'ZGHD,FD\<)$3E9]TF@:8E1(83@5=9%)
M)-%L0X_(13*4A>@"/4W4P^8Y'D\OE)_7RI+GL`T51X"M"B*@LHJ`'J%[[VG5
M;%%:FBBK5'7MGB2N'ERCCN4I2PR(*."N:B22`2)1*)VI05,"?5=P0IB@8H`(
M#SOW5R'(8PCAB4IAOU<=2?X;]G[S7U__`$P^Q_8GN+(SN8Y6<9/NG#:\>))M
M]-8_+;(VG64JQM;Y4)!(-1(XR\J7?&24DVBK!]/:SL"2JLA6HXAG#R'L22*@
M1\O")]Y032D51*B^(/4HE[5?`2&[O.<)S_\`E3R(X+8C#Y1V-V$?'H:^@?O-
M]DH_N=B8>=QS)![IQR%$C>59821N233K&+M&?BO:+:LV-N>W[4V&XV[8YA[!
M6=%8BM6-$OUF1J)$LU3KQ\=$KIJ?HU$NHJ.U!Z@X5,;NZD`I0P<SEI\S,.:T
MA63]-C\H[`/]??7M?:'VO]O^T/:2>S8,&/)P9%_XDR*&^ID869FN.G9&!\@`
MMK<U=]PJW'?MTZ7:6S8<>@C(-Y-_&1LZBV58_M9#1Y@1;6)9BIW)ME79R'`1
M3-Y:H$!0H%`P!G3>#RLS,X^*;-CVR&]CTW`=&MV7_P!O;7YQ?>?VU[4]I^^^
M3X;VCG--Q\>TNI(80RL+O"KCYPF@N1<&ZDD@FJ\^4VYY;9U]E(@%!1K54E9*
M*BF9!,!3J,G!V+EZL'<)3K+JMS=!^`@@`>T<YA[HYB7DL^7'!MBPN0!WD:$G
M_57N/8WMZ#A^*@S"+YV3&K,>Y3J%'X6)[ZA'L6MM;-4I=FLW*L[09.7<8IV]
MRJ#Y!(QT3HB`"/4XE[1#X0'IFGXW+?"S8)E:R[@&[B+Z@UZ/F<"+DN-RL:1`
M6V$KWA@-"*@+#Q$G//F\;$LUGCUR8`(@B0QA(`B`&.J(`()))]?E&-T`OPYU
M#)R8,2)IIY`L8_;\.^N&86#E9\Z8N+"6F/9W=Y/<!6S76CK\V1*J1FS>&-T[
MD6KL#*DZA[!*<A`'I\/01S2I[FXUVVDNH[R/]M>FE]D<U&@9?2<]P;7]HKOJ
MYH&QOU2*6!TA#,_`3IHF!R_,'@(E*7H"*1NGPB)NGQ9BY?NG'12N'$7D[SH/
M[36=Q_L3+D8-R,ZQQ]RZM_8*F%JW4A#/V=4H<&X=R4FNDB8R21W;YT<QNT%'
M*Q2"/83J(^P"%#QZ9Y8OR'-9<<>LD[&P`Z`?#L'C7NECXCVUQ\LMEBQ4%V)(
MW,?B>I/8*FGRKXYW2G:[XQQ3>@7?<^G:QM)W9.3.K-:QDG/66ZQ,A`JMH[W>
MNQ"S5]8HV$D2E$[4%``_@(^W.M\)QD'#S8<.5CM-C?33`$`G9DL%].0@=`+%
M0Q^6]ZX'SG.9'/ORV5C9*8^49(K;K#=C(3ZD2DW\S7!L+7L1>HXW21Y_0NW^
M.M7XT:_WIH_B^:MUI2"H4GK^5O3R)<N[M)!;(7<LR_EUPIS).M'%9BW=NB@S
M0.DB4`.3L#<JN7-F\BF=,'41QA!^@Q_3^8>H/FE$MU-KD^7QKSDGTBXD+XJA
M)"\I<V\WJ>J-A5.R-EU'0?-V6J,R.O?4<U!0M@6/5].Y#UNZ.JC38=%U`4J8
MM,X[;AMW;$O,1\9'.$Y!TV54CW<:JLX;-G*Z+55,13,F8>FHQ?K<?C\6)(W!
M+8VX$:^3%F!#&Q(`<J#I;?M#6O6VG.!/G9;S2(8P<@J01INFQ[$"X!NH>PO?
M;N(Z5Z-^(<UMBQ<:]/3&\X6PU_;#VG1Y[M%6PC5*RMY<@JIF-.(LV,8@A)+H
MD(HJ0&Z)BF-T,0INH9ZWD4QTRB,5E,6Q.FHOL&[OUO>]M+WM7E<=G99"ZL/.
MUK]=NXV/9I;I?6UKU(_,&IZ8I3%*8I3%*8I3%*8I3%*^+AN@[06:ND4G#9PD
M=%=!8A5$5D52B11)1,X"4Y#E$0$!#H(8!(-P=:53MR"XNZBC]L-ZU6MO4/7M
MAMC)2?C]?W.70AE!;^<5LNI`.U^B;EL9T(]C?H94@#T#J4,]IQGW&@XQ8>-Y
M1E:6WD):S$=VNAM^=;G$]D^Y>7XK*Y[B>#R9^*AD"2211M(J,1NLVT$KIVD6
M\:VYIWT^:I&NF\_L:SH6\B"J:K:#@#E3A%^T#B)9)\;O<O$A$Q1[$O)*8`\?
M`>F2\I[ZR\V-HL",10L+;KW8_`]!^%:#Z)H&VSH1(.P@C]AJREBQ9QC-K'QS
M5!DQ9()MFC-JD1!NV;HE`B2***8%(FFF0````.@9X<DL2S&Y-35RLI2F*4Q2
MM'<A]HK:DUA,V=DF1277,G#POF@(I)2+\BH)NE"@("<&B:9E`+UZ&.4`'P$<
MU'.\D>*XS(RU6\HL%_WCH+_#K^%>A]K\,.=YK%P':T)NSD==JZD#Q/0?&J$I
M.2>R[]W)R#A5T]?.%7+EPL<3JJK+*&544.<?$QCG.(B/PB.<+EDDFD>65BTC
M$DD]I-?4$,,6/#%CP(%A10J@=`!H*A?R"KS2.G8J;9MRH#-MW)7YDR]J:SYF
M='HL;H';YZK=8.[X3`3K\>>W]JY3R0Y&*[W"$%?`&]Q\+_OKF7OW!CAR,//C
MCL90RL1VLMB"?&Q_96OZMK"VVYH,A&LTD6'<)4G;Y0S=)R8O@;W;Y!C*E*/@
M)@^3U^'-KF\W@X,GHR,6E[0NMOC_`&5HN,]K\IRL/U$*JD)Z%[C=\.\>-=J&
ME-@BZ]V^JT"E[@+[V+M/W7IU_.[P`3"`?Y.N8_\`S)Q>S?O:_=;6LH>RN<,O
MIF./;?YMVG[JW+3=!QD:HF^M3DLPX(/<G'-P,G&E-T\!7,8`6="4?@^27\@Y
MY_D/<V1D!HL1?3C/;^K_`&5ZWB?96'ALLV>_KS#HO1!\1U-6D\2N/CZ_V>-L
MDBP,PH]9<(.3&%N9%&17:'*9O&,?D`D8/,(`J"'@1,!^$0S(]J\'+R.8F=D*
M1B1M>Y_6W8`?`]36+[Z]SP</Q\G&8C*>0F3;8?\`=H>I('0D:`?C6,P-`NM9
MY&;HD;5QGW/?N2C[<VP;5HOD2QC;$UU!7]9NJVN.OH2:NR4NQA4X2'$ON;J!
M%(XN%3]W:81SIL#9L/!2KQZ"+FTBR?49^DKEG,9`/^)="BJ/T$=FVN*99Q9N
M3@;,F63A'^F"1I\\2KL$H/381('D9B3N4]=;5!Z&K7J@;?U*LENR+WU;I:,V
M17W[.*F]72]&F(.5=:KVVRNQ()5)T5W.4=*<=Q;=JX%$K853I"D<PG$`AYC%
M9\7';&#R$X^:JG7?9L/:@D7L9I2`E['<&[Q9Q\J1Y+^K)&@];&+J-4\N:A)1
MCU41!BX%QMVD]MY8\2I;U"*GS#T;KN\5O>(<;F^FH2*L:$Y3PB==U5\RU@Y<
M@O)6AQ&OBR]@/<T"(&2%ZTD$EC%*=(Z0YZ2.1<G.]Q/DN-@)](G3I].%"`6!
M%MX!%QJY8`KIHY42#CN($*GZHVW@&_62?<SD]++M-B!T3:=:]`.8=7TQ2F*4
MQ2F*4Q2F*50A^\K^]S_27EM2]E?_T/8SZ:_\AG%'^"=&_4S;*#MJYNM3?RM6
MTQ2F*4Q2F*4Q2F*5TMBKT1:X22KL\R1D8B7:+,9!DX("B#IJX3,DLBJF;J4Z
M:B9A`0'P$!RUE5U*L+J18BI89I<>6.>"1DF1@59205(U!!&H(.H(JN&U^EQH
M=S)K3NO#6;5TTJH=4'M`ME@J9RG.83&[2Q+Y!!,!$?'M(`C\/7-'/[;XF8NZ
M8YBD(ZQL4/Y`V_977>-^_'W+P<9,++YJ/D<!181YT$.6MOC*C,?Q8VK#3\,N
M7=+3\O6/,7:S9L@/_1(NQR,)9H\I`'J4JRDY"/)!<0'X3+#U#KD/^1Y43;L7
MF\E0!:Q(8?D=/V5LU^[OMOD&O[C^T?`Y#GYI(DEQW/P$4JQC\%ZU'KDCQ_\`
M4,M^LIV,V+M_5MLK,2T6E3RUBIE;@',+]7$.LG+%GXQNT=-UV@`)@/U#XN@A
MX9A9?&<T\$Z9O+1285M=Z`$`=MU4:COKUWLO[A_:WC/<G&<C[7^W')X?N02@
M1?3YDDN]FT]/TI&*LC]"IO<&JA*UL:84AFG[0.&AY5,ID7+EAW`S>BD/EE?-
MR*`51))V!>\I3``@`^P,Y#-DQ1RND<VY`=#WU^J.'Q.1DXF)D9''MCY$D:LT
M3$$QL0"4)4D$J=-"?C7,;6FWVJ^T*I5BNQ=M;3<R4DA"RMB1K:$T=#HJT@?K
M%15(2!)JE[1(!BBL'Z,!ZFZ#L>':/+S8HO*\E_*C-M#'N)T_*XOT%>%^ZGK>
MW?8_,<DF5DXD87;)D00&>3'C;1Y5C`)N!INL=E]W9>KUZWRLYD4>"C8%EP:B
MV4'#M46*+6)V!&&%-)(@)$!!L"A0[.O3P^`N=/CS_=:E5;@(A$-/+(G3LL-U
M?F)+[3^QF9+)*?O!FG(=BQ:3CY]23<EFV]3W]IJI7FI>N2\(QDMD-]+2FF&4
MI:T7B:QYV'FBNY21.X=+0Q&(^\K/47RXJ'\M,O>`![0`,\+SG#\@LTW(38!@
MA=KVWH?,>X!B3?NKZ.^SN!]I^4Y3#]O1^[SS)7'964XL\(2(6'JF0[5C,>@W
M,;=X-<[0.Q+QL>J*/[W3755EFJA$>JJ!VZ$F02F[W"+583+H=H@'<!@`/'PS
MSKQ2Q';,A5O'0_E6L]]<3[3XCFI,;V?[B3D>/[66YV'^'?8*_P`5OXUM>'JE
M=@'#QW#Q#1@Y?G,H[61(;S%1,;N,`&.8XIIB;Q[2]I>OP9+-EY.0L:3S,RJ+
M`$]*Y_CX&'B/+)BXR1NYNQ`U)_T[*R1-)54Q2)IG4,<>A2D*)A,/MZ%``$1'
MIF.-38=:RSH+GI4A-6<9MG;-=MSMH-Q$P1A(9Q-RI19-2HF[1ZH`KT6<G$@]
M0!,INOQYZ#C/;7)\DRD0F/'[6;33P'4UY+F_>G"<,CJ<D398Z(FNOB>@_.K<
M]-Z#I&FXX"0S,KR>73`DA/NR@=XMXB(I(=0[6K<!'\T@`)OAZYU;B>$PN(BV
MXZ7E/5CU/]@\*X1S_N;D_<$V_+EM`/E0:*/P[3XFMXYN*\]3%*8I3%*8I3%*
M8I3%*8I3%*8I3%*8I3%*CIOGBSIOD8S:M]FU-C.N(_K]7OE042>LNH=!]U=H
M'3<MQ,'M$ABCF'EX&'G($R\99%'2XU'P/4?A7IO;7O/W3[.R7R_;'.Y&%.WS
M>FU@P[F0W1A_O*:A2OZ:3JHG$^E]Z[CULDF<YFK"(V'.KQ34!\"$;Q$LK(1Y
M0*01+XD'P_R!FH_Y:Q(R3B9.1#I:RR&W[;G]M=-7[]>Y<T!?<_`<)RXMJV1A
M0B1O]Z6)8W_:/VUPC\?_`%':@H(T[EO)3Z!!$4RWRL4NQJ'$>@"!P^H6A1+V
MD#I\0B/QY8>)YJ*/;B\_)N_OJC?M*L:E3[B_:O/6W-_9G#1__P##R<F#\KRM
MXW_"N)[]ZM=;-X2VDKNFF8!`\Q5B1`K`!CF$IBP!FPE`Q>A?D^/3V>.4,/NJ
M-/)G8SO_`'D(_=:L@<K_`$XYH_XGVIS^$3_ZG(26W_S2?$U\_P#''U3(<P_6
M6C])6(`3[?\`J5Y/L>JIS@8%`%](^":28"4P>T3#U#PPDGNQ%'JP8C-;L+#]
M]7C"_IKR;;.7]RXVO_>1POIW?RP=2=1X=:YJ7+?U`V`]9/AU67Q0+Y?1E?6S
M015+T[E>J[E3]&/0>A?;XY')F^[$'EX:!SX2`?CJPJ)O:_\`3[+_`(7W.Y.(
M]?/@2-^'E7KX]*UQMSDERUVC2)2D6;A2X;K.!3=,GT=>HQRFR?H`)FKDAS+A
MW]`.8BA?^"8>GCT','D/^8.4P)</,X(`MT*R)H1T/S_G6TX/@/LMPW)8W*8/
MW?FLAL5?`G!93HP(V]".A_&J.)'<_(^D[ZE:=,T>1DF9G35.9I)3L95:K'7,
M8A2H3$<4J+$P%`!%)PH(^WJ`=2YSC)XS-Q9F@E@(F478`A@/B02!^=?6D'MW
M[3<I]N(N>/N1,:4$C'R6CEB.5X>@]VEL=-\:@=-=#4[Y*"B+?$L4K%#$<(F\
ME\1F\[@4:.A2$I@!1$Y!!1,%#$-VFZ"'QY!!DY&)(7QY2DEK$CN[J^=\[!P\
MU3!DQ+-CAKBX-C;HPZ$:?OUKO&C1NR;(,F2";=JV2(@W;H$`B2*290*1-,A?
M`"E*&1,S.S.[$L3<D]IJ5$2-%CC0*BBP`Z`#H!61PE9G[&\28040_E':YRII
MH,VRJYS',8"`'1,H]/E#X]?`/A\,D@QI\EQ'CPL[GL`O4.5F8N#$TV9D)'$.
MUB!_M/X5/_1?"25>N6T_MIN:-CDQ\Q*N).B>_NP[3=OOAVXG!HEU$!Z`8%!Z
M?`&>]X7V6[,L_+K9.Q`=3_O$?NO7*_<OW(B1&Q/;[;I#UE(T'^Z#V^)%6=P<
M'$5N+9PD%'MHN*8)`BT9-$P311('B/0`\3&,(]3&$1,81ZB.='BBC@C6*%`L
M:C0#H*XW//-DRO/D2EYF-R2;DFNVR2HJ8I3%*8I3%*8I3%*8I3%*8I5"'[RO
M[W/])>6U+V5__]'V,^FO_(9Q1_@G1OU,VR@[:N;K4W\K5M,4IBE,4JG[D_7T
M''+^:D]X4/D?>]>+ZDU,WXSKZ`"^J*5?9[2\W)39:QG=1F(.$K%L=HKP:HOY
MI=%HI&(]A5>I#$R#B!(N5RHDTY,\A"8'/RC$]"(,I+>0*,@3M*OSM&RV#>4#
M,Y`[L+CO2:/_`"L8DXR$(!=LDNY1@`#(0<?8L1'E64-?:26,3-G["YN;9K7+
MZDUS;5_"/XK;5UU1E)O5%<A9NP;.1NF^:GL8ZC`:^P>R:CC67'NS-(R99-A%
M55ZS<)KE/^D[W$^I,GM;E\V;^2>6ABD"KY",67(AFFL.L,[MBS+V*$:X";JG
MRO0BR>7P,;&`W\5/-%O-F1I,:)HHKDW]5)H<N`DZGU%=3NVD=#M?8/J$WN"Y
M'U%G_C?:G;BM;C%_0U=6.*'!456K[AIC702FIMEQ</'O[M(;`I)EG,B"2ZPM
MTS+'5*D*?EC!P[YDD_!SYL*W23C97#&P&8<]?JL9AVXT40>\A!4HB-N.\BH>
M33&1N0APIR(V7,B1E%R<8\=*8LC^[.T_I`1@[M\C@`>F"<GO.S?44D8Z@V!E
M7]H0FZF2>[:I?%6NMV,G!423F.0_%:+CHJC.T&"\-;:6VUP_FUHV4<)BN[;-
MW*Q^PR)^V;C46;FN&B:=QQV1%QD<\C+M:[962N9N!T3TP$(MH(RK`D->L?DV
MFAX_F)(H(VR8VS)(8U;<++AAL4!M"S,Y(8'_`+RZVT%=/M[;'JS568U_2:).
M6>08P&SMRUY784SJ-W*2.U20&S8>-H49/1E3HTM%042^I#U1PD_54B6#HB:@
M^]@=,I3TXF3)S,[BVRH4CB;$@+(20&D^MRXIRS'Y+8\6/*06!M,2BL=*FY!,
M>*/ET@DT7)EV.-=L?T6+-$%`N7OD29$0LIUB56(N34O^*FV^;$YZA/([7.Z&
M5W?:`CX&S/M?/5]>DK5%K3Z+L=59P#!E8W<.Q<3CR8A';I=!1I(2B3E(3'6!
MJJF*)<CB+3\3GRY-QDK-Y"^C%3-DJ5"CM"",G0KM4,';?:L?D]L.5QJX^H>-
M0X755/TT+LY8]AFWJ`#NW.5*`)>H\^MCOW<=6A:[JNNP4Q#ZIF`:R-NN;%41
M0G7P&=E;U5V*(>8T8)F(590#B!5Q`I?8`AG,ON-G\KCX4<6-$PP6(WN._70^
M%?H'_0A[/^W/,>ZL[F>>Y?'?WI`&&)B2"VT>6\Z$^5W%RJ@:KJ:H]XYZDVWR
MAM3ZJ:Q9"LI$QRTG*RKKSBQL>BDFH=N@JH0A^KA\HGV)E`/C$?`,YI[;X7-]
MQ9,D</EA1268]`;:#XDU]^_?3[N^T/L7PN!R'.H9^2RI0D./&1ZCJ"/4<W(L
MJ*;D]IL!UK5ET>WC5UTDZ?:V4A7[?5Y3R%VPF52<MGS1<#-G;%4`*<Q3*$*H
M@J3Q'P$/'-7FQYW$Y[XDRLN2C:=A/<1\:Z#[2Y/VE]R?9N+[HX7)AR/;N9`2
MVZU@"O\`,CE!T!74.I_=7LL].?:^R]S\8*78MP5MW%VUB"\-]:2A"`[MD2Q4
M%.,L:[<R956Z[ML`$.!_%0Q!4]AL^C?;&3R.7P^+)RD)3*M;7JP[&([+C\^O
M;7X3_P!0?M_V1[9^Z?N3C?M]R\>7[>]0,!'\D,C"\D*MT<(U[$:"^WLJ7MOU
MU2[XV8,[97(B<:QK]*49-Y%@U=I-WZ!3E1=)$62.5-=,JA@*<.A@`1\?'-Z\
M<<E@Z`@&^H!U[_C7',;-S,/U3B94D1D0JVQF7<IZJVTBZFPN#H>ZNNFM0:PL
M+4K.7HE9>(D3%(@C$M$EBD$.G:#A!-);H`!X!W=,QLGC\++%LG%C?XJ#^VI\
M3EN3P#?"SI8O]UB!^5[5K@_$[11U.\*8BD`"'1))XZ31``^`$P4Z=,U9]K\$
MS;OH%O\`C6\7WQ[H5=O^;2'XVO\`G:LVKFB]1U0Z:L+0:X@X2,)R.5X]%ZN!
MQ#H)P.[*L`'`/8(``AF=C\/Q>*08,")6';M!/YFM9E^X><S@5RN5G=3V;B!^
M0L*VJ0A$B%33(1,A0`"D(4"$*`>``4I0```,V0`&@&E:<DDDDZU^\52F*4Q2
MF*4Q2F*4Q2F*4Q2F*4Q2M.<AF>RI#1&X6.FW)FFUW>MKBWUVY37*U60N"L"^
M)`J-W)P$C=T61$GE''P(IVB/3IFMY<9+<=D#$#&;RZ*;,5W+O"GL8IN`[;VL
M16QXEL5>1Q6S0OT]S>XNM[';N':H:V[POH:HI+LR6XP\9!W1J.!W[KS:^MFN
MGI7E+&[?9V5O6=U6)(LHROM4HP;,EW#6:V)*S;@ZPOH5N#==OY)4UC!U*&3R
MV6T#8R<)&O\`EV1D>C#$VC!I82L3J+%U2*3:90;7U-B!>IN-Q/JY\F'FY5/)
MK"[M+'J@*2AGO;;&=Z!Q%K8#NN*Z9_,^HGK>\W*5LNT-\S;VT47C2I9K/5=1
M)VZ(I=4FB^\[.FM=UQE7G<-(VBL23D6ZC!),SI1-=18R1^T!#)M]+#GX'JLR
M)R[@N1=F1<%/39?_`&<LZ[&VW5"+Z%B2D;$R\?%SHH421^/W+'>VUSF2`JQO
M?>L!#B]R;@#0`5VD#?O4;)O+1M^L-1VD-+L6G-95S<]RCJM_UTTATM\;B;PC
MXFM%VI8EI:;1`N8(]B\A(CV*C'`J=H`4.W5XJS)-S292%6FBA.T79/J/H'/I
MAM;1>K\S+IZNU3H;U=(,9N,@7%E5I(LO)VLWD;T/4Q?/M[7V!_35K74.1KI7
MRXYW7U)HAWK5-=AL:$J%7_P\^M->R>MVS>)MBUTVAM2*MI9F;DHI><C20T`V
MB7BAD5B^00Y#FZ$/XSX#9/TT*NNZ4E8E5M`H'%O,&O\`_P"XBQ$G2[[>MJQN
M6,"_YE)#\R[I`5\Q8_7QQ;0.W_AG>0`:V2_2]=54]X^K,YXX\LK3:)*PM=E1
M$QK,U`C&6F+&>6HTW(7>RH;(ID&BOKUJ6TPD7`-F219*-:6!J@10BZ:ZX&/V
M1ROD1\9P3HQ>62:+>P%BR'&5Y%<$7C/KE5!*`;O46X0!ZN2/'?E>11]L>.(Y
MP%ON"E<@I"ZD&S@Q!FL&+%=C6W$H;P.'%LV?>.,>FK3N>,L<3M"6IS):Y-+;
M$LH*Q&E4U5T#.Y6(CR(M8]R_12(L*94T1`%`ZIICU(&]S4ACF00$;#%&3;L8
MQJ6!U-CNO<`D`W`)M6FQV9EEW`Z2N!?M`<@$:"XMT)`)%B0+U)C,.IZ_G0/B
M#_<#%*_`I)#[4TQ_RD*/_8Q2OR+9N/M;HC_E2(/_`,'%+FM=LM0:U8SDU8T:
M76QF;"L*\R_4AH]1Q(JB4""H\4,@(N3B0H!U/U$0``R/T8KN?37S==!K\>_\
M:S)>0SYDQHI<V5HX5M&"[$(+WL@)LHN;V6POK6-SO''2MB7%T^H$&DY'NZK1
M[?ZO-\KIU`"-132*'4/@*&:R?@>'R26EX^/<>T"W[JVF+[J]PX:A8.6F"#L+
M$C]MZZ9GQ5T4S5*K^PS)T)#`<I'R[ATF!@'J'R#J=.F01^V.#C.X<>A/C<UD
MR^]?<\J[6Y>4#PL/W5N.!IU4JR0(URN0L(3H`#]6QK1JH<`$1#S%DDBK*B`C
M[3&$<V\.+C8R[<>!$7^Z`/W5Y_(S<S+8OE94DC?WF)_>:R3)ZQJ8I3%*8I3%
M*8I3%*8I3%*8I3%*8I5"'[RO[W/])>6U+V5__]+V,^FO_(9Q1_@G1OU,VR@[
M:N;K4W\K5M,4IBE,4IBE=-#5VOUPCY*O04-!)RDDZF9-.&C&4621EWYBF?2K
MXC)!`KN2>&*`JKJ=RJ@@'<8<HH"HD:BT:BP`Z`7O8#H!<DZ=IJK,SNTCDESU
M)U)^)KN<K5*8I3%*8I6M-JZFI6XZC*TR\0[66AY9LHV<(N$@4^2H0R?4.OB`
ME`W@(=!`<BG@BR(GAFC#1,+$'H16?QG*<APV?B<IQ>6\'(0.'CD0V964W!!%
M:;XL</\`5?$VLRE;UU'F(28D5)!\]=&,L\7.8!*FFJNH8QSIHICVD#KT`,PN
M,XG"XB!L;!AV1%BQ[=37K/N!]R/=WW.YF/GO>/*-E<BD2QJ2``J+V*HT%SJ3
MVFL(VOP`T/N'=M8WA;($CFQUQN"(-_$&3\Z2QEVJSYN!@3<*M%#B*8F`>G7(
MLK@^-S<['Y#)Q@V3$+*3_K';;LK,X#[L^_/;'L[G/8G!\]+C^W.0D#S1KH2;
M6(5NJAQ8.!:X%35BHIA",&T9&-DFC)HD1%!!(H$(0A``H``!T#V!FWM7.2;D
MD]:['%4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE:JWKL-YJ32NVMIQ
M\<VF'VN=<7.[LXIXLJW:23JKUZ0FD&+E=`IED6[I5F!#F(`F*4PB'CFNY7-;
MCL"?,1`S)MT/3S,J_LO>L[C<1<[.QL1W*J[6)'4:$U2I^*XILO2!=N6#3&JY
MJJK3;J-I]8L"<E8Y%Q=:=I!_M>8D))G(-TTJW''F$$T8=T**BZS$1<!T$Y!R
M[DLF3CC%)Z:G((RY(_[J8TL,%RP^60M(Q91T7:";WJ?$Q(\AS")V"?\`#I);
M^*?U&V@?J555=>F[=H0!5B/%#E]8.0NH=Q[,E:`SC'NK;//03"MUN3.Y6L24
M+1*]<$DDG,M[H@UD'[B9,V)WF*B7M*8Q@`1Z9&7,<7BIN2"%F5LD;1VB"1T&
MO]X+<]UZP,:)9\[&P]X176`[CV>LBL=!V+N^)`K1NN_5=UW.4B@3FQ-87RD6
MF[0.J+`->:C"3;-FRW+M"VZQIZB4DC+$\],LA4E7#D3$(<B"A1`HFZE"]\C'
M^HEQXF)>,QJ^G1WP#R!'B!$I`/\`$5'?;+/&9`7(=K!425]>I6+(3&/XEW&G
M<#KTOCT9ZR>E9`6#]73.](ZJR$4VLJ=P>Q=.+#ITY381-5N[6HDG;5)+ZNC[
MTLDR.D"(NC^8"B:9TP$P28)3.EQ(1($:7T/FZ*<H,8`;7UD*LMA?:1YK"QK$
MSH'P4R7:SB,3G3M&,%,Q%[?(&!-[7!TO6Q++ZJ^C:BVNTO.T7:K2KP3':,C0
MK26&A5XK<S72MSC*'L\^OTT)U20`:Q8)AN0`D46/O:2G>AYA0'I'QSORD>*V
M)"S2S+ANB&P)BSY_0QI>M@KN4-B=RJZDJ+U;EHN%/+#/*H$;3H[:V67'QVR9
M(V[0PC22Q^4M&X!TK>5MYD1U+M6H]?RVEMPNMA;-K;N\3M)@8F`L$YJNAQ]I
M@*?(W"[DB9]TV7BH^8L;<5BQ:C]9-N1582`FD<P1IE8TG(YG'"47QL>&65['
M9&,@SK"&-OUMC3J6MM3TR6(!!,TF'-'A8^=:\<^1+#$!\TC0)&\NT>"RQ$*;
M,Q<*H)!`A<S]9G3VQ6%]2TK2;9,3-&V)J*JD>7*.-%56S5S8>^:EIB6GX64B
MG+Y9NYC2V07C5L[(@JN`$$2B3OZ8GU[28W#YD,8]'*<:,;,$?$R<E&`&A)^G
M"L+^4.">RDT"XTW)8\K$RXZ2'R]"\4L43*3V:R7!(UVD"LDX\>K30MJ6#C%K
M"\Z^L=9VIR-I#FY,U88&9]?Q::=FME>1:LI2=DV$S-J%-62BY!FW<F:'=)^9
MT*/<&UQ@,O);%B)]5,/'G:^G^-B1Y)``N=H]3TPYL"WEONN*Q\A&Q\>3+8?R
M!EY$(UU_D9+P7)T&XA-Y4:A;FUA>K><MJVF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2F*50A^\K^]S_27EM2]E?_3]C/IK_R&<4?X)T;]3-LH.VKF
MZU-_*U;3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*
M8I3%*8I3%*8I3%*8I3%*QFYU"O[`J%HHMK8A)UBY0$O6+#'"LLW!_"SC!>-D
MV8KMSI+H^\,W)R=Q#%.7KU`0'(,K&AS('QLA-T+6N.G0@CIX@5-CY$N+-'D0
M-:5#<&H@O?3AX?/SJF7U4F5-:&A(-5JA8[*V9*,Z]1I+6\6L=FA*IMC2*=,E
M561W/;YZJ?8)S&,0HA6>"+)]7UEW;S(3\9?2]2W=N]&,FW:M^I-[X\N>+T-C
M`>F$`T'1&9DOW[2[6OT!(Z5('5>@M5:6KMEJFN*PG`0-OEW4Y8&(/G[TK^3>
M1$?!.%S*/G+A5,%(N+02[2"4H`3KTZB(C(ZK)CMBN+P$R$C_`-ZQ9_\`K,Q/
MXZ5`KLDJ3KI*H0`^$8"I^0`J-IO30X@'?T&1/KZ:47UJG$-ZH0]_O)VK=I7;
M;)WBN,9!F:?%M,,J[99ETX8I.BJD:@L8B8%(/3+4BC1VD5!O,:H3W[(6QU8]
M[^@QB+GS%+`G05DR9V5*LBO+HS.3V?XCK(XT_29%5]O3<+VN361!Z>_$T*RC
M4`U@F6`0J7[#I,@L%B`25G_$-#:8QX+?6?G>-X;$>>9W>9X=G7R_DY=`HQS"
M8A8HV.R^!Q=WH'_H;F^-];U!D2ODB03&X=9P?$9(43#_`*84?"VEJ_1_3ZXI
M+/\`8#]SKA5Y_B02<)-Q[RTVEW#Q1+59&5OMI*9#N)=2.I!;;98Y!Y*!%IM?
M?EDBBKW=`RN&/H!`N(=GI/`RVZK]-*TV.@/_`*N*1BR1_(-!:P%1Y%LLELA0
MUTE4WZ'UH1CRL1VN\/D9_F()UN36S]O<7=+;SMM"O&QJPZE+/K=<35R3CI^>
M@%%6)YJ$L2D#/)P<BP2LE:6G:XR='CWP+M#+MRF$G7KUBBQX(<YN22)?JVC1
M&-K[EC9GCW`Z$Q,[M&2+HSL5MN-9!RIVQ5PC(?IPTC`?PF5!%+M/5?4C`5[?
M,%6_05K:#X!\7:\WL;&.HDC]5V6PUBS+0SRY6]_"PK^G[`:;1@6M3B7DTNPJ
MD.VO+%)\=DP30;*G(!3D$GR<H<>)H<&!UW)C;1&2;LH2&2!%W'4JD4LB*I-E
M#&PO5C3.SY3Z#UC(7``"LTKI)(UAIN=T5F:UR1UKJH+TZ.(];M&I;=$ZS50E
M=(-6K77*2MIM+F)AA8OIJ28O%X9Q+JQDE),GE@=F2<.$E%B^8`=W0I0#(QB<
M3(.7`;3^DL8/6RI"N.MK]#Z**A(U(4$ZB]1Y!^JQI,287QWE:1EZ!F>5IV)M
MU'JLS`'0;B!8&U3@RE4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4I
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MIBX[Z4Q<=]*8N.^E4(=0_P`2O[W/])F4J7^RO__0W-K;_P`AJU_Y6?\`U6W_
M`/5I_P"K_P#-_P#T?_\`M_\`^C?_`"?3(CUJ6LX^^3%*??)BE/ODQ2GWR8I3
M[Y,4I]\F*4^^3%*??)BE/ODQ2GWR8I3[Y,4I]\F*4^^3%*??)BE/ODQ2GWR8
MI3[Y,4I]\F*4^^3%*??)BE/ODQ2GWR8I3[Y,4I]\F*4^^3%*??)BE/ODQ2GW
MR8I3[Y,4I]\F*4^^3%*??)BE/ODQ2GWR8I3[Y,4I]\F*4^^3%*??)BE/ODQ2
MGWR8I3[Y,4I]\F*4^^3%*??)BE/ODQ2GWR8I3[Y,4I]\F*4^^3%*??)BE/OD
MQ2GWR8I3[Y,4I]\F*4^^3%*??)BE/ODQ2M/?_$__`&+_`.L__P"^?_#_`/\`
*OG_\`R^KORK_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g309840g74a77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g74a77.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0:<4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````,0```<(````&`&<`-P`T
M`&$`-P`W`````0`````````````````````````!``````````````'"````
M,0`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````!``````!````<`````P`
M``%0```/P````^0`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``,`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#SYA/B5:I)TU/WJHQ6Z>0DIO4N+1))@"5O4]-S&/=7-;G,NKQW%M@<
M/4M;ZM;0YO[K?YW_`$=GZ-85'9:.-LTXXT^"2G7Z;U2WI?UAJQS4+=E=AR3Z
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MBQ[/^L_IOH*W=?52`7NT+G,&WW>YK;+G-]O\BBQ$=,^Z)[3'EX_V5%L:[8Y,
MQ'TI]\Q^?N^FDIJ875\#.:QV+87-LJ]=I<W9#-[L8;VV;7M?ZU=C-FW_`(S9
M^B]2YJD[GWQ.L3$]MW_2VI)*?__9.$))300A``````!5`````0$````/`$$`
M9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0
M`&@`;P!T`&\`<P!H`&\`<``@`#8`+@`P`````0`X0DE-!`8```````<`"``!
M``$!`/_N``Y!9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!
M`0$!`0$!`0$!`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`__``!$(`#$!P@,!$0`"$0$#$0'_W0`$`#G_
MQ`".```"`00#`0``````````````!@$%!P@*`@0)`P$!````````````````
M`````!```0,#`P("!@<#"`<%"0```0(#!!$%!@`A!S$200A182(3%`EQ@9&A
ML<$R\%05T4)R(S,D1!;A\5*"LL(T0W.S)35BDE.#=;47&#@1`0``````````
M``````````#_V@`,`P$``A$#$0`_`-.E.09#N/XY?O4/XO<=P*;?]73PT'99
MR+(ZBE\OX-:T%YN5?7_B2`=!4V<BR,*5_P">Y"FI'2]7(&AH:[RR*BF@K<?)
M\E3V]N09$2`37^-W/QZ&OQ>P`.@88.39*FO;D.1CNH"H7RZ@^QML1,`\=`UQ
M<HR?LWR3)%``_JOUTI2NVWQN_JT%?@95DP6D'),A2-_:%]NU=QT']]Z5T#K&
MRK)J)ID60U_VC?;OTZ^,X==`T0,HRA1[3DN1``5_]?O`W"D^B?0`UT#I#R;)
MJ(!R;(R*;`W^[[_7\=7?\-`UQ,HR/O23D>1TVJ!?;NH=?1\?MOH'N%E&1_U5
M,DR#T?UEXO!VVZ?W\]#H':#E&2E3=,EOM*IZ7FYCZ:!R=7[-`_V[)LC[T*.1
M7Q5`!_ZS=:=-ZE%P[?MT#U;LBR(GN&07W=05O>;D:4`H1[R<30:!V@9#?PM-
M<@OK:^ZG>+M/)(KL*^^<V^O0/<&^Y$5)4N_WP&E=KM,-?0:5VJ-`UQ[WD'8G
M_P`]OBCTK_&)OKVIW_5H,T?(?>+V_P":;B%IV\W)V.J\7(O-2;C/D)K_``F7
ML4O.%G<>@?3H-G'XIWI\0I-/`)`'JZ"FXT!\4[XR5?9^-`!H#XMRO_4'[!ZO
M&GJT!\4Z1_U*M_5O]_30'Q3O[RK_`%?=H#XIS]Y4/#8>C<:"/B7#_B5_R[^(
MVIH#XISI\2K:GJ]8]1T$B4Y^\*^S?[]QH#XMS]Y5MZ!^U=`?%.?O*OP_+UZ`
M^*='^)5^.@/BG#M\0K>O@?ST!\4YO_>5#Z`!3;P\*:"?BG!_B5;#;;[J#01\
M6X:?WA6WJI^6@/BG-_[PH_3OH#XIW]Y5]>@!*<_>5?9N/#QZ:"1*<_>55]=.
MM?4.E-!'Q;G7XA7V?E3;IH(^*</^)5X>'W]-M`?%.'K(5]GU:"?B7/WE7T^G
MUZ`^*<_>5>K;\?#0!E.?O*OIH*^/J]!T!\6X/\0K_P!W?;T['0'Q3O7XE7V?
M7TT!\4YU^)5U^W[M`?%.?O*M!'Q;G[PO[#H)^*</^)74^@=.@Z;;Z`^*<&WQ
M"M_5]N_AH#XIW]Y5_J_ET!\4Y^\J^P?5X#>OV:`^*=_>5?A^%!H#XIS]Y5Z?
M5H#XIS][/2GAT_VNF@__T-,Q/ZS^7AN*#ZM!WF?T_9^9T%895N?6@T]'3\1H
M*FT*`T%04!)/A7MWT#%$[>Q"NP[;_I*NFX%:>G0-$3M[>ZE"?9!(Z=M*'?H/
M:T#+"H#OL?`D4VH:]?3H&V(35(]'AUH:#P].^@;+>%=5`DD"I.X*-JI'C4FA
M^@:!SADA(5Z*%'I`-!0=?1H&^W;*`!K4=W8.BJBE#78:!VC*`2E1HD#;P"$^
M-$GIN$_=H'>"FI!`)`6D5I45]!\*Z"X-OH"UN-P$U]`(-3X>`T#S;A10`64T
M)[:']033N*?2$G8TK30/<(*[4E(6OVR>[M40-@30^`%=`\0552VI0ITW.U13
MPK3;0.,*ON:[F@J:U'UUZ?SOOT%:\OOG.XGX7\XO"F-2Y2<DO;N3.L7J#9G6
M9(L$8VZ6F1*N)"EI^(:0Y4M#VZ#I70;A.%9YB7(F.1<JPV^0[_9I;;:TOPG&
MU%I2T]Q:=2VHEEYLU!2JBA3IH&Q0[5`>U[2BE/>:J4I*0LBO\Y02:FGAH.%1
M0&HH:@&HH:=0#T--!/\`+3ZZ=U/IIO\`1H``E02-U*W2D?J(]0ZG0!!!H00=
MA0BAW%0*==QOH``FM`30]IH*T-*@'UTT!X*/@D@*/@DGH%>@G014`E-0"#VD
M>(/^R1X&GAH)K]^V@/RJ?J&Y/U#03VD]`3U\#X#N/V#?Z-!QZBH.WI%*?;TT
M$T/H/4#ZU?I'TJ\/3H(!!I0@[$BF^R:!1%/!/<*^BN@"0.I`ZG<@;#J?JT'*
MAJ10U!`(IN"4]X!]92:_1H(`V[@/9ZU'3KUKTZZ`5[*@E7LJ.P2K91VKL#N=
MM`=/L)^H=3]`T!0U(IT'<?2!MN138;]=!)!'4$;=VX(]G_:^C01Z?4`3Z@JH
M23Z`H@T].@/SH?I!W!^@C030^@]*]/`]#]&@@BFQV(V(/AH#015.VXW(`W&Z
MCN`/6:;:#EVG<E)`2H))(Z*5^E)/@5#H/'01_*4_[P)!'T@C0'J\3T&@!O6F
M_;LJF]/I]&@-`:`T$>G0&WJ])_,Z"*)]`]'AU]&@_]'3+30*IN>H]%!_KT'>
M:!`&_P"?T;:"K,$J2DDGJ03O0^OH!305EFG;N/$U%=R-]AX@D:"N0TU2.P!)
M'C[T=/30D$@#0-4,40`2"3OM0BG7U^&@8X24=R`%*/=[*NY)HCTCVMZ>OPT#
MC#J34@[T5X[[4/V:!O@*%$"HJ%=Q`(J!MO3P%3H&Z'4)]14"-]R#0U'I'W:!
MOMW]JV>GLFIIZMM_Y=`[QBI*$A('=1::J2#1*@$*4/94JH0H[)W(KZ-!GKAO
MD-\V68\'/>9?%>'KM>^%HT"\79W++9D.(OO(MECF/-WBXHQI%Y<RUJ-!#1+K
MBH@2D)-:4-`M+@6)Y!GN5XWAN)P7KID^67J!CM@MBI49@3KO<I"(<&(EZ<[&
MCLO/..]J2M:4U--!E'SAY3?,3Y7YEA1SQQS<^/DY4]*9L$Q=VQZ\VZYKMY3_
M`!*,S/QZ[7>`)""XDN-*<2\@*!*0""0^W!W!'*_/F1C$>)L,GY??6(CLZ:RP
M_;8$"S0VU#NFW>]WN;;;1;81!`]X\^A-?'0/?+7`/,/E^R.#B_,&#3<+O<R,
MU<('Q4^VW:%<(1%/>0[E9I]SM4ME1_\`A/J[>AIH,`?.]S!E_#?#L.YX6^(%
MWRK)TXFJX=O<]:XTRTW.X/OQ!OV3/[C0*5LD:#RU\CD^==?-QQC<YTB3/FS;
MW=)4J7,=4X^_)>MDQV2\ZXLU6XMU94KZ?1H-Q7R9<TYUQIS%AF-6.>5X]G&0
M6S'+Y8)ZGG[>XW<I"6_BV&@2(TQM0'M4`\/'0;!G,?,_&/`/'60\N\T9C`P;
MCC$3`<O^678/-VVU&[7&)8K>J4(@DNA4J9*8935"2MUY"`.Y:007>#/,EP5Y
MFL8>R_@7EC#^5,;AR_@Y]SQ.Z!]=JE.!2F(=WML@HF6U^2A!*4O(;4H`[;'0
M5NS<V\57O/.0N,[-FMFG9WQ3;8-\Y`QV-\6JXXI:[I&?DQ9\[^K,=I#D6.X4
M^[*E$!1`H#0*GQ?RUQWS9A%MY+XIRVW9EA5]ES6K9DEK<?\`@9KELDF%/BH1
M-;;7W1I32FUE.P6DCJ"`"F]YB^#F>;6/+6]R5C8YRFXXG+?_`,;B6ZYD#M@2
MTX47-3:B(Z7'(C*EENO<$`FE`=`T\I\I<>\)X)D/)G*N4VS","Q=AJ7D.174
M2$6VU1E*]RRMU4-$A2>\J"22"2H@`$D`A;?R]>;3RV>:RSY!?/+US%AG*\+&
M7X;.4(QRX%R?8#-#JK:+U:Y<>%<8,>X?#.^Y<<:2'?=K[">TT!IS[GSASBS,
M^->-^1,^Q_&,RY=N]PLW&N/71YY%PRZZ6U*538EK30(?D,^\2%U)".X=U*C0
M39.?>&\AY=RO@*Q<@6"Y\QX39FL@RW`(<AY=[L5D?=;8:N,UM`4TJ.I]U"34
MCM*A7?;0-O(/(.%\3X1E/)/(N16[$L&PNS3+[E&27=U3%NM%KALNO/2I#C=5
MD]K:NQ`J7%>R/'03QYGV&<JX=C?(?'>16W+\(RZW,W?&[_;5JD6VZV]]*O=7
M&,7%)4S5Q)0H*I0U'706/YO\Z_E0\MU^QW$^<^<^/..\FRDH;L.-7V[-N7R=
M\2^W&8DO6J$7Y5OAO/K2EM]UM+140.ZI%0OAEW(6%83Q]D?*F5Y!#L7'N&XI
M)S;),JE%;]LMV+PK>J\2;W)`2Y(CQHL!DN%7NDJ2BIK2N@LWY=/.1Y:/-FG)
M#Y=.7\=Y03AG\-.3G'F+BRJT)NR76[?[]%R@PUM?$_"D>/<4DBM#0+H0^8^,
MYW(&5\3PLNMLCD/"<?BY5EF(]TQ=RLV-W(R41;S-46O=ICO_``CI2$GHGUC0
M<<!Y<XQY/P5?)''F96G*,$0]D8=R6V(E?PYI_$'94')-EME]P6IVV+:6IM*T
MJ<2I/ZDD:#$+#_FH?+ZY!SRR<:8?YH,#OF=Y)>V\:LV/0OX]\=-O;CSD;^$L
M$V`12[[YLBG>5=U-!ESR#S!QGQ5?./,;S[+;9BMXY9R=[$,!A7%Y\2<IRB.P
MW)=LEL2EL)<G(8<2L_S@E0J*#0,^:YEB7'6)WO.N0<GLV%87C,63/R#*<ENL
M.RV*RP6WFH;\Z\7>=)CP8S/OW66D*40E;CB$@E2@-!97R_\`FT\MOFGC9-)\
MO?+V+<J1\/DQH.2N8S\27K0]**S$]^M]MH/,R@R2VXD%MY*24%5#0&/E#S'<
M&\*Y1QYAW*O)&-8-EG+%Z58N.K%>I$AFXY7>@4M.,6X,]Q9;[EA-7`$J<-!O
M307<N]UA6*W3;S=)0C0+-;I-UG2UN$-QK?&C/2)3LE#"5O2&XL)CO!`ZK'B1
MH%+C+E#`N9L%QODWC');=EV"9?#7/QO(K4M;D"YQ6I#T-Q<93@#B@S(CK0:C
M<IJ-B-!9#EKSP>5#@CE+%>%^4N7[)C7*>:H@.63"V(=[OEZ]W=7G(UKFWAG'
M[7<6+%;[C(;*6')ZF4.*2:$TT&5(6E:0X%!2%*2`X.T)47$][=*42"XG<`=1
MX:"1^U=!;_E#E3CWA3"IW(/*F40,.P>U3+=#F7^[N/(MT>7=9'P,%#RXR'%-
MK<?5VH!H5JV&^@J.>\@X7QA@F1<E9U?;=C&!XK8SD>195-6H6VSV6/[D)G/M
MQ2ZYV]LAM1611*5!5:4T%IK7YN?+A?,6XES6S\OXK<<:YYO0Q?B"]1G9;T?.
M+_'6ZT]9[8ZBWE;<UCW"BXVYVK[Z@TH=!>O*\JQG`\=O&89O?[/B.*8[#<N-
M_P`DR2XQ;-9+/`9[O>R[E<Y[C$2&PGM([EJ%5;"IVT%DO+_YN?+AYK(^7R_+
MQR]BO*<3`[C&M66.8P[+=;LLR<'E0D26Y<)D^[G(CK6S(02VZE!4@D`G09%@
M$UZDI-%4_FGK0CP-/3H#01]/\F@G0&@B@]'J^KT:#__2TRTU[JT%.GJ]&V@J
M#!HI(.VZ/5T/XZ"KHJ013QVZ"OJ\>M-!56`>W[*_5X?1MH*]#VW(ZT(Z[`?S
M:>L_7H&J*:@IIN!4UV(\`?`TK30,D'TU(]H@#<C<$`>LUT#?#%2$DD$#P&X\
M"%=#0UT#="J`BJ4^S4J.W>H`@*2?$[D'0-T,42*^)K7P'3V?530-T$^TGH=P
M-_QI7J-`^Q0I7NTI!4:$T'@D!7<:>@5^_0;"F.>=?`?+OY!O*I$Q?'[+GW-K
MN->8+#XDA>:/QXW%L/-9CL-^[Y'A$7WL>_/3X<M"XB9:`E)35(-3H/.KR@7R
M#9_-3P!D>17)FV6R#S!A-VO%WFR6X4&'$1?6I<V7+>]ZPQ%BME16KN`[4CT:
M#UG^:+RAQGG6&X7"\O.28X_QBWS3RM?,ZQ^+D3EYS)7*\RX_U>2J_B%RFNKP
M2;%2HV]4=M$=HJ!42"F@6Y\C,K',VX!\U'`%NRK&L'Y7Y.MF(N8A<LKOJ;#&
MR*):;FF;<,;7=%-QF(4MQ([:>\27EN'K305KS@W>T8MPOY</+Q-S>U9_R)Q3
M#R:9F-UL5W_S%:K>S?74+MN.1[\"XU+=MG::MA:NRN@U\/F:&O!F$([0DGE:
M"4MH":;XGE`K5OV0I954^LZ"F_+*YW\BF/9]POB'(7D0N/(O,S%PO")G,[/F
M3Y.Q9BX.N,W"1$6KCVU/-8[&1$A*2QV-FCI!4JI.@][.%)MCN/F9XPG8W9%8
MY89?*>/OVFPJGOW,V>&Y=&UL0%7"25/S/AD5'>LDD#?0>D/SW(\N5\KCS%,P
M(9FW'^/\#(A-*;^);:<//O&<A"O=LI,E(?6THN!OVO<@D[#0/GR_/)WR9P-F
M_/OF,YEN_&S'*GF9_P`BFZX'PU9W[+QCB%FQ2UPHUN?M4=];CSM[G!)5,<=)
M)<*E)_5H//UWC/S)Y[\SWYE4G@/GMC@%NW\/X2]EDN?QE8^0O\ZVXX]<E)M,
M1[(HDA-J=0EM0+L:CH[_`%Z#-?Y(#4FW?+>X>CW5<E,F+>N3ESGI,=3#KBDY
MI<E.R3'<0A3#3Q5WT```4*;:#7L.8^8&9YC$?-S?X!Y&<PZ+YJ1'B<V1YEI_
MR<WY=T2I'$$7'&,6>>5D/QDY^X,R5R%M^[![C0;T#8H^<7-1E'RP^>KK8U.3
MH]\QC"KO8ULMK?6N'<;O;9<<+9:!6\$^_'>*'9)T&&?R:K?>W^??-!D?F`CP
M,1\WS''7#^&N8+BF/P\2X[F>7FT6]N9B/(6-)MZ%.9+=K[<91:N,F8[*4PI"
M0U[E:Z@,>?G'0\XY'\[ECNN#JN,G(O(_Y:&_-%BZH"GE)?O:.2,>1=;6Z%I4
MEV5*Q6WN5;%%]RZ]-!;#Y<L_E%'S#N`/./R.JZV^Y?,<P[G^9>;9,3.;-BM6
M#NV2;C%KF-K0&&ER?@BIH*H%;T&@],/G<YCG&;X7Y??([Q7@=]Y/RKS2<K0[
MUG&!8K+CP;Y?.$>'U_YZY%@6R[3'F(%MN-_=M#32%R%^[#"E``E0!"G_`".,
M\SC&<+YW\EW+6&W_`(WRWRR<G396+X/DWPLNX6?C#-Y#UYQ^TNW*(EUBZ/V5
M;JDN/Q'.TA8VT%E/+SRWP3Y=OF%_,0__`'=E8ICO)O(N9X7-XIS#DG'EW2%D
M/%[+%P;AVC"KO<+<Y$89CW%^+[YAE27'7.TG^SV#UG^83+A7CY='G0N%D+4N
M+/\`*)S7)M#L9#H28MRP&_.L?#LHV6EUHM>[;4A:J$!*=P0&+7R>>49&?<'1
M[,[Y@^*^9%85QWQA;1B_'?%!XUNG&P-B=8-JR^:EP?YNNK?PWN/BEH"JLE?\
M\U"S.9\Z<7>5GYI7FER7GC)HO&^/<F>4C#D8->KZU-;L^33K<K)69=KM$Y/;
M%?O27G$#W0*E$J``T&4'R<K!<[/Y`.*)%YMDVWC+<MYCS.V0+G'6B2NT9!R[
MF\JT3)MOGH"VGKA`::>9*Q0,/I4`0YN%F^$,8M4?YT'FA?:Q^TLQ8WECXY=A
M%O'+0B&S/1D?]>[#6+8VS'N+J![3\?L?_P#:-=!6/FFLR7.?_E1.,B6\TUYQ
M[G[]:$..B.S_`)7LZ4A]U`4$I!)%5G?ZM!T_GCPYQ\M7$]YN]HN61\#XCYGN
M,\B\RV.VUJ9,<N?%4.YKHF?;X13(EVZ%D2XS[@1L`BJ]@-!GSY9^??*ISA"N
MB?+!DF"7JWXU9\83>8V"VQBW1[1:I$1]./P[A'C1V&4RH:&GFPTX5.(!K7VM
M!K1_-3QGG7SE^:OG>_\`#G!_(_*-C\FN`8IB_'^<X3>+9;8?'7*MGO#_`"-E
M.1RF[C)9G75IZUT9+<(*4D)'B-!L2<4\RL>8CY>N.\S,MO-O<A^6JXW*]M.,
M>X=B9E%P^3:LSA"(E"'4N,Y=9K@BI!6Y[LJ))))##?Y&O/W$V;^1K@[A;%<N
MB7'DOB_");F?8LW&FQ[I843\JOC\)N:'$,]ZY#:PI/M=#3PT&,/GQSR7Y.//
M"?,!Y;N4<&SGFCF&Y<5X#RSY.,SPE&5WW*[*_<)D2'EV#75J.[?,:?B1'"XY
M[J0E`<1W&HV`>\7,/.G'7E_XRN',G,=];Q#";:YC5MO-TDP9\X6ZY93<X%GM
M-O?;ML>5+D.2+C<F455_51PL"M*:"ZT63'FQ8TR(XEZ++89DQG4!00['?;2Z
MRX@*2A02MM0(JD&AZ#0>5GSKFGG_`)>W)349#[CKF9\6EMF*VMYU83EK2E*2
MVTE:E=J4DDTT%TOF9L/O_+'\UK+"'%OK\N$H-(:0M;SSQB8VV\TVA`*UN"A!
M`%:C0:N7%7$W,/E-\R7RQ?+M._C63>7GE3D#AGS1\5WBX)?D3<.R;,.-H$7D
MW$DR>PLQ6G+S(;D=B@.P>[\0JH>]WSX++E-R\J6"3FK5>,@XKQGS$<=9)SKC
MUFC.7%Z7QU"G+<G&3"A`SYMH9]QWRT[MJ!H>HT'H1Y:_,!Y3>:HM_:\JV38%
M>K9CD+'FKE#P*T,6QJR6IZ`M.,VV8RS&BI9?@6X+;4E:'55)ZZ"XF,\U\:9;
MRAFO#%AR),WDCC.UVJY9C8/<W'NMD"\=Z[:ZBX28;<63[P)/>E"J@[5T%V]!
M'4'Z33[?H\-!.@-`:#__T],SIL!Z_H'3T[Z#NH%2/145)_'UZ"KQB5%)K0U)
MZ>'<:'T:"L-"O=L%>D]"*D$=*=1305V&2L#W@JE-"D"@J0>I\-`UQ3L:C<)]
ME0'B:?JVW.@9+>`2.[H*J-?Z)IMZ:Z!RA_I2KJ5>RH4^P_=H&J#VE05WU.P*
M/$*4"I6W38H&@<(FX%!T(!I]50:>G0-D#]22:#IOX^K?UZ!^B4/8*JW(V2>W
M<$G=7H]7CH'*V@(74`EL]M4]J$T50A.R=C2O6F@N!;.]9;*J]JNU*J**2$FM
M5`;5*0-O$:!XMB$MJ3VCLH2/82WVE*B%^R2#[LE2B5']7=7?0/T%2`4+;;[E
MI44@J6LJ%`5HHH$`%#B1OU-=`[P.XA/7WC@`6M8-.^E2KVB:E1-*^.@MOSWP
M/8_,%QXK#[O/D6N5`G_QW'KBRXKL@WR/$DPV5RF$D"1#>1+55!KZ1H/)SRT<
M19GPYYU^-L0S"VNQI;%^N:+?-:;68MVCMV^6EB9;U[I>1);[5!(W!-*;:#=P
M\C_DKO\`=+W8>9N26)EHLMBD1;UBUB2E46Y72>PXER'+FJJ%MPJ%1"30DZ#V
MRN%MMEVB/6R[P+9=($IYDRH-TML6Z6MQ,.:Q.8#MMG-O1G_[X&W4J4DJ;6Q4
M4IH/OVI3[*11(V2*UH!L`#Z`-!U$VNU-RI=S9M=I9N=Q;9:N%Q:MT1NY7!MD
M%MENXS6VDR);<=#A"4N*4D()%-!,*V6R!'1;[?;;9;+>TU*,>%;X46#$85*D
M-2'6FHL-IF.TAQ;BR:)J2#H.FC'[`BUMV`6#'S82FBK(+-;18TMK>3**%6;X
M;^&K497]<3[NH=%1OOH.W*M=MF6\VB5`MTZU.)]W(M<Z%%DVQ]I.[;+D&0TY
M%<8;4TCL1VT33;0?%JS6:-<%76-9K/$NC\4VQVZQ+;"8N?\`"FEHDM6XSVF$
M21`2XV$I:4HH37V0-!Q78L>DRI$V78;+)N$R&NWS;A(LUM?D2X"UU?@R7WXZ
MWI,"0NBO<.$M)I^G0<VK#CK"K:XQC^/,.V9+HM#C%BM3'\&#J@E2+.&8J/X<
MF0E/]<&>Q*P!4'0?15LMCLZ)=I-NM<B[0H[C-ONSMNB.W.W,SDLLS(4.8ZTN
M7!CRVHO]X]RM'?4`U%=!$>TVF'/D72-:[6Q<9J&FY=T9MT)JZ3D-!08%QFML
MIDS1%15*0ZM1H=M`LY)QKQWFDB!/S'!,+RV;:7$O6F7D^,V6^2[<XE84A4=Z
MYPI,A);7ND=Q"?"F@;GH,)^&NWR8UMDVQZ'(MKEI?@LR;8Y!EM"',B28#[2X
M;\&1'=/]0I!;[12E-!2K+C&*8Y\2O&L6QG'%R7DJD&P8W8[`IY2`>UQS^%08
MOQ*4+*E("ZA`50:"G97Q_@6=)A_YXPG#\S5:W$RK=_F7'+/>E1G4.=R%Q7;I
M#DKBOH6.[M20@[;:!KBM,PF&HUO8BP8\5'NXD:.RW&AQFFFPI`9ALH1';4C=
M*$H2E!KTT'13:;2U.=NT>U6YNZ/M-Q'[B(D9NY3(;1#Z(\NXI;$MR,ATDI;4
MLI"J:#Z2+=:+BY!7/M=NFO6V1\7;7Y]NB2W+9-]V4IF0')+3JXDD(]@NME*R
M-JTT'*;"M]TA2+9=H,*[0945R/*@W"%&F6R5'<[.^-*A2VI$66TI(31+B%=J
MTE74Z!;Q3`L&P)F7#P7"\4PR//=$JX(Q>PVJR-W"0.T!<U-MBQDR'4IH`I52
M!4:"O1;9;HBYBHELMD!5V4IV[+AP8<9=S=55"EW-3+*/CG5-`I4IWO*D'MZ;
M:#ZPK;:K;;V[9;[;:X%K9*TQ[5;[;%AVYF'*="WHS4!AIN&U5+='$A':LNK)
MW4=!3+)B6(8VZXYCF'XACK\MMIF5(Q[&['8776&@I3+$I^UV^,]):CK'L]ZE
M==!U)&!X!+RB/G$K"<3F9K&:1'CY;)Q^U/9&PTP5^Y;:O;\1<YIEGO/NP%[5
M.@5>9.&^/>><'>XWY0LSE_PV3>L=R";94SI49BYSL1O5OR*RP9QC.->_@-W=
MOWI2JJ#[D)IVBF@N<VTVPA#+24(:92EIM#2$MMH;;`2A#;:`$(;2D``#8#;0
M=:?;K?<HSL*Y6ZUW6&\MEUZ'<(4:;%=6POWC#CC$QIUA3L=[VT53L=!]I,&#
M-BO0[A#B7"#*0(\VVS&69<"4PXTD!,B-)0Y&DL^[2$.-J24U`VVT'2=L./R%
MVQR18K*\[8EI59'7[+:7W;*GL"`W9'W8BW;4VE**)#!;"$!(&@J$IB)/BRX$
MV+$FP9+(9DQ)T5$R'-:6?:9EP)*'HDMM*B3VJ001L=`LXCQ_Q]@#,Z)@F#XG
MA,.[/(EW"/BM@M-C3.E)0H-OW`VN+&^*6VVI21WU*.[;05EFS6>/<IU[C6JU
MQ[Q<VV&KG=684=NZ7%$<?W=N9-;;2^^U&"R&TJ40-]!4-`:`T!H#0?_4TRTF
MJO`;=/L)IH.ZR?9/W>NE=]Z:"LQQNFNZ?=BH!!Z`#V0*[Z"KQ]QZU)[J=%?I
MJGK0UI]G305^(%`$D$]O:24^TD@_T*@J-=P-]`T12H"A`]D;@D$@'85Z^GQT
M#%!_6DG:H/LU\:?7T^_0.L8@I[13<`;;4\/#0,\!M=>@"0GLK45()02JG7;M
M^_0.43]"=@!T%"-Z$55U\?ST#=;R`XBJ:^R!4].I]6@>HBB2V!U()I4=$@J)
M^P'0.EO-2C:JJCM430`4!.PZ[$';07$MP62VH45L*J])-`*`FOCH'>VU.YZ?
MJ'@:'MH?KIH'>WI-6E5/MJ]D)%20`"31-3MH'R"F@0H$%.YK^5/2*=-`VQ2/
M<FE3^G;8BM3ZATT&6'DTP?$LT\UO"3F38W9\@=L^0RIMK%TB-/KAR&K1+6E]
MAYP5:4%TH`3N*Z#:B"66TH0RVEIMMI+:&V_90@I```%!L@"@T'!->T=Q"CXD
M>)](Z#03Z/P\=B-]_1H)T$#\_P`]!.@CZ_VKH#;]OV]6@G0&@C?U?L=`?E^W
MUZ"=!'U5IZ?]/JT$Z"#^WI^JOJT!O^W[#T:`'[?:=!.@CK_I'^K03H#01^WV
M]1]V@G]OV^K00?V^OPT!]G3\/3]N@G01^W\A^[03H#01_K'7[]]]`#Q^G_1^
M6@G0'^C01T]9^OP^W03H(_T_C]?HT$4'W4Z']/HZ]=!__]73*'Z_K/YZ#O(Z
M?[GY#05MC]2?Z/Y:"KQ^J?H1_P"#H&.W?V8_[Q&@KK']H]_W0_XAH&>%_91/
MZ2O^%6@<HGZO]X?AH'.#^GZ_^70-D/J/I'X:!K@_J;^K\%:!XA_VC?\`\S_P
M7M`ZV[_L?H_Y$:"Y%K_[/Z$?\;>@=+9^A']!O0/=KZP_Z*_^`:!V@_V:?Z2M
M`WP?[+_?'XJT&;WD&_\`ZPXD_P#JMQ_^TR]!LY#I]9_$Z"=`:`T!H#00.GUG
M\3H`=3]/Y#00G_E3^>@D]#]!_#00G_E3^>@Y:"/$?0?Q&@G0&@-`:`T!H(/0
M_0?PT$Z`T!H(\3]`_$Z"=!`Z?6?Q.@!U/T_D-!.@@=!]`_#0`Z#Z!^&@/$?0
:?Q&@!T^L_B=!.@XG]2?K_#0<M`:`T!H/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g309840g86k91.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g86k91.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0]T4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@`````````````!/````;D````&`&<`.``V
M`&L`.0`Q`````0`````````````````````````!``````````````&Y```!
M/``````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````#-@````!````<````%``
M``%0``!I````#+P`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"`!0`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#J;*.FXW3,&Q]./6;,:HESJ:W%SMF^P[G5/]VQN[^6@-R>A'=#\*R"
M##:L<P"W=M+]C&._XUOL_P"N?HE<LIJNP>FMMJ%H9BX]C=\%@<UKH=K]%S?Z
MG_?U2_9G2@UE)Q6,VCV.:7`M!BENUX=ZM=OZ-GZ3?ZGZ)/`TZ-C'"X@T/JV,
M<=,R[C5CUX;BR0]HJI)$;PUSV>EZC/4>S]'_`%$5V'BM<''%QPQTD-=30/"(
M?Z36[4+&P<>FQSJJFUN>0;W``;RWW,Y#][G-_/9L5JQ\;ZI)J)W-+22`YQ]T
MG<]_L<W^PC028"]@UG48KO:W&QFN&W044DDGZ7\Y4S^JF-.*UI_5*'/`'M--
M`=[O:T[14HYC"YU=-(#01M>PM)W;C-EOJ6N^DWZ?I?F?Z53?Z=0]1VYK*VAS
M2/<X@Z:;7?1W?SB/"%<$>P=7IW2NF6XH==A8[W[G`N-%;>"?S0Q6?V+T?_N!
MC?\`;+/_`"*;H[MV"W]X.>'<\AQGZ2O*,[E@G\Q\VE^Q>C_]P,;_`+99_P"1
M2_8O1_\`N!C?]LL_\BKJQ<KK%F/JW+Q\CZ9(IK!+=@<\,=OSJ_?9M]&O_A?W
M$%K=_8O1_P#N!C?]LL_\BE^Q>C_]P,;_`+99_P"16=3T^G/W6U9-3G/)LM;7
MZH+76M=6_P!5E><YC;/3+JOY"T*,/.QJFTT74,J9]%OHV&).[EV6DI?]B]'_
M`.X&-_VRS_R*#F='Z2S#O<W!QPYM;R"*F<AI_DK0J%PK`N<U]FLN8TL;Y>QS
M[?\`JT//_H.1_P`4_P#ZDI*?_]#L#)PNG-!@_8Z2->(`D_\`D4Q+?3<6<,F"
M-3Q[&EA^E9^]O1*:WOQ<#80-N%2=9@^W\[3:UO\`+>@0TAOJ0TD@LD1([?V7
M?ON4@V#:QD<('936N@ZF.06\F1]*R/:Y_P#(1'V-EK&N?%E8-CWCW->?![H]
MG[O^K%`M`;!#G._<G:=/SX?^8H.CU0&[-S?=M/;=NW.9_79]*Q%>=4KG5OKV
M^KZA+'5UGZ,MG;9OW^W]*[_2J%C6OWN#MUCAM?83[B6&&;;*Y9]/^0F:1O;#
M8;J6`B)@PZLCZ.Q2>'/V[2=P#^3PULN:X/\`HM]-KG>RM%;L;=SI+-F$T=]S
MR[XESB59NM%-9L+7.#8EK&ESM3&C&^YRJ=&+3@@@@G>_=&NNX^*!=ZK<W/>7
MWUU^GB['TM-C@=]V_P!*IPN9_P`;^@^@HCN6M/YCYNCCY%6317D4NW57-#ZW
M01+7#<WVOVO;_:4O39^Z/N7-7LR/^;F'DUY&;CLQ<%SW_9&UESRZK:TV5/'J
MNNQW?I65U;/TBV.D57556"RW*O%K_68[+V![&O#?U=HI#'-;7M_PK/4]Z"UO
M!K1P`)\$ZH]0LO9D8;:]X#[8ADP[]':[;D?HK=E/M^E_I%>2M)C0!_>%J0,_
M^@Y'_%/_`.I*.@9_]!R/^*?_`-24D/\`_]'L0ZS[%T\-+X^QTZ-[RPC73W?F
M>S>A6677!PL#RUKB6`L@<%SF_GMV.5?JQRQT?ISL)C;+_LM(`.V8V@_X9]=/
MTVUL]_T*_5_/6>3]8@+;/L^.]U=I+02T;:O?L;RUOMM;78]__GWU?T4@.@T;
M6.'I!\.SL,WB#766@O%LP1!(EON_/_<=N2?7;N:TAVIVR1+0)]W;\V?96LJI
M_P!8C2]CJ:G6N:QK'?HP01_.>DUC[&6L>T_]J'XS]_\`->NK6&;+*7?:&,98
M7NV^UC=U;3^BW&I]E7YK_P#U:C:\8R3V^C8NKL%C:]K@01+2TG4[MOZ3]UGL
M0;,GJE;W''Z<Z]C00QQL$:3[ZVN#MM=G\YZ=GZ7_`+<4=M;8VR1)&X@3!UVN
M_.:FVLTF"2V"(!VM!W-[)6O/+DBN+\'J>D$GI]1+7-,?1<-I&O&R&[51+=O4
M^J61<PEF*!;2QSK(!LEM7J,L99M_PC:=[/\`KWJ*WT,-'3:]H@%SR`(C5[N(
M5.NW=U3K%8?96ZLXI+J9L<`6_FTN];8[V^]C*OYK]+]-1G<^;1F*G(=B0EP<
M3[;]6L;&]:W']7%8T75.V6ME@&]ICVV?UF*YT_!=A,M8<F_+]2PV!V0X/<P$
M-;Z-;FLK_0MV^W<A]"_Y%P>?Z/7SH?HM^E_*5Y!:XN=@BOJ%%K*K[VWW!QK8
M*_29MKN:[U)9O95:YV^S=_AMBU@VJBLBMFUC9.U@_(UJ(D@!5KI2XJ\!3@49
M#\[.-XMZGC,:VF_[,^D5L]K\AGHN:ZEUGZ2/TS-^_P!/TOTBU\_^@Y'_`!3_
M`/J2@6]+L?F_:FYV14W=6XT-+/3(K-CG5^^MS_3N]7])[_S/T:L9_P#0<C_B
MG_\`4E/D0:K[.RP/_]+KKA^H=-\\2H'X$,T_SE6(<TAPEMFA<3J6SIMT)_MJ
MU:''`Z7H"W[+7H9Y#6'G^IN54MEGM+1$`5CZ1/T_T;H_,3QL'1P']7%=SV.:
M26;=Q'F2`.=2B;9;(!;P0W@F-NWB$)@?8\DS)[DQ`CE6]N.<&TE^W+-C2`T$
MG33V-_E5O?[T5\Y<->8#2-AU)_2.VC>-8`G>[:"[^NW>Y0!(>9.NI,'0CANI
M'YB(\&3N@N!U;XCG;^\Y1`$M`U,?1@'0_'Z/_J1%DZ/1]",]+J/$E\<#3>[B
M%<OJ-U1K%CZB8/J5D!P@AVFX/;V_=5/H7_)E6H.K]6\?2=PM!1G<N7F_G)_W
MI?FX^5@6=/Z7<['S<D-Q:'FIFZK38TE@WOH?X?G;U8IPK[::[#G9+2]H<6S4
M8D3']'"LYN+7F8EV)82VO(8ZMY;$@.&UVW>'M_Z*+76VJMM;?HL:&B>8`A!C
M<CJ%>3BV8;6YUY&3D"EY>:F@!S+'?2^S_3W,;Z;/\)8KG[.N_P"Y^3_X%_Z0
M3=0;8[)Z?L#"&Y!<[>8/\U<W]%[F[G^_^6KR2G%;7E'K+\`Y]PK;CLN$FO>7
M%[ZW;/T&UU7T?4_E^FKU]+J>FY+'6OO/IV'?9MW:M/M_1LK:H4.<>M9;26P*
M*(`:0[Z60?>_Z#F^[V*QG_T'(_XI_P#U)24__]/K['@8/3-WT&X;9!)$;F-9
MN]L?]4JYK[@@L:=I:#X]W,?'MT^FK`K;?A=.=7;2/3Q*FDNL#2';6_F_NH3L
M&PM:WU<8[8()M;&X"/H^[PV)X(H:MW#.`A$<0!K75'6YD[0'"#I&LM^BP03_
M`--%R+&QMI+]AX?9`)=]%SF[(;[$F85G)OH:"XN(;:W7^2FLP+"XAMU!:8!!
MN;KV_P"BC8[LON8['K&GBUB\-=+9YU/SY3M)(VO=)(TXGG;V]KO:CNZ?;/\`
M/T&/"UC9"J7]%S;=VWJ#*F/.E;+:P&-GZ,Q[]K?]?]$K'=)S8ZTD#]0]1T-X
M?TVMPU!+X<(U][O=[5?6;TJZG&P:Z<C(J-H+B[](UQU<YS9<-OYI5O[=A?\`
M<BK_`#V_WIAW+GY"#.1&W$4Z2!]NPO\`N15_GM_O2^W87_<BK_/;_>@L:O4W
MULS.FA^I?D%K!!(#O2M=O<X#V^UKF?\`&65K159V5TYY:Y]M+G,,L)<TD'C<
MW7VJ7V["_P"Y%7^>W^])35QC_ES-]UA'HX\,=]`&;Y=5[G?V_8Q6L_\`H.1_
MQ3_^I*7V["_[D5?Y[?[T'-S,-V%D!M]9)J?`WM_=/FDI_]DX0DE-!"$`````
M`%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3
M`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``-@`N`#`````!`#A"
M24T$!@``````!P`(``$``0$`_^X`#D%D;V)E`&1``````?_;`(0``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("
M`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@!/`&Y`P$1
M``(1`0,1`?_=``0`./_$`-@``0`!!`(#`0`````````````'!08("00*`@,+
M`0$!``(#`0$!``````````````($`P4&`0<($``!!`$#`@0#`0H*"`$'!@\$
M`0(#!08`$0<2""$3%`DQ(A5!43(CI18W=V@9*K2UU=87EUB8.5EA<4)RLC,D
M&":1U"55EE<*@5+2TZ8HL=%BDD,TE)5&5F8G.(@:$0`!`P,#`@0$`P<#`P0`
M!@,!$0(#`"$$,1(%05%A(A,&<8$R%)%"!_"AL<%2(Q718@CA,R3Q<D,6@J)3
M8S07DG,F_]H`#`,!``(1`Q$`/P#L">W)[<W9=RWV/]L_(_(':[VVYAFF7\4X
MS=Y-E.5\`\39)DE_<&B^<;:WE_=8D;;6]D9,Y7RD$3232.7=SE77@[5)VMZS
M0E]JKV\X7I'-VA=HL4BHCD9+VV<'QO5%WV5&NPM%V7;7J'M7B5Z_V6'MW+\.
MT?M!7_\`UPX,^SX__P`&:(>U$\#7B[VL_;K9]_VE=G[?A]]VY<%M^*[)\<,3
MXKKW:[^DU[M**A3X5Y?LL/;NVW_[1^T';[O_`&X<&;?^7\C->(>U-I['\*_$
M]K+V[%3=.TGM`5$^*IVX\%JB?_8S1#VIM/8_A7ZOM8>W<BHU>T?M!15^"+VX
M<&(J_P"I%PS==$/:FTG0'\*+[6'MW)LB]H_:"BK\-^V_@Q-_C\/_``9_HT0]
MJ;3JA3X5^I[5_MWNVV[1NT)=]]MNV_@U=]OCMMAGV:7KQ$UKQ=[67MV-5$=V
MD]H#57X([MQX,15_U(N&:]0G05Z&DW`*?"B>UE[=CE5K>TGM`5S4W<U.W'@M
M51%3=%5$PS=$5-""-13:45"GPK]3VL/;N7X=H_:"O^KMPX,7_3__`"9KQ"-1
M7B'L:\5]K/VZTWW[2NS]-OCOVX\%IMO\-_\`P9X:]VN[5[M/8_A3]EG[=FRN
M_P"TGL_V1=E7_MQX+V1?CLJ_D9LB[:(>U-IT0K\*\E]K#V[D17+VC]H*-3;=
MR]N'!B(F_P`-U_(S;QUXA[5XETNM/V6/MV[;_P#:1V@[)\5_[<.#-DW^'C^1
MFO4/:O=I['\*)[6'MW*BJG:/V@JB>*JG;AP8J(GW55,,V31#VKQ/`U^)[6/M
MVK\.TCM`7?X;=N'!B[__`&,T0]J]VGL?PK\7VL_;K3=5[2>S]$3XJO;CP7X?
MZ_\`P9X:([M3:>Q_"OU/:R]NQ41R=I/:`K5\$<G;CP6J*OW$7\C-ET0]J;2-
M0?PHOM9>W8GQ[2>T!-O!=^W'@Q-O_+AFB'M3:>Q_"B>UC[=JING:1V@*GW4[
M<>#%3_R_D9KQ#VIM(*$%?A7[^RP]N[P_^Z/V@^/P_P#NX<&>/^K_`,&:(>U>
M(>QK\_99>W:OP[2.T#[G_P#CCP9\?_8S7J'M7NT]C^%>R+VK/;RG=T0]HG:)
M,_X]$7;;P=([;[O2S"U70@C44+2-0:Y/[)_V_O['/:;_`'9N$_YD:\KRU/V3
M_M_?V.>TW^[-PG_,C2EJ?LG_`&_O['/:;_=FX3_F1I2U/V3_`+?W]CGM-_NS
M<)_S(TI:G[)_V_O['/:;_=FX3_F1I2U/V3_M_?V.>TW^[-PG_,C2EJ?LG_;^
M_L<]IO\`=FX3_F1I2U/V3_M_?V.>TW^[-PG_`#(TI:G[)_V_O['/:;_=FX3_
M`)D:4M3]D_[?W]CGM-_NS<)_S(TI:G[)_P!O[^QSVF_W9N$_YD:4M3]D_P"W
M]_8Y[3?[LW"?\R-*6I^R?]O[^QSVF_W9N$_YD:4M3]D_[?W]CGM-_NS<)_S(
MTI:G[)_V_O['/:;_`'9N$_YD:4M3]D_[?W]CGM-_NS<)_P`R-*6I^R?]O[^Q
MSVF_W9N$_P"9&E+4_9/^W]_8Y[3?[LW"?\R-*6I^R?\`;^_L<]IO]V;A/^9&
ME+4_9/\`M_?V.>TW^[-PG_,C2EJ?LG_;^_L<]IO]V;A/^9&E+4_9/^W]_8Y[
M3?[LW"?\R-*6I^R?]O[^QSVF_P!V;A/^9&E+4_9/^W]_8Y[3?[LW"?\`,C2E
MJ?LG_;^_L<]IO]V;A/\`F1I2U/V3_M_?V.>TW^[-PG_,C2EJ?LG_`&_O['/:
M;_=FX3_F1I2U/V3_`+?W]CGM-_NS<)_S(TI:G[)_V_O['/:;_=FX3_F1I2U1
M[RU[6O850\7\AW5=V@=J@I]7A63GA%#=MG"XY(Q0M*;,/..1#A3)8)X96(YC
MVJCFN1%145->$I0!2E?.0_**_P#_`%Y;_P#[Q,_^NUX@K(I[U__0[<WM,_X<
MW:'^A7$/X`W41J:D[4?"O?W8X!@-MG])R'<8I:95D>%XW\F/TBU\5KE4,A),
ME;7#+96`XT[Q2I7HQ7QN9&LRHJ+U;MZCAI)'8LF$YT;<>9Z;W@D1H+DI?3L>
ME=1PL3LC!FQ1L;ZCOK<"@``4$@$A?Y=*PCSSCTBTQZ,SBO"<0PHVTN1UM%Y`
M!+A=AJ$,)+LA"CF13Q$"C1#;RPQ12;J[='[?+K?P1\?'D"/DUGB:VWIH=^@!
M`LA*V)(KNN+P^-D:XYK7/D;$=H`'F1!;Q/?]U65)VX<(7Q]3G63$6N?5MN7B
MU%9T_']78&XG':B%#M84/=Q&QD"UP5LQ[YGS-^2)$\QVVZ:LC,R8`_%QL:."
M1@>09=H?M0VVH026HB'72MH]_J<:_CG\-#&QC"YJ[?4(.H1!=$T^0KD\B=OV
M&B8W/2X)9JZQK;PG([Z\*D*L1FUZ2SSNQVF%Z0XW0R!>7`I3B)%(F1$8UB-7
MJJ8V<PS"7*PF>F6;&M``^9*=U.U+#O6[X#%QCE^KFX$4;3&UC&AH![;GJMR>
MF@`JT>`N+<#O://+NRPHEM83-;^B#N_,)8'$-+!.5&+Y*02SRAS)LQS6KTR^
M"N5%UEYD>E+APQF/U=K5+0`NMSKJ#5_E<?C8'X\#<:$QB4ER`>90B%=`0*EO
M/N!G8Y68>7BXN&YADN1D3#O^M5Q<ESBC92QQ1PQDA,8PFP:\ML;$=$WH2-5W
M54W6IB38T[IQ-C[(8V@^71UE)TL+5H>,G]O&;D89<1^-@0R$,VANQ^NI+5#0
MET.E7H[A$>X,A=G&`!U)5U7G`X608Q*.:H7&)(41TXDC!8LB(NFF3SP-5\;]
MDV=\435)TN.VT!!8T@O`\P<'>-]J6!K%#-P>-@SP<<(Y(62A\HV!V\OT())V
M!A`!-UUKGD!8308KAQ-GQUBU!R+1VEB%=CU%,.N.##&ECB"Q6@LIQ,DIIJ/9
MU0QD(J/?M\JJFT'X<+\J>''>7XDC06JJE`I0H+#NE:GBO:F-R$G*3Y8:>,0$
M//UDE3Y/#N2-*C_D?BWBB\Y0PN(G#*$D">DN[0&[#LF&UE@4%#'.T!*RD(@%
M%](4Q\4<;RI6K)ONYR-^:_A_<8^!EH2V16M+2U'-!MJ=;&Y2MWPT>/%PN8W%
MQF+O#"W8`4*A2YP)-KD[15H4&`<#8MS,/5KC194>=BF7E\6"$ZWNZIE7$'44
M08ZS3Q@"X^7-ZJ+RO*\V18FNZE3;66:/,R>.]=^Q82&L#K`ZD^)<+'5/"MGR
M6([-]O/Q8L"!A@.PZ,:\N.YQ)`)+@`$N@4VJ7:'BOARHR=M<N'K2@W15DD5-
M>RD0VK18/(`5KWK-Y(;["-DTL475*JL'\'(KD5-=E.R<F+U6N8][6A2&@A=;
M=^@^)KGI<6,\?(&X<+YH6M`>T#;YK^*I9=-=*]><=M?#1K)R*.D<2(:\STAD
M(%;*PA'"L;60/E)/#;.8&2GP<_9[51-DV55R8F?,'I(QH<P!54(FM@#J*Q\9
MER0QLQY\"`HEDNJWO=&IV%0QDO;9U<5J%@<6)0)+;1S9#<Y()$3-&75CQQF/
MO2:1EH36V#WO>@T,8KH&PM:O4YSO#8X^?@?Y(NR\-Q9M\H:$!4V3<@=XW!5:
MV,;.-_RLKL[$8_*$8`:P(2TW";D:4ZE5\*DG#L8I.2AKG&2\,X]I*AE:!5EO
MN:V-8<BDK1MRK<&)EH,315[]O-A>]_GJ]BKT)X(M*;'@Q9!/`'EP<2-OY5_*
M;(XC\/&M9R'`<3P@PLN5LD_(O>24`VL!^D:$//<:#O5UMXTXOBQ^YQ.BP&@N
M&6\%,:?:7!\<3L4J1'20V,8-TQK6&$C#0.<V*9L2R/D;L[;?7K3%ZL.5E.38
M7(UHN\]"6]`3U"HE<]EXN5+GQ/`]+,:2UH#`DCNA#>B_.J[@\O:E619;#C'%
MC,MQ_*#I\;#G**$&C`OZ81D5MAD\1)DS@3(O6,)ZTV58BF+XILNJN?@\FX8?
MW$S62,&\`#\CCY7JGF!((3N*J9O!<SR.8!D^G'E8P!D1N@-PZP1UNB]*@"JQ
M[BB_.S$2'`B,%R6EAN`:W"SUC+HW*HSIQJZ*\">X0975S'SL)ZDD21$:B;IX
M[>7&DQFXDK7QRPO()>`C_$[3<WL0;)>NP/'#'&!B/9$^"5/[C?J5/J0@+V(J
MBWW"/'-Q29S0QU-?27^9`D`UMA4Q%6M32MMPV046R%.A+KB"#&=+]FR.ZW;]
M:]6R6,:8QSXF0Z/?'$;@@`N0J[10;?#X4,)BFXZ9V/$Z"`J7$!KB`;FPN!J:
MMJB[>*Z_X8_HYPQE3C7(7%UUBD&4GY-&2:2=8''G/L'^=ZV%L03EEC1RM=*L
M3&HCVI]MR7*Q(^5;R$^*)./R&/VAH`0`"R)KK\:KS?:1<J_*Y#$$D63&\M+0
MK4_*BC5!^-3C6]O.`EV60RY'38YF%E'`%'-7U8Q`0,CH_)#M[&C<&>]A1\<W
MS-1ZHQB)U(FZ[:YS(FBB$?H0F-BDC0GN&N!&E6&YF,R'`9!Q[8WH1N<P.)2X
M#MP\H(KBX!@'#@&/9#0%4->2X:PEA!LA9&$`2>GF<V3'[4TN"22LL&$(KDZ6
M/<O4B*J*NI9D4ADAE$0.X`EKFW'^YH!N*\Y>'(S,J#/;A1,V6+41W@X60M(-
M7%6X3QA62X\9-@X$23S'/I1;M\(\5T$N\(T8_G2#BRR1&,=Y:]3%5WRK\=1D
MQC*)FN0L`&X-;])ZGJ;BM9DX#,AF3"\0[@YKG/:U0T]04"_&U1#D_%"AMM[G
M%,*Q`G)R"0R!,2+\T"MAB*-;%9RJZ(\\@$N<='/A8YCXG2)]\B*FKC'8[A%%
M*YS<,`@%`386N@4+\#7<<-C^VG^E!R&.WT@T[YVM\R@*VQ`"*@)!5.E95]DV
M!@8KS!:RV0`4MV\`N2M-K*X4$2M"(@19ZUTBDR'$/8_?YE3I\=:GG9\>;&A]
M`%J6(/YCWTKCO?G$>AQ'W^-!&S$=(!KYB>^B7K;OKDJ^,4TI32E-*4TI32E-
M*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI
M45<Z?F8Y5_1]E_\`$!^HNTJ3?J%?)NU[4J__T>W-[3/^'-VA_H5Q#^`-U$:F
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MNVVL;?\`S(<O'?&(V->"'+YGGZ4!ZGJ@JOB9\G+.SL/-P6PP1R(J'?*7':`S
M_=UZH*M$C+(<JQJ<PZMF:XVVKLAI[5SWC6IT<0WJHUIG`M84,2+,C/,65S'M
M(>B?8NI-@=B9;6MD`D:W:>W:ZV(([+:N@AP&DO;#'OP/2+7-0%H4HCO&WX50
MI>9.0^7\Q!!RVBL,3HL5'.AQRSMAK.""QFB.AK"R`2YHAV6A*SU,?1Z=\TJ2
M3*Q5W1VKDO&XN!BB3'R&R3O(+PTA0HW!0-!?J@ZU2XKBN+]OX^>8(Q*Z8@%=
MJ"Q\I70$.6Z:5Z\IN*RH,9](H[$CU=>&>YJY$2==`V%><A1YL`;H/,(/C,1K
MI(G(J*B*GCOOK'%OD:LDS0X$CZ4:00@!/8BMMQW&/D8^.=[3!O))V!K2/R@'
M0`#0@WKF8E3UMT!R'B>/T2%W6$5@38"$\P*S=8"^<40:\*(E?I4@[G.:Z2;I
MBE>KF(BN:NO<F69HPLJ:1(I7&VHVE++UTZ:5J\Z:'C\[`?-EAC,B0KH6(J#I
M=56N#VV"CY"/67>:WQ&)`3U.4XI="#6(GJZQ]-DD,4-J18R1I,+.6C6>0Y)'
MR/;NK51JZR<R]\<GIXL+7R[F/:HL06_2G4=^G>L?NP/Q,7+@XV$Y3(W,>UQ!
MON:24:"EK@]EK(+E/B4(VD+M^/,GJ,OK[:6NI<A,N#B[:QQAQ;H0VY(.1`2X
ML4O>1BS+\GX#J1'(CE76LPLY\4K/O<=\;PKFH``Y+[=$([>/2N0]O>X&S%G'
M9F(8)&M+FQM">I8V<$NFH74BK`L:SD`X3CV*2]Q7)/3VU(-!4V=5+`)6QJ=$
M!ZJTL0)FD#S2I%NQLB.14\?L7>V'X/J90$$C%#B2UP4V6P/\:V.-D86&WEW1
M%\;S&Y3JME1K3KXI5<NL%)QO(,JDQJRKIL=R*TDOQZ_$TDR0DZP@`;6'@1-G
MC%G%%BM:]S.EDDK'2;JJ-5-8&944T4$&1N$\3`TE_E0$[@5"J4/:JF%RSY\>
M#-RL=WKM`:YSW;?*MB`A"I\*L/$*./!$R.U6GRBLE(R!A65)GM385V/W["8$
MAFJZ^XE<:P@<&655_`(G0K%7=$U;RI'3>@P3Q2>1&"-P+FWU+;7/C6SR<R'F
MYL:&;;'Z;?[;HW!S@EP2T)<^-6WG.!V&:5P:7.0Y-650N04EG2-#0MU=*,*L
MBD$0@P2QQ6`+&O8Q[YE^:)$5%W14U+&RVXKG"&*,R;7!P.JG0$]_A6WX_+CP
M)7'$X]D[W1%KGN(#FGH0XKM(UMUJ_K##*"OP/(,>HX5K<M,J'!2V622PXZ*'
MEYDOJ:S(0I)%<\KS1D9%(K$8][(V(YRMVU4BR99,B.=Y+X&O5&J[R#5I[74C
MYUI<K/S7\I@Y.5&TX(D!2(A[I(Q9S';>Q/7Q2HWPV]N:[CQ<<O(,=B=%<C#Y
M!D14H]/]6L1^A!HBGO9,YPQ"QKY22KY:ODW5=M;3(CCES&31"0JT[6A2@/4?
M#JEZO9^'".0DSF3NM&L;$)VM.MAH;W/1*K>86E=6R`78(A$[;(R@!@$H![&?
MZ6^96"PV5H,QT\H@:$/=+YG2QC&HCV[)XK7C9)*YT+G;7L#G$N(\W@#8$I9-
M>E>\/!&QDL,Q$C#N*E-#J&]QWJ,[;DL2>/D0,`(FO.XWJ6V=Q`LA$IV2$S#^
MHGEEL8Q)DE;+`FZ+(Z29&RHBM1$35N#CB?LGR2*R=R`Z;;H$"]#:UK5MG8;L
M,8(<UCVSR$,L-D8;IU06NEJKM=99_DF!8K?T.&68QV0GLK:7&;`Z1V0"N8Z&
M4E8X&1P3S`6%:0J]+X55BHCE5-TU"6#"Q\V2%^2US(VJ7@>7M?Q!\:HMFX]F
M?FQ\AEM8Z,;MP`##V0Z*#5\YM@`-U74M==U%IBY`EB'96E=6F-!>\T9D14!$
MC84&>3#9O^1R;]2JB_,NJ>+G''?)-`]LB@M"A;:'NB:U'!R#E',QH\EDD9:H
M?KJ=/`BH8YWS%M7CF'?781)L;H;@$$EH9;W6]8TBU]5%/!%)(Y[Y=W[)$U4^
M9/%?'6TX;&DR)YC$\C(<PHNA0:?]:M<=A8.%+R1Q%<][5+2B$[4OX'6N3Q91
M4W]*%GF-!D64QC6)`P\K[LEE@`28^&'THM>#-*LPY/S(U\;E<UJ[ZQ\AD3OP
MF8#\>/U&J5`0@=23U'C5W/@;!PL.5GQQF+:$C82VRZN(%OYUF]VLWM='SB?B
MA)8AN1`UED03)U,'+A9(Z55B<&Z)D[5V\?%51$US'*X[_P#'LRA_V20!;7YK
M7!^_!/)[?9D1@MP2]J-O;YZ&MI&N5KXC32E-*4TI32E-*4TI32E-*4TI32E-
M*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E15SI^9CE7]'V7
M_P`0'ZB[2I-^H5\F[7M2K__2[<WM,_X<W:'^A7$/X`W41J:D[4?"KR[A+'+X
MLS("(J:F?CY:_&IW6UJ=6#H/?>HLVH%"$Z`BRL&S1HUTFZ-C:U-D5=U373\9
M]J,,/;(X9P<[R@&[4'50!X=:['VU`U[`]DKCD'>-ER$`%^P7XW\*Z\?)B`]N
M_O)\"\G4X%4%@/=YB4O%&12BA^DI2^0JXZ:2KFD%+'#'D(EE@%:N[4\SSNE/
MCK![=@BP^7]U<&]S@,G$^\B"DGU&*9`H-E8R4H%0`5M/<C<K#_\`JG-Q#:_U
M#A3+8I(0(P-I(^I\0!)6SM:PKLN=#^+^9?<%]S5Q%5;A<5YU2]H'`8\T48%/
MD-T*^PQO(K0*!L<HU+AT5D"XHCT2*]L)2(WYG.?K5\3S;,/A8,O'8P97NOD'
MO@?(7;8\6(#9/*?J01F%Y;^<B1MDK+R&5B2^YL[_`"_'R31>W<".)R.(_P#)
M+GN?$=07^H98@XJ@8UUU`JJ]MGNF<E%\OVW#G(>=<$\ITW(?%^:9OCUSVT09
M3508_FX@9E@[$,B!R-8)3;.R1))'S-<L<CW)XN555O6XWI<W'R_$S.:_D(,5
MTC9P3Z4D8&QS`'#<UT8#I%T+2`@*;NE]M^X'R>X?;.)G9>%D0YN4Q@$6XOQW
M`Z2!P1WJ;F-:YJ;=CM>F)O:7SWW<=NG9OR!W`<95O"A'#''G/.<6&:8KFT&:
M$\@9^&9D-/%D`-213N"H::K&'M&0;$32JLKU>L;MNEW/8.?D\3[<]BR9;`_A
MW10PEK"/40EY,@<[RWV[6@`D6<;*FFQ<GEFR?J,_@VX[)8.0RIG/E:7.!:`0
M(VA-KFM!=N<Z_P!(`0$[&0.Y7#LB]P_$<_-X^QFLH#^T*VY4BS.\9?6>?`8K
M].FR1:1CQ\FBQCZ.2!(Y8X?I\LJOZ429&KK=3X@]M\E^J./*#*[CHV*8PAE,
M4DS=IW$@J6>5-ESYBE=KG9<_,/\`T.S88(!)S'&F86<L'W$<#R06IYAO1Y(<
MNWR@52^"N\#W&>9F<:\[83AW">5<)<@\I6.`8KQF0':5/+X7&ZV)]+99\=D\
M?E8D-04=]422;NC?/'),C%ZV=4FLG'PYGJ<&[EL5@P,R$2RF(G_Q]X>^(/+_
M`*W&,-/E`#]S&JPNMHN1Y/G^4AYSG_:N$P<+#D@,QY'.?+-Z19#*YKF^5I>\
MR$MOZ;6D(_8"Z$</[@Q^T#N.]T/N(R7&SLW;Q=:\6._)N8KZ6F0VV16!6-TU
M:9=0L)EI9"3K!CUEB9*L<;)%1C]D:NLQ>4AXWVCRAA8'S3<_+'&%0$F*-Q.A
MLUC7O-E(:FIJQ[CRG1>].:R))C`P<!C2/3S(&N*-`L#N>YK&J0-S@I2]5SMC
M]X#GCE/FCC[C3D'D?AO+:ON+'-P2+'^'P,G'R7CLQX#78_3YJS)T=5WM<^:Q
M5%?6^3YQ0;EV3K;K?<3%CLS7\+F9./E94</K1Y$"B%SX_P#N,VGS-<]%827`
M-47UKBV>X,#[GC>1Y&/%/'S9+2(FN<9X/4*M,CB`U^T)&]`TJ5MI6^G%LM)P
M>\KA;1V-<CWF+5.,81>VN1O&GL+G-E'^LBY%,'6M40:]J0*Q!26.VC:JL8UR
MO:JK9FQV9+996QO@BE<Z1H8H#&`[2V]RUQ*CYV33Z#E8)Y3C(H<?.R,>'=,]
MK2J%CG#R+J6@J6_$UD%R-D-5G-#D7)=1D85`"/C8`]J'81DBELR(Y6B%OQP!
M&0-+C%JS7-DFG1S7/3Y53IWUJ\6%^))%A2Q%[C(41$VBXW'H21H*Y3A(<G$Y
M"'CWXSW.<\AKM0``44]%(T'2O8<#BF;UL?)BB24T`M#Z''F7Q(4"Y0M(,V&,
MQ:6(9(UGLI$57R/DZV>&V^HM?/AO?A[]S"Y7;`?(IN%7ITM6%F3F8#SQA:V2
M4RDN(4[=W3<NG@E7#FF$7&*X0)?\89.^WO;,#_JZ:T,F8&&#/LASX#:F&>RK
MXH/%BN2-R*Y/LU7QIXI\A[.1AVPM-G`>8]EW6/[J8/*#,Y)V'RD$?H[K*`;C
MPL#4!-ON0<:QNZR'%HH;*WD97Q02V-C:FGNHW/3ZXRL*L6D*.(CGI'*^-G4L
M+G;LUN=F)/)'%,4%R@#0%_*2!J>R]>M=!+C<9E<GB866_9B`DHP(-P^G<E_@
M%UJVXLKCLZ0GC&2@.L3,_<(V'D6!T%G!QB?([H.&\B=86L':\A'Q10HUCF,=
MU)X:R^BQLWWKI0&PZ1D)ZHZ7'PN3I5J3C\[&G;RF/E!L<`.Z$';ZC>_6Z=ZM
M;**3)<#RLK&*7.V)3&#4]/DLS'R[VERI'F"%5.23[++`7!.BS,8J+$JOB39$
M3?/%-#E8OK2XBS`ES!_2$T+1^[H=:N8+\7DH\//R<$L=&7.%[N;_`+F@ZA.N
MNM6W9YC6<?EUN)Y9:C?E"!D4+\76V+*$J\@,-'<HP]9:L61R%0PPN<NS'(CT
M;O\`'4X\*7.BER<:+^SL._:`7-`.I';_`*ULY)/N)#+C/<()V(2-6@`^5P[+
M9*NG,>3:*C;?'YU`F1)'3W"5U4K?5G(ZZ$:\^R2XB9"V>QJXV)Y+TC155-DV
MVUB@Q7RB*+#.S<]OFT^DVM>QZUK./]MYL[HSC3F`@ASW="&Z,#.@/6]7=5\[
M\7<FX9@EOQWCDM"T46N#R2Z46N?(6/73R`K(6D_0Y2!FP2.?(4K/G;T_,FVJ
MTW%<A@967%F2A[U)#;V6]DM=;!M:V+VYRV%D9SN3SC+CO),35<I.J)<@'1!T
MJZL?OG`%9KE.)YB#<G)1S5%3?69$2CT5H>_I;/.DGG2(U('-266*-S$<UJ;*
MU-5#`US<:#(@<QA?N<Q/J`_ZZ`FO>6Q'YC.-Q,[CFQP,<"6,!+GM!TZ7^)^=
M8M\5W7(.#8QF-SS5RO=Y`S%2Y;>JMK*M?>-1UA+&BH/;FNC22-Q+W,09$="C
MUZD5NNCY2/%SYL6+B^-8PR(T[3MT[@>'77XUMLG#X^/-P8>&PML<K2)(]^U2
M%U:-#W-327S!0Y/BW%X]74RQB6I>3V$F61UM6Q]V8?Z>*)A"SQGPBL:]G2[P
M=T.3=KD^.M:./DQI,ULCQN:&C;?R@*;:53@X/)CS^7S'3?\`Z>V/<ZVWI9%_
MTK\QC"ZT_%+YCJ'Z7<Q67U*RJ[4D>866)DZRCW0\[8T<^5',ZMF;.:[94UAR
M9'PSX[VY&Z':@<-0>QJ[)SLIS?1R;P;-OD:>UVZW`K*_MNQ$Q_-4^5G@!QF0
M8L/#,60;"1:K"6,OIT19H?6RQ/;\=GJUN^VM'RN06X+<8$ECGDVTM\+?NKBO
M=G*8LWMUN)AF3T?54>5&6-^IK9)KEZ^24TI32E-*4TI32E-*4TI32E-*4TI3
M2E-*4TI32E6\#EV*6=G/2UN3X]87`JRM)J0;JM+LQW0.5D[9P("9"H5A<BH]
M',3I7XZ]:"]I>P*P=1<?C1WD(:ZSNQJN3SP"P3$DS1###Q23D$3R,A@@@B8L
MDLTTLBMCBBBC:KG.<J(U$W742X-!<X@-%>@%Q#6A2:]0AH5@)">`6*:"3&DP
MY@A$1(D\*^*2PD0O?#+&J)X.:JIJ3P8UWC:FJVJ+2'?25^%>@*WJ;$-UC7VE
M<?7M?/&X\(T8H-L@TCHB6.*@E?`CQY6*UZ=6['(J+LJ:\=Y0USK-(!!/4'0C
MP/0]:]%W.8+N!0CJ"-0>Q\*Y['LD8V2-[9(WM1['L<CV/8Y-VN:YJJUS7(NZ
M*G@NA!%CK0$$*#:O+2E-*4TI32E-*4TI32E-*4TI45<Z?F8Y5_1]E_\`$!^H
MNTJ3?J%?)NU[4J__T^W-[3/^'-VA_H5Q#^`-U$:FI.U'PKU=W%;8W&925U%E
M8F-Y/)B]*W'1H8(K"RLYY;*S]7*8.^>-]=3A0P;N(:B=3_EZM_!>NX)T<>.)
M)\<R8X>[<I(`"#0HA<>U?3/9D[<?`#I("Z$S.W$6VV:B%"I).G:M.G>KV?\`
M,G=7Q'B]9C]_3<;<V\7YSC&<<8<HYO>%`X;#F518QE3DMLZ>LR6_!'FZHU1(
M`2E6:&-'(B;KK'[APSE3X&5PDT?JQO>'@AP<()&.;(P;0BN.W5!MW#K79\D.
M/S^"YC@Y(&OR)=DD(`*ME8X;"\)].PR`I=2TI:HCLO;?K[SVZ,5[2'9CCE-R
M_@BUEX7>T8IM@%?<O#V!%J7F!"GAAG6^.2Y$KH'$.&B)EK8H7O8UZ>4N;F(9
M)9?;V1Q:,=Q;(?MB]HV`Q-;O:YOG`;*_<\CS[2X@!PM6+V[[1@CX;F?;_.O>
M]_*B66?)82[;*XJQPW;"7,9L"$M)<'%03NJU.V;M4[NKFW)K>Z_)>#<3X[P$
MRZ&I\;X6XTMAYLYR8P9KW\D7^89/5UEZ&*P-1Q11*J.,::)CW.8,^-Z&;2;+
MS!!R>8Z>%V?EXY8V.,)#""`/K*R.<3OW,<"`K7!SAY&;OV_C^XN&Y7$R^0FP
M)V11L:UL+299N@#S(T,BV;0\F/ZGN+2@0BV\5]O;E+'O;EY][3ESO'K'E7EK
MD;+[+&!Z:RS$/BX:OMLDQV^JK/([BQP6&[(E6MKI8Y!1P)'QSK&JN>GPX[-X
MC/R/;OM'BFOQVS\>(C,YWF#M@?N$1`#@5<$<YH4*$%:K!]L\S#D>\<::'`9!
MR<F1)'*7O,C/786M8]&^3:Y"X@2-(4`FN/CWMV<KY'W`<'YD9F."`8AA':K4
M<-<E#5Y&2V^0D&XMBL-)F4-/1I0A!6(DL'X*)DY@Q+Y'M51V^.W:YIQLWF?U
M)Y#,;(>.YH%D0:X-D8)9)7!SB0YK"!(K7#U`"+KUMG'R/;^%^ESG^E+-P7'M
MQ7@%Q;)(V.%C3$=K28R8W$EPC.TA`I08_8IP5WX<,YC3=K_"?..#U?!O"'))
M5SA7([<4RRDYE,PFXR)F47]`:&K[/B@O'1LHOB8)8BSG2RL<JJ_RG.'8XWC>
M2&)P,O/9>.,#':A&.IDG$396PLE;*"T%T9:#M#FQ[&%)7,5];"]I^Z(N,Y;C
M."Y+&Q^!Y"=DYDE,CLO&]3TW21Q"(-8?,QZ+M]4.<7.B$FQF4&7>W=D'(=]W
MSU>=YI2NP?O`BP$BL,Q5EK:9K@%GADLE[2Y+F=3;4>,8^C?RF'%(B"JRC8;`
M1)H/5`/<V1O.-X8S^V<OC,B1L6>.7?F0/:"Y@:6L9L0D.)=&)(WK=H?N!<=/
M<[@G<K[VS^1S@#Q,G$C#<I_N%X7SL`;L\CMCVJ0-[!Y-MJYO:=VY=V_#O)N'
M!\X<C]MM?@."4[Y0[S@/!;*TR?D2\H@8@J\KD_,>1*VIEP"PA&@]4^6E%6(F
M=9>I$3\(O2MS^4Y1V5RG,MB.5(P#T8AM8'/N^1IV!SO-^1H:T@HUL8`96NP_
M;/N/!P./X896'_@L%VQKG1.=E31,1L8D:XNC#G,:T%P>]P.KI"KSL\X,QJN9
MBO)5&#84D>+Y%<,S8C*S9L?A%R3.2HV`Q55-/#/&97/QH=T!36%HT,TLE429
MB-=K)R<SC-ARN8_[B-NS8-^YK-=Q4$$.N+>9H;H:W/N#*F;G\;ENB>_(;%LV
MZM;&TWW,U)=U(T`%C5^\<\86>%XT9429%>\LT%GGU586TN7@@U]I4#CS1`G4
M(8S;BW)R!CRR(6RSCR,%';*JHZ5%5J4\_DF3SL>[&;!,V(IL)(*W#B=H#2`M
MC<]4K7Y&;B\GGQR1B+!R!C$,#%(<4)+]R`,LMG#<4J+^1LFYO*Y4IHK;$RUQ
M>NQ^8.(2QK0X(:SHZ8G6`D,EH9!_TL+62-5T<<DCM]DUL<*+BOL)71SM,I>I
M1QOX&P-[]ZV''X/"#CIXX<P?>R/LYM]Q[$IUK9;!GE=C7'U$;ZB@GR$&FF@9
M"$(G3;M+AZ8+-T/G1R#5LDSU6?='-1[';+MKB7X[I\R;;N$!<#<Z)JT>/:OE
M;.)R<OEWQ.C>UAE(+OZ;W^)32L1I,T8;4?DM:&@Q6%I69#98]]+;YQIEA&(3
MYT41+Y)!8O*>J/'@:S?PZG*J>&MR,<^H,F)AVM<P.W:@+;Q^)KZ5_BV8,_W<
M)<6A&O+K,`_J/6_4UC?CW(O*&.X-R)6YQQE;8\XDO'*?'K5DT`5UZH28H<<Y
MP#9HR#]XIV)-)"R)DSWJJ[(FNEEPL#)R<-V+R#7D;G.!!+4*%%T;I922$J>3
MA<=%R6#DX>=OAV.+PNX%?#IX+H*XG$W!.<`98`?R']:R!2[:>YP88^V'%I<<
M-$>PQIF7C/.($FC:L/X`4-?,F8C4?L]-3S^7QGX\C,78P!NUY`4O!LC+`C6Y
M.G2H<WR_&C#3BT#TVRHWSH;'8;*4T46\:N3GK*F88?F7+/(M*;E[QHPG8'A5
M96$5]JS,I40.F!QJ.Q@.BA0XB/S'2=<,'E*N[E<FRX.'@.:[#XO"E;%KZDA=
MY?3U<7(BH+)<U@XN$1\=#CX4YV$J\_47-\;ZC]U6T:5(:;17=IBPM73%AB%6
M,I+FVU;CQ%I`CW"V`Z'CGV(U=(]6DL&5'NV5K')\=8_3CC]:%N2XO#B`GE+@
M#J"A#5Z$UV./)FOPY&XDOJ9+6J&H0\IT[*>G2H#QXSC.HYKMZK%Y,PRBCSO'
MLK"/$#P27#L/A2IB&&NCE#M+AUX8#9V"HRKD^=D:=2ND7?PW\L6?-PS9L@PQ
MNA>PA9?4D.XG:%#=H(%WCK:U8#E9DL>",C'=%R390I=?;U`!1-/J\=!4ZP8=
MGL.!"?T*XC.8^LN$-MZ<BP#?:!0B$CR^2&&XM)+2*?=%9%LKD>SQ>K=:03XA
MS-O)SC8]J!R':I'4]/C6/,Y;C3F9)YG+$<^Q`!;?\T1I^=7!R30V.:Y]5VU_
MBV/OQYE>*)F<Q<>1UXT#)!^H[T-34M*&:<LS^OIG:KEFV16[)K'@Y$>'B20L
MR7[]Q+$V][*3=/ATJMQ\4>/QSOLY'_Y)Q6)0U[K_`-3B02$M;IUJR[WFBLQ'
M+\6XXP;!/RFP!Y8U$^S$56K6,&(C]*)/71US(6S&,,52U?(/)Y>SD:[9=7<;
MC'9F/DYV5E;,Q-P!_-W*KT3RV(76H2<)DX\&7F9N9LSB-Y:+D$CH>@M87J;K
M6]XT;EX&!U>1'5M\1#'+>8?959DS*2.9&E/FK;",84*V%B'19/DE>Z)J[+\%
M36H;B9S\5^;)&UV."@>"+I:X4D%;:7JIQV?R,44TF3@-,@:?3>UW_<LB.4$`
M]ZR+[38+(#F6V#NJ6S5J06<>.95-+/Z:XJ86;-\P.1J*&]OCT[HQ')\$7XZU
M/.B#[&%T4@]0IN9JA\#UKD/=IFR/;XGCFB$(>W?&`-S7'L5N/E6TK7'5\CII
M2FE*:4II2FE*:4II2FE*:4II2FE*:4II2K1Y`RH#!L$S/-;4A@M9B6*Y!DAY
M,N_EP"4E4793ROZ?'I9&,JKMXZU?-Y1PN(Y+*:4D9`\M_P#=M(:/FX@?.K_%
MXISN2X_#`7U9F-^3G`']U=<GLP[/NY2WXT[<>Y?%N(N"L3R7'7<G]S%9E`O*
M&167+/<GD7-"9CD6)X7GY$W&^*57&N&QCYM"XJ!UGD+D:)#&R2/97MZ#,9E>
MWVF'"C;]SB\)!@MQ6E8GS"*`2SRR$L5X>V1X9L_[CB/5VMW&C%)B\OE<B<MY
M;CY7-33NG(\T4,<\HCCBB&[ZF-C89-Z%FY_I*_8*5S=SYW79+4\3X1W7V?(O
M'%ARAW-<.XGW%<5F<0C8+P/QMP?6'WV77\>)<K4F1YV)R159W;8V#2S'$7KI
M"1BG1R`B^;T)@PL;C<GD..8Z=TV+%!F9+S+Y'.RH./E=C8I@(#?3=*\R@`R[
MW0L21QU]];D8(.;D9&(<TQP0P^EYVMAGSH(I\H3;E]2.`EA5L>QLKW>G96^^
MNYQRK!/;-Y,XYP+*)*;DG+.9[2Q`Q&O0H'(^%>U_F;GJP!QK*R:]J0D8[C+\
M&D=(,]W2D`Q;5Z6HGA[)!+._]-L#FW;XQ-AP<B]QL)#$_),$CNC]OI1D=O(:
MN&1F)E>_^4Q(6I'CY<F"P"TI@;'BF1@3S`R;Y%&KAN'>H>Y`XCR&^[4>[HS`
M<QY)P#B7,^^OCO`.V_#./[N3%<3S^HKZWB+BC,,D*@A#]7<8ED66U-O9,2*:
M`<XN)Q:ND215?GP\;(GR?TZQ.1)?F9/)YTS(Y/ICPGYL^3C-<VR$8L1=$QW_
M`&XY6MV@H!KILK&A9[ORN/>W[7'X;"9)*T>8YK<1C)AO-R?7FCCF</J?&YNX
M@&NU;A="S%<.Q3&8U<K,>QNDI&JYW6Y4JZT8'J<__:<[R-U7[5U'D)VY6?FY
M+`C))7N'@"XD?NJOQ\3X,'#AD_[C(FAWQ#0O[UJYM5*MTTI32E-*4TI32E-*
M4TI32E15SI^9CE7]'V7_`,0'ZB[2I-^H5\F[7M2K_]3MS>TS_AS=H?Z%<0_@
M#=1&IJ3M1\*JO<GBU3:<E/R*P'KA[2BPP"&@LQQHH[PIY1UAY]/):N8DD8+Y
MNB5(>IR;(YR)NJKKI.,R'MQ6XL;WECY"7-7RV`0IW\:^H^R\O)Q.+)BAWQOR
M"#NNQJ`*Y._1:PGRG$LCAKL5DRJ1UM;26\%=%2P>K%IHZZW,:R2Y@6Q<J100
MKT+]ZQ7JNZ/1/AOX<F!CIVXQ+8D52A<H&A2OIV!FP<AD9<D,,8#8RXOL;M%F
MJ-2:NHC&_P`C;,R^952R3U%6-239.PAQ(=<@<#!G"USI'R#R6A,#4(F5SW-C
MDEZ=U^.JYR/5BCB+O*]Q.U-5NI\.@^%1P7-Y0/QAF-;<O$>CG%Q)OH=@^D#L
M*B`_*K&KM\>!OC0A\>OK*$(?)+>Z2*:SM/**^@TE=6O<YYU_?>?.]8VO5C(A
MG*B;HF]R#$CR\?*,(?\`<1@NVM:J-MN<3T:VWS-=#E.;QF5C9#(6.!9M<$3:
M;:%+-!2^I6IPPW&::\R*J2*QLR&U]X3;T=Y=2E0U`,NX39I"'O*C(]'&@:LB
M:W=G6Y-TZ=]:C)EE9%(STVA6`$-U.J=-;WK4\OF38?'2SAH,THVOB"%W6PMW
M-_!:C/)KJJN\TGM,?CL`64V;FH6D`$%5)D"AD)*7(2<G0Y]>?'(PM"6*Y7,5
M/CMJU"R:"%L<SVN#H@EUVK8(.XT2N@P^.8_A&1Y""9\377\P;90U#UZ$50\_
MK<3/"Q<%]S=&5UD"]GY,PUPAA^%?7RSDDK1[6,A'FSVQ5'ZM8W-:[\(U%W1R
M;6\9\VY\@:S<UR[E(#]H%R.@`<B^%4^%=R.">5;+BAN2UP_NDHV4`>4H18`'
M;KTJW>/*N\KZO+JWC[D:(D3&#;6BC+RR)Y4,5XOIB?0W%6U7DO4>&;Y481TJ
MQ6(FVVVLN9-#))BOS<-1(`498[=%:[Q\15OD8]ABFR.*,66]C7JPJK;^;H._
M[ZD+(ZL$X4HV]JOIU5:00UMLV*0-@L"/JYAI;%I2)ZD.7U*JYS.F1C-]E7;6
M'&>6O9'$XES%+=5-U1-#_.N??/D1"1\62),ESMP*%P`71/AH:L.UXEXTRKCZ
MEQ/C[-I;B*W(N+6PR@@A3+:*WJVBQV.,5#`99(K(*PZ()'KYCFPN&B8L7VIL
M8N0SL;+FR<O&V%J`,1&[2NU[ET(N/'<2M4X>6Y)V;)-R/&L;L\H:+[@[1Y4`
MCX)\ZRYXZQ,CCVEQ.OKB"+^LP>JQO'"[(")]@!9VD-FDY!%H4^1)XQT*(@22
M1&.5TT;7+OMMKG^0S&\ADY#W-#'RE[@#8IM_*-%L;=JXV:/'^WE;EAK<Z9TC
MFM<4>UIZ`)>P)%]*]F49MF.19-F,>48L)'AU;C;BZ2Y9/`VQ,L862*QP:/AG
M38)D7BC?%/N^.H18>-%C8KH)G#+<]'!/+M[.^-2P..@QH<+[#._O.E\S3T'R
M/7I4&X-R`5G]5]6)P@BD'C-G!KH[$9LA5TRN;&PU8#9((4(8]SV),QL:M8]_
M2F^RHM[)PHL+)9&S,WJ%*:-7P7\+UUV9Q_\`C\?*B9('Y``+W!UFEP5JC4?%
M;I60=?C6.1Y*E]901^GJJVPN+#&Y%I8S0!HV0AQS59C&QRC1^1/(]&(R-[EC
MV^&M?)([T?3#_,YP`<`Z_6XZW3\:X"?F.1+'\5Z>\S$-:]26^((ZGXFH2_I?
M.M8".1U`DY$K,:NF6XT%`1+?Y3]&HB58%&7*.,T=LIK45TD3DZ5VW57;:V_^
M-8U[,(O]'>U%<-K-SM;'H.];QW",Q\5_&0O$&?)&AW'R7NK5_-62%!R+P3R%
MP-99Z$['C<BO6Y%95U93Q0EY2S)8IR6B4(40\:'R'PFC-C5K6;M>KDV\-:N3
M`Y7!Y2/"D#FPQ[02?HVFY=V1#7!OQN9P^6^U<V4XK2UKGN!#=O4GH!KJ:U6=
MT><=T_('Y&Y8)QIF#J.JIJS\L<:I($#O\>L(RB0*VT(>H<^SHTECG:OWS%C5
M=D77>>W\?VUA',QY>0B$I<?3>Z[7A%(`7Y>*U]1X#"XS$QFPXF6V2>9Y17)Y
M?S77I6/5.?DN$`E5T.47>$Y+%*#D-C16M25?8A<L+61D<4,TYB"T?K#'(URH
MWH=)NY?'PUMIQC\@Z-[L:.?%NP.!#7M(^`5R#YI76PPQXLLCVM<)GM)#@Y'`
M#N-3;K64'#V/Y[:FU<N;T!M+FF46=I;5@"),6X'"G##1SQCC"M62$6P1)2H&
MR.8C6-ZU14<U=<_RTF!#ZAP9-^+$P-.@612>O:P/C;I7/9','['+8^9IQFRA
M9.KG!$(/?\I\;5DY:5UIQO7UC:R.SR@EEVZ"&LK!I!K2ODLQV25V1&7)#D/!
MJ@C!4;(V-KG;(OV+K21/9E^H^8MCC#-3H4-VAHL20>M<]Z^+S&:]H;M=(T*Y
MZ%A`L6@'\Q'C5!CFNP@#+[(%MP_6CR37,=>:ZW^IDF*Y7O-D@3Y6O5S7-?,Q
M%5OCMOJ#FQEWI1`$+90B`=O^AKI8Y</)R<?'PQ'ZL01A<$#0!T7^`JBTAN40
M\D34E2ZK3C+(<0!-8)34L;,HAR^`9T2-LIHX8C+`J>5=W2=:(L"M;T[IOJS+
M]H>/!=N^^9(0"7>4L/;HT#LFMUK!-A2>C_D\I7<@V4A^]W]O8-"!XC3QJH9Q
MR*;QU9"UP&(DYVEN57`*8'5M+O\`'9Y&)"6TB&2.0D:-(G*G2R5CM_BBZQ8F
M%#FM>^3(]$L!-SY7?/0W\*AB8$W)LCR'9+(&MW?VR_:UR%0G0K\*S?[-[?'T
M-.KX9'%7)I!I,DA#8D)#\B%D4H3^I9)6^5MXM:[9%7QUS//0Y#71.>XB(-TZ
M%>M<%[]]3*C^Y@B9'BL(:X-TW=REE-;$M<Y7RFFE*:4II2FE*:4II2FE*:4I
MI2L1NZKGOG;@T+$2.$NTC->ZDB^*L8;T+#L\Q7!Y,2A$B@>(4;)DXI+#V6+Y
M',:V+96*Q57XII7J>-8:?M`^_C_)]YP_K_XF_DO2B>-/V@??Q_D^\X?U_P#$
MW\EZ43QI^T#[^/\`)]YP_K_XF_DO2B>-<0[OU[ZK0(NML_9QYFL:X\>8,X`[
MG?B$L(T0B-T1`I8I%1)`0//$]6O8]JM<U5145-0>QDC2R1@<P]"%'X&I,<^-
M[9(Y"UX*@@H0?`C2ORO[\^^FI`#JZKV;^9:RLKA8`:^NK^=N(`@``A8FPC!A
MB#5$8XHHT+$9'&QK6,:B(B(B:RO>^1SGO<7/)4DW)/<GJ:QM8UC0U@`:-`+"
MN!D/>]WJY=4D4.6>R[RMD]&8Z!Y=+D/-7#%U4E/&GC)&<1765(2'.X<F)LC%
M<Q58]J.3941=8RUI=$\M&]C@YIZM<-'-/1PZ$7%9`YS1(UKT:]I:Z^K38M/<
M$6(-CUJG3]X_=^4^WD)]DKD4A^054%%?/GY=X/E?=T@L7DC4UNZ3'W+950\/
MR,'FZX6-\$:B:]>!*R6.0;HWOWN!N'/_`*G`V+O]QOXUXQ8S"Z-VUT;=K$MM
M;_2U/I;X!!7)3O3[RFU-10-]E3DYM%0*"ZAI4YDX42II'5G3]-=45J4/HZU:
M_H3R%A8SRMDZ=MM3=(]\S<ASR<AI4.)\P)&TH[46)&NEM*@V-C8GP-:T0."%
MH^DW6XT-[_&^M7'^T#[^/\GWG#^O_B;^2]1J2>-/V@??Q_D^\X?U_P#$W\EZ
M43QI^T#[^/\`)]YP_K_XF_DO2B>-/V@??Q_D^\X?U_\`$W\EZ43QK9GPMFV9
M\C<7XCFO(7%]QPOF5^"03>\87]U69%<8B3#8FAQ`G75,R.L/D)%&C):Z)J(C
M)D:OS(NE>5*.E*:4II2FE*:4J*N=/S,<J_H^R_\`B`_47:5)OU"ODW:]J5?_
MU>W-[3/^'-VA_H5Q#^`-U$:FI.U'PJ+>]S.>5L-YSPR?$J^*7#6X>,1?'DU`
MMM$$0RX)9-,-`2JN:?&"]/+D8USFJY$^W7=^VL3B\GC\DY;O_*WD-&XM_+X6
M1>]?5_:&!C9_MC*:Z0C*&2=H!11M%B>R]*@S),[R')>4<,J6D1V0\XCB++&V
MP*\LI902(0)K&1%7Z:/"K]U5'(L;6OZ=UV35J/'BBP,S(#?[@*-<ME\._P#.
MN_Q>*Q^/XJ>)H,)<%W:`!1N1-5T'BE4@CA?.9,COC0.9B(<5/&+:5`(CR!,:
M2ODA!];%73L0`H2PGW:-ON[=?FU-G)XI@A8_C`9&E;_F6Z$Z@CK6P?S&+%#$
MP<26\B0T-=8.<YUT!U!:+G]U6L7#Q]D&4#XQ+U93?5Z-R4-ME"CX<:M:A\,-
M=D\4<74@T\!+G1+T-79LCDVV74&G/QL9^4S^U$[RE/S-=JWQ"7KJ&/GD@B]9
MJ-`#2?ZK785ZG4'PJE<P9*%C5(:59VA.*&!'^4/?2(<6,^54:\X6O#]2*TF-
M]?/^"BD<V-OW-6>)QY<G(#8XO4C+;ML/@I0I?4B]4XFL$,+&!CY'$DA`2$_-
MUNMEJ1,.M,"N,8))$L+:WJ[N00@D:[<A3*]`G$0%1TLTCE>.&4].CRO!C&-1
MJ)LB+K4YK,K'R&,?&QLS0@+=>A"]_CK5K'Q>2?.R56L9&'Z6:\N3ZQU+:KG$
MI%3*,<6X;SK+&K:ZJB;1@+:ZN.OJX5J`OJ'2,?,X4-AD,2$/9LKDDZ41/C'D
M@^)\0#SZ+VM<GU$-/U!WQ0E/A6HY63,F;F1R%H,A;M:/RL70CO8FW<5:U#'9
M8;&^QRV,>JAL*X^UN:XF82SQ^GMU#:\J1[QQH)R2B6=2(DV[EE:Q$1J>.K\[
M8<AX;C'>0\`$!'.:MO`)X=*P2Y61RD#H\)SB]@:UJJ"0#H%5!\.YJZ13:/E&
MG+&Q\<0ZJOZ,N89U9%#&"-(X>1A[GI&K&JU(IV/F5/PD>Z(WQU7<R;CYV.R'
M$/8\:ZF]OX6Z&JY>[!B<9W;,AC@UP-]3:_@=*_.!N*HJTF3'*\Y7V!SZE*HN
M<84.JIHJ"`A]:*R."#S%.L%<CWO8YOJF3.657/;OJ7-<L7L9-Z:-\P<+EQ+B
M%/P":?E2VM:CG998HGY\[MT+`0@*N>'FYOKMZ+HEJO+%J.DPO'20L7)R>AC!
MSM;W,,-NKTTVRE/,MJ]3[`$\B>8@FN';&BBP.>L,"JJHFZ:A-D33Y4?W!CD:
M^+:V1K0``&E`0!8DZG4UJ\R5_);LR:%AF9C$12!H#=H:;$:;B%4]:G3*@:V(
M*YA;,B5D\;I0)G5^PT;"R)/6`-,C?YLK"FN1=U=XN?MK40/D=LL1("A"WMH?
ME6BX;)DER8/5C;N`O<*O0IX5@W=93E^;Y01C^`#QXR3Q;%"3,0<V3Z7-C1TB
M(34B#HDCW6#;-L\DSI/PCVO:B+TM373,Q<;&QX\C-_N,GL@U#AH2>R(B=J^F
M8T>/Q\62,N9TGW;N@4[P+%>VU`FFIZU,V/Y,+6-RD2&Y']?]+:D\MH*!,%&<
M='(Q*V&P*CE,C9Y,J)`BJK?EUK,B.25V(_T?[:V`52!U06^-<YD<*'#'GF85
M$A/E)\J(A('[TKA<:Y3QIQM%D>*<>XQ9Q2Y)B1J6;C*IQ-+&9'(3&QJ6;YI&
M3QB22O=TM1-T^/@NK'(19N4V#)S<II,<HV@.\Q!'8:$]ZJ9N!R7-Y>)+F2-:
MUCU):=KBB61!KTJH<?SX5B^/W%HRZI(CJNI.J9?*!'I&V5O;D.6P^D-KV>97
M&2L?NLC$:YSG;[^.H97W^1E11F$^DXAUSN0-T5=0*CS3'2G'Q1!,0^0%051!
M;>/S#P[5#=%RO0XO@F1\><>7$,U79WA3<F-OR!K<A'GN9Y8`TI,Y,X\0TY#?
M*5&(Y9'JJ_=UL\KC\C(RH<W/B_O!@VAH(`3KI>U;7!X".?E,;D\T/#XVJT-)
M#;"ZBPK$SEWC&T`L:.FO&,M+?.@8P;RO$%;U6U$(9YI/_I%/+?7C#0.\R/RN
MEW7NF^M_QG)L#)G0';'$Y6E?I<1:W4G2]=M@G&Y,.S&R;8X=P!=TLH![KI64
MF%V6;X/6X]C=8Q;*<6JMI*V5X$;[Q0X!?1@41TY"OG8R8$A8(4ZG-16HOQUI
MLD8V5)D3R.VJYJWLI*EPZ6-S7&\AA\;D.?)(T[2>A1@NNY!XZFKOCN[6F!M\
MO!!'L+RF`MGUU>98/BLHSF5L$*"-F<V6&2"(ARMZ7;NWW1$\=]4GL9*^/%?*
MYL3W-!*61=?`IUK!]HS)=#`Q!&"%VCRGK\52K,Q%A^392<=<YT=2UAE;54WT
MDI[11Q+_`-#ZI6^D'8UYJ^6]K$=N[=/CJ[DIC8D38L1KWM).[56*FITJ4OH8
M\8;CX0=D-<7J/JO9%.E2?E7)L?#6+!VA]K26$]20RMJIY:J..0H@AW6XJ)WE
M13/;&KNEJ*O2KFZUT&`>3F,4<;AN"D`V`[56QL#_`#<TC<@31P$C>COPLM1=
M1<M7'(MU(0(8))+=5SK$>VK@(8+>-(E>QZH@VT4B];'-W=NK4^W5F3C_`+!A
MA<TM8THA/EO\;UU>1Q'%X?'X^7Z9>8CMVDDUDQV/3DT_+$N.7<_U.XG`MC1R
M/20"QUH.R](444*M1'NV5TCU15>Y?CK4>Y9C-%&8F%L+0`>NX]U-_E7#>_N*
M`]MOY;'=_P".Z9J@=SW%;@]<57P:FE*:4II2FE*:4II2FE*:4II2FE*:4K7M
M[A_<URUVYX)Q<)P-0XUDW+W+?*^/<=8E399++!2RM.B*/MB3)H(IYH8@ZP&6
M17M8[;;5,2SS<UQ?%0!H$K)GR..C(XHG.+O_`/+:/G5Z/&:>)Y?DGK_X[8]H
M&KG/E8S:.Y0G\*C_`+(N[_G#F;@'FK*^8\>P=W+/%62\FX]5U>&6;8*',2\)
MA+<+'5RV$8<C1Y#XV"OF>U&H[=5VU<SWQL]N<?S&`US\F;&=)L-E(<YC3X!Y
M:HK!%`X>X<OBLLAF+'-&W>%(`>QKW#2Y:'%?A40>V)W\\Y=T>6\OX[W$3<68
M?<X67%$/Q_3I8UN88M*8>D`0-V\T."KM8B(53RIQIY?,=MLFKF/C,DX7&SFR
MB69TFPN;9J[22W:4((2UK@+5;-<Z+EY\1D!CQPPN`<5.W<`'*+$%;WL2E;J-
M4ZE32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E15SI^9CE7]'V7_`,0'ZB[2
MI-^H5\F[7M2K_];MS>TS_AS=H?Z%<0_@#=1&IJ3M1\*J?=H9Z3)@/IM67<WL
M]#%`D43-XZZL]8^4D@=%=&DED9*QC(]W;-1NZ[:Z/B6!^.]KY0R/=^)2WR'6
MOJ_Z>M?Z#I97AN&R1Q_]SMH0'_:-:Q'S*#$^)JJ_RV4QM;/E$-*D,*2.<^%X
M[)6$C+:(Z<>.W4B=T<KFJL,:/15WV76VQF3YWVV*&;O3<2?Y%.R:=:^B<3G9
MON',<7^9D#'M"BRG3RZ[=#WJB9VV/'\8PVHJI;HG$,T-'I&@XZL\]]84%A.+
M<S'0WI#(0U]'/-"Y%16HZ%';>*ZRX;Y)I\ITC6#)C:JE-H<%`&WQN/C5B-D.
M0<G*)8[DL?SDOLS<!M<W:"7"RD$Z%!7$N\EQCC!])/>T[ZTO+,INZVBOP@(I
MI)1'?3FFQ9%Z1I!T0['/CE9U+LYTJ]#%Z7*GC()\^.6.*<$1-:7-)ZW(V]/#
M^=;/CX\CDLS-DQV%T4.,TR,7Z3T+=R`N(U_C5G\VP\D9[+A4&#5F&W](#9,6
MVK[V%B$G6H!7X(YL9L4<!04P2[.5>KH^UNWCJQQ<V#A#*?ERRLG(L6FP!'<7
MUJYQ>!QN&W-^\,C=[-S7_P"UP^D(3M*UPLNJ9R^.[?$N-`9<6L8Y[.KR-Z&0
M>J@%')BD(*&9*+#'",?`Q[8H(G1]#6KN]>K5G$DA9FQY>:?55H+;64Z#7IWZ
M]JH,DRCD12<AE!^"R0.C`4!P30H5W`ZD]:N/&\G$QRECH*L7(<OBRW$V'9#(
M9%)CXX4]83"PBP=9-=)Z8*9\$KG)"G2JHUJNZ5ZM89,=TTYGEDCCV2(T-\Q(
M.@0ZG37QK7\E'D919-*68YQY3M+B';U&B#4@'K_TJ^>0SL`'<HN>&CEXG5O&
M/RJ.BK21%K8Z*)"R$F<^-'VTYK)XHF3(U4?(OBJHB+JK@8V8$EQVEN2X$-4@
M[MQU\$NH[5K>-S<_(QS#Q,);F/D`9O*JYQLAZ"RI5#QU:'Z'4!\31#P8>;80
MGBRQHK&2$'%RI#"1*U)B89GNDC8]B1M:Q6N5[MMM99&2[WOY-?N@._0=0+#2
MXZ^%6.0GGDRIW\FY)XU86IU:ERFJZCM4D9/8RT>6XX&%D]'50!6PRY%/Z.60
MX+)"!:Y&5<D<:0A&2S4IJ/AE;*K86-3Y=_'53&:V;&F<_'>7.:=@4(YJGS+J
M/,-$N>M:;&CR,S$RY7XQDC0AH6VT77P"V-7CC)]7EO*0]W>50TWE6E..&XR=
MB6R,@L'$D!6%?`Q\!4:`?]2QW7\S45-E5/&I+&8<%\4<QN";?3I8@Z@K8UCY
M6+)P/;S\3&0-,9+TN`2B(3?PJT\;Y>Y:SG(^29[:@"QC#*521*X@JO=.V=CS
M/3AKYI"0LF5>ATR^6FS-ME7?5[*X[C<;&P1'D%^4Y%0I=+V"_"]:EWM_BL9O
M%8PR'29TI4AKNG8D=:M2LL@+G(,CN)@(BYRR6RVS`89*Q;(AD,PGK9YXHYHF
M3J)#X(BN8J(GBBZ\E9(V.%I<C0+*50*J#YUW[H#@X6/BXCT>UMB[S)X=#;OK
M7!.P(;*1$/$KIFO/L/0QBR+ZTMT-=,,\*4F>)GX2'RR%W<J(V-&JF^^HG*=%
M(6^IY&MZ6`)!4#QK)A^X8>,_L2-:9002;#<OU(M5#"X\NI,6M<:-.;*+;3>D
MA8L+(XX)/-5)X@=^M_5NNRN7;P^.VL62<::>.>.,;FZGOV)J/)0<9-GCD0=I
M#=VT+_\`F2JG:8*!5R5V-!#!'W]P?$0\%SQDDFAG1CH5@<R>2.=Y/G.7H7IE
M5&>.WAJ?W4[@9W2'TF#QMX?+\+UI(.8QGQ96?,L.,UI:">OCWU"+6+7*';H[
M'[TLG#C,3J#J/UY'ISZGTR%DN&4A?-+:V4IDX:[R-WC3=\*-ZTW373\;S/K0
MC[ILCXY``H<J72PTO\=#I6QPO=$&7C8D<X=ZCRH.H3L?C52XBPS.LZDN<N*O
MS[`/'JT>LA/AQ\U*FF+C!CL%LY$,E]2>(6]^[GQMZ6,^S7G*Y&'A^CC,A:V1
M[E0N"N"IML$!'1:J97,X7'M^VD3U)''R*!N!LO:W;6IG$R7+*BDL2+$@&;+;
M5##'1ERABV+ZNO$;^31,)<4);7U-H9#*KXT<V6%VR/V1-:Q^/B2EA,9;$T)U
M(W$^8&X0@)?0]*TCX8,WDX&XCWNX]H#7.;](W?6$**6_@:D+#X8LKXEL:+D;
M#!",URL>XL\AN:T@,.#%)8A$,K'C0ERBF$-NI14BCE'8]OG.V<J)K79#1#FQ
MSX>7MQXMH:P@N+U*$*+#:JD%+5H\O(S>(]PQ#B9GNP6.`:#?=J+ZCY&L?KK.
MJ4;/P:2.K_*5ISW&5QT`$<(=##4CI!)6&%32-@=:QLC5%D:C$<OP^S6YBQ'?
M8R3A_IH$(52Y2J@?TUWF'@Y)AC]?RO0DKU)NO@/"O'E*O@R'%JEUO;T%N*Q<
MAI3,6L1[(FR(`->,336%&Z2!HPDH4\LK7N>_J\$5BN^&O,&?[>=VUKF.\I:X
M(`H7<'=2MOYUFXS'S9.0RV8W'2'&5KW2-<$W(A'PMI4(</X`M3R!>9#=4]U3
M46.8Y85U(1C%G+8A1U4=?-.A15(Y!)/JTITG2G4Y$<[9$7QUO>0S8<GCX<>.
M=CLB20.=N"'<N@=?RI4>9FY+"D8V!K7->X#:ZQ*ZKX]=*RZ[(ZLB3NB2\/N&
M6+WX02,#"7*\2W@B\J5\KC:WRI(EE>Y_BJ2)T?#QUS?N5X'$>E'#M;ZBDBX/
M9#VK1^^)PWV0,9CRGW`4)95[UO%U\XK\_4TI32E-*4TI32E-*4TI32E-*5A_
MW9=VLO:P#B!L?`W-W.'Y6%V(JC\-8JN33T/T^&&7SKMOF1H+$7YO3$O^TK5^
MYI7H"UA3^U]*_L`=\W]5"_\`G6O%KW;\?V^=1-R)[AO'W*V0<?Y1G7MO=\5W
M=<7W1F0X26_C(N#Z-<'5A=.0:R*`^.*>1U>;(Q/,1R-ZMTV7QU%C&LG?DM']
M]T#X2?\`]N1-[?!4%]:R%[S!]L7?V/59(G^]EVGY+II4(TG<)VQX_P"I;7>U
MOWQ-A,QO/,3,&(P.\*%+I>3+$JTS.$D>>X?%-/;&&R.69R++&B]+'-1$3471
M1NQI<0M_L/@CA([1Q.WQ@=MKO,HN3<UGDS,F7(CR7RDS-G=,+#_N.8&$D:%6
M#:ALE63QWR!V:<58_!C>#>U%WOTH$&>T')3IVX1D1%J5E6+D$%41!UN3=RV)
MM?73DN=&))(X9/#Y/!-KL.7D8_V'I2)]L7F/P+V.C<X_U.+'$*5(6U49XF9'
MW_J-_P#Y+`V1+*T/:\-"'RC<T$@(J7K/QON]DM:UK>P#OF1&HC43^BA?!$39
M$_\`UK[FJY))).M2#0``-!^W>ME7;QS.[G_BJ@Y0=QUR!Q4Z](MAUPGDZE=0
M9C6+569-;YMA6.<_RH3O3>=`[?:2%[7?;I0U-NE>4TI32E-*4TI32E-*4TI3
M2E-*4TI32E15SI^9CE7]'V7_`,0'ZB[2I-^H5\F[7M2K_]?MS>TS_AS=H?Z%
M<0_@#=1&IJ3M1\*_.[[)0L7S"F+FA(L2"*P(5E8/&[SO))E/C(-BFC8]W0,Q
MB=35V^^W3XKKI.'QWY,+VAP:&DE>YM:OL/Z<0/R<#,AV_P!LO)+OZ43]YK#B
MX>S(<?7%[),?GRHVIM+:HQ(NG:0$2Z"=1AYG$Q+-"),;*YK.EVSNOY_%?#6_
MB;LE.0TO$`<`7`WTO\0*^AP//&3,FPV/^TWM:^4.N";Z%%0?Z52:+*K?)P),
M=K!9;7*>/GRT=/CC"G4(814U<W:2N(*C?&0<Z(.-(D8WJ?NGWJ+KV6%D#A*]
MVW'F\Q<FXD`]4T%RM7Y,/$Q'OSGN#(L@ASY"-Q*FX<T=$)OTJY^+*A;/''VF
M<T[\:L'6;1LCAOYHS)X"CB;$:N(K'&],`UDK`5:]6JV9$5JK\KDU1Y-P9,&8
M4F]@`(+1T2X*=/W5#,Y%L&=)CX\QE'I+'L!:UX"6<EW:V51^%7#/5YE0Y"TN
M@K5OJ>O;"85"(]I3(:=?D6<V%7(]2;$9R]?2KFM2--_#?4`[%EA='(X->YMB
M;*?#X?SJB>0P,K',.=DF')<[8B'RG4#X"HY;DE"9=9';08#DME*!<3CWAZ$N
M%C+DAD@LR3@`IXW3)7US"-D6-').S;;P\-6G19,>/C1-RH_,WRA%L;`$]S^Z
MMO'QT#VL:_EH\=K&@M"*"0"`+%"7D+?1:O2M'J*>DRPYZU^0$$5S1:R*4-M>
MTP.S6<61A,4SVR,8K'JV9L:)&JL8J^*KMC:]\F1$V[$*D*I!":'_`%KG^09E
M3R<5$A;$Z1RD7`1-?Y&K*:#17IH>'7=;Z6HSVJF@!,M;MTUG;,HVJ^R2H:>V
M2::`9(7JY5<ULL;58U%VU:]3+:TY<<@,D+[@-1H#D14ZGIV-7M^/Q>/DOQG[
MLN!X7:U`TO(VDIIK\EJ\<5$H<3L,3J:&Y?5PUX4,T;`&OC!L8BK)TCI1DZ?*
MDCD!>B*CM_\`5JCERR93<B1[=RNZZBW^M6?M<G(P\J3.PFRN?N.[0V%@1JJU
M$E)R%D/(U[E5U9XZ(9BXA,[JUA\2*QN1@%I!5E/)9TD$DDUT76_9G0C&L:NV
MKL\$>#'#'#.1DE`4_I(4CP`/\S73L]OX6%B8.*Z0MD='N<6_T];:(#:]^M2)
M%F3Q,JP@N@CCI:^$*&3+[*1))+.;+!F$.K"0H$:QRC#><QKW>*-AWW3I1=56
M0!T.3#,"YZ^0?EVG4$]R?WUS67P;CQ?*#)F$C7.(C;_^U90O0ZIXU^YKW"Y`
M5F6/X2VEK9ZK)JZ!]R96Q>D$D>K]O.\QT+E.9.UCG2)&C>A')XKOJWC</`,2
M?),A;)&ZP-__`$3I7-\?[8Q<:(\D)W[F$[5NX)H@7^-216U@(Y=`'<7#@<:-
MKTNK%E0+$00*7-([TU1810JXF)(PD8]TBIND;]^G5"1P<90`#*"@4ZCN.FM8
MY.5R),+-RN-PW/S&R[!NLC0`KAT*E;56LIJ,8K5IB<7`OB[YYP^\6*Y`@54&
M41+N%:3V$THL9,%6.U2)QGHBRM;MLJ[)J&-)([[B.21@@V%2YJG31+H3H'#2
MN;];D,IOKY\<;O2((:YOF<%&YB=%Z.K'7-.5X\*S/$JN9Q5S&:9Y3S!R)6C@
M3$EMAD>P:6-6%3/;/YK]NG=NWCK98/%?>8F5*H86A0.X3OT["OI#H1DX[I(,
M<,8YH-Q<I\-`-*RDXNLZ:.T(OLSPJ<:2F^JSXQ:1R^NMO20BLB7)(XTBV\Z9
MS59'%&JN'8C7;[NV359N,X1Q1XV>/.&[QH%)^CX#J>M?)_<T>;FN,>),#&7`
M%@""W3_K6-_,Q>5V68WC<#DK\CJ\F&KHLB*M6DQW%)63+,-/9B,2%Q#S%B(^
M9K5:CVL5-_N=!Q3<88T`Y!ICEC<2S:FUQZ`]A;]]=#P>*,;"AER6I+&/*WH3
M;Y=ZDK@ZTDXEXK@XPLCX,GN[2F/9':T,KXSI+*9T@,`QX\SI(E>D;VMA;U*J
MHU$VU2Y=HY+D),\1&*(.'E-P@NH_G6KYGCG\GR+.4@48T+@H?8(/,4/:H$XQ
MK..>'N7\M9G]K=\@7HB6F36%/8>?+&KF"&6<%8@LLQ4"P@S3M>Z1JL1K=D<U
M$VUM>0GS^5XS&&'`R&`HP.&O0+H#>]OWUNN4Q>3Y#C,1W'%D$<J-5I`U**#9
M5[5/.3<CG]Q6*0\N8EQPE7B&'1$XX3D4%T,TV0I$_`Q#@QQQ(ZO`]3$Y7J[J
M1SE1&^&M/%@1<).<+(S2[)D1VW;9.I)[V-:SB,)_MWE'\#GYHDR90'M!!(6_
M6]RE88\8<=9L)RV<2\Z(C'/J),-56+*ZP,OY+%JM;*R%%6![Q9'*J*[?K5OW
M==7GYF)_C0W9_P"1M!)1`U/]:Z_DLZ.;!A<`C6_]QR[=OAWK(SF-EQ7>>+E$
M\3W@QO/;!)5K7'4BL";Y($$,;/PL#?*27J1417.V1-<I"89&1F`(XV4%0;W/
MQK;?IVUIGR9\1SCBO*)NW!R+YKZ+4/\`&669+EE;:18PM]<36HQ(Q.+B"BM*
MO(J.%Y[O3DS/2;RW1PH[H^+E;LFMJ^"/&+6S[&AMP\JC=UKBME[UPN,Q,N'.
MS4C8UPN24!=85DC[?BV5_P`Q6659!3(`=)6V,-;'&+)!-6BL:L)`MB^1=Y)7
M3HO3\K-ON:I>[&"'!AA@FW1`C<5L3J$KY7[\R8H^"?BQ2[FR2-</AX?SK=CK
MYW7Q"FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II
M2FE*:4II2FE*:4II2FE*BKG3\S'*OZ/LO_B`_47:5)OU"ODW:]J5?__0[<WM
M,_X<W:'^A7$/X`W41J:D[4?"O'NOLZBIY-QJ2ZCZJLZH%%M'M]3',P%DQSY$
MAGA=TM<KGM3I5$5R.=XKLB:Z/B8S-CRM84>TDCXVK[+[`CY!WMWD'8!'K>L=
MH*$$HW4&L0+&UL:GC2QR*OIZR+E\8RPK:A*M[FU#<3.58(+NS:K$?Y=2UWGD
MN1JO;Y6\?S:WL;(9<YL+IG#CR`2#KN'Y1_[M!^^NVCP\X<G%CY;W3<-Y7$H`
MX2=6A/#0$H>M6_B*T^:9!BHEZ.EKGF&8U06-MD*_4&0%EV,$1QEHUXQ+()7'
M1RHZ29K7/@V1$7=-]3RC+"S(=`Y,*5[@&A%"%`-.G;K6YEC?Q7'9$H1L,TA#
M04*-%@T;ATT`.M7IR;("EI6T8@@N4P&DR7$U)8.E)$#8-Y<85P9*]R3/CZ?,
M\N55\Q4C1$WU4P&O;#),][F`>518DG5O^HK%Q;C/&24BF:T#>$5-2B:$%+"I
M0QJSN2PZ0B&<``80:GK`4)<L5<K2)I6GU,`C41LY1+?"/S_O&JJKK79,+1)*
MTAQ4GXCL?EX5HN2CP`\->YSLA\CGR)<N[$DZ#_V_*K"O_P`E;\ZGR"PR.E/H
M8ARBJ[%*^S,9=U5Y4,1;64TP-[(A@HVP[]*?(UJ(C6;(B:NQ1Y6+&^.''D$Z
MM:7$#:6GZ4!JUAYDK&Y&",5+IZKFC:6DE&@=2/Q\:AKF;";;E6"KK`<KGQG'
MAA1\BH))8).DH]5FA(&L;(21MN:PQA\:->N\42Q)NWQ\-CP^6SBI99)H`][B
M6N[IJ$!M9#XWKI&RQQX?JXN&9.2#MKP'(S:!8@:-(0VU*UZ>1[''N*\+H+R^
ML&ON\7'JL;Q7)+""2T.!.OYV!WK?E65*P$T2>6**5&K)"^97-Z7+OK-@MEY'
M-FB@8L,A<]S%VA&W:G<@@'Q2M5Q\4G(F:-KQZ4Q)D#=#LNQ?ZK@$C0@`%:YU
MZ/8.RBGIS3%;0!UC1*&JKMY9*^>M8ZN$-2R16/C=4/CZ%1SG,EB3J=U.75>+
M:V"67TP9G.5Y-E!NB?[M?`UM\1V-)B&3"?MD:X$.)LY;N4&U_P#II5]SX@':
M]5-2]`\1E"5/:$EE^20\486**%TSF;JA)DCE5.A6JD*(N_5LB:QDSVDRO^H/
M\MM/EX>-9IN==@XC,K-;OB]4,1H4*X]$2W\ZM>WJK(H.Q2F)CL6,HK2KLI(R
MY1[06IL:R6K-40I_F[DL"(<D;NKS-T545'(BZS0O$<D4S['U&D64%P*A1V47
MZ5N9LO!FA9QF7C[&O`<QO3<"H4V**+UL6X9X3XBR3CG!K>(`VR@`J(*\&::S
M*\T'TD$`LH[98U:0CG>G;U]3U5?M7QUI\_D>3AR\ECWM5[B3876_PZ]J_+_.
M\[RV%R>?A8TPC8V0J`-;DK?XU@WW&&76%<E6^&8Q@9$M(5=5IY)=5=6@I[0P
M@`6"ED>F>A1$ZR22,=U/5'QHC?@FNAX@8\L#<F;(`FV$7:T@E3WL+>%?3_:/
M'CE?;[<W(Y,?<.#@00`-3;\0*YU'*9DEH%C.(U\E=4;RET&,6!+Y8R#P19;&
MQB%\]9"2211X'SN\UZHD:;?9JO-N$4LTSMSU`<X#0$H%Z(MK5MLN+C^$C@GY
MB9KLE[4=(!WL"1H!TTJ,,EI,AMDQ"]LQG)D;B"$,J!HHW"3P!3I!%*1Y<4CI
M"9>E5:UC6[?'=4UL\:6!IRH&'^V@1W4'L*R-RX(1+'#,/L@%!/C\>E7[(9;5
MD>37"2VDSZ^ND.B@(,EC(&]6)$A\(H22>4.K9QX5C3I:CMUU4F#98L>-K6"7
M<`+64'RDGKJ5KG\C%QFSX\8<S9.Y`?GU_'I50XXH\FS&MFRN\8'3WH5/YGEE
M$>HFL*PATWH))8X>IOJ)8W]"IX+%\4\4U'/FBQ7-AC<71K=!8."*G@OXU2Y+
M+QL%\>'CN+XWN(%K-(UO5[9W-Q\7(Z.VQJ?&KJ*G>!1VH4,[(B<CF#4*&T\P
M9\*N@KW2(Z-51WSHKE3?5;%=FH'19#9(=ZN!U#05('B?^E:3"Q.9)<Z++$V'
MO#GQDB[!<M\%[5C_`(OP+9!7$LT%='>7Y4<XMIE=A8E1$7=5<-C99$P[/;&J
M1"JL4VR;O9]]K=R<VU\?GE<R`(0P`6+=/]1XUU.?R^$<6(';&MV1HH81I\"M
MZO->.,NIN#\YJ.-[B+%L+KAYF756&C+&A99%'Q.DN28"MSHR1F-3?RI4:B-:
MNWAMK%][CY/+84F="9)G$%I-GH!HHLA\17/_`.0Q8N8Q,CD\=TG*_D<%LT`H
M$T/745X\JFWW#,M#BTE4%9YA5XG7Y;BN38=7"JR.4.98XH)"&P1I.XY^ZOD)
MZG=*^":EQHAY`9&2Z4MQS*6.:\GKX+TZ)7O$8\?.OER,>1S<2:1S98WD_%0?
MY"J5/DV0<E"CY-R:7+8939UX2OKO*@''B@<Z2%H)LHL<358)&B*KT^^5R[^&
MJN1CX^),Z'!:!&"0#?\`$?&N]X+'_P`!B.BXN+T\-KB7%5*^"U8%57!_TC6&
M.8SF!_'^=,`GGQ"WQ&N'L9R"8A7?@Q&S*D:!.1580]L;U:U'*FMDQCX^/$T^
M.V7&7SAY(0$]4Z]KU6]R<T_*Q,?+SN/&3Q:H]KSMZI<]P;BXK.KLQ+RTK+R9
MLJ@@GNY02&9!?B0MCAOC86JR(URPQPP^8YK?F^1J]7V:Y?W$,9FR/%*0?E;_
M`$^'>OGWO+&PX_;T;\<I'O&QI-V-/2MG>N5KX]32E-*4TI32E-*4TI32E-*4
MTI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E15SI^9C
ME7]'V7_Q`?J+M*DWZA7R;M>U*O_1[<WM,_X<W:'^A7$/X`W41J:D[4?"O=W6
M5=6S/1;V\,KOIC<8"KWU5O.Z,`F1QY+XREE3J:#(QS_+Z^E7/1_AX-770\6Y
M[L?THFN]3>NYNHM^_P#E7V+]/L_+@X?(Q\2)Q>97%0%/TMLG7O6#M%:/R/(K
M)"XJ48**9:&O&QXE)0"*;SE:]'22K#))$4/,])$D;N^1$V79-;[*8(H(PS=Z
MHN5U7^%?6\:!^)&QXF<_'D9O=Z@+2'IVZ(4N.E7=2TL&.#!W%S5'5`M5+%7%
MRQR0R5[@W&2QQ5L\P$[GSB-JTCCZ5:J)MX(NJY>Y\DC(9-Q>%%KJFM]"JFJW
M)Y;.3QG8<<T+I0TN`!\VFH!'>JD=9XOFE/E^7133U..\>Y"_%LDMH*]M2>]E
M>(,7CPJBJQY%@$0;-(,QL+7HV+J>_951-3$63%+C8[&A\TK-[&JH4E'$GH0`
MOQM7.Q29'!SX^#DD?<9,&]M]P`)1Q!&CD"H?E7!-KQ@\F,#1V4ATN96-FUEG
MY`4M3CF2EX]*&'!4JR97LC]=+)-&0K6HQ8$5=D550T/,`D'INEB`5I57`.4[
MOD@3QK.,A^7CX[7",Y<36$)9QBWJ7&VNVR>-7W45V%<--@R1M)1VC+X>I;'6
MVU4/):YB\6O<+<G`2JDH4UQ<1JDY#%Z&*KD3J750S9?*&2-TKVB-2K2=L8)5
MH=UVMT&IK29XY/FW8W%8V4YI#W>8%$+BH'1`W05BCR+E];AA6)%Y8!=LM<OR
M;,)P1*AP8\5)6!?2;`6A$C0IP396P7(CTA1ZRR2K(C$1(EUOL+$?G_=^A*QL
M,3(P2X$[B5&[NB@W.EN]=_A.R,>"7!QV-F<R!JDE%U#G$ZDJT_).]2J3CGY6
M4=YC4M&`^4XBJ*EDL&-.8+,R?ULI4;WQNBGVF9%(K'>6UBLWZOLUK#EG'R8I
MF.)<U0C;$M1$_C6K;'%QOV,YRW-@>UZ-ZAQMH#\J]B`TE?=[EV$N8Y'6.KK)
MPA4:UK1K!#R9VNF45JCR0W(\"1JSI6%[6.=M\=1,F4^(EK/2@>2U1>R`(%_I
M55\:ML8S+P&PQL&.P,("%54?4O<:]Z_+6"2ZL:K.ZZNEKA@)I!;26JN!I\-L
M+,HD@43"70CRO.4T1`'NE<R)&PQM:B^+VIK*0(FOQR[<7(@+2'@`7>IM?LM:
M_BLN(13^V\K(+B`7B5S"H+3]5_B*I+\K`Q0W(J7(R@*RUN*N,N6OJ$G($>.+
M)*7.,+*QJQC12-8J(]VTJ*KF[;JFO'8_K,B?CM<6AR>:Q4V'[:5T.+C97(C"
MSVN$N/#;U240"RD?RTTJ;^`^YH#%<'6#&Y%S&D:5Y\X#@YJ&6K(+618F12GQ
MHLB2+&GF*]K?@BMW3?5?D^$R/6;]ZD4A%B#NT[I7RSW%[2/N+FLJ:%[<=ZZ*
MNX=[=:BGGKFW+<PLC,EQ7&8A2)V0T1\0YC%.AC0?KC+0V.*+S9&2R+MTJK4Z
M4W7PU9XSC\2`^GD9"MU!(M\$\:[;VG[3_P`1@-PLF<R.!+DZ?QJU.+",CQL%
MN,UV2--SK*RB2JVPMGQQ6E/*:&X!@8ACG$R!/+?(^*::)R-D8_I5=EU<R)(<
ME[IO0V8L80@:.0JI%E34`Z)7ONCBL5CF9_)1.=Q\0T"D?,=4Z+60O`>9R<:T
M\UQS")ZS)*N>99*F>F8.171SQ)".B.)1[EED+B?NJ)MTIU;^.M9RN(V:5S>.
M"0.T=N4.[_N3^%?/.>Q,GGYHL7A7IC%OE1VOA\JM9N>5_+O*G(ZUKY\>KW48
MADKJF2L*J;Q04<Z>I:][&SQ$-BBV<]C41[_E^*;ZM/Q7X''8AF:"[<@W*"U>
MO8ULAQO^+XKAXIC]QEM<X$$E8ST/C>KRSN^P05*TC"1"L5^FXP09:6=UYH8L
M)`\;&M@FA?N\]TLLN\?Q;OLB>&J>+!.]KONY?4+WH&M"KX^'C6GX^'GWY$D.
M:T21O>@%BGB.U</&<^XFR0?.*3,([7)9S:B%,=M%>A)-?,8&Z*`=D8[O_0SW
MEJKV?!OV[Z20YL#L:2(B(A]V@("`=?\`=:MKRG`\U@NXZ?B7-;""LJ%`4-]=
M;:U&''7;7S_;TA5,#G%;3UF&Y&[*"!);28RXO*^S@11\70^.:7Z3&\,17O5R
MJQROV<FVVMCF<_PK)?7&$9)9(_35$#2-7[?S:V2]4^5]P<)BY<#I('&60`$A
MOE:04)"W/X5;=O)=5E>RBKK]8L<=(4-R926S20X#Y@W%E/I99()71/=8JZ)K
M"5:YKFMV5?'6:+:Z82NB/KN`])PZ+;<A[7*5NFLQ<AC^0DQG2Y`:L(:`2`18
MWT^%7]<9'3XEE&,8<%=!VL.74$54);&$3FLF>*V1RU%<\D%9XH0V*W=$3H3?
M[[5&+%GR<?(RW1E8WDE+?_B-TO5;CVQMP,C(R,=\65#)N#$2Q2Y0W6N19XEC
MI!`M(/>'U%KZ8EZS6\+0*&PE:Q71UM.='(0IXTL^[97;,5OBB)]FO62R[&S;
M0]JW#;N'B19"FE6<;GLYOW$YXUK\=R!J.4]B7#HE6B!BM=:955`XS34]'R16
MBSA4.7UWUN9*X=\$\I\L0\;'BL%GA61CYGOC2-?F75K[F1L$KIG/=A'ZFG;?
MH/%5Z==*ARN5)AX@R,_)=)Q3W`R0EHU/TW&J%#:LO.TBLRZ/+S2E)FDQ406:
MOG%=%&.Z*TBBWE+(@F>I;7E2.W3IZFK\=_'7-\R_'1K0Q9R5W"X3LNEJY+WC
MR''OXB#&;&F82"#_`+1T[6K8YKG:^54TI32E-*4TI6-/=EW`V/;%PQD7,8G'
M5ER6%BRC2V]'59+B^,&1!$DPB,(@+RNRK`RYWE$,CC'B<^>61Z-8Q5756?(?
M#+BQM@<_U9`P)KN<0&A-2I/0%-2@JWB8ARS*UD@#VL+D/9H)<5T`:T$W(\+U
M$-/[CO:X.%Q75\G<BX]Q3RKRD5B-*%PYD%J-:9Q2Y9F@PY%1B]L-0?41H#W^
MJ8USU>D355.IR+X:VF;C##RIL82B0L*$A47J+]C8^(K78TOW$39=A:':`HJ=
M#;OK6>:*BHBIXHJ;I_J756LU?NE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*
M:4II2FE*:4II2FE*:4II2HJYT_,QRK^C[+_X@/U%VE2;]0KY-VO:E7__TNW-
M[3/^'-VA_H5Q#^`-U$:FI.U'PJD=Y+I+;+QZ)DT+AQ:>DL"AI'(J^I)GNH0^
MF)&JZ3K2%SME7;\'KI.)`BQS.]IVEQ'X)7W+]+WMAXO(?CD-Y)\KVL)T1&$Z
MZ?&L3,$Q^NJ@K8*HO8R[F6PC":R]%5"D@O)%#"F=(/#,C*V*3;S)W.:V+Q^"
MKK=Y$IEV2OC2(-W6-O+<Z]3T'6NTYOE)/5A@S8RUCA=S2H'>UKKTKVEO=G$U
M[)98[88/#B%_>`@,^KS.GR,-MG"/#9@5H;_IKA8F#>5O.CG-145FZ]6I^HW$
M;'LG$ID8TD($:4T)-UZVM5#&Q)\"7%CQY8\B66(%S@+L!"[2XW6ZVJW\PGM,
M?JLWOPKIYC#,D'MJ_%&J)/4.MTK86B&HQ(VN\X-0W=4<C'-D?*YVSE1-HPOC
MDEQH2PM`8A=<%%N/GX=JZSCN/BSGX.-DX#/4CA+'2%=Q;NZKW74(B)7)PHZ<
M_&J7*^4K*I%.OE$;7CPVY:"!V/K"70$L#<X;RR3!'21[/8L2(]$5=E3:66`V
M>3&P&/,#6DDH+V&IOH0#WM6HRHL=F5-C<7`\Y,$A4[;NC'Y/@#\ZN;/<TI,M
MNJE`K.#&,<P6IFK6C7/TN04\NF\LMP='.YL[ZTPP=B,=NZ.1-T1535?#@DQH
M)&;3)D3%20H(W65PZ@'Y56XWAI^-AERLN'U,B>?>"Q58UUAN\!^%1I:Y35IC
MC+$C")[PA;*:ZQX:9HLUK76O_0BO(!&LR$;%/,*J3)+'U1^7%LBJOAK88^/(
M)3']Z&,3:_5"VY0H.]D-[UL\J,Y&4&8\@]3;<J@=J@4=M$[U?EA<VEKCUU#"
MYH:UV/QRUY+(GFLD+KW1-KXB?2+&ZPGGD1S$C7='2+XHNVM9"T-RXY6,57D%
M?*H/9=`*]RL##PL;';*[?(]X**KF@_4;Z=ZJV-8G2Y'=\@.QL\;'[*P3$(*^
M9'0S$T4M2-++/6$PE$/'DG0PJ;\&Q[O+;+X>")KR7,DB;@MRF%[`'DC0.W$7
M!UT`K1\CF97&8W&F:+U20]>Y'Y3;P3XUXG'XIQNRVL`(5+@J;8_K$`ZTB?=!
M.ELR+"()>F">46`AZRN\7.V3[Y-2+,C,+&N>FYHN>QL`ORJW@>IR<$<4K6MR
M)&DWLK=$7QJD8[7X[F^1OOA@Y;,[)6Q/J2[``8.-O2>LQHZA/DB%DD5J*L+%
MV\Y[T;OX:LO$N.QD<I`](W0D]+%=?`]M:K9G)9O$\3-A1/VXC3YV-*]-`=:Y
M.&6^-<2X]4X'R,2!8VY5U8+8G#""UKIQ+)?*%@G@F9!.TX/=.A%7RV([Y5VU
MDRXY.4GES,1A]':$"DH1J1T0US[,3D^7GDY7BY?3C8T)N)2USWM4<$\>'QL/
MDBOJ[*AJ2[EL#)15+J["LAM^I,6KR(%:H-@^0>"3KE:]S=D3P^.LDD[7-:]L
M+HBYNT`HX';]9'4?"NWX;W2&S'#Y#'<R8KM-B"`+D'LO1*]9A6!5^5UM9:G1
M!YJE'Z2MM\=,BLI1"RHYW@F-F\Q0O6P$Q=7E.5-W1_#;4XH,T0.R(F?^*'*6
MN"*!J.Z)_&O<O.RN5P\O'C87XCG7#QMZW'P[&N'E&?G]*5F=TN8Q'4%?53V^
M4&-C(,R4@B:42OMR1`9I7>DEGA>]8^E&,551$UE^R=*UCL*>(LD)`9<!J7(!
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MI\_(@=E`8^YVW<=!^_6M5QOWSG9V+R'(+&"?3[,!_*;7)\5J3J#.LHL+6['P
MR/*L!QU^$Q/*N,BD@0*[N?(E'*#"EZ)IS)GR+TPJY>IG2NWAMJK+BXF/&)9A
M%+-ZRHU5`[GMX]ZY_.P<`0X/^4]/)R'SD)&JL;8M)TUZU8F&<)<T9MGK5K5I
M+W$_I)9=N7<GJ).2>(Y8Y1BD@1_GHK'(L3E:W;X[^"IK93<GQ47'DS;ADEWE
MVA4!T([>-9\WW)Q7$B*.(21/80``%&WYUR+4*OR[D'#6QT0H_)7'+"2\<&^H
M+.1',*,XD^-PK'K!)7'P1O\`3OZ>I=_%/#6"!\F!@Y8]1>/GLZUB#8?,'6KF
M2,>?`R<F?-)P\@-4H0A)\I75047I7MRLRQM9:FQ!M:8*WM+$JZQO"S50VP#%
M]0@MBWRG1IYT+3QYI&1M7=%7Q37N,V.-K@87NB#=KGBP)U'[B+UBP`V-LV/*
MTDL8`^1OTG^D_%$Z5?N%8Y7*I=M=ODBF=3EP'@4F1?1RK!DHY"$5[!9TC(&>
M=')]ZU>ER+X*FJLLX;_;B*N#U!+-P"(A46M6MYG-RYV1P8[=V/N!#G-!`(3^
M'>I=[5\SH6\QU>)U5K(PHW&K`TRCE*9,\9H:/A@8[RY7I+)!%&C7.7QW36MY
MC%E&#+.Z'R>H/,B*3>M?[MX>(>W_`/*/8/5;(UK2.QUM\:VG:XZOD=-*4TI7
MXJHU%<Y4:U$W555$1$3XJJKX(B:4KPCEBF3JBECE;\.J-[7IO_K:JII2HCYQ
MX2P[N`P9>/,\2PDQN2_QS(21J\MXCRR<8MQ;NO')?&J+(&XT-BR,7P>B;+J4
M#C!G8&>S_O8\A>T&XW;7-N.J!Q(\;U,2O;#EPL<@FC+">NTD*GQ1/@:T:^[]
MVW<%X'G78KS%B/&&*4/*64]^G!=/DF=UX'D9!=5S%*_Z8XI)%;*QR@Q*ORHJ
MJQ-]>2/<]SWN/F<23\34(VAC6M`LT`#Y6KL3Q_\`+C_W&_\`"FO*5YZ4II2F
ME*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*BKG3\S'*OZ
M/LO_`(@/U%VE2;]0KY-VO:E7_]/MS>TS_AS=H?Z%<0_@#=1&IJ3M1\*HG=>B
MXURC-F(E:4=<$8E1``/\)A$C`GO9'C(++U0K.0\Q>IZ(CNE$3?;PUT_&DSX4
M>+O`C$CB?F!>OMOZ;XL>=Q#L>;)#(QDGP*D-NNJ5BC3\@#5ASB;^FVJCZX\>
M6QE8SH&VC;(/1]2*UP\<\[.I&_>NZ=OBJ:V?V9?&/3E20$>7O_N^5?2>:X49
M(9BX,BR,(^FZC\SOC4FP6T5I4Q7#A:RTL[H/IM*E'^44`29`YU4.-"ULGEQ*
M4YRJFZ)MMJKZ1]0QR2%NTV/0A;G\*YI<G#R78^/(8XH3]1&H&I/C5@5]:(&)
M?"R8G!!DY148<UDZ>*&*H'<%'+,3'#-.C?6PN<]L;O+\QK4<J+XMU8D+CZ23
M%T0N!T-T_#YUO3FY<\F/EC-/V;6J@NYY!T)'Y3U'PJF9E)@`.322A49D4L(%
M)5F9B54EV%/E$909)]?,(0U9Y>EYS&C.1(F^6NRJFLN-%E2P-BDR&F[GB,%"
MU"A[=+ZWJEQG*<T(9,DRM$DKW!K5`<P;K@CI8DU;_)U`.+8OL*['3[_&,A%?
M#>88@K"PG79D$4)!0JFRQ3,><YWS)&]B*UJ;;:L<;.7M$;YFQY<:%LFA0+:U
MK>-7L:6?T&QSS^</))!N6=CX#I7[@U2P>@?02-->RM?`)8QD#=,Y4$2,(`]-
MZA[B00P19E&;"._RY/+WV5=]1S)"<DS;QN<NE[^/0KKWO6:9[)W#(QX6["T&
M,J@;J';@-2H6^E>RERW-"+XO%R1$J*,&PGR0FB=Z&=C\?<X,.)@QK&IZ2SII
MG.+;`CO&1$>[[W663%Q&XQG8-TA;M#K@[@ITZAU@M:7/AB+H,UT[I,UT>T?5
M_P!P*BDZM(0+5`9>)7U_(X#A:6LKHLG@&XV?CE@+(9F#+VRDJZNS*(2-SB+I
MXXS)FSR?.U7JB[:],(EEQ'-W.>&+)O%F;0"0.P4D)6V.,6/XN>??))+"?4W#
MZ"&@HG0`V3PJM6T&18\E1:+#E,D8L\M5<>GF@L$N[.9WIYXYX2/->#"R&=\2
MR*K5F;&U?@J[XHCCSNE:71DFX4$;1J$[G^"UD8V/+B]`MC4#<PFQ`'CU"WKR
MDP!_(N/5X>7<G4U/G\EU9MK:8R5U<A6#N(AJZ1PXX;1YGVXL4DCAIT7_`)[4
M7QZ=TNMS!A2>K@\<Y^%M:KA=)$W.55\I0*.U</E\T.)S,IDV$YV$05+0HW'N
M>RI7Y;<68X<^3(RAS;HZAK*T9]U9V5C&02>+%(D#)63SI*2US%3=BM7S$1-]
M5CR4X<(VN#(G$G:T#0ZIVKJ."S'0XD>"TMW3NW!J!`T]Z]Q%W-=UI'',3C8Z
MN_6-YBQMC9*,<'7RPM1/*5S18UCGVBC<O4[I\=88P(WNSHT,C$1>Q/CKXFK4
M_%18.:.5RV-.1M+0`5&W_6K<XJX'P+BFT?D18E/FEDXO_P`-!E&O'A'.B5?3
MEGU#9WQ*X=RJYCI&K\V^Z?#5GE.<SN0B]!CW0C1Q1;'4`IUJIG9V9R<$D>.'
MPXS`KR!J.P-2;6V9F2QV?U6E"!RFF@-KQKV5(:ZY;4C&*2/0DA^;TE0./D<H
MLC6J]4<NR[:KY1BQX6,CR"8E#BW4;B$+@4L4U%<OAQCC^;AR(VN?Q\[D<+EC
M5U=\3UJV8;<&W-N*#(:^ZM\CIXH+[%(G75OC_I[T%J2QCRGBSM9('-$SIE'>
MGEO:J(J*NLD+W1M;,)V-@?Y7^5KCM/@1KV(N*W'/>VVSG!R>((CQG.._:5#D
M-57*L3N,G3#,T%RR(0?#&,/LJ48Q$>?(XE)I*2*.5[7F%CKU,V5'-=$Y5UYB
MY,.+][CNQE]4('$*@TW>`_G5`90@>[CG8;AD2NL[L@L3X&K$"Y%O[?-%PPD$
MBK`CECK*:X-F;)7A#2&JI0A;]O&+H=LYC%5%1R_=UG?A8\>(,QCPZ34M%B4%
MDK>2\9Z.%/(XAY>PEP"!VY+$>/QJ;,@KRK6D:54WY6,A%759CRYX!%$M$ZY^
MIK$UX%?81OE%J1Q'+#*X=C7JY.I57??6LQ)6-E=%/`V1X:7>FZY#=NA(U<3>
MY\*XJ!YQW2!T3)9V1ND#'?\`<:`J$D6)4=:H_P"4Y%!R!:XEQCE$>2T^*"@C
M<JY?6JM;-7*;'+`(PM91_+(&:6]W4^%=VL>N_P`-7'X8DX^/(SHO2FD=_99J
M#WT\.]8878O(Q_>\SB`2N#G,8Y02&A;)KX`U1\OQRRP'DX:LL8JJ&_R<>LB;
M<1&1@$5=$$Q9&'/+'E?,]L@\2Q,>GS+]SQU+'R!E<>\@N$42VZ$GHGQKH>+.
M)R7'0Y.$US\2%QVQ.;N:7GN#T!0U:!>$8K#9_P!)U9D55)+A.0I]-]0?*MA:
MU;'M=.L,TC6JTYL[Y6JLBM;TJBIOJW!ES/9'@.@</5CO:P/^FE6LK)SX&9.!
ME8J#(:KRUHVM<!8%.B:5X8_R%/E&79I$#CA-//7!$2U]V=T3>LL+)GD5SF%M
M26"48=SV*U/CX;ZR9.!'!B8\DF0'`N`(%K"YMW/6JXC?B18&+ZN]DC2=O](&
MM9+=F=$.+RSCUA98X!7Y0[%K6.T,;"UQCB5=*LTT9B.ZG#&[]?0NZ-55VVUS
M_N+)<Z&6**=SL7>-H6WP3N.]<_[P=_\`\WEL,NF0W:/]MJV]ZXJOBE-*4TI6
M*7?%D.0XKVG<[7F*Y`+BUZ'Q[D"`7I<BP1`23`RPK(A.RH',YLBHR9=FQ/5'
M*J(F^HNTM4F?4*P)]FBNYS"XKR]_*MXIN.SSU+L.K+'/:7D*^A11UD.M3+FI
MLK1T`EH^3KB@FD1[$_V4U(:`'6O#KX5GMW@=V&(=H/&`_(>4UI-Z1;7]=C&.
MT`A8E?+;W%@_=HZV%A+``$QD#7/5\KVMW1$WW5-8#-_YF'@L:L\VX@:>5@5Q
MOJ@T&IT%6\;%$T63D22AD$0"DJ;N.UH0=S9>FIK3'[H7=)Q!S:'[<=#CF74,
M7),O>UV\Y=D'&*W%>9EN+!60Q)'3;!A3SL8D"GQM5[7*QW6BHNRZOYV-]IDS
M8V\.+"BCK^-4,:7UHA(B*4370I79&C_Y<?\`N-_X4U7J=:>/=M]VG#O;'PO#
MWOP\CD#DGD%\TF,8TV9P5?'7!$-B.L;(_H<V*-OS-8UN[G.^S;7E>CN:PFP7
M_P"(>BR_M%RWNY9VJY8[C_CN\KL'S6VAS/%8X0LZLAZYXU<'6$&QW!0<\EK"
MK9&PJB,557X+HITJ2-15-6OV6?\`Q%EOW;V&?8O1=J5W89=@&&95R=;B5.:8
M[7A#\?8I$I=M:+/>E!><4"&J.DBCZG+_`+*+I<4`:5U%4;M3_P#B9N/>X;NP
MQC@?(.%K;`\-SV^9B^+97-9PV)XUU+'(T=EP&*US&#E%Q^6U\:N1O4BKX:7J
M-CI7:B8]LC&O:N[7M:]J_=:Y$5%_^5%U[7E>6E*:4II2L,>]_O#QWLUXNKLV
MM:0O);S)[Q<;Q2B&<D,9=DP$BQ(F-*=\@P8@PZJ]?OE5R(U%77%>^?>$/L[B
MXLQT!ER)7[&-T"HI)/8?C<5^@O\`CE^@G*_K_P"\\OV[A<BS$XW#QON,F9UR
MV,O;&T,;JY[G.0#0(22*I'8SWK8YWEX)<7H=)/C&4XJ=$!DM#*]2(8'$M=(*
M2$6C4:0--$B?<<CO!4UA]B>]8?>6!/-Z'I9<+@'MU%[@@]C5[_DC_P`>.6_X
M_P#N7`XV?D6YG"YL9?CS`;2=MG->W5K@?D1I6<NN[K\WTTI32E-*4TI32E-*
M4TI32E-*4TI45<Z?F8Y5_1]E_P#$!^HNTJ3?J%?)NU[4J__4[<WM,_X<W:'^
MA7$/X`W41J:D[4?"J5WE&74N?8D#C&+1Y3<)`$&8.3=)3AB4MJXU3[)\JN:Q
M9JQ1(U9U*G_.7;[==3P;8/MY_N<@QQFX(:I+@B-^:W^%?6O8:,X?+GDS#%$R
M0E0W<24``07(*_NK$FU.K,LL;QHV,AU./$3#RPU\C?.?7FB1MCF-/:Y5;(-*
ML*NB1BJBNVV^*ZW#F.QVQATI=*T:]QV'CWKZEP\<^#BXTGW[WY:%2;*#V!T[
M5RJC+3\6NTLMHG@"5X]C<5B`1OB*?.]889Q245%B,&?&[RHF=2M<JILGAK$8
M&S1>DYJ2%QVGLET/@:<CQV-F(8GDEZM+MUU2]NH[DU'+Q<SRJ/,K*VI2:R^K
M'7J5T53=Q&RWB&S#_33RPBI1Y&22"O6%KD5WE)"GR]2ZV&[&@=B1PO#H';5W
M!-J*H!\#?YU8B;B\9%C0MG#FN+2%";$!!`U^/15J^*L^^%QMJ0,;<!5UA7QF
M4H\,C+A2IU8%!Z(&?=#`6'JS\'`J222;JC?MU0ECBE>6O?LD*H_HBK<BX*=[
M)53)?Q_'9;\W(</-&3TNESX*1I5T<EG04^11XG:UEG*9'4/,;9UIQ)5-]1,$
MC'@(2:M9(%YP;'(L<#G=;6,7=-UU4P8I',?.V9OE>A:0CMH*Z'OW&M5^)FBY
M''&=B.VQR.(\P`*`_2AO\]*M!M*0#BM'BX$T<5M21D6SVQ$K8Y39UTRJ0VCL
M9GL6*OLS8(?/&C<]RPMFV>C53;5MT^_(?DO!])[MJHC0;`.3JT:$C5*OX4T<
MT^?.2/2+0T!P2-A!NYO4^-K]*Y&&VE/18^?>#X`73VN65M8"0#D#QC,F;=7!
ML,=N;-)(G0\1M))(4](NEJ,C5OWRHFI9@EDDV#+#XHB3Y;-VC2W=;7K6Y$6:
M_-PH)<UDT<;W'?&$8&@*T=U6UZK..4]O3#PTF/\`'E1=U[:L6!L!3*>`K"9H
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M%-SSU``"H.JUO).1R^0PH9H/3<'!6@G5=?D.M6597>15V29%;SRM"P,`6;R\
MA;,R0ZKD(F\B"1\KG,ZK*"63S&1[^+4^.IP18[XL=@9NS";M.A2YMV\:Z2:$
M2\;#BF1,UX^AHL?^E3YA)M7E'TZS#RBJ)>T2O.(OK!XY4[81%VZI(D>LSCWK
M&KM_#=_@WQUJ\V-^-ZC7X[@PDC:+*O\`(5QN6'XF/+B.C=NO85QLO`*QR[-L
M*Z^=F(666)5Z]V1S?3SL<-?7C@"T50X0-S4K")Q?42*0]7M5Z-8GQ5<6(V.:
M$1RP%DT8`5FA:JJY3<C0)6'AI^27'+YF0M8C2Q-P<U;NN1M=?M5I1Y)3UQ="
M+DM?;UEO9VZLH7*`017CV#&[2M/F'>U!@+05RPQDR(UOF*W?9-]7VQ&6/),$
MK71LCN%`)"]%U+3=.U=!GXF:T-FAC;)$XH]XN6@Z'3H=4JN'I`RLNJYH$@UA
MD!TTE1+,YI-E1P/&;Y[QDCB1>IBQK)OT+]]\=M8+G(@E+DBB;Y@!Y7E;#6W:
MM:V'(:Q@AS0_RD$*`%Z*34U#FB78?&U4`'/'C5)#:1R#R0RY,VTBEAAG-N):
M:!T<#BZ^=96IOLYRJB(B+K7!WINSR\?W7(5'E0W0!W8A#7%9G&2\6.1S73C[
MR4BP*'2X#B=#V2HOAM\8XNYI-<,!:W?'-_-4UN>>CQB89V2B*_<4!`HG31;#
MD3M\S=WF/3=B)OK:L9/R/&P-DD:S+:"8U=])ZN)L;@?+6MAD8,W*^U79`8&<
MI""Z/S!4M9>YOX5^<WW5%D^<297CU'E%9AR65;416]Q06#V^0&Y8[&!T-H@K
MA@%B=O`B2HKG)LU-9.,BD@Q1CRRQOR]I):'#KH;*I[VJ/MCU<#C&X,N9$,N[
MP`\:]C_.H_H<5P3A]>4+6W$.Y$Q'+*;ZA4O>U\]0-ZU'S-E`",=),`17/1S9
MF[.=U;;*J:OOFS<__'0M`AR8G(Y+.MW(L5Z7K99V;F\_'@.Q\IL,S9$>U;G;
M:Z:@]*]^-<EX%:8A^5^*5Q0M?CQ"V%Q2FC$Q%1>7*P6,:(@EK:PT)O2V5D?5
M\N_2NRZCD<9ELRQ#DY`.\(TBZ]5(%P>BUADBY)DTV#/&#DO&UDC2``"+GJ1X
M]ZRP['\SK>1N2#<LB*?4DSC'QQXP5-(LOE^2CE(#@\AD<,#$7Q:B[(OP5=<S
M[FP9./CBA"NC/Y@+?,KK6J][3MQ?;+>'DP@Z>.1O]X=?`GO6VW7&U\1II2FE
M*Q:[UX;Z?M5YRAQG&:?,;F7CZ_8+CE\$+9UMDC@I4FBEK#5:+92-AZG1CO5$
MFD1&;^.HO^DH*FQ-P6M</LM5][3X?R[4+B5C2X@%=TJTMUE'%@7#N8V-H171
M$75:=APQ),JTU27(Z,(M_2D\*(K4VU(?2*\=KK6S#NE[6N-N[;C=.->2VV,%
M>-;!WE3;T[QH[:FM`U5&E!.,'*%ZI8'NC<CXW)TN\/%$5,#L>-^1CY1_[L>X
M#_VO".;\'"UK]C5B#+DQXYXF@&.3:H/=I#FGXAP45HY]SCLZ[<^W4;VYKCC#
MBS$:7-QN]SM^PVQY)2DKUY`R*EKXRHHX,@RAL#;*R2108G.:]ZMW8U$1$1$3
M89V9+G9$F5,GJ.331```/D`*I8\+8(RQO]1=\W.4GYDFNRM'_P`N/_<;_P`*
M:K5.M8ON6>U?P?[F.%8U0<E7=W@^5X63)+BV>XV&+865>,3(UYM<37ESBPG@
MD[+\JRL5CEZD7[-*]7H=*CWC7V6.T_CGL4S'L1C2^O,+Y`L&9'E^<GM$CRNR
MS.%0'"Y/!&SS!`9@5K86PPM5S&1MZ55=U55%["U8D>RK[4';IV]<?<E<O#%7
MF=9ARBSE+AJV(R2`2$6NP,3*K?&3ZJO'&?*G5=`UK?4R.7=W4K41$U$7J1\M
MA5P\`?\`PY7:'P!W5@=S-/F6;9&)CN0DY/A_%]R#6MQ_'[69)E'>^UB)>;9P
M5\LRO@8^*-6JB=2NVWUZE14"X%=A1K4:UK6HB-:B-:B?!$1-D1/]")KVO*_=
M*4TI5FY_R%A?%N*V6;\@Y"!BN*4_I_J=Y9+*@8?JR(A!_-6"*:7\,3,UB;-7
MQ=I7H!)05J[[O^7?;J[M.,&85R#W'8O4ICUB_)J#(:=+6:RI+*`$D:::(:2M
MCC,A(#F<R2)SF]?ALJ*B+KD_=_M/C_>'&LP,V5\;F/WL>W5KD(T-B"#<'P.H
M%?:OT-_6WW7^@WNR?W1[:AAG;/`89X)"C)HMS7@$A2US7-!:X`I>Q6K:['^9
M/;:[9^*8!^-.Y#'+Q,X8)D5IDV0"VM?<6J30[A,G`97SMKXQX'HU(4>[9?%5
M5=8O9WL[CO9N%-BXDKI9I'*^1P0N(TL%``'3\:M_KM^O'NW]>_<6)SGN&"+&
MQ,:/9!CQN5D;3=QW$`N<XW)('9*VR\=\CX/RSB==G7'.25^6XC;2'15U[5K,
MH1<E:<16G,B]1#!+N,<+)&[=J?,Q=O#QUV*K7PH@@H:O;2O*:4II2FE*:4II
M2FE*:4II2FE*BKG3\S'*OZ/LO_B`_47:5)OU"ODW:]J5?__5[<WM,_X<W:'^
MA7$/X`W41J:D[4?"N'W>U3;+.ZM)EDD$BI0?,%@(46<DLH@J,=&^5M,2V&,1
MSE;NC415^[KK.#>68TNUHW[BA/8"_P#&OI?L_,^TXG)>`2X2$HB@H`4[+5O6
M]]P/PEQ=11<L1,8N29A4T(-K411G'FJ41'Y,DS!9^MH\$:N27_\`)7P1576>
M'$Y;F,V3_'__`!Q.>0ZPT-K]3TK63<I[AY7D<C+PC(V..,N+24`:-?G7`Y9X
M=AP2MM+F/%8R\4)F0F@/B+(EN:&/RQIG!G122-ACA)6%_3(JO5CW[KI@<BW,
M$3!/MG3S`@(?AU4=JV'!<]F\G(U@RRW(],A-`20BUBOEJ8X7D7)<X^5^29D5
M-CY]-6OK"$BQ6GG<<"^<A[&M4HQAHT*-5CG)U/ZE7Q76W@;/'%QX]!6,<X$@
MW>;'Y!%KZ1QF>_[?%Q<C'<YD#3O)*EY"?3X7JM,J([RLQRI!LUJVXI8AV=EE
M,!DH1-OE%?/7K"##&_=T%,8UFRRKXL5SE1-]5))3BRSSO8KI=&("`PKKW<O2
MH^G-(,I\D0>R5CPUA"EL2$J/]PJ0'Y_38+:25<T/U;RFP@2D^DD<+):1D3LF
M+K/!Q!%7(DS43?97,8FZ:H.QYL]KG1NV@@N1;IJA['_6L3.!R,G"ARI)#``Y
M0Q4)"!`?&N&?A44Y^09&-8B[XM;@9!*(.]0TM2KZIJ'HU[Y51WD,':W?==V2
M1O1-NI=>C+<V#&QS$5>PM'5`TG]OPKV/DV1OQ\)D3FMR`6'=^7825^)7\$J-
M).6**KY<!PF.G?,T(&0D$Z%7LK1FB0REV4I,DG4KGL=$D*;*J[N1$3;6Q'&2
M'C79CI=I<4(.I6P_BM;P<3E97%22P3AS'GS)9P-@$\.]33@PF89\1E!>,T+$
MB&+-/RSUTJ"I6PSD$R!E!/5%?YDL$+W+$FS71[*OQUI\B/%A;"V=_G``:G7X
M_P"M:CG<[$X:?!@GGWME`;&E]$!W?-*@#(:K,,ZD+I<$RGZ.U:MHT\/HE?96
M,E83:0"PU9DGF/":&6]DRKNU9D?XJNR)K>XIP\&(29>,'OW(+V&AN.JA1X)6
MS@DAQ\K'R<S'=Z30G^W:=5'>J-CO%&6EMP.VRTR0*]QNZ-IX4M;-BS6DYKVS
M0,)E8^1&1%Q[I&W?S$3X[)JQD\A`#FQ8C`YDD8)VC1/].M>2\]@0LS68D"P%
MRM`'1+I4NVM2"D-)=25M-!9+8!ASSAJ\:SM:\2)(WSG/1[2!1QY$5B2>'6[X
M;[:UD3Y#ZC#,[TPTE.@)Z"M7!R;7G)QFM>0YA(+@"&D]O$U$V06XO(I9E-*3
MY8=,?'6W`#8R?JZDO9Z@,B<I&]1T"0HWH<CWHU/#P55ULXX#@!DK1=[5:;)X
MA.EZV_&)@PM+H0Z=%6VU-43056+''<7/RBEXFG#F)L[/!X[>6I]&:V&<5LA"
M]7P1"#6>F=)*Y?@U$V7PUC#LB/%FY-CAZ39MNX$6-OP%[51QN<<R-V>[<W9*
M0">O@/#M27':+&:^M*J0JX>6-&)'%5M9/*UHY+EED*B5.I\O2G2B.WZ?BFH1
MSY$LDC)7.*G\VEQTJ_+)_D&&4.VCJ3U[)\ZM#$.2J7.C;3!X[``HTB:."VK7
M,EEG!-<0^4=\I;8V/1R,&ZGHU=DWZ=7LK`EPHV9OIN:PBSNX&MOG:H3X'H!F
M3)_W(AN":.ID^/5>39U3!3VUD`1APXIMG\LKQD$G+?%')#N[:4=DD".>B+\K
M$7?5-CSCXLDC6,=',2!W4!?QKH,'D\C$XO+/VVY[PH!ZCJ*E&#,*&P6>N4I3
MK8=7"U]I&V!$GJF#N@*6O>O4Z=\J;M;OX(C4\4U1^VGBV%S4C52WQ5;UR\G$
M9;7'.$@;C.N&]G*J&O160WE8"1)$2ZF].^4VHF@:0K@0RQP"8EF)<[9\PLD,
MA$ZMWC3SD;XHFK.1]N'M:UN[>`H[E2#;MH!\%K3P!V?FY4>>UKH0X!.X"JGQ
M6U4T*O:9<XEGK['UMV.3!&RF-?*RDN?26C#H[LT5O4.V&<V-K$<J=6RJJHB:
MR^H(VSX;&CTT*N'U-5J%H.J@5;FB;D8^?QTF,Z*`QD,<-?`5/G+?.F,<KB4F
M!9"CJ:I&GJ[K*C<92,IH%C7S=8`4T>\:^E0N-JOVWW;]U-4>)XF?`DFSX&K(
MX%K`^R@A"?BE?/,3VUR'%.=R.._U7AQ:&'4CJ1\*QTQRI9@UYGWUS);',<1L
M6O-2D8"98R#U\;46$H)I#',9+&Z=/ECV16^"_#6\FF.;#A,AA;%E-**2!?JO
MA78Y.Z7'Q\F&(09`;]5AN/8BKL;5,*N*J@!P9X&#S8\>`LCHFQ-OC[9CB4L5
M%1L<,H\6Z(J(J*Q[?%-5]X;#-+)EDY8>"O1H;9%_9:J12Y+X'9?WS7YC'`D#
M4#H#63?9VE=CG(4^,5*5TXA(AY<CI(&?40)HHD9Z<:2*/H'@5K$16=7^G[=<
M_P`[--D8X?.TM((`30CN5ZUS7NZ*3)XX9\DTF\.`+?R_'XUM%UR-?,J:4II2
ML2>^Q^'1]I?.+L^.NZS%/R'M4M;#'41UL%&L*^64.QTD4;T@FZ7/1SD:K$5%
M\-1=I4X_J%:UO94S:BY#%YURI+K+<BRPVRQL0R\O:^HJ*JTQFHKXZK&BZRMI
M9'"P3N#$1LKGM263IZE547?4@NV_>O'%76TK9'WJ]U4':#P]_2@_#+C/"B,C
MI\<!HJ:*623S;.5R3'F/B1SX`*\:-\LKT1=FMU6?.6Y>%B-;_P!TN5Q^EC6-
MW%SCT%6L;$]>',FWIZ300!=SG.<&M:T=R36A;W%_<!X+[ELH]OCB7$K,Z3E2
MK[RNWC.\EJ!ZD]^.`A64"S/AKLEF9&)9/'DMHV*C4WW1WW%UL\_%.'E38I)\
MAU(1;*#\"+CPK7XTPGB]0=20G8@H0?$$$&NSAGMOEM%A%W;X+C4.89:"#%+2
M8T0?'5PVQ2SCQO'D/E_!C(T=[W]2_%6;?;JK64(M]*PT_IS[X_[(M!_696__
M`$M>*>U2VM_JK%KO&]R/N7[+>"<HYVY6[4ZH#&*"2OKFRB<@`GS/M;DR*NK&
M*-$[K?%ZN=JOV\48BZ7HC1U6M4/LT^\IRQSS+>]KV`]NM9DN=5DV=\HARIE,
M=.%+17&4S7%E#)(4[Q*"+OD:U$\',3[NO-*6<2378#_IS[X_[(M!_696_P#T
MM>J>U-K?ZJGGA#/.>,R(NX^8N':_BX<.(9U/,%E`N0K:22.D0ACV#JOIT@:U
MNRK\=]+UX0!H:R'U[4::4KU30PD1NB(BBGB=MU131LEC=LNZ=3'HYJ[*GW-*
M5KW]Q#N<QKM,X6@MOR*#R*]Y&L+#!\?%:('"(+-/3&%'6!TRL1S8A@V+T(U%
M5TCD^S==<)[_`/>)]G<7!E18WJY4TFQH/TA`I)_@!W-?I+_C)^@4W_(#WGR7
M!/Y88?%8&)]Q.^Y>6EXC:Q@[ESKDH@!ZU%GM-\[8AS-VWX]QW%BPU;=\&46/
M8*?),(+/%:A`U[(`+2*96.=YDT42>8UVRH[_`$:K_I[[V/O+!RGSXXCS('`.
M3Z2#<$?SK8_\H/\`CK+_`,?_`''Q.'B\K]WP>?$7PO-GM+2CFO'QN".E;6X8
M(!HTA'AB'B:JJV*&-D4;5<JN<J,8C6HJJNZ^'QU]#K\N5[=*4TI32E-*4TI3
M2E-*4TI32E-*5%7.GYF.5?T?9?\`Q`?J+M*DWZA7R;M>U*O_UNW-[3/^'-VA
M_H5Q#^`-U$:FI.U'PJH]UM'ZW-JN:(J!)Y,:;+Z<8F..RA:&0<QADL;MY$%\
MR9&-5FV[E7?=/AT_#RM9CN;)'Y-Y0G1?+8>/6NK]O\F['C&`'`"1YU\0!7LX
M<X.X.S3BP:6\H@;P\VP?9GGV;EBLJFY$*BG@G#1\RLKW@3CL=&K6[.V\=T7;
M4N3Y;EH,](9W-8UJ`#1S>Q[K53EL_D6YF3%(XQAWEVMLK?YK5E<TW/+-SBME
M3C9!@UGB"9&8`*=<$/K+Z^J:V:&`60OIGCC,)FG23;RV(DS6^*>.L^`SC69/
MJ_;SMR0P$[0K&DW('8`?A6S]J#C,/);-E1ROD1/_`&KUMV\:BO#>/8<ML2JC
MDHWZ;9ES$X_4![I&/2CA#`'H='Y3';!2DF-1C7NZ'+\/MU9RLPXT(EP&@M`7
M3521?Q05U?-\T[CS%)Q+%QB`7.U50?WC0U[>4N)K?&:1[:ED$E#;$NB;>`FC
MI<PUDQH(5H8R1Z21*L(J^;'X-5KD54^W6'#S63DNF5N0&:$>7<A+1^-9^`]U
M-SWLBD>DP(0]O^G>L0<E(O#L$R(;,"_I!T,TP.,.H2%%A@`C(22`64PA\A'I
MY!&HKY%7=ROWWWUO\=L+,^%^(PF(A7J%4G4I\>E?3\;TO4@FQ)?4.KM_?N.U
M7_Q[E*1Y<1C)L,DJX6]\T%A?.:IN0TEUB8,9-(4'MY![J\0J%\<[VI(O2CD5
M/'>IGXNS%^Z:=IF0(T_2YKSY@>FY$(^-<SGXCLL19#GC>Y2$"-80ZY77_P!:
MO,W),/K%J*//B:"ESG);8X*@'902E@#4]U"H];#?J`DDD!56Z59?->YF_P`B
MNWV76+'Q73LFFP&/=AL9N<KD)<W7;NU!TMXUIF2\I%DY#^/;++Q?E5P*(X&^
MWP/76J/37>6V(?(=#B=UD5);8C6!T64AF+"R3*JY7E8S19!"4&]Z&B'LKW3+
MXI)T.:JHFZZF<7'@^QR)6LDQY7$M(_(0`YS2#U"I6<Y,'WV&WE,5IBN821]-
MU<OCVJBXZ;7\<5]5'E!Q]EE_U*MA?Z062/T-=:3E322V*PL63I+8.]D*/V7:
M%5U/*CGSLETL#&MPRPD?[G-[?"R_&MZ,IF=%DMP90[&8TEP-[CLM23E&(OH(
M+./U4S::JLR,B`2)\9I+7.Z?2G1I,YS=QPSG*UJ_,K5<B)OX:J09;)7QJ")G
MM:PGIX@_,7K0<?R@F>&LQFF5P(1$M5O5T-#EM4^XJJ^UMFAXDH,E@</8"%K9
MRF$.%*LTZ()HXH7M<D2;=")X[;+JPXSXTVR1[6;I50$$(!T_G5B&08@$4D[1
M,Z92TH3M["L9;H#EE,^@(C.@7&:>E6(UM-$D)4J0DDM4<V679)339)$;')%\
MK6,V^^UOX'<<[#>TQ?\`E/<JNT5!<#H`.GSKH#)QV-C'TYW%[W7!T`MI4Y4E
MYD.89%A\GTT8<RL4Z@JY23+%ULTUE>0=Y9-KUPJ,%(%)+$]95Z?-5&I\=:O*
M@BQL;*:)26O1Q0`-10-.ZH0G2N=,^+@1R,`W1ERW"M^(%<`^RJ`,GB`9F-78
MO$K5FAID`G@-J+%5=U#-*CB;$4]SHU\SK<Y?#P^.H-QLF3%+SB.:[?\`5N!#
MAW3H.R5=_P`E,UD;FX1$+[$G1/`=*K/%..8[4E$<D5530Q4F55%_.;9&NB!M
MW7="8P8>O%#F5)"2K`N61KE8GP:BZP<K/*^!V%DRR#(A>U&M4M+7"Y)Z`!*Q
M<AR&3D9.'A0!SCO:T]F[M#\A7JSV2.X"JS0YHJTN::S!GB1CE]<"4/T.#*7[
MUC5:Y4145-E75+$)B#@X*I!'@1U%=]PK9()Y\;,'J0L:"O:K&HDJ@F"@`0A5
M1%%4FL]4CI1HX0D5ZS02JJ*BJ.WJ54;]\W5V1TY?*YX+GO<"?CT/SJUE8L#X
M#,'O=BR.5K1=7#PJ4XLB?8UE<+7W@=K7"I)^48D#4>.\`=T<,,P!TJ>G?&3"
MBHJ(NZR)TJGAK&QC&EQD@(R"/*3J#=5%<'E<?-!DOER8C"7$&/N3XIHA[U6^
M/)N0^2[&\Q;'*[%;2BJ[00,6UD\H4RC%:,XB2L(&C?%%(YL"-67Y5:]K]D7?
M6/,''83,:><R,E<TG;J'%=5\3IVK4<UD8/"^G-E32^O(V[05!)ZC5!5I<I46
M$@$8B358S;XU:S!E4.8WU9*PN*X-CZP22C18%?'%Z9TG5')MX(U/N;ZV?'S9
MF3]TV29CH00YC3T&H`^/451X7.R\1F9]Q)ZK#YHVFSFAWB:E?@[/B.+\RIL6
M8F,7N#R4UC6G92?*MAD)2C?.(KRT>Y))2GDK$UJM:U$;L[X:J\CA1\ECSY1:
M^/-4$-'E:/EV"+6A]S<<Z7%^];F3>JYP+8P/(%U7K439[GM<?G<57D][)2XT
M=9'`8O60S&-('+<2I",D.A:X.%I3U5K51W2C5V76TQ<"48)EQH@_(#07$@(;
M)IK;6MGAN.-AICXX=DM8#(>XJ3.S3BGF>/NFON5)K&Q)X?EKKBJA60P>(8NR
M;#T0/?6HYLS_`"$<U&2=.R[?%=:_W%G<8/;\''[&_P"3!:50J!UOT6M?[JYO
MB9_;\?&0A,\.!([=[Z5NHU\VKY332E-*5"?<=D(^)\&\GY$9CN,9<'48?=&E
MXSF<\`V+W@T`<KYZVYG):\>,(N)%8]7HK=E\4U%WTFU29=PNE:[O;U[\.W;F
M:[@XIP[@XKM_SVY"L"Q:JOP]:[",O9BXR*?)BV3``P5MK``$Q7,1RM7RVKT[
M[:D%(7M7KAXUL([@^WS#>Y#!_P`A,TN,SH`6'16`]O@>1S8QD`TK&NBFBBL(
MX"F.&-%>^&:-\;D?&]R>"KOK!)CQR30S/4EBA/RN:X(YKQU:X:C]]98<F2!D
MK(T\VTKU:6G<US3T(-UK3G[KG%."\.\>>V?@6!40M108EWU\`X]4HD<4AZUX
M++../U9_EMG*FE<SKD<Y?F>JKMJ]FY4V;/)E3D&5W;0`!``.@```':JF/$V&
M,L:INI)U))4D^))4UO\`H_\`EQ_[C?\`A36"IUYZ4J`^YOMLXL[MN%LSX'YC
MIY+C!<V#B&L8Q96C6`9`I,1@-E6E.CE08X(N!CV.Z53=-E1472E:B?9$]M_M
MT[5\(RWG'`0;VSY+S+(<_P`"+R'(SH#)*W%L8SJTJ@ZRJB@&':,A451"\AZ]
M3I'I]B;)KP7J3AM*"M^6O:C32E-*52;>^H\?@C*OKFII!I9/)B)M[$.M@DF5
MJN2*.8R:&-\BM:J]*+OLFE$72K>_I-XW_P#>#A'_`+64/_G^E>H>QK%?O!XZ
M[;^YKAVZQ/D3,L4G;CD%CEF,V%7F5"/9U-_75)S8"!9/62)(PB.1T4L:HJ2,
M=MKF?=/M7C/=W'MX_DB]K6/#V.84<UR$*%!!!!(((N.Q0U]9_1S]9?>?Z'^Z
M7^Z?9LL?W$L)AFBE:7131%P=L>`0;.:"UP*@WJ'_`&RJ+@3BCM-XKO:#),0J
M,EY2P[&\ZSJ4_+:9QY%_:UL<\L#VSF1RCC!)(K(XE1%8GQ\=0]J>T>+]H84F
M'QQ>XO=N>]Y!<X]-```!8"K'ZS?K?[V_7/W%![A]X/B:88_3AAA:6Q1,U(:"
M227&Y))-;"/Z3>-__>#A'_M90_\`G^NIKX\A[&K@I\@H<AAE(H+NHO!X)$AG
MGI[(*SAAF5J/2*64*:=D<BL<B]*JB[+OI7B$:U5]*4TI32E-*4TI32E-*4TI
M32E15SI^9CE7]'V7_P`0'ZB[2I-^H5\F[7M2K__7[<WM,_X<W:'^A7$/X`W4
M1J:D[4?"KSYPO*?$>6B"2X<;L;'*^.D#!C.,B7(*QU059.:M96R;NG#G0MTD
MCD\&JQ=_LUTV!$[+XQD>V01Q9"D@>7S`?4>AM:MMQV+E9!QWQQCT&27/X=:U
M_NY(!HLXQ?CFEMKRQL<L/K0[;Z!UN!JIKLID0$:.25BE/\U.J5$8O@FVNICX
M]\N)DYLC&".,$C=J0T7/R&E?6\W&BDQ1GY&!&UT35&\!7-&OS[5=S+P#,.0T
MQOF07Z'2\.V,_IKU("(1,CLGS[@7H\0WB3",0([K8YJ)&]CFO1-8G128W'F7
MBI-\^6+M)^AHU:5T)!_?:N;Y''R6X`R^!Q]QR6W`"EK3JT>-2YR7EX&-Y;=<
M@!G5]YCT,.+T$<TODP):G3`SRMGK(55K)'`0O8DR_!RM3?Q:FM'!BS38D.&U
MA&2KG)V:HU^)TJGQG%9W(\=_BMNS,#BY'*$;XGI>N&'R'#>`W^-CS5C0LE`;
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M;:L#D/C;#"K*L@L.3"Z"^A$/O+V_GC)+;=6O5$A+:]7_`/4-!D>](1I)NAD2
M*WX>&MC@9F4TROCPFOA*-:VPVCIX+U*:U<P>4S&<6R,<.!%N&P!`6CKN[VK*
MO&,?+I:B2PQ1P-G=61P2EE3S1+O2#1O=7ND294=*%Y,CG[/W1LG^G7/39<;G
M,@R"X1AIL!^8_5\_ATKC>5SHLSDGMSXS'CD$1V2_73Q2H+Y3O<CQFPLRL8QX
M]<HNLJF.,$6LF/ENHS:!187U+5BE:M+4^B\B/J5&QE3RN:FW4NM[Q\6/E,A9
MD3M]".-!=-J._-IYBJGN`*V'#X<0QW-R)@,=H*.8;*J@.^/\JR'P>TI)N.>3
M&977/DO1(Z*QJ#;,X6229"(Z\,P2K;YRN(B#(\U9NG=D:NV\%37.9<,GW^$<
M=Y]-VX%%0`*03XD(G>M)R,>7'SO'?9O:<-T1#RQ;.O8VL=*B"OY/R['N08\:
M!(GJ,(SBO`B=#'4K:12Q@$O&F],6QKWL(%A?O*CEV^??6\/&8V1@.R)PTYD)
M-]VVY"Z=C_*K<_&031-GVO?FQN[W3_K5)R^TN*YI1F`T]/=VXU_)99,PBPCE
M0,:1K0ZMY8A!#4$AG:QQ#(F-3YU5^V^LV*V"7TQG2.9$6@,("*1<H1JFB_*K
M3<6-S)(9I"V5S/*"JKX>->ZR2.P+K+YF55@A60.K`4AN[:*H!A<QCDL)6,<K
M&HY9/G<]ZH]&_P"M-15[3+CC$>8HVN*M:7$]A6/`?'@1.BR(B\,*FVZOT'$J
M_#;FVD;0-SJWNH8'CDU)@AD(,`K%GD52)G(NY*O5R]"K(]K4^[JL_-FR(VB2
M7THFE+J"5M<=QTZ5L<K*&9%C38I,4#7></L$Z(*L&D(N[2GL\;S:C,PT'$K[
MZ_3&F#JT8ZTFGE/4`)[U_!3AQ3IUJB],S5;\535_)CC!CR,.82RRQ[7#LW13
MW7]U7<>;#Q^4^YAE;*Z1FT;;@'H3\ZDI:W$0VWKX;AMM6A3U90@!'GL),:4D
M?U=172?_`*>!7(JM1?O$W36E<V0,BWQHXK?LFE;W'S.9S,C#8V+;E/8X.(0M
M!'TKX$5$]H(S-,I`J:YCIK&Q"6"$**5!Y#!HVS03O4='L69'B*GFNV7;XJNK
M$4\D44CW,/IAURFGSZ7TKM1C8?`\7#+FYT;7,4@*OFU`'SJZ*&OQN*>7BC%L
M?O\`SL8PN&[M#W,<RH,,FR.5I=6.<V18RIH9$:Y8U7?RW;ZRM^Z$?^3R98]D
MD^QH_,@9J1T'CWKY[R>?,_*=D<A./[SB6$7`"#ZNU<LK,KK'[N!E/538[:ER
M5].@M$"0"I,]I*P1E[>VD"L"BJJV%KE(ED<KHVHB_#5B+"AGC+I'[FM4JX@H
M!?:UION/0#6M/F00'&ER)7,R=K2X7#M/RCJ#5;P^/\O4S&TJB#ROR0M3JZ.#
M(%DK:6[K#1O2,)*&ZO6S2LGF<YDD;51^S7;Z2L;@F!KD`E`/ENYK@5MT^1K6
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M]O8M(#M?S?\`I6OY/CV0\,_)EE!R#+:UT\36QG7*UQ=-*4TI6KSW5Z_DV][>
M[?'\&KL\AH3J+)C<VR_",DH:1,9KJD40P:&W"ND>ZU$NE22%$B:[RD:KG^"Z
MQO51:U98T\U[U"OL^T!UK@^29KE1%]D=B/)7@XQ:Y/R3QWR4VF!C!4(B#'V8
M.Z1F(NGCW81!*V*9_P`'(NI@V1*@ZL[^^3NOINS3MUSGFHZKCR2ZHZ][<4Q)
M31@9LDNWJU(Q&2DSCM\@6%73S]+NORHUZ45536OY#..+]O%$UKLF61H`)0!J
MC<X^#0?Q2MAQN",V63U'%L#&$DCNAVM'17.0?C6A7W`>_GASN<_9L<?TUB7!
MS&G=KVR\CYEBX]%>)C]+'?5<9Y`E?E<XB4EHHDUU''M#/([X_<76\Y+%&'F9
M&*QQ<UCD4A%MK\.WA6DX[)=EX<&0]FU[PI:JH51/B.OC7:EC_P"7'_N-_P"%
M-5*LUQ+/ZDM;8?1_1_5_0E_2OJ*S)7_4O3R>A]<H[))T#]3T^:K&N?T;[(J[
M:4'CI6E;OQ[RN_'L)[>\P[B\_HNU3*,8QFPJJX>AQH[E6:]L2+RU@K`8V>NH
MJX"+RU(1\CGS-:B-7;==DU'S>%31G0FM-'M+^\GW(<T@\E\%X-@/">,R<88/
MRSW#6%QFLV=3-LZ(*XL<OR>M#3'!;-4.#BLU0=KV,25&[=75I<:5Z-KE+JOC
MLW_^)MS[G'NKP#@_E'@_%*G#N0,I3#A;_#2;62TK[$ETT%>>\:S*=Y@<I$;?
M,:J=;6N54^&O;C6H^4Z5W$XWI)&R1OWLC&O;O\=G(CDW_P#D77M1KSTI49<I
M<.<:\TTP6/\`)V)UF7T]<>EH&!:1NDA@/;#(.A+&M<W\(D,KF_ZETKT$C0UH
M'[^L^[4NTCE:EXGQ3M3P;*+9^,5V57]A:M(%$A%MBSQP0@/*FZIIECKWOD<J
M=+>I$3QWU\;_`%!_4O*]J<M!Q7'X3))/3:][GJGF)1K4(Z!2?%.]?O3_`(P_
M\/,?]<_9/(^]^;]SOP\$9DF-`R,!SBZ)K"][UT"O`:!<H353[@,M[,,*[,^,
M>?<;[7L:-O.<%GQBHJ"H7P#8_;1U)LU\060A'7+%7O%D;`K.KS'*U?AOJQSG
MZF?X_P!G\/[AQ,$.R\P[0UR[6%H\ZI<H;-[JN@K5?IU_P_S?=GZZ^_/TGY;W
M(V'CN`C,LLS`KY8WO:R'8U$#G!X<]4V@$:U=_M9<7=HG<3P2)BUQP#C<&7<0
M@4N*75F1!+/'D,4036"W*3^:JH42D>\S%1-GKX>&MO\`IY[V?[RP<M^3C"/,
M@<`[;])!N"/%-:X?_E'_`,=C_P`?O<7#XF#S)S.#Y"$OB<ZTC"PHYKQ^\$=-
M;UL__P"P/M"_]Q^'_P#[+)_];KZ(@[5^6=[OZC4X\5<*\8<)5=G2\78A5X?6
M7)[+2R#JHW1Q%GQCL$83*CG.WD0>)K=_N)KVO"2=34IZ5Y32E6_DN68KAE;]
M9S#)<?Q2G]1$)]5R6YKJ*M]5.CU@&]=:$BB^HF2-RL9U=3NE=D\%TI6GOW"O
M=KQOM7,PK&>&Q\-Y<R')!R;:SLZ[):RZQ^GK!I%':+(11'E*VT(G5%1C]MHT
M5=?9/TP_2^/WQ!G9^=FNAPHG!@VB[G&_6R`?OKF^?]P#A3!&V'?*^_9`*H-Q
M[R^$#=E%1W$UV/U$O*MI>38A)Q=+>5_J0[P,J&(FWE":<MNF.2C2I+%,L?S.
MW;OX+JWC_H_+)[_R?:3^0_\`!BB$QD`\WIN^D(B;EMVJ+_<D+>%9RS82KCM#
M?]P*&_:I3]LGW*S>^8OD/$\LPP;$<RP:OK\@B?4R2SU%G1&&)7S.5\SW/@-$
M,FA3I7P>R153[U=4/U0_3*/V)'QV9AYIFPIW%AW6<UX&X?$$`_!/&I\!SPYD
M3M=#LD8GB"#6V_7Q^NCII2FE*BKG3\S'*OZ/LO\`X@/U%VE2;]0KY-VO:E7_
MT.W-[3/^'-VA_H5Q#^`-U$:FI.U'PJC]X5)@TG*F(7UO*X#*(<?C!KYTF)9(
M<`PNPFG&8V!=F#OE(9%(NR=;GM:O@FNS]ORYHP9X81NQB\EPMJ@O?P%OG76^
MWLK+;B96.U@.+O#B>H-8U&85@E#G.*9D\D/'>0J.B\_'7&M?&3)(RO-C@D4)
MLBP3$HLVS'RM7I>UJZW;,G,EP<G%(+\-S_.FB*#K\KITKJVY67G8LF.Z%SL2
M25H=X#X]O"J/>SWPM;9/IQ:FSR"_K:^9Y.0H1-%6!BO1#IR84C5Z&%P$2++O
MOYLF[D^[I"V)[V,G#FPM<4V)<NN`O8%/@*W$$$4+U@RBR#'/T=TTJR>2>.+'
M+C\8Q.?+:^F$#\FR%GE<036RO;#*K(>B#I<DTJO<K4>OP1N_QUDPLYF$V:9V
M.Y\A\IT!U\>@M6]Q,[=AY6=AX>Z=Q+2.H_W?"K'!M,W*S860,6S%I0G5V.5M
M@X=L(AE6`*\9\SGL9YDAI!2ME5%ZM^I45-DU;R&8;<.4OV;B"XWN'$K^`%J]
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M,;%=&V,$T9$M7"R5)G1SDJR9S-^AJ)]BZ\?BS!T4462W^\%!_I`T!^&G>IM@
MFD<8(YF'+G\P<$0)3C6QQTF,O(;D0T*DKVG2!C^9,ZS%4I7O?`%'(]%'E.1B
M-:BKOTHFH9L4\>W';*#,]%/Y2G?X5FSX\KT&-PD=EA`Y.XZ_"K:IJ+%\DML@
M;+235Q&3S2_4)WRR0N(&K06NK)INLCYR6QD^7LWX/;NOQU:?+/%%C@3JV)$'
M0;CYNG@OSJ>;+E8D4,VQKGAH4V5>M4_)<>Q?%(\7Q;*3@;D><DG(`0[%&QC1
MACP*.5`:7"J2QECI$BJQ5V<BIX:M09&3DG(R<5KF[6[5;W)L@\:U44XR3.]D
M1#WA''_2JIBU"S%<BM,PDRUT6($#SF1AHDKRZZ6`5TC/*5J*+'!.SI8U=U16
MIK!DS">!F+]JN2#<V0W_`!6LN5)+D1XV)!A_W"4)6R5>N'RBVO&YQMV*`0/D
M'U"0LCZO)95S@VV<HH[@B2'JZ.S;`UOR-Z>ATFWP1-5LDO;R#68[R"P-0;4*
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M%N4-)T"=*U<O%29W&9;X\@."V<?RA`4`J8<@YTQK,)<?PTNOQ_'3<7KCC,H+
M6PK:AC*,1LC+6YM9")HGCBO%B='&KT\I953QUJCBQ8#IYSE*QVU`3]!/T@]K
M]:X_`XK*X.'-SI.0#B#Y6&Y/9!V[GI6%1G>7Q+Q#W3/XGM+.^*X7DKJ5L6:Q
M5$I0=!E-\#*31UUKD$*I'(X@E8DB3JEB<QR;>"ZSNS\;D<=F&`6<TZ8QA0C'
M%J$M;_NVWJKR&=C2X6+OW#F7(X@78UKRC5/3=H$J^R>];M=Y`YP`Q;';:T"N
M*\"SDL>0+J`NMPC-KG%`XK>^I0<@]0Z*<NG!6-CVLC:Q'.1/MU7P^0#,?-C>
MYPQV;BU0+M;9[F=P"JUK7<@_`=)QN:P;GR!C7-;N:QY`.TG^JX)^-</"N\+B
MCGSDR";C:YY%H<NXF'FS:HQ6WH!(L;Y%Q-#/3F%A'2RK+;4+WOD:U[V_#X)M
MJSQ&7!E0YV))%&62-#7;E:]FX>1P'1;5(2P9(_Q#6ESLDE)A9IV?46]]I"'Y
MUN3X`+Q.[Y"K<@!0@6^LJ&8PBG9`X8.IA)B5[8&,:[RI&;+\KD1=<GRSLF&,
MXI;NQ]WUZJ1^^M5R\D[.%FQ9(QZ;)0&N[_.L]M<_7!TTI32E:WO<PYNR7AC@
MZR("/P^AQ'):#*Z;+,FR:RL`3::0@$8:C^BQ!55I&3*664]DJR-1&-V5-]0<
M=!WK+$!=Q516*WLJ&<9)AO+-5@>/X8%9PVU3993D>&Y+E63C9-868ZD(8<7D
M5?600&-ZUZHAHFL8OAJ0T':HO12:V\<N\*<5\\XB7@G+V$TN=XJ8DB2U%W`Z
M6%KY8UB=+!)&^*8>;H79'L<CDU@FQ8,@L=+&"YNAZC0V/RO62#)GQ]WHR$!V
MHZ'XBM*GNV<5<<\68G[;N-\?X=08O4X_WV\`X]51UE>/$2/35\=C`(`ZP<QQ
MY$$,<+$1))'?>IJYDY$V3(Z>=Y=*=2?`(/W55QX8L>/TH6!K`53XE3^^M_4?
M_+C_`-QO_"FL=3KSTI4&]QO;MQ9W5<09;P?S)0-R+`\R%B'M`4FE&(CD&(B+
M#,#*@>R88L0J!KV/:J*BI]S2O04K"?LC]H'L[[#R\^MN),4L;*]Y&HC\3R&W
MRJQ)MR'8G9*B&8^,R>5\4`13$1LO2B.D1/%=>)WHO:HMX;]B'L&X/[CQ^Y;#
M<(NORIJ;PO),;Q\^\/+QG'K@Q)^HD("4AR2-'<0Y862=38UVV^":)^%%\+UN
M;1$1$1$V1$1$1/@B)X(B?ZM>UY7[I2FE*PJ[F.PG@/NIR6CS#DFG/3):0"*H
M;;5)Y(,YM/"3,5%7F)#*QDL<4I$G0Y4ZFH]41=M</[H]@<%[KRH,WD&O;E,:
M&[FE%:"H!^"E#K>OT/\`H_\`\F_U._13B.1X'VEGQ?X?(E,OIRL:\,E+0TO8
MH)!(:U1H4%>_G'L]X+S?MKBX9M<49%AW&N/E6F$PAD$#ETEG1TAC!382HY&S
M22SL5R3=:JDO4O5OJQR?L?@.4X+$]OS8Y;A8Z>FA(<T@(J]5&JZUJ/:/_(;]
M3?9GZC<Q^I_&<UN]R<B7_=%[6N9,Q[@\L<TA``0-J`;4LE61[9/%&"<>]H?#
M^2XG21UMQRG@N,9UF)BRRSSV5Y;5<4\SUDF>Y600K(K8V-V:U/LU:]L>U.*]
MIX;\3C&'SN5[G%7./1?`#05J/U>_6?WK^M?N"+G_`'EF-?)%'LBC8`V.)FI#
M0.YN2;FM@NNFKY-32E-*4TI5C\@\:X'RMC_Y*\BXM59?COKAK+Z1<0NG#]>&
MV5@Q70Q\:^;"V=Z-7?X.72E:D_<?[!.UI_;=>9K0\8U&'Y+AV0\?QU=EC+B:
M^26#+.2,0Q"T'-8A#F%1?3;V5S$<B]$B(J:[KV=^H7N#V49F\9*'8LGU1N"M
M7N.Q^%:KD^&PN6#!DQ^=NA%C\*R9/]KGLQ-XF9Q(WB:L%KHJ]@462P3F)EC9
M6$*5ZY;A2?.>4Z95W5?!6_+\-(?U%]T0^Y9?=0SEY)X`=8;2T!`S:B(/XWJ3
MN(P'8`XXP#[8:#Q[KJM2#VB]C/!_9C5Y()Q16&K:9:\/Z_?W!4AMF8/7NG>&
M$R21[VCB1/(<Y6,V1[D15W5$UB]X^_.=]ZRXSN6D:(85V,:$:"44^)MUIQO$
MX?%,>S%8F[4G4UF5KBJV=-*4TI45<Z?F8Y5_1]E_\0'ZB[2I-^H5\F[7M2K_
MT>W-[3/^'-VA_H5Q#^`-U$:FI.U'PJUN]`7&R.8N,67?IX+<BK\C'39+`IB#
M1(?+(<036CO\LB`>=D3F^8G2YWW>G7<^VG9;>.SG8[?[0=YK"]K`'45V_MH$
M\9GEH5'!1\1:L3LIQ.AR+(ZS)\HM3H(JVQ'&0AI2N2?T4KWCRRDS=2P"D+(]
MJL:K?LW39-;V+*F@B?C8\0<YS39-%\.M=IQLS\?%DQV-"$+7+/SW)!\^J*:P
MHXV@3T%=+ZF<>0I09)&ERSC330KY%BYPR1N<K^KHZT:FVRZQ#%A^R?*V4AX<
MX("BH0B=KUFP\/%EQ<K,];SB1$[CJ:@>^Y+R:SRW':*"EDJ@[BV(!FL3`YFE
MPQ0$(.QD<,J*L4<\*K(V3IW^7;?;;6P''8XQLB8R+*QH*`VN%)^(-DKK^.BA
MPX#*9A)$6_2.OA:JGQ9R3D];R3<1H)*M/44M[C]*\TQ2*KU1CVPP6T84WF10
MV04G3+"1MU(BJFJG)8<#L&+^Z#,Y[7.`"%!J">H.B5YSOMK'Y?$QF(^.1SMS
MBTH=O:I"J>6J\C,#:W)88B\@A9ZYL[()(;0TMS9!P%-L(420@6-B(JM:J?*J
M(FJ+\)Q@$L9VXYMX`:E!TJ69[4DQ^,@CXV5WI@`.%C8)?X^-6[R;C#+\)HHQ
MK&C(P>QFLIG>G9"5$261.%-.DL<I()$A<;Y(G*G2^%%75K!R/1DW;5)4`"]K
M`6Z$(;^-6.-EDV&25H]-HV[?@$)^-JN'%<43',+KG+DQ=@JC`1EUH,F\-A#$
M5`D<K'JUS$2)$ZWR;KM]NJ\^0^7,<#$&W-R-*JYF:W+E>(,,"]G=N]6MQ-R5
ME1A^6X-D>.QA3P+92&W73(QQK1QB8[,0U4D?"6V?I1T;_'YV]3/'6QS>/QFP
MP9F/D%VY`G8E$([)UK3>XL&.%V+-`\HTC:.P)%5K%L0(N\PL\X,R:2*ON:44
M.FH)FJO6ROBK@@K16].Z)7O?*Y\KDW<]V[UWVU"7)$6+%Q[<<*QRE_5222/G
M:U5LO*CQ&`M87N!\Q51M.M7KB&)QT#AL6N;6TL,G(O;!)2[M/K+9(I2('`(^
M5D;QT!GDC=(YS_!&)LCD^&JF9,_)!GB:&P-8W3R]"#K=0/WUKARV,V5[\>(C
M'<U%4J/@:_+^PJ)@*X6-\<%Y8Y1Y!#^A(Q93$8@=>WRUCZ)&*_=_1MMLJ:A%
M%)N<]ZNB:RW@-36WQY)H9S)`\_;>DKOAUJW[[(;?BK&`);>A"MIFRV3K:UKA
M&D.KRSRI8P('2R.D7RO011.6%-MG*J[[:LQ0X_)9$@AF+6@!`2B@"_[UO4,2
M(<K*]QF+7]`3J!UJ)<KQS(LUK(+BRK*9*>TBGL/JQA3@["H)].R.$<"9Q#8(
MVD3L;YB*USME\/'6UPLG'QG>A%(_U6V07:0MR0BD@:5(O9B9[R)@2T(6I8UE
M0'7X77X+0158JY#D\E#"+85,@4@^.#UC$1LML6AC$0TB.-R_,KE143X:YZ9^
M1-FS^J\QP->2'+YB?Z0FEZYJ/-Y!G(.+`6P!_E.JE=/E4;6N-8\E-0N9:-JW
MA2G'CX]3M2"G'F4R-XLAH+XVCDQV;H&NEV3X-16^.LT63.))2Z-04!<;N-NA
MU"5UBSY+\A8@CP`YQ0DA.AJQZ'.<M)Y%(>EPR*A(?-)9T[0A5&GN'LD%&]*I
M$:S0LLD1(56/?[/AJ]+B8;,.,C'5XT=>PU*IJFMZLR<5ACCI(RPMR0FTK?;W
M'PJ.^9N2<E#SMIF`8ZF#U%V\%M^-B58R&6T,&CB$E=;E1R>>CY4C7X*B(FRJ
MGQUL.*P\9^*6Y,@ED:3M+RH:#?RC2O>*X*/%P9!G9;IY-JC<>O1*R*-K<)8'
M899=B0NO@*&JL:16R/L;">=!HUGBEE1))X7+.N[FLV3JUI&.GWC&CD2%SW!W
M0"_2M<W*Y`&./$__`(Y<=UK6UK3[WB<+\K=PW=;QK?87PMGUUPWAY6#81RY/
MC]A-C-IS'C&19",?=XX$&*4,P^JQR)4G)<]$>Z-7;KM\.:AX_?S(RL]I''/>
M&.:7*W<S<8I7A?I:_:O<6KB_=V1D2-B]*-S3"TND<UR$L>X!\;?_`,()O\JY
M'(_$W,G(W=B3QSR[P_E_'G;K@<MK7<:18]7U;\7R_+JBE-`Q+*LYM!3GENJ*
M%4&](U6KTI$WPW5RZKQ_><UD9O(;'-Y%D4H@:?*UKRT@R'3^X[H1I;H*U_K?
M?\Q@MX^$_P",B,9>6ZN#2"T7_(WJ/C6,\7;)SWF^$83QNS!BL6'[>./.=*8R
MQM":Z/\`+SE;DG(KVQ'-HI`B7SEP28\^O@;/,B*U6=*KTHFKN/@\@_CQ*Z!S
M7LQ6Q-8Z[G*XF8KHERE[U:AXA^6_(Q9062-R)\@R$V>][`V$#P;M4]E-7UQ$
M-R1QIG5?R]E>#&8S$#Q!C'"6#8MDI$,9A<=8\>+(K7Z;5DNGA$G.A>T=SE1'
M([K5%UVWM_A&9?(<OR4K71,E<P-8`/*QC0BZA20NM;CVYPF1G9'$@'T(,"![
M5*>:1^XOUZ%2AZUVD.T:TX]RW/JS)/KA4V?P8%65SJ<8HEE0+'#`_P!5'$$Z
M&.)[FL?U*]55>I5UQ_/P9N+BO@$#1@^J2'$#<5/=:Y+FQR.+A9&*^/\`\(S$
MJ;W6R&MFNN+KBJ:4II2L,>_D;'+3M@Y5H[:_XZQZYL\2M_R8,Y(2B=4?5!8/
M/8D3+Z(@=L^[41LC6.=$YR.^Q-1?H.]3C5?"L#/9KY"N>3`>=<C2''JC$(;O
M':2EQO%&"F8Z%94E0/6W-E5WH%15`'16Y8SIG1Q(](GN7==]250.]>.UK85W
MJ<Z<B=N_"%]R;QICN'9/?4*/.(K,TLB@`):H*%Y1Z!0`&`GV-G)!&K888G[]
M2]2HK475+*RSB28[G,7')\Z?4B@>4?$W)LT7-7<'#^],D37).0-B_2O^X]DT
M&I-A6@3W`/<)X1[HCO;BXTQ^R.&YE'[NNVWD3,L3CQ[(F45)!<`H40.!E1E>
MRDM$&FN(V(V(B1_BN_BUVMSR>&,'.R<,$EK#8G4@@$?QK4X4[LC'9*]H#R2"
M!T()!'XBNU?'_P`N/_<;_P`*:IUGKSTI32E-*4TI32E-*4TI4=\K8-:<D8-<
MX?39]EW&5A:^D\C,\%+A!R:I],7"2_Z>21%-%'ZID2Q2;M7>-ZII7H*%:T3>
MX[B_+W:'P]27=+WD]U&6W?(>0%86"-<Y?7)3!0.IC3[$L^.`!DA'4+$L;(^I
M$<K]U\$U\\_43WAD^S>*Q<K#QV294TI8-R[6@-)+D&IT`'BO2OU+_P`4OT#X
M[_D#[VYCA.:Y:3$X;CL(9$OI!OJR;I&QM8TD$-"N5SD4`6UJQ_:UP/D;N'X8
MGQ1O=WW1X')P]%4XF%78YE5<S'GT<8O34L`BFKWJ,X0:-L;H^I=]M]8/TX][
M97O+"S79V,R/*@>`2Q=K@ZXL="-#6P_Y8?\`'?C?T`]R<)C<#R\F5P7(PN?&
M)MIFC<P@.#B`-P)N"GA78*XBP"UXQP.IPVZY#S+E.QK)K.6;-L^,A/RBT;86
M11\41Y0\4,4D==$2@\.S4Z88FHOPU]*%?DHE2J5)>E>4TI4$\U]P^!\"Q44N
M;AYF6S(7EQ@?DCA629@YC@VQNE]8W'JX]0FJDB=*R=*.\=OAKPN`UJ0:7*E=
M?'N>]]7D[".>2<8X<P&B_HUQ.P@%LXL[H;FNRC)VIY3C?4"%SA'4+6IU-B:D
M<<GP5V^OU![,_1#AN:]K8O*<IG2_?940>S81MC!"MLESHJK7!<M[MFP>1DQ(
M<<&.-R.55/=*YWN1^Z\%EG!V"\<\7859BD<HU>%9GEY^:XW?5$=.M!=8]FH-
M9CDA\8(]U$ZZJ862$QI+"^!%Z5^;?6E]B?HW@\UR'/Q<[FO.-AY#H0(G`%Q'
MYB0"0$2PZJ*N<W[FDXZ#"?C0@R3,#O-H`?#O6?O:Y[LG'G+?#6.9CR5AV>4>
M;S2GU]^%@_&N=93C"E`$+$PFLM:VMLX%83`K7/B69SXWJJ+LFVOE_P"H?M:'
MV9[GRN%@R'2XP8U['.3=M>%0H@4%>FB5ON&SCRW'PYNS:7*"/$%+>%9"_M%^
M`O\`U-S3_4ER5_-W7#[Q6T]-WA67_'F>TG)N'T^;XY%;P4]Y#+,%%>T]A0VC
M60SRCN0JJM1Q3Q'+)$NR2,:JILJ>"IJ0*WJ)!!0U>NO:\II2HJYT_,QRK^C[
M+_X@/U%VE2;]0KY-VO:E7__2[<WM,_X<W:'^A7$/X`W41J:D[4?"N3WJ4>$5
MYV.YKF-[68Y)-7%4M%<RTEY=VH9PKUG>V"&J#,CC"5IZ/=UHBND1$\4WUT_!
M\E+C,?C,:]S"[<6@@-(\5ZVKM?9V-RV:_)Q^*PG3N:CGM!:+=-3X&L$D"XL+
MQ(#$+_FJ,@^SLH;(D^+$<P2<XB>>1T.P\M.UH\"CR;.\&HWXZW[^:(R#EP\>
MX,#4`5MM/&N[QL+W-CSY.8WVS,[%#7`A6G:@OU_#N:KU/F7#-E97DKN:A"(B
M@HF^1!BF6^?73S$R"O-&6:F3TTL\X[&N:GRHW==MMMZDV9(&L8,!^]KBI4(?
M#6X\:RYG#>YL..$.]KY+%);^5"@!(*'5#5*GN<'/R8Q<CY>QJS('&+I:">/"
MLTB."@+='$^8I\&/,'D/B-;'T.1RHC5=]W7KLR/T(HL;#E:5#G*YJ$CLKNU9
M\;$]PP8\.1![:R_MR0Y%;V46W*`BZU2UJ.%N,:%PEOS!2#P"2R6)%I88QF$A
M3X9G-&'A(>E2K8T;*]51NZ*NZK]FO'YN3G9<<<>(\R/"``M2USUKHH>:]R\@
M?5Q_:F6Y@\EMJ6N2+W'<Z5;EQ;<%&`UV?)S+CL`?ES0.N!<,S1)U2ME\N%LD
MD5)(]L4$C6HKG-3J:FZ;ZL0ORF/?A'"D,@/TES=>MEJP>1]V-^\P6>U,H.`N
M"6=>U[KX55,ADXOY2HB0\4YEH1@9#9AY#&8AG7IB3_2`1RP13K2>6_=!$ZUC
M5=G2+_M+MKV#+?Q\[3-@2>H!8*W125U\:T6)G\[Q43QE>VLISW(4)8K0510J
M@?&JX!1\;_D+15=5S-%"['6/-LB'8IF,,1JEPN'>(0U:=Q,=9\W6UJ(CG.1-
MTVUA=RX=D33RX3O/XML/"^M5I9_<C<T[_;4_]PHUK=IN.R%%JH9`'Q@-6@UM
M/R=#&80^GO2VF8;G21V0GF-(:CIPJ:0QD"#*NVVVZ.^=-EUYC<NLKW/Q'_20
M$+;+\2FO_2L,CO<&5#/D2<#-Z3'.8?,RSF]$75;?PJZ[^DX6,2GLJ3DRWH#,
M:L6R`EQXUEWH9*<A$).JRH74[XY(YK!7.7P5&LCCWV7=-1QN8R&B<2X8?&\)
M=%#NA%^@KGH(_<LH=%_B7O$MT!;NM9-;'L.M4&GN>+Z)H<%KS!Y@H@K`+"R@
MQ3-VVA8\1!1$3)#):3H56]:HK=T\$1/@NK&5FOE]5S<$C=<`EB`IJ@=X5;Q^
M,YW((A@]MSF5KP0/*B?!?WUPR\QX3)?7'.Y8JE'&,)/C)=AF:(4XN&5J"R-1
M*-6-?#$Y&N3[?BFJ\6=(?5B;B2;D[M`1+]:W4?"^[VNF:/;.3OL"`6?2>B+7
MMM<^[?\`,21\*CY<J7ERN$<0,1B^:LD,LB9)'@3G]=2D#$3YHX=U3K1$1WCK
MV'(SL6(9K,)Y9<!-I`'7JM4LCB_<W&1ORLCVYDL:%*JU``BHA6RA:M^P_H^]
M28XCF7'3*FLL'SOI[+`\R:%"@RL3T_DP4[V2)!)N[9-]U^/PU99S,08TMX^5
MLQ:FX.:O\:G!Q?.Y")[8RG.E;]32WXJI-EJ[L0Y#X1(DE/L^71+VL65\9-?/
MB6:UP4->4GD^3`YE./)#\S%Z6*O0B(B_;JGE9&1(S^SB.9(`JJU5'=3>O,_V
M][J8UK(O;.2QY'E*M-^J!37"Y/S?MUS7)`)R.5:JLK1)P1:FM`Q7,HT?'6@L
ME%$/F#J465$D>V1Z]7BB[>.H8&7FX^.2S'>7E2XN+>IN@)JQQ/MKWJW$9''[
M=RWL8I>5:MRG4VN"E8_\C2<"%YAC^2KW!U^)UU&D"EAQ83G<<9!@$WK&2`2N
MI%B))W=N]KG+LSQVUN>/YJ5F+-C-XN2620V)V];7O8>-;R/%]X&/TO\`ZCDN
M(6^YB@)U\UAV[FPJZL@FP&3*:TREYJQAE.;,!8Q`F8/R"<TUY#T\U\AD>.NC
M3U#6+LG7LBKXHB:PX_+8[<<QR8$WJW:H+0G_`.:H00>Z,C$GW^ULG?""I5@(
M`OH7*?D*N#+,@XFAI7L&Y9QH#,UF:/43&XCR%'4P52(CY7D1P44I$T[9)7)U
M=*QM:C=UWWUC@S6;MTN'*[$:H<A83N\%=I6/`XWW=(7'']L9+L!P4@&-5\/-
M^[6I$P[,JX/\FUDYM%@)'-A6XEQ[",Y=6^B?$X2,BOG+QUK(;*>"9T;W2*QB
ML5%WW353*R\-YE$?'R>GM.W<6KN\4=H"E<GRG"<R?N9I>`F;T1SF;D_]NY2G
M@M1Y49UP+]#R["LT[@U(Y$R?-S"<2G#QO-T95T`QB/DI9(#Z5)YB'I%(QZHQ
M[%1?E=K9#D<F:3'S,3BG?9PQ)(#MNY/J"'2IY'M7W3AS8G(XWMB>/C6Q-#KM
M\Q/4$%$N.M7G%DG!%-AL4$W+P$%O1VCLEMKF3#<J06$<<B-T;(2)*7SYG2#Q
M^7)'(U4W^]U7'*32YB,P7NB<S:&J%*Z]4UT2O9O;?O";,]9_M[);%.C6`%JJ
MENJ)_&K+/.[6LESZAY%M\TPN\7<=N.+=XMR`]POE1R>3,!5-J(JTUJRJJN\Q
M%8G^O5MG*\ACX,V%#'D,UW(6774$JHMHE9)N!]\#%R,"/@LEKF_7MVK^(*UF
M)V;77#%_RWDB8!GU5D>2`"%DVM.#CEQ3M#&G1(V^5+95XK>F-?#H:Y41-<[S
M>1FNQ869$$C8G(0205_`FN8]S\5[DXSAH/\`*\7-#AN<`USTN?QK:?KE*^<4
MTI32E:[?<5[;.TCG_C>C-[L,X'XZI<"GL[/%,M)S5<3CJ;0U@22D^ED+B#OW
ML>'"J#RPD(OP1OS>,'`*"J&IM+@'`!1UJR?:QXDQ+ASB7*L7XL[C\)[B>(9,
MKL++#+7&1ZJ*XQ^2Q(D+M*W)):N*%)2U*E<YB2-:Y&;;(B:FI("U$H-*SPYC
MX0XSY\Q-V$<JXVS)L<4N$YH:FGUTD94"_))$76DB%1]355KD1^SF*J*BHNL9
MBC=-#.6K)&2GSU!&A!Z@UDCFEC9(QCD:]%^14?`@W!%:7O=TXOX\XUQWVXJC
M!L-Q[&A*;OOX"H*]U95B0&1U`,=C"*#)8)%ZXB&..%OA)([=6HJ^.K&3/+DR
MR9$[RZ5QN:PPQLB9L8$:/YFY^=;]H_\`EQ_[C?\`A36.O:\]*4TI32E-*4TI
M32E-*4TI4*<\]OO%W<CA#L!Y7QZ.^I&&QV8+DEF&-J[.&.2&,X`J!\<D,Z0S
M.8OBK7-<J*BZT7N#VYQ?N;!^PY6#?$';FD$AS7(0H(\"1VKZ)^F?ZI^\_P!(
M_<8]S^R>5.-R)C,;[!S)(R02Q[2""%`/<$6-</M_[;^*.V?$)<,XIQ]*6L*+
M<?8D2SS%GV1;NI&S&%3O?)(L;'=+4\$1$^&H>W?;/$^U\-V'Q4):QQ5Q)5SC
MW)K/^J/ZM^]OU@YYGN#WMRGW&8QFR-H`:R-O9C0``IN>I-3OKH*^:4TI32E?
MBM:[[YJ+M]U$7_\`#I2M??.'MD=IG<!RL+S#GV#D2Y9Z@8JZ^FVAE>!DTHDD
M3XG70D$K62NZ(D8Y6="O:J[JJZ^B<%^J/N[V]Q+N&X_-;]HA#=S02P'^DG^:
MUI\O@N-S<AF5/`LH-^BIWJ)_=([7.%L][6OK=SB(T%KQ-8<84>#&ULLH,U-1
MWG(^%88=41^2]&R`K26TC6->CNAZ-<GBFM?[;_4#W-[5R<W+XO-'J9!)D#P'
M-<XE=Q!ZZUGS>(P.2CBBRH58S1+$#L*V%<-\,<=<"<>4/%W&&/#X[A^.QRM!
MKXWRSO=.3*Z<LLD@A\LY!14[U<]SG*OV)LB(FM!S?-<C[AY+(Y7E<@R9DAN;
M"PL``+``5;QL>'$A9CX[-L318"I0\N/_`.8S_P#-3_\`%K55G4]Z\D1$39$1
M$^XG@FE>5^Z4II2HJYT_,QRK^C[+_P"(#]1=I4F_4*^3=KVI5__3[<WM,_X<
MW:'^A7$/X`W41J:D[4?"KN[WJ0RXQ_`/IL!!5@)>6TD8XZS.5X[PA?4.\F)4
M\U\2QL5O5X-\=;CBGACYPXHTM%?;?T2RH\7D><=/(QL!AC!+DL=SDN=%N+:U
MK#XYI)ZR;(,@RBU+LBQB"32Y)YVR/K*6!&CDM6/JZ8T12$:B(G5NJ(GQUOLO
M)88XPQ@8P"YT'=2?YU^G.;\[\7"X^)K,:0-#`!]<KKM"ZE4^&M1!QYRAPI-<
M9/\`D#DE=R'<OG/4RH"R$:2=D:$SR2SH-`0^9T">8_I5J=#-D^'AK.\3RMB#
MW-#&M%VD%!H%14^=6<J;_.,@Q8>6Q(D`)#7,>Y0`"@!)L@W*+K4LWG+O$&/T
MSA3K_'\+RY9JUPP60YE4#FL%(`/)'.F!L3X26Q^J@:Q'JWYE7=-]:XN897-=
MDL(:;A0+VM^!7X5SQ?+QW*MQN6Y3&&*Z)Q();&?J:VRD6(W(EO*1T-1U16%-
MF@^1PYAE&-WF$W!+Q8;D.['N*R>O9$KS'J96D$OE-KG3*Y8VNZVHJ?#PU=W^
MG]O-AAPD`4(.OAT3QKN(\O$R<7$R?:\3<C*8$+8]K@H(1MO*-R(5^-7$F3<>
MXQA<F.MEHJ:G#.N`*5F5Y%04L=N;6PCM`':EV<+ZL2X'FC\I[%>V+?J?LNZZ
MA(\C*A=-EC[EX#@A\R$H4`NH-C7+\IR#8.2&;S.3'CF9&O#E8T`*XEAL%85)
M`\SA8"KWN,HIN+N$["TR@W&\*KLAGH:,WSK8-L=3>WDM@:^/&;)\[*YY"H,J
MO6!ZJ]C5>B]+55(/F#LZ*-TS?5!=MWD-W!J:@W*5SSSQ&9SV-FY&81A-C=*V
M0D,9(UC6M'J*0H*^4'K9%-7'CW+W#%=BX!5MF6&A0VY(*PW5UDU;3#7U2+&P
M63TD5H</ZORV_-ULZDZD3=?%-5,W^UE.@E>&R@;MI(4`Z'X&Z'2JW(G)Q3BY
M[^09#B2PR>DI:F_ZE:[0BX!`-@:I&!954&\I6>25N9U/(6.CB**YE+D59;`O
M;8RRMB3:I-)B!?*,UG0.O2J(UR(FR:N.='+AM#&(=Q0^(10NA1;_`!%9I\C#
MY?VO%B\5/"W+#AN=&0Y'-"H[Q5?,=55:E;(;C'<'K[LZE,-O@<C*$+@%,/GD
M$K)A8#Q[0I(I7H^&"2:*)',79-H554^&L!?)D;&S-:T,&H"+\ZU7"\/E\CD8
MS<EK<?(B#M[@`K@2QS&]E`)N/Z@*QUK^6*')LA"CCR'&K_!4B6;(2:6^K;&<
M$I61ML!EC!*F>.0YKH611O1'JY5VU;CA;-BNEQSND5`1=O<7%M"I\$KK8&8A
MASF\7EQ.YF)VQK6N#D*G:7HJ7#E5!9*N43D[@A(OR$!RJFES0ZY,DI*-]W5.
M)4-JPMC&*K%)=81/?$[S%:K4D<B>&JP8<C>^*1K@P>8`J0FNG;]U:R;-YS']
MPP-RLR!L?HM:\;FB3>5/E:H)O862KH&XZXS"%"R/()##\SDLAG6(U67*P4:I
M@>TRJFD<.O1UQS=3V;KUHBJW5D9V2Q@C@+1C;2BZD]4JAG9GN+E.2RL.!@9@
M`("]H4N/E>+]VH#T6]>FU0JCJ"+2VLZUL1A,90H+'C],L)JR>NF/(5720NCB
MW5-_CMJLP>HX(PK_`#Z5U.+)CSYL>#@02`1M+7R$.MM1`UNA4]JAW("9F8F;
M;8G,+>OBB\J<-J-\MDTTBQ,D'5JM:4V-%5R[[[-1-OCJS`UAR&LR"6"NSB,S
M,N''R<8M<]RL=W`"E?Z5[=:C2OR"[K+W&GU.,A6LAK@K/,D9(KA0Y$;$`1$3
M(V1R"OF!AVV9LJ.3?XKJZZ*&:.4S3D-8H9W(Z?OK8S844>'R0DG="9`6QG4E
MR[AM!U1QJ0<CCQOD5AV)&6+6OJ[Z:X'HI@I(V50;AHQV3063&M=)*0CWPO:K
ME5S6HJZK0NR,)C<F(HTA%[_$5J<-DO'YL4\O'&7U,5K'RAW_`''$DH6:`-0.
M!'<BO7BN=]<Z8U;7L9T%"R9*FN&%1I(P[5D8L?X.)'N<C6+TJ]WQU"3'>6B9
MD:!^I.AJYRO#84`=E8>*693PTO)<;GI8E$[I5%R-,RRIU+<UV1PPT8@]E'-6
MR!P.)BJA"(EF$222-)XWKY'6]7+U.5_Q\4U9A=C8\<T,F.LCD0K9>_[ZK8N+
M@8V2X;'LS!*TN()1[W"UM$Z!`@JY(>0"3J>VH,1NEE$BB!MK"E<3-&A(PLD2
M%0>H79T"/Z=FJUR;*J(O@NJS<78\22M2^OCTKW-X;&&9AYO+\</NG%\;)-HL
M7*A30IJ5&EZCJLL<*M+9+(*OF.N4-G!)L'$/(=3$Q;2/6.P>N['N(<K%\M5<
MW[?CK8/CS(('MDEVQD`@:*#X5[(99WP8?IQN@9&2@%G=$+=+"]ZE_*QJNIPB
M6<ZU<<XFOECL08WM)E:LDSY/%K$<Z61[4:C45%\?'6OQBN2P-:A)L=*U$$G(
M\AGR-9B>G%#(',)'](&BV2K5QEE7?0T5@T:<:4((6N%C*ZTGK8""G,FDA#D3
MRUD\ARJBHW[=9IRZ'UX?4!&Y;=;=ZV&4S)B<Z7T6[I-SB=`2!HO0**S7["UQ
MD;N#Y%KH6P#7<%1.T"&-DR$$TC9&=)=ANG1$8^7JW:[9VVVM;S/K'C\5X),)
M15_J[#PKX;^N0SG>R>%FR&#8[(NB(')HWN/&MR6N4K\CTTI32E:8/=8[6.Y+
MGSD?LZY`X'P/$.4Z;@W,<WR+/^.<YOAJC',GAM!L82B@L!C)&C64,4U7/NUS
M7HWJ^'CJ)"N:4TK(QR-<.]<_VS,7Y$QGF3NP_I,P#C;A[);.VPXXWBGC*RA-
MH\=E6ICC0UT03&5PTUE$QKU2+X[^.O6Z?.O'F]9E=\W/>:]M_`]YRA@\.'OL
M*<H9"9<SL'!@-@D>C8Q0!8D<5:V]F0K!QQXFN<Z21%VV15U4R,A\&1ALV%T;
MWH0+O<;(UH[GJ=`+FKN!AC,]=NY'M:JFS0!]3G'H&B_B;"M!ON!][-ES_=^W
M5QMDW!O*?'>7A]W?;=G-[DE]CA8G'Q)MJ$TF>IHKZ6)(#"6.M=T8CE<B,<B^
M*+K<\ICPXF=DXT$N^)CD!^6GQ!L?A6JPY730"1[4))^8!0$>#@%'@:[6L?\`
MRX_]QO\`PIJE66O/2E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*5$G-.3\I
MXEAGU;A_CX+DO+_JP(OY-V%V/CX_TN9A*FV'KR9(H^L5\<:(S?=W7_HTKT(=
M:Z[GNF=_W<[A^$U/`^?<*4/%9^=ST653GQWPN5,/JL0RBIR$$<=\#YH1I?KM
M,.K]UZEC14VV77WC](OTUX7WEBY_)<S*]T43]@C:2VY"[B1>N2]S<]D\0Z"+
M%C&]X7<;BW2KNMO>![GHNSVKYW@X2QT,>TM9L%@Y$=:Q2AOR\":%AA/Y,JJR
ML%?%,U&KT^7YBKLOAJ]C_I)Q+_U(R_;$F<[_`!D<#9@/SD.7R+X$:]JQO]R3
M#@8^4;!_><XM3H""BUE![27N)<F]Y9G)^%<MUP#LDPFLJ\CK;ZF`0($JL,.6
MN*",9$QL+#(YYH71)\7L1Z_[.M5^KWZ<\5[,CXO/X>1PQIWN8YCBI#@-P(6Z
M("ORK/[:YR;EVY#,B,"1B%1H0:W8:^'5U--*4TI45<Z?F8Y5_1]E_P#$!^HN
MTJ3?J%?)NU[4J__4[<WM,_X<W:'^A7$/X`W41J:D[4?"O?[@$F>#T7&QG'UA
M+6W(EGE$KIXB'#N?%].K4\E$:Y//?)X[,\5=]FM]PGV^_(&2%8@_B:^\_H3'
MQ,^=[B@YC';)BOBA"."H=[K^'QZ5URO<X/Y0J\<[;^W.GR\OBNX[M^6*#",Y
MR"I*F#NZ;%IB0620S%Q2QJ--=F6+97Q.5'.4:+X(J[U9(!SGN;C^$?*YG'-@
MFG<1_P#(8V/<U@Z.^@@--BY[5T%?2?U+]P%W!847`Y,C8,CE8,(9`L(VR.$<
MA8>FQKPCP04#P#<UK%Y?[>^RKLTYKXCJ\-[@^6.*N7L=R7$LIRJ:VNB;RMOL
M4FLVHB1BBU0T71;R`S?@I'S0.C=TO14\5V?#R8#^=:,#-;Z<63Z;X'*XN<0T
MMCW(!H]H)(T=N"$5Q'N?V1[+]GNP\:7W=E8'N`P13LF+B]6DN:YSFM:C?,QQ
M`4A00X;:M;W"K3MA.]QKD@KN!EY>R7C63A7CPC&9>+YXP;Q,DD%"6(@]&CO"
M;3MKE)1VS&JLGE[+MOK2PMPHLGW.,Z.1N4W.;M#3Y6M](>H'+U79M^#JH?J'
M-Q<_NKVI)[@CFDX]WMZ)W_CD[G/,\Q9)=;.;N+AW([5=G9GFM=PY'RKR5C<N
M:XOV0OSBAFHG\O.GN+^&ED@$&R.RK?3Q=,3I?.B222&/:16L1=U:NNUX.6+"
M]GY/_P!@(9F'*D,"*"&N:P1AW4M+@42R[B*[#]%LK&X?*][>Z.)DS8/:&+AQ
M/W2G<TOC,GJ$```GSL!3H@/A5O<XSKC3NFK^T,'@#+Y,MH<HY3RC#J^ZKH;&
ML@)MIA*>'TSV&QCSJ4.XD=9'=*1HKU5J(FN&SH<A_N;CLH@MB=PV9,PC4F$A
M[4__`!1D5@_4GW%A>_\`A/:$F!F-=@3>X(L=YT+'2!K7#P;M>452B*M6QWF\
MKY3SUV6=L/'1E^\DG"."^5^?^0Q`C9_4U=_QCD[N#,='MF1S*[SC#U-*3SD5
M4]2O1LBKO7]XY<>;[BEYZ*(L9#@8#FD?]LOY?*Q-[%TW11P/0:@.<NM:?-8S
MD?TZX7V_+$YG(L'(NE>5]3;P>+.&DZ$-GDR`U_Y7/@:>@J3^8N%^.^8\@]K7
MC'D$G*(L%S;AK-GY.M#8OI[N,ZHPBQO`GA30CE.09ED`.YSG1/62-7M\/BG1
M\A@Q<K^JWN'$G+O[?`8\C4*#<'RI=".X(JG+%+[A_3?]$.)RRD<W*3QDL=<Q
MN;C+YC8/1?A:U7!9\6XK[=?=EVRW_:WEW)N0<?\`-MO?89D_&V97+\@FM)0X
MVJ.='#$(%$LSD)1K7I#YD.W4QR=2[9.'D^P]QYO`<E(/\9-Q\TH<=(71;27$
MZ>*V5$*VK8<K[$'L3-]A\CQW(3PNS.2CQYV&162->T$'\J!3HY4J;N\_W">#
M\^[6>;JKM[Y)M8.6H:+%Z[**06$\<G&8<CSVEQ/*75UB1!"Z!XHMEY+98W]?
M7(N^^^M)R[G<E!P\>',7\7+R<$4CVDM)C<R:5K?$2>@6D=02*ZKW=[_Q</B_
M=F#QF;"_G<+'F`+-S7L:-D/J]`7,DE!M86(TJSR>WS!N!^\SLFX\X8-O,#H.
MX?@[-OZ4AJVU/M1CK2GQ+(,A@RNP`M)SHXK>`RGBEEG8C52./=O3\==#B^I!
M[N]Y^W<5Q9QHXYTD;=1&]LKXPYJG7;&E^KCT05R.(W$]EYGZ6^X^.Q7^OEY`
MQ\AI>_;DF6")S7/4HYS9<G<WIY&M(^I8Z[F>V+A#@L+BGAWABUR?DCOER?EL
M'+B>9/KUP_,*.GGLP99OK`M=9/J:_'*Y.J17S0H]S5<BOZ4VUJL&,#GO;F%P
M_E@QR/NG"X=&#YG2Z^9PL`"-+@K6M]V>U,;B1R65/R&5D^Z.0R`<-A=_=:XO
M54;<,:J`FW9$KL)XV.8/0F5+K.#)<SF'J0KQ8IHR8PB$K$2-P`HJHD#;%7.D
MZW]2^8J[;(FM]G.8Z5IB@]/&#G%MM0O7X5]TX2"6(8.1RN4_TF0-))\JN;9Q
M<7:D$7`Z)JM>IF(LMJ`^MR>QF])**X%_K$B)L&QI(V)(0DV3KG@<[9$\5:U?
M'PU@$DK)FR1!.O85TTG,8.+D0/X['C?D!^[RDAJHJO[`COKTJW,9%IQ)&8)!
MZ.O:R#S4C?'TV$,,<RSLG-\M%9&I/4B,5R)NJ;;;)K+,V5[1E.)*E/\`TJWE
M\@_?+R`C?(6E;%6$D(C?!J7J@QXE/37&:V5(`>=$17.**6%6#RF-C%D]0QT#
M6L@>C8U8B.1-G;+MXZ\=,9&PM+T0I\*W'^6QY^.X>'D?1$@E#6-*N0EUB"23
M>_PZVJJV46*@BX[=-E"Q6UE&E99D7)05<PR5K7>2T*4A&K(JHU>KKZD14U**
M+(G+HX@Z1JJ@4I6K_P`K/COY7&Y$^IB[@(M@)<U4LY-+D(B6JV3\0H<3CR/.
MQAWV=K8A%2D1->DB2HZ)'L47TVP\BPN7?=FW4BZS,FDG$>(YZ1M=;L/C5QO*
M9>?+QV`6M9`TL\R'<ZZ)>X4=ZJF.WSCL.?-*`/#%7T4Y5C$L"1R3*I"^6R5?
M^?YB)TJ]&^/1MOK'-$?7:T/57`?^E8\G'CPN3DVO<)7R_P!MQ*M"-4VT151>
MJU8&"SXM=#D/J"*RMOYRIX[@6I82YEJ,5)`UP0[R?,=NV!J/?&JIOTJJ:NY<
M4D;VQN#O3`";M1XU<R\OE,>/[GD&_<8?Y7D`"-S0?,0-#T4?.KE@I:2GHR*V
MC#$41;4FR><YK("6GRO536-8BLB5'].ZN=NY-_\`5K%)-)*\&=[BX-`3PZ5K
MX/NY,]N9M#)'1[=HTVIY3WZUP<<0,8N6S^MR0,)+B"+$L`$M(T;TJL9HC7-<
MU$B1?F^WPWU![@0GIV2R6_&MIRD69)`S"&('S-;O#FOV+W8>JFK]"MB13IK&
MPJ0B:JG+'AAR"9[QH;A)MGL2>&-&Q0/CWZ4:B)\OQUA#6$`,/]QRJ.U<_G83
MYH68C,Z1DLC=PB"%S$LZ^I'5:S>[&"J._P"4LQR&M`#%*^DN%)D]&QA4JJYK
M^N$SI\R<-V^S=W.^&M7RV]F-%&YQ151;?AI7P[]=<7/X[VSPV%E2N?%ZBM*V
M3Q'1W>MKNN>K\I4TI32E:*?>5[@'<19/VH88=R7S1Q+C7)=KRE^4&:\/<@I@
M1-=#BU-CQHT5O-(`;!8^JE-Z!V/5G2Y7;;JNL;Q=KE-JSQ(C@4^=3K[5^(\*
M+@>3\O\`&O//(?.N6\JPTUCGMCR?F@&:9;CY(,3QP:>Q,"%%?#)#"Q-FR)U;
M;?9J8TUK&\7-9\<Z=O'#G<KB,&"<VX6)G6*#6H=X/4&6%S6QPVU?(DH1S"*2
MQK#$F&D1'-_";(OV:QF&,Y&/E%O_`)$1)8Y2K20A3XBIQY$L44\+'I%*`'"R
M$`JA^=:B/=_Q+'\&P[VW,4Q@#Z=18]WZ<!T]2(XDLZ4:N!CLX!1WFV$Y1Q/E
M11HG5+(]Z[>*JNK&1-)D2OGF<LKBI*`7^2"L,3&QM+6!&_\`6M[L?_+C_P!Q
MO_"FH4KSTI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*5B[W,=G'`/=O4
M4]3S5AR7DF/DJ12W->2M9?5R/W\\6"RCCD?Z,G?YXG-<U5\4V7QUU?M?WI[@
M]GS32\)F;!($<UPW,/8EMKCH:HYW&X?(L:S+A#@#;N/@:]MCV<=N5GP1!VVD
M<:4K.(A(/+$QR!BQN%*4CUC[6`Y>HIEM(8OFNGZE<KO]&R:\C]Z^Y8N?=[F;
MR;SS#C=YZA$VD:;4LE2=Q^&[$^Q..W[5$VI:O9VT]H7`_:50V]#PIB#:!M_/
M`1>VQI"V5[;*+YWI(C;*2.-[QQ/4/\N-K6M3JW5%7QU'W/[QY_W?D0S\WF;_
M`$P0UH&UC512&]RES7F%QV'QS#'B0AH.O<_$UDSKEZNTTI32E15SI^9CE7]'
MV7_Q`?J+M*DWZA7R;M>U*O_5[<WM,_X<W:'^A7$/X`W41J:D[4?"KP[UB88*
M_C-%1S"_K]R2"2^1D08TP8(<O67(J^=TNW1&HQ%ZE\%UM^+#BZ=#^46[U]N_
M15@=-[G,BG']")K@+N(<]P\HT^).G2M!/>=P`1W6"D`\PV+\-!I+07)L#Y-Q
M\MD665&2C(YP9M.)+)&XDJ!(D_Z?IZ51J+\41=;3,XV#(APY^-F>SEX22"-`
M"FX%/RN0+U'2OT3D^U^%]P^U\OVIC@ECG-="`H,,S5V2;@"`/,;DD$ZBM9E=
M[47-W*O)M!D'<_W%LYCQRO;4`208GCL\6465'0S.FK*M,A(K6^2'#%(Y'NC<
MDD:J[XZP\?ALQ<T\GE%KL[UVS>6S72A%<_0IY6HFH"&U?,LK]&N<Y2663W-[
MR8>-BA+&^HW;-Z8<2V-Q=].I5%)+B6FZUF5+V<V+>][*^<<[*XU3CG*.(ZKC
MBOPB\"--\AN-(`H8<$LXLD$AI(`OEC.<YKY)%7=R_-K98V/C/Q?=<65&9SR,
MT<B(A;MC<Q^XZH2[\O36N_A]G8C.>X3W1QDCYN.Q>'CX_P!(L#WEYG+S.2XE
MH8`$>`-S5-@"%I'#/9=:\8<C\C\0&%4.5=MG(]L%;8MQEE%18%'8PMG(.I0]
M080Y\%E5$(.CF0,ZNA[6JW;QWK\=CN9P!PN7E&28IMT+_P`S6!2&R+J6VVD>
M/>L_$>T/_KV9[LFP\^$^R<O'?OP@"YK)2F]NY4CC-PX.*Z:)4L<W^W#'E-[V
MJVW'E=A_$8G;AR1><@<@813U%E((=`893^B=`\)9'UQY(]9)'-/,Q(U<QFR[
MHJZJ10M9[AP.6,N[!APY8&L.O]V]NFT%21XUQ7*\#QO)-X?"]O208_%8_+09
MD9V@>LZ-J/;&+-<Y0TM!.ATK%ZJ]J/-+*[[T!\;RNJ*H^;<)N\=XF.5+4EO%
MO'UWEYF670=[721_]:PS)31DDD&>]!_+D5RHKD1-7%P;<?V;![?GS=_)#,Q)
M-Y:=I;B&1S6+J"=Y/:P32IS^W)\3W1[MY_E>6@9C<Q@9^##`00Z&;.#7EXZ;
M00\@`!S]P2PO>W/'MV=Q.0@]J4/#/<!C^+<J=NN#Y#CS<Q'I+(^4QMB"VH/2
MB"2&1[`Q:@F:-SYHW.=%(J^'@NMAR4>7F>[L_P!S860(()N/AQBS\W]MSW.)
M(LC]P":A*UF5[(S<CV-[+X;$Y.'!R.'RGRB5Z@.?(V+8YJ*AW1*AZD"]ZNSM
M_P#;5YJH<Y$[B.[?N9K.7\NXJ(LQ^.GC&BT^-89#/`2DV6F*=#7N]7M"CHD2
M-6HFW5NNVKF"R''DR)3$Z?D<F$PN+@H]-R*QH[N!(<?@G6J/'>W^5G]Q<.[W
MQS4_)8N)ME@A$;[RVL0!<BW7H5J1\H[..U_DWB3).+Z'"L5I,AY<JYU9R5BU
M43]9M&LM1R8R);$%LT$JU.35PYGX1&QK+$Y'+MJOG\.7XK\;'7%]*6.1H%@V
M2)2P[3J`'.:1U:XCK7U?FO9'"29'N#./&-9CY./)!D@!K7-]0;PY20076(12
MK6%*M;C'L3[CY.4*+F[N0Y\Q3,K?@?BVYXSX@FH*.#"Z>D$R"GNJ.N^M2B0Q
M37EP0^Q5"MD>^017HJINU=28<AD?.Y\<@/N;/@,7J(K&-!#P0S__`&C<?^IK
MYI[;]J9?&\I[?/,<K_D8\)[G84`B<[8X@-?/-N`79%M;&50/#3<M"8H<;^W[
MWG<9YW<Y]_W;=OOY5YU9+-?9/EV#V-ID+Q8I9.JEJC;42:<,3HEZ&Q#HQFZM
MW7X:]X/%R^,C$&.T.QMX,J#SR!0NYQ"J;I>RU@?[0]^\?SN?[A'.03\K*0CC
M`Z7:Q5`C4$,:`>B$@5N%QFG.XX=>S".RNXLXA<?:7:`5,<_Y1$SL;&<E*SJ;
M,-Z*:?I>DW0L;=ME5%UO\B2/D'1`.CCC5P`)(V]MW<GPKZ=]Q.<'"9R<<4LI
MW%[0Y`H&J*FUQ!<$7L@2I>QXC!+O("L%$LJP`N;(&B$7&0SV<#%OK1(AAVJ2
MR$B&!KR5;'NB-CZEW<Y$\=:UXRRQDI!(:TD`)](N?VUJMRL6;PO&CW#+B3/B
M?"TF.%H<0QJDV4$H%)\-!5*S/'\EXVDOC\GIHG+2"*TX<-!9K.WA=&0T8R*P
M$ZGDPRI'U0IUM5F_BGCJ#',R'1QQ27<;$J`%_P!.M;OV[R?%>Y,?$=QF0YK)
M"2T.!1A:0K"PV![Z@]*B(6^7D7&[$BOL+W$Y9*Z>JK;$UO42L<+U>Z*&&-4A
MGC;*UNRKU;_#?[-67QG#G;"X,D8""0-#\Z["+%BXO(Q<R7$CE?ZFYS!^5;!Q
M6X*?A7!/H!;_`!>MJ\]!?DYE5#.%!>FADC+UHU'>?T0^4N[XW]"HUCD5'*JZ
MFS+FQYGOPW>F'=`:DS&Q'9TT^)(UL4CVO,:@KT`4Z(;J2.PJQZ_D._;FD6%E
M41$&*U*(UA,HKHHE?*QK?2-(G1(YNI=FNCWZ]O'5B3#QQAC);D`Y#S<+?XI6
MU_QAFBR,T,!R=BM<H*[>R:)T.E7/F62MQ`..6EPVRR(2T<P5UA6PF$10FS^2
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MW*GAMK+E,;ASP^IC;7@!4/[]?^E<H1E8ON=DK\,NW-:T[4V-!U`N7`DW*C:`
MMZSN]O)18>1K<(=I,:CX6.KO-B(B9,KIG;R.ZY)(EF:NZ*B;=*:YWF=QC]0R
M`AS]*^4?\B&SCVUQWK0H!E$`@@@6^FU_%;UN*USE?CBFE*:4K4S[K^)\\93Q
MUA+.#!^W$BQ#)R*2\3G&?&Q\E]$^"LZ&<5ORR`BB3()(V2I)ZAJL1WE;[)J#
MU4=JR,1'=ZA[V1*@RDXLY4!SFGS>IYEBS@Y,Z_*5F,K2$@*1([')<7*PV9^-
MDAI6JQ'J.R/YT7=/MU,(@2H%5(-;%.][GO-NV;MIY(YHP#"P\YR'"ZT8^&JL
MSD`JAQY+`04FPL9$DBGE'%A(5R1Q+UO=LGPWU7DF+,KC(2$BFRHHG./Y1)(U
MEAU)W(.G4U?X[$;F3/B<JB-[@`BDM8YW6R!%/X"M!GN/=Y%]SAFGM[\96W;Q
MS-A7H.[WMJSB;F&ZH*X;AK*3+FK'.FK<,NXK@NS-=YMP[RDE@C58X7*NRIX[
M+DL=F)GYN(PG9%*]@74AKB%/X5K<=YDACD**X`VTKM1Q_P#+C_W&_P#"FJM2
MKSTI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*5%7
M.GYF.5?T?9?_`!`?J+M*DWZA7R;M>U*O_];MS>TS_AS=H?Z%<0_@#=1&IJ3M
M1\*]ON$GY/7XEQ[/C-97&21WES-8'6(3"V50<0E?U30K(O1!+,K^E'*CM]OA
MK?<'Z7JS^J\A6@!-2;U]Z_03&XS+Y;G(>3G>V,PQ[6-<6^H[<ZQ2Y35*U^&T
M=7G@EA-<@6M^M-5&7;I@%5Q*SU`[BGQM(G7RXQVO79W0Q7=+OEULX9'0R#:X
M-4I\C7Z4DR<K@6XD6#-#`)I6,#7V`WE`0!J>RG76HLJ[WDHNMIP:48O#\LGS
M.G=2,9+#%#(V,F)"X"53?HK963;.<CD;(W?6T$>#CS$N<)8#&5\+6(\:R\CB
MX/(19^1R+?4X^'&>)$4DZ[;]76T114X<PTHMUG=ACI-'76E>PH,<TQ9D6/ZM
M7NB'^HB'0S1LA##-,?,O3LY$;MXIOK5XLAC9ZK7D.(_<>GS2M)[0R)\?VSAY
MPSI(\@!SV-VZ,<"=KFD$ESF@"_[C466V1&X:<&14$$6IN(/CAH38_(*+N?IC
MDFC>(]\<_D"RL^5C41KD1/E5%76=C6R$[P`Q^O@O\ZZW&XIG-X$\.1&(69?F
MD:I:UNZQ:_13_453O:I5H^6Z*RQO$#+"LNJ[*LF$(QW-IB;!3XC[ZVCDD$DG
M6!CF"C!3JY\TCUZ8OANFVL9P7NDR6PR`PQC<WH4'9>]</RO!9_#Y^7'*^%_&
MLR&28S8V)Z43#YKG56@!H%W5;V>\39/E%G0&4V87'']K1T[*[*J19Y85?1GD
M06\<]5",L;2*VT2%92=_,:KU1/!4UGPN0CQ8IHGX[9&ON">A`(OX]J8O*\2'
MR9&5@MS<1\[G02,NLC?*CR?I=&2&LT.U>]5.XA``=3%5=@YH08,CCB'%)&3!
M8>6X:UB%F^14&FK'->JHJHNRIXN3;5)CWDOM<G]U;S#C.7'E0\AC`SN<D?E\
MI;]41</ZO4!":Z&P-6<#R`-8T>55V2UM#EU4//)C(U<`,5,V.O?%)+#]7>Q&
MMD*]/,R-JN^9.A47Q5-7#`YCX)(2Z-Y&Y3_*IS\&Z//Q7X>9+!.HD<YQ`.]4
M<&@Z!020+7M:O+(7X=@N.T%_#U4=3C8,0D5:Z%732I9_^E8PQXX(=V/8LC^E
MKE:KV/5/%V^H0MR<R:2,>:5Q55^2UFAER<K+S,6<B1^2XDEOTCT_)N*FY(`4
MZ`@'2J]D61U'(N".$J;-71DXX9)3,'6.NG^MN%F5L)4<C(I)Y//&;`KE17,8
M_=%\-0;"_#R$F8A:X+UM5+B,;)XSE6YP@)7(`?O5S?2W#Z=4"$O\2$(J$,8H
MSC1*RWY0CL&/J6&^<:%-T5[JV-8U](1(]9GERS/@^;RTWW1?%-7GSB)TC<-P
M(<EB+KX5UO+?;32/Q.!:S^XX(.H=U*6V@+9:D1X5KFE[+D.(WD(U30*-&+*(
M09Y]@\A73E@)7O<WS8(F(SK<S[/CXIJLV2/'B#)V*]RJ.W8K6C>V/C(/\;R>
M(1E3"SG!NUJ!%+NA.H!JI9'46!SF25LH-.26,L9I36.BGF*E8OF$LEC57-GC
M=TJU5^;Y=5F2M:[<6ES0;?Z5>XUV-%`^#,+I@'>4%$#0;!.QN#58DP+);@-Q
ML-J5D=C0PP5YJ$6DRUYD</F,BDD!FG:L[F1+LK43==2.9M:Z,1@,<5TN%[&M
M/'E\)@\CCNE;]JV97-#0+&VI`0+WJSK?%GY0YE:VQL1#L=('D-KJ&*9KV.FC
MZHF011#S-D"_!*L_S*K/NIKV*0PJ_8"UP0*?VO731\M#QNV8Q1&.<$M?+]+@
M#=2H1UT;:_8UZIURDQZ,A#.^E@S1CDM9T31C01IT3S$0_P#,&;*Q557^#ON^
M'AKPEK>VXBLT$/"1`2/R&#,E!<+IN=J`.A3M5!E9EA5WD7FU-+'2A#0V-(6U
MDJ%1-2-&DL/:3--YY6R=3'M1&[+\/#6<_:&*`L<\3Z.!-O`CPJ>*\8D$;)LE
M\GJ/V^4`!%LT(B#OUJWQ;PBORX+#JNWM(2K`$VR\L-L<=2^2<:.4=22I4:WK
MC>BNZ6+ONOS?9K.V%\F'+.6MVM(&M_D*R9K,%_H<IF8;71M(8CFDN0.(-KD?
M/Y55,R(Y"H`&@1N`R$$^,VUR*/ZNOGQM6#:M"@D18T:X@U&M\5<K/M5-0QCB
MOW>LYS'V#2`H\2?E6#$Q^(Y#-9G8.,Z.6([(PYFW<EW%#V:MT`-66'+D\(YY
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MA^DX`LI:,K)VWUCS=CUY>ET0]T+6#"GX3](N:N`6S9Z>1TBDL(C<K(_E\%WQ
MN:2YI&E9&.#6N"W->CVL^PS*NQ'CG,\-RTW$;BTRB]2ZGN\;6V\\^5_4KVF1
MV!<PHT,"NZ8HQXXF-:B>"KXZF*@2O6];*<UPK%N1<6NL)S6E"R+%LA$4&ZI;
M&)LX5@(LC)5@(B=X/9YD35_UIJ+XV/,9<%+'M>/!S2'-/Q!`(K)#-+CO]2%Y
M:]"%'9P((^8)%:6_>4J*V@QOVXZ*G$AKZFF[^.`JNL!':C!PZ\"&R%$%A8G@
MR*"")K6I]B)K+-(^9[Y97%TCB22=23J:Q1M:QNUH1HK>5'_RX_\`<;_PIJ-*
M\]*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E15S
MI^9CE7]'V7_Q`?J+M*DWZA7R;M>U*O_7[<WM,_X<W:'^A7$/X`W41J:D[4?"
MJ_WX4X]YBV`@&%EA"27UGYT\"/?`Y4&"6,<N-DD2N9.]/E^;P5%\%UN.)D?'
M)*6!7)7WK]!LAN)R?N'*]*-[V8[$#B&GZG*6D@W'6U:W77!>)DY"#1'"3TI-
M<^K0>`%]=8`6)DS&3DO*EGE<<+LSH1G2WI7QUNG&)\3&B(B8%2Y5!'9.E?I7
M&XG(YK*X[DN:E<K9`YL91[2Q@4:`;7)=;K5LU#,RL;6Z6VR082BJ@9++#IZ@
M!WU`^R,"97RUQI[6,G';6PHDD+W=36R+X(FK!=C,@A,41.02CUN`EPG\ZRY[
M,6"5C!@E)G;)6O?M:U@<7[PU4<7DHY+D=:I]ACME$TK&Q)+2X'O,?LC2^0WR
M2P)(;(UP(`Y0+72L"M)D\M[%;-Y<K(WN5.IRJGK',V#+>0'L>`(_#4_+Y5G9
MRS9\O'B]"/'8QS6^D"'(`A=M<@+VCS;E"@D!4:*M7B6\H\0M@,;R"K-RV*E+
MC<621"H$%XZ0CTDE3]03J)"1'S,6-6N5&>+]E367-C=D!N3&6Q[C8`Z)=?&M
MM[CQ,_.PN0=A9YQY7P(')NV!%]0,^EQ0$.M>P457)\0=P1]2`K<I-3(3[.RC
MK`QZQ,F"">0Z83Z8#8PJ\12`PK"+\),KO/5>M57QUZ'/Y(C*=$WTF`+?:O54
MZ@D7[5HV>Y./]V1X'%9?%%V$Z-I]5Y,3G(A5[7!6@EI#0U-EPE7C5Y&Z*+'J
M6[,*N\[/K!Q76%M8'V-A%55X,W77$P2S/C@@AC?UM1'+N]%1B(B:IRL?(9IX
MV@0!V@0"_6HMXO#Q73?:QB'AFN<YK6,:UKI"X$/#@%)*)<"R*I-22-@%(+2^
MDM+DBR#\_P`Z:)I,T14AL[HW-<UL?EI,"((]4<+LR-[O%SM]5'Y4GJ`LB2R+
MV'CX^-:(\QFSY[3CXI9.2H4`M#6].I:YSM)+D"P"59O'=99R97;Q6T,%#CEW
M?.,4L!6*='1^NE9+(X9/E]<2,D;$:U/ED547X:S9$D9CB])Y,C6=>_AX5N.;
MD9C\0R2.-L_)11[0P@[72!JC<[L"I4Z@>-5&^QIR7E[)8O'ML8LBRQP<:/>Y
MUA3O$:D=6L<4J^EE+@1%>YCTD>K9MT5-U74F2@1MV-+90`KAH>]:_C\UTF-Q
M[8W"+.8T%TNUNR3<A??4-/T@A!Y4*VJ',WJ\8MZG#KW$DMS(J7(*,`NHHQEI
M;&*,NP<TDTE\;RF/C!ZNJ9S6MZXDW7X+JYC^K&^=N0]H+V%";C33XFNKXK/Y
M/'R>2X[*Q(PL4SP^1P<Q6L0-;9I&Y/*%*.MU%2\=&"12RS'R1E!3M)BMJUGD
M.B0-95:I`\SF=$1*/W7P14V^[K7`O9("WZNAK2X^YV2,:)FQ[$+'^92Y-'`7
M(3O7`HG0`8T!#@]3&+`(<UL$3)W>I2&>59)2(27ILDDDJ+UHGV+\41-2>72S
MN?D/\Y'[6JSFQ-;ES-Y/(+VN:I*>50-"+V`T^'5:HG(]4[,,5MYH+B3'YYB@
MQ["V&.V@ZFE0/GGDA&?$R(B")JM<^)6]3%5%7QWUFPYCBS1ET.]HNB?ZTXP1
MX^?%"V/U#Z1+&$%0C3M%U5KBEG:'3M7OQ.B"Q)2JJIRXO(W2!K-)"$XMT!)J
MIM%*LKRC7S-=XHCE5/%5V73*F&0XO,(9_+^%8WR<AF8V)-G\<R)K9$W/#00U
M;@!&HG:]>..W><X?<'9$M\6+`3!]*@KT1E;])65SH2UD+DEE]6A4+E5%?$KD
M55V747#'EB9&(O."I.J_+I67F.)XGFV18,F.R1H.\'Z]Y%VH&@(AZ`I4!SX#
MRS?Y#DECA>1QDM-)`L66D]X>EN+#&;%(?7CU?KX*^XC)&1T<B2HO3'(KD3Y=
M;B'-X\01Q9..K@""$`!70DHH36U;_/GX?BH.-_R+'0PM&T,;"'-7:0#N0N8=
MR$'J;=:R]S3'JS!\>QJZ_*ZNL,AR'USSHWV`EBH!KHTV:1&2CP$'#<]'HQS%
M8GBB[IK0QN,DY:8O($Z("/E>]<!P7+YO/R\YQL?%3P\?C)Z;MKFES>X(\VXZ
M6*]DJ(LEIK.(ZSF(EJB2/3C.J[RL`@8+<0N%C3SHB`O*#$1TW4B>5TQ.<BHJ
M:S!S5\NX-6[2=/Y_C7=<'FX[\+"C`<A)#FR.)D802H<'*YQ\3<!#4?&&7EQ'
M<X_87%?1RD`Q^ADEB@F:\CR.CS=_,<3,1$]J/=L]K&KM\=9@86F)[8U`-];U
MTN/@187H\C!%+D-W$%H";`O@``T^*DU3@;^?C/'IK(M)LS\CJEL&6$33_/CE
M5C(XY82HU<Q(I%ZFH[KZ?NZS-8,W($<9$:FUT`J'(8+.:D$3F'';M`!8`TJ-
M7!.XU1*]=/<UN=MARZ>VGI"RVNEK`'C.@?(,*JLG`#C#1L4T2JU-FK&WI^";
MHNLSL::(RXX:';3<JNO6]:WD,B/VVW%P(\038Q!#CU!UW.+K@Z];U(E+G%?<
M$148-9:.GHZTBVG*O$2J&LP(Y%A,KHE<U'L)7YEB:U>J5GAMXZQR81AB=*^1
MHNB`J5Z?*N1R!D?<MG>6F',>&,],;O2=T>3>W=4`-9V]A&;299R1E$)6,5&/
M35=$H0[Z\,85YX<4RNB*>L'2Y[W]>SU>BO54\5UH^88UD,>R;<"5(O8]KU\;
M_7GVV[A/;?&3.SIYS+D*2]^X*1H.W@-*VUZYROR932E-*4TI32E:]/<AY^Y2
M[?N%J6^XIOJ["[J_RX:E.SZWH@,BK\2`B!+LO-FK;:`BI>^Y($8$QT[51KI]
MV?/TJE4RO'(8L'_Q>E-(1_\`J.C;N;$.H,AMY?-VK8XF-%-C9DLA\S3&T?[1
M(\-=(>XC!W7MWM6B[OD[Q.X'N6Q#LOK1>Q[NCR?).%^;.$^X//,VQ'CQQ6"9
MG74E.I]O%A$T+TE4HU]@BQLECBA8]'-ZD1$UO>;Q,?"Y/*Q<9RP-(3JBM!+5
M_P!I*=[7K2\?+)-BA\AW.W.;N`0.#7%H<!V<`H\#6Q=OO-96UK6_LQ?<%\&H
MGYL*O[$V_P#6VM6M6]IK]_;-Y7_EB^X+_5A5_P`K:+3::?MF\K_RQ?<%_JPJ
M_P"5M%IM-11Q)[]UMRM57]I4^VSWF6L5%E=YB\\N"4=;FH,!-*8\28:T,=!0
M_3;N)S-B0^B5!Y-V^:_;?1:;3TJ5_P!LWE?^6+[@O]6%7_*VBTVFG[9O*_\`
M+%]P7^K"K_E;1:;33]LWE?\`EB^X+_5A5_RMHM-II^V;RO\`RQ?<%_JPJ_Y6
MT6FTT_;-Y7_EB^X+_5A5_P`K:+3::MK-/>_R/#L.RS+C/;-[[1!,6QJ]R,HO
M(<%K*&@%&HZLJSG(O+Q";)::GAB%5Q):#S^GA1TGEOZ>E2TVD:UZ<$]\3(LW
MPO%<Q#]L[OJ+$R?'ZJ]'*QK":S(L>(AM`H3(YJ2^=/5NN*N1LN\!*C0+-&J.
M\MN^R%IM)TTJZ_VS>5_Y8ON"_P!6%7_*VBTVFG[9O*_\L7W!?ZL*O^5M%IM-
M/VS>5_Y8ON"_U85?\K:+3::?MF\K_P`L7W!?ZL*O^5M%IM-/VS>5_P"6+[@O
M]6%7_*VBTVFK`Y3]]B\XPX_R?/;3VT^]RL`QH&,TD[-<4K,0Q8=LA8PC7W.2
MM6\6I&=(0C4D])/O(K6]/S;H4TVIKI5\C>]%E)(XY#/;']P%S9X8IFNAXTJY
M87-EC:]'12_5&>;&J.^5W2G4GCLFBTVFO=^V;RO_`"Q?<%_JPJ_Y6T6FTT_;
M-Y7_`)8ON"_U85?\K:+3::SO[.N\*U[LP,R.L^VKGOMV7$2:P>(7G+&1L<(R
M/ZC&2]TU$T8HI"8@O3[3*JITJ]OW=`:\(36LU=>UY45<Z?F8Y5_1]E_\0'ZB
M[2I-^H5\F[7M2K__T.W-[3/^'-VA_H5Q#^`-U$:FI.U'PJ[>^8OT^'8?&PQH
MA$UU8+#U0>?UI$,(YZHBHK&.C5S51R_#?6UXPEKY7#H!7W?]!<./-YOF(IL?
MU(?08MT3S.3Q*]A6KVUKAS5<9ZE&O<UTI4\74YWGQM6:9JM?&YCR%1.IK6_'
M_1K<,)(K];8V9)@N^V$&Y@0-:?Z24!L5#>BFJ/;9`%E=-B;ZT0BJ;BD#XXTA
M\\&<Z9UE`2A-DNS6S.4P;96N5&(W=J^&K+/4QS(T.!W:]=1T^55XN&;C\CRS
MN3D]3[N1I!<CFQAK2-K+V&TZW.AUJH,QRW&BB+I\E?9P&%/2ZQT4J,T>EJZY
M6QA6&\;W"V,LA1TOEI"Z3IC^54W1-8]ZAP<Q#T/4D_PH_DN,DF;#E\8(I&,6
M&<M+/5<_ZHPOF99C5+P%*D%*O2\K:@&B6Y%E6PD,M+.FKV15\`I;YZ^MK29W
MD!.C8R$:(TKRXYDVE56*B^&L37'>&Z(`=;=;?A6BXZ?D,G-?Q^3$&,CBCD>=
MY<-KWR`(X$DNVM5S3:X(J*");S'\^%MZ<MMAC]L+6F7(;Y9'00"OA1Q(9`LR
M)&//+(JK'T*CHT:B;^&M@R6!^$8G-(G"H>__`*5MSQ(Y'$<W.#6NB>YD=O,'
M-4-<'#ZFZ;B=222+UP,#Q>UIN1;O("S!R`Z^DN[*&&QDD8TNP*/.6HA`((7R
MIY0Q"V1*V%>ESF(KE^[/+RXIL2.-D.V10+=D"J!W-[TS6M=Q4&$,ESFS9,35
M`^D!"\N`^D':2";H=*DXK.+=,8OQ+%HU:PI(YJNXFECE^D'I`K9K!L3$1YL4
M<+OFB1')NWX+MK7MCC]2*Q/<=_"J_P#]>A/)8N3@2.?)&"'L`(WL50+V:5T=
M;XBJK2$3GQ@$U%U'<2/EJZ4V>6.N3TH\\:SR7#%C<SRARG1J]9$57Q-1$\57
M6)[0W<'MV:D:_A5?-VPNE9E8)9&`^5H:7^8@H(RNI:"B:.)7051\X#H;6VQG
M*KJTFKP\2MIY:VOA*G9!;6$3/,>81.2K=V'/C^1KW(KU:O\`LIK/C2RQ1S1L
M8#O:A.J#PKWCV93,?+XK#@WY&2QI>[:T%C38,`'5BW0$`)UJOXQC-16IZX"W
M$J:3)C$G@D1CCO3D&U9;&0$+&U9AQ2VS20*_I<V*5R>*>#M8YII'$!S5<T53
MS,S(F:_'FQ7S9V.TAS5#=S6R-7;='.80'[5!<T&QN*XU[=XA91%5F/`.6?#*
MD<*W%7S%<3)-(00PH=H[Y4(5\:=/_P`Y';(NO0R9H8]YM(;?MTK+QF'RN+-Z
MO)9/]O)F,D92P"!NPJB(;]JX=4=:7V,#A8[5C5N0ML6R`4DY'II$&\AK_/M)
M)7-8(A[6JL".5$>L;O!--C&2_P!QZL2YUOX5GSO0P^2R)LZ<R\?Z0WO`4*2B
M,#;G;^9!912OJX0`+P0L>*O(<SZ@6"9N4'),*]-H!GQS2P23R/<K'(GATKNY
M=DUZYY>6(ZP-C6/(F?)F8.3$3+&\;`6>5P!!\Q4`@#4=5""HYR?U(>(E@XS,
MP`NV'>X;RDA]15DJ^:5B>K@<V1T;'R=+6N543X;?#66%S6Y+))AN:#?Q%=5@
MXO\`D<H'-:2R*RDG:^P'TFW12:X6*4&4$8E3U61-+MSK(M1K!)T\CTACRH7@
MODLV[,E62%Z.1'N^5B;JJ;IJ>7)%),]^-Y(Q^\=;4FR^.P.1R9A,QHAC5C@5
M#FH0[:S4(0B@7.FE<[+J:[X^%,R>OKZVW)JH&48V*5-J(6/86#CQ93#2H!R)
M#WE!!R>*,1/,:NR?#4\5T.3MQYO('%=Y%P$T[(36J@Y!G-Y$4./FS;2"]QD8
M6(TM(:A<T-`)%E-CK5*SZ:T+QNLLZ6>3USQA?44\$#V@5LY;G-*'1;&)I3IT
MC3\(W9[4^Q=>XS8&Y#V2G^T.O?MI5_B#,'2P2XS&R.<2'/(#WM;H482$7Z38
MGJ*YU[R-887A4-'9%5$LQU.E=+&#&^[$#8I39!9R%=`UU40D[G-B8Q-W;JJ_
M9I#B?=SN,0-BM[$_#O52+B<"?E(^4?'.R*.?<I_MDDM1U@3O"(JZ5#4`/GW<
M=Q9%F5K)FL)8^-9N@U[D2(F!]64,TER00],J1L5>IKMT^&K#D9&(VM:YRH1V
M[7%=V,Z1\#X<0%T#`4)0*$7Z@4Z(IZU($EI6G4U_.M!*Z(*28>`ML\9:E.BD
M8V1I`C7.<(1T.ZEB>B*GP^.JXQGLD8TO1Q^7[ZTOWL\>3@[.38X/:"YH:@:4
M-@[\PZ**]-.>./8XZ/1/($C#'6R-DCHHFP32)TOCKR76,:,&D">WJ5T&R*UR
M=6ZZS/:UD<YD&Z0V'FT\;:_.M?FQYO)[WY>P8SG%H:YU]IL2-JD[N@-UJJY'
MD-O:WKVV09!)!;1O(LQ1FQ"01PHB0QS3C1+'TJJ?-\J[(OCJLW_MKZ@`[=35
M[B^!XWCL(#!#1%'N5CW'=?4@.*_"];`>P>@#JN1+\B,QY$TV/OZ(Y$15C8^5
M'/1CVM:BL1ZKX+LJ?<UI>4<YT35T6O@7_(GDW9OMCBXOM=C&Y&HZD#^-;;=:
M*OQM32E-*4TI32E6]D^)XSFM1/09=0U>1TA+X9)ZNX#A/!ED'D;-`]X\['QJ
MZ*5B.:NW@J:\VC<QZ>9I4'L>XJ0<YH<`4#@A\1V-5@,,2O$&`!'A#"#@B%$%
M'C;#`,/`QL<,$,3$1D<44;41J(FR(FIN<Y[B][B7$W-0:T-`:T(T5R=1KVFE
M*HF37#\>QR_OH@";62EIK.VCK`F]9=@^N"F+:$*W95<04L/0Q-EW<Y-#85Z+
MD"M&GM5]V>"97RCR+V_<9=N60<?4EM<\C<M9;F8)&26.,4V:'Y(U]EC.1E9*
M(-*+E-F\U2$A'5T+6HJ-1$37H;Y-RUZ\$.3H*WS:\J--*4TI32E-*5A=[B>=
M+QUV3=QF0+B]!FL1_'\V#%XKE5N9C^-W@')]K5\:6(5W>@2P%4U8X'+9'2E-
MDB0=C5>Y[&M5R>%>E>A%OI6O3VN^]SEK-.49.ROD7B#A?`,=X=XBKHL$LN%N
M1RN3:GZ?BD&.5X]0=>NMK,25L-1;0],C'O>LK'->J.3Q]`\JDT=8H!6]S2O*
M:4II2FE*:4K5G[QUQD(/8YFM)208XZOSC+L(PS,#LPI+Z]Q2EQ&QM'GV%UD(
M^-0%70E6"=5BJ\B&-ZQJY$5-G*NO#TO4F];7J#/:-[V.YSN2LL_XW[B,7&F7
M!,6K<@QCDG&\+L</PN^JC;6.IJZ>O'M*ZN+G-CKHD*:Y6_.-(QRHCMTU,M1H
M-1NIN$K=_J-*:4II2FE*BKG3\S'*OZ/LO_B`_47:5)OU"ODW:]J5?__1[<WM
M,_X<W:'^A7$/X`W41J:D[4?"KS[S[6CHPL$M;V%3(!H<YC#K_IQ![#[(JMJ!
MQ()?3)U01(KW/5RJB;M3Q\-;GBF.E,T;2`3MNJ6O7V;]'H>0GGYJ/CW.:_=C
M%SPX-+&![R2%UT3YUK"#&#)',-:\@BN;!$0_R9XH1HA1V*XY&->QO58R>8L<
M+=^IZMV\=;E[2@:$5:_5PS,F#+ACD:&Y1)8-P))<3Y%31@*%QT"]*XP8P]X[
M+Z6D;%:2MQOZF4,7\C@G'#S#"P%LC6.2`V!9%D5B;[.:FZ+H&F'T9GJFZQ[I
M_*K&9FR,'&29S_16<Q`MZI<EJJ"THBGO5`XBXPLL%246YO&6023K"_U,?6*>
MU>M811[)[&^G8*]S'-E1S7-ZW>"HGAFS<UF2\O9"&DA+6OW^=6/<O,X_)8V,
MW"9(W(;YU4;FBR[F#4&XVH=!<+?VYQ5V,EC1E8F8++$TI9;D8J1TR#33F+`>
MZ<-)O4JI;&K(LS45DB-:J:QP[2")@241J=TM6;@N0QH,/D8.1A,3G-5K@$+F
M!JC:Y$\N@:?,"2M>O))0[7$#!XSH64-;3O)ELAX_17!,,JM+5`Q)HVS%O+L9
M7MC18UE2)VR_#66`/BR6MV`S[D`-QVN?"JD1:,F/,+96NR)/HNYK2+:A=J1@
M$WV[M*HN/VJG\=6@^/BV)4D-O5C5R7,D$1)J0!G,?(8R>-DK(1;"!DCG-V:K
MMD^^U&5ABS3ZQ%Q?;H+]/E6ZR<<3<CQ<\T\;(SC2/*`D@ES0!:RN82`H5%.E
M4:R%K0JY*[,[.[C/MX9129(X4D:VQFBEE?Z26.%T7T]%>UCOBK4<OCMOK,S>
M^1TN.QNQE_P[^-98LB98F<="ST]P`NGD)`1P)L[4BKYP,1V,U1&#U\)BQ-\U
M@97F-F62)T+!B9GS=*1R+7P"L6-L?RJK]UW35?(D]>0Y#T4E?QO^]:U/+QC(
MEQN3DF:K6-#@;%NTG:$Z;R2I-[)5)FQ6B*"*H+*UL\E>5,MC.R(MLCP6"NZQ
M!Y42%C8)GC*C$8FS^I/#[=Y-FE8]KV-#2`GX]:LNY#*!9GQXK,>%OE"M(WG\
MQ;=4W771#>J!Z.^M:T:GP*C?44ZFMOXKJT9UI3$=*#.EL!W.5K9@X8E?Y:(O
M2JHYR:MCTXW.DRY=[P$+1^;X'M5&;(Q8IQ-GR_\`FOC,8#;$]?+U.\E%^2U+
MU5<LJQ<D+JZ:"(H&CKH_RCE].H1AKT)]4K9FKY1!$4\:^.Z*WJ3;;5)T()@,
MKSM<X^7J!TKGYW3Y\D.$_(W`2N.U3?1!X-3I\:NK#8;PG!1+RTDK(;VR+-$C
MBG(ABE>(*Y7AD3N(<[J;/"0J1*BJG4BHFV^L>0R$9!9%N,8'_K6JSLN*'EIL
M%T3_`+:,-<XM"M5UB`G8CS>!O5R2T26N$R714U;7E5EXUL4,\\0[I&SMA:7-
M&TA5ZVC.B1'[ILO6NWCJJ'D2^FT$@C6@Y-N+SHPV1321R8RD@$HA.T%-%!4?
M#M4(Y'!3&!EV5HLD]?6S0B`JD,4,5F3-U/EC;^#ZI$;,GEL;\7JOAX)JW"V5
M?)]:*?#QKNL7,GQI(<&)K8Y9E+B226BP'6RBY[5[_5LJ*6,5J1UM@:-8R5@2
MO1RQ&>D5D`/4J]"M)9-&U\;%ZDW3[FO`"^3S$E@-R-4ZUCE@.3D.G8P2,86-
M4A`1N^OY$$@FU63AUQ=2FW#LB#`9;D5,B1A>E;T1P11K"38QJ,[RFD5_7UM<
M]>I7(FZ+MJQD,CVL]!Q,(.OCVK9YN'C0Q8<<<K@?5!4.UN"&%?ROT('1=*LV
MF"<(ZT]5=EY'ZQQ)"`DO3R(R7R]:3=,/1Y;(X?!5W1J[>.LN1.9&PAL`:6V4
M5NXL.*.1TT;/0"#S)?:B$!56^@%Z]&`83AT<-D5=&6TS<B*DL0Y1@IO2L,0J
M<<(`QTVT0D6[7(CU57.;LY/AK)E962\L#2UIC:EC^/QK%RV;EM$?^,Q&.8$;
M(V0C<&M`5[&BYU[)WJ_LU'EP66AEE;].M,A&AJO233.NAHA[!988>E7OG4.P
M(C;\CT5%ZMDU6@;)D^IL:NWS=M/X@5J.(R^-Y2+.CR)@_!AD5K@/3)<U"A1-
MS5*)\:CDNYFPW+P*:W@JJO#K>"$HB4VP:R5Q"(]TR>F&ZI)9Y2HD217.5VZZ
MOLB$^.^5CGNRV]`+)\?A5DPMY3!DDQ`7R,<0U`CO#:"ED-K:5)%`V:Q/EO9G
M+DU3;)8+'9B$*.+%`-"Z&OK8H$B\Z":%K%\5C^=4\=]4Y2=XA+=A:!;QU)K3
MY(@PN($.--Z&>US?(]JNN[S.4]">QM5E6MO1"0&7R90M++31_3*NN?83RR$E
M$-5LI2;,;'$1"CE1&3(B+]S5B&*0N=&R#<YQ73IV^%;$#+F&%B9V*78TOFDD
M#0$`/E!O=>[:SL]M.@LJC.\E(.FD*:=0OGC*(DE<3,DDR/ZY$=^"W^;;Y-DV
MUI>>G;*QNT!J'0:5\8_Y)2XKO;7%10$ES,A%\$T_]:W2ZY>OQ932E-*4TI32
ME-*4TI32E-*5C)W<\8X5RQPGD^+YO;6=2(V"2SIEJ,V*P$RPR.N@F)I:IM^(
M:!,QE@=&R-T:2)UH[;47:5)FM:3?:A#MJONMR`'%\%R0+!6\5V;,VR'*.0KR
MV*I>2A["NB-Q^MHK7)[:.]K2&L61EDR#9OWO7]V838;];5XY-PL%3^==DW7E
M>4TI32E-*4TI6MKW2N1^5,'[:CJ+BC$(,CM^1[`C%+.W/!(LZ?#*T>H.R".]
MNZ^&OM&'4Y%A40ADP20/;,.0]C>EZM<D77MWJ;$N>HJ"/9EQC*Q>&LTR+DV/
MC4G/R,H07U/&U:/34%94/@<]*ZJH'U=;:X\-/)&R26,CS'$3(LB.VV1)#1*B
M5W%:W.:5Y32E-*4TI32E:5_=MO.Z0G%(,+XQ^GX3Q(37@760\Q(BR7.+Y.*?
M)"&&(,E]6M-A($F?U0RP312;^**J)J!)W`'Z:RL3:4^O^59F^WBM%%VD\0U]
M5EE#FAE?36H]OD%*6<4X^Q7([>8R<U;<LRWC+?--O*V:14:]52/:/H1)_*U8
MSK6;>E>4TI32E-*5%7.GYF.5?T?9?_$!^HNTJ3?J%?)NU[4J_]+MS>TS_AS=
MH?Z%<0_@#=1&IJ3M1\*O#O:IQ[:CX^4\]H58+>6SS6/9(]A:2"!>5`](I(94
M;^#<JJU[7)]F^MMQA(?*&M5Q`2ON7Z(<C)Q^9[D=CXQDRG01[2$\J.<IN".H
MU!%:R.09$'2KH@Y8H:\DP1`Q!8/1LL)ZU"E;Y3'$2/+A$6=SI/G1[OM7?6\A
M;Y7.%R!?JB_*OT][;E]:7(SLR,_=-!*N.X@/+?`)N0)9!TM5N8YD=)C\EQG(
M$U?(9+!<4N51GK*"&9)4(X4L.QFZO+@LA(O+8BM:B[N:[QZM69(,E_H8KVE$
M!:E[.T(\*GGL@Y&-V"_>(63-?&YJ%S'$@C:$^AQ)-ULH&E54WDT:'#;)]=3Y
M!-C[`Y+J&I@VO6`F1.C@GGL+$=C6LQ\J<-DO6Q&R-C>J;JB+K#'B%\PB+P)%
M2]OP!ZTDX5\?+86=E9N,<MQ$?J`^F'L(4!K#K*T/+2J@N"HM4*\/?5CP<H2U
M-E9'6T=<:;'Z.<"24=RQ%0#/B%5T488;H5<CVM9+*Q?FV362)A?-]L)`UK20
M.R_]:MPB'(PY_;3)F"&,/:$<'D$JTN!(!+B#H5:TZ*:Y>3V\]-C$-Q3XI#D9
M9$D-I4-C:ID%=,<P<F9989H'N(EC:Y$CC=LUCD7;=-TU&&-LV4633[&C7Q2L
M6)&YP..<UT<8;LD!.USVM):-I5!_N.I!NE4)IX?(^#`7M7`F.VJY&?C-M734
MTT3'V<C9#0CXRH'0M+GC9!)+/!M^"<C454141920G%R7L+PX!@=8]-/W]*V>
M'E2<%RLG&YS'3XDD#7Q.WC<C1M>S:1Y1H&OT-[$@FI=DQ1#%IGY23#=EQR!P
MCOA].D\]X4Q0@)'U*QN=,I$FSY1V-3R_!575-KT+S%9I!MX?&N<?S(CBRX>,
M@=CQ#<22I#8F'<X>IH$N&R$WZ"HYL\DRB&2I'KPJ^(^C>1C\,)D4Q?UJ1TBC
M0PUY`+X!622R-WGGZ$1S=D1$35MK8'[P\':;VLGQ7^%;3'XK$B]?)FS7.@R`
M)7%0"U1NW/:Y2@'TMZ:K5FT<-S9,R@RW"9790/=0R*$/)/Y1X`Z.EEGBC'1D
M*R-65(D7PZ5;NJ*B[:E)Z$>P12;HRWKJ#V_G72Y,HW\1"UJ\5Z3@'D!&DHBK
M>]SU7N*O87&!<VL<=B&MEH<*J;DZXNZV*T?'>VJSC,<4+711PM>0PB8**+J<
MJ(SYMD3??7K,D8\4^Z/=DN:C218=B?WUQ_+NS..?D2MA$W(OB:QCO3\C$)0O
M)*-3<7$`7J4XDQ6JB)QN*KH@L2&:=8NI6V!#<E%C9M/-8OJ7-*)-`FV^=7*G
M2[X+\=5P,G(<))&O,I0;_P`OP6N&RLC/QI<;*Q\QTG(N`#B&`QE;)O4!KAV2
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M.+(1NF>A.U`\;O+8:#6ZV"K4?8R?R6E^;96R5\&.C#)9'4@\44DT@SI7LE+D
M.9T+7PR*]JO7=$7;9R?;JWD#`]%L4&\R$Z^/9.M;>7%X\XD;IW`<B7&.-Y-E
M2P#3]1%TL3V-2.\WCR2H)O2J;)!;,!9).L+I(JGC0/=*9YDZ1Q2M517-Z4:C
MF_Z%WU18V<O;$V1I:;7UK6S0^Y(<IF)%DXSL20!%42`D>5&J0?,JK?\`"H^K
MS77UGD>059ODXD]X%ABPQ,T8+XI%9Y$C3@$9#%##"K7M;U*_SY-G,1%54U?G
MCCB@BQVL)R0NY+C\?V2K&*S+P\C#CYEK/N"'1O.I7LUQ*DFQ-E:+$FU71BT%
M%DF88D.H]Z^^&@-(N`9I4GJK,N1I40Q$:)"QTS8X7-DAC^,<T:*B^.JIGFAA
MFNTQN0#N!X5AY[C,G&XOELHNABPHYF.B+;.`"*'W2Y4.[M/A5HV6/GY9D:@9
M4+7D5E83,5#+#7(-,#)&KNIG3,OF^>][4ZFLV3?=5UG9.(HB<:1P>X(;JM;6
M!^+Q6''FP-/KN`L7KN!ZJ+(.A/2U56DO+8PNXQIPJ56(TH9,PUQ4BSC.(F'5
MR>7*2J*SK):]WS(KE145-T74G,CBB9.'[L@Z@]*TG(8,4\V'E%A=F32`;7N!
M".30=AVMWJW3<9K+&L,*"Q,<X6&6(V6>T/6$*S(9TMC<:2<]TR3*J;1^4G2K
MOCKV+)D+P?6<UR)Y1<#JB5O'&3C,B'$R^3:'/LT(OI]MH;;XJ5[5M0]OI\S+
M<^"XCJ8+I](LT8E2^66,()7M:V">5ZJDDNZ;_!%VUS?,.B)2+<6KJ=:_,'_(
M6+)/&XL[72'#&1M)>``]R?4T=JVMZT-?DFFE*:4II2FE*:4II2FE*:4K!7W#
M\]PCC?MSN\HS?A3,>>(!+(-M!AF$XW893;090]LK:*\EJJZ:">0&K.5DDN[N
MGH147XZB[2IL*%5M6FWV5LD#R+GG*;$S`^9L/RFRPC(B[H?+N`*+C?"*\J2X
MKY9JZMRNN62P*+8BM1D!"H^1$<KMU;J0T\*BY-RI=*[/FE>4TI32E-*4TI6#
MGN31L?V0=P/F9/%B#68S32+<2P7)"3M9F6-N?C3&XZYM_%-FK$6E9*&OJ87G
MI)'NYJ)KQVFBU)NNM:R?9\X;SE.4N1>>P%MN-^.+.F*Q*WX6L5Y3F;!D*MHY
M:>XB/Y+4>:T;&/7DR^=`.Q(U)\I57;Q]&E>'6NPSI7E-*4TI32E-*5JI]Y&&
MIF[,C6V9AD$[>4>.WT0,5&%D-5?9`TP_Z=19176%K1B+C1OSJ0]Q<'0Z-FSM
M]D6+@J5)O6]1)[0/90O`N+E\_0\BY#9"<S8.-5OXP)`IZW',1L:O)S)["SKA
MZ&ZO*M9RBAGQQ>5,_H$Z&O57H[4UMM_;2HFMV.O*4TI32E-*5%7.GYF.5?T?
M9?\`Q`?J+M*DWZA7R;M>U*O_T^W-[3/^'-VA_H5Q#^`-U$:FI.U'PJ^N].'*
M[/'<-Q[&ZB.U'M3;V>WZWCQ>DBK`P9A9DEF>Q[&]<S]^G??;Q^S6WXOTVNFD
M>]"T!/FM?:/T6EXS%Y3ELWD<HQ%C(VL0$[B]S@0@524"=JUEYWC=;G3)3B9R
MI;K`J$BU(%J'-8V8Z(:=(VJ+&D?4#*4K/.<S9SV*NWCK>XV0^#<QH'IR'KV_
MUK]+<4^3AY,0;`,;+R61L<\E6M+@KBXKYFM7:#8%*XY&`AYQAM2T>RAEK(X[
M6;(8FI#$E;`I`H4AOE0)ZHU7^0WKG5KG*Z/IW5474V9,V/,)`#OLB_BE>/Y7
M$XWEN4P\G!1[W-],M4^H]H<X@D^5I!)1B@770BJ#9"56%W`F-T)I%OCI0L&*
M'%U+R/)40=C9#0YHT1'R@LE(8JN<BJ]=T5?!->_W)R^:0!LWU7[^'C6VP<B7
MD^*;F9N*(\J.0S,8\!6D_2]>CB`;"PL4O5T95*-5&_1A@FS1751$5'53D%0!
MAL(3T$!L8_G.E<^9(U:D:JG2NR[(BIK`PES-TAN#K5;A(9,Q,V.<,=CS.:9-
MK7.=M\Y:J(@52>NETJ@V%Q>"T]C75B5@(*6*4QHQTX4$#7!QM\A&&RRJX`Z.
M=Z+)TJBQKLU4\=2;&T2`R-<7$*-5_#K6P@Q^.S)\3*?D.?,UA>"P%R[BC@6@
M7:F@-SJ#5DBW^65II&'8N.3D3*V1F2//$%Z:%+*20,63H-EB8D93(6-B:B*J
MSOZG)OOJR(8)&>O*X-7RI^9`I%NW\*V&5B\?+Z/*<HT02R+$T/>C]B.)LO<E
MW^T("B5<'(66W%+#%E!DLD]O/:H2>E:.];"O22-?.(DBB:K(YHV)M&K4_!N7
MJ7;5;%@9+(8FN#6C1=#63B>/PGXYXV'#<["]!!N(VN2X`)N03JNHL%JS,:M/
M2@R2U+3*MER]I=4MO+-/+#,9`KA58D^[_E5W4[9=E_V5UGD5TA;*`0RQ2R@:
MUL.3XZ-S8W.D9+,UGF#411J"G;3PT-5_!*3*XS,L.L+`::><BS;0?+-,X%ZP
MC31698PS)'>F<V-R-1V[%<].I-0R78Z8XB98#S>/A5'E.0QY8,+&=&]K/[8>
M!M"CS`L:7$>92#:Z:5R,>C/,R(45]4"1`V/U5C>"VP\,[39+&"-\80GF0*K/
M33.5S.G[Y%1$5=M>RQQ#'#_4.\GZ2#HG>JF9R,T0RV,>YL+&;8P8U#O(?J*%
M"H%UT^=3/,-C6)WPF23QQQ9);O!HQ[->F92FESN&"`?+(V6&!DQ4C4ZGMZ%W
M^;[FH8[\F=@QFE8&G<G@+D_A7S3E&?>X&6BM@8QSB%(1P"ER"Y0=M.E7=VEX
M+D_"O/\`]'YCD;37W,=$<93T\"0&-='C\L\BP%7%(&RL6)XLS'M8]T>SI';(
MJ[ZO\UEP\IQ#G8`W08S@IT^KL"55>H6OD'OSD.-YG@&9W!N,S,20,>XAUB1J
MCSN!-P?@*J/>AC&+\,9D#R(!CPM57Y8\*B2SAKRC!HW22S36,31:Z3\`V:-_
MF>:]NR/35+A&S\M!)AOF4Q@N0D#X7/\`"ND_2KW/F9O'C`ER7RY,)+BQ0J($
M*G5-$%TK%J6XR"/*ZJQJ`X$J+.&/ZC&QL"6:UR*J-BDB5ZRJQ=^IG3U;*OC\
M=M9#'`V&:&5Y,S;#5%K[W!"W+XULI4-!WM46W=U_<52JV1;UP]ZP<:RJS3AE
ME/9CT3(Y''$MC26%EL3&GEPE1JB(Z)SF[M^Q=8&QR>DKHCMTW?Z>%2:PY,!E
M<Z1D+O(9+C8"4.P>-T=WJUW%1WT5]]5C'2-SVK?=,C*X11V.2=*P56/C=.Y?
M!K61[H]5V1%U$-=&YA8;]/\`6NJEC9ALP!CEQVC^TH+W`HF]UBB:DG2K=M2!
M"!*.TK,UJ+W%Y)Q:-10(WQ)&UR,<6':#RQ#GPE0-G1BSOC\N1$V:Y=EU:FAD
M@)CF@+)"%5?W]OEK6'VUR#.2DY1L7%RLY*/=(3)W!(!C-VEKD)#05'45[<NH
ML4^GUV/Y#B-T\26V&LQ2J9")&L?5M%F&@L9AR61QHR(EKHVO7H7?[NF"^=IF
MFARF-<B'=XZHO\JK.Y'+R<LY&).V69L;@6D``%Q*N"C56W2]JX#,BK_4(9Q6
M0V\R/'G.:R4VKMZX:OFE:^-P5D1,UD;YU@W5J-=TJYB;+XZR?;&)\;N0;MQW
M_P!)!)^`J._-Y+C\SC^3;Z#)'#<'.:[<`0=S!JBZ^!\*XV5Y@)CID9.:#SP!
M&CQ%2SL:^1DLA[O+DD=&*LTWRKNOQV55U''QY)21C?4MOE\:W&%QS>0P##QT
MK9)X_(0MP&Z`*EJDVEN,),P>J?CC4AC+61ATQ2EC2#PR%R,@@F#L%;$<PMB[
M_@FHZ-%W=M\=0?'D&5XD^L:Z?Q%<+E0<M@<[E?Y%=C=IA:U'*=H+G!S;L+3W
ML>E6MD5%C%_.-57X;RZ>.&=Z!PS&@"1.':DD$RRCN9%,Q\Z(L:=:NW_T:0S9
M&*2_'>&OT6Q-]=:Z#$FFFA?DAY.9O:=Q`<M]$U!`^JR5G9V(UP;.7K6Q!E.C
MBDPKTL@1$J30MG')<Q98GQO?'TNB1J>/S;IK2\H7^B&EHV[E5+U\1_7[)R)?
M9^'%D.C);FVVV*%NA!^=;>]:"OQQ32E-*4TI32E-*4TI32E-*5C9W893R?B7
M"V46'$_',/)N2$"RUL]$_*ZO#9PZ@^"4:QNP;JY3Z?$?4P2+-$V141SVHFZ:
M\<B7J;`"ZYK0A[-)>-VO=-R-'8\\Y[=<CXGB^5TUCPL3CYSL3K!2[BO-*N+;
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MC=W*FVO"4(O>I`&Y2U9(]H>+X]AO;EQ=CV)Y]CO*&.!4QDM1GF)@T=;C^1"6
M%S96+"JX''(X:8:.)2UB<V%K?PD;NM.OJU[7A5;UDCI7E-*4TI32E15SI^9C
ME7]'V7_Q`?J+M*DWZA7R;M>U*O_4[<WM,_X<W:'^A7$/X`W41J:D[4?"JWWX
M@D6&.\=P5IR55TM]<.J[)\KHHHI&A!+*+.NZ,6`Y$:QV_P`/LUNN(D$<DQ>U
M8T"C^?RK[M^A>P9_N1\T(D@;CQES4!/U.0CQ;<VK4[Q\18X^^[M<Z/&H[[UB
M58W3,^7U`1"RP(DWDR-B<UE@0US454W8J(J_#7493(I#''A!SH44VZ_^E?IK
MDI'9D4$4>,'P["X'H"U'!%5"6@KXU=?'MP7=-R`*UB927-#!<2VN./04?TE8
M>)`4Y\X[U:2\`4W\'LWYF.7K3P=J&7CQQB%\3]T3DOX_ZD7K3<C(^"6!X@<^
M*:2/TY;DR.8XML1;<6W71P0=*Y>!9CB5M074<W2.");UK#KVH=(^8=H(5E&K
MAO,ZU5+(TT?K>G@QS-G;(J:P9&--CR-#Q<A0#\15[F,/D,C-PI\!Y?,8I&MB
MD``+G.8;Z?0UKD'4::&K9+Q*Q)!R6WHB[&;(V1CC8_#=RN+L"K,><>4*O)B5
M6J&`[S72)(JHWY53?4_5C?+`R<`0+YD"6_F:W&/RS>.9!B201>@_<9"RS&,>
M"'/!_,X)M36ZUP:K'8[N6DK\F#:058-O+^[HZJ%976&51SOFL"!)4\WSXHAX
MHII%\43J^YJ4\SVNE?CN<8V@`./1O05DARHN-Q<AT$D<,I?''&YYVCT;!NX6
M1SB2!U)%4\#)8+)Q.#TY1<4M!:?4[`0>%BKZF&/R@4))>FQ$8[4<UO2J*SJ?
M]NL3H986-GE`VR:?SK>Y&'BRS_YF2)KG.@$2O5`UQ5Q8.A)O?5!7'+O9\?L\
MCMCLC8E:Z/K:!U1EF0)UPM.9*R)JO<.0/,K-MEW:OV+XZRMB&1'#'%!_<ZG1
M:K,QXW,QL>6$EX(0H6M4+L(\00OQKTT7I*>QL\TS6O2"L+EK4:=%&YD8=57A
M-96&J/OY4$52,Y'JBHFZ-5%U:](Y)BQ8"KFM(3NXZA?$UHN7Y"3%XYV/Q.07
M9+GN-[_4XEX77S%?QJ[*[)3\?S.J)JKPFYHS0HZDFO&6%B`_44@+*R(I[6I(
MH#:\1.EDG4BNGW:J)X:Q!L;L66&2`-E!+@3U2VWXK_"M;R/$.Y3%.;+Y9MX*
M$%/(J!O3=N-T2PNM7+?S/<6TK"J0<,$C9EJ-+)),3NL<LDXP$<SF>:44YS%1
M$ZMMT1J;[:HQ-:%$[B7?E[#XU>QGR_;,CY3/+Y([@@`;M$+DT:+@DIU6O45A
MMQ>W&.9%.=,JU;!2B\=/\KUX[>II(["XIU5625DD/BC$1S?]>K4<XQXYXPQ2
M;!X_;K7/Y7)\<[&FPF1B..7<%'TGH2".CEZV-;P\1;!?X1BUW;`BRFMHAI!S
MW0L=*.JCL21\<KFK(ULBL1';+LNVN(F<8,J6)CB(]UQ_K7XIY+?A<GR.%CRD
MPF9P1;$+91WK%3O>XY7D3@JNDN"O-J:+):NTMH!HG12SU\TK0F)!/&GF0^3.
M0V1SF[*K6KOX:WGM[/=A\A,8`/5<PAJW`(OIXBNX_2K-Q\/WA'`\EK98W-!5
M$<A/\`@\:UK@XA<X<*,>V-<A?6&0UOU%SI7MK*TAS6E/DE1J(4;"*JN1NZI\
MO@FMO)-#DR2.>/3W!?B>GPO7ZW_RC,B*/B\64,9MLPHKDT\0">MJLBHQC%C<
MSMI:]MX60I\I"GV?HQ*T/UA3)DMF-&@')FFD\M&-ZWN1J-3P^.K4^3.<2)CG
M,#`.BJ4&E;!AS<"".69C5<P`L:2XN07:%)``U*"K]JSP:?(X:^XKZW(JXFP8
M^8>2!9"D&C_!SQL:V9/-5D#UD:Y$W1S4UK7MWQA\:AXZ]*S9>/FY?'9$V+G/
MQI1$0WS(%-P;CJ;'O445=!C&"7,TU#50>3$5*6CCY9Y166JD++%(0WJC:R-8
MTV6/Q1-6ILF;*`,[R7(!\JZR(<AR/&MQ9,O:'!';&M#BPA"`4N5ZU?GU7*CP
MLA^FS1OJXPXKDMPXD,C)U=)*62&!U,=*CX(VJ_I3[]NR(GAJNUC`UA=]1)"=
MO$_&M(^#A\/D.-9DX[AEC^VUQ>;KY&EW3Y]"O>O</D=CE@1!T)TQE`T!E->2
M(-Z)&D'*L`@ODP,;_P!8,DZI&NVZ*OPT</3+6.:CE4?*H#@L'B,C8Z$,Y,O,
MD87<"UMWE3^4I?PKT7RL@PI,+KXB+&8<EC!8#9HT])511L:*X8ML;9XIVJJH
MFR_ZDUGC<LS9R4=_/X50Q,4OYB7D\O;#B/C.Y[`=SWN/F4*B>-6VS"*0B7'*
MNZFE2Y`]$1%6NL?+E?.Z1SHH'D%=41+G0M1SE?\`,F^RZS,GG`F<P#8Y5*?L
ME9\SEG0LR,S"+CB`%@?M6R(2@\;#IVKRSEV3#7^.X]25JV037/M"(FO<6]8W
M2-B8B,$5L+QPHXU<Y=E3P7[-(!C/BF=/)MDZ?MXUCXE\<>+D\D9`&.9Z9<?*
M04OK=7$UL`[&Y\F*YDOYK$VKBJTQ1Z0TPP:0%0R*1\LTDD:-9)&J)X?;K2<L
MZ+[5K6M._=JMJ^$_KABXD'M+C70,>Z0Y(5Y<H-M`MZVXZYNOR=32E-*4TI32
ME-*4TI32E-*5&?+'#O&W..)3X+RKBE;F6)E$C&$4MK&Z0.4@.1)1Y'L:YJJL
M<B(J>.O"%KT$C2N1QSQ)QGQ'1BXYQK@^-X73!Q>3`%050H#6Q[[JCY(8TED5
MR_%7.7?7M%)J1-*\II2FE*:4II2M-?O.4H^1\5]OU&'C^297FAW.\:X-CM4#
M6VU%:VH>`YB?909)36\;@;N1M&,0ZL$ZHYY[%(VQ+U>"Q.H^!J;2@=\JH/LR
M3\>?D_W)UV"%98237<@8;^5<>0X=_1S7@79>(^:E=38"Z*.7'WBC,1"E>YZE
M2JDJ+LJ)J70)I47'S'O:MV6E>4TI32E-*4TI775]XL5M+RQA><"\3<B1W(O'
MY%+4\[8;%<6@0!UE<#CPX1:4X%7;C^DDCED.FF=$DGEC]+'(JZQ__(?A60?0
M/C6SCVRZMU-V1\(@28':\<3,!RV8C&KIQZV#R2\\R@HC(Y6VC(CX8LQFF=;1
M1RM:Z*(UK=D1$UE/3X5!P0FZUGEKRO*:4II2FE*BKG3\S'*OZ/LO_B`_47:5
M)OU"ODW:]J5?_]7MS>TS_AS=H?Z%<0_@#=1&IJ3M1\*DSO.QRIOL#I9K&U($
M(JK,DD&J@*""2Y5\,#2&R%DB$D1-"8Q'(D*L<Y7;*OPUMN*>YDL@;&T@BY()
M3Y`C7QKZQ^D'(YF#SV2S%B)CEC`>X*=@!*6T*J1>M5N;YC?DG\>X^7@P5AB%
M=?#5N6$U`]=6GCUUE(D#I&S$I-,^Q#&B<2LQ+WPN?"C?+3J3?J<#&QPS+D?D
M[)]I+?J()'SZZ636OT.SC1C-Y3/XOD9I.1R&[XVR/W`.;T0`#:20U&@.0ZVJ
MX,YQ[C)UE?Y@)5'R9W9$&1W5XZXG)J3Q1_3!PE4P@<$*SC6+&=2^9(]!V?*Y
M7=.^JC9\LPQXY>!`-`@MUN:V'M63G8WX.'D2L_Q$3&!D88!*TN4I(7$AI9IY
M6@O-PBU9@]7CM)BMT0D=!4`&QCGAMK))?+8TR6`>R2Q$(657/)9&Y9.A[6>9
M$W;9%W28?+-)&KG.?I?^1KH<F;-?RF-"QDSG1.<'ER`DM!,9:0`@!*"Q*.*]
MJKW&^0U^>7>)999LM\=Q^FMXZ/*A!!`J8;)*P!LJ%$6T)*DRN&<LL;U44B-5
M1J-:J/\`%<N4S[2.?%:6/D<Q6NUVD]M+_$&N0Y_C.0PL#D<?&<Y_(O#G1A[G
M.=&YQ&T,V@`]4W-UN;5+_+N:<<W4^)LXNQ6VKBPGW`%C82-064:OM0X8UM!T
MW>\U$B@5%8Y8G*BHBIX*FM;C,FB;*,B4.#D*#J1T/0?OK6>SO;WNF$<H[W;R
M43X3Z;HPH=YF.)V'^DDD7NA!K$6QQX28VZ'H)YZ=T$H4!DQ3VR61,AB.D87.
M17LA&A]6H[WM8C4Z6/3????5\R/:(Y'-#F]!T'<7K[=QV<TP8N/R9]65S7.5
MH1J,L``23Y00%NI!-4ZMPFD%E)-OG6A*U`A&0AJ*5#9OLBV],8X+WQC!^0"[
M9%F54D5L:JGS+K*<N0(V/:`[RFR)W-R:AEY&9F-CCPVL)=,(T>=NQNI<$U=K
MM;8$^%<K&[<S,`<E9>@5%$TY65\H]G//Y;PS%<LXT*RL0>?U#)7,8]&HF_VH
MFR:]E$>-)$<>=SR+@^(ZFJO(<:[%9A;X))$!41@%2++:X`2_7P)J^@<*OE=6
MLQ\<6>LF/"J6U\5,284HLJ/:U[+)"V!I\@CVIYG4D*-\>K?9*_W$<A>Z4GU$
M552^NG[+6HS>3PL&)[,F1S2R-SP2\!H(0(YFTO(\PN$)7HE9"RB'PCT:"8D!
M7W$0_P!2I0?4O,LT)KE=,ZRL(?6/C]5Y<#4;\C(9$3;RT3==421YCO+F=;5\
M^Q\C&EFSQD\R]V*YVR5R!L9:_P`OIL):#M4GJ7-5=QJ(+BS'Q2X6_(QFUR2W
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MX.;GX9AQ8WAZN.TDHH`Z_&VBUK>#,RS)"&6S)XQL%)ZHAZQ+$&$N>R:UD#9>
MAVQ[%8K%<]RM<S;PUN<B/$C9L0G+'6]A_"OU+A`8,SF/8#FM"EWID@M4E%^D
M#1+K7&RFXQ6H+AKUNTIGE0>D<2&OJYVDQRK(Y[I'C3BC0CMD3=)6-W=N[JV\
M$CCXV3*"YC`YK;H2EOYULH<C),1GR<-[W%_E\J#334$KT(^"=:]M4-B<=D[(
M3"+2T*Q^OL1:\R*MBG:9-(.Y'-0F$AL3EDZNMW@Y41-T3[-8#+(CH3Y6DZ5?
MY"+E9<6/&P\>%K,AT9>KR"UH-_*0OATN;FN2\"+Z9>/K*P[)JTN2$`R](CV@
MJ[0X78P$=T0K8"%%\]LGFK'^"W^9RHFI$WCW;6R#H#J/&]4,?.<[.QVY/*?;
M2L5PB'U%C3Y7(JHY"-JWZ"H1)-.PR3'!:!ME8MORS132BKX%X(5DS\"+'$"$
MR$B*-(U\SS)7N2555&M:B>-YL;)V3/D>&EGY0TW'QKM@6<K/F-R\:)(XVN:[
M8X.+-25<H))L6M`V]7$FTPDS4X$5:+6)<^ONYF%VT,C8C!2#@V,?+8>K&01C
M)%=&C6HL;NG=%W7QU2]-SB7N<-HT[IVKF,;(Y#(=E#(@QQCP-+6.&X%K7+Y"
MTEQZJ?-?2N)%?O'RH".OI_4Q32R]1[KED1=3-"CMH2Z@JN<\UDD:+TRQR,1C
MU1>A4\->B-OHR/?(1($1J6<.MUL:GD8DD_'>C+.P8VQ'?VRI)^DL<U^T!4W!
MP)(ZBK>3%&,S"_D=E!M@'*C+,<%_HF$T!"IYCY''I&OJHGJNZ[L;MMTILGCJ
MT[)+L>';BAKQ8D=1\*A#D%F!%%-$-GT(6N#9.GE`3:?F>]5T2QGJQ+;(;.Y=
MC\-7!(\"_DDC<*0)'&L9#B10FME%$>CU:YRS.1RK]ZFL7IB5[(XVETCM0-?W
M_P"E8,D,_P#'P684<T#R-T94%I)4`.)1QT(M\ZST["Q:@G,3[VOMHK>4W&$<
M\II[9UE@?+^`DC@]$.YD*M\$W>]4^[K2\LZ0,]-\6TAW[=:^$?KS+D-X3%Q'
MP.CQVY*M:6)=+^;<03\A6U[6@K\HTTI32E-*4TI32E-*4TI32E-*4TI32E-*
M4TI32E-*5BEW;<*<Q<VXC@M9PES8O!F5XIR=C&66.2)AF(9E+:8J(I0&1T]6
MW,,?R43'LB^G'N(K;&,:18BX&QRM=#*]6^$*1VKT%`0E7+V]\%WO"5?EL63<
MP99S3>9?<BVYN4YEBO&F+V\?HPD!A$>SC3#L-`L&-B:FTA44LS=NE'(WPU[8
M``"A*UD1I7E-*4TI32E-*5JF[\^8^Z?C3D;!!>/,IX$XXX4GIK"TL\NY<K*B
M\;D6?U44QU9QM<QVV6X[)BN.98%#)#'<AQ$DB&^6JL?%UM6-]Q[)4PB`]5K*
M;L=Y%YCY9[8N.>0^>L=J\4Y-R:;,S+;'Z5];-5UM-%GF3"8;$"73RS5EA!)A
MHX$B$PKT$]?F;(KE1):)4-5K+/2E-*4TI32E15SI^9CE7]'V7_Q`?J+M*DWZ
MA7R;M>U*O__6[<WM,_X<W:'^A7$/X`W41J:D[4?"LG^=\/P/*L:CDSFZAH8:
MT>V;56,]A""R(L\6*%ZM9/NPR=$B;T1HBN5?@GCK88,V1%+_`&(]RD*$70_N
MKI_:G+\MQ/(+Q4)D=(6A[0#<`]QIKK6DT+(K.JY8@;7'UL]-,#-8W(F5V`UE
M8S5("R`$N$J6PL)]:60V-53H>YD'P=NJ)KM9HHGX;I'L*BP+0@4WN?VO7ZTQ
M\/U/;_V\\<K<TR!K/25H#B-R[M-K0MU0NM51Y4I,=QLJM)(R$JK+\\=]Q0PQ
M3&CX\]S8V(/=E!#O$K0DB<BHU951R(OBJZIX\>1,$;""TZ$D`N_]H)4UN_:7
MNG[J+-9]OZC&M.V73?J=P4JYW<I:K"@.')OX:\BQ&L,.R*DD"QRMI*RQL;0R
MX(,1HMI9N$&G?3X^V>.1%DG\J-SVN:BJNVK(QG-QGN#"V=C_`#%Q`")]+5U=
MX!2E;7(Y19(IV,/^2B<UTFXMVMB`OU&YR)HJ*#5ZU=?2X^#/B=<=(\M6&V4U
M2(8Q9HCS$=+)")92NDC:60Z%51$170*F[FIMJG*[(D>S(E;8(`HZ#N.W\:PF
M:/.,F5'$#`YVWU-00+7&J!1U1W0U'8&$9G79%+?A61SJJ8N(I!SRW2#EC!D+
MZ61945CG,5=V=7@U[E\-]EU:DRH98FQ&%)`-0.IUK<C,XD8LF)D3L,Q;M1H\
MS21==?BFH`JHF<DU:/F%R"J;1-'+L.@@GRY#I2:\:,TX:VJ!'-LA19HIVM$D
M?&L;EC>JO1'-W]=QTAB8^*5244=+E`AT/C\?C6NP8Y#G21X9?D-$;?I-@T^4
M.:X^7<H)<`51+=:]&).J0*>QO\")M+2N*)4DA\)$<<[;#:.6<&!Y,:L:!+(Y
MB.:QKMF+XJB?##DB02LCRF@/#4TLG>W6MUE2R9\L>'RC8XI!]*@W:/I+@+[M
M=44Z7JY2JROM0?0@E7]5EQ!=58SAA1A'65;)9OZAAIQE9%UD*UKI7-3IZ61J
MJ)]FL<3'L<7N#3`A"E0"G:M=/SKX96NEBAR..C8YJM+FM.W5Q-]K>E]2:NL,
M^Y*"JQZH@(6JK#"Y[Q30"5-,DCE1A`DYKI$%$KG(Y)DZ6N5)%<O5TKLF%[8F
MN?N"N(\M]/\`6M:^"+=+D9+91EO8`P-+2P!"CMJ;B\_3J`@%E%7+9LH;?**R
MP+<;D((56^KACBDGJ8"03&I.=N7O'(/902,<R%\6_F-5O@J>.C))(X'L8@)/
M[]/P2M"S#S&8,\)VXT[G[S82%KFV8=MP6NL7`HEZ_+:/)A2,;J,?`!J\<#!D
M:;!$))+<%LGE5?42/ED1T\JM^1GR*K=O#Q74&R0ELKI%]8FW:K&'C8KVYF;G
M9SY\ETBJ7`,!`LUHT;>YO?X"JG@_%QEK<W@R99`ZPLR(+X<^R>UH`-:J(QE=
M8#.<A-:9,X=6-BD:WP;OMX[KYD9T>R'^UM#`ENI[UJN5YV'C<<2/P'28@)8Y
M@"R;^["/*]H520:M:Y'N)LN=!9,`=BQL3H)75T4:"-E@>[J=../)#ULZ6;M8
MBM>[;=%\=98WQ^E]3O6!U-;[$$;.)9+@,_\`/CN&N/FOU!(/>Y-O"OV2\Q06
MG+*QL!T@`YKV3P2@3^K9".U[U.KA7M<8Q94:[>.1S^KPUB>V3U&,>1O=I>WP
M)JYC8'*3Y&[E<C9,V)2C@B_T.0[2G0@"HVRO,2"J2!M)QSDV60'Q0V$%Z1C+
MQX:BM(8DAPA<[*PJ:"<=-^MRO3H1%W3;X;3'Q")'QR9;&.:40.%SX7"U#%9C
M,R!F9?+18[0K3`9'%SG@HUX:H&T]NM684A-_2!30&D886LE>75,C<MG:%$P%
M)&RK"A%B5%]6USD=UQ+Y;-U>J(FO`(X,E^]@E`!5;#X_+XUUK))F1!@;ZL)W
M-<1Y6M:0N]SB;;;(AOH+FJP142?6(KZWRW);G'Z,"8<J$:W:P`..=OJGQR5X
M,$:,,:K_`)E<CTE7P\$V3469(+/09C1M>XV*7_$U0?@QQ0/^UQ(XN2D>"A9N
M<\BVI*[2BA#;XU5LJ'XV(+J\GQ\:R,"K'-&JVEVX3@VV,0@ZK:"!20AS^H9.
M]S7I$Z5R1IX)OK%&Z9K9H7%";FQ_`F]0XH>ZPV/$Y26)LTHN&L<"&.<?(YRD
M:!;@7JNW8?4,,,!82Q5-]C<A\ES(L@U9%DC7R.GI@SR('2L.;!`CFQJYK?G1
M5W1VH-`+?5<V[7:=4[D=JI<9GN9G9,,L+79D63Z99<N](@!KW,!^E3]2']U1
M=;X9>WV.UU>':UE->BS++)]+-(*22$=/^GD9;-B'B<9)!&DDJ]3D5=TZ=E35
MZ+(QX9WS&,R1$6W($/7RW*=JV4.>6RRQRMD;`3?RZ@G0WT&@M\ZO2A8P9PH]
MH=66%S,,_P`^"26,619?(\KK+V12$1_0C]]FINJ_=U1F)5TC6D1DV3^59I@9
MHWP8\<K8(@$<1NLJJ-!X:U:]C+2Y>-E'&M-EAV$9WZ%LX^0K56%GBP+)$21\
M!(\D4<,PI#4Z))&S*B(Y?M35V`28XQ\^6-K\/=])(#C^%_@HJIE??8.1#FGB
M1F8VCF!P;*4T<%.HUVHMJSV]NZHMZ7)+"MM"*V62OQQP#_ICB5$(6"5.DP=I
M2K-'$1OU(C_%$7P\-<_SLL<TKI(P[:2MTM^%J^.?KXX/]K<9(6'>_)W*0A"C
MZ2.XZI6W?7/5^1::4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*U7^ZV
M;ACN+N&<;R'+^9<7R?*.;Z,?`P.',\Q+C`K,;&HH[RZR+$LNSK/[S&<+H<9M
M,1"-3K,L!Y5,2#R$DD3H7S\S?VZ5Z$0K5>]M3*.*K+%.6<4X^DY@@R'#<QJ!
M\^I.7.4L8YE(IK&VHV6-,S'>0,&R'*L.M*XRJ>DLD09TCAY5Z)FL>FVO=0#T
MKSY5LRTI32E-*4TI32E:>?=%X?[81ZJ/N-Y6YV$X,Y6QK$KO#^-S[G,<'IJ;
M,;$D`VSKL*=4\@UMO0^?=GB-:XUL3)1HT<]9&1HY=0*!RCZB$2I"X`.@-9S]
MF/&O''$G;%Q!A?$UZW)\#AQG\H*?(69#795!<SYE8&YA<V`M_3HE18!D7=X0
ML+A40=L72V-$:U$UD=J14!XZUD_KRO::4II2FE*BKG3\S'*OZ/LO_B`_47:5
M)OU"ODW:]J5?_]?MS>TS_AS=H?Z%<0_@#=1&IJ3M1\*EON\HI[7#J$T9P\$]
M19ESPE%$>7%#-*/"L,;AE<QI/J9($8BJNT:JBKX+K;<6YHF>UX)81=/]:^D_
MIGG_`&O)9^.`2Z>(-0!38E2#T15\:U5<64^:9USR%3W%N%@U;?V<Y+Q;!@-Q
M6O;'^%AJJ-Q9<!+#+")CTZHU1L;OO4776Y+L2'CR^*/U7-'101XN^'C7Z"]S
M9\7M_P!GS3L@FGR(F!H+26$K^9]B"`?QJ4.ZOMV"KK.E=-F[CS!J:4BLAKQ1
M`[9L0,HL<0!0Z%/AM&[S.].DB*YC$<B;^*ZJ</R;RUQ;``Q;DJ1\1V\4UK0?
MIS[W_P`AA9X_Q1C:^<`J26G>"20Y/+I=/"HGAQB!E92X70K,VUEJQ`8[65?6
MVQ)@P\[O2OG>UKQV*XE7,B8BQ,E5%:JKOJ<N2]SW3RD;`\G:+`+UKZ)C&**7
MD.5R6[L8[B5.UH:2+?)$)U(Z5&Q-`N(8'D>08C96(AHU-*!7''N`/NZ>2G;(
MT@I@$@@S[F8,HIZJK.AZK^#5Z].M@V<96;C-S(VE@<I`4-<#T)6P*?SK,9G3
M97^(80]TTI<=@(:K]$*D-4`:VZI>J#!)?61F/9O8Y1-CE=9-?8V$=C%&)%;.
MLWR$1^1%N_R&RD,>]D3%1D?6K45?%='NC:<C%&,'D6:ET`_C;K6YCQ,6#$=B
M8L3I,J([7)="T`'=\.JU+!0@MW&&8-75S@+R)X\^T(TQ$YL$$#Q?(.\I?50^
M6Y99(NI.ELJ=2*C4UK'!T7E5VYI\4\;=*K<?EO@?.,C*2>'0JGE<4*BUU``/
MA:YKBRUD&%4PU`<&&.MCYCYPX8HZ]UL`=&^&2R%<$J*YD2(J[HO2JHC6[JNV
MO!*^>1T@<?+\T3I>KH='R>4[+QWF0-0!RKLD:5V.6P)L%UZE*XN,8;7XRF46
M\P=I(TM!PV0PFJ2_S7-F?$00]BND2+HG5'JK6]:IX;)KR;+,[8V.10O2L^5-
MD9DW'XN-/"Q/,;(H"*!XJ+"Z5QF22R2P79=M:I+`*57PT\4TJ1L@G<`Z4@R)
M7*IB#O":V+IZ7,;(Y/%%UX'@1F%L;2K@5ZV73MK>KLN"!E/#(6M9M7U.A-[#
ML2JDGL-*DP[-;.B`@O\`'<<@-?!Y41\Q$$8H-='-,.!(\.OZ94;-%`1YJ2.5
M$5S%W1%U69"R9Z/D(54`ZV-<T.&AGEDXSD>1<UA;N:=Q+GHKD<^UB0FT:`UZ
M9;M;W*9X:\FY*+KY*Z&.<5(70.:7U22PQ20-<CRA9(OF8B=2M>FR)MJR<>2.
M"*5S6['+8ZA._A6B@R8,7&R<7(;'&U':FQZ+?0$?PJ0*F]-KVVU!<Y)<51]W
MZ5TLMVV<$KTZ/G2$8I4'A5\'D2(V-7[?#P^[JM*W>6N9&U!VN/B*US^,PY&X
MG(X?'1Y.-CEY_MD.`<4*BYNNH'SJ-R!!@6VL+;93(6I*.GF!QI.2C9V*V$-S
MW="#JJ[];5ZG(GQVUZYQ4$L\WA^VM=QARRYGV$C,3TPNXG=9I(U<G4=CUZ5&
M!Q.>"W[L9^GNKJ"XCC8N1>?*.6%%,CU:W97>4^&/J:G4B_,OQU:;'B&$3F0_
M<-_+T/\`UK>,&!-$,XED[HU6,!5<.OS[):N'25&1C09'4`Y,7;ES3-(K!H31
MQ'">D\Q\K;0I9&]/KWQ1LW5$W:NVLCIL>8PN?&&-&I_TJ'*>EBOPL^3C6["T
MM<K=VXN0#8U#]()^=ZMZ>`^QK![#+8DIK:K(98Q1USIS)"48_IF@#%&\MZO(
M8Q6=37^&ZJB+J3MC97LQG;HS93;\36ZQIQC-9'C,#XI!M((`(MU)M95N*KMA
M8?3VUI22I:Q7)(@:C55*M<^OA!5BH\P9L[&V,;XYMI'NWWV\4746-]3<HV!@
M-R=?AVK6QQ`NRL9D9$S07#?)NW%W5I16HEATKWY5=#C5I1D54VTDJYU+]+6B
M0PVPK2'KY+Y`&12(/*YS'>6^-/F8U-TW^,<>`S21M+M@=U)M^/\`K6/"?+C.
ME:_(<NS:CR=I07&X_5\]#5G5?,](.=45UQCMA(#=.A@DA+,E%M1"S"'1#E`!
MSK$1.3&L2+.Z./J2%=D5-;)W$/\`2F>W);Y.P46O<BP\%JAGX65FO>S#;LR`
MW<J>5S0#N:2!9HU:KOJJ6#+6YN[2Q;=YG6AUI4\QU)*N.QU<=$TV)C8!"O-E
M>0U!E9NUSG,1R^/3K7.;"T1^GCH\"]UW?"M?QV!%Q^)NQ\"6=X`9*P2[G.VF
MY!'?K8_&O5CN)W%-#9HTQN;VY14ME-=ULT*3V`[86SHP9Z>;,^`:%O2]$>C&
M?8FO)IVS[6[=C6V1+"K.5FX)D@G+#B81;L;'(OD<NWS"P!)NWJ:M0?E0R@O&
MK6UK,H?&/*;/BYPTD#2BX5<OTY;4J*88:1\2??.16(NR[:M?8QOQ_5D?M:J*
M"J>*:FHY'#R\@^;CW2/QYB$;,RP1%W``]/BM;&>R`N#*L_OLL&QNRQJ*&B6M
M2M+(4R(!TTB%/KV&QN@A-49TNWF+#NOV+MKF^49Z<;6EX<2=1;]U?#/UJ3CO
M;O'\0[D69.1ZX>YP57$!-VTJBIH#6TK6BK\OTTI32E-*4TI32E-*4TI32E-*
M4TI32E-*4TI32E-*5KT]P/F##<!I.(>-\_X(L^?,6YWR[,,*+H:'`QN3K_&S
M:7C7*<KJ\KJ<'+"+AMIJ\RK:U\G5"HT;U>C_`+%B=4[@U("SG=DJB^UCBM=Q
MOVN4W%(F/\G`'8#<W(MOE'*?#`G!][FY5Y;V5]!:1XL"^4<B*M"-C"6='N5W
MD-WV^"3.@J'4ULEUY7M-*4TI32E-*5UM?=MN<SX2[L^-^XO$9.0J^03A^VX_
M.OT[=?Z9>*,?K[:U8<8?=WQ5]45F)6SHQ$C6>7H:D#G-<_I<J:AH\]R*G_\`
M&$Z&MH_M;5-;3]B_"$-3E,&:!6#,^R!F1"AT]>&9-DW)N99"7`#7T%O>U``-
M:79O%AA@*E;%'"C5Z7(K6Y#4/&M@>O*4TI32E-*5%7.GYF.5?T?9?_$!^HNT
MJ3?J%?)NU[4J_]#MS>TS_AS=H?Z%<0_@#=1&IJ3M1\*O/OCD@;@^,,4FQ%.^
MKGD`O!K3CV.402"4AA$HA`\(6\>W3)+U)\41-];SA%]>2S2W;=2!\$M>OK/Z
M1-D/+YY$+'P>FT.W%H17%$4$GQ`3HM:C.,,VL+&_NK*VP8@.X!GCAI<IFF(5
MU3!,LK9%B:7%(QSI6(C7,:S:+KZT>JIMKJ\W&9!%&R++\C@I:$N?%/V\*_4'
M,X$<^-CQ'+CDQ6DA\)%WBQ%P0@!NNI1"$J>9,?MKJZKX91(H85JBK&.TN[4Z
M`YQ`RIT0C!*&7+.-/%NY)%D'8Q$_VM]TH!P9"^02$R;@$`!"'J2NO@AKD#R>
M!AM=`R)@QP\-(8T>7H>P"?,GPJ.,W?=V]80%CM:!:V`S!2"1B2+"O5S*SR75
M\T%S4OB4.>NGCB5S4>BO5$21_BK=2Q9&13[YGEK$(L`;G4$.U_9*Z_#P>/\`
MM8#E/<R*20[2XA0"/-_;-R'W0FP"H.M4`?*;BW-'EO\`$<INC!Y9PS&L#@B`
M>HPTICHHC>AS"*J297)UN@=-*].GQ547663'8&^3)C:S4!3NO;3H?!4J['C8
MF$V5F!E1Q;@$>ZX!)#18$'=IU``(-4JHL0\LFH:_.<:+H7V=O.9CXA\-C;@T
MX$!#5$>4#$T<MX!JQM?)!^$4:--XU<BJW65T7H%S\?(WM:!N-@2HT!TMWZ]:
M]SG9.!A\G+QLL4LK8BQX86LWO`.X[B2-X6QL'G4`H:ET7'B'RYZZFBQJJQ/&
M3J8K%6$9"K);*"_*GJ;9QJ$2S'%.G]-,0.K&B*.]&0=#TVD2J]S",9Q>\S.:
M[<=MP1<(@`\#JNO6N(CY?)A?PV'R,<D^9.UXFVM",V-:^-$:`$4!X.[<%<HT
MJ".2:.&BRQN)T`&17-&8;#/);K8I)*.>&V!I5=3RS!V*A"3MEZHXW/6-%ZW.
M>UVVK^-(9(3DRR,;(QJ(FH/4H0I\==*[G@LHS\>)YVM9DRG=M;8-[.DTW%&C
M<@!(05DY6\F5W']5F.`@6.,Y'/R(+4"O!L5D`)Q)9!7!PU6,)*(5/:^G;(C&
M.(1=WLZG.W76FDQCE.;.Z-R1KIUZJZ]OE7&R>U9>6S^"YV<Y.&W`>2""'MF1
MRF21"W8':D!;%`*CBJXKMHK0N2:V-6]>B%AC%C"G)`C4;#"J-BFKAWPQQ*_=
M'L<J.1'.1R^*>NR0YK`V(!@L4_8UWN5[HPV8NUK6.PG$M+PXM!.I0%KBJIH;
MW"A+Y;\#\=8SF&2%6!N08#R#QS6US8S6C7%I7WF/9O$4R7Z?98]&Z(`H*(5&
MN666=S72;)Y>R;K5SW2XL+&B&:/+<;*T;2Q-0[5?!/G7YV]^^^^8AA&+AXF1
MA9[GD%6M<V2(:%KT4$WLT`IU-9>YB!P?QX$'FF7@X]4PXXD,05I/!^&'EDF;
MZ=81(9&M)GDF1-G+&]V_P\-:C&=R.9(_&QR]Y<#U[#K7R'C\KW-RCYN.XR2:
M5\[KM!)!/BH*#\!6NSN"SL?FO(+67&%K!*NMD;65=HD3HKF0>8&"1)K`1RQ,
M9"\E7I`YSW*C?%4^S6^Q(/L8X`]KC(BN[*O2OT[^FO"3>T>.V\U,]V1*0_TQ
M=C2"01N"W1%`;4!165;C%'"#:H8:51ASR$%;R*.YL"N=TN+()D\R17O^1B1[
M+MLBIK*YKLB966W&OK4>//+-)+!Z;,:5UAJ0O^U!VN5MVJQ*/'G6UL'FAV7A
M`(@LT$U`0>48APL[7*-+72RBK((J^#98U8L;'*BIO]EF63;&_$;CJ%7<B$'Q
M[U>R>1?A@XS<&1Y)5KF-`:$U+@H4]1=3>JY;24]A%8CO."Q"<"(4D\@68CS#
M8PX6NE8XZ=K&RRR)NJ,:Y6MDWV9LNVHP1N8\%K/4!L!VK7OR,UD<$C_4G:]S
M@TD`(ILC&J@;HIN1J:X*1LN7UN6UAPA%"#*$6+*-&^*RM7P+T*'+!Z:#H61[
M45=M]TW5=]]M>O=]NY\,T:.-B.@7L5JUC++CR\:SU1R+@X;GE6,&NYU[A/\`
M2K,R'):^[QT4H-"8+<">9LTE-7=5T-%!(YY0R`$OC'1K'>*3-1RR)_LI\-9X
M6212NC>08K6<?+?2X_A6TQ>+,>>]S6_]QH1Q/E<=`X%%0_TZ"KH@<ZZP$B\Q
MROM`!2$--BFFG1ED=*.KP6SJAXLQ'E3V8\C&JQS6Q*UW0CDV36,L,64UDY"6
ML-`/D1T_&M8<B*+D_M)LB*;):=GF"-!0.2UK-(5=>J53<-IU/%>9E%JT,@81
MA-+46I%+9Y@19M3RC1A)0PHXHZQJ*J]4D3"FLW7X[+K+E;+_`&0+F*CB%#4Z
M*%U^:5BGY;*Q<AN+)CL,KWD%S0YL#&:AQ4@EW^T*U?"J64093<C9(P'&!&89
MDX0<P]K<*7]7=Y,37>4+NY[W2@[(U9FQN1R)XK]B#(U^'"#*3*PIM2P^?\EK
M;87%X>7Q6+/-R!BYZ)S@_P!`M`<2=2W1'=BB=*F8?'(,@HJ(6X#L7@AO/GQ^
MU@EC$*C\EJDF0+(I-:.7,2B(QCGKUIX(FRZJ1RO8^1\;@PG4?LM<;R>7!QF9
MF"$MGR?()8R-P*V:XV<6IU#0E4V,<QF,GC8?9U]5972I7P'Y305N26@+%)1"
M?)J[.1LLC9(46*21\S5CZNIBN5$760>G%*V3)B,L?5H<6@V[C3OI7D^0[E<R
M"/($F+]N-X,+BQI2X!*;?$``KUK,GL7RL8CF.[Q)<@C@-K<-;+-B(TT\T/4V
M58WW3T)BZX'3JW9K&R.8UJ;)K6\OCI@QY+8B&.?J?X5\6_6[%]#@<=[X&22O
MRE]?:&O((LT[?*>^BUMVUR]?ENFE*:4II2FE*:4II2FE*:4II2FE*:4II2FE
M*:4II2L!N^=_*V-D=N7+6#8QR/G&!<-<OV&;\TX9PRF,.Y6O\-_H]RZIJ&4$
M&535X5KCP.5V`<]Y7PG`DF5['(R79KFKYH0?RH:D/I<.MJHWM\<B9]S-3<P<
MR%&<CIP7R)F]?8\`T7+MABEAGU'3U=.RDSB(S\CSKFM!I"LQ`F<",^P,FC8U
MRN<SJZ&^H@`-1)4DUL2TI32E-*4TI32E:>?="[:>W[FP*NL.7NYCD[C3)6X]
M:5?'O#6-\S8I@&(\KY8,`?9TU%98YF5%?4=L=;$#^0LL\+HVQJJN141=1-G*
M+GM4P?*`19=:S@[*<?X[Q3M?XCQOBG,WY_@M)1&5]/D[Y\2*4J8>[M&W`"$X
M)08QB9#*.[]2"UX0,$;D&W7J?U/=,ZE#:H=!64VO*4TI32E-*5%7.GYF.5?T
M?9?_`!`?J+M*DWZA7R;M>U*O_]'MS>TS_AS=H?Z%<0_@#=1&IJ3M1\*KW?QD
M-SC&!XE;T%$;DML-='."I0R11G6$ZP"1L&:I3F1N*E<]$B3?X[IMXIMON"AC
MGRGQRS".(B[B"4_"OL?Z-019/*\O#-(UL9@;K;J2J]`/S?*M<UMDMI(+7N@H
M5HR;*:I&L*:W8N/F5A+B$G/#?&0JK-9A*BO9Y?7YCD39=M;QD<;996^MOC:"
MCFC<O;X`]5K]%P8#'P-EDR`YXW%J/#PYJ(';FVVGY(-:_,;FMQ[*W(N)ZJ3'
MV!V=(.^TLI&W,0!2R*1'3*XV&5+(KK<_R)&2-5[D1C=M]>N+7L:(PX2!"4T^
M=M!WJ'+8N$R/"9`T_>.D9($9Y'/`">H4(V@H-P(L+FJM?7D=6`S`2L;,&9<1
M5E[B^7DP2&DQ0A.6)@UD.#*L*LF=)^$:B,VV1SE1$U&!BAV0V46):YB@>*A:
MHMP'YO(LY7_(-D,37LFB;]"NU+20H(Z&XN@J[JN[PS.<BII;:Z`K\+-R(1UO
M>4U@QM>%9CI'ZTR*U<Z<..%)V,\SYE;$Q>I?#QU7DBRH@\QPG[AK;-(Z=`GP
MJAEMS^`X#/9CQ.FY%L#A&R5J.<TJ@++.75%0FK:Y\XPXU%N`!Z>^,L\>IA3;
M.EOZ.V%E(`M;#J686TM!E\DRFJY8F,;&_P`MT22*G4[QVN<;R&4V"3=&T2R(
M'-([=AT)JC[*Y/G.8@BS<W%;%FB0!["WR.:W\P:3];KJ0JIH*C'&*&XFPDK+
M@/3F2VEI)6E9"GI9%/K\9&&K#8UB\R)TA%1,@B.<Y$5Z2.<BKLJIFRI-KFP2
M-VM:%#;VW$D?C>NW;D\8WW&SCV2.>X1[MM[/D)<+I]+AN0=$OK5KY,3F$(%,
MW$8%%B&@,)(@?9CUKU)@@<T*9QQT3H3`IY7HA$;5\=MMT7;>.,<5KY1EE2=+
M$VZV&A[&NF&)CY#I))W-$@>T*BM0ZV%P1^7^%6S'2T5N>/DF079466XL)73E
M5M7#*]EA;5T<1+(0WL:^8&N;,B^7O\JHB[^.^O?N9H620P1@8TA*$W*&U_%*
MW[L:39#BPXXDQY2X%[G!H8UUMQ!^H]P+WJ38,\R_)!'RD>9CP$->3#(QB-D1
MS^M4!<\Q7/)'5\<Y$B[JB2[[_8FJCHXHG*TASU'_`%_E6B_^L<7A3-QV_P!X
M[]WP5-QV]0$:!VJJ8;B9-/2P_DA56D^-C1(M[:030B/?-92>$I`K'),H!3'*
MBR[N7J^"^&VI2Y9?-ZLS_P"YT!OIT^-:?F&X.8]^#RV1C-Y"13$U%\K1<@Z%
MX3Z;6JKWN6P-M`PS\P>29,9&&D-^;&\[ZAY+5C`$4B5$DD1B(YC&]3U1=]M8
MC#.]I?'C':BJ!9.Y2L'"\7Q>'!D)C11M#5\@0%O5QLOQZ5'!&(WF.9I-<QVB
M4=A<30E206;GJ+()*U96NABA9)ZH>95ZTZ$=XN5-_LU:.0<C&;$YJ[!TKH,3
M.X1V$^*/'=DX=T<S4.%C?\I!M=-*N>[`=?H2Z2:)2(!&">@A=&.RYGG5_G$#
M0S,\]BH[I8QK^GJW\-56-#&M0W77M6/#Y*3!F1V.3B/)(==QC`T#DU\2%2J.
MQ0J%`AB@7"%)%)"^:">LE<,G2Y/+@F\Y8W/17>+41SD7[?AKW>7.=M>K?G6V
M=B3<MCOF8\.8""UI#P#?4A%3Y@5'^0$8;$KHKF5MRR4B`T:A@]/]6E.7[Q(T
M*1C9B29&MC8KFM1JM79?'?5V!DZK%Y5'U'0#Y=JLQ#DGQ!^-#Z;XP6EWY2GP
MT"=%/C7G,3D,]JX5Y'T+%XZI1QJ=PQ*6L*+$L[FRF`0SA#N@8[H57/V:J_8J
MZA)L$>X`.G#OJ4(1X`H2M9^.AXN.%KFL=+G2R;B0FT.ZA'%?&VJ=JLBP/LL8
MK)*>L(L;MWKP*D!0@W26]3%:/5LY=FLK=Y*^#K5SG.1K5:F^^VK443,E_JR-
M;'Y2XJ4:X@:#Q-7BYKYFRR-5%+@TJH']*=?`:5=(&,I>8P-C60MMIF5UA$^F
M.J;%PCW%3=<DCSA9X/+)#\U55K(_D:JJJKX[ZKC(,<SIHBT.<+@A0GA_J:P<
MA*,3.=F8@C0L\^YJDBW4:.%E)"E/"J[B^.<?B\AUEC*`LF;#(YP=PVKE()'F
M9`HCHF+"JL)5S&[/Z6HUJ?'QUE=D9K<.2$3$8I-VK;O_`.E<MS4N5E\<]XC8
M["LT^?:"I4:W;<ZFKJ(N6.S<.YMKL:UE@?..">^E=$:T19GM&>(2]CX*X69=
MVK&Y$7=/'Q75%DC7Q/C#"/G;\.IJ9X":+AG08.)Z)<`7L$@<[=U#D*N3O^%5
M#*4-O3'2QJ7:B(C_`#I?7O4<%S425SY1QX5C\MD7B[H3;;?==](@R_0UCP)V
M\3BQQO;'!.39NP;GC1%)6YT6J&D@P@QLH!XE(@4'C;KX#^F<C?/DAL)D0<<2
M?=6N1\:O1-_'?;6;;<-VN>3TZ_AK7KY,C)DQWYD0,+W6;8(X:;FC5PZ7`K,/
ML'I[`KG3(,J_*H$ZN?A"!)2UB,F"<]TZOBL&G1)Y9$KFKLN^SD^YK7\Q*QO'
MQXPQMKP]=QU^"5\3_79Q9[6PH7P2;SEKN?8Z:`=!6YC7)U^2::4II2FE*:4I
MI2FE*:4II2FE*:4II2FE*:4II2FE*T]^]#W.Y3VM=N&'9=AO<%B/!-[DO(K<
M4A$RW`+;.XN5AR\8OB2N.ZQ];$\3%#SHQO/2T/=$#"R)6R/3K37AU`J0T<?W
MU9OL2\F66>]IUS3S5]!04N#9F54XYBN.99QADU=CX5JXR\,C8/QK96;:);"R
M-E(6"Q>A+ED5S4Z-M2.@J`U=6[;7E>TTI32E-*4TI76T]V[A_`N6.Y22IK^2
M\N3E8OM?N&W'$V-\%,Y;<3QI3Y[C-Y+?AV)MQ2!8];V>2AA5D;XI'SNB)D8K
M6QO<]L$\Y/A613Z8"=:W$=@V>`\D=I7$&4`%#$-6MOJ(R`3!1.-(Z>VQ/++[
M%[C'7X37G68-&1CEI42@RI"1-'/(.Z9KE21-9#KX5C-B0=168>O*4TI32E-*
M5%7.GYF.5?T?9?\`Q`?J+M*DWZA7R;M>U*O_TNW-[3/^'-VA_H5Q#^`-U$:F
MI.U'PKT>XDMS#C?$YE1.!&@V9&^NAG&62RF%>,`O54EI-&H<L$L;72?*_K:J
M)X;>/1^WS#ZF4V4.4L"$&P-_J'7PK[K^A<'W')>XV%I+/M`MT!4N"&W6Z7"5
MKKNLKLY.3L=Q&Z6>M).'M,KEN2(/(K9*<0(B5I0;E>GI+;_I4<N^S7M:B(Y%
M77118D?V,V5&Y4(;M!NI_E7VV(MBX[(?BXS'8PV1!NK@YS@-C[>9I5/!52K1
MRS`JFW*J;"TRPBQ#@#9E`A5/$2$M9;/`85$-8%LDFALR)"&.A3RD5R*KFJY$
M763&R)<?>V&$`N.URH5"]!T^=;J/F9)H,B"3C#'D1G8UKB$<UKD)9;R@!'7\
M+5<^.VF#<I89F!^5Y9?X%=\;@@%T=%43(0W,IBX)B)X;'R%A9.2R;J8\9$1T
M4;V[JY-]>3P2X,T$<,3)8YB5)_)XA?W&N?=/SO%<MQW^,XAN5B9DCA)(Y6^D
M&D`;?!$=N*@FG&$7(_(.7ODX@K:&IQW%@1KOZ,77U?Y.0D!P*TMLT$4,#3KJ
MU+:BNB;&B,B9L]5ZDV9)PX,5OW9<<ASD53NOI\&@>->^X1QW`PN'NC*DF=EJ
MSU&[B\J?*`XDEK6#\RZFU</D#EB*K%(R/*75-]E9&0Q5%^!4>0/50#/;*B$D
MN<R=H@D3FK"4QT3G1N8Y7*NL./QYGF$43G,BVJTG4_\`7M6]X+BGMQAB<;C2
M1\<R(N8YZN<;H0!93JX%;U8D.5%9=C@<5$$=CKAK*4"CH:ML#JV"DGLFF6+Z
MHZ,<64V&SMXEG>Z5C4>YZ;+LB)K*^$Q3O,K_`%"!<G54LH\!:N@CXW#XB5K\
M@1.$L?JOE((?O`V@.:2=J,0(T_&N9D^7,H,CJ4NLDJ1L8#IB&@5(PZV\Q62O
M3SX"9ADG6(.:4U(8VO<BHQT:O1'+MMC@Q&S0O;'`XS[E+E2W\^M>X^/)DX>3
M-BXCG9+Y07[AZ8$8\4\P#5*>*5RL8J;LC*HC;R:EEK;`7SG.#&<LK$<D$S&2
MOD<TH4<=TCDW>Y4<UZ)LGCK'.R`0%D6\3!W4_L/PJQE<VX83AC1`QL"=!YKC
MX.<?@H(J5)*^OK+B4*O)"(`E5S7QE&#I7`2R`M63X*L/J2!W?@V/_"=")LNR
M;:UR/(2ZU1BY0YW'MS,R$LRF.N6M.]PW67J@.IT4Z5QF%W6.!JBLLV07HZ.&
MC81*R(P8='OC:C$<V$B%(NIVW^RK57[-961-<25TK%F3<?RV2P-$(GQG$'RA
M6EVJ'4$JEN]<&!P8<=+>VM+33V`9JF),=3C&L#+&<QHY,T=C%/!USL=LO1LO
M3_M>.LQ=(7.CBE>`>Q-_"U4)L.+*9R.$9W#'<S;9VUQ:[5"$-C>J]FG*4><7
M@=FD]/B][3`,'*A&@A%'(IA/*5IU<&R7=!D\[RY7-5&L<G2OAMJ(Q701[@'.
MC.O@>Q_E6O\`;7!8W`X>7PV1(Z;&EDW1.>5+B1<$G^D].JK42Y/CISX_7R6E
MA%:$DC$2EB6+P"#@`YU)BV](]JQBS2^$C.I6R-56N\%74XI@J%@VHB$*A/QZ
M]J^B<9-CQGT88&'&C!3RKM<0A%Q<]NQO5N5UZ*ZRGHJW'JU3BI`B3!GH.#*Y
MN[E<?`$])'>:Q/OF^"R?%%UE^T;Z9E=(C4*64+V6LV7+D8T6/.<E_I;G`EKK
M@'^HC5+H>E<G'HC;7(K<;(:B`&004B>&(M!_1E^E?(X7TYS45DDJ,<CNE%56
MKX>&VO9VL9#&8I25U34+K:L4V6V#&CDPI"YCY`U0I(74D:W[U3KQEW/4SU>.
MEP*38>MD:=63C2SN=6L<0E69;O\`43PL+(V:D2JC)7*C/BNLT(CW!\X\C4LX
M:KU`\*Q,GQ(<V*:;&>2H`^IH9NL7[;"PZBXUJMN^J3U0L60$V$,$,#`8PR#)
MED68H=$,D4.*&)B2,EZF,5[E1J;:JNVESFQ(;K_I5N`XN-ENR<6"/UD)<]K1
MM0'R^93J$)0!:M:4?Z?;TPD=E:&2CUAC*NG,D5(NM[UGB8HK7RQS2R;(B-8K
M'2-14V5=]6`"Z)X+&A7!2-?QJR,ALT67FNB8V$E7O:I%K*51$\52J[QIF>4$
MKD/J1A:/)`VR1#!B-=&^2JG3I.1&O:+,.Z>%J[L:]/%-E^S3+QXHS&&/<^'Q
MO<?Z5J.>XWCLB/C_`/MR8<A!+_\`>OE)10ZZ!2*J-10<@9H8VN$J(<A,?%/8
MO'Q.G(;$T6)72RP%Q-\V*!T*;JY45-]M_CJO*<<#U&':W1216=W+\#[69))G
MYCX0H8TSO!))L"#8D'HM6Q)+=A$&%RO/$IJ=\P=@Z`8B.!L2?(\:1J+%)'-%
M,BMW=NCM9XV`!K-9'7"G]_PJ_ER<9GQQ&%L3\EP!%PJZJ#?I>U4=PE%SA46.
M$1!Y6?/4K'&X:M#7Z@9'$]"6+":YWF/2*14\.F1/#5Z,9/%S19@<P/=H3H!I
M<5HLS*Q^%>Z:8XPPW_47N^EWA9/CI6RGV[<6`P_,CZBL'+&'CQ9ZRCDND]0.
M0TA8Y&VD:_@HK%RL^;9$W3;7+^X'R32&>1ZDN^7R\*^&?KIRQY/VEQ^]C0YN
M58@"[4MM=J6UN%US%?DFFE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2
MM:WN3_TKQ8GPL=A%;R-9<?"\E7L',R<18;7YWR$!CUSQAF]%AUO78X:&9.?1
MTW(=G6EV31$84L,#>E[4ZEU$JH[(?X6J0T/>U61[46'\J8A@7+HV9&<T6G'Y
M>;5$G%EOW"8_#C'*MJ-#1-CRXRTIFB"&!TJY$KFU["$<](&[HO2J:F406J`^
M-;8->5[32E-*4TI32E8C]P?9=Q/W#9!39W97/(_%O*M`!-1UO+_">93\?<E-
MQ4OK6PPXK(1Q#V'8K8RJV64.:%[//BCD:K7L1=>)UZUZI0#I4U\.<0X+P-QK
MBW$_&U7+4X?B(A`]=`27-86!1)YQ5M;W%O9$N<39W5Y<GD&&DR*KYRIWO7Q=
MKTWKRI-TI32E-*4TI45<Z?F8Y5_1]E_\0'ZB[2I-^H5\F[7M2K__T^W-[3/^
M'-VA_H5Q#^`-U$:FI.U'PKG]_P#C(.8XKQ]CQB6`[C+ZXDAM*V>.,FN48$.2
M1WD2RCQE13,79S5D9MT[[ZWW!3OQIY9FM#D`L=#7W+]$<AV)E>Y<IN0UFR"*
MSM'*YR!4<0GP-:LGXU/E-:0?!;0R1U`AM,TRY),*M)*:"#HG%&:(](!1"(NM
M.N-Z21N<B)OONG3,R!'*=S-I)!0(`OSZ_'6OTAD2MXK[;#;C.D]1'N$;&H)"
M;.)-W$%"A"("?"O-:4.MXX`PS(625$%K40DWA14Y#[>'R9U('C$<V5)JZ*!'
M(R61.M[VHW=/E55S^J]V4[(@0N#O+8)\^_@*U#)#D\S-R$+S,UCB`P69<(5Z
M$G4?N->&-3\<W%1?US'W5H-:R!RAA1)7/F2PJI&-M73SN>/Y\,*RHB3M>K4>
MJ=3=GIK%)'EQRL>]P:\=;Z%4^'P_TK8<A/R>,_CY<?&A9'&UXDN4`>FS;J5*
M*0>FAJ[/J/Y)O+Y!7*Z'&86V3,?2A@E+KKNS@L@.J0Q@8"-%&$6)84:Y$>JI
MUN396IOB$9E6!T;W$A2;$!#HINNO[JUDHAY1F)P,7%29']KU&RO\[(W!WTJ;
MNZVLEJAN3CZ/+"ZK(L@#DI@HR#5R*$2>13C('M299X9)8GO9#.]'-CD:U'M8
MB]?4KMTL_=>F988#N!3:>U=O'RDW$8KL>+(]7+:P>FH'I+HA`Z@(2"?@E77@
MF1T5AD&2UM*`X;\GBGY!56<<HQ`=G'75T()G18I$R&-\;FM=%$D;6K(K]FJY
M4<F'*AFA9'(]R[@A!UO<6Z_&M9R&)))Q_&NS)@YL[1$[4&,EY>U6J2.SB3IM
MZ6J@Y?88WBHK;/(<EIZJ4GR6">OHB5/$EG(;YPMA`1.YYHA'IW;/9]YNQ4>J
M;IJ>/!D9#MD4)<=2CK:=.QK8863-D%T.)C228\9()#AM>@LYI&B*+'QM4@6)
MN33?DC/00QE4%H*ZGFL1IH'AO"F8WJL00&QM447ID5Z.=))X*BHN_P`*S&1#
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M(6-8S+(D:R#JJ,(Z)5C=LO2U6M7XZQQ/:V=DK5+`=-$JQ]D_,GQ2_'D8INYM
MBVRH1IU'>]1IB1\6$)D5X\`$#U;#Z^!'0K<.@"+B@<:"#*3&DT,,Y$?7\$1F
MZ)X[;ZLY,C\M\<3'*+$]%(T)3J*Z++X/&R<?CXIWODDB(<#]*$$W(&MJ\,?M
M8KNI1U&I1<LY/R`>5&3;L8^9&EO']67#"-$QKU<]5<]6-:JM:J[(N&6%T<^V
M<@6UT'AH*W&2X8L8EV;&,%SHT]E`"D]N]?IM158>81>'P/CLH3AAU04O\H)+
MD::184;/'-)!'#`R-5W>C'JS_9\?#4V3RSQ^@"#&AZ;=I^-41$>6?`,9QVO!
M)4;$2Z)>Y/1:JC<SQ5Q=5%*732U)A$HS!8$=`26=%(L)M;%<S.C8+Y#9-E_!
M*K7.^/PUA^VG\Q+';@%7HG=*R?99@QLU\(>S(8-2AVCH[9^9?C<5219,(N76
M(>-?5")*)RPV514%.KB)V$&QC#QS9%/Y\CIHB94<G3"V->G??==9GQ9<#(YI
M@`Q^A-T^51;R&8Z?[;+EA$[@H+VJT(U7?V@ED']1-ZM3!\PFS@RUH;<*QIYJ
MV0J"GF>^62&9.N5(F2^J)CD*+>Y.MCF1N:]_BJ(BZSY.-'A^E-'*'[KD?^@M
M5_E<:3!Q8I6-C;&Y`\V!Z"R`C;T*FPJZJ3'[TFPKA:FJ,L[6;SW2Y!*U2[F8
MR-[VUC>IL+8:]6%+TN^;Y8E14ZG;ZP2OB/J2O.UO1H^GQZWJI/R.-AX1QYN0
MB^S:4<P^5H:;NMJ[RZ=SVK$#NW[L^<NV?-^/^.P\.XPS:_Y<%EQZA'MR6)D%
M7G4I;0ZB+()EL*T-^(R+.GGS^5Y\+]W(Y=D36HARG3\H[B\>+<^2,&(J0T$.
M\YD%R&ABN;M*DA$NH^:>^.>Q.!GX#/XC"?-Q.2Y\4<;)#%(_)(_LD*2UL+G$
M"0@$@:5&/)O,/<-Q3W(8`)QKR]E0?<3)0XY9WO'_`!['()P?B&'5XQ)>;VN9
M`L-LI\B!MX(YV#1EM80B)&Y-EV1([\=N?.UDCY^.C+I)MR;61M9]#0@'J.<%
M!)4*`O6N(_4:.#W9)[>XG(Y":?W!+Z28\+BR*(MD6:5[W^8MV@M9O"VK'Z[[
MNNY*K_(CN&N<JR6[EY8R'F\XSC=>N;BJ3C/`A8*X2>NQ:596BGMOXRGS%OWD
M5=DW3IUCB?(R&#[69K\F7!DG=O)_MDO+80T+Y4VG3ZCJM:?_`#,[7X/-X7(R
M1R,S)XVXS'DB/&Q(P7%X`"O=]6\H2"G2JIVN<\\NQ<MA3T)N8YY8WO#!.9Y=
MCF0VY,%519)9V,\M<W%1XX&IC];!72M;Z>)WX>-JN14<NZ=-QV)+_D>2XKE,
MQWV<3(3O*./J/:TN"VL5/E3RGX5T/"R\QG<_[=^\Y5TK,[#?DY+'>:)A<YP@
M#&+Y/+MUU-RM=ESVRK#,\JS*URK*K,=L_P"3,U?/02#'QF@N:1YD,L9,WX`D
M61C_``ZMY47XKK5^ZHL7'8V'&:K-RAUK_P#6M!^MXQ<;A,/#9BN9/]QNW;@6
MD(ALB@_NK=AKAZ_+M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4
MTI32E-*4TI32E-*4TI32E-*4TI32E-*5%7.GYF.5?T?9?_$!^HNTJ3?J%?)N
MU[4J_]3MS>TS_AS=H?Z%<0_@#=1&IJ3M1\*XWN+9+48_BO%[+[9E5995:#K+
M'Y*ELL6A!I6-&CF<U"%>1*O5$GB]$3[FND]O023RY7I'SM8O@EUK[A^B$;G\
MAS[X@3,V&,`="TO=N4]+"QK6WBE1E#OK1-986%.#7CMMRK$*-SK0:NC=]3L(
MZZL*&D9)),$*_P`/F<UNZIK?$LW1&2%KU*(=%T!)![FOT5SV?Q;<:+%=,N6\
M[6C0$_2T.>#8*1VJV.1JA_)XDV2X=F6.7,"UK![$(;U-<;1R%P2-FI[J0%TC
MXBPYVR,5BHO5,UR=:IMML,65N`YL>7CN:54'4'L0O?\`A6HXC(EXYSN-DPIV
M/+W7<C@]"$<Q0%:5!4:!.M5C!L2&K\2R&XOOK)KC[6AB65HHP84`RUK&$K`3
M&CIJN`<2GZ.B1O5.JH]?O/&IF9SI)FM8&@`%`J]>O0W/RK8Y,)'(\9A89C:V
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M;/C<<O-_N,):T*`@10[Q4V/@*Q2#%]P#T,J<1N$KA_:<CFM;=KG'5P?H4&@3
MI7EE0I><1U@F35P8577!@5[ZZY=#";7,1/6>HB1Z]3R!FJLC6+NBM7Q79%U3
MA><661V/(XRE;MNO1/G73\><3"P9)(@'/DD>\$+M=^77L4`6IJCIQXZB&NKX
MVR4U77J/`UY/ISI*@6.)WJVR0>9#%#&Y?ED:U6KLB>.Z:I-DE$KY9#_<<;_$
M_MI7(9F3CSOB4GUWO!&T*P.)0-"W/PKQH\/O0BZE]@I5D$=YQ&*3VL2B-GK8
M_45EE)6V+HVI800DP>6Y=MX^CYMNK=9SY&]CP&AJ6<G?4*.BBJS\[B2,MN/-
M_P"1&?[P9Y@'V<T.'0A;=U\*E`+",8(MJK$<&:J4>.8R6\1T,T(Z$20#$6IS
M^HA[(VP3F.DV9]\K4\/%=5'SS2;Y9SYR0/Y"N?@Y7-X?BI>1Y2#_`,O*R[V7
M;N<&--NJ(OC5I3)@Z8YD).63%0VHP2%TD@+(I*__`*5'R$MN5;YCQ6LCVVW5
M/@NLA8[='Z":H>]]$K=X_(>XF\M@Q83&GC7.20OL;Z"+0.)[7J&H5J,C!@-K
M7,8$6DKXV%?]#+-$CE8R4>,E6.=#,YNZ.5-E;LJ;HNIN9-!,Z-__`'&]KC]U
M?2OO&L@W2,)8;*`I!&H*=:HZ8V/B+I%D#*"(:^29)1E\R!L1C43JEFA\QTT,
MK51$5&_;MK.99,JP()33X49R,4S&.&0TXQMY[$$=`"G6JSQ]B-K>O*K6#!Y'
M;7B$NQFOH[*N$)'`DA>D\PSS^J2:4-RM>]NSG*W[$7625\(+5#F,8/.H-R._
MQKE_<W/Q\-$S)&8(AZ@!?("0JC^GHE<A^)A5E10#9"ZEAR-MM+'""&(LT##!
MIO,(-+(F1D(LS7#-=)YDC4D7=6HNO'2RR22NQ0[T]O4W`[?OJ$'+0#)G$\DS
ML-T8=ZJINW:`)TN@05^&B!8BRXM"9:-P$:06M^/B=;$7=$N4A&@%31#$D$$2
M#EN2186,=\J=>^WPB&Y.2(HQ*5T:'%&^.MOWU8@SN.R98Q%QLPR2',9+,\EJ
M)Y@WRA%;8$];5X"CG2Y%29=2WI!C:&,J(NF;7"C21#RP.\XVP#EB>0OD,>O0
MU%7=?]6O&3,CBDQWX[2]Y'F73X'2L_)8,69AY.'F&2""0!S3N):YP^EH/C9:
MJ6.YE!7$6A>''5E@.6PD28^A5RJQ8XW,0>U?*D#&&1HCE79K4:U/!/MU')BE
M!9',PM<;@'Q[5B;P^-GXL$O+MD#L<M.V2WS8`JM-KGK6(V:=K?"O,F7YAF^6
M8F1GUI(+CCKHD>VFC.QV2JLF'BQU-BLLOT_RI%0B9HZ>8]N^^R>.O8<00/B=
MM,4IE:\/2Y<SZ;ZH"MM+U2]T<+[8Y*/U>1Q8'<CDQ^C&97.M&P[P8VM01NW"
MSK71>U?LO:IPGQYS=!SD50Y&V]LK\&:VR.IR*ZI<<,D-:D(@-E)=$BUA3&>8
MUJPN63S'.1&M\=2P^.A8W)?BAH?)O):?-N+EW':/B4L@KD9/;OMSDLR3D?2?
M'SY:/.Z6ZQHFYL9)(MI^-<#).%NW#'+S.K;&L>GQX7)!K2NR]9"$.%&`N5D(
M,I<8\]+(>K#M'DR2DQ#Q,22217*OBNIX/%B/&.(S%:8WA$*Z`D@$Z[6DDM"V
M-=9[>]H\7Q<^5R/^/QY^3R[`!7-+7!)/[90,+_S$?54B<'<5\8\,X434\;X@
MZL+S=9"AY+^=Z6N0B,5T`30[^U_"^G%<O1'"U&QIMTM1-968SV.],?\`;8Y7
M)<[NI=U-NI.E:]W!\%[=SIG<>Z.`-(]1S7%VSKL<TDD`?E&@K:)[9;K2KR7)
M<=R2ENJ[(!@2IGM.E:X4,%9&^3"O7^'DFD7=47[U&_#6J]S>B]C)(9FEBBPL
M:^1?KV'3<=QF9BO8_CGN"/%RYW5#HE;G-<97Y9II2FE*:4II2FE*:4II2FE*
M:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2HJYT_,Q
MRK^C[+_X@/U%VE2;]0KY-VO:E7__U>W-[3/^'-VA_H5Q#^`-U$:FI.U'PK,K
MD3B?">4V4T>95Y!R4!!156X<\L!X\YL44!#^L62-S^N*)$\?AJU!E38WJ"%R
M;A>P.GQK><%[EY?VX_(DXG($;I0`Y6AP(:218KH347P=I'"8^1"Y/'2W?U,,
M!:R%KLIOG`($K)(UA?7*;Z1Z*R5R>+-]EU<_S&=Z!Q][?3)7Z6JOQ1:W,_ZA
M^Z<B%\$N8PL<_=_VV*JKJEKU5,/[6^%,%HY<=QS$T%JYIB9I(YSS2YG^L>Z0
MB%Q),TD[AI'N55C5RMW7X:QY'*9V3)ZLLRN^``_"L7(>_P#W5R>7%FY7)$Y#
M&@`@!H&W2PLH[UPH>TW@\:&887%R112CQ[(T0:YM(!#B19398/6CQDMB*A8X
M^1/+>BL5-D5-FIM%W)9CBKI+_`?Z5?\`_P"T/>?JQSOY0.G8QS&N<QI<UKD7
M:2%!L+B]4W_LXX$;&V`?%[`,=IC#5&!R&Y$&=)&Y'QQ/@@+9&\5CT14B5.A%
M3X:.Y+,=]4JE.H%7X_UB]^1O,@Y*(R;=JF&,D610K;./]6OC7XWLU[?VVQ]V
MF($K8V1'J3)77ELYLLJJYRIY2E*QL:J[?I1$3?4CRF:6-C]7R`6L*C__`'![
M]]&/'_RS?3:U!_;9H/E7(_[0."?2"`NQ@YXH,\Y(T,E_</9'.3(DDTFSBEW=
M(K41?NM1$^")KS_)9BN/JZZV%0'ZM^^!.[)')1B<MVD^E&I';Z:X9/9?V\'"
M6`1^#^O@M1YQ#T-M;$IY(Y,4L$T3Y)B'/Z70S.;\?!J[:FSEL^)[)(YT<T@A
M`+$5Z[]7O?C@UIY@;1H`Q@`_`5[JCLW[?Z,&.LK\/F97P5(M(('-=6I$`58%
M!&.**%',2]HC(8XF[=&WBF_QTEY;/FD?+)-_<<XDE`%)U)2L!_57WKMC:.3:
M-K]X2-@.XE5)2_SJHKVG<)N1C9,?LI8HGD20039%=2#C.*B9%/Z:!YBQ#MD2
M-%5&(B*_YOBJKK&>2RS_`/)T[#_2HQ_JE[RB?+)%GQMD>07$11@N313M4_.O
M`+M)X-`:0V#%RU0J)89?.N[6?Y%<COP:RE.6-S5;X*FRHBKM\=>GDLPD.]6_
MP%>Y/ZJ>]<J-D4W)-+&E1_;8+_(54X.V'AP:&S'CQPCT]O3F4)T+[6P?%)6'
MQNB*@:QTRMC61CU^9-G)OK%]YD[VR>IYP5^8K'+^IWO&;[0R<BU8)6R,_ML"
M/;H=+Z:&U6<SLD[=8P*^N;AI7IZL9@@3G7UNXB(>+J\N-25*\Y[6([9-U79-
MD^S5AW+9SI))3+YW:V'\*VL?ZT?J%$'AG,-#7.+B/2C13J?IZU[BNRKMU."2
MM-PEY8'4Q7B$7%I-!*D;FO8R:-Y*MEC:YOWJ[II%RV?`_?%.C^Z"J\WZO^_<
M@@R<LU05!$;`A\$%<RK[.N!:4%X%9BQPD;Q5"\^*_MVFL&61TJQ1&H5ZF).I
MW^RY%V\/AH[ELY[R]TWF/@/]*J9?ZH^\LY\#\O/8_P!-VYH,3$7Q"(=.M<YW
M:9P@YE.QV,EN^B$N+#>^[M7RR3N1J(XZ5Q*O/;'T_*DJN1OCM\=1;RF:TO(E
M^H(;#3^58W_J9[O?ZZ\@T>H`"D;``FFU!Y?DE4XCLU[?23_JLF&2):[MZK..
MXM(K"1&.<]C)2XR6S/8U7KLBKMMX?#0\IFE@C,WD'1`E;'&_6'W]BQ/@BY=O
MH."%IC8YOX$$+XU[Y^S_`(%)>Y\N(S*^1%;*Y+BS:LS7;[ME5"$61%W^"[ZQ
MMS\IB;9=#V%97?K1^H3F",\RW8`@'IL0?#RVJA`]C?;96U$U(#@THX,YYED_
MR[JU:2A9T*#S2,*0GSV(V)-HT1VT>ZJW;?5F3FN1ED;+).K@`-!TK$/UA]_"
M9TXY=H>6!A_ML0M:5`(1-=>]>C&^Q3MOQ&!X^/8E:UT4A?KIFQ91?*LY3F.B
MEEG<XU5F6>)ZMDZM^MJ[+NFLF1S_`">26F:<$@(/*W3\*KS_`*K^]<E[Y)N0
MC<YP2\4?QM:Q!T(TZ57?^S?@)P)-9/BAAE>5-*0\,Z]MC1HY9I?.<L$!),L4
M"-E\6HU$Z%3PVUA=R_(%P?ZZ.1%``_A6./\`5+WE%(R6/D(Q*T`;O28I2URB
MGYU:MAV"=L=D6.9/A=A%*.-.(C0\ENPX9H"=O.:5$.7&PIST3;=Z.7;PUECY
M[E(F&-N0K25N`3^)%JV+/UF]_1[DY*(DN!4PQDJ-$.VWRKDWW8=VSY,F)MN\
M(+.9A+(XL<BDR*Z2(&.*99VQK&TQ&3L61R[H]%1479=2@]P\KCC($.2GJ_58
M7_=5)GZK^]HY,V5G),$F0[<\B-@)*)JG:IVX_P"'>/.,%*=AF/05<QCG*04Z
M24HM[';(D"%$NDG:-&C?EC1R,;]B:UD^3-D.W32%SJYGF?=7.\_'!#RF>Y^/
M']+!Y6#Q#0C5[E%J3M8*YZFE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4I
MI2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*BKG3\S'*OZ/LO\`X@/U%VE2
M;]0KY-VO:E7_UMIO8]^W$_[4.#/^VO\`[/OZ"/R`I?Z+?Z1/JWY;_D=Y*_1O
MRH]'_P!)]9])T^?Y?R=>^WAJ`6Z5D.U;I^^LK?WC7]0K\?Z]\U>>3]EI^\:_
MJ%?C_3S4\G[+3]XU_4*_'^GFIY/V6G[QK^H5^/\`3S4\G[+3]XU_4*_'^GFI
MY/V6G[QK^H5^/]/-3R?LM/WC7]0K\?Z>:GD_9:?O&OZA7X_T\U/)^RT_>-?U
M"OQ_IYJ>3]EI^\:_J%?C_3S4\G[+3]XU_4*_'^GFIY/V6G[QK^H5^/\`3S4\
MG[+3]XU_4*_'^GFIY/V6G[QK^H5^/]/-3R?LM/WC7]0K\?Z>:GD_9:?O&OZA
M7X_T\U/)^RT_>-?U"OQ_IYJ>3]EI^\:_J%?C_3S4\G[+3]XU_4*_'^GFIY/V
M6G[QK^H5^/\`3S4\G[+3]XU_4*_'^GFIY/V6G[QK^H5^/]/-3R?LM/WC7]0K
M\?Z>:GD_9:?O&OZA7X_T\U/)^RT_>-?U"OQ_IYJ>3]EI^\:_J%?C_3S4\G[+
M3]XU_4*_'^GFIY/V6G[QK^H5^/\`3S4\G[+3]XU_4*_'^GFIY/V6G[QK^H5^
M/]/-3R?LM/WC7]0K\?Z>:GD_9:?O&OZA7X_T\U/)^RT_>-?U"OQ_IYJ>3]EI
M^\:_J%?C_3S4\G[+3]XU_4*_'^GFIY/V6G[QK^H5^/\`3S4\G[+3]XU_4*_'
M^GFIY/V6G[QK^H5^/]/-3R?LM/WC7]0K\?Z>:GD_9:?O&OZA7X_T\U/)^RT_
M>-?U"OQ_IYJ>3]EI^\:_J%?C_3S4\G[+3]XU_4*_'^GFIY/V6G[QK^H5^/\`
M3S4\G[+3]XU_4*_'^GFIY/V6G[QK^H5^/]/-3R?LM/WC7]0K\?Z>:GD_9:?O
M&OZA7X_T\U/)^RT_>-?U"OQ_IYJ>3]EI^\:_J%?C_3S4\G[+3]XU_4*_'^GF
MIY/V6G[QK^H5^/\`3S4\G[+3]XU_4*_'^GFIY/V6K'Y,_P#^A7^CS-_RL_[&
M/R8_)2__`"@^F_7OJ'T;Z65]2]#U>'J_1]?E[^'7MKPKUKT;5LB_.ND?_P#V
/N_\`Z[_$.O;U/R>-?__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g309840g91d00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g91d00.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0ZP4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````[@```<(````&`&<`.0`Q
M`&0`,``P`````0`````````````````````````!``````````````'"````
M[@`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````#!,````!````<````#L`
M``%0``!-<```"_<`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``[`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#U5)),2`"28`Y*2ETEE_MQMVY^#0<BBLD.R7.;548^EZ3W^ZW;^^RO
MTO\`A$1G6*A!R:W4,,?II:^H;OH;[:G.]+=^_<VMB;[D>_\`#_&9/:GVU_=L
M<?\`B?.Z"#9979OKJ>UUU4.+`02#])H>/S=Z,J+.ELJR'7TVOK+WN>X:'5^M
M@]P_.3QNQ';:T;JLO)SJLFMSZ:*XB7$->W7>WT)V_I-WT[&^Q7KG.:S>W\TR
MX>+?SO\`HJAEVYOHLQ\`N%[)!<&@B6Z,:]U@]/;9^=^>I48O4*<BRQSVW,N<
MXN:Y[H`.K6M;M?Z?I?S?L^FE6NP&B`=-R=?S_P"Y4[+RW]297C;;,9OMN$>(
M)+Q=.W<SV?H]JT5G9?4'X6+4:ZQ=9MUKG:2&#WM9#7_I/]&M`:B4B-=J3$Z;
MVNDDD@E22222G__0]2MMJIK=;:\5UL$N>XP`/-Q7+]1ZN_K&[&Q@ZKIL_I;C
M+77`?X)GT=E#O\)_KO'UG+;U/JYP['EG3<"7Y!$P?3_G[';?=[7?J]7_``BD
M2<Q[S33ZF.VN643Z9VM/Z*IK6D/]NS]-4U0RGQ$@:1&_]9MXL<8#W)ZD#CK\
MO\)JMZGU#U;'[F.Z>!Z3*&,'I[=.8#'^OM^BS=^AK5IN?DY.,QU6.?4Q'@65
M51M=6]CVM]MN[V-L;3Z^[_!/M_2;%0R[3==#V@L!VLK:`&-T&_:UGLW;OS_W
M$;&ZI7@4@-I<_)N)8^W4AM8>UHVM8US[;/>[VL;_`#O_`!B9QQJSHN-3-1AZ
MO#^47H*,UG3JK<>QK[!38QN-6SW.++1OKJ#GEK?T.VYF^QW\U4KSLBM]5-F[
M8RPATN,:`;X/W+*Q<.W'=?C5,&6172'FUVR27WN<?S]GM?\`^=J^#1BU.]4F
MRJO]'6PC<X_G.8/W_=[?["GPFQ6MCPTKP+5SWQ<1H<0!.NO%PQE+B7Q<^F[,
MMQV!T[18UQ`VN`/IO<QP.[]WZ:M[QOV=XE9EV(S(;CYW3S[``\,K_1[@2'-?
M^9N>QNYOI7?OJ>?D65X[\EC]K+"VM@#3O,G:WT]6[7/>[\Y/J];TZ,5D:5J-
MVW774RVU^ULS._OJ-SFN/_24+NHXM>$_-8\745B2ZHAP,';HX':JV+3;]B94
MVWU#>U[76OW.(&YQ:SW>][JZWOK][E#[.,7'R:,AE;<>YVMCK-I>2T-W-:&.
MVV;:_P";_P#/B;,T+.^VQ*_&.(T!ION!]'$^L/\`C!QL)M=72F#*R7%K[/4E
MK&,GW,=^?Z]K1^C]OZ/^>_X.S1H^NW1KL`9S2_8&S:R`'5N'\Y58'.;[V?2_
MX3_!+@.N]%%3K,_`8[[+/Z:MQW65F=KKCHUSJ+'?G[?T?_%K%W.#7,!(8X@N
M;.A+?H%S?Y$J+W#;>CRN.4(UOU/YO78?US%GUC=DM!Q\*UY]%MAU@CWLO=[O
M3^T6>^O\RFQ=OT;K7[1]2NZHX^17J:R9]I^B?^DU>4=)Z7^T+R+3Z>+7K<^8
M+O\`@:R?SG_1<_\`P2[GZN9>!@Y#&9`?38]I96TDN`U#=KO;O]_TF)1)!6<Q
MC@-([@?^BO\`_]'4IL#\'JKK&N>]XKMLV#<X,%PMNL]/3U65?3LJW>^M:E&5
MT>CJF-3BY#;GW5!P86O)#'5E[+6V[?3I^T-]]GJJGEC(Z'UU]C6RTN=94#H'
MU6&7,G_@]WIJ[D=4JRWTG$K9;5?^ASJ?97DM!+#3=5;86LNJHC])4JL35@Z$
M=V_*Y1N`OBB>OAU86X6*_)K9D9C,2_,/]$=!L,^QOI;G?X1K/\(Q"=@58_5]
MSG!S,>P7!GYE=`'Z)UUI/J>IZFY_IL]3V,^T7JYU7%P:\AF9]KJPG,K].RVL
M!V0YK=&"NW=O9M8K>%CV=6M9EWU&G`K`]!E@'K7P=S+<AWTF8V[](RC_``UG
MZ7^;_G$(`U$"Z_EZE@)A'B)(!%2)_2_N.CTZJP5OR+06V9+M^P\M9&RFMW\I
MM;??_P`+O2MP\<ACKV-,DBQ_!]VN[>W:[Z7M5MP):0T[7$:'F#XK-QL7/QL8
MU7N;>T-#G/<]SCN;[G.&]I^D[\Q6H"M`6GDEQ&R-_L#'$ORC;954U@P6MV4%
MC2W806U5!KMWZ1KFG?\`\&I96'EOLK=98PXU;FE]8!`+!V-7O8_^T[]'_@T7
M(ZBZG-JQF5>HVP@/<#[F[OHNV;?<QO\`A/=]!0J=U-N1<W)8;:+'/#`W8`UD
M_HMOT'?S?\[ZGYZ/6@*%7K_%;TLFR#6G?Q"-]S,7J#*,?':6?GN:X[Y<#M]L
M;?3^AO?O6=UKI5`HLRLV[TK;3+17N()GU/TFGN_1CTF>S]&M7(R<7`PVV64E
MPL;^E%8&Z`/TKW[BW=M_[<4>N=.LZAA-;CN`NK<'U%W!\B4)[$?G_P!RNQ`<
M0)-5>@\?WGRWK?4W9%[\>KV,K)9:]I/Z0M^BW7_!5_\`@W\XLP,>6.L#2:ZR
M`]XX:7?0W?UEUV=]6_VIU08+'C'ZA7M999`-1K8!ZD,:=[GL9_1_^VK/])7I
MO^KM/2<&UN94U^)B;6UEI@7"YVVU]X=].QGL]3]__!J"BZ,<\(1`COU'YR>(
MZ;U(X-A%@-F'80;Z08.GT;:O^%K_`/!%Z!]7#T]V14^YS0'0,)E@VV2(=X>[
M^U_Q?TU@=*^J&2,P9S*?6Q*WAU%3YG:=:[??M=<UL_H?\^]=-B_5;+M+;\RX
MU6A_JM:#ZA!/^#>_V_0V_F(Q![6QYYXR;!HU1+__TO2\_IV'U"GT<JO>T:L<
M-'-/[U;Q[FK#L^I-1<?3S'AG8/8UQ_SF^G_U"Z9)1S]N_55LV+WJ]%U^'_.<
M;`^JO3,-XM>'95K=6FV"T'Q;4T-9_GK9223H<->FJ\%F3CXOUEWXK%S6Q)`D
MP)\2E(,CF.0L_JG\_BQSN=QS'M_FY]GJ?]/TO5_,]54:_3DS]HF-/I\PW^>_
M-_S_`&?94#*=Z1L=[4(P(LSH]J=G'IKJ:6M:UK@8)$21^:YW]E%W-')'$_(=
MUB]/]/UZN9WOV^GOV<V?V/\`MU5Z/2VX_P!.?2/^DYVU_P`U^;Z?^D_,^S>A
M_A$C+)UCK_>4(XND].GI=EN+19:XV,%D:LW'<W:[W>UGT/I*TN:JV;*?'8[]
MZ.'_`,S_`,%_W(_Z\M/I^S[2=GK?0=/J[I^D(]3U?\)_4_P2/%DTXHU]4<.,
M7PSO_!;)Z?B'+&9Z<9#==\G]WT^/H_11WL98-KVAPD&'"1(U:=52ZO\`S>/_
M`#7](J_G?C_@_P#A?W56.S<)^W;X/[W_`'S]"@21?#$$==5PB#7%(Q/2P=NE
M.PFE8MNWT\?;OG[4W^DS_HW?S?J>WZ/]&_X?_A%'$V_;6QZ_^#C?/J\"?M6[
M_!_^HTN*?[GXJX<>OK_YI?_9`#A"24T$(0``````50````$!````#P!!`&0`
M;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<````!,`00!D`&\`8@!E`"``4`!H
M`&\`=`!O`',`:`!O`'``(``V`"X`,`````$`.$))300&```````'``@``0`!
M`0#_[@`.061O8F4`9$`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#`P,#`0$!
M`0$!`0$!`0$"`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P/_P``1"`#N`<(#`1$``A$!`Q$!_]T`!``Y_\0`
MT0`!``("`P$!`0````````````@)!@<$!0H#`@$!`0`#``,!`0$`````````
M```%!@<#!`@"`0D0``$$`00"`0,#`P("!P4$"P(!`P0%!@`1$@<3""$Q(A1!
M%0DR(Q9184(S<8%2)#0E%Y%B0U48H34W.))C=)755B='MUAX$0`!`P,"`P8#
M!`8'!04%!P4!`@,$`!$%(08Q01)187$B$P>!D12AL3)"\,%2@B,5T6)R,R06
M")*BTD,TX?%C)1>RPG-4-5.3H].T-U>S1'4F=O_:``P#`0`"$0,1`#\`]_&E
M*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*POL
M3')>6X5D-!`F2*^PG056OEQ9+T1UJ?%=;F0T5Y@VW!:<DQQ$T14W`E37;@2$
M19;#[C84VE6H(O<'0_8=.^NADXKDV!*C-.J0ZI/E4"00H:C4<K@7[JZ;J7.$
MSG#X,R6?#(:SE3Y1!<00E0KN`11Y*2615?$LOQ>84_[)[?5%1.;*0Q"F.(1_
MTZO,@]J%:CY7M\*X,)D#D(#3KA_Q2?(X.86G17S(N.XULW4=4M45/:/VBJ/7
M2DJ6HM#+S//<I2<N-8G`\RJL:`#:2KFW<CM/O1JIB3(::3B/E>,U1M%0'%")
MRF1=A)0U#A.R9ZP>EM"2HV'%1L"0D:>/+G4C`AL2"MZ;.:C04$=3CB@D7/!(
MZB`5'_OJO7#OY3\Y@9>Q![6ZRI(F-/R&FIR4"7-;D%+'=?7E."-;R)K5J,=@
MOEE1CDYQW%Q%^%J'^<LG`F"/F\0IE/,=*DK3WV7Q'R\:M*=KXS(0S)PF62_V
M$*2M![KIX'YU<CB&6T&=XO19CBT]NSQ[(ZV-:U,YM"%'XDD.0\@-$-IYLMP<
M`D0@,5%?E-7^.^U*9:D,+"F5BX/:#5*?8=C/.,/(Z74&Q'?62:YJXJ:4KC2I
ML.$+1S)<:(#[[45DI3[3`O27UXLQVB=($<?>)-A!-R)?HFOI*5*OTI)L+Z=G
M;7RI:$`%:P`387-M3P'B:Y.OFOJFE*:4II2FE*:4II2FE*:4II2FE*:4II2F
ME*:4II2FE*:4II2FE*:4II2FE*:4II2FE*__T/?QI2FE*:4II2FE*:4II2FE
M*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*C+!-OKSV#G5:.DQ1]J5
M26<6*V*MQ&,BB(0O$2?TG(E.0WBW3Y0I8BOQMJR.?^88!#EKR(B^DGF6U</D
M?NJH-_\`E6Z7&;VB3T=0'(.HX_,7/B:DUJMU;ZK&]FYCL[M^U&0TQRIZBEJ(
M+PMBC_X#D,+DFS=W(U'\ZT=7;[4^GQO\KI^THS+>,$E*1ZSBC<VULDD`7[!Q
M\2:QC?4Q][,F(M1]!I">D7TNH`DV[3POV`5$7L7!ZO.<;L:Z7%8*P&*ZY4SU
M`4DPYS0DY'5MY$0T9-S[7!WXD!+NFN7=>W(6Y\-+Q\II)=*"6UVU0L#RD'B-
M=".8)%=':6YIVULU#R41Y0:"P'$7\JVR?,DC@=-0>1`(J=O\9H7;?K-%2V1\
M8BYOE7[$D@R)1JP*"T\+0$F[+`W#<I$'_M\E_76`[.;D-89+4@$%+JP/`&WW
MWKTSNIQAW*EU@@A32"?$B_W6JP;5JJMTTI6N.UL-/-\+LJN(JM74-6;C'90'
MXW8MY6&DF$33NQ>-7U%65+;<1<54V5$5)#%S/HIC;JA=D^58[4*T/]/B*BLU
MCSDL>\P@VD)LML]BTZI/ST/<:^74F>)V)A5?>O-HQ9LF[67<9!($9M(:!YN"
M%_P/M.`ZG_9Y\?JBZ_<K!./FN,`W;T4D]J3P_H^%?.#R8RN.9E$6>U2L=BTZ
M$?K\#6S-1U2]5^>WOM%V3UI<P^MND<79N\T=JV;C(<ALXH/5>,Q)KC@UD.,$
MUZ)73+>:U&<=)'3(&FE;7@9']L=,8W+-5]+MK%%YX#S.*L$(OP%U$`J(UM?0
M6N-:[#4[;&-2)&Y,JEELGRMINIQ?:;)!(2#I>VIOKH:@%@_\A'LQU;E+#7=$
M),TQZ:^KDNKLJ2GQZV9CH3J/.8[;T<&'"<4'747B\$IO84`5;3YU29&7W=MF
M6AK<V/4&EDVNE*;VX]"T^55OC\*N,.#M+<\1;VVLBA3B`+]*E&U^'6A7F3?X
M?&KWL1RFFS?%\?S#'I23*/):B#=5<A./(X=A'"0TC@@1BV^VA\7`W50,5%?E
M-:$P^W)8:D,JNTM(4#W$7JEO,N1WG6'4V<0H@CO%9%KEKBII2FE*:4II2FE*
M:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*_]'W\:4II2FE*:4II2FE
M*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2H_>Q<*P9Q"JS*G
M^+;`LAK\@C'Q0D1E3_%?0Q5%W:\SC1'^G$-_TU/[><09CL)W^ZD-J0?$ZC[:
MJ^[&EI@,Y%G^_B/)<'@#90^1^RNXRSO7"<7QJ'=%/9G6EK30[6IQ^,\CLY]+
M",,B*,HFA<"$R*EL9GMMLNR*NR:X(6#G39*F$-$(2HA2R/*+&Q\?`5V,CN3&
M8Z(B2X\%.+0%)0#YE7%QX#M)JM#)+ZPRW(;;(;!.=A=3W9CH-(1""N*@LQV4
MVY*W'9$6P3Z\136JPXK6/B,QD'^&VGB>?,D^)UK$<A->RDZ1,='\5Q5[#6PX
M`#P%A6X>L_7W+\WEQ)=U!E8YBI;//V$YM&IDYH2!5BP*\WF9R%);+X?,0:$=
MU12)$%8+,;EB1&ULQ'`Y*.FG!/>3P/@/C:K/@=GSI[K;\YHM01KKHI7<!Q%^
MTVTX7JQ3$<3Q_!<:IL0Q:N;JL>Q^"W7U5>T;C@QXS:D6RN/&X\ZXXX9&9D2D
M9DJJNZZRQMM#2`VVFR!_W_?6TK6IQ16LW5_1I]U9'K[KYII2FE*C1B#9X!WK
MEF);&--V'!7+*8G-@;"SB'*?L8D0!^Q>(OOJ?PA<&V]_]['+/U^#B2SJ_&5Z
M:O[)_"3X:#XU48*?Y7N:=!&D:8CU4#L6G\8'CJ3W`5)?5<JW54QW18R+3M3.
M),E\9!-7DBO9(%%0"+5BW71&AX(@_P!MB**%^JGNJ[JJKK7]OM(9P\()%NI/
M4?$FY_3LK`]TOK?SV14M5^E?2/!(L!_3WWJ-7:^,P<HP3((DMMOS0J^5:U\@
MAW.).KV')+;C9;BJ(Z+:MFF^R@:IJ.WKA8V=VUE8<A`*TM*6@\TK0DJ21\K'
MM!(KN['SDK`;GQ,V,LA*GDMK')3:U!*@?G<=A`-6A>B5%?8]ZJ]40,B9?BS'
MH%Y;18LC976*>\R>ZN*955''-PE5LUI\$7BH`Z@JB*.L2VPTZQ@L>V\++Z2;
M=Q42/L(->BMQ.-.YF<MDW1U`?$``_:#4NM3]0E-*4TI32E-*4TI32E-*4TI3
M2E-*4TI32E-*4TI32E-*4TI32E-*4TI7_]+W\:4II2FE*:4II2FE*:4II2FE
M*:4II2FE*:4II2FE*:4II2FE*:4II2L0S[.\7ZRQ"]SK-+-NHQK'8?YEG.,'
M'2$3=;C1V&&&A)V3+F2WVV66@12<=<$4^5UUY4IB%'=E25]+"!<G].9X`5SQ
MHSTM]J-'1U/+-@/TY#B:KKJ?Y-J'*,G"LQ#I#.[_`!QEU0LKT;>HAV$5I5-&
M7VZ<V7:XT=XHJ"]91RV5?C=-EAL+F<AN*2MK"8"0^PDV4NZ4A/CU$)^'5?NJ
M1S<'%[;C(=SF?88?6/*BRE%7@$@JMW])'?5AV"Y_C78E,U<XY,5X/%&6=`D"
MC-C4R9#*/?@V,=",6I#?R*J!&V2BJ@9)\ZM4J%+A+2W+84VX1>QM]A%P?@:K
M4+(P<DVIZ#)2ZV#8D7T\00"/B!7;952MY'C5]0N(*C;U,^`G)504<DQG&VC5
M4^4X.D)?]6OB,\8\AE]/%"P?D;UR3(Z9<23%7^%Q"D_,6J(O0_3G7>7X8EOD
MM%+F7<2VLZBP%ZTLH\?S0IBR&B;C0Y,<6S&)(;9<15)%5M51$55U;L[FLI%F
MK:CRNF.I*5)L$\%#MM?C>J)MG;N%FXY#\N%U2T+4A=U*M=*K<`0.%JEAC^$X
MCB@`&.XY45*@A(CT2$R,LN0\2\DTA*6ZI#\*I&JJFJK(FRY1O)DK7XDV^7"K
MQ%QT&$+1(C;?]E(!^?'[:RG75KN4TI32E-*4TI4;_8EAZFAX7V5`!S\_`LC:
M>=...[[E19JREC%3[A0@DK";;XK\+S5/U74_@%!UR7CEGR2&R/WAJD_.JMNA
M)8;@9=`_B17@H]O0JP6/B*Z/LOV<QVF@O5^!/-W]X^V(MV:M.?LU=Y!W5[=Q
M&SL)+8_0!1&T)4Y$NRCKN8O:TN2M+DY):CCE^8]UN7B?A4?FM[08C2FL8L/2
MSS%^A/>3^8]P^)J#E/B^6YE*><I*6XOY+[SKTF1%BO2$-]UU"?=?E;(RADZ[
MN9$2;*NZZT!V9`Q[:$.R$-H2+`7Y#L'&LN8@9/*O..,17'7%*))`-KDW))X#
MYU*KJ[U;D.2&[?M"/%6$""K6(H<><DTO(O(;QUM7X10B;%-X[9.>5#5#(.*B
M5+SFYVY++L*`DEI8(4HCB#H0`>WF36A[<V6Y%?9GY10]5!"DH!O8C4%1&FAX
M`?/E4X666H[33##3;###8,LLL@+;3+38H#;338((-MM@*((HB(B)LFJ.````
M-*T<DDDDZU]-?M*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2
MFE*:4II2O__3]_&E*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4I
MI2FE*:4JK'^5JYNX74/7]1#\@4=UG3I79@JH)R*RGD2*B*[L2<FW#=?<V5%3
MFR*[HJ)O1-_..)QD5M/]VI[7X`D?IW5<]DMMJR,A:OQI:T^)%_T[ZBAU-05V
M/8!CC%>"?]^K8MM,?^%.3-L6&Y+[IE\[H'-`%/H(`B:]$[(Q</$[7PT>&@!"
MV$.*/-2UI"E*/Q-AV``<J\N[YRLS+[KS4B:LE:'UMI')*&U%*4CX"Y[22>=2
MFZ1[`8Z\SF'9V+CS='8,.U=RK9.J+49_8F9IL-`X4C\&2`EQ05+@I<?E=E[V
MX,:K)8]2&D@R$'J3W]HOWC[;5U]JY=&(RB''UD1'!TK[K\%6YV/V$U:;"G0[
M**Q.KY3$V'*:;?CR8SH/,O-.@+C;C;@*HD)@2*G^RZR5:%-J4A:2%@Z@UNC;
MB'4)<;6%((N"-00:CUT@[^WYCW7BY&XO[?FJW#0''1D4:NCG_>/!5;3D$,-D
MV'<=B3?=>-@S0]2'@Y/-4?I_V#;]=5;;A]+(;DA<D2NL>#@)_54C]5VK93Z:
M4KXLR(\D5..^R^"*HJ;+H.BA)]44@(D14U^`@\#>OT@CB*T+[(^PN,>MW7KF
M;9!#>N9TR<U48WC<60,.3>VSH&\3*S#8DA!AQ8K1NOOJVYP$41!(R$5BLSF(
M^%AF4\DJ439*1H5'QY`#4FI/$XI_+RA&94$I`NI1X)'AS-]`*K\Z^]_^_<WO
M`OPZDP=GKLS>:2$]=6M?:OB!*"K#OW!FI(?9--E/]K1@U%1^Q?E.;:L3=NZ$
M)R*,?'8PZK]*EJ4%*L;738$FW:4@'E49NW,;1VJXK&N3GW\NFW4EM*2$7%[*
MN0`3V!14.8JT?K_L7'.R:<[?'W7D_&>2//@3`!J?7OD*D`2&FW'05MX$4FS$
MB$T1?G="1)[(8Z5C7@S*191%P1J".XU%XO+0LQ',B$Y=(-B#H4GL(^[D:^W9
M-&N28'EE,#7F>F4DY8K2-JZ1S(S2RH8@VGR3BRF`X[?.^OB`]]/-BO7MTK!^
MW7[*Y<G'$O'S8Y%^MM0[=;:?;6IN@\6P2YZSQ;($Q3'G;.3%<8L)CU9"DRGI
ME5)E5:/O&\VX3;SK,='"3[54CY*FZ[K*YV1-9R4M@RG/3ZK@=1M90!'/OM4'
MMF)CG\/`DIA,^L464>E-R4DI)O;G:]2,;;;:`&F@!IML4!MML1```4V$0`40
M1$43X1/A-0!))))N:M(````L*_>OROVFE*:4II2FE*:4II2FE*:4II2FE*:4
MII2FE*:4II2FE*:4II2FE*:4II2FE*__U/?QI2FE*:4II2FE*:4II2FE*:4I
MI2FE*:4II2FE*:4II2FE*:4II2FE*U?W#U%AO=^"6V`9O!6756*"_%DM&;4V
MGMHX.)7W-<\!@H3(+CBDB%NVX*D!B0$0KTLACXV3BN1)2+MJ^8/(CO%=N#-D
M8^2W*C*LXGY$<P>XU7IBWIMW/@M-+QPY^+Y?6T4I8V,64"P=K+2VHW"><C?N
M%;9QV8==/A(B`8),=;V(>#A[*NKEL[/+P^*CX?+GK$<=+;J=>IL?A"D\0I(\
MNG4"`*SO>VU#F,O*S6%LDR#UN-*-K.'\10K@4J/FUZ;$FN2/K[W&6Z)A$I%3
MR?!7&-C\MJ2;(2W*`O-1^U=]EW1=]MU2ZG<^%`O]7_NK_P"&J(-F[B)M]`/]
MM'_%6T<$Z)[WIY)'!O&\%87X>7]_60CPOBGF)N!3E/B/NALB;NDVO)$42^-]
M0V0S^WY(_B0U/J'`]/3]I(-OTM4_BMK;JAJ_@STQD'B.LJ_W0"DG]+UM_J>E
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M7'H<'`@B]E6%]>!M6O;)WMC/<2-(QN3AH:S#:+D#@I/#K;)U!!MU)N;::D7M
M)_\`D<S.T[-QKUF['@MNQ\"S/";6W@1D<!\*[)IJTLFYA2G19:)9$>&ZPTV3
MFR.>!U0$>+F\/O"1]>U@)EB(#J;^!/3<'O`^X]]6+:S'T3F<BC6:V;#O`ZK$
M>)^\=U=]1PJ^NIJN#5-@W6Q8$5F"#:JH)&%D/"J$OR7(-E55^55=]>PH3$>+
M#BQXB`F*AM(0!P"0!:WPKQ-.D294R5)F+*I:W%*63Q*B3>_QK?/1_9,;K7,/
MW"S;<<I+:(M7;&R!.O1&2>:>9GM,@A&_^*ZW]X"BF39%Q12V18K<.*7E(82S
M;ZALW3W]J;\K\N\5.[5S:,+D"N1?Z1U/2JW+6X5;G;GSL3;LJS>CR.@R6(,[
M'[BNN(I(*J]7RV9*-\OH+PMF1L.?'R)H)(OU365O1WXRRV^RI"^P@C[ZVZ/*
MC2VP[%?0XV>:2"/LK17K<?X=+G.-(!`&-Y]=0V>3Z/KX'$9%M%)0!Q518Y;D
M6_)55?A=T2<W'YWX$CFY&03X\*K.T?X<;)Q+:,S'$CPT-2/U7:MM8[DV7XIA
M=>MOF&38_BM6A*'[CD=Q7TL%7$%3\8RK*1&9)S@*KQ0E)43Z:X7Y$>,CU)+Z
M&V^U1"1\S:N5EA^0OTV&5+<[$@D_(5U.&=F==]BLO/X%G.)9BW&`#E?XUD%7
M<N1!=54;68S`E/O1.:BJ)Y!%55%U\1YD26"8LIMP#]E05;QL=*^WXDJ*0),9
M;9/[22/O%9QKLUUZ:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II
M2FE*:4II2O_5]_&E*:4II2FE*:4II2FE*:4KI\@R&BQ2DL\DR:XK:#'Z6([/
MMKFWF,5]970F$Y.R9DR2;;##0)^I$FZJB)\JFN-UUIAM;SSB4-)%R2;`#M).
M@KE88?E/-QXS*G'UFR4I!*E$\``-2?"JE.[/Y:\)HK9[%_7S"I';=D,=2+*;
M9RRQS&(\A?,V/X]7(@1KNSBLO""&Z\=:P6^S;I)L6LRW#[HX?$)/T@#P_;42
ME%^Q(MU+/@`.PUN>R_87<VYW`F6%,*T/IH"5K"3S6KJ#;0/+J)-^*1PJ%K/L
M%[^=W$X<'LK.6X!R$5VLZGQ"KHH%4Z!(7X)Y=54K=@@BJ?<DB2I*NX\E'X7)
MWO<?W`SI7_)(CHCDZ*"$I3;N58#YN*KT:Q[(^RVS`U_G+-1C.2!U-%Q2UWMS
M0%*41KR90*S>OQK^0-]M'1S7O)Y.2*GY_;<:N/=-EV6.]E,`N/\`TCLOTUU4
MY#WB60H3W4>+C)^PJ57=7`_TKL@H5C67>\,RQ]H0BMI.]E?R38^PKCUCD$EE
M%Y*#=%U%DKR\!^40(-99S]E1/T_J7_5==P;B]Z8WF,D.)']6(?N2#\JCCM;_
M`$G3[(3%4PL\^O))^]13\Z[^C_D5[YZ]=CU_<'5<.W)TGO&<Z!<=<W<I1X;^
M$Y%=/K7VV!^51N$BJI?)(FR:DHWO+NG$!*-R[7ZD7MUCK9)^:5H/@+5$R_\`
M3#[=;H+KNP/<,)=M?TB6Y0`[PE;;J1WJZB.RIU].^\/1/;:P*PKXL$RV<\L9
MO&<SX5_Y$A5060KK\%/'IRS#7BPTLAJ6X7V^!%5$75=M^YFT]R^DRQ/#$]6G
MI/>11/8E7X%WY!*B>X5YZWU[#>XVQ/J),S#F7AVP3]3&NZV$CFM('J-@<RM`
M2/VB!>IA:T"L9II2FE*:4II2FE*:4II2FE*T)FSD;&^Z>L,C=C+XLE@7>$2Y
M@"FS4EQ6)=,+FRB1*]+>5OYW1!55_P"'4[#O(PN3C7\S2D.CP_"K[+&JSD+1
M-PX67;R/(6RH]_XD?,W%;KMK6!1UD^XM)+<2NK8KTV9)<786F&`5PR_U(E1-
MA%-R(E1$155-0K;:WG$--)*G%$``<R:L3SK;#3C[RPEI`))/(#C5/F7V\:_R
MK([R&RXQ$M[NSL8S+JHKK;,R8Z^VCBHB)SXG\I^BZVK'L+BP8L=P@N(;`/B!
M7G;*26YF1G2F@0TXZI0OQL3I6C.W<4O,XQ)K$\9HYM_D5_D./UE+#A1W7W!G
M2+`%\SAM@3<5@(C;OD=<46VV^1$J(BZHONFA$C:$N&$=4IYUI+8Y]?6#<>"0
MJYY"]7WVE+K.\X<P+*8K+3JG3RZ.A0L?%138<S:K8Z#UBPZQ]:L.Z![)K(-S
M&IL5@P9DV"(A)J\E47)<R[QR>\VX]"G1[.4Z3;R)LZ"J+@$V9MKF+6%C+PT?
M$S&PI"6P#;DKF4GD;\#^K2MG<R[Z,L_DXBRE2G"1?FGL4.8MQ%:/J_27)<7H
M&Z>K[&@9-^VN%&J#O*5^ED+3@C*08UC,@2[=MZ9#;YMJZ$<!=$`7B"JJ)H6W
MMROXK'QL;D`7T,I"4N#190-$A0)()`TN"+VO:]9AN79C&6R,O)XQP,./**U-
MJU0%JU44D"X!-S8A5K\:XP>IW9Y;<IV&@JH*KRM[510E($)-PQ\B5`$B7?;Y
MX_[ZL9WECAPCO$^"?^*JNGV^RQ/FE1P/%?\`P5L7%_4J=#D?EWV<.0S!W8&\
M6CO-2#8`^;9_NDPVE8=Y")<4CF@DGP2[(NHN7N]#R2AO&H4/_$/4/E;]=34'
M82XZPX[EW$G_`,(%)_VB?U5G_1]7%Q#.NW\'"PM9;L&UI+:,5QQ=ES8=A7K(
M*P.6``DN0I2FP><V1"5`79"YHD7F7E3(6(F^FE(4A:2$BP!2K@!R%N'QJ9V\
MPF!D<]CO56HI<0L%1NHA:>)/,WXGP[ZDQJNU;:IG]B1I^]\TD6.8P79L&A.9
M38W!9MKN+"@5[4QU"F-PV;!J*EE9((E(>\:&:"`?TMBB7U&PMN9&'&7EX'U#
MY0#=2UCIN+V2$J2!XVN>9MI64RO<7<\&?*1A\A]/&2L@!*$'JZ21=16E1-^R
M]AR'$F!%W!RSUA[%QGLCK:WFQ8[,[RU[CC[G]31`Y/QJ[1@V5L:BSB[B0DB>
M1KDB_>"&N%[[V>[L')P\QA'5?RMU=@";E"N);4?S(4/PDZVN#<BYW?V]WJWO
M_&S,/FVT?S9E`*BD6"T<`XD<$K2?Q`:7((L"0/35AF30\TQ'%\OKT%(.48_3
MY!%$7$=1MFWKX\\&O(@BAJTC_%5V3=4^B:N,9Y,F.Q(2/*M`5\Q>H20RJ.^\
MPH^9"RGY&U9+KFKAII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2F
ME*:4II2O_];W\:4II2FE*:4II2FE*:4K37>O?/7/KK@DGL#LNRE0ZD)+==70
M*R(MA=WUN^T\]'J:>#Y&&G9;S<<R4WG6([0BI.N@/SJ-RN6A8:(N;.<Z6AH`
M!=2CR"1S/R':0*F<#@,EN3(-XW%LA3Y%R2;)2D<5*/(#N!)X`$Z5YA/8/VE[
MD]QLX6-82)E#AC4B&M-US33[*5C-,R+[C42=81T5EO)<L?1TQ&03(..&O%EM
MAG=!\Y[OWM-R2P%=0;6>EJ.DGS*OIU#F;G51%AP2*]H>VGM3C\:A2T=%V4]<
MF8X$CTT6NH()_"+`]*`23Q4;<)O^L_IGB-(\7_J6['D9+7I$LG<`2=#E2AB.
MH!Q9V9OQD<26<A3^V&T2,LM$*.*O/QA\8C84HMLYW=#!<4XHAM%KLIM8E(.H
M4H<P"0.?4=:Y-V^\D5A+NU?;A[Z:`VD%V1^&2Z3<=0X*0D\E$!9Y=`T-F]?7
MP*F%&K:N%$K:Z$T+$.!`C,Q(<5@/Z&8\:.#;++0_H(BB)J]I2E"4H0D!`%@!
MH`.P"L,<=<><6Z\XI;JB25$DDD\22=23S)J.7>'=EU@%K"QK&X%><^56#93+
M2R1Z0$1M^0_'C,0X+1,`\^7XQF3CCB@&PIXSY*HPF8RYQWIMM-A3RA?7@!PY
M:D_*J/NK=+N#6S%BL)5)6GJNJ_2!>PT!!)T/,`=]<CHSN6W[!EV=!DD2$%K`
MA!8P["N;..S-B(\$>2W+BN.O(S+8=>;43;7QNB:_:"A]_P!8?+'))<0ZV$OH
MUTX$'QN:^]J;F=SGKQY324RFP#=-^E23IP)-B#WZWK*,BS*CNNQ8O4-]A\.]
MJK.`3\J1<,1IT(I25\NT:%*J7$?CR(8QHB@KRFA"^7%!^-UOZ=J_5[2F[C=D
MM*CH?2T62+E0587-].)'EL;BYOI:IEO<KL#<T/%14NMRBT7$NH44E)%^!%CP
M!\P(L;"U:%[:]*<1R5NRNNN9'^)WKC*N,8\ZC98C+?`5_LMM@RLRE_)^BDV3
MK`?&S*)OK',Y[?XO(=<C'?X6:!H$@!LGE=(%T^*2+<;&O1FS??7<F"]*!N`?
MS+$E5E%PDOI2=#TK)LL`:]+@-^'4D5A71WMMVMZR92/5_>4*\O\`#VWH@/#9
MS7[?)<2@FP,>)+QBP<GR(=MC8-@BE"0R04!?`;9B33GUM;W&SNRYJ,%O-+CV
M/-NEPDN.('`%*KGK;[4_B3RYBI7?OLILWW8Q#F\?:EQF/F4W"V`D,M.J&I2M
M'2/2>/)?]VN^I(LH7;XKE%#FV.4N6XO8LVV/Y!7Q[2IL6$<%N5#DAS;-6W0;
M>9<%=Q-LQ%QLT421"143TS%E1YT9B7$="XSB0I*AP(/`UX,R&/F8J=+QN1CJ
M:G,.%"T*XI4DV(/Z6/$5W^NQ73II2FE*:4II2FE*:4K27?M)-L<#*ZJ@$K?"
MK:NRZ"JKQ)$J7N<OB6Z+L$4B<447<T;V3Y5-3.!=2F>EAP_PGTEL_O"P^VU5
M[<[+B\6N2R/X\9:7D_N&Y'RO4?LAQ_V`[P:@R),:JH<,M&FI]?""^KEI_`FS
MD21._:Y-I96$EQ%0DYMJ($G]#1)MJQ1)6W,&M8'J.S$D@JZ-01H0+V`^'S-5
M.="W;N5MM2O28QZP"$A>A!U!5T]15\1;N%=KC7J$"^8LRRIWCNB,,8L#;9[(
M6ZFY-MX+X)N*;<$C+]?ZM?$K>;J@4PH@3WK-S\A8?::Y87MZRDA60G*5W(%A
M\U7/V"I78AA.,X)5!3XS6,P(R*+DAWY=F3I"!P65/EGN])D$.Z(JKQ`5X@@B
MB"E0ES),YTO2GBMSOY=P'`#PJ^08$/',"/"82VUW<2>TGB3WFLKUUJ[E-*4T
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MWU#QC%L/I)`UL[*XJV^7S&2;HL?@1HDW\N6^^O$I;H">PLLH9DYQ%>/)%UEG
MNJT,KB86$CJ!DKDI6H\>A"4JN5=E[@`<ZUSVA]3&9F;G'T*$1$92$\O46I2;
M)3VVL23P%7;XKCT+$<9Q[%:U3*OQNDJJ*$3O'RG%J8+$%@W>""'E-MA%+9$3
MDJ[:K#+26&6F4?@0D`>`%JO[SBGG7'E?B4HD_$WKOM<M<=-*4TI32E-*4TI3
M2E-*4TI32E-*5^2(0%2,A`4VW(E013=41-U79$W5=M.'&@!.@&M?EUUIAIQY
M]QMEEH"-UUTQ;:;`4W(W'#5!`!1-U55V37X2`"2;"OT`J(2D7)KXPYT&Q8"5
M7S(L^,XFX2(<AF4P:;JFX/,&;9)NB_1=?B5I6`I"@4]HUKZ6VMM12X@I5V$6
M/VURM?5?%-*4TI32E-*4TI7_U_?QI2FE*:4II2FE*:4K7/;':N&]+8%D/8V>
M6;=;C^/0G)+@^2.,ZSEH!+$IZAB0_'&=;V3HHVPRA(IDORJ"BJG3GSH^-B/S
M92^EEM-SVGN':3P`J0Q6,F9G(1<;`:*Y+J@!V#M4;7LD#4GD*\F_LG[(=C^V
M/9B9!D3HQZV,_-K\#Q)GB-5B%"^ZCQMFZRT+LR8\VP+T^:[R=><%!'@T#++?
MFO=>Z7\FX[D)JK16[AML<@3H!VJ5I<G[@`/;'MW[?,8Q,;"8I(5/>L7GC?4I
M'F4?V4(%^E(MWW4239AZD^N>(=/8A2]J]DR(4&ZFJW-H/WJ0$.-4I8QT!FTF
M-2Q;']^L&E(F14C")%X(*(:$H]W9NTYDI].5D0UO9QU)*&TI4HM-VO8)`OU=
M.JC;37OO'>Z/N)$1'7L[!S$L[4C+"77"4@RGPK5:EW_N^K\"0;&P)T"0)CWQ
M]4]96%]VSE614>)#8QF(MK?Y!D$>NIQ1&HX`C*S9+<894MFO:3B&Y'XOL'=3
MY:*_F\G(Q,/!O2+XR.M2T(LG12KW/5;J/$V!-A<UBD/!L+RKT^%#6O)R$A!Z
M>I14!:P"1<<AP'*N9UMW/U3W#&L)?5_8&+YPS4FRW:ICUK'G/UI25>2-^?$$
MDE0QD_CN>-7`%'."\579=1`U%QPJ7FXZ?CEI;GPW65J%P%I*;CNN-:CQ[*X#
ME-GDM9E%+365W7O5$>KE#51'["3`E0Y,UX3?B16W)`Q9#4I.+B"0H0DA<?MW
MJ^X<=)E+9D1T=82FQ`X\;W`YUE&^<)D)LB-.AL*=0&^A24@E0U)!L.(-^5=I
MZS8#D5-87N4WU5.IFGH(T];%M(DB#.DJ<AF5+EI$DMM/-Q0_';`")$\A*2HF
MR(J\FWL<_$2\_(1TK78`'C8<2>RN?8V$F0/JYLUE3:E@)2E0LJP-R2#PY6^-
M2[5AA7ADJRTL@&R9!]6P5X&C(2-H753F+9D"*HHNRJB?Z:LMS:U]*T.PO>VM
M0&S?LS,LC[^[6P!OVCPKUCHNI,7PZ\JH67XCB]\SV,=[5N6]E+=G9"_%F,0J
MYWA&-N"1/D);@"FBKKB8C_62Y3;V;:AMM-)4D+2D]=RKJ-U*&B;`$)UUKXGR
M7L=&@O,X5V7ZZU)NE2AT=-@``$GS&Y(OII6Q'Z"A]H,+NL6SV##H>S.N[-:B
M?84,G\J+!LYU5$M:C)*!Z0`29^%9E3S(\QEF0`F31<%5'6D=2,SF"B9EA_&9
M-L>LV=%)/X5%-PM!YI4"#8\1H1I5KV1OC+;2GQ\[@G2&G!9;:QY7$!5E-K')
M0((ZDZI.H-C8Z9]3>[\I]8NVYG279,DV,%NKY:^6R[P2#CV16)1V:_*ZV5-_
M$-JAN`1K\E55&U:-'^"."?*L^W>Z9^S<^=G9QV^+=79M1X(4K\*DD_D7P(Y'
MXUL'O3L/"^ZNRF_=/:$<)SS#74^@:J<;1^-M83<>JUJ0;74GN(J]U%14145%
M14W14^45%^BHOZHNO45>`>%?W2E-*4TI32E<.QEC7U\Z>?\`1"ARI9?"K]L9
M@WB^$V5?@/HGSKZ0DK6A`XD@?.OAQ8;;6XK@D$_(7K7'3697F?8%6Y/D$2'$
MGSI=FT@P&)$>(ZQ"GOQ`=::DOR7$139(5_N&BJ/U^NI'+PVH$]Z*RLE";<;7
MU`/(#M[*BL#D'\IBX\Z0A*7%E7X;VL%$#B3V=O\`16Q["#'LX$ZMEBIQ+"')
M@R@1>*G'ELG'>%"^=E)MQ4WU'(6IM:'$&RTD$>(U%2KC:'6W&G!="DD$=H(L
M:TIT7,?JJN_ZVLW'/W3KR\FUD?\`*(4ES:"6^<ZGL5;0&T5MYF1\$*<$%0VV
M14U,YM*778^1;'\.0V%'L"QHL?,7^-5[;:ULL2L2\?XT1TI%^);/F;/^R;?"
MM[ZA*LE-*4TI32E-*4TI6@?8>KLDQ*MS.C-ANYZ]NX>213>%"18XN`S*'B0D
M)@+BM.N"NW)MHMMUV19[;RVE35PG[^A(04'QXC[18=YJL;K;>3CV\C&($F(Z
MEP7UTX*^%C<CF!6FFO7K/>R)D/*<X[$K)D:S@1I[$BM;L+5Q&9@K(;C0(\QB
MEB0(7A,"%0#;=5W;3;=9IO<L'&(7&@8HI(-CU$`W&AZK7)/QJNN;/R68<1,R
MF;2OJ%QTI)%CJ`FY2`/A\ZVGB_J_UQ2`I7;4S+)7E%QMVPD28$9I`7=`&#6R
M6&W@+_B1XG1+_3;XU%R]TY62"EMP-(/)(U^9N1\+5-P=E82&0MUI3[@/%9T_
MV18'XWJ1$2'$KXK$*!%CPH<5H&8T2(RW'C1V6TV!IAAD0::;!/A!%$1-5U2E
M+45+42H\2=2:MB$(;2E"$A*`+``6`'8!7(U\U]4TI32E-*4TI32E-*4TI32E
M-*4TI32E5]_R#V-Q%P3!H$20;5/8Y--*V:!"1)$J%7@[4BX:!L@-\Y!<5)-R
M1%V7CNE&WVZ\B!#0A5FE.^;Q`NG]=:?[6L1G<KD''4`O(8'3?L*K*_4/`FJK
MK/OV\RVM/";GM:QO*NG>%',?L\G?D1F78GVMHY'E2=I(PE#847F+"ILG%=4.
M3)SKL9I$IV0J*;6OU6/9X]U_A6J0H>UX\Y]V"Q$3/22%%/2%`\_#OM\:V9ZW
M>Q<?JG/XLJNR.):8W/=:B9?05UE&GK(K^:BLYJ"S*V2SK.1&T?PNW(%^TU37
M<P>2FX.6TX^AQ,!9LL$&UNT7YCCIQJ.W-AL;N>`^S&=95E&P2VI*DE5Q^51%
MSTG@;\.-7X8[D%/E='5Y'03F;*FN8;4ZOFL*JMOQWDW15140FW`)%$P)$(#%
M1)$5%36R,/M266WV%A32Q<$<P:\Z28S\.0]%DME#[:BE0/$$5W.N6N"FE*:4
MII2FE*__T/?QI2FE*:4II2FE*U;W#W+U[T5A-CGO9%_%I*6$A-16C,"LKNR5
MEQZ/34<%3%ZRM)0M$HMA_2(D9J+8D2='(Y*'BHJY<UX(93V\2>0`YD]@J4Q&
M&R.=G-8_&1E.2%=G!(YJ4>`2.9/WUY<_<+W,S7VKR6,<MA[%^N,?=\N+8,W*
M&6+$PF58?N[B2RRREG=RA,@!>/".T7C:3<G#<P+=&Z9&X'AH6\>WJE!//FI1
M[;?`#XFO66QMB1=IQR$D/YA[13@!X$Z(0.(%_BH\>``_GK5U^]4W4//+ZECV
M(Q3-RN@6C+A5R3(X@XRQ,:%P"F)"DFT_(;11$G!;:)>/DWK>V8"L_DQD76C_
M`">*K^'?@Z[P"AVI1RXB_P`:VR=BU0<6_MF+-]//36P9:TZJC1CKZ)Y!Q_GP
M/2%'A:\MNV.U[3]CG9/V;GUDUC%(TDHX(%"JJP)/%UACP1:R+$D3;&0LE6F1
M(W#(C1!^?G6TXO*S<%)^NQ<@LR0DIZA8GI5Q'F!'V<=1K5-D^U6QY$(Q,KC#
M*8)2;+6NY4G46Z"D@D\@0""0=*HG[I[?L^Z,J8>A5/[10Q":@XWC<-IMV1S<
MXL#)EG&:1R?;32V%$^_@.S8;_*E7WY"Y"[7)%_F>VKE&@PXEG&8C35DV`0E*
M>E.FF@'9K4Q/4G_*.@0R7+*>[R<<YR"LAU4W'\*Q]B_<H*Z-8+.<BY,Y8,E6
MK*E.,-J33+@.QT$A5P7.0C(Q8)0GJ?";*',V^7Z6JMYQK"YU*6)D1V265$@-
MA1Z2=#U%)2-0.'5?P/"R7J'W"[!RYZW4Y<N0_CK[+5C59!45",2PD`\@&S(I
MFV)D=Q'([@JV3JFV8INABOS]OQ$-]/8>8JM-;%VSG&Y*8#;\22T0#KU#7AHH
MJ/(@CJ!%;-Q#^17K"Y9LARK&\APR1#;EC$F3_!)H[&?%%5&M.?&4WJJ6ZB<B
M1YI09#Y,T5%1.:/AG)$F+'$A"4N+2DJ)L$A1`ZCW#B:R?,X&?BXTN8RRJ1':
M"OPBRB4@FW3KYC;@"34U\3S:#D6'5&86`-8]$M151"RELM,CRFNPHIMRWDCM
MO,V"@)L%LGD!P=D^=?&6Q1QN5F8MF0F26E$=;>J56%R1:_#GV$&JICYXFX^-
M/=94QZB;]*]"FYL`;VX\NVXJI/\`DEAM]7=\>M/L3&HJK(('[@N,9736L./.
MJ;UO'[2'=T,:RC26WXLH'FK26`J8%P0=TU6<AZ;'TV16PE:XK@790N"`05#7
MM`/@;'E5^PL49C`;BQ`=4B1Z?6A0-B`?*L:<OPGX$<S4GV^HI?JCV#AOL5#[
M(R#LKK'V0M8M1V#/O(L*+.QNUSHV+K`;V>[%D/QY<%F3).*X[_9\2.[`/$D%
M)7*8+^3OISC<]Q^+,6/4*[72I>K:M!^'7H[KBL]PV?&40K!NP&V),1!],(O9
M01HX-?S?G[['G6:>Y?4C&7X,6=U<%L\CPMHGISC;:^>PQ=55;".[Q^'4JU-9
M(<D51!'414Y+O0M]X/\`FF*5,81_CHWF21Q*?S)_]X=XTXUOGLGO,[;W.C%3
M7?\`R;($-K!/E2X=&UD'O/0KN5KPJ47\?O<4OL[I1O'[J4$O(>LI4?%WWR<Y
M295`Y'61C$N2/U16X;;D-#_^(D/DJJ7)=:?[3[E5N':S+<A=YT,AI=S<D`>1
M1\4Z?NFL=_U&;%1LOW"EO0V@G$Y(&0T`+)2HFSJ!X+\UN06.`M4Z]:=6!TTI
M32E-*5KOMNP.KZRSF:T)$X&-V;((+:.KREQRB"2@6P\!5_<B7X$44E^$UW\6
MV'<E!0>!=3]]1F:=+.(R3@XAE?V@BOCT[4C2=883`%L6U_8HTYP!;\:>>V)R
MUD$H\`7D;\TB)53<E557=5WU]YA[U\I.=OH7"/EH/NKCP#'TV%QC)&H923XJ
M\Q^TULK4;4O4;>RX,_"^T<([2JH<B7"L3##,LB0&'9,J3'L%)N%(5H?(9HT2
M-D*-B)*<4$550E1;#CW&I>,G8Q]82M`]5LD@6(_$FY[1^NJIEF7X.9QN9C-J
M4VLAEY*022%?A58?LG[AVFI):KU6NFE*:4II2FE*:4KK+FH@7]394=HRDBNM
MH4FOFL[J*N1I31,NH))\@?$MQ)/D5V77(TZMAUMYLV<2H$'O&M<3[+<EEV.Z
MF[2TE)'<18UI;H;(YCE1;]>WBL-Y#UQ/6A<;;7B<JG;W;K9Z"KCBF"JV;?)-
MDXB/Q\[K,9QA/KM9!D?X>2GK'<H_B'P-5_;,E?TSV*D$?5PU^F>](_`KXBM^
M:@ZLM-*4TI32E-*4TI32E-*5'GVC]G^I?4'IK*>[NY+YJHQG'8ZMP*UEV.M]
MEV0OM.E4XEBM>^\PMI?V[K2HVVBH#30F\Z3;#3C@=.=-8Q\=<A]7E'`<R>0'
M?]W'A5@VQMK*[MS$7"XACJDN'4F_2V@?B<61>R4\SS-DBZB`:./XTOYVX/LU
MWGE_2WLI!QOK6;V!F$R7Z]W41QJ%11H$LVHU5U-DUA)<;21DK@MB<"Q-!2QE
MNNQU1LUBME6\1N7ZJ2N/-LGK5Y#P`[$']1YG3LK:O<;V17MS"1,QMQ;DA$=D
M"4DZJ)&JGT`<$?M(_(D!6HZC7I-U<*\ZTTI32E-*5H#V<P6BSOIK,(]Y9U-`
M&.UTC+8>1WL^-5U%"_0,.S9$ZTLYKK$*OK#K@>:D//&+3++A.$J<=TA<_CT9
M+%R6%*"5I'4DDV`*==3R!%P>XU9=HY1_%9Z"\PTMP.*#:D)!4I86;62D7)5>
MQ2!J2`.=>`WL/W2Q>5WY>#C<-7^H';"1!_=%8_\`,I,QUUO\K)8@H:K^T)+%
MQ66%1'#C'S5$/B`T''9=]A$5F0`6DIZ3;CQT/P%A;QYUZGRGLLF9AY\^,\4[
MB<7ZJ4$^0#IU:/\`64;GJX!5D_AN3-3",FAP[;&\JKY+4^M"3!LF94)T7FI=
M>XHD9QW6RX."]%,N/SLN^RZL<QE,Z"\TVH$.(T/+M%>?82WL+F&52V5MO,.V
M6D@A0L;*!';Q%J].'H=[`==.]8'B5QG&/5KT2_L9>.);6S,!J756+;4Z2U'<
MG$Q':<C6A2%-I20T)S^G==<>T\BU%AKQF0=2U);<-@L@$I.NE^^_"N3?N(>G
M9!O-8EA<B&\T.I3:2H!2?+KT@D7%N-;WR_W4Z4Q')G<;*5>9&D<0_)OL4BU-
MOCS3QCR6.$Y;J,[+<:3X-6&G&Q+XY*J$B24O=V&B2?IE.*61Q4@!21\;ZVYV
M!J'@>W^XI\,3$LH:!X(<*D+([>GIT!Y7(OX5(W#LTQC/Z&'DV(V\6YIYJ*C<
MF,2\FG0V\L:4R:"]%ELJNQMN")C_`*;*BZGXLJ/-91(BNA;*N!'W=Q[JJDV#
M+QTA<2:PIN0GB"/M':#R(TK*==BNI32E-*5__]'W\:4II2FE*:4J$WME[P]8
M^L%2[7.O-9?V=-BFY28+62&R)@EYBS.RF:!JE'5^0%3;8Y3G_P`-HDW)*QN'
M=,#`-6<5ZDTCRMCCXJ_9'V]@J[;1V-EMV/@LI]+&I/G=4-/!`_,KN&@YD5YF
MN\_8#LSV%S.PS+L2\E379<A%JL<AR+#_`!O'H^WCCUF.T\B7+&(T*$ORBD\\
MX9$9$1*NL'S6=FYB0Y+GOV0-0FY"$`=@)T[SQKU;MG:F-V]&8QV(B]3RC8KL
M"ZXH]I`!-^0&@X`5DO3W3SUY9Q+;)8K[=<U)138:5E7F&6_$3I,JZV]%6V52
M1`(N3<<2Y+S/8-5_&XV7NU[HC+4U@D*LXYJ%.'FA':.TG_LK768G^5$%(C-R
M-Y.(ZFVU6+45)_"Z\1KU\>E*;J/*PNH6!W=NPX%>W7T3-334U?%I:BFJ!1_\
M&NC*Z?Y$MYQ8[EA82GW2=DO"VAN.'OP^-];%$B1X;#46,V$,(%@`+"H?`8B3
MB6I<C(S%RLM*=]1YPZW5V"^O2.7CH`-*B9[,X-DG;O7S6/XK+KFEC9'6VI.3
M93\2(4>/%EQGHEP(QWY,*0S)EHX"DTK6P_>H*B*O*\T7&RA)LJI5UTJ*%)`+
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M5'L>20`4]X%Q?B:WIAOL'8X["@]=]@6=[9]<U=O&;R.E_,:F93@GB5V"S+PB
MUDK-B7V(L+*V*'($I#`J/B/[=SD</DI6$G_S3'H:5*]-21UIZDJ"A8]0N"%=
MAO;MN#67;X]O\?G8KS<<K9>2X%.-)4$V(/%M0!!23V\+_O5LC^4RM=L>J/6_
ML"ADS++JW';D@M)`NF7)C(*6G3%+66V0;$X+,![[R'<#/;;<MM9]G4OS(L[3
M^,M1)`TO<W4!V7U`KCV<RIK^;XMD6G?3@(OJ2&U`K3WD@7(YV-1W[F[1ZAK,
M?F8-ZVNWU]BG;]1U[$:9O\OR"UR:CO<?M*^Q_8!QB971JEB[FY"TV$25#ERV
MRBJ0APYDB0^5GP`TO&;:0M;<M+8/4MPJ:*%`D%M0L@WM9041:]5[#XG*NR4S
M=P`(D1%.$=+:`EP+21<+2;D`7NE21K:O0725TD\3J*G)0;GS2QZOKK]N0J2V
M9DI:UF-:"\3B*DEN0]Y$)2WYHOS]=6+I!3TJL1;7OJ/2I2%)6A12H&X(X@\B
M#VBH->F=X]T][>Y=U2;@LTF6NY!C8-&)DOY5/^3D.+NAP<:;$CKA=;Y*!_#V
MR(**1)2O;.:K`>X&8VZ0!%DE13W$76BWBDVX?TUO/OGC4;U]D]I;Z22K(P$H
M2L]H40R[<ZG1:0KCKQ[C=+E658[A&/6N5Y;<U]!CU+&679VUG):B0XK7,6FQ
M)UXA$GY#[@-,MCNX\\8M@A&0HOI9]]F,RX^^X$,I%R3H!^GVFO"3++LAU#+*
M"IU1L`.)JI3(?Y707*GH."=/R;W&6W#;BRK:[=@9!9"'-$DA6U]=91X39KQ5
M&U<>/C]515V&B?YV=DRS'Q>'<?3RM<K/>$I2JPJY*VBS%B"1D\LVP>958('=
MU*4FK#?7KV*PGV,Q6;D.*,6=18TDIBOR7&;QMAFWI)DEDWHQ&D=YYN373A:<
M6-(3BCOB-%$#`P&X8[()R#2E?3N,OI-E(<24K23PN#R/(\ZJTV$8:TA,AMYA
M0NE;:@I*@.-B.8YCE6_M2%=*M$^PLQ3PB)B[$IV/,S?)*/&64C@+DDV)$T)$
MQ6@)4^`:CIR^J+R05^"WU.8!($U<I0\C#2W/B!8?::K>Z5E6.;A(-G)+R&AX
M%0*OL!K=L*(U`AQ(+'/P0HS$1GR$IN>*,T#+?,U^3/@";K^JZA5**U*4KB3>
MK$A"6T)0D>4``>`K6G;7:E5U5C3]N_&_>;M\%;H<:9ELPY5O*YMMKRD/"X$*
MOBHYS??(2X`FP";B@V7:AXZ=D5+;@LA3@',]*1V758V^1/8*C\CE\=B&T.Y!
M\I0HV`2.I9[>E-Q>W>0.TU5CDG\C_?&"Y9%=S'J#"6<(D3106*R5>/6CL-.2
MN,1\H*Q<JOW+Q_*>2N!%V7[-OE*5N&9NS:LAM68PK0QZE6"T*4I)[NO@%=@4
M@7Y5;MMC:6[&'$8;,N'((3<H<2$J'?T:DI[2E1M?6K5>H.V<1[LP.F[`PN64
MBJM6D"1%>XI-I[1IIHY]-8@"D`3J]QU!/BJ@2*A"JBJ+J<Q\^/DHC4R*J[2A
M\0>8/>.=1TZ$_CY+D60FSB?D1R([C6S==VNI32E?AUUMEIQYTQ;::`W7#)=A
M!ML5(S)5^$$11577Z`20!QK\)`!).@K7G56:RNP<-B91+BQH9S9ULPTQ%&4C
M8QX%C(ALD:R45">(&=S5LW&^7PA(J$(]_)PTP)BXH43TA-[]I2"?AKI49AL@
MK*0&YJD!/4I5@+\`H@<>=AKQU^0V-J/J4II2H_Y#B>24/<^-Y[BM65C59'$7
M'LTBQB;86,V"(35R\B_CLN>,`;53<,S56>`I]R:G6)<=[#R8$ISI=;5UM'CK
MP*?C\N=5F3`EQ]P1,I";ZF74^F\!IH-0OEPT[]+#C4@-056:FE*:4II2FE*K
M#[7]T\RP[NBUH\?AU4W!L3M?V:QJWHS:3KMV&GAN'1M4)YR$X$Q3&/P'BB-B
MIB6Y)K.<IO"5#S#C#"$JA-*Z5"VJB/Q:\M>'AK6PX/V\@Y#;S,J4ZM&2?1U)
M4#Y4`_ANGG<6)UYZ&M_1_>#HAVKK[!ZSOHTB8X+4BJ*BD/3JU>(JX[+5APXK
MD=M2VY,N.D6WP/Z:G$[RPA:;<4\L*)U3TFX\>5O`FJPOVZW,'W6DQVU)2+A7
M6`E7A?6Y["!XUIWW.]ZJ7UQP?#>R:+(<3/#9]38Y7<6MFHS/SJN*[%B5M/#A
MA+B3&K"WG.O,-@B(^Y):\0[$#B:ZV?W*Y"&-5C"AQ+UU7.H*186T((YZ]W<:
ME]C^WZ]R3,ICY[+R);2DH2D:%*S<E1T((2`#V6-^!%>'O^1C^1/M3^0;MQ,L
MR?SXOUABBR('5O5\6;(<J\;KG2%)-U:`K[D:RS*]1L2FS$%$0!!AI$::%%JN
M3RDC*/!U[RH'X4@Z)_I)YGGX`"O8GM_[?XO86*^DBV=R3MB\\0.I9Y)',-I_
M*GQ4=2:KT8?>C/,R8SSL>1'=;?CR&'#:>8>:-'&GF76U$VG6C%"$A5%%4W34
M;5]4D*!2H`I(L0>=>Q[^'K^9VKRW#YG0GM[G-W/[0H4@IUGFEDP-@_G^/QHC
M4-W'[";YAE2,TJQ81Y#=1?W"/S-35\#\MPP^Y41&'D95]:@".@VN;<"DVUTX
M@GY\+^2_=CV<>;FM9G9\!"8#E_6;!Z0VLDGK`X!M7"P_";:6.EYG>/M!!QCJ
M:DSWJBRH,B?R+(@I8C\T7'FX01HS\NS215_DP9H2V/&T!":(@(^)*FQ`JRF9
MW(W%Q;4_&+0X7'.D$W(&ES<7!N.'QK'=N;-=FYR1BLTTZR&FBL@6!-R`FRK*
M!!N3<<;$=M:K+^0;%VNM#NG,=?+L-MMZ/^R-(Z[CWF8C@971SVS_`"/VM7"+
M:,'*4I`H<D3^[KHIWJR8*5"*K^9$](1RO^U?]GNX\N^I17MK)3DUH,U/\F2"
MHN_F"1Q3;]NW/\//NJ#<W^7[+8\"2RWCN/G-862HS2QV>SS3=Q1Y`]E?@:%G
M=.)$VFPC]XDN^_TG)[G4E(4S$3VGS:?"_*N)6%V0'%>G(R"^02.C4]QZ;Z_I
MV5Y_OY%OY>>[/9S'[CH7%,WLHO4ME,BR<Y?A1X%0_F$V"1DF.1Y5(37GP.-(
MX..,.*8SI+0&7]L`YUF3E\M)2_'ES`MHK_*``0/``D<['N->H_;SVOP&$^AW
M&YB5-Y7TO(EPE2FNK\R@JX#MM+BQ2"1Q)M23J-K9:F+ZN=]!A=Y5X'G%HL;`
MKBRCQV[B2I.IA[TM\&W9BJ1_;2%S4WP1%\1?W!_XT*3A91R$AQ*DE;=B0.8/
M+X'G\QWY![D>V;&Z2C+8L):S"+!?(/('&]A_>)'X"?Q#RJY$>C""&-=:80D^
MHDK94[$*1:M3OR6):6SD](GXKS,F,@QC9F.DR+:MIPX*BIO]5@5N2<UD$!RP
M=60--``/Z!<UFR8\/;&*>2E*O29"B>K\15PL=!8DV%K:5$4^QLQ*_7(TNYHS
M?.KHL)(?6O!I2W_#&$3JL?A;?'CVV7Z_7YU?AA\>(OTOTZ>BW&PZK]O5QO\`
MIPK)#N/+F=]>):_4ZK]-ST6_9Z;VM_W\:L\]4O:+(\0D5V3TTR6M6DUF-G&'
M"^JUMDB"`R'F8CCRLMS%CJIQ)"J+@+]A*H<T6L,RYNULEZ:5J5"4;E/)2>VW
M`*';^HU>),#&[ZPOJJ:2C)('2%6U0L:VOJ2@\;=G>*]#V+9-3YECM/E-!*&9
M3WL%FP@/IQY*T\GRTZ($:-R8[B$VZ&ZJVX)"ORBZUV-(:EL-26%7:6D$'N/Z
M:]]8!,B/P)3\.2CI?;44J'>/U'B#S&M=_KFKK4TI7__2]_&E*:4KB3Y\&JA2
M[*TFQ*VN@1W9<Z?/DLPX4.*P"N/R9<J0;;$>.RV*D9F2"*)NJ[:^5*2A*EK4
M`@"Y)T`'>:^D(6XM+;:"IQ1L`!<DG@`!J35*GM]_*9&HWY_7_K/(@VMBR3L2
MY[0EQ6K"F:1V-_3@[22_%.E1G7$WFR6CCH0*C;3B;.:S'<N_VXY7#P:DK>X%
MW0I']C74]YT[C6X;*]IG9@;R6YT+;C'5+&J5G7_F7'E2?V00H]HJB9QR]RRZ
MD29,B==W=K)<EV%A/DO2Y+SSQ$;\^SG/DZ[L1[\G#55(EV3=51-8ID,BAD.2
MYKQ4XH\S=2B>0OJ37IW`[?D9%QG&8B*E+2$]G2VVD<U$"R1]YX7J76`^M=E4
M-4]_F`+#EV+#LJ)`D!+CSTKS509GL0GHHC"A2U%49?=+\B0(DK8@VO).WBML
M9#<!;E9<%C#7N&=0ZNW#K-M$GC8<OG5IQ^1Q>.DR,=M90DYEKRO3B`J.U?\`
M$B-Q"G0-`H@A.I)(\M2GKZ^)61FXD)D66&A00`41-D1-D^B(G_L3Z_/U5=:J
MPPS&:;8CM)0RD6"4BP`\*[<:*U%2L(*E.*45*6HE2UJ/%2E'51\>`T%AI72Y
M=E5?A]*_;SD-\T((\"OC[+-M)[R\(T&$U\FZ\Z2[J@H2B"*6WQKLMMEQ02/^
MZN.=-:@1U/N`D\`D<5*/``<R:AE-S+,)^8U=W<VTV.,&RBNR*NB`Q%LE=9-<
M4C1FE:2YNB8>0)+#JF#"?\TN2<1D0VV&U(0GB.)^_N'95"<GY!R<S)D/J`2L
M$I0-/_A`?G7;\0.B>9K8>+=:WWL%G<O"^M,+AX4TXP=SEEE=%.C_`(:"_P")
M@KD*\72KFW3>-QFN%`64]_<<11!$7C4L1VPMUWJY"WZOZ>50FYL_`QX)1C_2
M4X;E%P%J/:H7\J1J>GF2"K2U]MY/1]E=1VCW6L7J#)<CA8_7Q(]9>-UE]?1L
MD!R,S(==KY--CLYB6#;[Y-J"^)04-E$/Z4X$^F^/64\`HG4:"WS-24#?N%3$
M0U'"4QVT`#UE`+)MK<`*OK?AIV=E1'MZ[+!R2YN<E9AXC/(&I4["\FA6%+=_
MM<=D>+-+%SBI=;CR5CM;-(A*JDFPALB"G='1T)2FZAVC47[^DUTV)Z<F](R$
M>='+9XH"M;`<$>HD@&W`7^%9/^U-%5.Y5UK?6]NVU#(I,&JF)_E-%-0W&S9O
M:""\E;84A^(Q-&F0>;)$(5<'=-<=R%!MY`'CP/@>-ZFO2"F#.Q$I:P$ZA)_B
M(/8M"3TE';8!0XB]<?KK%L)JLFQ>K[SJ\CB8=E58U.2UH)K==-J)$F7'BA96
M!V+!K%A()HS8-;_VQ-M]DD78-?:UN*"RPL>HD_/].7RJGYZ)EH<%EV*BRRV5
ME)!)(-A<7U2L:7%['0\["\O$*?"^Y.H+'K_(<&%.N3K6<3@U5@;TF+:8W'KX
MPU<V'.-METI#+"`026251>%#`]_E.#/XIC%2(S;.49E>JPEQ1;U"%*O="M3J
M.S0]H%8EA,WD)#ST\Q7HLQF0H`JN%$I/XQH-#\O$5'7`O4[U7]2L]H,BHL2R
MB]RS)9;\+'[/(9T3(FL7%V5!C&58S)&L9BNHY-`1>1N1-0.6Q_*H7YA-LR\S
M'R\R"64IB,^HYU*Z5%.NB=#<Z'C8=^M2VZ/<*8XK&PLHK_J7.D>DVE-SH+N$
M6)&O?VVJQ'4'75JM'N%5P7W2ZQRV/O'&QONNKA]P1^'/';-X_/\`@B:`O)"A
M\5W+CNNZ_JFLQR;BL5[E;9R*#8.+:!/[Q0?L(KTMM!M.XO8'?^#='4J.B04C
ML_AAY/\`O!7VVUJ7G\I2Y"716*1ZJ0XW4SNQZJ'>Q6G'`6P4ZNU>J([H"GC>
M9"P81SB:HB.`!(BJB*GH'>K<A[&Q8[%_XDA"2.TF_2/G:O#NTG&&)\F0_P`&
MV%JOV`6*C\KU#;KOKRCP*EB18<-A;9R,TMM:$"'+ERB$2?1'R3R-Q1=W0&QV
M%$1/C?==>@=J;5QFUL9'B1(Z!*Z!ZCEAU+5S)5QM?@.`%J\R;MW9E-UY21,F
M25F+UGTF[GH0B_E`3PO;B>)-]:F#ZPS9=9VU#8KF64;R*NG0;U406S?AUT*9
M8PG7"'97W(4L/[?+?B+SFVW)=?.[(T=6-5)4V!(2I("K:ZFUK]FMZ[>Q9DIO
M,(B(<48RT*ZDWTN!<*MPOI:_8:LXUF-;-4.NX.Q*>D[FQ%V\B6UEC_7L`[&<
MS4L1Y"1L@R!M?V]R9YWX[`$PPS&=:1QP#W7[-^2HMLP^/=?Q,WT7$(D2%!">
MHVNE.J@-#>_"J+G\JQ&SN.^H9<7%BH+BN@=5E+'2@JU```UU/9:NXL/;C!6H
MQG64&439FR>-B6S5P(ZDH(7]R2W93G`$27BO%HOE/C=-ET;V=DU*`<=:2CMN
M3]EA7Z[O_#H0HLLOK<Y"P`^?4;?(U"S/\]O.QLA>R&\5AMU6FXL.%$%P(<"$
MRI*U'8%UQUPB(C(W#(E4W"5401XB-[Q>,8Q481V222;DGB3_`$=E9EF<Q)S4
MPRY`";"R4C@D?'GS)YGNTK07;E5$MNN<K8EM`Y^/5/SXQ$**3,R`B2HSK:K\
M@7D;055-MQ)4^BKJ'WM!8R.U,['D(!3].M0OR4@=23W6(XU+;&GOXW=N`DQU
MD*^I0DVYI6>E23VW!.E3(_BOJ[>%T/E%A.;DMUESV'8R*17@(6'V8=34U\Z3
M#4D1'&EL(YM&0[CY&2'?<51//6PVW$8AU:P>A3Q*?```V^(->G]Z+;5E&T)M
MUI:%_$DD7^'WU9KJ[54*:4K7_:MJ-+UOFMB2H*MX[9,-JI`/]Z<P4!A$5Q"#
MDKTD41%1=U^$15^-=[&,_49&$S;BXGY`W/V"HS,R!%Q.1?O^%E5O$BP^TUQ.
MG:4*#K'#*\0!LBI6+!Y`%0WD6Y':OD2$B$IJ[-7=5^NN3,/_`%.3G/7T+A`\
M!H/L%<>`C?28;&L$:AH$^*O,?M-;+U&U+U\GVO.R\SY'6?,TXUY63\;S7D!0
M\C1[+P=#?<5_14U^@V(-J_%#J!%R+CE6DNG+ZSC+D?7&56#\O)L,M9(Q95E)
M>>GWF-SI#\BKM!?F*$FQ1I%4#<$$%L%:%?JF\QEF6E?39"*V$QWT:@#1*TV"
MDZ:#M`[ZK^"D/I^LQ4UTJEQEFQ4;E;:KE"KG4Z7!/<*WEJ&JPUK?MKM;$.EL
M$N>PLWE/L4E,#0_CP@8>M+6=)<1F%4T\61)B-2[*:ZNS8$ZV*(BD1"`D2=2=
M-8Q\9R5()]-/(:DD\`D<R>0KLPXCTU]$=@#K/,Z``<23R`YFJJYG\L%E&R=!
M7I9&<0)\>`S,A?8R=R#]Z_D)_P"6K6"^Z)`2-HA`.RIY"W14I$C>TJ*^D2<(
MXW&/#KNE1':+IM^G&K?&VE$ELJ,;--N/CCT=*D@]ALHG].%6C].]S8)WGAD3
M-L"M$G5[JMQK&$\/BLJ*U6,Q)D5%K'W7PS(P2!W45)LT7D!$*[ZNF.R,7*1D
MRHCG4V>/:#V$=HJJ3X$G'2%1I2++'#L([1W5M77>KI5Y6?:B9F==<9I94UDD
M6(WEF3,9#P05GN+-NWV`>:D*)*((Z9":BHEN:+NOZ8UCD0G\U,:FME3Q=44W
MX7"B3<<^[E7HO+NY&+MK'/XQX(C)80%V'FZ2E(!!Y6Y\#K4`YO8-IB]4[:3\
MMLJFFI`.P>??MI;,*$#6Q&ZH*]XTY<43BB*IJJ(B*J[+;WX>/"777HS5K:DI
M'#QM5"QTG.RY4.!CI,AR2MP!"$J4;J/8+\.WD!<G2]5@^XGN+F7L[D%93C.L
M*[JK"O-&PS&#=<;;=<>==D3;^TCBX31SITR0\XRVNXQ&GB$?O-TSH3:"E*0I
M1(3<)[@238?$W/?7MS;&VH^"86\MM)RCX275#M"0.D'C8``7YV[``(5ZY*M-
M-*5RX$^=53HEG63)5=8U\EF9`GP9#L2;"EQG!>CRHDI@VWH\AAT$(#`D(21%
M1=]"`001I7RM"5I4A:04$6(.H(["*OH]:_Y$+_L3KFGZQRDFBS_'3E27)4EU
M1BY$T42##/)(3"N\G<A.'!!)K2J@<FD>!.)D#78Q^.1,<5&=D%+(5UI2.9.A
M\+`#OMX5YV]R<4_M%0S6+@>K#>'IJ6;GT;$E*5<R"5'I)-K^4ZD7FCGO=$W%
M[2'7U-/&DLOUD"S_`"9ZR`\C4]OS-HPVR;2B@MKLJE_Q[IM\:^L=MY,Q#SKT
MDA27%)L.-TGB;U0LSNY6-=CL1X:5)6TE=U7`LH<`!W537[J^RF*74V1@?4<F
MP$YXN2.QL@&8)Q5LIBH]+Q7'S9::<_$B/$83'^1(ZO\`9'<4<4^1R?.#;D)Q
M:/20>FZ>*@-+DW/'NXUK6P?;C%!V)NZ?%7]4X`ZVTNW2@JUZRGI&HO=`/#17
M&UJS]=&MNII2FE*M"],/;YNHJ2]?NW[/R85;194#!LGL)!<\5M)'%V!2V<V0
M\H,XX[.:#\=Q4XPG5XDO@+=KB3U1I+,QDV4E0)\.?V7O6;;ZV>C+0)LB$S=]
M39ZT#\_,*2!^<&Q/[7CQM7Q/IS%[&@JBR6YDUF17`.38T%F9#C21ADI`PTD"
M:P;SY)QYFHHGRO%%^-]3\W<$EF4Z(T<.0T6!5J;DB_XAH.ZO-6-VA"D063-F
M*:R+ER$W2+`$BW21U'A<ZBOEU38PL"SK*,2M[-@&7G?P6)CAHQ%=FP)!BPAJ
MX7!ER0R^2;*J_>G'=?C?\SS+F0Q\.<PR;@7(M<A*@/NM^NFU)#6(R^1Q<F0F
MRCTA5[)*D$CGP)!^8M5_/\?W9,J7"RGJV>Z3K-4"91CRF9$K,>5("+=000B4
M08&6ZR^`BB)S>=)?E=2VQ<@IQF3CG#?T_,GP/$?/7XFH/W1Q*&I,/,-)`]4=
M"^]21=)\>G3X"K)]:!634TI7_]/W\:4KAV%A`J8,NSM)T.MK8$=V7/L+"2S#
M@PHD<%<?E2Y<@VV(T=EL5(S,A$13=5VU^*4E"2I:@$@7).@%?2$*<4E"$E2R
M;`#4D]@'.O-S_(1[V6/<M[:]0=573D?J"GDI$NK:N>04[%LX;J.%(22RJ&>*
M1)`HD=K?A*-M'R14\2#B&\]WN9%UW&8YVV.2;*4#_>$=_P"QW<^/97ISVW]O
M6L0PQG,S'OEUBZ$*']R#PT/_`#".)XIO;C>JN:NKGW4YBMK6#?DOFV*J($X$
M<'#0/.^@_*-HOT1/N,OM'YUE\R8U":]1S59T2D?B6KDE(XDFMYPV&E9J5Z#%
MDLI'4XXK1#2!Q6LFP``!XG6KH?6'U0QCJ['F^S^WXD)AP(S$R%2W<8B.*ZKG
M"/97\5X"\]F\9C^)!X&C"FGV^780G]M;8>4ZC,9M(7.4+MMD>5D'7@=.KAKR
M\:JN^-^IE#_(^P$+&.ZNAUYO^\F*&FA3KZ?'2]E#^K7<YYDR]CYC-N($>#61
M1B184)JTN*:H-R'$)X6GW'+2;`9.5()TB\3:FK8<45?C?6E(3TI`J4VVRC8^
M';CY4/+E/K+A2VVMP(T`Z24@BXMKVGAIK6O+/>FCO2[#QM1F(\N4LEF1&G1'
M6((<YAQ9L!Z5#F)&^CGB</@7VEL7QKZ`)(`XU<<;N#$Y9AYZ%*"O3!ZTFZ5H
MM^T@V4/&UC43J%[(^Y<E&4Q/*`RCBOC91X[EC`ZGQ,Y00'KV<,-$\F6WKO\`
M9BCR\X<M@4.0\9N%`?DR&(,1DN27%=*4Z`K5QL+\`.)Y5F6[MZ1L/CI&9F24
MA8!])-[^DF]NHVUZU=O%(X6N*G#C/ISU4..Q,DR3(;V/55LA][!+7&;N17W%
MK%L1DO3'Y+3D09:V]EQ;0@%?*WX#121K7'N_,8C"H908IB/1VNB5ZI"@7DFQ
MZ-3IIH$\;Z"L=V[N?>,Z[ARB7V5NJ7&+:`E26UZ^8A(-^TJ)(`U-JQC/NV<+
M]1<%&LZ[H/VJYRR6XW38O!F!:YGEMR;3G&SR"[DH].*OKG#02_&%`95Q1;4B
M/?6*L;KS>\,@IC#VBXQG5Q]8!Z4WX`'R@GBE.I-KDV%3V92QC&1-SCRI.1<T
M;:2;7/'EKT@_B(TUYDU7Y=O]Y]IJY9=I]T9X03W/S1Q.HR"R8I*HW$W;CA$*
M8Y7\HP;#N#2KNB[F:_<MO_G*8B$L0VRL)TZW#=2N_E:_9P[`*H*H4B6I3LN0
M4]6O0C1*>[OM^AK#YW7&7P)$.XHL_M[J?4&4F#59NC.25#[OP9L'&LQDP$;E
M*""8N1W`+_B_U3GC[D<2KI?8`0>)22#_`-OV41"EQ"7,?D76W/[1L?&UOUUM
M['&(W;5;<7_7%/"Z>[\P>*MAF75N.LA35^?T+8`<O*.O:QI&VPELE'4Y=0UY
M8CQ%Y6D15^;,Q*:=0@EP.1U<%7O8]BOZ>(YU<=I[QFP7TQ);BFW01J#8BYXW
M/XD]H)(%9G34N6=W8Q:VU57IF>6=7$TS<8]C\=')>6X;F==)B.VM>VPZ\86U
M7(BMJ]#%@C;<)"%$,%!.8]$=0!/2E?`GD1^KOK4<QNU;>0QS&2;:7#]-8]1)
M_$%)MJ.`T(/<KPJX;UEI<CQWH;K*ERV/80[^OQY&ID*U:<8L8+)3ICM=`ELO
M"#K+T*L<9:4"$2'ALJ(J;:B)2DJD.J01TWK'<BMIR=+6Q;T2LD6[+_KK.^Q,
M@QS$<=?RG((4*:5*7FIFI,=EZ2=P\)-0V*YQQIYR-*D&O%7`1%!OD2KQ1==1
MZ9]$P^Z72EOIUL;=0[.^YY=M063EQ<?$=G2@GI:%Q>U^KD$]YX"JBLQ[Z[[S
M"[R?(<<S^WQFGP\ICC#%:YX:Z[M80?D2:YJ$BA&6MK0;5G=Y'?*:[GR^=JVW
MFELNQU2/,MX@]')M!.G+4GCX5C;^[LV[)]=,Q2$E5PD6Z0.0X:]]^-9S[,95
M*R6@]=>U9HE&GWV`I8V+C(BTJ2ZY^KL9!@NW!I%?FN$";;"A:JGN(DLY#;<Y
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MN(0YZ2*1R09J`1#M$!EB0>S;JD*/B(*GVHB'NJHB+KBW-$<EXIT-?B00NW:!
M>_WW^%<^SYS4'-L*>T0X"B_856L3\1;XU:3.FQZZ%,L9;B-1(,61,DNK\HW'
MC-&^\?\`OQ;!5UE"$*<6AM`NM1`'B:W!QQ#3:W7#9"023V`"YK0W2-,%[79=
MV)<P67'>S;^39,PYS`/N,T5:_)KZJ+(1Y'`<%&VR4-MQ5E&]OA$VG,TZ&7(N
M/97Y8R`"1IYSJL_/3X56]NL&0S.RLEOSS'2H`B_\--TH!ORMK;L(KXYEZS]>
MY*DF54LR<5M7EY@]5GSK?*I;EYJI_DRC9HJ_#),*B[+OLBHO)"W/DX82A2PZ
MT.2]3\#>_P`[UPY'9F&GE2VVRP\>:+`?%)!'RM6@;7U'S=AU?V;(<:LF%%%0
MIQ6-4^);IN*MM0K-LA1%7[D-%7;^E-6-G>D0I_CQ'$J_JV(^TBJF_P"WDY*O
M\-.:4C^MU)/V!585FOII=VF*ONYSV52X7B$`7K7.I%-%E64]<7K6'95C'@V$
MYJ%%A/FRVJJX<=]!X_T'OQU6-W;A.7Q<C'Q5F/"6D^LL_B+=O,E-C9-QQ)OI
MRJU;-VB,-E8^2G!,B:VH%E";]`<N.E2K@%5CP`MKSJ$$7W([SF+"Z[]8Z2!@
M?6>$ME7XU`C45386[U2#I^&PRVWNQEURV]J\3DE_P`QY'W35?(2*:XUB)&Z-
MP.G';0QX3!8%KV%@.76M7E"E:FPU)OQK9\V=K[<:3D-VY&\Q\WM<DD\^A"?,
M4IT%SH-.%62>I?LIVEV);3.ON[<8KX&4MU[EIC^58Y'1JENXD/PA.@V[;<^8
MQ"O6U>\K:M"RP\TA(C8DVJGH+&,W3CDEO<,!`TT=;(4@]ROV5=F@!Y51/YWM
M3++ZMO3U%7-IP%*QWI_:3VZDCG4]]<U?=:!]@08NJ;$L#68]%EYQF536M^%U
M&U6!%<1ZQ?='@Z3C4;R-*B<"%'B;4OC4Y@OX3\J<?PL,J5^\19(^)-5K<X]>
M-"QH/GDR$(_=!ZE'X`5OIEH&&FF6DXMLM@TV.ZKQ!L4`$W555=A3]?G4(222
M3QJR````<!4<^]^_`ZOK95;B5=6Y7V#M'6/0V%@_75D!F0T;HS+B?&BRC#8$
M!1C!Q=<1P2W`%YZD(^$S&1C./8UALG7I+BBE!([PE1/P%N5Q4-.W)A,1);8R
M3[ES8E+:0I8!YV*D@?$W[C4#<-_DOS#&\U:QCV#ZTIZ.LF/,"W?805DVM;&>
M<5I+!ZNM[*V"Y@(7R9L267&Q$MFS+[=9]-SN8V]E!C=T8H,E7X5H)*2F]NH7
M)"D]MB".8OI5_P`=C,-N3%_S/;&4+R4Z*0L`*"K7Z5``%*NRX(/(VUJ<';$B
M/BN:]:=S5<E@J:6XUCF138J-O#-HK9L9E?+!U45@HBQA=)3Y"NXM<55-]:GA
ME)R&/G8RX)*?5:_M`:@>(M66;@2K%Y3&9L72@+]%[^RHZ$_V3?[*E"BHJ(J*
MBHJ;HJ?**B_147]475<JW5"/W*EMRHN!X_*A0Y4-9]ID0G(`'W&K"M89KHIM
M-&A(WP8MWOOVWW5-E39=7':$"-)D2)+[25K:Z>FX!L57\POP(`M?O-9_O[(R
MHL6'#CNJ0V\5%=B1<)Z;)-N1)O;G8=E0(R#&:+**Y^LO*V+/BO-FVGE9;5Z.
MIBH^:(^HJ[%D!RW$P5"1=7?)8K'Y>(["R,1#L=:2"%`&U^8/$$<B-0:S3&9;
M(X:6S.QLM;,E"@04DB]N1'!0/,&X(XUGW\9%7D>*]I=]X>C\Y[%*J!2FZADY
M^$EPMC(2EDJVNS3<Z;2./*2BB*X`)ON@CMYHPN(?V_N/<N%ZE&*RM/23S!\R
M#XE!%_"O5T[,L[BVUMO-]*1*?;/4!R(\JQX!8-JN6U;ZKE>>3^07JRQQC*^R
MX,"*;<#)Q8S6C5AIQ`D1GIT>RM8K0HV(*XQ81I#?`.2(/%?UVUE&1C#%;K0\
MX+1W5E23R\X(/R43\+5O&(F'.[#<CM*O+80$*'/^&H*'?YD`?&]>7CW13L+\
M"E6,O_\`3A%#\]("/(Z-[Y"1E;Y47@L-04?Q?_A^7ER^_AKN9WZG^'_\KW?M
M=_ZJT3V*_P`M>O/#@_\`]HUZ.NUO2MKZ/]:]_4Y]-K>7JJNW5;KTO32E-*4T
MI7855K8T=E"MZB9(K[.ND-RH4V*X33\=]HN0.-F/_L5%^"15145%5-?25*0H
M+0HA0X&NO+B19\5^%-82[%=24J2H7"@>((_2W$5.SN/WDO\`L[KW%J:OJW,?
MS<,;8QK,KR*H-0W6("NM!+Q[Q.J_%?MX[B*[S1/QEY"VI;B8]IF:\S'DLI-E
MNN%1/<0-!\>-97%]J,:C<D?*3%AW%16DAEI6I*@21ZMQ924"UA^8ZJT%C`15
M555555555555W557ZJJ_JJZZ=:YPT%?S2E-*4TI32E7)>NEKVG/ZWH7>RI;\
MDX$:-#P]R><C]_9Q>,BG7M6CKBH?%I7%_%4E\J1^/)=D'5MPL=;4-:7&P$+4
M2.W4<3W=E>,_=J;@W]VK7@W2IQM(2\4D>GZ@))#9&MQ?SGAU7MK>K`(^2=:=
MD_A0\IJW<=R21806SM:MD3.P+BU$%IV4J&X;;H`(<744@5$433[MXU4?,XD.
M&,\'H02=%:E([A<<.P&Q[*BVY>W-P+9$R.8^24L"Z=`LGM-CQX7(ZAVFK??0
M\U@=X18,=UU(SV&WT110R)'&8R0764D;J2JJ%&144ONY;?ZKOU]E*4,VK713
M2OO!KN>Y*$G;2--4/HM?CP4.//2KI=:Y6`4TI7__U/?QI2J3?Y6/:YFIJ0];
M,$MW1NK16)_:4J"XZRL"F-EB758H4AIT/(Y<B^,B8WLHI'!L%5?(8IE_N%N$
M,,#"Q'?XZ]7".2>(3?M5Q/=XUN'M%M`RY)W+D&`8K6C(/YE\"NW8C@#^T>ZJ
M"")!$B7Z"BJNWRNR)NNR?KK&J](@%1"0+DU:Y_'_`-`0+F;+S_*(C4IC')$-
MV-%='DU)R5YM)48'0)O9V+01.!H*KLLEU"_14U\[2A-YO)2LY)1U1HZNAE)X
M=0U*_'A;Q[J[GNGEWMF;>QVRL<Z49&:WZTQ:=%=!\J6K\>DV-QV#^L:L9]AI
M=0W@+D&?+<8GS+"$[2QVAYE+EPGVW7P=';BD9N(9J1*J<2X[;ELBZPR#UWMI
M6/>W[,US=&/=ALA8;)*[\$H(Z5'QUTYWJM7++JQ#$<FE5=;*=L8U3/2O<B>.
M<)S%8,`.+^*9RU<8,N2HK0$BC]-]=]M(]1`4KRWKT;.D.B#,6RT2\&U=-M=;
M<K:Z>%?+UZS?J?#Z:5@_;&-9-&HNR96-4^+P[.,Q(DM6'XS]7D.63%_<6K"C
M6SF6S#3I-!S<;:!5$OE$Y7VW7#UM+!4BY-OL'?PK$MT0,E#=BY?$M*BH2Q8W
M5TN.6_&I21<$:Z]1%^PU-VP>]<?4?$Y^.,T2%&L66I5_$\;%Y;64?DX$5Z\E
MVCS8/`AHHL,(JDI+N#?RI:A).8<CR8Z_66)=[H"-%#O!!'3;MN*Q+<>YX47I
M1EW%/.K%NBP5=/>#9('CQK36:Y)CWL_U_=Q\*R6]Z[Q^,Y"HXLBO:"IML<@5
M#\"QM8Z,QY`1H"VT<"!7&7?MC$"%\B;>L@WGN.<QNB*Y*B_414(ZTH</4EU:
MPH>HJQ5U%*CI>^J>^KSM%O&9_;+KV,E*9*U]"E)'2IL(*3T#LNGB4FUCQTJN
M.7EY=S=D9-VN^)E0Q37$>O(CRDX$7'ZIU1DV@"[S4)5M-Y.$2;$.Y"N^VK1C
M\8-OX>)B-/JE?Q7R.:U#1/@A-AXZU`S9_P#.LG)R>OTX_AM`\D)XJ\5&Y\-*
M[R1.C1@4C<%2151&Q-OF1()'Q3F8"BJ@+\JJ)\?77,E"EFP%<2EI3Q-?N+*9
MF-^5DN0[JB[[;HJ?[HJBJ?[HJIK\4A2#90UK]2H*%QPK`LV8O*"?C_:.%OI`
MS+KRQCWT22!.-E-@0'$ER8#ZLJ)R&5\6_C)>)-DX/_'J8PTWZ=\L.:L.Z'N/
M(U'9&.I:$R6='VM1WCF*NLZEP;#LUD]?>PO5S%9A=7G./P[[*JRGBNPG+F;(
M"2[(BR6XSHP7?%82'67T,/A6N0_<NZ:`QF(T;"Y;#RL:AZ6ZI'IO*_$T$G4)
MYZCL(XZW%<+S,W(S<1D491U,)E"KM7)2KJ&G.VA[N0M4KK&Q@5$&79V<MB#7
MP6'),N7)<1MF.PT*D;CAE\(B(G_2J_"?.JRI24)4M:@$`7).@`[ZFVVW'G$,
MLH*G5$``"Y)/``#B34#NRO8GJ+O&-:]:=99062YMB\Q,CGT;-5:Q7GJNH:?B
MV[T%R;#CM37*U)PFXT"JXH@7$245351F9G&9M$K%XV4')J`%]("A<`B]B0`3
MKP!O74]P]D;EB[;<>DXY2$AQ)MU))TO<$`D@VOQYBW&H9X!U5VAFUU<]85.-
MSHU#=7\R9.SEQ.%=3XM;S$<MC(G!$7K5&G2;993<R,EW'@/+7+!QR)ST.<LE
M(;0D*000>I(L+7'`VK"\-MZ=E9;2/16B.".M1%@!SM?B>ZI(>[>.T^(X=TUC
M,`.%9CE3=4L03047]OKH%#%YN<40>9@RA'MLBJJZK7NA<PL41^+UE6^0K^A/
M^F9I$?*[@CI'^'1#;'P"B/NJ[2;D[6&=7#E?[7:7;%#A\*S_`&JECI*LYS<>
MMCFC$-A2%#<4?E=UV$45?TUZ0R68&W]JOYM<)Z0(L0.%MH=3B^E`T2.W[A<U
MXCAX<[@W@G"(FLQC*G*;#KJNEM'4LZJ/(?>;#G6$=>=R]0>PE'(K:V5"G2'(
M_P#YQA61,LQ[R$JBJ.*5>Z9_D!'/?:3%)P6RV7F);:A=A>Z>UM\-I>V_DRWE
M$"ZXZSZ<AL\_+?S)!T*D%2>T@FU2N_\`VIW3L=:X^X\4'<4LV0^@>I'<'+S6
M\JB-0E82KL!M>M:9GZEU,G\R=@UU(K9)\7(U)<FLFK;)$1"9CV+;)V3#9(FZ
M>5))<U_J0=D3<(.[Y+24MSF0ZG]H:*MWC@?LK`<EL*(\I3V-D%E?[)U3?N/$
M?;6)VDWMJS_Q;H/+FQ"=<6<&1(O8=@V])FXA7H]*D,2GXI%L3"5YDKKB"3PM
MBV0D1<BYVV\0W]3GXA/IH20$$<'3PMVC6]N7A75>=SSWT>UIZ1ZSB@5.)5<E
ME/&]N!TM?2_#C4Y:Z!%JJ^#5P6_##KHD>#$:W5?''BL@PR"DOR2BV";JORJZ
MI+BU.+6XLW6HDGQ.IK2&FT,MMM-ILVE(`'8`+"N;KXK[II2M*^QV,WF9=#]L
MXOC39OWUU@][#K([1(#DJ2L0W$B-JJ%]\L`5M$^JJ>R*BKOJ.R[#LK%SX[/]
MZMI0'C;A\:[^*>;CY&$^]_=)<23X7JESI3'HF/=>48-1BCS;%H[&V5UM6Y1S
MWG#0VY"$(F*Q`$6A%?Z4#_55WU#VXQ4;%;0Q"6&P'7FPZX>:EKU-_P"R+)'8
M!6(^Y>6E9;>695(<):9<+38Y)0C06_M&ZB>9-2RZ)A29W;.%-Q3X&S9N37"5
M>/\`W:#"E2Y0;\3_`.;'9(-MOGEMNGU2>W&M",--ZQQ``\21:H;:3;CFX,=Z
M1L0HD^`2;_,:5:WK(JWBH69YEF13.XYN48QB+N9574-<53);1Q6&8=O;QY#D
M^8SLCC\AZ,(JR2--.<28W7;8%6W8^)%&*$>7,]!V6KJ!M>Z4'0'L!)OWU0LK
M.G'.&7`QYDL04%*@#:RUBY(XW*4BQL#:NBM_;R\<9?8J,/@5TDFR;"3/L7YJ
MQG_N$G/Q0B1!<)O]!(MN2?**GQJ08V8V2E3L_J;_`*J>(\;FHR1[A.A*T,XP
M)>M;S*O8^%A\KBHE6UM87MG.N+:4Y-LK&2Y+F2G>*&\^Z7(R40$0`?T011!%
M$1$1$35U88:C,MQV4]+2!8"LZE27IDAV5(7U/+-R>_\`30=U13]FZ>-.Q_&I
M33!OW:7PU=:U':5V3+"QCN$Y%;;`"=>(GX[7`4^>2[)\K\XW[W0XSVW\=*4G
M_'(E!".TA:5=0[3^$&W;6T^Q4R4UN/)1$J_P*XI6YV`H4GI/8#YE"_95Y]?@
M-G,]:<=P.[;-W(('5F.0'@D1R_(9OJ;'X)MLJRZ3CC<AF=%1I?GDBHO_`$:Z
M6W77,9_*5N$];:4!7R`4/E>K)N:.WEF,PRV`4NE93XW*DGYVKF]9=I4+W4U%
MDN4W4"J6N8=I+)V:^#)N3Z<BC"VPTJ^67+EPP:=%MH3</R;(BKJ8R6,>3EI$
M6*RI?4KJ2`+^56H\`+VO4+A\Q&7@HDZ9(2WTIZ5E1MYD:$=Y-KV&NM0>[I[.
M_P#4_*0GQH[D6FJ&':ZG9=)5==8*03KL]\/@67YNP;@F_$0%%5536@X#$G%1
M5!T@R'""JW`6X#X:ZUEFZ,ZG-S4*921%:!";\3<ZJ[KV&G=6)8?@&59U,&+C
MU6Z^RC@#+LWD)BJK6B54.3.FD*MMM-"*JJ#R-43X%5UVLCEX.+:6Y)>`4!?I
MN+G^@=YT%='$X+)9E]#4..HH)`*B#TCX\SV`7)Y5)#JO/.D.F<N8ZIP)RX[#
MSOL#*(;N=7F+Q@LJR#:MPX]2LJ3,0VV6ZJI:CHBM,*_X`\AN'S547R-EO>K9
MTC?36W\0E[(9F=*2ATQDAQMBP"`5N7`(0`.OHZ@D!14018^T\'['[PA;!<SV
M64SC\-!BJ6V)2BVX^22LA#=B4E9)Z.OI*B4A((U$\]:I67UHOOCHG&N\L8_:
MK-0KK^N%YS',A%E'G:Y][QJ]'DM(H++K9B-(CK2DGT0A5"34-FL+'S,;TG#T
MOIU0OFD_K!YBK%MO<<O;DSUV1UQEZ.-DZ*'ZE"^A^'"J3.PO0OIG#:?,JG/.
MP.LY.46[%A6/8"]^]7\217SMQ="8[%8D.8Y(DL&IM(4;=K[=G`5=QHF4AOL1
M3%G[@9#Z2+(`-S;AU$:CXCQK6-N9AL91G+X+:TI*;W];J`Z2>/0%$)(OH;'A
M<6MI7DA]LO6BX]>.P;&!%9E2\$LY;DC%;5XD?=9A2#=<C5ED\"(GYC#0*(FJ
M#YA!5VY(2)"H0I4=I\&Z3H3V*'$']-17JC:V[8V>+T%ZS>79`*D7_&@_A=1V
MI/!0XH5H="DF*&ORKC32E-*4TI32E-*4TI32E-*5:]Z*^D!YU'C=U=MU+P8:
MV!O8+BTH/`_E4QM3!O()[<A6A;QZ$\.\83^V8Z/)?[(IYNH](*%)"#P/'P/#
M^GY5GN[]S)9;?Q&/<O)4DAQ23^`$?A!Y+/\`N^/"S7KCJK'W)5D_E=G1STKB
M6,E/!M4-(KJ;H;D]YDHXH@)L@B!*.Z+NOQMJPY7.2O391"9<0%"_44VOW)&M
M>:,#MB"7I3F3D,NJ0;="5WZ3S*R+?T5)+IWHCK&7VGC,>U>DU]+?W$.#'LD=
M":WCDJ6CC,.:RW*<1F1&6>XTI$Z2JV.ZH2?U)T8V4DY-^+CITDML+5TJ4``3
M?A?NO:]K7%2LW!0L+&G9C%PP[+;3UH2HDI%M5=-N=KD$WL>%7C^O'JD'2^5V
M^86.4LY)-D5SM32-PJ\H$:+`ENL/R9$E'7Y*N2WOQP$?&J`(J7R7+XON"VTG
M$27I2Y/J+*>E-A8`<3S.IK*MT;T7N"''@MP_2;2KJ7=745*`(&MAH+GCK\JF
M1JU51::4K__5]VG;78E5U+UGG'95TH?MV&8Y97;C1F+?Y<B,PJ0*\",@3RV-
M@;3`)ONIN(B?*IKJ3YC>/A2IKQ_AM(*C\!P^)TKOXK'O9;)0L;''\9]Q*!W7
M.I\`+D]PKQB9MF%YV!E^2YQDLE9E]E=W8WUK(7?B<RRDN271;%57@PTI\&Q3
MX!L4%/A->7YLMV=+D3'S=UQ94?CR^'"O<>,Q\?%8^'CHJ;1V6PD?`<3WDZGO
M-?+#Z9W(<FJZIAHY!$^U(<8;!7''A;>`8\<03=3*9,)MI$^J\EVU`9A]QJ&6
MF!>2\H-H',E6GW5>=GP&9673,F$)QL-"GW5'@$MCJ%_$V^%Z]*W4&&5/1G4,
M&#?V$"L&K@2\CS&ZFOM1($:8^"S+.3*E/D#;42MC@+2&2HB-LHNM.P.*1AL5
M$QZ/Q)3=1[5'51^>G@!7GC>FY).\MT9',K2?XS@2V@:V0GRH2!VVU(_:)J&/
M97LET_W/F%-`ZZS>+D0UE3/;!`AV<&/)?*<"R7ZQVQAQ&K!DVFVE0V5)#%-T
MW3YU,0YD5]QZ.R^E3Z/Q`'4?H:T+VLC?0.Y9J8CTYB^CI!M<A/5U`>!(N*C=
MVSD%OB)T=GC81VY129DZX!SDC4^IK8R/S([C*(31OO"HHCG%'DXHB&B?&IB.
MA+G4E?#EXFM$SDM^!Z#T7I!N5+OP*$BY'CW\>^LBQGJ[->UO8>DJ7,:N8F*T
MCV(W-]<64&7!K@QFH=:OWX,9V5%;"1)M[M]II1$N6\9/CB):_?40S&*NH=9N
M`._A]U9GOC=$%U$MF%*0ZMQ"4`H4%#IMU*X=YU[T@5Q>[;J%-[E<>RV5&C5K
M5OF=TY^X.(W%>LJN8U7US+WG5!<6J@*7B;7?9439/M'66RC)>=RRVDJ+_J)1
M8<0DWX=@-A^AKPIGWG7\SE%N7Z_64GP`)`'R%8A'[!KX/KW[*7].]):N)-LY
M7#&.(]%)@\KKZ;&\=5KRB`E(GPY(2BXJO$71)=E542KR<>N3N[:<9Y(,9*`;
MW!N&EK<<^"2"G7B0>5;]L5MS"^WF9+ETS5J)*2""GU4H0WQYD$*TX`BM34=0
MQCN.U]/'$&VJRN;856TX"3H-<I#WQLJ$\^I&J_55)5U<GG52'W'5?B4J_P`Z
M^FFTLLH;3H$IM6$6KT.;YU=>)H3!UI%Y<09?0W_$UXT,6O.QS540OA5Y(7T^
M>^R%HZ>E-SH?$:?8:Z3I0OJN;?I]XK),<_(CO''-5*.X!F'SN($VH((B2D1J
MI[F1;;@BJB)\[[]:3TJ2%#\0KG8ZDGI_+7T2BG!DUO=/VQO4EE1QJXJ1P3)I
MB1&-U3EMJ1JT`NL.D)(@HI*OW*J(FW&7D&.TREJSR5D]7:#;3X&OL-+#[CA<
MNTI('3V$<ZF=Z]^QL;H[T?Q1Z.VU=Y'"B9_.I8+[Z_C5M4UE-[^WR;$AW<49
M,Y21AE-E<'==T%$W[VZMS1<`D*='7+4D$(!Y`:J/8.SM.E6[VZV/D-UQG'DJ
M]+%L%74X03<W-D([5'G^R-3R!KW_`/7SMCMOL[!)]SD60LM6ULB6E'$OKDL=
ML&V[23+FO'4.S#A&TS$3915OQMDSN"#MLF`3-P97*2FGERW?1=Z[HZCTVU%N
MD:6M;E7J3#X##X]>.;C8MA#K!0`H)!42.*BHW45'6YOX6X#:O\?$[KVE]FLR
M[*SG.*#%X423D.-86-S.&$N2Y)E%C^,^U%?<%&'&X$`%0U(Q079`)\JJ:MFP
MDQ(^7>F39:&EVZ$)4H`J4LFP`/\`5^]-9S[HF=*QOT\&$X['+I6M:4DI2E&I
MN1WGX6-^->C)!$4V%$%/KLB(B;_]6MRKSS5:?OQ_YG?]6XZ**X4F#D2FR*;D
M:64RF@-\4_W5HD_WUF'N&?5E;;AA/45ODV[=4"O27L$CZ;'[_P`L5!*6HB1U
M'@#TNJ^RP-3>O.C>[<`Q*;?WOMQDU5C^,5"2)SK5)92&X<*$R#:`PTQ<J^\@
MHB``B'(EV^$U(YOV\]P]OXS(9K(>^,QC%1FU+40TXKH0.0"7KFV@``UK',-[
MB>W>X\M!P^/]C(;^6E.A"076T]:U<R5-6%]223I4+^O.D.WN[L\?RW#;:[9J
M6K5'/_5N^AGBKTAR.J(MC$9KI+\R;9J*(J"PZX:+LCKC>Z[>>=J^W6^O</<C
MF;P$V0F"'K_S-Y)CDD?\Q(0I2UN=R%*/#K6GEZ'W7[C;$]NMM-X//PHZIQ8M
M_+&5B2`%?\M16D)0WWK2D<>A"N=VF(U%KC.+UE7D>53,MLZV'QL<FM8\&!(G
M$'(S?>9A-,QV6V@^$4E-Q13<S(MRU_1#;^.GXO$0<?D\P[/GMHLM]Q*$J</;
MTH``MP%^I1XJ4HZU_.O<&1@97+SLAC,.UCX#B[H8;4M:6QV=2R2>TVZ4C@E*
M1I6D^F64S'-NQ.VGGR?CS;:3B>-(J(K0TM8D)5DL*NRB+XLM)\"/W>15W4EU
M>\PKZ2%CL2G0I1ZB_P"VKD?`5G6`3]?D,MG%ZI4YZ3?_`,-%M1XFI)F8MB1F
M0@`"IF9J@B`BBJ1$2JB"(HFZJOPB:KG&K;PU-1N[$]N>@.K;:-39?G3<>9)8
M"0#E7475[7"VXCO!'+:GKYM8+RJTJ*TCRNAN/(40D5>IDYK.'0T[D4.--+X*
M+:^D_O!-OMKGQK!R[CK..>:=>1Q2EQ'4/W>J_P!E;JPW-\1[#H(>481D=1E%
M!/'>/:4TUF;'YH@JY'>\1*<68PI(CK#J`\T7VF(JBIKDCR8\MI+\9Y*V3P(-
MQ_W]W$5^/QWXKJF9#2D.CB"+'].^LIUSUPU%/O#U^3+W7,JPMJ+$R%&Q_<JI
M5_'C78M`VTT['/=&(E@TRVB?TB#R)]RH7W+:L!N$XX")*N8?*W%/](/V52-T
M;5&6)G0K)G_F!X+`T&O)0'/GSJ%V/3;;K7/:>?9P)$"RQNXC/3X$H";?%CEX
MYC*B*[JC\)TQ%454)"^-TU>I26,SC'VX[J5(<3H1R/$>&M9K"7)P&8C.RF5(
M<:7Y@>:3H;=NA-K:&K*,R[1HZ7K:5G=//C3V9L+QXZ;>[PS+>6#@0HI-"BDC
MK+X$KS9;$'C)"V5%UET3&/OY!,!U!0L'SW_*!J3\N%;3/S$:-B5Y-EP+04^2
MVO4HZ)'SXCE8U]>HL8F8WA\=VX$"R3(Y4O)LC?\`$C;IV5R^<OP._"'O"CN`
MUL2KQ(2VVWTRTI$J8KTO^F;`0C^RG0'X\?C3!0EPH"/7UENJ+CA_KKU(_=T'
MPKCYOTMUSG+C]A>4PQ+,PW>NZJ057/5&Q5$=DFUO$EDV"?U2&G=A1$^B;:0L
MSD,?I'D$-_LG5/R/#X6K\R6W\5E=944%W]I/E5\QQ^-ZI^[*[C]>\5R,L7P3
M(^P>RK"/9'`E/T6,5,BM7PRS9?2OL7;>K.V?1I$\91XJQW23DCB"2(/"CW=2
MY,3CH6)7-F$D69!XCLO>_B-+<ZZCWLTVS$7D9F;3"A`7)>MH.^UK>!UORJ8/
M0O3G0O8N2XUV<=QE.09#C+"3J'KW.84"@>Q:U:6.LN]F8Y'\SEI*;DDW^.^4
MB1%:4$X<C%3TS[>1S4B!D<U!=:;9%VFE)LE"CQ4=3U+TL+FP'`<Z[.U_Y-A8
M\_'X'(-/O/$!UU*KJ4E/!(%@4HN;Z#4G4G2K&-=*INH'X?TSB.1]H=FXMDI7
M;:8[:M6M1#@3&(D!^MMUDO$,@%B/2!)MJ3%(";<!23X7X%46\RLW-BXS%2HO
M1_$;*5$IN>I&G&LTA;<QTW,9N%-]2[3H6A(59/2Y<\+>&HJ2=!T5U9CA@]$Q
M6),E-_(RK=Q^U=$OM^\`FN.QVC11W0@;%47Z:KLC.Y:2"ER8H)/)/E^ZU6V+
MMG!PU!;6/05CFKS'_>N/LK7'LMTOG_:>)#4=>9X_BK,6.XDK#A!JNH<F5%\C
M;,NR@--V$8OA!1MQ7HA*@J0"J*>L&]XMB;LWUAS&VYNIR*4I/7&/E:D<P%NI
M'J`\NE14V="4I/FKT#[.;[VEL/,"3N/:C<H*4.B2!U.QN1*&E'TR.=TA+@UL
MHCRU6CU1A_8>`9^YUA>]@9;T)E.0S8D.K>8QTI];D<A]Q&(K*7<"QCDXRZZ2
M"R8>:+R54(P+=%\?[*P.ZML[H5L[);GG;9S,IQ*&RE@K;?43TI'JH<22DDV0
MH=;=R;J2>/L+>V>VIN?:Z=XXW:\'<V&BMJ4X"^$.,)`ZE'T5H4`0`2L'I<M:
MR5#43M_^F_V*_P#]LLJ__=,S_P#CVO27_I)[K?\`\W3?_NU__GUYK_\`5OVG
M_P#X0A?_`'B/_P`FNER/HGV!QO'[O()GMIDHQ:2IL+5]7JZ6PVK<"*[)(3=_
M?#\:'X^._$EW7X15^-?#OM5[I1VW'W?>Z;Z2`5'^&L:#4Z^L;?*N:/[I^U<I
M]F,S[(0O5<4$C^(@ZJ-AIZ(^^J:.S<YF4%'<Y582W+*\F/[A(G.J[(L+>>]N
M<E\S)3>,5(WCW7Y05_UU*X^*YDIS;2W%**C=2B;FPXDGF3VGF:ELM-9PF*=>
M::2E*$A*$#1-SH`!V#C;L%1O[6ZG'V-QR!:&%9-J;ZA&!9U-DI1RCRF9$@W'
MXC[(RO$\Q,55;+=#;(1)%^NT\U,BXM4_&SF5*27"JXMP-K:&UB.-Z@&49>:_
MA-S;?G)9ELM@6)(L4D]0-K@I5J%)/$>->?CV+]<,Z]=LN6FR6NEGC]F;SN+Y
M'X^<"VC-*BN1UE-"D9+*&AHCS:*A;*AH*"2;=`K94H^@YU(Y<C\1VCGR[*]0
M[8W!_/L>EU]D,Y%``=;!N`?VD'FA7%)XC@=14>-*LE-*4TI32E-*4TI32E3Q
M]2_4C*^T)V/]FY+B5E8=8Q;]EIB($1Q[_+'Z^5'64TXP+;KJ8VR2J$B0H>)T
MA-H2W%Q1[,1,5Q3WKR$I"$DV)`)-M`+_`*<JR_W$WE-P3#.,PD=;F4?4`IP)
M*DL()%U&WYR/P\DCS'D#Z`^UJ*,775C&AF=/$HXS,B#&B"$6.C%<B,1ZY6&5
M%IMCQ*@BV/P"H.R?":Z.&4IG*1R6^I*U=.HX7Y]Q'W7K'=RH$K"3#]04N(3U
MW"N)'(GF#?YVJ!Z*J;[*J;_"[*J;I]=E_P!=:78'B*Q,$B]C4[>LG`QWK*JG
MW%@"Q&XLBS.01DX$6)(?-YMG?[B56D+;BGT)=DUF>7!E9>0VPUYRH)`[2`!?
MXFMMV\?HMO1'9;X+805DGDDDD#X`_JJQ3T/]J\4EYG;TF5=E6#=#_CAP*>/E
M-M+C4M/+:FQI0D@6D@8E>W*CMF`.BB#R^PE1535NV[*EXF6IC-25(CK;L@J5
M=`(/"][`V\*S_=\*!GX"96VX:');;UW0A%G"DBP-@+J%_&KCZ++<5REE9&,Y
M+09$PFZ*]1W%?:MBHH*DA'`D/B*BAINB_*;IK0&9,:2.J/(0XGM2H*^XFLFD
MPID-71+B.-+[%I4D_:!60:YZZU?_UO2S_,)W!,H\+Z]Z7J9CC"YM,FY7E;31
MH/GH\>?BLTD-Y$7D3$R[<<>7=$3E"'Z_.V9>Y.44Q"B8QI5B\2I7]E-K#XJ^
MZML]E\&W+R<_-OHNF,D);_MK!N?$)_\`:KS[ZQ>O2E6->@O33N6YO!RRS@.'
M28^X&1S)!L[QW);*\<9JB<)/EPW_`/OI`G_"&R_5-=;`0E9G<BIRTWQ\'0=A
M=_[+W^`J9WSET;/]O&\*TX$YW,V6L?F3&[^SJ`"?WE=E?W^1CNS)NT^Y\7]0
M,`O3JZ)I8<WLV5#>E?\`F4Z;&_<&:&4W7`[-G1ZZJ4#_``VA<<E2Y(`@$8".
MM/E+60B.TX$ONGI23<V)!Y#4V`)L!<FP'&L:PD>/@]O3MV3(Y6\24,#33DIP
M$Z"QT"CHFQ-:(P)G&(&6=;8G&L<>OKJML\CK)"T^$R\/E0\5#&'`:K<I;FT-
M')LK<+2,K@&ZLM]I$5%>V442(QCC+4Z#%$IMV:DN`E+1:4&^@:.70DJ5U"^O
M4>-SK4CL#ZIW<Z9)CNH@O-FX6Z'4J60LW19:P$VMPL.%AI6_^Q.OKS*&Z2-5
MV;0PX4\QF),,OS1J)C!1I\9F0K3R2^32_8CG$T7_`(U^J7EEY#945)UM]M;%
MGL5.GQ?2A/)ZP%`=9/!22+7L=/M[ZLYZS]E.H,ZR(NNZ2Z=K\OJV0AI1W$?\
M1Z84-@/*Q6S@-Z#9/1VTW,&W%<395X_:6W0<C/(0'2GR'G7F?+8+(X9YQF8V
M/*JQ4D]2;^/](%?SN3I'JK)(,O*[S"ZJPO8LZ#+9ENI(%I9;\Z''>D28;;X0
MI2O,KLXCC9(XJ(I(JIJJ[F/TF$S$V..B3Z!'4G0]E[CF+Z'B*@\?@<1,SD&3
M)Q[2WBZ+DCC;M'`\.8-5H^RF90<@ZB[LQR#C$W'SZ_S3`*RQD/0@C1+J"]:4
M4J+:P7&F6VSC`T'B1-R(``%W02%$RW9\!<7/[<E.2T.B2P\I(!N4$)<!2H7T
M-]>^YJ[[FEHD8;.1D1E-_3NM))(L%`J00I/=R[K5I=1$P453<2%15/\`4239
M4_\`8NK_`,*IE:AMZ-]N;*:9;-R)*<)Q!<1`:"2)&\*<U(=T$$55W^%)=EWW
M34PR^DH05'SI^ZHQUE06K2Z#]];!I:TXC3!FZ3G%K82<1?(:&B%]VY%Q`-]A
M3Z_5?UU'/NA94`+:UW66RD`D\JX.<7X8YC<^8B&Y.D@M=41F@)U^9;SA)B!&
M9:!%)PS>)%V1/HBZY(,94N4TRD:7N>X#B:^9;XCQW'#QM8=Y/`5V698I(P7I
M:+UVVZ'[Q/<H<2<)XD46[BTL(O[T.^_W-1Y'Y2_"[(*;I]-9;O>6,AN'*%"[
MH!#:?``)-OC>O8?MSC%8;VXP,1383(>3UJ[RZLKN?W;?"M`XW#;2YR=[$+"M
M%_`,=<QK$W)LN-"?N[RW<L8UA;P5D/BR<Z2\<HX[:J2<3;%%^-5)E()?]%LG
MT4]">R_$W\385:$#I<66G4A2$V3<@%1-Q=-SQ_$0/`<J[3I+U.RSN/M[#NH)
M4O\`8&*>D?S[-;/DKQUL%^PB?V01ES^Y<R@2.T*"7$724E7BBHL]MO"NYS(I
MA^N$!*?46>)`)L0GO.B0>7'E5#WOEQM?%H6['*WEGI2G2W402"KN`%R.9TX&
MO4]"B-0(<2"PIJS"C,1&5=,G'%:C-`RVKCA*I.&H`FY+\JOSKT2D!*0D<`*\
ML$E1*CQ-0&[_`&?\M]J?7_#60)XV+/%S?;;X<^%GEK3S_+R?8J!$J^6R_&V_
M^NL]W"@Y#>^RL8@7/KI4?`N))^Q!KT'[=+&%]H_=K<+ILDQ5MI)X7#*P/FIU
M(J[B7$BSXS\*=&CS(<ELV9,26RW(C2&33B;3[#PFTZV:+LHDBHJ:]1OL,267
M(\EE+C"P0I*@%)4#Q!!N"#S!%J\%,/OQGFY$9Y;;Z#=*DDI4DC@018@CM!K]
M1XT>&PS%B,,Q8T=L6F(T=H&&&&@3B#;++0BVVV")L@BB(B:_6F6F&FV6&DH9
M2+)2D`)`'``#0`=@K\=>=D.N//NJ6\HW4I1)42>)).I)[36I^]LF7%NK\GF-
MD82K"*E'#4$7<7K<OQ'3Y)_1X89.FB_ZBB?5=3&%B_5Y.*T1=`5U'P3J?NM4
M!N*;]#AISX5993TI\5>4?*]_A3K25B6%]=XW4NY'CD=*ZF9EV;BW%:#;<N:!
M6=@Z\?Y*BB>>0:\E7;BG^FF1^JF3Y+Y87=:S;RG@-!R[+5^XCZ+'XN''^I:`
M0V+^9/$ZGGVDUH'V#[QH[6C_`,-PFU6Q6>X!W=M7F8PPALD?_EC,C["DG)=$
M2<4$5OQIQY+R5$LFV\`^F0)L]CI0G\*5#4GM(Y`<K\ZJ&[MT1E13CL9)ZW%_
MC4DZ!/[(/,GG;EXU`^]I*[(ZF=2VL=N3!GQW([S;@"2CS%4%YI21?&^R2H0$
MGR)(BIJZY"!%R<*3`FLA<5U!2H'L/W$<0>1UK.<=D)>*FQLA!>+<II84DCM'
MW@\".8TKI_XS\SN,-[[S3J)V<[)HLAJ+HRBH1K&&_P`1E(3%DTT2H++C]:LA
MMQ43<_L1=^"*GDO;:',-N;,X#U2IE"W$CQ;58'NN.->R<T\C,[:PV>]+H><;
M;4?!Q-R.^QX5?)K1ZHM-*5BV4X5BV:PDK\GIHEK'$N;2O(;<B.YQ(4<C2V#:
MDL&B&O\`2:;[_.Z:[,:7)AN!R,\I"^X_>.!KJ3($.>T69D=+B.\?<>(^%1/Q
M3K:@F=T2\;QR=:RL#Z[<B7UK53Y\F57AETCSM1H\4%:!@C:=BB3BGR-4CF/)
M475KEY1\8=,F0A`R,D%`4!97I#B3X\!PT-4:!AHRL^Y#B..'$1"%E"E73ZQ&
M@&G(6)XZBILZI=:)4:_<')[S#_6CM^^QP75MF<76`TZR1`[$BWEC`H[*>V8(
MI"5?6V+KR*GT\>^Z?5(;<+[D?"Y%UF_J!LCPN0"?@#>I;!,MOY>`T[^`N7\;
M:@?$BU4<^L>+US./V.6&V#MK-GO5;3IBA%#A1`9,FV55/L*2\[N:I\J@BFK-
M[*8:&Q@I&;Z`9S[JD=7-*$6\H[+DW/;IV5G_`+XYN:_GXV"*R(##25]/)2UW
MNH]M@`!V:]M3)Q#))N(9+39%!>?:=JY\>0Z,=S@<B(+@_F0RW5`-N7&Y`0E]
MJH7SK8)\1$Z(_&6D$*2;7Y'D?@:QS&3G,;.C3&E$%"A>W-/YA\1I5NN.9'49
M730;VDEM3*^>R#K;C9(I-D0HIQWPWY,R&"7B8%LHJFL8D1W8KSC#Z"EQ)L1^
MG*O0L64Q-CM28S@4RL7!'Z<1S%:0?<.G]F8:<^#&7=?N,\`8<1'I-8](?_NN
MH*MD8,5FZ%NFR;"OU'>;2/6VROM9DCY*']-5M1^GWDW;@_#(^*%7^X5(O5>J
MV4TI7`EUE9/>AOSJ^!-D5SZ28#TN)'DO0).RHDB&X\V9Q7]OCF"B6WZZZS\*
M'*<CNR8C3CK2NI!4E*BA7[2"02D]XL:[+$V9%;D-1I;K;3J>E82I20M/[*P"
M`H=QN*C1[&>S53T8%750:QG),OM1_+&H=E.Q(U?4HIA^?.D-,/%S?>#@RT.Q
M%L1*J(B<H3/[C9PH:;#?J25Z]-[6':3W\A5IVIL^1N4ONJ>]&$WH56N5*_92
M+C@-2>6G;5;_`'7[79;W160<;=1G#JIM3.SHZJP??8R#D;3C+UD9@U)*/7NL
M;@SL31$?(ON`=J#F-S2LPPEFQ89'X@+D+\3;@.SG\*U;;VRH.WI2Y!(DR3^%
M2@`6QSZ4W()5?CQ%K<ZK.[>Z[S_*[T'JYR-+HXK$8(<!)GB*.^XHMRGR84/"
M\3A%R1P2(E;3BB;ILO[@LACX#2FWFU"42;J`N".6O9^O6OC=.'RV5?0]'>08
M*4BR"2DA7YB01J?MMI;M[BBS'KGJ]M,,2WFRGH<MQR=)=CORV6ICXMH^V9L"
M+33;1`FX-BO%=^2J6^N*3%R>84)Z82/3(\MS8E/+GKX_JKGA3\'MU!Q*\BX7
M@?.0"4A1XVL#;PU[];UV/9O7_7'L;UI=X?=MP+RFMV%2NLHR\I%!=,@OXEQ!
M(D_(C6,(C5=MPY"1`:*V1`L&I#D1_ID,*0L<AII\;@@U></F'HZV\CAYJ%V[
M=4D?LJM8VX7!U\#K7F)]@NA\M]=^Q;#`LK5F6*-#94%W$^(>04,AUUJ)9,-J
M1.1G%-DVWF3^]IT"3Y'B12#;B'05(.E;UALJUF(+4ML=*^"T_LJYB_,=AYBW
MA6C]?=2E-*4TI32E-*5)'UXZ-?[6NCM;?E'PJCDMC:."?!^UEH@/!3Q5$D-L
M3;)"?=_X&UV'[B3:2QT!4URZM&$G4]O</TTK,/<KW`;V=`3$AV5G9"#Z8(T;
M3J"XKD;'1*>9XZ`WO_Z.E9#+D55;^3,K,(PBH1N!$K6V:RHCC%!IB!7R$89;
M;D1F8P&J-JOP@;K\;[\N:B8['QEF.RGZMP@"^I&NI`/#LOWUYXV_EL[G<CZN
M1FN*BMA2EJX=1/`+(M?76W8.RNU?[OJ+^RFX_?U#3>)RW7X@SFWGW7PCKR`9
M,F.(J+K3RB*JC?$P1=T551%UQ?Y=E1V&I,:03-3973P%^P&_$=_&OO\`SA!E
M2WX4V&D8U9*>NY)MVD`<#W:COKAV'36.7M6-I@EV3QO[%$:E2FY%>_L2@;'F
M1AN9"?0DV1'4+Y39?KOK]9W%-BO^ADX^@XV%E#OXV/PM7S(V?C9T7ZK"2SU'
M5(*KH/=>W4#XW\*X/:-G?8GC.+X`@Q(\)RACE9O1EYN2Y++NTA@%545N.CR<
ME+BBNDJ_.R*FN;",1ITR9DSU%P.GI!Y`\#WFWRKK;FE3<7C<=A$A"6E,#K(X
MDCB!V"^M[:_.M!P)$^-+8<K7I+,U7&Q8*&;@/DZICXP;\2H9$1[;)\[KJTO(
M:6VH/I26[:WX6^-46.Y(;>08JU!ZXMTWO?D-.^K,N@+#NBMETDV"Y:?^H"3A
M.E8H(Q/6YL(#?CCS8D)LVI1FO+R-D!"H+L:?76=K6$91!V\'.L<.FYN>=AS3
MXZ5L#;:G<$Z-WEGTSQZK"R2!:YX!=^S7XUZ#OWKMK_\`EZN__"']X_YO_P#=
M+_Y'_1_X7_;^G_WM:WZV4_\`ET_]+U<?^=^SX?I>L!^GPO\`\VK_`*[HX?\`
M]O\`M^/Z6K__U[6/Y/,Z3,O;?,H#$A'X."4^-X9&045!:?BUC=Q:MKN9B1MV
M]R^"JFR?8B*FZ+K`-_R_J=Q/M@W0RA*/C;J/VJKUI[2X_P"BV?%>4FSDAU;A
M\+]"?L3?XU`6L@#:V5?6GR\<Z4VPZH+L2,?+DA45/E%_';+6=Y*28<"5(2?.
ME.GB=!]IK:=M8U&6SN-@.)NRMSS?V4@J5]@M7HU]/L3CXIT;1319%N1DK]AD
M,G@""O@5XH%:VFVVX!6P&E%/TY+JY;(A"'MV"2/XKP+BCVE1T_W;5E/O)EU9
M7?\`FD@_X>(4QVQR"6P`;=GG*C7F\P\'.Z?8/M#(,MRDJ6PO+_(;$;`HR3I\
MV<5C.>@T=0R[,K8KEG)"(TQ&%Z5';7B@H?)0$N?+1V\C.A0G)GH@A:P>)*D@
M!*4ZI'4;FUR*D=WR%8'`8&-%A^LVVP+B]@.NW4M5@H](U)L#QJ9W62,Y%V;4
M(PQDMD?5>(V%+D&6912C46]A:6=I-9JHUM&!^P=A?M\"0[#B)+DNR#;C*B*(
M"#8=G%E$G)M@>JMR&P6U..)Z%K4I5P"+D^1/E'42;=UA77]LVFF,PZ_(=8:^
MH"G&FD+ZDCRA)Z38`E5RHA(`[N-9Q=9!EY=Y45!4R9K]5PHH;E#$%Q];%R^<
MEQN80VA(GWP>45%=E).";?KJ[H0W],I2AYM=?"M*RN6<Q^8#K\OT\:TE'6#P
MLNXN?`VK;G0G3'9,WO*J"SPBYQJFP'L2U["L,MNZN96A9Q9L<6JVDJG)49DI
M3LLG%5Q!(A%H%WV77P\\V(Y(<!4I`38?:367[OW'C9&/DXZ&M#RUR5+"TF_E
M-C^EZM=SB&[/Q*]CL-F\\D(I+338J;CKD%QN:#38)\D;A1]D1/E5754S414_
M$Y&&@76XRH#QMI]MJS:"\(\V*^K\*'$D^%]?LJ!?<^'KV-U'G>*Q&_+)O\8F
M)6BB(A'8L-#/JMO]#6;&:V_TUYQP,XX?.XZ8[H&7QU>%^E?V$UI^8B?S/$3H
MK>I=:/3XVNG[;56+UYDB9/BU?,<$VI\-%J[:.[\.L64!!9D(X/U%7D07$3]$
M/;ZZWB?'^FDK0DW;/F2>U)U%8[#>]=A"B++&BAV$:&LU5MM54E`%)41%5115
M5$^FZ[?.VNI<]M=FP[*Q7)J2PM':J5%RB=CL.JD_F6+,1&@:L8[1M.^*3((V
MB8:$6B0MU(%$UY"NVNS'>;:#J51DN*4+"]]#V@<ZX'FEN%M27RA*3<VYCL-<
MC#\?GY[<Q.TWQ_#ZVP3(&*S&+&:*LLY+FXMOS'[.K!Q06;$QQN(*(ZB$T+S@
MK]V^VOW,RI6V\$Y*80/YD^0D7XH2;ZV[>?=I>K?[<[=@;SW8S&R15_)XR"X0
M-`XM)%DD\DZZGGJ`:UAFN6V&?YSO9O2J#`\2LY,"#-5EYUVPR"3Y:Z#+1OEY
MK*2]/5#06$,F8J$1?)*NL%4IU^2I;I*4I422K0K6>SPN?$UZ^=<0XIME`Z(3
M?E2`-`!H-.?`:#@F]:4R;K6_H[ZKZ[8MZQR<3B7F3S(+[Y4^/U$5%:@OV;[S
M3(M.A'_(>5#05!LQ054B3?@:B!MLH4LJ4I1)/#P)\-3WGPKI28[R9#<5*T!0
M%U6-PE([=.R_@.\U<-_&[CUIEF=]H]VG&ELXHW04O6>(V$D3$<B2L?!^UL@4
MTW<-C]N85S;X!R2H;J0%MK'MQCW.O(Y=:"&5@-(N/Q=)*E*'=>P!YV-8?[P9
MQB9*Q^*96%*9NM5C>V@2@'^L0"HCE<5;U]/E?IK5*Q6H4=!5KG;_`+VY-FK2
MQYN.]6Q)RMOBZIM>6)6'BM3^,0%P/S6DF3(1=U14;5414^4J>S8ASWNA,R8L
M8>.:L#Q!44E``/<I2C\*V3W$G#9G^GC#X!8*,GG9/J$<"&PL.$D'6Q2AM/[U
M7*Z](5XEII2HU=ZBF393U1UN3+TF%?Y&=Q=QFW7&1>JJ@!\C;KC)"Z+:QG)!
M*J**IP39=U^+'@R8L7+Y%)LMMH)2>Q2SR^RJCN5*9TW!8=0ZFW7BM8[4-BYO
MW&YK`LW]2XCB3)^"7BQ73=)]NER!SE`9;V(C8BVD:*Y+;`51$!'@=5$_J<_7
M4E!WB\V$HG,!8_:3HKY<#]E1&3V!'=*W<9)+:C^16J?@>(^-_&HT6/3?9E</
ME3$;.UC$@*U-QX`R&'(!QWQ"Y'>ISF>0.?U^$41^21$WU:6=PXE[14H-K'$+
M\I'STJE2-JYQC5,(NH/`MV6#\M:U%GZ93@E:RY)P?,I-S:J_%QZF:Q6^.9:V
M(-[@R#(P%=%IMP@1PMOMY(G]1"BQV=WAB<+!=D)>#\HI/IMM^92U6T'EO87X
MDZ`5W\!LC-YN>U&5%5'B]0]1UP="4)OJ?-:YMP`U)J1'H-ZF93UE.M^[NTV#
MKLYRVME0Z?%Y#*M3L=K[6<,ZTF7(FBE'M[,H[0A'38HS/,7-S-1;P+;N'EMR
MYN=RFF0DJ4KI_9ZU=2K]Y-M.0KTGF\G%^CA8/&:P(R4IZOVNA/2FW<!SYFK/
MM7"JO32E8[EV0,XKB]]D;_!0IJN9.$#54!UYEDEC,*J?/]^0HA\?/W:[,..J
M7*8C)XK4!\^)^`UKJ3Y:8,*5,7^%M!5XD#0?$V%8;T[BJXUA-:_.!"R+(F_\
MAR6:8\9$RTM3<G*C_P`"HK$;DHT@[(@\5_55UVLO)$F:X&S_`(=OR('()3H/
MG:_QKHX&&J'CF2Z/\4[_`!'#S*U^8_*]OA7.[)[-Q[K*G"SN5=E2I1^&MJ(A
M-?G3W$V\A!Y2$&HS`KNXX7P/PB(I*@K\XW&2<H_Z$<#07*CP`[_U"OO,9F'A
M8WU$HDDFR4C\2CW=PYGE5;'</O58UHS<:[!Z3KK[J',&)N/W$FHR>2Y=+56#
M;\>3&-F570X;=FL$N;8JXVV9BJ"Z.VZ0&]H^3VNA"YT!$G!O>12T$@I)_*I)
M%A<?A-['A<&I;8^4Q>[%N-PI:XV<9\Z6U@$*`_,E0-S8_B%KCC8BL)ZQ]7LN
MAMG?]-OP,ZZ.SZ$N9899OV<6NR+'3?0Q<Q:\KIDDTD6$9MH6"=;<5/.T2.<%
MWU(>W.3;P#,B)<N8&0KU6EC\39.BD*3?46`U'`@@C72+]S,"[N-Z-.:`;ST=
M'I.H.B7$C5*T*M8&Y.AL""+'37+W>I>SVG763P'*U)EQ&R)JEF/-$2DH;M/,
MMN,OM[C_`%`1"B?.^WSK8$YW$*2%">V+]IL?E6*+VSGD**3BW21V"X^8TK/L
M&ZT[]J[!N3B]7D.,.&1*Z_+FM5$,Q9<4/^_1)4A!E-J0_:!LN<A^439=]1F0
MRVVY".F4I+O@DDCP.EOG4SBL%N^(YUPDK8[>I0`/BDW!^5;Q8H,^QSMCJ&[[
M*R&GR*98GDE'%.&V,0ZMTZQ]R,"/-1("SUD.SR;W5M!#^A=T-%2NK>Q\G%Y9
MC&1UMI3T+/4;]0"K'36UN/&K4W'RT3-X*3F9;3JU^HV.E-NDE-QK87OPX#LY
MU,752J^5#CVS[+R>DI&<`P3(I.(Y#D$3\JSRB#'%ZTJ*4W7&!;HWORV5@6TU
MQ@Q_(4"5AI.3>SBB036-VT[GX\BTY<=H'IZD`%=^)Z;Z#EK8\=.VJSG-VM;;
MD14I@(DR%#JZ5DA`%[#JMJ;F^EQPU[*I6S6G[LZI??[!Q3MS/ITE7"_>+>-D
M-_$O6QD;MK)GO-63ZSX9\N+A&7VJJ*J;?*9_O'VZS6UHCF;P^:D2(Z/[VY(<
M2#^;0D*2/S'0CCPX7;97N=A]U36L)F,-'C2E_P!U8!3:U#\EE#RJ/Y1J#PXV
MO'S.N_,R=98L9,.9;6]@V3=AE%W)EV`O3VU1%0'3<-QU[PJ)*+KB*/+X%11%
M7.\3CV\TIR1+FJ+H.J;W4>\D\OG6YSMQ.X>''9@8M"4$$=0%FPKL`3I>VI!(
MX\Q48PRS(6[U,E&UE+=(\3R33/R$BGOR:X.<F_QU$E'Q[<./QMMJ[&!$,7Z,
ML#Z>W#]?CWU01EL@F=_,1*5]7>]^/PMPMRMPM4P>J\@RK)L>F7]^^P]O-)FN
M\3#;'DC1DVD^0&DX*#;Q+P+;DBB6ZJFJ#FXT2%*1%B]0`3=0)OJ>'V5K.V)L
M_)05SI_025D((`&@T-[=_P!U0WR*#:5]U8LV\=Z/.*9)==\K9MH\KC[A*^RI
MI_<8=5542150D^BZT"$ZR[&94PL%OI`TY:<#WUDF38DQYTE,MM272M1U!%[D
MZB_$'D:UOFWL@[ZY4$R\@S67;>U`HU1CCJ-O#;S&TW!YY@UYLPH2DBO/#LHB
MJ"BJ1"BQN<:@K8292.IT?AL;'_N[?Z:O/MKAL_F\P8N+<]/'BQ?<*>I"4\@.
M7J*U"!<<R?*#5,'8O8F7=K9C=9WG%N_<Y%>R5?ER75466&Q1`C0(,?=0AUT%
M@4;99#[0`43Y7=5J2$);2$I&E>SH<./`C-18R.EE`L._M)[2>)-81KZKLTTI
M32E-*4TI6[>A>Y['I//*K)$@I?XVLR+_`)1BK[I-Q;RN:<W(17?@U/C(JDPX
MJ*/+[30FR(5Y4/R&$NB.Z4J4FWZ?T\158W1M/%;JBM,Y!@%]I74VOFE78>U)
M_,DZ'CQ`KT9Y5VIB78'2=!F'6MVV]C>5RHS+"5_A8=:;\,ARPI;./',UKIT)
MYKQR6-T43'BNXK\MOM*?REY">HH03KK8W%B/GI\Z\Y;]CR,'C7H)267BZ$D)
M%NH6).NETD`:CB-.%1C5%3X5-E_T76A5BA!&A&M;"ZMGRH><X^VP^XVU-FA!
ME-B:B#T>2A`8FFZ"O%50A7ZB0HJ?*:B,XRV[C)16D%24W!Y@C]+58=KR'F<W
M!2VLA"U=*AR((/'[ZE_D76./Y?<,3L@_)D/QX:06A"=^&QP!TW1)T&Q0A?0G
M2120Q#X^135'AY.9!:4Q&<2FZKFXYVX7.@^/SK4<EA,=E'T2IC*U]*.D640+
M7)O8:GX'X5UV`^N2MYB4VAA7F5R(@OS:JC@U4BQE0T:,D.8ZD`'G)@0ME031
ML1%=B7Y1-2+^6R>3C?1LQ27"/,47)('8!P':=:A8NW\'A)O\RD3P&0?('"$A
M*CPNHV!4`=`;'G:XJ\7TBZ/O\$@9!GN9U$BGN<A9BU=%66,98]E!IV'#D39<
MIA\$DQ#LY/B0&R0"1MCDJ*ACM;]G85^`V_,F-=+[@`2#Q"1J;]ES;X"L_P#<
M3<D7*O1<=CWPN,R2I2@;I4LZ``\PD7U[3IPJ?>KO69U__]"5W?V7-9[W?VSF
M<<WSBY)V!E5I#*4#02/PI%Q*6&+P,&XT+@14!%02)/CZK]=>8,[(^JS.3D`Z
M*>61X7T^RO<6UHA@[<PD0BRD1FP?'I!/VFL.P<4+*:W?_A"::;_]I(3XI_UH
MA*NJ5N8D8EVW-:?OK7/;5*5;JC$\0TX1X]-ON)KTQ]$HV/3/6G#BC:892*OT
M0?F&!&J_I\DJJNM9P``PF)`X?3M_^R*\P;X).\=T%7'Z]_\`_J*KS6]G=?1?
M6[V3[1P#-<&NLSQ/,Y3L[")%$4J/<3JZ\L_W.GL,5L8E9;P?W9I\OP'!<A3&
MEV?9\8N*!CPY.&EU]"UP/794A2"`H)6FY20I"B%`$$6.AT)JXS_K=S8'"Y'&
MS4M2XJ>AZ^J1T`C^(GJ2>A23U7ZA8@7J^3U*Z(?P7KB[N.Q*:'_FG;\J%D67
MXS+BLRH&-U<6$$+&,*%N6#[[X4-4(K(\[CJ_G.O*B[;:EF&O2ZUE(2\L]2K<
M+V``!XV2`$B_9?G67N.%AQI$9]5F=$K!L;W)*@1:UU$D6J*'<70SN,]X0<HA
MW%K21*QZ'/I@C?D`Y908;SLVN1BZ;DL.-OU<U]6C^PW!%L514(D<6;:D_P`!
M2.D&_P!G;6Z[5<A;MB0W<A,2Y/93T/-*`/J!))0H@G4$$7-CK?@:[VI]J^T\
M'SENHGK#R/K/'7L;3,YUWYI62UU?D+SC+D^ML?S&''V*ML1=<60,@D%#W794
M5O\`!%:<;O<AY5[6X:=OC4#NW8T-#F1E89@MH8;2I20;INJYT!%[6';8=E6K
MBZV;8O`8$T8(Z+J$BMDV0\A-#WXJ"BN^_P!-M1E8]5?O<>3.5</+(G3USBM[
ME2H;^*P;20I5*60R$E6--*?"37L.1VX[4@6'6WA:910%PDX$18WG]JP#GOKD
MN*7BG%E3Z&B"ZV3?J4E`!NF_F-@2/-W58<5O:&_&=Q$6?'5G&TV;"U#I5;\I
M/4/,`".(Y=]02[9]>^R\<R.9V9U-CU38PLJ@P[3/NMHDP0*MR1J*CMI*Q5&@
M98DI-=Y(J`ANF\2KXR$A\?/M[=V+<BHP^=DN(6RHI9?*2>ILGRI<XD=/(\`-
M+BVO[F]M9!$A63Q#"%(=`4ZR#:R[>8M\`;\^9.MM=-$+GES'<6%8]5]IP;<5
M4%JCQ&83YNC\$#2JK:D*+^JB/Q^FKD&82T^HWFH2F?VO63;[ZJY<E(5T.8J6
MEW]GTE7^ZMR]5^LW=7LO:Q8F04MEU/U$DEDLCFV".Q,SM8;:J<BJB1W&S9AO
M3&7`^QUM1%%0R\@*H+)XL00L/15_4+2?[P?W0_LG\Y':G0<[&U<3\::^.B2@
ML,'\I_O3XC\@\=3RTJ:/N3CT;KK"L%Q?K.E:JXN/81FD3&**HB--18LF,E'^
M,Z$5KQ"_-E2#4S/B3CKJD9JJDJK3?<DK<:QBBYYBM>AX$V3KV:</C7H+V-'H
M?YG3'8\X9:Z2+7&J]`..O'Q&M4CX)C^66]W$-B)>=K=TSY4M,7PF$-ADTFA>
MBH82\BR=A4D+!;K$%2:!Q&U%1$W541XEET*#-GNI9BM+<>L2$<;=I('P-KV'
M*U]-0F9.#B&?K\M,0E_JZ4]1T"CIYK_9I?2ZK@:[#O>H>SZ&VKNM,HA6U;?]
M@*.3]@Y/>U\^NKVWO*Z*I=7$YF*VUAV$UK+LV6IJC2<57[1XKKF?P>??FP<6
MU`>;4\X`I:D*`2@'S$&UAII<FP!OW'JO[GP,3&S9@R\>2YZ960VXE:G'3<(;
ML#U$`\@-3V<:OV]5>S_7VVQ"LZBZ0NV9,/K6BA0`AG3R*%RUALDC,S)X#$F+
M#&TCVMFX3[\ID2$WY')5^]%7T/"<A);3#B.I*6D@6'8-+]^O$CG7D^:);CSL
MJ6@AQQ9))[3J1W=P[*R+VE[-'K?JNV2))5C(,J%W':16GE9D1UEM$EE9-&!M
MNMK75ZF0F*_:\3?^NH?=N9_DN&D/H5:4YY&^WJ5S_=%S\JO'M=M([OW=`A/-
MWQK)]9\GAZ:#?I/+SFR=>1/96T?X[^H7>ONERS&WABQD/:$QJ_Y.(A2V\7BM
M%'QMAXR;1T/R0<>F<%(DVDBJ[%NB7?VEVXO![:3,E)_\PG*]51/'IMY`3QX$
MJ_>JC?ZC]\-;LWXYC<>O_P`EQ*/IVP-$]8/\50'#B`C0#1'9:I^ZU.O/M-*5
M&Y(Y77LZ;C[?-G$<`:>B*\+^S4BQ<-DGXO,?%R5NT<`B#X^J;\D5$L/4&MM=
M(_$[)U\$BJIT*?WCU'\#$/3Q4JWW$U(Q]EJ2R]'?;%UA]IQEYHTW!QIT%!QL
MT_43`E14_P!%U7P2""#8BK4I(4"E0NDBQJ/W4T__``K)LEZ:LC,2K94S(\*)
M=S"3BUG)=DN1A,=Q:<KI+NY"2HI$Z6VZ"NT[E4_61XN7;3JL=#G<XD`7_>%C
M\*K.$7_+Y<W`.J_NSZC-^;2R3;]Q5Q\:D-J!JSUI'V"[DC]&]<6.9#32LFO7
MI,>EQ3&(2&4F^R&<+IQHQ*T)NM08L>.[)E.B)*W'9-412XHO6E.26VC]'"<D
M2U&R&T`DJ)\.`'%1X`"N5D1>OKG36X\-.JW%D!*1\>)/!(XDU3;D'OK[G8[<
M?Y#;TM%5T2O-/)1NX8,C'FV$5S:)(LV9;ELTKB.(AJ4UMQ5%-N/TU3,J[[AX
M7_&Y'"E$/B;(ZD)']9222GXD5:,2][>9L_18[-I7,X`%?0M1_JI4`%?N@U;5
MZO\`LMC/LO@[^15,-VER"A?AUF6X](<:<*OLI$,)(R8)@Z;LBEFFCJ1G7!`R
M5HQ(4(5U8L'FF,W$+[2>EQ)`6GL-KZ=H/(]U1&8Q#V'DAEQ04VH72KM%^?>.
M8K[^P=K92FL0P2B@!<V>0W/[Q,I2DM1ALJ?&$&R<@/&ZX`>.?+`$$=B)Q6E0
M454U?,`AELS)TAPH:;1TA0%R%.>4$>`N:SW=+C[J<?C8C0<?==ZR@FP4AKSD
M$]A-AWFM7W'M1F5(3E?:=;M4UN#.RMVTBTBH#VRCYE@/PHT@XRFFZ"CJ;I\<
M_P!=2T?:<239QC*A;/\`5`)^^H*3OJ=#):DX,MR!R4H@?(I%QX'XU%C-L[R3
ML"X6ZR28,B0($S$CL-^&%7QE-7/Q83*DX8,H9*NYF9DOU)?C5QQ^-BXQGT8R
M./$GB3VG]+50,KEYN8D?43%@D:)2-$I'8!^LW/?4<^]7H#/5^2I.\:^9N$Q#
M$^*D4\K",4?Q(O\`\1O@I_'SQ%=57W*<C-[(SQE=/26@$W_;*D]%N_JL?A5J
M]L&I3N^MO_2]74ETE5N2`A77?NZ;CXU8C_&E5Y#7>LE:_=_E#"MLNR:RQEJ4
M3W]NC5Z-#(HS3R(C,21<0Y;@H'V&I*:?U;KB6R4/(P;9=OTJ<44W_9X:=UP:
M]#;O6TK,N!JW4E"0JW[7'YV(JP'5NJKUC&6YKB&!5#M_FV34>*4K)"V=G?6<
M2LB*Z7]##;LMUI'I#G_"V'(R_1%UP2),>*V7I+R6VAS40!]M<S$=^2X&H[2E
MN'DD$G[*B)G_`+#]$=CT]-;8-V+CV2WF"9E1WZ54"4<6\<@QY9,V3D"MGC!L
M)\;\?[B..#H#L*ELB[ZD=JYG%Y*;(Q\6<VM;[*T6!UO:X(!U.HY5";RQ.1QV
M/BY.3"<0F-(;<O:XM?I4"1H-#SJ;K#[,EEF3'=;?CR&FWV'FB0VGF701QIUL
MQ51-MP"145/A4776(*2018BI0$*`4DW2159'LCD-3D79TURHD%*:JJV%2RY`
MJ*QW)\-V4[)&*2)NXVP4E&R)?A7`+;[415U+:D9Z/BP7D6ZUE0[;$``GQMIW
M5BF]Y<>5FB&%]7IMA"CRZ@22!X7L>^]1FRL8YXQD02F_+'*CM4>:X\U<;_!?
M4A$-BY$J?1-E^=2>9^G_`)1D_J[?3?3N=5^%NDWJ#P@DG,8H0[_5?4-]%N/5
MUBW"G5GI%16/J-EN=]N5]G2Y)*9M<SQ^"ZX,=!HH55$6F&W@R&U=9>GR&G3:
MX*P^`/"JJ6Z#KR5C=OF+@GLH\I;,](4M!!MY;"P4#>X-N&AUKV\-R%[.1\(V
MTW(QCSB$+21?S7L5(4"+%-^.HTJJZJZ!N?\`)D9MW(_^,LOFZ4N-*3\J7'15
M5F,VTK?E:>--D,E%!%-]E5=M<#^Z&3"NPD_6D6L1H#S/>.S[:GXVQI(R5I2T
M_P`M"B;@^90Y)M:X/:?&QK\]FY46'971T^'DM9#Q:(V3T")(,*^3(EN))=9F
M1F'1%\C9XHZKFYDI*J_ZZ8>",A"E/S_.X\K11%U`#2X)&FO"VFE-QY56(R4&
M)BCZ;4=-RE)L@E1O90!UTXWUUO6M^]/8/JJKZON,GS&.59E%7$%G%Z]M0<GW
M5LXZ)-U%6XC@F_!+Y5U71VB-;FN_QOUDQYVWY+:DN=<1:M0.=AS!X'O%67#P
M8_N458^/'+60;2"5D7#:21<]0X@\`DV)/#MKSY=@Y_D/9.2S<FR*2KDB02MQ
M(8$?X=7!$B)BO@MDJ^-AE"7=?ZC-5,MR55UUI$AR2ZIUT^8_(#L'=7IO;>W,
M;M?%,8K&-6:2+J4;=3B^:UD<2?D!8#0"L(UP5/4TI32E-*4TI32E-*5+;U.]
MH+/U[R]MBYBKDO5U]-C+EF+26PFA$=%1:#)Z"+)+\:/?P&?A53BDIE/$:[HV
M;?$ZA9!4TLI<MQ!M<=AMRJM[DVY$S\4)<:09;>J%*`.O8;@Z'[#J.=_1<QC?
M5W<^/46;43L:QI[V"S.J[['WF8ZS8CB+L#_%IP/*P:$#@.`CK3@D!;$*HG'$
MR>2Q]T-N>7]E6H^_2O/F8VWC9;ZVLA$*)3:BDE-TJN-+'2Q'8==.!M7X:ZSQ
MCK^'8Y%35-C>W=9">DUP3'VYAC)%O=LVF6$AM*K:KR)417!%%X_=MKN')S,H
M\S#ER4-QUJ`/3]U]?M-NVH@8/'8./(R,"$X]+;22GJ-R.^QZ>'.PO;A6G^E&
MKW(<V<M95I-*/3LR9DP">=\;SU@KS01O%_R&P<=<-Q11$38/A/\`2;W(J-&@
MAI+"/5=5H;"XZ=2>WL'QJL[-3-FY14AR4X6&4&X)-B57`%N':?A7H.]">JJD
M:NQ[>D37'[ER59XO706C$8\&&`079C\D>/-R5)-40/E!$$^BJOQ);(QK*8Z\
MH3=\DH'<-+_$U#^YN9DJF(P@`$5*4N'M*C>WP%62ZO\`644TI7__T=QW6_[S
M;[JI+^Z6&Y+\JJ_F/?*_[KKRA(-WWB>/4?OKWQ#`$2*!P]-/W"N?B4A(V34S
MB_"'*..J_P#[5%D1Q1?T^7'!3_IU`;@;+F)E@<0`?D1^JKWL"2(VZ\85&P65
M(_VD&WVVJ^7&+&ZRCT7R1G%9DJ/DT'JS/J*OD077&IS%G40[EB(D5UA4>:E'
M';;X**H2$2;?IK1MHR!)VWB7`=0UTGQ22G]58E[@PF\9[IYEJ6V/IC/2X0>!
M0X4N'Q%E&_QJF/T@]Z)'3N3PL1[K.;FO7,R5&9I;>Z0+NWZTL)$H&Y%I5R[(
M95@U1FT:E)BL&G$A\C8\E-"GD.'@HU;=X[(;GL*GX-I+4I*25(2.E+H[@+#J
M[.W@>5>G"JM:R\K8%S33XEK4VD1B=764"0U+A3H<EL78\J+)9(VGV'FR0A(5
M5%1=<U8(I"D*4A:2E8-B#H01Q!';6*=B%UX&./GV98XU4XWY6@*RR>U@4<*+
M*-5&.;%M/DPQA3.2JC9`X#FZ[(OSK]"B@]0-J[F.>R#$MEW&*=$T'R^G?J^`
M&I[QSYU6/VO@7K=E&52G,)]L.NL27(H$:CR&FGY1CUQ7RZUIPC;\%FW.%MM]
MH7G$%77%5$+931-=UF<A"0%H2JQN#?G5^&X=[+0^96*?65M]"E>BM)4-;7`3
M;2YU`!MSJPCLM1K.C+EO'[!9T2/BE7!B6D:4+J2Z<EKX4B<W,CFK;@/U)F?D
M`N*BNZ+MJ%R3CB8<QQK1SH)%N58WN-Q]G"Y1QFZ7PV>&A';X6%ZK=BO3(DF+
M(K$7]PBR([]<()L7YS+H'#$$3]5D"*(GZ_36;1%N)EQU()]3K'WU@D%QYN;$
M<8)]<.)M;C>XJU>=UYB$^24LZAN*^9$;JUKTBL;?</;D](8@NL,2'EV_K,5+
M_?5ZG[<PF35US,:TIS]H#I5\5)L3\37J*-DY\0=+$I:4]E[CY&XKBKUEAQFV
M;M<\]XB$D!R=,5LN/_`Z`O`+S9?\0GR14^NNC'V9MJ,X'6\6@J'[14H?)1(^
MRNP[G<J\DH7,4!W62?F`#6;Q(D2!':B08S$.*P`ML1HK+;##+8"@@#;30B`"
M(HB(B)MMJSI2E"0A"0$C@!H!4225$DFYK2WL#UMBW8G761,Y%(F5;U9C]^=9
M?UO)9].[+KC:<?::%4&4VIMMD31?!*"*BBJ(J=27MUG<YCXM375(<6$MF]BE
M:O*#?Q.M]*F<-NW([.7*R<*04,^F?5%KA2$^8@CMXV(U%]*@7ZK=/=.>C?7V
M2]^=H]DU'GS..%:W;RHDB(42/'G/I,IZFO+\BTMK:9,A!Y!8`U\<9%'<.1+%
MXS8C^QI^1AY.0',FBS:B+=*4I\UD]O5<$FI?([OD>XK6/.(@J3"-W`.9)T*U
MDV"0D"VM@!SUJ/W>/M#>^\.?U_172TR3A?2334ZQ[([&R*ME0V+6AIVTN)EI
M9JPT=G5856L0%)]M4!R2I(#@_<VVO>>=^N7_`"V$^E+RTJ*G.*6D`74M9'``
M`VYD\*^GHD/:.-.3R72_E5V#;3:DJZ2H]-K@D*<5?R@7Z1<G6U3_`.G9E+E^
M:]-SX;/7K5KT9TGDN'9MD_65JU8X5;5EC94L/!VW+!J/%!JR?@TEA928KZ>2
M(KG(MO(B:F)CL60,1Z:F%2(T=2%J94%(()3TZBVOE*NDZIOWUG6*8E,N9<K0
M^&)#Z5H2ZDA?5YNK36_X@D$?BMW5K?&Z^Q]R_:FNJ0)]_J[!Y96,OBA)%8Q:
MID,^<U<!LA_*S2VCMM!R5"\!_&R-KK-\-%<]P-\--$$X#'JZC^RH@CX'K4`!
M_5KTWG93/LG[0/R"0C>V;0$#]M"5`D"W$>DA1)/[9MV5?2RRS'9:CQVFV&&&
MP9889`6F666A0&VFFP00;;;`4011$1$39->I@`D!*0`D#05X"4I2U*6M1*R;
MDG4DGB2>VOIK]KYII2L#K<(&!G^1YX=HY(>O:JNJ&JW\9&V8$:`+*JJ/^=PI
M!O/-*?\`2"#R5-E^NNXY,4Y!CPN@!#:U*OS)5;CX6J/:QZ6LE+R/J$K=0A-N
M0";\/&^M9YKIU(5&WOF,[C5E@O;4!N23V(W+=?>-Q>:))H+,OO\`RB:V)6V'
M`)H454!5E;%O]NUCP2A);G8APCI>02B_):1<6\1]U5'<R%0W<;GF@>J.X$N6
MYM+-C?P/WU(UA]F4PS)CN"ZQ(:;?8=!=P=9>!'&W`5/A1,"147_1=5T@I)2H
M64#5L2I*TI6DW21<'N-0E]P;.4CV$4PR`_"-NXM'HJ$*NK*:*%$C2#'CR$!9
M>>$%WV)2+X^-7C9;*"Y.?*?.D)`/<;D_<*S?W$?<2UC8P7_#45J([2.D#[S4
M(I,:/,CO1);#4F+):-B1'?;%UE]ET5!QIULT('&S%5145%14U?'&VWFUM.H"
MFE`@@BX(.A!!X@UF+;KC+B'F7"EU)!!!L01J""-00>!K-_XW,`M,7[<]@)<,
M'6\0KH=+C[!D3RLR+&9+6]@1P+Q^!YZJJ7"%S<D-O\@=D5#5=>:(N!_D.[-T
M1(XM`2M/0.Y8#@'[H5:O5PSYW!M':\Z2;SUMJZSVE!+:C^\4]53RK2'*O92Z
MEDC+T3KG$F:R,6Q<F;2X!EUXQYMIS=%B?(:4A51%$5-]U5$T-T"-MN./SR'R
MK]U&GWUGK*C,W=*5Q;BQ@D?VEFY^-JW=DF'8ME\=(N34%9<M@*BT<V*V<F,A
M*A$L28*#+AD2I\JT8*NH:/*DQ5]<9]2%=QM\^WXU8I4*).;]*7&0XC^L+_(\
M1\*T%;^IW7LT_)5V614JJX9DTW*BSXR-DJJC383(I2!\:_`JKI+M]=U^4L#&
M[LHT+.!MP=XL?L(JJ2=B85]74T76CV)((^2@?OK1V1_Q[X[G.2L/YIV5DDS!
M*XQ>K\1I*^!439$K\?@4BWO7BL`D*CQ%Q1J(TJ-+Q0A)2-:GN<S-VN1V\G*Z
M<8T>H,MCI"E=JU$J)MP%@+`GGK5NVK"Q^ST27<7&*\FZGI+SA"BE/[*$@)";
MZ$WO<@<M*W_ZX/)C=-?]02"0)/6%F=36,JVC(%CCANA7%%`]GG60=8<+DN^P
M/-_*HJ:GLK!BQVL=*Q["6X#K("4IX)4@!)3^G$WJ#P.1F2'<I`R<A3F18>42
MI7XEI62I*OTT`L*DIJ%JQU4)[E8[7=O=M.0<@O;B;C.#0&*:GQZOF##JH]Q)
M:&5?V3R`+KLBR-]UN,1[MJ`Q4#943=9^'[?8K<++.0SBWEMV/0T%="`/VC8=
M14>V]K6TJF9?W(R^WI3^,P*64+%NMTIZUDV!Z1<](2GF.F][Z\*@)E'3[75U
ME2]A8I-GRJO'[:',NX$XFWY46N*0VU)D178[#"OQP8=(70-.0@O+DJ(NU7S_
M`+=1]FR(.[MNO.EB&^AQUM9ZB&^H=100`2`">H&YMK?0U8-O>Y,C>L>=L_<C
M+0D36%MLNH'2"X4GI"P20"5`=)38=5A;45;=0=D]UY_U]CM)USCTK]GA5==1
MRLJKR:&1:>.((,.1+":[#CP(Z04;5TFD)P2V_N#RX+H0B;=CRE3IDT+0[_$0
M@`]/2OS))L#>X.G`=QJC#(;KF048['0"VID>DXY<!76CRJ`N1TVMKQ/>*^6/
M^J&<SYC*Y'9T]+`)/)*<CR'+2Q12$U1MJ.VTU&<=\B)R4GT%$7=%)4VUWI&\
M8+2>F)'6LCA?RC]9^RH^)L#)/*"ITIMM)U-KK5^H7^-2@Z]Z$P7`6R>_%_R2
MY=$@=MKUB-(5L#0A-J!!1M8L)D@+9?@W23X(U3XU4,GG)V4ZD/+Z8Y_(.'Q[
M?C\JOF'VWC<-TN,-]<H?\Q7XOW?V?AKWUS^W^Q.J,*H"J^U+2`S4Y,R_7+2O
ML29\FUAF/"5QK8`.S3AM(2(;HB@@1"G)%5-53*3L;#CE.3<2&7/+TD7ZAST&
MI';5[P>,S.0EI7A65F0T>KJ!"0DCAYC8`]@OK5.WLIB?6N+9M43>J;:-8X=F
M6/MY%7LQ9?Y<:LD+.G0I=<P3JI-8;%8?D%F0GE;W(578=AR;<D/'Q9;+F,<"
MHKK?4`#<#4C3G;3@=16];-R.6FX^0SFV5)G1W2@E0L5:`@GE?7B-#QJEGOB'
M*Z:I;SL+/)L8J/\`<'T9FLS&GIUK.E$\]$@Q8;[C4AV=+051`^1'95(D`5)+
M%!SN.,=#2;I6A`\MNS2P/`_95>.PMR97,!B*V'E/.GSW-D@F_6YI=*0.)UY`
M7)`-$O:O:60=K9,_?7)JQ#:YL4M.VX11*B!R3BTTBKLY)>XH3[NR*X?Z(*"(
MPDN4Y+=+KG#D.0'Z<:]:[0VEC=GXEO'04]3QU=<(\SB^T]B1P2G\H[223K+7
M5JU4TI32E-*4TI32E-*4TI32E34]3_<+-?7N6_BSD[\SKJ^F-ORX,QER=_C=
M@9<7+FF95T4:"2FR3&114=`4,4\@_=^(CQ''T*E)5Z?`])L?'X52=Z[>EY?'
M.R,-Z:<VV+HZAY7`-2A6HL3^57(Z'0W%T<#V4R.R8K;*!%QJ96R6F)(2(83'
M6I\9U!<%Z-(&P(`%UM=P).2)_O\`34\G:\!2"MN2X;BZ3=-N[EK7E61O7,QI
M*HTO'M-NMJ*7$*2L*!!LH6*M#X@U+'`\#@E,?L<*K)<R5F95[R5=:T[/==?1
MN1):*&PRK[Y+*_.-5$1XHH_'^U:D.3\@&(RT*<>:4I.@N>7$#PX]U7*&SB<0
M94UMQ#49]*%ZFR=+\"=/S7M?G5[WJ-@=IUAU?'H\L)JKR7(;>7D1T$J0VW8P
M8TF/#C16'XANJZW(5J(AN!Q10(MB3DBZU/;$!S&8U$>20)"U%73?47MI;MTU
MK#-[91G-9IV7#251&TA`7;0VO<W[-=*E=JR53::4K__2WKF55*HLNRBEG,.Q
MIE5D-S7RH[X&V\R_$L9#+K3K;@BX!@8*BHJ(J+KRK/:+$Z6R>*7%#Y$U[PQ+
MZ9.+QTA)NE;*#\TBL<%Y^.02(RHDB.XW(85?IYF#%UO?_;F":CWF42&76%_@
M6D@_$6J;@RW($V+-9_O6G$J'BDWJ]+T%S^NM\9R/!'W4.01MY;61704FWJJR
MC0X5DVG+=M49DBTI!]5\RK\_.NY[<3`(4[$.J_Q##Q(']4Z'Y*!^==+_`%!X
M@JS&%W5&;)@S8J$E0X=:;D`]Y01_LFJ?/>_TFRWHCL.XRW"<>M;GI_*)KMG4
M6%=&.=_B\R83LB;C]LW$;5R)'B.H2QGS`6C8(1Y<Q)-:&X@WND:5Q[(WC%R4
M%C'Y"2E&3:'3YC;U$C@03IU6T(O<\:F5_#]VUV1<2NP>IKV1;7&!8Y0PK_'I
M-B<V2UB]@5BW!>H8$B0X;,6#9,OD^,4$1`<8,Q1.1:^VRH@@\!55]T,9C8[L
M+(Q>A,MY2@M*;>:POUV'/D3STJLWW#]BL\[\[CS&;D%I81\8H[ZRHL5Q()4Q
MNHJ*NFG28,5XJTWBC+;RQ!7)+Z@AFX:I\"@BG&XHE1'(5H>T-O0</B8;C;25
M3'6TK6X0.JZ@#8'B$C@!?OJ/.$X)E_8^1UN)8/C]GDN06TIF)"KJR,;[A.OF
MC8$^YLC$2.)+N;KI`T";J1(B;Z^`"HV`UJP3\C"QD=<J=(2VRD<2>/<!Q)[A
M7J*Z5S2AZ'Z4Z^Z.[$>M,\R+&<?*BS-V%'BVE37R)+[\B1CI/VLN+^Z1:5B:
MD-/&+C:@SQ14VXIU9.7@1'1'><)7P-A<#Q_HU->+]W;YV\O/Y+^&KTW73=*4
M@A(/[6H%SQ(%]216[,'Z-ZK?F4^?X_-NK>M<=2WIJ^;*B.4[#HN&K2+'2L8L
M#6OD"J"V^\?C<;3DBJ.OF+BL<EU,YA%RK5/[(OS`Y?JJ%QNV,`)#.8A!2TJ\
MZ`2"@7X$"P.G($Z'PJ,/NY_(55^LEK&Z\PBDK\Q[/D0$L;-FU=D#08I#EL*=
M6=F,)]B7/L)JJC@Q0<9XL;&3@\@0I12PGQK9]I;*D;C2N6\\6<<DVZ@+J41Q
M">6@XJ.E]+'6U5$_^6+VWF/BZQ/Z^K`$E+\:!A@DP2*NZ":V-G82%%$^/^8G
MQ_O\ZX_55V"M+1[7[;2FRG)*CVE:1]R!^NKL?1#V3ROV>Z8?S3-J.#49)29/
M/Q>?*IXLF'27?XD.!.9LZYB7)F.,EXYZ-/@CI@+S:J.R%Q'E2>I(-JR+=V"8
MV]EU08SY<8*`L7MU)O?RJM87TOP&A&E30?88E,NQI++4B.^V;+[#[8.LO-."
MH.-.M.(0.-F*JBBJ*BIK[0M3:DK0HA8-P1H01P(/;564E*TJ0M(*2+$'4$=]
M4/\`NA,QW,?>3J;J'L]V3B_1>%4=7,6'6$W6PG(UH'[C>6=:PX)5;=B8_P#<
MVW?'_:4$^B[KKH9-:9DJ"UDI*_IGGQZJ^H]1%B3=1U\Q`%SVU<X:5XG8>2FX
M=E/\P6[T`!/X4I3Y4V%M+GJMP-AV5*;HJ[ZQZ:Z?]ARPK$<;N*3OMBHJ?6JI
MNI6/W_8^7NYE26%!<X-D\2%+D6D6EPVZ;$I)R/#&XF9H9\D+4MB7,;A,7G'(
M;+9BRK&,"4J<7UHZ2VL7*NE"AK?2Q.M9?E&LEG,I@VY;S@F1;B20"E".A84E
MQ!L$]2TD6MK<"L%SQZF]1>C(71F+6A2LWRE@[WL^[AM@Y-Y6<=N.M+7_`([8
M/&[/0$B16MC>_'`E^#>%=9=N&:K"PHVV\/YLM*T-N("M"=.!)T3V#6O2GM=M
M:/GLA-WQN?\`A[9QOG'58)6XBR@G7\24C57[2B$\S5OWIAT7#Z6Z:QXY]3^#
MGV:UE9DF=.R6FDL8MA-B#)C8V;H@CB1,<:D*R+:JNSRNG]2V3>MB[5C[4P,6
M$E(,U8"G5VU4HZV[;)X#XFO,?NY[AS/<;>$_++6H8MM11';)N$-ITO;AU+M<
MD=PY5+G5SK+Z:4II2FE*:4K%LWQ]O*L0R/'31%_=JB;$:W1%XRB9(X;B;H6R
MM2@`D7;=%3=-=F'(5$EQY*>*%@_;K]E=/(14SH,N(K@XV4_$C3Y&HX]>=^8O
MC/5]2SF$]X\EHG9V/NTT82D6TA*QP_V]PF77$*.RL$FF5<>(`\P$B?39+'/P
M$N7E7C"9_P`,Y984=$@*%SKXWT%S:JEC-T0(6$CC(O\`^,:NV4#59*#8:<KB
MVIL+U$7/,UR/M?*7+:3#-UY&DB5E57,/2/PJ\'G#98$`1QUYU3>53/9.9K]$
M^$U=L9`BX6)Z7JBY-U*40+G]0'*LYS&4F[AG>OZ!L!TH0D$V3?XW)YFLWP?U
MT["RR2RY9USN)U`OM#+E7K+T2P*/ON\L"J-I9+KZ"FP^9&6]U_J^%34?D=T0
M(B%)C+#S]M.G5(\5?T7J4Q.S,I.<0N6V8\6^O5HLCN3QOXVJPG!\"QCKRF2D
MQ>M8@L..#)GRD:8&=;ST89C'96LAEIG\R>ZRP`J:HFPB@HB"B(F8ONKD2'Y+
MMO6<5=1[3P^P``=PK9(L=N'%CPV`0PTGI2.P<?M))/>:P3JG&KJHR7MJXNX#
ML1W(<T-ZO=<!`";4Q`?_``Y$?<G3\"K*)$W-?I_2/ZRF3E,OQL4RRNX:9L>Y
M1.H^P5#X:$_&EYR1(;LIZ1=)[4`:'PU-;LU#U/TTI32E1KS;A@G>6#9L9&%/
MG$*5AE\XA?VX]@V,=*5TQV`422ZXTBDI$J!')43?;>Q0S];A)T+_`)K!#J/#
M@L#X7/C53R`_EVX\9D1HQ)267/[7%L_$V'@*D/964"H@RK.SEQX,"$R;\J7*
M=!EAEH$W(C<-4%/]$3ZJOPGSJ`0A;JTMMI*EDV`'$U:776V6UNNK"6TBY)-@
M!XU3]FUVSDN7Y-?QP\<>XO+.?'%145_'DRW7&%(2$2$R:5%)%3=%5=];1C8Z
MXL")'<_&AL`^/.O/&7E(FY2?+:_NW'5$>%]/GQK'0P:^[(8L,,QRN6RM+VMG
M5[31@XL2.DM@XR2[%\&G4AU[#CHJX\2<03_?9%Z>X'(Z<-DFI"D]+C*T`'\Q
M4D@`?/\`77;VTQ*>SF,7$2KK;?0LD`^4)4"2>SAW7.E3P]=,-E=#V0]*VUJ]
M=+(Q"@OZRX<`FX\JRKXR5F0Q8IN(!/,MOHWX=Q%Q&6QYIR769ICJ.W,.HKZW
MHJ`PL\R$CR'Y7%;$V^&=T9M@(Z8\Q1DMCD"20XGYV/SJ8&HRIVFE*I-]VLX.
MS[RNHQ2ECP<'IJRDCNF\L=MEUV`-Q.D>1U1!A4EVB@1ILBBVB[ZR'=TQ;V=4
MT@G^$@)%N-R+DCON?LKT%[?X]J/M=+[H2/7<4M5^'2E72`>ZR3QTUJHKLNS[
M*I[>-DR7[LW'I$\9U%)K9"/5K;0B!1&Y3;:*TXAL'Q13)P'1Y;+\JFNSBFL3
M+:5%=CVFA-E]7XCVD$_]EM*Z.??SV/D(GL3`K&%SJ;]/\`[`H`6UX:D@ZU63
M[Z1.S^V6Z/.`GRK'',4KBCS<,KDD?@5+RD9RLJA0!)Y9#DAHD"6X:FXPTV*H
MOBY\.&7@TX]M3T=14WSOQ'9PY=OZ6UKVI]P8,N6YA,G&;8R+Q'IN#@X0-6S<
MGI/-`!LJY'XK=55&HNO0M-*4TI32E9I@77^4]E9%&QG$JQ^QGNMG)E.@TZ4.
MKKF.*R[6TD-MN)#KH@DG-PD^25!%%,A%?MM!<<;:21UK4`/$U%YK,0L#C)>5
MR"R(S*"HVU4;<$I&EU'@!\R!<U8]G?J;UM(Z6K:;#*^SA]N8NAR_\B=E,NP,
M\*5P<LX%RTXK*5/A4-JWQ":,HB`Z1<S=24<P$Q"^MI]*T6U!N#?^KQ'S(K!L
M-[XLN95U68B+;Q[JPE(390;3P"CP)MQ6`#?BG@!56\V%+KI<F!/C/PYL-]R-
M+B26C9D1Y#)J#K+S3B";;C9HJ*BINBZB2"DE*A90KT0P^S)9:D1W4K86D*2I
M)!"@=001H017%U^5RTTI32E<F'#EV,N-`KXLB=.FOM18<*(RY)E2Y4AP6F(\
M:.R)NOOO.D@@`HI$2HB)OH2`"2=*_%*2A*E+4`D"Y)X`5=!ZU=+=HX9UZE7D
M$+(;*;^4LPJ0($N2SB3;X[_M".>!71DDYR<?;1?&VZI(*?U$5IQS[$*,A,J:
MV"O5(*AH/^WGR^VO&WN5,;W5N63+P6$<#+(]-;H0H%Y23;K(X6`'2D_B*0"K
M2P%KG2][G/1E`WDPY=;4EA&8?FMC`D/M2*FM6$K[U88O<4=4G&44F33Q"Y\)
M\_.JY+R2W<J',.2TZ3T]2=.LD\3;0CQ\:[$##-,8%36X@'V$CKZ%`GTP$WZ0
M3J#W"UN`K5[7MAG-KG;^5Y1-GRBE3/R4M6)DTLD@NB6[$T+(YBNN/M)]1%00
M4^&T%$1%FI.!>6GZEJ>Z<F-2LJ.I[CQ'=K5:A;LC-N&$]BV4X0^4(2@>4=I!
MT5VJT[_'T)^I'M;&[8@UV%Y?-:<S58:R:2Y!&VXN7UC4992N;^542[8C`3CH
M"`@ZVBF*)Q-$G]M[B,__`,OG^7(HN.SJMQ_>',?'MJK;RV@G%_\`F^*\V'<L
M=#?H*N'+\!N.D\1P/*\[-7"L\K__TY^^\.(R,*]K^[ZA]AQAN7FDS)(7D1S^
M[!RMF/D<9X"=1",%&S4=TW'D*[+MKS?N^*8NX\H@BP4YUCP6`K]=>R_;N:F?
ML[!N!5U(:],^+9*?N`J*>JU5UJ87J9VHYU]F^-VS\M6XM/:#6W#?(=WL5N"%
MF2IBJ$JM0E<4T7;="8'5<8DG;^[(DZ_3#D>5?9YM#?P-EUI$O'C??M;E,-;K
MRT"ZV1Q5=`ZD6''S(ZFA7H@_[O-C_*,RHDIGZ*@/1Y$=X/\`1>3;K+K9?[H2
M+K<P;V(.E>+B""018BNEQ[$<4Q%F5'Q3&,>QB/.DK,FL8]2UM*S,EJ*"LJ4U
M6QHP2)*BFW,T4MOUU^U]N.NND%UQ2B!87)-AV:\JA%V=_&GZN=H99-S.?09'
MC=O;V;]M>-XGD#E=76\R6^Y)FNO0)<:P9AG+>=4C6+X$1?HB*NODI2=2-:M>
M/WUN3&QD1&)B5,)3TI"TA12.5CQTY7O4BNH/7/I[U^JK.%U'@]9CDFR;WG61
M.2;"ZLS:;1&&9ES8NR[`HHN"A(R)HR)JI(&ZJNOT`#0"H/*YK*9EP/9&8IU:
M1I>P`\$@`#O-KGG5<CCDEUQQV8KA3'7''9A/)L\4MPR.23J?.SI/$2DG_:WU
ME$DK5(?+G]YUF_C>O*LI3BY,A;U_5*U=5^VYO]M6$>L0R4ZRW=1Q(Q9%<E7\
MD)&OQ]XPR5C[_;XEM!D<N/QYN>_W;ZO^`"QBV.N_%5O"YM6T['#HV_']2_3U
MKZ;_`+/5R[KWJFOW]]#N^LA[URKMKK+&YW96-]A28EG(C5#S#E]C-C$JJZL?
MKI\&7)9?EP'5A\XKL='!;:_M&(<!5R4<05'J%>F-C[UPT'$,XG).>@ZSU640
M2E84HJ_*"0H7L;BQ`O?E6L^I_0_%>M"J.P_>7/L5ZCPTT=D0>LY.0-GGF4.,
MF38,OL4KDJ3%@BO!QP(/Y<H@)`)&"553\Z$H'4XH!/V?.NUF=_/S4O0MIQ7'
M'@?,\4^1([0%:"_[2^D#L-6+XM[_`'J[U'4X]U]UGU%W%%Z\B#)CXQ;8_P!=
M!!QZWA17S&RNJA+V[KL@O6QD"929!QRDDXA*XBEOKB7-BME@*=T<!Z2`2%`<
M>D@6(%C>W"LODXV9-<F3)^7BF<#=Q*G>I8)_"%%`4A-]`D%0'`:59)@V<8MV
M3BE+F^%VS5WC.015EU=DTU(CH\V#SD=YMV-+9CRXLB-)9-MUIT`<;<!1)$5-
M=A"T.H2XVL*;/`@W!\#5><;6TM3;B;+2;$5K+NOUIZ=]@6*Q.RL6&QLZ07PH
M\BK9DFGR*I"1_P`UJ+:0C;<=BD7W>!]'F.2JO#=5UQR([,II3,AL*:/(UW(>
M2F0`XB,\0VNW4GBDVX&QYCM&MKB]C4+\OPCUN]+6'IV`5C]SW&=?/6EN<GNE
MNYF'Q+".K+MU.0VV:JO%J.1+'#\<7WT4DY(VIEJF9S(8?:K1^BCI5F'!9M`N
MI6N@4;WLF_Q5P'.VE;#V5F_<">EZ:XIG;#"NI]XCI19.I0DZ761SN0@>95M`
M<A_C]]?IGL%G5A[*=MPIMSB&,WA'@<+(N;I9?G,-P7',SG19,1QJ;3T+9@->
M*.H#<H17@GAXC9_:_9KZG7=U;A!<R+A\G5R^'=W``<!H-8;W\]SH2(\;V[V1
M:/M^./X@;TZS<\2-3?B;DDWNKS'2^;6[UY)II2FE*XEA/A54";:6,EF%7UL2
M3/GS)!HVQ$A0V3D2I+[B_`,L,-D1*OT%%77RM:6T*6M0"$@DGL`XFOI*5+4E
M"!=1-@.TFJB\C_DVRC)\J?QSHCJ&)?0HDMWC>9=:2FRLZQE]&OSOVF%^UMT+
M3X_<!2)KQ_<B$VA;AJIX[.Y?<>15CMLX?UBG52UJZ4A-[=2N'2.RY)/(7TJP
MY3&8;;..3D=S9?T4JT2A">I15:_2D:E1[;``<S;6IW]+>P]?V>U#JLAHTPO-
MGFWC.C"T&[JY/XX@1%6720ZTGW7`4C\+C`&*`6RFB<ET25@<MCXR)$YEL<.K
MTU%:03WE*3\>FL^Q^Y\+EI2HL!YSKU*0XD(*@.P!2Q?NZK\3:I(:B:GJB!@^
M`8H?=7:N/Y'C-7;^%V!E%$=@PDEN/&LB<?D@VPZJLO-&5LV*H0$(.,K^NRZM
MDV?,&%Q$B/*6@64VH))&J>'#N%43'8O'G<.>BRX3;BKI=05)!L%<;7'"YJ5%
M1C]#0,^"CI:JG97^INLKXL$"V_4TC--\U_W7=5U6'7WGC=YU2SWDG[ZNK,>/
M'3TQV$(3V)2!]PKM]<5<U-*4TI32E=$.48R5T6-CD5$61"UYRH!MZ];H6=B7
MS%5)(_.1K857EX]OA=<?K,^IZ7JI]7]FXO\`+C7)Z3O1ZOI*]+ML;?/A7>ZY
M*XZT?[#T#EWUC<28I*U88\]%R"%(!4%Z.<(U!YUAS95;<:C/&:+^J@B:F,$^
M&<DP%_W;ET'P5I5?W/'5(P\E3?\`?-6<2>PI-]*CW.Q'OOO2JK;:TLJ"NQJ>
MQ!F5\%NQ<AU<AMQGR)-.!"&UE&\R:\3&07,'47@*"F^K&S.V_@GG6VH[JY:2
M05$"XMR!)``\!XU4I&-W3N>.R\_*8;@K2%!(*@#?4$@`DGQ.AX"LFQSU"KV^
M+N6Y;+EJH[E#QZ*U!$#W%4']PL4G&^W]47:.T2_HJ:XY6\WE`IAQ$I[U'J^P
M6M\S7-#]O(Z2%3YZE]R`$CYGJ)'P%2:PWKW$<!B%%QBGCP2>``E3B3SV4T0(
MC!)DYWE(>$#-5$=T`=_A$U5)D^7/<]24\5'D.0\!P%7?'XN#BVO2A1TH2>)Y
MGQ/$UK3V`H+`Z"GSZA;0\@ZXM&KZ/LI<G:I7HY6C2B(KY6VUC-/."2HGA:<V
MW54%9'`O,_4.P))_PTE/0>Y6O2?GI\:B=SQW_I6<I#'^,B+ZP/VD:=:?`@7(
M[JW+CE[$R:AI\A@(8P[FNBV+`.(HN-A*:%SQFBHFY-J2BJI\+MNFZ;+J'?95
M'?=87;K0H@_`VJ?BR$2XS$EN_IN("A?CJ+ZUW6N*N>O/C[C8>=CV_P!OXW;F
MZT-S<%-;>$Q<<98M(D*WK'AXDJ*+33S2H"JB\4XKM\ZQC/.NP-S2I`%UI<"A
M?F"D&WR-NZO1^UF&,KLN#$42&U-*02.((41?YB_?X&JZNMV\DRK'<XP`[F*L
M>!$9:KAG-.2W8SJRW&C"(Z;B^&LVB\2'@2MFZ)!Q7DA2F87&BO8W*",HK*KD
M@VTMH#VG73ML0:@=NMS9L?-8/ZU(;2@A(4+V/402GL3IKV%0(UK+^L^K!QA+
M&7E3,!R]FM2XM5"<XSF/VQM&XUG)!?$Y$,GPF@)B:\D:-$X_<:)'9K+?7M)$
M:_T8("KBW4H@D#P%K^-36V,#_*9*U3"G^9D$HL;]*`0"H'M43;M`[-:H:]M?
M71WK_*,CS'#ZU&L0>O+$;6GA,(#6)RW)[H",>.TV`LX^\9(+.R;1R5&UV%0U
MSR8!:CQY3)*F%(23W$@?8?OT[*V?V\]Q4YF1(VWFW`C-M+4&U'0/(23IK_S$
M@:C\R?,-0JH2:C:V&FE*RO",)RCL;*J7"L,J)5YDN03!A5E=$'<W'%$G'7G3
M79N-#B1VS=?>-1;99`C-4$577RM:4)*E&P%<$F2Q#8<DR'`EE`N2?TXG@!S.
ME>BCJ+U4I_6/I/*(U6@Y+V%DM-#3.,@5IH6Q!ISG,@T:'&9F-TE<VX9`!DIO
M&/E-$78`8Z0V]D8"7K(2ER]^9/Y03XV^=>=-_9B=F8F6D,E9C>ETH;OY4I!\
MR[<UD$W.N@`&@UU?K2:\Y5'?OGU`N^V,2R'MG`ZP&\BQB(KMA!:;$2S6-$0"
MEL0VVA5QV^K8B\P-4XO@/A55/AM4\\8R)$=*/^J6=0.SD3WDZ#M^%>@O9_=T
M_&L2,?EG"=NI/D6JY])9.H'_`(=M5"UDGS#BJJAW&W&G#:=`VG6C)MQMP5!Q
MMP%43`P)$(#`DV5%^474)7IQ*DK2E:%`I(N"-00>8K\:5^U_4155$1%5579$
M3Y557Z(B?JJZ4J]+T']*;K`)]5W1VS15S=U+KE?Q#'+4?-9XN[+07(MQ+@.,
M$W$OCB@2@ADCD,'$39'E)&NK(>CKC*"5*+O5^Z`/M)/+2VE8_NS<\R9D/Y7C
MEI&)0D^HL$]3JNQ-M`VG4'4E:B-.D7583V9VW$Q!9=%5MG(R-&&3%PFVS@0%
MD<7$61NZ)N/^!>0@@JGW"JK^FNWB,&Y/Z)#IM$O^\;=FG"^EZR3<.Z&<3ZD1
MA)5D.D$:>5-^W7C;4#PO6`]272976Y?C%]-DS9ULKTP$DOF:NLSXQQ))1U(E
M\9,RO$2BFR(AHJ)LB[26>C?0/0)D5H);18:#F#<7\1>H;:DW^:QLMCISZEON
MW5J>2A8V[+&VG?4;9D5^#+DPI(*W(B/O1GVU^H.L.$VX*_[B0KJXMN)=;0Z@
MW0H`CP-9R\TMAYUAP6<0H@CO!M4X_6SLQRJBX]^TV90\NPN>-C`12)'E9BS4
ME1)#2JB"ZPVKJ-&&Z_:FRILNJ+FF9..RB<FP"$%04%#DH<0?&WQO6I;:E0LQ
M@U864H*<"%)4D\2@G0CPN!W$#NKT=_\`U%XK_P!N+_\`@O\`^K__`(DO^3_\
MH_Y7_-_][Z_[:T?^?QN[_H_7X_[M8]_E6;W_`/U#Z7AS_:X_97__U+\_YA^I
M)5=F_7G=4)APZS):9S![UX!<((ES0NO6-.3Q</&U^YUDYX0^[<EAE\)^N/\`
MN9C5!Z%E4)\BD^FH]A&J;^()'PKT/[*9I"HV2P+J[.)6'6QV@BRP/`@'XU2[
MK*JWFNXQZU_8[F)9$BJRB'%G"`\C.$_MY-A1%(_"Z(NH*?*\-D^5U%9F`<A!
M<90/XP\R?$<OB+BK5L[.C`9N/*=41#6.AS^RKG^Z;'P!J]'U%]D:>[H*KKC,
MKQH+F+X(F'W,U\58R"M?5`@5/YB_:MI"W1II'"19#2@@J1B2+8ME;J;FQT8C
M)N]&4:\HZM"X!PX_F'`CB>/;5(]X?;)[#SGMU;=B^IMJ3_$7Z?F#"CJ2;7LT
MLGJ2K\*22DV\M[`-:)6!5JGO7(\GQ#I?M3*L+X_Y9CF`95=X^1L-2A;M:RFE
MRXCRQGP<8D>!UI#X&)`:CLJ*BJFORN]C&6)&1@,23:.MY"5?V2H`^&E4W>G'
M\I5U(OSPCVEOX\N%<RF`Q_LD*FJJ&:.0XJMG`RF+20H,1*IXE%0F"SRCEOYE
M5M>;?&AR^BN-:CNSVZ$=KZ[;K2BVD>=JY4=/S(*B2>]-R>SLJTO(?6W$<KO%
MR6IR&;55=P8V<J%6-0YL644LUE.2JF:Z3@169R.\MN#[:;[MH*;)J*DX*#)D
M_4+"@2;J`.BC^KOM7G#(;)Q<Z<9A4MOJ5=:4\%'GQU3?G;[ZD/1TE;CE17T=
M/&&)65D<(L2.)$?!L-U4C<-2<===,E,S)5(S)5555=2Z$(;0EMM("$BP'8!5
MJCQV8K#49A`2RA(`'8!6CO:CN6?T'T7G?9E32S+RWI:MUJGC1HARX\6UFMN,
M0+.V$!+Q4]?)47)!E]O%.*JG+?7UP!/8*FL+CTY3*0X*W.A#BP">=N8':HC0
M#F:\YL6,.4S;3MGNK*@[*R'+<;CSCREZ_&QL<?N+JS8B-QJJFCW%:4:5CE>;
MCK4'Q-02B-*B"H(V25.0XW);>E9-[JQJF@`$FQ;6I838I"@I;B$^<I4+?B`%
MK&IZ?EI;CZ<5AH_TR&GR0V4V2MM*"H*6HI(LM5D>I=2KD:C5-2XZDZ-[C[5+
M%:/%:9FTP&!5PDC]L9-4W%1CM5;Q)]T[%RG#6[0*6_OG(=!9,UWX_P".<.4]
M$95\";C,.CS1$SE)B1&4I=AM-)LZI*TA+B2NRVTJZ5FS:@BRD]*BD$W`%0+[
M<52I4MXJ9DNN*ZFDJ2HJ;(1=#BD]21=:2NZ5=0"B`02:O!ZMZWQ[J/`L;Z]Q
M9MT*;'(2QF7)!DY)ER7WW9EA/D&1%_?GSY#CI(B\04^(H@HB:L$=AJ*PW'93
M9M(L/T[ZZ#SKC[BWG3=:C<U$GV6]QL>P"LL<>Z_N8DO)&W3A6F2-M)+K,<<!
MSPN1H2.M.,7%XXY]C8-"\TT7+EN8\-4O<>[T0E*QF&L_F%$C35+?:5<B1V<!
M^:W`[/[?>U#V70C<>[^J'M)L!=U72M\'@$`>8).GFM=5P&[DW$%/7#H7L;WA
M[5>EVDNX@]6U=Q&LNR,NG<GIEP7(I?[4$@U'SV]ND<66FA-0AL%YC%5`&]?6
MQ-BS,WD/YUF5^JYU@K6K7]U'*_(G@!HG0:]SW;]W<9MG##:.T6/IH0:*6VT6
M23K_`'CA_$`=5`$E2SJO4BWJ%QW'J7$J"FQ?'*Z/44&/5D*FIJR(*A&@5M='
M;BPXK**I%P98:%-U52+;=5555=>FFVVV6T--("6T@``<`!P`KPL\\[(>=??<
M*WEJ*E$ZDDZDFNYU]UQ4TI32E1B]S5OA]7^Y2QPC"Q3$G/*K9<36G6="3(!'
M9EXBY42R?A$%5^G(?KJ%W%ZO\DR7H_C](_+\W^[>I?`^G_.,?ZOX/4'SY?;:
MJ4_6.NKV<+LK-EL%L9MV_'F/?"N>"&Q'6(QO]1;'SF>WZJ:KJY>RL6*WM5Z6
MT@?5.R5A9Y^4#I'@`;CQ-9G[XRY;N[6(CJS](U%06QR\Y/41WDBQ\!4I:>TD
MTEM67$-=I57/B6$?<B%%=B/@^`DH*)\#(-BV7Y15UK<AA$EAZ.Y^!:2#\160
M1)"XDF/*;/\`$;6%#X&_V\*M<Z^[2Q+L2MC2*BSBA:_CMN6-"^\#5I`>7B+H
MK&<47)$87EXB\VA-ENGSONB8[D,7,QKJD2&CT7T5;RJ\#^KC6_8K-0,NPAV*
M\GU;74B_F2>8(X\>?`UK>U<&G]F\9<5PQ3*\$FUW$GVA;)ZO*RG((MFHF7V5
MZ?:.ZJOW)\(6I!JSNVI*3Q:DI/\`M"U1+UV=XPU#@]$4D^*234D-5ZK97Y,P
M:`W'#%MML2-QPR0```12(S(E01$13=57X1-.&IX4XZ#C6`4O;75F27SV*X[V
M3@=]DT<G1>Q^GRZ@L[ILF!4WQ*LA3WIB$P`JIIPW!$7?;9==1J?!?<++,QI;
MP_*E:2?D#>NTY"F,MAYZ(ZEH\RE0'S(M6P==NNK577\FG?5_U[AF*]88=<3J
M6Z[`.;97]A6/N1+!K%:AQED:^/,CF$J,ES9O(+BMJ*N,1W&E50<,5H^]LH_$
MBQX,1PI>?)N1^+I%M!;4=1-O`$<ZN.T,:Q*D2)DI`4TR!8'AU'F>1Z0/F0>5
M0+ZKZ4I,?K:G(+Z-)DY@ZC=DLE9TR,5-(<5'FFX?X<EE1F1T5.3RJ3GDWXJ*
M?&M<V7[9X7#X^+)RT)$C-+2%+4OS!!.O2@'0=/`JMU$WU`TK#-[^Z.<S.2E1
ML1/7'PB%%*`WY2L#3J6H>8]7$)OT@6T)UJX3UJ[;N<M6RQ#*9QV5G`CE955G
M*<;_`#)4%'6VI,*06PN2G8KCJ&#B\C\9*A+]J+KM;GPK$#T9<-'2PHV4-2`>
M(([B/M'?7-LW<4G)^O!GN=<E`ZDJT!4G@0;<2#;7L/=4H[FL8NZBTIY2JD>U
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MK!5O`BY\:\\5X%_@^8VP1I<ZILHLZ4K4J,\[&=>AR'2=:/FV0H]&EL$*D*[@
M:+LJ*FZ:E8:X^0Q[)*4K:4@`@ZZ@6(^!JOY%N9B,O)"5J;?2X2E0-B03<&_8
M1_0:W#U)E&0Y9FEI/O'_`-Q?_P`?"",DF&8[,02L(B--M,PVF66B?^]2XBBE
MQ4EWVU7]PQ(L.`PW'0$#U;V'/RG77LT^=6[:$^=D<K+?F.%Q08MU&WE\P(`L
M`!?7AV=U89EO6N09YF^9P8]`C]7)M9,:>5FVV%8<29]A>9)*<)3,A@E,@`35
M0+Z?*:[<;)P(>)AHD/!2BW^$:D]Q'+LUM72EX?,S=QSI./:4TI#X(<OT])%B
M%).A)TZO+<U41[D>F&0^NL^/EM"9W_6%[(1D+%AAP3Q2W>52&CM1-Y]S\23\
MK"DJNSB(K1[."*NUA,II]Q8;04"^@)OIXZ<*]:[1S[F2A-0\B^E67;1YE`=(
M<`_.!K8_M`:7U``-A"6CH[C)KBLQ_'ZV9<7=S,8KZNK@,G(F3ILDT;8CQV01
M2,S-?^A$^5V1%77*2`"2;"K:\\U':<?>6$M(!))X`#C5T_KWU"QZSPX%S3VK
M5EV9<5`!E]TD!E^MJBDFW*7$J9+!@R-JN00&8]Q!9$D?C[`!$G\=B69+"S/9
M'6572`K4)'`^4VU-_A7D_P!Q?<F=D\HTSA)*T8AI)%BFP6L\5*"A>X%@`?PZ
M\R:L@QON'#LJJS@9#(:I)\MK\"7!E^5(DL)32L/N1YS;`16634U11<)LA0OC
M=$54B)FWIT5TO1/.V#<<`1SX$\JZ&.W?BYS"8T^[3JD])!N4FXMQ`YUO#$_7
M27$Q+]XJ>OG'<0E/.(]E=Y%BA1.NC*_$4)6279,5;0M2Q\0B3PBCB;(G+??K
MK3G<@$SU!89&@7<(0-;:&X3QTX\:[;:]KX<KQ:"V9)U+=BXZK3JU392CIJ!:
MUJW'V#T'9=-X;BEE?3,;AR\KF2EIL:HG8\U$IHT1E]^V*;6DY4''-^2T`BT1
M\N?+DORB?66P\C&Q8\B9(2J0ZHV`/4>D#4WN;B]J^<!N*)F9LR)CH:T0V$"Z
MBGI'456"0FP(-KGX5YVOY"?7'#;2]G]D=31A:S&,3A=BXG5P$:@6:--`97]:
MC:-,C>L@B_FL-B7Y2;N?#XFC_P"PL?D%Q522W>/:XN=2.=AQM^@O6H;9]QL1
MCY[&V,G+L2H(0LCRMD\$+5P`.@2>"3H;#44ZZ^:VJK!?6'UXX?M_9F<PON_M
MS,2HI3?].Z(<>_L&B7;DJ+RBM$GQ\.K\\-K%B<;?IE2$Z?E!^\_J^=>;_=CW
M+_ZG:NWY':F0\D_`LH/V.*!_J#\U>@+KC(X&4XI3NA+&3/@1(D>S:\BK*CS8
MS:-<GP0D<V?5OF*KNABOZ_*:J64B.0ITA"FR&U*)3V$$Z6\*AL'D&<EC(KJ'
M@IY"$A>NH4!8W\;7[^-:/[NH*:T<3*L=F1K*P!8\?((U;)9FDU'\"C"L7V8Q
M..1T06D;(BV%4X_1?K8=N2WF/\%*24-&Y05`C6^J03QXWMXU4-Y8^-*MDX"P
MY(38.!!"O+;RJ(%R+6M<Z6M7R]<^MKS,\MKK"ID`VXW9#3P8:(X3]I93V%:9
MAIP`T!HRD`FZH2D2HFR?U)W<_)]0-XEIKJD/6MV#73XDBU1FTX194]GWGNB)
M&ZK@<3Y=;]@`-SVVK*;'UIRW*,^LH-6\ZX]:V4G\:LC5=A9Y$5FZZ9/UR4\=
ML'77FG4-%XGR1!^1^-=.%GE-L,040'%SD^7I'=\";]HZ?C4CDMIH>E2LHYEF
M6L8YY^M6MNK7F0FVNAZOA6SL0Z8<ZG?D1+^MFQ\NV-N8Y:5\VKEQXKIH;4=N
MNG<78P&`BI$J;FJ?7;XU#9O(S93WHOLK9:38A"A8WMQ-P">ZK'MG#XV!'^HB
MR&Y#ZK@NI((M?@+$@<K\R>-6)?X!F7_RU[_\IG[I_P"'>_\`N[_L?\O_`,5_
MM_5J:^@F?LG_`.E7Y\/Z>ZJW_-,?^T/_`*];EQ[?"O_5]P_L?TQ4]_=-9QUC
M9M14DWE0\>/3Y+0&M/D\':906;3A`3C",6+("Z0;$4<W`^A*BQF8QK66QTJ`
MZ!9:38]BN*3\#:IK;V9?P&8@Y5@F[2P5#]I)T4D^()^-C7CAR&AML5OKG&;^
M$]6W>/VD^FMX$@5!Z'8ULIV',CN"2(N[3[))O]%3Y3X77F23'=B2'HKZ;/-J
M*2.\5[=A3&,A$C3HJ^J.Z@*2>XB__?73ZX*[-95C&76&,N@#8G*KE>%TXPNJ
MW(B&B\E?K'%(6VG>?W*V2B!E\H0+NJP.5PB)RA*C.>E.3P4-`2.%R-01R4-1
MWZ6O>UMZ.X5M6,R3'U.$<T4@ZE`.AZ0KRE)YH.AY$:WM5Z#]Y)U;#B5&=.2,
MRQF.RD5F[AHCF853H+_;9M6YTJ.-FT(;(OE5J2(IRY.[HFI'#;[F8UQ..W.R
MKI2``Z`2KQ5J>L?UDZ]Q.M0N[?9/%;BCKS_MQ,;ZUJ*E1U*"4:Z]+9L"TH?_
M`&;GEUT4D``V88MF>"=K8X_,QNVK<FHK&._`L(VQ(X+4EHF94"UK);;4R&;K
M+BB3;[8*0%OLHJBKJ<*=$R+")4*0EUA7`I/V$<0>T$`CLKS3EL-EMOSW,?EX
M+L:<V=4J%CW%)&BAV*22#R->5+W6]3\@]7NT)L%B)-E]99-)D3^O\D<3SM.P
MRV=D4%C(:9::9NZ8S4"!4%764!T=T)>/VXCI-Q^&O0>S-T,[@QZ&W7`,HT+.
M)X7Y!8[01Q[#>_*\XOXL?;?/7<_JO6O,[*5DN*W=5=/X+,L')<VUQ>PH*IZX
M.F9F.O.(.-/U%=(\;)#M'?$$;40)1U]MK)\IY53?<?:T*/&5GX2`V[Z@#B18
M)5U&P4!R5>U[<;WX@D^@77+6,UQ)\"#:0Y5=9PHEC7S6'(TV!.CLRX<N,\*@
M]'E19`.,/L.@JH0&*B2+LJ:5])44D*22%#@1QK5-5Z\]"44T;*EZ4ZHJIX&K
MC<ROZ]Q.+):-5Y*;+S-2!M%O\[BJ:^/3;ZNKTT]7;87^=<KDF0]_?/K7_:43
M]YK(<[[)P3JNE&SRVYATL005NOKV@\MA/)M$08U551A*3(5/A%401II%W,@'
M=4ZF0R4'%QU2I\A+;(YGB>X`:D]P!J3P6WLSN6>WC<'CUR):N2>"1VJ4;)0D
M=JB!\:J:]C/>2ZR3SX[B:V&*X^\VO"#"D(UE=TR39-N%=SXL@XE16/$:BC#1
MD1HBKS=^0'+LENO+;A4N+@$*CX[@IU6BSVVL3;P%U<+E/"O2>W_;':^P6V<G
MOEY$[/'S-Q6_,TFVH*@I(ZC?\R[(&H"5D7J/OJ]ZV]C>XG94:L;5VNP/'IM?
M)SW)6T)NJQJH?<,SKZGFVZ,S*K>*PZW$$T)>6[CG!D21+/LC8HG/W;21&!!=
M=5^)6NH![['0:=I)UJA>Z_NZ]$C=+SB?J5`AB.C\"+"P4H<#TW&IU[`!I7J8
MZAZAP7H[!:?KSKVJ&LH:AM=W'$8.RM9KFRR;:YF,,1DG6<LDW-S@*(B(("("
M(IZ2A0HV/C-Q8K82R@6`_I[Z\3Y+)3,M,>GSWBN2X;DG[AV#NK9NNU71II2F
ME*:4KCRHD6?%DP9T:/,A3&'HLN'*9;D19460V33\:3'>$VGV'VC43`D42%51
M45%U^*2%`I4`4D6(/.OT$I(4DV4*KWF>A\3'\YR&]ZORR'CN&91^193<&M:M
MR1'IL@(W#!S')\%QC\.E>$D;6,XRXK`_(&8B#8\^U7U[5E31$`5BI"NM31T*
M%\.IL\`"-"DCD+'2U1F\,:UNZ-"5)46\M'3T)=&H6CCTN)XW!U"@>9N#>NM=
M]5.T0=<`'<6>`#$6W@MY8@Z)%LIH+M4VX"`GRJ*F^WTW7X71D[QQA2"IIX'L
ML/\`BK+E;`S(40EY@I[>I0_]VN^I_4O/%E1W;')<;J0;<5S\BN>M;&=')LU\
M+K#10:MLG%1.7_/!1W3Y5==9_>,%2"E$%:P>2ND#_P!ZNY%]O\BE:5N9)ML@
M\4=1(\/P??6P7,"3J;L3J"WEY??9*Y;6MSC4^1?NJ]%9*QKO'!&L;=>>.M;.
M7((C!7G>9;$B_:J%$_7C*P,NRB&TR$(2X`@6)Z5:]1YZ=PJ;&+.#RF!?<R#[
MZG%K:47#<#J3Y>D&_2+C47-3#U4JOE0+]S,D=NXD7J9)L^'26E>W:94W5V$J
MMDV\5YZ0S#I9<F)X9(U1K'5UYL'420O$'$\:$)VC";9@9V))5E$*7%ZNGI"E
M(OI<W*2%6U&EP#SO5(W/NW);?EQ6<0XE$KIZRLI2LBY(`2%@I!T.MB>RU4]]
MH="5]!4.Y3@3EA$D4J+.F5QRWI!_C,*CI3*V27_>V94+CS5%,N0#N*H2?=3M
M]>T^.AXM_+[70MI^.DK6T5*4%(&I*"JZ@I(UM>Q`TL>-EV%[O9.;E6,-NE;;
MK$A00AT(2@I6=`%A-DE*CI?IN">8X7,>@7=MYW1T8R>66!VF5X+<O8C:6<AP
MW9UI#9B1)U-96#KA$;\UV%*\+CJ_+QL*9*ID2Z@=I91W)XI)D*)D-*Z"3^:P
M!!/?8V/>+U==SXYO'9(AA-F'$]0'9J00.ZXN/&U:O_D8]:,I[?QO&^R<`A_N
MN2]<P;:/;X]':DR+;(<=FR(,II*6-'8?_+L*.2T^[^/]A/,ON<5)P`;/I[OP
M\B>U&GPD]4F/<]/-0N#H.9!%[<Q?G:NSM?*QX;DB#,-HSXMU<DFQ&IY`@VOR
M-N5ZBGA^20LJQZLN(;P&K\5H9C*$GEASVQ1N;#D-[\V7HT@2%1+9?C7I7!9>
M+G,5"R45P%#C8)%[E*K>9*NPI-P0;<*\GY[#2\!EIV+EME+C3A`)%@I-_*I/
M:%"Q!';6>45[:XU;0;RDFO5]G7/"_%DLK\B2?!`X!(K;S#H*HN-FA`X"J)(J
M*J:[\J,S,8<CR$=32AJ/UCL(Y&NC#F2($EJ7%<*7D&X/ZCV@\QSJ9>)^VSCX
M,PLGPZ5+L246VW\4<1U9KI%L@-T\]Q'&3X_3:4[S+]!35%F[.+9*XLY`:_\`
M$TM^\`0?D*TO';_2Z$MS<<LO_P#A>:Y_LJ((_P!HUF?K58A*=[3C)%GUQ?YN
M_:#5VC#L6P@L6@O>-B7%-]\(\EM8JBX`JJB0_*JBBNHW<:.G^5'J2K_#A/4D
MW22DVT/,5+;1<"_YVD(6@?5J4$J'2H!8N`1R/=4HM5JKC4'_`&;]L<EZDG)B
MG5G7:=B98$9'[:QF3ACXUCANJ:,09$>-(8LKJU(0YNQV7(XL-D*DYR+@G#-A
M;G5'2[@\"N3?\Q4E*1X!2DJ7^[IWWTKX8RVU&)1CYS/HCK'Y0E:U?$I2I*/W
MM>ZVM1QZ)_DOF7^;5_7_`'OA59A\RUL&*AC)\?\`W&!75-G)/A&9R*BO9<^;
M"AR#<;%9+<H_"1(1->-2-NF0]V26<B<5G\<8TH*Z3H4]*CP"DJU`.EC<C@>!
MN+G(VW$D8Y.5P.0$F(4]0L0KJ2./2I.A(UN+`Z6XZ5;=J\U3Z:4K$,\PFD[$
MQ*\P[(&!>K;N$[%,^`&[#?VY1;"*IHJ!+@R$%ULO^T/^BKKK3(C,Z*]$?3=M
M:2/#L([QQ%=W'3Y&+FQY\55GFU`CO[0>XC0]U4*]Q?QV=LWF5-1&,9L+<XRE
M&@Y+C<FI_;;:N\Y>#\S]RE1EKGPW5=GU;5ODOR8[%K.(^*W'AGG8L6(E^.HW
M"KZ=E]2+'M!^%;#,SNSMQQF)TZ<J+,0FRDV)5VVT2H*%[])&NNHY5KKLGH++
MO5;'4>R#!ID6O98DRFK*(_%LH]U*9`]Q=NX:O1AEBR1GXG.#C;**HM[(J:B,
MGBLR9S(RGE]502E5[H'<+</`V)^VK#A,[MQ&+E'!W7Z""M2"+.&WYC?CXBX'
M#305!VR[[S*1;+-K4AUU:(B`4[K#,YHMMU5Q^633$LW25?\`@)L41$3;Z[S3
M.UX*6/3>4I3W[0-O@!J/G>JS(WSE%RO5C(0B/;\!`5\2JP-_`@5EN(9@O<)Y
M#UYV'34MWC.1T4UB96E#,&'H_P#;!Z.XBO&:B3;G('$5'6G0$P)"1%2(S.$C
MX^,U(BK7UA8!N;\>!&@UN*LVT]W9&9E"AWH0XA/6A2`1TE)'&Y-Q8\_CH:LZ
M_C%_A^Z6]9XN;=K]CXDYFW8.<S[.OPJ%V#50GSZVZW?\11X%=7N$^3&56SBF
MDJS<%F9^*VVVT$=#D>>X;>P#9A>OEH@+[@MTK`(">1MR4>.NHX"VMX;W.]VL
MOG9,7%X:?Z..C@%:FE$>L[S)5I=M/Y4"Z2;DE7EZ9>]I_P`=N#9=)G2\1NH]
M-%DF4@,7R*E:R&E:?XHB-PYCDAJ;#84DW3R!*(=]D79$1.*9LMOU5/XJ<J.H
M_EU(\`H$$#_:JL8_W(=^G1%SN,;EH'YM`?$I*2E1\.FJ&<G]<\AH>Q+*)&ET
MK=74Y1(8>;:=D"40*^Q()###115!T&S9(6_E$5-MT3Y1(%>?;8C/PI*5JF("
MD$BUBH73>YL?LJTHVD]*FQLG"<;1CG%(<"3<*2DV5:P!%^7&U7J9QC"+_'YC
MX5JR8#T"NH<CXQQ-X)$JSR4UE.SP0E%R*CEP4C8_M$FP39-D1)>7'`V/&L#9
M*4+('.Z[F_=K?Y5`0):C[G3.H@J6MUL$_ELV0DCO\H'?<U1=A/:V72<R9P[.
M[>/*:KW+*LAR'0!A&)P/$H165;\$5N-(<$^"(T*D9)\[K\P.4Q4=6.;G00YT
MA*3TDE0"3QM>Y%N>MN-6G!9Z8G,/8K)EH+*E`K"0DJ6#H"18&^H&E^`K77=N
M'-4%^EW!<)V#D+\I]X5432)9HH.R6>8HFP/H]Y`%?E/N_1$U);<R!DQC%<`#
MC0`'>GE\N'RJ$WEB4PIHG,DEE\DG^JOB1X&]P/'E6B.G/0#$NP^V6>VWZQN9
MCT5JUNEP)&FBK[7(:9IRRE7;K!F(.4\*+'=D.P414?D-I\$TIM%$YMMM,M<>
M$D^MTE2@.``!4;?#4BWAV5JFU-^YU.TD0LBZ`CK#33Y)]3H)Z`DZ<0;)2X3>
MW$7'54A0]?,RE6%DRR]5L0V''2A27WW7%F,(IF)BS$CR'6$;:3^YY$'C^FZ?
M.I-.YX8:9"67%.]/F`'"W'B=:S!S9&1+\DKD,H8ZCTJ4H^:YTX#0]M^?"]2"
MZYZZ@X'`+[BD7<YID+64CKA,*;2D2,16R!K@PV9KLI#S7]5_357RN4>R;X!'
M2RDGI%M1?M[ZO."P<?"1B4GJDK2.M5[@VY)X::Z<^VN1ZU>LN;=C=RN1D&56
MM3K6:7Y,(4D,Q*65-,IEY;,QB-MFM8CDB`P]P5UXA%4%=M[*M[^>&)B(0ZN!
M<7;1`'$CO[#\.=4MN,=KC(;@R:NBW4&FPH7<*C<`V/#M''B3P%[187\?V88!
MGM#.Z^N<7E8VUDE=?2K)]@J&Q@/1)D>4\_*JH[<UB8^@,(C9,N+Y#3[A:3YU
MVG-H9-O(1'FIP=80I-E*)"DA)O:VM^ZQ^`KHL^X6%=Q,^,_C%,2G4+!2V`4+
M4H6O?RD7YW'Q-6J!24S=B5P%16!;&"M':!`BC8FVJ;*V4U&DDD"I^BEMK1`T
MT'/5#2?5[;"_SXUD)?>+09+RO1_9N>GY<*X&08ABF5M-,Y/C5#D33)@XRW=U
M,"S%HVW$=!6TF,/<-C'==MD7Z+\*NOA^+&D@)D1T.`?M)!^\5RQITR$HJARW
M&E$:E"BGNY$5VG[96_\`R^#_`.!_;/\`PC'_`-V__+_^7_X'_P#5?\O_`&UR
M>FW^P.%N`X=GAW<*X?5=_P#M%?BZN)_%V^/?QK__UO?QI2J2OY0?3);J)/\`
M93K*J4[F"V+G:]+$_.D2K>`TW%AQ,N@1E<?9!ZGC,"$YIH&T..GGV4@<4LSW
MYM@S6_YO`:O*0/.D7)4GM`[1S[JVOVJWNG&O#;V5?"8+A_A*40`A7$I)/Y5<
MNP^-4&(J*FZ?*+\HJ?14UBW#0\:]*\=1PK^Z4K[19,F#);F0I#L26TBH#[*H
MA()?U`8DAM/-K^H&)#O\[;ZX),6/,:+,EH+;/(_J(U'P-2&-RF0Q$E,O'2E-
M/CF+$$=A!!!'<0:VMB?<608Q.BV:.38]G`=1V)=X_(6!9M\5%00XZ&TRZNZ+
MSXN@!I\>+;X6N_R&7`D"9@IZF71P!/V7UN.Y23WDUH:=]XC.P#BMZX)$F.K0
MJ2!\#TD@I4.:D+![`*F_C/N_<Y!6GC'8\/"^V,8M63C66/Y56PJBXF1S'QJR
M'ABA")!'?[G*]\E)=T--3$7?.X\82G-8SUF1^=(Z#_M)!0?"P\:K4WV;V'GB
MW)V3N94&=Q"%++@'@E:DO)-^?6H=@K:71&:>DG4V52\NPWIVWZORVVA.5\RZ
M1RSR>OBQ9)B_*B5A2,BLW:YAYUM$)6(,?F*(*_;]NK-!]P]NRCTNJ<CJ_KIT
M^:"K[0*IFZ/:'W5,=MEV8UDXB#=*6W+*[+E+B&[FW]95NVIMI[3="JSY_P#U
M!A<=M^"U5^CWTWV\'[5YM_\`;CJ:_P`V;;M?^<L6_M?JK./_`$M]PNOH_P`H
MS+_V-/G>U:WOO>'J"J,VJJ%EV2N)OQ=KZJ)"A*NWQR>M[&!)057]19-4_P!/
MTU$S/<';D31M]Q]7_AI_6HI%6G$^PWN!D_-(B,0T?^,YK\FPX?G:H@]I?R'9
M._\`D1</"GPUAH5`FXJQ\MRLW-Q1/F5';JX`.)O]KD15%5^'DV^:Y)WQG<GT
MMX+%^BV?^8YYOB+@('^_W5H&.]F-E;;ZY&]=RB6^D#_#L'HUY@V475=Q'I=]
M5W9GVWE>8VDVTD3I:R;$C=G6ED]^==RW'%W^7C(XT%L!511MM#XIMP($3;40
MG".S)!FYR6J3+)X7(2.[D;=P"1W&K,]O:-B(*,/LK%MX_&(%NH@%P]^I4`>U
M2BM1XW!J7'IQ_'_G7LE*;RS)RL,%ZHBR83[]_.ARPM\R;=>1V3&Q))32-RP*
M,V0NV!FK+)N`HH\2$":]M;8[V2")$U!9QZ;63:Q5X"V@[Z\S[\]T6,.MV+CG
M1)S"[]2R>I*#VJ-[E5];:C2O3)UMUMAO4>%T?7^`TS-'C&/Q4C0(;9N/NF2K
MR?ES9;Y'(FSI;BJ;KKA$1$OZ(B(FX18K$*.U&C-A+*!8"O+\Z;*R,IZ;,=*Y
M+BB5$]I^ZLZUV*ZE-*4TI32E-*4TI32E-*4TI6D/8%F0U@'^0PX03IF'W]#E
M#+1(//C7SVP?X*0%\*S(7G]-@W7]-EF\`M/\P$=9LV^VIL_O#3[;57-T(5_*
MS+;3=R,ZAT?NJ%_L)K;T*T@SZJ)=LO@-;-KV+1J2Z2--C"D1AE@^Z1J(M@C!
MH1*NR"GUU#K;4AQ32AYP;6[P;5/MNH<:0\E7\-20H'N(O?Y55[WKFU;GG8,^
MTIT0ZN!%CTL.8A*J63<%R01SP%41`9?>D$C7ZDT(DNRJHIJ^W(#V/QR4/Z.K
M5U$?LW`T/?8:_*L.W;E&,KEEN1M66TA`5^U8DDCNN=.T:\ZTK-IKN_K+JMQZ
MCL\CM7*2U<8J*B#(L9TI`A.HHA%C`;B@I$@JJ["BDFZIOKM9N6Q#Q4]U\W3Z
M*P$\U'I-D@<23PL*Z&!@R9^6@,14GK]9!*N2!U"ZB>``XW-3Q]&N@+OH#IH*
MO*R;#+LPM/\`*[Z`VB+^R%(KX<2%2.NHJH_+@QHV[ZC]@O.&([H/(O/.V,2Y
MB,:&G[?4.*ZU#LN!9/P''OKU%N+)MY3(%QF_H(3TI/;8G7XU,S5BJ!K%K'!\
M,MQD#:8GCD])3[DN24JEKGG'I;S;#3LLW3CJXLIQJ,V*N;\U%L4WV%-N5AYZ
M*HKC.J;43<E)*;^-N-<$F-'FH#<MA#J!P"P%`>%[V^%8NQTIU1'5%#`\?/9`
M'C(B++!4;)HQ16Y1O`6ZM)RW1>:;H6Z$2+W59C*J%CD'?]HC[JCD[?PB3<8I
MB_>@'[ZS:HQK',?1U*&@I:5'RY/?M-7"K_,7S]SJQ&&E<).2_);_`%UTG7WW
MC=YY:SWDG[ZD68L:.+1XZ&Q_52$_<!6H\49E4/>/8]4<E"KLLHZ'+X4=P>!-
MR8@A2S4CJ""VXA.B9.*J<]E!%WXJNI>59_!XUX?B:<6V?`^=/Z[5`PKQMRY>
M.?P/M-NCQ3Y%?JO\*WOJ#JRU3!?O.R+Z[??<%U]^WLGGG004!QUV:\;C@H)&
M*"9DJILJIM]%76WPDI1#BI2+)#:?N%>;\@M;D^:M:KK+J[G]XU#OV?Q6`Y3U
M67-M`U8L3FZ>8Z*;+,AR67WHXO)]#.*ZPO%?KQ-4^FVV+>]N$BNXF%GD-@36
MG4MJ4.*D+!L#V]*AIV7-;=[%YV4UF)NWUN$P765.I2>"5H(!([.I)U[;"O0S
MTS.M[/J+J^QON2W4WK_$)5H1@39G-?H8#DAQP#=?-'''"4BW)5W7_JU&XXN*
M@0E._P!X6D7\>D7JVSTH3.F):_NPZJWAU&ME:[E=2FE*:4J$'OU7K+Z7K9*1
MP>&#FU2KQDRCBLQY5;<1B5245\;3KQM@6ZHA*HI\_&J=OA"E8="TC\+R3X:*
M%:)[9.)3N%QM2K=<=8`[2"DV^0->4O*8@P,DO880W*]IBUG`S"=$@..Q^09,
M-\2^4%&5'C]44=MMTU\0'/5A15EP*46Q<]IMK]M,LT&,G.:#10D.JLDZ6%]/
MA;AW5)7TOR*!B/=]!DMM51;:JI'(EA8,2!:-1C,6<%3-H7442<!%YI]/N`?E
M/KKHYB0U%7C)+PNVB0"1R(L>/AQ%2VW8C\YO-PXYZ7G(B@%<P;BP'.RN!KU]
M,NMR&FGV3%QEYL'6G!7<7&W!0P,5_42$D5-:""%`$'0UDQ!22E0LH&OIK]K\
MK0N6^L?1V;6S][>X'!6UER$E3)=7-M:/\U]34WG)<>GG0HC[LHE577";\KBJ
MJJ6Z[ZA)6W,-,=+[\%)=)N2"I-SWA)`-^?;5E@[PW'CHZ8L7*+#"18!02NP[
M`5`D`<@#85Q?8:UQ7`.A<MB3*1UW'RH`Q*NJ*EMEH(IV325E3Q5Q4;C1(#R@
M:EL1(@?"*2IKYSSL:#A):5LDL>GT!*>5_*GP`TKZVLS-R>YH"FI`$OU?4*E$
MZ]/F5WDD7'QKR%Y<%GD>=Y"D2F?2P?M90+65[+\IX2C$C!N<`$G#-WQ>0R1$
M'D2JB(FVH"`IB)BXI=DCT@@>91`&NMOA>PJU99$K(9R>&(:O7]0^1()/ETOI
MVVN3PUJ:7IWZMYOVQEDK')Y)35MG$=<M8]Q#6?7Q:V)N;UC9040E64XXHLQ&
M^;1FX>Y$(;KJ,>"<_/CPL8L`M@J4\`?*.P6M>Y^%_B:FXQ7M/%3,EFFU*2Z0
MA,<D><_M*O<"PYVO:]QJ!5F'2/IKVCTMW'A+=?25;N$8_:OS9>15]NR[5G53
M&9@64<XEF^%V<J8U*-E658,=W-N7C133GA;?SD?<$>7)*7&@KS.`BQ3TVMTZ
M&]M+6^/.NODMV[8E[3EX^&%M/*39+1220KJ"K]6J;`ZWZK]U]*LY@=6=;53U
MI(JL#Q*J?NH$FLM7:R@K:\YU?,#QRXCZPX[/)B2/_,1-N:_*[K\ZO:,=`:+J
MFH325+!"K)`N#Q!L.=98[E\J^EE+V2?6EM04D*6I72H<"+DV(Y5''`?2+J?$
M+V;=W13\W%)ROT-9><6JZIC(0.--S8\0P"]EMF*HIOHC!`NRL<DY+`0=GXJ(
MZIUT*>\UTA?!(\!^(]YT[JMF3]P\[/CHCL%$<=-EJ;_$H\S<WZ1W)U'[52_A
M5U?6M^&N@PX#6P#XH45B*WQ:;%IH>#``.S;0((IM\"B(GPFK4A"&Q9"`D=PM
M5%<===/4ZXI2NTDG[ZYFOJOBFE*:4II2O__7]_&E*:4JBCW@_C/FO3<C[A]=
MJ\9"3)!6N0]2U\5MDV7'!-ZUML/<<EBV;;KZ*Z56#8J*F21OM064RO=>Q?74
M]D<,@!TZJ:`L">93KH>[Y5NVP_=+Z1$?#;C<)8&B'R;E(T`2L`7('[5R>VJ,
MG6G6'76'VW&7V'7&7F70)MUEYHU;=:=;-$,'&S%4)%1%14UD+C:VEJ;<24K!
MU!XUZ&:=;?;0\RL*:4+@C4$5^-?%<E-*5^3`'!4'`$Q7ZB8H0KM\INBHJ+\Z
M5^@V((XUVD2YN(.WXEM9,B*((-?F/NQP%$V1&XL@W8H(B?Z`FH][%8V1J[";
M)[0.D_--C5@A[KW)!TC9E\)[%*ZP/`+Z@/@*['_,,J5-ENW]O]HM<B__`*20
M^7_VZZO^7L->_P!%_O+_`.*I,^X.[K6_FW_X;7_!762;>WF*OY5K9/B2*)M%
M.DC'-%394**#@1EW3_W-=MK%XUC^ZA-@]I2"?F;G[:B9>Z-Q3;B1F9!2>064
M`^*4=(^RLHZXZOSOM;(8V'=:8I8Y5?OH"M5=2TTB,M..<$?E/O&Q"@1$+=2=
M>-ML415541%5+!CL3D,L[Z,",IQ?/@`/$FP%4K,Y_$X%CZK+34M(/"]RI7@`
M"3\JO9]5OXJL=Q%RFSGV'>B9;D+8!+#K1A&I.*U4I"9>8&]GL/F.1R8KC:H;
M`*L`T51)'A76O[=V%%QY;EY.STKCTD>5)^9!(^5>=MX>ZT_+AZ!A.J/!)MU@
M^=8^0*0>SC5Q\6+&A1H\*%'8B0XC#46)$BM-QXT6-';%IB/'8:$&F6&6@00`
M401%$1$1$UH@````TK("2HE2C<FOOK]K\II2FE*:4II2FE*:4II2FE*:4KI,
MDIFLAQ^[HGN'CMZN=7*ICR$%EQG&0<4?U\1DA?\`5KE8=4P\T^C\2%`_(WK@
MDL(E1GXR_P`#B"D_$6J"%-A_='9^.)AS.244'&\'L?\`$)E:4^=$=?<JRX..
MVC<6!)=LQCMH'A%PT:+BBH`D*EJ]/3<+BI?UAAK<E/)#@.E@%Z^6_#7NOWUF
M<?';BSD'^7_S!MN%'46BG4*)0;>:PN1:UA>W=>MCX_ZB4L28T_DF5R[F*`[N
M5\"M2H1QS[OM.84^<[XD^/Z0`EV^J:Z<G><I8(BQ4MGM)ZC]P'WU(0_;V$VH
M*FS5N]R1T#YW4?NJ2>'8#B.`07:_$Z5BJ9D&CDI[RR9D^88J9!^993WI5A*!
MI7"\8&XH-(2H""B[:JTN;*G.>K*?4M??P'@.`^`J[0<="QK7HP8R6T<[<3XD
MZGXDUF&NK7=II2FE*:4II2H[=INIB79_4^?*ZVQ`D39N$Y`X\8LL#"MVC_`=
M>>5-@;C27W'B4EV_LBGPBJNI[&`RL;E8(!*PD.I'>DZV\0:J^9(A9?"9,D!H
MJ4RLG066+I)/<H7K!>ZO8BC;J;?$,'DK:6D]I^LG7C&Z5U>PYNS,""ZJ(LZ6
MXTI`+C?]H-^2$2HB:DL'MJ0\ZS+G(Z(Z3<)/%5N%QR';?7NYU$;DW?%88?@X
MUSU):@4E0_"F_&Q_,KLMH.-^51"QCK?.LQ$BQC&+&U9;-&CD!^-"AMFO_"4Z
MQD0H0D(_*CY.6WZ:NTK+XV"#Z\I((Y#4_(7K.H6!R^14/IH2RDG\1\J?FJP^
M\U(JJ](J3(7\:F]I6S=O#HKV/?.X?6M*=-;.1(\@(T.YFR$:D28HOOH9M-M@
M)H*@2D)+K,MVY!C<K<:$6R,>TZ'"#;^(4@A/4.0%[VOKSK7MEX-_:SLF>IY*
MLBZT6P4WLVE1!58\U&P%["W*IZ``-`#;8"VVV(@VV`H```(@B`"*((B(ILB)
M\(FH;AH.%6;CJ>-?K2E-*4TI6&=B8C&SS!LJQ"4W&,;^DGP&"EL@^S'FN,$M
M?,5LT5.<*<+;H$FQ"0(HJBHBZZDZ*F;#DQ56LX@C7M(T/P.M=[&35XW(0YS9
M/4TXE6AM<`ZB_>+CXUYU<ZZO>Q_)YN,9QB4+_(ZZ0<`V+"MC37G?N5L"@2#9
M<67%D(N[1M*H&BHJ:PUYK(XR0Y#4IQMT'@DD`]A%N-^5>GXS^'S<1K((2RZP
MI/%24DI[0;BXMS!K6%!U91X9DME<5[4^%+?:>AN53ZJ#$#RO-NNMMLN-C(;5
M#:1$$U7@GPG^W),RDZ4PW#E#5"KW(LHFUM?GV:UPXW!XR!+>R,$D)<3:P(*`
M+W/3\1VV'*O4!@3<EG!<+9FBZ$QK$\<:E@]OYADMT\,'Q=Y*I>1'47EO\[ZW
M"$%)AQ$K_&&DW\>D7KS+DE(5D9ZFB/3+RR+<+=1M]E99KLUTJ:4K#NP,*JNQ
M<,R+"KE-H&05SL(W4'F<20BB]"G-!S;Y/0)K3;P)R1%($1?A==2=#:GQ)$-[
M^[<3;P[#\#8UW\7D'L5D(F0C_P!ZTL*MVCF#W$7!\:B%U!Z'=;8+8OY#FXP,
M\R`Y"$T)5;<"D5EAPECK802-]ZW<<'BIMR7'&!7[>!)]RUK&;0AQ`E4YTR%)
M/E!_`/W;F_??3NJYYKW"R,\K3C&1#0H64I-BXK]^P(`Y6L>^IH46+8QB[3S&
M,XY0XZQ)-'9#-%45]0T^X*;"X\W7QXX.FB?"*2*NVK4S&CQ@4QV$-I/'I2$W
M^0%4:3,ES%)5+E..J`L"M2E$>'437?:YJZU-*4TI32E-*4TI32E-*5__T/?Q
MI2FE*:4J(WL1Z3=%>R(O6&74!T69$""UGF*_BUN1EXVE:8"S,XS\2ZC,IMQ"
M2V9"@H@D*;Z@,QMK%9M-Y<>S]M%IT5\^?QJV;=WIGMLJ`Q\HF+>Y;7<H/POI
M\+53MVE_$7WMCEC,=ZNO\5['H10S@M3[`,3R<Q3Y!B1$LD6B\WU3FDX07X78
M=U0<TR/MMD&E*5C9*'6^04>E7]'VUM.']Z,0^A*<S#<8=YE`ZT_\7V?]L),U
M]2/97KZU6GR?IC.6I*15F_DT]263U/XJ.N,^4[K&3MZEHE-I?[9O"[QV)11%
M%5JTK:F?B+#;N-62>'390^8N!\;5>X6_=I3VU.L9EL)'$+N@_)0!/PO6NSZ>
M[9`T;+K+/T)=OA,0OU3Y^GW)`4?_`+==`X7+`V./=O\`V34J-RX!0ZAEV+?V
MQ7>5?KUWM=2(L:JZ@[%G.S);4)KPXE=>()#YBVTDN2<0(T!DB/\`YKYMM(B*
MJDB"2IV&]MYQU2$HQCMU<--/B>`^-JZCV\]KL)=6YFV`$6OKKKV"UU</RWMS
MXBI08U_&'[A9"3?Y>`4^*LN;[R,ES+&6Q:)"X\7(U-8W4_Z?.XLD*I]%W^-3
MD?V^W$\1ZC+;:>U2Q]PN:JTSW<V?&"O1D.O*')+:A?XJL/TX5.7I?^'NMB+'
MM>]NP"LGVW67?\6P`29@$(^%TVYV06\,9+J*2&V0-1011V)'/GBEQQ?MO#8(
M<R<@NK!_"G1/Q[?#A6=YWWFR,D*9PD0,-D:K5JOARL;#M!XU;YUMU-UQU#0L
M8WUOAU%B54RTRVXW4P66),XF6Q;&19S^*S;.62#N3K[CAD2JJK\ZT2+#BPF@
MS$CI;;')(`^?;6/SLC.R;RI$^6MUXGBHD\>SL^%;$UV:Z5-*4TI32E-*4TI3
M2E-*4TI32E-*4TI32E1XKWF>N^Z[:KD$,/'^UHC=Q6OR7D4',RA258GPHZEL
M0.30G@2`N^Y$*#]-M3K@,["LN#5^*KI/_P`-6J3\""*K#1&,W%(95I&FH"T]
MGJHT4/%0(-2'U!59Z:4II2FE*:4II2FE*U=W-BJY?USDE8Q"6=91X:VM.P'R
M\5G6[R&`815XDY(;$V>*[H2.*FVZZE,-+^AR45]2K-]5E?V5:'Y<?A4+N&!_
M,</-C)1=WIZD_P!I.H^=K?&NLZFH<!L,7QO,:3%\9AVTZEA-S9L"MA)*8F`R
MB3HWG!KRL$,HCW'=%V+]4VU]Y5Z>W+DQ9$MQ02LC51U'(V\*^,&QC'8$.;$A
M-(4ML'RI%P;:B]K\:W&@H*((H@BGPB(B(B)_LB?":B*G:_NE*:4II2FE*:4I
MI2OF3+1$ADTV1HB(AD`J2(*JHHA*F^PJJ[?Z;Z_+"][:U^W(%@=*UOEO3O6V
M=9)0Y;E>+0;B^QO9*R9(.2+:MBYYFF9\1I]N':,1WMS;"2VZ($J[(FZ[Q\K%
M8^;(8E28R5OM_A)O]HX'NN#4M"SN6QT25!A35-Q7OQ`6\-"1=)(T)21<<:V9
MJ1J(II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2O_]'W\:4II2FE*:4II2FE
M*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*TSWGAL[*\,6
M91"Y_E&)S6,CQ\V!4I1R(1"<F+'4?O\`*_'%2;$?DGFFT^F^IC"3&XDP)D?]
M(ZDH7V6//X'[+U7]R8]V=CRN)?Z]A0<;(X]2>(^(^VU;,QRPGVU#3V5I6OT]
ME.KHLF=5R1\;T&6ZR)/QS;4W";X.*NPDO-$V0D0MT2-D-H:?=;:<"VTJ("AS
M'(U,Q7''HS#KS1;=4@%23Q22-1\#7=:X:YZ:4II2FE*:4II2FE*C)UH2]=]J
MYGU>\(,4N0&>98>*$?C:!Y%"97-*Z:"O%EKX`$54_'(E_J^+)D4B?BX>43J\
MW_"<\1^%1\1I51Q*CB\WD,*O2.[=YGP)\Z1X'7X5)O5;JW4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI7__TO?QI2FE*:4I
MI2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4K&,KS7#\$K%NLURG'\2J$
M/Q_N.1V\"FAD[Q(_"V_/?8;=>4!54`54E1%^-1V3R^*PL?ZO+Y)B+%O;J=6E
M";\;`J(N>X:U*XC!YK<$H0<%B9,R9:_0RVMQ5N%R$`D#O.E=9A?9_7'8S3[V
M`YWB69!%1"E)C605=RY%`BXB<EF#)>=C@1?"*8BBK]-=;$;CP&?2M>$S466$
M\?2=0LCQ"22/B*[6<VIN;;*VT;BV_,@J7^'UV7&PKN25I`)[@36=:FJ@*US5
M=M=>W?9.4=0U>1!*[%PNIKKW)L<2MN&CK*JV9KY%?**S?KVJ:5^0S:1RX,27
M7!\B<A147:`C;HP4S<&2VM&GA6>B-)<>:Z'!T(6$%)ZRD-JN%I-DK)%]0-:L
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M0J]E!*P"4FQL>&AK)M2-1=:[P7MCK_LN?F=9A&0A>3NO<C?Q+,&`KK>!^SY!
M&5Q'Z\G+2OA-3E!6B_NQB>97;X-=0.%W/@]PO99C#S@\[!?++XZ'$]#HO=-U
MI2%6L=4%2>^K+G]H;CVO'P<K/8TQV,E&$B,>MM?J,JM9=FUJ*;W'E6$J_JU^
M\Y[5Z\ZTDXI#SO*JW&I.<7S&,XJU/_(4KF\D$V+4%A8[#PM*IO`BN.J#0J8H
M1(I)O]9G<N"V\YC6LSDFX[DQX-,A5_XCAM9(L#;B-38"XN=:^<!M'<FZ&LN]
M@,2[*:@1R_(*.G^&TF]UFY%^!-DW4;&P-C7%QGN'KC,<ZS;K3&\E;L\WZY_!
M_P`SHQK;F,=+^XCSA\I\VNC5<_RC]?Q7WN"_!;+KBQVZ\!ELUE]O8_(!S,0.
MGUV^AP>GU</,I`0J_P#44JW.U<N5V7N;"8#!;HR>++6!R?5],[UMJ]7H_%Y$
MK4XBW]=*;\KUB'=MIT]A1X7V1VQE;&$,T&1Q:^ENW'GXZ3;&P!]R/3RG(D65
M)*$:QS=/9````E,Q!2WD,QO/$[-QKK^<R;47'2%I:NX"05FY```-C8'6U@!<
MD6O47@O;_-[^R[$;;F'>F96(VI[I:("@VFP4220"+J`Z;W42``2;5OK4C473
M2E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E?-MUIY")EUMT1,FR5L
MQ-!<!=C`E%51#!?A4^J:^4K0L$H6"`;:&^HXCQKZ4A:"`M!!(OJ+:'@?"OIK
MZKYK%TSC#%L\@I4RS&UN,3@A:915_O=;^X8Y6G'26%A>0_R?R*J&L54<\KX@
M'C5"WV5%U&_SG$&1.B#*1_JHJ.MY'J(ZFD6OU.)O=";:W4`+:U+?R'-_2XZ=
M_)Y7T4QPML.>DOH>6#TE#2NFSBNKR]*23?2UZ[*COJ3)JJ%>XY;UE]26+9/5
M]O3SHUE6S6@<-DW(LV&X]&?`'FB!5$EV(51?E%UV(4V'D8K,W'RFWX;@NE:%
M!:%`$@V4DD'4$:'B"*ZL_'S\5,?Q^3A.QYS1LMMQ*D+2;`@*2H!0N""+C@0>
M%=MKM5TZ:4K_T_?QI2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE
M*:4JG5NIH?8[W>]AWNXJ*9G>(^MV(FU@?5P^>7$L9##,=)<IFD5]IFVGVDEI
MTQ;/9MYZ1'$^0M@B>4Q%A;]]W]]+W5#7-QF`BGZ>&+E*BD"Y#=P%J6038Z*4
MI`-PD"O:BIF0]L_8CVV1LJ>C'YG<\P&7/T2I`)/2DNV);0VDI!4-4I0X4V*E
M5L_UUSOUZM>Y\SJNI_73(^B^Z:?JRYG.Q<OI6L(I)U0],II$1BYI:RX?:8%Z
M>L5Q)/X8N)'YJAK\)JP;#S>QI6[<K'VSL.1AMVM8UQ5GT".VI!+92'&T+(%U
M=!Z^@'IOKPJJ^Y6`]QXFR,)+W?[EQL_L=_+-("H[AE.H<"7`HM.K;!-D=:>C
MU"GKZ;IXFM1V_N?W9U[F_7#-WW1ZV=M1\H[`I<1R[KSK"+8/V6,Q+>2,=^7$
MORE&DD*\R5M'24Q5[BBB0DJI6I7NUN_!9?`)F;MP&31(FMLOQHB5%325FQ(=
MOKT\+W/FL""#I<8?LAL7<F"W,N!L?=&'<B8YV1'F3E("'U-IN$J9Z?*5\>D6
M/3<@@BQV'39E7]=^_'NOGEJTX_6X=T!BF2S([)(+TABFQ/`)YQFC42$'9'@X
M"JHJ(I;K\:G(F68P/O7[O9N2DF/$PC+J@.)"&(JK#O-K#QJN3L))W)_IY]BM
MOPU!,F;N*0PDG@DN2)B.H]H%[D=@K0H?R*]M5..8OV]<=@]$W55=90RQ>^OU
M#!LE[`Q[%)$V6S^7^^.2^+EHQ$C"XJ&B@*NMJ0_)`%,3[[[HC0,=NB5F\,[&
M=D@.8UM*_J6V2I0OZA/X@D7U)MU)N.(&@J_TU;.F9/+;-A;<W`Q+8B$M9=U:
M/I'I`2D]/I!.B"I1&FIZ56/!1EAD??7L)V][%=A=*>N%EUYB=-U%15<W)\IS
MZFL[=R\N[1N*Z%="CQ"4H<1HY*L[JTA\F'#4ME`5TN=O7?.Z=]YS:.P9$&+$
MQC*%.O26UK+CBPD]*0/PI!5T_AOY5&_`5D&,]O?;C9GMKMS?7N;%R4R;F9"T
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ME2G+$-6Z`]T_B<'%14;:U&&#[@^Z\_UP;]HFF^GV\"Q*[B4>0U+U58G?Y84C
M*6*%ZU%EI\8U/!9G6T6$C33PO+Q)_P"4^-9ZS[I^[K^PA[B)&+&%BO);=04*
M]1Z[P;*[`V0D*6ANR5!7%>M:K(]E_8N/[FJ]J%JS1W#,84ZRX'$>C'LP70W<
MCJ<44MN.]2DE.H;T-7-8E?MY7BN,Y2S'.(SDN/4M^U%<-'#C-W-;&L0CFX@@
MCALC)05)$1%5-]DUZQQ<Y.3QF.R26RE,AAMT)XV#B`NU^=KVKQ%F,<K$9?*X
ME;@6N+)=9*@+!1;6I!('*_3>U41]`=XYCZ]>AV9=BX.%8Y<L>RA5+S-M$_+B
MOUEA5TI3V!'F/A?>;CH(N_=X]]]EUXQV/O#+;']E\IG<-Z9EC/A!"T]0*%(;
MZAW$@6!Y5_0+W%V%A/<?_4%A=M9XNB$K;'J`MJZ5!:''>@]X!5<ITOPN*F%0
M^POM+U_[$])]>]\1NLYF+=^P;-ZIK,'BSQGX5-:CD]'@/VDQQ/W)V!(>C-2"
M7RM.MND39[ALNJ0=]>Y&%WWM#![S;QZ\=FT**$1PKJ8-B0DK4?,4GI"OQ!0)
M*3<5BN0]N/:;<7MKOK<GM^[E$9;;KB`XN4I'1)2392PVD>0+`6I`\JDE("DV
M-Q&?JR\]G<?R+WAONB'.N:N@Q#MW.LPRFSS1B98VEM(IRNY:8[008ZK&95:V
M(XZX\^@"ID`":?=MGFV9ON)!F>[\W9BH#<&+DY+[RWP5+64%P^DVD:#R)*BI
M5A<@!7&M2W9`]J\CC/8;'^X"<F]D9N&BQF$1BE#;8<])/K.J/F/G4$A*+D`*
M44G2^Z<[]B['L7JOT1[.L<*P*QMNS.XZBHN&LAQEB]:H["!>O8]:V>)%/><>
MI);TZL-UAU#-QL>&ZJH[ZMN;W[(SVVO9G<3^(A.2LAE4(<#K0<#:D.^DM;/4
M26R5(*DFY(TXVJC[?]M(VVMW?Z@-JQLYD&H>+PKCC99?+1=0MH/-HD=``=2$
M+"5)L`3U<+UKK$8_L'.]WO<B#Z_3\`I;=QS'Y-[=Y[&G3HT>/$A1UK*VK@PA
M<YR[68Z2&\Z!-LMM*J_)#O`XI&^'O>#W49V._"9E$H+CDD*4`$@=*$)3?S+4
M=200D#MM5FS3GMRQ[$>RDCW%CY%^$`ZEIJ(I"%%2E'K6XI5O*VD`A*2%*4H<
M@:^^>>UN4=E^GU/FF;X'UW:Y_B?L71]99;49)C#&18P5A#C6$Q;FNJ+!YX*^
MQ5@P:51=<0#%Q15`-!'DS?N7D=P^U<?+9C#07,Y%SK<1Y#K(=:Z@E2NM+:B0
ME=B$FQ-B%6T-AQ[>]HL5M?WHF8/!;@R3.W9FVG9T=QA\LO\`0I2$^FMQ`!6B
MX*M4BX*;ZIN>V[`A>R#_`/(ZS7XAF?7D#(7^J[*=B3US4W<FA@]<+<V"C4W,
M&,7DDY1S`U60W_:7[?E-M=C.,[^7[]AG%9:"C(JQRU,%Q#A;3%ZUV0XD:E[0
MW4/+PUKI[=?]LF_],RY&9PF2<QJ<LA,@-.-)=5-]-'\1I9T2QJ+(/FXUO*V[
MQ]E>ZN^.X.J?7*9UUA>.]&#6UF2Y)GU187,K(,HL_P`T&H$5J&3K4"$4FKEM
M@OC4N$8G"+<Q;&Z2=X^X.[=Z;IVUL)R!$@8;I0Z[)0I9<>5U`)'3<)3="P-.
M""HG4)%!A["]K]C>WVS-W>YC.2G9+/E:V&8CB&TLL(Z25J*K%:NEQM1UM=82
M!Y2HZ@M_?;MJ/ZM679/[#C,#MCKWO:NZDSFN:C.R<?N0:CS9DQVL:=D..USL
M\&$84D<>1IP",/@D$:K*]ZMSH]MW]P?1QV]RP<RF%(2$DM+`2I2BD$DI*K=-
M[FQ!(T(`N<+_`$][/=]V8VV/YA*<VADMOKR$594$O-DE*4A9``6$$]5K)Z@0
MDZ@DYIW!WU[?]!].TF2]H)UA79+G'9]13%DM-1W=[C75&&6E6W)?7(8$-/-9
MV4&R%QD3!Q\'!!4%73(-Y?=.]?=/96U8>0W&,<WD)F10CU4-K<:AL+0"?52G
M5:TJN`05`@&W42*@]E^WOLQ[A[UG8O:ARKN+@8IQST''6FG\A);<*1Z*U:(0
MI%E$$(()%PA(54RO6W+,MS7K]R]RSLCK/M97[J6%)F'5\:3`J9=0$:&HQK:N
MD//K7WL683PNM(J;-JVJHBJNM7]O\IE,O@US<GG\?DKO$-OPP4H*+)\JTDGI
M<2KJN.SIOK6)^Y^'P^#W$C'XC;&4Q`2PDNQIRDK<2X5*\S:T@=;2D])2K]KJ
ML;5('5YK.::4II2H7^X?K9U?VWA66=C9C$O7LHZ\ZPS1_&I%9D-G51&'*VIM
M+V(4J#$="/,X6#:$O--R'[5^-9)[J>WVW-T8K)9_+-/'(P<<^6BAQ2$CH0MQ
M/4D:*\W;Q&E;C[+>Z&Z]FYS$;9PCT=.*R65C!\+90XHA;C;2NE:A=/D-M.!U
M&M1(]&^F>N\(]9*'V\BUMQ8]L4V"]S7*G-R6W_89JX];YW31HKU.#_X@-O5-
M,TT1(*JA*KB??LJ9A[.[1P.']OH7NDU'=7N9F'/<\SJ_35Z2Y#8!0#:Q0@`]
M_FXVK8O?K?&Y<][IY#V9=E,M[0?R&-:\K+?JI]9N(Z5!PCJN''%*`OP\I\MQ
M6[\N]U\KQSTLP?V@8PK'I.195;0ZV3C+LZR&EBB]D%_3N.L207\XB\-,ABA+
M\$XN^Z)\W')>[N3@^TF']Q48EA4^2Z$%HJ7Z8_BNMD@_BX-@Z\S5#P_L7B,G
M[XY[VI<SDE.-B,J6E\)1ZJK,LN`%)\G%VQMR'*]=IV?[9]NT??;_`$%U3TY5
M]B9-8];4>:4#DG(4HXL&1/>)RUE9+-F.,Q&J.NA-\6T`FG7I+C8<TY(B\^X?
M<[=,3>:]E[:VHW/R+F/:?:NYZ825:K4ZI1"0VE.@L4E2BD7UM74VK[/[-G^W
MK?N'N[>KN-Q364=C/!+/JJ6$"S:6$I!475J-S<*2E"5*Z3:]:-@_R">PF1]=
M9?F.+^M56X[TU+M(_=EE:9>$>AJGJR6K3M=C,5'&K2;81H8&]+V.2D40W1'4
M,%U3F??'?4_!93*8[V_;*L4I8GK6]9M!2JQ2TFX6I03=2]5]`%[$$5?9'^G/
MVXQFY<-A<K[H.A&;0A6,0W'NZX%IN%OJL6TH4JR6]$>H3:Z2DUO_`+!]V'(6
M'=`%U7@*YCVG[(UT*QPC"[:X"MKZ.*ZS%*PFY%:@PGDC09,@F@X>!'D9=<Y@
M+:BMWSGN\IK%;(_RWA/JMR9]M*H["U]*&P;=2G5@:A*B4BW3?I4HE(38YWMS
MV+2_FO<0;MW#]%M+;#JD2I+;?6MU0*NA++9.BE)`4;]725)3915<<;`O;GL9
MK-^S^G.[NLJ3"NUL(ZWN>SL>7'+UVZQ++*.KK2F^-J0?.7$<4]ON\AJ2`Z*B
MT;>Q?&%]T,^G,;BVIO#;S,3<L.`Y+:])PK9>;0CJL#J1XW-[*!"5)L>7</LY
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MC*97*[HV-[:P,@[$A9-SJD.-DI6IOKZ0@$6TLE9(X*/1<6%C9_\`3]AL+AMG
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M;5P>Z,D[OK'1"\HN0E-P'UH2DK99>.O5=02%%2A>YL0#;$6O_P`U_P#)7_\`
M\].?_P"-:'48W_\`N5_J`_\`\&K_`/2MU,+_`/VA_P!+W_\`T@__`%KM?3JO
MV6MO7[TU]1JC&L?H+?*>U;#*L;IK+-+L\<P;'Q@YI;E*GY+<M@11P,K)I&QY
M-HHHX:ELWQ)MKW!E;']J/;")CX+#N2R3C[2%ON>E':Z9#G4IU8X?C387&@4;
M^6Q_-W>UT/W%][?>.;E,C(9Q.(;CO.(C-!Z4]U16^E##9.I'0HJ-CKTIMYKB
MS3I[(NQ\GPQBS[3QC&L7R=9TIH&L/R5K*<9N:A`8>K<@I[$$1YN)8-O*B,O;
MNBK:DOVD.O0VU)^?R.(1)W)CH\;(]9`##H>:<1H4.MJ&H2H$^56HM?@17EC>
MF-VSBLXY$VGE94O%>FDDR6"P^TYJ%LN(.A4@@>9/E-[<0:VEJRU4Z__4]_&E
M*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2JL.V<$ILA]OK&Z
M]8>\HW7_`+00Z"&UV7AL_",IR'"KJB"LK7(\K)[J!CT[&ZR0Y6K!;<;?=,C<
M1E0\,E$4_-NYL+$G>Z+\OVZWBF#[B)92);"H[SK#C80@A3KB6E-()3Z84%$W
M/01T.<?6FS]P3<;[,QH/NKL)61]J5R%&%)1*89E-.E:P4L-+>0^L!?JE)2D`
M)ZP>MHV3AN,=?.Q^^/9"=[#]_P",S^U[;USO:K+:/K?K[-VF\5P*555(KE4>
MP6CC0+)VJK6VB&#%61,?5Q=U115-1&/P11O3?SV^M\1U[F=P+J'VXL:1_!CE
MMO\`C!7II2KH0$GTT=2U7-[6-3>5W&ASV_\`;%CVW]NY3>T&=S-.1W9LR*3(
MEI<<_P`.4>JI:`XLJ'JN=#:+"U[@U'&%UO3KU;Z^QK+V,]>/_3BD[6QE[KZ=
MB'7&:MYOFENMY-=*-FYP\>D9'2V(LHZTV,V(PPID*R'DXMD5";P$3_+NR&Y&
M_,#_`")G)-&,IB+(^H?7ZBC:1TM%U"K=0`<0E-R.M>B2=-?W/-_S9[BNQ?;3
M<O\`F9_$/B6F1-C&+&;])(ZHO4\&'47Z5*+3BEV!]-&J@)L6.,=5_P#U6^Z%
MQFW9-0M7=^O]57=A8C&HLO&]PW%!Q'$&)M_)M',>/'+-'*]D'V&8$F9*0G@$
MF>0D*:](QVVO_4OW;E9C<#7TSV$0F2P&W_489]".%.%9:])?E`4E+:W%W4`4
MW!%87&RN[?\`TB]CX6"VN]]6QN)Q<.0IV/Z4F1]1)*64MAX/(LLE*E.H;19)
M(78@UK#H'`>QZS!\-J^L^_/5[).H!GO.XMD^9]<2X7:CF-+?RC.,_4Y'$K76
MY@JCH1UE@1<5!6S5GQKJM[*PF<CX?%QMO[VVV_MCU"67I$4IF%KU%7!0\E)"
MN(3U@Z6Z5='35K]Q-Q;:E9[-R]T^WF[(N\BV`^Q&FI5`#_HI\P<94L%/X2OT
MR!?JZDA?56666"W\[W![GO\`U&[PPNC[(FT-9%[LP3.<(RZPJJ68V%8Q&M:N
M[&B<H)\N08-/>!N21MR"?1>0*8-RS^&FO>Z>[)OM?O&(SGULI$^/(COJ0VKR
M`+0YZ1;420%=(7<**^*;A,-&S^.C^S&R,?[Q[#G2-L-R%JQDN+*CH<=22LJ;
M<:]4/(2+J3U%`"D!%K*"5*=[]?Y(_P!T^HJT/?F.P_:3'L.N8%9_G6`Y653V
M`"5EC^_7Z-T-#,J:![@-ESB3'(W)LP5L@(!0_P`WG@\@O=GM?]'O9A'N,Q$6
ME'U$9[HD^57J.?PVU(;/][=#A3<$6((%_P!V!N/&-[']Y/YA[>25^T\F:VM?
MTLN/ZD,]:/29NZZEQX?W-G&PNR@>H*!/3FZ8M3A[B]H6][V=CCV;2/51FFR/
M%HN.9@S,@M#%K`L,O_,2D/'#IW)`*81(\UZ<(F@^+X5=2Z\;%'NIN*5-W%'.
M75MGTW60T^%)'2@+?ZO3+7IWU"$N*<L;=-0/\VFGV6VG#Q^U9*<&G=Q<9?4]
M&*5GJ641^GU0\'`#8N+:2T2">O6M!T6$8$W_`!:YGBC?<V*OX@_DD9V1VB&+
M=C!CL)\>X,4FA%=Q]W$@SATSG,MP^3=:8(Z\A[^(2-*7!Q&&3_ISS&-3NR,K
M&*D@F7Z,KTDGZUA726RP)!NH!%PT1=0/X05#0LAG=PJ_U8X/+JV1+3F4Q5`0
M2_"+RA_+I"2H/"08HLDERRGP>E)3^,A)MCZLCQHG6/7,6%/9M8<;`\0CQ+2.
MS*C,649G'ZYMB>Q'G,QYL=F8T*."#S;;H"2(8B2*B>F=M-MM;<P#3+X=:3"8
M"5@$!8#20%`*`4`H:@*`(O8@&O(&[7'7MU;F>?CJ9>7D)!4V2E10HO+)02DE
M)*3H2DE)(N"1K5(#/7G6B>@.9X\G?V&EC3WL0Q9/Y]_A?:J4L.S2M@`.//4R
MX5_E;DXF10_,W!.&G)$\N^^WCYK!;?'LCE8(WM$,`YU*C)]"9Z:5]"1Z11]/
MZQ5;7J#91RZJ]XN;DW0?]1.$R1]NYPRB=ME`B?4P/54CK6?6#GU7TX1?3I4Z
M'-+]%3G]@,:Q6Q]I?2BVL^Q:3'[BC>OUH,6FT673;'->;5/R2IL*FCG4=4K*
M@/+]RDPTV-./+9438MZ8_&O^X_M')?SS+,IGK]-E3;ZE/Z(_`I#:FT6Y^JMO
MCI>L#]N\IEHWM-[YPXNVGY$*0&O5?2['2B-8N?WB''4NN7N;>@ASAK;2NCZ.
MQ?$H&.>_K5?V70WC.0YKV8_DLF'09G$#`7I5!D3<N'=-V>/PWKEZL;=-QPJI
M)S3@M*C9&2BB]39N.QC&-][$,;A8>0_+EEU26Y"?IB6W0I+@6TDK*`226?4!
MMY220*[V_,MF)&3_`-.ZY.UY#"XT&"&$J=C*,L)>9*5-%#R@V%D``2"TH%7F
M``)K1,'!\!'UX_C_`*T>Z<5.KQ[O&1/QO(1Q3L=(.?6)=@7DDZ.DA%B0V]/+
M"6X4?S6S$&*I@I^3@HDM*:P^$&Q/9*/_`)NC&.QF%*:=]&5TR5?5.$MMI]#K
M0H*\G4\EM%Q?JZ;$Z#(SVX3[D_ZB91V/+$J3@$H>9^HA=41'T;20ZZKZCTW$
ME("^F.MU=B!T]5P,L@==]A3/:_VCO/73V"PRG[.G2:D,LPF^P',["LIZ!^L9
M9%ZUNYF,)3%D<"Q!EVO2O>F@Z!O(XFPD*RC&"SKON7[C3-A[XB-;A6I/K,.1
MGU)0T4@76XIGT_52OI+7I*<!!5U:`BH>3N7;C/M#[3P/<OVYG/;5;2X8\IJ7
M&0MQX+)LVTE_U/16@J2]ZR6BDA!2;D&M33.OND6_26IQRE[[J9*L>RE-:=@]
MAW^$]E1F9O97X,U9N--8^WB;^6LF$$VA:D28HL.$V9..-D?`:T]@]H#V?8@1
M-ZM*MGT+DRG(\L`RNA74T&_0+X(3:REHZ20HE22>D6]C<>^U>^LO)SO;UY/5
MM=Q$.&S*A**876GI?+QD".05A14A#A4`4A*5`=1E+WCAUW;>[&!WG3/;^'8G
MW8QU-*A6F%YMB&5W$*7@_P"YV2NW=?:5U0]CY2%5]T?QGID=]'&`5%(34=:-
MO'$RY7N]AYFTMU1(N[QC"E;$AAY:2QU+_B)6ELM7U/E+B572#J"163["S4&'
M[%[@@;WV9-F;%5F$J;DQ9,=M2970BS2VUN!ZVB3UI;6FRU#0I!K$8>"99(]H
M/8>\]..\L,KLIM'*R/WEA'8&#9G*KL8RA'I[4.?57O[%^QVDMV6W-=9;!UU&
MS-\51QOX"-:PN3<]Q=]3/:K>41O).%(R$>3'?*67KJ`4AST_36HJ"U)`)L2L
M>9/"8>W!AV_:GVV@>]>PISF)9"SBY425&2M]BR"I#C7J^JVD)+25**4]0#9'
M2K\6ALDZ\Z,;],+C&JGO^MDSV_8ZLLNUNR,EP;LB(U([/6%-_/QYO&X>*2\E
M80(Q"C+Y1BCF8.$;H$7`:3D,%LT>TDO'Q=[MJ>&>0N9*=CRT@R^A74T&DLJ=
M%D\%%'22%$J!-AH6+W)OY7OA"RDOV[=3'.V5H@0F)4)1$'K3T/%Y4A+!NJ_4
MD+"P"D)0H#J-K7L#5=I6.*QG>MLJZLQV+"=F'FD3N&D<ML*NL>>BJ"LV#S)"
MY7I$D(A\E_M&*JA_")KTOOF-N-_&MJP&2QL=I!5]0F<WUQW&B+641JGI.O8>
M!KR)[<R]IQLNZC<^)RTEY82(RL:Z&Y33P5>Z`=%]0TM^('5-1O\`X\,9P+&\
M)[4'#NR<?[&M;/M&TL,S<PK&L@QO`\;O'(S0MT&(!>UT`;.K8BBAA)B\XY-D
M`@JB(D5!]B<?A<?B-R#%9]B?)<R*E/F.TZU':<L+-L^HA/6@#4*1=-BD#0`G
M3O\`4EE-PY/.[2.:VQ)QD1K$MHC"2^R]+>:"C=Z1Z2U]#A5H4.66"%%0N2!8
M7K=*\WTTI32E:O[O;!WI;MYIQ]J,#G5^?MG)?1XF8X'BEL)/O#&9D2"::1>1
M(VV9JB?:*KLBUW=Z0K:6Z$E82#CI(N;V'\%>IL";#G8$]@-6O8:BC?&S%I;*
ME#+1"$BUS:0WH.H@7/`7(':0-:AOZBUE.7\<=35V.1PF:*1U[WE'L\FAPKB3
M#KJZ9EW9"6-B,!ZMB7,K]I8>-3:"-Y'":5&D-%$BRGVOCQ3["QH[\Y"8:H.0
M"W0E92E*GY74KI*0L]`)N`FY((3>X)VOWDE31_J9F2XV,<5/3DL6I#"E-I4M
M:8\+H1UA:FT^H0+**[)"@5]-B!6KF4+N^3Z%XKCE_:]45WK_`(_D;<C#>P8Z
MYA)O\\DOY??-PZ]NG;HSLZ2)!E2I[JO3*Z(XXW&;!4Y%R+S[E&MX.>R^-@3)
M&-1L=B1=B2/6+DA1?=`2$!OK;2E1=/4XT@D)`XFY]0X5_8;7^H/+Y/'1,N[[
MBR(I$F&?IDM1$B,T5++A=#;JE)2TGI;><`4M2KV%A8MCL*,/\E)3$MZXY'_T
MMUS/[4+5LD]6TLZI/RO(=6%7X%XHNWY/E^4^SZ[;MC66Q[_>J)397_EQ`Z++
MZK=3>MRCHM^]?NKS3DWW3_I@#)AN!O\`S8L^I=OHOT.>6P<*[_N=/]:M$=35
ML)OUD_D=8#(*A]J7V#W&4B8TS?I'JU*G>0@G"]2,RW";W^?QFI"?'PJZIVV(
M[2?;WWZ0)K12J;.NH!RR/(?Q7;!/[H56@[PE/J]T_P#3,X<<\E2,=C;)):NO
M^(/P6=*1?EUJ1WVK#95*4:L_CMR'JW+\7LN^\<P!$Q/K^]A9;%I.P<;<9G.2
MRB9$&/A74CT86YK1C8O0E<;=YBJ*V*.1#D0MQO8J=MW*1W-Z,0OX,9Q+P;DM
M'J)Z70V$-D6<20ZINX-P1TCJFF9P=E?ZD\;NS#2VO;V3D?\`$2VE1U.PW@4A
M(4R7BMT*NTH%E+H!38@A1*=G5L+);[V7[@R[V"ML-P/N&1ZQ9;589U-C'^49
M"Q`PLJJT29E%QEL>D?QYU&W&I"HPS*<EGY2_L#P$2L4=K(S?<#=.4WS)B0MU
M*V\^AB$UZSH2QZ:^IU;P;4T;67Y4K*SU'R"P!JTI_%X_VNV9AO;F'-R&RT[J
MCN2<@_Z#)7)]1OI8;CET/"X*/.IM+8Z1YSU$B3_\;T5B'Z@=9L1[&':M#/SL
MDF0`L&XQJ>>9(9`(VD&MF(3)+Q+=I!4D7BI#LJZ+[!-H:]KL"A#Z'$^I(\R>
MH#_J'-/.E)TX'2W82*RG_4VZX][S;H<<C+97Z<3RK*"H6B,Z^1:TZ\1YKVX@
M'2M0^^V.TMOVKZZV>#9_4XI[-45Z,GK'&KJFR>PK,W@.6\10KY=E34=M5TQQ
M;9A4`IKD9AUEY]#,41#"K^]4")*W+L61ALVW&]PF7@8C3C;RD2$EP625MMK0
MV4K&A<*$E*E@D``BY?Z>\E.A[1]RHN?VZ]+]K)$?IG/M.L(7%6&U76E#CK;C
M@4V=0TE:DJ2V4I))2<MRB9[-9IUOVO%]I*CJKIOIK_TFS.#D=IBDRZS'(ELY
MD!IJ#=MQ*QRY<"JJ%\CKD=H3D/+L(H7U22R3ON)E\!N5OW&BXW$[4_ECZ75L
MJ6^[UJ2`EP!!</0C4E(!4K@`:A\2S[68/<^T'O:>9E\WO;^<1E,MR$M1F>A*
MR5M%2PT"XYHE*U$(3J3:JY^E<@ZKIJG!L3N.NO2/,$AV5=%>[8R7-#JKJVI5
MLQ7]RLL.N*RNR1J_"$>PC*9C$3@#Y&DW55P;:<[;D2+B,9+P.T900XD&8Z^4
M.+;Z_P`2V%I0Z'`G@%I1J!U)[?2^^,=NV;,S^8A;EWW"ZVEJ&/8C>HTV[T?@
M1);6MDLE0XMJ6`">E?"TO&JZ)_\`5-_(Z_\`OM5Y9?0'BD0_#>?DU8%UQ2@4
MF>7[-^(XRV((9)%=DN<338%+D@ZDVPU_ZC^_2_K&^I6%(*;.71_AD:J\EB!Q
M/05'46!-[8TN2]_Z3?Z9F_Y>]THW%<*NUTN'ZUWRH_B=0)O8=:4)N#<@6)Q*
MNN(6)^@_KT=]A?2/;'6JUV;M91&[)RN=A3P6AY3;N8[)P6=/J0LW+-H3GA)!
MB,,U>`>!>*D2Q+$MK&>R>QC,Q&(R>W^B2'A*>4P0OUW"T8ZE)"RL?Q0L)3ZF
M@Z-+FIF3"?S'^H;W'3C\YG</NCU(I85"CHD@M_3MAY,I"'"@(-F2@J66M5>I
MK85)C^-"I*M]=''V,G_R&HMLYR.RHH,:'F#%/BM:Z,$!QVFF9G34MA:Q8S[9
MFX^P#L57W#$7#<%Q=:)_I\C&/L1:TY'UXKLQU3:0E\(92>D>DVI]MM2P""2I
M(*.HD!14%5EG^J.8)7N6EM>*^FF,P&4.K4J,7'UCK/K.IC..H;4H$`(64N=`
-22D)*:L*UNE><*__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g309840g95a35.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g309840g95a35.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0M^4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````,````,<````&`&<`.0`U
M`&$`,P`U`````0`````````````````````````!``````````````#'````
M,``````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````".(````!````<````!L`
M``%0```C<```",8`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``;`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#I?J^YGUMS>H=4ZC^GZ=B9+L7IV`XS1%;03FWT?S>1?=ZNZKUFO^S?
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M]#^F_P`(DIE_B^R&5_4;!R<FT-8QE]EUUCH``NO<^RVQ_P"[])[WK<P^L=,S
MK33BY#7VA@M%9EKS63#<BME@:^S'?^9D5_H?Y:\\I<6_XLN@&QQ;@_M"K]HO
MTVMQ_M5VY]OJ;F;&9'H?37<6=&PV]4P.H9>;=;EX[K:\(6O8T$W,/KU"NJJK
MUMU-'J[/\'Z'JI*;&7UWH^'<ZC)RZZ[*P#<"9%0=]!^4YLLQ:W_F69'I,5;J
M/UGZ9@=1P>GV75^KFE[W$NAM=+:K;OM#G_S?Z2RNJFMN[])ZGL^@LO\`Q?UU
M9?U8OIS6-LR[LK+KZO6\277NL>VZO):?S_L[J6?\4H]0^QCZT_4YN`6?8VUY
MS<?T]6>FW'K;7Z4?X/8WV)*=BOK5-_6JL+&S,*VEU+GV4-LW90?[7UN])DL9
MC^B[_"(A^L?0MEKVYU-@H>*K/3>'D6$.?Z+6U;W/NVUV.])GZ3V+,S@T_7WI
M+P`9P,L;AY/H[_-0Z!54?KM]:;BQIM:<)C;(]P:['8YS&N_=<YC=R2GH</.Q
M,_%9EX-S,G'L!-=M3@YICVGW#]UWM<N4=G'ZK8]./D6W=4ZQ;6++G7WV.JK!
MT]GJ&S\\.97LK]6WW^K97^C5OZCF*^O1J1UK.T']9BROK#AOZTW'Z_TEKLW!
MS:&@^D-SVEN[FIDO_.].QGTZ;J_TB5"[[+A.0C*(VE7%_@_^C),WZQ.S\*PV
MX^;A=09'H/Q'6ACY_P!-I6W8S_">HS?_`-Q[%C_;^N?]R<[_`#[_`.]=9TSK
M?6RV[.ZW73T_I>,PNLMLK?4\NTV[66VN?M_ZU^D?LJJ5?ZV_6GJG1NH4XV&V
MAU=E/J.-K7..[<YFFRVK]U`R`%E=@P3S3X(5Q$7KX/\`_]#TO.Z7T[J(8,W'
MKO-1FI[A[V$Q[J;?YRE_M^E4]1Q.D=-P[3=CX[&WN&UU[I?:6_N/R+=][F?R
M?45Q))32S^B])ZE95;GXE6391/I/L8'%H/TF[C^8[\^OZ"&_ZN]"??9D.P*/
M6MK%%CPP`NK`%;:W;8]OIM]+_BOT7\VM%))3A9?3<3I.&ZKIN)B4X>593CY&
M,:I8_P"T6UX;]U3'UU;&U7N]FS],AX5/3^C]2&._'8STL:L5WMWN%8=]KMNJ
MJ]>RUV)B.KP-[*<?V?Z3_`K2ZS'V1D_9_P"?I_I<^G_.-^AM_P"U/_</_NUZ
M2!E1^UF?T+Z5'\[/VGC,^A_*_P"X?_M20UM>".'4-6ZKH.7E?:K,"WU\RI[K
MW[75"RJ@5_TV'U5Y56RZEE;+O7_T?^#N]-\V[H'4:\?'R\-UE5;P*7;=HI>+
MOV<W8^M[;*_UC]%^@]GI_I/YA,W;]B$?LS^A9'.[TOHX_P"]_P!Y7_<K_@/L
M"#7/[4I_H.V7QLCTI^UU_1_PG[1_TN[V?;_22U5Z.Q9"KZIA]74F]-:U];#=
MBY`H#7"K'95:RS&^BYM/HV,]-C/^$K_G?T:>NCZNXF4[)JP&8[[QD5/>VH"R
MYS;JL`M]:NS_``V1?Z=;;OI^I_@/3>FRMO[+'_)7T[/Y[=]GGT^W_HS_`(%&
MMV[\G_DWC*G=,_2QOY[_`../_#_9$M57#L4_2,3H>%F6T=.P6X.0:F67-:QM
M9(=]'=L/Z5S7?2M;OKW^SUEXQT;K?5>D,#^F9EF+O`+V-+75N,1O?1<VRG?_
M`,)Z?J+VW"V_:W1]G^A_@]WJQ%4;M_\`X+_Z#+A6?1'_`(BN/S>/DBM-='D>
MI]?ZQU<UCJ>=9DL8]KFUG:RL.!T?Z%#:JM_\MS%VO^,4@=:QI/\`VF_]&/0N
MX_\`$7R/R]OY2Z3ZS?TZK_D7^:_[U/Y[Z3OYK_@/_1B9D^74TV_A\I1Y@&,#
M,U+T@QC_`-)__]DX0DE-!"$``````%4````!`0````\`00!D`&\`8@!E`"``
M4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S
M`&@`;P!P`"``-@`N`#`````!`#A"24T$!@``````!P`(``$``0$`_^X`#D%D
M;V)E`&1``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`,`#'`P$1``(1`0,1`?_=``0`&?_$`+L```(#`0$`
M`P`````````````)!P@*!@4#!`L!``("`P$!`0`````````````!`@,$!08'
M"0@0```'`0`!`P("`PD-"0````$"`P0%!@<("0`2$Q$4%18A6`HQ(M.6>+@9
M.1I!,B.4U%75MA=WE[<X0I,EM7;6-U<Z$0`"`0,#`P($`04,"P`````!`@,`
M$00A$@4Q$P9!(E%A,@>1<8$C%@CPP4*R,W,45!4U=3>AT:+20Y/45E<8&?_:
M``P#`0`"$0,1`#\`?#Y5/)YK]2WC-_&KP,I&.>P=DEJW"6K0GR#9_'8I&6Y%
M-Y'-V[1VRD6(6E:N*C-/WKANX1A((H+E16<+IF:(GTJ:J+;CTJS^&^&+D^I0
M+*9Z>C9CN/>I)H56\[3TW-S^DNY65<D(I((5BK6>7EH&K5Y%U[OM4@3</P2]
MH+NUQ*40+4BQ]-!70Z7XZ$L;AI/2_&O/O>6]LKJ+B;C<OBYZ=><N[6LP(9VG
MGNGXQ+3#BD0#6PF(9FC88%O%3$0+D5BK*$+\?HHO?KTJ./"7T_K_`%WC?7&P
M[0E9(2RN^\==@8K.;%8)NP%QVLQ.7X>=AE$(:<*W5BXJIOWCKY&Z+9D@:07=
M./MTE%U`]`H86('RISWIU&CT45'&N9C#;+G5FS.P3U]K$-:F[)L^F\POUKS"
M\,DF,HQEB!"W>DRD-98<KI5@5%T5!P0CQFHLV7*H@LJF<HZ5F1\!D59*IWQY
M:<WLM]NNDJY)H4;E,7:M`LTM;;+(0V?:_M]7CEG\S,N'#QPLNA&@HH/[THJ'
M,;VA]?IZ0ZFK&^E:U:^G5='HHH]%%'HHH]%%<M/W:IU>9I%>L$]'Q,WI%C?5
M*BQCM42.[/9(RGVB_P`A$Q:92F%5RSIM+E9!3Z^TI4&1Q^ON]H&**]::F(VN
MP\M8)ET1C#P48_F)9\H150C.-C&JKU\Z.F@158Y&[5`YQ`A3&$`_0`C^CU%V
M5$9W-E`)/Y!5D,,F1-%CPKNF=@JCXEC8#7XDU5[D+M7#NWJ59[WAK^PN8BH6
MQ>GSC2TP9H"6;R";%I)-'B;/[IX16+E&+PIVZGR`<1*<JA$SD$OK7\9RN)RT
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M:%TGAQ1!>0=%0D!]H%8)B/M-M.,X[-@1'S^1EFR/47L@^0`L3^4FQ^`KR;[J
M?<OPCR+/R\'[<?;'BN%\<4E4E,0ES)5N1O=I&>.#<+$)$I>,W_3OI:18KR"\
M1WF3_)T?T93$WTH*C!,[F1LE*0.H<X(>QI;)!E`,6CA0Y@!%1)ZF<PB`IF']
MWUN]K#TKPS<I]:I7WKDG96/TJP;CSIU;J<K1:XS5F[?G]GG8=U*P,&3VG6F*
MG8CQS?\`'8UFF?W*,W0"]*D7W)KNCF^,)*5.A76HL&&H;2D4_P!(CVU^LAHO
M^.L/]'^K=B_"J]S?&C^D1[:_60T7_'6'^C_1L7X4;F^-?__0]+P579UU1YK]
M&Z*O*CI]:)NK=$[1&J/A!1>-D[A)Q]708I`14R+5M$U2]N&*"28F10;D*DF`
M$*7Z1'6K6T6U;YO4JJH]%%5VY^YJH_.+_H%Y1WLPY3Z)Z)NW2MK9R@QXMXB\
M:!7*5`V1E"?8,F1@AW;FF%?!]P*SC[EXM[E#%]H%*9-[54WK'R/-<4Z8QCA[
M#LM_V\=<[G'KST)4)6X#G&<T"FH,Y]^XNFCWPE:N+]!JUC*K)O@C8V+>OEFD
M>I[O@,LS^X5,"X)/2H.ZE\B'7_CVB*GJW8/-&-73G:QV^+I=BT#EW7;E.6[,
MI.:0<N8Y>>HVH9O44[)'N@CUT45VT@S1.L!"JF;JJ((KE``/0ZTXFGVRO7ZI
M5:]5*21F:I=*Y"6RLS#8#@WEJ]8XQK,0LD@"I2*`B^C7B:I?<4#>TX?4`'TZ
MC69/PE?UI/G%_E+V_P#G$=!^D.IJQOI6G)]H=^TCDN<RG)8&F3.Z=1[_`#B%
M?Q#GBH2\;!3-F45<F:N;1;[3*).XW/L]C%$E"N)=RW<C[DE13052;O%6SJ`%
M]?2JT=&=Y]I<+42(WKK/EW%[/SVI.5V%T>;YIVFW62_XD6SRK2(BY6?KND9C
M2X>_1BDF_;L`4CGS`1?+D`0(F)#J*F`#H#K3/ZYMV3VS&HOH2$OE>7Q>7H2>
MGM=$</B1]<2HAH89]:Q2+M^#88IHPBBG4=%<E25:"F<BQ2'(8H.HV]/6EIY5
MY`>F^WF=DN?C\YNSJ0P6"G)"LP70_6NGVW*:_J,W!O`:3P9KFN>YOH]Z>5R.
M4**9963/&IJKF,B*)'#9R@15(@#J=:Z3CWR;#O'5&V<*;?C3C#>JL*8R$Y-1
M4#;RZ-EMUJK%>M@G8J;<7%?ILZB,C&W",D$&;^(05,P=`?Y/D(JBF7H*V%QT
MI..O=G=W7;SF<?9!<N?:3#RF)U_7;9F?.-?V^.<1UE=Z+SIJC26N=QV5Q34(
ML;`WJK559JU"(^!BD@=HD)E7:[I0]:E8;3K3W[[T_P!@Y_DMCODYX\+'<IZ(
M7DE%:!F/1>16M8:I'0*\J_L,D_L[:BNW'R.$A:(QD1'34DX,/U*C^DI3!_)4
M1H00UC55_"=VWG?:&9;Y*Y/RUGO*%#H.J1S*-I%`>1[TDX_LU=))25EL"\35
M*;&#+K@R22`J3/Z)-TTT0.<J1!]48^-CXJ&/&@2.,F]E``N?72MARG*\IR\Z
M9/+<C-DY*H%#2NSL%%[*"Q)L+DV^))ZDU$?0WF^NO*O:69\S=)<C*X)FMP?#
M+R6UVK7H>]J/,S7=6*'97:MU#-:Y,I@4TQ!_OF*LBO+"411^Q*L9+Y+[U@!;
MBX-62USL7R2-J!/[?AOCWK+G)JY$O[6VJVU[<6F]&W.F1C122<S#;)8.KRL3
M1)-Q&)'60AY&;=SHE*":K%-X;[,IK2`7U-6.\=/?&<>1GG1EO>?5^6I;IC9I
M2B7VASCUO*/Z;=X9C$RKR+2F6K=DWGXEU$3S)VS?%;MQ60<`"B**Q%44W2(L
M;5<22I%7E[?5KY)1+=Y::7%VB'J\HO[SGAV=R-`C8A:)";X2.I!.MM4A6]OR
MD1^1,I@(JJ!JVAC:6.9EO(@(!^&ZU_QL/W&MGC\SR6)Q/)\)CY3)QF9+#),@
M_P"(V/W>UN/4JIF<[;[2VUB"44C'KY.>H;=O_2EZJRLL[)FN06F=H=)K22ZA
M8L'E<>KPM@M2S<!*DZE9^5:+&*N8OO(R!%$!^A1$V8BV`^-:1S<UPG._CSZ/
MZAH*VE93&5)W6$+!(UE16;M36&>?BD6VCW;L@,UD%#BB",FE[3_7Z&$1#^YZ
M"X4V-`4D7%7?LGCN\H]NRNJ8E8[9`RN6TI==Q7Z<XT]E^&(*++_<(E>B1F5S
M+HQ9Q$&";M1=./(8Q6Q4BF,`QWI>_K3V/:WI4+_T,W;7^8LZ_P"(##_)/3[B
MT;&H_H9NVO\`,6=?\0&'^2>CN+1L:O_1\WPB0SGCKS86#G72/=%6(C3?N>45
M9%,4R.YR`/\`F>'=(./JW0%O9V6?@=BN!3)/"NT02`?F3-ZB.M6MJMZ_0*]2
MJJDS>6+(-[J7/W2'6V#=J].Y%<LRSHMXC,K@+#GQ\2_#Z0P9#8V[>`<YY^<V
MLG.P[-PX%<9]4@2!_<"(IC\0(U);7`(I8W@DE.S>_:YHN\;]WUT^2LY+J=5J
M]<SZF35#CHRVR<6QC+E/M[\\GZ/9G,A59./D6C([)B2.<G346,#LH^T"@J36
M'04[[KS?N(>/]*HFWZU2*]9NL+S%)Y3B4-G^>Q-WZCTAB^DU$4*/GK=%)&=3
MAW,O,F0,LX>,8TJSOX#K@=<J9W4`">G2DX^<1[VQJGC<TG2MLJV0\[9+'6S)
M9**P)G]YKNY23Z3OT1$QK[0=8;24#GE!>Q2<B"RD37XR>]QA.B>6,03%](U-
M;7TI[/CH_J^.$OY&W,/_`"2H_IU`]3^6D<^$K^M)\XO\I>W_`,XCH/TAU-3;
MZ5JL4Q$O^EOVF_2J9:M1TC-7&?49_6LNLV53,7!7"M-H#GN'?N8F"EIVNVIK
M'MII"T3[E[]&Y3*??+D*<I5/88]:.B4^O6?%O4MUSVR91KO7W<M]SFWHL6UF
MJ,[K]$4B9E"-E6,VQ2>$;Y&W5,1M*QB"Y0`X?OT@^OU#Z@+J%[=!2R?,IDT+
MX^_":WY?P:?O2^<O-:J6="]M\^WEK2C4+9<;=KTW#.)J+B(4JT4[L<4#7X?B
M3`6*YFYA.D(D,CTJ2ZM<TV?Q*0D37_&CQ,PA6#>.9K\^T.;6;MBB1-26LL?^
M8YY^8!$?JXE9R5<NE1_[2JQA_N^@=*3?4:N^USO/V5WDM-94:G--(F81"M2^
M@M:S"M[O*UQLLV<-H"2M:3(D\^A&[AFB<C55P9`ATB&`H"4H@ZC66_3_`/\`
M5ESG_N:G/YIV[>EZU9_`-:P?3JNLGW[*#_T]]8_[Y:5_J0MZ0JQ^HKZOEK8,
M9/SO>)IE),FDBR5-CAE6CYLB[:JF0Z"MCA`RC=P11(YD5TBG((@/M.4!#](`
M/H/44E^EJUD*)IK)J(K)D525(9-5)0I3IJ)G*)3IJ$,`E.0Y1$!`0$!`?3J%
M9<_V4_\`Z.NBOY2ZW_*W/_2%6/U%:?E9B*0EV,`M),4IR3CI28CH=1TB22?1
M4&YAV4S)-&1C@X<,8IY86"3A4A1(BH]0*<0%4@"ZKK$IY"<.M6%]7Z[%3[%T
MG#76X6'1Z1,*)F^SG*O<YA[-MSM7(D(1PXAG3Q6/=_0"B5TU/^CV&(8V2ANH
MJAA9C4H\G>3?6>1<N<952J#G=EAW%JEK8:1M)+*:3*]EV<4R7;%&)G8YK]JD
MG$D$G^#]_P!3&^HB'T^B9`QO>@,5%A3[O'-V)OO9#._7#0LYHU,SFL'8P<!,
MUIO9DG5BMRYONY)FV6F9B29K,8&+^,77L*4X*O$``P_0X!4ZA;6.M6*Q:]^E
M6MZ^VB>YVYHV/;:Q%1$W/YO3W%BBHF>!X,.^=(NVC<J$@$>Z9/1;B5P(C\:I
M#?4`_3ZUO)Y;X/'Y67&H+QK<`]#^6U>B_:CP_!\_^XWB/AO)94L.#R.6(G>+
M;W%!5C==ZLM]/52*S(?VBCI__P"D<&_[K0O_`'IZ\_\`UYY#^IP_[7^]7T@_
M]`/MM_WGSGXXO_3U_]+0?Y4O$+8.G]*IO:G']SCL>[=REW69B/DGP@QK6HK4
M5RV=5%2:DDV[HL+=ZXDS3;,I%=NZ:/F*24>^(#8B*[5$5)6MH>E2YBGDXU>K
M5B/J_>_$?5N#:]!D:0UEMN983?\`?,(N,NFF*:\Q3;ACD;?%6'XB#=1V,8J5
MR#5,1(D\>>PQP+T;?@:AGO;4^N?(1@MPY1XHY,V.JU_8&+&#TGHKJBL/N;Z;
M6J.>6;NI*.J--OX,M5M$E82,`;.7!(`R;>-74,@DX.J15N4Q8&Y-31X7O'3K
M'C;P+2LMV"YYW=+'?=3#0D'6;.K*]A(UJI2ZQ75HU5U:*Y6'SAPF^A%3%.#4
MI3HF((@4PB0H!:DS7I6?9N5]:\Y^=JC^0-QRONG5_-Q(:O1M80PJCS>M66BP
MXX:XS"R,&-;A04_+]@K]UD9&P-$I`&T<_"0'X7*;I0ZC8]:D+%;7L:LYY48S
MO3R&<.ZK5\3Y,L.5Y@R-3KA^4-K58I]3[8K6KG$201F?Y%3YF=BL[C81NT/)
MK?F"3-8)8&Y63:)144!0X=:2V!U-3!P5UWT14.9\0JMPX3ZSJ&:\O<DY;E&B
MQL_A-@8;;H^\0!LYSJK-\0H\M8X1_8,TB:9`SDM8)!Y'HB15VP(DJB+=PFY*
M1`N=:71XKYWJ/GCOON7:]EX)[+K&<]LZA-7&N.XW%9.87H<A9-FMENB4KLHJ
M_C$64)&0=_<B^=-?O!3.U^I4S%'Z^@5)K$``U;3R1\(=#9AWKCGEOXMH*NQ7
M:@JPS;H#"(=V1A=+Y7XFLNL]DIRE&.549J1F\H>F@EV:*:[ULHT:.&S5[[ET
MDSYT@1;::81'^3RF7.L1Y,GY>[7O6R330"Q^(3/+^KY=(PTTJ+=NFSOVJ:-6
MH'$Z9",Y%T5)]*&L+MNU(4QRE5'XR*%Z6WYZ5\NY<8:=VIXZK)S)UA>:RON^
MAUP;'*76HP39O4,\U%M9SWBE1E;9-4&3J6J=`73:0*[H_P`<A-1B#A50Z:KH
M?8Z0-C<=*7?XT^E]Q\?.31O"W??.'0M=6QB1GHO)N@<HQK4=_P`ET"@2$Y(S
MK=F::R:J6V60=UQ>7!%F!&1E`BU&Z+I!DY0.19=*D1NU%-0R[;]HZ6VJH67.
MJ/J&-\GT*$L[^V6+9<Y_V=W#HZYS\8C&4NNTS.[_``:.G5',J2U=K3KR?=MX
M%W+2A6+-JFX9$D!.ZC8`?.DW>1K,=KYD\Q_)/DNJ^`ZENN%Q-#'/M-3Q6FRE
MYN%7F'M8U/-IA_(UZ%^Z>>Q"GZ$R>QSA<&K-ZY9G9"JFH!#*+UO4A8J5OK34
MD/(3=W%)LNLMN$^RY3.G;B,B,=AHC*5E]IT>30BYF3L]BL65O'S!WE6<`K^%
MM(22F7:;R765=*?9(((H*.74;?.DQ?L\5>Z)XW;:G@_0?&W6%'<;5HM6GJQI
M#O(I)/-8!*,K4G&R*=\FW[J/>5M$JR*'P."-G:*AEQ!04?8`G0J3V/0UQ'D-
M?=,[5Y5./.J\QX#[7G<LY/E*)&7%=YC+IA*W`M0URP6JP2-!0;24FPDXX\)(
ME-'J.W++[U</:;X$A*L)ZT"VTB]:.]`Z^?4O`JON$5ROUM>):Y'DFD7B5:R(
M5]D@Y!FC.&:!?ZP:;%O3(F0<0I2%>*.%RE*\;F]AO?[0=1MKUI"O[/!$](\B
M5_1^;.@^/.I:$.L:FSN]2T>2R.09YQ!_'1_PR<2O=EDW\>M7TA_*[,C,Q&KD
MJR[KV")1^GI"I/8Z@U)_[0SU-JW&-X\=G0V-R3=E<:1H.Z&/'R)%UX&TP#^O
MYJTGZE96;==LJ\@9^/.9%8I%$UDC>Q9$Z:Z2:A`T(+W!J><9\DWBV\L.6PM)
MVF9I>:Z80A5G&5[%96=&M]<L`MTQ=.<OTE9>#CK4S<'3.)"QSHCQPW1^KZ/2
M)^\%JQ&H-19/B+BN[+XJ/''GIS7R[:A87%.0^215;WW:*5!4=-DT7%!S\LU$
MPU5E`8).#`FH<TI]2G`"B<!^H#9W&^55]L?.J!^1_P`\7-7,&./N:/&]*5&X
M:0,6XJT?H&>L6BN-XU$N$UB/YFL3#?VQ=_O1Q7%1BHQ!Y%D=*&=NW2RB8M'-
M1/XU<J?$:4USK]VZ?^(>]/GSEP]>O>4J([>/':RCET[=.:_4EG#ERX6,=9=P
MNL<3'.81,8PB(B(CZT_D/]R\C_-_OBO;?V;/\]OME_B:_P`1ZPA^O$Z^\E?_
MT]_'HHH]%%'HHH]%%'HHH]%%'HHKPK2C8'-9L;>I.V3"U+P4NC67\D43QS*P
M*Q[@D,[D"`V>B=DVD3)G5`$5A%,H_O#?WHPD#F.01$"3:;7Z7MI?\]7XIQUR
M<=LM&;%#KO`ZE+C<!J-2+VU&OJ*6B^ENBX/LO'>993J?2G\!<N:KUJUML+"A
M\ZL)@UXIUKJ%;*E7"N,1D&475'I9QPJ+1RD^>$$$P^['VF]^A+9R<IC8#<C(
M4;'9R0L5]RLHT_1FPU.AN?G7I"1>/3^'\OY)%XOC+/#R44$:&7+*]N1)']]L
MD%G&T#<"J]?9TM)FH:KKN"VSAB%OVAJ6-E>[O?\`.=P&LYJI8W^@OHW!]-N=
M5FH"%J-9=V:)?C;JDS.JSB&(E4!<2?0J*9_DR,C(R<.3B%FGW!W99++<M:-V
M!`47'N4:*/\`16MXSB^)YW%\WFP./$;P0138V^;8(@<J&-U9I'",.W(UFD;2
MU^I%K#-^F\2>T&EZ7'W!S*5?1;#)5"CI1%0N\O;;-;81>R-[!5HO.XVMNM!6
MLE:4ITN,HP&+!U&$BW9W2:1&ZIB9HS\0PQ9"RWC=BJV5BQ(O<!0-UQM-Q:XL
M;VL:Y]O&N:3/S.-DQ`N5CQB23=)&L:1L$*.TI<1!'[D>QM^U]Z!22POQL_VU
MS+6JUGEND]%=K0.KLK0\SQS"4#2[.ZM*M)2>JVZ$81-:ITO+IVVN!&.B/(19
M!*815:K)F;`HDH4M3\M@1QP2M.=D@.VRL;[?J%@I-Q8W7ZM#II69!X7Y+DY/
M(8D?'@3XK()0TL*!.Y;ML6>15[;W7;("8R&!W6()Z,W5V"$L495C7AP64E;!
MGU116&FWO\!8V[5H*.LN=5*>M7Y8_*]8M=MA)IBNTC9)XU?&!^T*9(IW3<JD
M_P"T</>L?=]Q91]+6W.`54FU@2""`2#J/B*QOU6YTX\F4,(=I8Y9/Y2+<8X&
M*2R*F_>Z1LK!G167VOK96MSDUVOS?6YV_P!>G[I8X=WE-MC*1ITC(Y-L+6K9
M[/3B$>Z@CW2ZJT$M.K5?G6<LU78S#Q^C$/$'":J+HZ9P,,'Y;!C>9'E8&-@K
MDH]E)M;<VW:`;BS$[2#<&LF'PSR+)@P,B##C=,J)I(0)\<O*JW#=N/N]QW4J
MP:-5,BD$%017=V[H_&:+;34FT7$\?/-Y6C04L="MVV6K]8F=,DRPV?1EUN$/
M`R%0HSVXRBB2$>G,/F)G*CA`"`/SH^^Z7.Q89>U)+9[J#HQ`+FRAF`*KN/3<
M1?3XBL'$\=YC.Q!FXV'N@*2,MWC5G6%=TK1QLPDD$:W+F-6L`U_I-O/>]1X9
M'$MJCZZ.&I*'K5=PRY&5J%X*%:T^W+PS:K0$N/Y:'[1E8G%CCB,I4W_A#DT@
MU!-T;[A'WQ/(8B]R\OT2B-O:VCM:P.GK<6/TFXUU%6)XQS<AQ`F&"9\1\F/]
M)%[X8PQ=E]^I0(^Y/Y0;&NOM-N0M?3=,</.EJ!&2UTH]APBH,U+)HJF1W:YP
M54E[14UI^.GV<3&03AO:F=4CWS*160^4A'J/S>W_``""ZY:I>0B)SX59TDA7
M5MC,`2+@V`UL+&WKKZ`FLO%\:S%3QO/EBAGQ\Z8[(N_'&SJC[2I9F!0N0R`V
M]IM?W,JG[BO4F-T"A9M*7C3G=I>6C(F.I$G:WFEZE96=H<=!1#V<UV:H=)K5
MCF<\I2XR22ZSB21:L6*C@&QE04*)?3/(XL,,#39!8M%ON$8DJ`+N54$JNO4V
M`Z5`>,<QGY_(Q87&")(LLP;7FB55E+,%@661T6606(`0LS`;@+&NT;]&XX\T
M"NYBRM;E_;K6Y:L(1*/JES?UY>3?9[(ZNQAW=W9UY>D1,X^SB)7F4&+R10=K
M,2E4(F/R)@:X9V*9DQQ)>5NE@Q%]N^VZVT':-UB;VK";QWETP,CDWQ0N)$"6
MN\8<*)1`6$9<2,HF81EE0J&T)T-LO?[69_\`'O$__K/</_),T]91K4IU-8I_
M4:LH]%%'HHK]/3K3^I\N/\DK/O\`5NH>M3Y#_<O(_P`W^^*]H_9L_P`]OME_
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M=N%V8@WN;HR6%A;HQ/YJP.'Y7`P.'\FP,E)CD9T$<2E0NU-D\4]VN03<Q!;"
MU@2=3I54H;A[2V="Q`L^^QRX7G!>B.@-BC*I.,9MUEVBU+HB<TJ>M%-L;N2@
M9>6JT[`/-17-&2R,;+))*13<ZC-3[A0J&M7B<@0XF\Q--#/(X!OL82EB5-P2
M"-^AL>@TUTZF;S7C7SN:["9D.#G<?BX[.I43128BPJDB`,JNK"$;T+H2'8!Q
MM&Z<YG`=)D=$Y,NS!GBD!'8'8].GK'6:U&3T!$E0U"`GJBO&T9HC'O$"/:Y`
M6%11607!H$V_*JH+6.3="DAEMA3M/QLJB)5A9R0`0/>"++IZ`]=-Q]%OII(>
M>XV/C_*\)WS9),^.%4=V5FO"RR`RFX-G9``HW=M;#=(5NT5;]R-O^P:5)7-'
M3LWD8FM[1S_KV,1-WA[N\3S]EC-AI%JEJ0PB(6>8UZ,=76RUY\Z?68J#R7<L
MW@1HD2;$2.ACYO&YN3D-*,B,JLL;H&#>W85)4`&PW$$E]6(.WITVG`^6<#Q'
M&Q89XW)663#RH,AHVC'=.0DB+(692["-'4+#=8PR]RY8D-!Z]#NW2>C>43GV
MF7'*D*YINIY11],M9Y62<6^FQ+CE+!ZQ=Y&KTN/0F(Z>>O#13Z+:H/Y2+)$R
M;1;YE7ADSMR8AAESI_(,**6/MR2(KFYW*.S&&(47!Z$"Y%B#<FUJW:YV%XYQ
MWVRY_,P\HY&-BSR0IM`CD89V4\8>0E2H&Y78JC[T9;!`0QM,SY,FJAO&HZ35
M8?%;E6MA?9%+O%M6K;N6MF4RN7TFLYL^5J"32-<$N3.U4^GL#)(K2<`:*E"'
M<BH]3-]L&Q'&O'F9&1&L3I*4/O%RA10OMT]UU4>JV.NO2N7?RJ'+X+C..RIL
MV')PUG4"!PL<ZS2/,.Y<CME))&N0DN]++9#[JC'6.,]QGICHEGF]ORQI4=WZ
M(YZZ-6<71.UJV&.D\6=8P\D*"+2%C_PY&,G)7(4'R$P5=99%%8S$[$PG^_3Q
M\GB\QVS1!+&(YIXY?=>X,>SVZ:6)0'=^:W\*MGQ7F'"00^/OR.)E'+P>/R\2
MT>S85R!D`2W8WNJY!4QV`)`</IVS,$]@&RDT#K">JDMF2E9Z6H]:8IHV%:U)
M3M9ML'F@Y>HU/^&QRT>\KIFHIR970"#DZB)F8MB`L#Q#)?"RN]R3QM'V\A!U
MO<$)L]!:WK?KZ6UN-1!SW#G`\5@RHLG^D\;.Y]FS:\;3=Z^IN'O=-O2QW[C;
M8W+Y]S#LN2VS&-,JLMFEEN%1Y1IG*&AUN?E;5`U=_%9[.&FZEHU.G&-:L,HA
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M%:P6"HNIU#,%<AG+_+22]MAIJ73F$[BPJK-LBQ+#G(9`[,U>.905/T&!0OT_
M<'UMB+UQ*MMO2'O[*#T)^MCC7\2KO_#>E:I[Q\*/[*#T)^MCC7\2KO\`PWHM
M1O'PH_LH/0GZV.-?Q*N_\-Z+4;Q\*UD[+S3.:=Q+.<KL+-$Q=@E<9K>8)VIV
MT>+0Z3^#BX6/5E#LD1!Z9HN>*,8I`'W@!P^O[@^L/DL1L[`RL-'"M(MKGH*[
MK[6^8XWV_P#N'XIYIF8<F1B\=EB5HT(5G`5A92V@.OK6>G^SF;5^L=EW\5;9
=_">N"_47+_K\?X-7T0_^@GAW_CWD_P#GP?ZJ_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
